PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Stracker, TH; Morales, M; Couto, SS; Hussein, H; Petrini, JHJ				Stracker, Travis H.; Morales, Monica; Couto, Suzana S.; Hussein, Hussein; Petrini, John H. J.			The carboxy terminus of NBS1 is required for induction of apoptosis by the MRE11 complex	NATURE			English	Article							NIJMEGEN BREAKAGE SYNDROME; DNA-DAMAGE RESPONSE; ATAXIA-TELANGIECTASIA; CELLULAR-RESPONSE; ATM ACTIVATION; CHECKPOINT; MICE; PROTEIN; RECRUITMENT; METABOLISM	The MRE11 complex (MRE11, RAD50 and NBS1) and the ataxia-telangiectasia mutated (ATM) kinase function in the same DNA damage response pathway to effect cell cycle checkpoint activation and apoptosis(1-3). The functional interaction between the MRE11 complex and ATM has been proposed to require a conserved C-terminal domain of NBS1 for recruitment of ATM to sites of DNA damage(4,5). Human Nijmegen breakage syndrome (NBS) cells and those derived from multiple mouse models of NBS express a hypomorphic NBS1 allele that exhibits impaired ATM activity despite having an intact C-terminal domain(3,6-11). This indicates that the NBS1 C terminus is not sufficient for ATM function. We derived Nbs1(Delta C/Delta C) mice in which the C-terminal ATM interaction domain is deleted. Nbs1(Delta C/Delta C) cells exhibit intra-S-phase checkpoint defects, but are otherwise indistinguishable from wild-type cells with respect to other checkpoint functions, ionizing radiation sensitivity and chromosome stability. However, multiple tissues of Nbs1(Delta C/Delta C) mice showed a severe apoptotic defect, comparable to that of ATM- or CHK2-deficient animals. Analysis of p53 transcriptional targets and ATM substrates showed that, in contrast to the phenotype of Chk2(-/-) mice, NBS1(Delta C) does not impair the induction of proapoptotic genes. Instead, the defects observed in Nbs1(Delta C/Delta C) result from impaired phosphorylation of ATM targets including SMC1 and the proapoptotic factor, BID.	Sloan Kettering Inst, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Weill Cornell Grad Sch Med Sci, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Petrini, JHJ (corresponding author), Sloan Kettering Inst, New York, NY 10021 USA.	petrinij@mskcc.org	Stracker, Travis H/I-2815-2015; Morales-Ballús, Mònica/AAE-3086-2021	Stracker, Travis H/0000-0002-8650-2081; Morales-Ballús, Mònica/0000-0002-9478-6280; Petrini, John/0000-0001-5102-5679	NCI NIH HHS [R13 CA162528] Funding Source: Medline; NIGMS NIH HHS [R01 GM056888-09, R01 GM056888, R01 GM059413, R01 GM059413-08, R01 GM056888-08] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056888, R01GM059413] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bender CF, 2002, GENE DEV, V16, P2237, DOI 10.1101/gad.1007902; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Kamer I, 2005, CELL, V122, P593, DOI 10.1016/j.cell.2005.06.014; Kang J, 2005, MOL CELL BIOL, V25, P661, DOI 10.1128/MCB.25.2.661-670.2005; Kang J, 2002, EMBO J, V21, P1447, DOI 10.1093/emboj/21.6.1447; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Morales M, 2005, GENE DEV, V19, P3043, DOI 10.1101/gad.1373705; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; Theunissen JWF, 2006, METHOD ENZYMOL, V409, P251, DOI 10.1016/S0076-6879(05)09015-4; Theunissen JWF, 2003, MOL CELL, V12, P1511, DOI 10.1016/S1097-2765(03)00455-6; Williams BR, 2002, CURR BIOL, V12, P648, DOI 10.1016/S0960-9822(02)00763-7; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; XU Y, 1996, GENE DEV, V10, P24111; Yamazaki V, 1998, CANCER RES, V58, P2316; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022	29	96	102	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2007	447	7141					218	U7		10.1038/nature05740	http://dx.doi.org/10.1038/nature05740			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17429352	Green Accepted			2022-12-28	WOS:000246338700046
J	Koizumi, S; Shigemoto-Mogami, Y; Nasu-Tada, K; Shinozaki, Y; Ohsawa, K; Tsuda, M; Joshi, BV; Jacobson, KA; Kohsaka, S; Inoue, K				Koizumi, Schuichi; Shigemoto-Mogami, Yukari; Nasu-Tada, Kaoru; Shinozaki, Yoichi; Ohsawa, Keiko; Tsuda, Makoto; Joshi, Bhalchandra V.; Jacobson, Kenneth A.; Kohsaka, Shinichi; Inoue, Kazuhide			UDP acting at P2Y(6) receptors is a mediator of microglial phagocytosis	NATURE			English	Article							NUCLEOTIDE RECEPTOR; APOPTOTIC CELLS; IN-VIVO; RELEASE; ATP; INVOLVEMENT; CHEMOTAXIS; ACTIVATION; MIGRATION; CLONING	Microglia, brain immune cells, engage in the clearance of dead cells or dangerous debris, which is crucial to the maintenance of brain functions. When a neighbouring cell is injured, microglia move rapidly towards it or extend a process to engulf the injured cell. Because cells release or leak ATP when they are stimulated(1,2) or injured(3,4), extracellular nucleotides are thought to be involved in these events. In fact, ATP triggers a dynamic change in the motility of microglia in vitro(5,6) and in vivo(3,4), a previously unrecognized mechanism underlying microglial chemotaxis(5,6); in contrast, microglial phagocytosis has received only limited attention. Here we show that microglia express the metabotropic P2Y(6) receptor whose activation by endogenous agonist UDP triggers microglial phagocytosis. UDP facilitated the uptake of microspheres in a P2Y(6)-receptor-dependent manner, which was mimicked by the leakage of endogenous UDP when hippocampal neurons were damaged by kainic acid in vivo and in vitro. In addition, systemic administration of kainic acid in rats resulted in neuronal cell death in the hippocampal CA1 and CA3 regions, where increases in messenger RNA encoding P2Y(6) receptors that colocalized with activated microglia were observed. Thus, the P2Y(6) receptor is upregulated when neurons are damaged, and could function as a sensor for phagocytosis by sensing diffusible UDP signals, which is a previously unknown pathophysiological function of P2 receptors in microglia.	Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol & Syst Pharmacol, Fukuoka 8128582, Japan; Natl Inst Hlth Sci, Div Pharmacol, Setagaya Ku, Tokyo 1588501, Japan; Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Pharmacol, Yamanashi 4093893, Japan; Natl Inst Neurosci, Dept Neurochem, Tokyo 1878502, Japan; NIDDKD, Mol Recognit Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA	Kyushu University; National Institute of Health Sciences - Japan; University of Yamanashi; National Center for Neurology & Psychiatry - Japan; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Inoue, K (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol & Syst Pharmacol, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	inoue@phar.kyushu-u.ac.jp	Jacobson, Kenneth Alan/A-1530-2009; Shinozaki, Youichi/AAC-9431-2019; Shinozaki, Youichi/E-8594-2010; Tsuda, Makoto/AAE-7256-2020; Koizumi, Schuichi/E-8568-2010	Jacobson, Kenneth Alan/0000-0001-8104-1493; Shinozaki, Youichi/0000-0002-6448-1304; Shinozaki, Youichi/0000-0002-6448-1304; Koizumi, Schuichi/0000-0001-6184-3106	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK031116] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DK031116-20] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; CHANG KG, 1995, J BIOL CHEM, V270, P26152, DOI 10.1074/jbc.270.44.26152; Communi D, 1996, BIOCHEM BIOPH RES CO, V222, P303, DOI 10.1006/bbrc.1996.0739; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Erlinge D, 2005, INT J CARDIOL, V100, P427, DOI 10.1016/j.ijcard.2004.10.005; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; GREENBERG S, 1995, TRENDS CELL BIOL, V5, P93, DOI 10.1016/S0962-8924(00)88957-6; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Koizumi S, 2003, P NATL ACAD SCI USA, V100, P11023, DOI 10.1073/pnas.1834448100; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lazarowski ER, 2000, J BIOL CHEM, V275, P31061, DOI 10.1074/jbc.M003255200; Lazarowski ER, 2003, MOL PHARMACOL, V63, P1190, DOI 10.1124/mol.63.5.1190; Lazarowski ER, 1997, J BIOL CHEM, V272, P24348, DOI 10.1074/jbc.272.39.24348; Mamedova LK, 2004, BIOCHEM PHARMACOL, V67, P1763, DOI 10.1016/j.bcp.2004.01.011; Mellor EA, 2001, P NATL ACAD SCI USA, V98, P7964, DOI 10.1073/pnas.141221498; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; NAKAJIMA K, 1992, J NEUROCHEM, V58, P1401, DOI 10.1111/j.1471-4159.1992.tb11356.x; Nasu-Tada K, 2005, GLIA, V52, P98, DOI 10.1002/glia.20224; Nicholas RA, 1996, J AUTON PHARMACOL, V16, P319, DOI 10.1111/j.1474-8673.1996.tb00044.x; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ohsawa K, 2000, J CELL SCI, V113, P3073; Ravichandran KS, 2003, CELL, V113, P817, DOI 10.1016/S0092-8674(03)00471-9; SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786	28	570	601	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					1091	1095		10.1038/nature05704	http://dx.doi.org/10.1038/nature05704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17410128	Green Accepted			2022-12-28	WOS:000245950400052
J	Bisson, JI				Bisson, Jonathan I.			Post-traumatic stress disorder	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MEDIAL PREFRONTAL CORTEX; DSM-IV DISORDERS; PSYCHOLOGICAL TRAUMA; COMBAT VETERANS; RISK-FACTORS; FOLLOW-UP; EXPOSURE; THERAPY; COMORBIDITY; PREVALENCE		Cardiff Univ, Univ Wales Hosp, Cardiff CF14 4XW, Wales	Cardiff University	Bisson, JI (corresponding author), Cardiff Univ, Univ Wales Hosp, Cardiff CF14 4XW, Wales.	bissonji@cf.ac.uk						*AM PSYCH ASS, 2004, PRACT GUID TREATM AC; American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Bisson J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003388.pub2; Bisson JI, 1997, BRIT J PSYCHIAT, V171, P78, DOI 10.1192/bjp.171.1.78; Bisson JI, 2004, BRIT J PSYCHIAT, V184, P63, DOI 10.1192/bjp.184.1.63; BISSON JI, PSYCHIAT B, V27, P145; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; BREMNER DJ, 2005, DOES STRESS DAMAGE B; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brewin CR, 2005, J TRAUMA STRESS, V18, P53, DOI 10.1002/jts.20007; Brewin CR, 2002, BRIT J PSYCHIAT, V181, P158, DOI 10.1192/bjp.181.2.158; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Bryant RA, 1999, AM J PSYCHIAT, V156, P1780; Carty J, 2006, J AFFECT DISORDERS, V90, P257, DOI 10.1016/j.jad.2005.11.011; Creamer M, 2001, PSYCHOL MED, V31, P1237, DOI 10.1017/S0033291701004287; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Ehlers A, 2003, ARCH GEN PSYCHIAT, V60, P1024, DOI 10.1001/archpsyc.60.10.1024; FOA EB, 1991, J CONSULT CLIN PSYCH, V59, P715, DOI 10.1037/0022-006X.59.5.715; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Furedi Frank, 2003, THERAPY CULTURE CULT; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Galea S, 2003, AM J EPIDEMIOL, V158, P514, DOI 10.1093/aje/kwg187; Gunnell D, 2005, BRIT MED J, V330, P1148, DOI 10.1136/bmj.330.7500.1148-b; Hull AM, 2002, BRIT J PSYCHIAT, V181, P433, DOI 10.1192/bjp.181.5.433; JONES E, 2005, MAUDSLEY MONOGRAPH, V47; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Lee C, 2002, J CLIN PSYCHOL, V58, P1071, DOI 10.1002/jclp.10039; Mayou RA, 2002, BEHAV RES THER, V40, P665, DOI 10.1016/S0005-7967(01)00069-9; National Collaborating Centre for Mental Health, 2005, POSTTRAUMATIC STRESS; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Perkonigg A, 2000, ACTA PSYCHIAT SCAND, V101, P46, DOI 10.1034/j.1600-0447.2000.101001046.x; PITMAN RK, 1991, J CLIN PSYCHIAT, V52, P17; Power K, 2002, CLIN PSYCHOL PSYCHOT, V9, P299, DOI 10.1002/cpp.341; RACHMAN S, 1980, BEHAV RES THER, V18, P51, DOI 10.1016/0005-7967(80)90069-8; Raskind MA, 2003, AM J PSYCHIAT, V160, P371, DOI 10.1176/appi.ajp.160.2.371; ROSE S, 2005, PSYCHOL DEBRIEFING P; Rubin GJ, 2005, BRIT MED J, V331, P606, DOI 10.1136/bmj.38583.728484.3A; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Sijbrandij M, 2006, BRIT J PSYCHIAT, V189, P150, DOI 10.1192/bjp.bp.105.021121; Stein DJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002795.pub2; Summerfield D, 2001, BRIT MED J, V322, P95, DOI 10.1136/bmj.322.7278.95; van Emmerik AAP, 2002, LANCET, V360, P766, DOI 10.1016/S0140-6736(02)09897-5; WALTERS JTR, 2006, IN PRESS PSYCHOL MED; World Health Organisation, 1993, ICD 10 CLASSIFICATIO; Young EA, 2004, ARCH GEN PSYCHIAT, V61, P394, DOI 10.1001/archpsyc.61.4.394	51	56	61	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2007	334	7597					789	793		10.1136/bmj.39162.538553.80	http://dx.doi.org/10.1136/bmj.39162.538553.80			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161SX	17431265	Green Published			2022-12-28	WOS:000246037300030
J	McIvor, A; Little, P				McIvor, Andrew; Little, Paul			10-minute consultation - Chronic obstructive pulmonary disease	BRITISH MEDICAL JOURNAL			English	Editorial Material									McMaster Univ, Firestone Inst Resp Hlth, St Josephs Healthcare, Hamilton, ON L8N 4A6, Canada; Univ Southampton, Community Clin Sci Div, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England	McMaster University; University of Southampton	McIvor, A (corresponding author), McMaster Univ, Firestone Inst Resp Hlth, St Josephs Healthcare, T2127, Hamilton, ON L8N 4A6, Canada.	amcivor@stjosham.on.ca		Little, Paul/0000-0003-3664-1873					0	6	6	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 14	2007	334	7597					798	798		10.1136/bmj.39084.666736.94	http://dx.doi.org/10.1136/bmj.39084.666736.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161SX	17431268	Green Published			2022-12-28	WOS:000246037300034
J	Clavien, P; Petrowsky, H; DeOliveira, ML; Graf, R				Clavien, Pierre-Alain; Petrowsky, Henrik; DeOliveira, Michelle L.; Graf, Rolf			Medical progress: Strategies for safer liver surgery and partial liver transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PORTAL-VEIN EMBOLIZATION; METASTATIC COLORECTAL-CANCER; MAJOR HEPATIC RESECTION; SELECTIVE INTRAARTERIAL CHEMOTHERAPY; POSITRON-EMISSION-TOMOGRAPHY; SINGLE-CENTER EXPERIENCE; BILE-DUCT CANCER; TERM-FOLLOW-UP; LIVING-DONOR; HEPATOCELLULAR-CARCINOMA		Univ Zurich Hosp, Dept Visceral & Transplantat Surg, Swiss HPB Ctr, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Clavien, P (corresponding author), Univ Zurich Hosp, Dept Visceral & Transplantat Surg, Swiss HPB Ctr, Ramistr 100, CH-8091 Zurich, Switzerland.	clavien@chir.unizh.ch	De Oliveira, Michelle L./AAU-5621-2020; Petrowsky, Henrik/J-6377-2019	Petrowsky, Henrik/0000-0001-5744-0531; Graf, Rolf/0000-0001-7449-7302	NIDDK NIH HHS [DK54048-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054048] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abdalla EK, 2001, BRIT J SURG, V88, P165, DOI 10.1046/j.1365-2168.2001.01658.x; Adam R, 2004, ANN SURG, V240, P644, DOI 10.1097/01.sla.0000141198.92114.16; Aloia T, 2006, J CLIN ONCOL, V24, P4983, DOI 10.1200/JCO.2006.05.8156; Aoki T, 2004, ARCH SURG-CHICAGO, V139, P766, DOI 10.1001/archsurg.139.7.766; Armuzzi A, 2002, ALIMENT PHARM THER, V16, P1977, DOI 10.1046/j.1365-2036.2002.01374.x; Azoulay D, 2000, ANN SURG, V231, P480, DOI 10.1097/00000658-200004000-00005; Azoulay D, 2001, ANN SURG, V233, P565, DOI 10.1097/00000658-200104000-00013; Barbaro B, 2003, ACTA RADIOL, V44, P98, DOI 10.1034/j.1600-0455.2003.00016.x; Belghiti J, 1999, ANN SURG, V229, P369, DOI 10.1097/00000658-199903000-00010; Belghiti J, 2000, J AM COLL SURGEONS, V191, P38, DOI 10.1016/S1072-7515(00)00261-1; Bilchik AJ, 2005, J CLIN ONCOL, V23, P9073, DOI 10.1200/JCO.2005.03.2334; Bolognesi M, 2002, HEPATOLOGY, V35, P601, DOI 10.1053/jhep.2002.31352; BROELSCH CE, 1991, ANN SURG, V214, P428, DOI 10.1097/00000658-199110000-00007; Broering DC, 2002, J GASTROINTEST SURG, V6, P905, DOI 10.1016/S1091-255X(02)00122-1; Bruix J, 1996, GASTROENTEROLOGY, V111, P1018, DOI 10.1016/S0016-5085(96)70070-7; Bucuvalas JC, 2001, PEDIATR TRANSPLANT, V5, P274, DOI 10.1034/j.1399-3046.2001.005004274.x; Bustos M, 2003, GASTROENTEROLOGY, V125, P192, DOI 10.1016/S0016-5085(03)00698-X; Cameron AM, 2006, ANN SURG, V243, P748, DOI 10.1097/01.sla.0000219669.84192.b3; Child CG, 1964, LIVER PORTAL HYPERTE, P50; Clavien PA, 2003, ANN SURG, V238, P843, DOI 10.1097/01.sla.0000098620.27623.7d; Clavien PA, 2002, SURGERY, V131, P433, DOI 10.1067/msy.2002.122374; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; D'Angelica M, 2007, ANN SURG ONCOL, V14, P759, DOI 10.1245/s10434-006-9074-0; Dahm F, 2005, AM J TRANSPLANT, V5, P2605, DOI 10.1111/j.1600-6143.2005.01081.x; de la Grandmaison GL, 2001, FORENSIC SCI INT, V119, P149, DOI 10.1016/S0379-0738(00)00401-1; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Elias D, 2002, SURGERY, V131, P294, DOI 10.1067/msy.2002.120234; Ellis LM, 2005, J CLIN ONCOL, V23, P4853, DOI 10.1200/JCO.2005.23.754; Fan ST, 1999, ANN SURG, V229, P322, DOI 10.1097/00000658-199903000-00004; Farges O, 2003, ANN SURG, V237, P208, DOI 10.1097/00000658-200302000-00010; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fernandez FG, 2005, J AM COLL SURGEONS, V200, P845, DOI 10.1016/j.jamcollsurg.2005.01.024; Goere D, 2006, J GASTROINTEST SURG, V10, P365, DOI 10.1016/j.gassur.2005.09.001; Harada H, 1997, HEPATOLOGY, V26, P1162; Heinrich S, 2006, J HEPATOL, V45, P35, DOI 10.1016/j.jhep.2006.02.020; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Imamura H, 1999, HEPATOLOGY, V29, P1099, DOI 10.1002/hep.510290415; Imamura H, 2005, J HEPATO-BILIARY-PAN, V12, P16, DOI 10.1007/s00534-004-0965-9; Ishizawa T, 2007, AM J SURG, V193, P149, DOI 10.1016/j.amjsurg.2006.07.015; Jaeck D, 2004, ANN SURG, V240, P1037, DOI 10.1097/01.sla.0000145965.86383.89; Jamagin WR, 2002, ANN SURG, V236, P397, DOI 10.1097/01.SLA.0000029003.66466.B3; Juweid ME, 2006, NEW ENGL J MED, V354, P496, DOI 10.1056/NEJMra050276; KAM I, 1987, HEPATOLOGY, V7, P362, DOI 10.1002/hep.1840070225; Kawasaki S, 2003, ANN SURG, V238, P84, DOI 10.1097/01.SLA.0000074984.83031.02; Kemeny NE, 2006, J CLIN ONCOL, V24, P1395, DOI 10.1200/JCO.2005.03.8166; Kianmanesh R, 2003, J AM COLL SURGEONS, V197, P164, DOI 10.1016/S1072-7515(03)00334-X; Kokudo N, 2004, SURG CLIN N AM, V84, P643, DOI 10.1016/j.suc.2003.12.004; Kokudo N, 2003, NUCL MED BIOL, V30, P845, DOI 10.1016/S0969-8051(03)00113-6; Kokudo N, 2001, HEPATOLOGY, V34, P267, DOI 10.1053/jhep.2001.26513; Kooby DA, 2003, J GASTROINTEST SURG, V7, P1034, DOI 10.1016/j.gassur.2003.09.012; Kooby DA, 2003, ANN SURG, V237, P860; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Madoff DC, 2005, J VASC INTERV RADIOL, V16, P779, DOI 10.1097/RVI.0000159543.28222.73; MAKUUCHI M, 1990, SURGERY, V107, P521; Malago M, 2003, ANN SURG, V238, P853, DOI 10.1097/01.sla.0000098619.71694.74; Man K, 2006, AM J TRANSPLANT, V6, P697, DOI 10.1111/j.1600-6143.2005.01231.x; Man K, 2004, ANN SURG, V240, P159, DOI 10.1097/01.sla.0000129673.13552.c0; MCCORMACK L, IN PRESS ANN SURG; MEAD JE, 1989, P NATL ACAD SCI USA, V86, P1558, DOI 10.1073/pnas.86.5.1558; Michalopoulos GK, 2005, ADV BIOCHEM ENG BIOT, V93, P101, DOI 10.1007/b99968; Middleton PF, 2006, LIVER TRANSPLANT, V12, P24, DOI 10.1002/lt.20663; Mullin EJ, 2005, AM J SURG, V190, P87, DOI 10.1016/j.amjsurg.2005.01.043; NAGASUE N, 1987, ANN SURG, V206, P30, DOI 10.1097/00000658-198707000-00005; Nagino M, 2006, ANN SURG, V243, P364, DOI 10.1097/01.sla.0000201482.11876.14; Nagino M, 2000, SURGERY, V127, P155, DOI 10.1067/msy.2000.101273; Nakamuta M, 2005, TRANSPLANTATION, V80, P608, DOI 10.1097/01.tp.0000166009.77444.f3; Neuhaus P, 1999, ANN SURG, V230, P808, DOI 10.1097/00000658-199912000-00010; Nocito A, 2007, HEPATOLOGY, V45, P369, DOI 10.1002/hep.21516; Ogata S, 2006, BRIT J SURG, V93, P1091, DOI 10.1002/bjs.5341; Oussoultzoglou E, 2006, ANN SURG, V244, P71, DOI 10.1097/01.sla.0000217609.26178.35; Pediaditakis P, 2001, HEPATOLOGY, V34, P688, DOI 10.1053/jhep.2001.27811; Peralta C, 1999, HEPATOLOGY, V30, P1481, DOI 10.1002/hep.510300622; Peralta C, 2002, TRANSPLANTATION, V73, P1203, DOI 10.1097/00007890-200204270-00004; Petrowsky H, 2006, ANN SURG, V244, P921, DOI 10.1097/01.sla.0000246834.07130.5d; Petrowsky H, 2006, J HEPATOL, V45, P43, DOI 10.1016/j.jhep.2006.03.009; Poon RT, 2005, J HEPATO-BILIARY-PAN, V12, P31, DOI 10.1007/s00534-004-0945-0; Poon RT, 2004, ANN SURG, V240, P698, DOI 10.1097/01.sla.0000141195.66155.0c; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Rous P, 1920, J EXP MED, V31, P609, DOI 10.1084/jem.31.5.609; Rubbia-Brandt L, 2004, ANN ONCOL, V15, P460, DOI 10.1093/annonc/mdh095; Rudiger HA, 2003, J HEPATOL, V39, P972, DOI 10.1016/S0168-8278(03)00415-X; Rudiger HA, 2002, ANN SURG, V235, P400; Scappaticci FA, 2005, J SURG ONCOL, V91, P173, DOI 10.1002/jso.20301; Selzner M, 1999, HEPATOLOGY, V30, P469, DOI 10.1002/hep.510300215; Selzner MK, 2004, ANN SURG, V240, P1027, DOI 10.1097/01.sla.0000146145.69835.c5; Selzner N, 2003, GASTROENTEROLOGY, V125, P917, DOI 10.1016/S0016-5085(03)01048-5; Selzner N, 2006, BRIT J SURG, V93, P587, DOI 10.1002/bjs.5281; Selzner N, 2006, J HEPATOL, V44, P694, DOI 10.1016/j.jhep.2005.07.032; Selzner N, 2002, HEPATOLOGY, V36, P812, DOI 10.1053/jhep.2002.35535; Seyama Y, 2003, ANN SURG, V238, P73, DOI 10.1097/01.SLA.0000074960.55004.72; STRAIN AJ, 1987, BIOCHEM BIOPH RES CO, V145, P436, DOI 10.1016/0006-291X(87)91340-4; Takahashi T, 2004, WORLD J SURG, V28, P475, DOI 10.1007/s00268-004-7128-7; Tan HP, 2005, J HEPATOL, V43, P13, DOI 10.1016/j.jhep.2005.05.002; Tanaka K, 2005, J HEPATOL, V42, P25, DOI 10.1016/j.jhep.2004.11.004; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Tian YH, 2006, P NATL ACAD SCI USA, V103, P4598, DOI 10.1073/pnas.0600499103; Troisi R, 2005, AM J TRANSPLANT, V5, P1397, DOI 10.1111/j.1600-6143.2005.00850.x; Trotter JF, 2006, LIVER TRANSPLANT, V12, P1485, DOI 10.1002/lt.20875; Trotter JF, 2002, NEW ENGL J MED, V346, P1074, DOI 10.1056/NEJMra011629; Vajdova K, 2004, LIVER TRANSPLANT, V10, P520, DOI 10.1002/lt.20126; Vauthey JN, 2006, J CLIN ONCOL, V24, P2065, DOI 10.1200/JCO.2005.05.3074; Wakabayashi H, 2001, CANCER, V92, P2384, DOI 10.1002/1097-0142(20011101)92:9<2384::AID-CNCR1586>3.0.CO;2-H; Weigand MA, 2001, TRANSPLANTATION, V72, P694, DOI 10.1097/00007890-200108270-00023; Xu X, 2006, LIVER TRANSPLANT, V12, P621, DOI 10.1002/lt.20630; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yersiz H, 2003, ANN SURG, V238, P496, DOI 10.1097/01.sla.0000089852.29654.72; Zhao Y, 2004, AM J TRANSPLANT, V4, P1399, DOI 10.1111/j.1600-6143.2004.00527.x	109	702	790	0	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 12	2007	356	15					1545	1559		10.1056/NEJMra065156	http://dx.doi.org/10.1056/NEJMra065156			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156CA	17429086				2022-12-28	WOS:000245624400008
J	Halonen, J; Halonen, P; Jarvinen, O; Taskinen, P; Auvinen, T; Tarkka, M; Hippelainen, M; Juvonen, T; Hartikainen, J; Hakala, T				Halonen, Jari; Halonen, Pirjo; Jaervinen, Otso; Taskinen, Panu; Auvinen, Tommi; Tarkka, Matti; Hippelaeinen, Mikko; Juvonen, Tatu; Hartikainen, Juha; Hakala, Tapio			Corticosteroids for the prevention of atrial fibrillation after cardiac surgery - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ARTERY-BYPASS SURGERY; C-REACTIVE PROTEIN; CARDIOPULMONARY BYPASS; INFLAMMATORY RESPONSE; DEXAMETHASONE; METAANALYSIS; PREDICTORS; ACTIVATION; THERAPY	Context Atrial fibrillation (AF) is the most common arrhythmia to occur after cardiac surgery. An exaggerated inflammatory response has been proposed to be one etiological factor. Objective To test whether intravenous corticosteroid administration after cardiac surgery prevents AF after cardiac surgery. Design, Setting, and Patients A double-blind, randomized multicenter trial ( study enrollment August 2005 - June 2006) in 3 university hospitals in Finland of 241 consecutive patients without prior AF or flutter and scheduled to undergo first on-pump coronary artery bypass graft (CABG) surgery, aortic valve replacement, or combined CABG surgery and aortic valve replacement. Intervention Patients were randomized to receive either 100-mg hydrocortisone or matching placebo as follows: the first dose in the evening of the operative day, then 1 dose every 8 hours during the next 3 days. In addition, all patients received oral metoprolol (50-150 mg/d) titrated to heart rate. Main Outcome Measure Occurrence of AF during the first 84 hours after cardiac surgery. Results The incidence of postoperative AF was significantly lower in the hydrocortisone group (36/120 [30%]) than in the placebo group (58/121 [48%]; adjusted hazard ratio, 0.54; 95% confidence interval, 0.35-0.83; P=. 004; number needed to treat, 5.6). Compared with placebo, patients receiving hydrocortisone did not have higher rates of superficial or deep wound infections, or other major complications. Conclusion Intravenous hydrocortisone reduced the incidence of AF after cardiac surgery.	Kuopio Univ Hosp, Dept Surg, Kuopio 70211, Finland; Kuopio Univ Hosp, Dept Internal Med, Kuopio 70211, Finland; Univ Kuopio, Ctr Comp, FIN-70211 Kuopio, Finland; Univ Tampere, Ctr Heart, FIN-33101 Tampere, Finland; Oulu Univ Hosp, Dept Surg, Joensuu, Finland; N Karelia Cent Hosp, Dept Surg, Joensuu, Finland	Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Tampere University; University of Oulu	Halonen, J (corresponding author), Kuopio Univ Hosp, Dept Surg, POB 1777, Kuopio 70211, Finland.	jari.halonen@kuh.fi	Halonen, Jari/K-9329-2018					Almassi GH, 1997, ANN SURG, V226, P501, DOI 10.1097/00000658-199710000-00011; Aranki SF, 1996, CIRCULATION, V94, P390, DOI 10.1161/01.CIR.94.3.390; Bruins P, 1997, CIRCULATION, V96, P3542; Brunton L.L., 2006, PHARM BASIS THERAPEU; CRESWELL LL, 1993, ANN THORAC SURG, V56, P539, DOI 10.1016/0003-4975(93)90894-N; Crystal E, 2002, CIRCULATION, V106, P75, DOI 10.1161/01.CIR.0000021113.44111.3E; Dernellis J, 2004, EUR HEART J, V25, P1100, DOI 10.1016/j.ehj.2004.04.025; Hakala T, 2002, Scand J Surg, V91, P339; Hall RI, 1997, ANESTH ANALG, V85, P766, DOI 10.1097/00000539-199710000-00011; Halonen J, 2006, CIRCULATION S, V114; Halvorsen P, 2003, ANESTH ANALG, V96, P1578, DOI 10.1213/01.ANE.0000063922.90966.3A; Ishida K, 2006, EUR J CARDIO-THORAC, V29, P501, DOI 10.1016/j.ejcts.2005.12.028; Lahtinen J, 2004, ANN THORAC SURG, V77, P1241, DOI 10.1016/j.athoracsur.2003.09.077; Lamm G, 2006, J CARDIOTHOR VASC AN, V20, P51, DOI 10.1053/j.jvca.2005.03.026; Mahoney EM, 2002, J AM COLL CARDIOL, V40, P737, DOI 10.1016/S0735-1097(02)02003-X; Majahalme S, 2002, INT J CARDIOL, V82, P209, DOI 10.1016/S0167-5273(01)00622-2; Miller S, 2005, HEART, V91, P618, DOI 10.1136/hrt.2004.033811; Patti G, 2006, CIRCULATION, V114, P1455, DOI 10.1161/CIRCULATIONAHA.106.621763; Prasongsukarn K, 2005, J THORAC CARDIOV SUR, V130, P93, DOI 10.1016/j.jtcvs.2004.09.014; Rubens FD, 2005, ANN THORAC SURG, V79, P655, DOI 10.1016/j.athoracsur.2004.07.044; Svedjeholm R, 2000, SCAND CARDIOVASC J, V34, P516; Wan S, 1997, CHEST, V112, P676, DOI 10.1378/chest.112.3.676; Yared JP, 2000, ANN THORAC SURG, V69, P1420, DOI 10.1016/S0003-4975(00)01180-2; Zaman AG, 2000, CIRCULATION, V101, P1403, DOI 10.1161/01.CIR.101.12.1403	24	249	270	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2007	297	14					1562	1567		10.1001/jama.297.14.1562	http://dx.doi.org/10.1001/jama.297.14.1562			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155PG	17426275				2022-12-28	WOS:000245589800024
J	Stanley, P				Stanley, Pamela			A method to the madness of N-glycan complexity?	CELL			English	Editorial Material							GLYCOSYLATION; METASTASIS; GALECTINS; BINDING; CELLS	Cell-surface glycoprotein receptors have varying numbers of N-glycan sites. In this issue of Cell, Lau et al. (2007) report that increasing intracellular UDP-GlcNAc leads to increased branching of N-glycans, increased receptor association with cell-surface galectin-3, and enhanced signaling. They also show that the kinetics of this response differ between growth-promoting receptors, which have 8-16 N-glycans, and those that induce growth arrest, which have very few N-glycans, suggesting that hexosamine flux may regulate the transition from growth to arrest.	Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Stanley, P (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	stanley@aecom.yu.edu		Stanley, Pamela/0000-0001-5704-3747				Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Dam TK, 2005, BIOCHEMISTRY-US, V44, P12564, DOI 10.1021/bi051144z; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; Granovsky M, 2000, NAT MED, V6, P306; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; LAU KS, 2007, CELL; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109	12	27	27	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					27	29		10.1016/j.cell.2007.03.022	http://dx.doi.org/10.1016/j.cell.2007.03.022			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418781	Bronze			2022-12-28	WOS:000245661100006
J	Wang, XD; Song, JH; Liu, J; Wang, ZL				Wang, Xudong; Song, Jinhui; Liu, Jin; Wang, Zhong Lin			Direct-current nanogenerator driven by ultrasonic waves	SCIENCE			English	Article							PIEZOELECTRIC NANOGENERATORS; NANOWIRE; GROWTH; TRANSISTOR	We have developed a nanowire nanogenerator that is driven by an ultrasonic wave to produce continuous direct-current output. The nanogenerator was fabricated with vertically aligned zinc oxide nanowire arrays that were placed beneath a zigzag metal electrode with a small gap. The wave drives the electrode up and down to bend and/or vibrate the nanowires. A piezoelectric-semiconducting coupling process converts mechanical energy into electricity. The zigzag electrode acts as an array of parallel integrated metal tips that simultaneously and continuously create, collect, and output electricity from all of the nanowires. The approach presents an adaptable, mobile, and cost-effective technology for harvesting energy from the environment, and it offers a potential solution for powering nanodevices and nanosystems.	Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Wang, ZL (corresponding author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.	zhong.wang@mse.gatech.edu	Wang, Xudong/A-7067-2009; Song, Jinhui/C-7524-2013; Dee, Chang Fu/G-4842-2010; wang, jie/GRS-0942-2022; Wang, Zhong Lin/E-2176-2011	Song, Jinhui/0000-0002-0042-2014; Dee, Chang Fu/0000-0003-1015-9181; Wang, Zhong Lin/0000-0002-5530-0380				Bachtold A, 2001, SCIENCE, V294, P1317, DOI 10.1126/science.1065824; Bai XD, 2003, APPL PHYS LETT, V82, P4806, DOI 10.1063/1.1587878; Chen J, 2005, SCIENCE, V310, P1171, DOI 10.1126/science.1119177; Fruhauf J, 2005, MICROSYST TECHNOL, V11, P1287, DOI 10.1007/s00542-005-0612-7; Gao PX, 2007, ADV MATER, V19, P67, DOI 10.1002/adma.200601162; Hsu JWP, 2005, NANO LETT, V5, P83, DOI 10.1021/nl048322e; Huang Y, 2001, SCIENCE, V294, P1313, DOI 10.1126/science.1066192; Javey A, 2003, NATURE, V424, P654, DOI 10.1038/nature01797; LI V, 2006, MATER TODAY, V9, P18; Mitcheson PD, 2004, J MICROELECTROMECH S, V13, P429, DOI 10.1109/JMEMS.2004.830151; Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120; Paradiso JA, 2005, IEEE PERVAS COMPUT, V4, P18, DOI 10.1109/MPRV.2005.9; Patolsky F, 2005, MATER TODAY, V8, P20, DOI 10.1016/S1369-7021(05)00791-1; Patolsky F, 2006, SCIENCE, V313, P1100, DOI 10.1126/science.1128640; Song JH, 2006, NANO LETT, V6, P1656, DOI 10.1021/nl060820v; Tian ZRR, 2003, NAT MATER, V2, P821, DOI 10.1038/nmat1014; Wang XD, 2005, J AM CHEM SOC, V127, P7920, DOI 10.1021/ja050807x; Wang XD, 2004, NANO LETT, V4, P423, DOI 10.1021/nl035102c; Wang XD, 2006, NANO LETT, V6, P2768, DOI 10.1021/nl061802g; Wang ZL, 2007, MRS BULL, V32, P109, DOI 10.1557/mrs2007.42; Wang ZL, 2006, SCIENCE, V312, P242, DOI 10.1126/science.1124005	21	1910	1999	59	1392	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2007	316	5821					102	105		10.1126/science.1139366	http://dx.doi.org/10.1126/science.1139366			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412957				2022-12-28	WOS:000245470500041
J	Lippard, SJ				Lippard, Stephen J.			Frank Albert Cotton (1930-2007) - Inorganic chemist, educator and discoverer of the quadruple bond. Obituary	NATURE			English	Biographical-Item									MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Lippard, SJ (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lippard@mit.edu							0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2007	446	7136					626	626		10.1038/446626a	http://dx.doi.org/10.1038/446626a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17410166	Bronze			2022-12-28	WOS:000245438300028
J	Reischauer, RD				Reischauer, Robert D.			Benefits with risks - Bush's tax-based health care proposals	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Urban Inst, Washington, DC 20037 USA	Urban Institute	Reischauer, RD (corresponding author), Urban Inst, Washington, DC 20037 USA.							BURMAN LE, 2007, PRESIDENTS PROPOSED; *TAX POL CTR, 2007, PROP STAND DED HLTH	2	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2007	356	14					1393	1395		10.1056/NEJMp078034	http://dx.doi.org/10.1056/NEJMp078034			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153GG	17409319				2022-12-28	WOS:000245419600001
J	Royer, DL; Berner, RA; Park, J				Royer, Dana L.; Berner, Robert A.; Park, Jeffrey			Climate sensitivity constrained by CO2 concentrations over the past 420 million years	NATURE			English	Article							CO2-FORCED CLIMATE; MODEL	A firm understanding of the relationship between atmospheric carbon dioxide concentration and temperature is critical for interpreting past climate change and for predicting future climate change(1). A recent synthesis(2) suggests that the increase in global-mean surface temperature in response to a doubling of the atmospheric carbon dioxide concentration, termed 'climate sensitivity', is between 1.5 and 6.2 degrees C ( 5-95 per cent likelihood range), but some evidence is inconsistent with this range(1-5). Moreover, most estimates of climate sensitivity are based on records of climate change over the past few decades to thousands of years, when carbon dioxide concentrations and global temperatures were similar to or lower than today(1,6), so such calculations tend to underestimate the magnitude of large climate-change events(7) and may not be applicable to climate change under warmer conditions in the future. Here we estimate long-term equilibrium climate sensitivity by modelling carbon dioxide concentrations over the past 420 million years and comparing our calculations with a proxy record. Our estimates are broadly consistent with estimates based on short-term climate records, and indicate that a weak radiative forcing by carbon dioxide is highly unlikely on multi-million-year timescales. We conclude that a climate sensitivity greater than 1.5 degrees C has probably been a robust feature of the Earth's climate system over the past 420 million years, regardless of temporal scaling.	Wesleyan Univ, Dept Earth & Environm Sci, Middletown, CT 06459 USA; Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA	Wesleyan University; Yale University	Royer, DL (corresponding author), Wesleyan Univ, Dept Earth & Environm Sci, Middletown, CT 06459 USA.	droyer@wesleyan.edu		Royer, Dana/0000-0003-0976-953X				Alley R, 2007, CLIMATE CHANGE 2007; Berner R.A., 2004, PHANEROZOIC CARBON C; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; Dessert C, 2001, EARTH PLANET SC LETT, V188, P459, DOI 10.1016/S0012-821X(01)00317-X; Forest CE, 2002, SCIENCE, V295, P113, DOI 10.1126/science.1064419; Frakes L. A, 1992, CLIMATE MODES PHANER; Hegerl GC, 2006, NATURE, V440, P1029, DOI 10.1038/nature04679; Higgins JA, 2006, EARTH PLANET SC LETT, V245, P523, DOI 10.1016/j.epsl.2006.03.009; Houghton J. T., 2001, CLIMATE CHANGE 2001; Huber B. T., 2000, WARM CLIMATES EARTH; Knutti R, 2002, NATURE, V416, P719, DOI 10.1038/416719a; Montanez IP, 2007, SCIENCE, V315, P87, DOI 10.1126/science.1134207; Moulton KL, 2000, AM J SCI, V300, P539, DOI 10.2475/ajs.300.7.539; Pagani M, 2006, SCIENCE, V314, P1556, DOI 10.1126/science.1136110; Riebe CS, 2004, EARTH PLANET SC LETT, V218, P421, DOI 10.1016/S0012-821X(03)00673-3; Royer DL, 2006, GEOCHIM COSMOCHIM AC, V70, P5665, DOI 10.1016/j.gca.2005.11.031; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130	17	162	171	6	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2007	446	7135					530	532		10.1038/nature05699	http://dx.doi.org/10.1038/nature05699			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392784				2022-12-28	WOS:000245242900047
J	Marson, AG; Al-Kharusi, AM; Alwaidh, M; Appleton, R; Baker, GA; Chadwick, DW; Cramp, C; Cockerell, OC; Cooper, PN; Doughty, J; Eaton, B; Gamble, C; Goulding, PJ; Howell, SJL; Hughes, A; Jackson, M; Jacoby, A; Kellett, M; Lawson, GR; Leach, JP; Nicolaides, P; Roberts, R; Shackley, P; Shen, J; Smith, DF; Smith, PEM; Smith, CT; Vanoli, AA; Williamson, PR				Marson, Anthony G.; Al-Kharusi, Asya M.; Alwaidh, Muna; Appleton, Richard; Baker, Gus A.; Chadwick, David W.; Cramp, Celia; Cockerell, Oliver C.; Cooper, Paul N.; Doughty, Julie; Eaton, Barbara; Gamble, Carrot; Goulding, Peter J.; Howell, Stephen J. L.; Hughes, Adrian; Jackson, Margaret; Jacoby, Ann; Kellett, Mark; Lawson, Geoffrey R.; Leach, John Paul; Nicolaides, Paola; Roberts, Richard; Shackley, Phil; Shen, Jing; Smith, David F.; Smith, Philip E. M.; Smith, Catrin Tudur; Vanoli, Alessandr A.; Williamson, Paula R.		SANAD Study Grp	The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial	LANCET			English	Article							DOUBLE-BLIND; ANTIEPILEPTIC DRUGS; CARBAMAZEPINE; SEIZURES; MONOTHERAPY; CHILDREN	Background Valproate is widely accepted as a drug of first choice for patients with generalised onset seizures, and its broad spectrum of efficacy means it is recommended for patients with seizures that are difficult to classify. Lamotrigine and topiramate are also thought to possess broad spectrum activity. The SANAD study aimed to compare the longer-term effects of these drugs in patients with generalised onset seizures or seizures that are difficult to classify. Methods SANAD was an unblinded randomised controlled trial in hospital-based outpatient clinics in the UK. Arm B of the study recruited 716 patients for whom valproate was considered to be standard treatment. Patients were randomly assigned to valproate, lamotrigine, or topiramate between Jan 12, 1999, and Aug 31, 2004, and follow-up data were obtained up to Jan 13, 2006. Primary outcomes were time to treatment failure, and time to 1-year remission, and analysis was by both intention to treat and per protocol. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN38354748. Findings For time to treatment failure, valproate was significantly better than topiramate (hazard ratio 1.57 [95% CI 1.19-2.08]), but there was no significant difference between valproate and lamotrigine (1.25 [0.94-1.68]). For patients with an idiopathic generalised epilepsy, valproate was significantly better than both lamotrigine (1.55 [1.07-2.24] and topiramate (1.89 [1.32-2.70]). For time to 12-month remission valproate was significantly better than lamotrigine overall (0.76 [0.62-0.94]), and for the subgroup with an idiopathic generalised epilepsy 0.68 (0.53-0.89). But there was no significant difference between valproate and topiramate in either the analysis overall or for the subgroup with an idiopathic generalised epilepsy. Interpretation Valproate is better tolerated than topiramate and more efficacious than lamotrigine, and should remain the drug of first choice for many patients with generalised and unclassified epilepsies. However, because of known potential adverse effects of valproate during pregnancy, the benefits for seizure control in women of childbearing years should be considered.	Univ Liverpool, Div Neurol Sci, Liverpool L9 7LJ, Merseyside, England; Royal Liverpool Childrens NHS Trust Alder Hey, Dept Neurol, Liverpool, Merseyside, England; Univ Newcastle, Sch Populat & Hlth Sci, Newcastle Upon Tyne, Tyne & Wear, England; Univ Liverpool, Ctr Med Stat & Hlth Evaluat, Liverpool L69 3BX, Merseyside, England; Univ Liverpool, Div Publ Hlth, Liverpool L69 3BX, Merseyside, England; Southport & Formby Dist Gen Hosp, Merseyside, England; Whiston Hosp, St Helens & Knowsley Hosp NHS Trust, Liverpool, Merseyside, England; Royal Shrewsbury Hosp, Shrewsbury, Salop, England; Royal London Hosp, London E1 1BB, England; Royal Bolton Hosp, Bolton, England; Leeds Gen Infirm, Leeds, W Yorkshire, England; Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England; Arrowe Pk Hosp, Wirral, Merseyside, England; Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Sunderland Royal Hosp, Sunderland, England; So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; Ninewells Hosp, Dundee DD1 9SY, Scotland; Walton Ctr Neurol & Neurosurg NHS Trust, Liverpool, Merseyside, England; Univ Wales Hosp, Cardiff, Wales	University of Liverpool; Alder Hey Children's NHS Foundation Trust; Newcastle University - UK; University of Liverpool; University of Liverpool; Whiston Hospital; Barts Health NHS Trust; Royal London Hospital; Royal Bolton Hospital; Leeds General Infirmary; University of Leeds; University of Sheffield; Newcastle University - UK; Sunderland Royal Hospital; University of Glasgow; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Dundee; Walton Centre; Cardiff University	Marson, AG (corresponding author), Univ Liverpool, Div Neurol Sci, Clin Sci Bldg,Lower Lane, Liverpool L9 7LJ, Merseyside, England.	a.g.marson@liv.ac.uk	Williamson, Paula R/B-6425-2016; Gamble, Carrol/AAE-9895-2019; Leach, John Paul/AGZ-0356-2022; Leach, John Paul/AGU-8942-2022; Marson, Anthony/AAW-9776-2020; Cooper, Paul N/L-9819-2013; Lueck, Christian Joseph/O-4031-2016; von Oertzen, Tim J/B-6295-2013	Williamson, Paula R/0000-0001-9802-6636; Gamble, Carrol/0000-0002-3021-1955; Leach, John Paul/0000-0003-2086-9937; Marson, Anthony/0000-0002-6861-8806; Cooper, Paul N/0000-0002-7232-3365; Lueck, Christian Joseph/0000-0003-1537-7612; von Oertzen, Tim J/0000-0003-2164-7842; Tudur Smith, Catrin/0000-0003-3051-1445; Shackley, Philip/0000-0002-1862-0596	Wellcome Trust Funding Source: Medline; Department of Health [HTA/95/13/01, HTA_485] Funding Source: Medline	Wellcome Trust(Wellcome Trust); Department of Health		Adab N, 2004, J NEUROL NEUROSUR PS, V75, P1575, DOI 10.1136/jnnp.2003.029132; [Anonymous], 1981, Epilepsia, V22, P489; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Beran RG, 1998, EPILEPSIA, V39, P1329, DOI 10.1111/j.1528-1157.1998.tb01332.x; Biton V, 2005, NEUROLOGY, V65, P1737, DOI 10.1212/01.wnl.0000187118.19221.e4; BRODIE MJ, 1995, LANCET, V345, P476, DOI 10.1016/S0140-6736(95)90581-2; Ericksson AS, 1998, EPILEPSIA, V39, P495, DOI 10.1111/j.1528-1157.1998.tb01411.x; French JA, 2004, NEUROLOGY, V62, P1252, DOI 10.1212/01.WNL.0000123693.82339.FC; Hauser W, 1990, EPILEPSY FREQUENCY C; Marson AG, 2002, EPILEPSIA, V43, P505, DOI 10.1046/j.1528-1157.2002.20801.x; MARSON AG, 2005, COCHRANE DB SYST REV, V4; Marson AG, 2007, LANCET, V369, P1000, DOI 10.1016/S0140-6736(07)60460-7; Medical Research Council, 1998, GUID GOOD CLIN PRACT; Morrow J, 2006, J NEUROL NEUROSUR PS, V77, P193, DOI 10.1136/jnnp.2005.074203; Motte J, 1997, NEW ENGL J MED, V337, P1807, DOI 10.1056/NEJM199712183372504; *NAT I CLIN EXC, 2004, CLIN GUID, V20; *NAT I CLIN EXC, 2004, TECHN APPR GUID, V76; Nicolson A, 2004, J NEUROL NEUROSUR PS, V75, P75; Privitera MD, 2003, ACTA NEUROL SCAND, V107, P165, DOI 10.1034/j.1600-0404.2003.00093.x; SHIELDS WD, 1983, NEUROLOGY, V33, P1487, DOI 10.1212/WNL.33.11.1487; SMITH CT, 2001, COCHRANE DB SYST REV, V4; SNEAD OC, 1985, NEW ENGL J MED, V313, P916, DOI 10.1056/NEJM198510103131503	22	565	585	1	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2007	369	9566					1016	1026		10.1016/S0140-6736(07)60461-9	http://dx.doi.org/10.1016/S0140-6736(07)60461-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151JO	17382828	Green Accepted			2022-12-28	WOS:000245286500030
J	Shimizu, K; Phan, T; Mansuy, IM; Storm, DR				Shimizu, Kimiko; Phan, Trongha; Mansuy, Isabelle M.; Storm, Daniel R.			Proteolytic degradation of SCOP in the hippocampus contributes to activation of MAP kinase and memory	CELL			English	Article							LONG-TERM-MEMORY; MEDIATED GENE-EXPRESSION; SIGNAL-REGULATED KINASE; ELEMENT-BINDING PROTEIN; SYNAPTIC PLASTICITY; NEUROTRANSMITTER RELEASE; SUPRACHIASMATIC NUCLEUS; DEPENDENT ACTIVATION; NEURONAL PLASTICITY; NEUROTROPHIC FACTOR	Because activation of ERK1/2 MAP kinase (MAPK) is critical for hippocampus-dependent memory, there is considerable interest in mechanisms for regulation of MAPK during memory formation. Here we report that MAPK and CREB-mediated transcription are negatively regulated by SCOP (suprachiasmatic nucleus [SCN] circadian oscillatory protein) and that SCOP is proteolyzed by calpain when hippocampal neurons are stimulated by brain-derived neurotrophic factor (BDNF), KCl depolarization, or NMDA. Moreover, training for novel object memory decreases SCOP in the hippocampus. To determine if hippocampus-dependent memory is influenced by SCOP in vivo, we generated a transgenic mouse strain for the inducible overexpression of SCOP in the forebrain. Overexpression of SCOP completely blocked memory for novel objects. We conclude that degradation of SCOP by calpain contributes to activation of MAPK during memory formation.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Zurich, Swiss Fed Inst Technol, Brain Res Inst, CH-8057 Zurich, Switzerland	University of Washington; University of Washington Seattle; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	dstorm@u.washington.edu	Mansuy, Isabelle M/N-3042-2015; Kimiko, Shimizu/ACS-9013-2022; Shimizu, Kimiko/G-4956-2014	Mansuy, Isabelle M/0000-0001-7785-5371; Kimiko, Shimizu/0000-0003-4943-2552; Shimizu, Kimiko/0000-0003-4943-2552	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH073601] Funding Source: Medline; NINDS NIH HHS [NS 20498, R01 NS020498] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Athos J, 2002, NAT NEUROSCI, V5, P1119, DOI 10.1038/nn951; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; BERNINGER B, 1993, NEUROREPORT, V4, P1303, DOI 10.1097/00001756-199309150-00004; Blum S, 1999, J NEUROSCI, V19, P3535; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Chan D, 1998, NETW COMPUT, V9, P18; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K; Cline H, 2003, CURR BIOL, V13, pR514, DOI 10.1016/S0960-9822(03)00443-3; Coogan AN, 1999, J NEUROPHYSIOL, V81, P103, DOI 10.1152/jn.1999.81.1.103; Dash PK, 2000, NEUROREPORT, V11, P2811, DOI 10.1097/00001756-200008210-00040; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DINGLEDINE R, 1983, FED PROC, V42, P2881; DIVIRGILIO F, 1987, J BIOL CHEM, V262, P9189; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Frankland PW, 2003, NEUROSCIENTIST, V9, P104, DOI 10.1177/1073858403252225; Grammer M, 2005, NEUROBIOL LEARN MEM, V84, P222, DOI 10.1016/j.nlm.2005.07.007; Heerssen HM, 2002, TRENDS NEUROSCI, V25, P160, DOI 10.1016/S0166-2236(02)02144-6; Hegde AN, 2004, PROG NEUROBIOL, V73, P311, DOI 10.1016/j.pneurobio.2004.05.005; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Hetman M, 2000, ACTA NEUROBIOL EXP, V60, P531; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kelly A, 2003, J NEUROSCI, V23, P5354; Li YX, 1998, J NEUROSCI, V18, P10231; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; Mazzucchelli C, 2000, CELL MOL LIFE SCI, V57, P604, DOI 10.1007/PL00000722; Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X; NIXON RA, 1986, J NEUROSCI, V6, P1264; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Ohno M, 2001, NAT NEUROSCI, V4, P1238, DOI 10.1038/nn771; ONIZUKA K, 1995, BRAIN RES, V697, P179, DOI 10.1016/0006-8993(95)00838-H; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Shimizu K, 2003, J BIOL CHEM, V278, P14920, DOI 10.1074/jbc.M213214200; Shimizu K, 1999, FEBS LETT, V458, P363, DOI 10.1016/S0014-5793(99)01190-4; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; Sindreu CB, 2007, NEURON, V53, P79, DOI 10.1016/j.neuron.2006.11.024; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; Watt WC, 2004, NEURON, V41, P955, DOI 10.1016/S0896-6273(04)00075-3; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002	51	89	91	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2007	128	6					1219	1229		10.1016/j.cell.2006.12.047	http://dx.doi.org/10.1016/j.cell.2006.12.047			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382888	Green Accepted, Bronze			2022-12-28	WOS:000245396200025
J	de Wildt, SN; Verzijden, R; van den Anker, JN; de Hoog, M				de Wildt, Saskia N.; Verzijden, Ron; van den Anker, John N.; de Hoog, Matthijs			Lesson of the week - Information technology cannot guarantee patient safety	BRITISH MEDICAL JOURNAL			English	Article; Proceedings Paper	16th Annual Meeting of the European-Society-of-Pediatric-and-Neonatal-Intensive-Care	SEP 15-17, 2005	Antwerp, BELGIUM	European Soc Pediat & Neonatal Intens Care			CALCULATOR	Human error and software inadequacy can combine to make drug doses calculated on handheld computers unreliable	Erasmus MC Sophia Childrens Hosp, Dept Paediat, NL-3015 GJ Rotterdam, Netherlands; Ron Verzijden Management Consultants, Toronto, ON M5J 2Y5, Canada; Childrens Hosp, Natl Med Ctr, Div Pediat Clin Pharmacol, Washington, DC 20010 USA	Erasmus University Rotterdam; Erasmus MC; Children's National Health System	de Wildt, SN (corresponding author), Hosp Sick Children, Div Clin Pharmacol & Toxicol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	s.dewildt@erasmusmc.nl	de Wildt, Saskia/AFX-4656-2022; de Hoog, Matthijs/A-3882-2013; de Wildt, Saskia/A-9589-2008	de Wildt, Saskia/0000-0002-0502-0647; de Wildt, Saskia/0000-0002-0502-0647				Bates DW, 2003, NEW ENGL J MED, V348, P2526, DOI 10.1056/NEJMsa020847; *EUR SPREADSH RISK, 2006, SPREADSH MIST NEWS S; LAUDON KC, 2000, MANAGEMENT INFORM SY, P377; LUTEN R C, 1986, Journal of Emergency Medicine, V4, P9, DOI 10.1016/0736-4679(86)90107-1; MELZERLANGE M, 1991, AM J DIS CHILD, V145, P264, DOI 10.1001/archpedi.1991.02160030032016; NEU J, 1982, CRIT CARE MED, V10, P610, DOI 10.1097/00003246-198209000-00012	6	11	11	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 21	2007	334	7598					851	852		10.1136/bmj.39104.625903.80	http://dx.doi.org/10.1136/bmj.39104.625903.80			2	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	162MD	17446618	Green Published			2022-12-28	WOS:000246090800037
J	Mehta, DK; Aronson, JK				Mehta, Dinesh K.; Aronson, Jeffrey K.			Give a drug a good name	LANCET			English	Editorial Material									Royal Pharmaceut Soc Great Britain, London SE1 7JN, England; Univ Oxford, Dept Clin Pharmacol, Oxford, England	University of Oxford	Mehta, DK (corresponding author), Royal Pharmaceut Soc Great Britain, London SE1 7JN, England.	dmehta@bnf.org						Aronson J, 2004, BRIT J GEN PRACT, V54, P559; Aronson Jeffrey K, 2004, Expert Opin Drug Saf, V3, P167; Aronson JK, 2000, BMJ-BRIT MED J, V320, P506, DOI 10.1136/bmj.320.7233.506; SASHKOVA G, 2004, WHO DRUG INFO, V18, P123; 2002, WHO DRUG INFO, V16, P194; 1965, WHO CHRONICLE, V19, P446	6	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1326	1328		10.1016/S0140-6736(07)60612-6	http://dx.doi.org/10.1016/S0140-6736(07)60612-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	159HL	17448803				2022-12-28	WOS:000245856100008
J	Dolan, L				Dolan, Liam			SCARECROWs at the border	SCIENCE			English	Editorial Material							ARABIDOPSIS ROOT; HOMEODOMAIN		John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Dolan, L (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.	liam.dolan@bbsrc.ac.uk		Dolan, Liam/0000-0003-1206-7096				Bower FO., 1935, PRIMITIVE LAND PLANT; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; Maizel A, 1999, DEVELOPMENT, V126, P3183; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Wada T, 2002, DEVELOPMENT, V129, P5409, DOI 10.1242/dev.00111	8	4	5	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					377	378		10.1126/science.1142343	http://dx.doi.org/10.1126/science.1142343			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446377				2022-12-28	WOS:000245813400027
J	Wang, JX; Scully, K; Zhu, X; Cai, L; Zhang, J; Prefontaine, GG; Krones, A; Ohgi, KA; Zhu, P; Garcia-Bassets, I; Liu, F; Taylor, H; Lozach, J; Jayes, FL; Korach, KS; Glass, CK; Fu, XD; Rosenfeld, MG				Wang, Jianxun; Scully, Kathleen; Zhu, Xiaoyan; Cai, Ling; Zhang, Jie; Prefontaine, Gratien G.; Krones, Anna; Ohgi, Kenneth A.; Zhu, Ping; Garcia-Bassets, Ivan; Liu, Forrest; Taylor, Havilah; Lozach, Jean; Jayes, Friederike L.; Korach, Kenneth S.; Glass, Christopher K.; Fu, Xiang-Dong; Rosenfeld, Michael G.			Opposing LSD1 complexes function in developmental gene activation and repression programmes	NATURE			English	Article							POLYCOMB PROTEIN; PITUITARY-GLAND; HISTONE; RECEPTOR; EXPRESSION; ESTROGEN; MICE; PIT-1; IDENTIFICATION; TRANSCRIPTION	Precise control of transcriptional programmes underlying metazoan development is modulated by enzymatically active co-regulatory complexes, coupled with epigenetic strategies. One thing that remains unclear is how specific members of histone modification enzyme families, such as histone methyltransferases and demethylases, are used in vivo to simultaneously orchestrate distinct developmental gene activation and repression programmes. Here, we report that the histone lysine demethylase, LSD1 - a component of the CoREST-CtBP co- repressor complex - is required for late cell-lineage determination and differentiation during pituitary organogenesis. LSD1 seems to act primarily on target gene activation programmes, as well as in gene repression programmes, on the basis of recruitment of distinct LSD1-containing co- activator or co- repressor complexes. LSD1-dependent gene repression programmes can be extended late in development with the induced expression of ZEB1, a Kruppel-like repressor that can act as a molecular beacon for recruitment of the LSD1-containing CoREST-CtBP co- repressor complex, causing repression of an additional cohort of genes, such as Gh, which previously required LSD1 for activation. These findings suggest that temporal patterns of expression of specific components of LSD1 complexes modulate gene regulatory programmes in many mammalian organs.	Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, Sch Med, La Jolla, CA 92093 USA; Natl Inst Environm Hlth Sci, Res Triangle Pk, NC 27709 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, Grad Program, La Jolla, CA 92093 USA; Univ Calif San Diego, Mol Pathol Grad Program, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, 9500 Gilman Dr,Room 345, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu	Garcia-Bassets, Ivan/F-5075-2010; Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592; Korach, Kenneth/0000-0002-7765-418X; Jayes, Friederike/0000-0001-8862-9345; Garcia-Bassets, Ivan/0000-0002-6941-9585	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES070065, ZIAES070065] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; BEHRINGER RR, 1988, GENE DEV, V2, P453, DOI 10.1101/gad.2.4.453; BORRELLI E, 1989, NATURE, V339, P538, DOI 10.1038/339538a0; Botz J, 1996, MOL CELL BIOL, V16, P3401; Chamberlain EM, 1999, MOL CELL BIOL, V19, P3600; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; DAY RN, 1990, MOL ENDOCRINOL, V4, P1964, DOI 10.1210/mend-4-12-1964; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Gage PJ, 1996, DEVELOPMENT, V122, P151; GODFREY P, 1993, NAT GENET, V4, P227, DOI 10.1038/ng0793-227; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; HU NP, 1994, ONCOGENE, V9, P1021; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Keegan CE, 2003, GENE DEV, V17, P677, DOI 10.1101/gad.1085903; KORACH KS, 1994, SCIENCE, V266, P1524, DOI 10.1126/science.7985022; Lasorella A, 2005, MOL CELL BIOL, V25, P3563, DOI 10.1128/MCB.25.9.3563-3574.2005; LIEBERMAN ME, 1983, J STEROID BIOCHEM, V19, P275, DOI 10.1016/S0022-4731(83)80037-5; LIN CJ, 1992, NATURE, V360, P765, DOI 10.1038/360765a0; Long JY, 2005, J BIOL CHEM, V280, P35477, DOI 10.1074/jbc.M504477200; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; MAYO KE, 1992, MOL ENDOCRINOL, V6, P1734, DOI 10.1210/me.6.10.1734; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Ooi GT, 2004, MOL CELL ENDOCRINOL, V228, P1, DOI 10.1016/j.mce.2004.07.018; Oswald F, 2005, MOL CELL BIOL, V25, P10379, DOI 10.1128/MCB.25.23.10379-10390.2005; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Postigo AA, 1999, P NATL ACAD SCI USA, V96, P6683, DOI 10.1073/pnas.96.12.6683; Satijn DPE, 1997, MOL CELL BIOL, V17, P6076, DOI 10.1128/MCB.17.10.6076; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; Scully KM, 2002, SCIENCE, V295, P2231, DOI 10.1126/science.1062736; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Ward RD, 2005, MOL ENDOCRINOL, V19, P698, DOI 10.1210/me.2004-0341; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; WILLIAMS TM, 1991, SCIENCE, V254, P1791, DOI 10.1126/science.1840704; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhu XY, 2006, GENE DEV, V20, P2739, DOI 10.1101/gad.1444706	50	411	433	4	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2007	446	7138					882	887		10.1038/nature05671	http://dx.doi.org/10.1038/nature05671			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17392792				2022-12-28	WOS:000245785700035
J	Graber, ML; Kumar, A				Graber, Mark L.; Kumar, Atul			Commentary: Reaching a milestone in diagnosing coeliac disease	BRITISH MEDICAL JOURNAL			English	Editorial Material									Vet Adm Med Ctr, Northport, NY 11768 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA)	Graber, ML (corresponding author), Vet Adm Med Ctr, Northport, NY 11768 USA.	mark.graber@med.va.gov		Graber, Mark/0000-0002-3600-0446				Green PHR, 2001, AM J GASTROENTEROL, V96, P126, DOI 10.1111/j.1572-0241.2001.03462.x; Hopper AD, 2007, BMJ-BRIT MED J, V334, P729, DOI 10.1136/bmj.39133.668681.BE; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Rostom A, 2006, GASTROENTEROLOGY, V131, P1981, DOI 10.1053/j.gastro.2006.10.004	4	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 7	2007	334	7596					732	733		10.1136/bmj.39161.587720.BE	http://dx.doi.org/10.1136/bmj.39161.587720.BE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AO	17383984	Green Published, Bronze			2022-12-28	WOS:000245763300029
J	Clapham, DE				Clapham, David E.			SnapShot; Mammalian TRP channels	CELL			English	Editorial Material									Harvard Univ, Sch Med, Dept Neurobiol, Childrens Hosp, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Clapham, DE (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Childrens Hosp, HHMI, Boston, MA 02115 USA.		Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; 					0	108	121	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					220	220		10.1016/j.cell.2007.03.034	http://dx.doi.org/10.1016/j.cell.2007.03.034			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418797	Bronze			2022-12-28	WOS:000245661100023
J	Liu, S; Li, P; Dybkov, O; Nottrott, S; Hartmuth, K; Luhrmann, R; Carlomagno, T; Wahl, MC				Liu, Sunbin; Li, Ping; Dybkov, Olexandr; Nottrott, Stephanie; Hartmuth, Klaus; Luehrmann, Reinhard; Carlomagno, Teresa; Wahl, Markus C.			Binding of the human Prp31 nop domain to a composite RNA-protein platform in U4 snRNP	SCIENCE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; TRI-SNRNP; MOLECULAR-BASIS; HUMAN U4/U6.U5; SPLICEOSOME; COMPLEX; RECOGNITION; ASSOCIATION; INTERACT; GENE	Although highly homologous, the spliceosomal hPrp31 and the nucleolar Nop56 and Nop58 (Nop56/58) proteins recognize different ribonucleoprotein (RNP) particles. hPrp31 interacts with complexes containing the 15.5K protein and U4 or U4atac small nuclear RNA (snRNA), whereas Nop56/58 associate with 15.5K-box C/D small nucleolar RNA complexes. We present structural and biochemical analyses of hPrp31-15.5K-U4 snRNA complexes that show how the conserved Nop domain in hPrp31 maintains high RNP binding selectivity despite relaxed RNA sequence requirements. The Nop domain is a genuine RNP binding module, exhibiting RNA and protein binding surfaces. Yeast two-hybrid analyses suggest a link between retinitis pigmentosa and an aberrant hPrp31-hPrp6 interaction that blocks U4/U6-U5 tri-snRNP formation.	Max Planck Inst Biophys Chem, Abt Zellulaire Biochem, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, AG Flussig NMR Spektroskopie, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, AG Makromol Rontgenkristallog, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society; Max Planck Society	Luhrmann, R (corresponding author), Max Planck Inst Biophys Chem, Abt Zellulaire Biochem, Fassberg 11, D-37077 Gottingen, Germany.	Reinhard.Luehrmann@mpi-bpc.mpg.de; taco@nmr.mpibpc.mpg.de; mwahl@gwdg.de	Wahl, Markus C./D-6365-2017	Wahl, Markus C./0000-0002-2811-5307; Carlomagno, Teresa/0000-0002-2437-2760				Agalarov SC, 2000, SCIENCE, V288, P107, DOI 10.1126/science.288.5463.107; Aittaleb M, 2003, NAT STRUCT BIOL, V10, P256, DOI 10.1038/nsb905; BRINGMANN P, 1984, EMBO J, V3, P1357, DOI 10.1002/j.1460-2075.1984.tb01977.x; Brow DA, 2002, ANNU REV GENET, V36, P333, DOI 10.1146/annurev.genet.36.043002.091635; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Burge CB, 1999, RNA WORLD, P525; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Gornemann J, 2005, MOL CELL, V19, P53, DOI 10.1016/j.molcel.2005.05.007; HASHIMOTO C, 1984, NUCLEIC ACIDS RES, V12, P3283, DOI 10.1093/nar/12.7.3283; Kuhn-Holsken E, 2005, RNA, V11, P1915, DOI 10.1261/rna.2176605; Liu SB, 2006, RNA, V12, P1418, DOI 10.1261/rna.55406; Makarova OV, 2002, EMBO J, V21, P1148, DOI 10.1093/emboj/21.5.1148; Moore T, 2004, STRUCTURE, V12, P807, DOI 10.1016/j.str.2004.02.033; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Nottrott S, 1999, EMBO J, V18, P6119, DOI 10.1093/emboj/18.21.6119; Nottrott S, 2002, EMBO J, V21, P5527, DOI 10.1093/emboj/cdf544; REED R, 1997, EUKARYOTIC MRNA PROC, P103; Schneider C, 2002, MOL CELL BIOL, V22, P3219, DOI 10.1128/MCB.22.10.3219-3229.2002; Schultz A, 2006, J BIOL CHEM, V281, P28278, DOI 10.1074/jbc.M603350200; Schultz A, 2006, MOL CELL BIOL, V26, P5146, DOI 10.1128/MCB.02374-05; SHAKKED Z, 1994, NATURE, V368, P469, DOI 10.1038/368469a0; Small EC, 2006, MOL CELL, V23, P389, DOI 10.1016/j.molcel.2006.05.043; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Szewczak LBW, 2005, RNA, V11, P1407, DOI 10.1261/rna.2830905; Vidovic I, 2000, MOL CELL, V6, P1331, DOI 10.1016/S1097-2765(00)00131-3; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; Watkins NJ, 2000, CELL, V103, P457, DOI 10.1016/S0092-8674(00)00137-9; Watkins NJ, 2002, MOL CELL BIOL, V22, P8342, DOI 10.1128/MCB.22.23.8342-8352.2002; Will CL, 2006, COLD SPRING HARB MON, V43, P369; Williamson JR, 2000, NAT STRUCT BIOL, V7, P834, DOI 10.1038/79575; WU JC, 1983, J BIOL CHEM, V258, P4694	31	102	104	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2007	316	5821					115	120		10.1126/science.1137924	http://dx.doi.org/10.1126/science.1137924			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412961	Green Published			2022-12-28	WOS:000245470500045
J	Rossouw, JE; Prentice, RL; Manson, JE; Wu, LL; Barad, D; Barnabei, VM; Ko, M; LaCroix, AZ; Margolis, KL; Stefanick, ML				Rossouw, Jacques E.; Prentice, Ross L.; Manson, Joann E.; Wu, LieLing; Barad, David; Barnabei, Vanessa M.; Ko, Marcia; LaCroix, Andrea Z.; Margolis, Karen L.; Stefanick, Marcia L.			Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; ESTROGEN PLUS PROGESTIN; RANDOMIZED CONTROLLED-TRIAL; REPLACEMENT THERAPY; SECONDARY PREVENTION; MYOCARDIAL-INFARCTION; EQUINE ESTROGEN; WOMEN; HEALTH; ATHEROSCLEROSIS	Context The timing of initiation of hormone therapy may influence its effect on cardiovascular disease. Objective To explore whether the effects of hormone therapy on risk of cardiovascular disease vary by age or years since menopause began. Design, Setting, and Participants Secondary analysis of the Women's Health Initiative (WHI) randomized controlled trials of hormone therapy in which 10 739 postmenopausal women who had undergone a hysterectomy were randomized to conjugated equine estrogens (CEE) or placebo and 16 608 postmenopausal women who had not had a hysterectomy were randomized to CEE plus medroxyprogesterone acetate ( CEE + MPA) or placebo. Women aged 50 to 79 years were recruited to the study from 40 US clinical centers between September 1993 and October 1998. Main Outcome Measures Statistical test for trend of the effect of hormone therapy on coronary heart disease (CHD) and stroke across categories of age and years since menopause in the combined trials. Results In the combined trials, there were 396 cases of CHD and 327 cases of stroke in the hormone therapy group vs 379 cases of CHD and 239 cases of stroke in the placebo group. For women with less than 10 years since menopause began, the hazard ratio (HR) for CHD was 0.76 (95% confidence interval [CI], 0.50-1.16); 10 to 19 years, 1.10 ( 95% CI, 0.84-1.45); and 20 or more years, 1.28 ( 95% CI, 1.03-1.58) ( P for trend=. 02). The estimated absolute excess risk for CHD for women within 10 years of menopause was - 6 per 10 000 person-years; for women 10 to 19 years since menopause began, 4 per 10 000 person-years; and for women 20 or more years from menopause onset, 17 per 10 000 person-years. For the age group of 50 to 59 years, the HR for CHD was 0.93 ( 95% CI, 0.65-1.33) and the absolute excess risk was - 2 per 10 000 person-years; 60 to 69 years, 0.98 ( 95% CI, 0.79-1.21) and - 1 per 10 000 person-years; and 70 to 79 years, 1.26 ( 95% CI, 1.00-1.59) and 19 per 10 000 person-years (P for trend=. 16). Hormone therapy increased the risk of stroke ( HR, 1.32; 95% CI, 1.12-1.56). Risk did not vary significantly by age or time since menopause. There was a nonsignificant tendency for the effects of hormone therapy on total mortality to be more favorable in younger than older women ( HR of 0.70 for 50-59 years; 1.05 for 60-69 years, and 1.14 for 70-79 years; P for trend=. 06). Conclusions Women who initiated hormone therapy closer to menopause tended to have reduced CHD risk compared with the increase in CHD risk among women more distant from menopause, but this trend test did not meet our criterion for statistical significance. A similar nonsignificant trend was observed for total mortality but the risk of stroke was elevated regardless of years since menopause. These data should be considered in regard to the short-term treatment of menopausal symptoms.	NHLBI, Womens Hlth Initiat Branch, Bethesda, MD 20892 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med, Boston, MA 02115 USA; Albert Einstein Coll Med, Dept Obstet & Gynecol, New York, NY USA; Albert Einstein Coll Med, Dept Womens Hlth, New York, NY USA; Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA; Mayo Clin, Div Womens Hlth Internal Med, Scottsdale, AZ USA; Univ Minnesota, Berman Ctr Clin Res, Minneapolis, MN USA; Stanford Univ, Dept Med, Palo Alto, CA 94304 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Fred Hutchinson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Yeshiva University; Yeshiva University; Medical College of Wisconsin; Mayo Clinic; Mayo Clinic Phoenix; University of Minnesota System; University of Minnesota Twin Cities; Stanford University	Rossouw, JE (corresponding author), NHLBI, Womens Hlth Initiat Branch, 6701 Rockledge Dr,Bldg 2,Suite 10018, Bethesda, MD 20892 USA.	rossouwj@nih.gov	Barad, David/AAF-4332-2021	Barnabei, Vanessa/0000-0002-9650-0143; Margolis, Karen/0000-0003-1862-7402				*ACOG TASK FORC HO, 2004, OBSTET GYNECOL S, V104, pS1; Alexander KP, 2001, J AM COLL CARDIOL, V38, P1, DOI 10.1016/S0735-1097(01)01329-8; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barrett-Connor E, 1998, ANNU REV PUBL HEALTH, V19, P55, DOI 10.1146/annurev.publhealth.19.1.55; COX DR, 1972, J R STAT SOC B, V34, P187; Dwyer KM, 2002, AM J EPIDEMIOL, V156, P438, DOI 10.1093/aje/kwf051; Grodstein F, 2006, J WOMENS HEALTH, V15, P35, DOI 10.1089/jwh.2006.15.35; Grodstein F, 2003, NEW ENGL J MED, V348, P645, DOI 10.1056/NEJMsb022365; Grodstein F, 2001, ANN INTERN MED, V135, P1, DOI 10.7326/0003-4819-135-1-200107030-00003; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; Harman SM, 2005, CLIMACTERIC, V8, P3, DOI 10.1080/13697130500042417; Heckbert SR, 2001, ARCH INTERN MED, V161, P1709, DOI 10.1001/archinte.161.14.1709; Heckbert SR, 1997, ARCH INTERN MED, V157, P1330, DOI 10.1001/archinte.157.12.1330; Hendrix SL, 2006, CIRCULATION, V113, P2425, DOI 10.1161/CIRCULATIONAHA.105.594077; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Hsia J, 2006, ARCH INTERN MED, V166, P357, DOI 10.1001/archinte.166.3.357; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Johnson MS, 2005, ANN INTERN MED, V142, P855, DOI 10.7326/0003-4819-142-10-200505170-00011; Mack WJ, 2004, FERTIL STERIL, V82, P391, DOI 10.1016/j.fertnstert.2004.01.034; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Prentice RL, 2006, AM J EPIDEMIOL, V163, P589, DOI 10.1093/aje/kwj079; ROSSOUW JE, 1995, AM J CARDIOL, V76, pC86, DOI 10.1016/S0002-9149(99)80476-7; Rossouw JE, 2005, MATURITAS, V51, P51, DOI 10.1016/j.maturitas.2005.02.015; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; Waters DD, 2002, JAMA-J AM MED ASSOC, V288, P2432, DOI 10.1001/jama.288.19.2432	28	1202	1263	3	56	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2007	297	13					1465	1477		10.1001/jama.297.13.1465	http://dx.doi.org/10.1001/jama.297.13.1465			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AM	17405972	Green Published			2022-12-28	WOS:000245404100023
J	Pessiglione, M; Schmidt, L; Draganski, B; Kalisch, R; Lau, H; Dolan, RJ; Frith, CD				Pessiglione, Mathias; Schmidt, Liane; Draganski, Bogdan; Kalisch, Raffael; Lau, Hakwan; Dolan, Ray J.; Frith, Chris D.			How the brain translates money into force: A neuroimaging study of subliminal motivation	SCIENCE			English	Article							BASAL GANGLIA; ORBITOFRONTAL CORTEX; REWARD; HUMANS; CIRCUITS; AMYGDALA; REPRESENTATION; STRIATUM; PARALLEL; BEHAVIOR	Unconscious motivation in humans is often inferred but rarely demonstrated empirically. We imaged motivational processes, implemented in a paradigm that varied the amount and reportability of monetary rewards for which subjects exerted physical effort. We show that, even when subjects cannot report how much money is at stake, they nevertheless deploy more force for higher amounts. Such a motivational effect is underpinned by engagement of a specific basal forebrain region. Our findings thus reveal this region as a key node in brain circuitry that enables expected rewards to energize behavior, without the need for the subjects' awareness.	UCL, Wellcome Trust, Ctr Neuroimaging, Inst Neurol, London WC1N 3BG, England; Univ Paris 06, INSERM, Unite 610,Grp Pitie Salpetriere, Ctr Neuroimagerie & Rech, F-75013 Paris, France	University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Pessiglione, M (corresponding author), UCL, Wellcome Trust, Ctr Neuroimaging, Inst Neurol, 12 Queen Sq, London WC1N 3BG, England.	pessigli@ccr.jussieu.fr	Pessiglione, Mathias/E-2141-2017; Draganski, Bogdan/C-3096-2016; Frith, Chris D/A-2171-2009; Kalisch, Raffael/A-9863-2018; Kalisch, Raffael/H-6624-2016	Pessiglione, Mathias/0000-0002-6992-3677; Draganski, Bogdan/0000-0002-5159-5919; Frith, Chris D/0000-0002-8665-0690; Schmidt, Liane/0000-0002-4159-9705; Dolan, Ray/0000-0001-9356-761X	Wellcome Trust [078865] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Berridge KC, 2004, PHYSIOL BEHAV, V81, P179, DOI 10.1016/j.physbeh.2004.02.004; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Critchley HD, 2002, NEUROSCIENTIST, V8, P132, DOI 10.1177/107385840200800209; Dai TH, 2001, EXP BRAIN RES, V140, P290, DOI 10.1007/s002210100815; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; DETIMERS C, 1995, J NEUROPHYSIOL, V74, P802; Elliott R, 2003, J NEUROSCI, V23, P303; Etkin A, 2004, NEURON, V44, P1043, DOI 10.1016/j.neuron.2004.12.006; Friedman DP, 2002, J COMP NEUROL, V450, P345, DOI 10.1002/cne.10336; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Heimer L, 2006, NEUROSCI BIOBEHAV R, V30, P126, DOI 10.1016/j.neubiorev.2005.06.006; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; Lehericy S, 2006, CEREB CORTEX, V16, P149, DOI 10.1093/cercor/bhi089; MCALONAN GM, 1993, NEUROSCIENCE, V52, P605, DOI 10.1016/0306-4522(93)90410-H; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; PANAGIS G, 1995, BEHAV BRAIN RES, V68, P165, DOI 10.1016/0166-4328(94)00169-G; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Tindell AJ, 2004, J NEUROSCI, V24, P1058, DOI 10.1523/JNEUROSCI.1437-03.2004; Vaillancourt DE, 2004, NEUROIMAGE, V23, P175, DOI 10.1016/j.neuroimage.2004.04.040; Yelnik J, 2007, NEUROIMAGE, V34, P618, DOI 10.1016/j.neuroimage.2006.09.026	30	417	428	1	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2007	316	5826					904	906		10.1126/science.1140459	http://dx.doi.org/10.1126/science.1140459			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	166HM	17431137	Green Accepted, Green Published			2022-12-28	WOS:000246369800042
J	Katona, G; Carpentier, P; Niviere, V; Amara, P; Adam, V; Ohana, J; Tsanov, N; Bourgeois, D				Katona, Gergely; Carpentier, Philippe; Niviere, Vincent; Amara, Patricia; Adam, Virgile; Ohana, Jereny; Tsanov, Nikolay; Bourgeois, Dominique			Raman-assisted crystallography reveals end-on peroxide intermediates in a nonheme iron enzyme	SCIENCE			English	Article							SUPEROXIDE REDUCTASE; ACTIVE-SITE; DESULFOARCULUS-BAARSII; ELECTRONIC-STRUCTURES; PYROCOCCUS-FURIOSUS; CATALYTIC PATHWAY; MECHANISM; DIOXYGEN; BINDING; IDENTIFICATION	Iron-peroxide intermediates are central in the reaction cycle of many iron-containing biomolecules. We trapped iron(III)-(hydro) peroxo species in crystals of superoxide reductase (SOR), a nonheme mononuclear iron enzyme that scavenges superoxide radicals. X-ray diffraction data at 1.95 angstrom resolution and Raman spectra recorded in crystallo revealed iron-(hydro) peroxo intermediates with the ( hydro) peroxo group bound end-on. The dynamic SOR active site promotes the formation of transient hydrogen bond networks, which presumably assist the cleavage of the iron- oxygen bond in order to release the reaction product, hydrogen peroxide.	Univ Grenoble 1, CNRS, CEA, Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble, France; Univ Grenoble 1, CNRS, CEA,Lab Chim & Biol Met, Inst Rech Technol & Sci Vivant, F-38054 Grenoble 9, France; European Synchrotron Radiat Facil, F-38043 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); European Synchrotron Radiation Facility (ESRF)	Bourgeois, D (corresponding author), Univ Grenoble 1, CNRS, CEA, Inst Biol Struct Jean Pierre Ebel, 41 Rue Jules Horowitz, F-38027 Grenoble, France.	dominique.bourgeois@ibs.fr	, Bourgeois/AAI-2337-2020; Katona, Gergely/B-3491-2008; Carpentier, Philippe/AAF-5995-2019; Adam, Virgile/B-9359-2009	Katona, Gergely/0000-0002-2031-8716; Adam, Virgile/0000-0003-2209-7846; Amara, Patricia/0000-0001-9634-7305; Niviere, Vincent/0000-0002-5132-457X; Ohana, Jeremy/0000-0002-2772-7483				Adam V, 2004, STRUCTURE, V12, P1729, DOI 10.1016/j.str.2004.07.013; Berglund GI, 2002, NATURE, V417, P463, DOI 10.1038/417463a; Bourgeois D, 2005, CURR OPIN STRUC BIOL, V15, P538, DOI 10.1016/j.sbi.2005.08.002; Brines LM, 2007, EUR J INORG CHEM, P29, DOI 10.1002/ejic.200600461; Brunold TC, 1999, J AM CHEM SOC, V121, P8277, DOI 10.1021/ja990334s; Bukowski MR, 2005, ANGEW CHEM INT EDIT, V44, P584, DOI 10.1002/anie.200461527; Carey PR, 2004, BIOCHEMISTRY-US, V43, P8885, DOI 10.1021/bi049138a; Clay MD, 2006, BIOCHEMISTRY-US, V45, P427, DOI 10.1021/bi052034v; Clay MD, 2002, J AM CHEM SOC, V124, P788, DOI 10.1021/ja016889g; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Emerson JP, 2002, BIOCHEMISTRY-US, V41, P4348, DOI 10.1021/bi0119159; Girerd JJ, 2000, STRUCT BOND, V97, P145; Jenney FE, 1999, SCIENCE, V286, P306, DOI 10.1126/science.286.5438.306; Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; Kuhnel K, 2007, P NATL ACAD SCI USA, V104, P99, DOI 10.1073/pnas.0606285103; Loew GH, 2000, CHEM REV, V100, P407, DOI 10.1021/cr980389x; Lombard M, 2000, J BIOL CHEM, V275, P27021; Mathe C, 2006, BIOPHYS CHEM, V119, P38, DOI 10.1016/j.bpc.2005.06.013; Mathe C, 2005, J AM CHEM SOC, V127, P16436, DOI 10.1021/ja053808y; Mathe C, 2002, J AM CHEM SOC, V124, P4966, DOI 10.1021/ja025707v; Niviere V, 2004, BIOCHEMISTRY-US, V43, P808, DOI 10.1021/bi035698i; Rodrigues JV, 2006, BIOCHEMISTRY-US, V45, P9266, DOI 10.1021/bi052489k; Roelfes G, 2003, INORG CHEM, V42, P2639, DOI 10.1021/ic034065p; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Tobi D, 2005, P NATL ACAD SCI USA, V102, P18908, DOI 10.1073/pnas.0507603102; Yeh AP, 2000, BIOCHEMISTRY-US, V39, P2499, DOI 10.1021/bi992428k	27	125	127	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					449	453		10.1126/science.1138885	http://dx.doi.org/10.1126/science.1138885			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446401	Green Submitted, Green Accepted			2022-12-28	WOS:000245813400057
J	Rother, KI				Rother, Kristina I.			Focus on research: Diabetes treatment - Bridging the divide	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NIDDKD, Clin Endocrinol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Rother, KI (corresponding author), NIDDKD, Clin Endocrinol Branch, Bethesda, MD 20892 USA.				Intramural NIH HHS [Z99 DK999999] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK055104, Z01DK047049] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Meier JJ, 2005, DIABETOLOGIA, V48, P2221, DOI 10.1007/s00125-005-1949-2; Perrier S, 2006, FEBS LETT, V580, P6289, DOI 10.1016/j.febslet.2006.10.061; Ruiz PJ, 2007, ANN RHEUM DIS, V66, P422, DOI 10.1136/ard.2006.060541	4	174	189	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 12	2007	356	15					1499	1501		10.1056/NEJMp078030	http://dx.doi.org/10.1056/NEJMp078030			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156CA	17429082	Green Accepted			2022-12-28	WOS:000245624400003
J	Klompas, M				Klompas, Michael			Does this patient have ventilator-associated pneumonia?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROTECTED SPECIMEN BRUSH; INTENSIVE-CARE UNITS; NOSOCOMIAL PNEUMONIA; BRONCHOALVEOLAR LAVAGE; CRITICALLY-ILL; DIAGNOSTIC-ACCURACY; RANDOMIZED-TRIAL; INFECTIONS; POSTMORTEM; VALIDATION	Context Ventilator-associated pneumonia (VAP) is a common and serious nosocomial infection. Accurate, timely diagnosis enables affected patients to receive appropriate therapy and avoids mistreatment of patients having other conditions. Objective To review the published medical literature describing the precision and accuracy of clinical, radiographic, and laboratory data to diagnose bacterial VAP relative to a histological gold standard. Data Sources English-language articles identified by a structured search strategy using MEDLINE ( January 1966-October 31, 2006) and Google Scholar. Additional articles were identified through the reference lists of studies and review papers identified by the search strategy. Study Selection Included studies described clinical findings associated with VAP in 25 or more patients receiving mechanical ventilation who subsequently underwent pulmonary biopsy or autopsy. Fourteen studies describing clinical findings in 655 patients met inclusion criteria. Data Extraction Data were abstracted onto a structured form, allowing calculation of the likelihood ratios (LRs) for each sign or combination of findings. Data Synthesis The presence or absence of fever, abnormal white blood cell count, or purulent pulmonary secretions do not substantively alter the probability of VAP. However, the combination of a new radiographic infiltrate with at least 2 of fever, leukocytosis, or purulent sputum increases the likelihood of VAP ( summary LR, 2.8; 95% confidence interval, 0.97-7.9). The absence of a new infiltrate on a plain chest radiograph lowers the likelihood of VAP ( summary LR, 0.35; 95% confidence interval, 0.14-0.87). Fewer than 50% neutrophils on cell count analysis of lower pulmonary secretions makes VAP unlikely ( LR range, 0.05-0.10). Conclusions Routine bedside evaluation coupled with radiographic information provides suggestive but not definitive evidence that VAP is present or absent. Given the severity of VAP and the frequency of serious conditions that can mimic VAP, clinicians should be ready to consider additional tests that provide further evidence for VAP or that establish another diagnosis.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Infect Dis,Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; Harvard Pilgrim Hlth Care, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Klompas, M (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Infect Dis,Channing Lab, 15 Francis St,PBB-4, Boston, MA 02115 USA.	mklompas@partners.org	Klompas, Michael/Z-2415-2019					AlvarezLerma F, 1996, INTENS CARE MED, V22, P387, DOI 10.1007/BF01712153; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Balthazar AB, 2001, BRAZ J MED BIOL RES, V34, P993, DOI 10.1590/S0100-879X2001000800004; Bregeon F, 2000, EUR RESPIR J, V16, P969, DOI 10.1183/09031936.00.16596900; CELIS R, 1988, CHEST, V93, P318, DOI 10.1378/chest.93.2.318; CHASTRE J, 1984, AM REV RESPIR DIS, V130, P924; Chastre J, 2006, CURR OPIN CRIT CARE, V12, P446, DOI 10.1097/01.ccx.0000244125.46871.44; Cook D, 1998, J CRIT CARE, V13, P159, DOI 10.1016/S0883-9441(98)90000-4; CROCE MA, 1994, J TRAUMA, V37, P721, DOI 10.1097/00005373-199411000-00005; Eddy DM., 1992, META ANAL CONFIDENCE; Fabregas N, 1996, ANESTHESIOLOGY, V84, P760, DOI 10.1097/00000542-199604000-00002; Fabregas N, 1999, THORAX, V54, P867, DOI 10.1136/thx.54.10.867; Fagon JY, 1996, JAMA-J AM MED ASSOC, V275, P866, DOI 10.1001/jama.275.11.866; FAGON JY, 1993, CHEST, V103, P547, DOI 10.1378/chest.103.2.547; Gibot S, 2004, NEW ENGL J MED, V350, P451, DOI 10.1056/NEJMoa031544; Heyland D, 2006, NEW ENGL J MED, V355, P2619, DOI 10.1056/NEJMoa052904; Heyland DK, 1999, AM J RESP CRIT CARE, V159, P1249, DOI 10.1164/ajrccm.159.4.9807050; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P313, DOI 10.1001/jama.273.4.313; HORAN TC, 2004, HOSP EPIDEMIOLOGY IN, P1659; JIMENEZ P, 1989, CRIT CARE MED, V17, P882, DOI 10.1097/00003246-198909000-00007; Johanson WG, 2003, INTENS CARE MED, V29, P23, DOI 10.1007/s00134-002-1589-7; JOHANSON WG, 1972, ANN INTERN MED, V77, P701, DOI 10.7326/0003-4819-77-5-701; Kirtland SH, 1997, CHEST, V112, P445, DOI 10.1378/chest.112.2.445; Legras A, 1998, INTENS CARE MED, V24, P1040, DOI 10.1007/s001340050713; Luna CM, 1997, CHEST, V111, P676, DOI 10.1378/chest.111.3.676; MARQUETTE CH, 1995, AM J RESP CRIT CARE, V151, P1878, DOI 10.1164/ajrccm.151.6.7767535; MARQUETTE CH, 1993, AM REV RESPIR DIS, V147, P211, DOI 10.1164/ajrccm/147.1.211; MEDURI GU, 1994, CHEST, V106, P221, DOI 10.1378/chest.106.1.221; Minei JP, 2000, SHOCK, V14, P331, DOI 10.1097/00024382-200014030-00016; MONTRAVERS P, 1993, AM REV RESPIR DIS, V147, P38, DOI 10.1164/ajrccm/147.1.38; OSLER W, 1907, PRINCIPLES PRACTICES, P183; Papazian L, 1996, AM J RESP CRIT CARE, V154, P91, DOI 10.1164/ajrccm.154.1.8680705; PAPAZIAN L, 1995, AM J RESP CRIT CARE, V152, P1982, DOI 10.1164/ajrccm.152.6.8520766; Papazian L, 1997, ANESTHESIOLOGY, V87, P268, DOI 10.1097/00000542-199708000-00013; Petersen IS, 1999, SCAND J INFECT DIS, V31, P299, DOI 10.1080/00365549950163617; PUGIN J, 1991, AM REV RESPIR DIS, V143, P1121, DOI 10.1164/ajrccm/143.5_Pt_1.1121; Rao VK, 1998, CHEST, V114, P549, DOI 10.1378/chest.114.2.549; Rello J, 2002, CHEST, V122, P2115, DOI 10.1378/chest.122.6.2115; RELLO J, 1993, CHEST, V104, P1230, DOI 10.1378/chest.104.4.1230; RELLO J, 1991, CHEST, V100, P439, DOI 10.1378/chest.100.2.439; ROUBY JJ, 1992, AM REV RESPIR DIS, V146, P1059, DOI 10.1164/ajrccm/146.4.1059; ROUBY JJ, 1989, ANESTHESIOLOGY, V71, P679, DOI 10.1097/00000542-198911000-00010; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Schurink CAM, 2004, INTENS CARE MED, V30, P217, DOI 10.1007/s00134-003-2018-2; TIMSIT JF, 1993, CHEST, V104, P104, DOI 10.1378/chest.104.1.104; Torres A, 2000, CRIT CARE MED, V28, P2799, DOI 10.1097/00003246-200008000-00020; TORRES A, 1994, AM J RESP CRIT CARE, V149, P324, DOI 10.1164/ajrccm.149.2.8306025; Torres A, 2001, EUR RESPIR J, V17, P1034, DOI 10.1183/09031936.01.17510340; Trouillet JL, 1998, AM J RESP CRIT CARE, V157, P531, DOI 10.1164/ajrccm.157.2.9705064; Urli T, 2002, J HOSP INFECT, V52, P130, DOI 10.1053/jhin.2002.1271; WUNDERINK RG, 1992, CHEST, V101, P458, DOI 10.1378/chest.101.2.458	51	216	225	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2007	297	14					1583	1593		10.1001/jama.297.14.1583	http://dx.doi.org/10.1001/jama.297.14.1583			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155PG	17426278				2022-12-28	WOS:000245589800027
J	Prentice, MB; Rahalison, L				Prentice, Michael B.; Rahalison, Lila			Plague	LANCET			English	Review							YERSINIA-PESTIS INFECTION; EXPERIMENTAL PNEUMONIC PLAGUE; COMPLETE GENOME SEQUENCE; RESPONSE REGULATOR PHOP; FLEA-BORNE PLAGUE; PLASMINOGEN-ACTIVATOR; PASTEURELLA-PESTIS; BUBONIC PLAGUE; V-ANTIGEN; CAENORHABDITIS-ELEGANS	Bubonic plague is an often fulminant systemic zoonosis, caused by Yersinia pestis. Conventional microbiology, bacterial population genetics, and genome sequence data, all suggest that Y pestis is a recently evolved clone of the enteric pathogen Yersinia pseudotuberculosis. The genetic basis of this organism's rapid adaptation to its insect vector (the flea) with transmission between mammalian hosts by novel subcutaneous and pneumonic routes of infection is becoming clearer. This transition provides a paradigm for the way in which new pathogens could emerge. Plague in humans is controlled by suppression of rodent reservoir hosts and their fleas and by early detection and treatment of cases of disease. Detection systems for plague in non-endemic regions might now be needed because of a bioterrorism threat. Rapid diagnostic tests are available and a subunit vaccine is in clinical trials.	Natl Univ Ireland Univ Coll Cork, Dept Pathol, Cork, Ireland; Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; WHO, Collaborating Ctr Plague, Antananarivo, Madagascar	University College Cork; University College Cork; World Health Organization	Prentice, MB (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Pathol, Cork, Ireland.	m.prentice@ucc.ie	Prentice, Michael/AAE-7246-2019	Prentice, Michael/0000-0003-1117-2388				Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; ACHTMAN M, 2004, YERSINIA MOL CELLULA; *ADV COMM, 1906, J HYG LOND, V6, P467; Alibek K., 2000, BIOHAZARD; *AM SOC MICR, SENT LEV CLIN MICR L; *AM SOC MICR, 2006, AM SOC MICR; Anisimov AP, 2004, CLIN MICROBIOL REV, V17, P434, DOI 10.1128/CMR.17.2.434-464.2004; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P130; Bacot A W, 1914, J Hyg (Lond), V13, P423; Bearden SW, 1997, INFECT IMMUN, V65, P1659, DOI 10.1128/IAI.65.5.1659-1668.1997; Begier EM, 2006, EMERG INFECT DIS, V12, P460, DOI 10.3201/eid1203.051051; Bercovier H., 1984, BERGEYS MANUAL SYSTE, P498; Bijlsma JJE, 2005, MOL MICROBIOL, V57, P85, DOI 10.1111/j.1365-2958.2005.04668.x; Boisier P, 2002, EMERG INFECT DIS, V8, P311, DOI 10.3201/eid0803.010250; BONACORSI SP, 1994, ANTIMICROB AGENTS CH, V38, P481, DOI 10.1128/AAC.38.3.481; Bossi Philippe, 2004, Euro Surveill, V9, pE5; Boulanger LL, 2004, CLIN INFECT DIS, V38, P663, DOI 10.1086/381545; BRUBAKER RR, 1965, SCIENCE, V149, P422, DOI 10.1126/science.149.3682.422; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; Brubaker RR, 2004, MICROB ECOL, V47, P293, DOI 10.1007/s00248-003-1022-y; Brubaker RR, 2003, INFECT IMMUN, V71, P3673, DOI 10.1128/IAI.71.7.3673-3681.2003; BURROWS TW, 1956, BRIT J EXP PATHOL, V37, P481; BUTLER T, 1977, B WORLD HEALTH ORGAN, V55, P39; Butler T, 1983, PLAGUE OTHER YERSINI; Byrne WR, 1998, ANTIMICROB AGENTS CH, V42, P675, DOI 10.1128/AAC.42.3.675; Carniel E, 2003, ADV EXP MED BIOL, V529, P3; CAVANAUGH DC, 1959, FED PROC, V18, P562; *CDCP, EM PREP RESP LAB RES; Chain PSG, 2006, J BACTERIOL, V188, P4453, DOI 10.1128/JB.00124-06; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chanteau S, 2003, LANCET, V361, P211, DOI 10.1016/S0140-6736(03)12270-2; CHANTEAU S, 2004, ATLAS PESTE PADAGASC, P53; Christie A.B., 1990, BACTERIAL DIS, P399; Christopher GW, 1997, JAMA-J AM MED ASSOC, V278, P412, DOI 10.1001/jama.278.5.412; Cohn Samuel K., 2002, BLACK DEATH TRANSFOR; Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; CROOK LD, 1992, ARCH INTERN MED, V152, P1253, DOI 10.1001/archinte.152.6.1253; Darby C, 2002, NATURE, V417, P243, DOI 10.1038/417243a; DAVIES DAL, 1956, BIOCHEM J, V63, P105, DOI 10.1042/bj0630105; Davis KJ, 1996, ARCH PATHOL LAB MED, V120, P156; DEALMEIDA AMP, 1993, MICROB PATHOGENESIS, V14, P9, DOI 10.1006/mpat.1993.1002; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Dennis D. T, 1999, WHOCDSCSREDC992; DEVIGNAT R, 1951, Bull World Health Organ, V4, P247; Drancourt M, 2006, LANCET INFECT DIS, V6, P234, DOI 10.1016/S1473-3099(06)70438-8; Drancourt M, 2004, EMERG INFECT DIS, V10, P1585, DOI 10.3201/eid1009.030933; Drancourt M, 1998, P NATL ACAD SCI USA, V95, P12637, DOI 10.1073/pnas.95.21.12637; DROZDOV IG, 1995, J MED MICROBIOL, V42, P264, DOI 10.1099/00222615-42-4-264; Du YD, 2002, INFECT IMMUN, V70, P1453, DOI 10.1128/IAI.70.3.1453-1460.2002; Duncan SR, 2005, J MED GENET, V42, P205, DOI 10.1136/jmg.2004.025346; Eisen RJ, 2006, P NATL ACAD SCI USA, V103, P15380, DOI 10.1073/pnas.0606831103; Elvin SJ, 2006, VACCINE, V24, P4433, DOI 10.1016/j.vaccine.2005.12.016; Elvin SJ, 2004, NATURE, V430, P417, DOI 10.1038/nature02822; FINEGOLD MJ, 1969, AM J PATHOL, V54, P167; FRIESEN HG, 1995, MRC COMMUNIQUE, V21, P2; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; Gani R, 2004, EMERG INFECT DIS, V10, P608, DOI 10.3201/eid1004.030509; Garcia E, 2003, J BACTERIOL, V185, P5248, DOI 10.1128/JB.185.17.5248-5262.2003; Gilbert MTP, 2004, MICROBIOL-SGM, V150, P341, DOI 10.1099/mic.0.26594-0; Gomes-Solecki MJC, 2005, CLIN DIAGN LAB IMMUN, V12, P339, DOI 10.1128/CDLI.12.2.339-346.2005; Grabenstein JP, 2004, INFECT IMMUN, V72, P4973, DOI 10.1128/IAI.72.9.4973-4984.2004; Guiyoule A, 2001, EMERG INFECT DIS, V7, P43, DOI 10.3201/eid0701.010106; Han YP, 2004, MICROBIOL IMMUNOL, V48, P791, DOI 10.1111/j.1348-0421.2004.tb03605.x; Heath DG, 1998, VACCINE, V16, P1131, DOI 10.1016/S0264-410X(98)80110-2; Higgins JA, 1998, J CLIN MICROBIOL, V36, P2284, DOI 10.1128/JCM.36.8.2284-2288.1998; Hill J, 2006, INFECT IMMUN, V74, P3068, DOI 10.1128/IAI.74.5.3068-3070.2006; Hinchliffe SJ, 2003, GENOME RES, V13, P2018, DOI 10.1101/gr.1507303; Hinnebusch B. J., 2004, Microbe-vector interactions in vector-borne diseases, P331, DOI 10.1017/CBO9780511754845.015; Hinnebusch BJ, 1998, J INFECT DIS, V178, P1406, DOI 10.1086/314456; Hinnebusch BJ, 1996, SCIENCE, V273, P367, DOI 10.1126/science.273.5273.367; Hinnebusch BJ, 2002, SCIENCE, V296, P733, DOI 10.1126/science.1069972; HINNEBUSCH J, 1993, J CLIN MICROBIOL, V31, P1511, DOI 10.1128/JCM.31.6.1511-1514.1993; Hu P, 1998, J BACTERIOL, V180, P5192, DOI 10.1128/JB.180.19.5192-5202.1998; HULL HF, 1987, J INFECT DIS, V155, P113, DOI 10.1093/infdis/155.1.113; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V284, P1649; Jarrett CO, 2004, J INFECT DIS, V190, P783, DOI 10.1086/422695; Joshua GWP, 2003, MICROBIOL-SGM, V149, P3221, DOI 10.1099/mic.0.26475-0; Kadlec RP, 1997, JAMA-J AM MED ASSOC, V278, P351, DOI 10.1001/jama.278.5.351; Kawahara K, 2002, INFECT IMMUN, V70, P4092, DOI 10.1128/IAI.70.8.4092-4098.2002; Keeling MJ, 2000, NATURE, V407, P903, DOI 10.1038/35038073; Kool JL, 2005, CLIN INFECT DIS, V40, P1166, DOI 10.1086/428617; Kutyrev V, 1999, INFECT IMMUN, V67, P1359, DOI 10.1128/IAI.67.3.1359-1367.1999; Lahteenmaki K, 1998, INFECT IMMUN, V66, P5755; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Lindler LE, 1998, INFECT IMMUN, V66, P5731, DOI 10.1128/IAI.66.12.5731-5742.1998; Loiez C, 2003, J CLIN MICROBIOL, V41, P4873, DOI 10.1128/JCM.41.10.4873-4875.2003; Lukaszewski RA, 2005, INFECT IMMUN, V73, P7142, DOI 10.1128/IAI.73.11.7142-7150.2005; MacIntyre S, 2001, MOL MICROBIOL, V39, P12, DOI 10.1046/j.1365-2958.2001.02199.x; MAIR NS, 1986, YERSINIOSIS; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Mecsas J, 2004, NATURE, V427, P606, DOI 10.1038/427606a; Melo AC, 2003, LETT APPL MICROBIOL, V37, P361, DOI 10.1046/j.1472-765X.2003.01377.x; MEYER KF, 1961, BACTERIOL REV, V25, P249, DOI 10.1128/MMBR.25.3.249-261.1961; MIGLIANI R, 2003, PESTE HUMAINE MADAGA; MOLLARET H. H., 1963, BULL SOC PATHOL EXOTIQUE, V56, P1168; Motin VL, 2004, J BACTERIOL, V186, P6298, DOI 10.1128/JB.186.18.6298-6305.2004; Mwengee W, 2006, CLIN INFECT DIS, V42, P614, DOI 10.1086/500137; Overheim KA, 2005, INFECT IMMUN, V73, P5152, DOI 10.1128/IAI.73.8.5152-5159.2005; Oyston PCF, 2000, INFECT IMMUN, V68, P3419, DOI 10.1128/IAI.68.6.3419-3425.2000; Parent MA, 2006, INFECT IMMUN, V74, P3381, DOI 10.1128/IAI.00185-06; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Prentice MB, 2001, J BACTERIOL, V183, P2586, DOI 10.1128/JB.183.8.2586-2594.2001; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; Rahalison L, 2000, J CLIN MICROBIOL, V38, P260; Raoult D, 2000, P NATL ACAD SCI USA, V97, P12800, DOI 10.1073/pnas.220225197; Rasoamanana B, 1996, T ROY SOC TROP MED H, V90, P651, DOI 10.1016/S0035-9203(96)90420-4; Ratsitorahina M, 2000, LANCET, V355, P111, DOI 10.1016/S0140-6736(99)05163-6; Rebeil R, 2004, MOL MICROBIOL, V52, P1363, DOI 10.1111/j.1365-2958.2004.04059.x; Reed DS, 2006, VACCINE, V24, P2283, DOI 10.1016/j.vaccine.2005.11.047; Schubert S, 1998, INFECT IMMUN, V66, P480, DOI 10.1128/IAI.66.2.480-485.1998; Scott S., 2001, BIOL PLAGUES EVIDENC; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; SHARP S, 2006, SENTINEL LAB GUIDELI; SHARP S, 2005, YERSINIA PESTIS; Simond, 1898, ANN I PASTEUR, P625; Sing A, 2002, J IMMUNOL, V168, P1315, DOI 10.4049/jimmunol.168.3.1315; Sing A, 2002, J EXP MED, V196, P1017, DOI 10.1084/jem.20020908; Skurnik M, 2000, MOL MICROBIOL, V37, P316, DOI 10.1046/j.1365-2958.2000.01993.x; SMITH H, 1960, BRIT J EXP PATHOL, V41, P452; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; STRALEY SC, 1984, INFECT IMMUN, V45, P655, DOI 10.1128/IAI.45.3.655-659.1984; TEH WL, 1913, J HYG, V13, P237; TIEH TH, 1948, J INFECT DIS, V82, P52, DOI 10.1093/infdis/82.1.52; Titball RW, 2003, BIOCHEM SOC T, V31, P104, DOI 10.1042/BST0310104; Titball RW, 2001, VACCINE, V19, P4175, DOI 10.1016/S0264-410X(01)00163-3; Weir E, 2005, CAN MED ASSOC J, V172, P1555, DOI 10.1503/cmaj.050297; Welkos SL, 1997, MICROB PATHOGENESIS, V23, P211, DOI 10.1006/mpat.1997.0154; WHITE FN, 1918, INDIAN J MED RES, V6, P190; Wiechmann I, 2005, AM J PHYS ANTHROPOL, V126, P48, DOI 10.1002/ajpa.10276; Wilmoth BA, 1996, J CLIN MICROBIOL, V34, P2829, DOI 10.1128/JCM.34.11.2829-2830.1996; Wren BW, 2003, NAT REV MICROBIOL, V1, P55, DOI 10.1038/nrmicro730; WU LT, 1922, J HYGIENE, V26, P62; Yersin Alexandre, 1894, ANN I PASTEUR PARIS, V8, P662; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9; Zhou DS, 2004, VACCINE, V22, P3367, DOI 10.1016/j.vaccine.2004.02.035; ZIEGLER P, 1982, BLACK DEATH; Zurek L, 2001, J MED ENTOMOL, V38, P333, DOI 10.1603/0022-2585-38.2.333; 2001, MMWR MORB MORTAL WKL, V50, P893	145	210	224	4	80	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2007	369	9568					1196	1207		10.1016/S0140-6736(07)60566-2	http://dx.doi.org/10.1016/S0140-6736(07)60566-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155RH	17416264				2022-12-28	WOS:000245595100031
J	Shibata, N; Chisholm, MF; Nakamura, A; Pennycook, SJ; Yamamoto, T; Ikuhara, Y				Shibata, N.; Chisholm, M. F.; Nakamura, A.; Pennycook, S. J.; Yamamoto, T.; Ikuhara, Y.			Nonstoichiometric dislocation cores in alpha-alumina	SCIENCE			English	Article							SAPPHIRE ALPHA-AL2O3; BASAL SLIP; CRYSTALS; DEFORMATION	Little is known about dislocation core structures in oxides, despite their central importance in controlling electrical, optical, and mechanical properties. It has often been assumed, on the basis of charge considerations, that a nonstoichiometric core structure could not exist. We report atomic-resolution images that directly resolve the cation and anion sublattices in alumina (alpha-Al2O3). A dissociated basal edge dislocation is seen to consist of two cores; an aluminum column terminates one partial, and an oxygen column terminates the second partial. Each partial core is locally nonstoichiometric due to the excess of aluminum or oxygen at the core. The implication for mechanical properties is that the mobile high-temperature dislocation core structure consists of two closely spaced partial dislocations. For basal slip to occur, synchronized motion of the partials on adjacent planes is required.	Univ Tokyo, Inst Engn Innovat, Bunkyo Ku, Tokyo 1138656, Japan; Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA; Osaka City Univ, Dept Intelligent Mat Engn, Sumiyoshi Ku, Osaka 5588585, Japan; Univ Tokyo, Dept Adv Mat Sci, Chiba 2778561, Japan	University of Tokyo; United States Department of Energy (DOE); Oak Ridge National Laboratory; Osaka Metropolitan University; University of Tokyo	Shibata, N (corresponding author), Univ Tokyo, Inst Engn Innovat, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1138656, Japan.	shibata@sigma.t.u-tokyo.ac.jp	liu, kun/AAV-7039-2020; Shibata, Naoya/E-5327-2013; Pennycook, Stephen/AAA-1112-2019; Chisholm, Matthew F./F-7198-2017; Ikuhara, Yuichi/N-1001-2015; Ikuhara, Yuichi/F-3066-2010; Nakamura, Atsutomo/H-3335-2012	Pennycook, Stephen/0000-0002-3210-6323; Chisholm, Matthew F./0000-0003-0546-5109; Ikuhara, Yuichi/0000-0003-3886-005X; Nakamura, Atsutomo/0000-0002-4324-1512				BildeSorensen JB, 1996, ACTA MATER, V44, P2145, DOI 10.1016/1359-6454(95)00264-2; Chisholm MF, 2005, SCIENCE, V307, P701, DOI 10.1126/science.1105962; GESCHWIND S, 1961, PHYS REV, V122, P757, DOI 10.1103/PhysRev.122.757; GILMAN JJ, 1959, ACTA METALL MATER, V7, P608, DOI 10.1016/0001-6160(59)90130-0; Hirth IP, 1992, THEORY DISLOCATIONS; KENWAY PR, 1993, PHILOS MAG B, V68, P171, DOI 10.1080/01418639308226398; KRONBERG ML, 1957, ACTA METALL MATER, V5, P507, DOI 10.1016/0001-6160(57)90090-1; LAGERLOF KDP, 1984, ACTA METALL MATER, V32, P97, DOI 10.1016/0001-6160(84)90206-2; LAGERLOF KPD, 1994, J AM CERAM SOC, V77, P385, DOI 10.1111/j.1151-2916.1994.tb07006.x; Luzzi DE, 1998, ACTA MATER, V46, P2913, DOI 10.1016/S1359-6454(97)00418-7; MITCHELL TE, 1976, PHILOS MAG, V34, P441, DOI 10.1080/14786437608222034; Nakamura A, 2002, ACTA MATER, V50, P101, DOI 10.1016/S1359-6454(01)00318-4; Nellist PD, 2004, SCIENCE, V305, P1741, DOI 10.1126/science.1100965; PENNYCOOK SJ, 1990, PHYS REV LETT, V64, P938, DOI 10.1103/PhysRevLett.64.938; WHITWORTH RW, 1975, ADV PHYS, V24, P203, DOI 10.1080/00018737500101401	15	88	88	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2007	316	5821					82	85		10.1126/science.1136155	http://dx.doi.org/10.1126/science.1136155			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412952				2022-12-28	WOS:000245470500035
J	Kibar, Z; Torban, E; McDearmid, JR; Reynolds, A; Berghout, J; Mathieu, M; Kirillova, I; De Marco, P; Merello, E; Hayes, JM; Wallingford, JB; Drapeau, P; Capra, V; Gros, P				Kibar, Zoha; Torban, Elena; McDearmid, Jonathan R.; Reynolds, Annie; Berghout, Joanne; Mathieu, Melissa; Kirillova, Irena; De Marco, Patrizia; Merello, Elisa; Hayes, Julie M.; Wallingford, John B.; Drapeau, Pierre; Capra, Valeria; Gros, Philippe			Mutations in VANGL1 associated with neural-tube defects	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLANAR CELL POLARITY; TISSUE POLARITY; GENE; STRABISMUS; GOGH	Neural-tube defects such as anencephaly and spina bifida constitute a group of common congenital malformations caused by complex genetic and environmental factors. We have identified three mutations in the VANGL1 gene in patients with familial types (V239I and R274Q) and a sporadic type (M328T) of the disease, including a spontaneous mutation (V239I) appearing in a familial setting. In a protein-protein interaction assay V239I abolished interaction of VANGL1 protein with its binding partners, disheveled-1, -2, and -3. These findings implicate VANGL1 as a risk factor in human neural-tube defects.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Ctr Hlth, Res Inst, Neurosci Res Ctr, Montreal, PQ, Canada; Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ, Canada; Inst Hereditary Dis, Minsk, BELARUS; Ist Giannina Gaslini, Unita Operat Neurochirurg, I-16148 Genoa, Italy; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA	McGill University; McGill University; Universite de Montreal; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Texas System; University of Texas Austin	Gros, P (corresponding author), McGill Univ, Dept Biochem, 3655 Promenade Sir William Osler,Rm 907, Montreal, PQ H3G 1Y6, Canada.	philippe.gros@mcgill.ca	Berghout, Joanne/M-5493-2017; Valeria, Capra/AAB-1501-2019; De Marco, Patrizia/AAB-3172-2019; capra, valeria/N-4367-2013	Berghout, Joanne/0000-0002-9250-9159; De Marco, Patrizia/0000-0001-8498-3750; capra, valeria/0000-0002-3097-0388	NIGMS NIH HHS [R01 GM074104] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074104] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Doudney K, 2005, AM J MED GENET A, V136A, P90, DOI 10.1002/ajmg.a.30766; Doudney K, 2005, AM J MED GENET A, V138A, P415, DOI 10.1002/ajmg.a.30931; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; PANG D, 1993, NEUROSURGERY, V32, P755, DOI 10.1227/00006123-199305000-00009; STEIN KF, 1953, J HERED, V44, P59, DOI 10.1093/oxfordjournals.jhered.a106356; Strutt H, 2005, BIOESSAYS, V27, P1218, DOI 10.1002/bies.20318; Taylor J, 1998, GENETICS, V150, P199; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003; Tortori-Donati P, 2000, NEURORADIOLOGY, V42, P471, DOI 10.1007/s002340000325; van der Linden IJM, 2006, P NUTR SOC, V65, P204, DOI 10.1079/PNS2006495; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wolff T, 1998, DEVELOPMENT, V125, P1149	18	210	257	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 5	2007	356	14					1432	1437		10.1056/NEJMoa060651	http://dx.doi.org/10.1056/NEJMoa060651			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153GG	17409324	Bronze			2022-12-28	WOS:000245419600006
J	Xiao, SH; Zhou, CM; Yuan, XL				Xiao, Shuhai; Zhou, Chuanming; Yuan, Xunlai			Palaeontology - Undressing and redressing Ediacaran embryos	NATURE			English	Letter							NEOPROTEROZOIC DOUSHANTUO FORMATION; ANIMAL EMBRYOS; SOUTH CHINA; PRESERVATION; PHOSPHORITE; LAGERSTATTE		Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24060 USA; Chinese Acad Sci, Nanjing Inst Geol & Paleontol, State Key Lab Paleobiol & Stratig, Nanjing 210008, Peoples R China	Virginia Polytechnic Institute & State University; Chinese Academy of Sciences; Nanjing Institute of Geology & Paleontology, CAS	Xiao, SH (corresponding author), Virginia Polytech Inst & State Univ, Dept Geosci, Blacksburg, VA 24060 USA.	xiao@vt.edu	Xiao, Shuhai/A-2190-2009; Zhou, Chuanming/E-5313-2010	Xiao, Shuhai/0000-0003-4655-2663; 				Bailey JV, 2007, NATURE, V445, P198, DOI 10.1038/nature05457; CHEN J. Y., 2004, DAWN ANIMAL WORLD; Donoghue PCJ, 2007, NATURE, V445, P155, DOI 10.1038/nature05520; Dornbos SQ, 2006, PALAIOS, V21, P3, DOI 10.2110/palo.2004.p04-37; Hagadorn JW, 2006, SCIENCE, V314, P291, DOI 10.1126/science.1133129; Xiao SH, 1999, LETHAIA, V32, P219, DOI 10.1111/j.1502-3931.1999.tb00541.x; Xiao SH, 2000, J PALEONTOL, V74, P767, DOI 10.1666/0022-3360(2000)074<0767:PAEFTN>2.0.CO;2; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Xiao SH, 2007, GEOLOGY, V35, P115, DOI 10.1130/G23277A.1; Yin CY, 2004, ACTA PALAEONTOL POL, V49, P1; Yuan X., 2002, DOUSHANTUO FOSSILS L; ZHANG Y, 1998, PALEONTOL SOC MEM, V50, P1	12	39	48	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2007	446	7136					E9	E10		10.1038/nature05753	http://dx.doi.org/10.1038/nature05753			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17410133				2022-12-28	WOS:000245438300029
J	Zinman, B; Hoogwerf, BJ; Garcia, SD; Milton, DR; Giaconia, JM; Kim, DD; Trautmann, ME; Brodows, RG				Zinman, Bernard; Hoogwerf, Byron J.; Garcia, Santiago Duran; Milton, Denai R.; Giaconia, Joseph M.; Kim, Dennis D.; Trautmann, Michael E.; Brodows, Robert G.			The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							GLYCEMIC CONTROL; SYNTHETIC EXENDIN-4; TREATED PATIENTS; PLASMA-GLUCOSE; METFORMIN; ROSIGLITAZONE; COMBINATION; MELLITUS; THERAPY; WEIGHT	Background: Exenatide therapy is effective in combination with metformin or sulfonylureas for treating type 2 diabetes. Thiazolidinediones (TZDs) also are commonly used, but the efficacy of exenatide with a TZD has not been reported. Objective: To compare the effects of exenatide versus placebo on glycemic control. Design: Placebo run-in, randomized, double-blind, placebo-controlled trial conducted from May 2004 to August 2005. Setting: 49 sites in Canada, Spain, and the United States. Patients: 233 (exenatide group, n = 121; placebo group, n = 112) patients with type 2 diabetes that was suboptimally controlled with TZD treatment (with or without metformin). Mean ( SE) baseline glycated hemoglobin A(1c) level was 7.9% +/- 0.1 %. Interventions: Subcutaneous abdominal injections of 10 mu g of exenatide or placebo twice daily, added to a TZD (with or without metformin) for 16 weeks. Measurements: The primary outcome was change from baseline in hemoglobin A(1c) level. Other outcomes were fasting serum glucose level, body weight, self-monitored blood glucose level, and any adverse events. Results: Exenatide treatment reduced hemoglobin A,c level (mean difference, -0.98% [95% Cl, -1.21% to -0.74%]), serum fasting glucose level (mean difference, -1.69 mmol/L [-30.5 mg/dL] [Cl, -2.22 to -1.17 mmol/L {-40.0 to -21.1 mg/dL}]), and body weight (mean difference, -1.51 kg [Cl, -2.15 to -0.88 kg]). Sixteen percent of patients in the exenatide group and 2% of patients in the placebo group discontinued treatment because of adverse events. In the exenatide group, 40% (n = 48) of patients experienced nausea (mostly mild [n = 21] or moderate In = 19]), 13% experienced vomiting, and 11% experienced hypoglycemia. in the placebo group, 15% of patients experienced nausea, 1 % experienced vomiting, and 7% experienced hypoglycemia. Limitations: Combinations with TZDs and sulfonylureas were not tested. Trial duration was relatively short. Only 71 % and 86% of patients in the exenatide and placebo groups, respectively, completed the study. Conclusions: Exenatide therapy improved glycemic control, reduced body weight, and caused gastrointestinal symptoms more than placebo in patients with type 2 diabetes that was suboptimally controlled with TZD therapy.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5T 3L9, Canada; Univ Toronto, Toronto, ON, Canada; Cleveland Clin, Cleveland, OH 44106 USA; Hosp Univ Nuestra Senora Valme, Seville, Spain; Eli Lilly & Co, Indianapolis, IN 46285 USA; Amylin Pharmaceut, San Diego, CA USA; Eli Lilly & Co, Hamburg, Germany	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Cleveland Clinic Foundation; Hospital Valme; Eli Lilly; Bristol-Myers Squibb; Amylin Pharmaceuticals, LLC; Eli Lilly; Lilly Deutschland GmbH	Zinman, B (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 60 Murray St,Suite L 5-024,Mail Box 17, Toronto, ON M5T 3L9, Canada.	zinman@mshri.on.ca	Zinman, Bernard/E-7266-2013					Blonde L, 2006, DIABETES OBES METAB, V8, P436, DOI 10.1111/j.1463-1326.2006.00602.x; Bloomgarden ZT, 2005, DIABETES CARE, V28, P488, DOI 10.2337/diacare.28.2.488; Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; Cavalot F, 2006, J CLIN ENDOCR METAB, V91, P813, DOI 10.1210/jc.2005-1005; Cohen FJ, 2003, DIABETES CARE, V26, P1847, DOI 10.2337/diacare.26.6.1847; Dailey GE, 2004, AM J MED, V116, P223, DOI 10.1016/j.amjmed.2003.07.022; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; DeFronzo RA, 1999, ANN INTERN MED, V131, P281, DOI 10.7326/0003-4819-131-4-199908170-00008; Degn KB, 2004, DIABETES, V53, P2397, DOI 10.2337/diabetes.53.9.2397; Drucker DJ, 2003, DIABETES CARE, V26, P2929, DOI 10.2337/diacare.26.10.2929; Edwards CMB, 2001, AM J PHYSIOL-ENDOC M, V281, pE155, DOI 10.1152/ajpendo.2001.281.1.E155; Egan JM, 2002, J CLIN ENDOCR METAB, V87, P1282, DOI 10.1210/jc.87.3.1282; Fonseca V, 2000, JAMA-J AM MED ASSOC, V283, P1695, DOI 10.1001/jama.283.13.1695; Heine RJ, 2005, ANN INTERN MED, V143, P559, DOI 10.7326/0003-4819-143-8-200510180-00006; Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Kendall DM, 2006, DIABETES CARE, V29, P154, DOI 10.2337/diacare.29.1.154; Kolterman OG, 2005, AM J HEALTH-SYST PH, V62, P173, DOI 10.1093/ajhp/62.2.173; Kolterman OG, 2003, J CLIN ENDOCR METAB, V88, P3082, DOI 10.1210/jc.2002-021545; Koro CE, 2004, DIABETES CARE, V27, P17, DOI 10.2337/diacare.27.1.17; Kudzma DJ, 2002, AM J MANAG CARE, V8, pS472; Little R.J.A., 2002, STAT ANAL MISSING DA; Meriden T, 2004, CLIN THER, V26, P177, DOI 10.1016/S0149-2918(04)90017-3; Monnier L, 2003, DIABETES CARE, V26, P881, DOI 10.2337/diacare.26.3.881; Morton AP, 2005, MED J AUSTRALIA, V182, P492, DOI 10.5694/j.1326-5377.2005.tb06795.x; Nesto RW, 2004, DIABETES CARE, V27, P256, DOI 10.2337/diacare.27.1.256; Nielsen LL, 2004, REGUL PEPTIDES, V117, P77, DOI 10.1016/j.regpep.2003.10.028; Nielsen Loretta L, 2003, Curr Opin Investig Drugs, V4, P401; Parkes DG, 2001, METABOLISM, V50, P583, DOI 10.1053/meta.2001.22519; Poon Terri, 2005, Diabetes Technol Ther, V7, P467, DOI 10.1089/dia.2005.7.467; Purnell Jonathan Q, 2003, Treat Endocrinol, V2, P33, DOI 10.2165/00024677-200302010-00004; SCHNABEL C, 2004, INCRETIN MIMETICS DP, P35; Seufert J, 2004, CLIN THER, V26, P805, DOI 10.1016/S0149-2918(04)90125-7; Verbeke G, 2000, LINEAR MIXED MODELS; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; *WORLD MED ASS DEC, 1997, JAMA-J AM MED ASSOC, V277, P925, DOI DOI 10.1001/JAMA.1997.03540350075038; Wysowski DK, 2003, DIABETES CARE, V26, P1852, DOI 10.2337/diacare.26.6.1852	37	343	366	1	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2007	146	7					477	485		10.7326/0003-4819-146-7-200704030-00003	http://dx.doi.org/10.7326/0003-4819-146-7-200704030-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153VB	17404349				2022-12-28	WOS:000245463200001
J	Kaiser, U; Schwarz, A; Wiesendanger, R				Kaiser, Uwe; Schwarz, Alexander; Wiesendanger, Roland			Magnetic exchange force microscopy with atomic resolution	NATURE			English	Article							NIO(001) SURFACE; ANTIFERROMAGNETISM; 1ST-PRINCIPLES; STM	The ordering of neighbouring atomic magnetic moments ( spins) leads to important collective phenomena such as ferromagnetism and antiferromagnetism. A full understanding of magnetism on the nanometre scale therefore calls for information on the arrangement of spins in real space and with atomic resolution. Spin-polarized scanning tunnelling microscopy accomplishes this(1) but can probe only conducting materials. Force microscopy can be used on any sample independent of its conductivity. In particular, magnetic force microscopy(2) is well suited to exploring ferromagnetic domain structures. However, atomic resolution cannot be achieved because data acquisition involves the sensing of long-range magnetostatic forces between tip and sample. Magnetic exchange force microscopy has been proposed(3) for overcoming this limitation: by using an atomic force microscope(4) with a magnetic tip, it should be possible to detect the short-range magnetic exchange force between tip and sample spins. Here we show for a prototypical antiferromagnetic insulator, the ( 001) surface of nickel oxide, that magnetic exchange force microscopy can indeed reveal the arrangement of both surface atoms and their spins simultaneously. In contrast with previous attempts to implement this method(5-8), we use an external magnetic field to align the magnetic polarization at the tip apex so as to optimize the interaction between tip and sample spins. This allows us to observe the direct magnetic exchange coupling between the spins of the tip atom and sample atom that are closest to each other, and thereby demonstrate the potential of magnetic exchange force microscopy for investigations of inter-spin interactions at the atomic level.	Univ Hamburg, Inst Appl Phys, D-20355 Hamburg, Germany; Univ Hamburg, Microstruct Res Ctr, D-20355 Hamburg, Germany	University of Hamburg; University of Hamburg	Schwarz, A (corresponding author), Univ Hamburg, Inst Appl Phys, Jungiusstr 11, D-20355 Hamburg, Germany.	aschwarz@physnet.uni-hamburg.de	Wiesendanger, Roland/P-9726-2016	Wiesendanger, Roland/0000-0002-0472-4183				ALBRECHT TR, 1991, J APPL PHYS, V69, P668, DOI 10.1063/1.347347; ANDERSON PW, 1950, PHYS REV, V79, P350, DOI 10.1103/PhysRev.79.350; [Anonymous], 2005, PHYS REV LETT; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Castell MR, 1999, PHYS REV B, V59, P7342, DOI 10.1103/PhysRevB.59.7342; Castell MR, 1997, PHYS REV B, V55, P7859, DOI 10.1103/PhysRevB.55.7859; Foster AS, 2001, SURF SCI, V490, P211, DOI 10.1016/S0039-6028(01)01334-6; GIESSIBL FJ, 1995, SCIENCE, V267, P68, DOI 10.1126/science.267.5194.68; Heinze S, 2000, SCIENCE, V288, P1805, DOI 10.1126/science.288.5472.1805; Hillebrecht FU, 2001, PHYS REV LETT, V86, P3419, DOI 10.1103/PhysRevLett.86.3419; Hoffmann R, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.085402; Holscher H, 2002, APPL PHYS LETT, V81, P4428, DOI 10.1063/1.1525056; Hosoi H, 2004, NANOTECHNOLOGY, V15, P505, DOI 10.1088/0957-4484/15/5/018; Kubetzka A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.087204; Langkat SM, 2003, SURF SCI, V527, P12, DOI 10.1016/S0039-6028(03)00076-1; Liebmann M, 2002, REV SCI INSTRUM, V73, P3508, DOI 10.1063/1.1502446; MARTIN Y, 1987, APPL PHYS LETT, V50, P1455, DOI 10.1063/1.97800; Momida H, 2005, SURF SCI, V590, P42, DOI 10.1016/j.susc.2005.06.006; Nogues J, 1999, J MAGN MAGN MATER, V192, P203, DOI 10.1016/S0304-8853(98)00266-2; Okazawa T, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.195406; Regan TJ, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevLett.87.214422; WIESENDANGER R, 1991, J VAC SCI TECHNOL B, V9, P519, DOI 10.1116/1.585560	22	170	172	6	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2007	446	7135					522	525		10.1038/nature05617	http://dx.doi.org/10.1038/nature05617			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392782				2022-12-28	WOS:000245242900045
J	Bhattacharyya, SN; Filipowicz, W				Bhattacharyya, Suvendra N.; Filipowicz, Witold			Argonautes and company: Sailing against the wind	CELL			English	Editorial Material							MICRORNA	The 3'-untranslated region (UTR) of mRNA is crucial for posttranscriptional regulation. In this issue, Vasudevan and Steitz (2007) report a new function for AGO2 and FXR1 - two proteins that have been linked to the regulation of microRNAs and translation repression. AGO2 and FXR1 bind to the AU-rich element in the 3'-UTR of TNF alpha mRNA, unexpectedly activating its translation in a cell growth-dependent manner.	Friedrich Miescher Inst, CH-4002 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Filipowicz, W (corresponding author), Friedrich Miescher Inst, CH-4002 Basel, Switzerland.	witold.filipowicz@fmi.ch						Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; PILLAI RS, 2006, TRENDS CELL BIO 1229; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848	9	22	23	1	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2007	128	6					1027	1028		10.1016/j.cell.2007.02.033	http://dx.doi.org/10.1016/j.cell.2007.02.033			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382873	Bronze			2022-12-28	WOS:000245396200007
J	Corbesier, L; Vincent, C; Jang, SH; Fornara, F; Fan, QZ; Searle, I; Giakountis, A; Farrona, S; Gissot, L; Turnbull, C; Coupland, G				Corbesier, Laurent; Vincent, Coral; Jang, Seonghoe; Fornara, Fabio; Fan, Qingzhi; Searle, Iain; Giakountis, Antonis; Farrona, Sara; Gissot, Lionel; Turnbull, Colin; Coupland, George			FT protein movement contributes to long-distance signaling in floral induction of Arabidopsis	SCIENCE			English	Article							INTEGRATOR FT; CONSTANS; PHLOEM; TRAFFICKING; LEAVES; ACTIVATION; TISSUES; TOMATO; GENES; ROLES	In plants, seasonal changes in day length are perceived in leaves, which initiate long-distance signaling that induces flowering at the shoot apex. The identity of the long-distance signal has yet to be determined. In Arabidopsis, activation of FLOWERING LOCUS T ( FT) transcription in leaf vascular tissue ( phloem) induces flowering. We found that FT messenger RNA is required only transiently in the leaf. In addition, FT fusion proteins expressed specifically in phloem cells move to the apex and move long distances between grafted plants. Finally, we provide evidence that FT does not activate an intermediate messenger in leaves. We conclude that FT protein acts as a long- distance signal that induces Arabidopsis flowering.	Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; Univ London Imperial Coll Sci & Technol, Div Biol, Wye TN25 5AH, Kent, England	Max Planck Society; Imperial College London	Coupland, G (corresponding author), Max Planck Inst Plant Breeding Res, Carl von Linne Weg 0, D-50829 Cologne, Germany.	coupland@mpiz-koeln.mpg.de	Fornara, Fabio/AAL-3306-2020; Turnbull, Colin/B-4742-2008; Coupland, George/AAP-8609-2020; Fornara, Fabio/B-9978-2012; Searle, Iain/AAE-8869-2019; Searle, Iain/C-9300-2009	Fornara, Fabio/0000-0002-1050-0477; Turnbull, Colin/0000-0001-6635-1418; Coupland, George/0000-0001-6988-4172; Fornara, Fabio/0000-0002-1050-0477; Searle, Iain/0000-0003-4306-9756; Farrona, Sara/0000-0002-6855-2237; Giakountis, Antonis/0000-0001-8648-9908				Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Ayre BG, 2004, PLANT PHYSIOL, V135, P2271, DOI 10.1104/pp.104.040592; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Bohlenius H, 2007, SCIENCE, V316, P367; Gallagher KL, 2005, GENE DEV, V19, P189, DOI 10.1101/gad.1271005; Giavalisco P, 2006, PROTEOMICS, V6, P896, DOI 10.1002/pmic.200500155; Haritatos E, 2000, PLANT PHYSIOL, V123, P929, DOI 10.1104/pp.123.3.929; Haywood V, 2005, PLANT J, V42, P49, DOI 10.1111/j.1365-313X.2005.02351.x; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Imaizumi T, 2006, TRENDS PLANT SCI, V11, P550, DOI 10.1016/j.tplants.2006.09.004; Imlau A, 1999, PLANT CELL, V11, P309, DOI 10.1105/tpc.11.3.309; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kim M, 2001, SCIENCE, V293, P287, DOI 10.1126/science.1059805; KNOTT JAMES E., 1934, PROC AMER SOC HORT SCI, V31, P152; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Lang A., 1965, ENCYCL PLANT PHYSIOL, VVolume XV/1, P1380; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lough TJ, 2006, ANNU REV PLANT BIOL, V57, P203, DOI 10.1146/annurev.arplant.56.032604.144145; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Searle I, 2004, EMBO J, V23, P1217, DOI 10.1038/sj.emboj.7600117; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Teper-Bamnolker P, 2005, PLANT CELL, V17, P2661, DOI 10.1105/tpc.105.035766; Turnbull C., 2004, FLOWERING NEWSLETTER, V37, P3; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; ZEEVAART J. A. D., 1958, MEDEDEL LANDBOUWHOGESCH WAGENINGEN, V58, P1; ZEEVAART JAD, 1976, ANNU REV PLANT PHYS, V27, P321, DOI 10.1146/annurev.pp.27.060176.001541	33	1452	1636	27	522	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2007	316	5827					1030	1033		10.1126/science.1141752	http://dx.doi.org/10.1126/science.1141752			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17446353	Green Published			2022-12-28	WOS:000246554000047
J	Grassly, NC; Wenger, J; Durrani, S; Bahl, S; Deshpande, JM; Sutter, RW; Heymann, DL; Aylward, RB				Grassly, Nicholas C.; Wenger, Jay; Durrani, Sunita; Bahl, Sunil; Deshpande, Jagadish M.; Sutter, Roland W.; Heymann, David L.; Aylward, R. Bruce			Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study	LANCET			English	Article							SURVEILLANCE; SENSITIVITY; VIRUS; INDIA	Background A high-potency monovalent oral type 1 poliovirus vaccine (mOPV1) was developed in 2005 to tackle persistent poliovirus transmission in the last remaining infected countries. Our aim was to assess the efficacy of this vaccine in India. Methods We estimated the efficacy of mOPVl used in supplementary immunisation activities from 2076 matched case-control pairs of confirmed cases of poliomyelitis caused by type 1 wild poliovirus and cases of non-polio acute flaccid paralysis in India. The effect of the introduction of mOPVl on population immunity was calculated on the basis of estimates of vaccination coverage from data for non-polio acute flaccid paralysis. Findings In areas of persistent poliovirus transmission in Uttar Pradesh, the protective efficacy of mOPVl was estimated to be 30% (95% CI 19-41) per dose against type 1 paralytic disease, compared with 11% (7-14) for the trivalent oral vaccine. 76-82% of children aged 0-23 months were estimated to be protected by vaccination against type 1 poliovirus at the end of 2006, compared with 59% at the end of 2004, before the introduction of mOPV1. Interpretation Under conditions where the efficacy of live-attenuated oral poliovirus vaccines is compromised by a high prevalence of diarrhoea and other infections, a dose of high-potency mOPVl is almost three times more effective against type 1 poliomyelitis disease than is trivalent vaccine. Achieving high coverage with this new vaccine in areas of persistent poliovirus transmission should substantially improve the probability of rapidly eliminating transmission of the disease.	Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England; WHO, Natl Polio Surveillance Project, New Delhi, India; Enterovirus Res Ctr, Bombay, Maharashtra, India; WHO, Global Polio Eradicat Initiat, CH-1211 Geneva, Switzerland	Imperial College London; World Health Organization; Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); ICMR - Enterovirus Research Centre; World Health Organization	Grassly, NC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Norfolk Pl, London W2 1PG, England.	n.grassly@imperial.ac.uk	Grassly, Nicholas C/C-6381-2008	Grassly, Nicholas C/0000-0001-6067-4507; Deshpande, Jagadish/0000-0001-5194-0375				[Anonymous], 2004, Wkly Epidemiol Rec, V79, P121; [Anonymous], 1995, J Infect Dis, V171, P1097; Aylward RB, 2006, RISK ANAL, V26, P1441, DOI 10.1111/j.1539-6924.2006.00840.x; Aylward RB, 2005, SCIENCE, V310, P625, DOI 10.1126/science.1115547; Banerjee K, 2000, B WORLD HEALTH ORGAN, V78, P321; Caceres VM, 2001, CLIN INFECT DIS, V33, P531, DOI 10.1086/321905; Gary HE, 1997, J INFECT DIS, V175, pS135, DOI 10.1093/infdis/175.Supplement_1.S135; GHENDON YZ, 1961, ACTA VIROL, V5, P265; Graf H, 2006, BIOLOGICALS, V34, P141, DOI 10.1016/j.biologicals.2006.03.011; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; HALSEY N, 1985, B WORLD HEALTH ORGAN, V63, P1151; HENRY JL, 1966, J HYG-CAMB, V64, P105, DOI 10.1017/S0022172400040389; Hills, 1993, STAT MODELS EPIDEMIO; Kohler KA, 2003, EPIDEMIOL INFECT, V131, P711, DOI 10.1017/S0950268803008562; Marx A, 2000, EPIDEMIOL REV, V22, P298, DOI 10.1093/oxfordjournals.epirev.a018041; ONORATO IM, 1991, J INFECT DIS, V163, P1, DOI 10.1093/infdis/163.1.1; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; Posey DL, 1997, J INFECT DIS, V175, pS258, DOI 10.1093/infdis/175.Supplement_1.S258; Sutter R. W., 2004, VACCINES, P651; *WHO, 2005, WKLY EPIDEMIOL REC, V80, P409; *WHO, 2004, WKLY EPIDEMIOL REC, V79, P401; *WHO, 2004, WKLY EPIDEMIOL REC, V79, P229; *WHO, 2004, WKLY EPIDEMIOL REC, V79, P316	23	105	116	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1356	1362		10.1016/S0140-6736(07)60531-5	http://dx.doi.org/10.1016/S0140-6736(07)60531-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	159HL	17448821				2022-12-28	WOS:000245856100028
J	Sherman, DG; Albers, GW; Bladin, C; Fieschi, C; Gabbai, AA; Kase, CS; O'Riordan, W; Pineo, GF				Sherman, David G.; Albers, Gregory W.; Bladin, Christopher; Fieschi, Cesare; Gabbai, Alberto A.; Kase, Carlos S.; O'Riordan, William; Pineo, Graham F.		PREVAIL Investigators	The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venousthromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison	LANCET			English	Article							MOLECULAR-WEIGHT HEPARINS; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; METAANALYSIS; PROPHYLAXIS; GUIDELINES; MANAGEMENT; STATEMENT; DIAGNOSIS; STANDARD	Background Venous thromboembolism prophylaxis with low molecular weight heparin or unfractionated heparin is recommended in acute ischaemic stroke, but which regimen provides optimum treatment is uncertain. We aimed to compare the efficacy and safety of enoxaparin with that of unfractionated heparin for patients with stroke. Methods 1762 patients with acute ischaemic stroke who were unable to walk unassisted were randomly assigned within 48 h of symptoms to receive either enoxaparin 40 mg subcutaneously once daily or unfractionated heparin 5000 U subcutaneously every 12 h for 10 days (range 6-14). Patients were stratified by National Institutes of Health Stroke Scale (NIHSS) score (severe stroke >= 14, less severe stroke < 14). The primary efficacy endpoint was the composite of symptomatic or asymptomatic deep vein thrombosis, symptomatic pulmonary embolism, or fatal pulmonary embolism. Primary safety endpoints were symptomatic intracranial haemorrhage, major extracranial haemorrhage, and all-cause mortality. This study is registered with ClinicalTrials.gov, number NCT00077805. Findings In the efficacy population (ie, one or more dose received, presence of deep vein thrombosis or pulmonary embolism, or assessment for venous thromboembolism), enoxaparin (n=666) and unfractionated heparin (669) were given for 10 center dot 5 days (SD 3-2). Enoxaparin reduced the risk of venous thromboembolism by 43% compared with unfractionated heparin (68 [10%] vs 121 [18%1; relative risk 0 - 57, 95% CI 0.44-0-76, p=0 - 0001; difference -7.9%, -11.6 to -4-2); this reduction was consistent for patients with an NIHSS score of 14 or more (26 [16%] VS 52 [30%]; p=0 - 0036) or less than 14 (42 [8%] vs 69 [14%]; p=0 - 0044). The occurrence of any bleeding was similar with enoxaparin (69 [8%]) or unfractionated heparin (71 [8%]; p=0 - 83). The frequency of the composite of symptomatic intracranial and major extracranial haemorrhage was small and closely similar between groups (enoxaparin 11 [l%] vs unfractionated heparin 6 [l%]; p=0 - 23). We noted no difference for symptomatic intracranial haemorrhage between groups (4 [1%] vs 6 [1%], respectively; p=0-55); the rate of major extracranial bleeding was higher with enoxaparin than with unfractionated heparin (7 [l%] vs 0; p=0 - 015). Interpretation Our results suggest that for patients with acute ischaemic stroke, enoxaparin is preferable to unfractionated heparin for venous thromboembolism prophylaxis in view of its better clinical benefits to risk ratio and convenience of once daily administration.	Univ Texas, Hlth Sci Ctr, Dept Med Neurol, San Antonio, TX 78229 USA; Stanford Univ, Med Ctr, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA; Monash Univ, Box Hill Hosp, Melbourne, Vic 3004, Australia; Univ Roma La Sapienza, Rome, Italy; Univ Fed Sao Paulo, Disciplina Neurol, Sao Paulo, Brazil; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Paradise Valley Hosp, National City, CA USA; Univ Calgary, Calgary, AB, Canada	University of Texas System; University of Texas Health San Antonio; Stanford University; Box Hill Hospital; Monash University; Sapienza University Rome; Universidade Federal de Sao Paulo (UNIFESP); Boston University; University of Calgary	Sherman, DG (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Med, Div Neurol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	sherman@uthscsa.edu	ince, birsen/AAI-1704-2019; bladin, chris/B-9136-2013	Albers, Gregory/0000-0003-0263-4632; Kase, Carlos/0000-0002-3047-5010				Adams HP, 2003, STROKE, V34, P1056, DOI 10.1161/01.STR.0000064841.47697.22; Albers GW, 2004, CHEST, V126, p483S, DOI 10.1378/chest.126.3_suppl.483S; Alikhan R, 2003, THROMB HAEMOSTASIS, V89, P590, DOI 10.1055/s-0037-1613391; Bath PMW, 2000, STROKE, V31, P1770, DOI 10.1161/01.STR.31.7.1770; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Counsell C, 2002, STROKE, V33, P1925, DOI 10.1161/01.STR.0000018820.99077.46; Diener HC, 2006, STROKE, V37, P139, DOI 10.1161/01.STR.0000195182.67656.ee; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Hacke W, 2003, CEREBROVASC DIS, V16, P311, DOI 10.1159/000072554; Hillbom M, 2002, ACTA NEUROL SCAND, V106, P84, DOI 10.1034/j.1600-0404.2002.01215.x; Hull RD, 2005, AM J MED, V118, P456, DOI 10.1016/j.amjmed.2005.01.025; Johnston KC, 1998, STROKE, V29, P447, DOI 10.1161/01.STR.29.2.447; Kamphuisen PW, 2007, THROMB RES, V119, P265, DOI 10.1016/j.thromres.2006.03.010; Kelly J, 2004, STROKE, V35, P2320, DOI 10.1161/01.STR.0000140741.13279.4f; Kelly J, 2001, STROKE, V32, P262, DOI 10.1161/01.STR.32.1.262; LENSING AWA, 1992, THROMB HAEMOSTASIS, V67, P8; Leys D, 2001, CEREBROVASC DIS, V11, P1, DOI 10.1159/000049137; MCCARTHY ST, 1977, LANCET, V2, P800; MCCARTHY ST, 1986, AGE AGEING, V15, P84, DOI 10.1093/ageing/15.2.84; Mismetti P, 2000, THROMB HAEMOSTASIS, V83, P14; Nicolaides AN, 2006, INT ANGIOL, V25, P101; RABINOV K, 1972, ARCH SURG-CHICAGO, V104, P134; Raskob GE, 2003, CHEST, V124, p379S, DOI 10.1378/chest.124.6_suppl.379S; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; World Health Organization, 2015, ATL HEART DIS STROK; Yalamanchili Kiran, 2005, Am J Ther, V12, P293, DOI 10.1097/01.mjt.00001= 32251.03275.3c	28	198	215	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1347	1355		10.1016/S0140-6736(07)60633-3	http://dx.doi.org/10.1016/S0140-6736(07)60633-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	159HL	17448820				2022-12-28	WOS:000245856100027
J	Kulkarni, RN; Kahn, CR				Kulkarni, Rohit N.; Kahn, C. Ronald			Ephs and ephrins keep pancreatic beta cells connected	CELL			English	Editorial Material								How insulin-secreting beta cells of the pancreas communicate with each other is largely unknown. In this issue of Cell, Konstantinova et al. (2007) show that the signaling proteins EphA and ephrin-A modulate insulin secretion, providing fresh insights into the functional significance of the clustering of beta cells, which occurs in islets.	Harvard Univ, Sch Med, Dept Med, Joslin Diabet Ctr,Div Cell & Mol Physiol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Joslin Diabet Ctr,Div Obes & Hormone Act, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Kulkarni, RN (corresponding author), Harvard Univ, Sch Med, Dept Med, Joslin Diabet Ctr,Div Cell & Mol Physiol, Boston, MA 02215 USA.	rohit.kulkarni@joslin.harvard.edu	Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228				BONNERWEIR S, 1982, DIABETES, V31, P883, DOI 10.2337/diabetes.31.10.883; Geng XH, 2003, DIABETES, V52, P767, DOI 10.2337/diabetes.52.3.767; HALBAN PA, 1982, ENDOCRINOLOGY, V111, P86, DOI 10.1210/endo-111-1-86; Hribal ML, 2003, FASEB J, V17, P1340, DOI 10.1096/fj.02-0685fje; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Li JS, 2004, AM J PHYSIOL-ENDOC M, V286, pE818, DOI 10.1152/ajpendo.00307.2003; SAMOLS E, 1990, METABOLISM, V39, P55, DOI 10.1016/0026-0495(90)90212-U	8	7	7	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					241	243		10.1016/j.cell.2007.04.006	http://dx.doi.org/10.1016/j.cell.2007.04.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448984	Bronze			2022-12-28	WOS:000246474600010
J	Goes, NB; Colvin, RB; Harris, NL; Bazari, H				Goes, Nelson B.; Colvin, Robert B.; Harris, Nancy Lee; Bazari, Hasan			A 56-year-old woman with renal failure after heart-lung transplantation - Collapsing glomerulopathy, associated with severe hyaline arteriolopathy, probably caused by chronic cyclosporine toxicity (with other potential factors including hyperlipidemia and hypertension). Hypertensive arteriosclerosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; KIDNEY-TRANSPLANTATION; CHRONIC NEPHROPATHY; ALLOGRAFTS; RECIPIENTS; PROLIFERATION; INFECTION; ORGAN		Massachusetts Gen Hosp, Div Nephrol, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Goes, NB (corresponding author), Massachusetts Gen Hosp, Div Nephrol, Dept Med, Boston, MA 02114 USA.							Barisoni L, 1999, J AM SOC NEPHROL, V10, P51; Barisoni L, 2000, KIDNEY INT, V58, P137, DOI 10.1046/j.1523-1755.2000.00149.x; CATTRAN DC, 1992, NEPHROL DIAL TRANSPL, V7, P48; Choi HK, 2000, ARTHRITIS RHEUM, V43, P405, DOI 10.1002/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5; Cosio FG, 1999, AM J KIDNEY DIS, V34, P731, DOI 10.1016/S0272-6386(99)70400-2; D'Agati VD, 2004, AM J KIDNEY DIS, V43, P368, DOI 10.1053/j.ajkd.2003.10.024; DISCHE FE, 1988, LAB INVEST, V58, P395; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Halloran PF, 2005, NEW ENGL J MED, V352, P1056; Kasiske BL, 2003, AM J TRANSPLANT, V3, P178, DOI 10.1034/j.1600-6143.2003.00010.x; Lipshutz GS, 2005, AM J TRANSPLANT, V5, P366, DOI 10.1111/j.1600-6143.2004.00685.x; Markowitz GS, 2001, J AM SOC NEPHROL, V12, P1164, DOI 10.1681/ASN.V1261164; Meehan SM, 1998, TRANSPLANTATION, V65, P1192, DOI 10.1097/00007890-199805150-00009; Menahem SA, 2005, TRANSPLANTATION, V79, P259, DOI 10.1097/01.TP.0000145057.41418.22; MIHATSCH MJ, 1995, TRANSPLANT P, V27, P39; Milstone A, 2004, TRANSPLANTATION, V77, P1019, DOI 10.1097/01.TP.0000119156.52197.CA; Moudgil A, 2001, KIDNEY INT, V59, P2126, DOI 10.1046/j.1523-1755.2001.00727.x; MYERS BD, 1988, KIDNEY INT, V33, P590, DOI 10.1038/ki.1988.38; Mylonakis E, 2001, TRANSPLANTATION, V72, P1587, DOI 10.1097/00007890-200111270-00001; Nadasdy T, 2002, HUM PATHOL, V33, P437, DOI 10.1053/hupa.2002.124333; Nankivell BJ, 2004, TRANSPLANTATION, V78, P461, DOI 10.1097/01.TP.0000128612.75163.26; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; NIZZE H, 1988, CLIN NEPHROL, V30, P248; Ojo AO, 2003, NEW ENGL J MED, V349, P931, DOI 10.1056/NEJMoa021744; Pascual M, 2002, NEW ENGL J MED, V346, P580, DOI 10.1056/NEJMra011295; PRASHAR Y, 1995, FEBS LETT, V358, P109, DOI 10.1016/0014-5793(94)01382-B; RANDHAWA PS, 1993, AM J SURG PATHOL, V17, P60, DOI 10.1097/00000478-199301000-00007; Shankland SJ, 2000, KIDNEY INT, V58, P674, DOI 10.1046/j.1523-1755.2000.00213.x; Stokes MB, 1999, AM J KIDNEY DIS, V33, P658, DOI 10.1016/S0272-6386(99)70216-7; WEISS MA, 1986, AM J KIDNEY DIS, V7, P20, DOI 10.1016/S0272-6386(86)80052-X; [No title captured]	31	13	13	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 19	2007	356	16					1657	1665		10.1056/NEJMcpc079008	http://dx.doi.org/10.1056/NEJMcpc079008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AB	17442909				2022-12-28	WOS:000245762000010
J	Hart, RA; Xu, XY; Legere, R; Gibble, K				Hart, Russell A.; Xu, Xinye; Legere, Ronald; Gibble, Kurt			A quantum scattering interferometer	NATURE			English	Article							DEGENERATE FERMI GAS; GROUND-STATE; ATOMIC FOUNTAIN; OPTICAL LATTICE; FREQUENCY-SHIFT; SPECTROSCOPY; OCCUPATION; COLLISIONS; SOLITON	The collision of two ultracold atoms results in a quantum mechanical superposition of the two possible outcomes: each atom continues without scattering, and each atom scatters as an outgoing spherical wave with an s-wave phase shift. The magnitude of the s-wave phase shift depends very sensitively on the interaction between the atoms. Quantum scattering and the underlying phase shifts are vitally important in many areas of contemporary atomic physics, including Bose - Einstein condensates(1-5), degenerate Fermi gases(6-9), frequency shifts in atomic clocks(10-12) and magnetically tuned Feshbach resonances(13). Precise experimental measurements of quantum scattering phase shifts have not been possible because the number of scattered atoms depends on the s-wave phase shifts as well as the atomic density, which cannot be measured precisely. Here we demonstrate a scattering experiment in which the quantum scattering phase shifts of individual atoms are detected using a novel atom interferometer. By performing an atomic clock measurement using only the scattered part of each atom's wavefunction, we precisely measure the difference of the s-wave phase shifts for the two clock states in a density-independent manner. Our method will enable direct and precise measurements of ultracold atom - atom interactions, and may be used to place stringent limits on the time variations of fundamental constants(14).	Penn State Univ, Dept Phys, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gibble, K (corresponding author), Penn State Univ, Dept Phys, 104 Davey Lab, University Pk, PA 16802 USA.	kgibble@psu.edu		Gibble, Kurt/0000-0003-3652-9638				Buggle C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.173202; Chin C, 2000, PHYS REV LETT, V85, P2717, DOI 10.1103/PhysRevLett.85.2717; Chin C, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.032701; Chin C, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.230801; DeMarco B, 1999, SCIENCE, V285, P1703, DOI 10.1126/science.285.5434.1703; DePue MT, 1999, PHYS REV LETT, V82, P2262, DOI 10.1103/PhysRevLett.82.2262; Ensher JR, 1996, PHYS REV LETT, V77, P4984, DOI 10.1103/PhysRevLett.77.4984; Fertig C, 2000, PHYS REV LETT, V85, P1622, DOI 10.1103/PhysRevLett.85.1622; GIBBLE K, 1993, PHYS REV LETT, V70, P1771, DOI 10.1103/PhysRevLett.70.1771; GIBBLE K, 1995, PHYS REV LETT, V75, P2666, DOI 10.1103/PhysRevLett.75.2666; Gupta S, 2003, SCIENCE, V300, P1723, DOI 10.1126/science.1085335; Hall DS, 1998, PHYS REV LETT, V81, P1539, DOI 10.1103/PhysRevLett.81.1539; Hamann SE, 1998, PHYS REV LETT, V80, P4149, DOI 10.1103/PhysRevLett.80.4149; Inouye S, 1998, NATURE, V392, P151, DOI 10.1038/32354; KASEVICH M, 1991, PHYS REV LETT, V66, P2297, DOI 10.1103/PhysRevLett.66.2297; Khaykovich L, 2002, SCIENCE, V296, P1290, DOI 10.1126/science.1071021; KOKKELMANS SJJ, 2000, THESIS U EINDHOVEN; Legere R, 1998, PHYS REV LETT, V81, P5780, DOI 10.1103/PhysRevLett.81.5780; LEGERE RJ, 1999, THESIS YALE U; LEVITT MH, 1986, PROG NUCL MAG RES SP, V18, P61, DOI 10.1016/0079-6565(86)80005-X; Modugno G, 2002, SCIENCE, V297, P2240, DOI 10.1126/science.1077386; MONROE CR, 1993, PHYS REV LETT, V70, P414, DOI 10.1103/PhysRevLett.70.414; Myatt CJ, 1997, PHYS REV LETT, V78, P586, DOI 10.1103/PhysRevLett.78.586; O'Hara KM, 2002, SCIENCE, V298, P2179, DOI 10.1126/science.1079107; Stenger J, 1998, NATURE, V396, P345, DOI 10.1038/24567; Strecker KE, 2002, NATURE, V417, P150, DOI 10.1038/nature747; Thomas NR, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.173201; Treutlein P, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.051401; Widera A, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/8/152; Wynands R, 2005, METROLOGIA, V42, pS64, DOI 10.1088/0026-1394/42/3/S08	30	19	19	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2007	446	7138					892	895		10.1038/nature05680	http://dx.doi.org/10.1038/nature05680			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17443182	Green Submitted			2022-12-28	WOS:000245785700037
J	Wang, CC; Lee, JC; Luo, SY; Kulkarni, SS; Huang, YW; Lee, CC; Chang, KL; Hung, SC				Wang, Cheng-Chung; Lee, Jinq-Chyi; Luo, Shun-Yuan; Kulkarni, Suvarn S.; Huang, Yu-Wen; Lee, Chia-Chen; Chang, Ken-Lien; Hung, Shang-Cheng			Regioselective one-pot protection of carbohydrates	NATURE			English	Article							SOLID-PHASE SYNTHESIS; OLIGOSACCHARIDE SYNTHESIS; O-GLYCOSYLATION; EFFICIENT; HEMAGGLUTININ; STRATEGY; ETHERS	Carbohydrates are involved in a wide range of biological processes(1-4). These structurally diverse compounds are more complex than other biological polymers, and are often present as heterogeneous mixtures in nature. The chemical synthesis of carbohydrates is one way to obtain pure oligosaccharides, but it is hampered by difficulties associated with the regioselective protection of polyhydroxyls and challenges related to the stereoselective assembly of glycosidic linkages(5-14). Here we describe a combinatorial, and highly-regioselective, method that can be used to protect individual hydroxy groups of a monosaccharide. This approach can be used to install an orthogonal protecting group pattern in a single reaction vessel (a 'one-pot' reaction), which removes the need to carry out the time-consuming isolation and purification of intermediates. Hundreds of building blocks have been efficiently prepared starting from D-glucose, and the iterative coupling of these building blocks enabled us to assemble beta-1,6-glucans and a library of oligosaccharides based on the influenza-virus binding trisaccharide.	Natl Tsing Hua Univ, Dept Chem, Hsinchu 300, Taiwan; Acad Sinica, Taiwan Int Grad Program, Chem Biol & Mol Biophys Program, Taipei 115, Taiwan; Acad Sinica, Inst Chem, Taipei 115, Taiwan; Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	National Tsing Hua University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Hung, SC (corresponding author), Natl Tsing Hua Univ, Dept Chem, Hsinchu 300, Taiwan.	hung@mx.nthu.edu.tw	Lee, Jinq-Chyi/C-1373-2010; Wang, Cheng-Chung/ABG-6014-2020; Wang, Cheng-Chung/D-8946-2015	Wang, Cheng-Chung/0000-0002-2562-0658; 				Bertozzi CR, 2001, SCIENCE, V291, P2357, DOI 10.1126/science.1059820; DANISHEFSKY SJ, 1993, SCIENCE, V260, P1307, DOI 10.1126/science.8493573; De Meo C, 2005, TETRAHEDRON-ASYMMETR, V16, P303, DOI 10.1016/j.tetasy.2004.11.043; Demchenko AV, 2003, SYNLETT, P1225, DOI 10.1055/s-2003-40349; Douglas NL, 1998, J CHEM SOC PERK T 1, P51, DOI 10.1039/a705275h; Ernst B., 2000, CARBOHYDRATES CHEM B, V1-4; Flitsch SL, 2005, NATURE, V437, P201, DOI 10.1038/437201a; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; HATAKEYAMA S, 1994, TETRAHEDRON LETT, V35, P4367, DOI 10.1016/S0040-4039(00)73357-0; Huang XF, 2004, ANGEW CHEM INT EDIT, V43, P5221, DOI 10.1002/anie.200460176; Jobron L, 1999, J AM CHEM SOC, V121, P5835, DOI 10.1021/ja9836085; Kim JH, 2005, J AM CHEM SOC, V127, P12090, DOI 10.1021/ja052548h; Kocienski P. J, 2005, PROTECTING GROUPS; Lee JC, 2004, J AM CHEM SOC, V126, P476, DOI 10.1021/ja038244h; Parrish CR, 2005, ANNU REV MICROBIOL, V59, P553, DOI 10.1146/annurev.micro.59.030804.121059; Pellissier H, 2005, TETRAHEDRON, V61, P2947, DOI 10.1016/j.tet.2005.01.070; Plante OJ, 2000, J AM CHEM SOC, V122, P7148, DOI 10.1021/ja0008665; Plante OJ, 2001, SCIENCE, V291, P1523, DOI 10.1126/science.1057324; Schofield L, 2002, NATURE, V418, P785, DOI 10.1038/nature00937; Sears P, 2001, SCIENCE, V291, P2344, DOI 10.1126/science.1058899; Shie CR, 2005, ANGEW CHEM INT EDIT, V44, P1665, DOI 10.1002/anie.200462172; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; TSUNODA T, 1980, TETRAHEDRON LETT, V21, P1357, DOI 10.1016/S0040-4039(00)74575-8; Varki A., 1999, ESSENTIALS GLYCOBIOL; Wang CC, 2002, ANGEW CHEM INT EDIT, V41, P2360, DOI 10.1002/1521-3773(20020703)41:13<2360::AID-ANIE2360>3.0.CO;2-R; Wright JA, 2001, TETRAHEDRON LETT, V42, P4033, DOI 10.1016/S0040-4039(01)00563-9; Wuts P. G. M., 2007, GREENS PROTECTIVE GR; YAMADA H, 1994, TETRAHEDRON LETT, V35, P3979, DOI 10.1016/S0040-4039(00)76718-9; Zhang ZY, 1999, J AM CHEM SOC, V121, P734, DOI 10.1021/ja982232s	29	300	301	0	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2007	446	7138					896	899		10.1038/nature05730	http://dx.doi.org/10.1038/nature05730			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	158IR	17443183				2022-12-28	WOS:000245785700038
J	Whitehurst, AW; Bodemann, BO; Cardenas, J; Ferguson, D; Girard, L; Peyton, M; Minna, JD; Michnoff, C; Hao, WH; Roth, MG; Xie, XJ; White, MA				Whitehurst, Angelique W.; Bodemann, Brian O.; Cardenas, Jessica; Ferguson, Deborah; Girard, Luc; Peyton, Michael; Minna, John D.; Michnoff, Carolyn; Hao, Weihua; Roth, Michael G.; Xie, Xian-Jin; White, Michael A.			Synthetic lethal screen identification of chemosensitizer loci in cancer cells	NATURE			English	Article							SALICYLIHALAMIDE-A; V-ATPASE; CHECKPOINT; DISCOVERY; COMPLEXES; MITOSIS; DRUGS	Abundant evidence suggests that a unifying principle governing the molecular pathology of cancer is the co-dependent aberrant regulation of core machinery driving proliferation and suppressing apoptosis(1). Anomalous proteins engaged in support of this tumorigenic regulatory environment most probably represent optimal intervention targets in a heterogeneous population of cancer cells. The advent of RNA-mediated interference (RNAi)-based functional genomics provides the opportunity to derive unbiased comprehensive collections of validated gene targets supporting critical biological systems outside the framework of preconceived notions of mechanistic relationships. We have combined a high-throughput cell-based one-well/one-gene screening platform with a genome-wide synthetic library of chemically synthesized small interfering RNAs for systematic interrogation of the molecular underpinnings of cancer cell chemoresponsiveness. NCI-H1155, a human non-small-cell lung cancer line, was employed in a paclitaxel-dependent synthetic lethal screen designed to identify gene targets that specifically reduce cell viability in the presence of otherwise sublethal concentrations of paclitaxel. Using a stringent objective statistical algorithm to reduce false discovery rates below 5%, we isolated a panel of 87 genes that represent major focal points of the autonomous response of cancer cells to the abrogation of microtubule dynamics. Here we show that several of these targets sensitize lung cancer cells to paclitaxel concentrations 1,000-fold lower than otherwise required for a significant response, and we identify mechanistic relationships between cancer-associated aberrant gene expression programmes and the basic cellular machinery required for robust mitotic progression.	Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Simmons Canc Ctr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Biostat & Clin Sci, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	White, MA (corresponding author), Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA.	michael.white@utsouthwestern.edu	Peyton, Michael/A-8728-2008	Roth, Michael/0000-0002-9056-332X	NCI NIH HHS [P50 CA070907] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjamini Y, 1995, J R STAT SOC B, V57, P57, DOI DOI 10.2307/2346101; Boyd MR, 2001, J PHARMACOL EXP THER, V297, P114; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Davies KJA, 2005, HANDB ENVIRON CHEM, V2, P63, DOI 10.1007/b10146; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Jordan MA, 1999, METHOD CELL BIOL, V61, P267; Kawasaki-Nishi S, 2003, FEBS LETT, V545, P76, DOI 10.1016/S0014-5793(03)00396-X; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Moritz M, 2001, CURR OPIN STRUC BIOL, V11, P174, DOI 10.1016/S0959-440X(00)00187-1; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Toschi L, 2005, Future Oncol, V1, P7, DOI 10.1517/14796694.1.1.7; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Wit E, 2003, BIOINFORMATICS, V19, P1055, DOI 10.1093/bioinformatics/btg003; Wu YS, 2002, J AM CHEM SOC, V124, P3245, DOI 10.1021/ja0177713; Xie XS, 2004, J BIOL CHEM, V279, P19755, DOI 10.1074/jbc.M313796200	21	385	408	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2007	446	7137					815	819		10.1038/nature05697	http://dx.doi.org/10.1038/nature05697			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429401				2022-12-28	WOS:000245626800045
J	Kott, A				Kott, Andrea			Steven's violin	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2007	297	14					1529	1530		10.1001/jama.297.14.1529	http://dx.doi.org/10.1001/jama.297.14.1529			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155PG	17426262				2022-12-28	WOS:000245589800001
J	Alonso, MC; Drummond, DR; Kain, S; Hoeng, J; Amos, L; Cross, RA				Alonso, Maria C.; Drummond, Douglas R.; Kain, Susan; Hoeng, Julia; Amos, Linda; Cross, Robert A.			An ATP gate controls tubulin binding by the tethered head of kinesin-1	SCIENCE			English	Article							HAND-OVER-HAND; NECK-LINKER; DIMERIC KINESIN; CATALYTIC CORE; MECHANISM; STEPS; HYDROLYSIS; MICROTUBULES; MOLECULES; MOTILITY	Kinesin-1 is a two-headed molecular motor that walks along microtubules, with each step gated by adenosine triphosphate (ATP) binding. Existing models for the gating mechanism propose a role for the microtubule lattice. We show that unpolymerized tubulin binds to kinesin-1, causing tubulin-activated release of adenosine diphosphate (ADP). With no added nucleotide, each kinesin-1 dimer binds one tubulin heterodimer. In adenylyl-imidodiphosphate (AMP-PNP), a nonhydrolyzable ATP analog, each kinesin-1 dimer binds two tubulin heterodimers. The data reveal an ATP gate that operates independently of the microtubule lattice, by ATP-dependent release of a steric or allosteric block on the tubulin binding site of the tethered kinesin-ADP head.	Marie Curie Res Inst, Mol Motors Grp, Surrey RH8 0TL, England; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Cross, RA (corresponding author), Marie Curie Res Inst, Mol Motors Grp, Surrey RH8 0TL, England.	r.cross@mcri.ac.uk	Cross, Robert A/F-1798-2011	Cross, Robert A/0000-0002-0004-7832; Drummond, Douglas/0000-0003-4155-3747; Amos, Linda/0000-0001-8305-5346	Medical Research Council [MC_U105184313, G0200542(63814), G0200542, U.1051.04.002(78842)] Funding Source: Medline; MRC [G0200542, MC_U105184313] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Asenjo AB, 2006, NAT STRUCT MOL BIOL, V13, P648, DOI 10.1038/nsmb1109; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Carter NJ, 2006, CURR OPIN CELL BIOL, V18, P61, DOI 10.1016/j.ceb.2005.12.009; Case RB, 2000, CURR BIOL, V10, P157, DOI 10.1016/S0960-9822(00)00316-X; Crevel I, 1999, EMBO J, V18, P5863, DOI 10.1093/emboj/18.21.5863; Cross RA, 2000, PHILOS T ROY SOC B, V355, P459, DOI 10.1098/rstb.2000.0587; Cross RA, 2004, TRENDS BIOCHEM SCI, V29, P301, DOI 10.1016/j.tibs.2004.04.010; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hackney DD, 2002, BIOCHEMISTRY-US, V41, P4437, DOI 10.1021/bi0159229; Hahlen K, 2006, J BIOL CHEM, V281, P18868, DOI 10.1074/jbc.M508019200; Hirose K, 1999, MOL BIOL CELL, V10, P2063, DOI 10.1091/mbc.10.6.2063; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; Mather WH, 2006, BIOPHYS J, V91, P2416, DOI 10.1529/biophysj.106.087049; Nishiyama M, 2002, NAT CELL BIOL, V4, P790, DOI 10.1038/ncb857; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rice S, 2003, BIOPHYS J, V84, P1844, DOI 10.1016/S0006-3495(03)74992-3; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Rosenfeld SS, 2001, J BIOL CHEM, V276, P40167, DOI 10.1074/jbc.M103899200; Sugata K, 2004, BIOCHEM BIOPH RES CO, V314, P447, DOI 10.1016/j.bbrc.2003.12.093; TORNISHIGE M, 2000, J CELL BIOL, V151, P1081; VILDIZ A, 2005, TRENDS CELL BIOL, V15, P112; Walczak CE, 2006, NAT CELL BIOL, V8, P903, DOI 10.1038/ncb0906-903; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753	29	90	93	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2007	316	5821					120	123		10.1126/science.1136985	http://dx.doi.org/10.1126/science.1136985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412962	Green Accepted			2022-12-28	WOS:000245470500046
J	Colf, LA; Bankovich, AJ; Hanick, NA; Bowerman, NA; Jones, LL; Kranz, DM; Garcia, KC				Colf, Leremy A.; Bankovich, Alexander J.; Hanick, Nicole A.; Bowerman, Natalie A.; Jones, Lindsay L.; Kranz, David M.; Garcia, K. Christopher			How a single T cell receptor recognizes both self and foreign MHC	CELL			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDE-MHC; NEGATIVE SELECTION; DEGENERATE RECOGNITION; ANTIGEN RECOGNITION; HELICAL RESIDUES; STRUCTURAL BASIS; TCR BINDING; ALLOREACTIVITY; SPECIFICITY	alpha beta T cell receptors (TCRs) can crossreact with both self- and foreign- major histocompatibility complex (MHC) proteins in an enigmatic phenomenon termed alloreactivity. Here we present the 2.35 angstrom structure of the 2C TCR complexed with its foreign ligand H-2L(d)-QL9. Surprisingly, we find that this TCR utilizes a different strategy to engage the foreign pMHC in comparison to the manner in which it recognizes a self ligand H-2K(b)-dEV8. 2C engages both shared and polymorphic residues on L-d and K-b, as well as the unrelated QL9 and dEV8 peptide antigens, in unique pair-wise contacts, resulting in greater structural complementarity with the L-d-QL9 complex. In the structure of an engineered, high-affinity 2C TCR variant bound to H-2L(d)- QL9, the "wild-type" TCR-MHC binding orientation persists despite modified TCR-CDR3 alpha interactions with peptide. Thus, a single TCR recognizes two globally similar, but distinct ligands by divergent mechanisms, indicating that receptor-ligand crossreactivity can occur in the absence of molecular mimicry.	Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; University of Illinois System; University of Illinois Urbana-Champaign	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kcgarcia@stanford.edu		Jones, Lindsay/0000-0003-4360-6451; Bankovich, Alexander/0000-0003-2368-4479	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048540, T32AI007290, R56AI048540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055767] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007290, AI 48540] Funding Source: Medline; NIGMS NIH HHS [GM55767] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anikeeva N, 2003, BIOCHEMISTRY-US, V42, P4709, DOI 10.1021/bi026864+; Archbold JK, 2006, J BIOL CHEM, V281, P34324, DOI 10.1074/jbc.M606755200; Balendiran GK, 1997, P NATL ACAD SCI USA, V94, P6880, DOI 10.1073/pnas.94.13.6880; BEVAN MJ, 1984, IMMUNOL TODAY, V5, P128, DOI 10.1016/0167-5699(84)90233-0; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buslepp J, 2003, IMMUNITY, V19, P595, DOI 10.1016/S1074-7613(03)00269-3; Chen JZ, 2003, MICROBES INFECT, V5, P233, DOI 10.1016/S1286-4579(03)00016-9; CONNOLLY JM, 1994, P NATL ACAD SCI USA, V91, P11482, DOI 10.1073/pnas.91.24.11482; Daniel C, 1998, IMMUNITY, V8, P543, DOI 10.1016/S1074-7613(00)80559-2; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Davis-Harrison RL, 2005, J MOL BIOL, V346, P533, DOI 10.1016/j.jmb.2004.11.063; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; DeLano W.L, PYMOL MOL GRAPHICS S; Ely LK, 2006, P NATL ACAD SCI USA, V103, P6641, DOI 10.1073/pnas.0600743103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 2005, CELL, V122, P333, DOI 10.1016/j.cell.2005.07.015; Garcia KC, 1997, P NATL ACAD SCI USA, V94, P13838, DOI 10.1073/pnas.94.25.13838; Ge Q, 2006, P NATL ACAD SCI USA, V103, P1822, DOI 10.1073/pnas.0510561103; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Hansen T, 2000, IMMUNOL TODAY, V21, P83, DOI 10.1016/S0167-5699(98)01426-1; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Hornell TMC, 1999, J IMMUNOL, V163, P3217; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; Huseby E, 2004, EUR J IMMUNOL, V34, P1243, DOI 10.1002/eji.200425000; Huseby ES, 2006, NAT IMMUNOL, V7, P1191, DOI 10.1038/ni1401; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; Jones LL, 2006, J BIOL CHEM, V281, P25734, DOI 10.1074/jbc.M604343200; Kieke MC, 1999, P NATL ACAD SCI USA, V96, P5651, DOI 10.1073/pnas.96.10.5651; KRANZ DM, 1984, P NATL ACAD SCI-BIOL, V81, P573, DOI 10.1073/pnas.81.2.573; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Lee PUY, 2000, J EXP MED, V191, P1355, DOI 10.1084/jem.191.8.1355; Luz JG, 2002, J EXP MED, V195, P1175, DOI 10.1084/jem.20011644; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; McFarland BJ, 2003, IMMUNITY, V19, P803, DOI 10.1016/S1074-7613(03)00320-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; RODEWALD HR, 1989, J IMMUNOL, V143, P4238; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Santori FR, 2002, IMMUNITY, V17, P131, DOI 10.1016/S1074-7613(02)00361-8; Schlueter CJ, 1996, J IMMUNOL, V157, P4478; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHERMAN LA, 1993, ANNU REV IMMUNOL, V11, P385, DOI 10.1146/annurev.immunol.11.1.385; Shusta EV, 2000, NAT BIOTECHNOL, V18, P754, DOI 10.1038/77325; SKYULEV Y, 1994, P NATL ACAD SCI USA, V91, P11487; Speir JA, 1998, IMMUNITY, V8, P553, DOI 10.1016/S1074-7613(00)80560-9; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Tallquist MD, 1998, J IMMUNOL, V160, P802; TJOA BA, 1994, MOL IMMUNOL, V31, P705, DOI 10.1016/0161-5890(94)90144-9; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; UDAKA K, 1992, CELL, V69, P989, DOI 10.1016/0092-8674(92)90617-L; Udaka K, 1996, J IMMUNOL, V157, P670; Willcox BE, 1999, IMMUNITY, V10, P357, DOI 10.1016/S1074-7613(00)80035-7; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4	63	181	189	2	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					135	146		10.1016/j.cell.2007.01.048	http://dx.doi.org/10.1016/j.cell.2007.01.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418792	Bronze			2022-12-28	WOS:000245661100017
J	Edery, I				Edery, Isaac			A blend of two circadian clocks, seasoned to perfection	CELL			English	Editorial Material							DROSOPHILA; PACEMAKERS; BEHAVIOR; NEURONS	The daily activity of the fruit fly Drosophila is controlled by both a "morning" and an "evening" circadian clock. In this issue Stoleru et al. (2007) demonstrate that day length determines which clock dominates the neural circuitry governing circadian behavior. Thus, these findings suggest a mechanism by which the system for circadian timing adapts to changes in the seasons to impose appropriate rhythms of daily activity.	Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Edery, I (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	edery@cabm.rutgers.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042088] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS042088] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bachleitner W, 2007, P NATL ACAD SCI USA, V104, P3538, DOI 10.1073/pnas.0606870104; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Murad A, 2007, NEURON, V53, P689, DOI 10.1016/j.neuron.2007.01.034; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; PITTENDRIGH CS, 1991, J BIOL RHYTHM, V6, P299, DOI 10.1177/074873049100600402; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; STOLERU D, 2007, CELL	10	0	0	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					21	23		10.1016/j.cell.2007.03.020	http://dx.doi.org/10.1016/j.cell.2007.03.020			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418778	Bronze			2022-12-28	WOS:000245661100003
J	Houwing, S; Kamminga, LM; Berezikov, E; Cronembold, D; Girard, A; van den Elst, H; Filippov, DV; Blaser, H; Raz, E; Moens, CB; Plasterk, RHA; Hannon, GJ; Draper, BW; Ketting, RF				Houwing, Saskia; Kamminga, Leonie M.; Berezikov, Eugene; Cronembold, Daniela; Girard, Angelique; van den Elst, Hans; Filippov, Dmitri V.; Blaser, Heiko; Raz, Erez; Moens, Cecilia B.; Plasterk, Ronald H. A.; Hannon, Gregory J.; Draper, Bruce W.; Ketting, Rene F.			A role for Piwi and piRNAs in germ cell maintenance and transposon silencing in zebrafish	CELL			English	Article							SMALL RNAS; PROCESSING BODIES; DROSOPHILA; SIRNAS; MIGRATION; HOMOLOG; PATHWAY; PROTEIN; TESTES; VASA	Piwi proteins specify an animal-specific subclass of the Argonaute family that, in vertebrates, is specifically expressed in germ cells. We demonstrate that zebrafish Piwi (Ziwi) is expressed in both the male and the female gonad and is a component of a germline-specifying structure called nuage. Loss of Ziwi function results in a progressive loss of germ cells due to apoptosis during larval development. In animals that have reduced Ziwi function, germ cells are maintained but display abnormal levels of apoptosis in adults. In mammals, Piwi proteins associate with approximately 29-nucleotide-long, testis-specific RNA molecules called piRNAs. Here we show that zebrafish piRNAs are present in both ovary and testis. Many of these are derived from transposons, implicating a role for piRNAs in the silencing of repetitive elements in vertebrates. Furthermore, we show that piRNAs are Dicer independent and that their 3' end likely carries a 2'O-Methyl modification.	Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; Univ Calif Davis, Davis, CA 95616 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands; Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; Univ Munster, ZMBE, Inst Cell Biol, D-48149 Munster, Germany; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98019 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); University of California System; University of California Davis; Cold Spring Harbor Laboratory; Leiden University; Leiden University - Excl LUMC; Max Planck Society; University of Munster; Fred Hutchinson Cancer Center	Ketting, RF (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	ketting@niob.knaw.nl	Filippov, Dmitri/J-7612-2017; Hannon, Gregory/AAB-3568-2019; Houwing, Saskia/E-4384-2011; Kamminga, Leonie/O-5722-2019; Kamminga, Leonie M/E-1771-2012; Moens, Cecilia/AAN-1536-2020; Berezikov, Eugene/D-3363-2013	Filippov, Dmitri/0000-0002-6978-7425; Kamminga, Leonie M/0000-0002-0508-7796; Berezikov, Eugene/0000-0002-1145-2884; Moens, Cecilia/0000-0002-1099-0728; Ketting, Rene/0000-0001-6161-5621; Draper, Bruce W/0000-0002-4397-7749				Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Braat AK, 1999, DEV DYNAM, V216, P153, DOI 10.1002/(SICI)1097-0177(199910)216:2<153::AID-DVDY6>3.0.CO;2-1; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; CARMELL MA, 2007, IN PRESS DEV CELL; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Draper BW, 2004, METHOD CELL BIOL, V77, P91; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; GRUIDL ME, 1996, P NATL ACAD SCI USA, V93, P13937; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hashimoto Y, 2004, DEV BIOL, V268, P152, DOI 10.1016/j.ydbio.2003.12.013; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Krovel AV, 2002, MECH DEVELOP, V116, P141, DOI 10.1016/S0925-4773(02)00154-5; Kuramochi-Miyagawa S, 2001, MECH DEVELOP, V108, P121, DOI 10.1016/S0925-4773(01)00499-3; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lingel A, 2005, CURR OPIN STRUC BIOL, V15, P107, DOI 10.1016/j.sbi.2005.01.010; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Rongo C, 1997, COLD SPRING HARB SYM, V62, P1; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; SELMAN K, 1993, J MORPHOL, V218, P203, DOI 10.1002/jmor.1052180209; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Tan CH, 2002, MECH DEVELOP, V119, pS221, DOI 10.1016/S0925-4773(03)00120-5; URAMOCHIMIYAGAW.S, 2004, DEVELOPMENT, V131, P839; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Westerfield M, 1993, ZEBRAFISH BOOK; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; Yoon C, 1997, DEVELOPMENT, V124, P3157; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	53	769	822	5	88	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					69	82		10.1016/j.cell.2007.03.026	http://dx.doi.org/10.1016/j.cell.2007.03.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418787	Green Submitted, Bronze			2022-12-28	WOS:000245661100012
J	Watts, B; Argekar, P; Saint, S; Kauffman, CA				Watts, Brook; Argekar, Pushkar; Saint, Sanjay; Kauffman, Carol A.			Building a diagnosis from the ground up	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PULMONARY BLASTOMYCOSIS		Louis Stokes Cleveland VA Med Ctr, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Watts, B (corresponding author), Louis Stokes Cleveland VA Med Ctr, 10701 E Blvd, Cleveland, OH 44106 USA.	brook.watts@med.va.gov	Saint, Sanjay/AAF-5126-2019		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK067451] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK67451] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Areno J P 4th, 1997, Semin Respir Infect, V12, P252; Bradsher RW, 2003, INFECT DIS CLIN N AM, V17, P21, DOI 10.1016/S0891-5520(02)00038-7; Chapman SW, 2000, CLIN INFECT DIS, V30, P679, DOI 10.1086/313750; Durkin M, 2004, J CLIN MICROBIOL, V42, P4873, DOI 10.1128/JCM.42.10.4873-4875.2004; KLEIN BS, 1986, NEW ENGL J MED, V314, P529, DOI 10.1056/NEJM198602273140901; MEYER KC, 1993, NEW ENGL J MED, V329, P1231, DOI 10.1056/NEJM199310213291704; Pappas P G, 1997, Semin Respir Infect, V12, P243; Patel RG, 1999, SOUTH MED J, V92, P289, DOI 10.1097/00007611-199903000-00006; Wise GJ, 1999, UROL CLIN N AM, V26, P701, DOI 10.1016/S0094-0143(05)70212-3	9	10	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2007	356	14					1456	1462		10.1056/NEJMcps055322	http://dx.doi.org/10.1056/NEJMcps055322			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153GG	17409328				2022-12-28	WOS:000245419600010
J	Patton, GC; Viner, R				Patton, George C.; Viner, Russell			Adolescent health 1 - Pubertal transitions in health	LANCET			English	Review							BODY-MASS-INDEX; SECONDARY SEXUAL CHARACTERISTICS; GENDER DIFFERENCES; BRAIN-DEVELOPMENT; MAJOR DEPRESSION; FOLLOW-UP; EATING-DISORDERS; GROWTH-PATTERNS; SECULAR TRENDS; BLOOD-PRESSURE	Puberty is accompanied by physical, psychological, and emotional changes adapted to ensure reproductive and parenting success. Human puberty stands out in the animal world for its association with brain maturation and physical growth. Its effects on health and wellbeing are profound and paradoxical. On the one hand, physical maturation propels an individual into adolescence with peaks in strength, speed, and fitness. Clinicians have viewed puberty as a point of maturing out of childhood-onset conditions. However, puberty's relevance for health has shifted with a modem rise in psychosocial disorders of young people. It marks a transition in risks for depression and other mental disorders, psychosomatic syndromes, substance misuse, and antisocial behaviours. Recent secular trends in these psychosocial disorders coincide with a growing mismatch between biological and social maturation, and the emergence of more dominant youth cultures.	Univ Melbourne, Murdoch Childrens Res Inst, Dept Paediat, Melbourne, Vic, Australia; UCL, Inst Child Hlth, Gen & Adolescent Paediat Unit, London, England	Murdoch Children's Research Institute; University of Melbourne; University of London; University College London	Patton, GC (corresponding author), Ctr Adolescent Hlth, William Buckland House,2 Gatehouse St, Parkville, Vic 3052, Australia.	george.patton@rch.org.au	Patton, George C/B-5246-2013; Ribeiro, Ana Cristina/HHN-7466-2022; Viner, Russell/A-1441-2009	Patton, George C/0000-0001-5039-8326; Ribeiro, Ana Cristina/0000-0002-0493-8376; Viner, Russell/0000-0003-3047-2247				Abraham S, 2001, INT J EAT DISORDER, V29, P23, DOI 10.1002/1098-108X(200101)29:1&lt;23::AID-EAT4&gt;3.0.CO;2-Z; Adriani W, 1998, BEHAV NEUROSCI, V112, P1152, DOI 10.1037/0735-7044.112.5.1152; Ahlgren M, 2004, NEW ENGL J MED, V351, P1619, DOI 10.1056/NEJMoa040576; Alsaker FD, 1996, J CHILD PSYCHOL PSYC, V37, P249, DOI 10.1111/j.1469-7610.1996.tb01403.x; Angold A, 1999, PSYCHOL MED, V29, P1043, DOI 10.1017/S0033291799008946; Angold A, 1998, PSYCHOL MED, V28, P51, DOI 10.1017/S003329179700593X; [Anonymous], 1995, PSYCHOSOCIAL DISORDE; [Anonymous], J ADOLESCENT RES, DOI DOI 10.1177/074355489381003; ANTHONY JC, 1995, DRUG ALCOHOL DEPEN, V40, P9, DOI 10.1016/0376-8716(95)01194-3; Arlt W, 2002, ENDOCRINOLOGY, V143, P4665, DOI 10.1210/en.2002-220456; ARO H, 1987, CHILD DEV, V58, P261, DOI 10.2307/1130306; BEESON PB, 1994, AM J MED, V96, P457, DOI 10.1016/0002-9343(94)90173-2; BILLE B, 1962, ACTA PAEDIATR SCAND, V51, P9; Biro FM, 2006, INT J ANDROL, V29, P272, DOI 10.1111/j.1365-2605.2005.00602.x; Bond L, 2001, BRIT MED J, V323, P480, DOI 10.1136/bmj.323.7311.480; Book AS, 2001, AGGRESS VIOLENT BEH, V6, P579, DOI 10.1016/S1359-1789(00)00032-X; Bradley SJ, 1997, J AM ACAD CHILD PSY, V36, P872, DOI 10.1097/00004583-199707000-00008; BROOKSGUNN J, 1989, CHILD DEV, V60, P40, DOI 10.1111/j.1467-8624.1989.tb02693.x; Brown JD, 2005, J ADOLESCENT HEALTH, V36, P420, DOI 10.1016/j.jadohealth.2004.06.003; BROWN RT, 1986, J CLIN CHILD PSYCHOL, V15, P194, DOI 10.1207/s15374424jccp1503_1; Burwell R G, 2003, Pediatr Rehabil, V6, P137; Cameron JL, 2004, ANN NY ACAD SCI, V1021, P110, DOI 10.1196/annals.1308.012; Cauffman E, 1996, DEV PSYCHOL, V32, P631; CLAMPIT MK, 1983, ADOLESCENCE, V18, P811; Coffey C, 2003, BRIT MED J, V326, P1064, DOI 10.1136/bmj.326.7398.1064; Cohen RZ, 1999, AM J PSYCHIAT, V156, P1059; Cyranowski JM, 2000, ARCH GEN PSYCHIAT, V57, P21, DOI 10.1001/archpsyc.57.1.21; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P1, DOI 10.1196/annals.1308.001; Delemarre-van de Waal HA, 2002, BEST PRACT RES CL EN, V16, P1, DOI 10.1053/beem.2001.0176; Dick DM, 2000, DEV PSYCHOL, V36, P180, DOI 10.1037//0012-1649.36.2.180; DUKEDUNCAN P, 1985, J YOUTH ADOLESCENCE, V14, P227; Dunger DB, 2005, BEST PRACT RES CL EN, V19, P375, DOI 10.1016/j.beem.2005.04.005; Ernst P, 2002, EUR RESPIR J, V20, P635, DOI 10.1183/09031936.02.00962002; Facchinetti F, 2000, FUNCT NEUROL, V15, P137; Felson RB, 2002, CRIMINOLOGY, V40, P967, DOI 10.1111/j.1745-9125.2002.tb00979.x; Francis DD, 2002, J NEUROSCI, V22, P7840; FREUD A, 1969, ADOLESCENCE; Frezza EE, 2006, GUT, V55, P285, DOI 10.1136/gut.2005.073163; Friedland O, 2005, J RHEUMATOL, V32, P1354; Furlong A., 1997, YOUNG PEOPLE SOCIAL; Garrison CZ, 1997, J AM ACAD CHILD PSY, V36, P458, DOI 10.1097/00004583-199704000-00007; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giles GG, 2003, INT J CANCER, V103, P241, DOI 10.1002/ijc.10810; Gillespie KM, 2005, DIABETES, V54, P1245, DOI 10.2337/diabetes.54.4.1245; Gleicher N, 2006, REPROD BIOMED ONLINE, V12, P587, DOI 10.1016/S1472-6483(10)61184-4; Gluckman PD, 2006, TRENDS ENDOCRIN MET, V17, P7, DOI 10.1016/j.tem.2005.11.006; Goodyer IM, 2000, BRIT J PSYCHIAT, V177, P499, DOI 10.1192/bjp.177.6.499; Goodyer IM, 2000, BRIT J PSYCHIAT, V176, P142, DOI 10.1192/bjp.176.2.142; GOTTLIEB G, 1976, NEURAL BEHAV SPECIFI; Graham P., 2004, END ADOLESCENCE; Guerra S, 2004, AM J RESP CRIT CARE, V170, P78, DOI 10.1164/rccm.200309-1224OC; HAFNER H, 1993, BRIT J PSYCHIAT, V162, P80, DOI 10.1192/bjp.162.1.80; Hall G. Stanley, 1905, ADOLESCENCE ITS PSYC; Hardy R, 2006, J HYPERTENS, V24, P59, DOI 10.1097/01.hjh.0000198033.14848.93; Harreby M S, 1997, Ugeskr Laeger, V159, P171; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Hayward C, 1999, J ADOLESCENT HEALTH, V25, P143, DOI 10.1016/S1054-139X(99)00048-8; HAYWARD C, 1992, AM J PSYCHIAT, V149, P1239; Hayward C, 2002, J ADOLESCENT HEALTH, V30, P49, DOI 10.1016/S1054-139X(02)00336-1; Herman-Giddens ME, 2001, ARCH PEDIAT ADOL MED, V155, P1022, DOI 10.1001/archpedi.155.9.1022; HermanGiddens ME, 1997, PEDIATRICS, V99, P505, DOI 10.1542/peds.99.4.505; Herzog AG, 1997, EPILEPSIA, V38, P1082, DOI 10.1111/j.1528-1157.1997.tb01197.x; Insel TR, 1997, AM J PSYCHIAT, V154, P726; Jones M., 1950, J EDUC PSYCHOL, V41, P129, DOI DOI 10.1037/H0061970; JONES MC, 1965, CHILD DEV, V36, P899, DOI 10.2307/1126932; Jordan SJ, 2005, CANCER EPIDEM BIOMAR, V14, P2045, DOI 10.1158/1055-9965.EPI-05-0085; Juul A, 2006, INT J ANDROL, V29, P247, DOI 10.1111/j.1365-2605.2005.00556.x; Kaplowitz P, 2006, CURR OPIN OBSTET GYN, V18, P487, DOI 10.1097/01.gco.0000242949.02373.09; Kaplowitz PB, 2001, PEDIATRICS, V108, P347, DOI 10.1542/peds.108.2.347; Kessler RC, 2003, J AFFECT DISORDERS, V74, P5, DOI 10.1016/S0165-0327(02)00426-3; KESTENBERG JS, 1967, J AMER ACAD CHILD PS, V6, P426, DOI 10.1016/S0002-7138(09)61682-4; KILLEN JD, 1992, AM J DIS CHILD, V146, P323, DOI 10.1001/archpedi.1992.02160150063023; Klein P, 2003, NEUROLOGY, V60, P495, DOI 10.1212/01.WNL.0000048560.53624.AF; Laitinen J, 2001, AM J CLIN NUTR, V74, P287; Lamason R, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-2; Lanza Stephanie T, 2002, Prev Sci, V3, P69, DOI 10.1023/A:1014675410947; Laurell K, 2004, CEPHALALGIA, V24, P380, DOI 10.1111/j.1468-2982.2004.00681.x; LeResche L, 2005, PAIN, V118, P201, DOI 10.1016/j.pain.2005.08.011; Lerner R. M., 1986, CONCEPTS THEORIES HU; Lewis DA, 1997, NEUROPSYCHOPHARMACOL, V16, P385, DOI 10.1016/S0893-133X(96)00277-1; Loud KJ, 2006, ARCH PEDIAT ADOL MED, V160, P1026, DOI 10.1001/archpedi.160.10.1026; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Martin CA, 2002, J AM ACAD CHILD PSY, V41, P1495, DOI 10.1097/00004583-200212000-00022; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; MECHANIC D, 1983, J HUM STRESS, V9, P4, DOI 10.1080/0097840X.1983.9936119; MOORE J, 1992, INT J PRIMATOL, V13, P361, DOI 10.1007/BF02547823; Mul D, 2001, PEDIATR RES, V50, P479, DOI 10.1203/00006450-200110000-00010; MUSSEN PH, 1958, CHILD DEV, V29, P61, DOI 10.2307/1126270; Nicolai T, 2001, PEDIATR ALLERGY IMMU, V12, P142, DOI 10.1034/j.1399-3038.2001.0007.x; NOLENHOEKSEMA S, 1994, PSYCHOL BULL, V115, P424, DOI 10.1037/0033-2909.115.3.424; O'Dea JA, 1999, ADOLESCENCE, V34, P671; PAIKOFF RL, 1991, J YOUTH ADOLESCENCE, V20, P191, DOI 10.1007/BF01537608; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Patton GC, 2004, PEDIATRICS, V114, pE300, DOI 10.1542/peds.2003-0626-F; Patton GC, 1996, J EPIDEMIOL COMMUN H, V50, P661, DOI 10.1136/jech.50.6.661; PATTON GC, IN PRESS J AM ACAD C; PETERSEN AC, 1991, J YOUTH ADOLESCENCE, V20, P247, DOI 10.1007/BF01537611; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; PRIMUS RJ, 1989, DEV PSYCHOBIOL, V22, P633, DOI 10.1002/dev.420220608; Pundziute-Lycka A, 2002, DIABETOLOGIA, V45, P783, DOI 10.1007/s00125-002-0845-2; Puylaert D, 2004, J PEDIATR ORTHOPED, V24, P144, DOI 10.1097/01241398-200403000-00002; Rahman Q, 2005, NEUROSCI BIOBEHAV R, V29, P1057, DOI 10.1016/j.neubiorev.2005.03.002; Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823; Rhee Hyekyun, 2005, J Pediatr Health Care, V19, P95, DOI 10.1016/j.pedhc.2004.10.004; Riley JL, 1999, PAIN, V81, P225, DOI 10.1016/S0304-3959(98)00258-9; Rosenblum L. A., 1990, ADOLESCENCE PUBERTY, P63; RUTTER M, 1976, J CHILD PSYCHOL PSYC, V17, P35, DOI 10.1111/j.1469-7610.1976.tb00372.x; Sandhu J, 2006, INT J OBESITY, V30, P14, DOI 10.1038/sj.ijo.0803156; Schlegel A., 1991, ADOLESCENCE ANTHROPO; Schofield, 1965, SEXUAL BEHAV YOUNG P; Shankar RR, 2005, J CLIN ENDOCR METAB, V90, P163, DOI 10.1210/jc.2004-0926; Shughrue PJ, 2000, FRONT NEUROENDOCRIN, V21, P95, DOI 10.1006/frne.1999.0190; SIMMONS RG, 1979, AM SOCIOL REV, V44, P948, DOI 10.2307/2094719; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Spear LP, 2004, ANN NY ACAD SCI, V1021, P23, DOI 10.1196/annals.1308.002; SPEAR LP, 1983, DEV PSYCHOBIOL, V16, P83, DOI 10.1002/dev.420160203; Stafford DEJ, 2002, CURR OPIN OBSTET GYN, V14, P445, DOI 10.1097/00001703-200210000-00002; Stattin H., 1990, PUBERTAL MATURATION; STATTIN H, 2003, PUBERTAL MATURATION; Stice E, 2001, DEV PSYCHOL, V37, P608, DOI 10.1037//0012-1649.37.5.608; Stroud LR, 2002, BIOL PSYCHIAT, V52, P318, DOI 10.1016/S0006-3223(02)01333-1; Svalheim S, 2006, SEIZURE-EUR J EPILEP, V15, P571, DOI 10.1016/j.seizure.2006.07.003; Swarr AE, 1996, DEV PSYCHOL, V32, P636, DOI 10.1037/0012-1649.32.4.636; Teilmann G, 2002, BEST PRACT RES CL EN, V16, P105, DOI 10.1053/beem.2002.0184; Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593; THORLEY G, 1984, PSYCHOL BULL, V96, P116; van Ginkel R, 2003, GASTROENTEROLOGY, V125, P357, DOI 10.1016/S0016-5085(03)00888-6; VANDENBERG SM, 2006, BEHAV GENET, V36, P1; Varraso R, 2005, AM J RESP CRIT CARE, V171, P334, DOI 10.1164/rccm.200405-674OC; Verthelyi D, 2001, INT IMMUNOPHARMACOL, V1, P983, DOI 10.1016/S1567-5769(01)00044-3; Vincent HK, 2006, INT J OBESITY, V30, P400, DOI 10.1038/sj.ijo.0803177; Viner R, 2002, ARCH DIS CHILD, V86, P8, DOI 10.1136/adc.86.1.8; VINER RM, 2006, ARCH DIS CHILD S, V91, pA86; Wade TJ, 2002, J AM ACAD CHILD PSY, V41, P190, DOI 10.1097/00004583-200202000-00013; Wang YF, 2002, PEDIATRICS, V110, P903, DOI 10.1542/peds.110.5.903; WATSON AR, 2003, FORFAR ARNEILS TXB P, P599; Wedderkopp N, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-52; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Wichstrom L, 1999, DEV PSYCHOL, V35, P232, DOI 10.1037/0012-1649.35.1.232; Wichstrom L, 2001, J RES ADOLESCENCE, V11, P131, DOI 10.1111/1532-7795.00007; Willoughby MT, 2003, J CHILD PSYCHOL PSYC, V44, P88, DOI 10.1111/1469-7610.t01-1-00104; Young EA, 2004, ANN NY ACAD SCI, V1021, P124, DOI 10.1196/annals.1308.013	144	512	525	3	60	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2007	369	9567					1130	1139		10.1016/S0140-6736(07)60366-3	http://dx.doi.org/10.1016/S0140-6736(07)60366-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	151XF	17398312				2022-12-28	WOS:000245323700033
J	Richards, T				Richards, Tessa			A better way to die - Why dying and death need to be "rehabilitated" back to a more central position in society	BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com							0	4	4	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 21	2007	334	7598					830	830		10.1136/bmj.39188.592940.59	http://dx.doi.org/10.1136/bmj.39188.592940.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	162MD	17446614	Green Published			2022-12-28	WOS:000246090800030
J	Bowman, JL; Floyd, SK; Sakakibara, K				Bowman, John L.; Floyd, Sandra K.; Sakakibara, Keiko			Green genes - Comparative genomics of the green branch of life	CELL			English	Article							LAND PLANTS; EVOLUTION; ARABIDOPSIS; EUKARYOTES; ORIGINS	As more plant genome sequences become available, researchers are increasingly using comparative genomics to address some of the major questions in plant biology. Such questions include the evolution of photosynthesis and multicellularity, the developmental genetic changes responsible for alterations in body plan, and the origin of important plant innovations such as roots, leaves, and vascular tissue.	Monash Univ, Sch Biol Sci, Melbourne, Vic 3800, Australia	Monash University	Bowman, JL (corresponding author), Monash Univ, Sch Biol Sci, Clayton Campus, Melbourne, Vic 3800, Australia.	john.bowman@sci.monash.edu.au	Sakakibara, Keiko/Q-5748-2018	Sakakibara, Keiko/0000-0003-4420-9351; Bowman, John/0000-0001-7347-3691				Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Floyd SK, 2007, INT J PLANT SCI, V168, P1, DOI 10.1086/509079; Floyd SK, 2006, CURR BIOL, V16, P1911, DOI 10.1016/j.cub.2006.07.067; Friedman WE, 2004, AM J BOT, V91, P1726, DOI 10.3732/ajb.91.10.1726; Grossman AR, 2007, CURR OPIN PLANT BIOL, V10, P190, DOI 10.1016/j.pbi.2007.01.012; Harrison CJ, 2005, NATURE, V434, P509, DOI 10.1038/nature03410; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Nishiyama T, 2003, P NATL ACAD SCI USA, V100, P8007, DOI 10.1073/pnas.0932694100; Ohno S., 1970, EVOLUTION GENE DUPLI; Ruiz-Trillo I, 2007, TRENDS GENET, V23, P113, DOI 10.1016/j.tig.2007.01.005; Turmel M, 2003, PLANT CELL, V15, P1888, DOI 10.1105/tpc.013169; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691	18	157	160	2	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 20	2007	129	2					229	234		10.1016/j.cell.2007.04.004	http://dx.doi.org/10.1016/j.cell.2007.04.004			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448980	Bronze			2022-12-28	WOS:000246474600006
J	Lohman, DJ; Bickford, D; Sodhi, NS				Lohman, David J.; Bickford, David; Sodhi, Navjot S.			The burning issue	SCIENCE			English	Editorial Material							FOREST; SMOKE		Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	National University of Singapore	Lohman, DJ (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.	lohman@nus.edu.sg; dbsns@nus.edu.sg	Bickford, David P/A-5306-2011	Bickford, David P/0000-0003-1478-3387; Lohman, David/0000-0002-0689-2906				Barber C, 2000, TRIAL FIRE FOREST FI; Byron N, 2004, AGR ECOSYST ENVIRON, V104, P57, DOI 10.1016/j.agee.2004.01.006; FAO, 2007, FIR MAN GLOB ASS 200; Glover D., 1999, INDONESIAS FIRES HAZ; Jayachandran S, 2005, 95 BREAD; Kinnaird MF, 1998, CONSERV BIOL, V12, P954, DOI 10.1046/j.1523-1739.1998.012005954.x; Marten G. G., 1986, TRADITIONAL AGR SE A; Nichol J, 1998, ATMOS ENVIRON, V32, P3917; Nichol J, 1997, ATMOS ENVIRON, V31, P1209, DOI 10.1016/S1352-2310(96)00260-9; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Sastry N, 2002, DEMOGRAPHY, V39, P1, DOI 10.1353/dem.2002.0009; Tomich TP, 2004, AGR ECOSYST ENVIRON, V104, P229, DOI 10.1016/j.agee.2004.01.017; 2007, STRAITS TIMES   0106, P24	13	54	54	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					376	376		10.1126/science.1140278	http://dx.doi.org/10.1126/science.1140278			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446376				2022-12-28	WOS:000245813400026
J	Lacroix, J; Hebert, PC; Hutchison, JS; Hume, HA; Tucci, M; Ducruet, T; Gauvin, F; Collet, JP; Toledano, BJ; Robillard, P; Joffe, A; Biarent, D; Meert, K; Peters, MJ				Lacroix, Jacques; Hebert, Paul C.; Hutchison, James S.; Hume, Heather A.; Tucci, Marisa; Ducruet, Thierry; Gauvin, France; Collet, Jean-Paul; Toledano, Baruch J.; Robillard, Pierre; Joffe, Ari; Biarent, Dominique; Meert, Kathleen; Peters, Mark J.		TRIPCI Investigators	Transfusion strategies for patients in pediatric intensive care units	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-TRANSFUSION; RANDOMIZED-TRIAL; GENERATION; MORTALITY; STORAGE	BACKGROUND: The optimal hemoglobin threshold for erythrocyte transfusions in critically ill children is unknown. We hypothesized that a restrictive transfusion strategy of using packed red cells that were leukocyte-reduced before storage would be as safe as a liberal transfusion strategy, as judged by the outcome of multiple-organ dysfunction. METHODS: In this noninferiority trial, we enrolled 637 stable, critically ill children who had hemoglobin concentrations below 9.5 g per deciliter within 7 days after admission to an intensive care unit. We randomly assigned 320 patients to a hemoglobin threshold of 7 g per deciliter for red-cell transfusion (restrictive-strategy group) and 317 patients to a threshold of 9.5 g per deciliter (liberal-strategy group). RESULTS: Hemoglobin concentrations were maintained at a mean (+/- SD) level that was 2.1 +/- 0.2 g per deciliter lower in the restrictive-strategy group than in the liberal-strategy group (lowest average levels, 8.7 +/- 0.4 and 10.8 +/- 0.5 g per deciliter, respectively; P < 0.001). Patients in the restrictive-strategy group received 44% fewer transfusions; 174 patients (54%) in that group did not receive any transfusions, as compared with 7 patients (2%) in the liberal-strategy group (P < 0.001). New or progressive multiple-organ dysfunction syndrome (the primary outcome) developed in 38 patients in the restrictive-strategy group, as compared with 39 in the liberal-strategy group (12% in both groups) (absolute risk reduction with the restrictive strategy, 0.4%; 95% confidence interval, -4.6 to 5.4). There were 14 deaths in each group within 28 days after randomization. No significant differences were found in other outcomes, including adverse events. CONCLUSIONS: In stable, critically ill children a hemoglobin threshold of 7 g per deciliter for red-cell transfusion can decrease transfusion requirements without increasing adverse outcomes.	Univ Montreal, Hop St Justine, Montreal, PQ H3T 1C5, Canada; McGill Univ, Montreal, PQ, Canada; Univ Ottawa, Ottawa, ON, Canada; Univ Toronto, Toronto, ON, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Univ Alberta, Edmonton, AB, Canada; Univ Libre Bruxelles, Brussels, Belgium; Wayne State Univ, Detroit, MI USA; Inst Child Hlth, London, England	Universite de Montreal; McGill University; University of Ottawa; University of Toronto; University of British Columbia; University of Alberta; Universite Libre de Bruxelles; Wayne State University; University of London; University College London	Lacroix, J (corresponding author), Univ Montreal, Hop St Justine, Rm 3431,3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	jacques_lacroix@ssss.gouv.qc.ca	Peters, Mark/AAD-7518-2019	Peters, Mark/0000-0003-3653-4808				[Anonymous], 1989, AM REV RESPIR DIS, V139, P1058; Armano R, 2005, CRIT CARE MED, V33, P2637, DOI 10.1097/01.CCM.0000185645.84802.73; Bell EF, 2005, PEDIATRICS, V115, P1685, DOI 10.1542/peds.2004-1884; Bilgin YM, 2004, CIRCULATION, V109, P2755, DOI 10.1161/01.CIR.0000130162.11925.21; BLACKWELDER WC, 1984, CONTROL CLIN TRIALS, V5, P97, DOI 10.1016/0197-2456(84)90116-8; BLACKWELDER WC, 1982, CONTROL CLIN TRIALS, V3, P345, DOI 10.1016/0197-2456(82)90024-1; Desmet L, 2004, CRIT CARE CLIN, V20, P299, DOI 10.1016/S0749-0704(03)00113-1; Fergusson D, 2003, JAMA-J AM MED ASSOC, V289, P1950, DOI 10.1001/jama.289.15.1950; Garrett AD, 2003, STAT MED, V22, P741, DOI 10.1002/sim.1360; Gauvin F, 2006, TRANSFUSION, V46, P1899, DOI 10.1111/j.1537-2995.2006.00995.x; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hebert PC, 1999, NEW ENGL J MED, V340, P1056; Jonas RA, 2003, J THORAC CARDIOV SUR, V126, P1765, DOI 10.1016/j.jtcvs.2003.04.003; Kirpalani H, 2006, J PEDIATR-US, V149, P301, DOI 10.1016/j.jpeds.2006.05.011; Lacroix J., 2006, PEDIAT CRITICAL CARE, P1394; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Laverdiere Caroline, 2002, Pediatr Crit Care Med, V3, P335, DOI 10.1097/00130478-200210000-00001; Leteurtre S, 2006, LANCET, V367, P897, DOI 10.1016/S0140-6736(06)68371-2; Leteurtre S, 2003, LANCET, V362, P192, DOI 10.1016/S0140-6736(03)13908-6; LUBAN NLC, 1991, TRANSFUSION, V31, P229, DOI 10.1046/j.1537-2995.1991.31391165172.x; Marshall JC, 1999, CRIT CARE MED, V27, P676, DOI 10.1097/00003246-199904000-00005; Morris KP, 2005, ARCH DIS CHILD, V90, P724, DOI 10.1136/adc.2004.062174; Nahum Elhanan, 2004, J Intensive Care Med, V19, P38, DOI 10.1177/0885066603257966; POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006; Proulx F, 1996, CHEST, V109, P1033, DOI 10.1378/chest.109.4.1033; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Sanchez MM, 2006, STAT MED, V25, P1169, DOI 10.1002/sim.2244; Schulz KF, 2002, LANCET, V359, P781, DOI 10.1016/S0140-6736(02)07882-0; Shanwell A, 1997, TRANSFUSION, V37, P678, DOI 10.1046/j.1537-2995.1997.37797369441.x; STACK G, 1995, TRANSFUSION, V35, P199, DOI 10.1046/j.1537-2995.1995.35395184274.x; Vamakas EC, 2006, CRIT CARE MED, V34, pS151, DOI 10.1097/01.CCM.0000214310.70642.8C; Vamvakas EC, 2003, TRANSFUSION, V43, P963, DOI 10.1046/j.1537-2995.2003.00426.x; van de Watering LMG, 1998, CIRCULATION, V97, P562; Yazer MH, 2004, TRANSFUSION, V44, P10, DOI 10.1046/j.0041-1132.2003.00518.x	34	709	725	2	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2007	356	16					1609	1619		10.1056/NEJMoa066240	http://dx.doi.org/10.1056/NEJMoa066240			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AB	17442904	Green Published			2022-12-28	WOS:000245762000003
J	Budd, PM				Budd, Peter M.			Putting order into polymer networks	SCIENCE			English	Editorial Material							INTRINSIC MICROPOROSITY; HYDROGEN ADSORPTION; ORGANIC FRAMEWORKS; SURFACE-AREA; CRYSTALLINE; STORAGE		Univ Manchester, Sch Chem, Organ Mat Innovat Ctr, Manchester M13 9PL, Lancs, England	University of Manchester	Budd, PM (corresponding author), Univ Manchester, Sch Chem, Organ Mat Innovat Ctr, Manchester M13 9PL, Lancs, England.	peter.budd@manchester.ac.uk						Budd PM, 2004, ADV MATER, V16, P456, DOI 10.1002/adma.200306053; Cote AP, 2005, SCIENCE, V310, P1166, DOI 10.1126/science.1120411; El-Kaderi HM, 2007, SCIENCE, V316, P268, DOI 10.1126/science.1139915; Germain J, 2006, CHEM MATER, V18, P4430, DOI 10.1021/cm061186p; Ghanem BS, 2007, CHEM COMMUN, P67, DOI 10.1039/b614214a; Lee JY, 2006, CHEM COMMUN, P2670, DOI 10.1039/b604625h; Lin X, 2006, ANGEW CHEM INT EDIT, V45, P7358, DOI 10.1002/anie.200601991; McKeown NB, 2006, CHEM SOC REV, V35, P675, DOI 10.1039/b600349d; Tilford RW, 2006, CHEM MATER, V18, P5296, DOI 10.1021/cm061177g; Wong-Foy AG, 2006, J AM CHEM SOC, V128, P3494, DOI 10.1021/ja058213h	10	35	47	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					210	211		10.1126/science.1141929	http://dx.doi.org/10.1126/science.1141929			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431160				2022-12-28	WOS:000245654500030
J	Taylor, R; Davison, JM				Taylor, Roy; Davison, John M.			Pregnancy plus - Type 1 diabetes and pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OUTCOMES; WOMEN; CARE		Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England; Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Taylor, R (corresponding author), Newcastle Gen Hosp, Magnet Resonance Ctr, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.	roy.taylor@ncl.ac.uk						Brown SC, 1999, DIABETIC MED, V16, P573, DOI 10.1046/j.1464-5491.1999.00124.x; CEMACH, 2005, CONF ENQ MAT CHILD H; Diabet Contr Complicat Trial Res Grp, 1998, ARCH OPHTHALMOL-CHIC, V116, P874; Feig DS, 2006, DIABETES CARE, V29, P232, DOI 10.2337/diacare.29.02.06.dc05-1482; Jensen DM, 2004, DIABETES CARE, V27, P2819, DOI 10.2337/diacare.27.12.2819; Penney GC, 2003, BJOG-INT J OBSTET GY, V110, P315, DOI 10.1016/S1470-0328(03)02967-7; Ratner RE, 2000, DIABETES CARE, V23, P639, DOI 10.2337/diacare.23.5.639; Taylor R, 2002, OBSTET GYNECOL, V99, P537, DOI 10.1016/S0029-7844(01)01790-2; Temple RC, 2006, DIABETES CARE, V29, P1744, DOI 10.2337/dc05-2265	9	25	27	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2007	334	7596					742	745		10.1136/bmj.39154.700417.BE	http://dx.doi.org/10.1136/bmj.39154.700417.BE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AO	17413175	Green Published			2022-12-28	WOS:000245763300032
J	Reiner, SL				Reiner, Steven L.			Development in motion: Helper T cells at work	CELL			English	Review							AUTOIMMUNE INFLAMMATION; LINEAGE; DIFFERENTIATION; CYTOKINE; T(H)17; IL-23; DISTINCT; GROWTH; BETA	In mammals, helper T cells orchestrate defense against diverse pathogens. However, these warriors of the immune system can also result in self-inflicted injury culminating in autoimmune and allergic diseases. Recent findings-such as the discovery of the Th17 lineage-have revealed additional complexity in the fates chosen by helper T cells and have begun to reshape our view of how signaling and transcriptional networks generate appropriate and inappropriate immunity.	Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Reiner, SL (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	sreiner@mail.med.upenn.edu						Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	20	219	238	1	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					33	36		10.1016/j.cell.2007.03.019	http://dx.doi.org/10.1016/j.cell.2007.03.019			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418783	Bronze			2022-12-28	WOS:000245661100008
J	Vijayanand, P; Seumois, G; Pickard, C; Powell, RM; Angco, G; Sammut, D; Gadola, SD; Friedmann, PS; Djukanovic, R				Vijayanand, Pandurangan; Seumois, Gregory; Pickard, Chris; Powell, Robert M.; Angco, Gilbert; Sammut, David; Gadola, Stephan D.; Friedmann, Peter S.; Djukanovic, Ratko			Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BRONCHOALVEOLAR LAVAGE; BRONCHIAL-ASTHMA; FLOW-CYTOMETRY; FREQUENCY	BACKGROUND The number of type 2 helper CD4+ T cells is increased in the airways of persons with asthma. Whether the majority of these cells are class II major-histocompatibility-complex-restricted cells or are among the recently identified CD1d-restricted invariant natural killer T cells is a matter of controversy. We studied the frequency of invariant natural killer T cells in the airways of subjects with mild or moderately severe asthma to investigate the possibility of an association between the number of invariant natural killer T cells in the airway and disease severity. We also studied whether an increased number of these cells is a feature of chronic obstructive pulmonary disease (COPD). METHODS We enumerated invariant natural killer T cells by flow cytometry with the use of CD1d tetramers loaded with alpha-galactosylceramide and antibodies specific to the invariant natural killer T-cell receptor in samples of bronchoalveolar-lavage fluid, induced sputum, and bronchial-biopsy specimens obtained from subjects with mild or moderately severe asthma, subjects with COPD, and healthy control subjects. Real-time polymerase-chain-reaction analysis was performed on bronchoalveolar-lavage cells for evidence of gene expression of the invariant natural killer T-cell receptor. RESULTS Fewer than 2% of the T cells obtained from all subjects on airway biopsy, bronchoalveolar lavage, and sputum induction were invariant natural killer T cells, with no significant differences among the three groups of subjects. No expression of messenger RNA for the invariant natural killer T-cell-receptor domains V alpha 24 and V beta 11 was detected in bronchoalveolar-lavage cells from subjects with asthma. CONCLUSIONS Invariant natural killer T cells are found in low numbers in the airways of subjects with asthma, subjects with COPD, and controls.	Univ Southampton, Southampton Gen Hosp, Inflammatory Cell Biol Grp, Div Infect Inflammat & Repair, Southampton SO16 6YD, Hants, England; Univ Southampton, Southampton Gen Hosp, Roger Brooke Lab, PrimerDesign, Southampton, Hants, England; Univ Bern, Inselspital, CH-3010 Bern, Switzerland	University of Southampton; University of Southampton; University of Bern	Vijayanand, P (corresponding author), Univ Southampton, Southampton Gen Hosp, Inflammatory Cell Biol Grp, Div Infect Inflammat & Repair, Level F,S Block,Mail Point 810,Tremona Rd, Southampton SO16 6YD, Hants, England.	vijay@soton.ac.uk	Sammut, David/AAM-9164-2021	Djukanovic, Ratko/0000-0001-6039-5612				Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Bousquet J, 2000, CLIN EXP ALLERGY, V30, P2; DJUKANOVIC R, 1991, AM REV RESPIR DIS, V143, P772, DOI 10.1164/ajrccm/143.4_Pt_1.772; Gunther U, 2005, J IMMUNOL, V174, P8219, DOI 10.4049/jimmunol.174.12.8219-a; Gunther U, 2005, J IMMUNOL, V174, P5414, DOI 10.4049/jimmunol.174.9.5414; Hamzaoui A, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/71214; Ho LP, 2005, LANCET, V365, P1062, DOI 10.1016/S0140-6736(05)71143-0; Karadimitris A, 2001, P NATL ACAD SCI USA, V98, P3294, DOI 10.1073/pnas.051604498; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Larche M, 2003, J ALLERGY CLIN IMMUN, V111, P450, DOI 10.1067/mai.2003.169; Lucas M, 2003, J VIROL, V77, P2251, DOI 10.1128/JVI.77.3.2251-2257.2003; Metelitsa LS, 2004, CLIN IMMUNOL, V110, P267, DOI 10.1016/j.clim.2003.11.005; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Pham-Thi N, 2006, J ALLERGY CLIN IMMUN, V117, P217, DOI 10.1016/j.jaci.2005.09.052; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Soethout EC, 2004, CLIN DIAGN LAB IMMUN, V11, P795, DOI 10.1128/CDLI.11.4.795-798.2004; Thomas SY, 2006, NEW ENGL J MED, V354, P2613; VIGNOLA RM, 2002, EUR RESPIR J, V37, pS51; Weyde J, 1997, J IMMUNOL METHODS, V207, P115, DOI 10.1016/S0022-1759(97)00103-8; Yang S, 2005, J IMMUNOL, V175, P4914, DOI 10.4049/jimmunol.175.8.4914; 1997, THORAX S, V52, pS1	22	158	168	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 5	2007	356	14					1410	1422		10.1056/NEJMoa064691	http://dx.doi.org/10.1056/NEJMoa064691			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153GG	17409322	Bronze			2022-12-28	WOS:000245419600004
J	Brewer, NT; Salz, T; Lillie, SE				Brewer, Noel T.; Salz, Talya; Lillie, Sarah E.			Systematic review: The long-term effects of false-positive mammograms	ANNALS OF INTERNAL MEDICINE			English	Review							BREAST SCREENING-PROGRAM; SERVICES TASK-FORCE; QUALITY-OF-LIFE; PSYCHOLOGICAL CONSEQUENCES; ABNORMAL MAMMOGRAMS; WOMENS ANXIETIES; RE-ATTENDANCE; CANCER; IMPACT; BEHAVIOR	Background: Although abnormal screening mammograms deleteriously affect the psychological well-being of women during the time immediately surrounding the tests, their long-term effects are poorly understood. Purpose: To characterize the long-term effects of false-positive screening mammograms on the behavior and well-being of women 40 years of age or older. Data Sources: English-language studies from the MEDLINE, Web of Science, EMBASE, CINAHL, PsycINFO, and ERIC databases through August 2006. Study Selection: Studies were identified that examined the effects of false-positive results of routine screening mammography on women's behavior, well-being, or beliefs. Data Extraction: Two investigators independently coded study charactedstics, quality, and effect sizes. Data Synthesis: 23 eligible studies (n = 313 967) were identified. A random-effects meta-analysis showed that U.S. women who received false-positive results on screening mammography were more likely to return for routine screening than those who received normal results (risk ratio, 1.07 [95% Cl, 1.02 to 1.121). The effect was not statistically significant among European women (risk ratio, 0.97 [Cl, 0.93 to 1,011), and Canadian women were less likely to return for routine screening because of false-positive results (risk ratio, 0.63 [Cl, 0.50 to 0.801). Women who received false-positive results conducted more frequent breast self-examinations and had higher, but not apparently pathologically elevated, levels of distress and anxiety and thought more about breast cancer than did those with normal results. Limitations: Correlational study designs, a small number of studies, a lack of clinical validation for many measures, and possible heterogeneity. Conclusions: Some women with false-positive results on mammography may have differences in whether they return for mammography, occurrence of breast self-examinations, and levels of anxiety compared with women with normal results. Future research should examine how false-positive results on mammography affect other outcomes, such as trust and health care use.	Univ N Carolina, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Brewer, NT (corresponding author), Univ N Carolina, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, 306 Rosenau Hall,CB 7440, Chapel Hill, NC 27599 USA.	ntba@unc.edu	Brewer, Noel T/C-4375-2008	Brewer, Noel T/0000-0003-2241-7002; Lillie, Sarah/0000-0001-9854-7191				ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Aro AR, 2000, EUR J CANCER, V36, P1089, DOI 10.1016/S0959-8049(00)00065-4; Aro AR, 2001, BREAST CANCER RES TR, V70, P145, DOI 10.1023/A:1012939228916; Bank LC, 2003, J COMPOS CONSTR, V7, P1, DOI 10.1061/(ASCE)1090-0268(2003)7:1(1); BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Barton MB, 2004, J NATL CANCER I, V96, P529, DOI 10.1093/jnci/djh083; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Boyd KC, 2003, J OCCUP ENVIRON MED, V45, P1247, DOI 10.1097/01.jom.0000099980.38936.09; Brett J, 2005, PSYCHO-ONCOLOGY, V14, P917, DOI 10.1002/pon.904; Brett J, 1998, J PUBLIC HEALTH MED, V20, P396, DOI 10.1093/oxfordjournals.pubmed.a024793; Brett J, 2001, J PUBLIC HEALTH MED, V23, P292, DOI 10.1093/pubmed/23.4.292; Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7; BREWER NT, IN PRESS HLTH PSYCHO; Brodersen J, 2004, J MED SCREEN, V11, P39, DOI 10.1258/096914104772950745; BULL AR, 1991, BRIT J RADIOL, V64, P510, DOI 10.1259/0007-1285-64-762-510; Burman ML, 1999, ANN INTERN MED, V131, P1, DOI 10.7326/0003-4819-131-1-199907060-00002; Chiarelli AM, 2003, J MED SCREEN, V10, P129, DOI 10.1258/096914103769011021; Cockburn J, 1994, J Med Screen, V1, P7; COCKBURN J, 1992, SOC SCI MED, V34, P1129, DOI 10.1016/0277-9536(92)90286-Y; Cullen J, 2004, J CLIN ONCOL, V22, P943, DOI 10.1200/JCO.2004.05.191; CYRLAK D, 1988, RADIOLOGY, V168, P661, DOI 10.1148/radiology.168.3.3406395; Derogatis L. R., 1977, SCL 90 MANUAL SCORIN; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Derogatis LR., 1994, SCL 90 R ADM SCORING; ELLMAN R, 1989, BRIT J CANCER, V60, P781, DOI 10.1038/bjc.1989.359; Elmore JG, 2005, JAMA-J AM MED ASSOC, V293, P1245, DOI 10.1001/jama.293.10.1245; Elmore JG, 2003, JNCI-J NATL CANCER I, V95, P1384, DOI 10.1093/jnci/djg048; Fletcher SW, 2003, NEW ENGL J MED, V348, P1672, DOI 10.1056/NEJMcp021804; Ford ME, 2005, CANCER EPIDEM BIOMAR, V14, P190; French DP, 2004, BRIT J CANCER, V91, P1887, DOI 10.1038/sj.bjc.6602224; Goldberg D, 1978, MANUAL GEN HLTH QUES; GRAM IT, 1990, BRIT J CANCER, V62, P1018, DOI 10.1038/bjc.1990.430; Hofvind SSH, 2003, CANCER CAUSE CONTROL, V14, P391, DOI 10.1023/A:1023918610664; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; *INT BREAST CANC S, 2002, INT J QUAL HEALTH C, V14, P449; International Agency for Research on Cancer, 2002, IARC HDB CANC PREV; Jatoi I, 2006, BREAST CANCER RES TR, V100, P191, DOI 10.1007/s10549-006-9236-6; Johnson EJ, 2003, SCIENCE, V302, P1338, DOI 10.1126/science.1091721; Johnson MM, 1996, CAN J PUBLIC HEALTH, V87, P176; Kahn BE, 2006, J PUBLIC POLICY MARK, V25, P79, DOI 10.1509/jppm.25.1.79; Karliner LS, 2005, J GEN INTERN MED, V20, P432, DOI 10.1111/j.1525-1497.2005.40281.x; Kellner R, 1987, ABRIDGED MANUAL ILLN; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Lafata JE, 2004, CANCER EPIDEM BIOMAR, V13, P2126; Lampic C, 2003, EUR J CANCER, V39, P1730, DOI 10.1016/S0959-8049(02)00451-3; Lampic C, 2001, EUR J CANCER, V37, P463, DOI 10.1016/S0959-8049(00)00426-3; LERMAN C, 1991, ANN INTERN MED, V114, P657, DOI 10.7326/0003-4819-114-8-657; LERMAN C, 1991, HEALTH PSYCHOL, V10, P259, DOI 10.1037/0278-6133.10.4.259; LERMAN G, 1995, PSYCHOSOCIAL EFFECTS, P65; Lidbrink E, 1996, BRIT MED J, V312, P273; Lipkus IM, 2000, PSYCHO-ONCOLOGY, V9, P402, DOI 10.1002/1099-1611(200009/10)9:5<402::AID-PON475>3.3.CO;2-L; Luce MF, 1999, J CONSUM RES, V26, P242, DOI 10.1086/209561; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Mandelblatt J, 2003, ANN INTERN MED, V139, P835, DOI 10.7326/0003-4819-139-10-200311180-00011; MANT D, 1990, BRIT J GEN PRACT, V40, P423; McCann J, 2002, BREAST CANCER RES, V4, DOI 10.1186/bcr455; McCaul KD, 1996, HEALTH PSYCHOL, V15, P423, DOI 10.1037/0278-6133.15.6.423; McNaughton-Collins M, 2004, AM J MED, V117, P719, DOI 10.1016/j.amjmed.2004.06.036; Meiser B, 2000, BREAST CANCER RES TR, V59, P101, DOI 10.1023/A:1006330631832; Meystre-Agustoni G, 2001, J MED SCREEN, V8, P213, DOI 10.1136/jms.8.4.213; Mushlin AI, 1998, AM J PREV MED, V14, P143, DOI 10.1016/S0749-3797(97)00019-6; O'Sullivan I, 2001, J MED SCREEN, V8, P145, DOI 10.1136/jms.8.3.145; Olsson P, 1999, J MED SCREEN, V6, P89, DOI 10.1136/jms.6.2.89; Ong G, 1997, J Med Screen, V4, P158; Orwin R.G., 1994, HDB RES SYNTHESIS; Pinckney RG, 2003, AM J MED, V114, P120, DOI 10.1016/S0002-9343(02)01438-9; Pisano ED, 1998, CANCER DETECT PREV, V22, P161, DOI 10.1046/j.1525-1500.1998.CDOA21.x; Pisano ED, 1998, RADIOLOGY, V208, P245, DOI 10.1148/radiology.208.1.9646820; Rakowski W, 1997, HEALTH PSYCHOL, V16, P433, DOI 10.1037/0278-6133.16.5.433; Sandin B, 2002, J PSYCHOSOM RES, V52, P303, DOI 10.1016/S0022-3999(01)00227-6; Scaf-Klomp W, 1997, J EPIDEMIOL COMMUN H, V51, P705, DOI 10.1136/jech.51.6.705; Schwartz LM, 2000, BMJ-BRIT MED J, V320, P1635, DOI 10.1136/bmj.320.7250.1635; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Spielberger CD, 1970, MANUAL STATE TRAIT A; STEWART KA, 2006, HLTH SERVICES RES; SUTTON S, 1998, PSYCHOL HEALTH MED, V3, P81; Taylor KL, 2004, JNCI-J NATL CANCER I, V96, P1083, DOI 10.1093/jnci/djh194; Thomas DB, 2002, JNCI-J NATL CANCER I, V94, P1445, DOI 10.1093/jnci/94.19.1445; Vernon Sally W., 1999, Journal of the National Cancer Institute Monographs, P101; Watson EK, 2005, PSYCHO-ONCOL, V14, P939, DOI 10.1002/pon.903; Weil JG, 1997, BRIT MED J, V314, P754, DOI 10.1136/bmj.314.7082.754; Welch HG, 2004, SHOULD I BE TESTED C; Woodward V, 2001, J ADV NURS, V33, P29, DOI 10.1046/j.1365-2648.2001.01635.x; Yankaskas BC, 2004, J MED SCREEN, V11, P187, DOI 10.1258/0969141042467430; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	87	329	339	1	33	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2007	146	7					502	510		10.7326/0003-4819-146-7-200704030-00006	http://dx.doi.org/10.7326/0003-4819-146-7-200704030-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153VB	17404352				2022-12-28	WOS:000245463200004
J	Bannani, A; Bobisch, C; Moller, R				Bannani, Amin; Bobisch, Christian; Moeller, Rolf			Ballistic electron microscopy of individual molecules	SCIENCE			English	Article							SCANNING-TUNNELING-MICROSCOPY; EMISSION MICROSCOPY; REAL SPACE; JUNCTIONS; C-60; SPECTROSCOPY; TRANSISTORS; RESOLUTION; SUBSTRATE; TRANSPORT	We analyzed the transport of ballistic electrons through organic molecules on uniformly flat surfaces of bismuth grown on silicon. For the fullerene C-60 and for a planar organic molecule (3,4,9,10-perylene-tetracarboxylic acid dianhydride), the signals revealed characteristic submolecular patterns that indicated where ballistic transport was enhanced or attenuated. The transport was associated to specific electronic molecular states. At electron energies of a few electron volts, this "scanning near-field electron transmission microscopy" method could be applied to various adsorbates or thin layers.	Univ Duisburg Essen, Ctr Nano Integrat Duisburg Essen, Dept Phys, D-47048 Duisburg, Germany	University of Duisburg Essen	Moller, R (corresponding author), Univ Duisburg Essen, Ctr Nano Integrat Duisburg Essen, Dept Phys, Lotharstr 1, D-47048 Duisburg, Germany.	rolf.moeller@uni.due-de	Bobisch, Christian A/B-7733-2008					AITMANN EI, 1993, PHYS REV B, V48, P18244; Ast CR, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.113102; BELL LD, 1988, PHYS REV LETT, V61, P2368, DOI 10.1103/PhysRevLett.61.2368; BINNIG G, 1983, PHYS REV LETT, V50, P120, DOI 10.1103/PhysRevLett.50.120; BINNIG G, 1982, APPL PHYS LETT, V40, P178, DOI 10.1063/1.92999; Bobisch C, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/5/055606; BRAUN F, 1874, POGG ANN, V153, P556; Chizhov I, 2000, J CRYST GROWTH, V208, P449, DOI 10.1016/S0022-0248(99)00382-6; de Andres PL, 2001, PROG SURF SCI, V66, P3, DOI 10.1016/S0079-6816(00)00022-8; FEENSTRA RM, 1987, PHYS REV LETT, V58, P1192, DOI 10.1103/PhysRevLett.58.1192; FINK HW, 1991, PHYS REV LETT, V67, P1543, DOI 10.1103/PhysRevLett.67.1543; Forrest SR, 1997, CHEM REV, V97, P1793, DOI 10.1021/cr941014o; Glockler K, 1998, SURF SCI, V405, P1, DOI 10.1016/S0039-6028(97)00888-1; HAMERS RJ, 1986, PHYS REV LETT, V56, P1972, DOI 10.1103/PhysRevLett.56.1972; Hauschild A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.209602; Hauschild A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.036106; Javey A, 2003, NATURE, V424, P654, DOI 10.1038/nature01797; Joachim C, 2005, P NATL ACAD SCI USA, V102, P8801, DOI 10.1073/pnas.0500075102; KAISER WJ, 1988, PHYS REV LETT, V60, P1406, DOI 10.1103/PhysRevLett.60.1406; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Li WJ, 2005, J PHYS CHEM B, V109, P6252, DOI 10.1021/jp0501648; MONCH W, 2004, ELECT PROPERTIES SEM; Narayanamurti V, 2001, PHYS REP, V349, P447, DOI 10.1016/S0370-1573(00)00119-8; Nitzan A, 2003, SCIENCE, V300, P1384, DOI 10.1126/science.1081572; Ono T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.026804; Park J, 2002, NATURE, V417, P722, DOI 10.1038/nature00791; Prietsch M., 1995, Physics Reports, V253, P163, DOI 10.1016/0370-1573(94)00082-E; Rippard WH, 2001, APPL PHYS LETT, V78, P1601, DOI 10.1063/1.1352045; Rogero C, 2002, J CHEM PHYS, V116, P832, DOI 10.1063/1.1424291; Schottky W, 1939, Z PHYS, V113, P367, DOI 10.1007/BF01340116; SIRRINGHAUS H, 1994, PHYS REV LETT, V73, P577, DOI 10.1103/PhysRevLett.73.577; Stipe BC, 1998, SCIENCE, V280, P1732, DOI 10.1126/science.280.5370.1732; Temirov R, 2006, NATURE, V444, P350, DOI 10.1038/nature05270; Timp G., 1999, International Electron Devices Meeting 1999. Technical Digest (Cat. No.99CH36318), P55, DOI 10.1109/IEDM.1999.823845; Troadec C, 2004, NANOTECHNOLOGY, V15, P1818, DOI 10.1088/0957-4484/15/12/022; Umbach E, 1996, APPL PHYS A-MATER, V63, P565, DOI 10.1007/BF01567212; Yamachika R, 2004, SCIENCE, V304, P281, DOI 10.1126/science.1095069	37	43	46	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2007	315	5820					1824	1828		10.1126/science.1138668	http://dx.doi.org/10.1126/science.1138668			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395824				2022-12-28	WOS:000245280100037
J	Albert, I; Mavrich, TN; Tomsho, LP; Qi, J; Zanton, SJ; Schuster, SC; Pugh, BF				Albert, Istvan; Mavrich, Travis N.; Tomsho, Lynn P.; Qi, Ji; Zanton, Sara J.; Schuster, Stephan C.; Pugh, B. Franklin			Translational and rotational settings of H2A.Z nucleosomes across the Saccharomyces cerevisiae genome	NATURE			English	Article							HISTONE H2A; EUKARYOTIC GENOME; YEAST; VARIANT; GENES; WIDE; IDENTIFICATION; PROMOTERS; CORE; MAP	The nucleosome is the fundamental building block of eukaryotic chromosomes. Access to genetic information encoded in chromosomes is dependent on the position of nucleosomes along the DNA. Alternative locations just a few nucleotides apart can have profound effects on gene expression(1). Yet the nucleosomal context in which chromosomal and gene regulatory elements reside remains ill-defined on a genomic scale. Here we sequence the DNA of 322,000 individual Saccharomyces cerevisiae nucleosomes, containing the histone variant H2A.Z, to provide a comprehensive map of H2A.Z nucleosomes in functionally important regions. With a median 4-base-pair resolution, we identify new and established signatures of nucleosome positioning. A single predominant rotational setting and multiple translational settings are evident. Chromosomal elements, ranging from telomeres to centromeres and transcriptional units, are found to possess characteristic nucleosomal architecture that may be important for their function. Promoter regulatory elements, including transcription factor binding sites and transcriptional start sites, show topological relationships with nucleosomes, such that transcription factor binding sites tend to be rotationally exposed on the nucleosome surface near its border. Transcriptional start sites tended to reside about one helical turn inside the nucleosome border. These findings reveal an intimate relationship between chromatin architecture and the underlying DNA sequence it regulates.	Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; Penn State Univ, Dept Biochem & Mol Biol, Ctr Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Pugh, BF (corresponding author), Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA.	bfp2@psu.edu	QI, JI/E-2797-2016; Albert, Istvan/J-3734-2015	Albert, Istvan/0000-0001-8366-984X; Mavrich, Travis/0000-0001-9252-5020				Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Boeger H, 2004, MOL CELL, V14, P667, DOI 10.1016/j.molcel.2004.05.013; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Gavin IM, 1997, EMBO J, V16, P6263, DOI 10.1093/emboj/16.20.6263; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; Krogan NJ, 2004, P NATL ACAD SCI USA, V101, P13513, DOI 10.1073/pnas.0405753101; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Lipford JR, 2001, MOL CELL, V7, P21, DOI 10.1016/S1097-2765(01)00151-4; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Malave TM, 2006, BIOCHEM CELL BIOL, V84, P437, DOI 10.1139/O06-073; Martinez-Campa C, 2004, MOL CELL, V15, P69, DOI 10.1016/j.molcel.2004.05.022; Nieduszynski CA, 2006, GENE DEV, V20, P1874, DOI 10.1101/gad.385306; Pinto I, 2000, EMBO J, V19, P1598, DOI 10.1093/emboj/19.7.1598; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036	30	522	539	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2007	446	7135					572	576		10.1038/nature05632	http://dx.doi.org/10.1038/nature05632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392789				2022-12-28	WOS:000245242900056
J	Ohtake, F; Baba, A; Takada, I; Okada, M; Iwasaki, K; Miki, H; Takahashi, S; Kouzmenko, A; Nohara, K; Chiba, T; Fujii-Kuriyama, Y; Kato, S				Ohtake, Fumiaki; Baba, Atsushi; Takada, Ichiro; Okada, Maiko; Iwasaki, Kei; Miki, Hiromi; Takahashi, Sayuri; Kouzmenko, Alexander; Nohara, Keiko; Chiba, Tomoki; Fujii-Kuriyama, Yoshiaki; Kato, Shigeaki			Dioxin receptor is a ligand-dependent E3 ubiquitin ligase	NATURE			English	Article							ARYL-HYDROCARBON RECEPTOR; BOX PROTEIN TIR1; AUXIN RECEPTOR; AH-RECEPTOR; TRANSCRIPTION; ALPHA; PROTEOLYSIS; EXPRESSION; PROMOTERS; COMPLEX	Fat-soluble ligands, including sex steroid hormones and environmental toxins, activate ligand-dependent DNA-sequence-specific transcriptional factors that transduce signals through target-gene-selective transcriptional regulation(1). However, the mechanisms of cellular perception of fat-soluble ligand signals through other target-selective systems remain unclear. The ubiquitin-proteasome system regulates selective protein degradation, in which the E3 ubiquitin ligases determine target specificity(2-4). Here we characterize a fat-soluble ligand-dependent ubiquitin ligase complex in human cell lines, in which dioxin receptor ( AhR)(5-9) is integrated as a component of a novel cullin 4B ubiquitin ligase complex, CUL4B(AhR). Complex assembly and ubiquitin ligase activity of CUL4B(AhR) in vitro and in vivo are dependent on the AhR ligand. In the CUL4B(AhR) complex, ligand-activated AhR acts as a substrate-specific adaptor component that targets sex steroid receptors for degradation. Thus, our findings uncover a function for AhR as an atypical component of the ubiquitin ligase complex and demonstrate a non-genomic signalling pathway in which fat-soluble ligands regulate target-protein-selective degradation through a ubiquitin ligase complex.	Japan Sci & Technol Agcy, ERATO, Kawaguchi, Saitama 3320012, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Univ Tokyo, Fac Med, Dept Urol, Bunkyo Ku, Tokyo 1138655, Japan; Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; Univ Tsukuba, TARA Ctr, Tsukuba, Ibaraki 3058577, Japan; Japan Sci & Technol Agcy, SORST, Kawaguchi, Saitama 3320012, Japan	Japan Science & Technology Agency (JST); University of Tokyo; University of Tokyo; National Institute for Environmental Studies - Japan; University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST)	Kato, S (corresponding author), Japan Sci & Technol Agcy, ERATO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan.	uskato@mail.ecc.u-tokyo.ac.jp						Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Baba T, 2005, MOL CELL BIOL, V25, P10040, DOI 10.1128/MCB.25.22.10040-10051.2005; Beischlag TV, 2005, J BIOL CHEM, V280, P21607, DOI 10.1074/jbc.C500090200; Brunnberg S, 2003, P NATL ACAD SCI USA, V100, P6517, DOI 10.1073/pnas.1136688100; Carlson DB, 2002, J BIOCHEM MOL TOXIC, V16, P317, DOI 10.1002/jbt.10051; Davarinos NA, 1999, J BIOL CHEM, V274, P28708, DOI 10.1074/jbc.274.40.28708; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Harper JW, 2002, TRENDS CELL BIOL, V12, P104, DOI 10.1016/S0962-8924(01)02238-3; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7; Lin TM, 2002, TOXICOL SCI, V68, P479, DOI 10.1093/toxsci/68.2.479; Matthews J, 2005, MOL CELL BIOL, V25, P5317, DOI 10.1128/MCB.25.13.5317-5328.2005; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; Poellinger L, 2000, FOOD ADDIT CONTAM A, V17, P261, DOI 10.1080/026520300283333; Roberts BJ, 1999, J BIOL CHEM, V274, P36351, DOI 10.1074/jbc.274.51.36351; ROMKES M, 1987, TOXICOL APPL PHARM, V87, P306, DOI 10.1016/0041-008X(87)90292-4; SWANSON HI, 1993, PHARMACOGENETICS, V3, P213, DOI 10.1097/00008571-199310000-00001; Valley CC, 2005, MOL CELL BIOL, V25, P5417, DOI 10.1128/MCB.25.13.5417-5428.2005; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747	30	402	421	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2007	446	7135					562	566		10.1038/nature05683	http://dx.doi.org/10.1038/nature05683			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392787				2022-12-28	WOS:000245242900054
J	Cawthorne, P; Ford, N; Limpananont, J; Tienudom, N; Purahong, W				Cawthorne, Paul; Ford, Nathan; Limpananont, Jiraporn; Tienudom, Nimit; Purahong, Wirat			WHO must defend patients' interests, not industry	LANCET			English	Editorial Material									Med Sans Frontieres, Bangkok 10240, Thailand; Chulalongkorn Univ, Fac Pharmaceut Sci, Bangkok, Thailand; AIDS Access Fdn, Bangkok, Thailand; Thai Network People Living HIV AIDS, Bangkok, Thailand	Chulalongkorn University	Cawthorne, P (corresponding author), Med Sans Frontieres, Bangkok 10240, Thailand.	msfb-bangkok@brussels.msf.org						*ABB, 2006, ABB REP STRONG 4 Q R; [Anonymous], 2001, DECL TRIPS AGR PUBL; *BRIST MYERS SQUIB, BRIST MYERS SQUIBB C; CHAN M, 2007, COMMUNICATION   0212; Okie S, 2006, NEW ENGL J MED, V354, P1977, DOI 10.1056/NEJMp068069; Pinheiro E, 2006, AIDS, V20, P1745, DOI 10.1097/01.aids.0000242821.67001.65; REVENGA A, 2006, EC EFF AIDS TREATM E; SCHWAB S, 2007, COMMUNICATION   0117; TREERUTKUARKUL A, 2007, BANGKOK POST    0213; TREERUTKUARKUL A, 2007, BANGKOK POST    0202; *WHO, 2005, EXT REV HLTH SECT RE; Wilson D, 1999, LANCET, V354, P1893, DOI 10.1016/S0140-6736(99)06114-0; ZAMISKA N, 2007, WALL STREET J   0314	13	12	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2007	369	9566					974	975		10.1016/S0140-6736(07)60473-5	http://dx.doi.org/10.1016/S0140-6736(07)60473-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	151JO	17382809				2022-12-28	WOS:000245286500009
J	Alekshun, MN; Levy, SB				Alekshun, Michael N.; Levy, Stuart B.			Molecular mechanisms of antibacterial multidrug resistance	CELL			English	Review							STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; FLUOROQUINOLONE RESISTANCE; TETRACYCLINE-RESISTANCE; PSEUDOMONAS-AERUGINOSA; VANCOMYCIN RESISTANCE; BACTERIAL-RESISTANCE; MACROLIDE RESISTANCE; BACILLUS-SUBTILIS; DRUG-RESISTANCE	Treatment of infections is compromised worldwide by the emergence of bacteria that are resistant to multiple antibiotics. Although classically attributed to chromosomal mutations, resistance is most commonly associated with extrachromosomal elements acquired from other bacteria in the environment. These include different types of mobile DNA segments, such as plasmids, transposons, and integrons. However, intrinsic mechanisms not commonly specified by mobile elements-such as efflux pumps that expel multiple kinds of antibiotics-are now recognized as major contributors to multidrug resistance in bacteria. Once established, multidrug-resistant organisms persist and spread worldwide, causing clinical failures in the treatment of infections and public health crises.	Schering Plough Res Inst, Kenilworth, NJ 07033 USA; Tufts Univ, Sch Med, Ctr Adaptat Genet & Drug Resistance, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	Merck & Company; Schering-Plough Research Institute; Tufts University; Tufts University	Alekshun, MN (corresponding author), Schering Plough Res Inst, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA.	michael.alekshun@spcorp.com; stuart.levy@tufts.edu						Ainsa J.A., 2002, INT MICROBIOL, V5, P155, DOI [10.1007/s10123-002-0082-z, DOI 10.1007/S10123-002-0082-Z]; Alangaden GJ, 1998, ANTIMICROB AGENTS CH, V42, P1295, DOI 10.1128/AAC.42.5.1295; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Alekshun MN, 2000, BACTERIAL STRESS RESPONSES, P323; BARBER M, 1947, BRIT MED J, V2, P863, DOI 10.1136/bmj.2.4534.863; BARBER M, 1961, J CLIN PATHOL, V14, P385, DOI 10.1136/jcp.14.4.385; Barbosa TM, 2000, J BACTERIOL, V182, P3467, DOI 10.1128/JB.182.12.3467-3474.2000; Chesneau O, 2005, ANTIMICROB AGENTS CH, V49, P973, DOI 10.1128/AAC.49.3.973-980.2005; Connell SR, 2003, ANTIMICROB AGENTS CH, V47, P3675, DOI 10.1128/AAC.47.12.3675-3681.2003; COOK M, 1989, AM J PHYS ANTHROPOL, V80, P137, DOI 10.1002/ajpa.1330800202; Courvalin P, 2006, CLIN INFECT DIS, V42, pS25, DOI 10.1086/491711; COURVALIN P, 1994, ANTIMICROB AGENTS CH, V38, P1447, DOI 10.1128/AAC.38.7.1447; Cui LZ, 2006, ANTIMICROB AGENTS CH, V50, P1079, DOI 10.1128/AAC.50.3.1079-1082.2006; Cui LZ, 2006, ANTIMICROB AGENTS CH, V50, P428, DOI 10.1128/AAC.50.2.428-438.2006; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Davies J, 1997, TRENDS MICROBIOL, V5, P234, DOI 10.1016/S0966-842X(97)01033-0; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Drlica K, 2003, CURR TOP MED CHEM, V3, P249, DOI 10.2174/1568026033452537; Falagas ME, 2005, CLIN INFECT DIS, V40, P1333, DOI 10.1086/429323; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Fuda CCS, 2005, CELL MOL LIFE SCI, V62, P2617, DOI 10.1007/s00018-005-5148-6; Gerrits MM, 2002, ANTIMICROB AGENTS CH, V46, P2996, DOI 10.1128/AAC.46.9.2996-3000.2002; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; HAGMAN KE, 1995, MICROBIOL-SGM, V141, P611, DOI 10.1099/13500872-141-3-611; Hayden MK, 2005, J CLIN MICROBIOL, V43, P5285, DOI 10.1128/JCM.43.10.5285-5287.2005; Hegde SS, 2005, SCIENCE, V308, P1480, DOI 10.1126/science.1110699; Hershberger E, 2004, CLIN INFECT DIS, V38, P92, DOI 10.1086/380125; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Hirata T, 2004, ANTIMICROB AGENTS CH, V48, P2179, DOI 10.1128/AAC.48.6.2179-2184.2004; Hisanaga T, 2005, J ANTIMICROB CHEMOTH, V56, P447, DOI 10.1093/jac/dki249; Jacobs Michael R., 1999, American Journal of Medicine, V106, p19S, DOI 10.1016/S0002-9343(98)00351-9; Jacoby GA, 2005, NEW ENGL J MED, V352, P380, DOI 10.1056/NEJMra041359; Levin AS, 1999, CLIN INFECT DIS, V28, P1008, DOI 10.1086/514732; LEVY SB, 1976, NATURE, V260, P40, DOI 10.1038/260040a0; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; LEVY SB, 1992, ANTIMICROB AGENTS CH, V36, P695, DOI 10.1128/AAC.36.4.695; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Lomovskaya O, 1999, ANTIMICROB AGENTS CH, V43, P1340, DOI 10.1128/AAC.43.6.1340; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; Matsuoka Mayumi, 2004, Current Drug Targets - Infectious Disorders, V4, P217, DOI 10.2174/1568005043340696; MATTHEWS PR, 1988, J GEN MICROBIOL, V134, P1455; Mazel D, 1998, SCIENCE, V280, P605, DOI 10.1126/science.280.5363.605; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; MCMURRY L, 1980, P NATL ACAD SCI-BIOL, V77, P3974, DOI 10.1073/pnas.77.7.3974; Meka VG, 2004, CLIN INFECT DIS, V39, P1010, DOI 10.1086/423841; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Moore IF, 2005, BIOCHEMISTRY-US, V44, P11829, DOI 10.1021/bi0506066; Murakami S, 2003, CURR OPIN STRUC BIOL, V13, P443, DOI 10.1016/S0959-440X(03)00109-X; Musher DM, 2002, NEW ENGL J MED, V346, P630, DOI 10.1056/NEJM200202213460820; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; NEYFAKH AA, 1991, P NATL ACAD SCI USA, V88, P4781, DOI 10.1073/pnas.88.11.4781; NICOLOFF H, 2007, AGENTS CHEMOTHE 0112, DOI DOI 10.1128/AAC.01128-06; Nicoloff H, 2006, J BACTERIOL, V188, P4413, DOI 10.1128/JB.01502-05; NOBEL WC, 1992, FEMS MICROBIOL LETT, V72, P195; Ochs MM, 1999, ANTIMICROB AGENTS CH, V43, P1085, DOI 10.1128/AAC.43.5.1085; Oethinger M, 2000, ANTIMICROB AGENTS CH, V44, P10, DOI 10.1128/AAC.44.1.10-13.2000; Perreten V, 2003, ANTIMICROB AGENTS CH, V47, P1169, DOI 10.1128/AAC.47.3.1169-1172.2003; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; Poirier Florence, 2001, Cancer Cell Int, V1, P2, DOI 10.1186/1475-2867-1-2; Roberts MC, 2004, MOL BIOTECHNOL, V28, P47, DOI 10.1385/MB:28:1:47; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Ross JI, 1998, ANTIMICROB AGENTS CH, V42, P1702, DOI 10.1128/AAC.42.7.1702; Ruzin A, 2005, ANTIMICROB AGENTS CH, V49, P1017, DOI 10.1128/AAC.49.3.1017-1022.2005; Sapunaric FM, 2005, FRONTIERS IN ANTIMICROBIAL RESISTANCE: A TRIBUTE TO STUART B. LEVY, P3; Schneiders T, 2003, ANTIMICROB AGENTS CH, V47, P2831, DOI 10.1128/AAC.47.9.2831-2837.2003; Schumacher MA, 2002, MOL MICROBIOL, V45, P885, DOI 10.1046/j.1365-2958.2002.03039.x; Schwarz S, 2004, FEMS MICROBIOL REV, V28, P519, DOI 10.1016/j.femsre.2004.04.001; Sharma SK, 2006, CHEST, V130, P261, DOI [10.1378/chest.130.1.261, 10.1016/S0012-3692(15)50981-1]; Skold O, 2001, VET RES, V32, P261, DOI 10.1051/vetres:2001123; SLOAN J, 1994, MOL MICROBIOL, V11, P403, DOI 10.1111/j.1365-2958.1994.tb00320.x; Stanton TB, 2003, APPL ENVIRON MICROB, V69, P3874, DOI 10.1128/AEM.69.7.3874-3882.2003; Stein GE, 2006, CLIN INFECT DIS, V43, P518, DOI 10.1086/505494; Tait-Kamradt A, 2000, ANTIMICROB AGENTS CH, V44, P3395, DOI 10.1128/AAC.44.12.3395-3401.2000; TENNENT JM, 1989, J GEN MICROBIOL, V135, P1; Tran JH, 2002, P NATL ACAD SCI USA, V99, P5638, DOI 10.1073/pnas.082092899; WATANABE T, 1963, BACTERIOL REV, V27, P87, DOI 10.1128/MMBR.27.1.87-115.1963; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Weisblum B, 1998, DRUG RESIST UPDATE, V1, P29, DOI 10.1016/S1368-7646(98)80212-4; Wilson P, 2003, J ANTIMICROB CHEMOTH, V51, P186, DOI 10.1093/jac/dkg104; Wolter N, 2005, ANTIMICROB AGENTS CH, V49, P3554, DOI 10.1128/AAC.49.8.3554-3557.2005; Woolridge DP, 1997, J BIOL CHEM, V272, P8864; Zhanel GG, 2001, DRUGS, V61, P443, DOI 10.2165/00003495-200161040-00003	82	902	976	22	502	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1037	1050		10.1016/j.cell.2007.03.004	http://dx.doi.org/10.1016/j.cell.2007.03.004			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382878	Bronze			2022-12-28	WOS:000245396200012
J	Clark, RA; Inglis, SC; McAlister, FA; Cleland, JGF; Stewart, S				Clark, Robyn A.; Inglis, Sally C.; McAlister, Finlay A.; Cleland, John G. F.; Stewart, Simon			Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DISEASE MANAGEMENT PROGRAMS; OLDER PATIENTS; HIGH-RISK; INTERVENTIONS; ADMISSION; STRATEGIES; COMMUNITY; OUTCOMES; CLINICS; CARE	Objective To determine whether remote monitoring (structured telephone support or telemonitoring) without regular clinic or home visits improves outcomes for patients with chronic heart failure. Data sources 15 electronic databases, hand searches of previous studies, and contact with authors and experts. Data extraction Two investigators independently screened the results. Review methods Published randomised controlled trials comparing remote monitoring programmes with usual care in patients with chronic heart failure managed within the community. Results 14 randomised controlled trials (4264 patients) of remote monitoring met the inclusion criteria: four evaluated telemonitoring, nine evaluated structured telephone support, and one evaluated both. Remote monitoring programmes reduced the rates of admission to hospital for chronic heart failure by 21% (95% confidence interval 11% to 31%) and all cause mortality by 20% (8% to 31%); of the six trials evaluating health related quality of life three reported significant benefits with remote monitoring, and of the four studies examining healthcare costs with structured telephone support three reported reduced cost and one no effect. Conclusion Programmes for chronic heart failure that include remote monitoring have a positive effect on clinical outcomes in community dwelling patients with chronic heart failure.	Baker Heart Res Inst, Prevent Cardiol Unit, Melbourne, Vic 3004, Australia; Univ S Australia, Div Hlth Sci, Adelaide, SA 5001, Australia; Univ Queensland, Fac Hlth Sci, Brisbane, Qld, Australia; Univ Alberta, Div Gen Internal Med, Edmonton, AB, Canada; Univ Hull, Kingston Upon Hull HU6 7RX, N Humberside, England	Baker Heart and Diabetes Institute; University of South Australia; University of Queensland; University of Alberta; University of Hull	Stewart, S (corresponding author), Baker Heart Res Inst, Prevent Cardiol Unit, Melbourne, Vic 3004, Australia.	simon.stewart@baker.edu.au	McAlister, Finlay/C-4151-2013; Cleland, John G./AAZ-4185-2020; Stewart, Simon/M-3316-2016; Clark, Robyn A/D-1604-2009	McAlister, Finlay/0000-0001-7435-3341; Cleland, John G./0000-0002-1471-7016; Stewart, Simon/0000-0001-9032-8998; Clark, Robyn A/0000-0002-5063-2618				Bunn F, 2005, BRIT J GEN PRACT, V55, P956; CLELAND JG, 2000, HEART, V84, P8; Cleland JGF, 2005, CAN MED ASSOC J, V172, P207, DOI 10.1503/cmaj.045307; Davis RC, 2002, BRIT MED J, V325, P1156, DOI 10.1136/bmj.325.7373.1156; Duffy Joanne R, 2005, J Cardiovasc Nurs, V20, P325; Duffy JR, 2004, J NURS CARE QUAL, V19, P349, DOI 10.1097/00001786-200410000-00011; Ezekowitz JA, 2005, CAN MED ASSOC J, V172, P189, DOI 10.1503/cmaj.1032017; Gonseth J, 2004, EUR HEART J, V25, P1570, DOI 10.1016/j.ehj.2004.04.022; Gustafsson F, 2004, EUR HEART J, V25, P1596, DOI 10.1016/j.ehj.2004.06.023; Gwadry-Sridhar FH, 2004, ARCH INTERN MED, V164, P2315, DOI 10.1001/archinte.164.21.2315; Hamner JR, 2005, ADV NURS SCI, V28, P175, DOI 10.1097/00012272-200504000-00009; Holland R, 2005, HEART, V91, P899, DOI 10.1136/hrt.2004.048389; Jaarsma T, 2006, Eur J Cardiovasc Nurs, V5, P197, DOI 10.1016/j.ejcnurse.2006.04.002; Krishna S, 2002, METHOD INFORM MED, V41, P360; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Louis AA, 2003, EUR J HEART FAIL, V5, P583, DOI 10.1016/S1388-9842(03)00160-0; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; McAlister FA, 2001, AM J MED, V110, P378, DOI 10.1016/S0002-9343(00)00743-9; Mistiaen P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004510.pub3; Mortara Andrea, 2005, Monaldi Arch Chest Dis, V64, P143; Murray E, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004274.pub4; Philbin EF, 1999, J GEN INTERN MED, V14, P130, DOI 10.1046/j.1525-1497.1999.00291.x; Phillips CO, 2005, EUR J HEART FAIL, V7, P333, DOI 10.1016/j.ejheart.2005.01.011; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; Scalvini S, 2004, J TELEMED TELECARE, V10, P113, DOI 10.1258/135763304773391576; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; SPAEDER J, 2006, AM HEART J, V151, P844; Stewart S, 2001, EUR J HEART FAIL, V3, P315, DOI 10.1016/S1388-9842(00)00141-0; Taylor S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002752.pub2; Tsai AC, 2005, AM J MANAG CARE, V11, P478; Whellan DJ, 2005, AM HEART J, V149, P722, DOI 10.1016/j.ahj.2004.09.023; Windham BG, 2003, AM J MANAG CARE, V9, P447; Yu DSF, 2006, EUR HEART J, V27, P596, DOI 10.1093/eurheartj/ehi656	34	416	427	0	35	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2007	334	7600					942	945		10.1136/bmj.39156.536968.55	http://dx.doi.org/10.1136/bmj.39156.536968.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165YN	17426062	Green Published, Bronze			2022-12-28	WOS:000246343800039
J	Lynn, J; Baily, MA; Bottrell, M; Jennings, B; Levine, RJ; Davidoff, F; Casarett, D; Corrigan, J; Fox, E; Wynia, MK; Agich, GJ; O'Kane, M; Speroff, T; Schyve, P; Batalden, P; Tunis, S; Berlinger, N; Cronenwett, L; Fitzmaurice, JM; Dubler, NN; James, B				Lynn, Joanne; Baily, Mary Ann; Bottrell, Melissa; Jennings, Bruce; Levine, Robert J.; Davidoff, Frank; Casarett, David; Corrigan, Janet; Fox, Ellen; Wynia, Matthew K.; Agich, George J.; O'Kane, Margaret; Speroff, Theodore; Schyve, Paul; Batalden, Paul; Tunis, Sean; Berlinger, Nancy; Cronenwett, Linda; Fitzmaurice, J. Michael; Dubler, Nancy Neveloff; James, Brent			The ethics of using quality improvement methods in health care	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL-RESEARCH; SERVICES RESEARCH; UNITED-STATES; DELIVERY; IMPACT	Quality improvement (QI) activities can improve health care but must be conducted ethically. The Hastings Center convened leaders and scholars to address ethical requirements for QI and their relationship to regulations protecting human subjects of research. The group defined QI as systematic, data-guided activities designed to bring about immediate improvements in health care delivery in particular settings and concluded that Ql is an intrinsic part of normal health care operations. Both clinicians and patients have an ethical responsibility to participate in QI, provided that it complies with specified ethical requirements. Most QI activities are not human subjects research and should not undergo review by an institutional review board; rather, appropriately calibrated supervision of QI activities should be part of professional supervision of clinical practice. The group formulated a framework that would use key characteristics of a project and its context to categorize it as QI, human subjects research, or both, with the potential of a customized institutional review board process for the overlap category. The group recommended a period of innovation and evaluation to refine the framework for ethical conduct of QI and to integrate that framework into clinical practice.	Hastings Ctr, Garrison, NY 10524 USA; RAND Corp, Washington, DC USA; Vet Hlth Adm, Natl Qual Forum, Washington, DC USA; Natl Comm Qual Assurance, Washington, DC USA; Montefiore Med Ctr, Bronx, NY 10467 USA; Vet Hlth Adm, Seattle, WA USA; Yale Univ, New Haven, CT USA; Inst Healthcare Improvement, Cambridge, MA USA; Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA; Amer Med Assoc, Chicago, IL 60610 USA; Joint Commiss Accreditat Healthcare Org, Oak Brook Terrace, IL USA; Bowling Green State Univ, Bowling Green, OH 43403 USA; Vanderbilt Univ, Ctr Med, Nashville, TN 37232 USA; Dartmouth Med Sch, Hanover, NH USA; Hlth Tech, San Francisco, CA USA; Univ N Carolina, Chapel Hill, NC USA; Agcy Hlth Care Policy & Res, Rockville, MD USA; Intermt Inst Hlth Care Delivery Res, Salt Lake City, UT USA	RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Yale University; Institute for Healthcare Improvement; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; American Medical Association; University System of Ohio; Bowling Green State University; Vanderbilt University; Dartmouth College; University of North Carolina; University of North Carolina Chapel Hill; Agency for Healthcare Research & Quality	Baily, MA (corresponding author), Hastings Ctr, 21 Malcolm Gordan Rd, Garrison, NY 10524 USA.	bailym@thehastingscenter.org	Young, Alexander/A-1523-2009; Wynia, Matthew/T-2210-2019	Young, Alexander/0000-0002-9367-9213; 	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R13HS013369] Funding Source: NIH RePORTER; AHRQ HHS [1R13HS13369] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AG HLTH RES QUAL, 2005, NAT HLTH QUAL REP; AGICH G, 2007, HLTH CARE QUALITY IM; Baily MA, 2006, HASTINGS CENT REP, V36, pS1, DOI 10.1353/hcr.2006.0054; BEECHER HK, 1966, NEW ENGL J MED, V274, P1354, DOI 10.1056/NEJM196606162742405; Berwick DM, 1998, ANN INTERN MED, V128, P651, DOI 10.7326/0003-4819-128-8-199804150-00009; Davidoff F, 2005, QUAL SAF HEALTH CARE, V14, P319, DOI 10.1136/qshc.2005.014787; DAVIDOFF F, 2007, HLTH CARE QUALITY IM; DUBLER NN, 2007, HLTH CARE QUALITY IM; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Green LA, 2006, HEALTH SERV RES, V41, P214, DOI 10.1111/j.1475-6773.2005.00458.x; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Ham HP, 2002, J PEDIATR-US, V141, P300, DOI 10.1067/mpd.2002.126531; Institute of Medicine, 2001, CROSS QUAL CHASM; *INV REG CAN STROK, 2004, NEW ENGL J MED, V350, P1414; JENNINGS B, 2007, HLTH CARE QUALITY IM; JONAS H, 1970, EXPT HUMAN SUBJECTS, P6; LANG N, 2007, HLTH CARE QUALTY IMP; Leach DC, 2001, QUAL HEALTH CARE, V10, P54; LEVINE ROBERT J., 1988, ETHICS REGULATION CL, V2nd; Lynn J, 2002, ANN INTERN MED, V137, P117, DOI 10.7326/0003-4819-137-2-200207160-00010; Margolis PA, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.3.e42; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; *NAT BIOETH ADV CO, 2000, ETH POL ISS RES INV, P36; *NAT I HLTH, HLTH SERV RES HIPAA; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1978, BELM REP ETH PRINC G; Newgard CD, 2005, HEALTH SERV RES, V40, P1247, DOI 10.1111/j.1475-6773.2005.00408.x; Rollow W, 2006, ANN INTERN MED, V145, P342, DOI 10.7326/0003-4819-145-5-200609050-00134; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; Wynia MK, 2007, HLTH CARE QUALITY IM; Zwarenstein M, 2006, J CLIN EPIDEMIOL, V59, P1125, DOI 10.1016/j.jclinepi.2006.05.010; 2005, N ENGL J MED, V352, P1825; 1999, GUIDELINES DEFINING	32	195	197	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2007	146	9					666	673		10.7326/0003-4819-146-9-200705010-00155	http://dx.doi.org/10.7326/0003-4819-146-9-200705010-00155			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	162EV	17438310				2022-12-28	WOS:000246070500006
J	McClellan, M				McClellan, Mark			Drug safety reform at the FDA - Pendulum swing of systematic improvement?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material											McClellan, M (corresponding author), Stanford Univ, Stanford, CA 94305 USA.							BACIU A, 2006, FUTURE DRUG SAFETY P; *FOOD DRUG ADM, 2007, FUT DRUG SAF PROM PR; Philipson TJ, 2005, ASSESSING SAFETY EFF; PLATT R, 2007, I MED FOR WASH DC MA	4	57	57	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 26	2007	356	17					1700	1702		10.1056/NEJMp078057	http://dx.doi.org/10.1056/NEJMp078057			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	160LQ	17435081				2022-12-28	WOS:000245942600002
J	Dean, R; Bonsall, MB; Pizzari, T				Dean, Rebecca; Bonsall, Michael B.; Pizzari, Tommaso			Aging and sexual conflict	SCIENCE			English	Editorial Material							YOUNG SPERM; AGE		Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England	University of Oxford	Dean, R (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, S Parks Rd, Oxford OX1 3PS, England.	tommaso.pizzari@zoo.ox.ac.uk		Bonsall, Michael/0000-0003-0250-0423	NERC [NE/D002788/1, NE/D003865/1] Funding Source: UKRI; Natural Environment Research Council [NE/D003865/1, NE/D002788/1, NE/C507196/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Chow V, 2006, J REPROD MED, V51, P149; Jones TM, 2007, BEHAV ECOL, V18, P251, DOI 10.1093/beheco/arl077; Jones TM, 2004, P ROY SOC B-BIOL SCI, V271, P1311, DOI 10.1098/rspb.2004.2723; Lovlie H, 2005, CURR BIOL, V15, P1222, DOI 10.1016/j.cub.2005.05.060; Reinhardt K, 2005, AM NAT, V165, P718, DOI 10.1086/430010; Snook RR, 2004, NATURE, V428, P939, DOI 10.1038/nature02455; Wagner RH, 2004, P ROY SOC B-BIOL SCI, V271, pS134, DOI 10.1098/rsbl.2003.0142; White J, 2006, J ORNITHOL, V147, P88; Wyrobek AJ, 2006, P NATL ACAD SCI USA, V103, P9601, DOI 10.1073/pnas.0506468103	9	14	14	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					383	384		10.1126/science.1142201	http://dx.doi.org/10.1126/science.1142201			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	158RY	17446381				2022-12-28	WOS:000245813400032
J	Evans, JT; Smith, EG; Banerjee, A; Smith, RMM; Dale, J; Innes, JA; Hunt, D; Tweddell, A; Wood, A; Anderson, C; Hewinson, RG; Smith, NH; Hawkey, PM; Sonnenberg, P				Evans, Jason T.; Smith, E. Grace; Banerjee, Ashis; Smith, Robert M. M.; Dale, James; Innes, John A.; Hunt, David; Tweddell, Alan; Wood, Annette; Anderson, Charlotte; Hewinson, R. Glyn; Smith, Noel H.; Hawkey, Peter M.; Sonnenberg, Pam			Cluster of human tuberculosis caused by Mycobacterium bovis: evidence for person-to-person transmission in the UK	LANCET			English	Article							LENGTH-POLYMORPHISM ANALYSIS; VARIABLE NUMBERS; TANDEM REPEATS; INFECTION; PCR; DIFFERENTIATION; DISCRIMINATION; IDENTIFICATION; DIAGNOSIS; OUTBREAK	Background Despite a recent resurgence in the incidence of bovine tuberculosis in UK cattle herds, no associated rise in the number of cases in man has been noted. Disease due to human Mycobacterium bovis infection usually occurs in older patients, in whom drinking unpasteurised milk in the past is the probable source of infection. Person-to-person transmission is very rare. Methods After identification of two epidemiologically-linked cases of human M bovis infection through routine laboratory and surveillance activities, all patients identified with M bovis infection in the Midlands from 2001-05 (n=20) were assessed by DNA fingerprinting (MIRU-VNTR and spoligotyping), with additional interviews for patients with a clustered strain. Findings A cluster of six cases was identified. All clustered cases were young and UK-born; five patients had pulmonary disease, and one patient died due to M bovis meningitis, with four patients possessing factors predisposing to tuberculosis. All patients had common social links through visits to bars in two different areas. With the exception of the first case, there was an absence of zoonotic links or consumption of unpasteurised dairy products, suggesting that person-to-person transmission had occurred. Interpretation This report of several instances of M bovis transmission between people in a modem urban setting emphasises the need to maintain control measures for human and bovine tuberculosis. Transmission and subsequent disease was probably due to a combination of host and environmental factors. Prospective surveillance and DNA fingerprinting identified the cluster, enabling health protection teams to set up control measures and prevent further transmission.	Birmingham Heartlands Hosp, Hlth Protect Agcy, W Midlands Publ Hlth Lab, Reg Ctr Mycobacteriol, Birmingham B9 5SS, W Midlands, England; Natl Publ Hlth Serv Wales, Ctr Communicable Dis Surveillance, Zoonoses Surveillance Unit, Cardiff, Wales; Hlth Protect Agcy Ctr Infect, TB Sect, London, England; Vet Labs Agcy, TB Res Grp, Weybridge, Surrey, England; Heart England NHS Fdn Trust, Birmingham Chest Clin, Birmingham, W Midlands, England; Hlth Protect Agcy Reg Surveillance Unit W Midland, Birmingham, W Midlands, England; Univ Birmingham, Sch Med, Div Immun & Infect, Birmingham, W Midlands, England; UCL, Dept Primary Care & Populat Sci, London, England	Health Protection Agency; Heart of England NHS Foundation Trust; University of Birmingham; Health Protection Agency; Veterinary Laboratories Agency; Heart of England NHS Foundation Trust; University of Birmingham; University of London; University College London	Evans, JT (corresponding author), Birmingham Heartlands Hosp, Hlth Protect Agcy, W Midlands Publ Hlth Lab, Reg Ctr Mycobacteriol, Birmingham B9 5SS, W Midlands, England.	jason.evans@heartofengland.nhs.uk	Smith, Noel H/C-6708-2011; Hewinson, Glyn/F-7077-2010; Hewinson, Glyn/J-1902-2014; Hewinson, Glyn/AAA-2364-2019	Sonnenberg, Pam/0000-0002-1067-1583; Hewinson, Glyn/0000-0002-5517-4281				Allix C, 2006, J CLIN MICROBIOL, V44, P1951, DOI 10.1128/JCM.01775-05; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Cousins DV, 1998, INT J TUBERC LUNG D, V2, P471; Cowan LS, 2005, J CLIN MICROBIOL, V43, P688, DOI 10.1128/JCM.43.2.688-695.2005; DANKNER WM, 1993, MEDICINE, V72, P11, DOI 10.1097/00005792-199301000-00002; de la Rua-Domenech R, 2006, TUBERCULOSIS, V86, P77, DOI 10.1016/j.tube.2005.05.002; *DEEP HLTH, 2004, STOPP TUB ENGL ACT P; Delahay RJ, 2002, VET J, V164, P90, DOI 10.1053/tvjl.2001.0667; Drobniewski FA, 2003, LANCET INFECT DIS, V3, P141, DOI 10.1016/S1473-3099(03)00544-9; DUPON M, 1992, Q J MED, V85, P719; Evans JT, 2004, J CLIN MICROBIOL, V42, P4175, DOI 10.1128/JCM.42.9.4175-4180.2004; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Gardam MA, 2003, LANCET INFECT DIS, V3, P148, DOI 10.1016/S1473-3099(03)00545-0; GENEWEIN A, 1993, LANCET, V342, P841, DOI 10.1016/0140-6736(93)92698-S; Gibson AL, 2004, J CLIN MICROBIOL, V42, P431, DOI 10.1128/JCM.42.1.431-434.2004; GOYAL M, 1994, J CLIN MICROBIOL, V32, P3070, DOI 10.1128/JCM.32.12.3070-3071.1994; Grange JM, 2001, TUBERCULOSIS, V81, P71, DOI 10.1054/tube.2000.0263; Gutierrez MC, 1998, LANCET, V351, P758, DOI 10.1016/S0140-6736(05)78537-8; Hawkey PM, 2003, J CLIN MICROBIOL, V41, P3514, DOI 10.1128/JCM.41.8.3514-3520.2003; Hewinson RG, 2006, VET MICROBIOL, V112, P127, DOI 10.1016/j.vetmic.2005.11.050; Hilty M, 2005, VET MICROBIOL, V109, P217, DOI 10.1016/j.vetmic.2005.05.017; *HLTH PROT AG, TUB MYC BOV; Jalava K, 2007, EPIDEMIOL INFECT, V135, P40, DOI 10.1017/S0950268806006509; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; KLINE SE, 1995, NEW ENGL J MED, V333, P222, DOI 10.1056/NEJM199507273330404; LOBUE P, 2006, MYCOBACTERIUM BOVIS, P6; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; PablosMendez A, 1997, AM J PUBLIC HEALTH, V87, P574, DOI 10.2105/AJPH.87.4.574; Richter E, 2003, J CLIN MICROBIOL, V41, P2672, DOI 10.1128/JCM.41.6.2672-2675.2003; Rivero A, 2001, CLIN INFECT DIS, V32, P159, DOI 10.1086/317547; Roring S, 2002, J CLIN MICROBIOL, V40, P2126, DOI 10.1128/JCM.40.6.2126-2133.2002; Skuce RA, 2005, VET REC, V157, P501, DOI 10.1136/vr.157.17.501; Skuce RA, 2002, MICROBIOL-SGM, V148, P519, DOI 10.1099/00221287-148-2-519; Smith NH, 2006, J THEOR BIOL, V239, P220, DOI 10.1016/j.jtbi.2005.08.036; Smith NH, 2003, P NATL ACAD SCI USA, V100, P15271, DOI 10.1073/pnas.2036554100; Smith RMM, 2004, EMERG INFECT DIS, V10, P539, DOI 10.3201/eid1003.020819; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; [No title captured]	38	131	133	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2007	369	9569					1270	1276		10.1016/S0140-6736(07)60598-4	http://dx.doi.org/10.1016/S0140-6736(07)60598-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164YA	17434402				2022-12-28	WOS:000246269700029
J	Palmowski, M; Schreiner, K; Hansmann, J; Grenacher, L				Palmowski, Moritz; Schreiner, Karin; Hansmann, Jochen; Grenacher, Lars			Bronchopulmonary sequestration: a differential diagnosis in young adults for recurrent pneumonia	LANCET			English	Editorial Material									Univ Heidelberg, Dept Diagnost Radiol, D-69120 Heidelberg, Germany; German Canc Res Ctr, Jr Grp Mol Imaging, D-69120 Heidelberg, Germany; Univ Heidelberg, Acad Hosp, Theresienkrankenhaus, Dept Pneumol, D-68165 Mannheim, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Palmowski, M (corresponding author), Univ Heidelberg, Dept Diagnost Radiol, D-69120 Heidelberg, Germany.	m.palmowski@dkfz.de						Bolca N, 2004, EUR J RADIOL, V52, P185, DOI 10.1016/j.ejrad.2004.03.005; Cooke CR, 2006, RESP CARE, V51, P661; Corbett Harriet J, 2004, Paediatr Respir Rev, V5, P59, DOI 10.1016/j.prrv.2003.09.009; FELKER RE, 1990, AM J ROENTGENOL, V154, P241, DOI 10.2214/ajr.154.2.2105007; Petersen G, 2003, J THORAC CARDIOV SUR, V126, P2086, DOI 10.1016/S0022-5223(03)01297-2	5	6	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 14	2007	369	9569					1318	1318		10.1016/S0140-6736(07)60603-5	http://dx.doi.org/10.1016/S0140-6736(07)60603-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164YA	17434408				2022-12-28	WOS:000246269700035
J	Gornall, J				Gornall, Jonathan			Duplicate publication: a bitter dispute	BRITISH MEDICAL JOURNAL			English	Article												jgornall@mac.com						CAREY B, 2004, NY TIMES        1204; *CHA BIOT, OUR PEOPL; Cha KY, 2005, FERTIL STERIL, V84, P1712, DOI 10.1016/j.fertnstert.2005.06.036; Cha KY, 2001, J REPROD MED, V46, P781; *CHA MED GROUP, 2006, MED NEWS TODAY  1124; *FDN TAXP CONS RIG, SECR PROC LETS QUEST; HARRIS P, 2004, OBSERVER        0530; Kennedy Donald, 2006, Science, V311, P335; KIM JH, 2004, KOREAN J OBSTET GYNE, V47, P16; KIM KS, 2007, STEM CELLS      0201; ORNSTEIN C, 2007, LA TIMES        0218; Parry J, 2006, BRIT MED J, V332, P67, DOI 10.1136/bmj.332.7533.67-a	12	2	2	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 7	2007	334	7596					717	720		10.1136/bmj.39168.517234.AD	http://dx.doi.org/10.1136/bmj.39168.517234.AD			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AO	17413170	Green Published			2022-12-28	WOS:000245763300024
J	Grijalva, CG; Nuorti, JP; Arbogast, PG; Martin, SW; Edwards, KM; Griffin, MR				Grijalva, Carlos G.; Nuorti, J. Pekka; Arbogast, Patrick G.; Martin, Stacey W.; Edwards, Kathryn M.; Griffin, Marie R.			Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis	LANCET			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; CHILDREN YOUNGER; DISEASE; PREVENTION; INFLUENZA; EFFICACY; IMPACT; TRIAL; HIV	Background Routine infant immunisation with seven-valent pneumococcal conjugate vaccine (PCV7) began in the USA in 2000. Although invasive pneumococcal disease has declined substantially, the programme's effect on hospital admissions for pneumonia is unknown. We therefore assessed the effect of the programme on rates of all-cause and pneumococcal pneumonia admissions. Methods Data from the Nationwide Inpatient Sample, the largest inpatient database available in the USA, were analysed with an interrupted time-series analysis that used pneumonia (all-cause and pneumococcal) admission rates as the main outcomes. Monthly admission rates estimated for years after the introduction of PCV7 vaccination (2001-2004) were compared with expected rates calculated from pre-PCV7 years (1997-1999). The year of vaccine introduction (2000) was excluded, and rates of admission for dehydration were assessed for comparison. Findings At the end of 2004, all-cause pneumonia admission rates had declined by 39% (95% CI 22-52) for children younger than 2 years, who were the target population of the vaccination programme. This annual decline in all-cause pneumonia admissions of 506 (291-675) per 100 000 children younger than 2 years represented about 41000 pneumonia admissions prevented in 2004. During the 8 study years, 10 659 (2%) children younger than 2 years admitted with pneumonia were coded as having pneumococcal disease; these rates declined by 65% (47-77). This decline represented about 17 fewer admissions per 100 000 children in 2004. Admission rates for dehydration for children younger than 2 years remained stable over the study period. Interpretation The reduction in all-cause pneumonia admissions in children younger than 2 years provides an estimate of the proportion of childhood pneumonias attributable to Streptococcus pneumoniae in the USA that are vaccine preventable. Our results contribute to the growing body of evidence supporting the beneficial effects of the pneumococcal conjugate vaccines in children.	Vanderbilt Univ, Sch Med, Dept Prevent Med, Village Vanderbilt,Suite 2600,1500 21st Ave, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Ctr Educ & Res Therapeut, Nashville, TN 37212 USA; VA TN Valley Hlth Care Syst, Mids Geriatr Res Educ, Nashville, TN USA; VA TN Valley Hlth Care Syst, Clin Res Ctr Excellence, Nashville, TN USA; Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Centers for Disease Control & Prevention - USA	Griffin, MR (corresponding author), Vanderbilt Univ, Sch Med, Dept Prevent Med, Village Vanderbilt,Suite 2600,1500 21st Ave, Nashville, TN 37212 USA.	marie.griffin@vanderbilt.edu		Grijalva, Carlos/0000-0002-2329-7797	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R03HS016784] Funding Source: NIH RePORTER; AHRQ HHS [1R03 HS016784] Funding Source: Medline; PHS HHS [U38/CCU417958] Funding Source: Medline; ATSDR CDC HHS [TS-0825, TS-1392] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); ATSDR CDC HHS		Abramson JS, 2000, PEDIATRICS, V106, P362; *AG HEALTHC RES QU, HEALTHC COST UT PR; *AG HEALTHC RES QU, 1996, HEALTHC COST UT PROJ; *AHRQ, 2002, HCUP FACT BOOK; Anderson Robert N, 2005, Natl Vital Stat Rep, V53, P1; ANDREWS BE, 1987, Q J MED, V62, P195; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P893; [Anonymous], 2006, MMWR-MORBID MORTAL W, V55, P1065; Black SB, 2002, PEDIATR INFECT DIS J, V21, P810, DOI 10.1097/00006454-200209000-00005; *CDCP, COV IND VACC VACC SE; *CDCP, NAT IMM PROGR VACC C; *CDCP, INFL ACT; Cook T.C., 1979, QUASIEXPERIMENTATION; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Drummond P, 2000, ARCH DIS CHILD, V83, P408, DOI 10.1136/adc.83.5.408; Farha Talal, 2005, Paediatr Respir Rev, V6, P76, DOI 10.1016/j.prrv.2005.03.001; Grijalva CG, 2006, PEDIATRICS, V118, P865, DOI 10.1542/peds.2006-0492; Grijalva CG, 2006, CLIN INFECT DIS, V43, P680, DOI 10.1086/506945; Guevara RE, 1999, AM J EPIDEMIOL, V149, P282, DOI 10.1093/oxfordjournals.aje.a009804; Hansen J, 2006, PEDIATR INFECT DIS J, V25, P779, DOI 10.1097/01.inf.0000232706.35674.2f; Healthcare Cost and Utilization Project, HEALTHC COST UT PROJ; Hebert PL, 2005, MED CARE RES REV, V62, P560, DOI 10.1177/1077558705279310; Heffernan RT, 2005, J INFECT DIS, V191, P2038, DOI 10.1086/430356; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jackson ML, 2004, CLIN INFECT DIS, V39, P1642, DOI 10.1086/425615; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Levine OS, 2006, LANCET, V367, P1880, DOI 10.1016/S0140-6736(06)68703-5; Little R.J.A., 2002, STAT ANAL MISSING DA; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Melegaro A, 2004, EUR J EPIDEMIOL, V19, P353, DOI 10.1023/B:EJEP.0000024701.94769.98; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Mulholland K, 2005, TROP MED INT HEALTH, V10, P497, DOI 10.1111/j.1365-3156.2005.01430.x; Nuorti JP, 2000, ANN INTERN MED, V132, P182, DOI 10.7326/0003-4819-132-3-200002010-00003; NUORTI JP, 2006, 5 INT S PNEUM PNEUM; O'Brien KL, 2003, VACCINE, V21, P1815, DOI 10.1016/S0264-410X(02)00807-1; Obaro SK, 2006, LANCET INFECT DIS, V6, P150, DOI 10.1016/S1473-3099(06)70411-X; Poehling KA, 2004, PEDIATRICS, V114, P755, DOI 10.1542/peds.2003-0592-F; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wardlaw T, 2006, LANCET, V368, P1048, DOI 10.1016/S0140-6736(06)69334-3; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; 1998, MMWR MORB MORTAL WKL, V47, P797	45	502	533	0	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2007	369	9568					1179	1186		10.1016/S0140-6736(07)60564-9	http://dx.doi.org/10.1016/S0140-6736(07)60564-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155RH	17416262				2022-12-28	WOS:000245595100029
J	Li, QJ; Chau, J; Ebert, PJR; Sylvester, G; Min, H; Liu, G; Braich, R; Manoharan, M; Soutschek, J; Skare, P; Klein, LO; Davis, MM; Chen, CZ				Li, Qi-Jing; Chau, Jacqueline; Ebert, Peter J. R.; Sylvester, Giselle; Min, Hyeyoung; Liu, Gwen; Braich, Ravi; Manoharan, Muthiah; Soutschek, Juergen; Skare, Petra; Klein, Lawrence O.; Davis, Mark M.; Chen, Chang-Zheng			miR-181a is an intrinsic modulator of T cell sensitivity and selection	CELL			English	Article							TYROSINE-PHOSPHATASE; LIGAND RECOGNITION; IN-VIVO; RECEPTOR; MICRORNAS; DISCRIMINATION; ANTIGEN; TCR; ANTAGONISM; MECHANISM	T cell sensitivity to antigen is intrinsically regulated during maturation to ensure proper development of immunity and tolerance, but how this is accomplished remains elusive. Here we show that increasing miR-181a expression in mature T cells augments the sensitivity to peptide antigens, while inhibiting miR-181a expression in the immature T cells reduces sensitivity and impairs both positive and negative selection. Moreover, quantitative regulation of T cell sensitivity by miR-181a enables mature T cells to recognize antagonists-the inhibitory peptide antigens-as agonists. These effects are in part achieved by the downregulation of multiple phosphatases, which leads to elevated steady-state levels of phosphorylated intermediates and a reduction of the T cell receptor signaling threshold. Importantly, higher miR-181a expression correlates with greater T cell sensitivity in immature T cells, suggesting that miR-181a acts as an intrinsic antigen sensitivity "rheostat" during T cell development.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Baxter Lab, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Grad Program Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Grad Program Biophys, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Inst Stem Cell Canc & Med, Stanford, CA 94305 USA; Alnylam Pharmaceut, Cambridge, MA 02142 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	mdavis@pmgm2.stanford.edu; czchen@stanford.edu		Davis, Mark/0000-0001-6868-657X; Chen, Chang-Zheng/0000-0002-1620-242X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328, R01AI073724] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL081612-02, R01 HL081612, R01 HL081612-01, R01 HL081612-03, R01-HL081612] Funding Source: Medline; NIAID NIH HHS [T32 AI007328, R01 AI073724] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BODMER H, 1994, SCIENCE, V263, P1284, DOI 10.1126/science.7510069; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; DEMAGISTRIS MT, 1992, CELL, V68, P625, DOI 10.1016/0092-8674(92)90139-4; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Dittel BN, 1999, IMMUNITY, V11, P289, DOI 10.1016/S1074-7613(00)80104-1; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kersh GJ, 1996, J EXP MED, V184, P1259, DOI 10.1084/jem.184.4.1259; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; PIRCHER H, 1991, NATURE, V351, P482, DOI 10.1038/351482a0; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Rabinowitz JD, 1996, P NATL ACAD SCI USA, V93, P1401, DOI 10.1073/pnas.93.4.1401; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Salmond RJ, 2005, J IMMUNOL, V175, P6498, DOI 10.4049/jimmunol.175.10.6498; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Sumen C, 2004, J CELL BIOL, V166, P579, DOI 10.1083/jcb.200404059; Theodosiou A, 2002, GENOME BIOL, V3; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; WINKLER DG, 1993, P NATL ACAD SCI USA, V90, P5176, DOI 10.1073/pnas.90.11.5176; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Yamasaki S, 2006, NAT IMMUNOL, V7, P67, DOI 10.1038/ni1290	44	949	1062	0	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2007	129	1					147	161		10.1016/j.cell.2007.03.008	http://dx.doi.org/10.1016/j.cell.2007.03.008			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17382377	Bronze			2022-12-28	WOS:000245661100018
J	Rosenfield, A; Min, CJ; Freedman, LP				Rosenfield, Allan; Min, Caroline J.; Freedman, Lynn P.			Making motherhood safe in developing countries	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ, Averting Maternal Death & Disabil Program, New York, NY 10027 USA; Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Columbia University; Columbia University	Rosenfield, A (corresponding author), Columbia Univ, Averting Maternal Death & Disabil Program, New York, NY 10027 USA.							ABOUZAHR C, 2004, MATERNAL MORALITY 20; Koblinsky M., 2003, REDUCING MATERNAL MO; Pathmanathan I., 2003, INT BANK RECONSTRUCT; ROSENFIELD A, 1985, LANCET, V2, P83; *UN POP FUND, CAMP END FIST FREQ A	5	43	44	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2007	356	14					1395	1397		10.1056/NEJMp078026	http://dx.doi.org/10.1056/NEJMp078026			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153GG	17409320	Bronze			2022-12-28	WOS:000245419600002
J	Ambrosini, A				Ambrosini, Anna			Occipital nerve stimulation for intractable cluster headache	LANCET			English	Editorial Material							HYPOTHALAMIC-STIMULATION		INM Neuromed, Headache Clin, I-86077 Pozzilli, Isernia, Italy	IRCCS Neuromed	Ambrosini, A (corresponding author), INM Neuromed, Headache Clin, I-86077 Pozzilli, Isernia, Italy.	anna.ambrosini@neuromed.it		AMBROSINI, Anna/0000-0003-4231-2187				Ambrosini A, 2005, PAIN, V118, P92, DOI 10.1016/j.pain.2005.07.015; Anthony m, 1985, MIGRAINE CLIN RES AD, P169; Burns B, 2007, LANCET, V369, P1099, DOI 10.1016/S0140-6736(07)60328-6; Leone M, 2006, NEUROLOGY, V67, P150, DOI 10.1212/01.wnl.0000223319.56699.8a; Magis D, 2007, LANCET NEUROL, V6, P314, DOI 10.1016/S1474-4422(07)70058-3; May A, 1999, NAT MED, V5, P836, DOI 10.1038/10561; May A, 1998, LANCET, V352, P275, DOI 10.1016/S0140-6736(98)02470-2; Peres MFP, 2002, CEPHALALGIA, V22, P520, DOI 10.1046/j.1468-2982.2002.00410.x; Schoenen J, 2005, BRAIN, V128, P940, DOI 10.1093/brain/awh411; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x	10	11	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2007	369	9567					1063	1065		10.1016/S0140-6736(07)60377-8	http://dx.doi.org/10.1016/S0140-6736(07)60377-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151XF	17398291				2022-12-28	WOS:000245323700008
J	Kleinert, S				Kleinert, Sabine			Adolescent health: an opportunity not to be missed	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Kleinert, S (corresponding author), Lancet, London NW1 7BY, England.							BEARINGER LH, 2007, LANCET          0327, DOI DOI 10.1016/S0140-6736(07)60367-5; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; PATEL V, 2007, LANCET          0327, DOI DOI 10.1016/S0140-6736(07)60368-7; PATTON GC, 2007, LANCET          0327, DOI DOI 10.1016/S0140-6736(07)60366-3; Royal College of Paediatrics and Child Health, 2003, BRIDG GAPS HLTH CAR; SAWYER SM, 2007, LANCET          0327, DOI DOI 10.1016/S0140-6736(07)60370-5; TOUMBOUROU JW, 2007, LANCET          0327, DOI DOI 10.1016/S0140-6736(07)60369-9; TYLEE A, 2007, LANCET          0327, DOI DOI 10.1016/S0140-6736(07)60371-7; *UNAIDS WHO, 2006, AIDS EP UPD; 2006, WORLD DEV REPORT 200	10	72	72	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2007	369	9567					1057	1058		10.1016/S0140-6736(07)60374-2	http://dx.doi.org/10.1016/S0140-6736(07)60374-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	151XF	17398287				2022-12-28	WOS:000245323700004
J	Shannon, C				Shannon, Colleen			MTAS: Where are we now?	BRITISH MEDICAL JOURNAL			English	Editorial Material												colleenshannonuk@yahoo.co.uk							0	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 21	2007	334	7598					824	825		10.1136/bmj.39188.477002.59	http://dx.doi.org/10.1136/bmj.39188.477002.59			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	162MD	17446610	Green Published			2022-12-28	WOS:000246090800027
J	Jazayeri, M; Movshon, JA				Jazayeri, Mehrdad; Movshon, J. Anthony			A new perceptual illusion reveals mechanisms of sensory decoding	NATURE			English	Article							VISUAL-MOTION; DISCRIMINATION; POPULATIONS; NEURONS; CORTEX; CAT	Perceptual illusions are usually thought to arise from the way sensory signals are encoded by the brain, and indeed are often used to infer the mechanisms of sensory encoding(1). But perceptual illusions might also result from the way the brain decodes sensory information(2), reflecting the strategies that optimize performance in particular tasks. In a fine discrimination task, the most accurate information comes from neurons tuned away from the discrimination boundary(3,4), and observers seem to use signals from these 'displaced' neurons to optimize their performance(5,6,7). We wondered whether using signals from these neurons might also bias perception. In a fine direction discrimination task using moving random-dot stimuli, we found that observers' perception of the direction of motion is indeed biased away from the boundary. This misperception can be accurately described by a decoding model that preferentially weights signals from neurons whose responses best discriminate those directions. In a coarse discrimination task, to which a different decoding rule applies(4), the same stimulus is not misperceived, suggesting that the illusion is a direct consequence of the decoding strategy that observers use to make fine perceptual judgments. The subjective experience of motion is therefore not mediated directly by the responses of sensory neurons, but is only developed after the responses of these neurons are decoded.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Jazayeri, M (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl, New York, NY 10003 USA.	mjaz@cns.nyu.edu			NATIONAL EYE INSTITUTE [R01EY004440, R01EY002017] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY002017-24, R01 EY004440, R01 EY004440-26, R01 EY002017] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BRITTEN KH, 1992, J NEUROSCI, V12, P4745; DEAN AF, 1981, EXP BRAIN RES, V44, P437; Eagleman DM, 2001, NAT REV NEUROSCI, V2, P920, DOI 10.1038/35104092; Gregory R. L., 1997, EYE BRAIN PSYCHOL SE; Hol K, 2001, VISION RES, V41, P685, DOI 10.1016/S0042-6989(00)00314-X; HUTTENLOCHER J, 1991, PSYCHOL REV, V98, P352, DOI 10.1037/0033-295X.98.3.352; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; PATTERSON RD, 1976, J ACOUST SOC AM, V59, P640, DOI 10.1121/1.380914; Rauber HJ, 1998, PERCEPTION, V27, P393, DOI 10.1068/p270393; REGAN D, 1985, J OPT SOC AM A, V2, P147, DOI 10.1364/JOSAA.2.000147; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6	13	118	118	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2007	446	7138					912	915		10.1038/nature05739	http://dx.doi.org/10.1038/nature05739			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17410125	Green Accepted			2022-12-28	WOS:000245785700042
J	Rubincam, DP; Paddack, SJ				Rubincam, David P.; Paddack, Stephen J.			As tiny worlds turn	SCIENCE			English	Editorial Material							RADIATION; DYNAMICS; TORQUES		NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Rubincam, DP (corresponding author), NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.	David.P.Rubincam@nasa.gov	Rubincam, David/D-2918-2012					Beekman G, 2006, J HIST ASTRON, V37, P71, DOI 10.1177/002182860603700106; Bottke WF, 2006, ANNU REV EARTH PL SC, V34, P157, DOI 10.1146/annurev.earth.34.031405.125154; Cuk M, 2005, ICARUS, V176, P418, DOI 10.1016/j.icarus.2005.02.001; Kaasalainen M, 2007, NATURE, V446, P420, DOI 10.1038/nature05614; KRESAK L, 1968, PHYS DYNAMICS METEOR, P391; Lowry SC, 2007, SCIENCE, V316, P272, DOI 10.1126/science.1139040; O'Keefe J. A., 1976, TEKTITES THEIR ORIGI; PADDACK SJ, 1975, GEOPHYS RES LETT, V2, P365, DOI 10.1029/GL002i009p00365; PADDACK SJ, 1969, J GEOPHYS RES, V74, P4379, DOI 10.1029/JB074i017p04379; Radzievskii V.V., 1954, DOKL AKAD NAUK SSSR, V97, P49; Rubincam DP, 2000, ICARUS, V148, P2, DOI 10.1006/icar.2000.6485; SLABINSKI VJ, 1977, B AM ASTRON SOC, V9, P438; Taylor PA, 2007, SCIENCE, V316, P274, DOI 10.1126/science.1139038; Vokrouhlicky D, 2003, NATURE, V425, P147, DOI 10.1038/nature01948	14	2	2	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					211	212		10.1126/science.1141930	http://dx.doi.org/10.1126/science.1141930			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431161				2022-12-28	WOS:000245654500031
J	Goldston, D				Goldston, David			Back to school	NATURE			English	Editorial Material									Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA	Princeton University	Goldston, D (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA.								0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2007	446	7137					714	714		10.1038/446714a	http://dx.doi.org/10.1038/446714a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429368	Bronze			2022-12-28	WOS:000245626800009
J	Kobatake, S; Takami, S; Muto, H; Ishikawa, T; Irie, M				Kobatake, Seiya; Takami, Shizuka; Muto, Hiroaki; Ishikawa, Tomoyuki; Irie, Masahiro			Rapid and reversible shape changes of molecular crystals on photoirradiation	NATURE			English	Article							SINGLE-CRYSTAL; PHOTOCHROMISM; DIARYLETHENE; PHOTODIMERIZATION; AZOBENZENE; POLYMERS; BEHAVIOR; ISOMER; LIGHT	The development of actuators based on materials that reversibly change shape and/or size in response to external stimuli has attracted interest for some time(1). A particularly intriguing possibility is offered by light-responsive materials, which allow remote operation without the need for direct contact to the actuator. The photo-response of these materials is based on the photoisomerization of constituent molecules ( typically trans - cis isomerization of azobenzene chromophores), which gives rise to molecular motions and thereby deforms the bulk material. This effect has been used to create light-deformable polymer films and gels(2-10), but the response of these systems is relatively slow. Here we report that molecular crystals based on diarylethene chromophores and with sizes ranging from 10 to 100 micrometres exhibit rapid and reversible macroscopic changes in shape and size induced by ultraviolet and visible light. We find that on exposure to ultraviolet light, a single crystal of 1,2-bis(2-ethyl-5-phenyl-3-thienyl) perfluorocyclopentene changes from a square shape to a lozenge shape, whereas a rectangular single crystal of 1,2-bis(5-methyl-2-phenyl- 4-thiazolyl) perfluorocyclopentene contracts by about 5 - 7 per cent. The deformed crystals are thermally stable, and switch back to their original state on irradiation with visible light. We find that our crystals respond in about 25 microseconds ( that is, about five orders of magnitude faster than the response time of the azobenzene-based polymer systems(7-10)) and that they can move microscopic objects, making them promising materials for possible light-driven actuator applications.	Kyushu Univ, Grad Sch Engn, Dept Chem & Biochem, Fukuoka 8128581, Japan; Osaka City Univ, Grad Sch Engn, Dept Appl Chem, Sumiyoshi Ku, Osaka 5588585, Japan	Kyushu University; Osaka Metropolitan University	Irie, M (corresponding author), Kyushu Univ, Grad Sch Engn, Dept Chem & Biochem, Hakozaki 6-10-1, Fukuoka 8128581, Japan.	irie@cstf.kyushu-u.ac.jp	Kobatake, Seiya/P-4989-2015	Kobatake, Seiya/0000-0002-1526-4629				AGOLINI F, 1970, MACROMOLECULES, V3, P349, DOI 10.1021/ma60015a015; EISENBACH CD, 1980, POLYMER, V21, P1175, DOI 10.1016/0032-3861(80)90083-X; Finkelmann H, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.015501; Ikeda T, 2003, ADV MATER, V15, P201, DOI 10.1002/adma.200390045; Irie M, 2001, SCIENCE, V291, P1769, DOI 10.1126/science.291.5509.1769; Irie M, 2000, CHEM REV, V100, P1685, DOI 10.1021/cr980069d; IRIE M, 1990, ADV POLYM SCI, V94, P28; Kobatake S, 2004, B CHEM SOC JPN, V77, P195, DOI 10.1246/bcsj.77.195; Kobatake S, 2002, CHEM LETT, P1224, DOI 10.1246/cl.2002.1224; Kobatake S, 2000, J AM CHEM SOC, V122, P12135, DOI 10.1021/ja001996g; MATEJKA L, 1981, POLYMER, V22, P1511, DOI 10.1016/0032-3861(81)90321-9; MERIAN E, 1966, TEXT RES J, V36, P612, DOI 10.1177/004051756603600704; Miyasaka H, 1997, CHEM PHYS LETT, V269, P281, DOI 10.1016/S0009-2614(97)00282-0; Morimoto M, 2005, CHEM COMMUN, P3895, DOI 10.1039/b505256d; NAKANISHI H, 1981, J PHYS CHEM-US, V85, P3636, DOI 10.1021/j150624a022; NOVAK K, 1993, ANGEW CHEM INT EDIT, V32, P1614, DOI 10.1002/anie.199316141; Toh NL, 2005, ANGEW CHEM INT EDIT, V44, P2237, DOI 10.1002/anie.200462673; Wayman C.M., 1998, SHAPE MEMORY MAT; Yu YL, 2003, NATURE, V425, P145, DOI 10.1038/425145a; Yu YL, 2004, CHEM MATER, V16, P1637, DOI 10.1021/cm035092g	20	922	936	30	840	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2007	446	7137					778	781		10.1038/nature05669	http://dx.doi.org/10.1038/nature05669			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429396				2022-12-28	WOS:000245626800036
J	Hawkes, N				Hawkes, Nigel			The royal colleges must up their game - or die - The debacle over doctors' specialist training begs the question of what the royal colleges are for	BRITISH MEDICAL JOURNAL			English	Editorial Material												niget.hawkes@thetimes.co.uk							0	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 7	2007	334	7596					724	724		10.1136/bmj.39170.469780.59	http://dx.doi.org/10.1136/bmj.39170.469780.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AO	17413172	Green Published			2022-12-28	WOS:000245763300026
J	Dente, KM				Dente, Karen M.			Scientists on the move	CELL			English	Editorial Material								In today's global world, scientists are increasingly mobile and the traditional view of "brain drain" is being replaced by "brain circulation." Countries such as China and India are tapping into a global pool of science talent attracting not only their own citizens back from abroad but also scientists from the US and Europe.											0	1	1	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					15	17		10.1016/j.cell.2007.03.012	http://dx.doi.org/10.1016/j.cell.2007.03.012			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418776	Bronze			2022-12-28	WOS:000245661100001
J	Francis, CW				Francis, Charles W.			Prophylaxis for thromboembolism in hospitalized medical patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FATAL PULMONARY-EMBOLISM; DEEP-VEIN THROMBOSIS; LOW-DOSE HEPARIN; VENOUS THROMBOEMBOLISM; CLINICAL-PRACTICE; CONTROLLED-TRIAL; PREVENTION; RISK; PLACEBO; METAANALYSIS		Univ Rochester, Med Ctr, Dept Hematol & Oncol, Rochester, NY 14642 USA	University of Rochester	Francis, CW (corresponding author), Univ Rochester, Med Ctr, Dept Hematol & Oncol, 601 Elmwood Ave,Box 610, Rochester, NY 14642 USA.	charles_francis@urmc.rochester.edu						Ageno W, 2002, HAEMATOLOGICA, V87, P746; Agu O, 1999, BRIT J SURG, V86, P992, DOI 10.1046/j.1365-2168.1999.01195.x; Albers GW, 2004, CHEST, V126, p483S, DOI 10.1378/chest.126.3_suppl.483S; AMARAGIRI SV, 2000, COCHRANE DATABASE SY, V0003; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; ANDERSON FA, 1994, ARCH INTERN MED, V154, P669, DOI 10.1001/archinte.154.6.669; ANDERSON FA, 1991, ANN INTERN MED, V115, P591, DOI 10.7326/0003-4819-591; Baglin TP, 1997, J CLIN PATHOL, V50, P609, DOI 10.1136/jcp.50.7.609; Cohen AT, 2006, BMJ-BRIT MED J, V332, P325, DOI 10.1136/bmj.38733.466748.7C; Cohen AT, 2005, THROMB HAEMOSTASIS, V94, P750, DOI 10.1160/TH05-06-0385; Collaboration AT, 1994, BMJ-BRIT MED J, V308, P235; COLLINS R, 1988, NEW ENGL J MED, V318, P1162, DOI 10.1056/NEJM198805053181805; Collins R, 1996, BMJ-BRIT MED J, V313, P652; Dentali F, 2007, ANN INTERN MED, V146, P278, DOI 10.7326/0003-4819-146-4-200702200-00007; Dexter PR, 2001, NEW ENGL J MED, V345, P965, DOI 10.1056/NEJMsa010181; Gardlund B, 1996, LANCET, V347, P1357; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Goldhaber SZ, 2000, CHEST, V118, P1680, DOI 10.1378/chest.118.6.1680; Goldhaber SZ, 2004, AM J CARDIOL, V93, P259, DOI 10.1016/j.amjcard.2003.09.057; GUBITZ G, 2004, COCHRANE DB SYST REV, V3; HAAS SB, 1992, J BONE JOINT SURG BR, V74, P799, DOI 10.1302/0301-620X.74B6.1447236; Haas SK, 2002, SEMIN THROMB HEMOST, V28, P577, DOI 10.1055/s-2002-36702; HALKIN H, 1982, ANN INTERN MED, V96, P561, DOI 10.7326/0003-4819-96-5-561; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; KAKKAR VV, 1969, LANCET, V2, P230; KAKKAR VV, 1975, LANCET, V2, P674; Kamphuisen PW, 2005, J THROMB HAEMOST, V3, P1187, DOI 10.1111/j.1538-7836.2005.01443.x; KEANE MG, 1994, CHEST, V106, P13, DOI 10.1378/chest.106.1.13; Kearon C, 2003, CIRCULATION, V107, pI22, DOI 10.1161/01.CIR.0000078464.82671.78; Khorana AA, 2006, J CLIN ONCOL, V24, P484, DOI 10.1200/JCO.2005.03.8877; Kirwan CC, 2003, BRIT MED J, V327, P597, DOI 10.1136/bmj.327.7415.597; Kucher N, 2005, NEW ENGL J MED, V352, P969, DOI 10.1056/NEJMoa041533; Leizorovicz A, 2004, CIRCULATION, V110, P874, DOI 10.1161/01.CIR.0000138928.83266.24; LINDBLAD B, 1991, BRIT J SURG, V78, P849, DOI 10.1002/bjs.1800780725; LOWE GDO, 1992, BMJ-BRIT MED J, V305, P567; Mismetti P, 2000, THROMB HAEMOSTASIS, V83, P14; MOSER KM, 1981, ANN INTERN MED, V94, P439, DOI 10.7326/0003-4819-94-4-439; Samama MM, 1999, NEW ENGL J MED, V341, P793, DOI 10.1056/NEJM199909093411103; SANDLER DA, 1989, J ROY SOC MED, V82, P203, DOI 10.1177/014107688908200407; STEIN PD, 1995, CHEST, V108, P978, DOI 10.1378/chest.108.4.978	40	143	153	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 5	2007	356	14					1438	1444		10.1056/NEJMcp067264	http://dx.doi.org/10.1056/NEJMcp067264			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153GG	17409325				2022-12-28	WOS:000245419600007
J	Yin, LM; Zhu, MY; Knoll, AH; Yuan, XL; Zhang, JM; Hu, J				Yin, Leiming; Zhu, Maoyan; Knoll, Andrew H.; Yuan, Xunlai; Zhang, Junming; Hu, Jie			Doushantuo embryos preserved inside diapause egg cysts	NATURE			English	Article							ANIMAL EMBRYOS; PB AGES; MICROFOSSILS; CONSTRAINTS; TAPHONOMY; GUIZHOU; FOSSILS; WENGAN	Phosphatized microfossils in the Ediacaran ( 635 - 542 Myr ago) Doushantuo Formation, south China, have been interpreted as the embryos of early animals(1-4). Despite experimental demonstration that embryos can be preserved(5), microstructural evidence that the Doushantuo remains are embryonic(6) and an unambiguous record of fossil embryos in Lower Cambrian rocks(7), questions about the phylogenetic relationships of these fossils remain. Most recently, some researchers have proposed(8) that Doushantuo microfossils may be giant sulphur-oxidizing bacteria comparable to extant Thiomargarita sp. Here we report new observations that provide a test of the bacterial hypothesis. The discovery of embryo-like Doushantuo fossils inside large, highly ornamented organic vesicles (acritarchs) indicates that these organisms were eukaryotic, and most probably early cleavage stage embryos preserved within diapause egg cysts. Large acanthomorphic microfossils of the type observed to contain fossil embryos first appear in rocks just above a 632.5 +/- 0.5-Myr-old ash bed(9), suggesting that at least stem-group animals(6) inhabited shallow seas in the immediate aftermath of global Neoproterozoic glaciation.	Chinese Acad Sci, Nanjing Inst Geol & Paleontol, State Key Lab Paleobiol & Stratig, Nanjing 210008, Peoples R China; Harvard Univ, Bot Museum, Cambridge, MA 02138 USA	Chinese Academy of Sciences; Nanjing Institute of Geology & Paleontology, CAS; Harvard University	Yin, LM (corresponding author), Chinese Acad Sci, Nanjing Inst Geol & Paleontol, State Key Lab Paleobiol & Stratig, Nanjing 210008, Peoples R China.	leimingyin@yahoo.com.cn	Zhu, Maoyan/K-1124-2014	Zhu, Maoyan/0000-0001-7327-9856				Bailey JV, 2007, NATURE, V445, P198, DOI 10.1038/nature05457; Barfod GH, 2002, EARTH PLANET SC LETT, V201, P203, DOI 10.1016/S0012-821X(02)00687-8; Buban JP, 2006, SCIENCE, V311, P212, DOI 10.1126/science.1119839; BUCKLANDNICKS J, 1993, BIOL BULL-US, V184, P269, DOI 10.2307/1542445; Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; Chen DF, 2004, PRECAMBRIAN RES, V132, P123, DOI 10.1016/j.precamres.2004.02.005; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; Donoghue PCJ, 2006, EVOL DEV, V8, P232, DOI 10.1111/j.1525-142X.2006.00093.x; Donoghue PCJ, 2007, NATURE, V445, P155, DOI 10.1038/nature05520; Dornbos SQ, 2006, PALAIOS, V21, P3, DOI 10.2110/palo.2004.p04-37; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; GREY K, 2005, MEMOIRS ASS AUSTRALA, V31, P1; Hagadorn JW, 2006, SCIENCE, V314, P291, DOI 10.1126/science.1133129; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; Knoll AH, 2006, PHILOS T R SOC B, V361, P1023, DOI 10.1098/rstb.2006.1843; Marcus NH, 1998, LIMNOL OCEANOGR, V43, P763, DOI 10.4319/lo.1998.43.5.0763; Raff EC, 2006, P NATL ACAD SCI USA, V103, P5846, DOI 10.1073/pnas.0601536103; Van Waveren Isabel M., 1993, Special Papers in Palaeontology, V48, P111; VOREBEVA NG, UNPUB GEOLOGY; Xiao SH, 2000, J PALEONTOL, V74, P767, DOI 10.1666/0022-3360(2000)074<0767:PAEFTN>2.0.CO;2; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Xiao SH, 2007, GEOLOGY, V35, P115, DOI 10.1130/G23277A.1; Yin CY, 2004, ACTA PALAEONTOL POL, V49, P1; Yuan XL, 1998, ALCHERINGA, V22, P189; Zhang Y, 1998, J PALEONTOL, V72, P1; ZHOU C, 2006, GEOL J, V41, P1; ZHU M, IN PRESS PALAEOGEOGR	27	239	298	4	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2007	446	7136					661	663		10.1038/nature05682	http://dx.doi.org/10.1038/nature05682			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17410174				2022-12-28	WOS:000245438300038
J	Saulsbury, FT				Saulsbury, Frank T.			Clinical update: Henoch-Schonlein purpura	LANCET			English	Article							NEPHRITIS; CHILDREN; THERAPY; GLYCOSYLATION; PREDNISONE; CHILDHOOD		Univ Virginia Hlth Syst, Dept Pediat, Div Immunol & Rheumatol, Charlottesville, VA 22908 USA	University of Virginia	Saulsbury, FT (corresponding author), Univ Virginia Hlth Syst, Dept Pediat, Div Immunol & Rheumatol, Charlottesville, VA 22908 USA.	fts@virginia.edu						Allen AC, 1998, NEPHROL DIAL TRANSPL, V13, P930, DOI 10.1093/ndt/13.4.930; Calvino MC, 2001, MEDICINE, V80, P279, DOI 10.1097/00005792-200109000-00001; Davin JC, 2001, KIDNEY INT, V59, P823, DOI 10.1046/j.1523-1755.2001.059003823.x; Foster BJ, 2000, J PEDIATR-US, V136, P370, DOI 10.1067/mpd.2000.103448; Huber AM, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-7; KOSKIMIES O, 1981, ARCH DIS CHILD, V56, P482, DOI 10.1136/adc.56.6.482; LIJIMA K, 1998, PEDIATR NEPHROL, V12, P244; NARCHI H, 2005, ARCH DIS CHILD, V90, P16; Niaudet P, 1998, PEDIATR NEPHROL, V12, P238, DOI 10.1007/s004670050446; Novak J, 2001, J CLIN IMMUNOL, V21, P310, DOI 10.1023/A:1012284402054; Ronkainen J, 2003, CLIN NEPHROL, V60, P80; Ronkainen J, 2002, LANCET, V360, P666, DOI 10.1016/S0140-6736(02)09835-5; Ronkainen J, 2006, J PEDIATR-US, V149, P241, DOI 10.1016/j.jpeds.2006.03.024; ROSENBLUM ND, 1987, PEDIATRICS, V79, P1018; Saulsbury FT, 1999, MEDICINE, V78, P395, DOI 10.1097/00005792-199911000-00005; Saulsbury FT, 1997, J RHEUMATOL, V24, P2246; Saulsbury FT, 2001, CURR OPIN RHEUMATOL, V13, P35, DOI 10.1097/00002281-200101000-00006; Shin JI, 2005, SCAND J RHEUMATOL, V34, P392, DOI 10.1080/03009740510026544; Trapani S, 2005, SEMIN ARTHRITIS RHEU, V35, P143, DOI 10.1016/j.semarthrit.2005.08.007; YOSHIKAWA N, 1981, CLIN NEPHROL, V16, P223	20	182	208	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2007	369	9566					976	978		10.1016/S0140-6736(07)60474-7	http://dx.doi.org/10.1016/S0140-6736(07)60474-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151JO	17382810				2022-12-28	WOS:000245286500010
J	Allingham, JS; Sproul, LR; Rayment, I; Gilbert, SP				Allingham, John S.; Sproul, Lisa R.; Rayment, Ivan; Gilbert, Susan P.			Vik1 modulates microtubule-Kar3 interactions through a motor domain that lacks an active site	CELL			English	Article							KINESIN-RELATED PROTEIN; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; MITOTIC SPINDLE; BUDDING YEAST; PLUS ENDS; KAR3; NCD; DROSOPHILA; CIK1	Conventional kinesin and class V and VI myosins coordinate the mechanochemical cycles of their motor domains for processive movement of cargo along microtubules or actin filaments. It is widely accepted that this coordination is achieved by allosteric communication or mechanical strain between the motor domains, which controls the nucleotide state and interaction with microtubules or actin. However, questions remain about the interplay between the strain and the nucleotide state. We present an analysis of Saccharomyces cerevisiae Kar3/Vik1, a heterodimeric C-terminal Kinesin-14 containing catalytic Kar3 and the nonmotor protein Vik1. The X-ray crystal structure of Vik1 exhibits a similar fold to the kinesin and myosin catalytic head, but lacks an ATP binding site. Vik1 binds more tightly to microtubules than Kar3 and facilitates cooperative microtubule decoration by Kar3/Vik1 heter-odimers, and yet allows motility. These results demand communication between Vik1 and Kar3 via a mechanism that coordinates their interactions with microtubules.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rayment, I (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53706 USA.	ivan_rayment@biochem.wisc.edu; spg1@pitt.edu	Allingham, John/AAW-9262-2020; rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835; Hoverman, Lisa/0000-0002-3396-6982	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K02AR047841, R01AR035186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054141, R37GM054141] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR013790, S10 RR13790] Funding Source: Medline; NIAMS NIH HHS [K02 AR047841, R01 AR035186, K02-AR47841, AR35186] Funding Source: Medline; NIGMS NIH HHS [R37 GM054141, R01 GM054141, GM54141] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alonso MC, 1998, EMBO J, V17, P945, DOI 10.1093/emboj/17.4.945; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barrett JG, 2000, MOL BIOL CELL, V11, P2373, DOI 10.1091/mbc.11.7.2373; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Chu HMA, 2005, EMBO J, V24, P3214, DOI 10.1038/sj.emboj.7600790; DeLano W.L, PYMOL MOL GRAPHICS S; ENDOW SA, 1990, NATURE, V345, P81, DOI 10.1038/345081a0; Endres NF, 2006, NATURE, V439, P875, DOI 10.1038/nature04320; Gulick AM, 1998, BIOCHEMISTRY-US, V37, P1769, DOI 10.1021/bi972504o; HATSUMI M, 1992, J CELL SCI, V101, P547; Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4; Hirose K, 1998, J MOL BIOL, V278, P389, DOI 10.1006/jmbi.1998.1709; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; KIMBLE M, 1983, J CELL SCI, V62, P301; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Mackey AT, 2003, J BIOL CHEM, V278, P3527, DOI 10.1074/jbc.M206219200; Maddox P, 1999, J CELL BIOL, V144, P977, DOI 10.1083/jcb.144.5.977; Maddox PS, 2003, CURR BIOL, V13, P1423, DOI 10.1016/S0960-9822(03)00547-5; Manning BD, 1999, J CELL BIOL, V144, P1219, DOI 10.1083/jcb.144.6.1219; Manning BD, 2000, TRENDS CELL BIOL, V10, P281, DOI 10.1016/S0962-8924(00)01774-8; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; MCDONALD HB, 1990, CELL, V61, P991, DOI 10.1016/0092-8674(90)90064-L; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; Molk JN, 2006, J CELL BIOL, V172, P27, DOI 10.1083/jcb.200510032; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAGE BD, 1992, GENE DEV, V6, P1414, DOI 10.1101/gad.6.8.1414; PAGE BD, 1994, J CELL BIOL, V124, P507, DOI 10.1083/jcb.124.4.507; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Pidoux AL, 1996, MOL BIOL CELL, V7, P1639, DOI 10.1091/mbc.7.10.1639; ROUSSEL A, 1991, SILICON GRAPHICS GEO; Sablin EP, 2004, J BIOL CHEM, V279, P15707, DOI 10.1074/jbc.R300036200; Sablin EP, 1996, NATURE, V380, P555, DOI 10.1038/380555a0; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; Sack S, 1999, EUR J BIOCHEM, V262, P1, DOI 10.1046/j.1432-1327.1999.00341.x; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; SCHULZ GE, 1992, CURR OPIN STRUC BIOL, V2, P61; Sharp DJ, 2000, MOL BIOL CELL, V11, P241, DOI 10.1091/mbc.11.1.241; Song YH, 2001, EMBO J, V20, P6213, DOI 10.1093/emboj/20.22.6213; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Troxell CL, 2001, MOL BIOL CELL, V12, P3476, DOI 10.1091/mbc.12.11.3476; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Wendt TG, 2002, EMBO J, V21, P5969, DOI 10.1093/emboj/cdf622; Westhead DR, 1999, PROTEIN SCI, V8, P897; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531	51	64	64	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1161	1172		10.1016/j.cell.2006.12.046	http://dx.doi.org/10.1016/j.cell.2006.12.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382884	Green Accepted, Bronze			2022-12-28	WOS:000245396200021
J	Mandon, EC; Gilmore, R				Mandon, Elisabet C.; Gilmore, Reid			The tail end of membrane insertion	CELL			English	Editorial Material							ENDOPLASMIC-RETICULUM MEMBRANE; SIGNAL-RECOGNITION PARTICLE; ANCHORED PROTEIN; INTEGRATION; MECHANISMS; PATHWAY	Many membrane proteins are inserted into cellular membranes via a carboxy-terminal tail-anchor segment, but the mechanism of insertion is poorly understood. In this issue of Cell, Stefanovic and Hegde (2007) report the identification and initial characterization of a soluble ATP-dependent receptor for the insertion of newly synthesized tail-anchored membrane proteins.	Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Gilmore, R (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA.	reid.gilmore@umassmed.edu						Abell BM, 2004, EMBO J, V23, P2755, DOI 10.1038/sj.emboj.7600281; ANDERSON DJ, 1983, P NATL ACAD SCI-BIOL, V80, P7249, DOI 10.1073/pnas.80.23.7249; Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200; Kim PK, 1997, BIOCHEMISTRY-US, V36, P8873, DOI 10.1021/bi970090t; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; Mukhopadhyay R, 2006, FEBS LETT, V580, P3889, DOI 10.1016/j.febslet.2006.06.017; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Steel GJ, 2002, BIOCHEMISTRY-US, V41, P11914, DOI 10.1021/bi026105r; Yabal M, 2003, J BIOL CHEM, V278, P3489, DOI 10.1074/jbc.M210253200	9	5	5	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2007	128	6					1031	1032		10.1016/j.cell.2007.03.001	http://dx.doi.org/10.1016/j.cell.2007.03.001			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382875	Bronze			2022-12-28	WOS:000245396200009
J	Cui, HC; Levesque, MP; Vernoux, T; Jung, JW; Paquette, AJ; Gallagher, KL; Wang, JY; Blilou, I; Scheres, B; Benfey, PN				Cui, Hongchang; Levesque, Mitchell P.; Vernoux, Teva; Jung, Jee W.; Paquette, Alice J.; Gallagher, Kimberly L.; Wang, Jean Y.; Blilou, Ikram; Scheres, Ben; Benfey, Philip N.			An evolutionarily conserved mechanism delimiting SHR movement defines a single layer of endodermis in plants	SCIENCE			English	Article							ASYMMETRIC CELL-DIVISION; ARABIDOPSIS ROOT; SCARECROW GENE; INTERCELLULAR MOVEMENT; RADIAL ORGANIZATION; EXPRESSION; TRAFFICKING; PROTEIN; NETWORKS; MERISTEM	Intercellular protein movement plays a critical role in animal and plant development. SHORTROOT (SHR) is a moving transcription factor essential for endodermis specification in the Arabidopsis root. Unlike diffusible animal morphogens, which form a gradient across multiple cell layers, SHR movement is limited to essentially one cell layer. However, the molecular mechanism is unknown. We show that SCARECROW (SCR) blocks SHR movement by sequestering it into the nucleus through protein-protein interaction and a safeguard mechanism that relies on a SHR/SCR-dependent positive feedback loop for SCR transcription. Our studies with SHR and SCR homologs from rice suggest that this mechanism is evolutionarily conserved, providing a plausible explanation why nearly all plants have a single layer of endodermis.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; Univ Utrecht, Dept Mol Genet, NL-3584 CH Utrecht, Netherlands	Duke University; Duke University; Utrecht University	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	philip.benfey@duke.edu	Vernoux, Teva/J-1695-2019; Cui, Hongchang/ABD-3278-2021	Vernoux, Teva/0000-0002-8257-4088; Cui, Hongchang/0000-0002-9870-748X; Blilou, Ikram/0000-0001-8003-3782; Scheres, Ben/0000-0001-5400-9578	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043778] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM043778] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Benfey PN, 2001, PLANT PHYSIOL, V125, P109, DOI 10.1104/pp.125.1.109; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; DOLAN L, 1993, DEVELOPMENT, V119, P71; Gallagher KL, 2005, GENE DEV, V19, P189, DOI 10.1101/gad.1271005; Gallagher KL, 2004, CURR BIOL, V14, P1847, DOI 10.1016/j.cub.2004.09.081; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Kamiya N, 2003, PLANT J, V36, P45, DOI 10.1046/j.1365-313X.2003.01856.x; Kim JY, 2002, P NATL ACAD SCI USA, V99, P4103, DOI 10.1073/pnas.052484099; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kurata T, 2005, DEVELOPMENT, V132, P5387, DOI 10.1242/dev.02139; Lee JY, 2006, P NATL ACAD SCI USA, V103, P6055, DOI 10.1073/pnas.0510607103; Lee JY, 2003, SCIENCE, V299, P392, DOI 10.1126/science.1077813; Levesque MP, 2006, PLOS BIOL, V4, P739, DOI 10.1371/journal.pbio.0040143; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Lim J, 2000, PLANT CELL, V12, P1307, DOI 10.1105/tpc.12.8.1307; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Sassa N, 2001, PLANT CELL PHYSIOL, V42, P385, DOI 10.1093/pcp/pce048; SCHERES B, 1995, DEVELOPMENT, V121, P53; Sena G, 2004, DEVELOPMENT, V131, P2817, DOI 10.1242/dev.01144; Wang YC, 2005, NATURE, V434, P229, DOI 10.1038/nature03318; Weinl C, 2005, PLANT CELL, V17, P1704, DOI 10.1105/tpc.104.030486; Wu XL, 2003, DEVELOPMENT, V130, P3735, DOI 10.1242/dev.00577	27	397	444	2	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					421	425		10.1126/science.1139531	http://dx.doi.org/10.1126/science.1139531			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446396				2022-12-28	WOS:000245813400049
J	Cahn, P; Sued, O				Cahn, Pedro; Sued, Omar			Raltegravir: a new anti retroviral class for salvage therapy	LANCET			English	Editorial Material							INHIBITORS; INTEGRASE; EFFICACY		Fdn Huesped, Dept Clin Res, Buenos Aires, DF, Argentina		Cahn, P (corresponding author), Fdn Huesped, Dept Clin Res, C1202ABB, Buenos Aires, DF, Argentina.	pcahn@huesped.org.ar	Sued, Omar/H-3325-2019	Sued, Omar/0000-0001-5818-770X				Cahn P, 2006, CLIN INFECT DIS, V43, P1347, DOI 10.1086/508352; COOPER D, 2007, 14 C RETR OPP INF LO; *DHHS PAN ANT GUID, 2006, GUID US ANT AG HIV 1; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; KASSAHUN K, 46 ANN INT C ANT AG, pA372; Katlama C, 2007, AIDS, V21, P395, DOI 10.1097/QAD.0b013e328013d9d7; MARKOWITZ M, 2006, 16 INT AIDS C TOR CA; Markowitz M, 2006, JAIDS-J ACQ IMM DEF, V43, P509, DOI 10.1097/QAI.0b013e31802b4956; Palmisono L, 2007, EXPERT REV ANTI-INFE, V5, P67, DOI 10.1586/14787210.5.1.67; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; STEIGBIGEL R, 2007, 14 C RETR OPP INF LO; TEPPLER H, 2006, 46 ANN INT C ANT AG	12	48	49	3	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 14	2007	369	9569					1235	1236		10.1016/S0140-6736(07)60571-6	http://dx.doi.org/10.1016/S0140-6736(07)60571-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164YA	17434380				2022-12-28	WOS:000246269700004
J	Lanata, CF				Lanata, Claudio F.			Human resources in developing countries	LANCET			English	Editorial Material							HEALTH-WORKERS; MORTALITY		Inst Invest Nutr, Lima 12, Peru		Lanata, CF (corresponding author), Inst Invest Nutr, Lima 12, Peru.	clanata@iin.sld.pe	Lanata, Claudio F./N-7997-2018	Lanata, Claudio F./0000-0002-6994-7425				Anand S, 2007, LANCET, V369, P1277, DOI 10.1016/S0140-6736(07)60599-6; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; Buchan J, 2004, B WORLD HEALTH ORGAN, V82, P587; Eastwood JB, 2005, LANCET, V365, P1893, DOI 10.1016/S0140-6736(05)66623-8; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; *UN, 2005, MILL DEV GOALS; Victora CG, 2006, B WORLD HEALTH ORGAN, V84, P792, DOI 10.2471/BLT.06.030502; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	12	8	8	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 14	2007	369	9569					1238	1239		10.1016/S0140-6736(07)60573-X	http://dx.doi.org/10.1016/S0140-6736(07)60573-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	164YA	17434382				2022-12-28	WOS:000246269700006
J	Smith, R; Hourihan, MD				Smith, R.; Hourihan, M. D.			Rational imaging - Investigating suspected cerebral venous thrombosis	BRITISH MEDICAL JOURNAL			English	Article							CT VENOGRAPHY; SINUS THROMBOSIS; ANGIOGRAPHY		Univ Wales Hosp, Cardiff CF14 4XW, Wales	Cardiff University	Hourihan, MD (corresponding author), Univ Wales Hosp, Cardiff CF14 4XW, Wales.	hourihanmd@cf.ac.uk						Alberico RA, 1999, AM J NEURORADIOL, V20, P328; Casey SO, 1996, RADIOLOGY, V198, P163, DOI 10.1148/radiology.198.1.8539371; Einhaupl K, 2006, EUR J NEUROL, V13, P553, DOI 10.1111/j.1468-1331.2006.01398.x; Hagen T, 1996, RADIOLOGE, V36, P859, DOI 10.1007/s001170050152; ISENSEE C, 1994, STROKE, V25, P29, DOI 10.1161/01.STR.25.1.29; Khandelwal N, 2006, AM J ROENTGENOL, V187, P1637, DOI 10.2214/AJR.05.1249; Ozsvath RR, 1997, AM J ROENTGENOL, V169, P1699, DOI 10.2214/ajr.169.6.9393193; Wetzel SG, 1999, AM J NEURORADIOL, V20, P249; YUH WTC, 1994, AM J NEURORADIOL, V15, P309	9	13	16	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 14	2007	334	7597					794	795		10.1136/bmj.39154.636968.47	http://dx.doi.org/10.1136/bmj.39154.636968.47			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161SX	17431266	Green Published			2022-12-28	WOS:000246037300031
J	Roscioli, JR; McCunn, LR; Johnson, MA				Roscioli, J. R.; McCunn, L. R.; Johnson, M. A.			Quantum structure of the intermolecular proton bond	SCIENCE			English	Article							GAS-PHASE; INFRARED-SPECTRUM; TRANSFER PATHWAYS; MATRIX-ISOLATION; HYDROGEN-BONDS; ARGON MATRICES; CM(-1) REGION; BOUND DIMERS; SPECTROSCOPY; COMPLEXES	A proton shared between two closed-shell molecules, [A . H+ . B], constitutes a ubiquitous soft binding motif in biological processes. The vibrational transitions associated with the shared proton, which provide a direct probe of this interaction, have been extensively studied in the condensed phase but have yielded only limited detailed information because of their diffuse character. We exploited recent advances in gas-phase ion spectroscopy to identify sharp spectral features that can be assigned to both the shared proton and the two tethered molecules in a survey of 18 cold, isolated [ A . H+ . B] ions. These data yield a picture of the intermolecular proton bond at a microscopic scale, facilitating analysis of its properties within the context of a floppy polyatomic molecule.	Yale Univ, Sterling Chem Lab, New Haven, CT 06520 USA	Yale University	Johnson, MA (corresponding author), Yale Univ, Sterling Chem Lab, POB 208107, New Haven, CT 06520 USA.	mark.johnson@yale.edu						Asmis KR, 2003, SCIENCE, V299, P1375, DOI 10.1126/science.1081634; AULT BS, 1975, J PHYS CHEM-US, V79, P615, DOI 10.1021/j100573a014; BARNES AJ, 1970, T FARADAY SOC, V66, P1932, DOI 10.1039/tf9706601932; BARNES AJ, 1983, J MOL STRUCT, V100, P259, DOI 10.1016/0022-2860(83)90096-0; BARNES AJ, 1970, T FARADAY SOC, V66, P1920, DOI 10.1039/tf9706601920; CLELAND WW, 1994, SCIENCE, V264, P1887, DOI 10.1126/science.8009219; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; Diken EG, 2005, J PHYS CHEM A, V109, P1487, DOI 10.1021/jpO44155v; Fridgen TD, 2006, PHYS CHEM CHEM PHYS, V8, P955, DOI 10.1039/b516661f; Fridgen TD, 2005, PHYS CHEM CHEM PHYS, V7, P2747, DOI 10.1039/b504926a; Frisch M.J., 2009, GAUSSIAN 09 LINUX VE; Garczarek F, 2006, NATURE, V439, P109, DOI 10.1038/nature04231; Hammer NI, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1927522; Headrick JM, 2004, J CHEM PHYS, V121, P11523, DOI 10.1063/1.1834566; Huang XC, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1834500; HUNTER EP, 2005, NIST CHEM WEBBOOK NI; JOHNSON MA, 1988, TECHNIQUES CHEM, V20, P591; Kaledin M, 2006, J PHYS CHEM A, V110, P2933, DOI 10.1021/jp054374w; Luecke H, 1998, SCIENCE, V280, P1934, DOI 10.1126/science.280.5371.1934; McCoy AB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1857472; Moore DT, 2004, CHEMPHYSCHEM, V5, P740, DOI 10.1002/cphc.200400062; Nizkorodov SA, 1996, J CHEM PHYS, V105, P1770, DOI 10.1063/1.472052; Novak, 1974, STRUCT BOND, P177, DOI [10.1007/BFb0116438, DOI 10.1007/BFB0116438]; OKUMURA M, 1986, J CHEM PHYS, V85, P2328, DOI 10.1063/1.451079; PRICE JM, 1991, J PHYS CHEM-US, V95, P2182, DOI 10.1021/j100159a020; Roscioli JR, 2006, J PHYS CHEM A, V110, P4943, DOI 10.1021/jp056022v; Scoles G, 2000, SCIENCE, V287, P2429, DOI 10.1126/science.287.5462.2429; SHIMANOUCHI T, 2005, NIST CHEM WEBBOOK NI; Stoyanov ES, 2000, PHYS CHEM CHEM PHYS, V2, P1137, DOI 10.1039/a907815k; Stoyanov ES, 2006, J PHYS CHEM A, V110, P12992, DOI 10.1021/jp062879w; Zundel G, 2000, ADV CHEM PHYS, V111, P1	31	219	219	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					249	254		10.1126/science.1138962	http://dx.doi.org/10.1126/science.1138962			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431174				2022-12-28	WOS:000245654500044
J	Osborne, AR; Rapoport, TA				Osborne, Andrew R.; Rapoport, Tom A.			Protein translocation is mediated by oligomers of the SecY complex with one SecY copy forming the channel	CELL			English	Article							ESCHERICHIA-COLI; ENDOPLASMIC-RETICULUM; CONDUCTING CHANNEL; ATPASE SECA; CRYSTAL-STRUCTURE; DISULFIDE BRIDGE; MEMBRANE-PROTEIN; CROSS-LINKING; ER MEMBRANE; BINDING	Many proteins are translocated across the bacterial plasma membrane by the interplay of the cytoplasmic ATPase SecA with a protein-conducting channel, formed from the evolutionarily conserved heterotrimeric SecY complex. Here, we have used purified E. coli components to address the mechanism of translocation. Disulfide bridge crosslinking demonstrates that SecA transfers both the signal sequence and the mature region of a secreted substrate into a single SecY molecule. However, protein translocation involves oligomers of the SecY complex, because a SecY molecule defective in translocation can be rescued by linking it covalently with a wild-type SecY copy. SecA interacts through one of its domains with a nontranslocating SecY copy and moves the polypeptide chain through a neighboring SecY copy. Oligomeric channels with only one active pore likely mediate protein translocation in all organisms.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_raoport@hms.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM052586] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Dapic V, 2000, J BIOL CHEM, V275, P25000, DOI 10.1074/jbc.M001100200; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Eichler J, 2004, TRENDS BIOCHEM SCI, V29, P221, DOI 10.1016/j.tibs.2004.03.001; Gumbart J, 2006, BIOPHYS J, V90, P2356, DOI 10.1529/biophysj.105.075291; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; Ismail N, 2006, J CELL SCI, V119, P2826, DOI 10.1242/jcs.03018; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Mitra K, 2006, NAT STRUCT MOL BIOL, V13, P957, DOI 10.1038/nsmb1166; Mori H, 2003, J BIOL CHEM, V278, P14257, DOI 10.1074/jbc.M300230200; Mori H, 2001, P NATL ACAD SCI USA, V98, P5128, DOI 10.1073/pnas.081617398; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Or E, 2005, J BIOL CHEM, V280, P9097, DOI 10.1074/jbc.M413947200; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; Plath K, 2004, MOL BIOL CELL, V15, P1, DOI 10.1091/mbc.E03-06-0390; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994; Schaletzky J, 2006, MOL BIOL CELL, V17, P3860, DOI 10.1091/mbc.e06-05-0439; Scheuring J, 2005, J MOL BIOL, V354, P258, DOI 10.1016/j.jmb.2005.09.058; Sharma V, 2003, P NATL ACAD SCI USA, V100, P2243, DOI 10.1073/pnas.0538077100; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; TANI K, 1990, J BIOL CHEM, V265, P17341; Thanassi DG, 2005, MOL MEMBR BIOL, V22, P63, DOI 10.1080/09687860500063290; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vassylyev DG, 2006, J MOL BIOL, V364, P248, DOI 10.1016/j.jmb.2006.09.061; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023	32	120	125	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2007	129	1					97	110		10.1016/j.cell.2007.02.036	http://dx.doi.org/10.1016/j.cell.2007.02.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418789	Bronze			2022-12-28	WOS:000245661100014
J	Fernandez, JE				Fernandez, John E.			Materials for aesthetic, energy-efficient, and self-diagnostic buildings	SCIENCE			English	Review							COMPOSITES; COATINGS	It has become desirable to reduce the nonrenewable content and energy footprint of the built environment and to develop "smart buildings" that allow for inexpensive monitoring and self-diagnostic capabilities. Latest-generation embedded sensors, self-healing composites, and nanoscale and responsive materials may augur a time when buildings can substantially adjust to changing environmental and functional demands. However, faced with the legal liability resulting from unknown lifetime performance, designers and engineers have had little incentive to incorporate new material technologies into building designs. As efficiency issues become more acute, the potential for improvement in performance from new materials, together with partnerships between the materials science community and those entrusted with the design and engineering of the built environment, may offer real breakthroughs for the future.	MIT, Dept Architecture, MIT Bldg Technol Program, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Fernandez, JE (corresponding author), MIT, Dept Architecture, MIT Bldg Technol Program, Room 5-418,77 Massachusetts Ave, Cambridge, MA 02139 USA.	fernande@mit.edu						[Anonymous], 2006, BAS RES NEEDS SOL ST; APTE J, 2006, ANN M AM SOC HEAT RE; ARASTEH D, 2006, AM COUNC EN EFF EC S; Babu KG, 2004, CEMENT CONCRETE COMP, V26, P605, DOI 10.1016/S0958-9465(03)00034-9; Bastianini F, 2005, CONSTR BUILD MATER, V19, P525, DOI 10.1016/j.conbuildmat.2005.01.004; Bencardino F, 2006, CEMENT CONCRETE COMP, V28, P832, DOI 10.1016/j.cemconcomp.2006.07.015; Chong K P., 2002, PROG STRUCT MAT ENG, V4, P417, DOI DOI 10.1002/(ISSN)1528-2716; Coluci VR, 2006, NANOTECHNOLOGY, V17, P617, DOI 10.1088/0957-4484/17/3/001; CONNOR JJ, 2003, INTRO STRUCTURAL MOT, P286; Dempsey DD, 2006, J COMPOS CONSTR, V10, P392, DOI 10.1061/(ASCE)1090-0268(2006)10:5(392); Dharap P, 2004, NANOTECHNOLOGY, V15, P379, DOI 10.1088/0957-4484/15/3/026; FERNANDEZ J, 2006, MAT ARCHITECTURE, P44; Green MA, 2005, PROG PHOTOVOLTAICS, V13, P447, DOI 10.1002/pip.612; Haldar J, 2006, P NATL ACAD SCI USA, V103, P17667, DOI 10.1073/pnas.0608803103; HAUNG Z, 2000, J PHOTOCH PHOTOBIO A, V130, P163; Hollaway LC, 2003, CONSTR BUILD MATER, V17, P365, DOI 10.1016/S0950-0618(03)00038-2; Imerito T, 2005, JOM-US, V57, P18, DOI 10.1007/s11837-005-0177-z; Jung YC, 2006, NANOTECHNOLOGY, V17, P4970, DOI 10.1088/0957-4484/17/19/033; KELLER T, 2003, 7 INT ASS BRIDG STRU; Kischkoweit-Lopin M, 2002, SOL ENERGY, V73, P77, DOI 10.1016/S0038-092X(02)00036-1; Krogman KC, 2005, NANOTECHNOLOGY, V16, pS338, DOI 10.1088/0957-4484/16/7/005; Kunzel H.M., 1999, J THERMAL ENVELOPE B, V23, P95; Lampert CM, 2004, MATER TODAY, V7, P28, DOI 10.1016/S1369-7021(04)00123-3; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Lin YT, 2006, NANOTECHNOLOGY, V17, P5781, DOI 10.1088/0957-4484/17/23/012; Lu SW, 2007, CONSTR BUILD MATER, V21, P1839, DOI 10.1016/j.conbuildmat.2006.05.062; Mufti AA, 2003, CONSTR BUILD MATER, V17, P379, DOI 10.1016/S0950-0618(03)00039-4; Norris A, 2008, CONSTR BUILD MATER, V22, P111, DOI 10.1016/j.conbuildmat.2006.05.047; Nosonovsky M, 2005, MICROSYST TECHNOL, V11, P535, DOI 10.1007/s00542-005-0602-9; POVOLEDO E, 2006, NY TIMES        1128, P10; Smith GB, 2004, SOL ENERG MAT SOL C, V84, P395, DOI 10.1016/j.solmat.2004.02.047; Tang CY, 2005, JOM-US, V57, P32, DOI 10.1007/s11837-005-0230-y; *US DOE, 2001, PROM SOL STAT LIGHT; Van Den Einde L, 2003, CONSTR BUILD MATER, V17, P389, DOI 10.1016/S0950-0618(03)00040-0; Walp MS, 2004, ADV MATER PROCESS, V162, P34; Weinlader H, 2005, SOL ENERGY, V78, P177, DOI 10.1016/j.solener.2004.04.013; Wittkopf SK, 2006, ENERG BUILDINGS, V38, P1120, DOI 10.1016/j.enbuild.2006.01.005	37	57	59	2	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1807	1810		10.1126/science.1137542	http://dx.doi.org/10.1126/science.1137542			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395820				2022-12-28	WOS:000245280100031
J	Cox, G; Thomson, NC; Rubin, AS; Niven, RM; Corris, PA; Siersted, HC; Olivenstein, R; Pavord, ID; McCormack, D; Chaudhuri, R; Miller, JD; Laviolette, M; Busse, W; Schellenberg, R; Slutsky, AS; Nair, P; Goodwin, S; Currie, K; Bourbeau, J; Houghton, F; Patterson, N; Metha, S; Howard, J; MacBean, L; Martel, S; Boulet, LP; Morel, L; Trepanier, L; Bicknell, S; Livingston, E; Lafferty, J; Prys-Picard, C; Fletcher, G; Higgins, B; Small, T; Foggo, B; Berry, M; Shaw, D; Sheldon, N; Barnes, N; Watson, D; Cardoso, PG; Soares, PRD; Rasmussen, F; Christensen, HM; Olsen, M				Cox, Gerard; Thomson, Neil C.; Rubin, Adalberto S.; Niven, Robert M.; Corris, Paul A.; Siersted, Hans Christian; Olivenstein, Ronald; Pavord, Ian D.; McCormack, David; Chaudhuri, Rekha; Miller, John D.; Laviolette, Michel; Busse, W.; Schellenberg, R.; Slutsky, A. S.; Nair, P.; Goodwin, S.; Currie, K.; Bourbeau, J.; Houghton, F.; Patterson, N.; Metha, S.; Howard, J.; MacBean, L.; Martel, S.; Boulet, L. -P.; Morel, L.; Trepanier, L.; Bicknell, S.; Livingston, E.; Lafferty, J.; Prys-Picard, C.; Fletcher, G.; Higgins, B.; Small, T.; Foggo, B.; Berry, M.; Shaw, D.; Sheldon, N.; Barnes, N.; Watson, D.; Cardoso, P. G.; Soares, P. R. D.; Rasmussen, F.; Christensen, H. M.; Olsen, M.		AIR Trial Study Grp	Asthma control during the year after bronchial thermoplasty	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONTROLLED TRIAL; SMOOTH-MUSCLE; AIRWAY; QUESTIONNAIRE; DISEASE	BACKGROUND Bronchial thermoplasty is a bronchoscopic procedure to reduce the mass of airway smooth muscle and attenuate bronchoconstriction. We examined the effect of bronchial thermoplasty on the control of moderate or severe persistent asthma. METHODS We randomly assigned 112 subjects who had been treated with inhaled corticosteroids and long-acting beta(2)-adrenergic agonists (LABA) and in whom asthma control was impaired when the LABA were withdrawn to either bronchial thermoplasty or a control group. The primary outcome was the frequency of mild exacerbations, calculated during three scheduled 2-week periods of abstinence from LABA at 3, 6, and 12 months. Airflow, airway responsiveness, asthma symptoms, the number of symptom-free days, use of rescue medication, and scores on the Asthma Quality of Life Questionnaire (AQLQ) and the Asthma Control Questionnaire (ACQ) were also assessed. RESULTS The mean rate of mild exacerbations, as compared with baseline, was reduced in the bronchial-thermoplasty group but was unchanged in the control group (change in frequency per subject per week, -0.16+/-0.37 vs. 0.04+/-0.29; P=0.005). At 12 months, there were significantly greater improvements in the bronchial-thermoplasty group than in the control group in the morning peak expiratory flow (39.3+/-48.7 vs. 8.5+/-44.2 liters per minute), scores on the AQLQ (1.3+/-1.0 vs. 0.6+/-1.1) and ACQ (reduction, 1.2+/-1.0 vs. 0.5+/-1.0), the percentage of symptom-free days (40.6+/-39.7 vs. 17.0+/-37.9), and symptom scores (reduction, 1.9+/-2.1 vs. 0.7+/-2.5) while fewer puffs of rescue medication were required. Values for airway responsiveness and forced expiratory volume in 1 second did not differ significantly between the two groups. Adverse events immediately after treatment were more common in the bronchial-thermoplasty group than in the control group but were similar during the period from 6 weeks to 12 months after treatment. CONCLUSIONS Bronchial thermoplasty in subjects with moderate or severe asthma results in an improvement in asthma control.	McMaster Univ, St Josephs Healthcare, Firestone Inst Resp Hlth, Hamilton, ON L8N 4A6, Canada; Univ Glasgow, Gartnavel Gen Hosp, Glasgow, Lanark, Scotland; Irmandade Santa Casa Misericordia, Porto Alegre, RS, Brazil; Univ Manchester, Wythenshawe Hosp, Manchester, Lancs, England; Univ Newcastle, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; Odense Univ Hosp, DK-5000 Odense, Denmark; Montreal Chest Inst, Montreal, PQ, Canada; Glenfield Gen Hosp, Univ Hosp Leicester, Natl Hlth Serv Trust, Leicester LE3 9QP, Leics, England; London Hlth Sci Ctr, London, England; Univ Laval, Laval Hosp, Laval, PQ, Canada	McMaster University; University of Glasgow; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Newcastle University - UK; University of Southern Denmark; Odense University Hospital; McGill University; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Laval University	Cox, G (corresponding author), McMaster Univ, St Josephs Healthcare, Firestone Inst Resp Hlth, 50 Charlton Ave E,Rm T2123, Hamilton, ON L8N 4A6, Canada.	coxp@mcmaster.ca	Cardoso, Paulo F.G./C-5768-2012; Slutsky, Arthur S/A-6013-2008; Mccormack, David/G-3331-2011; Slutsky, Arthur/M-3325-2019	Slutsky, Arthur S/0000-0002-6063-3876; Thomson, Neil/0000-0003-1632-6630; Pavord, Ian/0000-0002-4288-5973; Niven, Robert/0000-0003-2249-960X				Adkinson NF, 1997, NEW ENGL J MED, V336, P324, DOI 10.1056/NEJM199701303360502; [Anonymous], 2004, GLOB STRAT ASTHM MAN; Balon J, 1998, NEW ENGL J MED, V339, P1013, DOI 10.1056/NEJM199810083391501; CARROLL N, 1993, AM REV RESPIR DIS, V147, P405, DOI 10.1164/ajrccm/147.2.405; Cox G, 2006, AM J RESP CRIT CARE, V173, P965, DOI 10.1164/rccm.200507-1162OC; Cox PG, 2004, EUR RESPIR J, V24, P659, DOI 10.1183/09031936.04.00054604; Danek CJ, 2004, J APPL PHYSIOL, V97, P1946, DOI 10.1152/japplphysiol.01282.2003; Doherty DE, 2004, AM J MED, V117, p11S, DOI 10.1016/j.amjmed.2004.10.017; *FOOD DRUG ADM, 1997, FDA NEW DRUG APPL FL; *FOOD DRUG ADM, 2003, 103976 FDA BLA; *FOOD DRUG ADM, 2000, 21077 FDA NDA; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Miller JD, 2005, CHEST, V127, P1999, DOI 10.1378/chest.127.6.1999; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; *NAT CTR HLTH STAT, 2002, ASTHM PREV HLTH CAR; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Pauwels RA, 1998, NEW ENGL J MED, V338, P139; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Woodruff PG, 2004, AM J RESP CRIT CARE, V169, P1001, DOI 10.1164/rccm.200311-1529OC	22	421	489	2	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2007	356	13					1327	1337		10.1056/NEJMoa064707	http://dx.doi.org/10.1056/NEJMoa064707			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150MN	17392302				2022-12-28	WOS:000245221000006
J	Nissen, SE; Tardif, J; Nicholls, SJ; Revkin, JH; Shear, CL; Duggan, WT; Ruzyllo, W; Bachinsky, WB; Lasala, GP; Tuzcu, EM				Nissen, Steven E.; Tardif, Jean-Claude; Nicholls, Stephen J.; Revkin, James H.; Shear, Charles L.; Duggan, William T.; Ruzyllo, Witold; Bachinsky, William B.; Lasala, Gregory P.; Tuzcu, E. Murat		ILLUSTRATE Investigators	Effect of torcetrapib on the progression of coronary atherosclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ESTER TRANSFER PROTEIN; HIGH-DENSITY-LIPOPROTEIN; INTRAVASCULAR ULTRASOUND; CHOLESTEROL LEVELS; STATIN THERAPY; BLOOD-PRESSURE; DISEASE; HDL; INHIBITION; APOLIPOPROTEINS	BACKGROUND Levels of high-density lipoprotein (HDL) cholesterol are inversely related to cardiovascular risk. Torcetrapib, a cholesteryl ester transfer protein (CETP) inhibitor, increases HDL cholesterol levels, but the functional effects associated with this mechanism remain uncertain. METHODS A total of 1188 patients with coronary disease underwent intravascular ultrasonography. After treatment with atorvastatin to reduce levels of low-density lipoprotein (LDL) cholesterol to less than 100 mg per deciliter (2.59 mmol per liter), patients were randomly assigned to receive either atorvastatin monotherapy or atorvastatin plus 60 mg of torcetrapib daily. After 24 months, disease progression was measured by repeated intravascular ultrasonography in 910 patients (77%). RESULTS After 24 months, as compared with atorvastatin monotherapy, the effect of torcetrapib-atorvastatin therapy was an approximate 61% relative increase in HDL cholesterol and a 20% relative decrease in LDL cholesterol, reaching a ratio of LDL cholesterol to HDL cholesterol of less than 1.0. Torcetrapib was also associated with an increase in systolic blood pressure of 4.6 mm Hg. The percent atheroma volume (the primary efficacy measure) increased by 0.19% in the atorvastatin-only group and by 0.12% in the torcetrapib-atorvastatin group (P=0.72). A secondary measure, the change in normalized atheroma volume, showed a small favorable effect for torcetrapib (P=0.02), but there was no significant difference in the change in atheroma volume for the most diseased vessel segment. CONCLUSIONS The CETP inhibitor torcetrapib was associated with a substantial increase in HDL cholesterol and decrease in LDL cholesterol. It was also associated with an increase in blood pressure, and there was no significant decrease in the progression of coronary atherosclerosis. The lack of efficacy may be related to the mechanism of action of this drug class or to molecule-specific adverse effects.	Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; Pfizer, New London, CT USA; Inst Kardiol, Warsaw, Poland; Harrisburg Hosp, Pinnacle Hlth, Harrisburg, PA USA; Tchefuncte Cardiovasc Associates, Covington, LA USA	Cleveland Clinic Foundation; Universite de Montreal; Pfizer; Institute of Cardiology - Poland	Nissen, SE (corresponding author), Cleveland Clin, Dept Cardiovasc Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.	nissens@ccf.org		Nicholls, Stephen/0000-0002-9668-4368				Agerholm-Larsen B, 2000, CIRCULATION, V101, P1907, DOI 10.1161/01.CIR.101.16.1907; Brousseau ME, 2004, NEW ENGL J MED, V350, P1505, DOI 10.1056/NEJMoa031766; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Hirano K, 2000, CURR OPIN LIPIDOL, V11, P589, DOI 10.1097/00041433-200012000-00004; Hirano K, 1997, ARTERIOSCL THROM VAS, V17, P1053, DOI 10.1161/01.ATV.17.6.1053; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; Klerkx AHEM, 2006, ARTERIOSCL THROM VAS, V26, P706, DOI 10.1161/01.ATV.0000205595.19612.c9; Kuivenhoven JA, 2005, AM J CARDIOL, V95, P1085, DOI 10.1016/j.amjcard.2004.12.064; Libby P, 2005, J AM COLL CARDIOL, V46, P1225, DOI 10.1016/j.jacc.2005.07.006; Matsuura F, 2006, J CLIN INVEST, V116, P1435, DOI 10.1172/JCI27602; McKenney JM, 2006, J AM COLL CARDIOL, V48, P1782, DOI 10.1016/j.jacc.2006.06.066; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; MOREHOUSE LA, IN PRESS J LIPID RES; MORTON RE, IN PRESS ATHEROSCLER; Navab M, 2006, NAT CLIN PRACT ENDOC, V2, P504, DOI 10.1038/ncpendmet0245; Nissen SE, 2006, NEW ENGL J MED, V355, P638; Nissen SE, 2006, NEW ENGL J MED, V354, P1253, DOI 10.1056/NEJMoa054699; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Schoenhagen P, 2005, J AM SOC ECHOCARDIOG, V18, P193, DOI 10.1016/j.echo.2004.11.013; Schoenhagen P, 2003, J AM SOC ECHOCARDIOG, V16, P277, DOI 10.1067/mje.2003.45; Shah PK, 2001, CIRCULATION, V104, P2498, DOI 10.1161/hc4501.098468; Shah PK, 2001, CIRCULATION, V104, P2376, DOI 10.1161/hc4401.098467; Sipahi I, 2006, J AM COLL CARDIOL, V48, P833, DOI 10.1016/j.jacc.2006.05.045; Tall AR, 2007, ARTERIOSCL THROM VAS, V27, P257, DOI 10.1161/01.ATV.0000256728.60226.77; Tardif JC, 2004, CIRCULATION, V110, P3372, DOI 10.1161/01.CIR.0000147777.12010.EF; Tardif JC, 2006, CIRCULATION, V113, P2936, DOI 10.1161/CIRCULATIONAHA.105.598987; Taylor AJ, 2005, CIRCULATION, V111, P1727; Taylor AJ, 2004, CIRCULATION, V110, P3512, DOI 10.1161/01.CIR.0000148955.19792.8D; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	35	777	806	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2007	356	13					1304	1316		10.1056/NEJMoa070635	http://dx.doi.org/10.1056/NEJMoa070635			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150MN	17387129	Bronze			2022-12-28	WOS:000245221000004
J	Woehlke, G; Schliwa, M				Woehlke, Guenther; Schliwa, Manfred			Kinesin Kar3 and Vik1 go head to head	CELL			English	Editorial Material							CRYSTAL-STRUCTURE; MOTOR; PROTEIN; MOTILITY; ROTATION; NCD	The yeast kinesin motor protein Kar3 forms a heterodimer with a nonmotor protein Vik1. A study in this issue by Allingham et al. (2007) reveals that Vik1 unexpectedly has a structure similar to a kinesin motor domain yet lacks a nucleotide-binding site and is thus catalytically inactive. However, this does not hinder movement of the heterodimer because other features of the remarkably divergent Vik1 motor domain are retained, including the ability to bind microtubules.	Tech Univ Munich, Dept Phys E22, D-85747 Garching, Germany; Univ Munich, Inst Cell Biol, D-80336 Munich, Germany	Technical University of Munich; University of Munich	Woehlke, G (corresponding author), Tech Univ Munich, Dept Phys E22, James Franck Str, D-85747 Garching, Germany.	guenther.woehike@lrz.uni-muenchen.de; schliwa@med.uni-muenchen.de		Woehlke, Gunther/0000-0001-8462-9962				Adio S, 2006, J BIOL CHEM, V281, P37782, DOI 10.1074/jbc.M605061200; Barrett JG, 2000, MOL BIOL CELL, V11, P2373, DOI 10.1091/mbc.11.7.2373; Chu HMA, 2005, EMBO J, V24, P3214, DOI 10.1038/sj.emboj.7600790; Endres NF, 2006, NATURE, V439, P875, DOI 10.1038/nature04320; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Scholey JM, 1996, J CELL BIOL, V133, P1, DOI 10.1083/jcb.133.1.1; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531; Zhang YR, 2004, BIOPHYS J, V87, P1795, DOI 10.1529/biophysj.104.039842	10	3	3	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2007	128	6					1033	1034		10.1016/j.cell.2007.03.003	http://dx.doi.org/10.1016/j.cell.2007.03.003			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382876	Bronze			2022-12-28	WOS:000245396200010
J	Coovadia, HM; Rollins, NC; Bland, RM; Little, K; Coutsoudis, A; Bennish, ML; Newell, ML				Coovadia, Hoosen M.; Rollins, Nigel C.; Bland, Ruth M.; Little, Kirsty; Coutsoudis, Anna; Bennish, Michael L.; Newell, Marie-Louise			Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POSTNATAL TRANSMISSION; SOUTH-AFRICA; PREVENT; ZIDOVUDINE; EFFICACY; INFANTS; WOMEN; POPULATIONS; NEVIRAPINE	Background Exclusive breastfeeding, though better than other forms of infant feeding and associated with improved child survival, is uncommon. We assessed the HIV-1 transmission risks and survival associated with exclusive breastfeeding and other types of infant feeding. Methods 2722 HIV-infected and uninfected pregnant women attending antenatal clinics in KwaZulu Natal, South Africa (seven rural, one semiurban, and one urban), were enrolled into a non-randomised intervention cohort study. Infant feeding data were obtained every week from mothers, and blood samples from infants were taken monthly at clinics to establish HIV infection status. Kaplan-Meier analyses conditional on exclusive breastfeeding were used to estimate transmission risks at 6 weeks and 22 weeks of age, and Cox's proportional hazard was used to quantify associations with maternal and infant factors. Findings 1132 of 1372 (83%) infants born to HIV-infected mothers initiated exclusive breastfeeding from birth. of 1276 infants with complete feeding data, median duration of cumulative exclusive breastfeeding was 159 days (first quartile [Q1] to third quartile [Q3], 122-174 days). 14.1% (95% Cl 12.0-16.4) of exclusively breastfed infants were infected with HIV-1 by age 6 weeks and 19.5% (17.0-22.4) by 6 months; risk was significantly associated with maternal CD4-cell counts below 200 cells per mu L (adjusted hazard ratio [HR] 3.79; 2.35-6.12) and birthweight less than 2500 g (1.81, 1.07-3.06). Kaplan-Meier estimated risk of acquisition of infection at 6 months of age was 4.04% (2.29-5.76). Breastfed infants who also received solids were significantly more likely to acquire infection than were exclusively breastfed children (HR 10.87, 1.51-78.00, p=0.018), as were infants who at 12 weeks received both breastmilk and formula milk (1.82, 0.98-3.36, p=0.057). Cumulative 3-month mortality in exclusively breastfed infants was 6.1% (4.74-7.92) versus 15.1% (7.63-28.73) in infants given replacement feeds (HR 2.06, 1.00-4.27; p=0.051). Interpretation The association between mixed breastfeeding and increased HIV transmission risk, together with evidence that exclusive breastfeeding can be successfully supported in HIV-infected women, warrant revision of the present UNICEF, WHO, and UNAIDS infant feeding guidelines.	Univ Kwazulu Natal, Dept Paediat & Child Hlth, Nelson Mandela Sch Med, ZA-4013 Congella, South Africa; Univ Kwazulu Natal, Africa Ctr Hlth & Populat Studies, ZA-4013 Congella, South Africa; Univ Kwazulu Natal, Ctr HIV AIDS Networking, ZA-4013 Congella, South Africa; UCL, Ctr Paediat Epidemiol & Biostat, Inst Child Hlth, London, England; Univ Oxford, Nuffield Dept Clin Med, Oxford, England	University of Kwazulu Natal; University of Kwazulu Natal; University of Kwazulu Natal; University of London; University College London; University of Oxford	Rollins, NC (corresponding author), Univ Kwazulu Natal, Dept Paediat & Child Hlth, Nelson Mandela Sch Med, Private Bag 7, ZA-4013 Congella, South Africa.	rollins@ukzn.ac.za	Newell, Marie-Louise/AAE-8222-2019	Newell, Marie-Louise/0000-0002-1074-7699; Bland, Ruth/0000-0003-1675-9268				Alioum A, 2003, AM J EPIDEMIOL, V158, P596, DOI 10.1093/aje/kwg188; Alioum A, 2001, STAT MED, V20, P3539, DOI 10.1002/sim.1076; Becquet R, 2006, 16 INT AIDS C TOR CA; Blackard JT, 2001, VIROLOGY, V287, P261, DOI 10.1006/viro.2001.1059; Bland RM, 2003, ARCH DIS CHILD, V88, P778, DOI 10.1136/adc.88.9.778; Brambilla D, 2003, J CLIN MICROBIOL, V41, P1888, DOI 10.1128/JCM.41.5.1888-1893.2003; Cassol S, 1997, J CLIN MICROBIOL, V35, P2795, DOI 10.1128/JCM.35.11.2795-2801.1997; Coovadia H, 2004, NEW ENGL J MED, V351, P289, DOI 10.1056/NEJMe048128; Coutsoudis A, 1999, LANCET, V354, P471, DOI 10.1016/S0140-6736(99)01101-0; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Coutsoudis A, 2002, HEALTH POLICY PLANN, V17, P154, DOI 10.1093/heapol/17.2.154; Coutsoudis A, 2001, AIDS, V15, P379, DOI 10.1097/00002030-200102160-00011; Cox D. R., 1984, ANAL SURVIVAL DATA; Creek T, 2006, 2006 HIV AIDS IMPL M; Dabis F, 2005, AIDS, V19, P309; Doherty T, 2006, B WORLD HEALTH ORGAN, V84, P90, DOI 10.2471/BLT.04.019448; Fawzi W, 2002, JAIDS-J ACQ IMM DEF, V31, P331, DOI 10.1097/00126334-200211010-00010; Hilderbrand K, 2003, SAMJ S AFR MED J, V93, P779; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KwaZulu Natal Provincial Department of Health, 2003, PROT PHAS IMPL COMPR; Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500; Leroy V, 2005, AIDS, V19, P1865, DOI 10.1097/01.aids.0000188423.02786.55; Leroy V, 2003, AIDS, V17, P1493, DOI 10.1097/00002030-200307040-00010; Mbori-Ngacha D, 2001, JAMA-J AM MED ASSOC, V286, P2413, DOI 10.1001/jama.286.19.2413; Miotti PG, 1999, JAMA-J AM MED ASSOC, V282, P744, DOI 10.1001/jama.282.8.744; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Renjifo B, 2004, AIDS, V18, P1629, DOI 10.1097/01.aids.0000131392.68597.34; Renjifo B, 2001, J HUMAN VIROL, V4, P16; Rollins N, 2004, JAIDS-J ACQ IMM DEF, V35, P188, DOI 10.1097/00126334-200402010-00014; Smith MM, 2000, NUTR REV, V58, P333, DOI 10.1111/j.1753-4887.2000.tb01830.x; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Thorne Claire, 2005, Curr Opin Investig Drugs, V6, P804; *UNAIDS WHO, 2005, AIDS EP UPD; WHO, 2006, ANT DRUGS TREAT PREG; *WHO, 2001, WHORHR0112WHOCAH0121; WHO, 2001, NEW DAT PREV MOTH CH; *WHO UNICEF UNAIDS, 1998, WHOFRHNUTCHD98LED; *WHO UNICEF UNAIDS, 2000, WHOSCHCAH004; World Health Organization, 1991, WHOCDDSER9114; [No title captured]	42	445	453	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2007	369	9567					1107	1116		10.1016/S0140-6736(07)60283-9	http://dx.doi.org/10.1016/S0140-6736(07)60283-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151XF	17398310				2022-12-28	WOS:000245323700031
J	Storici, F; Bebenek, K; Kunkel, TA; Gordenin, DA; Resnick, MA				Storici, Francesca; Bebenek, Katarzyna; Kunkel, Thomas A.; Gordenin, Dmitry A.; Resnick, Michael A.			RNA-templated DNA repair	NATURE			English	Article							DOUBLE-STRAND BREAKS; REVERSE-TRANSCRIPTASE; SACCHAROMYCES-CEREVISIAE; POLYMERASE-ETA; RECA PROTEIN; RECOMBINATION; RIBONUCLEOTIDES; REPLICATION; OLIGONUCLEOTIDES; RETROTRANSPOSONS	RNA can act as a template for DNA synthesis in the reverse transcription of retroviruses and retrotransposons(1) and in the elongation of telomeres(2). Despite its abundance in the nucleus, there has been no evidence for a direct role of RNA as a template in the repair of any chromosomal DNA lesions, including DNA double-strand breaks (DSBs), which are repaired in most organisms by homologous recombination or by non-homologous end joining(3). An indirect role for RNA in DNA repair, following reverse transcription and formation of a complementary DNA, has been observed in the non-homologous joining of DSB ends(4,5). In the yeast Saccharomyces cerevisiae, in which homologous recombination is efficient(3), RNA was shown to mediate recombination, but only indirectly through a cDNA intermediate(6,7) generated by the reverse transcriptase function of Ty retrotransposons in Ty particles in the cytoplasm(8). Although pairing between duplex DNA and single-strand (ss) RNA can occur in vitro(9,10) and in vivo(11), direct homologous exchange of genetic information between RNA and DNA molecules has not been observed. We show here that RNA can serve as a template for DNA synthesis during repair of a chromosomal DSB in yeast. The repair was accomplished with RNA oligonucleotides complementary to the broken ends. This and the observation that even yeast replicative DNA polymerases such as alpha and delta can copy short RNA template tracts in vitro demonstrate that RNA can transfer genetic information in vivo through direct homologous interaction with chromosomal DNA.	NIEHS, Mol Biol Lab, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Resnick, MA (corresponding author), NIEHS, Mol Biol Lab, NIH, US Dept HHS, POB 12233, Res Triangle Pk, NC 27709 USA.	resnick@niehs.nih.gov	resnick, Michael/F-1668-2019; Dmitry, Gordenin/C-3907-2018; Kunkel, Thomas A./D-5088-2019	resnick, Michael/0000-0002-8473-7506; Dmitry, Gordenin/0000-0002-8399-1836; Kunkel, Thomas A./0000-0002-9900-1788	Intramural NIH HHS [Z01 ES065072-17] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065072, Z01ES065070] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; BALTIMORE D, 1985, CELL, V40, P481, DOI 10.1016/0092-8674(85)90190-4; BOEKE JD, 1986, MOL CELL BIOL, V6, P3575, DOI 10.1128/MCB.6.11.3575; DERR LK, 1993, NATURE, V361, P170, DOI 10.1038/361170a0; Franklin A, 2004, IMMUNOL CELL BIOL, V82, P219, DOI 10.1046/j.0818-9641.2004.01221.x; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Kasahara M, 2000, GENE DEV, V14, P360; Lesage P, 2005, CYTOGENET GENOME RES, V110, P70, DOI 10.1159/000084940; McCulloch SD, 2006, DNA REPAIR, V5, P1373, DOI 10.1016/j.dnarep.2006.06.003; McElhinny SAN, 2003, MOL CELL BIOL, V23, P2309, DOI 10.1128/MCB.23.7.2309-2315.2003; Moore JK, 1996, NATURE, V383, P644, DOI 10.1038/383644a0; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Murakami E, 2003, J BIOL CHEM, V278, P36403, DOI 10.1074/jbc.M306236200; NevoCaspi Y, 1997, CURR GENET, V32, P32, DOI 10.1007/s002940050245; Niimi A, 2004, MOL CELL BIOL, V24, P2734, DOI 10.1128/MCB.24.7.2734-2746.2004; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paques F, 1998, MOL CELL BIOL, V18, P2045, DOI 10.1128/MCB.18.4.2045; RICCHETTI M, 1993, EMBO J, V12, P387, DOI 10.1002/j.1460-2075.1993.tb05670.x; Rumbaugh JA, 1997, J BIOL CHEM, V272, P22591, DOI 10.1074/jbc.272.36.22591; Shcherbakova Polina V., 2006, V47, P391; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Storici F, 2006, MOL CELL BIOL, V26, P7645, DOI 10.1128/MCB.00672-06; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Teng SC, 1996, NATURE, V383, P641, DOI 10.1038/383641a0; Vengrova S, 2006, EMBO REP, V7, P59, DOI 10.1038/sj.embor.7400576; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Zaitsev EN, 2000, GENE DEV, V14, P740	29	158	167	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2007	447	7142					338	341		10.1038/nature05720	http://dx.doi.org/10.1038/nature05720			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168JK	17429354	Green Accepted			2022-12-28	WOS:000246520300050
J	Treasure, T; Utley, M; Hunt, I				Treasure, Tom; Utley, Martin; Hunt, Ian			When professional opinion is not enough	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							METASTASES		Guys Hosp, London SE1 9RT, England; UCL, Clin Operat Res Unit, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; University College London	Treasure, T (corresponding author), Guys Hosp, London SE1 9RT, England.			Utley, Martin/0000-0001-9928-1516				DIAMOND J, 2001, SNAKE OIL; Horton R, 1996, LANCET, V347, P984, DOI 10.1016/S0140-6736(96)90137-3; Inoue M, 2004, ANN THORAC SURG, V78, P238, DOI 10.1016/j.athoracsur.2004.02.017; National Institute for Clinical Excellence (NICE), 2004, IMPR OUTC COL CANC M; Nauenheim KS, 2007, DIFFICULT DECISIONS, P151; NICE, 2005, LUNG CANC DIAGN TREA; Pastorino U, 1997, J THORAC CARDIOV SUR, V113, P37, DOI 10.1016/S0022-5223(97)70397-0; Patel A, 2007, DIFFICULT DECISIONS, P158; Porter R., 1997, GREATEST BENEFIT MAN; Rena O, 2002, EUR J CARDIO-THORAC, V21, P906, DOI 10.1016/S1010-7940(02)00088-X; Simmonds PC, 2006, BRIT J CANCER, V94, P982, DOI 10.1038/sj.bjc.6603033; STANGL R, 1994, LANCET, V343, P1405, DOI 10.1016/S0140-6736(94)92529-1; Young C, 2005, LANCET, V366, P107, DOI 10.1016/S0140-6736(05)66846-8	13	43	43	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2007	334	7598					831	832		10.1136/bmj.39161.403218.AD	http://dx.doi.org/10.1136/bmj.39161.403218.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	162MD	17446615	Green Published			2022-12-28	WOS:000246090800031
J	Chung, HY; Weinberger, MB; Levine, JB; Kavner, A; Yang, JM; Tolbert, SH; Kaner, RB				Chung, Hsiu-Ying; Weinberger, Michelle B.; Levine, Jonathan B.; Kavner, Abby; Yang, Jenn-Ming; Tolbert, Sarah H.; Kaner, Richard B.			Synthesis of ultra-incompressible superhard rhenium diboride at ambient pressure	SCIENCE			English	Article							LATTICE STRAINS; OSMIUM DIBORIDE; HARD; BORIDES; STATE	The quest to create superhard materials rarely strays from the use of high-pressure synthetic methods, which typically require gigapascals of applied pressure. We report that rhenium diboride (ReB2), synthesized in bulk quantities via arc-melting under ambient pressure, rivals materials produced with high-pressure methods. Microindentation measurements on ReB2 indicated an average hardness of 48 gigapascals under an applied load of 0.49 newton, and scratch marks left on a diamond surface confirmed its superhard nature. Its incompressibility along the c axis was equal in magnitude to the linear incompressibility of diamond. In situ high-pressure x-ray diffraction measurements yielded a bulk modulus of 360 gigapascals, and radial diffraction indicated that ReB2 is able to support a remarkably high differential stress. This combination of properties suggests that this material may find applications in cutting when the formation of carbides prevents the use of traditional materials such as diamond.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Tolbert, SH (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	tolbert@chem.ucla.edu; kaner@chem.ucla.edu	Kavner, Abby/A-4904-2009; Tolbert, Sarah H./L-2321-2016; Kaner, Richard B./K-1594-2019	Kaner, Richard B./0000-0003-0345-4924				ALEKSANDROV IV, 1987, ZH EKSP TEOR FIZ, V66, P384; Allen PB, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.172102; Amulele GM, 2006, J APPL PHYS, V99, DOI 10.1063/1.2164533; Chiodo S, 2006, CHEM PHYS LETT, V425, P311, DOI 10.1016/j.cplett.2006.05.055; Cumberland RW, 2005, J AM CHEM SOC, V127, P7264, DOI 10.1021/ja043806y; Cynn H, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.135701; FINK CG, 1934, T ELECTROCHEM SOC, V66, P381; Gao H, 1999, NATURWISSENSCHAFTEN, V86, P507, DOI 10.1007/s001140050665; Gou HY, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2208367; HAMPEL CA, 1961, RARE METALS HDB; He DW, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.184121; He DW, 2002, APPL PHYS LETT, V81, P643, DOI 10.1063/1.1494860; Hebbache M, 2006, SOLID STATE COMMUN, V139, P227, DOI 10.1016/j.ssc.2006.05.041; Kaner RB, 2005, SCIENCE, V308, P1268, DOI 10.1126/science.1109830; Kenichi T, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.012101; Kiefer B, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.014102; LAPLACA S, 1962, ACTA CRYSTALLOGR, V15, P97, DOI 10.1107/S0365110X62000298; MANGHNAN.MH, 1974, PHYS REV B, V9, P1421, DOI 10.1103/PhysRevB.9.1421; McMillan PF, 2002, NAT MATER, V1, P19, DOI 10.1038/nmat716; MCSKIMIN HJ, 1957, PHYS REV, V105, P116, DOI 10.1103/PhysRev.105.116; Occelli F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.095502; RAO L, 1995, J MATER RES, V10, P353, DOI 10.1557/JMR.1995.0353; RUOFF AL, 1975, J APPL PHYS, V46, P1389, DOI 10.1063/1.321737; SINGH AK, 1993, J APPL PHYS, V73, P4278, DOI 10.1063/1.352809; Singh AK, 1998, J APPL PHYS, V83, P7567, DOI 10.1063/1.367872; Solozhenko VL, 2001, APPL PHYS LETT, V78, P1385, DOI 10.1063/1.1337623; VEGAS A, 1995, Z KRISTALLOGR, V210, P574, DOI 10.1524/zkri.1995.210.8.574	27	656	687	8	231	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					436	439		10.1126/science.1139322	http://dx.doi.org/10.1126/science.1139322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446399				2022-12-28	WOS:000245813400053
J	Daley, GQ				Daley, George Q.			Gametes from embryonic stem cells: A cup half empty or half full?	SCIENCE			English	Review							GERM-CELLS; IN-VITRO; DIFFERENTIATION; DERIVATION; OOCYTES; MICE	When first reported 4 years ago, gametogenesis from embryonic stem (ES) cells promised an accessible in vitro model to facilitate molecular analysis of the germ lineage. Formation of primordial germ cells is robust, but terminal gametogenesis remains inefficient and doubts about gamete function persist. Although useful for research, clinical use of ES cell-derived gametes appears a distant prospect.	Childrens Hosp Boston, Div Pediat Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Cambridge, MA 02138 USA; Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; Harvard Stem Cell Inst, Cambridge, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University	Daley, GQ (corresponding author), Childrens Hosp Boston, Div Pediat Hematol Oncol, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu						Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Kee K, 2006, STEM CELLS DEV, V15, P831, DOI 10.1089/scd.2006.15.831; Lacham-Kaplan O, 2006, STEM CELLS, V24, P266, DOI 10.1634/stemcells.2005-0204; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Mizuno K, 2006, MOL REPROD DEV, V73, P437, DOI 10.1002/mrd.20395; Nayernia K, 2004, HUM MOL GENET, V13, P1451, DOI 10.1093/hmg/ddh166; Nayernia K, 2006, DEV CELL, V11, P125, DOI 10.1016/j.devcel.2006.05.010; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Zwaka TP, 2005, DEVELOPMENT, V132, P227, DOI 10.1242/dev.01586	13	49	56	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					409	410		10.1126/science.1138772	http://dx.doi.org/10.1126/science.1138772			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446394				2022-12-28	WOS:000245813400045
J	Kovaleva, EG; Lipscomb, JD				Kovaleva, Elena G.; Lipscomb, John D.			Crystal structures of Fe2+ dioxygenase superoxo, alkylperoxo, and bound product intermediates	SCIENCE			English	Article							ACTIVE-SITE FE-2+; CATECHOL 2,3-DIOXYGENASE; SUBSTRATE-BINDING; RING-CLEAVAGE; EXTRADIOL; ACTIVATION; MECHANISM; ENZYMES; COMPLEX	We report the structures of three intermediates in the O-2 activation and insertion reactions of an extradiol ring-cleaving dioxygenase. A crystal of Fe2+-containing homoprotocatechuate 2,3-dioxygenase was soaked in the slow substrate 4-nitrocatechol in a low O-2 atmosphere. The x-ray crystal structure shows that three different intermediates reside in different subunits of a single homotetrameric enzyme molecule. One of these is the key substrate-alkylperoxo-Fe2+ intermediate, which has been predicted, but not structurally characterized, in an oxygenase. The intermediates define the major chemical steps of the dioxygenase mechanism and point to a general mechanistic strategy for the diverse 2-His-1-carboxylate enzyme family.	Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Lipscomb, JD (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	lipsc001@umn.edu		Lipscomb, John/0000-0002-8158-5594	NIGMS NIH HHS [R01 GM024689-27, R01 GM024689, R37 GM024689, R37 GM024689-26, R01 GM024689-28, GM24689] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024689, R01GM024689] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARCIERO DM, 1985, J BIOL CHEM, V260, P4035; ARCIERO DM, 1986, J BIOL CHEM, V261, P2170; Bugg TDH, 2001, CHEM COMMUN, P941, DOI 10.1039/b100484k; Carredano E, 2000, J MOL BIOL, V296, P701, DOI 10.1006/jmbi.1999.3462; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Deeth RJ, 2003, J BIOL INORG CHEM, V8, P409, DOI 10.1007/s00775-002-0430-7; Groce SL, 2005, BIOCHEMISTRY-US, V44, P7175, DOI 10.1021/bi050180v; Groce SL, 2004, BIOCHEMISTRY-US, V43, P15141, DOI 10.1021/bi048690x; Hajdu J, 2000, NAT STRUCT BIOL, V7, P1006, DOI 10.1038/80911; HAN S, 1995, SCIENCE, V270, P976, DOI 10.1126/science.270.5238.976; HAYAISHI O, 1955, J AM CHEM SOC, V77, P5450, DOI 10.1021/ja01625a095; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; Hogg M, 2004, EMBO J, V23, P1483, DOI 10.1038/sj.emboj.7600150; Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; Komatsuzaki H, 1998, INORG CHEM, V37, P6554, DOI 10.1021/ic980509j; LIPSCOMB JD, 1992, MET IONS BIOL SYST, V28, P243; Miller MA, 1996, J BIOL CHEM, V271, P5524, DOI 10.1074/jbc.271.10.5524; Sato N, 2002, J MOL BIOL, V321, P621, DOI 10.1016/S0022-2836(02)00673-3; Senda T, 1996, J MOL BIOL, V255, P735, DOI 10.1006/jmbi.1996.0060; SHU LJ, 1995, BIOCHEMISTRY-US, V34, P6649, DOI 10.1021/bi00020a010; Siegbahn PEM, 2004, J AM CHEM SOC, V126, P8919, DOI 10.1021/ja0493805; Vetting MW, 2004, J BACTERIOL, V186, P1945, DOI 10.1128/JB.186.7.1945-1958.2004; Wallar BJ, 1996, CHEM REV, V96, P2625, DOI 10.1021/cr9500489; Wolfe MD, 2001, J BIOL CHEM, V276, P1945, DOI 10.1074/jbc.M007795200	24	287	290	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					453	457		10.1126/science.1134697	http://dx.doi.org/10.1126/science.1134697			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446402	Green Accepted			2022-12-28	WOS:000245813400058
J	Bridge, JA; Iyengar, S; Salary, CB; Barbe, RP; Birmaher, B; Pincus, HA; Ren, L; Brent, DA				Bridge, Jeffrey A.; Iyengar, Satish; Salary, Cheryl B.; Barbe, Remy P.; Birmaher, Boris; Pincus, Harold Alan; Ren, Lulu; Brent, David A.			Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment - A meta-analysis of randomized controlled trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PLACEBO-CONTROLLED TRIAL; SEROTONIN REUPTAKE INHIBITORS; OBSESSIVE-COMPULSIVE DISORDER; MAJOR DEPRESSIVE DISORDER; DOUBLE-BLIND; PAROXETINE TREATMENT; ADOLESCENTS; CHILDREN; MULTICENTER; FLUOXETINE	Context The US Food and Drug Administration (FDA) has issued warnings that use of antidepressant medications poses a small but significantly increased risk of suicidal ideation/ suicide attempt for children and adolescents. Objective To assess the efficacy and risk of reported suicidal ideation/ suicide attempt of antidepressants for treatment of pediatric major depressive disorder (MDD), obsessive-compulsive disorder (OCD), and non-OCD anxiety disorders. Data Sources and Study Selection PubMed ( 1988 to July 2006), relevant US and British regulatory agency reports, published abstracts of important scientific meetings (1998-2006), clinical trial registries, and information from authors. Studies were published and unpublished randomized, placebo-controlled, parallel-group trials of second-generation antidepressants ( selective serotonin reuptake inhibitors, nefazodone, venlafaxine, and mirtazapine) in participants younger than 19 years with MDD, OCD, or non-OCD anxiety disorders. Data Extraction Information was extracted on study characteristics, efficacy outcomes, and spontaneously reported suicidal ideation/ suicide attempt. Data Synthesis Twenty-seven trials of pediatric MDD( n= 15), OCD ( n= 6), and non-OCD anxiety disorders ( n= 6) were selected, and risk differences for response and for suicidal ideation/ suicide attempt estimated by random-effects methods. Pooled risk differences in rates of primary study-defined measures of responder status significantly favored antidepressants for MDD( 11.0%; [95% confidence interval {CI}, 7.1% to 14.9%]), OCD( 19.8% [ 95% CI, 13.0% to 26.6%), and non-OCD anxiety disorders (37.1% [22.5% to 51.7%]), corresponding to a number needed to treat (NNT) of 10 ( 95% CI, 7 to 15), 6 ( 4 to 8), and 3 ( 2 to 5), respectively. While there was increased risk difference of suicidal ideation/ suicide attempt across all trials and indications for drug vs placebo (0.7%; 95% CI, 0.1% to 1.3%) ( number needed to harm, 143 [ 95% CI, 77 to 1000]), the pooled risk differences within each indication were not statistically significant: 0.9% ( 95% CI, - 0.1% to 1.9%) for MDD, 0.5% (- 1.2% to 2.2%) for OCD, and 0.7% (- 0.4% to 1.8%) for non-OCD anxiety disorders. There were no completed suicides. Age-stratified analyses showed that for children younger than 12 years with MDD, only fluoxetine showed benefit over placebo. In MDD trials, efficacy was moderated by age, duration of depression, and number of sites in the treatment trial. Conclusions Relative to placebo, antidepressants are efficacious for pediatric MDD, OCD, and non-OCD anxiety disorders, although the effects are strongest in non-OCD anxiety disorders, intermediate in OCD, and more modest in MDD. Benefits of antidepressants appear to be much greater than risks from suicidal ideation/ suicide attempt across indications, although comparison of benefit to risk varies as a function of indication, age, chronicity, and study conditions.	Univ Pittsburgh, Western Psychiat Inst & Clin, Pittsburgh, PA 15213 USA; Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; Ohio State Univ, Columbus Childrens Res Inst, Columbus, OH 43210 USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Stat, Pittsburgh, PA 15213 USA; Univ Hosp Geneva, Dept Psychiat, Geneva, Switzerland; Columbia Univ, Coll Phys & Surg, Dept Psychiat, Presbyterian Hosp, New York, NY USA; RAND Corp, Santa Monica, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Geneva; Columbia University; NewYork-Presbyterian Hospital; RAND Corporation	Brent, DA (corresponding author), Univ Pittsburgh, Western Psychiat Inst & Clin, 3811 Ohara St,BFT 311, Pittsburgh, PA 15213 USA.	brentda@upmc.edu	Bridge, Jeff/GQR-0436-2022; BARBE, Remy/B-3433-2008	BARBE, Remy/0000-0002-1851-1787	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH066371, K01MH069948] Funding Source: NIH RePORTER	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; Apter A, 2006, J CHILD ADOL PSYCHOP, V16, P77, DOI 10.1089/cap.2006.16.77; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berard R, 2006, J CHILD ADOL PSYCHOP, V16, P59, DOI 10.1089/cap.2006.16.59; Birmaher B, 2003, J AM ACAD CHILD PSY, V42, P415, DOI 10.1097/01.CHI.0000037049.04952.9F; BLACK B, 1994, J AM ACAD CHILD PSY, V33, P1000, DOI 10.1097/00004583-199409000-00010; Braconnier A, 2003, J AM ACAD CHILD PSY, V42, P22, DOI 10.1097/00004583-200301000-00007; Bridge JA, 2005, AM J PSYCHIAT, V162, P2173, DOI 10.1176/appi.ajp.162.11.2173; Cheung AH, 2005, J CHILD PSYCHOL PSYC, V46, P735, DOI 10.1111/j.1469-7610.2005.01467.x; Curry J, 2006, J AM ACAD CHILD PSY, V45, P1427, DOI 10.1097/01.chi.0000240838.78984.e2; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DETSKY AS, 1992, J CLIN EPIDEMIOL, V45, P255, DOI 10.1016/0895-4356(92)90085-2; Donnelly CL, 2006, J AM ACAD CHILD PSY, V45, P1162, DOI 10.1097/01.chi.0000233204.51050.f0; DUBITSKY GM, REV EVALUATION CLIN; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Emslie GJ, 2006, J AM ACAD CHILD PSY, V45, P709, DOI 10.1097/01.chi.0000214189.73240.63; Emslie GJ, 2002, J AM ACAD CHILD PSY, V41, P1205, DOI 10.1097/00004583-200210000-00010; Emslie GJ, 1997, ARCH GEN PSYCHIAT, V54, P1031; Emslie GJ, 2002, J CHILD ADOL PSYCHOP, V12, P299; EMSLIE GJ, IN PRESS J AM ACAD C; Geller DA, 2004, J AM ACAD CHILD PSY, V43, P1387, DOI 10.1097/01.chi.0000138356.29099.f1; GELLER DA, 2004, J AM ACAD CHILD ADOL, V40, P773; Glod CA, 2004, 157 ANN M AM PSYCH A; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Guy W., 1976, DHEW PUBL; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; HEDGES LV, 1982, PSYCHOL BULL, V92, P490, DOI 10.1037/0033-2909.92.2.490; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; James A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004690.pub2; Kaizar EE, 2006, CLIN TRIALS, V3, P73, DOI 10.1191/1740774506cn139oa; Keller MB, 2001, J AM ACAD CHILD PSY, V40, P762, DOI 10.1097/00004583-200107000-00010; Kraemer HC, 2005, CONTEMP CLIN TRIALS, V26, P518, DOI 10.1016/j.cct.2005.05.002; Liebowitz MR, 2002, J AM ACAD CHILD PSY, V41, P1431, DOI 10.1097/00004583-200212000-00014; Mandoki MW, 1997, PSYCHOPHARMACOL BULL, V33, P149; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; March JS, 2006, J CHILD ADOL PSYCHOP, V16, P91, DOI 10.1089/cap.2006.16.91; March JS, 2004, JAMA-J AM MED ASSOC, V292, P1969; MARCH JS, 1998, JAMA-J AM MED ASSOC, V280, P1852; MARCH JS, IN PRESS BIOL PSYCHI; Martin A, 2004, ARCH PEDIAT ADOL MED, V158, P773, DOI 10.1001/archpedi.158.8.773; MAVISSAKALIAN MR, 1995, AM J PSYCHIAT, V152, P673; Mayes TL, 2007, CNS SPECTRUMS, V12, P147, DOI 10.1017/S1092852900020666; McMahon FJ, 2006, AM J HUM GENET, V78, P804, DOI 10.1086/503820; MEYER WJ, 2004, AM AC CHILD AD PSYCH; Pine DS, 1998, ARCH GEN PSYCHIAT, V55, P56, DOI 10.1001/archpsyc.55.1.56; POSNER K, SUIC CLASS PROJ; Poznanski EO, 1995, CHILDRENS DEPRESSION; RIDDLE MA, 1992, J AM ACAD CHILD PSY, V31, P1062, DOI 10.1097/00004583-199211000-00011; Riddle MA, 2001, J AM ACAD CHILD PSY, V40, P222, DOI 10.1097/00004583-200102000-00017; Rosenthal Robert, 1994, HDB RES SYNTHESIS, V621, P231; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Rynn MA, 2001, AM J PSYCHIAT, V158, P2008, DOI 10.1176/appi.ajp.158.12.2008; Rynn MA, 2007, AM J PSYCHIAT, V164, P290, DOI 10.1176/appi.ajp.164.2.290; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Safer DJ, 2006, J CHILD ADOL PSYCHOP, V16, P159, DOI 10.1089/cap.2006.16.159; SIMEON JG, 1990, PROG NEURO-PSYCHOPH, V14, P791, DOI 10.1016/0278-5846(90)90050-Q; TOURIAN KA, 2004, 157 ANN M AM PSYCH A; *US FDA, 20415 US FDA NDA; US FDA, REV EV CLIN DAT NDA; US Food and Drug Administration, REL PSYCH DRUGS PED; von Knorring AL, 2006, J CLIN PSYCHOPHARM, V26, P311, DOI 10.1097/01.jcp.0000219051.40632.d5; Wagner KD, 2006, J AM ACAD CHILD PSY, V45, P280, DOI 10.1097/01.chi.0000192250.38400.9e; Wagner KD, 2004, AM J PSYCHIAT, V161, P1079, DOI 10.1176/appi.ajp.161.6.1079; Wagner KD, 2004, ARCH GEN PSYCHIAT, V61, P1153, DOI 10.1001/archpsyc.61.11.1153; Wagner KD, 2003, JAMA-J AM MED ASSOC, V290, P1033, DOI 10.1001/jama.290.8.1033; WALKUP J, 1999, 46 ANN M AM AC CHILD; Walkup JT, 2001, NEW ENGL J MED, V344, P1279, DOI 10.1056/NEJM200104263441703; Weissman MM, 1999, JAMA-J AM MED ASSOC, V281, P1707, DOI 10.1001/jama.281.18.1707; Weisz JR, 2006, PSYCHOL BULL, V132, P132, DOI 10.1037/0033-2909.132.1.132; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1	71	657	668	9	109	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2007	297	15					1683	1696		10.1001/jama.297.15.1683	http://dx.doi.org/10.1001/jama.297.15.1683			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	157UR	17440145				2022-12-28	WOS:000245747400022
J	Hernandez, RD; Hubisz, MJ; Wheeler, DA; Smith, DG; Ferguson, B; Rogers, J; Nazareth, L; Indap, A; Bourquin, T; McPherson, J; Muzny, D; Gibbs, R; Nielsen, R; Bustamante, CD				Hernandez, Ryan D.; Hubisz, Melissa J.; Wheeler, David A.; Smith, David G.; Ferguson, Betsy; Rogers, Jeffrey; Nazareth, Lynne; Indap, Amit; Bourquin, Traci; McPherson, John; Muzny, Donna; Gibbs, Richard; Nielsen, Rasmus; Bustamante, Carlos D.			Demographic histories and patterns of linkage disequilibrium in Chinese and Indian rhesus macaques	SCIENCE			English	Article							MACACA-MULATTA; MITOCHONDRIAL-DNA; HUMAN GENOME; FREQUENCIES; ORIGIN; GENES; LOCI; MAP	To understand the demographic history of rhesus macaques ( Macaca mulatta) and document the extent of linkage disequilibrium (LD) in the genome, we partially resequenced five Encyclopedia of DNA Elements regions in 9 Chinese and 38 captive-born Indian rhesus macaques. Population genetic analyses of the 1467 single-nucleotide polymorphisms discovered suggest that the two populations separated about 162,000 years ago, with the Chinese population tripling in size since then and the Indian population eventually shrinking by a factor of four. Using coalescent simulations, we confirmed that these inferred demographic events explain a much faster decay of LD in Chinese (r(2) approximate to 0.15 at 10 kilobases) versus Indian (r(2) approximate to 0.52 at 10 kilobases) macaque populations.	Cornell Univ, Ithaca, NY 14850 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Dept Anthropol, Davis, CA USA; Calif Natl Primate Res Ctr, Davis, CA USA; Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Genet Res & Informat Program, Beaverton, OR 97006 USA; Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78227 USA; Univ Copenhagen, Dept Biol, Ctr Comparat Genom, DK-2100 Copenhagen O, Denmark	Cornell University; University of Chicago; Baylor College of Medicine; Oregon Health & Science University; Oregon National Primate Research Center; University of Washington; University of Washington Seattle; Texas Biomedical Research Institute; University of Copenhagen	Bustamante, CD (corresponding author), Cornell Univ, Ithaca, NY 14850 USA.	cdb28@cornell.edu	McPherson, John D/D-2633-2017; Nielsen, Rasmus/D-4405-2009; Wheeler, David A/M-9740-2018	McPherson, John D/0000-0001-8049-9347; Nielsen, Rasmus/0000-0003-0513-6591; Wheeler, David A/0000-0002-9056-6299; Bustamante, Carlos D./0000-0002-4187-7920; Indap, Amit/0000-0002-3322-4735; Hubisz, Melissa/0000-0002-9561-6830	NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163, R24RR015383, R24RR005090] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abegg C, 2002, BIOL J LINN SOC, V75, P555, DOI 10.1046/j.1095-8312.2002.00045.x; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; DEISON E, 1980, MACAQUES STUDIES ECO, P10; Eberle MA, 2006, PLOS GENET, V2, P1319, DOI 10.1371/journal.pgen.0020142; Falush D, 2003, GENETICS, V164, P1567; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Ferguson B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-43; Fooden J., 1980, P1; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Hayasaka K, 1996, MOL BIOL EVOL, V13, P1044, DOI 10.1093/oxfordjournals.molbev.a025655; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Ling BH, 2002, AIDS, V16, P1489, DOI 10.1097/00002030-200207260-00005; Morales JC, 1998, J HUM EVOL, V34, P1, DOI 10.1006/jhev.1997.0171; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Raveendran M, 2006, GENOMICS, V88, P706, DOI 10.1016/j.ygeno.2006.08.009; Rogers J, 2006, GENOMICS, V87, P30, DOI 10.1016/j.ygeno.2005.10.004; Smith DG, 2005, AM J PRIMATOL, V65, P1, DOI 10.1002/ajp.20094; Viray J, 2001, COMPARATIVE MED, V51, P555; Weiss RA, 2001, NATURE, V410, P1035, DOI 10.1038/35074222	19	133	136	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					240	243		10.1126/science.1140462	http://dx.doi.org/10.1126/science.1140462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431170				2022-12-28	WOS:000245654500040
J	Lo, JC; Wang, YG; Tumanov, AV; Bamji, M; Yao, ZM; Reardon, CA; Getz, GS; Fu, YX				Lo, James C.; Wang, Yugang; Tumanov, Alexei V.; Bamji, Michelle; Yao, Zemin; Reardon, Catherine A.; Getz, Godfrey S.; Fu, Yang-Xin			Lymphotoxin beta receptor-dependent control of lipid homeostasis	SCIENCE			English	Article							HEPATIC LIPASE; LIPOPROTEIN METABOLISM; ATHEROSCLEROSIS; INFLAMMATION; LIGHT; MICE; MECHANISMS; DISEASE; ALPHA; TNF	Hyperlipidemia, one of the most important risk factors for coronary heart disease, is often associated with inflammation. We identified lymphotoxin ( LT) and LIGHT, tumor necrosis factor cytokine family members that are primarily expressed on lymphocytes, as critical regulators of key enzymes that control lipid metabolism. Dysregulation of LIGHT expression on T cells resulted in hypertriglyceridemia and hypercholesterolemia. In low-density lipoprotein receptor-deficient mice, which lack the ability to control lipid levels in the blood, inhibition of LT and LIGHT signaling with a soluble lymphotoxin beta receptor decoy protein attenuated the dyslipidemia. These results suggest that the immune system directly influences lipid metabolism and that LT modulating agents may represent a novel therapeutic route for the treatment of dyslipidemia.	Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; Univ Ottawa, Inst Heart, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	University of Chicago; University of Chicago; University of Ottawa; University of Ottawa Heart Institute	Fu, YX (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	getz@bsd.uchicago.edu; yfu@uchicago.edu	Tumanov, Alexei/AAR-1607-2021; Lo, James/GYR-1149-2022	Tumanov, Alexei/0000-0001-6042-0152; Lo, James/0000-0003-0244-1670; fu, yang-xin/0000-0001-8441-6617	NATIONAL CANCER INSTITUTE [P01CA097296] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anand S, 2006, J CLIN INVEST, V116, P1045, DOI 10.1172/JCI27083; Anders RA, 2005, J IMMUNOL, V175, P1295, DOI 10.4049/jimmunol.175.2.1295; Barcat D, 2006, ATHEROSCLEROSIS, V188, P347, DOI 10.1016/j.atherosclerosis.2005.11.022; Dichek HL, 2001, J LIPID RES, V42, P201; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Ozaki K, 2004, NATURE, V429, P72, DOI 10.1038/nature02502; Reardon CA, 2003, ARTERIOSCL THROM VAS, V23, P1449, DOI 10.1161/01.ATV.0000079793.58054.2E; Reardon CA, 2001, CURR OPIN LIPIDOL, V12, P167, DOI 10.1097/00041433-200104000-00010; Santamarina-Fojo S, 2004, ARTERIOSCL THROM VAS, V24, P1750, DOI 10.1161/01.ATV.0000140818.00570.2d; Schreyer SA, 2002, J BIOL CHEM, V277, P12364, DOI 10.1074/jbc.M111727200; Shaikh RB, 2001, J IMMUNOL, V167, P6330, DOI 10.4049/jimmunol.167.11.6330; Wang J, 2001, J CLIN INVEST, V108, P1771, DOI 10.1172/JCI200113827; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719	18	113	119	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					285	288		10.1126/science.1137221	http://dx.doi.org/10.1126/science.1137221			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431181				2022-12-28	WOS:000245654500053
J	Bennett, J				Bennett, Jean			Retinal progenitor cells - Timing is everything	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSPLANTATION		Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Bennett, J (corresponding author), Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA.							Humayun MS, 2000, INVEST OPHTH VIS SCI, V41, P3100; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; O'Brien KMB, 2003, MOL VIS, V9, P401; 2006, US ADULTS DIABETES F	5	12	17	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 12	2007	356	15					1577	1579		10.1056/NEJMcibr070209	http://dx.doi.org/10.1056/NEJMcibr070209			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156CA	17429090				2022-12-28	WOS:000245624400014
J	Clotet, B; Bellos, N; Molina, JM; Cooper, D; Goffard, JC; Lazzarin, A; Wohrmann, A; Katlama, C; Wilkin, T; Haubrich, R; Cohen, C; Farthing, C; Jayaweera, D; Markowitz, M; Ruane, P; Spinosa-Guzman, S; Lefebvre, E				Clotet, Bonaventura; Bellos, Nicholas; Molina, Jean-Michel; Cooper, David; Goffard, Jean-Chrostophe; Lazzarin, Adriano; Woehrmann, Andrej; Katlama, Christine; Wilkin, Timothy; Haubrich, Richard; Cohen, Calvin; Farthing, Charles; Jayaweera, Dushyantha; Markowitz, Martin; Ruane, Peter; Spinosa-Guzman, Sabrina; Lefebvre, Eric		POWER 1 2 Study Grp	Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials	LANCET			English	Article							OPTIMIZED BACKGROUND REGIMEN; HIV-1-INFECTED PATIENTS; ANTIRETROVIRAL DRUGS; DURABLE EFFICACY; TMC114/RITONAVIR; RISK; AIDS	Background The continuing, randomised, multinational, phase IIB POWER 1 and 2 studies aim to evaluate efficacy and safety of darunavir in combination with low-dose ritonavir in treatment-experienced HIV-1-infected patients. We did a pooled subgroup analysis to update results at week 48 for patients receiving the recommended dose Of darunavir-ritonavir compared with those receiving other protease inhibitors (PIS). Methods After 24-week dose-finding phases and primary efficacy analyses, patients randomised to receive darunavir-ritonavir were given 600/100 mg twice daily, and patients receiving control PIs continued on assigned treatment into the longer-term, open-label phase; all patients continued on optimised background regimen. We assessed patients who had reached week 48 or discontinued earlier at the time of analysis; for the darunavir-ritonavir group, only patients who received 600/100 mg twice daily from baseline were included. Analyses were intention-to-treat. The POWER 2 study (TMC114-C202) is registered with ClinicalTrials.gov (NCT00071097). Findings At week 48, 67 of 110 (61%) darunavir-ritonavir patients compared with 18 of 120 (15%) of control PI patients had viral load reductions of 1 log(10) copies per mL or greater from baseline (primary endpoint; difference in response rates 46%,95% Cl 35%-57%, p < 0.0001). Based on a logistic regression model including stratification factors (baseline number of primary PI mutations, use of enfuvirtide, baseline viral load) and study as covariates, the difference in response was 50% (odds ratio 11.72, 95% CI 5.75-23.89). In the darunavir-ritonavir group, rates of adverse events were mostly lower than or similar to those in the control group when corrected for treatment exposure. No unexpected safety concerns were identified. Interpretation Efficacy responses with darunavir-ritonavir 600/100 mg twice daily plus optimised background regimen were greater than those with control PI and were sustained to at least week 48, with favourable safety and tolerability in treatment-experienced patients. This regimen could expand the treatment options available for such patients.	Hosp Univ Germans Trias & Pujol & irsiCaixa Fdn, Barcelona 08916, Spain; SW Infect Dis Assoc, Dallas, TX USA; Hop St Louis, Dept Infect Dis, Assistance Publ Hop Paris, Paris, France; St Vincents Hosp, Sydney, NSW 2010, Australia; Univ New S Wales, Sydney, NSW, Australia; Univ Erasme, Brussels, Belgium; Hosp San Raffaele, I-20132 Milan, Italy; Univ Cologne, Innere Med Klin 1, Cologne, Germany; Hop La Pitie Salpetriere, Paris, France; Cornell Univ, Weill Med Coll, New York, NY USA; Univ Calif San Diego, San Diego, CA 92103 USA; Community Res Initiat New England, Boston, MA USA; AIDS Healthcare Fdn Res Ctr, Beverly Hills, CA USA; Univ Miami, Miami, FL 33152 USA; Rockefeller Univ Hosp, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; Tibotec, Mechelen, Belgium; Tibotec, Yardley, PA USA	Institut de Recerca de la Sida - IrsiCaixa; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; St Vincents Hospital Sydney; University of New South Wales Sydney; Universite Libre de Bruxelles; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Cologne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Cornell University; University of California System; University of California San Diego; University of Miami; Rockefeller University; Johnson & Johnson; Johnson & Johnson USA	Clotet, B (corresponding author), Hosp Univ Germans Trias & Pujol & irsiCaixa Fdn, Ctra Canyet S-N, Barcelona 08916, Spain.	bclotet@irsicaixa.es	; LAZZARIN, Adriano/K-3607-2018	Goffard, Jean-Christophe/0000-0002-2730-7673; LAZZARIN, Adriano/0000-0003-2551-7754				*AIDS CLIN TRIALS, DIV AIDS TABL GRAD S; BELLOS NC, 2006, 44 ANN M INF DIS SOC; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DAQILA RT, 2003, TOP HIV MED, V11, P92; De Meyer S, 2005, ANTIMICROB AGENTS CH, V49, P2314, DOI 10.1128/AAC.49.6.2314-2321.2005; DEMEYER S, 2006, 8 INT C DRUG THER HI; FDA Guidance for Industry, 2002, ANT DRUGS US PLASM H; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Haubrich R, 2007, AIDS, V21, pF11, DOI 10.1097/QAD.0b013e3280b07b47; Hicks CB, 2006, LANCET, V368, P466, DOI 10.1016/S0140-6736(06)69154-X; Johnson M, 2005, AIDS, V19, P685, DOI 10.1097/01.aids.0000166091.39317.99; Johnson Victoria A, 2005, Top HIV Med, V13, P51; Johnson Victoria A, 2004, Top HIV Med, V12, P119; Katlama C, 2007, AIDS, V21, P395, DOI 10.1097/QAD.0b013e328013d9d7; LOUTFY M, 2001, 8 EUR C CLIN ASP TRE; MOLINA JM, 2006, 16 INT AIDS C; Nelson M, 2005, JAIDS-J ACQ IMM DEF, V40, P404, DOI 10.1097/01.qai.0000185314.56556.c3; Olsen CH, 2005, AIDS, V19, P319; POCOCK SJ, 1979, BIOMETRICS, V35, P183, DOI 10.2307/2529944; Ratnam I, 2006, CLIN INFECT DIS, V42, P418, DOI 10.1086/499356; *US DHHS, 2006, GUID US ANT AG HIV 1	21	389	412	1	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2007	369	9568					1169	1178		10.1016/S0140-6736(07)60497-8	http://dx.doi.org/10.1016/S0140-6736(07)60497-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155RH	17416261				2022-12-28	WOS:000245595100028
J	Levine, OS; Cutts, FT				Levine, Orin S.; Cutts, Felicity T.			Pneumococcal vaccination and public health	LANCET			English	Editorial Material							CONJUGATE VACCINE; DISEASE		Johns Hopkins Bloomberg Sch Publ Hlth, GAVIs PneumoADIP, Baltimore, MD 21205 USA; Londe Maures, Provence, France	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Levine, OS (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, GAVIs PneumoADIP, Baltimore, MD 21205 USA.	olevine@jhsph.edu						*CDCP, 2005, MMWR-MORBID MORTAL W, V54, P893; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Madhi SA, 2007, VACCINE, V25, P2413, DOI 10.1016/j.vaccine.2006.09.010; Ray GT, 2006, PEDIATR INFECT DIS J, V25, P494, DOI 10.1097/01.inf.0000222403.42974.8b; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	7	5	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2007	369	9568					1144	1145		10.1016/S0140-6736(07)60539-X	http://dx.doi.org/10.1016/S0140-6736(07)60539-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155RH	17416242				2022-12-28	WOS:000245595100005
J	Hackney, DD				Hackney, David D.			Processive motor movement	SCIENCE			English	Editorial Material							DIMERIC KINESIN; ATP HYDROLYSIS; MICROTUBULE; PROTEIN		Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Hackney, DD (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	ddh@andrew.cmu.edu						Alonso MC, 2007, SCIENCE, V316, P120, DOI 10.1126/science.1136985; Arnal I, 1998, STRUCTURE, V6, P33, DOI 10.1016/S0969-2126(98)00005-7; Asenjo AB, 2003, NAT STRUCT BIOL, V10, P836, DOI 10.1038/nsb984; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hackney DD, 2005, P NATL ACAD SCI USA, V102, P18338, DOI 10.1073/pnas.0505288102; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; Hirose K, 1999, MOL BIOL CELL, V10, P2063, DOI 10.1091/mbc.10.6.2063; Hoenger A, 2000, J MOL BIOL, V297, P1087, DOI 10.1006/jmbi.2000.3627; Hoenger A, 2000, BIOL CHEM, V381, P1001, DOI 10.1515/BC.2000.123; KUZNETSOV SA, 1986, P NATL ACAD SCI USA, V83, P8530, DOI 10.1073/pnas.83.22.8530; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Tomishige M, 2006, NAT STRUCT MOL BIOL, V13, P887, DOI 10.1038/nsmb1151; Vilfan A, 2001, J MOL BIOL, V312, P1011, DOI 10.1006/jmbi.2001.5020; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753	15	23	23	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2007	316	5821					58	59		10.1126/science.1141549	http://dx.doi.org/10.1126/science.1141549			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412943				2022-12-28	WOS:000245470500026
J	Stefanovic, S; Hegde, RS				Stefanovic, Sandra; Hegde, Rarnanujan S.			Identification of a targeting factor for posttranslational membrane protein insertion into the ER	CELL			English	Article							SIGNAL RECOGNITION PARTICLE; TAIL-ANCHORED PROTEIN; ENDOPLASMIC-RETICULUM MEMBRANE; SACCHAROMYCES-CEREVISIAE; TRANSLOCATION COMPLEX; MECHANISM; SYNAPTOBREVIN; POLYPEPTIDE; TRANSPORTER; ELONGATION	Hundreds of proteins are anchored in intracellular membranes by a single transmembrane domain (TMD) close to the C terminus. Although these tail-anchored (TA) proteins serve numerous essential roles in cells, components of their targeting and insertion pathways have long remained elusive. Here we reveal a cytosolic TMD recognition complex (TRC) that targets TA proteins for insertion into the ER membrane. The highly conserved, 40 kDa ATPase subunit of TRC (which we termed TRC40) was identified as Asna-1. TRC40/Asna-1 interacts posttranslationally with TA proteins in a TMD-dependent manner for delivery to a proteinaceous receptor at the ER membrane. Subsequent release from TRC40/Asna-1 and insertion into the membrane depends on ATP hydrolysis. Consequently, an ATPase-deficient mutant of TRC40/Asna-1 dominantly inhibited TA protein insertion selectively without influencing other translocation pathways. Thus, TRC40/Asna-1 represents an integral component of a posttranslational pathway of membrane protein insertion whose targeting is mediated by TRC.	NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Hegde, RS (corresponding author), NICHHD, Cell Biol & Metab Branch, NIH, Room 101,Bldg 18T,18 Lib Dr, Bethesda, MD 20892 USA.	hegder@mail.nih.gov		Hegde, Ramanujan/0000-0001-8338-852X	Intramural NIH HHS Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008862, Z01HD008862, ZIAHD008752, Z01HD008752] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abell BM, 2003, J BIOL CHEM, V278, P5669, DOI 10.1074/jbc.M209968200; Abell BM, 2004, EMBO J, V23, P2755, DOI 10.1038/sj.emboj.7600281; ANDREWS DW, 1989, J CELL BIOL, V108, P797, DOI 10.1083/jcb.108.3.797; Auld KL, 2006, GENETICS, V174, P215, DOI 10.1534/genetics.106.058362; Borgese N, 2001, MOL BIOL CELL, V12, P2482, DOI 10.1091/mbc.12.8.2482; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Brambillasca S, 2005, EMBO J, V24, P2533, DOI 10.1038/sj.emboj.7600730; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Gupta GD, 2003, FUNGAL GENET BIOL, V40, P271, DOI 10.1016/S1087-1845(03)00109-9; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; HARTMANN E, 1994, NATURE, V367, P654, DOI 10.1038/367654a0; High S, 2004, BIOCHEM SOC T, V32, P659, DOI 10.1042/BST0320659; Kim PK, 1999, J BIOL CHEM, V274, P36876, DOI 10.1074/jbc.274.52.36876; Kim PK, 1997, BIOCHEMISTRY-US, V36, P8873, DOI 10.1021/bi970090t; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; Kurdi-Haidar B, 1998, J BIOL CHEM, V273, P22173, DOI 10.1074/jbc.273.35.22173; KurdiHaidar B, 1996, GENOMICS, V36, P486, DOI 10.1006/geno.1996.0494; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Metz J, 2006, J BIOL CHEM, V281, P410, DOI 10.1074/jbc.M507481200; Mukhopadhyay R, 2006, FEBS LETT, V580, P3889, DOI 10.1016/j.febslet.2006.06.017; OGG SC, 1995, CELL, V81, P1075, DOI 10.1016/S0092-8674(05)80012-1; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shan SO, 2005, FEBS LETT, V579, P921, DOI 10.1016/j.febslet.2004.11.049; Shen J, 2003, BIOMETALS, V16, P369, DOI 10.1023/A:1022504311669; Steel GJ, 2002, BIOCHEMISTRY-US, V41, P11914, DOI 10.1021/bi026105r; Toikkanen J, 1996, YEAST, V12, P425, DOI 10.1002/(SICI)1097-0061(199604)12:5<425::AID-YEA924>3.3.CO;2-2; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; WALTER P, 1983, METHOD ENZYMOL, V266, P19599; Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x; Whitley P, 1996, J BIOL CHEM, V271, P7583, DOI 10.1074/jbc.271.13.7583; Yabal M, 2003, J BIOL CHEM, V278, P3489, DOI 10.1074/jbc.M210253200	37	301	305	0	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2007	128	6					1147	1159		10.1016/j.cell.2007.01.036	http://dx.doi.org/10.1016/j.cell.2007.01.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382883	Bronze			2022-12-28	WOS:000245396200020
J	Hennessy, S; Strom, BL				Hennessy, Sean; Strom, Brian L.			PDUFA reauthorization - Drug safety's golden moment of opportunity?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Educ & Res Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Hennessy, S (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.							BAKKE OM, 1995, CLIN PHARMACOL THER, V58, P108, DOI 10.1016/0009-9236(95)90078-0; [Department of Health and Human Services Centers for Medicare & Medicaid Services], 2007, FED REG, V72, P15198; *HJ KAIS FAM FDN, 2006, PRESCR DRUG TRENDS; Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215; 2006, FUTURE DRUG SAFETY P	5	22	22	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 26	2007	356	17					1703	1704		10.1056/NEJMp078048	http://dx.doi.org/10.1056/NEJMp078048			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	160LQ	17435082				2022-12-28	WOS:000245942600003
J	Blumenthal, R; Dimitrov, DS				Blumenthal, Robert; Dimitrov, Dimiter S.			Targeting the sticky fingers of HIV-1	CELL			English	Editorial Material							INHIBITION; INFECTION; PEPTIDE; FUSION; ENTRY; GP41	Although human blood plasma contains molecules that inhibit the activity of HIV-1, their identity is largely unknown. Winch et al. (2007) now identify a peptide corresponding to a portion of alpha 1-antitrypsin that potently inhibits entry of HIV-1 into host cells by binding to a hydrophobic segment of the viral envelope glycoprotein gp41.	NCI Frederick, Ctr Canc Res Nanobiol Program, NIH, Ft Detrick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Blumenthal, R (corresponding author), NCI Frederick, Ctr Canc Res Nanobiol Program, NIH, Ft Detrick, MD 21702 USA.	blumen@helix.nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC008303, Z01BC010701, Z01BC008303, ZIABC010701] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Dimitrov DS, 1996, NAT MED, V2, P640, DOI 10.1038/nm0696-640; Dimitrov DS, 2004, NAT REV MICROBIOL, V2, P109, DOI 10.1038/nrmicro817; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Gerber D, 2004, J BIOL CHEM, V279, P48224, DOI 10.1074/jbc.M403436200; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Liu SW, 2007, CURR PHARM DESIGN, V13, P143, DOI 10.2174/138161207779313722; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770	8	15	16	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2007	129	2					243	245		10.1016/j.cell.2007.04.005	http://dx.doi.org/10.1016/j.cell.2007.04.005			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448985	Bronze			2022-12-28	WOS:000246474600011
J	Brinster, RL				Brinster, Ralph L.			Male germline stem cells: From mice to men	SCIENCE			English	Review							SELF-RENEWAL; MOUSE; CULTURE; TRANSPLANTATION; TRANSMISSION; EXPANSION; GDNF; RAT	The production of functional male gametes is dependent on the continuous activity of germline stem cells. The availability of a transplantation assay system to unequivocally identify male germline stem cells has allowed their in vitro culture, cryopreservation, and genetic modification. Moreover, the system has enabled the identification of conditions and factors involved in stem cell self-renewal, the foundation of spermatogenesis, and the production of spermatozoa. The increased knowledge about these cells is also of great potential practical value, for example, for the possible cryopreservation of stem cells from boys undergoing treatment for cancer to safeguard their germ line.	Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Brinster, RL (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.			Brinster, Ralph/0000-0003-1408-7656	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044445] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD044445] Funding Source: Medline; PHS HHS [HDO44445] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Brinster RL, 2002, SCIENCE, V296, P2174, DOI 10.1126/science.1071607; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; Buageaw A, 2005, BIOL REPROD, V73, P1011, DOI 10.1095/biolreprod.105.043810; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; De Rooij DG, 1998, INT J EXP PATHOL, V79, P67, DOI 10.1046/j.1365-2613.1998.00057.x; Ebata KT, 2005, MOL REPROD DEV, V72, P171, DOI 10.1002/mrd.20324; Falender AE, 2005, GENE DEV, V19, P794, DOI 10.1101/gad.1290105; Hamra FK, 2005, P NATL ACAD SCI USA, V102, P17430, DOI 10.1073/pnas.0508780102; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kubota H, 2006, NAT CLIN PRACT ENDOC, V2, P99, DOI 10.1038/ncpendmet0098; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nagano M, 1998, TISSUE CELL, V30, P389, DOI 10.1016/S0040-8166(98)80053-0; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Oatley JM, 2006, METHOD ENZYMOL, V419, P259, DOI 10.1016/S0076-6879(06)19011-4; Russell LD, 1990, HISTOLOGICAL HISTOPA, P1; Ryu BY, 2005, P NATL ACAD SCI USA, V102, P14302, DOI 10.1073/pnas.0506970102; Suzuki A, 2007, DEVELOPMENT, V134, P77, DOI 10.1242/dev.02697; Wong MD, 2005, ANNU REV GENET, V39, P173, DOI 10.1146/annurev.genet.39.073003.105855	21	194	208	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					404	405		10.1126/science.1137741	http://dx.doi.org/10.1126/science.1137741			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446391	Green Accepted			2022-12-28	WOS:000245813400042
J	Duarte, CM; Marba, N; Holmer, M				Duarte, Carlos M.; Marba, Nuria; Holmer, Marianne			Rapid domestication of marine species	SCIENCE			English	Editorial Material							AQUACULTURE		UIB, CSIC, IMEDEA, Inst Mediterraneo Estudios Avanzados, Esporles 07190, Mallorca, Spain; Univ So Denmark, Inst Biol, DK-5230 Odense M, Denmark	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Southern Denmark	Duarte, CM (corresponding author), UIB, CSIC, IMEDEA, Inst Mediterraneo Estudios Avanzados, Esporles 07190, Mallorca, Spain.	carlosduarte@imedea.uib.es	Marbà, Nuria/N-8143-2019; Duarte Quesada, Carlos Manuel/ABD-6208-2021; Duarte, Carlos M/A-7670-2013; Marba, Nuria/H-8136-2015; Holmer, Marianne/M-6989-2014	Marbà, Nuria/0000-0002-8048-6789; Duarte, Carlos M/0000-0002-1213-1361; Marba, Nuria/0000-0002-8048-6789; Holmer, Marianne/0000-0002-6095-5488				Diamond JM, 2001, NATURE, V411, P755, DOI 10.1038/35081231; *FAO, 2006, FAOSTAT AGR; *FAO, 2006, 500 FAO UN FAO; FAO, 2006, FAO FISH INF DAT STA; GROOMBRIDGE B, 2000, GLOBAL BIODIVERSITY; Hale E. B., 1969, BEHAV DOMESTIC ANIMA, P22; Mannion AM, 1999, PROG PHYS GEOG, V23, P37, DOI 10.1191/030913399677315626; Naylor RL, 1998, SCIENCE, V282, P883, DOI 10.1126/science.282.5390.883; Neori A, 2004, AQUACULTURE, V231, P361, DOI 10.1016/j.aquaculture.2003.11.015; Normile D, 1997, SCIENCE, V275, P309, DOI 10.1126/science.275.5298.309; Olive PJW, 1999, HYDROBIOLOGIA, V402, P175, DOI 10.1023/A:1003744610012; Pullin R.S.V., 1996, P409; Sorgeloos, 1999, WORLD AQUACULTURE, V30, P11; Woods LC, 2001, AQUACULTURE, V202, P343, DOI 10.1016/S0044-8486(01)00783-9	14	170	172	2	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					382	383		10.1126/science.1138042	http://dx.doi.org/10.1126/science.1138042			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446380				2022-12-28	WOS:000245813400031
J	Kastelein, JJP; van Leuven, SI; Burgess, L; Evans, GW; Kuivenhoven, JA; Barter, PJ; Revkin, JH; Grobbee, DE; Riley, WA; Shear, CL; Duggan, WT; Bots, ML				Kastelein, John J. P.; van Leuven, Sander I.; Burgess, Leslie; Evans, Greg W.; Kuivenhoven, Jan A.; Barter, Philip J.; Revkin, James H.; Grobbee, Diederick E.; Riley, Ward A.; Shear, Charles L.; Duggan, William T.; Bots, Michiel L.		RADIANCE 1 Investigators	Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHOLESTERYL ESTER TRANSFER; HIGH-DENSITY-LIPOPROTEIN; INTIMA-MEDIA THICKNESS; TRANSFER PROTEIN INHIBITOR; CARDIOVASCULAR-DISEASE; SECONDARY PREVENTION; DOUBLE-BLIND; PROGRESSION; RISK; ATORVASTATIN	BACKGROUND: Torcetrapib, an inhibitor of cholesteryl ester transfer protein, may reduce atherosclerotic vascular disease by increasing levels of high-density lipoprotein (HDL) cholesterol. METHODS: A total of 850 patients with heterozygous familial hypercholesterolemia underwent B-mode ultrasonography at baseline and at follow-up to measure changes in carotid intima-media thickness. The patients completed an atorvastatin run-in period and were subsequently randomly assigned to receive either atorvastatin monotherapy or atorvastatin combined with 60 mg of torcetrapib for 2 years. RESULTS: After 24 months, in the atorvastatin-only group, the mean (+/- SD) HDL cholesterol level was 52.4 +/- 13.5 mg per deciliter and the mean low-density lipoprotein (LDL) cholesterol level was 143.2 +/- 42.2 mg per deciliter, as compared with 81.5 +/- 22.6 mg per deciliter and 115.1 +/- 48.5 mg per deciliter, respectively, in the torcetrapib-atorvastatin group. During the study, average systolic blood pressure increased by 2.8 mm Hg in the torcetrapib-atorvastatin group, as compared with the atorvastatin-only group. The increase in maximum carotid intima-media thickness, the primary measure of efficacy, was 0.0053 +/- 0.0028 mm per year in the atorvastatin-only group and 0.0047 +/- 0.0028 mm per year in the torcetrapib-atorvastatin group (P=0.87). The secondary efficacy measure, annualized change in mean carotid intima-media thickness for the common carotid artery, indicated a decrease of 0.0014 mm per year in the atorvastatin-only group, as compared with an increase of 0.0038 mm per year in the torcetrapib-atorvastatin group (P=0.005). CONCLUSIONS: In patients with familial hypercholesterolemia, the use of torcetrapib with atorvastatin, as compared with atorvastatin alone, did not result in further reduction of progression of atherosclerosis, as assessed by a combined measure of carotid arterial-wall thickness, and was associated with progression of disease in the common carotid segment. These effects occurred despite a large increase in HDL cholesterol levels and a substantial decrease in levels of LDL cholesterol and triglycerides.	Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; Tygerberg Hosp, Tygerberg, South Africa; Univ Stellenbosch, ZA-7505 Tygerberg, South Africa; Wake Forest Univ, Winston Salem, NC 27109 USA; Heart Res Inst, Sydney, NSW, Australia; Pfizer, New London, CT USA; Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Tygerberg Hospital; Stellenbosch University; Wake Forest University; University of Sydney; Heart Research Institute; Pfizer; Utrecht University; Utrecht University Medical Center	Kastelein, JJP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9,Room F4-159-2, NL-1105 AZ Amsterdam, Netherlands.	j.j.kastelein@amc.uva.nl	Kastelein, John/AAF-7950-2020; Grobbee, Diederick/C-7651-2014; van Leuven, Sander I/R-7844-2017	Grobbee, Diederick/0000-0003-4472-4468; van Leuven, Sander/0000-0003-1432-069X				BAGDADE JD, 1991, J CLIN INVEST, V87, P1259, DOI 10.1172/JCI115127; Barter P, 2006, J AM COLL CARDIOL, V47, p298A; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Boekholdt SM, 2004, CIRCULATION, V110, P1418, DOI 10.1161/01.CIR.0000141730.65972.95; Bots ML, 2007, EUR HEART J, V28, P398, DOI 10.1093/eurheartj/ehl482; Bots ML, 2003, STROKE, V34, P2985, DOI 10.1161/01.STR.0000102044.27905.B5; Brousseau ME, 2004, NEW ENGL J MED, V350, P1505, DOI 10.1056/NEJMoa031766; Cannon CP, 2006, NEW ENGL J MED, V354, P778; Clark RW, 2004, ARTERIOSCL THROM VAS, V24, P490, DOI 10.1161/01.ATV.0000118278.21719.17; de Groot E, 1998, J AM COLL CARDIOL, V31, P1561, DOI 10.1016/S0735-1097(98)00170-3; de Grooth GJ, 2004, ATHEROSCLEROSIS, V173, P261, DOI 10.1016/j.atherosclerosis.2003.11.020; de Grooth GJ, 2002, CIRCULATION, V105, P2159, DOI 10.1161/01.CIR.0000015857.31889.7B; DEGROOT E, IN PRESS NAT CLIN PR; Espeland MA, 1999, ANN EPIDEMIOL, V9, P196, DOI 10.1016/S1047-2797(98)00069-6; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Grundy, 2004, CIRCULATION, V110, P763, DOI 10.1161/01.CIR.0000140446.06098.6B; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hodis HN, 2002, AM J CARDIOL, V89, p19E; Hodis HN, 2002, CIRCULATION, V106, P1453, DOI 10.1161/01.CIR.0000029092.99946.08; Hogue JC, 2007, ATHEROSCLEROSIS, V190, P429, DOI 10.1016/j.atherosclerosis.2006.02.023; Junyent M, 2006, ARTERIOSCL THROM VAS, V26, P1107, DOI 10.1161/01.ATV.0000218507.95149.42; KAJINAMI K, 1992, CLIN CHIM ACTA, V211, P93, DOI 10.1016/0009-8981(92)90108-3; Kastelein JJP, 2007, CURR MED RES OPIN, V23, P885, DOI 10.1185/030079907X182121; Kastelein JP, 2005, AM HEART J, V149, P234, DOI 10.1016/j.ahj.2004.06.024; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Liang Q, 2000, IEEE T MED IMAGING, V19, P127, DOI 10.1109/42.836372; Okamoto H, 2000, NATURE, V406, P203, DOI 10.1038/35018119; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Smilde TJ, 2001, LANCET, V357, P577, DOI 10.1016/S0140-6736(00)04053-8; Taylor AJ, 2004, CIRCULATION, V110, P3512, DOI 10.1161/01.CIR.0000148955.19792.8D; TAYLOR AJ, 2005, CIRCULATION, V111, pE446; TAYLOR AJ, 2005, CIRCULATION, V110, P3615; van Wissen S, 2002, ATHEROSCLEROSIS, V165, P361, DOI 10.1016/S0021-9150(02)00280-0; Wang JG, 2006, STROKE, V37, P1933, DOI 10.1161/01.STR.0000227223.90239.13; WHO, 1998, FAM HYP FH REP WHO C; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	39	531	557	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2007	356	16					1620	1630		10.1056/NEJMoa071359	http://dx.doi.org/10.1056/NEJMoa071359			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AB	17387131				2022-12-28	WOS:000245762000004
J	Mahajan, A				Mahajan, Ashish			Do patients understand risk?	LANCET			English	Editorial Material									Univ Alberta, Fac Med & Dent, Edmonton, AB T6G 2R7, Canada	University of Alberta	Mahajan, A (corresponding author), Univ Alberta, Fac Med & Dent, Edmonton, AB T6G 2R7, Canada.	amahajan@ualberta.ca						Calman KC, 2002, LANCET, V360, P166, DOI 10.1016/S0140-6736(02)09421-7; Woloshin S, 2007, ANN INTERN MED, V146, P256, DOI 10.7326/0003-4819-146-4-200702200-00004	2	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 14	2007	369	9569					1243	1243		10.1016/S0140-6736(07)60575-3	http://dx.doi.org/10.1016/S0140-6736(07)60575-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164YA	17434385				2022-12-28	WOS:000246269700009
J	van Santbrink, H; Cornips, EMJ				van Santbrink, Henk; Cornips, Erwin M. J.			A man with a hole in his head	LANCET			English	Editorial Material									Acad Hosp Maastricht, Dept Neurosurg, NL-6202 AZ Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	van Santbrink, H (corresponding author), Acad Hosp Maastricht, Dept Neurosurg, POB 5800, NL-6202 AZ Maastricht, Netherlands.	hvsa@snch.azm.nl							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2007	369	9569					1286	1286		10.1016/S0140-6736(07)60600-X	http://dx.doi.org/10.1016/S0140-6736(07)60600-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164YA	17434404	Bronze			2022-12-28	WOS:000246269700031
J	Tornqvist, TE; Paola, C; Parker, G; Liu, K; Mohrig, D; Holbrook, JM; Twilley, RR				Toernqvist, Torbjoern E.; Paola, Chris; Parker, Gary; Liu, Kam-biu; Mohrig, David; Holbrook, John M.; Twilley, Robert R.			Comment on "Wetland sedimentation from Hurricanes Katrina and Rita"	SCIENCE			English	Editorial Material							MISSISSIPPI RIVER; DELTA PLAIN		Tulane Univ, Dept Earth & Environm Sci, New Orleans, LA 70118 USA; Univ Minnesota Twin Cities, St Anthony Falls Lab, Minneapolis, MN 55414 USA; Univ Minnesota Twin Cities, Dept Geol & Geophys, Minneapolis, MN 55414 USA; Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA; Univ Illinois, Dept Geol, Urbana, IL 61801 USA; Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; Univ Texas, Dept Geol Sci, Austin, TX 78712 USA; Univ Texas, Dept Earth & Environm Sci, Arlington, TX 76019 USA	Tulane University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Louisiana State University System; Louisiana State University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Arlington	Tornqvist, TE (corresponding author), Tulane Univ, Dept Earth & Environm Sci, New Orleans, LA 70118 USA.	tor@tulane.edu	Mohrig, David/O-1758-2013; Tornqvist, Torbjorn E./A-9851-2009	Mohrig, David/0000-0003-1828-4526; Tornqvist, Torbjorn E./0000-0002-1563-1716				Allison MA, 1998, GEOLOGY, V26, P175, DOI 10.1130/0091-7613(1998)026<0175:IOFPSF>2.3.CO;2; Allison MA, 2001, GEO-MAR LETT, V21, P66; Barras J.A, 2006, 061274 US GEOL SURV; Bobrovitskaya NN, 1996, IAHS-AISH P, P115; Day JW, 1997, COAST MANAGE, V25, P115, DOI 10.1080/08920759709362315; Draut AE, 2005, CONT SHELF RES, V25, P91, DOI 10.1016/j.csr.2004.09.002; KEOWN MP, 1986, WATER RESOUR RES, V22, P1555, DOI 10.1029/WR022i011p01555; KESEL RH, 1988, ENVIRON GEOL WATER S, V11, P271, DOI 10.1007/BF02574816; Kuecher G.J., 1993, P 8 S COAST OC MAN P, P1197; Meade RH, 1996, SEA LEVEL RISE COAST, V2, P63, DOI DOI 10.1007/978-94-015-8719-8_4; NYMAN JA, 1995, ESTUAR COAST SHELF S, V40, P665, DOI 10.1006/ecss.1995.0045; Roberts HH, 1997, J COASTAL RES, V13, P605; Stokstad E, 2006, SCIENCE, V313, P1713, DOI 10.1126/science.313.5794.1713; Tornqvist TE, 1996, SCIENCE, V273, P1693; Turner RE, 2006, SCIENCE, V314, P449, DOI 10.1126/science.1129116; van de Plassche O, 2006, GEOLOGY, V34, P829, DOI 10.1130/G22598.1; Wellner R., 2005, GULF COAST ASS GEOL, V55, P867; WELLS JT, 1987, ESTUAR COAST SHELF S, V25, P111, DOI 10.1016/0272-7714(87)90029-1	18	37	37	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					201	201		10.1126/science.1136780	http://dx.doi.org/10.1126/science.1136780			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431155				2022-12-28	WOS:000245654500022
J	Higgins, CF				Higgins, Christopher F.			Multiple molecular mechanisms for multidrug resistance transporters	NATURE			English	Review							DISULFIDE CROSS-LINKING; RETRACTED ARTICLE. SEE; DRUG-BINDING-SITES; P-GLYCOPROTEIN; ATP-BINDING; ESCHERICHIA-COLI; EFFLUX TRANSPORTER; STRUCTURAL BASIS; 3-DIMENSIONAL STRUCTURE; TRANSMEMBRANE DOMAINS	The acquisition of multidrug resistance is a serious impediment to improved healthcare. Multidrug resistance is most frequently due to active transporters that pump a broad spectrum of chemically distinct, cytotoxic molecules out of cells, including antibiotics, antimalarials, herbicides and cancer chemotherapeutics in humans. The paradigm multidrug transporter, mammalian P-glycoprotein, was identified 30 years ago. Nonetheless, success in overcoming or circumventing multidrug resistance in a clinical setting has been modest. Recent structural and biochemical data for several multidrug transporters now provide mechanistic insights into how they work. Organisms have evolved several elegant solutions to ridding the cell of such cytotoxic compounds. Answers are emerging to questions such as how multispecificity for different drugs is achieved, why multidrug resistance arises so readily, and what chance there is of devising a clinical solution.	Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, London W12 0NN, England	Imperial College London	Higgins, CF (corresponding author), Univ Durham, Vice Chancellors Off, Univ Off, Durham DH1 3HP, England.	chris.higgins@durham.ac.uk						Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Abramson J, 2004, MOL MEMBR BIOL, V21, P227, DOI 10.1080/09687680410001716862; Adler J, 2005, J BIOL CHEM, V280, P2721, DOI 10.1074/jbc.M412332200; AHMED M, 1995, J BACTERIOL, V177, P3904, DOI 10.1128/jb.177.14.3904-3910.1995; Aires JR, 2005, J BACTERIOL, V187, P1923, DOI 10.1128/JB.187.6.1923-1929.2005; Bolhuis H, 1996, EMBO J, V15, P4239, DOI 10.1002/j.1460-2075.1996.tb00798.x; Buchler M, 1996, J BIOL CHEM, V271, P15091; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; Chang G, 2006, SCIENCE, V314, P1875, DOI 10.1126/science.314.5807.1875b; Cupp-Vickery J, 2000, P NATL ACAD SCI USA, V97, P3050, DOI 10.1073/pnas.050406897; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Dong JH, 2005, SCIENCE, V308, P1023, DOI 10.1126/science.1106592; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; HIGGINS CF, 1986, NATURE, V323, P448, DOI 10.1038/323448a0; Holland I. B., 2003, ABC PROTEINS BACTERI; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lewinson O, 2004, P NATL ACAD SCI USA, V101, P14073, DOI 10.1073/pnas.0405375101; Lewinson O, 2001, BIOCHEMISTRY-US, V40, P12612, DOI 10.1021/bi011040y; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loe DW, 1998, CANCER RES, V58, P5130; Loo TW, 2005, J MEMBRANE BIOL, V206, P173, DOI 10.1007/s00232-005-0792-1; Loo TW, 2000, J BIOL CHEM, V275, P5253, DOI 10.1074/jbc.275.8.5253; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P14020, DOI 10.1021/bi0511179; Ma C, 2004, P NATL ACAD SCI USA, V101, P2852, DOI 10.1073/pnas.0400137101; Ma Y, 2002, CELL, V111, P63, DOI 10.1016/S0092-8674(02)00977-7; Martin C, 2000, BIOCHEMISTRY-US, V39, P11901, DOI 10.1021/bi000559b; Martin C, 2000, MOL PHARMACOL, V58, P624, DOI 10.1124/mol.58.3.624; Martin C, 2001, BIOCHEMISTRY-US, V40, P15733, DOI 10.1021/bi011211z; Mazurkiewicz P, 2004, BBA-BIOENERGETICS, V1658, P252, DOI 10.1016/j.bbabio.2004.06.004; MITCHELL P, 1957, NATURE, V180, P134, DOI 10.1038/180134a0; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Neyfakh AA, 2002, MOL MICROBIOL, V44, P1123, DOI 10.1046/j.1365-2958.2002.02965.x; Payen LF, 2003, J BIOL CHEM, V278, P38537, DOI 10.1074/jbc.M305786200; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Putman M, 1999, BIOCHEMISTRY-US, V38, P13900, DOI 10.1021/bi991262k; Ramon R, 2001, J BIOL CHEM, V276, P7150, DOI 10.1074/jbc.M010368200; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Rius M, 2003, HEPATOLOGY, V38, P374, DOI 10.1053/jhep.2003.50331; Rosenberg MF, 2003, J BIOL CHEM, V278, P8294, DOI 10.1074/jbc.M211758200; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Rosenberg MF, 1997, J BIOL CHEM, V272, P10685; Saier MH, 2001, SEMIN CELL DEV BIOL, V12, P205, DOI 10.1006/scdb.2000.0246; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; Schuldiner S, 1997, J EXP BIOL, V200, P335; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Schumacher MA, 2004, EMBO J, V23, P2923, DOI 10.1038/sj.emboj.7600288; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Shapiro AB, 1997, EUR J BIOCHEM, V250, P130, DOI 10.1111/j.1432-1033.1997.00130.x; Sharoni M, 2005, J BIOL CHEM, V280, P32849, DOI 10.1074/jbc.M504910200; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Soskine M, 2006, J BIOL CHEM, V281, P36205, DOI 10.1074/jbc.M607186200; STEIN WD, 1994, MOL PHARMACOL, V45, P763; Stenham DR, 2003, FASEB J, V17, P2287, DOI 10.1096/fj.03-0107fje; TAME JRH, 1994, SCIENCE, V264, P1578, DOI 10.1126/science.8202710; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; van Veen HW, 2000, EMBO J, V19, P2503, DOI 10.1093/emboj/19.11.2503; van Veen HW, 1998, NATURE, V391, P291, DOI 10.1038/34669; Vazquez-Laslop N, 1999, BIOCHEMISTRY-US, V38, P16925, DOI 10.1021/bi991988g; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Yerushalmi H, 2000, BIOCHEMISTRY-US, V39, P14711, DOI 10.1021/bi001892i; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Zelcer N, 2003, J BIOL CHEM, V278, P23538, DOI 10.1074/jbc.M303504200; Zgurskaya HI, 1999, P NATL ACAD SCI USA, V96, P7190, DOI 10.1073/pnas.96.13.7190; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6; ZOINERCIKS JK, UNPUB J BIOL CHEM	77	688	728	4	253	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					749	757		10.1038/nature05630	http://dx.doi.org/10.1038/nature05630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429392				2022-12-28	WOS:000245626800031
J	Sutter, NB; Bustamante, CD; Chase, K; Gray, MM; Zhao, KY; Zhu, L; Padhukasahasram, B; Karlins, E; Davis, S; Jones, PG; Quignon, P; Johnson, GS; Parker, HG; Fretwell, N; Mosher, DS; Lawler, DF; Satyaraj, E; Nordborg, M; Lark, KG; Wayne, RK; Ostrander, EA				Sutter, Nathan B.; Bustamante, Carlos D.; Chase, Kevin; Gray, Melissa M.; Zhao, Keyan; Zhu, Lan; Padhukasahasram, Badri; Karlins, Eric; Davis, Sean; Jones, Paul G.; Quignon, Pascale; Johnson, Gary S.; Parker, Heidi G.; Fretwell, Neale; Mosher, Dana S.; Lawler, Dennis F.; Satyaraj, Ebenezer; Nordborg, Magnus; Lark, K. Gordon; Wayne, Robert K.; Ostrander, Elaine A.			A single IGF1 allele is a major determinant of small size in dogs	SCIENCE			English	Article							BODY-SIZE; WILD CANIDS; GROWTH; MORPHOLOGY; ORIGINS	The domestic dog exhibits greater diversity in body size than any other terrestrial vertebrate. We used a strategy that exploits the breed structure of dogs to investigate the genetic basis of size. First, through a genome-wide scan, we identified a major quantitative trait locus (QTL) on chromosome 15 influencing size variation within a single breed. Second, we examined genetic variation in the 15-megabase interval surrounding the QTL in small and giant breeds and found marked evidence for a selective sweep spanning a single gene (IGF1), encoding insulin-like growth factor 1. A single IGF1 single-nucleotide polymorphism haplotype is common to all small breeds and nearly absent from giant breeds, suggesting that the same causal sequence variant is a major contributor to body size in all small dogs.	NHGRI, Bethesda, MD 20892 USA; Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Calif Los Angeles, Dept Ecol & Environm Biol, Los Angeles, CA 90095 USA; Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA; WALTHAM Ctr Pet Nutr, Melton Mowbray LE14 4RT, Leics, England; Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA; Nestle Res Ctr NRC STL, St Louis, MO 63164 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Cornell University; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; University of Southern California; Mars; WALTHAM Petcare Science Institute; University of Missouri System; University of Missouri Columbia	Ostrander, EA (corresponding author), NHGRI, Bldg 50,Room 5349,50 S Dr MSC 8000, Bethesda, MD 20892 USA.	eostrand@mail.nih.gov	Parker, Heidi/C-6954-2008; Gray, Melissa/B-5025-2008; Fiumefreddo, Andrea/T-2977-2019; Davis, Sean/AAD-1801-2021	Gray, Melissa/0000-0002-1756-5468; Davis, Sean/0000-0002-8991-6458; Ostrander, Elaine/0000-0001-6075-9738; Bustamante, Carlos D./0000-0002-4187-7920; Zhao, Keyan/0000-0002-8800-2304; Nordborg, Magnus/0000-0001-7178-9748; Karlins, Eric/0000-0002-7541-393X; Parker, Heidi G./0000-0002-9707-6380	NHGRI NIH HHS [5T32 HG002536, P50 HG002790] Funding Source: Medline; NIGMS NIH HHS [R01 GM063056-06, R01 GM063056] Funding Source: Medline; PHS HHS [063056] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790, T32HG002536, Z01HG200325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063056] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chase K, 2005, GENOME RES, V15, P1820, DOI 10.1101/gr.3712705; Chase K, 2002, P NATL ACAD SCI USA, V99, P9930, DOI 10.1073/pnas.152333099; Cohen P, 2006, HORM RES, V65, P3, DOI 10.1159/000090640; EIGENMANN JE, 1984, ACTA ENDOCRINOL-COP, V106, P448, DOI 10.1530/acta.0.1060448; Epstein H., 1971, ORIGIN DOMESTIC ANIM; Favier RP, 2001, J ENDOCRINOL, V170, P479, DOI 10.1677/joe.0.1700479; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Kooijman R, 2006, CYTOKINE GROWTH F R, V17, P305, DOI 10.1016/j.cytogfr.2006.02.002; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Olsen S.J., 1985, ORIGINS DOMESTIC DOG; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Pollinger JP, 2005, GENOME RES, V15, P1809, DOI 10.1101/gr.4374505; Sablin MV, 2002, CURR ANTHROPOL, V43, P795, DOI 10.1086/344372; Saetre P, 2004, MOL BRAIN RES, V126, P198, DOI 10.1016/j.molbrainres.2004.05.003; Sampson J, 2006, COLD SPRING HARB MON, V44, P19; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; TCHERNOV E, 1991, J ANTHROPOL ARCHAEOL, V10, P54, DOI 10.1016/0278-4165(91)90021-O; Van Valkenburgh B, 2004, SCIENCE, V306, P101, DOI 10.1126/science.1102417; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; Wang W, 2005, GENOME RES, V15, P1798, DOI 10.1101/gr.3765505; WAYNE RK, 1986, J ZOOL, V210, P381; WAYNE RK, 1986, EVOLUTION, V40, P243, DOI 10.1111/j.1558-5646.1986.tb00467.x; WAYNE RK, 1986, J MORPHOL, V187, P301, DOI 10.1002/jmor.1051870304; Webber C, 2005, GENOME RES, V15, P1787, DOI 10.1101/gr.3896805; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805; Woods KA, 1997, ACTA PAEDIATR, V86, P39	28	465	485	1	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2007	316	5821					112	115		10.1126/science.1137045	http://dx.doi.org/10.1126/science.1137045			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412960	Green Accepted			2022-12-28	WOS:000245470500044
J	Fenton, LK; Geissler, PE; Haberle, RM				Fenton, Lori K.; Geissler, Paul E.; Haberle, Robert M.			Global warming and climate forcing by recent albedo changes on Mars	NATURE			English	Article							THERMAL MAPPER OBSERVATIONS; INTERANNUAL VARIABILITY; POLAR-REGIONS; TES; FEATURES; MODEL	For hundreds of years, scientists have tracked the changing appearance of Mars, first by hand drawings and later by photographs(1,2). Because of this historical record, many classical albedo patterns have long been known to shift in appearance over time. Decadal variations of the martian surface albedo are generally attributed to removal and deposition of small amounts of relatively bright dust on the surface. Large swaths of the surface ( up to 56 million km(2)) have been observed to darken or brighten by 10 per cent or more(3-5). It is unknown, however, how these albedo changes affect wind circulation, dust transport and the feedback between these processes and the martian climate. Here we present predictions from a Mars general circulation model, indicating that the observed interannual albedo alterations strongly influence the martian environment. Results indicate enhanced wind stress in recently darkened areas and decreased wind stress in brightened areas, producing a positive feedback system in which the albedo changes strengthen the winds that generate the changes. The simulations also predict a net annual global warming of surface air temperatures by similar to 0.65 K, enhancing dust lifting by increasing the likelihood of dust devil generation. The increase in global dust lifting by both wind stress and dust devils may affect the mechanisms that trigger large dust storm initiation, a poorly understood phenomenon, unique to Mars. In addition, predicted increases in summertime air temperatures at high southern latitudes would contribute to the rapid and steady scarp retreat that has been observed in the south polar residual ice for the past four Mars years(6-8). Our results suggest that documented albedo changes affect recent climate change and large-scale weather patterns on Mars, and thus albedo variations are a necessary component of future atmospheric and climate studies.	US Geol Survey, Flagstaff, AZ 86001 USA; NASA, Ames Res Ctr, Carl Sagan Ctr, Moffett Field, CA 94035 USA; NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA	United States Department of the Interior; United States Geological Survey; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Fenton, LK (corresponding author), US Geol Survey, Flagstaff, AZ 86001 USA.	fenton@mintz.arc.nasa.gov; pgeissler@usgs.gov		Fenton, Lori/0000-0001-8116-4901				Byrne S, 2003, SCIENCE, V299, P1051, DOI 10.1126/science.1080148; CHRISTENSEN PR, 1988, J GEOPHYS RES-SOLID, V93, P7611, DOI 10.1029/JB093iB07p07611; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23823, DOI 10.1029/2000JE001370; Clancy RT, 2000, J GEOPHYS RES-PLANET, V105, P9553, DOI 10.1029/1999JE001089; de Vaucouleurs G., 1954, PHYS PLANET MARS; Flammarion C., 1892, PLANETE MARS SES CON, V1; Flammarion C, 1892, PLANETE MARS SES CON, V2; Geissler PE, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002345; Haberle RM, 1999, J GEOPHYS RES-PLANET, V104, P8957, DOI 10.1029/1998JE900040; HOUGHTON JT, 2001, CLIMATE CHANGE SCI B, P105; Kahre MA, 2005, ICARUS, V179, P55, DOI 10.1016/j.icarus.2005.06.011; Kieffer H. H., 1977, Journal of Geophysical Research, V82, P4249, DOI 10.1029/JS082i028p04249; KIEFFER HH, 1982, P LUNAR PLANET SCI C, V12, P1395; Liu JJ, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001921; Malin MC, 2001, SCIENCE, V294, P2146, DOI 10.1126/science.1066416; McKim R. J., 1999, MEM BR ASTRON ASS, V44, P1; PAIGE DA, 1994, J GEOPHYS RES-PLANET, V99, P25993, DOI 10.1029/93JE03429; PAIGE DA, 1994, J GEOPHYS RES-PLANET, V99, P25959, DOI 10.1029/93JE03428; PLESKOT LK, 1981, ICARUS, V45, P179, DOI 10.1016/0019-1035(81)90013-0; Renno NO, 1998, J ATMOS SCI, V55, P3244, DOI 10.1175/1520-0469(1998)055<3244:ASTTFD>2.0.CO;2; Smith MD, 2004, ICARUS, V167, P148, DOI 10.1016/j.icarus.2003.09.010; Szwast MA, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002485; Thomas PC, 2005, ICARUS, V174, P535, DOI 10.1016/j.icarus.2004.07.028; Vasavada AR, 2000, J GEOPHYS RES-PLANET, V105, P6961, DOI 10.1029/1999JE001108; ZUREK RW, 1993, J GEOPHYS RES-PLANET, V98, P3247, DOI 10.1029/92JE02936	25	59	59	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2007	446	7136					646	649		10.1038/nature05718	http://dx.doi.org/10.1038/nature05718			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17410170				2022-12-28	WOS:000245438300034
J	Tan, X; Calderon-Villalobos, LIA; Sharon, M; Zheng, CX; Robinson, CV; Estelle, M; Zheng, N				Tan, Xu; Calderon-Villalobos, Luz Irina A.; Sharon, Michal; Zheng, Changxue; Robinson, Carol V.; Estelle, Mark; Zheng, Ning			Mechanism of auxin perception by the TIR1 ubiquitin ligase	NATURE			English	Article							FUNCTIONAL GENOMIC ANALYSIS; GENE FAMILY-MEMBERS; BOX PROTEIN TIR1; INOSITOL HEXAKISPHOSPHATE; AUX/IAA PROTEINS; PLANT-GROWTH; DEGRADATION; PATHWAY	Auxin is a pivotal plant hormone that controls many aspects of plant growth and development. Perceived by a small family of F-box proteins including transport inhibitor response 1 (TIR1), auxin regulates gene expression by promoting SCF ubiquitin-ligase-catalysed degradation of the Aux/IAA transcription repressors, but how the TIR1 F-box protein senses and becomes activated by auxin remains unclear. Here we present the crystal structures of the Arabidopsis TIR1 - ASK1 complex, free and in complexes with three different auxin compounds and an Aux/IAA substrate peptide. These structures show that the leucine-rich repeat domain of TIR1 contains an unexpected inositol hexakisphosphate co-factor and recognizes auxin and the Aux/IAA polypeptide substrate through a single surface pocket. Anchored to the base of the TIR1 pocket, auxin binds to a partially promiscuous site, which can also accommodate various auxin analogues. Docked on top of auxin, the Aux/IAA substrate peptide occupies the rest of the TIR1 pocket and completely encloses the hormone-binding site. By filling in a hydrophobic cavity at the protein interface, auxin enhances the TIR1 - substrate interactions by acting as a 'molecular glue'. Our results establish the first structural model of a plant hormone receptor.	Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	University of Washington; University of Washington Seattle; University of Cambridge; Indiana University System; Indiana University Bloomington	Zheng, N (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Box 357280, Seattle, WA 98195 USA.	nzheng@u.washington.edu	Estelle, Mark/ABD-6742-2021; Tan, Xu/E-7170-2011; Villalobos, Luz Irina A Calderón/L-5876-2016	Tan, Xu/0000-0003-4861-4573; Sharon, Michal/0000-0003-3933-0595; robinson, carol/0000-0001-7829-5505; Calderon Villalobos, Luz Irina A./0000-0002-6093-1478				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Dharmasiri N, 2003, CURR BIOL, V13, P1418, DOI 10.1016/S0960-9822(03)00536-0; Dharmasiri N, 2004, TRENDS PLANT SCI, V9, P302, DOI 10.1016/j.tplants.2004.04.003; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; FARRIMOND JA, 1978, NATURE, V274, P401, DOI 10.1038/274401a0; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hanakahi LA, 2000, CELL, V102, P721, DOI 10.1016/S0092-8674(00)00061-1; Hoy M, 2002, P NATL ACAD SCI USA, V99, P6773, DOI 10.1073/pnas.102157499; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JONSSON A, 1961, ENCY PLANT PHYSL, V14, P959; KAETHNER TM, 1977, NATURE, V267, P19, DOI 10.1038/267019a0; Kepinski S, 2004, P NATL ACAD SCI USA, V101, P12381, DOI 10.1073/pnas.0402868101; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; KOBE B, 1993, J MOL BIOL, V231, P137, DOI 10.1006/jmbi.1993.1263; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Overvoorde PJ, 2005, PLANT CELL, V17, P3282, DOI 10.1105/tpc.105.036723; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Ramos JA, 2001, PLANT CELL, V13, P2349, DOI 10.1105/tpc.13.10.2349; Reed JW, 2001, TRENDS PLANT SCI, V6, P420, DOI 10.1016/S1360-1385(01)02042-8; Remington DL, 2004, PLANT PHYSIOL, V135, P1738, DOI 10.1104/pp.104.039669; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; Zenser N, 2001, P NATL ACAD SCI USA, V98, P11795, DOI 10.1073/pnas.211312798; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	43	1055	1138	12	247	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2007	446	7136					640	645		10.1038/nature05731	http://dx.doi.org/10.1038/nature05731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17410169				2022-12-28	WOS:000245438300033
J	Zhang, F; Wang, LP; Brauner, M; Liewald, JF; Kay, K; Watzke, N; Wood, PG; Bamberg, E; Nagel, G; Gottschalk, A; Deisseroth, K				Zhang, Feng; Wang, Li-Ping; Brauner, Martin; Liewald, Jana F.; Kay, Kenneth; Watzke, Natalie; Wood, Phillip G.; Bamberg, Ernst; Nagel, Georg; Gottschalk, Alexander; Deisseroth, Karl			Multimodal fast optical interrogation of neural circuitry	NATURE			English	Article							CHLORIDE PUMP HALORHODOPSIN; GREEN-ALGAE; IN-VIVO; MAMMALIAN NEURONS; EXCITABLE CELLS; REMOTE-CONTROL; ION CHANNELS; LIGHT; ACTIVATION; CHANNELRHODOPSIN-2	Our understanding of the cellular implementation of systems-level neural processes like action, thought and emotion has been limited by the availability of tools to interrogate specific classes of neural cells within intact, living brain tissue. Here we identify and develop an archaeal light-driven chloride pump (NpHR) from Natronomonas pharaonis for temporally precise optical inhibition of neural activity. NpHR allows either knockout of single action potentials, or sustained blockade of spiking. NpHR is compatible with ChR2, the previous optical excitation technology we have described, in that the two opposing probes operate at similar light powers but with well-separated action spectra. NpHR, like ChR2, functions in mammals without exogenous cofactors, and the two probes can be integrated with calcium imaging in mammalian brain tissue for bidirectional optical modulation and readout of neural activity. Likewise, NpHR and ChR2 can be targeted together to Caenorhabditis elegans muscle and cholinergic motor neurons to control locomotion bidirectionally. NpHR and ChR2 form a complete system for multimodal, high-speed, genetically targeted, all-optical interrogation of living neural circuits.	Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; Goethe Univ Frankfurt, Frankfurt Bioctr N220, Inst Biochem, D-60438 Frankfurt, Germany; Goethe Univ Frankfurt, Frankfurt Bioctr N220, Inst Biophys Chem, Dept Biochem Chem & Pharm, D-60438 Frankfurt, Germany; Max Planck Inst Biophys, D-60438 Frankfurt, Germany; Univ Wuezburg, D-97082 Wuezburg, Germany	Stanford University; Goethe University Frankfurt; Goethe University Frankfurt; Max Planck Society	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Wang, Liping/ABF-6317-2020; Gottschalk, Alexander/D-3155-2011; Ritter, Stefanie L/D-9312-2012; Wang, Liping/B-2827-2012; Macrae, Rhiannon/AAX-1536-2020	Wang, Liping/0000-0001-6893-3809; Gottschalk, Alexander/0000-0002-1197-6119; Nagel, Georg/0000-0001-8174-8712				ADAMS SR, 1993, ANNU REV PHYSIOL, V55, P755, DOI 10.1146/annurev.ph.55.030193.003543; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; BAMBERG E, 1993, P NATL ACAD SCI USA, V90, P639, DOI 10.1073/pnas.90.2.639; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brun S, 2003, MOL THER, V7, P782, DOI 10.1016/S1525-0016(03)00097-2; Chambers JJ, 2006, J NEUROPHYSIOL, V96, P2792, DOI 10.1152/jn.00318.2006; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; DUSCHL A, 1988, J BIOL CHEM, V263, P17016; Ehrengruber MU, 1997, P NATL ACAD SCI USA, V94, P7070, DOI 10.1073/pnas.94.13.7070; Faumont S, 2006, J NEUROPHYSIOL, V95, P1976, DOI 10.1152/jn.01050.2005; GRYGORCZYK R, 1989, METHOD ENZYMOL, V173, P453; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; HEGEMANN P, 1985, BIOCHIM BIOPHYS ACTA, V819, P195, DOI 10.1016/0005-2736(85)90174-9; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; Ibanez-Tallon I, 2004, NEURON, V43, P305, DOI 10.1016/j.neuron.2004.07.015; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Isles AR, 2001, J NEUROBIOL, V47, P183, DOI 10.1002/neu.1026; Jensen O, 1996, LEARN MEMORY, V3, P257, DOI 10.1101/lm.3.2-3.257; Johns DC, 1999, J NEUROSCI, V19, P1691; Kanold PO, 2003, SCIENCE, V301, P521, DOI 10.1126/science.1084152; Karpova AY, 2005, NEURON, V48, P727, DOI 10.1016/j.neuron.2005.11.015; KOBAYASHI K, 1995, J BIOL CHEM, V270, P27235, DOI 10.1074/jbc.270.45.27235; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; MacLean JN, 2006, NAT METHODS, V3, P129, DOI 10.1038/NMETH849; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Pettit DL, 2000, J NEUROPHYSIOL, V84, P28, DOI 10.1152/jn.2000.84.1.28; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Shoham S, 2005, NAT METHODS, V2, P837, DOI 10.1038/nmeth793; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Wang SSH, 2000, P NATL ACAD SCI USA, V97, P8635, DOI 10.1073/pnas.130414597; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zennou V, 2001, NAT BIOTECHNOL, V19, P446, DOI 10.1038/88115; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	48	1248	1345	9	332	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2007	446	7136					633	U4		10.1038/nature05744	http://dx.doi.org/10.1038/nature05744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17410168				2022-12-28	WOS:000245438300032
J	Armstrong, K; Moye, E; Williams, S; Berlin, JA; Reynolds, EE				Armstrong, Katrina; Moye, Elizabeth; Williams, Sankey; Berlin, Jesse A.; Reynolds, Eileen E.			Screening mammography in women 40 to 49 years of age: A systematic review for the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							CARCINOMA IN-SITU; BREAST-CANCER RISK; TERM FOLLOW-UP; FALSE-POSITIVE MAMMOGRAMS; SWEDISH RANDOMIZED-TRIALS; ATOMIC-BOMB SURVIVORS; ABNORMAL MAMMOGRAMS; PSYCHOLOGICAL CONSEQUENCES; RADIOLOGIC TECHNOLOGISTS; PSYCHIATRIC MORBIDITY	Background: The risks and benefits of mammography screening among women 40 to 49 years of age remain an important issue for clinical practice. Purpose: To evaluate the evidence about the risks and benefits of mammography screening for women 40 to 49 years of age. Data Sources: English-language publications in MEDLINE (19662005), Pre-MEDLINE, and the Cochrane Central Register of Controlled Trials and references of selected studies through May 2005. Study Selection: Previous systematic reviews; randomized, controlled trials; and observational studies. Data Extraction: Two independent reviewers. Data Synthesis: in addition to publications from the original mammography trials, 117 studies were included in the review. Meta-analyses of randomized, controlled trials demonstrate a 7% to 23% reduction in breast cancer mortality rates with screening mammography in women 40 to 49 years of age. Screening mammography is associated with an increased risk for mastectomy but a decreased risk for adjuvant chemotherapy and hormone therapy. The risk for death due to breast cancer from the radiation exposure involved in mammography screening is small and is outweighed by a reduction in breast cancer mortality rates from early detection. Rates of false-positive results are high (20% to 56% after 10 mammograms), but false-positive results have little effect on psychological health or subsequent mammography adherence. Although many women report pain at the time of the mammography, few see pain as a deterrent to future screening. Evidence about the effect of negative screening mammography on psychological well-being or the subsequent clinical presentation of breast cancer is insufficient. Limitations: Few randomized, controlled trials assessed the risks of screening, and the literature search was completed in 2005. Conclusions: Although few women 50 years of age or older have risks from mammography that outweigh the benefits, the evidence suggests that more women 40 to 49 years of age have such risks.	Univ Penn, Philadelphia, PA 19104 USA; Johnson & Johnson Pharmaceut Res & Dev, Raritan, NJ USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	University of Pennsylvania; Johnson & Johnson; Johnson & Johnson USA; Harvard University; Beth Israel Deaconess Medical Center	Armstrong, K (corresponding author), Univ Penn, 1204 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.							ALEXANDER FE, 1994, BRIT J CANCER, V70, P542, DOI 10.1038/bjc.1994.342; American Cancer Society, 2002, CANC FACTS FIG 2002; ANDERSSON I, 1988, BRIT MED J, V297, P943, DOI 10.1136/bmj.297.6654.943; Armstrong K, 2000, NEW ENGL J MED, V342, P564, DOI 10.1056/NEJM200002243420807; Aro AR, 1996, EUR J CANCER, V32A, P1674, DOI 10.1016/0959-8049(96)00140-2; Aro AR, 2000, EUR J CANCER, V36, P1089, DOI 10.1016/S0959-8049(00)00065-4; BAINES CJ, 1990, CANCER, V65, P1663, DOI 10.1002/1097-0142(19900401)65:7<1663::AID-CNCR2820650735>3.0.CO;2-A; Bakker D A, 1998, Oncol Nurs Forum, V25, P115; Barth RJ, 2005, AM J ROENTGENOL, V184, P324, DOI 10.2214/ajr.184.1.01840324; Barton MB, 2004, J NATL CANCER I, V96, P529, DOI 10.1093/jnci/djh083; Barton MB, 2001, J GEN INTERN MED, V16, P150, DOI 10.1111/j.1525-1497.2001.00329.x; BASKINSMITH J, 1995, CANCER NURS, V18, P47; Baxter NN, 2004, JNCI-J NATL CANCER I, V96, P443, DOI 10.1093/jnci/djh069; BERAL V, 1988, BRIT MED J, V297, P757, DOI 10.1136/bmj.297.6651.757; Berry DA, 1998, JNCI-J NATL CANCER I, V90, P1431, DOI 10.1093/jnci/90.19.1431; BETSILL WL, 1978, JAMA-J AM MED ASSOC, V239, P1863, DOI 10.1001/jama.239.18.1863; BLACK WC, 1995, J NATL CANCER I, V87, P720, DOI 10.1093/jnci/87.10.720; Bluman LG, 2001, J WOMEN HEALTH GEN-B, V10, P589, DOI 10.1089/15246090152543175; BOICE JD, 1992, NEW ENGL J MED, V326, P781, DOI 10.1056/NEJM199203193261201; BOICE JD, 1995, JAMA-J AM MED ASSOC, V274, P394, DOI 10.1001/jama.274.5.394; BOICE JD, 1989, INT J CANCER, V44, P7, DOI 10.1002/ijc.2910440103; BOICE JD, 1991, RADIAT RES, V125, P214, DOI 10.2307/3577890; Brett J, 1998, J PUBLIC HEALTH MED, V20, P396, DOI 10.1093/oxfordjournals.pubmed.a024793; Brett J, 2001, J PUBLIC HEALTH MED, V23, P292, DOI 10.1093/pubmed/23.4.292; BREW M D, 1989, Australasian Radiology, V33, P335, DOI 10.1111/j.1440-1673.1989.tb03306.x; Bruyninckx E, 1999, SOC SCI MED, V49, P933, DOI 10.1016/S0277-9536(99)00181-1; BULL AR, 1991, BRIT J RADIOL, V64, P510, DOI 10.1259/0007-1285-64-762-510; Burman ML, 1999, ANN INTERN MED, V131, P1, DOI 10.7326/0003-4819-131-1-199907060-00002; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; *CDCP, 2005, LEAD CAUS DEATH REP; Chlebowski RT, 2002, J CLIN ONCOL, V20, P3328, DOI 10.1200/JCO.2002.06.029; Claus EB, 2001, J NATL CANCER I, V93, P1811, DOI 10.1093/jnci/93.23.1811; Cockburn J, 1992, Australas Radiol, V36, P115, DOI 10.1111/j.1440-1673.1992.tb03094.x; Cockburn J, 1994, J Med Screen, V1, P7; Costantino JP, 1999, J NATL CANCER I, V91, P1541, DOI 10.1093/jnci/91.18.1541; Cox B, 1997, J Natl Cancer Inst Monogr, P69; DARBY SC, 1987, BRIT J CANCER, V55, P179, DOI 10.1038/bjc.1987.35; DEAN C, 1986, J EPIDEMIOL COMMUN H, V40, P71, DOI 10.1136/jech.40.1.71; Dibble SL, 2005, WOMEN HEALTH ISS, V15, P55, DOI 10.1016/j.whi.2004.12.001; Domar AD, 2005, AM J ROENTGENOL, V184, P445, DOI 10.2214/ajr.184.2.01840445; Doody MM, 2000, SPINE, V25, P2052; Doody MM, 1998, CANCER CAUSE CONTROL, V9, P67, DOI 10.1023/A:1008801404245; Drossaert CHC, 2001, J MED SCREEN, V8, P204, DOI 10.1136/jms.8.4.204; Dullum JR, 2000, RADIOLOGY, V214, P547, DOI 10.1148/radiology.214.2.r00fe23547; ELLMAN R, 1989, BRIT J CANCER, V60, P781, DOI 10.1038/bjc.1989.359; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Elmore JG, 2002, JNCI-J NATL CANCER I, V94, P1373; EMSTER VL, 1996, JAMA-J AM MED ASSOC, V275, P913; Ernst MF, 2004, CANCER-AM CANCER SOC, V100, P1337, DOI 10.1002/cncr.20139; Ernst MF, 2001, EUR J CANCER, V37, P2435, DOI 10.1016/S0959-8049(01)00316-1; Ernster VL, 2000, ARCH INTERN MED, V160, P953, DOI 10.1001/archinte.160.7.953; Ernster VL, 2002, J NATL CANCER I, V94, P1546; EUSEBI V, 1994, SEMIN DIAGN PATHOL, V11, P223; Farrow J H, 1970, Cancer, V25, P468, DOI 10.1002/1097-0142(197002)25:2<468::AID-CNCR2820250226>3.0.CO;2-0; Fay MP, 2003, STAT MED, V22, P1837, DOI 10.1002/sim.1428; FLETCHER SW, 1995, RADIOL CLIN N AM, V33, P1259; Freedman GM, 2003, CANCER-AM CANCER SOC, V98, P918, DOI 10.1002/cncr.11605; FRISELL J, 1986, BREAST CANCER RES TR, V8, P45, DOI 10.1007/BF01805924; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Glasziou P, 1997, J Natl Cancer Inst Monogr, P73; GRAM IT, 1990, BRIT J CANCER, V62, P1018, DOI 10.1038/bjc.1990.430; Halapy EE, 2004, J MED SCREEN, V11, P32, DOI 10.1258/096914104772950736; HANCOCK SL, 1993, J NATL CANCER I, V85, P25, DOI 10.1093/jnci/85.1.25; Harris R, 2005, JNCI-J NATL CANCER I, V97, P1021, DOI 10.1093/jnci/dji221; Hendrick R E, 1997, J Natl Cancer Inst Monogr, P87; HILDRETH NG, 1989, NEW ENGL J MED, V321, P1281, DOI 10.1056/NEJM198911093211901; HOFFMAN DA, 1989, J NATL CANCER I, V81, P1307, DOI 10.1093/jnci/81.17.1307; Hofvind S, 2004, CANCER-AM CANCER SOC, V101, P1501, DOI 10.1002/cncr.20528; HOLM LE, 1989, JNCI-J NATL CANCER I, V81, P302, DOI 10.1093/jnci/81.4.302; Howe GR, 1996, RADIAT RES, V145, P694, DOI 10.2307/3579360; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; JACKSON VP, 1988, RADIOLOGY, V168, P421, DOI 10.1148/radiology.168.2.3393659; JOENSUU H, 1994, EUR J CANCER, V30A, P1299, DOI 10.1016/0959-8049(94)90177-5; KashikarZuck S, 1997, PAIN, V73, P165, DOI 10.1016/S0304-3959(97)00114-0; Keemers-Gels ME, 2000, BREAST CANCER RES TR, V60, P235, DOI 10.1023/A:1006457520996; Kerlikowske K, 2000, ANN INTERN MED, V133, P855, DOI 10.7326/0003-4819-133-11-200012050-00009; Kerlikowske K, 1997, J Natl Cancer Inst Monogr, P79; Kerlikowske K, 2003, JNCI-J NATL CANCER I, V95, P1692, DOI 10.1093/jnci/djg097; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P39, DOI 10.1001/jama.276.1.39; KERLIKOWSKE K, 1993, JAMA-J AM MED ASSOC, V270, P2444, DOI 10.1001/jama.270.20.2444; Kerner JF, 2001, BREAST CANCER RES TR, V69, P81, DOI 10.1023/A:1012457703106; Kini VR, 1999, AM J CLIN ONCOL-CANC, V22, P429, DOI 10.1097/00000421-199910000-00001; Kopans DB, 1999, RADIOLOGY, V210, P4, DOI 10.1148/radiology.210.1.r99ja504; KOPANS DB, 1993, AM J ROENTGENOL, V161, P755, DOI 10.2214/ajr.161.4.8372752; Kornguth PJ, 2000, J PAIN, V1, P268, DOI 10.1054/jpai.2000.7884; Lampic C, 2003, EUR J CANCER, V39, P1730, DOI 10.1016/S0959-8049(02)00451-3; Lampic C, 2001, EUR J CANCER, V37, P463, DOI 10.1016/S0959-8049(00)00426-3; Larsson L G, 1997, J Natl Cancer Inst Monogr, P57; Leaney B J, 1992, Australas Radiol, V36, P120, DOI 10.1111/j.1440-1673.1992.tb03095.x; Legorreta AP, 2004, AM J CLIN ONCOL-CANC, V27, P185, DOI 10.1097/01.coc.0000054695.47732.0A; LERMAN C, 1991, ANN INTERN MED, V114, P657, DOI 10.7326/0003-4819-114-8-657; Li CI, 2005, CANCER EPIDEM BIOMAR, V14, P1008, DOI 10.1158/1055-9965.EPI-04-0849; LI FP, 1983, CANCER, V51, P521, DOI 10.1002/1097-0142(19830201)51:3<521::AID-CNCR2820510325>3.0.CO;2-U; Lidbrink E, 1996, BRIT MED J, V312, P273; LINDBERG S, 1995, ACTA ONCOL, V34, P735, DOI 10.3109/02841869509127180; Lipkus IM, 2000, PSYCHO-ONCOLOGY, V9, P402, DOI 10.1002/1099-1611(200009/10)9:5<402::AID-PON475>3.3.CO;2-L; Lundell M, 1996, RADIAT RES, V145, P225, DOI 10.2307/3579178; Maibenco D, 1999, AM SURGEON, V65, P1061; Markle Lauralyn, 2004, Breast J, V10, P345, DOI 10.1111/j.1075-122X.2004.21352.x; MATTSSON A, 1993, J NATL CANCER I, V85, P1679, DOI 10.1093/jnci/85.20.1679; McCann J, 2002, BREAST CANCER RES, V4, DOI 10.1186/bcr455; Meissner HI, 2003, J WOMEN HEALTH GEN-B, V12, P261, DOI 10.1089/154099903321667609; Miller AB, 2002, ANN INTERN MED, V137, P305, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00005; MILLER AB, 1992, CAN MED ASSOC J, V147, P1477; MILLER AB, 1992, CAN MED ASSOC J, V147, P1459; MILLER AB, 1989, NEW ENGL J MED, V321, P1285, DOI 10.1056/NEJM198911093211902; MILLIS RR, 1975, BRIT J SURG, V62, P957, DOI 10.1002/bjs.1800621209; MODAN B, 1989, LANCET, V1, P629, DOI 10.1016/S0140-6736(89)92140-5; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; Mushlin AI, 1998, AM J PREV MED, V14, P143, DOI 10.1016/S0749-3797(97)00019-6; NIELSEN BB, 1991, J NATL CANCER I, V83, P1754, DOI 10.1093/jnci/83.23.1754; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; NYSTROM L, 1993, LANCET, V341, P973, DOI 10.1016/0140-6736(93)91067-V; O'Sullivan I, 2001, J MED SCREEN, V8, P145, DOI 10.1136/jms.8.3.145; Olivotto IA, 1999, BREAST CANCER RES TR, V54, P73, DOI 10.1023/A:1006152918283; Olivotto IA, 1998, NEW ENGL J MED, V339, P560; Olsen O, 2001, LANCET, V358, P1340, DOI 10.1016/S0140-6736(01)06449-2; Olsen O., 2001, COCHRANE DB SYST REV; Olsson P, 1999, J MED SCREEN, V6, P89, DOI 10.1136/jms.6.2.89; Ong G, 1997, J Med Screen, V4, P158; Paci E, 2002, BRIT MED J, V325, P418, DOI 10.1136/bmj.325.7361.418; PAGE DL, 1995, CANCER, V76, P1197, DOI 10.1002/1097-0142(19951001)76:7<1197::AID-CNCR2820760715>3.0.CO;2-0; PEETERS PHM, 1989, INT J CANCER, V43, P226, DOI 10.1002/ijc.2910430209; Pinckney RG, 2003, AM J MED, V114, P120, DOI 10.1016/S0002-9343(02)01438-9; Pisano ED, 1998, RADIOLOGY, V208, P245, DOI 10.1148/radiology.208.1.9646820; PUKKALA E, 1995, BRIT MED J, V311, P649, DOI 10.1136/bmj.311.7006.649; Rakovitch E, 2003, BREAST CANCER RES TR, V77, P285, DOI 10.1023/A:1021853302033; Rockhill B, 2001, J NATL CANCER I, V93, P358, DOI 10.1093/jnci/93.5.358; ROSEN PP, 1980, CANCER, V46, P919, DOI 10.1002/1097-0142(19800815)46:4+<919::AID-CNCR2820461311>3.0.CO;2-Z; ROWORTH MA, 1993, PUBLIC HEALTH, V107, P185, DOI 10.1016/S0033-3506(05)80440-8; RUTTER DR, 1992, BRIT MED J, V305, P443, DOI 10.1136/bmj.305.6851.443; Sapir R, 2003, J PAIN SYMPTOM MANAG, V25, P53, DOI 10.1016/S0885-3924(02)00598-5; Scaf-Klomp W, 1997, J EPIDEMIOL COMMUN H, V51, P705, DOI 10.1136/jech.51.6.705; Schwartz LM, 2000, WESTERN J MED, V173, P307, DOI 10.1136/ewjm.173.5.307; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; Shapiro S, 1972, Proc Natl Cancer Conf, V7, P663; Shapiro S, 1997, J Natl Cancer Inst Monogr, P27; Sharp PC, 2003, ARCH INTERN MED, V163, P833, DOI 10.1001/archinte.163.7.833; SHORE RE, 1986, J NATL CANCER I, V77, P689, DOI 10.1093/jnci/77.3.689; Smith RA, 2000, CA-CANCER J CLIN, V50, P312, DOI 10.3322/canjclin.50.5.312; STOMPER PC, 1988, ARCH INTERN MED, V148, P521, DOI 10.1001/archinte.148.3.521; STORM HH, 1992, J NATL CANCER I, V84, P1245, DOI 10.1093/jnci/84.16.1245; SUTTON S, 1995, J EPIDEMIOL COMMUN H, V49, P413, DOI 10.1136/jech.49.4.413; Tabar L, 2003, LANCET, V361, P1405, DOI 10.1016/S0140-6736(03)13143-1; Tabar L, 1999, JPN J CLIN ONCOL, V29, P608, DOI 10.1093/jjco/29.12.608; Tice JA, 2005, BREAST CANCER RES TR, V94, P115, DOI 10.1007/s10549-005-5152-4; Tice JA, 2005, CANCER EPIDEM BIOMAR, V14, P324, DOI 10.1158/1055-9965.EPI-04-0289; TOKUNAGA M, 1994, RADIAT RES, V138, P209, DOI 10.2307/3578591; Wahner-Roedler DL, 2003, MAYO CLIN PROC, V78, P708, DOI 10.4065/78.6.708; WALKER LG, 1994, PSYCHO-ONCOL, V3, P299, DOI 10.1002/pon.2960030406; Walter LC, 2001, J GEN INTERN MED, V16, P779, DOI 10.1046/j.1525-1497.2001.10113.x; Walter SD, 2003, ANN ONCOL, V14, P1190, DOI 10.1093/annonc/mdg320; Wolden SL, 2000, J CLIN ONCOL, V18, P765, DOI 10.1200/JCO.2000.18.4.765; Young KC, 2002, BRIT J RADIOL, V75, P362, DOI 10.1259/bjr.75.892.750362	154	155	159	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2007	146	7					516	526		10.7326/0003-4819-146-7-200704030-00008	http://dx.doi.org/10.7326/0003-4819-146-7-200704030-00008			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153VB	17404354				2022-12-28	WOS:000245463200006
J	Crouse, JR; Raichlen, JS; Riley, WA; Evans, GW; Palmer, MK; O'Leary, DH; Grobbee, DE; Bots, ML				Crouse, John R., III; Raichlen, Joel S.; Riley, Ward A.; Evans, Gregory W.; Palmer, Mike K.; O'Leary, Daniel H.; Grobbee, Diederick E.; Bots, Michiel L.		METEOR Study Grp	Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis - The METEOR trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTHY-YOUNG ADULTS; CARDIOVASCULAR-DISEASE; ATORVASTATIN; CHOLESTEROL; PRAVASTATIN; PREVENTION; SAFETY; HYPERCHOLESTEROLEMIA; METAANALYSIS; POPULATION	Context Atherosclerosis is often advanced before symptoms appear and it is not clear whether treatment is beneficial in middle-aged individuals with a low Framingham risk score (FRS) and mild to moderate subclinical atherosclerosis. Objective To assess whether statin therapy could slow progression and/or cause regression of carotid intima-media thickness (CIMT) over 2 years. Design, Setting, and Participants Randomized, double-blind, placebo-controlled study (Measuring Effects on Intima-Media Thickness: an Evaluation of Rosuvastatin [METEOR]) of 984 individuals, with either age (mean, 57 years) as the only coronary heart disease risk factor or a 10-year FRS of less than 10%, modest CIMT thickening (1.2-<3.5 mm), and elevated LDL cholesterol (mean, 154 mg/dL); conducted at 61 primary care centers in the United States and Europe between August 2002 and May 2006. Intervention Participants received either a 40-mg dose of rosuvastatin or placebo. Main Outcome Measures Rate of change in maximum CIMT (assessed with B-mode ultrasound) for 12 carotid sites; changes in maximum CIMT of the common carotid artery, carotid bulb, and internal carotid artery sites and in mean CIMT of the common carotid artery sites. CIMT regression was assessed in the rosuvastatin group only. Results Among participants in the rosuvastatin group, the mean (SD) baseline LDL cholesterol level of 155 (24.1) mg/dL declined to 78 (27.5) mg/dL, a mean reduction of 49% (P < .001 vs placebo group). The change in maximum CIMT for the 12 carotid sites was -0.0014 (95% CI, -0.0041 to 0.0014) mm/y for the rosuvastatin group vs 0.0131 (95% CI, 0.0087-0.0174) mm/y for the placebo group (P < .001). The change in maximum CIMT for the rosuvastatin group was -0.0038 (95% CI, -0.0064 to -0.0013) mm/y for the common carotid artery sites (P < .001), -0.0040 (95% CI, -0.0090 to 0.0010) mm/y for the carotid bulb sites (P < .001), and 0.0039 (95% CI, -0.0009 to 0.0088) mm/y for the internal carotid artery sites (P = .02). The change in mean CIMT for the rosuvastatin group for the common carotid artery sites was 0.0004 (95% CI, -0.0011 to 0.0019) mm/y (P < .001). All P values are vs placebo group. Overall, rosuvastatin was well tolerated with infrequent serious adverse cardiovascular events (6 participants [0.86%] had 8 events [1.1%] over 2 years). Conclusions In middle-aged adults with an FRS of less than 10% and evidence of subclinical atherosclerosis, rosuvastatin resulted in statistically significant reductions in the rate of progression of maximum CIMT over 2 years vs placebo. Rosuvastatin did not induce disease regression. Larger, longer-term trials are needed to determine the clinical implications of these findings.	Wake Forest Univ, Sch Med, Dept Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Neurol, Winston Salem, NC 27157 USA; Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA; AstraZeneca, Wilmington, DE USA; AstraZeneca, Macclesfield, Cheshire, England; Caritas Carney Hosp, Boston, MA USA; Univ Med Ctr Utrecht, Dept Epidemiol, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Wake Forest University; Wake Forest University; Wake Forest University; AstraZeneca; AstraZeneca; Utrecht University; Utrecht University Medical Center	Crouse, JR (corresponding author), Wake Forest Univ, Sch Med, Dept Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	jrcrouse@wfubmc.edu	Grobbee, Diederick/C-7651-2014	Grobbee, Diederick/0000-0003-4472-4468				Amarenco P, 2004, STROKE, V35, P2902, DOI 10.1161/01.STR.0000147965.52712.fa; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bots ML, 2006, CURR MED RES OPIN, V22, P2181, DOI 10.1185/030079906X148472; Bots ML, 2003, STROKE, V34, P2985, DOI 10.1161/01.STR.0000102044.27905.B5; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Crouse JR, 2006, J LIPID RES, V47, P1677, DOI 10.1194/jlr.R600012-JLR200; Crouse JR, 2004, CARDIOVASC DRUG THER, V18, P231, DOI 10.1023/B:CARD.0000033645.55138.3d; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; de Groot E, 1998, J AM COLL CARDIOL, V31, P1561, DOI 10.1016/S0735-1097(98)00170-3; Espeland MA, 2005, CURR CONTR TRIALS C, V6, DOI 10.1186/1468-6708-6-3; Espeland MA, 1999, ANN EPIDEMIOL, V9, P196, DOI 10.1016/S1047-2797(98)00069-6; ESPELAND MA, 1992, STAT MED, V11, P1041, DOI 10.1002/sim.4780110806; FURBERG CD, 1994, CIRCULATION, V90, P1679, DOI 10.1161/01.CIR.90.4.1679; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Jones PH, 2004, CLIN THER, V26, P1388, DOI 10.1016/j.clinthera.2004.09.006; Jones PH, 2003, AM J CARDIOL, V92, P152, DOI 10.1016/S0002-9149(03)00530-7; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; LCROUSE JR, 2007, CURR MED RES OPIN, V23, P641; Leiter LA, 2007, ATHEROSCLEROSIS, V194, pE154, DOI 10.1016/j.atherosclerosis.2006.12.001; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lonn EM, 2001, CIRCULATION, V103, P919; Mercuri M, 1996, AM J MED, V101, P627, DOI 10.1016/S0002-9343(96)00333-6; MYERS GL, 1989, CLIN LAB MED, V9, P105, DOI 10.1016/S0272-2712(18)30645-0; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Oren A, 2003, ARCH INTERN MED, V163, P1787, DOI 10.1001/archinte.163.15.1787; Pasternak RC, 2002, J AM COLL CARDIOL, V40, P567, DOI 10.1016/S0735-1097(02)02030-2; Paul TK, 2005, AM J MED SCI, V330, P105, DOI 10.1097/00000441-200509000-00001; Pitt B, 2000, CIRCULATION, V102, P1503, DOI 10.1161/01.CIR.102.13.1503; Rodriguez-Granillo GA, 2007, AM J CARDIOL, V99, P5, DOI 10.1016/j.amjcard.2006.07.054; SALONEN R, 1995, CIRCULATION, V92, P1758, DOI 10.1161/01.CIR.92.7.1758; Schuster H, 2004, AM HEART J, V147, P705, DOI 10.1016/j.ahj.2003.10.004; Smilde TJ, 2001, LANCET, V357, P577, DOI 10.1016/S0140-6736(00)04053-8; Ubels FL, 1999, NETH J MED, V55, P188, DOI 10.1016/S0300-2977(99)00053-4	35	560	594	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2007	297	12					1344	1353		10.1001/jama.297.12.1344	http://dx.doi.org/10.1001/jama.297.12.1344			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150JN	17384434	Bronze			2022-12-28	WOS:000245212600021
J	Sonntag, M; Ruzicka, T; Bruch-Gerharz, D				Sonntag, Monika; Ruzicka, Thomas; Bruch-Gerharz, Daniela			Treating excessive sweating with poison	LANCET			English	Editorial Material									Univ Hosp, Dept Dermatol, D-40225 Dusseldorf, Germany; Univ Hosp, Dept Dermatol, D-80337 Munich, Germany	University of Munich	Bruch-Gerharz, D (corresponding author), Univ Hosp, Dept Dermatol, D-40225 Dusseldorf, Germany.	brush-gerharz@med.uni-duesseldorf.de							0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 21	2007	369	9570					1372	1372		10.1016/S0140-6736(07)60634-5	http://dx.doi.org/10.1016/S0140-6736(07)60634-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	159HL	17448823	Bronze			2022-12-28	WOS:000245856100030
J	Yamamoto, Y; Brady, MP; Lu, ZP; Maziasz, PJ; Liu, CT; Pint, BA; More, KL; Meyer, HM; Payzant, EA				Yamamoto, Y.; Brady, M. P.; Lu, Z. P.; Maziasz, P. J.; Liu, C. T.; Pint, B. A.; More, K. L.; Meyer, H. M.; Payzant, E. A.			Creep-resistant, Al2O3-forming austenitic stainless steels	SCIENCE			English	Article							COAL POWER-PLANTS; OXIDATION; ALLOYS; PERFORMANCE; MECHANISM; VAPOR	A family of inexpensive, Al2O3-forming, high-creep strength austenitic stainless steels has been developed. The alloys are based on Fe-20Ni-14Cr-2.5Al weight percent, with strengthening achieved through nanodispersions of NbC. These alloys offer the potential to substantially increase the operating temperatures of structural components and can be used under the aggressive oxidizing conditions encountered in energy-conversion systems. Protective Al2O3 scale formation was achieved with smaller amounts of aluminum in austenitic alloys than previously used, provided that the titanium and vanadium alloying additions frequently used for strengthening were eliminated. The smaller amounts of aluminum permitted stabilization of the austenitic matrix structure and made it possible to obtain excellent creep resistance. Creep-rupture lifetime exceeding 2000 hours at 750 degrees C and 100 megapascals in air, and resistance to oxidation in air with 10% water vapor at 650 degrees and 800 degrees C, were demonstrated.	Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory	Yamamoto, Y (corresponding author), Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA.	bradymp@ornl.gov	Pint, Bruce A/A-8435-2008; More, Karren L/A-8097-2016; Brady, Michael/A-8122-2008; Payzant, Edward A/B-5449-2009; Lu, Zhao-Ping/A-2718-2009; Meyer, Harry M/G-6949-2017	Pint, Bruce A/0000-0002-9165-3335; More, Karren L/0000-0001-5223-9097; Brady, Michael/0000-0003-1338-4747; Payzant, Edward A/0000-0002-3447-2060; Lu, Zhao-Ping/0000-0003-1463-8948; Meyer, Harry M/0000-0003-4994-1664; Liu, Chain Tsuan/0000-0001-7888-9725; Maziasz, Philip/0000-0001-8207-334X; Yamamoto, Yukinori/0000-0003-4574-4890				*ALL LUDL, 2003, TECHN DAT BLU SHEET; BANGARU NV, 1984, J VAC SCI TECHNOL B, V2, P806, DOI 10.1116/1.582882; BRADY MP, 2005, P 19 ANN C FOSS EN M; BRADY MP, 2007, OXIDATION RESISTANT; Fujioka T., 1976, U.S. Patent, Patent No. [3,989,514, 3989514]; Kofstad P., 1988, HIGH TEMPERATURE COR, DOI DOI 10.1002/CRAT.2170240408; KVERNES I, 1977, CORROS SCI, V17, P237, DOI 10.1016/0010-938X(77)90049-X; MAZIASZ PJ, 1989, JOM-J MIN MET MAT S, V41, P14; McGurty J.A., 1978, U.S. Patent, Patent No. [4,086,085, 4086085]; Opila EJ, 2004, MATER SCI FORUM, V461-464, P765, DOI 10.4028/www.scientific.net/MSF.461-464.765; Pint BA, 2006, J ENG GAS TURB POWER, V128, P370, DOI 10.1115/1.2056531; Pint BA, 2004, MATER SCI FORUM, V461-464, P815, DOI 10.4028/www.scientific.net/MSF.461-464.815; PIVIN JC, 1980, CORROS SCI, V20, P351, DOI 10.1016/0010-938X(80)90005-0; RAMAKRISHNAN V, 1988, OXID MET, V30, P185, DOI 10.1007/BF00666596; Satyanarayana DVV, 2002, MAT SCI ENG A-STRUCT, V323, P119, DOI 10.1016/S0921-5093(01)01342-9; SHINGLEDECKER JP, 2005, P ECCC CREEP C LOND, P99; SHINGLEDECKER JP, CREEP DEFORMATION FR, P129; Sourmail T, 2001, MATER SCI TECH SER, V17, P1, DOI 10.1179/026708301101508972; SWINDEMAN RW, 1990, ORNL6629P1; Taneike M, 2003, NATURE, V424, P294, DOI 10.1038/nature01740; Viswanathan R, 2001, J MATER ENG PERFORM, V10, P81, DOI 10.1361/105994901770345394; Viswanathan R, 2001, J MATER ENG PERFORM, V10, P96, DOI 10.1361/105994901770345402; WAGNER C, 1959, Z ELEKTROCHEM, V63, P772; YAMAMOTO Y, 2006, P 20 ANN C FOSS EN M; Young DJ, 2006, OXID MET, V66, P137, DOI 10.1007/s11085-006-9030-1; Zhang Y, 2004, SURF COAT TECH, V188, P35, DOI 10.1016/j.surfcoat.2004.07.090	26	282	314	22	284	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					433	436		10.1126/science.1137711	http://dx.doi.org/10.1126/science.1137711			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446398				2022-12-28	WOS:000245813400052
J	Purohit, P; Mitra, A; Auerbach, A				Purohit, Prasad; Mitra, Ananya; Auerbach, Anthony			A stepwise mechanism for acetylcholine receptor channel gating	NATURE			English	Article							CYS-LOOP RECEPTOR; GATED ION-CHANNEL; TRANSITION-STATE; ALPHA-SUBUNIT; M2 SEGMENT; TRANSMEMBRANE SEGMENT; NICOTINIC RECEPTORS; PORE; DYNAMICS; RESIDUES	Muscle contraction is triggered by the opening of acetylcholine receptors at the vertebrate nerve - muscle synapse(1-4). The M2 helix of this allosteric membrane protein lines the channel, and contains a 'gate' that regulates the flow of ions through the pore. We used single-molecule kinetic analysis to probe the transition state of the gating conformational change and estimate the relative timing of M2 motions in the alpha-subunit of the murine acetylcholine receptor(5). This analysis produces a 'Phi-value' for a given residue that reflects its open-like versus closed-like character at the transition state. Here we show that most of the residues throughout the length of M2 have a Phi-value of similar to 0.64 but that some near the middle have lower Phi-values of 0.52 or 0.31, suggesting that alpha M2 moves in three discrete steps. The core of the channel serves both as a gate that regulates ion flow and as a hub that directs the propagation of the gating isomerization through the membrane domain of the acetylcholine receptor.	SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Auerbach, A (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA.	auerbach@buffalo.edu						AKABAS MH, 1994, NEURON, V13, P919, DOI 10.1016/0896-6273(94)90257-7; Auerbach A, 2005, P NATL ACAD SCI USA, V102, P1408, DOI 10.1073/pnas.0406787102; BALI M, IN PRESS J GEN PHYSL; Beckstein O, 2006, PHYS BIOL, V3, P147, DOI 10.1088/1478-3975/3/2/007; CADUGAN DJ, IN PRESS BIOPHYS J; Chakrapani S, 2005, P NATL ACAD SCI USA, V102, P87, DOI 10.1073/pnas.0406777102; Chakrapani S, 2003, J GEN PHYSIOL, V122, P521, DOI 10.1085/jgp.200308885; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Cymes GD, 2002, BIOCHEMISTRY-US, V41, P5548, DOI 10.1021/bi011864f; Edelstein SJ, 1998, ADV PROTEIN CHEM, V51, P121; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Leffler JE., 1989, RATES EQUILIBRIA ORG; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Mitra A, 2004, STRUCTURE, V12, P1909, DOI 10.1016/j.str.2004.08.004; Mitra A, 2005, P NATL ACAD SCI USA, V102, P15069, DOI 10.1073/pnas.0505090102; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Paas Y, 2005, P NATL ACAD SCI USA, V102, P15877, DOI 10.1073/pnas.0507599102; Panicker S, 2002, J NEUROSCI, V22, P1629, DOI 10.1523/JNEUROSCI.22-05-01629.2002; Pascual JM, 1998, J GEN PHYSIOL, V111, P717, DOI 10.1085/jgp.111.6.717; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; VILLARROEL A, 1991, P ROY SOC B-BIOL SCI, V243, P69, DOI 10.1098/rspb.1991.0012; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1; Zhang H, 1998, BIOCHEMISTRY-US, V37, P7952, DOI 10.1021/bi980143m; Zhou Y, 2005, BIOPHYS J, V89, P3680, DOI 10.1529/biophysj.105.067215	29	119	121	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2007	446	7138					930	933		10.1038/nature05721	http://dx.doi.org/10.1038/nature05721			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17443187				2022-12-28	WOS:000245785700046
J	Stein, WE; Mannolini, F; Hernick, LV; Landing, E; Berry, CM				Stein, William E.; Mannolini, Frank; Hernick, Linda VanAller; Landing, Ed; Berry, Christopher M.			Giant cladoxylopsid trees resolve the enigma of the Earth's earliest forest stumps at Gilboa	NATURE			English	Article							PSEUDOSPOROCHNUS-NODOSUS LECLERCQ; PIETZSCHIA-LEVIS; NEW-YORK; MIDDLE; ARCHITECTURE; VENEZUELA; BELGIUM; BANKS; CHINA; ROOT	The evolution of trees of modern size growing together in forests fundamentally changed terrestrial ecosystems(1-3). The oldest trees are often thought to be of latest Devonian age ( about 380 - 360 Myr old) as indicated by the widespread occurrence of Archaeopteris (Progymnospermopsida)(4). Late Middle Devonian fossil tree stumps, rooted and still in life position, discovered in the 1870s from Gilboa, New York(5), and later named Eospermatopteris, are widely cited as evidence of the Earth's 'oldest forest'(6,7). However, their affinities and significance have proved to be elusive because the aerial portion of the plant has been unknown until now. Here we report spectacular specimens from Schoharie County, New York, showing an intact crown belonging to the cladoxylopsid Wattieza (Pseudosporochnales)(8) and its attachment to Eospermatopteris trunk and base. This evidence allows the reconstruction of a tall ( at least 8 m), tree-fern-like plant with a trunk bearing large branches in longitudinal ranks. The branches were probably abscised as frond-like modules. Lower portions of the trunk show longitudinal carbonaceous strands typical of Eospermatopteris, and a flat bottom with many small anchoring roots. These specimens provide new insight into Earth's earliest trees and forest ecosystems. The tree-fern-like morphology described here is the oldest example so far of an evolutionarily recurrent arborescent body plan within vascular plants. Given their modular construction, these plants probably produced abundant litter, indicating the potential for significant terrestrial carbon accumulation and a detritus-based arthropod fauna by the Middle Devonian period.	SUNY Binghamton, Dept Biol Sci, Binghamton, NY 13902 USA; New York State Museum & Sci Serv, Albany, NY 12230 USA; Univ Cardiff Wales, Sch Earth Ocean & Planetary Sci, Cardiff CF10 3YE, Wales	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Cardiff University	Stein, WE (corresponding author), SUNY Binghamton, Dept Biol Sci, Binghamton, NY 13902 USA.	stein@binghamton.edu; chris.berry@earth.cf.ac.uk	Berry, Christopher/B-2201-2010	Berry, Christopher/0000-0001-9521-5618				Algeo T.J., 2001, PLANTS INVADE LAND, P213, DOI DOI 10.7312/GENS11160-013; BANKS HP, 1985, CATSKILL DELTA, P125; BECK CB, 1976, REV PALAEOBOT PALYNO, V21, P5, DOI 10.1016/0034-6667(76)90020-8; Berry C.M., 2001, PLANTS INVADE LAND E, P120; Berry CM, 2006, REV PALAEOBOT PALYNO, V142, P63, DOI 10.1016/j.revpalbo.2006.04.007; Berry CM, 2000, REV PALAEOBOT PALYNO, V112, P125, DOI 10.1016/S0034-6667(00)00038-5; Berry CM, 1997, INT J PLANT SCI, V158, P350, DOI 10.1086/297447; Berry CM, 2002, INT J PLANT SCI, V163, P699, DOI 10.1086/342037; BOYER J. S., 1996, INT ORG PALAEOBOT, V5, P13; BRIDGE JS, 1994, GEOL SOC AM BULL, V106, P1440, DOI 10.1130/0016-7606(1994)106<1440:MTARRI>2.3.CO;2; Dawson J.W, 1871, Q J GEOL SOC LOND, V27, P269; Driese SG, 1997, PALAIOS, V12, P524, DOI 10.2307/3515409; Driese SG, 2001, PLANTS INVADE LAND E, P237; GOLDRING W, 1924, NY STATE MUS B, V521, P50; Goldring W., 1927, SCI MONTHLY, V24, P514; Greb SF, 2006, WETLANDS TIME; Hammond SE, 2005, BOT J LINN SOC, V148, P275, DOI 10.1111/j.1095-8339.2005.00418.x; Hilton J, 2003, INT J PLANT SCI, V164, P793, DOI 10.1086/376815; Krausel R., 1935, SENCKENBERGIANA, V17, P1; Leclercq S., 1962, PALAEONTOGR ABT B, V110, P1; LEMOIGNE Y, 1983, GEOBIOS-LYON, V16, P513, DOI 10.1016/S0016-6995(83)80034-5; Meyer-Berthaud B, 1999, NATURE, V398, P700, DOI 10.1038/19516; PIGG KB, 1992, ANN MO BOT GARD, V79, P589, DOI 10.2307/2399754; Schuyler A., 1994, COURIER FORSCHUNGSIN, V169, P261; Soria A, 2004, AM J BOT, V91, P10, DOI 10.3732/ajb.91.1.10; Soria A, 2001, INT J PLANT SCI, V162, P911, DOI 10.1086/320773; STEIN WE, 1989, REV PALAEOBOT PALYNO, V60, P311, DOI 10.1016/0034-6667(89)90049-3	27	148	155	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2007	446	7138					904	907		10.1038/nature05705	http://dx.doi.org/10.1038/nature05705			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17443185				2022-12-28	WOS:000245785700040
J	Wald, A				Wald, Arnold			Fecal incontinence in adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SACRAL NERVE-STIMULATION; CHRONIC DIARRHEA; OUTCOME MEASURES; CONTROLLED-TRIAL; BIOFEEDBACK; LOPERAMIDE; SPHINCTER; CONSTIPATION; MULTICENTER; MANAGEMENT		Univ Wisconsin, Sch Med & Publ Hlth, Sect Gastroenterol & Hepatol, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison	Wald, A (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Sect Gastroenterol & Hepatol, H6-516 CSC,600 Univ Ave, Madison, WI 53792 USA.	axw@medicine.wisc.edu						[Anonymous], 1999, GASTROENTEROLOGY, V116, P732, DOI 10.1016/S0016-5085(99)70195-2; BACHOO P, 2000, COCHRANE DB SYST REV, V2; Bharucha AE, 2004, GASTROENTEROLOGY, V126, pS90, DOI 10.1053/j.gastro.2003.10.014; Bharucha AE, 2003, GASTROENTEROLOGY, V124, P1672, DOI 10.1016/S0016-5085(03)00329-9; Chapman AE, 2002, BRIT J SURG, V89, P138, DOI 10.1046/j.1365-2168.2002.02018.x; Chassagne P, 2000, AGE AGEING, V29, P159, DOI 10.1093/ageing/29.2.159; Cheung O, 2004, ALIMENT PHARM THER, V19, P481, DOI 10.1111/j.1365-2036.2004.01886.x; Cremonini F, 2003, NEUROGASTROENT MOTIL, V15, P79, DOI 10.1046/j.1365-2982.2003.00389.x; DEEN KI, 1993, BRIT J SURG, V80, P794, DOI 10.1002/bjs.1800800648; Ganio E, 2001, DIS COLON RECTUM, V44, P1261, DOI 10.1007/BF02234782; Gutierrez AB, 2004, DIS COLON RECTUM, V47, P727, DOI 10.1007/s10350-003-0114-6; Halverson AL, 2002, DIS COLON RECTUM, V45, P345, DOI 10.1007/s10350-004-6180-6; HILL J, 1994, DIS COLON RECTUM, V37, P473, DOI 10.1007/BF02076194; Jarrett MED, 2004, BRIT J SURG, V91, P1559, DOI 10.1002/bjs.4796; Karoui S, 2000, DIS COLON RECTUM, V43, P813, DOI 10.1007/BF02238020; Lefevre JH, 2006, BRIT J SURG, V93, P1265, DOI 10.1002/bjs.5383; Madoff RD, 2004, GASTROENTEROLOGY, V126, pS48, DOI 10.1053/j.gastro.2003.10.015; Malouf AJ, 2001, BRIT J SURG, V88, P1029, DOI 10.1046/j.0007-1323.2001.01807.x; Matzel KE, 2004, LANCET, V363, P1270, DOI 10.1016/S0140-6736(04)15999-0; Nelson RL, 2004, GASTROENTEROLOGY, V126, pS3, DOI 10.1053/j.gastro.2003.10.010; Norton C, 2005, DIS COLON RECTUM, V48, P1062, DOI 10.1007/s10350-004-0868-5; Norton C, 2003, GASTROENTEROLOGY, V125, P1320, DOI 10.1016/j.gastro.2003.09.039; NORTON C, 2000, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858; PALMER KR, 1980, GASTROENTEROLOGY, V79, P1272; Pettit PDM, 2002, CURR OPIN OBSTET GYN, V14, P521, DOI 10.1097/00001703-200210000-00014; Rao SSC, 2004, AM J GASTROENTEROL, V99, P1585, DOI 10.1111/j.1572-0241.2004.40105.x; READ M, 1982, DIGEST DIS SCI, V27, P807, DOI 10.1007/BF01391374; Rockwood TH, 1999, DIS COLON RECTUM, V42, P1525, DOI 10.1007/BF02236199; Santoro GA, 2000, DIS COLON RECTUM, V43, P1676, DOI 10.1007/BF02236848; SHIRRAN E, 2000, COCHRANE DB SYST REV, V2, P1406; Solomon MJ, 2003, DIS COLON RECTUM, V46, P703, DOI 10.1007/s10350-004-6643-9; Sun WM, 1997, SCAND J GASTROENTERO, V32, P34, DOI 10.3109/00365529709025060; Vaizey CJ, 1999, GUT, V44, P77, DOI 10.1136/gut.44.1.77; Wald A, 2003, GASTROENTEROLOGY, V125, P1533, DOI 10.1016/j.gastro.2003.09.007; Whitehead WE, 2004, GASTROENTEROLOGY, V126, pS1, DOI 10.1053/j.gastro.2003.10.055; Wong WD, 2002, DIS COLON RECTUM, V45, P1139, DOI 10.1097/01.DCR.0000027038.03012.E3	36	92	95	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2007	356	16					1648	1655		10.1056/NEJMcp067041	http://dx.doi.org/10.1056/NEJMcp067041			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AB	17442907				2022-12-28	WOS:000245762000007
J	Yang, JJ; Goldstein, JI; Scott, ERD				Yang, Jijin; Goldstein, Joseph I.; Scott, Edward R. D.			Iron meteorite evidence for early formation and catastrophic disruption of protoplanets	NATURE			English	Article							METALLOGRAPHIC COOLING RATES; PARENT BODIES; STONY-IRON; IVA IRON; CORE CRYSTALLIZATION; ASTEROIDS; DIFFERENTIATION; FRAGMENTATION; HISTORIES; ACCRETION	In our Solar System, the planets formed by collisional growth from smaller bodies. Planetesimals collided to form Moon-to-Mars-sized protoplanets in the inner Solar System in 0.1 - 1 Myr, and these collided more energetically to form planets(1). Insights into the timing and nature of collisions during planetary accretion can be gained from meteorite studies. In particular, iron meteorites offer the best constraints on early stages of planetary accretion because most are remnants of the oldest bodies, which accreted and melted in < 1.5 Myr, forming silicate mantles and iron-nickel metallic cores(2-4). Cooling rates for various groups of iron meteorites suggest that if the irons cooled isothermally in the cores of differentiated bodies, as conventionally assumed, these bodies were 5 -200 km in diameter(5,6). This picture is incompatible, however, with the diverse cooling rates observed within certain groups, most notably the IVA group(7,8), but the large uncertainties associated with the measurements do not preclude it. Here we report cooling rates for group IVA iron meteorites that range from 100 to 6,000 K Myr(-1), increasing with decreasing bulk Ni. Improvements in the cooling rate model, smaller error bars, and new data from an independent cooling rate indicator(9) show that the conventional interpretation is no longer viable. Our results require that the IVA meteorites cooled in a 300-km-diameter metallic body that lacked an insulating mantle. This body probably formed similar to 4,500 Myr ago in a 'hit-and-run' collision between Moon-to-Mars-sized protoplanets(10). This demonstrates that protoplanets of similar to 10(3) km size accreted within the first 1.5 Myr, as proposed by theory, and that fragments of these bodies survived as asteroids.	Univ Massachusetts, Dept Mech & Ind Engn, Amherst, MA 01003 USA; Univ Hawaii Manoa, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Hawaii System; University of Hawaii Manoa	Yang, JJ (corresponding author), Univ Massachusetts, Dept Mech & Ind Engn, Amherst, MA 01003 USA.	jiyang@ecs.umass.edu		Scott, Edward/0000-0002-5137-3830				Asphaug E, 2006, NATURE, V439, P155, DOI 10.1038/nature04311; Bottke WF, 2006, NATURE, V439, P821, DOI 10.1038/nature04536; Bottke WF, 2005, ICARUS, V179, P63, DOI 10.1016/j.icarus.2005.05.017; CHABOT NL, 2006, METEORITES EARLY SOL, V1, P747; Chambers JE, 2004, EARTH PLANET SC LETT, V223, P241, DOI 10.1016/j.epsl.2004.04.031; Davis D.R, 2002, ASTEROIDS, VIII, P545; Haack H, 1996, GEOCHIM COSMOCHIM AC, V60, P3103, DOI 10.1016/0016-7037(96)00139-1; HAACK H, 1992, J GEOPHYS RES-PLANET, V97, P14727, DOI 10.1029/92JE01497; HAACK H, 1990, J GEOPHYS RES-SOLID, V95, P5111, DOI 10.1029/JB095iB04p05111; Hevey PJ, 2006, METEORIT PLANET SCI, V41, P95, DOI 10.1111/j.1945-5100.2006.tb00195.x; Hopfe WD, 2001, METEORIT PLANET SCI, V36, P135, DOI 10.1111/j.1945-5100.2001.tb01815.x; JAIN AV, 1970, GEOCHIM COSMOCHIM AC, V34, P883, DOI 10.1016/0016-7037(70)90126-2; KEIL K, 1994, PLANET SPACE SCI, V42, P1109, DOI 10.1016/0032-0633(94)90011-6; Kleine T, 2005, GEOCHIM COSMOCHIM AC, V69, P5805, DOI 10.1016/j.gca.2005.07.012; MOREN AE, 1979, EARTH PLANET SC LETT, V43, P82; PETIT JM, 2002, ASTEROIDS, V3, P711; RANDICH E, 1978, GEOCHIM COSMOCHIM AC, V42, P221, DOI 10.1016/0016-7037(78)90174-6; RASMUSSEN KL, 1995, GEOCHIM COSMOCHIM AC, V59, P3049, DOI 10.1016/0016-7037(95)00194-8; RASMUSSEN KL, 1989, PHYS SCRIPTA, V39, P410, DOI 10.1088/0031-8949/39/3/031; Ruzicka A, 2006, METEORIT PLANET SCI, V41, P1959, DOI 10.1111/j.1945-5100.2006.tb00463.x; Schersten A, 2006, EARTH PLANET SC LETT, V241, P530, DOI 10.1016/j.epsl.2005.11.025; Scott ERD, 1996, GEOCHIM COSMOCHIM AC, V60, P1615, DOI 10.1016/0016-7037(96)00031-2; Scott ERD, 2001, METEORIT PLANET SCI, V36, P869, DOI 10.1111/j.1945-5100.2001.tb01927.x; Von Rosenberg DU., 1969, METHODS NUMERICAL SO; Wasson JT, 2006, GEOCHIM COSMOCHIM AC, V70, P3149, DOI 10.1016/j.gca.2006.03.023; Wasson JT, 2001, GEOCHIM COSMOCHIM AC, V65, P951, DOI 10.1016/S0016-7037(00)00597-4; WOOD JA, 1964, ICARUS, V3, P429, DOI 10.1016/0019-1035(64)90004-1; Yang CW, 1997, METEORIT PLANET SCI, V32, P423, DOI 10.1111/j.1945-5100.1997.tb01285.x; Yang JJ, 2006, GEOCHIM COSMOCHIM AC, V70, P3197, DOI 10.1016/j.gca.2006.04.007	30	106	106	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2007	446	7138					888	891		10.1038/nature05735	http://dx.doi.org/10.1038/nature05735			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17443181				2022-12-28	WOS:000245785700036
J	Lerdau, M				Lerdau, Manuel			A positive feedback with negative consequences	SCIENCE			English	Editorial Material							ORGANIC-COMPOUND EMISSIONS; ISOPRENE EMISSION; BIOGENIC ISOPRENE; FOREST; LEAVES; PLANTS; PATHWAY		Univ Virginia, Dept Environm Sci, Blandy Expt Farm, Charlottesville, VA 22904 USA	University of Virginia	Lerdau, M (corresponding author), Univ Virginia, Dept Environm Sci, Blandy Expt Farm, Charlottesville, VA 22904 USA.	mlerdau@virginia.edu	Lerdau, Manuel/E-7320-2011	Lerdau, Manuel/0000-0003-1864-0834				Fiore AM, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005485; Friedlingstein P, 1999, GLOBAL CHANGE BIOL, V5, P755, DOI 10.1046/j.1365-2486.1999.00269.x; Geron C, 2002, ATMOS ENVIRON, V36, P3793, DOI 10.1016/S1352-2310(02)00301-1; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Horowitz LW, 1999, J GEOPHYS RES-ATMOS, V104, P23823, DOI 10.1029/1999JD900205; Keller M, 1999, GLOBAL BIOGEOCHEM CY, V13, P19, DOI 10.1029/1998GB900007; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Loreto F, 2007, PLANT PHYSIOL, V143, P1096, DOI 10.1104/pp.106.091892; MONSON RK, 1995, ATMOS ENVIRON, V29, P2989, DOI 10.1016/1352-2310(94)00360-W; RASMUSSEN RA, 1970, ENVIRON SCI TECHNOL, V4, P667, DOI 10.1021/es60043a008; Sanadze GA, 2004, RUSS J PLANT PHYSL+, V51, P729, DOI 10.1023/B:RUPP.0000047821.63354.a4; Sharkey TD, 2001, ANNU REV PLANT PHYS, V52, P407, DOI 10.1146/annurev.arplant.52.1.407; Sharkey TD, 2005, PLANT PHYSIOL, V137, P700, DOI 10.1104/pp.104.054445; SHARKEY TD, 1995, NATURE, V374, P769, DOI 10.1038/374769a0; Velikova V, 2005, PLANT CELL ENVIRON, V28, P318, DOI 10.1111/j.1365-3040.2004.01314.x; Wiedinmyer C, 2006, EARTH INTERACT, V10, DOI 10.1175/EI174.1	17	48	52	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					212	213		10.1126/science.1141486	http://dx.doi.org/10.1126/science.1141486			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	156MV	17431162				2022-12-28	WOS:000245654500032
J	Schweitzer, MH; Suo, Z; Avci, R; Asara, JM; Allen, MA; Arce, FT; Horner, JR				Schweitzer, Mary Higby; Suo, Zhiyong; Avci, Recep; Asara, John M.; Allen, Mark A.; Arce, Fernando Teran; Horner, John R.			Analyses of soft tissue from Tyrannosaurus rex suggest the presence of protein	SCIENCE			English	Article							FOSSIL BONES; CELLULAR PRESERVATION; ANCIENT DNA; COLLAGEN; STABILIZATION; EXTRACTION; MATRIX; IRON	We performed multiple analyses of Tyrannosaurus rex ( specimen MOR 1125) fibrous cortical and medullary tissues remaining after demineralization. The results indicate that collagen I, the main organic component of bone, has been preserved in low concentrations in these tissues. The findings were independently confirmed by mass spectrometry. We propose a possible chemical pathway that may contribute to this preservation. The presence of endogenous protein in dinosaur bone may validate hypotheses about evolutionary relationships, rates, and patterns of molecular change and degradation, as well as the chemical stability of molecules over time.	N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA; N Carolina Museum Nat Sci, Raleigh, NC 27601 USA; Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; Montana State Univ, Image & Chem Anal Lab Facil, Dept Phys, Bozeman, MT 59717 USA; Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; Univ Chicago, Ctr Nanomed Pulm & Crit Care Med, Dept Med, Chicago, IL 60637 USA	University of North Carolina; North Carolina State University; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Montana State University System; Montana State University Bozeman; University of Chicago	Schweitzer, MH (corresponding author), N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Box 8208, Raleigh, NC 27695 USA.	schweitzer@ncsu.edu	Teran Arce, Fernando/I-7835-2018; Schweitzer, Mary/V-8143-2019; schweitzer, mary h/A-6756-2010; Allen, Mark/K-8070-2018	Teran Arce, Fernando/0000-0002-6518-8695; schweitzer, mary h/0000-0002-0427-3829; Allen, Mark/0000-0002-1825-0118				Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Avci R, 2005, LANGMUIR, V21, P3584, DOI 10.1021/la047682e; Bada JL, 1999, PHILOS T ROY SOC B, V354, P77, DOI 10.1098/rstb.1999.0361; Bann JG, 2000, J BIOL CHEM, V275, P24466, DOI 10.1074/jbc.M003336200; Berna F, 2004, J ARCHAEOL SCI, V31, P867, DOI 10.1016/j.jas.2003.12.003; Briggs DEG, 2003, ANNU REV EARTH PL SC, V31, P275, DOI 10.1146/annurev.earth.31.100901.144746; Briggs DEG, 2000, PALEOBIOLOGY, V26, P169, DOI 10.1666/0094-8373(2000)26[169:TBPOCF]2.0.CO;2; DENIRO MJ, 1988, GEOCHIM COSMOCHIM AC, V52, P2415, DOI 10.1016/0016-7037(88)90298-0; EGLINTON G, 1991, PHILOS T ROY SOC B, V333, P315, DOI 10.1098/rstb.1991.0081; GLIMCHER MJ, 1990, PALEOBIOLOGY, V16, P219, DOI 10.1017/S0094837300009891; Gotliv BA, 2006, J STRUCT BIOL, V156, P320, DOI 10.1016/j.jsb.2006.02.005; GUTTERIDGE JMC, 1981, BIOCHEM J, V199, P263, DOI 10.1042/bj1990263; Holtz Thomas R. Jr, 2000, Gaia (Lisboa), V15, P5; Hoss M, 2000, NATURE, V404, P453, DOI 10.1038/35006551; HUGHES JM, 1989, AM MINERAL, V74, P870; KEENE DR, 1991, J HISTOCHEM CYTOCHEM, V39, P59, DOI 10.1177/39.1.1983874; LINDAHL T, 1993, NATURE, V365, P700, DOI 10.1038/365700a0; MINDENKA P, 2006, FREE RADICAL RES, V40, P263; MOSBACH K, 1994, TRENDS BIOCHEM SCI, V19, P9, DOI 10.1016/0968-0004(94)90166-X; NEMETHY G, 1986, BIOCHEMISTRY-US, V25, P3184, DOI 10.1021/bi00359a016; Ottani V, 2001, MICRON, V32, P251, DOI 10.1016/S0968-4328(00)00042-1; Pruvost M, 2007, P NATL ACAD SCI USA, V104, P739, DOI 10.1073/pnas.0610257104; Rimblot-Baly Frederique, 1995, Annales de Paleontologie, V81, P49; Salamon M, 2005, P NATL ACAD SCI USA, V102, P13783, DOI 10.1073/pnas.0503718102; Schafer FQ, 2000, CELL MOL BIOL, V46, P657; Schmidt-Schultz TH, 2004, AM J PHYS ANTHROPOL, V123, P30, DOI 10.1002/ajpa.10308; Schweitzer MH, 2007, P ROY SOC B-BIOL SCI, V274, P183, DOI 10.1098/rspb.2006.3705; Schweitzer MH, 2005, SCIENCE, V307, P1952, DOI 10.1126/science.1108397; Schweitzer MH, 2005, SCIENCE, V308, P1456, DOI 10.1126/science.1112158; SEMAL P, 1995, J ARCHAEOL SCI, V22, P463, DOI 10.1006/jasc.1995.0045; Stankiewicz BA, 2000, GEOLOGY, V28, P559, DOI 10.1130/0091-7613(2000)28<559:AOOAPI>2.0.CO;2; Sykes GA, 1995, ORG GEOCHEM, V23, P1059, DOI 10.1016/0146-6380(95)00086-0; TUROSS N, 1993, METHOD ENZYMOL, V224, P121, DOI 10.1016/0076-6879(93)24010-R; VANDERREST M, 1991, BONE BONE MATRIX BON, V3, P187; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Zylberberg L, 2004, CR PALEVOL, V3, P591, DOI 10.1016/j.crpv.2004.07.012	36	127	133	3	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					277	280		10.1126/science.1138709	http://dx.doi.org/10.1126/science.1138709			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431179				2022-12-28	WOS:000245654500051
J	Ferguson, N				Ferguson, Neil			Capturing human behaviour	NATURE			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England	Imperial College London	Ferguson, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modelling, St Marys Campus, London W2 1PG, England.		Ferguson, Neil/B-8578-2008	Ferguson, Neil/0000-0002-1154-8093					0	203	205	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2007	446	7137					733	733		10.1038/446733a	http://dx.doi.org/10.1038/446733a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429381	Bronze			2022-12-28	WOS:000245626800021
J	Tawk, M; Araya, C; Lyons, DA; Reugels, AM; Girdler, GC; Bayley, PR; Hyde, DR; Tada, M; Clarke, JDW				Tawk, Marcel; Araya, Claudio; Lyons, Dave A.; Reugels, Alexander M.; Girdler, Gemma C.; Bayley, Philippa R.; Hyde, David R.; Tada, Masazumi; Clarke, Jonathan D. W.			A mirror-symmetric cell division that orchestrates neuroepithelial morphogenesis	NATURE			English	Article							SPINAL-CORD; GASTRULATION; MIGRATION; ORIENTATION; STRABISMUS; EXTENSION; MOVEMENTS; REQUIRES; CLOSURE; FATE	The development of cell polarity is an essential prerequisite for tissue morphogenesis during embryogenesis, particularly in the development of epithelia(1,2). In addition, oriented cell division can have a powerful influence on tissue morphogenesis(3). Here we identify a novel mode of polarized cell division that generates pairs of neural progenitors with mirror-symmetric polarity in the developing zebrafish neural tube and has dramatic consequences for the organization of embryonic tissue. We show that during neural rod formation the polarity protein Pard3 is localized to the cleavage furrow of dividing progenitors, and then mirror-symmetrically inherited by the two daughter cells. This allows the daughter cells to integrate into opposite sides of the developing neural tube. Furthermore, these mirror-symmetric divisions have powerful morphogenetic influence: when forced to occur in ectopic locations during neurulation, they orchestrate the development of mirror-image pattern formation and the consequent generation of ectopic neural tubes.	UCL, London WC1E 6BT, England; Univ Cologne, Inst Entwicklungsbiol, D-50923 Cologne, Germany; Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; Univ Notre Dame, Ctr Zebrafish Res, Notre Dame, IN 46556 USA	University of London; University College London; University of Cologne; University of Notre Dame; University of Notre Dame	Clarke, JDW (corresponding author), UCL, Gower St, London WC1E 6BT, England.	jonathan.clarke@ucl.ac.uk	Tawk, Marcel/M-2913-2018; Zebrafish, UCL/A-3125-2009; Clarke, Jonathan/C-5347-2009; Tada, Masazumi/A-1431-2009	Tawk, Marcel/0000-0003-4267-4743; Lyons, David/0000-0003-1166-4454	Biotechnology and Biological Sciences Research Council [BB/C516952/1] Funding Source: Medline; Medical Research Council [G0001188, G9900989] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0001188, G9900989] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bakkers J, 2004, DEVELOPMENT, V131, P525, DOI 10.1242/dev.00954; Carreira-Barbosa F, 2003, DEVELOPMENT, V130, P4037, DOI 10.1242/dev.00567; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Geldmacher-Voss B, 2003, DEVELOPMENT, V130, P3767, DOI 10.1242/dev.00603; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Goto T, 2002, DEV BIOL, V247, P165, DOI 10.1006/dbio.2002.0673; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; KIMMEL CB, 1994, DEVELOPMENT, V120, P265; Lowery LA, 2005, DEVELOPMENT, V132, P2057, DOI 10.1242/dev.01791; Lyons DA, 2003, DEVELOPMENT, V130, P3427, DOI 10.1242/dev.00569; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Papan C, 1997, DEV GENES EVOL, V207, P71, DOI 10.1007/s004270050093; Papan C, 1999, DEV GENES EVOL, V209, P135, DOI 10.1007/s004270050237; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Tada M, 2000, DEVELOPMENT, V127, P2227; von Trotha JW, 2006, DEV DYNAM, V235, P967, DOI 10.1002/dvdy.20715; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wei XY, 2004, DEV BIOL, V269, P286, DOI 10.1016/j.ydbio.2004.01.017; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39	21	157	159	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					797	800		10.1038/nature05722	http://dx.doi.org/10.1038/nature05722			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17392791				2022-12-28	WOS:000245626800041
J	Wall, WJ				Wall, William J.			Liver transplantation for polycystic liver disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									London Hlth Sci Ctr, London, ON N6A 5A5, Canada	London Health Sciences Centre	Wall, WJ (corresponding author), London Hlth Sci Ctr, London, ON N6A 5A5, Canada.	william.wall@lhsc.on.ca							0	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 12	2007	356	15					1560	1560		10.1056/NEJMicm055470	http://dx.doi.org/10.1056/NEJMicm055470			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156CA	17429087				2022-12-28	WOS:000245624400009
J	Benito-Leon, J; Louis, ED				Benito-Leon, Julian; Louis, Elan D.			Clinical update: diagnosis and treatment of essential tremor	LANCET			English	Article							PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; PROPRANOLOL; PRIMIDONE; STIMULATION		Univ Hosp 12 Octubre, Dept Neurol, E-28041 Madrid, Spain; Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10027 USA; Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA	Hospital Universitario 12 de Octubre; Columbia University; Columbia University	Benito-Leon, J (corresponding author), Univ Hosp 12 Octubre, Dept Neurol, E-28041 Madrid, Spain.	jbenitol@meditex.es	Benito-León, Julián/AAA-1331-2019	Benito-León, Julián/0000-0002-1769-4809				Benito-Leon J, 2006, NEUROLOGY, V66, P69, DOI 10.1212/01.wnl.0000192393.05850.ec; Benito-Leon J, 2006, NAT CLIN PRACT NEURO, V2, P666, DOI 10.1038/ncpneuro0347; Brin MF, 2001, NEUROLOGY, V56, P1523, DOI 10.1212/WNL.56.11.1523; CLEEVES L, 1988, J NEUROL NEUROSUR PS, V51, P379, DOI 10.1136/jnnp.51.3.379; FINDLEY LJ, 1985, J NEUROL NEUROSUR PS, V48, P911, DOI 10.1136/jnnp.48.9.911; GORMAN WP, 1986, J NEUROL NEUROSUR PS, V49, P64, DOI 10.1136/jnnp.49.1.64; HUBER SJ, 1988, NEUROLOGY, V38, P241, DOI 10.1212/WNL.38.2.241; Jain S, 2006, ARCH NEUROL-CHICAGO, V63, P1100, DOI 10.1001/archneur.63.8.1100; KOLLER WC, 1989, NEUROLOGY, V39, P1587, DOI 10.1212/WNL.39.12.1587; LEIGH PN, 1983, J NEUROL NEUROSUR PS, V46, P710, DOI 10.1136/jnnp.46.8.710; Lorenz D, 2006, MOVEMENT DISORD, V21, P1114, DOI 10.1002/mds.20884; Ondo W, 2000, MOVEMENT DISORD, V15, P678, DOI 10.1002/1531-8257(200007)15:4<678::AID-MDS1012>3.0.CO;2-0; Ondo WG, 2006, NEUROLOGY, V66, P672, DOI 10.1212/01.wnl.0000200779.03748.0f; Pahwa R, 2006, J NEUROSURG, V104, P506, DOI 10.3171/jns.2006.104.4.506; Putzke JD, 2006, J NEUROL NEUROSUR PS, V77, P1235, DOI 10.1136/jnnp.2006.086579; Schuurman PR, 2000, NEW ENGL J MED, V342, P461, DOI 10.1056/NEJM200002173420703; Shahed J, 2007, PARKINSONISM RELAT D, V13, P67, DOI 10.1016/j.parkreldis.2006.05.033; Zesiewicz TA, 2005, NEUROLOGY, V64, P2008, DOI 10.1212/01.WNL.0000163769.28552.CD	18	83	85	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2007	369	9568					1152	1154		10.1016/S0140-6736(07)60544-3	http://dx.doi.org/10.1016/S0140-6736(07)60544-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155RH	17416247				2022-12-28	WOS:000245595100010
J	Schmieder, RE; Hilgers, KF; Schlaich, MP; Schmidt, BMW				Schmieder, Roland E.; Hilgers, Karl F.; Schlaich, Markus P.; Schmidt, Bemhard M. W.			Renin-angiotensin system and cardiovascular risk	LANCET			English	Review							END-POINT REDUCTION; CONVERTING-ENZYME-INHIBITION; FACTOR-KAPPA-B; LEFT-VENTRICULAR HYPERTROPHY; CORONARY-ARTERY-DISEASE; ENDOTHELIAL PROGENITOR CELLS; TYPE-2 DIABETIC-NEPHROPATHY; AT(1) RECEPTOR BLOCKADE; LOW-DENSITY-LIPOPROTEIN; C-REACTIVE PROTEIN	The renin-angiotensin system is a major regulatory system of cardiovascular and renal function. Basic research has revealed exciting new aspects, which could lead to novel or modified therapeutic approaches. Renin-angiotensin system blockade exerts potent antiatherosclerotic effects, which are mediated by their antihypertensive, anti-inflammatory, antiproliferative, and oxidative stress lowering properties. Inhibitors of the system-ie, angiotensin converting enzyme inhibitors and angiotensin receptor blockers, are now first-line treatments for hypertensive target organ damage and progressive renal disease. Their effects are greater than expected by their ability to lower blood pressure alone. Angiotensin receptor blockers reduce the frequency of atrial fibrillation and stroke. Renin-angiotensin system blockade delays or avoids the onset of type 2 diabetes and prevents cardiovascular and renal events in diabetic patients. Thus, blockade of this system will remain a cornerstone of our strategies to reduce cardiovascular risk.	Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Schmieder, RE (corresponding author), Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, D-91054 Erlangen, Germany.	roland.schmieder@rzmail.uni-erlangen.de		Schlaich, Markus/0000-0002-1765-0195				AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; Abuissa H, 2005, J AM COLL CARDIOL, V46, P821, DOI 10.1016/j.jacc.2005.05.051; ADMIRAAL PJJ, 1990, HYPERTENSION, V15, P44, DOI 10.1161/01.HYP.15.1.44; Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; ALDERMAN MH, 1991, NEW ENGL J MED, V324, P1098, DOI 10.1056/NEJM199104183241605; Antony I, 1996, CIRCULATION, V94, P3115, DOI 10.1161/01.CIR.94.12.3115; Azizi M, 2006, J HYPERTENS, V24, P243, DOI 10.1097/01.hjh.0000202812.72341.99; Azizi M, 1996, J CLIN INVEST, V97, P839, DOI 10.1172/JCI118484; Bahlmann FH, 2005, HYPERTENSION, V45, P526, DOI 10.1161/01.HYP.0000159191.98140.89; Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Benson SC, 2004, HYPERTENSION, V43, P993, DOI 10.1161/01.HYP.0000123072.34629.57; Boos CJ, 2006, EUR HEART J, V27, P136, DOI 10.1093/eurheartj/ehi645; Boos CJ, 2005, J HUM HYPERTENS, V19, P855, DOI 10.1038/sj.jhh.1001933; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brunner HR, 2002, LANCET, V359, P990, DOI 10.1016/S0140-6736(02)08062-5; Burckle CA, 2006, HYPERTENSION, V47, P552, DOI 10.1161/01.HYP.0000199912.47657.04; Campbell DJ, 2005, CIRCULATION, V111, P315, DOI 10.1161/01.CIR.0000153269.07762.3B; Campbell DJ, 2001, LANCET, V358, P1609, DOI 10.1016/S0140-6736(01)06660-0; Campbell DJ, 2005, CIRCULATION, V112, P110, DOI 10.1161/CIRCULATIONAHA.104.525527; Carey RM, 2005, HYPERTENSION, V45, P840, DOI 10.1161/01.HYP.0000159192.93968.8f; Carlsson PO, 1998, DIABETOLOGIA, V41, P127, DOI 10.1007/s001250050880; Chai SY, 2004, CELL MOL LIFE SCI, V61, P2728, DOI 10.1007/s00018-004-4246-1; Chen HJ, 2001, BIOCHEM BIOPH RES CO, V282, P474, DOI 10.1006/bbrc.2001.4590; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dandona P, 2003, J CLIN ENDOCR METAB, V88, P4496, DOI 10.1210/jc.2002-021836; Danser AHJ, 2005, HYPERTENSION, V46, P1069, DOI 10.1161/01.HYP.0000186329.92187.2e; Danser AHJ, 1996, MOL CELL BIOCHEM, V157, P211; de Gasparo M, 2000, PHARMACOL REV, V52, P415; de Zeeuw D, 2004, CIRCULATION, V110, P921, DOI 10.1161/01.CIR.0000139860.33974.28; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; Dernellis J, 2004, EUR HEART J, V25, P1100, DOI 10.1016/j.ehj.2004.04.025; Devereux RB, 2004, CIRCULATION, V110, P1456, DOI 10.1161/01.CIR.0000141573.44737.5A; Dinneen SF, 1997, ARCH INTERN MED, V157, P1413, DOI 10.1001/archinte.157.13.1413; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Dzau VJ, 2001, AM J CARDIOL, V88, p1L; Ehrlich JR, 2006, EUR HEART J, V27, P512, DOI 10.1093/eurheartj/ehi668; Engelmann MDM, 2005, EUR HEART J, V26, P2083, DOI 10.1093/eurheartj/ehi350; Estacio RO, 2000, DIABETES CARE, V23, pB54; Esteban V, 2005, CIRC RES, V96, P965, DOI 10.1161/01.RES.0000166326.91395.74; Esteban V, 2004, J AM SOC NEPHROL, V15, P1514, DOI 10.1097/01.ASN.0000130564.75008.F5; Ferrario CM, 2006, HYPERTENSION, V47, P515, DOI 10.1161/01.HYP.0000196268.08909.fb; Fliser D, 2004, CIRCULATION, V110, P1103, DOI 10.1161/01.CIR.0000140265.21608.8E; Fox KM, 2003, LANCET, V362, P782; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Galzerano D, 2005, AM J HYPERTENS, V18, P1563, DOI 10.1016/j.amjhyper.2005.06.011; Gavras I, 2000, AM J HYPERTENS, V13, P512, DOI 10.1016/S0895-7061(99)00277-0; Gerstein HC, 2000, LANCET, V355, P253; Gillespie EL, 2005, DIABETES CARE, V28, P2261, DOI 10.2337/diacare.28.9.2261; Gradman AH, 2005, CIRCULATION, V111, P1012, DOI 10.1161/01.CIR.0000156466.02908.ED; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Griendling KK, 1997, CIRCULATION, V96, P3264; Groth W, 2003, J HYPERTENS, V21, P2175, DOI 10.1097/00004872-200311000-00028; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Hilgers KF, 2001, HYPERTENSION, V38, P243, DOI 10.1161/01.HYP.38.2.243; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hornig B, 2001, CIRCULATION, V103, P799, DOI 10.1161/01.CIR.103.6.799; Hosomi N, 2005, NEUROSCIENCE, V134, P225, DOI 10.1016/j.neuroscience.2005.03.054; Hou FF, 2006, NEW ENGL J MED, V354, P131, DOI 10.1056/NEJMoa053107; Ibsen H, 2005, HYPERTENSION, V45, P198, DOI 10.1161/01.HYP.0000154082.72286.2a; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Ingelfinger JR, 2006, NEW ENGL J MED, V355, P1608, DOI 10.1056/NEJMe068213; Jandeleit-Dahm KAM, 2005, J HYPERTENS, V23, P463, DOI 10.1097/01.hjh.0000160198.05416.72; John S, 1999, J HYPERTENS, V17, P1933, DOI 10.1097/00004872-199917121-00024; Jones A, 2003, HYPERTENSION, V42, P500, DOI 10.1161/01.HYP.0000088853.27673.D0; Kampf C, 2005, DIABETOLOGIA, V48, P1159, DOI 10.1007/s00125-005-1761-z; KANNEL WB, 1998, AM J CARDIOL, V0082; Kjeldsen SE, 2002, JAMA-J AM MED ASSOC, V288, P1491, DOI 10.1001/jama.288.12.1491; Kjeldsen SE, 2006, J HYPERTENS, V24, P1405, DOI 10.1097/01.hjh.0000234122.55895.5b; Klingbeil AU, 1999, J HYPERTENS, V17, P825, DOI 10.1097/00004872-199917060-00015; Klingbeil AU, 2003, AM J MED, V115, P41, DOI 10.1016/S0002-9343(03)00158-X; Klingbeil AU, 2003, AM J HYPERTENS, V16, P123, DOI 10.1016/S0895-7061(02)03154-0; Kohlstedt K, 2004, CIRC RES, V94, P60, DOI 10.1161/01.RES.0000107195.13573.E4; Koka V, 2006, CIRCULATION, V113, P1353, DOI 10.1161/CIRCULATIONAHA.105.575589; Kostenis E, 2005, CIRCULATION, V111, P1806, DOI 10.1161/01.CIR.0000160867.23556.7D; Kranzhofer R, 1999, BIOCHEM BIOPH RES CO, V257, P826, DOI 10.1006/bbrc.1999.0543; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Li J, 2005, FASEB J, V19, P617, DOI 10.1096/fj.04-2960fje; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lieb W, 2006, J MOL MED, V84, P88, DOI 10.1007/s00109-005-0718-5; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; LINZ W, 1995, PHARMACOL REV, V47, P25; Lithell H, 2003, J HYPERTENS, V21, P875, DOI 10.1097/00004872-200305000-00011; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; Madrid AH, 2002, CIRCULATION, V106, P331, DOI 10.1161/01.CIR.0000022665.18619.83; Mancia G, 1997, CIRCULATION, V95, P1464; Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32; Mancini GBJ, 1996, CIRCULATION, V94, P258, DOI 10.1161/01.CIR.94.3.258; Martin G, 2004, J CARDIOVASC PHARM, V43, P191, DOI 10.1097/00005344-200402000-00005; Mazzolai L, 2000, HYPERTENSION, V35, P985, DOI 10.1161/01.HYP.35.4.985; Modena MG, 2002, J AM COLL CARDIOL, V40, P505, DOI 10.1016/S0735-1097(02)01976-9; Neunteufl T, 2000, AM J CARDIOL, V86, P207, DOI 10.1016/S0002-9149(00)00857-2; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nickenig G, 1997, CIRCULATION, V95, P473; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Pastore L, 1999, CIRCULATION, V100, P1646, DOI 10.1161/01.CIR.100.15.1646; PAUL M, 1993, J CLIN INVEST, V91, P2058, DOI 10.1172/JCI116428; Pourdjabbar Ali, 2002, Can J Cardiol, V18 Suppl A, p7A; Pueyo ME, 2000, ARTERIOSCL THROM VAS, V20, P645, DOI 10.1161/01.ATV.20.3.645; Rabbani R, 1999, CARDIOVASC RES, V41, P402, DOI 10.1016/S0008-6363(98)00279-X; Remuzzi G, 2004, J AM SOC NEPHROL, V15, P3117, DOI 10.1097/01.ASN.0000146423.71226.0C; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Rizzoni D, 1998, J AM COLL CARDIOL, V32, P985, DOI 10.1016/S0735-1097(98)00322-2; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Ruggenenti P, 2000, AM J KIDNEY DIS, V35, P1155, DOI 10.1016/S0272-6386(00)70054-0; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Saris JJ, 2000, HYPERTENSION, V35, P764, DOI 10.1161/01.HYP.35.3.764; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; Schieffer B, 2000, CIRC RES, V87, P1195, DOI 10.1161/01.RES.87.12.1195; Schlaich MP, 1998, CLIN NEPHROL, V49, P153; Schmieder R, 2006, J HYPERTENS S1, V24, P53; Schmieder RE, 1996, CIRCULATION, V94, P1304, DOI 10.1161/01.CIR.94.6.1304; Schmieder RE, 2005, NEPHROL DIAL TRANSPL, V20, P2610, DOI 10.1093/ndt/gfi190; Schmieder RE, 2001, J AM COLL CARDIOL, V37, P175, DOI 10.1016/S0735-1097(00)01063-9; Schrader J, 2005, STROKE, V36, P1218, DOI 10.1161/01.STR.0000166048.35740.a9; Schupp M, 2006, HYPERTENSION, V47, P586, DOI 10.1161/01.HYP.0000196946.79674.8b; Sigmund CD, 2006, HYPERTENSION, V47, P145, DOI 10.1161/01.HYP.0000200278.64801.4e; STOLL M, 1995, J CLIN INVEST, V95, P651, DOI 10.1172/JCI117710; Strippoli GFM, 2005, J AM SOC NEPHROL, V16, P3081, DOI 10.1681/ASN.2004080634; Suissa S, 2006, KIDNEY INT, V69, P913, DOI 10.1038/sj.ki.5000159; TAKAGISHI T, 1995, BIOCHEM MOL BIOL INT, V35, P265; Tallant EA, 2005, AM J PHYSIOL-HEART C, V289, pH1560, DOI 10.1152/ajpheart.00941.2004; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Tigerstedt R., 1898, SKAND ARCH PHYSIOL, V8, P223, DOI [10.1111/j.1748-1716.1898.tb00272.x, DOI 10.1111/J.1748-1716.1898.TB00272.X]; Turnbull F, 2003, LANCET, V362, P1527; URATA H, 1990, J BIOL CHEM, V265, P22348; VANE JR, 1990, NEW ENGL J MED, V323, P27; Verdecchia P, 2003, AM J HYPERTENS, V16, P895, DOI 10.1016/S0895-7061(03)01018-5; Verdecchia P, 2003, HYPERTENSION, V41, P218, DOI 10.1161/01.HYP.0000052830.02773.E4; Wachtell K, 2005, J AM COLL CARDIOL, V45, P712, DOI 10.1016/j.jacc.2004.10.068; Wachtell K, 2005, J AM COLL CARDIOL, V45, P705, DOI 10.1016/j.jacc.2004.06.080; WAMHOLTZ A, 1999, CIRCULATION, V99, P2027; Wassmann S, 2004, CIRC RES, V94, P534, DOI 10.1161/01.RES.0000115557.25127.8D; Wattigney WA, 2003, CIRCULATION, V108, P711, DOI 10.1161/01.CIR.0000083722.42033.0A; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Williams B, 2006, CIRCULATION, V113, P1213, DOI 10.1161/CIRCULATIONAHA.105.595496; Wolf G, 2002, KIDNEY INT, V61, P1986, DOI 10.1046/j.1523-1755.2002.00365.x; Xiao HD, 2004, AM J PATHOL, V165, P1019, DOI 10.1016/S0002-9440(10)63363-9; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zhang Y, 2006, HYPERTENSION, V47, P410, DOI 10.1161/01.HYP.0000205119.19804.08; Zisman LS, 2003, CIRCULATION, V108, P1707, DOI 10.1161/01.CIR.0000094734.67990.99	151	466	504	2	76	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2007	369	9568					1208	1219		10.1016/S0140-6736(07)60242-6	http://dx.doi.org/10.1016/S0140-6736(07)60242-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155RH	17416265				2022-12-28	WOS:000245595100032
J	Squire, LR				Squire, Larry R.			Rapid consolidation	SCIENCE			English	Editorial Material							MEMORY		Vet Adm Med Ctr, San Diego, CA 92161 USA; Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Squire, LR (corresponding author), Vet Adm Med Ctr, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	lsquire@ucsd.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH024600] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH024600, R01 MH024600-33] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bartlett F. C., 1932, REMEMBERING; Day M, 2003, NATURE, V424, P205, DOI 10.1038/nature01769; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; SQUIRE LR, IN PRESS CURR OPIN N; SQUIRE LR, 2004, COGNITIVE NEUROSCIEN, V3; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935	9	19	21	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2007	316	5821					57	58		10.1126/science.1141812	http://dx.doi.org/10.1126/science.1141812			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412942	Green Accepted			2022-12-28	WOS:000245470500025
J	Weinhold, F; Landis, CR				Weinhold, Frank; Landis, Clark R.			High bond orders in metal-metal bonding	SCIENCE			English	Editorial Material							STABLE COMPOUND		Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Weinhold, F (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	weinhold@chem.wisc.edu; landis@chem.wisc.edu	Weinhold, Frank/L-5880-2019	Weinhold, Frank/0000-0002-9580-054X				Cotton F., 2005, MULTIPLE BONDS METAL, P707; Glendening ED, 1998, J COMPUT CHEM, V19, P628, DOI 10.1002/(SICI)1096-987X(19980430)19:6<628::AID-JCC5>3.0.CO;2-T; Landis CR, 2006, J AM CHEM SOC, V128, P7335, DOI 10.1021/ja060992u; Lewis GN, 1916, J AM CHEM SOC, V38, P762, DOI 10.1021/ja02261a002; LOWDIN PO, 1955, PHYS REV, V97, P1474, DOI 10.1103/PhysRev.97.1474; MULLIKEN RS, 1965, J CHEM PHYS, V43, pS002, DOI 10.1063/1.1701510; Nguyen T, 2005, SCIENCE, V310, P844, DOI 10.1126/science.1116789; NORBECK JM, 1974, J AM CHEM SOC, V96, P3386, DOI 10.1021/ja00818a008; POPLE JA, 1950, P ROY SOC LOND A MAT, V202, P166; REED AE, 1988, CHEM REV, V88, P899, DOI 10.1016/0030-4018(75)90085-1; Roos BO, 2007, ANGEW CHEM INT EDIT, V46, P1469, DOI 10.1002/anie.200603600; Sekiguchi A, 2004, SCIENCE, V305, P1755, DOI 10.1126/science.1102209; Shaik S, 2007, J COMPUT CHEM, V28, P51, DOI 10.1002/jcc.20517; Sutcliffe BT, 1996, INT J QUANTUM CHEM, V58, P645, DOI 10.1002/(SICI)1097-461X(1996)58:6<645::AID-QUA7>3.0.CO;2-Y; Weinhold F., 2005, VALENCY BONDING NATU, P555	15	59	60	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2007	316	5821					61	63		10.1126/science.1140756	http://dx.doi.org/10.1126/science.1140756			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412945				2022-12-28	WOS:000245470500028
J	Bianchi, DW; Fisk, NM				Bianchi, Diana W.; Fisk, Nicholas M.			Fetomaternal cell trafficking and the stem cell debate - Gender matters	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NONINVASIVE PRENATAL-DIAGNOSIS; FETAL MICROCHIMERISM; PROGENITOR CELLS; MATERNAL BLOOD; BONE-MARROW; PREGNANCY; WOMEN; LONG; TRANSPLANTATION; POSTPARTUM		Tufts Univ New England Med Ctr, Dept Pediat, Div Genet, Boston, MA 02111 USA; Tufts Univ New England Med Ctr, Dept Obstet, Div Genet, Boston, MA 02111 USA; Tufts Univ New England Med Ctr, Dept Gynecol, Div Genet, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; Queen Charlottes & Chelsea Hosp, London W6 0XG, England	Tufts Medical Center; Tufts Medical Center; Tufts Medical Center; Tufts University; Imperial College London; Imperial College London	Bianchi, DW (corresponding author), Tufts Univ New England Med Ctr, Dept Pediat, Div Genet, 750 Washington St,Box 394, Boston, MA 02111 USA.	Dbianchi@tufts-nemc.org	Fisk, Nicholas M/B-2126-2009	Fisk, Nicholas M/0000-0003-0031-7975	Medical Research Council [G0300340] Funding Source: Medline; NICHD NIH HHS [R01HD49469] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049469] Funding Source: NIH RePORTER; MRC [G0300340] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams KM, 2003, BLOOD, V102, P3845, DOI 10.1182/blood-2003-05-1570; Bianchi DW, 2001, AM J OBSTET GYNECOL, V184, P703, DOI 10.1067/mob.2001.111072; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Christner PJ, 2000, ARTHRITIS RHEUM, V43, P2598, DOI 10.1002/1529-0131(200011)43:11<2598::AID-ANR30>3.0.CO;2-8; Evans PC, 1999, BLOOD, V93, P2033, DOI 10.1182/blood.V93.6.2033.406k18_2033_2037; Guetta E, 2003, BLOOD CELL MOL DIS, V30, P13, DOI 10.1016/S1079-9796(03)00008-1; Imaizumi M, 2002, ENDOCRINOLOGY, V143, P247, DOI 10.1210/en.143.1.247; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Johnson KL, 2001, ARTHRITIS RHEUM, V44, P2107, DOI 10.1002/1529-0131(200109)44:9<2107::AID-ART361>3.0.CO;2-9; Johnson KL, 2002, HEPATOLOGY, V36, P1295, DOI 10.1053/jhep.2002.35622; Khosrotehrani K, 2004, JAMA-J AM MED ASSOC, V292, P75, DOI 10.1001/jama.292.1.75; Khosrotehrani K, 2003, ARTHRITIS RHEUM, V48, P3237, DOI 10.1002/art.11324; Klintschar M, 2006, EUR J ENDOCRINOL, V154, P237, DOI 10.1530/eje.1.02080; Koopmans M, 2005, AM J TRANSPLANT, V5, P1495, DOI 10.1111/j.1600-6143.2005.00858.x; LIEGEOIS A, 1977, TRANSPLANT P, V9, P273; Nelson JL, 1996, ARTHRITIS RHEUM, V39, P191, DOI 10.1002/art.1780390203; O'Donoghue K, 2004, LANCET, V364, P179, DOI 10.1016/S0140-6736(04)16631-2; O'Donoghue K, 2003, MOL HUM REPROD, V9, P497, DOI 10.1093/molehr/gag063; Ohtsuka T, 2001, ARCH DERMATOL RES, V293, P387, DOI 10.1007/s004030100245; Srivatsa B, 2001, LANCET, V358, P2034, DOI 10.1016/S0140-6736(01)07099-4; Stevens AM, 2004, LAB INVEST, V84, P1603, DOI 10.1038/labinvest.3700193; Tan XW, 2005, STEM CELLS, V23, P1443, DOI 10.1634/stemcells.2004-0169; Tokita K, 2001, LANCET, V358, P2047, DOI 10.1016/S0140-6736(01)07140-9; Wang Y, 2004, BIOCHEM BIOPH RES CO, V325, P961, DOI 10.1016/j.bbrc.2004.10.105; Yan Z, 2005, AM J MED, V118, P899, DOI 10.1016/j.amjmed.2005.03.037	25	25	26	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2007	297	13					1489	1491		10.1001/jama.297.13.1489	http://dx.doi.org/10.1001/jama.297.13.1489			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AM	17405974				2022-12-28	WOS:000245404100025
J	Margaretten, ME; Kohlwes, J; Moore, D; Bent, S				Margaretten, Mary E.; Kohlwes, Jeffrey; Moore, Dan; Bent, Stephen			Does this adult patient have septic arthritis?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SYNOVIAL-FLUID LEUKOCYTOSIS; BACTERIAL ARTHRITIS; INFECTIOUS ARTHRITIS; CLINICAL-FEATURES; JOINT DISEASE; LACTIC-ACID; RHEUMATOID-ARTHRITIS; GONOCOCCAL ARTHRITIS; ACUTE MONOARTHRITIS; RISK-FACTORS	Context In patients who present with an acutely painful and swollen joint, prompt identification and treatment of septic arthritis can substantially reduce morbidity and mortality. Objective To review the accuracy and precision of the clinical evaluation for the diagnosis of nongonococcal bacterial arthritis. Data Sources Structured PubMed and EMBASE searches ( 1966 through January 2007), limited to human, English-language articles and using the following Medical Subject Headings terms: arthritis, infectious, physical examination, medical history taking, diagnostic tests, and sensitivity and specificity. Study Selection Studies were included if they contained original data on the accuracy or precision of historical items, physical examination, serum, or synovial fluid laboratory data for diagnosing septic arthritis. Data Extraction Three authors independently abstracted data from the included studies. Data Synthesis Fourteen studies involving 6242 patients, of whom 653 met the gold standard for the diagnosis of septic arthritis, satisfied all inclusion criteria. Two studies examined risk factors and found that age, diabetes mellitus, rheumatoid arthritis, joint surgery, hip or knee prosthesis, skin infection, and human immunodeficiency virus type 1 infection significantly increase the probability of septic arthritis. Joint pain ( sensitivity, 85%; 95% confidence interval [CI], 78%-90%), a history of joint swelling ( sensitivity, 78%; 95% CI, 71%-85%), and fever ( sensitivity, 57%; 95% CI, 52%-62%) are the only findings that occur in more than 50% of patients. Sweats ( sensitivity, 27%; 95% CI, 20%-34%) and rigors ( sensitivity, 19%; 95% CI, 15%-24%) are less common findings in septic arthritis. Of all laboratory findings readily available to the clinician, the 2 most powerful were the synovial fluid white blood cell (WBC) count and percentage of polymorphonuclear cells from arthrocentesis. The summary likelihood ratio (LR) increased as the synovial fluid WBC count increased ( for counts < 25 000/mu L: LR, 0.32; 95% CI, 0.23-0.43; for counts >= 25 000/ mu L: LR, 2.9; 95% CI, 2.5-3.4; for counts > 50 000/ mu L: LR, 7.7; 95% CI, 5.7-11.0; and for counts > 100 000/ mu L: LR, 28.0; 95% CI, 12.0-66.0). On the same synovial fluid sample, a polymorphonuclear cell count of at least 90% suggests septic arthritis with an LR of 3.4 ( 95% CI, 2.8-4.2), while a polymorphonuclear cell count of less than 90% lowers the likelihood ( LR, 0.34; 95% CI, 0.25-0.47). Conclusions Clinical findings identify patients with peripheral, monoarticular arthritis who might have septic arthritis. However, the synovial WBC and percentage of polymorphonuclear cells from arthrocentesis are required to assess the likelihood of septic arthritis before the Gram stain and culture test results are known.	Univ Calif San Francisco, Div Rheumatol, Dept Med, Prime Program, San Francisco, CA 94143 USA; San Francisco VA Med Ctr, Dept Med, San Francisco, CA USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Margaretten, ME (corresponding author), Univ Calif San Francisco, Div Rheumatol, Dept Med, Prime Program, U-384,533 Parnassus Ave, San Francisco, CA 94143 USA.	mary.margaretten@ucsf.edu			PHS HHS [1 K08 ATO1338-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BAKER DG, 1993, NEW ENGL J MED, V329, P1013, DOI 10.1056/NEJM199309303291407; BONG D, 1981, JAMA-J AM MED ASSOC, V246, P1438, DOI 10.1001/jama.246.13.1438; BRANDT KD, 1974, ARTHRITIS RHEUM, V17, P503, DOI 10.1002/art.1780170502; BROOK I, 1978, ARTHRITIS RHEUM, V21, P774, DOI 10.1002/art.1780210706; Cathcart E S, 1979, Compr Ther, V5, P55; DEESOMCHOK U, 1990, Journal of the Medical Association of Thailand, V73, P615; Dubost JJ, 2002, ANN RHEUM DIS, V61, P267, DOI 10.1136/ard.61.3.267; Faraj A A, 2002, Acta Orthop Belg, V68, P388; FREED JF, 1980, JAMA-J AM MED ASSOC, V243, P2314, DOI 10.1001/jama.243.22.2314; FRISCHKNECHT J, 1975, ARCH INTERN MED, V135, P298, DOI 10.1001/archinte.135.2.298; GOLDENBERG DL, 1978, MEDICINE, V57, P239, DOI 10.1097/00005792-197805000-00004; Goldenberg DL, 1998, LANCET, V351, P197, DOI 10.1016/S0140-6736(97)09522-6; Graif M, 1999, SKELETAL RADIOL, V28, P616, DOI 10.1007/s002560050562; GRATACOS J, 1995, J RHEUMATOL, V22, P1504; Gupta MN, 2001, RHEUMATOLOGY, V40, P24, DOI 10.1093/rheumatology/40.1.24; Gupta MN, 2003, ANN RHEUM DIS, V62, P327, DOI 10.1136/ard.62.4.327; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P313, DOI 10.1001/jama.273.4.313; Hsieh YS, 2006, CLIN ORTHOP RELAT R, P172, DOI 10.1097/01.blo.0000203473.96549.4e; Jeng GW, 1997, AM J EMERG MED, V15, P626, DOI 10.1016/S0735-6757(97)90173-X; JONES A, 1990, ANN RHEUM DIS, V49, P1005, DOI 10.1136/ard.49.12.1005; Kaandorp CJE, 1995, ARTHRITIS RHEUM, V38, P1819, DOI 10.1002/art.1780381215; Kaandorp CJE, 1997, ARTHRITIS RHEUM-US, V40, P884, DOI 10.1002/art.1780400516; Klippel JH, 2001, ARTHRITIS FDN PRIMER; KORTEKANGAS P, 1992, SCAND J RHEUMATOL, V21, P283, DOI 10.3109/03009749209099243; KREY PR, 1979, AM J MED, V67, P436, DOI 10.1016/0002-9343(79)90790-3; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Lee C H, 2000, Chang Gung Med J, V23, P420; Li SF, 2004, ACAD EMERG MED, V11, P276, DOI [10.1111/j.1553-2712.2004.tb02209.x, 10.1197/j.aem.2003.09.018]; MANSHADY BM, 1980, J RHEUMATOL, V7, P523; MASUDA I, 1988, CLIN ORTHOP RELAT R, P173; MCCUTCHAN HJ, 1990, CLIN ORTHOP RELAT R, P226; Morgan DS, 1996, EPIDEMIOL INFECT, V117, P423, DOI 10.1017/S0950268800059070; MOSSMAN SS, 1981, NEW ZEAL MED J, V93, P115; OBRIEN JP, 1983, MEDICINE, V62, P395, DOI 10.1097/00005792-198311000-00005; PETERS RHJ, 1992, CLIN RHEUMATOL, V11, P351, DOI 10.1007/BF02207192; ROSENTHAL J, 1980, ARTHRITIS RHEUM, V23, P889, DOI 10.1002/art.1780230803; Ross JJ, 2004, MEDICINE, V83, P139, DOI 10.1097/01.md.0000126761.83417.29; Rousseau I, 2001, SKELETAL RADIOL, V30, P565, DOI 10.1007/s002560100392; Ryan MJ, 1997, BRIT J RHEUMATOL, V36, P370; Sack Kenneth, 1997, American Journal of Medicine, V102, p30S, DOI 10.1016/S0002-9343(97)00414-2; Saraux A, 1997, BRIT J RHEUMATOL, V36, P333; SCHLAPBACH P, 1990, CLIN RHEUMATOL, V9, P69, DOI 10.1007/BF02030245; SCHUMACHER HR, 1995, POSTGRAD MED, V97, P52, DOI 10.1080/00325481.1995.11945980; SCHUMACHER HR, 1995, POSTGRAD MED, V97, P63; SCHUMACHER HR, 1995, POSTGRAD MED, V97, P57; SCOPELITIS E, 1993, RHEUM DIS CLIN N AM, V19, P363; Sharma M, 1997, SCAND J RHEUMATOL, V26, P30, DOI 10.3109/03009749709065661; SHMERLING RH, 1990, JAMA-J AM MED ASSOC, V264, P1009, DOI 10.1001/jama.264.8.1009; SHMERLING RH, 1994, RHEUM DIS CLIN N AM, V20, P503; Smetana GW, 2002, JAMA-J AM MED ASSOC, V287, P92, DOI 10.1001/jama.287.1.92; Soderquist B, 1998, SCAND J INFECT DIS, V30, P591, DOI 10.1080/00365549850161151; Swan A, 2002, ANN RHEUM DIS, V61, P493, DOI 10.1136/ard.61.6.493; Thumboo J, 1998, ARTHRITIS RHEUM, V41, P736, DOI 10.1002/1529-0131(199804)41:4<736::AID-ART23>3.0.CO;2-P; Till SH, 1999, J ACCID EMERG MED, V16, P355; WEINBERGER A, 1985, CLIN RHEUMATOL, V4, P258, DOI 10.1007/BF02031605; Weston VC, 1999, ANN RHEUM DIS, V58, P214, DOI 10.1136/ard.58.4.214; Yu KH, 2003, RHEUMATOLOGY, V42, P1062, DOI 10.1093/rheumatology/keg297; YU LP, 1992, SCAND J RHEUMATOL, V21, P142, DOI 10.3109/03009749209095087	58	297	309	0	21	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2007	297	13					1478	1488		10.1001/jama.297.13.1478	http://dx.doi.org/10.1001/jama.297.13.1478			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AM	17405973				2022-12-28	WOS:000245404100024
J	Hsieh, MM; Everhart, JE; Byrd-Holt, DD; Tisdale, JF; Rodgers, GP				Hsieh, Matthew M.; Everhart, James E.; Byrd-Holt, Danita D.; Tisdale, John F.; Rodgers, Griffin P.			Prevalence of neutropenia in the US population: Age, sex, smoking status, and ethnic differences	ANNALS OF INTERNAL MEDICINE			English	Article							BENIGN IDIOPATHIC NEUTROPENIA; FAMILIAL LEUKOPENIA; LEUKOCYTE COUNTS; INFECTION; MARROW; WHITE; BLACK; NEGROES; CELL	Background: Benign reductions in neutrophil counts may be more common at certain ages and in certain ethnic groups and may be affected by sex and smoking status. Objective: To determine differences in neutrophil counts in the U.S. population according to ethnicity, age, sex, and smoking status. Design: Population-based, cross-sectional study. Setting: Various locations in the United States. Participants: 25 222 participants in the 1999 to 2004 National Health and Nutrition Examination Survey who were 1 year of age or older. Measurements: Complete blood counts and comparison of means and the proportion of participants with neutropenia. Results: Relative to white participants, black participants had lower leukocyte counts (mean difference, 0.89 x 10(9) cells/L; P < 0.001), lower neutrophil counts (0.83 x 10(9) cells/L; P < 0.001), and similar lymphocyte counts (0.022 x 10(9) cells/L; P = 0.36), whereas Mexican-American participants had slightly higher mean leukocyte counts (0.16 x 10(9) cells/L; P = 0.014), higher neutrophil counts (0.11 x 10(9) cells/L; P = 0.026), and higher lymphocyte counts (0.095 x 10(9) cells/L; P < 0.001). The prevalence of neutropenia (neutrophil count < 1.5 x 10(9) cells/L) was 4.5% among black participants, 0.79% among white participants, and 0.38% among Mexican-American participants. The prevalence of neutropenia was higher among males and children younger than 5 years of age. Neutrophil counts less than 1.0 x 10(9) cells/L were observed in fewer than 1% of the overall sample (0.57% in black participants, 0.11% in white participants, and 0.08% in Mexican-American participants). Smoking was associated with higher leukocyte and neutrophil counts but had a smaller effect among black and Mexican-American participants than among white participants. Limitation: Because estimates are based on single measures, fluctuations over time could not be determined. Conclusions: In the United States, neutrophil counts are lower in black persons than in white persons and neutropenia is more prevalent in black persons. Neutrophil counts are slightly higher in Mexican -American persons than in white persons, and neutropenia is uncommon in both groups. The clinical implications of these findings are unclear, but they suggest that when determining the need for a diagnostic evaluation for neutropenia, clinicians should consider the patient's age, sex, ethnicity, and smoking status.	NIDDKD, Mol & Clin Hematol Branch, NIH, Bethesda, MD 20892 USA; Social & Sci Syst Inc, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Social & Scientific Systems	Rodgers, GP (corresponding author), NIDDKD, Mol & Clin Hematol Branch, NIH, 9000 Rockville Pike,Bldg 10,9N 119, Bethesda, MD 20892 USA.	gr5n@nih.gov			Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		AGHAJI MAC, 1990, CENT AFR J MED, V36, P273; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; BAIN BJ, 1975, BRIT MED J, V1, P306, DOI 10.1136/bmj.1.5953.306; Bain BJ, 2000, BRIT J HAEMATOL, V108, P483, DOI 10.1046/j.1365-2141.2000.01922.x; BODEY GP, 1966, ANN INTERN MED, V64, P328, DOI 10.7326/0003-4819-64-2-328; BROUN GO, 1966, NEW ENGL J MED, V275, P1410, DOI 10.1056/NEJM196612222752504; Cancer Therapy Evaluation Program, 2003, CANC THER EV PROGR C; CARAMIHAI E, 1975, J PEDIATR-US, V86, P252, DOI 10.1016/S0022-3476(75)80483-5; *CDCP NAT CTR HLTH, 2005, VITAL HLTH STAT, V11, P1; DANCEY JT, 1980, AM J MED, V68, P251, DOI 10.1016/0002-9343(80)90362-9; Ezeilo G C, 1972, East Afr Med J, V49, P94; Ezeilo G C, 1974, East Afr Med J, V51, P936; EZEILO GC, 1972, LANCET, V2, P1003; Forbes WH, 1941, AM J MED SCI, V201, P407, DOI 10.1097/00000441-194103000-00013; Freedman DS, 1997, INT J EPIDEMIOL, V26, P757, DOI 10.1093/ije/26.4.757; JUMEAN HG, 1983, ACTA HAEMATOL-BASEL, V69, P59, DOI 10.1159/000206841; KARAYALCIN G, 1972, LANCET, V1, P387; MANT MJ, 1987, CLIN LAB HAEMATOL, V9, P281, DOI 10.1111/j.1365-2257.1987.tb00092.x; MASON BA, 1979, AM J MED, V67, P201, DOI 10.1016/0002-9343(79)90391-7; McGrath C R, 1982, Vital Health Stat 11, P1; National Center for Health Statistics, 2007, NAT HLTH NUTR EX SUR; Neser M L, 1968, S Afr Med J, V42, P444; RANA SR, 1985, ANN CLIN LAB SCI, V15, P51; REED WW, 1991, ARCH INTERN MED, V151, P501, DOI 10.1001/archinte.151.3.501; RIPPEY JJ, 1967, LANCET, V2, P44; Shah BV, 1996, SUDAAN USERS MANUAL; SHAPER AG, 1971, LANCET, V2, P1021; SHOENFELD Y, 1985, BIOMED PHARMACOTHER, V39, P23; SHOENFELD Y, 1982, ARCH INTERN MED, V142, P797, DOI 10.1001/archinte.142.4.797; SHOENFELD Y, 1988, EUR J HAEMATOL, V41, P273; Watson HG, 2001, BRIT J HAEMATOL, V112, P826; WEINGARTEN MA, 1992, ACTA HAEMATOL-BASEL, V87, P126; WEINGARTEN MA, 1993, ISRAEL J MED SCI, V29, P297; Wright DG, 2006, CLIN HEMATOLOGY, P192; 1982, VITAL HLTH STAT, V11, pR1	35	233	239	2	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2007	146	7					486	492		10.7326/0003-4819-146-7-200704030-00004	http://dx.doi.org/10.7326/0003-4819-146-7-200704030-00004			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153VB	17404350				2022-12-28	WOS:000245463200002
J	Smellie, WSA				Smellie, W. Stuart A.			Spurious hyperkalaemia	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PSEUDOHYPERKALEMIA; TEMPERATURE; HYPOKALEMIA; SERUM		Bishop Auckland Gen Hosp, Clin Lab, Bishop Auckland DL14 6AD, Durham, England		Smellie, WSA (corresponding author), Bishop Auckland Gen Hosp, Clin Lab, Bishop Auckland DL14 6AD, Durham, England.	info@smellie.com						ADAMS PC, 1981, BRIT MED J, V282, P1034, DOI 10.1136/bmj.282.6269.1034; COLUSSI G, 1995, AM J NEPHROL, V15, P450, DOI 10.1159/000168883; INGRAM RH, 1962, NEW ENGL J MED, V267, P895, DOI 10.1056/NEJM196211012671801; Johnston JD, 1997, BRIT MED J, V314, P1200, DOI 10.1136/bmj.314.7088.1200a; Mandal AK, 1997, MED CLIN N AM, V81, P611, DOI 10.1016/S0025-7125(05)70536-8; Masters PW, 1996, BRIT MED J, V312, P1652, DOI 10.1136/bmj.312.7047.1652; Seamark D, 1999, J ROY SOC MED, V92, P339, DOI 10.1177/014107689909200703; Smellie WSA, 2007, J CLIN PATHOL, V60, P966, DOI 10.1136/jcp.2006.044883; Smellie WSA, 2006, BMJ-BRIT MED J, V333, P83, DOI 10.1136/bmj.333.7558.83; STEWART GW, 1979, LANCET, V2, P175; Thurlow V, 2005, ANN CLIN BIOCHEM, V42, P196, DOI 10.1258/0004563053857761; Trull AK, 2004, ANN CLIN BIOCHEM, V41, P47, DOI 10.1258/000456304322664690; VERRESEN L, 1986, CLIN CHEM, V32, P698; WULKAN RW, 1990, J CLIN CHEM CLIN BIO, V28, P489	14	39	45	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2007	334	7595					693	695		10.1136/bmj.39119.607986.47	http://dx.doi.org/10.1136/bmj.39119.607986.47			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154ON	17395950	Green Published			2022-12-28	WOS:000245517100041
J	Buschman, TJ; Miller, EK				Buschman, Timothy J.; Miller, Earl K.			Top-down versus bottom-up control of attention in the prefrontal and posterior parietal cortices	SCIENCE			English	Article							LATERAL INTRAPARIETAL AREA; SELECTIVE VISUAL-ATTENTION; NEURAL MECHANISMS; SPATIAL ATTENTION; NEURONAL-ACTIVITY; EYE-MOVEMENTS; CORTEX; SYNCHRONIZATION; MODULATION; MACAQUE	Attention can be focused volitionally by "top-down" signals derived from task demands and automatically by "bottom-up" signals from salient stimuli. The frontal and parietal cortices are involved, but their neural activity has not been directly compared. Therefore, we recorded from them simultaneously in monkeys. Prefrontal neurons reflected the target location first during top-down attention, whereas parietal neurons signaled it earlier during bottom-up attention. Synchrony between frontal and parietal areas was stronger in lower frequencies during top-down attention and in higher frequencies during bottom-up attention. This result indicates that top-down and bottom-up signals arise from the frontal and sensory cortex, respectively, and different modes of attention may emphasize synchrony at different frequencies.	MIT, RIKEN MIT Neurosci Res Ctr, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT)	Miller, EK (corresponding author), MIT, RIKEN MIT Neurosci Res Ctr, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ekmiller@mit.edu	Buschman, Timothy J/B-3056-2009; Miller, Earl K./AAE-8187-2019	Buschman, Timothy J/0000-0003-1298-2761; Miller, Earl K./0000-0002-0582-6958	NINDS NIH HHS [R01NS035145] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035145] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; Chao LL, 1997, CEREB CORTEX, V7, P63, DOI 10.1093/cercor/7.1.63; Constantinidis C, 2005, J NEUROSCI, V25, P233, DOI 10.1523/JNEUROSCI.3379-04.2005; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Eglin M, 1991, CEREB CORTEX, V1, P262, DOI 10.1093/cercor/1.3.262; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Miller BT, 2005, NEURON, V48, P535, DOI 10.1016/j.neuron.2005.11.002; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schall JD, 2002, PHILOS T ROY SOC B, V357, P1073, DOI 10.1098/rstb.2002.1098; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0	27	1502	1580	14	285	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2007	315	5820					1860	1862		10.1126/science.1138071	http://dx.doi.org/10.1126/science.1138071			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395832	Green Submitted			2022-12-28	WOS:000245280100048
J	Hattendorf, DA; Andreeva, A; Gangar, A; Brennwald, PJ; Weis, WI				Hattendorf, Douglas A.; Andreeva, Anna; Gangar, Akanksha; Brennwald, Patrick J.; Weis, William I.			Structure of the yeast polarity protein Sro7 reveals a SNARE regulatory mechanism	NATURE			English	Article							LETHAL-GIANT-LARVAE; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; EXOCYTOSIS; TOMOSYN; COMPLEX; PHOSPHORYLATION; RESIDUES; VESICLES; EFFECTOR	Polarized exocytosis requires coordination between the actin cytoskeleton and the exocytic machinery responsible for fusion of secretory vesicles at specific sites on the plasma membrane(1). Fusion requires formation of a complex between a vesicle-bound R-SNARE and plasma membrane Qa, Qb and Qc SNARE proteins(2). Proteins in the lethal giant larvae protein family, including lethal giant larvae and tomosyn in metazoans and Sro7 in yeast, interact with Q-SNAREs and are emerging as key regulators of polarized exocytosis(3). The crystal structure of Sro7 reveals two seven-bladed WD40 beta-propellers followed by a 60-residue- long 'tail', which is bound to the surface of the amino-terminal propeller. Deletion of the Sro7 tail enables binding to the Qbc SNARE region of Sec9 and this interaction inhibits SNARE complex assembly. The N-terminal domain of Sec9 provides a second, high-affinity Sro7 interaction that is unaffected by the tail. The results suggest that Sro7 acts as an allosteric regulator of exocytosis through interactions with factors that control the tail. Sequence alignments indicate that lethal giant larvae and tomosyn have a two-beta-propeller fold similar to that of Sro7, but only tomosyn appears to retain the regulatory tail.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	Stanford University; Stanford University; University of North Carolina; University of North Carolina Chapel Hill	Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, 299 Campus Dr W, Stanford, CA 94305 USA.	pjbrennw@med.unc.edu; bill.weis@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150	NIGMS NIH HHS [R01 GM054712] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054712] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Betschinger J, 2005, CURR BIOL, V15, P276, DOI 10.1016/j.cub.2005.01.012; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Grosshans BL, 2006, J CELL BIOL, V172, P55, DOI 10.1083/jcb.200510016; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kagami M, 1998, GENETICS, V149, P1717; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Mohri K, 2004, J BIOL CHEM, V279, P31697, DOI 10.1074/jbc.M403351200; Musch A, 2002, MOL BIOL CELL, V13, P158, DOI 10.1091/mbc.01-10-0496; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Vasioukhin V, 2006, DEV NEUROSCI-BASEL, V28, P13, DOI 10.1159/000090749; Voegtli WC, 2003, J BIOL CHEM, V278, P34373, DOI 10.1074/jbc.M302773200; Wirtz-Peitz F, 2006, TRENDS CELL BIOL, V16, P234, DOI 10.1016/j.tcb.2006.03.006; Zhang XY, 2005, J CELL BIOL, V170, P273, DOI 10.1083/jcb.200502055	27	70	74	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2007	446	7135					567	571		10.1038/nature05635	http://dx.doi.org/10.1038/nature05635			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392788				2022-12-28	WOS:000245242900055
J	Matsui, T; Agrawal, A; Nahata, A; Vardeny, ZV				Matsui, Tatsunosuke; Agrawal, Amit; Nahata, Ajay; Vardeny, Z. Valy			Transmission resonances through aperiodic arrays of subwavelength apertures	NATURE			English	Article							QUASI-CRYSTALS; HOLE ARRAYS; OPTICAL-TRANSMISSION; DIFFRACTION; SHIFTS	Resonantly enhanced light transmission through periodic sub-wavelength aperture arrays perforated in metallic films(1) has generated significant interest because of potential applications in near-field microscopy, photolithography, displays, and thermal emission(2). The enhanced transmission was originally explained by a mechanism where surface plasmon polaritons ( collective electronic excitations in the metal surface) mediate light transmission through the grating(1,3). In this picture, structural periodicity is perceived to be crucial in forming the transmission resonances. Here we demonstrate experimentally that, in contrast to the conventional view, sharp transmission resonances can be obtained from aperiodic aperture arrays. Terahertz transmission resonances are observed from several arrays in metallic films that exhibit unusual local n-fold rotational symmetries, where n = 10, 12, 18, 40 and 120. This is accomplished by using quasicrystals with long-range order, as well as a new type of 'quasicrystal approximates' in which the long-range order is somewhat relaxed. We find that strong transmission resonances also form in these aperiodic structures, at frequencies that closely match the discrete Fourier transform vectors in the aperture array structure factor. The shape of these resonances arises from Fano interference(4) of the discrete resonances and the non-resonant transmission band continuum related to the individual holes(5). Our approach expands potential design parameters for aperture arrays that are aperiodic but contain discrete Fourier transform vectors, and opens new avenues for optoelectronic devices.	Univ Utah, Dept Phys, Salt Lake City, UT 84112 USA; Univ Utah, Dept Elect & Comp Engn, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Vardeny, ZV (corresponding author), Univ Utah, Dept Phys, Salt Lake City, UT 84112 USA.	nahata@ece.utah.edu; val@physics.utah.edu	Matsui, Tatsunosuke/AAT-5345-2020; Nahata, Ajay/B-2407-2019; Matsui, Tatsunosuke/J-7916-2017; Agrawal, Amit/C-3728-2009	Nahata, Ajay/0000-0003-0438-2213; Matsui, Tatsunosuke/0000-0003-2179-9432; Agrawal, Amit/0000-0001-8230-4603; Agrawal, Amit/0000-0002-9619-7623				Agrawal A, 2006, OPT EXPRESS, V14, P1973, DOI 10.1364/OE.14.001973; Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; Bethe HA, 1944, PHYS REV, V66, P163, DOI 10.1103/PhysRev.66.163; Cao H, 2004, OPT EXPRESS, V12, P3664, DOI 10.1364/OPEX.12.003664; de Abajo FJG, 2006, OPT EXPRESS, V14, P7, DOI 10.1364/OPEX.14.000007; Ebbesen TW, 1998, NATURE, V391, P667, DOI 10.1038/35570; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; Genet C, 2003, OPT COMMUN, V225, P331, DOI 10.1016/j.optcom.2003.07.037; Ghaemi HF, 1998, PHYS REV B, V58, P6779, DOI 10.1103/PhysRevB.58.6779; Janot C., 1994, QUASICRYSTALS PRIMER; Kaliteevski MA, 2001, J PHYS-CONDENS MAT, V13, P10459, DOI 10.1088/0953-8984/13/46/314; Koerkamp KJK, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.183901; Lee TDM, 2005, NANOTECHNOLOGY, V16, P2703, DOI 10.1088/0957-4484/16/11/039; MATSUI T, 2006, ENHANCED TRANSMISSIO; Osterbacka R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.226401; Penrose R., 1974, B I MATH APPL, V10, P266; Przybilla F, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2355450; Sarrazin M, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.085415; Sun M, 2006, CHINESE PHYS LETT, V23, P486, DOI 10.1088/0256-307X/23/2/059; Zoorob ME, 2000, NATURE, V404, P740, DOI 10.1038/35008023	21	260	267	0	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2007	446	7135					517	521		10.1038/nature05620	http://dx.doi.org/10.1038/nature05620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392781				2022-12-28	WOS:000245242900044
J	Avorn, J				Avorn, Jerry			Paying for drug approvals - Who's using whom?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Avorn, J (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							ANGELL M, 2007, COMMUNICATION   0314; BACIU A, 2006, FUTURE DRUG SAFETY P; CARPENTER D, 2007, WORKING PAPER SERIES; U.S. GOV'T ACCOUNTABILITY OFFICE, 2006, GAO06402; 2007, FED REG, V72, P1743	5	50	52	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 26	2007	356	17					1697	1700		10.1056/NEJMp078041	http://dx.doi.org/10.1056/NEJMp078041			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	160LQ	17435083				2022-12-28	WOS:000245942600001
J	Marcus, R				Marcus, Robert			Should you tell patients about beneficial treatments that they cannot have?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Addenbrookes Hosp, Cambridge CB2 2QQ, England	Addenbrooke's Hospital; University of Cambridge	Marcus, R (corresponding author), Addenbrookes Hosp, Hills Rd, Cambridge CB2 2QQ, England.	robert.marcus@addenbrookes.nhs.uk							0	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 21	2007	334	7598					826	827		10.1136/bmj.39171.426690.AD	http://dx.doi.org/10.1136/bmj.39171.426690.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	162MD	17446611	Green Published			2022-12-28	WOS:000246090800028
J	Frey, GD; Lavallo, V; Donnadieu, B; Schoeller, WW; Bertrand, G				Frey, Guido D.; Lavallo, Vincent; Donnadieu, Bruno; Schoeller, Wolfgang W.; Bertrand, Guy			Facile splitting of hydrogen and ammonia by nucleophilic activation at a single carbon center	SCIENCE			English	Article							ALKYL AMINO CARBENES; OXIDATIVE ADDITION; REACTIVITY; DIHYDROGEN; COMPLEXES; CHEMISTRY; CATALYSTS; CLEAVAGE; HYDRIDES; LIGAND	In possessing a lone pair of electrons and an accessible vacant orbital, singlet carbenes resemble transition metal centers and thus could potentially mimic their chemical behavior. Although singlet di(amino) carbenes are inert toward dihydrogen, it is shown that more nucleophilic and electrophilic ( alkyl)( amino) carbenes can activate H(2) under mild conditions, a reaction that has long been known for transition metals. However, in contrast to transition metals that act as electrophiles toward dihydrogen, these carbenes primarily behave as nucleophiles, creating a hydride-like hydrogen, which then attacks the positively polarized carbon center. This nucleophilic behavior allows these carbenes to activate NH(3) as well, a difficult task for transition metals because of the formation of Lewis acid-base adducts.	Univ Calif Riverside, Dept Chem, UCR CNRS, Joint Res Chem Lab, Riverside, CA 92521 USA	University of California System; University of California Riverside	Schoeller, WW (corresponding author), Univ Calif Riverside, Dept Chem, UCR CNRS, Joint Res Chem Lab, UMI 2957, Riverside, CA 92521 USA.	gbertran@mail.ucr.edu	Schoeller, Wolfgang W/A-5755-2011; Frey, Guido/B-5619-2009	Frey, Guido/0000-0001-9146-2179				Alder RW, 1996, ANGEW CHEM INT EDIT, V35, P1121, DOI 10.1002/anie.199611211; ARDUENGO AJ, 1991, J AM CHEM SOC, V113, P361, DOI 10.1021/ja00001a054; ARDUENGO AJ, 1994, J AM CHEM SOC, V116, P6641, DOI 10.1021/ja00094a020; Bourissou D, 2000, CHEM REV, V100, P39, DOI 10.1021/cr940472u; BRYAN EG, 1977, J CHEM SOC DALTON, P1328, DOI 10.1039/dt9770001328; CASALNUOVO AL, 1987, INORG CHEM, V26, P971, DOI 10.1021/ic00254a001; CRABTREE RH, 1990, ACCOUNTS CHEM RES, V23, P95, DOI 10.1021/ar00172a001; Denk MK, 2001, J ORGANOMET CHEM, V617, P242, DOI 10.1016/S0022-328X(00)00551-9; DIXON DA, 1995, TETRAHEDRON LETT, V36, P645, DOI 10.1016/0040-4039(94)02341-8; Frisch M.J., 2009, GAUSSIAN 09 REV A02; Hahn FE, 2006, ANGEW CHEM INT EDIT, V45, P1348, DOI 10.1002/anie.200503858; Herrmann WA, 1996, CHEM-EUR J, V2, P772, DOI 10.1002/chem.19960020708; HILLHOUSE GL, 1984, J AM CHEM SOC, V106, P5472, DOI 10.1021/ja00331a015; Himmel HJ, 2003, DALTON T, P3639, DOI 10.1039/b307051b; HOLL MMB, 1990, J AM CHEM SOC, V112, P7989, DOI 10.1021/ja00178a022; Jones M. Jr., 2004, REACTIVE INTERMEDIAT, P273; Kotting C, 1999, J AM CHEM SOC, V121, P8891, DOI 10.1021/ja991003i; Kubas GJ, 2004, ADV INORG CHEM, V56, P127, DOI 10.1016/S0898-8838(04)56005-1; KUBAS GJ, 1984, J AM CHEM SOC, V106, P451, DOI 10.1021/ja00314a049; Kubas GJ, 2001, J ORGANOMET CHEM, V635, P37, DOI 10.1016/S0022-328X(01)01066-X; Kubas GJ, 2006, SCIENCE, V314, P1096, DOI 10.1126/science.1135430; Lavallo V, 2005, ANGEW CHEM INT EDIT, V44, P5705, DOI 10.1002/anie.200501841; Lavallo V, 2004, J AM CHEM SOC, V126, P8670, DOI 10.1021/ja047503f; Lavallo V, 2006, ANGEW CHEM INT EDIT, V45, P3488, DOI 10.1002/anie.200600987; Lyon EJ, 2004, EUR J BIOCHEM, V271, P195, DOI 10.1046/j.1432-1033.2003.03920.x; McGrady GS, 2003, CHEM SOC REV, V32, P383, DOI 10.1039/b207999m; Nakajima Y, 2006, ANGEW CHEM INT EDIT, V45, P950, DOI 10.1002/anie.200503222; Pilak O, 2006, J MOL BIOL, V358, P798, DOI 10.1016/j.jmb.2006.02.035; Sabatier P, 1926, IND ENG CHEM, V18, P1005, DOI 10.1021/ie50202a005; Spikes GH, 2005, J AM CHEM SOC, V127, P12232, DOI 10.1021/ja053247a; Tomioka H., 2004, REACTIVE INTERMEDIAT, P375; Welch GC, 2007, J AM CHEM SOC, V129, P1880, DOI 10.1021/ja067961j; Welch GC, 2006, SCIENCE, V314, P1124, DOI 10.1126/science.1134230; Werner A., 1893, Z ANORG CHEM, V3, P267, DOI DOI 10.1002/ZAAC.18930030136; Zhao J, 2005, SCIENCE, V307, P1080, DOI 10.1126/science.1109389	35	667	668	6	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					439	441		10.1126/science.1141474	http://dx.doi.org/10.1126/science.1141474			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446400				2022-12-28	WOS:000245813400054
J	Kimble, J; Page, DC				Kimble, Judith; Page, David C.			The mysteries of sexual identity: The germ cell's perspective	SCIENCE			English	Review							STEM-CELLS; SPECIFICATION; MEIOSIS; PUMILIO; FATE	Animal germ cells differentiate as sperm or eggs, depending on their sex. Somatic signals tell germ cells whether they reside in a male or female body, but how do germ cells interpret those external cues to acquire their own sexual identity? A critical aspect of a germ cell's sexual puzzle is that the sperm/egg decision is closely linked to the cell-cycle decision between mitosis and meiosis. Molecular studies have begun to tease apart the regulators of both decisions, an essential step toward understanding the regulatory logic of this fundamental question of germ cell biology.	Univ Wisconsin, Howard Hughes Med Inst, Dept Biochem, Madison, WI 53706 USA; MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Kimble, J (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Dept Biochem, Madison, WI 53706 USA.	jekimble@wisc.edu						Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; BARTON MK, 1990, GENETICS, V125, P29; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Chen PJ, 2000, DEV BIOL, V217, P77, DOI 10.1006/dbio.1999.9521; Ciosk R, 2006, SCIENCE, V311, P851, DOI 10.1126/science.1122491; Crittenden SL, 2002, NATURE, V417, P660, DOI 10.1038/nature754; ELLIS R, 2006, WORMBOOK C ELEGANS, DOI DOI 10.1895/WORMBOOK.1.82.1; Forbes A, 1998, DEVELOPMENT, V125, P679; Huynh JR, 2000, DEVELOPMENT, V127, P2785; Kimble Judith, 2005, WormBook, P1; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Lin HF, 1997, DEVELOPMENT, V124, P2463; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Oliver B, 2002, INT REV CYTOL, V219, P1; Otori M, 2006, MOL BIOL CELL, V17, P3147, DOI 10.1091/mbc.E05-11-1067; Thompson B., 2007, TRANSLATIONAL CONTRO; Thompson BE, 2005, DEVELOPMENT, V132, P3471, DOI 10.1242/dev.01921; Wawersik M, 2005, NATURE, V436, P563, DOI 10.1038/nature03849; Xu EY, 2007, MOL REPROD DEV, V74, P912, DOI 10.1002/mrd.20687; ZARKOWER D, 2006, WORMBOOK C ELEGANS R, DOI DOI 10.1895/WORMBOOK.1.84.1	21	29	32	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					400	401		10.1126/science.1142109	http://dx.doi.org/10.1126/science.1142109			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446389				2022-12-28	WOS:000245813400040
J	Stitzel, ML; Seydoux, G				Stitzel, Michael L.; Seydoux, Geraldine			Regulation of the oocyte-to-zygote transition	SCIENCE			English	Review							MATERNAL MESSENGER-RNA; GENE-EXPRESSION; MOUSE OOCYTES; GERM-LINE; TRANSLATION; EMBRYO; EGG; DEGRADATION; DROSOPHILA; PROTEINS	Oocytes, the female germ cells, contain all the messenger RNAs necessary to start a new life but typically wait until fertilization to begin development. The transition from oocyte to fertilized egg ( zygote) involves many changes, including protein synthesis, protein and RNA degradation, and organelle remodeling. These changes occur concurrently with the meiotic divisions that produce the haploid maternal genome. Accumulating evidence indicates that the cell-cycle regulators that control the meiotic divisions also regulate the many changes that accompany the oocyte-to-zygote transition. We suggest that the meiotic machinery functions as an internal pacemaker that propels oocytes toward embryogenesis.	Johns Hopkins Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Sch Med, Predoctoral Training Program Human Genet & Mol Bi, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Stitzel, ML (corresponding author), Johns Hopkins Sch Med, Dept Mol Biol & Genet, 725 N Wolfe St,PCTB 706, Baltimore, MD 21205 USA.		SEYDOUX, Geraldine/AAA-2005-2020	Seydoux, Geraldine/0000-0001-8257-0493				Bowerman B, 2006, DEVELOPMENT, V133, P773, DOI 10.1242/dev.02276; DeRenzo C, 2004, TRENDS CELL BIOL, V14, P420, DOI 10.1016/j.tcb.2004.07.005; Evsikov AV, 2006, GENE DEV, V20, P2713, DOI 10.1101/gad.1471006; FitzHarris G, 2003, MOL BIOL CELL, V14, P288, DOI 10.1091/mbc.E02-07-0431; Gao S, 2004, CYTOGENET GENOME RES, V105, P279, DOI 10.1159/000078199; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; HARVEY W, 1981, DISPUTATIONS TOUCHIN, pR20; Keady BT, 2007, J CELL SCI, V120, P1093, DOI 10.1242/jcs.03416; Kishimoto T, 2003, CURR OPIN CELL BIOL, V15, P654, DOI 10.1016/j.ceb.2003.10.010; Kloc M, 2004, CURR TOP DEV BIOL, V59, P1, DOI 10.1016/S0070-2153(04)59001-4; Malcuit C, 2006, J CELL PHYSIOL, V206, P565, DOI 10.1002/jcp.20471; Mendez R, 2002, EMBO J, V21, P1833, DOI 10.1093/emboj/21.7.1833; Nakahara K, 2005, P NATL ACAD SCI USA, V102, P12023, DOI 10.1073/pnas.0500053102; Potireddy S, 2006, DEV BIOL, V298, P155, DOI 10.1016/j.ydbio.2006.06.024; ROSENTHAL ET, 1983, J MOL BIOL, V166, P309, DOI 10.1016/S0022-2836(83)80087-4; Sato K, 2006, MOL BIOL CELL, V17, P3085, DOI 10.1091/mbc.E06-03-0211; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Schultz RM, 2005, REPRODUCTION, V130, P825, DOI 10.1530/rep.1.00902; Stitzel ML, 2006, CURR BIOL, V16, P56, DOI 10.1016/j.cub.2005.11.063; Suzumori N, 2003, P NATL ACAD SCI USA, V100, P550, DOI 10.1073/pnas.0234474100; Tadros W, 2005, DEV DYNAM, V232, P593, DOI 10.1002/dvdy.20297; Tadros W, 2007, DEV CELL, V12, P143, DOI 10.1016/j.devcel.2006.10.005; Vardy L, 2007, DEV CELL, V12, P157, DOI 10.1016/j.devcel.2006.10.017; Vasudevan S, 2006, GENE DEV, V20, P138, DOI 10.1101/gad.1398906; Vitale AM, 2007, MOL REPROD DEV, V74, P608, DOI 10.1002/mrd.20648; Voronina E, 2003, CURR TOP DEV BIOL, V58, P53, DOI 10.1016/S0070-2153(03)58003-6; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Wolke U, 2002, CURR BIOL, V12, P289, DOI 10.1016/S0960-9822(02)00679-6; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079	29	190	202	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					407	408		10.1126/science.1138236	http://dx.doi.org/10.1126/science.1138236			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446393				2022-12-28	WOS:000245813400044
J	Wadman, M				Wadman, Meredith			Moment of reckoning	NATURE			English	News Item																		2006, NATURE, V443, P372	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2007	446	7138					844	845		10.1038/446844a	http://dx.doi.org/10.1038/446844a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17443154				2022-12-28	WOS:000245785700012
J	Perrier, E				Perrier, Emilie			A patient's journey - Intensive care	BMJ-BRITISH MEDICAL JOURNAL			English	Article												azanome@hotmail.com							0	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2007	334	7597					796	797		10.1136/bmj.39157.723090.BE	http://dx.doi.org/10.1136/bmj.39157.723090.BE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161SX	17431267	Green Published, Bronze			2022-12-28	WOS:000246037300032
J	Gibbs, RA; Rogers, J; Katze, MG; Bumgarner, R; Weinstock, GM; Mardis, ER; Remington, KA; Strausberg, RL; Venter, JC; Wilson, RK; Batzer, MA; Bustamante, CD; Eichler, EE; Hahn, MW; Hardison, RC; Makova, KD; Miller, W; Milosavljevic, A; Palermo, RE; Siepel, A; Sikela, JM; Attaway, T; Bell, S; Bernard, KE; Buhay, CJ; Chandrabose, MN; Dao, M; Davis, C; Delehaunty, KD; Ding, Y; Dinh, HH; Dugan-Rocha, S; Fulton, LA; Gabisi, RA; Garner, TT; Godfrey, J; Hawes, AC; Hernandez, J; Hines, S; Holder, M; Hume, J; Jhangiani, SN; Joshi, V; Khan, ZM; Kirkness, EF; Cree, A; Fowler, RG; Lee, S; Lewis, LR; Li, ZW; Liu, YS; Moore, SM; Muzny, D; Nazareth, LV; Ngo, DN; Okwuonu, GO; Pai, G; Parker, D; Paul, HA; Pfannkoch, C; Pohl, CS; Rogers, YH; Ruiz, SJ; Sabo, A; Santibanez, J; Schneider, BW; Smith, SM; Sodergren, E; Svatek, AF; Utterback, TR; Vattathil, S; Warren, W; White, CS; Chinwalla, AT; Feng, Y; Halpern, AL; Hillier, LW; Huang, XQ; Minx, P; Nelson, JO; Pepin, KH; Qin, X; Sutton, GG; Venter, E; Walenz, BP; Wallis, JW; Worley, KC; Yang, SP; Jones, SM; Marra, MA; Rocchi, M; Schein, JE; Baertsch, R; Clarke, L; Csuros, M; Glasscock, J; Harris, RA; Haviak, P; Jackson, AR; Jiang, HY; Liu, Y; Messina, DN; Shen, YF; Song, HXZ; Wylie, T; Zhang, L; Birney, E; Han, K; Konkel, MK; Lee, JN; Smit, AFA; Ullmer, B; Wang, H; Xing, J; Burhans, R; Cheng, Z; Karro, JE; Ma, J; Raney, B; She, XW; Cox, MJ; Demuth, JP; Dumas, LJ; Han, SG; Hopkins, J; Karimpour-Fard, A; Kim, YH; Pollack, JR; Vinar, T; Addo-Quaye, C; Degenhardt, J; Denby, A; Hubisz, MJ; Indap, A; Kosiol, C; Lahn, BT; Lawson, HA; Marklein, A; Nielsen, R; Vallender, EJ; Clark, AG; Ferguson, B; Hernandez, RD; Hirani, K; Kehrer-Sawatzki, H; Kolb, J; Patil, S; Pu, LL; Ren, Y; Smith, DG; Wheeler, DA; Schenck, I; Ball, EV; Chen, R; Cooper, DN; Giardine, B; Hsu, F; Kent, WJ; Lesk, A; Nelson, DL; O'Brien, WE; Prufer, K; Stenson, PD; Wallace, JC; Ke, H; Liu, XM; Wang, P; Xiang, AP; Yang, F; Barber, GP; Haussler, D; Karolchik, D; Kern, AD; Kuhn, RM; Smith, KE; Zwieg, AS				Gibbs, Richard A.; Rogers, Jeffrey; Katze, Michael G.; Bumgarner, Roger; Weinstock, George M.; Mardis, Elaine R.; Remington, Karin A.; Strausberg, Robert L.; Venter, J. Craig; Wilson, Richard K.; Batzer, Mark A.; Bustamante, Carlos D.; Eichler, Evan E.; Hahn, Matthew W.; Hardison, Ross C.; Makova, Kateryna D.; Miller, Webb; Milosavljevic, Aleksandar; Palermo, Robert E.; Siepel, Adam; Sikela, James M.; Attaway, Tony; Bell, Stephanie; Bernard, Kelly E.; Buhay, Christian J.; Chandrabose, Mimi N.; Dao, Marvin; Davis, Clay; Delehaunty, Kimberly D.; Ding, Yan; Dinh, Huyen H.; Dugan-Rocha, Shannon; Fulton, Lucinda A.; Gabisi, Ramatu Ayiesha; Garner, Toni T.; Godfrey, Jennifer; Hawes, Alicia C.; Hernandez, Judith; Hines, Sandra; Holder, Michael; Hume, Jennifer; Jhangiani, Shalini N.; Joshi, Vandita; Khan, Ziad Mohid; Kirkness, Ewen F.; Cree, Andrew; Fowler, R. Gerald; Lee, Sandra; Lewis, Lora R.; Li, Zhangwan; Liu, Yih-shin; Moore, Stephanie M.; Muzny, Donna; Nazareth, Lynne V.; Ngo, Dinh Ngoc; Okwuonu, Geoffrey O.; Pai, Grace; Parker, David; Paul, Heidie A.; Pfannkoch, Cynthia; Pohl, Craig S.; Rogers, Yu-Hui; Ruiz, San Juana; Sabo, Aniko; Santibanez, Jireh; Schneider, Brian W.; Smith, Scott M.; Sodergren, Erica; Svatek, Amanda F.; Utterback, Teresa R.; Vattathil, Selina; Warren, Wesley; White, Courtney Sherell; Chinwalla, Asif T.; Feng, Yucheng; Halpern, Aaron L.; Hillier, LaDeana W.; Huang, Xiaoqiu; Minx, Pat; Nelson, Joanne O.; Pepin, Kymberlie H.; Qin, Xiang; Sutton, Granger G.; Venter, Eli; Walenz, Brian P.; Wallis, John W.; Worley, Kim C.; Yang, Shiaw-Pyng; Jones, Steven M.; Marra, Marco A.; Rocchi, Mariano; Schein, Jacqueline E.; Baertsch, Robert; Clarke, Laura; Csuros, Miklos; Glasscock, Jarret; Harris, R. Alan; Haviak, Paul; Jackson, Andrew R.; Jiang, Huaiyang; Liu, Yue; Messina, David N.; Shen, Yufeng; Song, Henry Xing-Zhi; Wylie, Todd; Zhang, Lan; Birney, Ewan; Han, Kyudong; Konkel, Miriam K.; Lee, Jungnam; Smit, Arlan F. A.; Ullmer, Brygg; Wang, Hui; Xing, Jinchuan; Burhans, Richard; Cheng, Ze; Karro, John E.; Ma, Jian; Raney, Brian; She, Xinwei; Cox, Michael J.; Demuth, Jeffrey P.; Dumas, Laura J.; Han, Sang-Gook; Hopkins, Janet; Karimpour-Fard, Anis; Kim, Young H.; Pollack, Jonathan R.; Vinar, Tomas; Addo-Quaye, Charles; Degenhardt, Jeremiah; Denby, Alexandra; Hubisz, Melissa J.; Indap, Amit; Kosiol, Carolin; Lahn, Bruce T.; Lawson, Heather A.; Marklein, Alison; Nielsen, Rasmus; Vallender, Eric J.; Clark, Andrew G.; Ferguson, Betsy; Hernandez, Ryan D.; Hirani, Kashif; Kehrer-Sawatzki, Hildegard; Kolb, Jessica; Patil, Shobha; Pu, Ling-Ling; Ren, Yanru; Smith, David Glenn; Wheeler, David A.; Schenck, Ian; Ball, Edward V.; Chen, Rui; Cooper, David N.; Giardine, Belinda; Hsu, Fan; Kent, W. James; Lesk, Arthur; Nelson, David L.; O'Brien, William E.; Prufer, Kay; Stenson, Peter D.; Wallace, James C.; Ke, Hui; Liu, Xiao-Ming; Wang, Peng; Xiang, Andy Peng; Yang, Fan; Barber, Galt P.; Haussler, David; Karolchik, Donna; Kern, Andy D.; Kuhn, Robert M.; Smith, Kayla E.; Zwieg, Ann S.		Rhesus Macaque Genome Sequencing Consortium	Evolutionary and biomedical insights from the rhesus macaque genome	SCIENCE			English	Article							PRIMATE SEGMENTAL DUPLICATIONS; SUBSTITUTION; SEQUENCE; DATABASE; MODELS; SITES; MOUSE; DNA; INFORMATION; DIVERGENCE	The rhesus macaque ( Macaca mulatta) is an abundant primate species that diverged from the ancestors of Homo sapiens about 25 million years ago. Because they are genetically and physiologically similar to humans, rhesus monkeys are the most widely used nonhuman primate in basic and applied biomedical research. We determined the genome sequence of an Indian-origin Macaca mulatta female and compared the data with chimpanzees and humans to reveal the structure of ancestral primate genomes and to identify evidence for positive selection and lineage-specific expansions and contractions of gene families. A comparison of sequences from individual animals was used to investigate their underlying genetic diversity. The complete description of the macaque genome blueprint enhances the utility of this animal model for biomedical research and improves our understanding of the basic biology of the species.	Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78227 USA; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Washington Univ, Genome Sequencing Ctr, St Louis, MO 63108 USA; J Craig Veriter Inst, Rockville, MD 20850 USA; Louisiana State Univ, Ctr Biomodular Multiscale Syst, Dept Biol Sci, Biol Computat & Visualizat Ctr, Baton Rouge, LA 70803 USA; Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Indiana Univ, Sch Informat, Bloomington, IN 47405 USA; Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; Univ Colorado, Dept Pharmacol, Human Med Genet Program, Denver, CO USA; Univ Colorado, Dept Pharmacol, Program Neurosci, Denver, CO USA; Ctr Hlth Sci, Aurora, CO 80045 USA; Iowa State Univ, Dept Comp Sci, Ames, IA 50011 USA; British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; Univ Bari, Dept Genet & Microbiol, Bari, Italy; Univ Calif Santa Cruz, Genome Sci Ctr, Santa Cruz, CA 95060 USA; Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; Univ Montreal, Dept Informat & Rech Operat, Montreal, PQ H3C 3J7, Canada; Inst Syst Biol, Seattle, WA 98103 USA; Louisiana State Univ, Dept Comp Sci, Ctr Computat & Technol, Baton Rouge, LA 70803 USA; Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA; Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; Univ Colorado, Dept Prevent Med & Biometr, Denver, CO 80202 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Copenhagen, Inst Biol, DK-1017 Copenhagen, Denmark; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Oregon Reg Primate Res Ctr, Genet Res & Informat Program, Beaverton, OR 97006 USA; Univ Ulm, Inst Human Genet, D-89081 Ulm, Germany; Cardiff Univ, Inst Med Genet, Cardiff CF14 4XN, Wales; Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; Sun Yat Sen Univ, Ctr Stem Cell Biol & Tissue Engn, Guangzhou 510080, Peoples R China; S China Primate Res & Dev Ctr, Guangzhou 510080, Peoples R China; Howard Hughes Med Inst, Santa Cruz, CA 95060 USA	Baylor College of Medicine; Baylor College of Medicine; Texas Biomedical Research Institute; University of Washington; University of Washington Seattle; Washington University (WUSTL); Louisiana State University System; Louisiana State University; Cornell University; University of Washington; University of Washington Seattle; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver; Iowa State University; British Columbia Cancer Agency; Universita degli Studi di Bari Aldo Moro; University of California System; University of California Santa Cruz; Wellcome Trust Sanger Institute; Universite de Montreal; Institute for Systems Biology (ISB); Louisiana State University System; Louisiana State University; Utah System of Higher Education; University of Utah; University of California System; University of California Santa Cruz; University of Colorado System; University of Colorado Denver; Stanford University; University of Chicago; University of Copenhagen; Cornell University; Oregon Health & Science University; Oregon National Primate Research Center; Ulm University; Cardiff University; Max Planck Society; Sun Yat Sen University; Howard Hughes Medical Institute	Gibbs, RA (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.	agibbs@bcm.edu	Wilson, Richard K./AAF-4139-2019; Addo-Quaye, Charles/J-3694-2016; Ma, Jian/A-9838-2008; Harris, R. Alan/AAI-2784-2020; Vinar, Tomas/I-3695-2014; Hardison, Ross C/G-1142-2010; Schein, Jacquie E/G-3674-2015; Xing, Jinchuan/A-2489-2012; Cooper, David N/H-4384-2011; Mardis, Elaine/W-2202-2019; Bumgarner, Roger/AAA-6846-2020; Messina, Dave/B-2405-2009; Marra, Marco A/B-5987-2008; Han, Kyudong/AAF-1788-2019; Bumgarner, Roger E/K-3531-2015; Weinstock, George M/C-6314-2013; Nielsen, Rasmus/D-4405-2009; Raney, Brian/ABE-6267-2020; Jones, Steven J/C-3621-2009; Vallender, Eric/A-2450-2008; Wheeler, David A/M-9740-2018	Wilson, Richard K./0000-0002-1992-1358; Addo-Quaye, Charles/0000-0003-0598-5980; Ma, Jian/0000-0002-4202-5834; Harris, R. Alan/0000-0002-7333-4752; Vinar, Tomas/0000-0003-3898-3447; Hardison, Ross C/0000-0003-4084-7516; Cooper, David N/0000-0002-8943-8484; Marra, Marco A/0000-0001-7146-7175; Han, Kyudong/0000-0001-6791-2408; Bumgarner, Roger E/0000-0002-8168-6985; Weinstock, George M/0000-0002-2997-4592; Nielsen, Rasmus/0000-0003-0513-6591; Jones, Steven J/0000-0003-3394-2208; Vallender, Eric/0000-0003-3506-0540; Wheeler, David A/0000-0002-9056-6299; Messina, David/0000-0002-2287-2761; Worley, Kim/0000-0002-0282-1000; Clarke, Laura/0000-0002-5989-6898; Chinwalla, Asif/0000-0001-7831-3996; Lawson, Heather/0000-0002-3550-5485; Clark, Andrew/0000-0001-7159-8511; Indap, Amit/0000-0002-3322-4735; Hahn, Matthew/0000-0002-5731-8808; Rocchi, Mariano/0000-0002-9451-5616; Hubisz, Melissa/0000-0002-9561-6830; Birney, Ewan/0000-0001-8314-8497; Lesk, Arthur/0000-0002-2596-0601; Siepel, Adam/0000-0002-3557-7219	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, R01HG002939, U54HG003068] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashurst JL, 2005, NUCLEIC ACIDS RES, V33, pD459, DOI 10.1093/nar/gki135; Baas T, 2006, J VIROL, V80, P10813, DOI 10.1128/JVI.00851-06; Bailey JA, 2003, COLD SPRING HARB SYM, V68, P115, DOI 10.1101/sqb.2003.68.115; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Barton NH, 2006, CURR BIOL, V16, pR647, DOI 10.1016/j.cub.2006.07.032; Bartosch-Harlid A, 2003, EVOLUTION, V57, P2398, DOI 10.1554/03-036; Betancourt AJ, 2004, GENETICS, V168, P2261, DOI 10.1534/genetics.104.030999; Birtle Zoe, 2005, BMC Genomics, V6, P120, DOI 10.1186/1471-2164-6-120; Blanchette M, 2004, GENOME RES, V14, P2412, DOI 10.1101/gr.2800104; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Chismar JD, 2002, BIOTECHNIQUES, V33, P516, DOI 10.2144/02333st01_11836a; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Daza-Vamenta R, 2004, GENOME RES, V14, P1501, DOI 10.1101/gr.2134504; DUTRILLAUX B, 1979, HUM GENET, V48, P251, DOI 10.1007/BF00272830; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Gao LZ, 2003, TRENDS GENET, V19, P678, DOI 10.1016/j.tig.2003.10.002; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Goetting-Minesky MP, 2006, J MOL EVOL, V63, P537, DOI 10.1007/s00239-005-0308-8; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Groves C.P., 2001, PRIMATE TAXONOMY; Hahn MW, 2005, GENOME RES, V15, P1153, DOI 10.1101/gr.3567505; Han K, 2007, SCIENCE, V316, P238, DOI 10.1126/science.1139462; Harris RA, 2007, SCIENCE, V316, P235, DOI 10.1126/science.1139477; Hernandez RD, 2007, SCIENCE, V316, P240, DOI 10.1126/science.1140462; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; *I MED GEN CARD, 2006, HUM GEN MUT DAT; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kalafus KJ, 2004, GENOME RES, V14, P672, DOI 10.1101/gr.1963804; Kehrer-Sawatzki H, 2007, HUM GENET, V120, P759, DOI 10.1007/s00439-006-0270-6; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lynch M, 2001, GENETICS, V159, P1789; Lynch Michael, 2003, Journal of Structural and Functional Genomics, V3, P35, DOI 10.1023/A:1022696612931; Ma J, 2006, GENOME RES, V16, P1557, DOI 10.1101/gr.5383506; Makova KD, 2004, GENOME RES, V14, P567, DOI 10.1101/gr.1971104; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Milosavljevic A, 2005, GENOME RES, V15, P292, DOI 10.1101/gr.3162505; Murphy WJ, 2005, GENOMICS, V86, P383, DOI 10.1016/j.ygeno.2005.05.013; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nielsen R, 1998, GENETICS, V148, P929; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rogers J, 2006, GENOMICS, V87, P30, DOI 10.1016/j.ygeno.2005.10.004; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; She XW, 2006, GENOME RES, V16, P576, DOI 10.1101/gr.4949406; Spindel ER, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-160; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Taylor F, 2006, MOL BIOL EVOL, V23, P565, DOI 10.1093/molbev/msj060; Umeda S, 2005, INVEST OPHTH VIS SCI, V46, P683, DOI 10.1167/iovs.04-1031; van Baren MJ, 2006, GENOME RES, V16, P678, DOI 10.1101/gr.4766206; Ventura M, 2007, SCIENCE, V316, P243, DOI 10.1126/science.1140615; Wallace JC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-28; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WIENBERG J, 1992, CHROMOSOMA, V101, P265, DOI 10.1007/BF00346004; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861; Zahn LM, 2007, SCIENCE, V316, P215, DOI 10.1126/science.316.5822.215	71	986	1045	6	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					222	234		10.1126/science.1139247	http://dx.doi.org/10.1126/science.1139247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431167	Green Submitted			2022-12-28	WOS:000245654500037
J	Hadler, NM; Tait, RC; Chibnall, JT				Hadler, Nortin M.; Tait, Raymond C.; Chibnall, John T.			Back pain in the Workplace	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK-FACTORS; PSYCHOSOCIAL FACTORS; SICKNESS ABSENCE; FOLLOW-UP; WORKERS; PREDICTORS; DISORDERS; DURATION; INJURIES; SURGERY		Univ N Carolina, Sch Med, Dept Med, Div Rheumatol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Microbiol, Chapel Hill, NC 27599 USA; St Louis Univ, Sch Med, Dept Psychiat, St Louis, MO USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Saint Louis University	Hadler, NM (corresponding author), Univ N Carolina, Sch Med, Dept Med, Div Rheumatol, 3300 Thurston Bldg CB 7280, Chapel Hill, NC 27599 USA.	nmh@med.unc.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS013087] Funding Source: NIH RePORTER; AHRQ HHS [R01-HS-013087-01] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Battie MC, 2004, SPINE, V29, P2679, DOI 10.1097/01.brs.0000146457.83240.eb; Blum F., 2006, WORKERS COMPENSATION, V6, P3; Carragee E, 2006, SPINE, V31, P2942, DOI 10.1097/01.brs.0000248429.10963.13; Cassidy JD, 2005, SPINE, V30, P2817, DOI 10.1097/01.brs.0000190448.69091.53; Chibnall JT, 2006, SPINE, V31, P1272, DOI 10.1097/01.brs.0000217584.79528.9b; HADLER NM, 1978, ANN INTERN MED, V89, P992; HADLER NM, 1986, NEW ENGL J MED, V315, P1090, DOI 10.1056/NEJM198610233151711; Hadler NM, 1997, NEW ENGL J MED, V337, P341, DOI 10.1056/NEJM199707313370511; Hadler NM, 2003, JAMA-J AM MED ASSOC, V289, P2863, DOI 10.1001/jama.289.21.2863; Hadler NM., 2005, OCCUPATIONAL MUSCULO; Harkness EF, 2003, RHEUMATOLOGY, V42, P959, DOI 10.1093/rheumatology/keg265; Harris I, 2005, JAMA-J AM MED ASSOC, V293, P1644, DOI 10.1001/jama.293.13.1644; Hashemi L, 1998, J OCCUP ENVIRON MED, V40, P1110; Head J, 2006, J EPIDEMIOL COMMUN H, V60, P55, DOI 10.1136/jech.2005.038752; Hoogendoorn WE, 2000, SPINE, V25, P2114, DOI 10.1097/00007632-200008150-00017; Kaila-Kangas L, 2004, SPINE, V29, P1823, DOI 10.1097/01.BRS.0000134572.46151.0A; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Lotters F, 2006, OCCUP ENVIRON MED, V63, P794, DOI 10.1136/oem.2005.020420; Mixter WJ, 1935, NEW ENGL J MED, V213, P385, DOI 10.1056/NEJM193508292130901; Nielsen ML, 2006, J OCCUP ENVIRON MED, V48, P591, DOI 10.1097/01.jom.0000201567.70084.3a; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; Tait RC, 2006, J PAIN, V7, P951, DOI 10.1016/j.jpain.2006.05.007; Tait RC, 2004, PAIN, V112, P389, DOI 10.1016/j.pain.2004.09.027; Volinn E, 2005, SPINE, V30, P697, DOI 10.1097/01.brs.0000155404.32725.f8; Waddell G, 2002, BACK PAIN INCAPACITY	25	22	23	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2007	297	14					1594	1596		10.1001/jama.297.14.1594	http://dx.doi.org/10.1001/jama.297.14.1594			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155PG	17426279				2022-12-28	WOS:000245589800028
J	Hopper, AD; Cross, SS; Hurlstone, DP; McAlindon, ME; Lobo, AJ; Hadjivassiliou, M; Sloan, ME; Dixon, S; Sanders, DS				Hopper, Andrew D.; Cross, Simon S.; Hurlstone, David P.; McAlindon, Mark E.; Lobo, Alan J.; Hadjivassiliou, Marios; Sloan, Marion E.; Dixon, Simon; Sanders, David S.			Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ROUTINE DUODENAL BIOPSIES; TRANSGLUTAMINASE ANTIBODIES; REFLUX ESOPHAGITIS; PRIMARY-CARE; PREVALENCE; DIAGNOSIS; ASSOCIATION; SENSITIVITY; POPULATION; MORTALITY	Objective To determine an effective diagnostic method of detecting all cases of coeliac disease in patients referred for gastroscopy without performing routine duodenal biopsy. Design An initial retrospective cohort of patients attending for gastroscopy was analysed to derive a clinical decision toot that could increase the detection of coeliac disease without performing routine duodenal biopsy. The toot incorporated serology (measuring antibodies to tissue transglutaminase) and stratifying patients according to their referral symptoms (patients were classified as having a "high risk" or "low risk" of coeliac disease). The decision tool was then tested on a second cohort of patients attending for gastroscopy. In the second cohort all patients had a routine duodenal biopsy and serology performed. Setting Teaching hospital in Sheffield. Participants 2000 consecutive adult patients referred for gastroscopy recruited prospectively. Main outcome measure Evaluation of a clinical decision toot using patients' referral symptoms, tissue transglutaminase antibody results, and duodenal biopsy results. Results No cases of coeliac disease were missed by the pre-endoscopy testing algorithm. The prevalence of coeliac disease in patients attending for endoscopy was 3.9% (77/2000, 95% confidence interval 3.1% to 4.8%). The prevalence in the high risk and low risk groups was 9.6% (71/739, 7.7% to 12.0%) and 0.5% (6/1261, 0.2% to 1.0%). The prevalence of coeliac disease in patients who were negative for tissue transglutaminase antibody was 0.4% (7/2000). The sensitivity, specificity, positive predictive value, and negative predictive value for a positive antibody result to diagnose coeliac disease was 90.9%, 90.9%, 28.6%, and 99.6%, respectively. Evaluation of the clinical decision toot gave a sensitivity, specificity, positive predictive value, and negative predictive value of 100%, 60.8%, 9.3%, and 100%, respectively. Conclusions Pre-endoscopy serological testing in combination with biopsy of high risk cases detected all cases of coeliac disease. The use of this decision toot may enable the endoscopist to target patients who need a duodenal biopsy.	Royal Hallamshire Hosp, Dept Gastroenterol, Sheffield S10 2JF, S Yorkshire, England; Univ Sheffield, Sheffield, S Yorkshire, England; Univ Sheffield, Sch Med, Sect Oncol & Pathol, Div Genom Med, Sheffield, S Yorkshire, England; Royal Hallamshire Hosp, Dept Neurol, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield	Hopper, AD (corresponding author), 15 Nairn St, Sheffield S10 1UL, S Yorkshire, England.	andydhopper@aol.com		Dixon, Simon/0000-0001-7394-7009; Cross, Simon/0000-0003-2044-1754				[Anonymous], 2005, GASTROENTEROLOGY, V128, pS1, DOI 10.1053/j.gastro.2005.02.007; Bardella MT, 2000, ARCH INTERN MED, V160, P1489, DOI 10.1001/archinte.160.10.1489; Brocchi E, 2004, GASTROINTEST ENDOSC, V59, P331, DOI 10.1016/S0016-5107(03)02146-1; Collin P, 2005, EUR J GASTROEN HEPAT, V17, P85, DOI 10.1097/00042737-200501000-00017; Collin P, 2004, EUR J GASTROEN HEPAT, V16, P917, DOI 10.1097/00042737-200409000-00017; Collin P, 2002, QJM-INT J MED, V95, P75, DOI 10.1093/qjmed/95.2.75; Cuomo A, 2003, GUT, V52, P514, DOI 10.1136/gut.52.4.514; Dickey W, 1996, J CLIN GASTROENTEROL, V23, P21, DOI 10.1097/00004836-199607000-00007; Dickey W, 1999, AM J GASTROENTEROL, V94, P2182; Dickey W, 1998, SCAND J GASTROENTERO, V33, P612, DOI 10.1080/00365529850171882; Dobru Daniela, 2003, Rom J Gastroenterol, V12, P97; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Fasano A, 2001, GASTROENTEROLOGY, V120, P636, DOI 10.1053/gast.2001.22123; Feighery C, 1998, EUR J GASTROEN HEPAT, V10, P919; FERGUSON A, 1993, GUT, V34, P150, DOI 10.1136/gut.34.2.150; Goddard AF, 2000, GUT, V46, pIV1; Green PHR, 2003, GASTROINTEST ENDOSC, V58, P92, DOI 10.1067/mge.2003.242; Green PHR, 2001, AM J GASTROENTEROL, V96, P126, DOI 10.1111/j.1572-0241.2001.03462.x; Green PHR, 2003, LANCET, V362, P383, DOI 10.1016/S0140-6736(03)14027-5; Hill ID, 2005, GASTROENTEROLOGY, V128, pS25, DOI 10.1053/j.gastro.2005.02.012; Hill PG, 2006, ANN CLIN BIOCHEM, V43, P105, DOI 10.1258/000456306776021599; Hin H, 1999, BMJ-BRIT MED J, V318, P164, DOI 10.1136/bmj.318.7177.164; Hopper AD, 2003, GASTROINTEST ENDOSC, V58, P120, DOI 10.1067/mge.2003.199; Johnston SD, 1997, LANCET, V350, P1370, DOI 10.1016/S0140-6736(05)65142-2; Kori M, 2003, J CLIN GASTROENTEROL, V37, P39, DOI 10.1097/00004836-200307000-00011; Korponay-Szabo IR, 2005, ALIMENT PHARM THER, V22, P729, DOI 10.1111/j.1365-2036.2005.02663.x; Lankisch PG, 1996, Z GASTROENTEROL, V34, P473; Lima Vinícius Machado de, 2005, Arq. Gastroenterol., V42, P153, DOI 10.1590/S0004-28032005000300005; Lock RJ, 2004, EUR J GASTROEN HEPAT, V16, P467, DOI 10.1097/00042737-200405000-00005; LOGAN RFA, 1989, GASTROENTEROLOGY, V97, P265, DOI 10.1016/0016-5085(89)90060-7; Mahadeva S, 2002, J CLIN PATHOL, V55, P424, DOI 10.1136/jcp.55.6.424; Maki M, 2003, NEW ENGL J MED, V348, P2517, DOI 10.1056/NEJMoa021687; MARSH MN, 1995, QJM-MON J ASSOC PHYS, V88, P9; Nemec G, 2006, AM J GASTROENTEROL, V101, P1597, DOI 10.1111/j.1572-0241.2006.00597.x; Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019; Olds G, 2002, GASTROINTEST ENDOSC, V56, P407, DOI 10.1067/mge.2002.127412; Sanders DS, 2005, ANN SURG, V242, P201, DOI 10.1097/01.sla.0000171301.35513.cf; Sanders DS, 2003, EUR J GASTROEN HEPAT, V15, P407, DOI 10.1097/00042737-200304000-00012; Sanders DS, 2002, POSTGRAD MED J, V78, P31, DOI 10.1136/pmj.78.915.31; Sanders DS, 2001, LANCET, V358, P1504, DOI 10.1016/S0140-6736(01)06581-3; SHIDRAWI RG, 1994, J CLIN PATHOL, V47, P693, DOI 10.1136/jcp.47.8.693; Talal AH, 1997, AM J GASTROENTEROL, V92, P1280; Thomas PD, 2003, GUT, V52, P1; van Heel DA, 2006, GUT, V55, P1037, DOI 10.1136/gut.2005.075119; Voutilainen M, 2003, DIGEST LIVER DIS, V35, P94, DOI 10.1016/S1590-8658(03)00003-3; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909; West J, 2004, BRIT MED J, V329, P716, DOI 10.1136/bmj.38169.486701.7C; West J, 2003, GUT, V52, P960, DOI 10.1136/gut.52.7.960; Williams L, 2001, GASTROENTEROL TODAY, V11, P73	49	125	128	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2007	334	7596					729	+		10.1136/bmj.39133.668681.BE	http://dx.doi.org/10.1136/bmj.39133.668681.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AO	17383983	Bronze, Green Published			2022-12-28	WOS:000245763300028
J	Schrauder, A; Henke-Gendo, C; Seidemann, K; Sasse, M; Cario, G; Moericke, A; Schrappe, M; Heim, A; Wessel, A				Schrauder, Andre; Henke-Gendo, Cornelia; Seidemann, Kathrin; Sasse, Michael; Cario, Gunnar; Moericke, Anja; Schrappe, Martin; Heim, Albert; Wessel, Armin			Varicella vaccination in a child with acute lymphoblastic leukaemia	LANCET			English	Editorial Material							ZOSTER		Hannover Med Sch, Dept Virol, D-30625 Hannover, Germany; Hannover Med Sch, Dept Pediat Cardiol, D-30625 Hannover, Germany; Univ Hosp Schleswig Holstein, Dept Pediat, Kiel, Germany	Hannover Medical School; Hannover Medical School; University of Kiel; Schleswig Holstein University Hospital	Henke-Gendo, C (corresponding author), Hannover Med Sch, Dept Virol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	Henke-Gendo.Cornelia@mh-hannover.de	Schrappe, Martin/ABA-6144-2020; Cario, Gunnar/D-2535-2010; Schrappe, Martin/A-8109-2010					David DS, 1998, AM J GASTROENTEROL, V93, P810, DOI 10.1111/j.1572-0241.1998.230_a.x; Leung TF, 2004, EUR J HAEMATOL, V72, P353, DOI 10.1111/j.1600-0609.2004.00216.x; Ljungman P, 2003, SUPPORT CARE CANCER, V11, P739, DOI 10.1007/s00520-003-0527-8; Muller I, 2001, MED PEDIATR ONCOL, V37, P145, DOI 10.1002/mpo.1186; Sauerbrei A, 2002, J CLIN VIROL, V25, pS45, DOI 10.1016/S1386-6532(02)00033-1	5	50	52	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2007	369	9568					1232	1232		10.1016/S0140-6736(07)60567-4	http://dx.doi.org/10.1016/S0140-6736(07)60567-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155RH	17416267				2022-12-28	WOS:000245595100034
J	Affara, NI; Coussens, LM				Affara, Nesrine I.; Coussens, Lisa M.			IKK alpha at the crossroads of inflammation and metastasis	CELL			English	Editorial Material							CANCER DEVELOPMENT; MASPIN; BONE	The development of solid tumors is regulated by dynamic interactions between evolving neoplastic cells and their microenvironment. Luo et al. (2007) recently demonstrated that tumor-infiltrating immune cells expressing RANKL induce activation and nuclear localization of IKK alpha in prostatic epithelial tumor cells. This leads to repression of maspin, a critical suppressor of metastasis, and thus commits malignant prostatic epithelial cells to a metastatic fate.	Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Coussens, LM (corresponding author), Univ Calif San Francisco, Dept Pathol, 2340 Sutter St, San Francisco, CA 94143 USA.	coussens@cc.ucsf.edu	Coussens, Lisa/ABH-9834-2020					Clezardin P, 2005, CANCER RES, V65, P4971, DOI 10.1158/0008-5472.CAN-05-0264; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; LUO JL, 2007, NATURE; Sato N, 2004, ONCOGENE, V23, P1531, DOI 10.1038/sj.onc.1207269; Sheng SJ, 2004, FRONT BIOSCI-LANDMRK, V9, P2733, DOI 10.2741/1432; Zhang J, 2001, J CLIN INVEST, V107, P1235, DOI 10.1172/JCI11685	8	38	43	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					25	26		10.1016/j.cell.2007.03.029	http://dx.doi.org/10.1016/j.cell.2007.03.029			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418780	Bronze			2022-12-28	WOS:000245661100005
J	Lee, YS; Mulugu, S; York, JD; O'Shea, EK				Lee, Young-Sam; Mulugu, Sashidhar; York, John D.; O'Shea, Erin K.			Regulation of a cyclin-CDK-CDK inhibitor complex by inositol pyrophosphates	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; TELOMERE LENGTH; PROTEIN-KINASES; YEAST; PHO80-PHO85; HEXAKISPHOSPHATE; PHOSPHORYLATION; POLYPHOSPHATES; DICTYOSTELIUM; ENZYMES	In budding yeast, phosphate starvation triggers inhibition of the Pho80-Pho85 cyclin-cyclin-dependent kinase (CDK) complex by the CDK inhibitor Pho81, leading to expression of genes involved in nutrient homeostasis. We isolated myo-D-inositol heptakisphosphate (IP7) as a cellular component that stimulates Pho81-dependent inhibition of Pho80-Pho85. IP7 is necessary for Pho81- dependent inhibition of Pho80-Pho85 in vitro. Moreover, intracellular concentrations of IP7 increased upon phosphate starvation, and yeast mutants defective in IP7 production failed to inhibit Pho80-Pho85 in response to phosphate starvation. These observations reveal regulation of a cyclin-CDK complex by a metabolite and suggest that a complex metabolic network mediates signaling of phosphate availability.	Harvard Univ, Howard Hughes Med Inst, Fac Arts & Sci, Ctr Syst Biol,Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Harvard University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute	O'Shea, EK (corresponding author), Harvard Univ, Howard Hughes Med Inst, Fac Arts & Sci, Ctr Syst Biol,Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	erin_oshea@harvard.edu	Lee, Young-Sam/A-2499-2013		NHLBI NIH HHS [HL055672] Funding Source: Medline; NIDDK NIH HHS [DK070272] Funding Source: Medline; NIGMS NIH HHS [R01 GM051377, R01 GM051377-15] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051377] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Auesukaree C, 2005, J BIOL CHEM, V280, P25127, DOI 10.1074/jbc.M414579200; Carroll AS, 2002, TRENDS BIOCHEM SCI, V27, P87, DOI 10.1016/S0968-0004(01)02040-0; Dubois E, 2002, J BIOL CHEM, V277, P23755, DOI 10.1074/jbc.M202206200; FLEISCHER B, 1994, J BIOL CHEM, V269, P17826; Flick JS, 1998, GENETICS, V148, P33; Huang SD, 2005, GENETICS, V169, P1859, DOI 10.1534/genetics.104.038695; Huang SD, 2001, MOL CELL BIOL, V21, P6695, DOI 10.1128/MCB.21.19.6695-6705.2001; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; KAFFMAN A, 1994, SCIENCE, V263, P1153, DOI 10.1126/science.8108735; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; Luo HBR, 2002, BIOCHEMISTRY-US, V41, P2509, DOI 10.1021/bi0118153; MAYR GW, 1992, CARBOHYD RES, V234, P247, DOI 10.1016/0008-6215(92)85052-2; Mulugu S, 2007, SCIENCE, V316, P106, DOI 10.1126/science.1139099; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Schell MJ, 1999, FEBS LETT, V461, P169, DOI 10.1016/S0014-5793(99)01462-3; SCHNEIDER KR, 1994, SCIENCE, V266, P122, DOI 10.1126/science.7939631; Seeds AM, 2005, J BIOL CHEM, V280, P27654, DOI 10.1074/jbc.M505089200; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Wilson WA, 2002, CELL, V111, P155, DOI 10.1016/S0092-8674(02)01043-7; YE WL, 1995, J BIOL CHEM, V270, P1564, DOI 10.1074/jbc.270.4.1564; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200	25	214	222	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2007	316	5821					109	112		10.1126/science.1139080	http://dx.doi.org/10.1126/science.1139080			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412959	Green Accepted			2022-12-28	WOS:000245470500043
J	Palla, G; Barabasi, AL; Vicsek, T				Palla, Gergely; Barabasi, Albert-Laszlo; Vicsek, Tamas			Quantifying social group evolution	NATURE			English	Article							COMMUNITY STRUCTURE; NETWORK STRUCTURE; COLLABORATION	The rich set of interactions between individuals in society(1-7) results in complex community structure, capturing highly connected circles of friends, families or professional cliques in a social network(3,7-10). Thanks to frequent changes in the activity and communication patterns of individuals, the associated social and communication network is subject to constant evolution(7,11-16). Our knowledge of the mechanisms governing the underlying community dynamics is limited, but is essential for a deeper understanding of the development and self-optimization of society as a whole(17-22). We have developed an algorithm based on clique percolation(23,24) that allows us to investigate the time dependence of overlapping communities on a large scale, and thus uncover basic relationships characterizing community evolution. Our focus is on networks capturing the collaboration between scientists and the calls between mobile phone users. We find that large groups persist for longer if they are capable of dynamically altering their membership, suggesting that an ability to change the group composition results in better adaptability. The behaviour of small groups displays the opposite tendency - the condition for stability is that their composition remains unchanged. We also show that knowledge of the time commitment of members to a given community can be used for estimating the community's lifetime. These findings offer insight into the fundamental differences between the dynamics of small groups and large institutions.	HAS, Stat & Biol Phys Res Grp, H-1117 Budapest, Hungary; Univ Notre Dame, Ctr Complex Network Res, Notre Dame, IN 46566 USA; Univ Notre Dame, Dept Phys, Notre Dame, IN 46566 USA; Univ Notre Dame, Dept Comp Sci, Notre Dame, IN 46566 USA; Eotvos Lorand Univ, Dept Biol Phys, H-1117 Budapest, Hungary	Hungarian Academy of Sciences; University of Notre Dame; University of Notre Dame; University of Notre Dame; Eotvos Lorand University	Vicsek, T (corresponding author), HAS, Stat & Biol Phys Res Grp, Pazmany P Stny 1A, H-1117 Budapest, Hungary.	vicsek@angel.elte.hu	Barabasi, Albert-Laszlo/S-6474-2017; Palla, Gergely/H-1767-2016; Vicsek, Tamas/A-3305-2009	Palla, Gergely/0000-0002-3406-4200; Barabasi, Albert/0000-0002-4028-3522				Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Csermely P., 2006, WEAK LINKS; Derenyi I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.160202; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Ebel Holger, 2002, Complexity, V8, P24, DOI 10.1002/cplx.10066; Everett M.G., 1998, CONNECTIONS, V21, P49; FAUST K, 2005, MODELS METHODS SOCIA, pCH7; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Guimera R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.065103; Holme P, 2004, SOC NETWORKS, V26, P155, DOI 10.1016/j.socnet.2004.01.007; Hopcroft J, 2004, P NATL ACAD SCI USA, V101, P5249, DOI 10.1073/pnas.0307750100; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Li CG, 2005, J PHYS A-MATH GEN, V38, P9741, DOI 10.1088/0305-4470/38/45/002; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; ONNEAL JP, 2006, STRUCTURE TIE STRENG; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pollner P, 2006, EUROPHYS LETT, V73, P478, DOI 10.1209/epl/i2005-10414-6; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Scott J., 2000, SOCIAL STRUCTURE, V2nd; Shiffrin RM, 2004, P NATL ACAD SCI USA, V101, P5183, DOI 10.1073/pnas.0307852100; Wagner CS, 2005, RES POLICY, V34, P1608, DOI 10.1016/j.respol.2005.08.002; Warner S., 2003, Library Hi Tech, V21, P151, DOI 10.1108/07378830310479794; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts DJ, 2002, SCIENCE, V296, P1302, DOI 10.1126/science.1070120; Yeung YY, 2005, AM J PHYS, V73, P145, DOI 10.1119/1.1775799	29	1004	1094	7	316	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 5	2007	446	7136					664	667		10.1038/nature05670	http://dx.doi.org/10.1038/nature05670			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	153LZ	17410175	Green Submitted			2022-12-28	WOS:000245438300039
J	Qaseem, A; Snow, V; Sherif, K; Aronson, M; Weiss, KB; Owens, DK				Qaseem, Amir; Snow, Vincenza; Sherif, Katherine; Aronson, Mark; Weiss, Kevin B.; Owens, Douglas K.		Clin Efficacy Assessment Subcomm	Screening mammography for women 40 to 49 years of age: A clinical practice guideline from the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							BREAST-CANCER DETECTION; SERVICES-TASK-FORCE; CARCINOMA IN-SITU; DEATH RATES; RISK; MORTALITY; ACCURACY; THERAPY	Breast cancer is one of the most common causes of death for women in their 40s in the United States. Individualized risk assessment plays an important role when making decisions about screening mammography, especially for women 49 years of age or younger. The purpose of this guideline is to present the available evidence for screening mammography in women 40 to 49 years of age and to increase clinicians' understanding of the benefits and risks of screening mammography.	Amer Coll Physicians, Philadelphia, PA 19106 USA; Drexel Univ, Coll Med, Philadelphia, PA 19104 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Northwestern Univ, Chicago, IL 60611 USA; Vet Affairs Edward Hines Jr Hosp, Chicago, IL USA; Stanford Univ, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Stanford, CA USA	American College of Physicians; Drexel University; Harvard University; Beth Israel Deaconess Medical Center; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org						American Cancer Society, 2005, CANC FACTS FIG 2005; American College of Obstetricians and Gynecologists, 2003, OBSTET GYNECOL, V101, P821; Armstrong K, 2000, NEW ENGL J MED, V342, P564, DOI 10.1056/NEJM200002243420807; Armstrong K, 2007, ANN INTERN MED, V146, P516, DOI 10.7326/0003-4819-146-7-200704030-00008; Bakker D A, 1998, Oncol Nurs Forum, V25, P115; Baxter NN, 2004, JNCI-J NATL CANCER I, V96, P443, DOI 10.1093/jnci/djh069; Berg AO, 2005, ANN INTERN MED, V143, P355, DOI 10.7326/0003-4819-143-5-200509060-00011; Berg AO, 2002, ANN INTERN MED, V137, P344, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00011; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; BREW M D, 1989, Australasian Radiology, V33, P335, DOI 10.1111/j.1440-1673.1989.tb03306.x; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Elmore JG, 2002, JNCI-J NATL CANCER I, V94, P1373; Hofvind S, 2004, CANCER-AM CANCER SOC, V101, P1501, DOI 10.1002/cncr.20528; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Keemers-Gels ME, 2000, BREAST CANCER RES TR, V60, P235, DOI 10.1023/A:1006457520996; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P39, DOI 10.1001/jama.276.1.39; Leaney B J, 1992, Australas Radiol, V36, P120, DOI 10.1111/j.1440-1673.1992.tb03095.x; MILLER AB, 1992, CAN MED ASSOC J, V147, P1477; MILLER AB, 1992, CAN MED ASSOC J, V147, P1459; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; Mushlin AI, 1998, AM J PREV MED, V14, P143, DOI 10.1016/S0749-3797(97)00019-6; National Cancer Institute, BREAST CANC RISK ASS; Nelson HD, 2005, ANN INTERN MED, V143, P362, DOI 10.7326/0003-4819-143-5-200509060-00012; Olivotto IA, 1998, NEW ENGL J MED, V339, P560; Olsen O, 2001, LANCET, V358, P1340, DOI 10.1016/S0140-6736(01)06449-2; Paci E, 2002, BRIT MED J, V325, P418, DOI 10.1136/bmj.325.7361.418; PEETERS PHM, 1989, INT J CANCER, V43, P226, DOI 10.1002/ijc.2910430209; Ringash J, 2001, CAN MED ASSOC J, V164, P469; Rockhill B, 2001, J NATL CANCER I, V93, P358, DOI 10.1093/jnci/93.5.358; Schwartz LM, 2000, BMJ-BRIT MED J, V320, P1635, DOI 10.1136/bmj.320.7250.1635; Smith RA, 2006, CA-CANCER J CLIN, V56, P11, DOI 10.3322/canjclin.56.1.11	31	99	103	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2007	146	7					511	515		10.7326/0003-4819-146-7-200704030-00007	http://dx.doi.org/10.7326/0003-4819-146-7-200704030-00007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153VB	17404353				2022-12-28	WOS:000245463200005
J	Anderson, JB				Anderson, John B.			Climate change - Ice sheet stability and sea-level rise	SCIENCE			English	Editorial Material							GROUNDING-LINE; RETREAT		Rice Univ, Dept Earth Sci, Houston, TX 77251 USA	Rice University	Anderson, JB (corresponding author), Rice Univ, Dept Earth Sci, Houston, TX 77251 USA.	johna@rice.edu	Anderson, John/B-1011-2012					ALLEY RB, 1987, J GEOPHYS RES-SOLID, V92, P8931, DOI 10.1029/JB092iB09p08931; Alley RB, 2007, SCIENCE, V315, P1838, DOI 10.1126/science.1138396; Anandakrishnan S, 2007, SCIENCE, V315, P1835, DOI 10.1126/science.1138393; Anderson J.B., 1999, ANTARCTIC MARINE GEO; Horgan HJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027091; HUGHES TJ, 1977, REV GEOPHYS SPACE PH, V78, P1; Kamb B., 2001, ANTARCT RES SER, V77, DOI DOI 10.1029/AR077P0157; MACAYEAL DR, 1992, NATURE, V359, P29, DOI 10.1038/359029a0; Mosola AB, 2006, QUATERNARY SCI REV, V25, P2177, DOI 10.1016/j.quascirev.2005.12.013; PENCK A, 1928, SITZUNGSBER PREUS PM, V6, P76; THOMAS RH, 1978, QUATERNARY RES, V10, P150, DOI 10.1016/0033-5894(78)90098-4	11	11	11	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1803	1804		10.1126/science.1140766	http://dx.doi.org/10.1126/science.1140766			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	151HC	17395818				2022-12-28	WOS:000245280100029
J	Hall, W				Hall, Wayne			Psychoactive drugs of misuse: rationalising the irrational	LANCET			English	Editorial Material									Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4006, Australia	University of Queensland	Hall, W (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4006, Australia.	w.hall@sph.uq.edu.au	Hall, Wayne D/A-3283-2008	Hall, Wayne D/0000-0003-1984-0096				[Anonymous], 1999, HLTH EFFECTS CANNABI; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; GOLDSTEIN A, 1990, SCIENCE, V249, P1513, DOI 10.1126/science.2218493; Nutt D, 2007, LANCET, V369, P1047, DOI 10.1016/S0140-6736(07)60464-4	4	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2007	369	9566					972	972		10.1016/S0140-6736(07)60471-1	http://dx.doi.org/10.1016/S0140-6736(07)60471-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151JO	17382807				2022-12-28	WOS:000245286500007
J	Jelovsek, JE; Maher, C; Barber, MD				Jelovsek, J. Eric; Maher, Christopher; Barber, Matthew D.			Pelvic organ prolapse	LANCET			English	Review							ANTERIOR VAGINAL WALL; STRESS URINARY-INCONTINENCE; PROSPECTIVE RANDOMIZED-TRIAL; ABDOMINAL SACRAL COLPOPEXY; RECTOCELE REPAIR; UTEROVAGINAL PROLAPSE; GENITAL PROLAPSE; SEXUAL FUNCTION; RECONSTRUCTIVE SURGERY; POLYPROPYLENE MESH	Pelvic organ prolapse is downward descent of female pelvic organs, including the bladder, uterus or post-hysterectomy vaginal cull; and the small or large bowel, resulting in protrusion of the vagina, uterus, or both. Prolapse development is multifactorial, with vaginal child birth, advancing age, and increasing body-mass index as the most consistent risk factors. Vaginal delivery, hysterectomy, chronic straining, normal ageing, and abnormalities of connective tissue or connective-tissue repair predispose some women to disruption, stretching, or dysfunction of the levator ani complex, connective-tissue attachments of the vagina, or both, resulting in prolapse. Patients generally present with several complaints, including bladder, bowel, and pelvic symptoms; however, with the exception of vaginal bulging, none is specific to prolapse. Women with symptoms suggestive of prolapse should undergo a pelvic examination and medical history check. Radiographic assessment is usually unnecessary. Many women with pelvic organ prolapse are asymptomatic and do not need treatment. When prolapse is symptomatic, options include observation, pessary use, and surgery. Surgical strategies for prolapse can be categorised broadly by reconstructive and obliterative techniques. Reconstructive procedures can be done by either an abdominal or vaginal approach. Although no effective prevention strategy for prolapse has been identified, considerations include weight loss, reduction of heavy lifting, treatment of constipation, modification or reduction of obstetric risk factors, and pelvic-floor physical therapy.	Cleveland Clin, Dept Obstet & Gynecol A81, Cleveland, OH 44195 USA; Wesley Hosp, Wesley Urogynaecol Unit, Auchenflower, Qld 4066, Australia	Cleveland Clinic Foundation; Wesley Hospital	Jelovsek, JE (corresponding author), Cleveland Clin, Dept Obstet & Gynecol A81, 9500 Euclid Ave, Cleveland, OH 44195 USA.	jelovsj@ccf.org	Maher, Christopher F/H-7646-2012					Abramov Y, 2005, OBSTET GYNECOL, V105, P314, DOI 10.1097/01.AOG.0000151990.08019.30; Abrams P, 2002, AM J OBSTET GYNECOL, V187, P116, DOI 10.1067/mob.2002.125704; Altman D, 2006, OBSTET GYNECOL, V107, P59, DOI 10.1097/01.AOG.0000192547.58102.ab; [Anonymous], 2000, Eur J Obstet Gynecol Reprod Biol, V93, P135; Arya LA, 2005, AM J OBSTET GYNECOL, V192, P1687, DOI 10.1016/j.ajog.2004.11.032; Baessler K, 2005, OBSTET GYNECOL, V106, P713, DOI 10.1097/01.AOG.0000177970.52037.0a; Bafghi A, 2005, EUR J OBSTET GYN R B, V122, P232, DOI 10.1016/j.ejogrb.2005.01.008; Bafghi A, 2005, BJOG-INT J OBSTET GY, V112, P376, DOI 10.1111/j.1471-0528.2004.00415.x; Baragi RV, 2002, AM J OBSTET GYNECOL, V187, P111, DOI 10.1067/mob.2002.125703; BARBER M, 2003, J PELVIC MED SURG, V9, P208; Barber MD, 2007, INT UROGYNECOL J, V18, P799, DOI 10.1007/s00192-006-0240-5; Barber MD, 2002, OBSTET GYNECOL, V99, P281, DOI 10.1016/S0029-7844(01)01727-6; Barber MD, 2005, CLIN OBSTET GYNECOL, V48, P648, DOI 10.1097/01.grf.0000170424.11993.73; Bensinger G, 2005, AM J OBSTET GYNECOL, V193, P2094, DOI 10.1016/j.ajog.2005.07.066; Benson JT, 1996, AM J OBSTET GYNECOL, V175, P1418, DOI 10.1016/S0002-9378(96)70084-4; Boreham MK, 2002, AM J OBSTET GYNECOL, V187, P1501, DOI 10.1067/mob.2002.130005; Boreham MK, 2002, AM J OBSTET GYNECOL, V187, P56, DOI 10.1067/mob.2002.124843; Boyles SH, 2003, AM J OBSTET GYNECOL, V189, P70, DOI 10.1067/mob.2003.376; Brizzolara S, 2003, OBSTET GYNECOL, V102, P306, DOI 10.1016/S0029-7844(03)00515-5; Brown JS, 2002, AM J OBSTET GYNECOL, V186, P712, DOI 10.1067/mob.2002.121897; Brubaker L, 2006, NEW ENGL J MED, V354, P1557, DOI 10.1056/NEJMoa054208; Brubaker L, 2005, 3 INT CONS INC; Bruce RG, 1999, UROLOGY, V54, P647, DOI 10.1016/S0090-4295(99)00225-3; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; Bump RC, 1998, OBSTET GYN CLIN N AM, V25, P723, DOI 10.1016/S0889-8545(05)70039-5; Burrows LJ, 2004, OBSTET GYNECOL, V104, P982, DOI 10.1097/01.AOG.0000142708.61298.be; Carley ME, 2000, AM J OBSTET GYNECOL, V182, P1021, DOI 10.1067/mob.2000.105410; Chaliha C, 2006, INT UROGYNECOL J, V17, P492, DOI 10.1007/s00192-005-0053-y; Chen LY, 2006, OBSTET GYNECOL, V108, P324, DOI 10.1097/01.AOG.0000227786.69257.a8; Chiaffarino F, 1999, EUR J OBSTET GYN R B, V82, P63, DOI 10.1016/S0301-2115(98)00175-4; Clark AL, 2003, AM J OBSTET GYNECOL, V189, P1261, DOI 10.1067/S0002-9378(03)00829-9; Clemons JL, 2004, AM J OBSTET GYNECOL, V190, P1025, DOI 10.1016/j.ajog.2003.10.711; Coates KW, 1997, BRIT J UROL, V80, P217, DOI 10.1046/j.1464-410X.1997.00246.x; Collinet P, 2006, INT UROGYNECOL J, V17, P315, DOI 10.1007/s00192-005-0003-8; Colombo M, 1998, AM J OBSTET GYNECOL, V179, P13, DOI 10.1016/S0002-9378(98)70245-5; Cordozo L., 1995, DEWHURSTS TXB OBSTET, P642; COSSON M, 2005, NEUROUROL URODYNAM, V24, P121; Cruikshank SH, 1999, AM J OBSTET GYNECOL, V180, P859, DOI 10.1016/S0002-9378(99)70656-3; Cundiff GW, 2000, OBSTET GYNECOL, V95, P931, DOI 10.1016/S0029-7844(00)00788-2; de Tayrac R, 2005, J REPROD MED, V50, P75; de Tayrac R, 2007, INT UROGYNECOL J, V18, P251, DOI 10.1007/s00192-006-0135-5; DeLancey JOL, 2005, AM J OBSTET GYNECOL, V192, P1488, DOI 10.1016/j.ajog.2005.02.028; DeLancey JOL, 2003, OBSTET GYNECOL, V101, P46, DOI 10.1016/S0029-7844(02)02465-1; DeLancey JOL, 2002, AM J OBSTET GYNECOL, V187, P93, DOI 10.1067/mob.2002.125733; DELANCEY JOL, 1994, AM J OBSTET GYNECOL, V170, P1713, DOI 10.1016/S0002-9378(12)91840-2; Denehy TR, 1995, AM J OBSTET GYNECOL, V173, P1697, DOI 10.1016/0002-9378(95)90412-3; Dwyer PL, 2004, BJOG-INT J OBSTET GY, V111, P831, DOI 10.1111/j.1471-0528.2004.00194.x; Ellerkmann RM, 2001, AM J OBSTET GYNECOL, V185, P1332, DOI 10.1067/mob.2001.119078; FitzGerald MP, 2006, INT UROGYNECOL J, V17, P261, DOI 10.1007/s00192-005-1339-9; FRANCIS WJA, 1961, J OBSTET GYN BR COMM, V68, P1; Gandhi S, 2005, AM J OBSTET GYNECOL, V192, P1649, DOI 10.1016/j.ajog.2005.02.061; Goldstein SR, 2002, AM J OBSTET GYNECOL, V187, P521, DOI 10.1067/mob.2002.123938; Goldstein SR, 2001, OBSTET GYNECOL, V98, P91, DOI 10.1016/S0029-7844(01)01390-4; Grody M H, 1999, Int Urogynecol J Pelvic Floor Dysfunct, V10, P407, DOI 10.1007/s001920050070; Hagen S, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004010.pub2., DOI 10.1002/14651858.CD004010.PUB2]; Hall AF, 1996, AM J OBSTET GYNECOL, V175, P1467, DOI 10.1016/S0002-9378(96)70091-1; Hanavadi S, 2004, Ann R Coll Surg Engl, V86, pW18; Handa VL, 2003, OBSTET GYNECOL, V102, P1283, DOI 10.1016/j.obstetgynecol.2003.08.022; Harvey Marie-Andree, 2003, J Obstet Gynaecol Can, V25, P487; Heit M, 2002, OBSTET GYNECOL, V99, P23, DOI 10.1016/S0029-7844(01)01626-X; Hendrix SL, 2002, AM J OBSTET GYNECOL, V186, P1160, DOI 10.1067/mob.2002.123819; Hunskaar S, 2005, 3 INT CONS INC; Jackson SL, 1997, OBSTET GYNECOL, V89, P423; Jackson SR, 1996, LANCET, V347, P1658, DOI 10.1016/S0140-6736(96)91489-0; Jelovsek JE, 2006, AM J OBSTET GYNECOL, V194, P1455, DOI 10.1016/j.ajog.2006.01.060; Jelovsek JE, 2005, AM J OBSTET GYNECOL, V193, P2105, DOI 10.1016/j.ajog.2005.07.016; JORGENSEN S, 1994, OCCUP MED-OXFORD, V44, P47, DOI 10.1093/occmed/44.1.47; Julian TM, 1996, AM J OBSTET GYNECOL, V175, P1472, DOI 10.1016/S0002-9378(96)70092-3; Kahn MA, 2005, AM J OBSTET GYNECOL, V192, P1516, DOI 10.1016/j.ajog.2004.11.040; Kahn MA, 1997, BRIT J OBSTET GYNAEC, V104, P82, DOI 10.1111/j.1471-0528.1997.tb10654.x; Karasick S, 1997, AM J ROENTGENOL, V169, P1555, DOI 10.2214/ajr.169.6.9393164; Kearney R, 2004, OBSTET GYNECOL, V104, P168, DOI 10.1097/01.AOG.0000128906.61529.6b; Kenton K, 1999, AM J OBSTET GYNECOL, V181, P1360, DOI 10.1016/S0002-9378(99)70406-0; Keshavarz Homa, 2002, Morbidity and Mortality Weekly Report, V51, P1; Liu XQ, 2006, AM J PATHOL, V168, P519, DOI 10.2353/ajpath.2006.050399; Lo TS, 1998, J GYNECOL SURG, V14, P59, DOI 10.1089/gyn.1998.14.59; LUBOWSKI DZ, 1988, BRIT J SURG, V75, P1095, DOI 10.1002/bjs.1800751115; Lukacz ES, 2006, OBSTET GYNECOL, V107, P1253, DOI 10.1097/01.AOG.0000218096.54169.34; MACER GA, 1978, AM J OBSTET GYNECOL, V131, P203, DOI 10.1016/0002-9378(78)90665-8; Maher C, 2004, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004014.PUB3; Maher CF, 2004, OBSTET GYNECOL, V104, P685, DOI 10.1097/01.AOG.0000139833.48063.03; Maher CF, 2004, AM J OBSTET GYNECOL, V190, P20, DOI 10.1016/j.ajog.2003.08.031; MAKINEN J, 1986, ARCH GYNECOL OBSTET, V239, P17, DOI 10.1007/BF02134283; Mallipeddi PK, 2001, INT UROGYNECOL J PEL, V12, P83, DOI 10.1007/s001920170070; Mant J, 1997, BRIT J OBSTET GYNAEC, V104, P579, DOI 10.1111/j.1471-0528.1997.tb11536.x; Mattox TF, 2000, AM J OBSTET GYNECOL, V183, P1381, DOI 10.1067/mob.2000.111489; MELLGREN A, 1995, DIS COLON RECTUM, V38, P7, DOI 10.1007/BF02053850; Meschia M, 2005, NEUROUROL URODYNAM, V24, P587; Milani R, 2005, BJOG-INT J OBSTET GY, V112, P107, DOI 10.1111/j.1471-0528.2004.00332.x; Moalli PA, 2005, OBSTET GYNECOL, V106, P953, DOI 10.1097/01.AOG.0000182584.15087.dd; Moalli PA, 2003, OBSTET GYNECOL, V101, P869, DOI 10.1016/S0029-7844(03)00078-4; Nguyen JK, 2000, OBSTET GYNECOL, V95, P332, DOI 10.1016/S0029-7844(99)00561-X; Nichols CM, 2004, OBSTET GYNECOL, V104, P690, DOI 10.1097/01.AOG.0000139518.46032.e5; NORTON PA, 1995, OBSTET GYNECOL, V85, P225, DOI 10.1016/0029-7844(94)00386-R; Nygaard I, 2004, OBSTET GYNECOL, V104, P489, DOI 10.1097/01.AOG.0000136100.10818.d8; O'Boyle AL, 2003, INT UROGYNECOL J, V14, P46, DOI 10.1007/s00192-002-1006-3; O'Boyle AL, 2002, AM J OBSTET GYNECOL, V187, P99, DOI 10.1067/mob.2002.125734; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; Paraiso MFR, 2006, AM J OBSTET GYNECOL, V195, P1762, DOI 10.1016/j.ajog.2006.07.026; Paraiso MFR, 2005, AM J OBSTET GYNECOL, V192, P1752, DOI 10.1016/j.ajog.2004.11.051; Petros P E, 1997, Int Urogynecol J Pelvic Floor Dysfunct, V8, P270; Petros PEP, 1990, ACTA OBSTET GYN SCAN, V69, P7, DOI 10.1111/j.1600-0412.1990.tb08027.x; Piya-Anant Manee, 2003, Journal of the Medical Association of Thailand, V86, P509; Porter WE, 1999, AM J OBSTET GYNECOL, V181, P1353, DOI 10.1016/S0002-9378(99)70376-5; Pott-Grinstein E, 2001, J REPROD MED, V46, P205; Ray A, 2006, J Obstet Gynaecol, V26, P275; RICHARDSON AC, 1981, OBSTET GYNECOL, V57, P357; RICHARDSON AC, 1993, CLIN OBSTET GYNECOL, V36, P976, DOI 10.1097/00003081-199312000-00022; Romanzi Lauri J, 2002, Curr Opin Urol, V12, P339, DOI 10.1097/00042307-200207000-00013; Samuelsson EC, 1999, AM J OBSTET GYNECOL, V180, P299, DOI 10.1016/S0002-9378(99)70203-6; Sand PK, 2005, INT UROGYNECOL J, V16, P255, DOI 10.1007/s00192-005-1303-8; Sand PK, 2001, AM J OBSTET GYNECOL, V184, P1357, DOI 10.1067/mob.2001.115118; Schaffer JI, 2005, CLIN OBSTET GYNECOL, V48, P639, DOI 10.1097/01.grf.0000170428.45819.4e; Singh K, 2003, AM J OBSTET GYNECOL, V188, P910, DOI 10.1067/mob.2003.254; Singh K, 2003, OBSTET GYNECOL, V101, P320, DOI 10.1016/S0029-7844(02)02616-9; SNOOKS SJ, 1985, GASTROENTEROLOGY, V89, P977, DOI 10.1016/0016-5085(85)90196-9; SPENCEJONES C, 1994, BRIT J OBSTET GYNAEC, V101, P147, DOI 10.1111/j.1471-0528.1994.tb13081.x; Subak LL, 2001, OBSTET GYNECOL, V98, P646, DOI 10.1016/S0029-7844(01)01472-7; SULAK PJ, 1993, J REPROD MED, V38, P919; Swift S, 2005, AM J OBSTET GYNECOL, V192, P795, DOI 10.1016/j.ajog.2004.10.602; Swift SE, 2003, AM J OBSTET GYNECOL, V189, P372, DOI 10.1067/S0002-9378(03)00698-7; Swift SE, 2001, INT UROGYNECOL J, V12, P187, DOI 10.1007/s001920170062; Sze EHM, 1999, OBSTET GYNECOL, V93, P229, DOI 10.1016/S0029-7844(98)00376-7; Tan JS, 2005, INT UROGYNECOL J, V16, P203, DOI 10.1007/s00192-004-1243-8; Vakili B, 2005, AM J OBSTET GYNECOL, V193, P2126, DOI 10.1016/j.ajog.2005.07.065; WALTER S, 1982, BRIT J UROL, V54, P377, DOI 10.1111/j.1464-410X.1982.tb08949.x; WEBER AM, 1995, OBSTET GYNECOL, V85, P483, DOI 10.1016/0029-7844(94)00434-F; Weber AM, 1998, AM J OBSTET GYNECOL, V179, P1446, DOI 10.1016/S0002-9378(98)70008-0; Weber AM, 2001, AM J OBSTET GYNECOL, V185, P1299, DOI 10.1067/mob.2001.119081; Weber AM, 2000, AM J OBSTET GYNECOL, V182, P1610, DOI 10.1067/mob.2000.107436; Weidner AC, 2006, AM J OBSTET GYNECOL, V195, P1851, DOI 10.1016/j.ajog.2006.06.062; White G., 1912, AM J OBSTET DIS WOME, V65, P286; WILSON PD, 2005, 3 INT CONS INC; Wu JM, 2006, AM J OBSTET GYNECOL, V194, P1418, DOI 10.1016/j.ajog.2006.01.051; Wu V, 1997, OBSTET GYNECOL, V90, P990, DOI 10.1016/S0029-7844(97)00481-X; Young SB, 2001, AM J OBSTET GYNECOL, V185, P1360, DOI 10.1067/mob.2001.119073	136	535	562	0	87	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2007	369	9566					1027	1038		10.1016/S0140-6736(07)60462-0	http://dx.doi.org/10.1016/S0140-6736(07)60462-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151JO	17382829				2022-12-28	WOS:000245286500031
J	Mason, KD; Carpinelli, MR; Fletcher, JI; Collinge, JE; Hilton, AA; Ellis, S; Kelly, PN; Ekert, PG; Metcalf, D; Roberts, AW; Huang, DCS; Kile, BT				Mason, Kylie D.; Carpinelli, Marina R.; Fletcher, Jamie I.; Collinge, Janelle E.; Hilton, Adrienne A.; Ellis, Sarah; Kelly, Priscilla N.; Ekert, Paul G.; Metcalf, Donald; Roberts, Andrew W.; Huang, David C. S.; Kile, Benjamin T.			Programmed anuclear cell death delimits platelet life span	CELL			English	Article							BCL-X; IN-VIVO; APOPTOSIS; SURVIVAL; BAX; PROTEINS; INHIBITION; ACTIVATION; PATHWAYS; EXPOSURE	Platelets are anuclear cytoplasmic fragments essential for blood clotting and wound healing. Despite much speculation, the factors determining their life span in the circulation are unknown. We show here that an intrinsic program for apoptosis, controls platelet survival and dictates their life span. Pro-survival Bcl-X-L constrains the pro-apoptotic activity of Bak to maintain platelet survival, but as Bcl-X-L degrades, aged platelets are primed for cell death. Genetic ablation or pharmacological inactivation of Bcl-X-L reduces platelet half-life and causes thrombocytopenia in a dose-dependent manner. Deletion of Bak corrects these defects, and platelets from Bak-deficient mice live longer than normal. Thus, platelets are, by default, genetically programmed to die by apoptosis. The antagonistic balance between Bcl-X-L and Bak constitutes a molecular clock that determines platelet life span: this represents an important paradigm for cellular homeostasis, and has profound implications for the diagnosis and treatment of disorders that affect platelet number and function.	Walter & Eliza Hall Inst Med Res, Mol Genet Canc Div, Melbourne, Vic 3050, Australia; Walter & Eliza Hall Inst Med Res, Div Mol Med, Melbourne, Vic 3050, Australia; Walter & Eliza Hall Inst Med Res, Canc & Hematol Div, Melbourne, Vic 3050, Australia; Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; Peter MacCallum Canc Ctr, Trescowthick Res Labs, Melbourne, Vic 3002, Australia; Royal Childrens Hosp, Childrens Canc Ctr, Parkville, Vic 3052, Australia	Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; University of Melbourne; Peter Maccallum Cancer Center; Royal Children's Hospital Melbourne	Huang, DCS (corresponding author), Walter & Eliza Hall Inst Med Res, Mol Genet Canc Div, Melbourne, Vic 3050, Australia.	huang_d@wehi.edu.au; kile@wehi.edu.au	Ekert, Paul/Q-1842-2015; Ekert, Paul G/C-7247-2013; Kile, Benjamin T/F-6593-2011; Kile, Benjamin/GNP-3246-2022; Fletcher, Jamie/V-4667-2019; Roberts, Andrew W./C-6736-2012; Huang, David C. S./C-7586-2013	Ekert, Paul/0000-0002-2976-8617; Ekert, Paul G/0000-0002-2976-8617; Kile, Benjamin T/0000-0002-8836-8947; Kile, Benjamin/0000-0002-8836-8947; Roberts, Andrew W./0000-0002-7341-5720; Huang, David C. S./0000-0002-3101-4873; Mason, Kylie/0000-0002-6238-4092; Ellis, Sarah/0000-0002-5772-6051; Carpinelli, Marina/0000-0001-5115-7831; Fletcher, Jamie/0000-0003-2949-9469				Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; AULT KA, 1995, EXP HEMATOL, V23, P996; Berger G, 1998, BLOOD, V92, P4446, DOI 10.1182/blood.V92.11.4446; Bertino AM, 2003, TRANSFUSION, V43, P857, DOI 10.1046/j.1537-2995.2003.t01-4-00431.x; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Brown SB, 2000, J BIOL CHEM, V275, P5987, DOI 10.1074/jbc.275.8.5987; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Clarke MCH, 2003, J CELL BIOL, V160, P577, DOI 10.1083/jcb.200210111; Cohen Z, 2004, THROMB RES, V113, P387, DOI 10.1016/j.thromres.2004.03.020; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; de Botton S, 2002, BLOOD, V100, P1310, DOI 10.1182/blood-2002-03-0686; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; George JN, 1998, ANN INTERN MED, V129, P886, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00009; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; JACOBSON MD, 1994, EMBO J, V13, P1899, DOI 10.1002/j.1460-2075.1994.tb06459.x; Kaluzhny Y, 2002, BLOOD, V100, P1670, DOI 10.1182/blood-2001-12-0263; Kasai S, 2003, DEV BIOL, V264, P202, DOI 10.1016/S0012-1606(03)00400-7; Kaushansky K, 2005, J CLIN INVEST, V115, P3339, DOI 10.1172/JCI26674; KIENAST J, 1990, BLOOD, V75, P116; LEEKSMA CHW, 1955, NATURE, V175, P552, DOI 10.1038/175552b0; Li JZ, 2000, TRANSFUSION, V40, P1320, DOI 10.1046/j.1537-2995.2000.40111320.x; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Methot N, 2004, J EXP MED, V199, P199, DOI 10.1084/jem.20031791; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; MUSTARD JF, 1966, BRIT J HAEMATOL, V12, P1, DOI 10.1111/j.1365-2141.1966.tb00121.x; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Patel SR, 2005, J CLIN INVEST, V115, P3348, DOI 10.1172/JCI26891; Pereira J, 2002, THROMB HAEMOSTASIS, V87, P905; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Rand ML, 2004, J THROMB HAEMOST, V2, P651, DOI 10.1111/j.1538-7836.2004.00670.x; Rathmell JC, 2002, NAT IMMUNOL, V3, P932, DOI 10.1038/ni834; Rudin CM, 1997, ANNU REV MED, V48, P267; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vanags DM, 1997, BRIT J HAEMATOL, V99, P824, DOI 10.1046/j.1365-2141.1997.4813284.x; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; ZHANG H, 2007, IN PRESS CELL DEATH; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	44	731	768	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1173	1186		10.1016/j.cell.2007.01.037	http://dx.doi.org/10.1016/j.cell.2007.01.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382885	Bronze			2022-12-28	WOS:000245396200022
J	Waterhouse, J; Reilly, T; Atkinson, G; Edwards, B				Waterhouse, Jim; Reilly, Thomas; Atkinson, Greg; Edwards, Ben			Jet lag: trends and coping strategies	LANCET			English	Review							HUMAN CIRCADIAN-RHYTHMS; INTERMITTENT BRIGHT LIGHT; CORE BODY-TEMPERATURE; PHASE RESPONSE CURVE; LONG-HAUL FLIGHTS; SLEEP-WAKE CYCLE; EXTRAOCULAR LIGHT; INTERNATIONAL TRAVEL; DIM LIGHT; MELATONIN SUPPRESSION	The number of travellers undertaking long-distance flights has continued to increase. Such flights are associated with travel fatigue and jet lag, the symptoms of which are considered here, along with their similarities, differences, and causes. Difficulties with jet lag because of sleep loss and decreased performance are emphasised. Since jet lag is caused mainly by inappropriate timing of the body clock in the new time zone, the pertinent properties of the body clock are outlined, with a description of how the body clock can be adjusted. The methods, both pharmacological and behavioural, that have been used to alleviate the negative results of time-zone transitions, are reviewed. The results form the rationale for advice to travellers flying in different directions and crossing several time zones. Finally, there is an account of the main problems that remain unresolved.	Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 2ET, Merseyside, England	Liverpool John Moores University	Waterhouse, J (corresponding author), Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Henry Cotton Campus, Liverpool L3 2ET, Merseyside, England.	waterhouseathome@hotmail.com	Atkinson, Greg/ABA-2278-2021	Atkinson, Greg/0000-0002-5459-9042				Ansari MT, 2005, J TRAVEL MED, V12, P142, DOI 10.2310/7060.2005.12303; Arendt J, 1997, J BIOL RHYTHM, V12, P604, DOI 10.1177/074873049701200616; Arendt J, 2005, SLEEP MED REV, V9, P25, DOI 10.1016/j.smrv.2004.05.002; Arendt J, 1997, J BIOL RHYTHM, V12, P673, DOI 10.1177/074873049701200624; Ariznavarreta C, 2002, AVIAT SPACE ENVIR MD, V73, P445; Atkinson G, 2001, INT J SPORTS MED, V22, P232, DOI 10.1055/s-2001-16387; Baehr EK, 2000, J SLEEP RES, V9, P117, DOI 10.1046/j.1365-2869.2000.00196.x; Baehr EK, 1999, AM J PHYSIOL-REG I, V277, pR1598, DOI 10.1152/ajpregu.1999.277.6.R1598; Baehr EK, 2003, AM J PHYSIOL-REG I, V284, pR1542, DOI 10.1152/ajpregu.00761.2002; Barger LK, 2004, AM J PHYSIOL-REG I, V286, pR1077, DOI 10.1152/ajpregu.00397.2003; Beaumont M, 2004, J APPL PHYSIOL, V96, P50, DOI 10.1152/japplphysiol.00940.2002; Boivin DB, 2002, J BIOL RHYTHM, V17, P266, DOI 10.1177/07430402017003010; Boivin DB, 1998, NEUROREPORT, V9, P779, DOI 10.1097/00001756-199803300-00002; Boulos Z, 2002, AVIAT SPACE ENVIR MD, V73, P953; Bourgeois-Bougrine S, 2003, AVIAT SPACE ENVIR MD, V74, P1072; Brainard GC, 1997, J BIOL RHYTHM, V12, P537, DOI 10.1177/074873049701200608; Bratton RL, 1999, POSTGRAD MED, V106, P57, DOI 10.3810/pgm.1999.07.605; Brown TP, 2001, J R SOC PROMO HEALTH, V121, P177, DOI 10.1177/146642400112100315; Bubenik GA, 1998, BIOL SIGNAL RECEPT, V7, P195; Burgess HJ, 2003, J BIOL RHYTHM, V18, P318, DOI 10.1177/0748730403253585; Buscemi N, 2006, BMJ-BRIT MED J, V332, P385, DOI 10.1136/bmj.38731.532766.F6; Buxton OM, 2000, SLEEP, V23, P915; Buxton OM, 2003, AM J PHYSIOL-REG I, V284, pR714, DOI 10.1152/ajpregu.00355.2002; Buxton OM, 1997, AM J PHYSIOL-ENDOC M, V273, pE536, DOI 10.1152/ajpendo.1997.273.3.E536; Buxton OM, 2000, AM J PHYSIOL-REG I, V278, pR373, DOI 10.1152/ajpregu.2000.278.2.R373; Cagnacci A, 1997, J BIOL RHYTHM, V12, P509, DOI 10.1177/074873049701200604; Cagnacci A, 1997, AM J PHYSIOL-REG I, V272, pR482, DOI 10.1152/ajpregu.1997.272.2.R482; Cajochen C, 2003, J NEUROENDOCRINOL, V15, P432, DOI 10.1046/j.1365-2826.2003.00989.x; Cajochen C, 2006, EUR J NEUROSCI, V23, P1082, DOI 10.1111/j.1460-9568.2006.04613.x; Cajochen C, 1998, J SLEEP RES, V7, P145, DOI 10.1046/j.1365-2869.1998.00106.x; Caldwell JA, 2005, AVIAT SPACE ENVIR MD, V76, pC39; Campbell SS, 1998, SCIENCE, V279, P396, DOI 10.1126/science.279.5349.396; Cardinali DP, 2002, J PINEAL RES, V32, P41, DOI 10.1034/j.1600-079x.2002.10820.x; Chesson AL, 1999, SLEEP, V22, P641, DOI 10.1093/sleep/22.5.641; Cho KW, 2001, NAT NEUROSCI, V4, P567, DOI 10.1038/88384; Clayton JD, 2001, NATURE, V409, P829, DOI 10.1038/35057006; Coste O, 2005, STEROIDS, V70, P803, DOI 10.1016/j.steroids.2005.05.003; Danilenko KV, 2000, CHRONOBIOL INT, V17, P659, DOI 10.1081/CBI-100101072; Danilenko KV, 2003, J BIOL RHYTHM, V18, P170, DOI 10.1177/0748730403251732; Daurat A, 2000, PSYCHOPHARMACOLOGY, V149, P241, DOI 10.1007/s002139900367; Dawson D, 1998, ANN MED, V30, P95, DOI 10.3109/07853899808999390; de Castro JM, 2000, NUTRITION, V16, P800, DOI 10.1016/S0899-9007(00)00414-7; Dijk DJ, 1999, ANN MED, V31, P130, DOI 10.3109/07853899908998789; Driver HS, 2000, SLEEP MED REV, V4, P387, DOI 10.1053/smrv.2000.0110; Drust B, 2005, CHRONOBIOL INT, V22, P21, DOI 10.1081/CBI-200041039; Dubocovich ML, 2005, ENDOCRINE, V27, P101, DOI 10.1385/ENDO:27:2:101; Eastman CI, 2000, CHRONOBIOL INT, V17, P807, DOI 10.1081/CBI-100102116; Eastman CI, 2005, SLEEP, V28, P33, DOI 10.1093/sleep/28.1.33; Edwards B, 2002, J SPORT SCI, V20, P725, DOI 10.1080/026404102320219437; Edwards BJ, 2000, ERGONOMICS, V43, P1501, DOI 10.1080/001401300750003934; Flower DJC, 2003, AVIAT SPACE ENVIR MD, V74, P173; Foster RG, 1998, NEURON, V20, P829, DOI 10.1016/S0896-6273(00)80464-X; Gordijn MCM, 1999, J SLEEP RES, V8, P163, DOI 10.1046/j.1365-2869.1999.00156.x; Grajewski B, 2003, SCAND J WORK ENV HEA, V29, P337, DOI 10.5271/sjweh.740; Gronfier C, 2004, AM J PHYSIOL-ENDOC M, V287, pE174, DOI 10.1152/ajpendo.00385.2003; Haimov I, 1999, SLEEP MED REV, V3, P229, DOI 10.1016/S1087-0792(99)90004-7; Hebert M, 2002, J PINEAL RES, V33, P198, DOI 10.1034/j.1600-079X.2002.01885.x; Herxheimer A, 2003, BRIT MED J, V326, P296, DOI 10.1136/bmj.326.7384.296; Herxheimer A, 2002, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD001520, DOI 10.1002/14651858.CD001520]; Hofman MA, 2006, AGEING RES REV, V5, P33, DOI 10.1016/j.arr.2005.07.001; Jelinkova-Vondrasova D, 1999, NEUROSCI LETT, V265, P111, DOI 10.1016/S0304-3940(99)00220-7; Katz G, 2002, COMPR PSYCHIAT, V43, P37, DOI 10.1053/comp.2002.29849; Khalsa SBS, 2003, J PHYSIOL-LONDON, V549, P945, DOI 10.1113/jphysiol.2003.040477; Klerman EB, 2001, J INVEST MED, V49, P30, DOI 10.2310/6650.2001.34088; Krauchi K, 2006, AM J PHYSIOL-REG I, V290, pR1052, DOI 10.1152/ajpregu.00381.2005; Krauchi K, 1997, AM J PHYSIOL-REG I, V272, pR1178, DOI 10.1152/ajpregu.1997.272.4.R1178; Krauchi K, 2002, J BIOL RHYTHM, V17, P364, DOI 10.1177/074873002129002663; Lasko TA, 1999, J BIOL RHYTHM, V14, P122, DOI 10.1177/074873099129000506; LAWTON G, 2006, NEW SCI         0218, P34; Lemmer B, 2002, CHRONOBIOL INT, V19, P743, DOI 10.1081/CBI-120005391; Leproult R, 2005, CLIN ENDOCRINOL, V63, P298, DOI 10.1111/j.1365-2265.2005.02341.x; Lewy AJ, 2005, CHRONOBIOL INT, V22, P1093, DOI 10.1080/07420520500398064; Lewy AJ, 1998, CHRONOBIOL INT, V15, P71, DOI 10.3109/07420529808998671; Lieberman DZ, 2003, PSYCHIAT SERV, V54, P394, DOI 10.1176/appi.ps.54.3.394; Lindblom N, 2000, NEUROREPORT, V11, P713, DOI 10.1097/00001756-200003200-00012; Lowden A, 1999, J SLEEP RES, V8, P15, DOI 10.1046/j.1365-2869.1999.00129.x; Lucas RJ, 1999, CURR BIOL, V9, pR214, DOI 10.1016/S0960-9822(99)80132-8; Lushington K, 2002, J BIOL RHYTHM, V17, P377, DOI 10.1177/074873002129002582; Meir R, 2002, STRENGTH COND J, V24, P28, DOI 10.1519/00126548-200208000-00010; MENEY I, 1998, CHRONOBIOL INT, V14, P125; Middleton B, 1997, J BIOL RHYTHM, V12, P467, DOI 10.1177/074873049701200508; Mishima K, 1997, PSYCHOPHARMACOLOGY, V133, P168, DOI 10.1007/s002130050387; Mistlberger RE, 2005, J BIOL RHYTHM, V20, P339, DOI 10.1177/0748730405277982; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; Monk TH, 2005, J BIOL RHYTHM, V20, P366, DOI 10.1177/0748730405277378; Monk TH, 2000, J SLEEP RES, V9, P101, DOI 10.1046/j.1365-2869.2000.00184.x; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P1, DOI 10.1081/CBI-120017811; Nakao M, 2004, BIOL CYBERN, V91, P138, DOI 10.1007/s00422-004-0502-6; Nickelsen T, 2002, CHRONOBIOL INT, V19, P915, DOI 10.1081/CBI-120014108; OCONNOR P, 2004, FIMS FEDERATION INT; Paine SJ, 2006, J BIOL RHYTHM, V21, P68, DOI 10.1177/0748730405283154; Parry BL, 2002, J MOL MICROB BIOTECH, V4, P463; Rea MS, 2005, BRAIN RES REV, V50, P213, DOI 10.1016/j.brainresrev.2005.07.002; Reddy AB, 2002, J NEUROSCI, V22, P7326; Reilly T, 2005, CLIN SPORT MED, V24, P367, DOI 10.1016/j.csm.2004.12.004; Reilly T, 2003, BIOL RHYTHM RES, V34, P321, DOI 10.1076/brhm.34.4.321.26229; Reilly T, 2001, INT J SPORTS MED, V22, P166, DOI 10.1055/s-2001-16379; REILLY T, 2003, MED SPORTIVA, V7, pE1115; REILLY T, 1997, BIOL RHYTHMS EXERCIS, P75; REILLY T, 2005, SPORT EXERCISE ENV P, P89; Reiter RJ, 2003, BEST PRACT RES CL EN, V17, P273, DOI 10.1016/S1521-690X(03)00016-2; Revell VL, 2006, J CLIN ENDOCR METAB, V91, P54, DOI 10.1210/jc.2005-1009; Revell VL, 2005, J BIOL RHYTHM, V20, P353, DOI 10.1177/0748730405277233; Reynolds NC, 2002, MIL MED, V167, P451, DOI 10.1093/milmed/167.6.451; Richardson GS, 2005, J CLIN PSYCHIAT, V66, P3; Richmond L, 2004, J SCI MED SPORT, V7, P186, DOI 10.1016/S1440-2440(04)80008-2; Ruger M, 2005, J BIOL RHYTHM, V20, P60, DOI 10.1177/0748730404270539; Ruger M, 2003, J BIOL RHYTHM, V18, P409, DOI 10.1177/0748730403256650; Saletu B, 1997, WIEN KLIN WOCHENSCHR, V109, P714; Samel A, 1997, CHRONOBIOL INT, V14, P173, DOI 10.3109/07420529709001154; Sanders DC, 1999, J ANAL TOXICOL, V23, P159, DOI 10.1093/jat/23.3.159; Sato M, 2005, BIOL RHYTHM RES, V36, P287, DOI 10.1080/09291010500079734; Satoh K, 2001, CLIN NEUROPHARMACOL, V24, P334, DOI 10.1097/00002826-200111000-00004; Schwartz JRL, 2004, J CLIN PSYCHIAT, V65, P46; Shanahan TL, 2000, SEMIN PERINATOL, V24, P299, DOI 10.1053/sper.2000.9123; Shochat T, 1997, AM J PHYSIOL-REG I, V273, pR364, DOI 10.1152/ajpregu.1997.273.1.R364; Smith KA, 2004, J CLIN ENDOCR METAB, V89, P3610, DOI 10.1210/jc.2003-032100; Smith RS, 1997, SLEEP, V20, P362; Spitzer RL, 1999, AM J PSYCHIAT, V156, P1392; Steenland K, 1997, SLEEP, V20, P366; Straub WF, 2001, J MANIP PHYSIOL THER, V24, P191, DOI 10.1016/S0161-4754(01)84445-6; Suhner A, 2001, AVIAT SPACE ENVIR MD, V72, P638; Suhner A, 1998, CHRONOBIOL INT, V15, P655, DOI 10.3109/07420529808993201; Takahashi M, 2002, INT ARCH OCC ENV HEA, V75, P435, DOI 10.1007/s00420-002-0324-6; Takahashi T, 1999, PSYCHIAT CLIN NEUROS, V53, P257, DOI 10.1046/j.1440-1819.1999.00537.x; Takahashi T, 2001, PSYCHIAT CLIN NEUROS, V55, P275, DOI 10.1046/j.1440-1819.2001.00857.x; Takahashi T, 2000, PSYCHIAT CLIN NEUROS, V54, P377, DOI 10.1046/j.1440-1819.2000.00722.x; Van Dongen HPA, 2004, AVIAT SPACE ENVIR MD, V75, pA15; VANCAUTER E, 1998, AM J PHYSIOL-ENDOC M, V38, pE48; Warman VL, 2003, NEUROSCI LETT, V342, P37, DOI 10.1016/S0304-3940(03)00223-4; Waterhouse J, 2005, CHRONOBIOL INT, V22, P829, DOI 10.1080/07420520500263375; Waterhouse J, 2004, J SPORT SCI, V22, P946, DOI 10.1080/02640410400000264; Waterhouse J, 2004, CHRONOBIOL INT, V21, P445, DOI 10.1081/CBI-120038628; Waterhouse J, 2003, CHRONOBIOL INT, V20, P1061, DOI 10.1081/CBI-120025249; Waterhouse J, 2002, BRIT J SPORT MED, V36, P54, DOI 10.1136/bjsm.36.1.54; Waterhouse J, 1998, NEUROSCI LETT, V245, P97, DOI 10.1016/S0304-3940(98)00174-8; Waterhouse J, 1997, LANCET, V350, P1611, DOI 10.1016/S0140-6736(97)07569-7; Waterhouse J, 2000, ERGONOMICS, V43, P1514, DOI 10.1080/001401300750003943; WATERHOUSE J, 2001, HDB BEHAV NEUROBIOLO, P571; Wheatley D, 2005, J PSYCHOPHARMACOL, V19, P414, DOI 10.1177/0269881105053309; Wirz-Justice A, 2004, J PINEAL RES, V36, P192, DOI 10.1111/j.1600-079X.2004.00117.x; Wirz-Justice A, 2002, J PINEAL RES, V32, P1, DOI 10.1034/j.1600-079x.2002.10808.x; Wright HR, 2001, CHRONOBIOL INT, V18, P801, DOI 10.1081/CBI-100107515; Zhdanova IV, 1997, J BIOL RHYTHM, V12, P644, DOI 10.1177/074873049701200620; Zisapel N, 2001, CNS DRUGS, V15, P311, DOI 10.2165/00023210-200115040-00005; [No title captured]	146	242	253	1	53	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2007	369	9567					1117	1129		10.1016/S0140-6736(07)60529-7	http://dx.doi.org/10.1016/S0140-6736(07)60529-7			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151XF	17398311				2022-12-28	WOS:000245323700032
J	Smith, CE; Llorente, B; Symington, LS				Smith, Catherine E.; Llorente, Bertrand; Symington, Lorraine S.			Template switching during break-induced replication	NATURE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; MEIOTIC RECOMBINATION; CHROMOSOMAL TRANSLOCATIONS; GENE CONVERSION; REPAIR; DNA; MODEL; GAPS; DUPLICATION; DROSOPHILA	DNA double-strand breaks (DSBs) are potentially lethal lesions that arise spontaneously during normal cellular metabolism, as a consequence of environmental genotoxins or radiation, or during programmed recombination processes. Repair of DSBs by homologous recombination generally occurs by gene conversion resulting from transfer of information from an intact donor duplex to both ends of the break site of the broken chromosome(1). In mitotic cells, gene conversion is rarely associated with reciprocal exchange and thus limits loss of heterozygosity for markers downstream of the site of repair and restricts potentially deleterious chromosome rearrangements(2-5). DSBs that arise by replication fork collapse or by erosion of uncapped telomeres have only one free end and are thought to repair by strand invasion into a homologous duplex DNA followed by replication to the chromosome end (break-induced replication, BIR)(6). BIR from one of the two ends of a DSB would result in loss of heterozygosity, suggesting that BIR is suppressed when DSBs have two ends so that repair occurs by the more conservative gene conversion mechanism. Here we show that BIR can occur by several rounds of strand invasion, DNA synthesis and dissociation. We further show that chromosome rearrangements can occur during BIR if dissociation and reinvasion occur within dispersed repeated sequences. This dynamic process could function to promote gene conversion by capture of the displaced invading strand at two-ended DSBs to prevent BIR.	Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Univ Paris 06, Inst Pasteur, UFR 927, F-75724 Paris 15, France; Inst Pasteur, CNRS, URA 2171, Unite Genet Mol Levures, F-75724 Paris 15, France	Columbia University; Columbia University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Symington, LS (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol, 701 W 169th St, New York, NY 10032 USA.	lss5@columbia.edu	llorente, bertrand/M-3501-2016	Smith, Catherine/0000-0001-6779-8035; Llorente, Bertrand/0000-0002-6291-5797	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041784] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM041784, R01 GM041784-19, R01 GM041784-18] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Aguilera A, 2001, TRENDS GENET, V17, P318, DOI 10.1016/S0168-9525(01)02309-5; Bartsch S, 2000, MOL CELL BIOL, V20, P1194, DOI 10.1128/MCB.20.4.1194-1205.2000; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Davis AP, 2004, MOL CELL BIOL, V24, P2344, DOI 10.1128/MCB.24.6.2344-2351.2004; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Ferguson DO, 1996, P NATL ACAD SCI USA, V93, P5419, DOI 10.1073/pnas.93.11.5419; JINKSROBERTSON S, 1986, GENETICS, V114, P731; Koszul R, 2004, EMBO J, V23, P234, DOI 10.1038/sj.emboj.7600024; Kraus E, 2001, P NATL ACAD SCI USA, V98, P8255, DOI 10.1073/pnas.151008198; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Lemoine S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-467; Malkova A, 2005, MOL CELL BIOL, V25, P933, DOI 10.1128/MCB.25.3.933-944.2005; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; McVey M, 2004, GENETICS, V167, P699, DOI 10.1534/genetics.103.025411; Merker JD, 2003, GENETICS, V165, P47; Morrow DM, 1997, GENETICS, V147, P371; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; Nickoloff JA, 1999, GENETICS, V153, P665; RAY A, 1989, P NATL ACAD SCI USA, V86, P6225, DOI 10.1073/pnas.86.16.6225; Schmidt KH, 2006, MOL CELL BIOL, V26, P5406, DOI 10.1128/MCB.00161-06; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; Stark JM, 2003, MOL CELL BIOL, V23, P733, DOI 10.1128/MCB.23.2.733-743.2003; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; WHITE MA, 1994, CURR GENET, V26, P21, DOI 10.1007/BF00326300	26	257	260	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2007	447	7140					102	105		10.1038/nature05723	http://dx.doi.org/10.1038/nature05723			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17410126				2022-12-28	WOS:000246149300052
J	Fine, PEM; Griffiths, UK				Fine, Paul E. M.; Griffiths, Ulla Kou			Global poliomyelitis eradication: status and implications	LANCET			English	Editorial Material									Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Fine, PEM (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Paul.fine@lshtm.ac.uk						Arita I, 2006, SCIENCE, V312, P852, DOI 10.1126/science.1124959; Dowdle W, 2006, RISK ANAL, V26, P1449, DOI 10.1111/j.1539-6924.2006.00844.x; Fine P E, 2001, Dev Biol (Basel), V105, P129; Fine PEM, 1999, AM J EPIDEMIOL, V150, P1001, DOI 10.1093/oxfordjournals.aje.a009924; *GAVI, 2006, GAVI ROADM; GRASSLY NC, 2007, LANCET; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; MacLennan C, 2004, LANCET, V363, P1509, DOI 10.1016/S0140-6736(04)16150-3; Thomsen C, 2001, ANN PHYS-BERLIN, V10, P7; WHO, 2006, WKLY EPIDEMIOL REC, V81, P453; WHO, 2006, WKLY EPIDEMIOL REC, V81, P465	12	15	15	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1321	1322		10.1016/S0140-6736(07)60533-9	http://dx.doi.org/10.1016/S0140-6736(07)60533-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	159HL	17448799				2022-12-28	WOS:000245856100004
J	Pinnock, H; Shah, R				Pinnock, Hilary; Shah, Rupal			Asthma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EXACERBATIONS; CARE		Univ Edinburgh, Div Community Hlth Sci, GP Sect, Edinburgh EH8 9YL, Midlothian, Scotland	University of Edinburgh	Pinnock, H (corresponding author), Univ Edinburgh, Div Community Hlth Sci, GP Sect, Edinburgh EH8 9YL, Midlothian, Scotland.	Hilary.Pinnock@ed.ac.uk.com		Shah, Rupal/0000-0001-9079-0971	Chief Scientist Office [PCRCA/08/01] Funding Source: Medline	Chief Scientist Office		Boushey HA, 2005, NEW ENGL J MED, V352, P1519, DOI 10.1056/NEJMoa042552; British Thoracic Society & Scottish Intercollegiate Guidelines Network (joint publication), 2005, BRIT GUID MAN ASTHM; Campbell MJ, 1997, BRIT MED J, V314, P1439, DOI 10.1136/bmj.314.7092.1439; Cochran D, 1998, BRIT MED J, V316, P1546, DOI 10.1136/bmj.316.7144.1546; Foresi A, 2000, CHEST, V117, P440, DOI 10.1378/chest.117.2.440; Gibson PG, 2004, THORAX, V59, P94, DOI 10.1136/thorax.2003.011858; Gruffydd-Jones K, 2005, BRIT J GEN PRACT, V55, P918; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Pinnock H, 2003, BMJ-BRIT MED J, V326, P477, DOI 10.1136/bmj.326.7387.477; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Tomerak AAT, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005373; Walker Samantha, 2005, Prim Care Respir J, V14, P83, DOI 10.1016/j.pcrj.2004.10.005	12	12	12	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2007	334	7598					847	850		10.1136/bmj.39140.634896.BE	http://dx.doi.org/10.1136/bmj.39140.634896.BE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	162MD	17446617	Green Published, Green Submitted			2022-12-28	WOS:000246090800036
J	Fuller, MT; Spradling, AC				Fuller, Margaret T.; Spradling, Allan C.			Male and female Drosophila germline stem cells: Two versions of immortality	SCIENCE			English	Review							SELF-RENEWAL; SPERMATOGENESIS; NICHES; OVARY	Drosophila male and female germline stem cells (GSCs) are sustained by niches and regulatory pathways whose common principles serve as models for understanding mammalian stem cells. Despite striking cellular and genetic similarities that suggest a common evolutionary origin, however, male and female GSCs also display important differences. Comparing these two stem cells and their niches in detail is likely to reveal how a common heritage has been adapted to the differing requirements of male and female gamete production.	Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Carnegie Inst Washington, Dept Embryol, Baltimore, MD 21218 USA; Carnegie Inst Washington, Howard Hughes Med Inst, Baltimore, MD 21218 USA	Stanford University; Stanford University; Carnegie Institution for Science; Carnegie Institution for Science; Howard Hughes Medical Institute	Fuller, MT (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.			Fuller, Margaret T/0000-0002-3804-4987	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061986] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [P01DK53074] Funding Source: Medline; NIGMS NIH HHS [R01 GM080501, R01GM61986] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Brinster RL, 2007, SCIENCE, V316, P404, DOI 10.1126/science.1137741; Casanueva MO, 2004, DEVELOPMENT, V131, P1881, DOI 10.1242/dev.01076; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Gilboa L, 2004, CURR BIOL, V14, P981, DOI 10.1016/j.cub.2004.05.049; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Schulz C, 2004, GENETICS, V167, P707, DOI 10.1534/genetics.103.023184; Schulz C, 2002, DEVELOPMENT, V129, P4523; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910	17	325	333	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					402	404		10.1126/science.1140861	http://dx.doi.org/10.1126/science.1140861			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446390				2022-12-28	WOS:000245813400041
J	Hansson, GK				Hansson, Goran K.			LIGHT hits the liver	SCIENCE			English	Editorial Material							CORONARY-ARTERY-DISEASE; NECROSIS-FACTOR; HEPATIC LIPASE; ATHEROSCLEROSIS; INFLAMMATION; LIPOPROTEIN		Karolinska Inst, Dept Med, SE-17176 Stockholm, Sweden; Karolinska Inst, Ctr Mol Med, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Hansson, GK (corresponding author), Karolinska Inst, Dept Med, SE-17176 Stockholm, Sweden.	goran.hansson@ki.se	Hansson, Goran K/B-7423-2012	Hansson, Goran/0000-0003-4148-5190				BENDELAC A, 2006, ANNU REV IMMUNOL, V202, P49; BEUTLER B, 1986, NATURE, V320, P584, DOI 10.1038/320584a0; Dugi KA, 2001, CIRCULATION, V104, P3057, DOI 10.1161/hc5001.100795; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Lo JC, 2007, SCIENCE, V316, P285, DOI 10.1126/science.1137221; Mach F, 1998, NATURE, V394, P200, DOI 10.1038/28204; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Santamarina-Fojo S, 2004, ARTERIOSCL THROM VAS, V24, P1750, DOI 10.1161/01.ATV.0000140818.00570.2d; Schneider K, 2004, IMMUNOL REV, V202, P49, DOI 10.1111/j.0105-2896.2004.00206.x; STEMME S, 1995, P NATL ACAD SCI USA, V92, P3893, DOI 10.1073/pnas.92.9.3893; Tupin E, 2004, J EXP MED, V199, P417, DOI 10.1084/jem.20030997; Wang XS, 2005, NAT GENET, V37, P365, DOI 10.1038/ng1524	14	8	8	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					206	207		10.1126/science.1142238	http://dx.doi.org/10.1126/science.1142238			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431157				2022-12-28	WOS:000245654500027
J	Greer, DM; Plotkin, SR; Hasserjian, RP; Harris, NL; Steere, AC				Greer, David M.; Plotkin, Scott R.; Hasserjian, Robert P.; Harris, Nancy Lee; Steere, Allen C.			A 59-year-old man with neck pain, weakness in the arms, and cranial-nerve palsies - Lyme disease of the nervous system (neuroborreliosis).	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CEREBROSPINAL-FLUID; BORRELIA-BURGDORFERI; BANNWARTHS SYNDROME; ERYTHEMA MIGRANS; LYMPHOMA; BABESIOSIS; CELLS; MANIFESTATIONS; PARALYSIS; DIAGNOSIS		Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Neurol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University	Greer, DM (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.			Greer, David/0000-0002-2026-8333; Steere, Allen/0000-0002-5268-9853; Plotkin, Scott/0000-0002-6109-6419				Abbott RA, 2005, J NEUROL NEUROSUR PS, V76, P1306, DOI 10.1136/jnnp.2004.046284; BAIG S, 1989, LANCET, V2, P71; BARZA M, 1984, NEW ENGL J MED, V311, P172, DOI 10.1056/NEJM198407193110309; Bollen ELEM, 1997, ARCH NEUROL-CHICAGO, V54, P854, DOI 10.1001/archneur.1997.00550190044013; *CBTRUS, 2005, STAT REP PRIM BRAIN; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; COLOVER J, 1948, BRAIN, V71, P451, DOI 10.1093/brain/71.4.451; DRESSLER F, 1993, J INFECT DIS, V167, P392, DOI 10.1093/infdis/167.2.392; GLASS JP, 1979, NEUROLOGY, V29, P1369, DOI 10.1212/WNL.29.10.1369; Ishaq S, 2002, NEUROLOGY, V59, P1810, DOI 10.1212/01.WNL.0000035534.70975.C8; Jacobsen M, 2003, J INFECT DIS, V187, P963, DOI 10.1086/368131; Kieslich M, 2000, BRAIN DEV-JPN, V22, P403, DOI 10.1016/S0387-7604(00)00165-0; KIRSCH M, 1988, JAMA-J AM MED ASSOC, V259, P2737, DOI 10.1001/jama.259.18.2737; Krause PJ, 1996, JAMA-J AM MED ASSOC, V275, P1657, DOI 10.1001/jama.275.21.1657; Krause PJ, 2002, CLIN INFECT DIS, V34, P1184, DOI 10.1086/339813; LACHANCE DH, 1991, NEUROLOGY, V41, P95, DOI 10.1212/WNL.41.1.95; LAKOS A, 1992, J INFECTION, V25, P155, DOI 10.1016/0163-4453(92)93966-T; LUXON L, 1979, LANCET, V1, P90; NEWMAN NJ, 1995, AM J OPHTHALMOL, V120, P613, DOI 10.1016/S0002-9394(14)72208-1; Owens GP, 2003, J IMMUNOL, V171, P2725, DOI 10.4049/jimmunol.171.5.2725; Posner JB, 1995, NEUROLOGIC COMPLICAT, P143; REIK L, 1979, MEDICINE, V58, P281, DOI 10.1097/00005792-197907000-00001; REIK L, 1993, NEUROLOGY, V43, P2705, DOI 10.1212/WNL.43.12.2705; Roma AA, 2002, DIAGN CYTOPATHOL, V27, P271, DOI 10.1002/dc.10190; Rupprecht TA, 2005, NEUROLOGY, V65, P448, DOI 10.1212/01.wnl.0000171349.06645.79; Shenkier TN, 2005, HEMATOL ONCOL CLIN N, V19, P651, DOI 10.1016/j.hoc.2005.05.001; Smith RP, 2002, ANN INTERN MED, V136, P421, DOI 10.7326/0003-4819-136-6-200203190-00005; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Steere AC, 2003, NEW ENGL J MED, V348, P2472, DOI 10.1056/NEJM200306123482423; Steere AC, 2003, AM J MED, V114, P58, DOI 10.1016/S0002-9343(02)01440-7; STEERE AC, 1990, J INFECT DIS, V161, P1203, DOI 10.1093/infdis/161.6.1203; van der Velden VHJ, 2003, LEUKEMIA, V17, P1013, DOI 10.1038/sj.leu.2402922; Walther EU, 2004, EUR NEUROL, V51, P43, DOI 10.1159/000075086; WILSKE B, 1986, J INFECT DIS, V153, P304, DOI 10.1093/infdis/153.2.304; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667	35	8	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 12	2007	356	15					1561	1570		10.1056/NEJMcpc079005	http://dx.doi.org/10.1056/NEJMcpc079005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156CA	17429088				2022-12-28	WOS:000245624400011
J	Li, GH; Baker, SP				Li, Guohua; Baker, Susan P.			Crash risk in general aviation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HELICOPTER CRASHES; AIR TAXIS; ALCOHOL; PILOTS; ACCIDENTS; AIRCRAFT; COMMUTER		Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21209 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Injury Res & Policy, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Li, GH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Emergency Med, 5801 Smith Ave,Suite 3220, Baltimore, MD 21209 USA.	ghli@jhmi.edu			NIAAA NIH HHS [R01AA09963] Funding Source: Medline; NIA NIH HHS [R01AG13642] Funding Source: Medline; PHS HHS [CCR302486] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG013642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009963] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		*AMSAFE AV, INFL RESTR TECHN; Baker SP, 2006, ANN EMERG MED, V47, P351, DOI 10.1016/j.annemergmed.2005.11.018; BARON J, 2006, NY TIMES        1012, pA1; BILLINGS CE, 1973, AEROSPACE MED, V44, P379; BOOZE CF, 1977, AVIAT SPACE ENVIR MD, V48, P1081; BOOZE CF, 1989, AVIAT SPACE ENVIR MD, V60, P332; Bureau of Transportation Statistics, NAT TRANSP STAT; Cook CCH, 1997, ADDICTION, V92, P539, DOI 10.1046/j.1360-0443.1997.9255394.x; GIBBONS HL, 1988, AVIAT SPACE ENVIR MD, V59, P657; Groff LS, 2006, AVIAT SPACE ENVIR MD, V77, P1062; Hayden MS, 2005, AVIAT SPACE ENVIR MD, V76, P782; Kearney PJ, 2000, AVIAT SPACE ENVIR MD, V71, P19; LI GH, 1994, AVIAT SPACE ENVIR MD, V65, P979; Li GH, 1999, AVIAT SPACE ENVIR MD, V70, P305; Li GH, 2005, ACCIDENT ANAL PREV, V37, P179, DOI 10.1016/j.aap.2004.04.005; LI GH, 1993, J OCCUP ENVIRON MED, V35, P1244; Li GH, 2001, AVIAT SPACE ENVIR MD, V72, P52; Li GH, 2005, ACCIDENT ANAL PREV, V37, P143, DOI 10.1016/j.aap.2004.03.005; LI GH, 1994, AVIAT SPACE ENVIR MD, V65, P944; MCCORMICK BW, 1996, AIRCRAFT ACCIDENT RE, P501; *NAT TRANSP SAF BO, ACC FAT RAT 1986 200; Rostykus PS, 1998, JAMA-J AM MED ASSOC, V280, P997, DOI 10.1001/jama.280.11.997; SHANAHAN DF, 1989, J TRAUMA, V29, P415, DOI 10.1097/00005373-198904000-00001; URBAN RF, 1984, AVIAT SPACE ENVIR MD, V55, P308	24	38	38	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2007	297	14					1596	1598		10.1001/jama.297.14.1596	http://dx.doi.org/10.1001/jama.297.14.1596			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155PG	17426280				2022-12-28	WOS:000245589800029
J	MacArthur, RD				MacArthur, Rodger D.			Darunavir: promising initial results	LANCET			English	Editorial Material							ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTION; ENFUVIRTIDE; SUSCEPTIBILITY; TIPRANAVIR; RESISTANCE; INHIBITOR; EFFICACY		Wayne State Univ, Detroit, MI 48201 USA	Wayne State University	MacArthur, RD (corresponding author), Wayne State Univ, Detroit, MI 48201 USA.	rmacarthur@med.wayne.edu						Clotet B, 2007, LANCET, V369, P1169, DOI 10.1016/S0140-6736(07)60497-8; DEMEYER S, 2006, 13 C RETR OPP INF FE; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hicks CB, 2006, LANCET, V368, P466, DOI 10.1016/S0140-6736(06)69154-X; King M, 2006, ANTIVIR THER, V11, pS34; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; LOUTFY M, 2005, J INFECT DIS, V6, P284; MacArthur RD, 2005, HIV CLIN TRIALS, V6, P127, DOI 10.1310/A9B9-RQD7-U8KA-503U; Mocroft A, 2004, J INFECT DIS, V190, P1947, DOI 10.1086/425424; Staes M, 2006, ANTIVIR THER, V11, pS33; Youle M, 2006, HIV CLIN TRIALS, V7, P86, DOI 10.1310/2XVK-PBGL-735N-WH72	12	7	8	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2007	369	9568					1143	1144		10.1016/S0140-6736(07)60499-1	http://dx.doi.org/10.1016/S0140-6736(07)60499-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155RH	17416241				2022-12-28	WOS:000245595100004
J	Lerner, IV				Lerner, Igor V.			So small yet still giant	SCIENCE			English	Editorial Material							FLUCTUATIONS; CONDUCTORS; TRANSPORT; DRAG		Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Lerner, IV (corresponding author), Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England.	i.v.lerner@bham.ac.uk	Lerner, Igor V/E-4157-2018	Lerner, Igor V/0000-0002-9973-499X	EPSRC [EP/D031109/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D031109/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Altshuler B. L., 1986, Soviet Physics - JETP, V64, P127; ALTSHULER BL, 1985, JETP LETT+, V41, P648; GRAMILA TJ, 1991, PHYS REV LETT, V66, P1216, DOI 10.1103/PhysRevLett.66.1216; LEE PA, 1985, PHYS REV LETT, V55, P1622, DOI 10.1103/PhysRevLett.55.1622; LERNER IV, 1988, PHYS LETT A, V133, P253, DOI 10.1016/0375-9601(88)91027-4; Narozhny BN, 2000, PHYS REV LETT, V84, P5383, DOI 10.1103/PhysRevLett.84.5383; POGREBINSKII MB, 1977, SOV PHYS SEMICOND+, V11, P372; Price AS, 2007, SCIENCE, V316, P99, DOI 10.1126/science.1139227; SIVAN U, 1992, PHYS REV LETT, V68, P1196, DOI 10.1103/PhysRevLett.68.1196; SOLOMON PM, 1989, PHYS REV LETT, V63, P2508, DOI 10.1103/PhysRevLett.63.2508	10	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2007	316	5821					63	64		10.1126/science.1141972	http://dx.doi.org/10.1126/science.1141972			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412946				2022-12-28	WOS:000245470500029
J	Uiberacker, M; Uphues, T; Schultze, M; Verhoef, AJ; Yakovlev, V; Kling, MF; Rauschenberger, J; Kabachnik, NM; Schroder, H; Lezius, M; Kompa, KL; Muller, HG; Vrakking, MJJ; Hendel, S; Kleineberg, U; Heinzmann, U; Drescher, M; Krausz, F				Uiberacker, M.; Uphues, Th.; Schultze, M.; Verhoef, A. J.; Yakovlev, V.; Kling, M. F.; Rauschenberger, J.; Kabachnik, N. M.; Schroeder, H.; Lezius, M.; Kompa, K. L.; Muller, H. -G.; Vrakking, M. J. J.; Hendel, S.; Kleineberg, U.; Heinzmann, U.; Drescher, M.; Krausz, F.			Attosecond real-time observation of electron tunnelling in atoms	NATURE			English	Article							SHAKE-UP; XE 4D; KR 3D; IONIZATION; PHOTOIONIZATION; THRESHOLD; CYCLE; AUGER; SATELLITES; SPECTRA	Atoms exposed to intense light lose one or more electrons and become ions. In strong fields, the process is predicted to occur via tunnelling through the binding potential that is suppressed by the light field near the peaks of its oscillations. Here we report the real-time observation of this most elementary step in strong-field interactions: light-induced electron tunnelling. The process is found to deplete atomic bound states in sharp steps lasting several hundred attoseconds. This suggests a new technique, attosecond tunnelling, for probing short-lived, transient states of atoms or molecules with high temporal resolution. The utility of attosecond tunnelling is demonstrated by capturing multi-electron excitation (shake-up) and relaxation ( cascaded Auger decay) processes with subfemtosecond resolution.	Univ Munich, Dept Phys, D-85748 Garching, Germany; Max Planck Inst Quantum Opt, D-85748 Garching, Germany; Univ Bielefeld, Fak Phys, D-33615 Bielefeld, Germany; Vienna Univ Technol, A-1040 Vienna, Austria; FOM, Inst Atom & Mol Phys, NL-1098 SJ Amsterdam, Netherlands; Moscow MV Lomonosov State Univ, Inst Nucl Phys, Moscow 119992, Russia; Univ Hamburg, Inst Expt Phys, D-22671 Hamburg, Germany	University of Munich; Max Planck Society; University of Bielefeld; Technische Universitat Wien; AMOLF; Lomonosov Moscow State University; National Research Centre - Kurchatov Institute; Institute of High Energy Physics - IHEP; University of Hamburg	Uiberacker, M (corresponding author), Univ Munich, Dept Phys, Coulombwall 1, D-85748 Garching, Germany.	matthias.uiberacker@mpq.mpg.de; ferenc.krausz@mpq.mpg.de	Kling, Matthias Friedrich/AHH-0080-2022; Kabachnik, Nikolay M/D-9585-2014; Yakovlev, Vladislav S/C-4091-2015; Kling, Matthias F/D-3742-2014; Rauschenberger, Jens/C-4078-2011; Vrakking, Marc JJ/F-6770-2014; Uphues, Thorsten/D-1373-2014; Heinzmann, Ulrich/A-6248-2012	Kling, Matthias Friedrich/0000-0002-1710-0775; Yakovlev, Vladislav S/0000-0002-0648-9375; Vrakking, Marc JJ/0000-0002-3249-1663; Uphues, Thorsten/0000-0003-3423-4510; Schultze, Martin/0000-0003-0438-9255; Verhoef, Aart/0000-0003-2691-214X				AKSELA H, 1996, VUV SOFT XRAY PHOTOI, P401; Baltuska A, 2003, NATURE, V421, P611, DOI 10.1038/nature01414; BECKER U, 1989, PHYS REV A, V39, P3902, DOI 10.1103/PhysRevA.39.3902; Becker U., 1996, VUV SOFT XRAY PHOTOI, P135; Brabec T, 2000, REV MOD PHYS, V72, P545, DOI 10.1103/RevModPhys.72.545; Drescher M, 2002, NATURE, V419, P803, DOI 10.1038/nature01143; FAISAL FHM, 1973, J PHYS B-AT MOL OPT, V6, pL89, DOI 10.1088/0022-3700/6/4/011; Goulielmakis E, 2004, SCIENCE, V305, P1267, DOI 10.1126/science.1100866; HAYAISHI T, 1991, PHYS REV A, V44, pR2771, DOI 10.1103/PhysRevA.44.R2771; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; HOLLAND DMP, 1979, J PHYS B-AT MOL OPT, V12, P2465, DOI 10.1088/0022-3700/12/15/008; Istomin AY, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.032713; Itatani J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.173903; KAMMERLING B, 1992, J PHYS B-AT MOL OPT, V25, P3621, DOI 10.1088/0953-4075/25/17/014; KELDYSH LV, 1965, SOV PHYS JETP-USSR, V20, P1307; Kienberger R, 2004, NATURE, V427, P817, DOI 10.1038/nature02277; Kitzler M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.173904; Lablanquie P, 2002, J PHYS B-AT MOL OPT, V35, P3265, DOI 10.1088/0953-4075/35/15/304; LARKINS FP, 1971, J PHYS PT B ATOM M P, V4, P14, DOI 10.1088/0022-3700/4/1/004; *NAT I STAND TECHN, 1994, PHYS REF DAT; Penent F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.083002; REISS HR, 1980, PHYS REV A, V22, P1786, DOI 10.1103/PhysRevA.22.1786; Sansone G, 2006, SCIENCE, V314, P443, DOI 10.1126/science.1132838; SCHRODER H, 1993, BER BUNSEN PHYS CHEM, V97, P1688, DOI 10.1002/bbpc.19930971228; Scrinzi A, 1999, PHYS REV LETT, V83, P706, DOI 10.1103/PhysRevLett.83.706; Smirnova O, 2006, J PHYS B ATOM MOL PH, V39, P323; SVENSSON S, 1988, J ELECTRON SPECTROSC, V47, P327, DOI 10.1016/0368-2048(88)85020-5; Viefhaus J, 2005, J PHYS B-AT MOL OPT, V38, P3885, DOI 10.1088/0953-4075/38/21/011; WAGNER M, 1993, INT J MASS SPECTROM, V128, P31, DOI 10.1016/0168-1176(93)87014-J; Witzel B, 1998, INT J MASS SPECTROM, V172, P229, DOI 10.1016/S0168-1176(97)00264-4; Yudin GL, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.013409	31	709	732	6	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2007	446	7136					627	632		10.1038/nature05648	http://dx.doi.org/10.1038/nature05648			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17410167				2022-12-28	WOS:000245438300031
J	Odling-Smee, L				Odling-Smee, Lucy			Biofuels bandwagon hits a rut	NATURE			English	News Item																			0	12	12	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2007	446	7135					483	483		10.1038/446483a	http://dx.doi.org/10.1038/446483a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392760	Bronze			2022-12-28	WOS:000245242900021
J	von Bubnoff, A				von Bubnoff, Andreas			Superpostdocs reach for the stars	CELL			English	Editorial Material								In the US and now also in Europe, a growing number of special fellowship programs, sometimes called "superpostdocs," offer newly minted PhDs instant independence and enable them to undertake pioneering research. Job prospects for fellows are rosy, but such early independence is not for everyone.											0	1	1	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2007	128	6					1023	1026		10.1016/j.cell.2007.03.005	http://dx.doi.org/10.1016/j.cell.2007.03.005			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382872	Bronze			2022-12-28	WOS:000245396200006
J	Francis, PT				Francis, Paul T.			Surveillance of acute flaccid paralysis in India	LANCET			English	Editorial Material									Amrita Sch Med, Cochin 682026, Kerala, India	Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi	Francis, PT (corresponding author), Amrita Sch Med, Cochin 682026, Kerala, India.	paultfrancis@gmail.com						Kohler KA, 2003, B WORLD HEALTH ORGAN, V81, P2; *WHO, IMM VACC DEV VPD SUR; 2005, FIELD GUIDE SURVEILL	3	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 21	2007	369	9570					1322	1323		10.1016/S0140-6736(07)60610-2	http://dx.doi.org/10.1016/S0140-6736(07)60610-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	159HL	17448800				2022-12-28	WOS:000245856100005
J	Hankey, GJ				Hankey, Graeme J.			Clinical update: management of stroke	LANCET			English	Article							CLOPIDOGREL; PREVENTION; ASPIRIN; DIPYRIDAMOLE; TRIAL; RISK		Royal Perth Hosp, Dept Neurol, Perth, WA 6001, Australia	Royal Perth Hospital; University of Western Australia	Hankey, GJ (corresponding author), Royal Perth Hosp, Dept Neurol, Perth, WA 6001, Australia.	gjhankey@cyllene.uwa.edu.au	Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328				Amarenco P, 2006, NEW ENGL J MED, V355, P549; Bazzano LA, 2006, JAMA-J AM MED ASSOC, V296, P2720, DOI 10.1001/jama.296.22.2720; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; de Bruijn SFTM, 2006, STROKE, V37, P2531, DOI 10.1161/01.STR.0000241064.46659.69; Diener HC, 2007, CEREBROVASC DIS, V23, P368, DOI 10.1159/000100105; Halkes PHA, 2007, LANCET NEUROL, V6, P115, DOI 10.1016/S1474-4422(06)70685-8; Halkes PHA, 2006, LANCET, V367, P1665; Hand PJ, 2006, STROKE, V37, P769, DOI 10.1161/01.STR.0000204041.13466.4c; HANKEY GJ, 2005, STROKE TREATMENT PRE; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Mas J, 2006, NEW ENGL J MED, V355, P1660, DOI 10.1056/NEJMoa061752; Ringleb PA, 2006, LANCET, V368, P1239, DOI 10.1016/S0140-6736(06)69122-8; Rothwell PM, 2005, LANCET, V365, P256; Steiner T, 2006, CEREBROVASC DIS, V22, P294, DOI 10.1159/000094831; STEYER R, 2007, STREET COM      0226; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4	19	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1330	1332		10.1016/S0140-6736(07)60614-X	http://dx.doi.org/10.1016/S0140-6736(07)60614-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	159HL	17448805				2022-12-28	WOS:000245856100010
J	Young, J; Inouye, SK				Young, John; Inouye, Sharon K.			Delirium in older people	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CONFUSION ASSESSMENT METHOD; ELDER-LIFE-PROGRAM; MEDICAL INPATIENTS; MULTIFACTORIAL INTERVENTION; CEREBROVASCULAR EVENTS; COGNITIVE IMPAIRMENT; PREVENT DELIRIUM; RATING-SCALE; RISK-FACTORS; CARE		Univ Leeds, Acad Unit Elderly Care & Rehabil, Leeds LS2 9JT, W Yorkshire, England; Bradford Teaching Hosp NHS Fdn Trust, Bradford, W Yorkshire, England; Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA USA; Inst Aging Res, Aging Brain Ctr, Boston, MA USA	University of Leeds; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Young, J (corresponding author), St Lukes Hosp, Acad Unit Elderly Care & Rehabil, Bradford BD5 0NA, W Yorkshire, England.	john.young@bradfordhospitals.nhs.uk	Inouye, Sharon/R-7216-2019	young, john/0000-0003-4085-9306				Adamis D, 2005, J MED ETHICS, V31, P137, DOI 10.1136/jme.2002.000919; Adamis D, 2005, AGE AGEING, V34, P72, DOI 10.1093/ageing/afi019; Alagiakrishnan K, 2004, POSTGRAD MED J, V80, P388, DOI 10.1136/pgmj.2003.017236; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; American Psychiatric Association, 1999, PRACT GUID TREATM PA; Ancelin ML, 2006, BMJ-BRIT MED J, V332, P455, DOI 10.1136/bmj.38740.439664.DE; Brooke P, 1999, INT J GERIATR PSYCH, V14, P936, DOI 10.1002/(SICI)1099-1166(199911)14:11<936::AID-GPS39>3.3.CO;2-T; BRUCE AJ, 2006, INT PSYCHOGERIATR, P1; Caplan GA, 2006, AGE AGEING, V35, P53, DOI 10.1093/ageing/afi206; Cole M, 2003, J AM GERIATR SOC, V51, P754, DOI 10.1046/j.1365-2389.2003.51255.x; COLE MG, 1994, CAN MED ASSOC J, V151, P965; Cole MG, 2002, CAN MED ASSOC J, V167, P753; Dasgupta M, 2006, J AM GERIATR SOC, V54, P1578, DOI 10.1111/j.1532-5415.2006.00893.x; Elie M, 1998, J GEN INTERN MED, V13, P204, DOI 10.1046/j.1525-1497.1998.00047.x; Fick DM, 2002, J AM GERIATR SOC, V50, P1723, DOI 10.1046/j.1532-5415.2002.50468.x; Flacker JM, 1999, J GERONTOL A-BIOL, V54, pB239, DOI 10.1093/gerona/54.6.B239; Flaherty JH, 2003, J AM GERIATR SOC, V51, P1031, DOI 10.1046/j.1365-2389.2003.51320.x; Freter SH, 2005, AGE AGEING, V34, P387, DOI 10.1093/ageing/afi099; HODKINSON H M, 1972, Age and Ageing, V1, P233, DOI 10.1093/ageing/1.4.233; Inouye S. K., 2003, CONFUSION ASSESSMENT; Inouye SK, 2006, J GERONTOL A-BIOL, V61, P1277, DOI 10.1093/gerona/61.12.1277; Inouye SK, 2006, J AM GERIATR SOC, V54, P1492, DOI 10.1111/j.1532-5415.2006.00869.x; Inouye SK, 1999, AM J MED, V106, P565, DOI 10.1016/S0002-9343(99)00070-4; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Inouye SK, 2003, ARCH INTERN MED, V163, P958, DOI 10.1001/archinte.163.8.958; Inouye SK, 1996, JAMA-J AM MED ASSOC, V275, P852, DOI 10.1001/jama.275.11.852; INOUYE SK, 1994, AM J MED, V97, P278, DOI 10.1016/0002-9343(94)90011-6; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Inouye SK, 2000, J AM GERIATR SOC, V48, P1697; Kakuma R, 2003, J AM GERIATR SOC, V51, P443, DOI 10.1046/j.1532-5415.2003.51151.x; Kalisvaart KJ, 2006, J AM GERIATR SOC, V54, P817, DOI 10.1111/j.1532-5415.2006.00704.x; Lacasse H, 2006, ANN PHARMACOTHER, V40, P1966, DOI 10.1345/aph.1H241; Leentjens AFG, 2006, J PSYCHOSOM RES, V61, P123, DOI 10.1016/j.jpsychores.2006.01.009; Lundstrom M, 2005, J AM GERIATR SOC, V53, P622, DOI 10.1111/j.1532-5415.2005.53210.x; Lundstrom M, 1999, SCAND J CARING SCI, V13, P193, DOI 10.1080/02839319950162561; Marcantonio ER, 2001, J AM GERIATR SOC, V49, P516, DOI 10.1046/j.1532-5415.2001.49108.x; Marcantonio ER, 2000, J AM GERIATR SOC, V48, P618, DOI 10.1111/j.1532-5415.2000.tb04718.x; McAvay GJ, 2006, J AM GERIATR SOC, V54, P1245, DOI 10.1111/j.1532-5415.2006.00815.x; McCusker J, 2003, J GEN INTERN MED, V18, P696, DOI 10.1046/j.1525-1497.2003.20602.x; McCusker J, 2001, J AM GERIATR SOC, V49, P1327, DOI 10.1046/j.1532-5415.2001.49260.x; Milisen K, 2001, J AM GERIATR SOC, V49, P523, DOI 10.1046/j.1532-5415.2001.49109.x; Molloy D W, 1997, Int Psychogeriatr, V9 Suppl 1, P87, DOI 10.1017/S1041610297004754; Naughton BJ, 2005, J AM GERIATR SOC, V53, P18, DOI 10.1111/j.1532-5415.2005.53005.x; O'Keeffe ST, 2005, J AM GERIATR SOC, V53, P867, DOI 10.1111/j.1532-5415.2005.53266.x; O'Keeffe ST, 1999, AGE AGEING, V28, P115, DOI 10.1093/ageing/28.2.115; OKEEFFE S, 2004, LANCET, P363; OKeeffe ST, 1996, AGE AGEING, V25, P317, DOI 10.1093/ageing/25.4.317; Pitkala KH, 2006, J GERONTOL A-BIOL, V61, P176, DOI 10.1093/gerona/61.2.176; ROCKWOOD K, 1994, J AM GERIATR SOC, V42, P252, DOI 10.1111/j.1532-5415.1994.tb01747.x; Rothschild JM, 2000, ARCH INTERN MED, V160, P2717, DOI 10.1001/archinte.160.18.2717; Sasajima Y, 2000, EUR J VASC ENDOVASC, V20, P132, DOI 10.1053/ejvs.2000.1130; Schofield I, 1997, J ADV NURS, V25, P942, DOI 10.1046/j.1365-2648.1997.1997025942.x; Schuurmans MJ, 2001, J CLIN NURS, V10, P721, DOI 10.1046/j.1365-2702.2001.00548.x; SIDDIQI N, IN PRESS COCHRANE DA; Siddiqi N, 2006, AGE AGEING, V35, P350, DOI 10.1093/ageing/afl005; Swain DG, 2000, CLIN REHABIL, V14, P608, DOI 10.1191/0269215500cr368oa; Tabet N, 2005, AGE AGEING, V34, P152, DOI 10.1093/ageing/afi031; Trzepacz P., 2002, DELIRIUM OLD AGE, P51; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; U.S. Department of Health and Human Services, 2004, CMS PUB, P34; White S, 2005, AGE AGEING, V34, P603, DOI 10.1093/ageing/afi189; Whitehouse C, 2002, SIGHT SOUND, V12, P62; Wooltorton E, 2002, CAN MED ASSOC J, V167, P1269; Wooltorton E, 2004, CAN MED ASSOC J, V170, P1395, DOI 10.1503/cmaj.1040539; Young LJ, 2003, AGE AGEING, V32, P525, DOI 10.1093/ageing/afg094; 2006, PREVENTION DIAGNOSIS	66	258	269	1	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2007	334	7598					842	846D		10.1136/bmj.39169.706574.AD	http://dx.doi.org/10.1136/bmj.39169.706574.AD			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	162MD	17446616	Green Published			2022-12-28	WOS:000246090800035
J	Nachega, JB; Hislop, M; Dowdy, DW; Chaisson, RE; Regensberg, L; Maartens, G				Nachega, Jean B.; Hislop, Michael; Dowdy, David W.; Chaisson, Richard E.; Regensberg, Leon; Maartens, Gary			Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	13th Conference on Retroviruses and Opportunistic Infections	FEB 05-09, 2006	Denver, CO				ACTIVE ANTIRETROVIRAL THERAPY; TRIPLE-COMBINATION THERAPY; DRUG-RESISTANCE MUTATIONS; SOCIETY-USA PANEL; PROTEASE INHIBITORS; VIRAL SUPPRESSION; TREATMENT FAILURE; PHARMACY RECORDS; INFECTED ADULTS; EFAVIRENZ	Background: Adherence of 95% or more to unboosted protease regimens is required for optimal virologic suppression in HIV-1 infected patients. Whether the same is true for nonnucleoside reverse transcriptase inhibitor (NNRTI)-based therapy is unclear. Objective: To assess the relationship between adherence to NNRTI-based therapy and viral load in treatment-naive patients. Design: Observational cohort study. Setting: Private-sector HIV and AIDS disease management program in South Africa. Patients: 2821 adults infected with HIV who began NNRTI-based therapy between January 1998 and March 2003 (2764 patients [98%] were enrolled after December 2000). Measurements: Adherence was assessed by monthly pharmacy claims. The primary end point was sustained viral load suppression (< 400 copies/mL) in 100% of recorded viral load measurements throughout follow-up. Secondary end points included time to initial viral load suppression and time to subsequent virologic failure (< 400 copies/mL). Results: The median follow-up period was 2.2 years (interquartile range, 1.7 to 2.7 years). The proportion of patients with sustained viral load suppression ranged from 13% (41 of 325 patients) in patients who filled less than 50% of antiretroviral drug prescriptions to 73% (725 of 997 patients) in those who filled 100% of antiretroviral drug prescriptions. Each 10% increase in pharmacy claim adherence greater than 50% was associated with a mean absolute increase of 0.10 in the proportion of patients with sustained virologic suppression (P < 0.001). Predictors for shorter time to virologic failure after initial suppression in multivariable Cox regression included CD4(+) T-cell counts of 0.50 x 10(9) cells/L or less (hazard ratio, 1.60 [95% CI, 1.22 to 2.10] vs. CD4(+) T-cell counts > 0.20 x 10(9) cells/L), baseline viral load greater than 10(5) copies/mL (hazard ratio, 1.39 [CI 1.14 to 1.70]), nevirapine-based regimen (hazard ratio, 1.43 [CI 1.16 to 1.75]), and low pharmacy claim adherence (hazard ratio, 1.58 [CI 1.48 to 1.69], per 10% decrease in adherence to 50%). Limitations: Observational study with adherence stratification at study end and lack of standardized timing for outcome measurement. Conclusion: Virologic outcomes improve in a linear dose-response manner as adherence to NNRTI-based regimens increases beyond 50%.	Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; Johns Hopkins Sch Med, Baltimore, MD USA; Univ Cape Town, Groote Schuur Hosp, ZA-7700 Rondebosch, South Africa; Aid AIDS Dis Management Programme Pty Ltd, Cape Town, South Africa	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; University of Cape Town	Nachega, JB (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St,Suite W5031, Baltimore, MD 21205 USA.	jnachega@jhsph.edu	Maartens, Gary/F-3836-2014; Maartens, Gary/S-2788-2019	Maartens, Gary/0000-0003-3080-6606; Maartens, Gary/0000-0003-3080-6606; Nachega, Jean/0000-0002-2862-4443	NIAID NIH HHS [R01 AI 5535901, R01 AI 016137, K23 AI068582-01] Funding Source: Medline; PHS HHS [5 T32 GMO7309] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI068582, R01AI055359, R01AI016137] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Bacheler LT, 2000, ANTIMICROB AGENTS CH, V44, P2475, DOI 10.1128/AAC.44.9.2475-2484.2000; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bangsberg DR, 2004, J ANTIMICROB CHEMOTH, V53, P696, DOI 10.1093/jac/dkh162; Bangsberg DR, 2003, AIDS, V17, P1925, DOI 10.1097/00002030-200309050-00011; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bartlett JA, 2001, AIDS, V15, P1369, DOI 10.1097/00002030-200107270-00006; Benatar SR, 2004, NEW ENGL J MED, V351, P81, DOI 10.1056/NEJMhpr033471; Choo PW, 1999, MED CARE, V37, P846, DOI 10.1097/00005650-199909000-00002; Dezii C M, 2001, Manag Care, V10, P42; Dybul M, 2002, ANN INTERN MED, V137, P381, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00001; Egger M, 2006, J INFECT DIS, V194, P612, DOI 10.1086/506362; Gross R, 2006, J INFECT DIS, V194, P1108, DOI 10.1086/507680; Grossberg R, 2004, J CLIN EPIDEMIOL, V57, P1107, DOI 10.1016/j.jclinepi.2004.04.002; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Maggiolo F, 2005, CLIN INFECT DIS, V40, P158, DOI 10.1086/426595; Marzolini C, 2001, AIDS, V15, P71, DOI 10.1097/00002030-200101050-00011; Miller V, 1999, J INFECT DIS, V180, P530, DOI 10.1086/314890; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mocroft A, 1998, AIDS, V12, P2161, DOI 10.1097/00002030-199816000-00011; Moore RD, 2005, JAIDS-J ACQ IMM DEF, V39, P195; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Siddique MA, 2006, J INFECT DIS, V194, P661, DOI 10.1086/505913; Smith PF, 2005, ANTIMICROB AGENTS CH, V49, P3558, DOI 10.1128/AAC.49.8.3558-3561.2005; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; Wong MD, 2004, J GEN INTERN MED, V19, P366, DOI 10.1111/j.1525-1497.2004.30429.x; Wood E, 2006, AIDS, V20, P1117, DOI 10.1097/01.aids.0000226951.49353.ed; Yeni PG, 2004, JAMA-J AM MED ASSOC, V292, P251, DOI 10.1001/jama.292.2.251	37	272	280	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2007	146	8					564	U16		10.7326/0003-4819-146-8-200704170-00007	http://dx.doi.org/10.7326/0003-4819-146-8-200704170-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	158FV	17438315				2022-12-28	WOS:000245778000003
J	Dawes, CT; Fowler, JH; Johnson, T; McElreath, R; Smirnov, O				Dawes, Christopher T.; Fowler, James H.; Johnson, Tim; McElreath, Richard; Smirnov, Oleg			Egalitarian motives in humans	NATURE			English	Article							RECIPROCITY; PUNISHMENT	Participants in laboratory games are often willing to alter others' incomes at a cost to themselves, and this behaviour has the effect of promoting cooperation(1-3). What motivates this action is unclear: punishment and reward aimed at promoting cooperation cannot be distinguished from attempts to produce equality(4). To understand costly taking and costly giving, we create an experimental game that isolates egalitarian motives. The results show that subjects reduce and augment others' incomes, at a personal cost, even when there is no cooperative behaviour to be reinforced. Furthermore, the size and frequency of income alterations are strongly influenced by inequality. Emotions towards top earners become increasingly negative as inequality increases, and those who express these emotions spend more to reduce above-average earners' incomes and to increase below-average earners' incomes. The results suggest that egalitarian motives affect income-altering behaviours, and may therefore be an important factor underlying the evolution of strong reciprocity(5) and, hence, cooperation in humans.	Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA; Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, D-14195 Berlin, Germany; Stanford Univ, Dept Polit Sci, Stanford, CA 94305 USA; Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; Univ Miami, Dept Polit Sci, Coral Gables, FL 33124 USA	University of California System; University of California San Diego; Max Planck Society; Stanford University; University of California System; University of California Davis; University of Miami	Fowler, JH (corresponding author), Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA.	jhfowler@ucsd.edu	Fowler, James H/C-2750-2008	Fowler, James H/0000-0001-7795-1638; McElreath, Richard/0000-0002-0387-5377				Andreoni J, 2003, AM ECON REV, V93, P893, DOI 10.1257/000282803322157142; Bergstrom CT, 1998, P NATL ACAD SCI USA, V95, P5100, DOI 10.1073/pnas.95.9.5100; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; Bosman R, 2002, ECON J, V112, P147, DOI 10.1111/1468-0297.0j677; Falk A, 2006, GAME ECON BEHAV, V54, P293, DOI 10.1016/j.geb.2005.03.001; Falk A, 2005, ECONOMETRICA, V73, P2017, DOI 10.1111/j.1468-0262.2005.00644.x; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fowler JH, 2005, NATURE, V437, pE8, DOI 10.1038/nature04201; ORNE MT, 1962, AM PSYCHOL, V17, P776, DOI 10.1037/h0043424; SEFTON M, 2006, 2006005 CTR APPL EC, P1; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Xiao E, 2005, P NATL ACAD SCI USA, V102, P7398, DOI 10.1073/pnas.0502399102	14	340	347	2	65	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					794	796		10.1038/nature05651	http://dx.doi.org/10.1038/nature05651			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	156CX	17429399				2022-12-28	WOS:000245626800040
J	Treanor, JJ; Schiff, GM; Hayden, FG; Brady, RC; Hay, CM; Meyer, AL; Holden-Wiltse, J; Liang, H; Gilbert, A; Cox, M				Treanor, John J.; Schiff, Gilbert M.; Hayden, Frederick G.; Brady, Rebecca C.; Hay, C. Mhorag; Meyer, Anthony L.; Holden-Wiltse, Jeanne; Liang, Hua; Gilbert, Adam; Cox, Manon			Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RECOMBINANT HEMAGGLUTININ; IMMUNE-RESPONSES; ELDERLY ADULTS; HEALTHY-ADULTS; H3N2 VIRUS; A VIRUS	Context A high priority in vaccine research is the development of influenza vaccines that do not use embryonated eggs as the substrate for vaccine production. Objective To determine the dose-related safety, immunogenicity, and protective efficacy of an experimental trivalent influenza virus hemagglutinin (rHAO) vaccine produced in insect cells using recombinant baculoviruses. Design, Setting, and Participants Randomized, double-blind, placebo-controlled clinical trial at 3 US academic medical centers during the 2004-2005 influenza season among 460 healthy adults without high-risk indications for influenza vaccine. Interventions Participants were randomly assigned to receive a single injection of saline placebo (n= 154); 75 mu g of an rHAO vaccine containing 15 mu g of hemagglutinin from influenza A/New Caledonia/20/ 99(H1N1) and influenza B/Jiangsu/10/ 03 virus and 45 mu g of hemagglutinin from influenza A/Wyoming/3/03(H3N2) virus ( n= 153); or 135 mu g of rHAO containing 45 mu g of hemagglutinin each from all 3 components ( n= 153). Serum samples were taken before and 30 days following immunization. Main Outcome Measures Primary safety end points were the rates and severity of solicited and unsolicited adverse events. Primary immunogenicity end points were the rates of 4-fold or greater increases in serum hemagglutinin inhibition antibody to each of the 3 vaccine strains before and 28 days after inoculation. The prespecified primary efficacy end point was culture-documented influenza illness, defined as development of influenza-like illness associated with influenza virus on a nasopharyngeal swab. Results Rates of local and systemic adverse effects were low, and the rates of systemic adverse effects were not different in either vaccine group than in the placebo group. Hemagglutinin inhibition antibody responses to the H1 component were seen in 3% of placebo, 51% of 75-mu g vaccine, and 67% of 135-mu g vaccine recipients, while responses to B were seen in 4% of placebo, 65% of 75-mu g vaccine, and 92% of 135-mu g vaccine recipients. Responses to the H3 component occurred in 11% of placebo, 81% of 75-mu g vaccine, and 77% of 135-mu g vaccine recipients. Influenza infections in the study population were due to influenza B and A( H3N2), and influenza A infections were A/California/7/2004 like viruses, an antigenically drifted strain. Seven cases of culture-confirmed CDC-defined influenza-like illness occurred in 153 placebo recipients(4.6%) compared with 2 cases(1.3%) in 150 recipients of 75 mu g of vaccine, and 0 cases in recipients of 135 mu g of vaccine. Conclusions In this study, a trivalent rHAO vaccine was safe and immunogenic in a healthy adult population. Preliminary evidence of protection against a drifted influenza A( H3N2) virus was obtained, but the sample size was small. Inclusion of a neuraminidase component did not appear to be required for protection.	Univ Rochester, Med Ctr, Rochester, NY 14642 USA; Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; Univ Virginia, Charlottesville, VA USA; Ockham Dev Grp, Cary, NC USA; Prot Sci Corp, Meriden, CT USA	University of Rochester; Cincinnati Children's Hospital Medical Center; University of Virginia	Treanor, JJ (corresponding author), Univ Rochester, Med Ctr, Room 3-630,601 Elmwood Ave, Rochester, NY 14642 USA.	John_Treanor@urmc.rochester.edu						Brett IC, 2005, VIROLOGY, V339, P273, DOI 10.1016/j.virol.2005.06.006; Cox MMJ, 2005, CURR OPIN MOL THER, V7, P24; KATZ JM, 1990, J VIROL, V64, P1808, DOI 10.1128/JVI.64.4.1808-1811.1990; Lakey DL, 1996, J INFECT DIS, V174, P838, DOI 10.1093/infdis/174.4.838; Nichol KL, 1996, ARCH INTERN MED, V156, P1546, DOI 10.1001/archinte.156.14.1546; Ohmit SE, 2006, NEW ENGL J MED, V355, P2513, DOI 10.1056/NEJMoa061850; POWERS DC, 1995, J INFECT DIS, V171, P1595, DOI 10.1093/infdis/171.6.1595; Powers DC, 1997, J INFECT DIS, V175, P342, DOI 10.1093/infdis/175.2.342; Treanor JJ, 2006, J INFECT DIS, V193, P1223, DOI 10.1086/503050; Treanor JJ, 2001, VACCINE, V19, P1732, DOI 10.1016/S0264-410X(00)00395-9; Treanor JJ, 1996, J INFECT DIS, V173, P1467, DOI 10.1093/infdis/173.6.1467; Treanor JJ, 2005, HUM VACCINES, V1, P239, DOI 10.4161/hv.1.6.2376; WOOD JM, 1998, TXB INFLUENZA, P333; 2005, WKLY EPIDEMIOL REC, V80, P71; 2005, MMWR MORB MORTAL WKL, V54, P631	15	140	157	1	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2007	297	14					1577	1582		10.1001/jama.297.14.1577	http://dx.doi.org/10.1001/jama.297.14.1577			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155PG	17426277	Bronze			2022-12-28	WOS:000245589800026
J	Low, N				Low, Nicola			Screening programmes for chlamydial infection: when will we ever learn?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRACHOMATIS; SWEDEN; RISK; IMPACT; COUNTY; HIV		Univ Bern, Dept Social & Prevent Med, CH-3012 Bern, Switzerland	University of Bern	Low, N (corresponding author), Univ Bern, Dept Social & Prevent Med, CH-3012 Bern, Switzerland.	low@ispm.unibe.ch	Low, Nicola/H-4718-2019	Low, Nicola/0000-0003-4817-8986				Boeke A J P, 2005, Ned Tijdschr Geneeskd, V149, P878; Brunham RC, 2005, J INFECT DIS, V192, P1836, DOI 10.1086/497341; *CDCP, 2005, SEX TRANSM DIS SURV; *DEP HLTH, 2000, 2 REP NAT SCREEN COM; *DEP HLTH, 2004, NAT CHLAM SCREEN PRO; Egger M, 1998, BRIT MED J, V316, P1776, DOI 10.1136/bmj.316.7147.1776; Falk L, 2003, SEX TRANSM DIS, V30, P205, DOI 10.1097/00007435-200303000-00005; Gray JAM, 2004, BRIT J GEN PRACT, V54, P292; Herlitz CA, 2000, AIDS, V14, P881, DOI 10.1097/00002030-200005050-00015; HERRMANN B, 1995, SEX TRANSM DIS, V22, P253, DOI 10.1097/00007435-199507000-00009; *HLTH PROT AG, 2006, NEW FRONT ANN REP NA; Holland WW, 2006, POLICY BRIEF SCREENI; Low N, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11080; LOW N, 2006, RAPID REV EVIDENCE E; *NHS CANC SCREEN P, 2006, NHS CERV SCREEN PROG; Nicoll A, 2001, SEX TRANSM INFECT, V77, P242, DOI 10.1136/sti.77.4.242; Pimenta J, 2000, BRIT MED J, V321, P629, DOI 10.1136/bmj.321.7261.629; RIPA T, 1990, SCAND J INFECT DIS, P157; TAYLORROBINSON D, 1994, BMJ-BRIT MED J, V308, P150, DOI 10.1136/bmj.308.6922.150; Wilson JMG, 1968, PRINCIPLES PRACTICE	20	87	89	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2007	334	7596					725	728		10.1136/bmj.39154.378079.BE	http://dx.doi.org/10.1136/bmj.39154.378079.BE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AO	17413173	Green Published			2022-12-28	WOS:000245763300027
J	O'Donnell, KA; Boekel, JD				O'Donnell, Kathryn A.; Boekel, Jef D.			Mighty piwis defend the germline against genome intruders	CELL			English	Review							SMALL RNAS; DNA METHYLATION; DROSOPHILA; PROTEIN; RETROTRANSPOSON; FAMILY; DIVISION; SEQUENCE; ENCODES; GYPSY	Piwis are a germline-specific subclass of the Argonaute family of RNA interference (RNAi) effector proteins that are associated with a recently discovered group of small RNAs (piRNAs). Recent studies in Drosophila and zebrafish directly implicate Piwi proteins in piRNA biogenesis to maintain transposon silencing in the germline genome (Brennecke et al., 2007; Gunawardane et al., 2007; Houwing et al., 2007). This function may be conserved in mice as loss of Miwi2, a mouse Piwi homolog, leads to germline stem cell and meiotic defects correlated with increased transposon activity (Carmell et al., 2007).	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Boekel, JD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, 733 N Broadway, Baltimore, MD 21205 USA.	jboeke@bs.jhmi.edu		Boeke, Jef/0000-0001-5322-4946	NATIONAL CANCER INSTITUTE [P01CA016519] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA016519, P01 CA016519-330010] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aramayo R, 1996, CELL, V86, P103, DOI 10.1016/S0092-8674(00)80081-1; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BUCHETON A, 1995, TRENDS GENET, V11, P349, DOI 10.1016/S0168-9525(00)89105-2; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; CARMELL MA, 2007, DEV CELL; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Costa Y, 2006, HUM MOL GENET, V15, P2324, DOI 10.1093/hmg/ddl158; Cox DN, 2000, DEVELOPMENT, V127, P503; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; HOUWING S, 2007, CELL; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323; KIDWELL MG, 1983, P NATL ACAD SCI-BIOL, V80, P1655, DOI 10.1073/pnas.80.6.1655; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee DW, 2003, GENETICS, V164, P821; Lees-Murdock DJ, 2005, DEV DYNAM, V232, P992, DOI 10.1002/dvdy.20288; Lin HF, 1997, DEVELOPMENT, V124, P2463; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Robert VJP, 2004, COLD SPRING HARB SYM, V69, P397, DOI 10.1101/sqb.2004.69.397; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Selker EU, 2004, COLD SPRING HARB SYM, V69, P119, DOI 10.1101/sqb.2004.69.119; Shiu PKT, 2006, P NATL ACAD SCI USA, V103, P2243, DOI 10.1073/pnas.0508896103; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Takaori-Kondo A, 2006, INT J HEMATOL, V83, P213, DOI 10.1532/IJH97.05187; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130	40	203	219	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2007	129	1					37	44		10.1016/j.cell.2007.03.028	http://dx.doi.org/10.1016/j.cell.2007.03.028			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418784	Green Accepted, Bronze			2022-12-28	WOS:000245661100009
J	Hughes, ID; Dane, M; Ernst, A; Hergert, W; Luders, M; Poulter, J; Staunton, JB; Svane, A; Szotek, Z; Temmerman, WM				Hughes, I. D.; Daene, M.; Ernst, A.; Hergert, W.; Lueders, M.; Poulter, J.; Staunton, J. B.; Svane, A.; Szotek, Z.; Temmerman, W. M.			Lanthanide contraction and magnetism in the heavy rare earth elements	NATURE			English	Article							ELECTRONIC TOPOLOGICAL TRANSITION; 1ST-PRINCIPLES THEORY; FERMI-SURFACE; GD; METALS; BULK; GADOLINIUM; SYSTEMS; ALLOYS	The heavy rare earth elements crystallize into hexagonally close packed ( h. c. p.) structures and share a common outer electronic configuration, differing only in the number of 4f electrons they have(1). These chemically inert 4f electrons set up localized magnetic moments, which are coupled via an indirect exchange interaction involving the conduction electrons. This leads to the formation of a wide variety of magnetic structures, the periodicities of which are often incommensurate with the underlying crystal lattice(2). Such incommensurate ordering is associated with a 'webbed' topology(3,4) of the momentum space surface separating the occupied and unoccupied electron states ( the Fermi surface). The shape of this surface - and hence the magnetic structure - for the heavy rare earth elements is known to depend on the ratio of the interplanar spacing c and the interatomic, intraplanar spacing a of the h. c. p. lattice(5). A theoretical understanding of this problem is, however, far from complete. Here, using gadolinium as a prototype for all the heavy rare earth elements, we generate a unified magnetic phase diagram, which unequivocally links the magnetic structures of the heavy rare earths to their lattice parameters. In addition to verifying the importance of the c/a ratio, we find that the atomic unit cell volume plays a separate, distinct role in determining the magnetic properties: we show that the trend from ferromagnetism to incommensurate ordering as atomic number increases is connected to the concomitant decrease in unit cell volume. This volume decrease occurs because of the so-called lanthanide contraction(6), where the addition of electrons to the poorly shielding 4f orbitals leads to an increase in effective nuclear charge and, correspondingly, a decrease in ionic radii.	Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; Univ Halle Wittenberg, Inst Phys, D-06099 Halle, Germany; Max Planck Inst Mikrostrukturphys, D-06120 Halle, Germany; SERC, Daresbury Lab, Warrington WA4 4AD, Cheshire, England; Mahidol Univ, Fac Sci, Dept Math, Bangkok 10400, Thailand; Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus, Denmark	University of Warwick; Martin Luther University Halle Wittenberg; Max Planck Society; STFC Daresbury Laboratory; Mahidol University; Aarhus University	Hughes, ID (corresponding author), Univ Warwick, Dept Phys, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	i.d.hughes@warwick.ac.uk; j.b.staunton@warwick.ac.uk	Däne, Markus/H-6731-2013; Ernst, Arthur/K-1836-2012; Lueders, Martin/D-1622-2010	Däne, Markus/0000-0001-9301-8469; Ernst, Arthur/0000-0003-4005-6781; Staunton, Julie/0000-0002-3578-8753	Engineering and Physical Sciences Research Council [GR/S85856/01, GR/S85863/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Andrianov AV, 2000, PHYS REV B, V62, P13844, DOI 10.1103/PhysRevB.62.13844; ANDRIANOV AV, 1995, J MAGN MAGN MATER, V140, P749, DOI 10.1016/0304-8853(94)00767-5; Andrianov AV, 1997, PHYS REV B, V55, P14107, DOI 10.1103/PhysRevB.55.14107; BLANTER YM, 1994, PHYS REP, V245, P159, DOI 10.1016/0370-1573(94)90103-1; Blundell S, 2001, MAGNETISM CONDENSED, P91; CRACKNELL AP, 1973, FERMI SURFACE; Dugdale SB, 1997, PHYS REV LETT, V79, P941, DOI 10.1103/PhysRevLett.79.941; ERIKSSON O, 1995, PHYS REV B, V52, P4420, DOI 10.1103/PhysRevB.52.4420; EVENSON WE, 1968, PHYS REV LETT, V21, P432, DOI 10.1103/PhysRevLett.21.432; Fretwell HM, 1999, PHYS REV LETT, V82, P3867, DOI 10.1103/PhysRevLett.82.3867; Gschneidner K.A., 1978, HDB PHYS CHEM RARE E, V1; GYORFFY BL, 1985, J PHYS F MET PHYS, V15, P1337, DOI 10.1088/0305-4608/15/6/018; HARMON BN, 1995, J PHYS CHEM SOLIDS, V56, P1521, DOI 10.1016/0022-3697(95)00122-0; HEINEMANN M, 1994, PHYS REV B, V49, P4348, DOI 10.1103/PhysRevB.49.4348; HUBBARD J, 1979, PHYS REV B, V20, P4584, DOI 10.1103/PhysRevB.20.4584; Jensen J., 1991, RARE EARTH MAGNETISM, P286; KEETON SC, 1968, PHYS REV, V168, P672, DOI 10.1103/PhysRev.168.672; Kurz P, 2002, J PHYS-CONDENS MAT, V14, P6353, DOI 10.1088/0953-8984/14/25/305; LIFSHITZ IM, 1960, SOV PHYS JETP-USSR, V11, P1130; Luders M, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.205109; MILSTEIN F, 1967, PHYS REV, V159, P466, DOI 10.1103/PhysRev.159.466; Nordstrom L, 2000, EUROPHYS LETT, V49, P775, DOI 10.1209/epl/i2000-00218-2; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; Rado G. T., 1966, MAGNETISM B, VII, P337; STAUNTON JB, 1992, PHYS REV LETT, V69, P371, DOI 10.1103/PhysRevLett.69.371; Strange P, 1999, NATURE, V399, P756, DOI 10.1038/21595; Taylor K. N. R., 1972, PHYS RARE EARTH SOLI, P60; Turek I, 2003, J PHYS-CONDENS MAT, V15, P2771, DOI 10.1088/0953-8984/15/17/327	28	165	166	4	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2007	446	7136					650	653		10.1038/nature05668	http://dx.doi.org/10.1038/nature05668			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17410171				2022-12-28	WOS:000245438300035
J	Brent, AE; Yucel, G; Small, S; Desplan, C				Brent, Ava E.; Yucel, Gozde; Small, Stephen; Desplan, Claude			Permissive and instructive anterior patterning rely on mRNA localization in the wasp embryo	SCIENCE			English	Article							DROSOPHILA EMBRYO; GRADIENT; NASONIA; PROTEIN; GIANT; HUNCHBACK; KRUPPEL; LONG; SEGMENTATION; EXPRESSION	The long-germ mode of embryogenesis, in which segments arise simultaneously along the anterior-posterior axis, has evolved several times in different lineages of the holometabolous, or fully metamorphosing, insects. Drosophila's long-germ fate map is established largely by the activity of the dipteran-specific Bicoid (Bcd) morphogen gradient, which operates both instructively and permissively to accomplish anterior patterning. By contrast, all nondipteran long-germ insects must achieve anterior patterning independently of bcd. We show that bcd's permissive function is mimicked in the wasp by a maternal repression system in which anterior localization of the wasp ortholog of giant represses anterior expression of the trunk gap genes so that head and thorax can properly form.	NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA	New York University	Desplan, C (corresponding author), NYU, Dept Biol, Ctr Dev Genet, 100 Washington Sq E, New York, NY 10003 USA.	cd38@nyu.edu		Desplan, Claude/0000-0002-6914-1413	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051946, R01GM064864, R55GM051946] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM64864, GM51946] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bashirullah A, 1998, ANNU REV BIOCHEM, V67, P335, DOI 10.1146/annurev.biochem.67.1.335; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Bucher G, 2005, EVOL DEV, V7, P142, DOI 10.1111/j.1525-142X.2005.05016.x; Davis GK, 2002, ANNU REV ENTOMOL, V47, P669, DOI 10.1146/annurev.ento.47.091201.145251; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; Hewitt GF, 1999, DEVELOPMENT, V126, P1201; HULSKAMP M, 1990, NATURE, V346, P577, DOI 10.1038/346577a0; KRAUT R, 1991, DEVELOPMENT, V111, P601; KRAUT R, 1991, DEVELOPMENT, V111, P611; Lynch J, 2003, CURR BIOL, V13, pR557, DOI 10.1016/S0960-9822(03)00472-X; Lynch JA, 2006, NATURE, V439, P728, DOI 10.1038/nature04445; Lynch JA, 2006, DEV GENES EVOL, V216, P493, DOI 10.1007/s00427-006-0076-5; Lynch JA, 2006, NAT PROTOC, V1, P486, DOI 10.1038/nprot.2006.70; Olesnicky EC, 2006, DEVELOPMENT, V133, P3973, DOI 10.1242/dev.02576; PREISS A, 1985, NATURE, V313, P27, DOI 10.1038/313027a0; Pultz MA, 2005, DEVELOPMENT, V132, P3705, DOI 10.1242/dev.01939; Savard J, 2006, GENOME RES, V16, P1334, DOI 10.1101/gr.5204306; Schroder R, 2000, P NATL ACAD SCI USA, V97, P6591, DOI 10.1073/pnas.100005497; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; Wu XL, 1998, DEVELOPMENT, V125, P3765	20	47	47	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1841	1843		10.1126/science.1137528	http://dx.doi.org/10.1126/science.1137528			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395827				2022-12-28	WOS:000245280100042
J	Ruan, DK; He, Q; Ding, Y; Hou, LS; Li, JY; Luk, KDK				Ruan, Dike; He, Qin; Ding, Yu; Hou, Lisheng; Li, Jingyun; Luk, Keith D. K.			Intervertebral disc transplantation in the treatment of degenerative spine disease: a preliminary study	LANCET			English	Article							FOLLOW-UP; ARTIFICIAL DISC; PROSTHESIS; REPLACEMENT	Background Spinal fusion can be complicated by accelerated degeneration of the adjacent segments. Artificial disc replacements have been developed, but results are variable. Successful transplantations of intervertebral disc autografts, fresh allografts, and fresh-frozen allografts-ie, a non-fusion strategy-in which the mobility and stability of the spinal segment were preserved have been done in a primate model. Our aim was to determine the feasibility, safety, and long-term clinical results of disc transplantation in human beings. Methods Five patients, average age 47 years, with cervical disc herniation underwent transplantation of fresh-frozen composite disc allografts after disc excision. Serial MRI and static and dynamic radiographs were used to monitor the status of the grafts and the sagittal stability and mobility of the segment. Findings Good union of the graft endplates was seen by the end of 3 months after surgery in all patients. At a minimum follow-up of 5 years, the neurological symptoms of all patients had improved from before surgery levels. No immunoreaction was encountered. There was no olisthesis and only mild degenerative changes of the transplanted discs. All except one of the discs showed preservation of 7.0-11.3 degrees of sagittal motion at the final follow-up. MRI at 5 years showed preservation of hydration in at least two discs. Interpretation Despite signs of mild disc degeneration, the motion and stability of the spinal unit was preserved after transplantation of fresh-frozen allogenic intervertebral discs in our patients. With further refinements, such transplantations could be an effective treatment for degenerative disc disease.	Univ Hong Kong, Dept Orthoped & Traumatol, Hong Kong, Peoples R China; Navy Gen Hosp, Dept Orthoped Surg, Beijing, Peoples R China	University of Hong Kong; Sixth Medical Center of Chinese PLA General Hospital	Luk, KDK (corresponding author), Univ Hong Kong, Dept Orthoped & Traumatol, Pokfulam Rd, Hong Kong, Peoples R China.	hrmoldk@hku.hk	ding, yy/HHS-9589-2022					BABA H, 1993, SPINE, V18, P2167, DOI 10.1097/00007632-199311000-00004; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P1178, DOI 10.2106/00004623-199072080-00008; CLEMENTS DH, 1990, SPINE, V15, P1023, DOI 10.1097/00007632-199015100-00008; DVORAK J, 1991, J ORTHOPAED RES, V9, P828, DOI 10.1002/jor.1100090608; FRICK SL, 1994, SPINE, V19, P1826, DOI 10.1097/00007632-199408150-00006; Gillet P, 2003, J SPINAL DISORD TECH, V16, P338, DOI 10.1097/00024720-200308000-00005; Goffin J, 2003, SPINE, V28, P2673, DOI 10.1097/01.BRS.0000099392.90849.AA; GRIFFITH SL, 1994, SPINE, V19, P1842, DOI 10.1097/00007632-199408150-00009; Hilibrand AS, 1999, J BONE JOINT SURG AM, V81A, P519, DOI 10.2106/00004623-199904000-00009; LEHMANN TR, 1987, SPINE, V12, P97, DOI 10.1097/00007632-198703000-00004; Leivseth G, 2006, SPINE, V31, P1726, DOI 10.1097/01.brs.0000224213.45330.68; Lemaire JP, 2005, J SPINAL DISORD TECH, V18, P353, DOI 10.1097/01.bsd.0000172361.07479.6b; LUK KD, 1997, CLIN ORTHOP RELAT R, V337, P13; Luk KDK, 2003, SPINE, V28, P864, DOI 10.1097/00007632-200305010-00005; Matsunaga S, 1999, SPINE, V24, P670, DOI 10.1097/00007632-199904010-00011; OLSON EJ, 1991, SPINE, V16, P1081, DOI 10.1097/00007632-199109000-00013; PENTA M, 1995, SPINE, V20, P743, DOI 10.1097/00007632-199503150-00018; Putzier M, 2006, EUR SPINE J, V15, P183, DOI 10.1007/s00586-005-1022-3; SCHNEIDERMAN G, 1987, SPINE, V12, P276, DOI 10.1097/00007632-198704000-00016; Yonenobu K, 2001, SPINE, V26, P1890, DOI 10.1097/00007632-200109010-00014; Zeegers WS, 1999, EUR SPINE J, V8, P210, DOI 10.1007/s005860050160	22	80	101	1	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2007	369	9566					993	999		10.1016/S0140-6736(07)60496-6	http://dx.doi.org/10.1016/S0140-6736(07)60496-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151JO	17382826				2022-12-28	WOS:000245286500028
J	Chen, CH; Huang, HX; Ward, CM; Su, JT; Schaeffer, LV; Guo, M; Hay, BA				Chen, Chun-Hong; Huang, Haixia; Ward, Catherine M.; Su, Jessica T.; Schaeffer, Lorian V.; Guo, Ming; Hay, Bruce A.			A synthetic maternal-effect selfish genetic element drives population replacement in Drosophila	SCIENCE			English	Article							ANOPHELES-GAMBIAE; RESISTANCE; MOSQUITOS; DYNAMICS; SYSTEMS	One proposed strategy for controlling the transmission of insect-borne pathogens uses a drive mechanism to ensure the rapid spread of transgenes conferring disease refractoriness throughout wild populations. Here, we report the creation of maternal-effect selfish genetic elements in Drosophila that drive population replacement and are resistant to recombination-mediated dissociation of drive and disease refractoriness functions. These selfish elements use microRNA-mediated silencing of a maternally expressed gene essential for embryogenesis, which is coupled with early zygotic expression of a rescuing transgene.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Dept Pharmacol, Los Angeles, CA 90095 USA	California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Hay, BA (corresponding author), CALTECH, Div Biol, Mail Code 156-29, Pasadena, CA 91125 USA.	haybruce@caltech.edu	Chung, Sun-Lin/F-9574-2015; anand, amit/A-7222-2009; Albers, Pieter/I-2563-2017; Chen, Chun-Hong/E-3990-2010; Mockler, Todd C/L-2609-2013	Mockler, Todd C/0000-0002-0462-5775; CHEN, CHUN-HONG/0000-0002-3028-5508	NIGMS NIH HHS [GM70956, GM057422] Funding Source: Medline; NINDS NIH HHS [NS042580, NS048396] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070956, R01GM057422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048396, K08NS042580] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEEMAN RW, 1992, SCIENCE, V256, P89, DOI 10.1126/science.1566060; Beeman RW, 1999, HEREDITY, V82, P529, DOI 10.1038/sj.hdy.6885150; Boete Christopher, 2002, Malaria Journal, V1, pUnpaginated; Capurro MD, 2000, AM J TROP MED HYG, V62, P427, DOI 10.4269/ajtmh.2000.62.427; Coetzee M, 2004, AM J TROP MED HYG, V70, P103, DOI 10.4269/ajtmh.2004.70.103; della Torre A, 2002, SCIENCE, V298, P115, DOI 10.1126/science.1078170; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; GEER BW, 1962, AM NAT, V96, P175, DOI 10.1086/282220; Gould F, 2004, ANNU REV ENTOMOL, V49, P193, DOI 10.1146/annurev.ento.49.061802.123344; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; James AA, 2005, TRENDS PARASITOL, V21, P64, DOI 10.1016/j.pt.2004.11.004; Kambris Z, 2003, EMBO REP, V4, P64, DOI 10.1038/sj.embor.embor714; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Moreira LA, 2002, J BIOL CHEM, V277, P40839, DOI 10.1074/jbc.M206647200; Nimmo DD, 2006, INSECT MOL BIOL, V15, P129, DOI 10.1111/j.1365-2583.2006.00615.x; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; RIBEIRO JMC, 1994, J MED ENTOMOL, V31, P10, DOI 10.1093/jmedent/31.1.10; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Smith NGC, 1998, J THEOR BIOL, V191, P173, DOI 10.1006/jtbi.1997.0579; Vernick KD, 2005, CURR TOP MICROBIOL, V295, P383; Vlachou D, 2005, CURR OPIN MICROBIOL, V8, P415, DOI 10.1016/j.mib.2005.06.013; WADE MJ, 1994, GENETICS, V138, P1309	23	240	250	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2007	316	5824					597	600		10.1126/science.1138595	http://dx.doi.org/10.1126/science.1138595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160ZC	17395794				2022-12-28	WOS:000245983100045
J	Middleton, J; Latif, F				Middleton, John; Latif, Farid			Gambling with the nation's health	BRITISH MEDICAL JOURNAL			English	Editorial Material									Sandwell Primary Care Trust, W Bromwich B70 9LD, England; Shrewsbury & Telford Hosp NHS Trust, Telford, Shrops, England		Middleton, J (corresponding author), Sandwell Primary Care Trust, W Bromwich B70 9LD, England.	John.middleton@sandwell-pct.nhs.uk						American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; [Anonymous], 1999, PATH GAMBL CRIT REV; BROWN DJ, 1992, SOCIOL SOC RES, V76, P161; Devereux EC, 1980, GAMBLING SOCIAL STRU; Gerstein D., 1999, GAMBLING IMPACT BEHA; MCKEE M, 1995, BRIT MED J, V311, P521, DOI 10.1136/bmj.311.7004.521; MIDDLETON J, 2006, WELL 19 ANN PUBL HLT; MIKESELL JL, 1994, NATL TAX J, V47, P165; *MN I PUBL HLTH, 1996, YOUTH GAMBL WHAT WE; Mulleman RL, 2002, J EMERG MED, V23, P307, DOI 10.1016/S0736-4679(02)00543-7; National Council of Welfare, 1996, GAMBL CAN; ORFORD J, 2003, GAMBLING PROBLEM GAM, P23; QUINN A, 1998, REUTERS         0815; ROOM R, 1998, COMMUNITY EFFECTS OP; Rosenthal R.J., 1992, AM J ADDICTION, V1, P150, DOI DOI 10.1111/J.1521-0391.1992.TB00020.X; Stitt BG, 2003, CRIME DELINQUENCY, V49, P253, DOI 10.1177/0011128702251058; TOPP J, 1998, POLICY DISCUSSION PA; WEINSTEIN D, 1978, IMPACT LEGALIZED GAM; WILKINSON RG, 1992, AM J PUBLIC HEALTH, V82, P1082, DOI 10.2105/AJPH.82.8.1082; 1994, ECONOMIST       1119, P17	20	4	4	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 21	2007	334	7598					828	829		10.1136/bmj.39182.424965.AD	http://dx.doi.org/10.1136/bmj.39182.424965.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	162MD	17446613	Green Published			2022-12-28	WOS:000246090800029
J	Schievink, WI; Moser, FG; Pikul, BK				Schievink, Wouter I.; Moser, Franklin G.; Pikul, Brian K.			Reversal of coma with an injection of glue	LANCET			English	Editorial Material							SPONTANEOUS INTRACRANIAL HYPOTENSION; HEADACHE		Kaiser Permanente Med Ctr, Dept Neurosurg, Los Angeles, CA 90027 USA; Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Imaging Med Grp, Los Angeles, CA 90048 USA	Kaiser Permanente; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Schievink, WI (corresponding author), Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA.	schievinkw@cshs.org						Pleasure SJ, 1998, NEUROLOGY, V50, P1854, DOI 10.1212/WNL.50.6.1854; Schievink WI, 2005, J NEUROSURG, V103, P608, DOI 10.3171/jns.2005.103.4.0608; Schievink WI, 2006, JAMA-J AM MED ASSOC, V295, P2284; Weisfelt M, 2005, Ned Tijdschr Geneeskd, V149, P1001; Whiteley W, 2003, BRIT J NEUROSURG, V17, P456, DOI 10.1080/02688690310001611251	5	28	29	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 21	2007	369	9570					1402	1402		10.1016/S0140-6736(07)60636-9	http://dx.doi.org/10.1016/S0140-6736(07)60636-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	159HL	17448827				2022-12-28	WOS:000245856100034
J	Sobolev, AV; Hofmann, AW; Kuzmin, DV; Yaxley, GM; Arndt, NT; Chung, SL; Danyushevsky, LV; Elliott, T; Frey, FA; Garcia, MO; Gurenko, AA; Kamenetsky, VS; Kerr, AC; Krivolutskaya, NA; Matvienkov, VV; Nikogosian, IK; Rocholl, A; Sigurdsson, IA; Sushchevskaya, NM; Teklay, M				Sobolev, Alexander V.; Hofmann, Albrecht W.; Kuzmin, Dmitry V.; Yaxley, Gregory M.; Arndt, Nicholas T.; Chung, Sun-Lin; Danyushevsky, Leonid V.; Elliott, Tim; Frey, Frederick A.; Garcia, Michael O.; Gurenko, Andrey A.; Kamenetsky, Vadim S.; Kerr, Andrew C.; Krivolutskaya, Nadezhda A.; Matvienkov, Vladimir V.; Nikogosian, Igor K.; Rocholl, Alexander; Sigurdsson, Ingvar A.; Sushchevskaya, Nadezhda M.; Teklay, Mengist			The amount of recycled crust in sources of mantle-derived melts	SCIENCE			English	Article							MIDOCEAN RIDGE; OCEAN ISLAND; MAFIC LITHOLOGIES; GARNET PYROXENITE; PHASE-RELATIONS; PERIDOTITE; ECLOGITE; ORIGIN; PETROGENESIS; LITHOSPHERE	Plate tectonic processes introduce basaltic crust ( as eclogite) into the peridotitic mantle. The proportions of these two sources in mantle melts are poorly understood. Silica-rich melts formed from eclogite react with peridotite, converting it to olivine-free pyroxenite. Partial melts of this hybrid pyroxenite are higher in nickel and silicon but poorer in manganese, calcium, and magnesium than melts of peridotite. Olivine phenocrysts' compositions record these differences and were used to quantify the contributions of pyroxenite-derived melts in mid-ocean ridge basalts ( 10 to 30%), ocean island and continental basalts ( many > 60%), and komatiites ( 20 to 30%). These results imply involvement of 2 to 20% ( up to 28%) of recycled crust in mantle melting.	Max Planck Inst Chem, D-55020 Mainz, Germany; Russian Acad Sci, VI Vernadskii Inst Geochem & Analyt Chem, Moscow 119991, Russia; Russian Acad Sci, Siberian Branch, Inst Geol & Mineral, Novosibirsk 630090, Russia; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Univ Joseph Fourier Grenoble 1, Lab Geodynam Chaines Alpines, CNRS, F-38401 Grenoble, France; Natl Taiwan Univ, Dept Geosci, Taipei 106, Taiwan; Univ Tasmania, Australian Res Council, Ctr Excellence Ore Deposits, Hobart, Tas 7001, Australia; Univ Tasmania, Sch Earth Sci, Hobart, Tas 7001, Australia; Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Univ Hawaii, Dept Geol & Geophys, Honolulu, HI 96822 USA; Cardiff Univ, Sch Earth Ocean & Planetary Sci, Cardiff CF10 3YE, Wales; Russian Acad Sci, PP Shirshov Oceanol Inst, Moscow 117997, Russia; Univ Utrecht, Fac Geosci, Dept Petrol, Utrecht, Netherlands; Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Petrol, NL-1081 HV Amsterdam, Netherlands; Univ Munich, Dept Earth & Environm Sci, D-80333 Munich, Germany; S Iceland Nat Ctr, IS-900 Vestmannaeyjar, Iceland; Univ Asmara, Dept Earth Sci, Asmera, Eritrea	Max Planck Society; Russian Academy of Sciences; Vernadsky Institute of Geochemistry & Analytical Chemistry; Russian Academy of Sciences; Sobolev Institute of Geology & Mineralogy of the Russian Academy of Sciences; Australian National University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); National Taiwan University; University of Tasmania; University of Tasmania; University of Bristol; Massachusetts Institute of Technology (MIT); University of Hawaii System; Cardiff University; Russian Academy of Sciences; Shirshov Institute of Oceanology; Utrecht University; Vrije Universiteit Amsterdam; University of Munich	Sobolev, AV (corresponding author), Max Planck Inst Chem, POB 3060, D-55020 Mainz, Germany.	sobolev@geokhi.ru	Kamenetsky, Vadim/CAF-7424-2022; Kamenetsky, Vadim/K-2200-2019; Kuzmin, Dmitry/A-3809-2014; Sobolev, Alexander/AAB-4269-2021; Sobolev, Alexander/AAQ-6001-2021; Kamenetsky, Vadim/B-1019-2008; Yaxley, Greg/A-1167-2008; Sobolev, Alexander/E-6367-2010; Danyushevsky, Leonid/C-5346-2013	Kamenetsky, Vadim/0000-0002-2734-8790; Yaxley, Greg/0000-0003-0445-8812; Sobolev, Alexander/0000-0002-1997-2032; Frey, Frederick/0000-0002-5403-5677; Nikogosian, I.K./0000-0002-1270-5134; CHUNG, SUN-LIN/0000-0002-5362-4496; Danyushevsky, Leonid/0000-0003-4050-6850; Elliott, Tim/0000-0002-0984-0191; Kerr, Andrew C/0000-0001-5569-4730				ARNDT N, 2003, J EOPHYS RES, V108, pR20; BEATTIE P, 1993, CONTRIB MINERAL PETR, V115, P103, DOI 10.1007/BF00712982; Brandon AD, 2005, EARTH PLANET SC LETT, V232, P211, DOI 10.1016/j.epsl.2005.01.034; Danyushevsky LV, 2001, J VOLCANOL GEOTH RES, V110, P265, DOI 10.1016/S0377-0273(01)00213-X; EGGINS SM, 1992, CONTRIB MINERAL PETR, V110, P387, DOI 10.1007/BF00310752; Gudfinnsson GH, 2005, J PETROL, V46, P1645, DOI 10.1093/petrology/egi029; Hauri EH, 1997, EARTH PLANET SC LETT, V153, P21, DOI 10.1016/S0012-821X(97)00158-1; Hauri EH, 1996, NATURE, V382, P415, DOI 10.1038/382415a0; Herzberg C, 2002, J PETROL, V43, P1857, DOI 10.1093/petrology/43.10.1857; Herzberg C, 2006, NATURE, V444, P605, DOI 10.1038/nature05254; Hirschmann MM, 1996, CONTRIB MINERAL PETR, V124, P185, DOI 10.1007/s004100050184; Hofmann A.W., 2003, TREAT GEOCHEM, V2, P61, DOI DOI 10.1016/B0-08-043751-6/02123-X; HOFMANN AW, 1982, EARTH PLANET SC LETT, V57, P421, DOI 10.1016/0012-821X(82)90161-3; Humayun M, 2004, SCIENCE, V306, P91, DOI 10.1126/science.1101050; Ito G, 2005, EARTH PLANET SC LETT, V230, P29, DOI 10.1016/j.epsl.2004.10.035; Jarosewich E., 1980, GEOSTANDARD NEWSLETT, V4, P43, DOI [10.1111/j.1751-908X.1980.tb00273.x, DOI 10.1111/J.1751-908X.1980.TB00273.X]; Kamenetsky VS, 2001, GEOLOGY, V29, P243, DOI 10.1130/0091-7613(2001)029<0243:ROGCLI>2.0.CO;2; Kelemen PB, 1998, EARTH PLANET SC LETT, V164, P387, DOI 10.1016/S0012-821X(98)00233-7; KINZLER RJ, 1990, GEOCHIM COSMOCHIM AC, V54, P1255, DOI 10.1016/0016-7037(90)90151-A; Kogiso T, 2004, J PETROL, V45, P2407, DOI 10.1093/petrology/egh057; Kogiso T, 2003, EARTH PLANET SC LETT, V216, P603, DOI 10.1016/S0012-821X(03)00538-7; Kogiso T, 2006, EARTH PLANET SC LETT, V249, P188, DOI 10.1016/j.epsl.2006.07.016; Korzhinskii D. S., 1970, THEORY METASOMATIC Z; Kushiro I, 2001, ANNU REV EARTH PL SC, V29, P71, DOI 10.1146/annurev.earth.29.1.71; Lassiter JC, 1998, EARTH PLANET SC LETT, V164, P483, DOI 10.1016/S0012-821X(98)00240-4; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; MCKENZIE D, 1988, J PETROL, V29, P625, DOI 10.1093/petrology/29.3.625; MCKENZIE D, 1990, J PHYS EARTH, V38, P511, DOI 10.4294/jpe1952.38.511; Morgan JP, 2001, GEOCHEM GEOPHY GEOSY, V2; Pertermann M, 2003, J PETROL, V44, P2173, DOI 10.1093/petrology/egg074; Rapp RP, 1999, CHEM GEOL, V160, P335, DOI 10.1016/S0009-2541(99)00106-0; RINGWOOD AE, 1966, TECTONOPHYSICS, V3, P383, DOI 10.1016/0040-1951(66)90009-6; Ryabchikov ID, 2003, DOKL EARTH SCI, V389, P437; SLEEP NH, 1992, ANNU REV EARTH PL SC, V20, P19, DOI 10.1146/annurev.ea.20.050192.000315; Sobolev AV, 2005, NATURE, V434, P590, DOI 10.1038/nature03411; SOBOLEV VS, 1977, DOKL AKAD NAUK SSSR+, V237, P437; Walter MJ, 1998, J PETROL, V39, P29, DOI 10.1093/petrology/39.1.29; YASUDA A, 1994, J GEOPHYS RES-SOL EA, V99, P9401, DOI 10.1029/93JB03205; Yaxley GM, 2000, CONTRIB MINERAL PETR, V139, P326, DOI 10.1007/s004100000134; Yaxley GM, 1998, SCHWEIZ MINER PETROG, V78, P243	40	1063	1149	13	354	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					412	417		10.1126/science.1138113	http://dx.doi.org/10.1126/science.1138113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17395795	Green Accepted			2022-12-28	WOS:000245813400047
J	Torres, VE; Harris, PC; Pirson, Y				Torres, Vicente E.; Harris, Peter C.; Pirson, Yves			Autosomal dominant polycystic kidney disease	LANCET			English	Review							CHRONIC-RENAL-FAILURE; CONVERTING ENZYME-INHIBITION; CHRONIC SUBDURAL-HEMATOMA; RENIN-ANGIOTENSIN SYSTEM; SEMINAL-VESICLE CYSTS; PKD1 GENE-PRODUCT; INTRACRANIAL ANEURYSMS; BLOOD-PRESSURE; CELL-PROLIFERATION; ANTIHYPERTENSIVE THERAPY	Autosomal dominant polycystic kidney disease is the most prevalent, potentially lethal, monogenic disorder. It is associated with large interfamilial and intrafamilial variability, which can be explained to a large extent by its genetic heterogeneity and modifier genes. An increased understanding of the disorder's underlying genetic, molecular, and cellular mechanisms and a better appreciation of its progression and systemic manifestations have laid out the foundation for the development of clinical trials and potentially effective treatments.	Mayo Clin Coll Med, Rochester, MN 55905 USA; Catholic Univ Louvain, Clin St Luc, B-1200 Brussels, Belgium	Mayo Clinic; Universite Catholique Louvain	Torres, VE (corresponding author), Mayo Clin Coll Med, 200 1st St SW, Rochester, MN 55905 USA.	torres.vicente@mayo.edu		Torres, Vicente/0000-0003-2008-1576				Abbott Kevin C, 2002, BMC Nephrol, V3, P7, DOI 10.1186/1471-2369-3-7; Abderrahim E, 2004, NEPHROLOGY, V9, P331, DOI 10.1111/j.1440-1797.2004.00270.x; Aguiari G, 2004, FASEB J, V18, P884, DOI 10.1096/fj.03-0687fje; AHRABI AK, IN PRESS J AM SOC NE; Alehan FK, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.e13; ALPERN MB, 1991, RADIOLOGY, V180, P79, DOI 10.1148/radiology.180.1.2052727; Alvaro D, 2006, WORLD J GASTROENTERO, V12, P3537, DOI 10.3748/wjg.v12.i22.3537; Arnold HL, 2005, AM J GASTROENTEROL, V100, P2569, DOI 10.1111/j.1572-0241.2005.00263.x; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; Bae KT, 2006, CLIN J AM SOC NEPHRO, V1, P64, DOI 10.2215/CJN.00080605; Bajwa ZH, 2004, KIDNEY INT, V66, P1561, DOI 10.1111/j.1523-1755.2004.00921.x; Bajwa ZH, 2001, KIDNEY INT, V60, P1631, DOI 10.1046/j.1523-1755.2001.00985.x; BANKIR L, 1993, J AM SOC NEPHROL, V4, P1091; Basar O, 2006, PANCREATOLOGY, V6, P160, DOI 10.1159/000090258; Bello-Reuss E, 2001, KIDNEY INT, V60, P37, DOI 10.1046/j.1523-1755.2001.00768.x; Belz MM, 2003, KIDNEY INT, V63, P1824, DOI 10.1046/j.1523-1755.2003.00918.x; Bleeker-Rovers CP, 2003, AM J KIDNEY DIS, V41, DOI 10.1016/S0272-6386(03)00368-8; Bouby N, 1999, LIFE SCI, V65, P991, DOI 10.1016/S0024-3205(99)00330-6; BOUBY N, 1990, AM J PHYSIOL, V258, pF973, DOI 10.1152/ajprenal.1990.258.4.F973; Bukanov NO, 2006, NATURE, V444, P949, DOI 10.1038/nature05348; BURN TC, 1995, HUM MOL GENET, V4, P575, DOI 10.1093/hmg/4.4.575; Cadnapaphornchai MA, 2005, CONTEMP CLIN TRIALS, V26, P211, DOI 10.1016/j.cct.2005.01.001; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Chabardes D, 1999, CELL SIGNAL, V11, P651, DOI 10.1016/S0898-6568(99)00031-5; Chang MY, 2006, NEPHROL DIAL TRANSPL, V21, P2078, DOI 10.1093/ndt/gfl150; CHAPMAN AB, 1990, NEW ENGL J MED, V323, P1091, DOI 10.1056/NEJM199010183231602; Chapman AB, 2003, KIDNEY INT, V64, P1035, DOI 10.1046/j.1523-1755.2003.00185.x; CHAPMAN AB, 1994, J AM SOC NEPHROL, V5, P1178; Chapuis O, 2004, AM J KIDNEY DIS, V43, P161, DOI 10.1053/j.ajkd.2003.07.026; Chauveau D, 2000, J AM SOC NEPHROL, V11, P1767, DOI 10.1681/ASN.V1191767; Chauvet V, 2004, J CLIN INVEST, V114, P1433, DOI 10.1172/JCI200421753; Clausen P, 2006, AM J NEPHROL, V26, P335, DOI 10.1159/000094402; DALGAARD O Z, 1957, Acta Med Scand Suppl, V328, P1; Danaci M, 1998, NEPHROL DIAL TRANSPL, V13, P2825, DOI 10.1093/ndt/13.11.2825; DAVIES F, 1991, Q J MED, V79, P477; Davila S, 2004, NAT GENET, V36, P575, DOI 10.1038/ng1357; De Rycke M, 2005, MOL HUM REPROD, V11, P65, DOI 10.1093/molehr/gah128; Doulton TW, 2006, J HYPERTENS, V24, P939, DOI 10.1097/01.hjh.0000222765.30348.0d; Drenth JPH, 2003, NAT GENET, V33, P345, DOI 10.1038/ng1104; Dunn MD, 2000, AM J KIDNEY DIS, V35, P720, DOI 10.1016/S0272-6386(00)70021-7; Ecder T, 2001, AM J NEPHROL, V21, P98, DOI 10.1159/000046231; Ecder T, 2000, AM J KIDNEY DIS, V35, P427, DOI 10.1016/S0272-6386(00)70195-8; ELZINGA LW, 1992, J AM SOC NEPHROL, V2, P1219; ELZINGA LW, 1996, POLYCYSTIC KIDNEY DI, P483; Everson Gregory T, 2005, Curr Gastroenterol Rep, V7, P19, DOI 10.1007/s11894-005-0061-6; Fabris L, 2006, HEPATOLOGY, V43, P1001, DOI 10.1002/hep.21143; Fain PR, 2005, KIDNEY INT, V67, P1256, DOI 10.1111/j.1523-1755.2005.00203.x; FICK GM, 1993, J AM SOC NEPHROL, V3, P1863; FICK GM, 1995, J AM SOC NEPHROL, V5, P2048; Fick-Brosnahan GM, 2002, AM J KIDNEY DIS, V39, P1127, DOI 10.1053/ajkd.2002.33379; Foggensteiner L, 2000, J AM SOC NEPHROL, V11, P814, DOI 10.1681/ASN.V115814; GABOW PA, 1990, KIDNEY INT, V38, P1177, DOI 10.1038/ki.1990.330; GABOW PA, 1992, KIDNEY INT, V41, P1311, DOI 10.1038/ki.1992.195; GABOW PA, 1990, HEPATOLOGY, V11, P1033, DOI 10.1002/hep.1840110619; Gao ZQ, 2004, J BIOL CHEM, V279, P14225, DOI 10.1074/jbc.M312223200; Gattone VH, 1999, DEV GENET, V24, P309, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<309::AID-DVG14>3.0.CO;2-5; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; GEBERTH S, 1995, NEPHROL DIAL TRANSPL, V10, P1603; Gibbs GF, 2004, KIDNEY INT, V65, P1621, DOI 10.1111/j.1523-1755.2004.00572.x; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; GRAHAM PC, 1988, KIDNEY INT, V33, P1084, DOI 10.1038/ki.1988.115; Grampsas SA, 2000, AM J KIDNEY DIS, V36, P53, DOI 10.1053/ajkd.2000.8266; Grantham JJ, 2006, NEW ENGL J MED, V354, P2122, DOI 10.1056/NEJMoa054341; Griffin MD, 1997, J AM SOC NEPHROL, V8, P616; Grunfeld J P, 1985, Adv Nephrol Necker Hosp, V14, P1; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hanaoka K, 2000, J AM SOC NEPHROL, V11, P1179, DOI 10.1681/ASN.V1171179; Harris PC, 2006, CURR OPIN NEPHROL HY, V15, P456, DOI 10.1097/01.mnh.0000232888.65895.e7; Harris PC, 2006, J AM SOC NEPHROL, V17, P3013, DOI 10.1681/ASN.2006080835; Hateboer N, 1999, LANCET, V353, P103, DOI 10.1016/S0140-6736(98)03495-3; Hayashi T, 1997, GENOMICS, V44, P131, DOI 10.1006/geno.1997.4851; Heinonen PK, 2002, AM J KIDNEY DIS, V40, P504, DOI 10.1053/ajkd.2002.34902; Higashihara E, 1998, NEPHRON, V80, P421, DOI 10.1159/000045214; HOSSACK KF, 1988, NEW ENGL J MED, V319, P907, DOI 10.1056/NEJM198810063191404; Huan YH, 1999, J CLIN INVEST, V104, P1459, DOI 10.1172/JCI5111; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; IbraghimovBeskrovnaya O, 1997, P NATL ACAD SCI USA, V94, P6397, DOI 10.1073/pnas.94.12.6397; IGLESIAS CG, 1983, AM J KIDNEY DIS, V2, P630; Inagawa T, 2001, STROKE, V32, P1499, DOI 10.1161/01.STR.32.7.1499; Ishikawa I, 1996, AM J KIDNEY DIS, V27, P321, DOI 10.1016/S0272-6386(96)90353-4; Jafar TH, 2005, KIDNEY INT, V67, P265, DOI 10.1111/j.1523-1755.2005.00077.x; Jiang ST, 2006, AM J PATHOL, V168, P205, DOI 10.2353/ajpath.2006.050342; Johnson AM, 1997, J AM SOC NEPHROL, V8, P1560; KEITH DS, 1994, J AM SOC NEPHROL, V4, P1661; Kelleher CL, 2004, AM J HYPERTENS, V17, P1029, DOI 10.1016/j.amjhyper.2004.06.020; King BF, 2000, J AM SOC NEPHROL, V11, P1505, DOI 10.1681/ASN.V1181505; Kip SN, 2005, CIRC RES, V96, P873, DOI 10.1161/01.RES.0000163278.68142.8a; KLAHR S, 1995, J AM SOC NEPHROL, V5, P2037; Klein IHHT, 2001, J AM SOC NEPHROL, V12, P2427, DOI 10.1681/ASN.V12112427; Kocaman O, 2004, AM J KIDNEY DIS, V43, P854, DOI 10.1053/j.ajkd.2004.01.011; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Kumar S, 2006, NEPHROL DIAL TRANSPL, V21, P3576, DOI 10.1093/ndt/gfl405; Lantinga-van Leeuwen IS, 2004, HUM MOL GENET, V13, P3069, DOI 10.1093/hmg/ddh336; Lederman ED, 2000, AM SURGEON, V66, P200; Lee DI, 2004, J ENDOUROL, V18, P379, DOI 10.1089/089277904323056942; Lee DI, 2003, J ENDOUROL, V17, P345, DOI 10.1089/089277903767923100; LEIER CV, 1984, ANN INTERN MED, V100, P683, DOI 10.7326/0003-4819-100-5-683; Levine DZ, 2002, AM J KIDNEY DIS, V39, P637, DOI 10.1053/ajkd.2002.32402; Li AR, 2003, AM J HUM GENET, V72, P691, DOI 10.1086/368295; Li Y, 2005, J BIOL CHEM, V280, P41298, DOI 10.1074/jbc.M510082200; Loghman-Adham M, 2004, AM J PHYSIOL-RENAL, V287, pF775, DOI 10.1152/ajprenal.00370.2003; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; Lumiaho A, 2001, AM J KIDNEY DIS, V38, P1208, DOI 10.1053/ajkd.2001.29216; Magistroni R, 2003, J AM SOC NEPHROL, V14, P1164, DOI 10.1097/01.ASN.0000061774.90975.25; MASYUK TV, IN PRESS GASTROENTER; MCCUNE TR, 1992, CLIN TRANSPLANT, V6, P91; McPherson EA, 2004, J AM SOC NEPHROL, V15, P493, DOI 10.1097/01.ASN.0000109782.28991.26; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Nagao S, 2006, J AM SOC NEPHROL, V17, P2220, DOI 10.1681/ASN.2006030251; Naitoh H, 2005, J GASTROINTEST SURG, V9, P843, DOI 10.1016/j.gassur.2005.01.290; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nichols MT, 2004, HEPATOLOGY, V40, P836, DOI 10.1002/hep.20401; Nicolau C, 1999, RADIOLOGY, V213, P273, DOI 10.1148/radiology.213.1.r99oc05273; Nicolau C, 2000, J CLIN ULTRASOUND, V28, P277, DOI 10.1002/1097-0096(200007/08)28:6<277::AID-JCU2>3.0.CO;2-L; *NIH, 1999, REN DAT SYST US USRD; Nutahara K, 2005, NEPHRON CLIN PRACT, V99, pC18, DOI 10.1159/000081790; Okada H, 1999, HUM REPROD, V14, P110, DOI 10.1093/humrep/14.1.110; Omori S, 2006, J AM SOC NEPHROL, V17, P1604, DOI 10.1681/ASN.2004090800; Orth SR, 2000, NEPHRON, V86, P12, DOI 10.1159/000045708; Osawa H, 2006, TOHOKU J EXP MED, V209, P7, DOI 10.1620/tjem.209.7; OUE F, 1995, GASTROENTEROLOGY, V108, P487, DOI 10.1016/0016-5085(95)90078-0; Paterson AD, 2005, J AM SOC NEPHROL, V16, P755, DOI 10.1681/ASN.2004090758; Paterson AD, 2002, AM J KIDNEY DIS, V40, P16, DOI 10.1053/ajkd.2002.33908; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Pei Y, 2001, AM J HUM GENET, V68, P355, DOI 10.1086/318188; Persu A, 2004, KIDNEY INT, V66, P2132, DOI 10.1111/j.1523-1755.2004.66003.x; Pirson Y, 2002, J AM SOC NEPHROL, V13, P269, DOI 10.1681/ASN.V131269; Praetorius HA, 2005, ANNU REV PHYSIOL, V67, P515, DOI 10.1146/annurev.physiol.67.040403.101353; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Qian Q, 2003, J AM SOC NEPHROL, V14, P2280, DOI 10.1097/01.ASN.0000080185.38113.A3; Qian Q, 2003, HUM MOL GENET, V12, P1875, DOI 10.1093/hmg/ddg190; Qian Q, 2003, HEPATOLOGY, V37, P164, DOI 10.1053/jhep.2003.50006; Qian Q, 2007, J AM SOC NEPHROL, V18, P485, DOI 10.1681/ASN.2006050501; RAVINE D, 1994, LANCET, V343, P824, DOI 10.1016/S0140-6736(94)92026-5; RAVINE D, 1993, AM J KIDNEY DIS, V22, P803, DOI 10.1016/S0272-6386(12)70338-4; Reynolds DM, 2000, AM J HUM GENET, V67, P1598, DOI 10.1086/316904; Rossetti S, 2003, LANCET, V361, P2196, DOI 10.1016/S0140-6736(03)13773-7; Rossetti S, 2002, KIDNEY INT, V61, P1588, DOI 10.1046/j.1523-1755.2002.00326.x; Rossetti S, 2002, J AM SOC NEPHROL, V13, P1230, DOI 10.1097/01.ASN.0000013300.11876.37; Rossetti S, 2001, AM J HUM GENET, V68, P46, DOI 10.1086/316939; Rozanski J, 2005, TRANSPL P, V37, P666, DOI 10.1016/j.transproceed.2004.12.115; Ruggenenti P, 2005, KIDNEY INT, V68, P206, DOI 10.1111/j.1523-1755.2005.00395.x; Rundle DR, 2004, J BIOL CHEM, V279, P29728, DOI 10.1074/jbc.M400544200; Sakurai Y, 2001, J GASTROENTEROL, V36, P422, DOI 10.1007/s005350170088; Sampson JR, 1997, AM J HUM GENET, V61, P843, DOI 10.1086/514888; Sarnak MJ, 2005, ANN INTERN MED, V142, P342, DOI 10.7326/0003-4819-142-5-200503010-00009; Sasaki M, 2002, VIRCHOWS ARCH, V441, P98, DOI 10.1007/s00428-002-0635-8; Sauter D, 2006, KIDNEY INT, V69, P1024, DOI 10.1038/sj.ki.5000211; SCHEFF RT, 1980, ANN INTERN MED, V92, P202, DOI 10.7326/0003-4819-92-2-202; SCHEFFERS M, 2000, NETH PKD WORKSH, P53; SCHIEVINK W, 1997, LANCET, V26, P349; SCHIEVINK WI, 1995, J NEUROSURG, V83, P1004, DOI 10.3171/jns.1995.83.6.1004; Schrier RW, 2004, J AM SOC NEPHROL, V15, P1023, DOI 10.1097/01.ASN.0000118527.74850.66; Seeman T, 2004, PHYSIOL RES, V53, P629; Seeman T, 2003, BLOOD PRESS MONIT, V8, P107, DOI 10.1097/00126097-200306000-00003; Serafini F M, 1999, HPB Surg, V11, P191, DOI 10.1155/1999/85232; Sharp CK, 1999, AM J KIDNEY DIS, V34, P863, DOI 10.1016/S0272-6386(99)70043-0; Sherstha R, 1997, HEPATOLOGY, V26, P1282; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Silberberg M, 2005, AM J PHYSIOL-RENAL, V288, pF1153, DOI 10.1152/ajprenal.00008.2005; Simon P, 1996, NEPHROLOGIE, V17, P123; Sise C, 2000, KIDNEY INT, V58, P2492, DOI 10.1046/j.1523-1755.2000.00433.x; Stamm ER, 1999, AM J KIDNEY DIS, V34, P120, DOI 10.1016/S0272-6386(99)70117-4; Stengel B, 2003, NEPHROL DIAL TRANSPL, V18, P1824, DOI 10.1093/ndt/gfg233; SUJANSKY E, 1990, AM J MED GENET, V35, P510, DOI 10.1002/ajmg.1320350413; Sweeney WE, 2000, KIDNEY INT, V57, P33, DOI 10.1046/j.1523-1755.2000.00829.x; Sweeney WE, 2006, CELL TISSUE RES, V326, P671, DOI 10.1007/s00441-006-0226-0; Tahvanainen P, 2003, J HEPATOL, V38, P39, DOI 10.1016/S0168-8278(02)00348-3; Tao YX, 2005, J AM SOC NEPHROL, V16, P46, DOI 10.1681/ASN.2004080660; TELENTI A, 1990, MAYO CLIN PROC, V65, P933, DOI 10.1016/S0025-6196(12)65154-4; Torres V., 1996, POLYCYSTIC KIDNEY DI, P500; TORRES VE, 1992, KIDNEY INT, V42, P364, DOI 10.1038/ki.1992.297; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Torres VE, 2004, NAT MED, V10, P363, DOI 10.1038/nm1004; TORRES VE, 1994, J AM SOC NEPHROL, V5, P1186; TORRES VE, 1988, AM J KIDNEY DIS, V11, P318, DOI 10.1016/S0272-6386(88)80137-9; TORRES VE, 1993, AM J KIDNEY DIS, V22, P513, DOI 10.1016/S0272-6386(12)80922-X; Torres VE, 2001, J AM SOC NEPHROL, V12, P1, DOI 10.1681/ASN.V1211; TORRES VE, 1994, KIDNEY INT, V45, P1745, DOI 10.1038/ki.1994.227; TORRES VE, 1989, MAYO CLIN PROC, V64, P509, DOI 10.1016/S0025-6196(12)65554-2; TORRES VE, 1991, MAYO CLIN PROC, V66, P1010, DOI 10.1016/S0025-6196(12)61724-8; TORRES VE, 1985, PROBLEMS DIAGNOSIS M, P49; Torres VE, 2007, CLIN J AM SOC NEPHRO, V2, P112, DOI 10.2215/CJN.00910306; Torres VE, 2006, J AM SOC NEPHROL, V17, P2089, DOI 10.1681/ASN.2006060603; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Valente JF, 2001, NEPHROL DIAL TRANSPL, V16, P160, DOI 10.1093/ndt/16.1.160; van Dijk MA, 2003, NEPHROL DIAL TRANSPL, V18, P2314, DOI 10.1093/ndt/gfg417; Vassilev PM, 2001, BIOCHEM BIOPH RES CO, V282, P341, DOI 10.1006/bbrc.2001.4554; Vecchi ML, 2003, NEPHROL DIAL TRANSPL, V18, P190, DOI 10.1093/ndt/18.1.190; Wahl PR, 2006, NEPHROL DIAL TRANSPL, V21, P598, DOI 10.1093/ndt/gfi181; Wakai K, 2004, NEPHROL DIAL TRANSPL, V19, P2044, DOI 10.1093/ndt/gfh317; Walz G, 2006, NEPHROL DIAL TRANSPL, V21, P1752, DOI 10.1093/ndt/gfl246; Wang D, 2003, KIDNEY INT, V64, P1381, DOI 10.1046/j.1523-1755.2003.00236.x; Wang XF, 2005, J AM SOC NEPHROL, V16, P846, DOI 10.1681/ASN.2004121090; Watnick TJ, 1998, MOL CELL, V2, P247, DOI 10.1016/S1097-2765(00)80135-5; WATSON ML, 1992, KIDNEY INT, V41, P206, DOI 10.1038/ki.1992.28; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Wijdicks EFM, 2000, AM J KIDNEY DIS, V35, P40, DOI 10.1016/S0272-6386(00)70299-X; Wilson PD, 1999, LAB INVEST, V79, P1311; Wilson SJ, 2006, BBA-MOL BASIS DIS, V1762, P647, DOI 10.1016/j.bbadis.2006.04.006; Wong H, 2004, AM J KIDNEY DIS, V43, P624, DOI 10.1053/j.ajkd.2003.12.026; Wu GQ, 2002, HUM MOL GENET, V11, P1845, DOI 10.1093/hmg/11.16.1845; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; Yamaguchi T, 2004, J BIOL CHEM, V279, P40419, DOI 10.1074/jbc.M405079200; Yamaguchi T, 1997, AM J KIDNEY DIS, V30, P703, DOI 10.1016/S0272-6386(97)90496-0; Yamaguchi T, 2006, J AM SOC NEPHROL, V17, P178, DOI 10.1681/ASN.2005060645; Yersin C, 1997, NEPHROL DIAL TRANSPL, V12, P2069, DOI 10.1093/ndt/12.10.2069; YIUM J, 1994, J AM SOC NEPHROL, V4, P1670; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; ZERRES K, 1993, J MED GENET, V30, P583, DOI 10.1136/jmg.30.7.583	214	903	958	4	92	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2007	369	9569					1287	1301		10.1016/S0140-6736(07)60601-1	http://dx.doi.org/10.1016/S0140-6736(07)60601-1			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164YA	17434405				2022-12-28	WOS:000246269700032
J	Leibundgut, M; Jenni, S; Frick, C; Ban, N				Leibundgut, Marc; Jenni, Simon; Frick, Christian; Ban, Nenad			Structural basis for substrate delivery by acyl carrier protein in the yeast fatty acid synthase	SCIENCE			English	Article							BINDING-SITES; BIOSYNTHESIS; SYNTHETASE; IDENTIFICATION; ARCHITECTURE; RESOLUTION; REDUCTASE; PEPTIDE; ENZYMES; BIOLOGY	In the multifunctional fungal fatty acid synthase (FAS), the acyl carrier protein (ACP) domain shuttles reaction intermediates covalently attached to its prosthetic phosphopantetheine group between the different enzymatic centers of the reaction cycle. Here, we report the structure of the Saccharomyces cerevisiae FAS determined at 3.1 angstrom resolution with its ACP stalled at the active site of ketoacyl synthase. The ACP contacts the base of the reaction chamber through conserved, charge-complementary surfaces, which optimally position the ACP toward the catalytic cleft of ketoacyl synthase. The conformation of the prosthetic group suggests a switchblade mechanism for acyl chain delivery to the active site of the enzyme.	ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Ban, N (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland.	ban@mol.biol.ethz.ch						Bhaumik P, 2005, CURR OPIN STRUC BIOL, V15, P621, DOI 10.1016/j.sbi.2005.10.010; Crump MP, 1997, BIOCHEMISTRY-US, V36, P6000, DOI 10.1021/bi970006+; Fichtlscherer F, 2000, EUR J BIOCHEM, V267, P2666, DOI 10.1046/j.1432-1327.2000.01282.x; Findlow SC, 2003, BIOCHEMISTRY-US, V42, P8423, DOI 10.1021/bi0342259; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; HOLAK TA, 1988, EUR J BIOCHEM, V175, P9, DOI 10.1111/j.1432-1033.1988.tb14159.x; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Koglin A, 2006, SCIENCE, V312, P273, DOI 10.1126/science.1122928; KRESZE GB, 1977, EUR J BIOCHEM, V79, P181, DOI 10.1111/j.1432-1033.1977.tb11796.x; LYNEN F, 1980, EUR J BIOCHEM, V112, P431; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; MOHAMED AH, 1988, J BIOL CHEM, V263, P12315; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Rafi S, 2006, J BIOL CHEM, V281, P39285, DOI 10.1074/jbc.M608758200; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; SCHRECKENBACH T, 1977, EUR J BIOCHEM, V80, P13, DOI 10.1111/j.1432-1033.1977.tb11850.x; SCHUSTER H, 1995, EUR J BIOCHEM, V228, P417; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; von Wettstein-Knowles P, 2006, FEBS J, V273, P695, DOI 10.1111/j.1742-4658.2005.05101.x; Weissman KJ, 2004, PHILOS T R SOC A, V362, P2671, DOI 10.1098/rsta.2004.1470; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wong HC, 2002, J BIOL CHEM, V277, P15874, DOI 10.1074/jbc.M112300200; Xu GY, 2001, STRUCTURE, V9, P277, DOI 10.1016/S0969-2126(01)00586-X; Zhang YM, 2003, J BIOL CHEM, V278, P52935, DOI 10.1074/jbc.M309874200; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200; Zornetzer GA, 2006, BIOCHEMISTRY-US, V45, P5217, DOI 10.1021/bi052062d	29	147	157	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					288	290		10.1126/science.1138249	http://dx.doi.org/10.1126/science.1138249			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431182				2022-12-28	WOS:000245654500054
J	Cook, RL; Martin, PJ; Geremia, JM				Cook, Robert L.; Martin, Paul J.; Geremia, J. M.			Optical coherent state discrimination using a closed-loop quantum measurement	NATURE			English	Article							INFORMATION; FEEDBACK	Quantum mechanics hinders our ability to determine the state of a physical system in two ways: individual measurements provide only partial information about the observed system ( because of Heisenberg uncertainty), and measurements are themselves invasive - meaning that little or no refinement is achieved by further observation of an already measured system(1). Theoretical methods have been developed to maximize the information gained from a quantum measurement while also minimizing disturbance(2-4), but laboratory implementation of optimal measurement procedures is often difficult. The standard class of operations considered in quantum information theory(5) tends to rely on superposition-basis and entangled measurements(6), which require high-fidelity implementation to be effective in the laboratory(7). Here we demonstrate that real-time quantum feedback(8-10) can be used in place of a delicate quantum superposition, often called a 'Schrodinger cat state', to implement an optimal quantum measurement for discriminating between optical coherent states(11,12). Our procedure actively manipulates the target system during the measurement process, and uses quantum feedback to modify the statistics of an otherwise sub-optimal operator to emulate the optimal cat-state measurement. We verify a long-standing theoretical prediction(13) and demonstrate feedback-mediated quantum measurement(10,14) at its fundamental quantum limit over a non-trivial region of parameter space.	Univ New Mexico, Dept Phys & Astron, Quantum Measurement & Control Grp, Albuquerque, NM 87131 USA	University of New Mexico	Geremia, JM (corresponding author), Univ New Mexico, Dept Phys & Astron, Quantum Measurement & Control Grp, Albuquerque, NM 87131 USA.	jgeremia@unm.edu						Armen MA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.133602; Doherty AC, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.012105; Dolinar S. J, 1973, 111 MIT RES LAB EL; Fuchs C A, 1996, THESIS U NEW MEXICO; Fuchs CA, 1996, PHYS REV A, V53, P2038, DOI 10.1103/PhysRevA.53.2038; Geremia JM, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.062303; Geremia JM, 2004, SCIENCE, V304, P270, DOI 10.1126/science.1095374; Helstrom C. W, 1976, MATH SCI ENG SERIES, V123; HELSTROM CW, 1967, INFORM CONTROL, V10, P254, DOI 10.1016/S0019-9958(67)90302-6; Kraus K, 1983, LECT NOTES PHYS, V190; Leibfried D, 2004, SCIENCE, V304, P1476, DOI 10.1126/science.1097576; NIELSEN MA, 2000, QUANTUM COPUTATION Q; PERES A, 1991, PHYS REV LETT, V66, P1119, DOI 10.1103/PhysRevLett.66.1119; PERES A, 1990, FOUND PHYS, V20, P1441, DOI 10.1007/BF01883517; Sasaki M, 1996, PHYS REV A, V54, P2728, DOI 10.1103/PhysRevA.54.2728; SASAKIUSUDA T, 1995, QUANTUM COMMUNICATIONS AND MEASUREMENT, P419; Von Neumann J., 1955, MATH GRUNDLAGEN QUAN; WISEMAN HM, 1994, PHYS REV A, V49, P4110, DOI 10.1103/PhysRevA.49.4110; WISEMAN HM, 1995, PHYS REV LETT, V75, P4587, DOI 10.1103/PhysRevLett.75.4587	19	163	163	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2007	446	7137					774	777		10.1038/nature05655	http://dx.doi.org/10.1038/nature05655			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429395				2022-12-28	WOS:000245626800035
J	Fukuda, R; Zhang, HF; Kim, JW; Shimoda, L; Dang, CV; Semenza, GL				Fukuda, Ryo; Zhang, Huafeng; Kim, Jung-whan; Shimoda, Larissa; Dang, Chi V.; Semenza, Gregg L.			HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells	CELL			English	Article							INDUCIBLE FACTOR 1-ALPHA; PAS DOMAIN PROTEIN-1; C-OXIDASE; SACCHAROMYCES-CEREVISIAE; GROWTH-FACTOR; FACTOR-I; EXPRESSION; FACTOR-1; YEAST; GENE	O-2 is the ultimate electron acceptor for mitochondrial respiration, a process catalyzed by cytochrome c oxidase (COX). In yeast, COX subunit composition is regulated by COX5a and COX5b gene transcription in response to high and low O-2, respectively. Here we demonstrate that in mammalian cells, expression of the COX4-1 and COX4-2 isoforms is O-2 regulated. Under conditions of reduced O-2 availability, hypoxia-inducible factor 1 (HIF-1) reciprocally regulates COX4 subunit expression by activating transcription of the genes encoding COX4-2 and LON, a mitochondrial protease that is required for COX4-1 degradation. The effects of manipulating COX4 subunit expression on COX activity, ATP production, O-2 consumption, and reactive oxygen species generation indicate that the COX4 subunit switch is a homeostatic response that optimizes the efficiency of respiration at different O-2 concentrations. Thus, mammalian cells respond to hypoxia by altering COX subunit composition, as previously observed in yeast, but by a completely different molecular mechanism.	Johns Hopkins Univ, Sch Med, Vasc Biol Program, Inst Cell Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Semenza, GL (corresponding author), Johns Hopkins Univ, Sch Med, Vasc Biol Program, Inst Cell Engn, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu	Zhang, Huafeng/A-7188-2012; Dang, Chi/Y-3375-2019	Kim, Jung-whan/0000-0002-7829-1480; Dang, Chi/0000-0002-4031-2522				ALLEN LA, 1995, J BIOL CHEM, V270, P110, DOI 10.1074/jbc.270.1.110; Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Burke PV, 1998, J EXP BIOL, V201, P1163; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; FORSBURG SL, 1989, ANNU REV CELL BIOL, V5, P153, DOI 10.1146/annurev.cb.05.110189.001101; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hervouet E, 2006, BIOCHEM BIOPH RES CO, V344, P1086, DOI 10.1016/j.bbrc.2006.04.014; Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huttemann M, 2001, GENE, V267, P111, DOI 10.1016/S0378-1119(01)00385-7; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Kwast KE, 1998, J EXP BIOL, V201, P1177; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lofstedt T, 2004, J BIOL CHEM, V279, P39223, DOI 10.1074/jbc.M402904200; LOWRY CV, 1984, P NATL ACAD SCI-BIOL, V81, P6129, DOI 10.1073/pnas.81.19.6129; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MCEWEN JE, 1986, J BIOL CHEM, V261, P1872; Mukhopadhyay CK, 2000, J BIOL CHEM, V275, P21048, DOI 10.1074/jbc.M000636200; Napiwotzki J, 1998, BIOL CHEM, V379, P335, DOI 10.1515/bchm.1998.379.3.335; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Okuyama H, 2006, J BIOL CHEM, V281, P15554, DOI 10.1074/jbc.M602003200; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang J, 2006, CIRC RES, V98, P1528, DOI 10.1161/01.RES.0000227551.68124.98; WATERLAND RA, 1991, J BIOL CHEM, V266, P4180; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	43	883	918	7	81	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					111	122		10.1016/j.cell.2007.01.047	http://dx.doi.org/10.1016/j.cell.2007.01.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418790	Bronze			2022-12-28	WOS:000245661100015
J	Rossjohn, J; McCluskey, J				Rossjohn, Jamie; McCluskey, James			How a home-grown T cell receptor interacts with a foreign landscape	CELL			English	Editorial Material							RECOGNITION; PEPTIDE	The ability of a T cell receptor (TCR) to directly recognize foreign (allogeneic)-major histocompatibility complex (MHC) molecules underlies T cell-mediated rejection in patients receiving allogeneic organ transplants. In this issue, Colf et al. (2007) reveal that instead of mimicking the interactions formed with a self MHC, a single TCR adopts a completely different strategy to recognize a foreign MHC.	Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Prot Crystallog Unit, Clayton, Vic 3800, Australia; Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia	Monash University; University of Melbourne	Rossjohn, J (corresponding author), Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Prot Crystallog Unit, Clayton, Vic 3800, Australia.	jamie.rossjohn@med.monash.edu.au; jamesm1@unimelb.edu.au	McCluskey, James/A-1291-2007; Rossjohn, Jamie/F-9032-2013	McCluskey, James/0000-0002-8597-815X; Rossjohn, Jamie/0000-0002-2020-7522				BEVAN MJ, 1984, IMMUNOL TODAY, V5, P128, DOI 10.1016/0167-5699(84)90233-0; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; COLF LA, 2007, CELL; Ely LK, 2006, P NATL ACAD SCI USA, V103, P6641, DOI 10.1073/pnas.0600743103; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Macdonald WA, 2003, J EXP MED, V198, P679, DOI 10.1084/jem.20030066; MATZINGER P, 1977, CELL IMMUNOL, V29, P1, DOI 10.1016/0008-8749(77)90269-6; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; SHERMAN LA, 1993, ANNU REV IMMUNOL, V11, P385, DOI 10.1146/annurev.immunol.11.1.385; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257	10	11	12	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					19	20		10.1016/j.cell.2007.03.018	http://dx.doi.org/10.1016/j.cell.2007.03.018			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418777	Bronze			2022-12-28	WOS:000245661100002
J	Somesh, BP; Sigurdsson, S; Saeki, H; Erdjument-Bromage, H; Tempst, P; Svejstrup, JQ				Somesh, Baggavalli P.; Sigurdsson, Stefan; Saeki, Hideaki; Erdjument-Bromage, Hediye; Tempst, Paul; Svejstrup, Jesper Q.			Communication between distant sites in RNA polymerase II through ubiquitylation factors and the polymerase CTD	CELL			English	Article							UBIQUITIN-PROTEIN LIGASE; COUPLED DNA-REPAIR; STRUCTURAL BASIS; LARGE SUBUNIT; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION ELONGATION; IN-VIVO; COMPLEX; DEGRADATION; RESOLUTION	Transcriptional arrest triggers ubiquitylation of RNA polymerase II (RNAPII). We mapped the yeast RNAPII ubiquitylation sites and found that they play an important role in elongation and the DNA-damage response. One site lies in a protein domain that is unordered in free RNAPII, but ordered in the elongating form, helping explain the preferential ubiguitylation of this form. The other site is > 125 Angstroms away, yet mutation of either site affects ubiquitylation of the other, in vitro and in vivo. The basis for this remarkable coupling was uncovered: an Rsp5 (E3) dimer assembled on the RNAPII C-terminal domain (CTD). The ubiquitylation sites bind Ubc5 (E2), which in turn binds Rsp5 to allow modification. Evidence for folding of the CTD compatible with this mechanism of communication between distant sites is provided. These data reveal the specificity and mechanism of RNAPII ubiquitylation and demonstrate that Us can play a crucial role in substrate recognition.	Canc Res UK London Res Inst, Mech & Transcript Lab, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Cancer Research UK; Memorial Sloan Kettering Cancer Center	Svejstrup, JQ (corresponding author), Canc Res UK London Res Inst, Mech & Transcript Lab, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	j.svejstrup@cancer.org.uk	Sigurdsson, Stefan/L-9820-2015	Sigurdsson, Stefan/0000-0002-5284-0058; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Svejstrup, Jesper/0000-0003-4964-6147; Tempst, Paul/0000-0002-6680-3987				Archambault J, 1998, J BACTERIOL, V180, P2590, DOI 10.1128/JB.180.10.2590-2598.1998; Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Boeger H, 2005, FEBS LETT, V579, P899, DOI 10.1016/j.febslet.2004.11.027; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hemming SA, 2000, J BIOL CHEM, V275, P35506, DOI 10.1074/jbc.M004721200; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; Kobor MS, 2002, BBA-GENE STRUCT EXPR, V1577, P261, DOI 10.1016/S0167-4781(02)00457-8; Li SS, 2002, EMBO J, V21, P5921, DOI 10.1093/emboj/cdf589; LI Y, 1994, P NATL ACAD SCI USA, V91, P2362, DOI 10.1073/pnas.91.6.2362; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; NONET M, 1987, CELL, V50, P909, DOI 10.1016/0092-8674(87)90517-4; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; Somesh BP, 2005, CELL, V121, P913, DOI 10.1016/j.cell.2005.04.010; Svejstrup JQ, 2003, J CELL SCI, V116, P447, DOI 10.1242/jcs.00271; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a	27	59	60	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					57	68		10.1016/j.cell.2007.01.046	http://dx.doi.org/10.1016/j.cell.2007.01.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418786	Bronze			2022-12-28	WOS:000245661100011
J	Schanz, S; Metzler, G				Schanz, Stefan; Metzler, Gisela			A medical mystery - Skin discolorations in a bank employee	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Tubingen, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Schanz, S (corresponding author), Univ Tubingen, D-72076 Tubingen, Germany.	stefan.schanz@med.uni-tuebingen.de							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2007	356	14					1455	1455		10.1056/NEJMicm062084	http://dx.doi.org/10.1056/NEJMicm062084			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153GG	17409327				2022-12-28	WOS:000245419600009
J	Eaton, L				Eaton, Lynn			Week in medicine - Open all hours	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 31	2007	334	7595					668	669		10.1136/bmj.39163.683785.4E	http://dx.doi.org/10.1136/bmj.39163.683785.4E			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154ON	17395946	Green Published			2022-12-28	WOS:000245517100030
J	Passino, MA; Adams, RA; Sikorski, SL; Akassoglou, K				Passino, Melissa A.; Adams, Ryan A.; Sikorski, Shoana L.; Akassoglou, Katerina			Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75(NTR)	SCIENCE			English	Article							HEPATOCYTE GROWTH-FACTOR; PLASMINOGEN DEFICIENCY; LIVER-REGENERATION; ACTIN CYTOSKELETON; SIGNALING PATHWAYS; APOPTOSIS; RAT; P75; RHO; EXPRESSION	Differentiation of hepatic stellate cells (HSCs) to extracellular matrix- and growth factor-producing cells supports liver regeneration through promotion of hepatocyte proliferation. We show that the neurotrophin receptor p75(NTR), a tumor necrosis factor receptor superfamily member expressed in HSCs after fibrotic and cirrhotic liver injury in humans, is a regulator of liver repair. In mice, depletion of p75(NTR) exacerbated liver pathology and inhibited hepatocyte proliferation in vivo. p75(NTR-/-) HSCs failed to differentiate to myofibroblasts and did not support hepatocyte proliferation. Moreover, inhibition of p75(NTR) signaling to the small guanosine triphosphatase Rho resulted in impaired HSC differentiation. Our results identify signaling from p75(NTR) to Rho as a mechanism for the regulation of HSC differentiation to regeneration-promoting cells that support hepatocyte proliferation in the diseased liver.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Akassoglou, K (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	akass@ucsd.edu		Akassoglou, Katerina/0000-0002-2632-1465	NIGMS NIH HHS [5T32-GM07752] Funding Source: Medline; NINDS NIH HHS [NS051470, P30-NS047101] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101, R01NS051470] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Balabaud C, 2004, J HEPATOL, V40, P1023, DOI 10.1016/j.jhep.2004.04.003; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; Bataller R, 2001, SEMIN LIVER DIS, V21, P437, DOI 10.1055/s-2001-17558; Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2; Cassiman D, 2001, HEPATOLOGY, V33, P148, DOI 10.1053/jhep.2001.20793; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Hoshijima M, 1998, J BIOL CHEM, V273, P7725, DOI 10.1074/jbc.273.13.7725; HU ZY, 1993, AM J PATHOL, V142, P1823; Kato M, 1999, J HEPATOL, V31, P91, DOI 10.1016/S0168-8278(99)80168-8; Kisseleva T, 2006, J GASTROEN HEPATOL, V21, pS84, DOI 10.1111/j.1440-1746.2006.04584.x; LOMENHOERTH C, 1995, J NEUROCHEM, V64, P1780; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; MAHER JJ, 1993, J CLIN INVEST, V91, P2244, DOI 10.1172/JCI116451; Majdan M, 1997, J NEUROSCI, V17, P6988; Ng VL, 2001, J HEPATOL, V35, P781, DOI 10.1016/S0168-8278(01)00212-4; Novo E, 2006, GUT, V55, P1174, DOI 10.1136/gut.2005.082701; Oakley F, 2003, AM J PATHOL, V163, P1849, DOI 10.1016/S0002-9440(10)63544-4; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Roux PP, 2001, J BIOL CHEM, V276, P23097, DOI 10.1074/jbc.M011520200; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Teng KK, 2004, CELL MOL LIFE SCI, V61, P35, DOI 10.1007/s00018-003-3099-3; Trim N, 2000, AM J PATHOL, V156, P1235, DOI 10.1016/S0002-9440(10)64994-2; Uyama N, 2002, J HEPATOL, V36, P590, DOI 10.1016/S0168-8278(02)00023-5; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Zampieri N, 2006, BIOCHEM SOC T, V34, P607, DOI 10.1042/BST0340607	28	139	152	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1853	1856		10.1126/science.1137603	http://dx.doi.org/10.1126/science.1137603			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395831				2022-12-28	WOS:000245280100046
J	Check, E				Check, Erika			The hard copy	NATURE			English	News Item							HEMATOPOIETIC STEM-CELLS; BONE-MARROW; PROGENITOR CELLS; FUSION; BRAIN											Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Giles J, 2006, NATURE, V442, P344, DOI 10.1038/442344a; Jiang YH, 2002, EXP HEMATOL, V30, P896, DOI 10.1016/S0301-472X(02)00869-X; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268; Serafini M, 2007, J EXP MED, V204, P129, DOI 10.1084/jem.20061115; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	10	21	28	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2007	446	7135					485	486		10.1038/446485a	http://dx.doi.org/10.1038/446485a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392761				2022-12-28	WOS:000245242900022
J	Sacknoff, R; Sheridan, RL; Smith, RM; Velmahos, G; Schnitzer, JJ; Harris, NL				Sacknoff, Richard; Sheridan, Robert L.; Smith, R. Malcolm; Velmahos, George; Schnitzer, Jay J.; Harris, Nancy Lee			A 55-year-old man impaled in a rowing accident - Traumatic lacerations of the abdominal wall and viscera, with pelvic fracture.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYSTEMS		Massachusetts Gen Hosp, Dept Trauma, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Emergency Surg, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Surg Crit Care, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Orthoped, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Surg, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Orthoped Surg, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Sacknoff, R (corresponding author), Massachusetts Gen Hosp, Dept Trauma, Boston, MA 02114 USA.							Bass RR, 1999, J TRAUMA, V47, pS15, DOI 10.1097/00005373-199909001-00005; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; DeLong WG, 1999, J TRAUMA, V46, P1049, DOI 10.1097/00005373-199906000-00012; Gopal S, 2000, J BONE JOINT SURG BR, V82B, P959, DOI 10.1302/0301-620X.82B7.10482; Miller RS, 2005, J TRAUMA, V59, P1365, DOI 10.1097/01.ta.0000196004.49422.af; Salim A, 2006, ARCH SURG-CHICAGO, V141, P468, DOI 10.1001/archsurg.141.5.468; Senecal E, 2006, NEW ENGL J MED, V354, P2263, DOI 10.1056/NEJMcpc069007; van Olden GDJ, 2004, AM J EMERG MED, V22, P522, DOI 10.1016/j.ajem.2004.08.013; WEST JG, 1988, JAMA-J AM MED ASSOC, V259, P3597, DOI 10.1001/jama.259.24.3597	9	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2007	356	13					1353	1360		10.1056/NEJMcpc079004	http://dx.doi.org/10.1056/NEJMcpc079004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150MN	17392306				2022-12-28	WOS:000245221000011
J	Kim, TH; Abdullaev, ZK; Smith, AD; Ching, KA; Loukinov, DI; Green, RD; Zhang, MQ; Lobanenkov, VV; Ren, B				Kim, Tae Hoon; Abdullaev, Ziedulla K.; Smith, Andrew D.; Ching, Keith A.; Loukinov, Dmitri I.; Green, Roland D.; Zhang, Michael Q.; Lobanenkov, Victor V.; Ren, Bing			Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome	CELL			English	Article							ENHANCER-BLOCKING ACTIVITY; TRANSCRIPTION-FACTOR; X-INACTIVATION; WIDE ANALYSIS; H19 GENE; METHYLATION; BOUNDARIES; PROMOTER; SEQUENCE; RECEPTOR	Insulator elements affect gene expression by preventing the spread of heterochromatin and restricting transcriptional enhancers from activation of unrelated promoters. In vertebrates, insulator's function requires association with the CCCTC-binding factor (CTCF), a protein that recognizes long and diverse nucleotide sequences. While insulators are critical in gene regulation, only a few have been reported. Here, we describe 13,804 CTCF-binding sites in potential insulators of the human genome, discovered experimentally in primary human fibroblasts. Most of these sequences are located far from the transcriptional start sites, with their distribution strongly correlated with genes. The majority of them fit to a consensus motif highly conserved and suitable for predicting possible insulators driven by CTCF in other vertebrate genomes. In addition, CTCF localization is largely invariant across different cell types. Our results provide a resource for investigating insulator function and possible other general and evolutionarily conserved activities of CTCF sites.	Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; NIAID, Rockville, MD 20852 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; NimbleGen Syst Inc, Madison, WI 53711 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cold Spring Harbor Laboratory; Roche Holding; Roche NimbleGen	Kim, TH (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St,SHMl 142B,POB 208005, New Haven, CT 06120 USA.	taehoon.kim@yale.edu; biren@ucsd.edu	Smith, Andrew D./G-4104-2013; Lobanenkov, Victor V./AGQ-8903-2022; Lobanenkov, Victor/ABD-5710-2021	Smith, Andrew D./0000-0002-3337-1970; Kim, Tae Hoon/0000-0003-3950-7557; Lobanenkov, Victor/0000-0001-6665-3635	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [R21CA116365-01, R21 CA116365, R33CA105829, F32CA108313, F32 CA108313, R33 CA105829] Funding Source: Medline; NCRR NIH HHS [P41 RR 08605, P41 RR008605] Funding Source: Medline; NHGRI NIH HHS [U01 HG003151, R01 HG001696, U01HG003151, HG001696] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA108313, R21CA116365, R33CA105829] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008605] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001696, U01HG003151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000860] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Awad TA, 1999, J BIOL CHEM, V274, P27092, DOI 10.1074/jbc.274.38.27092; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Burcin M, 1997, MOL CELL BIOL, V17, P1281, DOI 10.1128/MCB.17.3.1281; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Dunn KL, 2003, BIOCHEM CELL BIOL, V81, P161, DOI 10.1139/o03-052; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Felsenfeld G, 2004, COLD SPRING HARB SYM, V69, P245, DOI 10.1101/sqb.2004.69.245; Filippova GN, 2002, CANCER RES, V62, P48; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Filippova GN, 1998, GENE CHROMOSOME CANC, V22, P26, DOI 10.1002/(SICI)1098-2264(199805)22:1<26::AID-GCC4>3.0.CO;2-9; Gerasimova TI, 2001, ANNU REV GENET, V35, P193, DOI 10.1146/annurev.genet.35.102401.090349; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Jeong S, 2004, NAT GENET, V36, P1036, DOI 10.1038/ng1004-1036; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Kim TH, 2005, GENOME RES, V15, P830, DOI 10.1101/gr.3430605; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lee JT, 2003, CURR BIOL, V13, pR242, DOI 10.1016/S0960-9822(03)00162-3; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Moon H, 2005, EMBO REP, V6, P165, DOI 10.1038/sj.embor.7400334; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Pugacheva EM, 2005, HUM MOL GENET, V14, P953, DOI 10.1093/hmg/ddi089; RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith AD, 2005, P NATL ACAD SCI USA, V102, P1560, DOI 10.1073/pnas.0406123102; Smith DR, 2005, WORD IMAGE, V21, P1, DOI 10.1080/0266628052000307175; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; UDVARDY A, 1985, J MOL BIOL, V185, P341, DOI 10.1016/0022-2836(85)90408-5; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2	53	762	790	2	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1231	1245		10.1016/j.cell.2006.12.048	http://dx.doi.org/10.1016/j.cell.2006.12.048			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382889	Green Accepted, Bronze			2022-12-28	WOS:000245396200026
J	Frayling, TM; Timpson, NJ; Weedon, MN; Zeggini, E; Freathy, RM; Lindgren, CM; Perry, JRB; Elliott, KS; Lango, H; Rayner, NW; Shields, B; Harries, LW; Barrett, JC; Ellard, S; Groves, CJ; Knight, B; Patch, AM; Ness, AR; Ebrahim, S; Lawlor, DA; Ring, SM; Ben-Shlomo, Y; Jarvelin, MR; Sovio, U; Bennett, AJ; Melzer, D; Ferrucci, L; Loos, RJF; Barroso, I; Wareham, NJ; Karpe, F; Owen, KR; Cardon, LR; Walker, M; Hitman, GA; Palmer, CNA; Doney, ASF; Morris, AD; Smith, GD; Hattersley, AT; McCarthy, MI				Frayling, Timothy M.; Timpson, Nicholas J.; Weedon, Michael N.; Zeggini, Eleftheria; Freathy, Rachel M.; Lindgren, Cecilia M.; Perry, John R. B.; Elliott, Katherine S.; Lango, Hana; Rayner, Nigel W.; Shields, Beverley; Harries, Lorna W.; Barrett, Jeffrey C.; Ellard, Sian; Groves, Christopher J.; Knight, Bridget; Patch, Ann-Marie; Ness, Andrew R.; Ebrahim, Shah; Lawlor, Debbie A.; Ring, Susan M.; Ben-Shlomo, Yoav; Jarvelin, Marjo-Riitta; Sovio, Ulla; Bennett, Amanda J.; Melzer, David; Ferrucci, Luigi; Loos, Ruth J. F.; Barroso, Ines; Wareham, Nicholas J.; Karpe, Fredrik; Owen, Katharine R.; Cardon, Lon R.; Walker, Mark; Hitman, Graham A.; Palmer, Colin N. A.; Doney, Alex S. F.; Morris, Andrew D.; Smith, George Davey; Hattersley, Andrew T.; McCarthy, Mark I.		Wellcome Trust Case Control	A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity	SCIENCE			English	Article							ENPP1; GAD2	Obesity is a serious international health problem that increases the risk of several common diseases. The genetic factors predisposing to obesity are poorly understood. A genome-wide search for type 2 diabetes-susceptibility genes identified a common variant in the FTO ( fat mass and obesity associated) gene that predisposes to diabetes through an effect on body mass index (BMI). An additive association of the variant with BMI was replicated in 13 cohorts with 38,759 participants. The 16% of adults who are homozygous for the risk allele weighed about 3 kilograms more and had 1.67-fold increased odds of obesity when compared with those not inheriting a risk allele. This association was observed from age 7 years upward and reflects a specific increase in fat mass.	Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England; Univ Oxford, Wellcome Trust, Ctr Human Genet, Oxford, England; Univ Bristol, MRC, Ctr Casual Anal Translat Epidemiol, Bristol, Avon, England; Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; Royal Devon & Exeter Natl Hlth Serv Fdn Trust, Mol Genet Lab, Exeter, Devon, England; Univ Bristol, Dept Oral & Dent Sci, Sch Dent, Bristol, Avon, England; London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; Univ Bristol, Dept Social Med, Bristol, Avon, England; Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; Univ Oulu, Dept Publ Hlth Sci & Gen Practice, FIN-90014 Oulu, Finland; Peninsula Med Sch, Epidemiol & Publ Hlth Grp, Exeter, Devon, England; NIA, Lonitudinal Studies Sect, Clin Res Branch, NIH, Baltimore, MD 21224 USA; Strangeways Res Labs, MRC, Epidemiol Unit, Cambridge, England; Sanger Inst, Metab Dis Grp, Wellcome Trust, Cambridge, England; Univ Newcastle, Diabet Res Grp, Sch Clin Med Sci, Newcastle Upon Tyne, Tyne & Wear, England; Barts & London Royal London Hosp, Dept Diabet & Metab Med, London, England; Univ Dundee, Populat Pharmacogenet Grp, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Diabet Res Grp, Div Med & Therapeut,Sch Med, Dundee DD1 9SY, Scotland	University of Exeter; University of Oxford; Wellcome Centre for Human Genetics; University of Bristol; University of Oxford; University of Bristol; University of London; London School of Hygiene & Tropical Medicine; University of Bristol; Imperial College London; University of Oulu; University of Exeter; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Wellcome Trust Sanger Institute; Newcastle University - UK; Barts Health NHS Trust; Royal London Hospital; University of Dundee; University of Dundee	Hattersley, AT (corresponding author), Peninsula Med Sch, Inst Biomed & Clin Sci, Magdalen Rd, Exeter, Devon, England.	Andrew.Hattersley@pms.ac.uk	Loos, Ruth J F/Q-2862-2016; Harries, Lorna/D-2241-2014; Davey Smith, George/A-7407-2013; Fox, Laura J/C-6249-2016; Doney, Alexander SF/P-7437-2017; Berryman, Katie/J-4236-2014; Palmer, Colin NA/C-7053-2008; Loos, Ruth/GON-5877-2022; Patch, Ann-Marie/F-8060-2011; Morris, Andrew D/C-2837-2009; Patch, Ann-Marie/C-4201-2018; Timpson, Nicholas John/O-7548-2015; Sovio, Ulla/H-8532-2019; Ben-Shlomo, Yoav/ABD-2004-2021; Ness, Andy R/M-7612-2013; Study, GoDARTS/K-9448-2016; Allen, Hana Lango/G-9026-2012; Attrill, Lauren/V-1688-2018; McCarthy, Mark/M-3763-2015; Lunnon, Katie/C-4638-2012	Loos, Ruth J F/0000-0002-8532-5087; Davey Smith, George/0000-0002-1407-8314; Doney, Alexander SF/0000-0002-6210-5620; Palmer, Colin NA/0000-0002-6415-6560; Patch, Ann-Marie/0000-0001-6121-4019; Timpson, Nicholas John/0000-0002-7141-9189; Sovio, Ulla/0000-0002-0799-1105; Ben-Shlomo, Yoav/0000-0001-6648-3007; Ness, Andy R/0000-0003-3548-9523; Allen, Hana Lango/0000-0002-7803-8688; Lawlor, Debbie A/0000-0002-6793-2262; Melzer, David/0000-0002-0170-3838; Zeggini, Eleftheria/0000-0003-4238-659X; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Karpe, Fredrik/0000-0002-2751-1770; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Freathy, Rachel/0000-0003-4152-2238; bennett, amanda/0000-0003-2140-8710; McCarthy, Mark/0000-0002-4393-0510; s, hema/0000-0002-3440-9475; Lindgren, Cecilia/0000-0002-4903-9374; Lunnon, Katie/0000-0001-7570-6065; Barroso, Ines/0000-0001-5800-4520; Weedon, Michael/0000-0002-6174-6135; Harries, Lorna/0000-0001-7791-8061; Frayling, Timothy/0000-0001-8362-2603; Ellard, Sian/0000-0002-7620-5526; Barrett, Jeffrey/0000-0002-1152-370X; Hattersley, Andrew/0000-0001-5620-473X	NATIONAL INSTITUTE ON AGING [Z01AG000631, Z01AG000965] Funding Source: NIH RePORTER; Medical Research Council [MC_U106179471, MC_U106188470, G0000934, G0600705, G0500070, G9815508] Funding Source: researchfish; MRC [MC_U106188470, G0000934, G0500070, G0600705] Funding Source: UKRI	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Boutin P, 2003, PLOS BIOL, V1, P361, DOI 10.1371/journal.pbio.0000068; Dina C, 2007, SCIENCE, V315, DOI [10.1126/science.1129402, 10.1126/science.1130571, 10.1126/science.1130012]; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Groves CJ, 2006, DIABETES, V55, P1884, DOI 10.2337/db05-1674; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Lobstein T., 2004, OBES REV S1, V5, P4, DOI [https://doi.org/10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Meyre D, 2005, NAT GENET, V37, P863, DOI 10.1038/ng1604; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Peters T, 2002, MAMM GENOME, V13, P186, DOI 10.1007/s00335-001-2142-7; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Swarbrick MM, 2005, PLOS BIOL, V3, P1662, DOI 10.1371/journal.pbio.0030315; VANDERHOEVEN F, 1994, DEVELOPMENT, V120, P2601; Weedon MN, 2006, DIABETES, V55, P3175, DOI 10.2337/db06-0410; Zhang SL, 2003, GENET EPIDEMIOL, V24, P44, DOI 10.1002/gepi.10196	16	3132	3327	7	562	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2007	316	5826					889	894		10.1126/science.1141634	http://dx.doi.org/10.1126/science.1141634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17434869	Green Accepted, Green Published			2022-12-28	WOS:000246369800038
J	Nishiyama, T; Ohsumi, K; Kishimoto, T				Nishiyama, Tomoko; Ohsumi, Keita; Kishimoto, Takeo			Phosphorylation of Erp1 by p90rsk is required for cytostatic factor arrest in Xenopus laevis eggs	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; METAPHASE ARREST; MEIOTIC MATURATION; CELL-CYCLE; VERTEBRATE EGGS; MAP KINASE; INHIBITOR; EXIT; DEGRADATION; INDUCTION	Until fertilization, the meiotic cell cycle of vertebrate eggs is arrested at metaphase of meiosis II by a cytoplasmic activity termed cytostatic factor (CSF)(1), which causes inhibition of the anaphase-promoting complex/cyclosome (APC/C), a ubiquitin ligase that targets mitotic cyclins - regulatory proteins of meiosis and mitosis - for degradation(2,3). Recent studies indicate that Erp1/ Emi2, an inhibitor protein for the APC/C, has an essential role in establishing and maintaining CSF arrest(4-6), but its relationship to Mos, a mitogen-activated protein kinase ( MAPK) kinase kinase that also has an essential role in establishing CSF arrest 7 through activation of p90 ribosomal S6 kinase (p90rsk)(8,9), is unclear. Here we report that in Xenopus eggs Erp1 is a substrate of p90rsk, and that Mos-dependent phosphorylation of Erp1 by p90rsk at Thr 336, Ser 342 and Ser 344 is crucial for both stabilizing Erp1 and establishing CSF arrest in meiosis II oocytes. Semi-quantitative analysis with CSF-arrested egg extracts reveals that the Mos-dependent phosphorylation of Erp1 enhances, but does not generate, the activity of Erp1 that maintains metaphase arrest. Our results also suggest that Erp1 inhibits cyclin B degradation by binding the APC/C at its carboxy-terminal destruction box(10), and this binding is also enhanced by the Mos-dependent phosphorylation. Thus, Mos and Erp1 collaboratively establish and maintain metaphase II arrest in Xenopus eggs. The link between Mos and Erp1 provides a molecular explanation for the integral mechanism of CSF arrest in unfertilized vertebrate eggs.	Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Lab Cell & Dev Biol, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Ohsumi, K (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Lab Cell & Dev Biol, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	kohsumi@bio.titech.ac.jp						Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; Dumont J, 2005, J CELL BIOL, V169, P227, DOI 10.1083/jcb.200501027; Dupre A, 2002, EMBO J, V21, P4026, DOI 10.1093/emboj/cdf400; GOTOH Y, 1994, ONCOGENE, V9, P1891; Gross SD, 1999, SCIENCE, V286, P1365, DOI 10.1126/science.286.5443.1365; HACCARD O, 1993, SCIENCE, V262, P1262, DOI 10.1126/science.8235656; Hansen DV, 2006, P NATL ACAD SCI USA, V103, P608, DOI 10.1073/pnas.0509549102; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Iwabuchi M, 2000, EMBO J, V19, P4513, DOI 10.1093/emboj/19.17.4513; Kishimoto T, 2003, CURR OPIN CELL BIOL, V15, P654, DOI 10.1016/j.ceb.2003.10.010; Lefebvre C, 2002, J CELL BIOL, V157, P603, DOI 10.1083/jcb.200202052; Liu JJ, 2005, CURR BIOL, V15, P1458, DOI 10.1016/j.cub.2005.07.030; LOHKA MJ, 1985, J CELL BIOL, V101, P518, DOI 10.1083/jcb.101.2.518; LORCA T, 1993, NATURE, V366, P270, DOI 10.1038/366270a0; Masui Y, 2000, NAT REV MOL CELL BIO, V1, P228, DOI 10.1038/35043096; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Ohsumi K, 2004, P NATL ACAD SCI USA, V101, P12531, DOI 10.1073/pnas.0405300101; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Schmidt A, 2006, J CELL SCI, V119, P1213, DOI 10.1242/jcs.02919; Schmidt A, 2005, GENE DEV, V19, P502, DOI 10.1101/gad.320705; Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953; Tung JJ, 2005, P NATL ACAD SCI USA, V102, P4318, DOI 10.1073/pnas.0501108102; Tunquist BJ, 2003, GENE DEV, V17, P683, DOI 10.1101/gad.1071303; Yamamoto TM, 2005, DEV BIOL, V279, P345, DOI 10.1016/j.ydbio.2004.12.025	29	91	92	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2007	446	7139					1096	1099		10.1038/nature05696	http://dx.doi.org/10.1038/nature05696			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17410129				2022-12-28	WOS:000245950400053
J	Herzberg, C				Herzberg, Claude			Food for a volcanic diet	SCIENCE			English	Editorial Material							MANTLE; PETROLOGY		Rutgers State Univ, Dept Geol Sci, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Herzberg, C (corresponding author), Rutgers State Univ, Dept Geol Sci, Piscataway, NJ 08854 USA.	herzberg@rci.rutgers.edu						Abouchami W, 2005, NATURE, V434, P851, DOI 10.1038/nature03402; ALLEGRE CJ, 1986, NATURE, V323, P123, DOI 10.1038/323123a0; Anderson D.L, 2007, NEW THEORY EARTH; BODINIER JL, 2004, J PETROL, V45, P1; CAMPBELL IH, 1992, SCIENCE, V258, P1760, DOI 10.1126/science.258.5089.1760; Dasgupta R, 2006, J PETROL, V47, P647, DOI 10.1093/petrology/egi088; Herzberg C, 2006, NATURE, V444, P605, DOI 10.1038/nature05254; HERZBERG CT, 1983, CONTRIB MINERAL PETR, V84, P1, DOI 10.1007/BF01132324; HOFMANN AW, 1982, EARTH PLANET SC LETT, V57, P421, DOI 10.1016/0012-821X(82)90161-3; Kelemen PB, 1998, EARTH PLANET SC LETT, V164, P387, DOI 10.1016/S0012-821X(98)00233-7; Morgan JP, 1999, EARTH PLANET SC LETT, V170, P215, DOI 10.1016/S0012-821X(99)00114-4; Niu YL, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002048; Pilet S, 2005, EARTH PLANET SC LETT, V236, P148, DOI 10.1016/j.epsl.2005.05.004; Sobolev AV, 2007, SCIENCE, V316, P412, DOI 10.1126/science.1138113; Sobolev AV, 2005, NATURE, V434, P590, DOI 10.1038/nature03411	15	2	2	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					378	379		10.1126/science.1141051	http://dx.doi.org/10.1126/science.1141051			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17395792				2022-12-28	WOS:000245813400028
J	Lin, HF				Lin, Haifan			piRNAs in the germ line	SCIENCE			English	Review							INTERACTING RNAS PIRNAS; DROSOPHILA OVARY; PIWI; MACHINERY; SPERMATOGENESIS; ELEMENTS; CELLS; MIWI	Small noncoding RNAs have emerged as potent regulators of gene expression at both transcriptional and posttranscriptional levels. Recently, a class of small RNAs that interact with Piwi proteins has been discovered in the mammalian germ line and Drosophila. These Piwi-interacting RNAs (piRNAs) represent a distinct small RNA pathway.	Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06510 USA	Yale University	Lin, HF (corresponding author), Yale Univ, Sch Med, Yale Stem Cell Ctr, 333 Cedar St, New Haven, CT 06510 USA.	haifan.lin@yale.edu						BRENNECKE J, 2007, IN PRESS CELL   0307, P64902, DOI DOI 10.1016/J.CELL.2007.01.043; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323; Kim VN, 2006, GENE DEV, V20, P1993, DOI 10.1101/gad.1456106; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wilson JE, 1996, DEVELOPMENT, V122, P1631	15	118	144	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					397	397		10.1126/science.1137543	http://dx.doi.org/10.1126/science.1137543			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446387				2022-12-28	WOS:000245813400038
J	Wilmot, CM				Wilmot, Carrie M.			An ancient and intimate partnership	SCIENCE			English	Editorial Material							DIOXYGEN		Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Wilmot, CM (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	wilmo004@umn.edu		Wilmot, Carrie/0000-0002-8706-0000	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066569] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM066569, R01 GM066569-05] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; Katona G, 2007, SCIENCE, V316, P449, DOI 10.1126/science.1138885; Koehntop KD, 2005, J BIOL INORG CHEM, V10, P87, DOI 10.1007/s00775-005-0624-x; Kovaleva EG, 2007, SCIENCE, V316, P453, DOI 10.1126/science.1134697; Niviere V, 2004, J BIOL INORG CHEM, V9, P119, DOI 10.1007/s00775-003-0519-7	5	2	3	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					379	380		10.1126/science.1141629	http://dx.doi.org/10.1126/science.1141629			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446378	Green Accepted			2022-12-28	WOS:000245813400029
J	Ahmed, SN; Scozzafava, J				Ahmed, S. Nizam; Scozzafava, James			Meningioma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Alberta Hosp, Edmonton, AB T6G 2B7, Canada	University of Alberta	Ahmed, SN (corresponding author), Univ Alberta Hosp, Edmonton, AB T6G 2B7, Canada.	jis9@ualberta.ca							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2007	356	16					E14	E14		10.1056/NEJMicm054643	http://dx.doi.org/10.1056/NEJMicm054643			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AB	17442901				2022-12-28	WOS:000245762000009
J	Doyle, J; Csete, M				Doyle, John; Csete, Marie			Rules of engagement - Complex engineered and biological systems share protocol-based architectures that make them robust and evolvable, but with hidden fragilities to rare perturbations.	NATURE			English	Editorial Material									CALTECH, Pasadena, CA 91125 USA; Emory Univ, Atlanta, GA 30322 USA	California Institute of Technology; Emory University	Doyle, J (corresponding author), CALTECH, Pasadena, CA 91125 USA.							Doyle JC, 2005, P NATL ACAD SCI USA, V102, P14497, DOI 10.1073/pnas.0501426102; Moritz MA, 2005, P NATL ACAD SCI USA, V102, P17912, DOI 10.1073/pnas.0508985102	2	37	37	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2007	446	7138					860	860		10.1038/446860a	http://dx.doi.org/10.1038/446860a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17443168	Bronze			2022-12-28	WOS:000245785700023
J	Thamer, M; Zhang, Y; Kaufman, J; Cotter, D; Dong, F; Hernan, MA				Thamer, Mae; Zhang, Yi; Kaufman, James; Cotter, Dennis; Dong, Fan; Hernan, Miguel A.			Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STAGE RENAL-DISEASE; RECOMBINANT-HUMAN-ERYTHROPOIETIN; PERFORMANCE MEASURES PROJECT; HEMOGLOBIN LEVELS; ANEMIA; MANAGEMENT; MORTALITY; SURVIVAL; FAILURE	Context Epoetin therapy for dialysis-related anemia is the single largest Medicare drug expenditure. The type of facility ( profit, chain, and affiliation status) at which a patient receives dialysis might affect epoetin dosing patterns and has implications for future epoetin policies. Objective To examine the association between dialysis facility ownership and the dose of epoetin administered. Design, Setting, and Participants Data from the US Renal Data System were used to identify 159 522 adult Medicare-eligible, end-stage renal disease patients receiving in-center hemodialysis during November and December 2004. Regression models were used to estimate the mean epoetin dose and dose adjustment by profit, chain, and affiliation status. Main Outcome Measures Weekly mean epoetin dose administered in December 2004 and the adjustment in dose between November and December 2004. Results Compared with patients in nonprofit dialysis facilities (n= 28 199), patients in large for-profit dialysis chain facilities ( n= 106 116) were consistently administered the highest doses of epoetin regardless of anemia status. Compared with nonprofit facilities, for-profit facilities administered, on average, an additional 3306 U/wk of epoetin. Among the 6 large chain facilities with a similar patient case-mix, the average dose of epoetin ranged from 17 832 U/wk at chain 5 ( nonprofit facilities with a mean hematocrit level of 34.6%) to 24 986 U/wk at chain 2 ( for-profit facilities with a mean hematocrit level of 36.5%). Dosing adjustments also differed by type of facility. On average, compared with nonprofit facilities, for-profit facilities increased epoetin doses 3-fold for patients with hematocrit levels of less 33% and also increased the doses among patients with hematocrit levels in the recommended target of 33% to 36%, especially in the largest for-profit chain facilities. The greatest difference in dosing practice patterns between facilities was found among patients with hematocrit levels of less than 33%. Conclusions Dialysis facility organizational status and ownership are associated with variation in epoetin dosing in the United States. Different epoetin dosing patterns suggest that large for-profit chain facilities used larger dose adjustments and targeted higher hematocrit levels.	Med Technol & Practice Patterns Inst, Bethesda, MD 20814 USA; Vet Affairs Healthcare Syst, Renal Sect, Boston, MA USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Boston University; Harvard University; Harvard T.H. Chan School of Public Health	Cotter, D (corresponding author), Med Technol & Practice Patterns Inst, 4733 Bethesda Ave,Suite 510, Bethesda, MD 20814 USA.	dcott@mtppi.org		Hernan, Miguel/0000-0003-1619-8456	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066011] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01-DK066011-01A2] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADAMSON JW, 1989, Q J MED, V73, P1093; [Anonymous], 2001, Am J Kidney Dis, V37, pS182; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coladonato JA, 2002, J AM SOC NEPHROL, V13, P1288, DOI 10.1097/01.ASN.0000013294.11876.80; Collins AJ, 2007, AM J KIDNEY DIS, V49, P135, DOI 10.1053/j.ajkd.2006.09.020; Cotter D, 2006, HEALTH AFFAIR, V25, P1249, DOI 10.1377/hlthaff.25.5.1249; *CTR MED MED SERV, 2004, ANN REP ESRD CLIN PE; *DAV INC, 2006, ANN REP; DELISSOVOY G, 1994, MED CARE, V32, P130, DOI 10.1097/00005650-199402000-00004; DEPALMA JR, 2000, DIALYSIS TRANSPLANT, V29, P677; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; ESCHBACH JW, 1985, KIDNEY INT, V28, P1, DOI 10.1038/ki.1985.109; ESCHBACH JW, 1989, NEW ENGL J MED, V321, P158, DOI 10.1056/NEJM198907203210305; ESCHBACH JW, 1989, ANN INTERN MED, V111, P992, DOI 10.7326/0003-4819-111-12-992; Foley RN, 2000, KIDNEY INT, V58, P1325, DOI 10.1046/j.1523-1755.2000.00289.x; Frankenfield DL, 2004, KIDNEY INT, V65, P1426, DOI 10.1111/j.1523-1755.2004.00515.x; Garg PP, 1999, NEW ENGL J MED, V341, P1653, DOI 10.1056/NEJM199911253412205; GOOZNER M, 1999, CHICAGO TRIBUNE 0524, pA1; GRAY BH, 1986, NEW ENGL J MED, V314, P1523, DOI 10.1056/NEJM198606053142335; HELD PJ, 1990, AM J KIDNEY DIS, V15, P441, DOI 10.1016/S0272-6386(12)70362-1; Kalantar-Zadeh K, 2003, AM J KIDNEY DIS, V42, P761, DOI 10.1016/S0272-6386(03)00915-6; KDOQI, 2006, Am J Kidney Dis, V47, pS16; LAUPACIS A, 1991, TRANSPL P, V23, P1825; *NAT I DIAB DIG KI, 2005, US REN DAT SYST 2006; NISSENSON AR, 1993, KIDNEY INT, V43, pS120; Parfrey PS, 2005, J AM SOC NEPHROL, V16, P2180, DOI 10.1681/ASN.2004121039; SCHLESINGER M, 1989, MED CARE, V27, P244, DOI 10.1097/00005650-198903000-00003; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Steinbrook R, 2007, NEW ENGL J MED, V356, P4, DOI 10.1056/NEJMp068296; Szczech LA, 2006, KIDNEY INT, V69, P2094, DOI 10.1038/sj.ki.5000267; TAMG DC, 1999, KIDNEY INT S, V69, pS107; Thamer M, 2006, AM J KIDNEY DIS, V48, P77, DOI 10.1053/j.ajkd.2006.03.040; US Renal Data System, 2006, US REN DAT SYST ANN; van Manen JG, 2002, AM J KIDNEY DIS, V40, P82, DOI 10.1053/ajkd.2002.33916; Zhang Y, 2004, AM J KIDNEY DIS, V44, P866, DOI 10.1053/j.ajkd.2004.08.002; 2001, AM J KIDNEY DIS, V38, P442	37	97	98	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2007	297	15					1667	1674		10.1001/jama.297.15.1667	http://dx.doi.org/10.1001/jama.297.15.1667			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	157UR	17440144	Bronze			2022-12-28	WOS:000245747400020
J	Vaira, D; Zullo, A; Vakil, N; Gatta, L; Ricci, C; Perna, F; Hassan, C; Bernabucci, V; Tampieri, A; Morini, S				Vaira, Dino; Zullo, Angelo; Vakil, Nimish; Gatta, Luigi; Ricci, Chiara; Perna, Federico; Hassan, Cesare; Bernabucci, Veronica; Tampieri, Andrea; Morini, Sergio			Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY-CARE PHYSICIANS; ANTIBIOTIC-RESISTANCE; UNITED-STATES; ANTIMICROBIAL RESISTANCE; RISK-FACTORS; INFECTION; CLARITHROMYCIN; MULTICENTER; MANAGEMENT; GUIDELINES	Background: Antimicrobial resistance has decreased eradication rates for Helicobacter pylori infection worldwide. Objective: To determine whether sequential treatment eradicates H. pylori infection better than standard triple-drug therapy for adults with dyspepsia or peptic ulcers. Design: Randomized, double-blind, placebo-controlled trial. Setting: Two Italian hospitals between September 2003 and April 2006. Patients: 300 patients with dyspepsia or peptic ulcers. Measurements: C-13-urea breath test, upper endoscopy, histologic evaluation, rapid urease test, bacterial culture, and assessment of antibiotic resistance. Intervention: A 10-day sequential regimen (40 mg of pantoprazole, 1 g of amoxicillin, and placebo, each administered twice daily for the first 5 days, followed by 40 mg of pantoprazole, 500 mg of clarithromycin, and 500 mg of tinidazole, each administered twice daily for the remaining 5 days) or standard 10-day therapy (40 mg of pantoprazole, 500 mg of clarithromycin, and 1 g of amoxicillin, each administered twice daily). Results: The eradication rate achieved with the sequential regimen was significantly greater than that obtained with the standard treatment in the intention-to-treat analysis (89% vs. 77%; P = 0.0134; difference, 12% [95% CI, 3% to 20%]), the modified intention-to-treat analysis (91% vs. 78%; P = 0.0022; difference, 13% [CI, 5% to 21%]), and the per-protocol analysis (93% vs. 79%; P = 0.0013; difference, 14% [CI, 6% to 21%]). Sequential therapy was significantly more effective in patients with clarithromycin-resistant strains (89% vs. 29%; P = 0.0034). The incidence of major and minor side effects did not differ between therapy groups (17% in both groups). One patient (0.7%) in the standard therapy group discontinued treatment because of side effects. Limitations: Follow-up was incomplete in 4.6% and 2.7% patients in the sequential therapy and standard therapy groups, respectively. The results may not be generalizable to other countries. Sequential therapy may be more effective because it includes 1 additional antibiotic (tinidazole) that is not contained in standard therapy. Conclusions: Sequential therapy is statistically significant compared with standard therapy for eradicating H. pylori infection and is statistically significantly more effective in patients with clarithromycin-resistant strains. Side effects are similar with both treatment regimens and are rarely severe enough to cause discontinuation of therapy.	St Orsola Marcello Malpighi Hosp, Dept Internal Med & Gastroenterol, I-40138 Bologna, Italy; Univ Bologna, I-40126 Bologna, Italy; Nuovo Regina Margherita Hosp, Rome, Italy; Univ Wisconsin, Madison, WI 53706 USA; Univ Brescia, I-25121 Brescia, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Poliambulatorio Nuovo Regina Margherita; University of Wisconsin System; University of Wisconsin Madison; University of Brescia	Vaira, D (corresponding author), St Orsola Marcello Malpighi Hosp, Dept Internal Med & Gastroenterol, Via Massarenti 9, I-40138 Bologna, Italy.	vairadin@med.unibo.it	Zullo, Angelo/AAV-7092-2020; hassan, cesare/H-2844-2012; Gatta, Luigi/S-6795-2016; Zullo, Angelo/I-8809-2018	hassan, cesare/0000-0001-7167-1459; Gatta, Luigi/0000-0001-5789-3813; Zullo, Angelo/0000-0003-2329-8105				De Francesco V, 2006, ANN INTERN MED, V144, P94, DOI 10.7326/0003-4819-144-2-200601170-00006; De Francesco V, 2006, ALIMENT PHARM THER, V23, P429, DOI 10.1111/j.1365-2036.2006.02769.x; De Francesco V, 2004, ALIMENT PHARM THER, V19, P407, DOI 10.1046/j.1365-2036.2004.01818.x; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Duck WM, 2004, EMERG INFECT DIS, V10, P1088, DOI 10.3201/eid1006.030744; Francavilla R, 2005, GASTROENTEROLOGY, V129, P1414, DOI 10.1053/j.gastro.2005.09.007; Graham DY, 2006, ALIMENT PHARM THER, V24, P845, DOI 10.1111/j.1365-2036.2006.03072.x; Hassan C, 2003, ALIMENT PHARM THER, V18, P641, DOI 10.1046/j.1365-2036.2003.01694.x; Houben MHMG, 1999, ALIMENT PHARM THER, V13, P1047; Howden CW, 1998, AM J GASTROENTEROL, V93, P2330, DOI 10.1111/j.1572-0241.1998.00684.x; Koletzko S, 2006, GUT, V55, P1711, DOI 10.1136/gut.2006.091272; Laheij RJF, 1999, ALIMENT PHARM THERAP, V13, P857; Laine L, 2000, AM J GASTROENTEROL, V95, P3393, DOI 10.1111/j.1572-0241.2000.03349.x; Lind T, 1999, GASTROENTEROLOGY, V116, P248, DOI 10.1016/S0016-5085(99)70119-8; Lind T, 1996, Helicobacter, V1, P138, DOI 10.1111/j.1523-5378.1996.tb00027.x; Maconi G, 1999, ALIMENT PHARM THERAP, V13, P1499; Malfertheiner P, 2002, ALIMENT PHARM THER, V16, P167, DOI 10.1046/j.1365-2036.2002.01169.x; Megraud F, 2004, GUT, V53, P1374, DOI 10.1136/gut.2003.022111; Misiewicz JJ, 1997, GUT, V41, P735, DOI 10.1136/gut.41.6.735; Newcombe RG, 2000, STAT CONFIDENCE, V2nd; Osato MS, 2001, ARCH INTERN MED, V161, P1217, DOI 10.1001/archinte.161.9.1217; Scaccianoce G, 2006, CAN J GASTROENTEROL, V20, P113, DOI 10.1155/2006/258768; Sharma VK, 2004, J CLIN GASTROENTEROL, V38, P326, DOI 10.1097/00004836-200404000-00006; Shirin H, 2004, J CLIN GASTROENTEROL, V38, P322, DOI 10.1097/00004836-200404000-00005; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Toracchio S, 2003, DIGEST LIVER DIS, V35, P541, DOI 10.1016/S1590-8658(03)00265-2; Vaira D, 2001, GUT, V48, P287, DOI 10.1136/gut.48.3.287; Vakil N, 2006, AM J GASTROENTEROL, V101, P497, DOI 10.1111/j.1572-0241.2006.00454.x; Vakil N, 2004, ALIMENT PHARM THERAP, V20, P99, DOI 10.1111/j.1365-2036.2004.02029.x; Zullo A, 2005, ALIMENT PHARM THERAP, V21, P1419, DOI 10.1111/j.1365-2036.2005.02519.x; Zullo A, 2003, ALIMENT PHARM THER, V17, P719, DOI 10.1046/j.1365-2036.2003.01461.x; 1997, GUT S2, V41, pS10	32	235	260	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2007	146	8					556	145		10.7326/0003-4819-146-8-200704170-00006	http://dx.doi.org/10.7326/0003-4819-146-8-200704170-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158FV	17438314				2022-12-28	WOS:000245778000002
J	Alexander, RM				Alexander, R. McNeill			Knut Schmidt-Nielsen (1915-2007) - Quests in comparative physiology - Obituary	NATURE			English	Biographical-Item									Univ Leeds, Inst Integrat & Comparat Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Alexander, RM (corresponding author), Univ Leeds, Inst Integrat & Comparat Biol, Leeds LS2 9JT, W Yorkshire, England.	r.m.alexander@leeds.ac.uk							0	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2007	446	7137					744	744		10.1038/446744a	http://dx.doi.org/10.1038/446744a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429390	Bronze			2022-12-28	WOS:000245626800029
J	Galindo, M; Lago, PM; Caceres, V; Landaverde, M; Sutter, R				Galindo, Miguel; Lago, Pedro Mas; Caceres, Victor; Landaverde, Mauricio; Sutter, Roland		Cuba IPV Study Collaborative Grp	Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIBODY-RESPONSE; POLIOMYELITIS; IMMUNIZATION; EXCRETION; CHILDREN; INFANTS; CIRCULATION; SCHEDULES; CAMPAIGN; VIRUS	Background: After poliomyelitis has been eradicated, access to live polioviruses will be highly restricted and the use of oral poliovirus vaccine (OPV) will probably be discontinued. Countries using OPV must decide whether to switch to inactivated poliovirus vaccine (IPV) or stop polio vaccination. Because data on the immunogenicity of IPV in tropical developing countries are limited, we conducted a randomized, controlled trial of IPV in Cuba. Methods: The study population consisted of healthy infants born in Havana. A total of 166 infants were randomly assigned to two groups. Group A received a combination of the diphtheria-pertussis-tetanus (DPT) vaccine, the Haemophilus influenzae type b (Hib) vaccine, and IPV (DPT-Hib-IPV) at 6, 10, and 14 weeks of age. Group B, the control group, received a combination of the DPT vaccine and the Hib vaccine at 6, 10, and 14 weeks of age. Another group (group C, 100 infants), which did not undergo randomization at the same time as groups A and B, received the DPT-Hib-IPV combination at 8 and 16 weeks of age. Serum samples were collected before vaccination and at least 4 weeks after the last dose. Stool samples were obtained before and 7 days after challenge with OPV. Results: The seroconversion rates in group A were 94%, 83%, and 100% for types 1, 2, and 3 poliovirus, respectively. There were no seroconversions in group B. The seroconversion rates in group C were 90%, 89%, and 90% for poliovirus types 1, 2, and 3, respectively. For groups A, B, and C, the virus isolation rates after challenge with OPV were 94%, 91%, and 97%, respectively, and the mean log(sub 10) viral titers of any serotype were 3.46, 3.89, and 3.37, respectively. There was one major adverse event, an episode of hypotonia. Conclusions: Vaccination with two or three doses of IPV resulted in a rate of seroconversion of at least 90%, except for seroconversion against type 2. The viral titer of OPV shed in the stool after OPV challenge was reduced in both groups receiving IPV.	Ctr Dis Control & Prevent, Coordinating Off Global Hlth, Div Epidemiol & Surveillance Capac Dev, Atlanta, GA 30333 USA; Cuban Minist Publ Hlth, Havana, Cuba; Pedro Kouri Inst Trop Med, Havana, Cuba; Pan Amer Hlth Org, Washington, DC USA; WHO, CH-1211 Geneva, Switzerland	Centers for Disease Control & Prevention - USA; Pan American Health Organization; World Health Organization	Caceres, V (corresponding author), Ctr Dis Control & Prevent, Coordinating Off Global Hlth, Div Epidemiol & Surveillance Capac Dev, Mailstop E-93,1600 Clifton Rd, Atlanta, GA 30333 USA.			Sarmiento, Luis/0000-0002-3694-1211				[Anonymous], 2003, Wkly Epidemiol Rec, V78, P241; Aylward RB, 2005, SCIENCE, V310, P625, DOI 10.1126/science.1115547; CODY CL, 1981, PEDIATRICS, V68, P650; Dayan GH, 2007, J INFECT DIS, V195, P12, DOI 10.1086/508427; du Chatelet IP, 2003, VACCINE, V21, P1710, DOI 10.1016/S0264-410X(02)00523-6; GHENDON YZ, 1961, ACTA VIROL, V5, P265; Greenwood BM, 1996, B WORLD HEALTH ORGAN, V74, P253; HENRY JL, 1966, J HYG-CAMB, V64, P105, DOI 10.1017/S0022172400040389; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; KOK PW, 1992, B WORLD HEALTH ORGAN, V70, P93; KRISHNAN R, 1983, B WORLD HEALTH ORGAN, V61, P689; Lago PM, 2003, INT J EPIDEMIOL, V32, P772, DOI 10.1093/ije/dyg185; Lago PM, 1999, B WORLD HEALTH ORGAN, V77, P681; Lago PM, 2001, INT J EPIDEMIOL, V30, P1029, DOI 10.1093/ije/30.5.1029; MARINE WM, 1962, AM J HYG, V76, P173, DOI 10.1093/oxfordjournals.aje.a120272; Murdin AD, 1996, VACCINE, V14, P735, DOI 10.1016/0264-410X(95)00211-I; RAMSAY ME, 1994, PEDIATR INFECT DIS J, V13, P1117, DOI 10.1097/00006454-199412000-00009; Rousset D, 2003, EMERG INFECT DIS, V9, P885; Shimizu H, 2004, J VIROL, V78, P13512, DOI 10.1128/JVI.78.24.13512-13521.2004; SIMOES EAF, 1985, AM J DIS CHILD, V139, P977, DOI 10.1001/archpedi.1985.02140120023021; Sutter RW, 2000, NEW ENGL J MED, V343, P767, DOI 10.1056/NEJM200009143431103; Sutter RW, 2004, B WORLD HEALTH ORGAN, V82, P31; VIDOR E, 1994, REV MED VIROL, V4, P261, DOI 10.1002/rmv.1980040405; *WHO DEP IMM VACC, 2004, WHOIVB0410; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; 2004, WKLY EPIDEMIOL REC, V79, P401; 2004, WKLY EPIDEMIOL REC, V79, P349	27	72	74	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 12	2007	356	15					1536	1544		10.1056/NEJMoa054960	http://dx.doi.org/10.1056/NEJMoa054960			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156CA	17429085	Bronze			2022-12-28	WOS:000245624400007
J	Reay, D; Sabine, C; Smith, P; Hymus, G				Reay, Dave; Sabine, Christopher; Smith, Pete; Hymus, Graham			Spring-time for sinks	NATURE			English	Editorial Material									Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JN, Midlothian, Scotland; NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; Univ Aberdeen, Aberdeen AB9 1FX, Scotland; No Arizona Univ, Flagstaff, AZ 86011 USA	University of Edinburgh; National Oceanic Atmospheric Admin (NOAA) - USA; University of Aberdeen; Northern Arizona University	Reay, D (corresponding author), Univ Edinburgh, Sch Geosci, W Mains Rd, Edinburgh EH9 3JN, Midlothian, Scotland.	David.Reay@ed.ac.uk	Smith, Pete/G-1041-2010; Reay, David/F-4054-2010; Masselink, Gerd/B-6743-2015; Blenkinsopp, Chris/AFF-8523-2022; Turner, Ian L/H-7122-2014; Alecha, Maria/B-4717-2016	Smith, Pete/0000-0002-3784-1124; Masselink, Gerd/0000-0001-6079-7611; Blenkinsopp, Chris/0000-0001-5784-2805; Turner, Ian L/0000-0001-9884-6917; Reay, Dave/0000-0001-5829-9007; Alecha, Maria/0000-0003-1540-1870	Natural Environment Research Council [NE/C51755X/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; RAUPACH MR, 2004, GLOBAL CARBON CYCLE, P526; ROSE S, 2007, ENERGY MODELING FORU; Tans P.P., 2007, TRENDS ATMOSPHERIC C; Watson AJ, 2003, GLO CH IGBP, P123; Watson RT, 2000, IPCC SPECIAL REPORT	7	34	36	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					727	728		10.1038/446727a	http://dx.doi.org/10.1038/446727a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429376				2022-12-28	WOS:000245626800017
J	Bearinger, LH; Sieving, RE; Ferguson, J; Sharma, V				Bearinger, Linda H.; Sieving, Renee E.; Ferguson, Jane; Sharma, Vinit			Adolescent health 2 - Global perspectives on the sexual and reproductive health of adolescents: patterns, prevention, and potential	LANCET			English	Article							TRANSMITTED-DISEASES; DEVELOPING-COUNTRIES; PREGNANCY; BEHAVIOR; CHILDBEARING; PRIORITIES; AGENDA; YOUTH; WOMEN; CARE	Worldwide, societal shifts and behavioural patterns exacerbated by unique developmental vulnerabilities create a confluence of factors that place today's adolescents at heightened risks for poor health outcomes. Country-level data show that continued investment in effective prevention and treatment strategies is essential to protect adolescents' sexual and reproductive health. Whereas strategies must be tailored to the developmental needs of this age group and their social contexts, effective approaches are multifaceted. All adolescents need access to quality youth-friendly services provided by clinicians trained to work with this population. Sex education programmes should offer accurate, comprehensive information while building skills for negotiating sexual behaviours. Girls and boys also need equal access to youth development programmes that connect them with supportive adults and with educational and economic opportunities. Although progress has been made since the 1994 International Conference on Population and Development, adolescents continue to be disproportionately burdened by threats to their sexual and reproductive health.	Univ Minnesota, Sch Med, Ctr Adolescent Nursing, Sch Nursing, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Healthy Youth Dev Prevent Res Ctr, Dept Pediat, Minneapolis, MN 55455 USA; WHO, Dept Child & Adolescent Hlth & Dev, CH-1211 Geneva, Switzerland; United Nat Populat Fund, Amman, Jordan	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Geneva; World Health Organization; United Nations Population Fund	Bearinger, LH (corresponding author), Univ Minnesota, Sch Med, Ctr Adolescent Nursing, Sch Nursing, Minneapolis, MN 55455 USA.	beari001@umn.edu						*A GUTTM I, 2004, THEIR OWN RIGHT ADDR; *A GUTTM I, FACTS BRIEF IND AB W; *A GUTTM I, 2006, US TEEN PREGN STAT N; Abma Joyce C, 2004, Vital Health Stat 23, P1; [Anonymous], 2005, SEXUALLY TRANSMITTED; [Anonymous], [No title captured]; Badiani R.I., 1997, BRASIL PESQUISA NACL; Bankole A, 1999, INT FAM PLAN PERSPEC, V25, P68, DOI 10.2307/2991944; BANKOLE A, 2004, RISK PROTECTION YOUT, P1; Blanc AK, 1998, STUD FAMILY PLANN, V29, P106, DOI 10.2307/172153; BLUM RW, 2006, RISK PROTECTIVE FACT, P1; Brindis C, 2002, J ADOLESCENT HEALTH, V31, P296, DOI 10.1016/S1054-139X(02)00492-5; BRNER N, 2002, MMWR-MORBID MORTAL W, V51, P198; BROWN A, 2001, SEXUAL RELATION YOUN, P1; *CDC, 2003, REPR MAT CHILD HLTH; *CDC, 2005, REPR MAT CHILD HLTH; Central Bureau of Statistics (CBS) [Kenya] Ministry of Health (MOH) [Kenya] ORC Macro, 2004, ORC MACR KEN DEM HLT; *CESDEM, 2003, ORC MACR ENC DEM SAL; *CPS MS, 2002, DIR NAT SURV STAT IN; *CSO, 2000, MACR INT ZIMB DEM HL; Darroch JE, 2001, FAM PLANN PERSPECT, V33, P244, DOI 10.2307/3030191; de Visser RO, 2003, AUST NZ J PUBL HEAL, V27, P146, DOI 10.1111/j.1467-842X.2003.tb00802.x; Eccles J. S, 2002, COMMUNITY PROGRAMS P; Fathalla MF, 2006, LANCET, V368, P2095, DOI 10.1016/S0140-6736(06)69483-X; Fortenberry JD, 1997, AM J PUBLIC HEALTH, V87, P417, DOI 10.2105/AJPH.87.3.417; FRAPPIER JY, 2004, ADOLESCENT SEXUAL HL; Germain A, 2005, INT FAM PLAN PERSPEC, V31, P90, DOI 10.1363/3109005; Glasier A, 2006, LANCET, V368, P1550, DOI 10.1016/S0140-6736(06)69485-3; Glasier A, 2006, LANCET, V368, P1595, DOI 10.1016/S0140-6736(06)69478-6; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; *I NAC EST CENS, 2002, NIC DEM HLTH SURV 20; *INSAE, 2002, ORC MACR ENQ DEM SAN; Jemmott LS, 1994, BE PROUD BE RESPONSI; *JOINT UN PROGR HI, 2004 REP GLOB AIDS E; Kaufman CE, 2001, STUD FAMILY PLANN, V32, P147, DOI 10.1111/j.1728-4465.2001.00147.x; KIRBY D, 2006, 2 FHI, P1; Kirby D., 2001, EMERGING ANSWERS RES; LLOYD CB, 2004, GROWING GLOBAL CHANG; Lonczak HS, 2002, ARCH PEDIAT ADOL MED, V156, P438, DOI 10.1001/archpedi.156.5.438; Marston C, 2006, LANCET, V368, P1581, DOI 10.1016/S0140-6736(06)69662-1; Martini J, 2006, BIRTHS FINAL DATA 20; Maticka-Tyndale E., 2001, TEENAGE SEXUAL REPRO; MCINTYRE P, 2002, ADOLESCENT FRIENDLY, P1; OJEDA GM, 2005, SALUD SEXUAL REPROD; Panchaud C, 2000, FAM PLANN PERSPECT, V32, P24, DOI 10.2307/2648145; POTTS H, 2005, INCREASING ACCESS HI; Resnick M D, 2000, Adolesc Med, V11, P157; Resnick MD, 2005, MED J AUSTRALIA, V183, P398, DOI 10.5694/j.1326-5377.2005.tb07101.x; REYNOLDS H, 2004, MATERNAL CARE ADOLES; Rissel Chris, 2003, N S W Public Health Bull, V14, P133, DOI 10.1071/NB03039; ROSS D, 2006, PREVENTING HIV AIDS, P357; SENDEROWITZ J, 1999, MAKING REPROD HLTH S, P1; Singh S, 2000, FAM PLANN PERSPECT, V32, P14, DOI 10.2307/2648144; Singh S, 1998, STUD FAMILY PLANN, V29, P117, DOI 10.2307/172154; Singh S, 1996, INT FAM PLAN PERSPEC, V22, P148, DOI 10.2307/2950812; Singh S, 2000, INT FAM PLAN PERSPEC, V26, P21, DOI 10.2307/2648286; Singh S., 2005, SEX ED, V5, P307, DOI [DOI 10.1080/14681810500278089, 10.1080/14681810500278089]; Speizer IS, 2003, J ADOLESCENT HEALTH, V33, P324, DOI 10.1016/S1054-139X(02)00535-9; *STAT CAN, PREGN OUTC AG GROUP; STLAWRENCE J, 1998, BECOMING RESPONSIBLE; Treffers PE, 2001, INT J GYNECOL OBSTET, V75, P111, DOI 10.1016/S0020-7292(01)00368-X; Tylee A, 2007, LANCET, V369, P1565, DOI 10.1016/S0140-6736(07)60371-7; *UBOS, 2001, ORC MACR UG DEM HLTH; *UN MILL, UN MILL PROJ PUBL CH; *UN STAT DIV, 2003, DEM YB; UNAIDS/WHO, 2004, UNAIDS WHO POL STAT; *UNAIDS WHO UNICEF, 2005, UNAIDS STAT S AFR TR; *UNFPA, 1999, 5 YEAR REV PROGR IMP; *UNFPA, 2003, REPR HLTH ED YOUNG P, P1; *UNFPA, 2006, STAT WORLD POP; *UNICEF, 1998, PROGR NAT; United Nations, 1995, POP DEV, V1; Weinstock H, 2004, PERSPECT SEX REPRO H, V36, P6, DOI 10.1111/j.1931-2393.2004.tb00002.x; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8; *WHO, 2006, AD PREGN UNM NEEDS D; *WHO, 2001, REPR HLTH STRAT ACC; *WHO, 2001, GLOB PREV INC SEL CR; *WHO, 2001, GLO CONS AD FRIENDL; *WHO, 2004, CONTR AD ISS AD HLTH; *WHO, 2001, 29 WHO, P1; *WHO, 2006, PREP HUM PAP VACC IN; *WHO, GEND REPR RIGHTS; WHO, 2006, GLOB STRAT PREV CONT; *WHO INF WORK GROU, 2001, PUNCT ASP INJ REASP, P1; *WHO UNAIDS UNFPA, 2004, PROT YOUNG PEOPL HIV; *WO, 2004, REPR HLTH STRAT ACC; *WORLD ANK, 2006, WORLD DEV REP 2007 D; World Health Organization, 2004, UNS AB GLOB REG EST; World Health Organization, 2002, WHO TRADITIONAL MED, P1; World Health Organization, 2005, MARR AD NO PLAC SAF; World Health Organization World Federation of Neurology, 2004, ATL COUNTR RES NEUR, P1; *YOUNG AD FERT SEX, YAFS 3 WHY FOC YOUNG	92	438	447	3	61	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2007	369	9568					1220	1231		10.1016/S0140-6736(07)60367-5	http://dx.doi.org/10.1016/S0140-6736(07)60367-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	155RH	17416266				2022-12-28	WOS:000245595100033
J	Duplessy, JC; Roche, DM; Kageyama, M				Duplessy, J. C.; Roche, D. M.; Kageyama, M.			The deep ocean during the last interglacial period	SCIENCE			English	Article							ANTARCTIC ICE-SHEET; NORTH-ATLANTIC OCEAN; SOUTHERN-HEMISPHERE; SEA-LEVEL; INTERMEDIATE COMPLEXITY; GLACIAL MAXIMUM; TEMPERATURE; RECORD; CIRCULATION; WIDESPREAD	Oxygen isotope analysis of benthic foraminifera in deep sea cores from the Atlantic and Southern Oceans shows that during the last interglacial period, North Atlantic Deep Water (NADW) was 0.4 degrees +/- 0.2 degrees C warmer than today, whereas Antarctic Bottom Water temperatures were unchanged. Model simulations show that this distribution of deep water temperatures can be explained as a response of the ocean to forcing by high-latitude insolation. The warming of NADW was transferred to the Circumpolar Deep Water, providing additional heat around Antarctica, which may have been responsible for partial melting of the West Antarctic Ice Sheet.	Univ Versailles, CNRS,CEA,UVSQ, LSCE,IPSL, Lab Commissarial Energie Atom, F-91198 Gif Sur Yvette, France; Vrije Univ Amsterdam, Dept Paleoclimatol & Geomorphol, NL-1081 HV Amsterdam, Netherlands; Univ Versailles, CNRS,Lab CEA,UVSQ, LSCE,IPSL, Lab Sci Climat & Environm, F-91198 Gif Sur Yvette, France	UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Vrije Universiteit Amsterdam; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Duplessy, JC (corresponding author), Univ Versailles, CNRS,CEA,UVSQ, LSCE,IPSL, Lab Commissarial Energie Atom, Parc CNRS, F-91198 Gif Sur Yvette, France.	Jean-Claude.Duplessy@lsce.cnrs-gif.fr	Roche, Didier M./C-9875-2010; KAGEYAMA, Masa/F-2389-2010	Roche, Didier M./0000-0001-6272-9428; KAGEYAMA, Masa/0000-0003-0822-5880				Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; BOWEN DQ, 2006, EOS S, V87; CHEN JH, 1991, GEOL SOC AM BULL, V103, P82, DOI 10.1130/0016-7606(1991)103<0082:PCOTLI>2.3.CO;2; Colhoun EA, 1999, QUATERN INT, V57-8, P5, DOI 10.1016/S1040-6182(98)00046-9; Cortijo E, 1999, PALEOCEANOGRAPHY, V14, P23, DOI 10.1029/1998PA900004; Curry R, 2005, SCIENCE, V308, P1772, DOI 10.1126/science.1109477; DICKSON R, 2002, SCIENCE, V416, P832; Driesschaert E., 2005, THESIS U CATHOLIQUE; DROXLER AW, 2003, AGU MONOGR, V137, P240; Duplessy JC, 2002, QUATERNARY SCI REV, V21, P315, DOI 10.1016/S0277-3791(01)00107-X; DUPLESSY JC, 1984, QUATERNARY RES, V21, P225, DOI 10.1016/0033-5894(84)90099-1; Fronval T, 1998, QUATERNARY SCI REV, V17, P963, DOI 10.1016/S0277-3791(98)00038-9; Groll N, 2005, J CLIMATE, V18, P4032, DOI 10.1175/JCLI3469.1; Israelson C, 1999, QUATERNARY RES, V51, P306, DOI 10.1006/qres.1998.2030; Jacobs SS, 2002, SCIENCE, V297, P386, DOI 10.1126/science.1069574; JACOBS SS, 1996, GEOPHYS RES LETT, V23, P657; Kaspar F, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022456; Kubatzki C, 2000, CLIM DYNAM, V16, P799, DOI 10.1007/s003820000078; Labeyrie L, 1996, PALEOCEANOGRAPHY, V11, P57, DOI 10.1029/95PA02255; LABEYRIE LD, 1987, NATURE, V327, P477, DOI 10.1038/327477a0; Lambeck K, 2001, SCIENCE, V292, P679, DOI 10.1126/science.1059549; LOZHKIN AV, 1995, QUATERNARY RES, V43, P147, DOI 10.1006/qres.1995.1016; MERCER JH, 1978, NATURE, V271, P321, DOI 10.1038/271321a0; Oppenheimer M, 1998, NATURE, V393, P325, DOI 10.1038/30661; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Overpeck JT, 2006, SCIENCE, V311, P1747, DOI 10.1126/science.1115159; Pahnke K, 2003, SCIENCE, V301, P948, DOI 10.1126/science.1084451; Rignot E, 2002, SCIENCE, V296, P2020, DOI 10.1126/science.1070942; Roche D, 2004, EARTH PLANET SC LETT, V218, P317, DOI 10.1016/S0012-821X(03)00700-3; Scherer RP, 1998, SCIENCE, V281, P82, DOI 10.1126/science.281.5373.82; Schrag DP, 2002, QUATERNARY SCI REV, V21, P331, DOI 10.1016/S0277-3791(01)00110-X; SHACKLETON NJ, 1974, METHODES QUANTITATIV, P203; Shepherd A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021106; Stirling CH, 1998, EARTH PLANET SC LETT, V160, P745, DOI 10.1016/S0012-821X(98)00125-3; Vandergoes MJ, 2005, NATURE, V436, P242, DOI 10.1038/nature03826; Vimeux F, 2002, EARTH PLANET SC LETT, V203, P829, DOI 10.1016/S0012-821X(02)00950-0	36	47	48	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2007	316	5821					89	91		10.1126/science.1138582	http://dx.doi.org/10.1126/science.1138582			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412954				2022-12-28	WOS:000245470500037
J	Alon, U				Alon, Uri			Simplicity in biology	NATURE			English	Editorial Material									Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.							Alon U., 2006, INTRO SYSTEMS BIOL D; PTASHNE M, 2002, GENES SIGNALS; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Simon HA, 1996, ARCHITECTURE COMPLEX	4	52	54	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2007	446	7135					497	497		10.1038/446497a	http://dx.doi.org/10.1038/446497a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392770				2022-12-28	WOS:000245242900032
J	Armanios, MY; Chen, JJL; Cogan, JD; Alder, JK; Ingersoll, RG; Markin, C; Lawson, WE; Xie, MY; Vulto, I; Phillips, JA; Lansdorp, PM; Greider, CW; Loyd, JE				Armanios, Mary Y.; Chen, Julian J. -L.; Cogan, Joy D.; Alder, Jonathan K.; Ingersoll, Roxann G.; Markin, Cheryl; Lawson, William E.; Xie, Mingyi; Vulto, Irma; Phillips, John A., III; Lansdorp, Peter M.; Greider, Carol W.; Loyd, James E.			Telomerase mutations in families with idiopathic pulmonary fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOMINANT DYSKERATOSIS-CONGENITA; REVERSE-TRANSCRIPTASE; APLASTIC-ANEMIA; CATALYTIC SUBUNIT; RNA; GENE; IDENTIFICATION; ANTICIPATION; SENESCENCE; SEQUENCE	BACKGROUND Idiopathic pulmonary fibrosis is progressive and often fatal; causes of familial clustering of the disease are unknown. Germ-line mutations in the genes hTERT and hTR, encoding telomerase reverse transcriptase and telomerase RNA, respectively, cause autosomal dominant dyskeratosis congenita, a rare hereditary disorder associated with premature death from aplastic anemia and pulmonary fibrosis. METHODS To test the hypothesis that familial idiopathic pulmonary fibrosis may be caused by short telomeres, we screened 73 probands from the Vanderbilt Familial Pulmonary Fibrosis Registry for mutations in hTERT and hTR. RESULTS Six probands (8%) had heterozygous mutations in hTERT or hTR; mutant telomerase resulted in short telomeres. Asymptomatic subjects with mutant telomerase also had short telomeres, suggesting that they may be at risk for the disease. We did not identify any of the classic features of dyskeratosis congenita in five of the six families. CONCLUSIONS Mutations in the genes encoding telomerase components can appear as familial idiopathic pulmonary fibrosis. Our findings support the idea that pathways leading to telomere shortening are involved in the pathogenesis of this disease.	Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21231 USA; Arizona State Univ, Dept Chem & Biochem, Temple, TX USA; Arizona State Univ, Sch Life Sci, Temple, TX USA; Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; Vet Affairs Med Ctr, Nashville, TN 37212 USA; Univ British Columbia, Terry Fox Lab, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, British Columbia Canc Agcy, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Arizona State University; Arizona State University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia	Armanios, MY (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, 1650 Orleans St,CRB 186, Baltimore, MD 21231 USA.	marmani1@jhmi.edu	Chen, Julian J.-L./D-6488-2014; Alder, Jonathan/AAF-3540-2020	Chen, Julian J.-L./0000-0002-7253-2722; Cogan, Joy/0000-0001-8106-1216; , Roxann/0000-0002-4266-613X; Loyd, James/0000-0002-5042-7390; Alder, Jonathan/0000-0003-3741-6512; Lansdorp, Peter/0000-0001-7435-1071; Greider, Carol/0000-0002-5494-8126	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000095] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL085406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI029524, R01AI029524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027406] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR-00095] Funding Source: Medline; NHLBI NIH HHS [K08 HL085406] Funding Source: Medline; NIAID NIH HHS [AI29524] Funding Source: Medline; NIA NIH HHS [R01 AG027406] Funding Source: Medline; PHS HHS [K08 118416, K08 85406] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Agusti C, 2002, AM J RESP CRIT CARE, V166, P426; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; BAERLOCHER GM, IN PRESS NAT PROTOC; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Chen JL, 2003, GENE DEV, V17, P2747, DOI 10.1101/gad.1140303; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Dokal I, 2003, BLOOD REV, V17, P217, DOI 10.1016/S0268-960X(03)00020-1; Drosopoulos WC, 2005, J BIOL CHEM, V280, P32801, DOI 10.1074/jbc.M506319200; Fogarty PF, 2003, LANCET, V362, P1628, DOI 10.1016/S0140-6736(03)14797-6; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Jacobs SA, 2006, NAT STRUCT MOL BIOL, V13, P218, DOI 10.1038/nsmb1054; Knight S, 1998, BRIT J HAEMATOL, V103, P990, DOI 10.1046/j.1365-2141.1998.01103.x; Lawson William E, 2006, Proc Am Thorac Soc, V3, P345, DOI 10.1513/pats.200512-137TK; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Loyd JE, 2003, AM J RESP CELL MOL, V29, pS47; Marshall RP, 2000, THORAX, V55, P143, DOI 10.1136/thorax.55.2.143; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; *NAT I ENV HLTH SC, TERT TEL REV TRANSCR; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Steele MP, 2005, AM J RESP CRIT CARE, V172, P1146, DOI 10.1164/rccm.200408-1104OC; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335	38	892	938	1	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2007	356	13					1317	1326		10.1056/NEJMoa066157	http://dx.doi.org/10.1056/NEJMoa066157			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150MN	17392301	Bronze			2022-12-28	WOS:000245221000005
J	Qi, B; Hardwick, JM				Qi, Bing; Hardwick, J. Marie			A Bcl-x(L) timer sets platelet life span	CELL			English	Editorial Material							GENOME-WIDE; BAX	Platelets are cell. fragments lacking nuclei that play a key role in blood clotting. Using an impressive genetic screen involving ENU-mutagenesis of whole mice, Mason et al. (2007) report in this issue their identification of mutations in the antiapoptotic protein Bcl-x(L) that cause accelerated death of platelets leading to platelet deficiency.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hardwick, JM (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Feinstone Dept Mol Microbiol & Immunol, 615 N Wolfe St, Baltimore, MD 21205 USA.	hardwick@jhu.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037402] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS037402] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bertino AM, 2003, TRANSFUSION, V43, P857, DOI 10.1046/j.1537-2995.2003.t01-4-00431.x; Clem RJ, 1998, P NATL ACAD SCI USA, V95, P554, DOI 10.1073/pnas.95.2.554; Dale GL, 2006, J THROMB HAEMOST, V4, P2664, DOI 10.1111/j.1538-7836.2006.02211.x; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; Kaluzhny Y, 2002, BLOOD, V100, P1670, DOI 10.1182/blood-2001-12-0263; Lewis J, 1999, NAT MED, V5, P832, DOI 10.1038/10556; ZHANG H, 2007, CELL DEATH DIFF 0205	8	20	21	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2007	128	6					1035	1036		10.1016/j.cell.2007.03.002	http://dx.doi.org/10.1016/j.cell.2007.03.002			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382877	Bronze			2022-12-28	WOS:000245396200011
J	Chou, CW; Laurat, J; Deng, H; Choi, KS; de Riedmatten, H; Felinto, D; Kimble, HJ				Chou, Chin-Wen; Laurat, Julien; Deng, Hui; Choi, Kyung Soo; de Riedmatten, Hugues; Felinto, Daniel; Kimble, H. Jeff			Functional quantum nodes for entanglement distribution over scalable quantum networks	SCIENCE			English	Article							ATOMIC ENSEMBLES; SINGLE-PHOTON; COMMUNICATION; CRYPTOGRAPHY; RETRIEVAL; MEMORIES; THEOREM; STATES; PAIRS	We demonstrated entanglement distribution between two remote quantum nodes located 3 meters apart. This distribution involves the asynchronous preparation of two pairs of atomic memories and the coherent mapping of stored atomic states into light fields in an effective state of near-maximum polarization entanglement. Entanglement is verified by way of the measured violation of a Bell inequality, and it can be used for communication protocols such as quantum cryptography. The demonstrated quantum nodes and channels can be used as segments of a quantum repeater, providing an essential tool for robust long-distance quantum communication.	CALTECH, Norman Bridge Lab Phys 12 33, Pasadena, CA 91125 USA	California Institute of Technology	Kimble, HJ (corresponding author), CALTECH, Norman Bridge Lab Phys 12 33, Pasadena, CA 91125 USA.	hjkimble@caltech.edu	Deng, Hui/AAD-6979-2020; de Riedmatten, Hugues/P-7563-2017; LAURAT, Julien/A-8542-2011; Felinto, Daniel/M-8756-2014; Choi, Kyung Soo/C-6073-2008; Deng, Hui/A-7115-2009; Deng, Hui/E-8950-2010; Laurat, Julien/Y-9272-2019	Deng, Hui/0000-0003-0629-3230; LAURAT, Julien/0000-0001-8318-6514; Felinto, Daniel/0000-0001-9078-7756; Choi, Kyung Soo/0000-0003-0757-1183; Deng, Hui/0000-0003-0629-3230; de Riedmatten, Hugues/0000-0002-4418-0723				Balic V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.183601; Beugnon J, 2006, NATURE, V440, P779, DOI 10.1038/nature04628; Blinov BB, 2004, NATURE, V428, P153, DOI 10.1038/nature02377; BOOZER AD, IN PRESS PHYS REV LE; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Chaneliere T, 2005, NATURE, V438, P833, DOI 10.1038/nature04315; Chen SA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.173004; CHEN ZB, IN PRESS QUANT PHYS; Chou CW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.213601; CHOU CW, 2006, THESIS CALTECH PASAD; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; CLAUSER JF, 1978, REP PROG PHYS, V41, P1881, DOI 10.1088/0034-4885/41/12/002; de Riedmatten H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.113603; Duan LM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.127902; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Eisaman MD, 2005, NATURE, V438, P837, DOI 10.1038/nature04327; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; Felinto D, 2006, NAT PHYS, V2, P844, DOI 10.1038/nphys450; Felinto D, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.053809; Fuchs CA, 1997, PHYS REV A, V56, P1163, DOI 10.1103/PhysRevA.56.1163; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; JIANG L, IN PRESS QUANT PHYS; Kuzmich A, 2003, NATURE, V423, P731, DOI 10.1038/nature01714; Laurat J, 2006, OPT EXPRESS, V14, P6912, DOI 10.1364/OE.14.006912; Matsukevich DN, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.013601; Sherson JF, 2006, NATURE, V443, P557, DOI 10.1038/nature05136; Thompson JK, 2006, SCIENCE, V313, P74, DOI 10.1126/science.1127676; van der Wal CH, 2003, SCIENCE, V301, P196, DOI 10.1126/science.1085946; Volz J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.030404; Zoller P, 2005, EUR PHYS J D, V36, P203, DOI 10.1140/epjd/e2005-00251-1	31	267	275	3	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2007	316	5829					1316	1320		10.1126/science.1140300	http://dx.doi.org/10.1126/science.1140300			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173PS	17412919	Green Submitted, Green Accepted			2022-12-28	WOS:000246885600044
J	Seager, R; Ting, MF; Held, I; Kushnir, Y; Lu, J; Vecchi, G; Huang, HP; Harnik, N; Leetmaa, A; Lau, NC; Li, CH; Velez, J; Naik, N				Seager, Richard; Ting, Mingfang; Held, Isaac; Kushnir, Yochanan; Lu, Jian; Vecchi, Gabriel; Huang, Huei-Ping; Harnik, Nili; Leetmaa, Ants; Lau, Ngar-Cheung; Li, Cuihua; Velez, Jennifer; Naik, Naomi			Model projections of an imminent transition to a more arid climate in southwestern North America	SCIENCE			English	Article							STORM TRACKS; DROUGHTS; CIRCULATION; SIMULATION	How anthropogenic climate change will affect hydroclimate in the arid regions of southwestern North America has implications for the allocation of water resources and the course of regional development. Here we show that there is a broad consensus among climate models that this region will dry in the 21st century and that the transition to a more arid climate should already be under way. If these models are correct, the levels of aridity of the recent multiyear drought or the Dust Bowl and the 1950s droughts will become the new climatology of the American Southwest within a time frame of years to decades.	Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA; Princeton Univ, Dept Geosci, Program Atmospher & Ocean Sci, Princeton, NJ 08544 USA; Natl Ctr Atmospher Res, Boulder, CO 80307 USA; Tel Aviv Univ, IL-69978 Tel Aviv, Israel	Columbia University; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; National Center Atmospheric Research (NCAR) - USA; Tel Aviv University	Seager, R (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	seager@ldeo.columbia.edu	Noojipady, Praveen/B-2511-2010; Vecchi, Gabriel/A-2413-2008	Vecchi, Gabriel/0000-0002-5085-224X; Seager, Richard/0000-0003-4772-9707; Nakamura, Jennifer/0000-0003-4113-8519; Li, Cuihua/0000-0001-8052-6317; Henderson, Naomi/0000-0002-9531-2159				Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Bengtsson L, 2006, J CLIMATE, V19, P3518, DOI 10.1175/JCLI3815.1; Cook ER, 2007, EARTH-SCI REV, V81, P93, DOI 10.1016/j.earscirev.2006.12.002; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; Cubasch U., 2001, PROJECTIONS FUTURE C, P525; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Herweijer C, 2006, HOLOCENE, V16, P159, DOI 10.1191/0959683606hl917rp; Herweijer C, 2007, J CLIMATE, V20, P1353, DOI 10.1175/JCLI4042.1; Huang HP, 2005, CLIM DYNAM, V24, P721, DOI 10.1007/s00382-005-0015-6; Kushner PJ, 2001, J CLIMATE, V14, P2238, DOI 10.1175/1520-0442(2001)014<0001:SHACRT>2.0.CO;2; Lau NC, 2006, J CLIMATE, V19, P3607, DOI 10.1175/JCLI3813.1; Lee SY, 1999, J ATMOS SCI, V56, P1353, DOI 10.1175/1520-0469(1999)056<1353:WATCZW>2.0.CO;2; Nakicenovic N., 2000, SPECIAL REPORT EMISS; Schneider T, 2006, ANNU REV EARTH PL SC, V34, P655, DOI 10.1146/annurev.earth.34.031405.125144; Schubert SD, 2004, SCIENCE, V303, P1855, DOI 10.1126/science.1095048; Schubert SD, 2004, J CLIMATE, V17, P485, DOI [10.1175/1520-0442(2004)017<0485:COLDIT>2.0.CO;2, 10.1175/1520-0442(2004)017&lt;0485:COLDIT&gt;2.0.CO;2]; Seager R, 2005, J CLIMATE, V18, P4065, DOI 10.1175/JCLI3522.1; STINE S, 1994, NATURE, V369, P546, DOI 10.1038/369546a0; Walker CC, 2006, J ATMOS SCI, V63, P3333, DOI 10.1175/JAS3821.1; Yin JH, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023684	21	1561	1587	9	465	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2007	316	5828					1181	1184		10.1126/science.1139601	http://dx.doi.org/10.1126/science.1139601			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	171GQ	17412920	Green Submitted			2022-12-28	WOS:000246724300040
J	Tamaki, S; Matsuo, S; Wong, HL; Yokoi, S; Shimamoto, K				Tamaki, Shojiro; Matsuo, Shoichi; Wong, Hann Ling; Yokoi, Shuji; Shimamoto, Ko			Hd3a protein is a mobile flowering signal in rice	SCIENCE			English	Article							PHOTOPERIODIC CONTROL; INTEGRATOR FT; SHOOT APEX; ARABIDOPSIS; PHLOEM; ACTIVATION; ORTHOLOG; CONSTANS; TISSUES; GROWTH	Florigen, the mobile signal that moves from an induced leaf to the shoot apex and causes flowering, has eluded identification since it was first proposed 70 years ago. Understanding the nature of the mobile flowering signal would provide a key insight into the molecular mechanism floral induction. Recent studies suggest that the Arabidopsis FLOWERING LOCUS T ( FT) gene is a candidate for encoding florigen. We show that the protein encoded by Hd3a, a rice ortholog of moves from the leaf to the shoot apical meristem and induces flowering in rice. These results suggest that the Hd3a protein may be the rice florigen.	Nara Inst Sci & Technol, Plant Mol Genet Lab, Ikoma 6300101, Japan	Nara Institute of Science & Technology	Yokoi, S (corresponding author), Nara Inst Sci & Technol, Plant Mol Genet Lab, 8916-5 Takayama, Ikoma 6300101, Japan.	simamoto@bs.naist.jp	Yokoi, Shuji/B-4102-2012; Wong, Hann Ling/S-8148-2017; Yokoi, Shuji/L-3988-2019; Ding, Cheng-Qiang/B-6287-2011	Wong, Hann Ling/0000-0001-8903-1812; Yokoi, Shuji/0000-0001-9358-1876; 				Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Arimura S, 2004, P NATL ACAD SCI USA, V101, P7805, DOI 10.1073/pnas.0401077101; Asano T, 2002, PLANT CELL PHYSIOL, V43, P668, DOI 10.1093/pcp/pcf083; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Bohlenius H, 2007, SCIENCE, V316, P367; Chailakhyan MK., 1936, C R ACAD SCI URSS, V13, P79; Corbesier L, 2005, PLANT CELL ENVIRON, V28, P54, DOI 10.1111/j.1365-3040.2005.01283.x; Giavalisco P, 2006, PROTEOMICS, V6, P896, DOI 10.1002/pmic.200500155; Guivarch A, 1996, TRANSGENIC RES, V5, P3, DOI 10.1007/BF01979917; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Imaizumi T, 2006, TRENDS PLANT SCI, V11, P550, DOI 10.1016/j.tplants.2006.09.004; Ishikawa R, 2005, PLANT CELL, V17, P3326, DOI 10.1105/tpc.105.037028; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Lang A., 1965, ENCYCL PLANT PHYSIOL, VVolume XV/1, P1380; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Muszynski MG, 2006, PLANT PHYSIOL, V142, P1523, DOI 10.1104/pp.106.088815; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Teper-Bamnolker P, 2005, PLANT CELL, V17, P2661, DOI 10.1105/tpc.105.035766; Thomas B., 1997, PHOTOPERIODISM PLANT; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; ZEEVAART JAD, 1976, ANNU REV PLANT PHYS, V27, P321, DOI 10.1146/annurev.pp.27.060176.001541; Zeevaart JAD, 2006, PLANT CELL, V18, P1783, DOI 10.1105/tpc.106.043513	28	825	924	15	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1033	1036		10.1126/science.1141753	http://dx.doi.org/10.1126/science.1141753			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17446351				2022-12-28	WOS:000246554000048
J	Shuchman, M				Shuchman, Miriam			Approving the vagus-nerve stimulator for depression	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Andress G, 2001, BRIT MED J, V322, P419, DOI 10.1136/bmj.322.7283.419; Rush AJ, 2005, BIOL PSYCHIAT, V58, P347, DOI 10.1016/j.biopsych.2005.05.025; US Senate Committee on Finance, 2006, REV FDAS APPR PROC V	3	34	34	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 19	2007	356	16					1604	1607		10.1056/NEJMp078035	http://dx.doi.org/10.1056/NEJMp078035			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AB	17442903				2022-12-28	WOS:000245762000002
J	Costello, A; Filippi, V; Kubba, T; Horton, R				Costello, Anthony; Filippi, Veronique; Kubba, Tamara; Horton, Richard			Research challenges to improve maternal and child survival	LANCET			English	Editorial Material									UCL, Inst Child Hlth, Ctr Int Hlth & Dev, London WC1N 1EH, England; London Sch Hyg & Trop Med, London WC1, England; The Lancet, London, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Costello, A (corresponding author), UCL, Inst Child Hlth, Ctr Int Hlth & Dev, London WC1N 1EH, England.	a.costello@ich.ucl.ac.uk		Kubba, Tamara/0000-0003-4670-9587				ADAM T, 2005, BMJ-BRIT MED J, V331, P1137; *B M GAT FDN, GLOB HLTH 14 GRAND C; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Glasier A, 2006, LANCET, V368, P1595, DOI 10.1016/S0140-6736(06)69478-6; Lawn JE, 2006, LANCET, V368, P1474, DOI 10.1016/S0140-6736(06)69387-2; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; *NORW EMB NEW DELH, NORW IND PARTN IN NI; Powell-Jackson T, 2006, LANCET, V368, P1077, DOI 10.1016/S0140-6736(06)69338-0; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X	10	25	25	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2007	369	9569					1240	1243		10.1016/S0140-6736(07)60574-1	http://dx.doi.org/10.1016/S0140-6736(07)60574-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	164YA	17434384				2022-12-28	WOS:000246269700008
J	Marks, TJ				Marks, Tobin J.			Frank Albert Cotton (1930-2007)	SCIENCE			English	Biographical-Item									Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University	Marks, TJ (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	t-marks@northwestern.edu	Marks, Tobin/AAG-1472-2019					COTTON FA, PUBLICATION LIST	1	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					214	214		10.1126/science.1142036	http://dx.doi.org/10.1126/science.1142036			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431163				2022-12-28	WOS:000245654500033
J	Pestov, D; Murawski, RK; Ariunbold, GO; Wang, X; Zhi, MC; Sokolov, AV; Sautenkov, VA; Rostovtsev, YV; Dogariu, A; Huang, Y; Scully, MO				Pestov, Dmitry; Murawski, Robert K.; Ariunbold, Gombojav O.; Wang, Xi; Zhi, Miaochan; Sokolov, Alexei V.; Sautenkov, Vladimir A.; Rostovtsev, Yuri V.; Dogariu, Arthur; Huang, Yu; Scully, Marlan O.			Optimizing the laser-pulse configuration for coherent Raman spectroscopy	SCIENCE			English	Article							CALCIUM DIPICOLINATE; CARS SPECTROSCOPY; BACTERIAL-SPORES; SCATTERING; SPECTRA; LIGHT	We introduce a hybrid technique that combines the robustness of frequency-resolved coherent anti-Stokes Raman scattering (CARS) with the advantages of time-resolved CARS spectroscopy. Instantaneous coherent broadband excitation of several characteristic molecular vibrations and the subsequent probing of these vibrations by an optimally shaped time-delayed narrowband laser pulse help to suppress the nonresonant background and to retrieve the species-specific signal. We used this technique for coherent Raman spectroscopy of sodium dipicolinate powder, which is similar to calcium dipicolinate ( a marker molecule for bacterial endospores, such as Bacillus subtilis and Bacillus anthracis), and we demonstrated a rapid and highly specific detection scheme that works even in the presence of multiple scattering.	Texas A&M Univ, Inst Quantum Studies, College Stn, TX 77843 USA; Texas A&M Univ, Dept Phys, College Stn, TX 77843 USA; Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA; Princeton Univ, Appl Phys & Mat Sci Grp, Engn Quadrangle, Princeton, NJ 08544 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Princeton University	Pestov, D (corresponding author), Texas A&M Univ, Inst Quantum Studies, College Stn, TX 77843 USA.	dmip@neo.tamu.edu	Pestov, Dmitry/B-2677-2009; Sautenkov, Vladimir A/N-7024-2013	Sautenkov, Vladimir A/0000-0001-8400-9405				Beaud P, 2001, CHEM PHYS LETT, V344, P407, DOI 10.1016/S0009-2614(01)00819-3; CARMONA P, 1980, SPECTROCHIM ACTA A, V36, P705, DOI 10.1016/0584-8539(80)80032-8; DUNCAN MD, 1982, OPT LETT, V7, P350, DOI 10.1364/OL.7.000350; Esposito AP, 2003, APPL SPECTROSC, V57, P868, DOI 10.1366/000370203322102979; Kano H, 2004, APPL PHYS LETT, V85, P4298, DOI 10.1063/1.1818741; Kee TW, 2006, OPT EXPRESS, V14, P3631, DOI 10.1364/OE.14.003631; KLICK D, 1981, APPL OPTICS, V20, P1178, DOI 10.1364/AO.20.001178; LEONHARDT R, 1987, CHEM PHYS LETT, V133, P373, DOI 10.1016/0009-2614(87)87085-9; Lim SH, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.041803; Lucht RP, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2410237; Materny A, 2000, APPL PHYS B-LASERS O, V71, P299, DOI 10.1007/s003400000343; Nelson WH, 2004, APPL SPECTROSC, V58, P1408, DOI 10.1366/0003702042641290; Nibler J. W., 1979, Raman spectroscopy, P253; Oron D, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.043408; Oron D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.063004; OUDAR JL, 1979, APPL PHYS LETT, V34, P758, DOI 10.1063/1.90663; Petrov GI, 2005, OPT EXPRESS, V13, P1299, DOI 10.1364/OPEX.13.001299; Potma EO, 2006, OPT LETT, V31, P241, DOI 10.1364/OL.31.000241; REGNIER PR, 1973, APPL PHYS LETT, V23, P240, DOI 10.1063/1.1654873; Rinia HA, 2006, J PHYS CHEM B, V110, P4472, DOI 10.1021/jp0564849; Scully MO, 2002, P NATL ACAD SCI USA, V99, P10994, DOI 10.1073/pnas.172290899; Shen Y. R., 1984, PRINCIPLES NONLINEAR; Spiro T., 1987, BIOL APPL RAMAN SPEC; TOLLES WM, 1977, APPL SPECTROSC, V31, P96, DOI 10.1366/000370277774463968; Voroshilov A, 1997, J CHEM PHYS, V106, P2589, DOI 10.1063/1.473363; WEN XN, 1991, J OPT SOC AM B, V8, P813, DOI 10.1364/JOSAB.8.000813; YACOBY Y, 1980, J APPL PHYS, V51, P3072, DOI 10.1063/1.328094; Zumbusch A, 1999, PHYS REV LETT, V82, P4142, DOI 10.1103/PhysRevLett.82.4142	28	264	267	4	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					265	268		10.1126/science.1139055	http://dx.doi.org/10.1126/science.1139055			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431177				2022-12-28	WOS:000245654500047
J	Kelemen, PB; Hirth, G				Kelemen, Peter B.; Hirth, Greg			A periodic shear-heating mechanism for intermediate-depth earthquakes in the mantle	NATURE			English	Article							GRAIN-SIZE; DEFORMATION; PERIDOTITE; ZONES; INSTABILITY; FOCUS; LOCALIZATION; DEHYDRATION; FLOW	Intermediate-depth earthquakes(1), at depths of 50 - 300 km in subduction zones, occur below the brittle - ductile transition, where high pressures render frictional failure unlikely. Their location approximately coincides with 600 to 800 degrees C isotherms in thermal models(2), suggesting a thermally activated mechanism for their origin. Some earthquakes may occur by frictional failure owing to high pore pressure that might result from metamorphic dehydration(2-5). Because some intermediate-depth earthquakes occur similar to 30 to 50 km below the palaeo-sea floor(6), however, the hydrous minerals required for the dehydration mechanism may not be present. Here we present an alternative mechanism to explain such earthquakes, involving the onset of highly localized viscous creep in pre-existing, fine-grained shear zones. Our numerical model uses olivine flow laws for a fine-grained, viscous shear zone in a coarse-grained, elastic half space, with initial temperatures from 600 - 800 degrees C and background strain rates of 10(-12) to 10(-15) s(-1). When shear heating becomes important, strain rate and temperature increase rapidly to over 1 s(-1) and 1,400 degrees C. The stress then drops dramatically, followed by low strain rates and cooling. Continued far-field deformation produces a quasi-periodic series of such instabilities.	Columbia Univ, Lamont Doherty Earth Observ, Dept Earth & Environm Sci, Palisades, NY 10964 USA; Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	Columbia University; Woods Hole Oceanographic Institution	Kelemen, PB (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Dept Earth & Environm Sci, Palisades, NY 10964 USA.	peterk@ldeo.columbia.edu	Kelemen, Peter B./D-6813-2013	Kelemen, Peter B./0000-0003-4757-0855	Division Of Earth Sciences [0814513] Funding Source: National Science Foundation	Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Bercovici D, 2002, REV MINERAL GEOCHEM, V51, P387, DOI 10.2138/gsrmg.51.1.387; Branlund JM, 2000, EARTH PLANET SC LETT, V182, P171, DOI 10.1016/S0012-821X(00)00239-9; CHRISTENSEN DH, 1988, J GEOPHYS RES-SOLID, V93, P13421, DOI 10.1029/JB093iB11p13421; Evans B, 2001, INT J EARTH SCI, V90, P88, DOI 10.1007/s005310000150; GOETZE C, 1978, PHILOS T R SOC A, V288, P99, DOI 10.1098/rsta.1978.0008; Green HW, 2002, REV MINERAL GEOCHEM, V51, P181, DOI 10.2138/gsrmg.51.1.181; HACKER BR, 2003, J GEOPHYS RES-SOL EA, V108, DOI DOI 10.1029/2001JB001129; Hirth G., 2003, INSIDE SUBDUCTION FA, V138, P83, DOI [10.1029/138GM06, DOI 10.1029/138GM06]; HOBBS BE, 1986, PURE APPL GEOPHYS, V124, P309, DOI 10.1007/BF00875730; Igarashi T, 2001, J GEOPHYS RES-SOL EA, V106, P2177, DOI 10.1029/2000JB900386; Jaroslow GE, 1996, TECTONOPHYSICS, V256, P17, DOI 10.1016/0040-1951(95)00163-8; Jiao WJ, 2000, J GEOPHYS RES-SOL EA, V105, P28125, DOI 10.1029/2000JB900314; Jung H, 2004, NATURE, V428, P545, DOI 10.1038/nature02412; Kameyama M, 1999, EARTH PLANET SC LETT, V168, P159, DOI 10.1016/S0012-821X(99)00040-0; KAMEYAMA MC, 1997, GEOPHYS RES LETT, V168, P159; Kanamori H, 1998, SCIENCE, V279, P839, DOI 10.1126/science.279.5352.839; Karato S, 2001, PHYS EARTH PLANET IN, V127, P83, DOI 10.1016/S0031-9201(01)00223-0; KELEMEN PB, 1995, J GEOPHYS RES-SOL EA, V100, P423, DOI 10.1029/94JB02063; Kirby S. H., 1996, GEOPHYS MONOGR SER, V96, P195, DOI DOI 10.1029/GM096P0195; Newman J, 1999, TECTONOPHYSICS, V303, P193, DOI 10.1016/S0040-1951(98)00259-5; OBATA M, 1995, TECTONOPHYSICS, V242, P313, DOI 10.1016/0040-1951(94)00228-2; OGAWA M, 1987, J GEOPHYS RES-SOLID, V92, P13801, DOI 10.1029/JB092iB13p13801; Peacock SM, 2001, GEOLOGY, V29, P299, DOI 10.1130/0091-7613(2001)029<0299:ATLPOD>2.0.CO;2; RALEIGH CB, 1967, GEOPHYS J ROY ASTR S, V14, P113; Regenauer-Lieb K, 2003, EARTH-SCI REV, V63, P295, DOI 10.1016/S0012-8252(03)00038-2; SAVAGE JC, 1969, TECTONOPHYSICS, V8, P115, DOI 10.1016/0040-1951(69)90085-7; SHIMADA M, 1983, TECTONOPHYSICS, V96, P159, DOI 10.1016/0040-1951(83)90248-2; VANDERWAL D, 1993, GEOPHYS RES LETT, V20, P1479, DOI 10.1029/93GL01382; WARREN J, UNPUB EARTH PLANET S; WHITEHEAD JA, 1974, GEOPHYS J ROY ASTR S, V39, P11, DOI 10.1111/j.1365-246X.1974.tb05436.x	30	209	215	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					787	790		10.1038/nature05717	http://dx.doi.org/10.1038/nature05717			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429398				2022-12-28	WOS:000245626800038
J	Costa-Mattioli, M; Gobert, D; Stern, E; Gamache, K; Colina, R; Cuello, C; Sossin, W; Kaufman, R; Pelletier, J; Rosenblum, K; Krnjevic, K; Lacaille, JC; Nader, K; Sonenberg, N				Costa-Mattioli, Mauro; Gobert, Delphine; Stern, Elad; Gamache, Karine; Colina, Rodney; Cuello, Claudio; Sossin, Wayne; Kaufman, Randal; Pelletier, Jerrf; Rosenblum, Kobi; Krnjevic, Kresimir; Lacaille, Jean-Claude; Nader, Karim; Sonenberg, Nahum			eIF2 alpha phosphorylation bidirectionally regulates the switch from short- to long-term synaptic plasticity and memory	CELL			English	Article							MESSENGER-RNA TRANSLATION; PROTEIN-SYNTHESIS; POTENTIATION; MECHANISMS; RECONSOLIDATION; CONSOLIDATION; REINITIATION; NEUROSCIENCE; ENHANCEMENT; INHIBITION	The late phase of long-term potentiation (LTP) and memory (LTM) requires new gene expression, but the molecular mechanisms that underlie these processes are not fully understood. Phosphorylation of eIF2 alpha inhibits general translation but selectively stimulates translation of ATF4, a repressor of CREB-mediated late-LTP (L-LTP) and LTM. We used a pharmacogenetic bidirectional approach to examine the role of eIF2 alpha phosphorylation in synaptic plasticity and behavioral learning. We show that in eIF2 alpha(+/S51A) mice, in which eIF2 alpha phosphorylation is reduced, the threshold for eliciting L-LTP in hippocampal slices is lowered, and memory is enhanced. In contrast, only early-LTP is evoked by repeated tetanic stimulation and LTM is impaired, when eIF2 alpha phosphorylation is increased by injecting into the hippocampus a small molecule, Sal003, which prevents the dephosphorylation of eIF2 alpha. These findings highlight the importance of a single phosphorylation site in eIF2 alpha as a key regulator of L-LTP and LTM formation.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Psychol, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Pharmacol, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Neurol, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Neurosurg, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; Univ Haifa, Ctr Brain & Behav, IL-30905 Haifa, Israel; Univ Michigan, Howard Hughes Med Inst, Dept Biol Chem, Ann Arbor, MI 48109 USA	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; Universite de Montreal; University of Haifa; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Costa-Mattioli, M (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada.	mauro.costa-mattioli@mail.mcgill.ca; nahum.sonenberg@mcgill.ca		Colina, Rodney/0000-0003-3731-5383	Canadian Institutes of Health Research [15121] Funding Source: Medline; NCI NIH HHS [R01 CA154916] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA154916] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chen A, 2003, NEURON, V39, P655, DOI 10.1016/S0896-6273(03)00501-4; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; COTE SL, 1993, IMMUNOHISTOCHEMISTRY, V2; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Masuoka HC, 2002, BLOOD, V99, P736, DOI 10.1182/blood.V99.3.736; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Pavlov I.P., 1927, CONDITIONED REFLEXES; Pittenger C, 2003, PHILOS T ROY SOC B, V358, P757, DOI 10.1098/rstb.2002.1247; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Schafe GE, 1999, LEARN MEMORY, V6, P97; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; SHEFFIELD FD, 1950, J COMP PHYSIOL PSYCH, V43, P471, DOI 10.1037/h0061365; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Small SA, 2000, NEURON, V28, P653, DOI 10.1016/S0896-6273(00)00144-6; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang HB, 2004, NAT NEUROSCI, V7, P635, DOI 10.1038/nn1248	41	349	368	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2007	129	1					195	206		10.1016/j.cell.2007.01.050	http://dx.doi.org/10.1016/j.cell.2007.01.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418795	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000245661100021
J	Gange, AC; Gange, EG; Sparks, TH; Boddy, L				Gange, A. C.; Gange, E. G.; Sparks, T. H.; Boddy, L.			Rapid and recent changes in fungal fruiting patterns	SCIENCE			English	Article							PLANTS; EUROPE		Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England; Belvedere, Salisbury SP5 3DZ, Wilts, England; NERC, Ctr Ecol & Hydrol, Monks Wood PE28 2LS, Cambs, England; Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3TL, S Glam, Wales	University of London; Royal Holloway University London; UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Cardiff University	Gange, AC (corresponding author), Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England.	a.gange@rhul.ac.uk	Boddy, Lynne/A-7250-2010	Boddy, Lynne/0000-0003-1845-6738; Sparks, Tim/0000-0003-4382-7051	Natural Environment Research Council [CEH010021] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; LAST FT, 1979, NATURE, V280, P168, DOI 10.1038/280168a0; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233	6	155	165	2	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2007	316	5821					71	71		10.1126/science.1137489	http://dx.doi.org/10.1126/science.1137489			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412949				2022-12-28	WOS:000245470500032
J	Fine, M; Tchernov, D				Fine, Maoz; Tchernov, Dan			Scleractinian coral species survive and recover from decalcification	SCIENCE			English	Article							EVOLUTION; CARBON		Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel; Hebrew Univ Jerusalem, Dept Evolut Systemat & Ecol, IL-91904 Jerusalem, Israel; Interuniv Inst Marine Sci, IL-88103 Elat, Israel	Bar Ilan University; Hebrew University of Jerusalem	Fine, M (corresponding author), Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel.	finema@mail.biu.ac.il	Fine, Maoz/S-5582-2019; Tchernov, Dan/AAE-2545-2021	Fine, Maoz/0000-0003-4911-4562; Tchernov, Dan/0000-0003-1135-8270				Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Hoegh-Guldberg O, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002528; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Stanley GD, 2001, SCIENCE, V291, P1913, DOI 10.1126/science.1056632	8	201	213	3	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1811	1811		10.1126/science.1137094	http://dx.doi.org/10.1126/science.1137094			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395821				2022-12-28	WOS:000245280100032
J	Pianta, RC; Belsky, J; Houts, R; Morrison, F				Pianta, Robert C.; Belsky, Jay; Houts, Renate; Morrison, Fred		NICHD Early Child Care Res Network	Opportunities to learn in America's elementary classrooms	SCIENCE			English	Editorial Material							TEACHER		Univ Virginia, Ctr Adv Study Teaching & Learning, Charlottesville, VA 22903 USA; Birkbeck Univ London, Inst Study Children Family & Soc, London, England; RTI Int, Dept Stat & Epidemiol, Res Triangle Pk, NC 27709 USA; Univ Michigan, Dept Psychol, Ann Arbor, MI 48103 USA; NICHD, NICHD Early Child Care & Youth Dev Res Network, CRMC, Rockville, MD 20852 USA	University of Virginia; University of London; Birkbeck University London; Research Triangle Institute; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Pianta, RC (corresponding author), Univ Virginia, Ctr Adv Study Teaching & Learning, Charlottesville, VA 22903 USA.	rcp4p@virginia.edu	Houts, Renate/AAC-5304-2019	Houts, Renate/0000-0002-1518-2631; Pianta, Robert/0000-0002-6280-8051; Belsky, Jay/0000-0003-2191-2503	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD033343] Funding Source: NIH RePORTER; NICHD NIH HHS [U01 HD033343-13] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Belsky J, 2005, ELEM SCHOOL J, V105, P305; Bogner K., 2002, SCI STUD READ, V6, P135, DOI [10.1207/S1532799XSSR0602_02, DOI 10.1207/S1532799XSSR0602_02]; Brophy J.E., 1986, HDB RES TEACHING, P328; *ED TEST SERV, 2004, WE STAND TEACH QUAL; Hamre BK, 2005, CHILD DEV, V76, P949, DOI 10.1111/j.1467-8624.2005.00889.x; HOWES C, 2005, MULTISTATE PRE K STU; *NICHD EARL CHILD, 2003, CHILD DEV, V0074; *NICHD EARL CHILD, 2000, CHILD DEV, V0071; Nye B, 2004, EDUC EVAL POLICY AN, V26, P237, DOI 10.3102/01623737026003237; Pianta RC, 2002, ELEM SCHOOL J, V102, P225, DOI 10.1086/499701; Sammons P., 2006, VARIATIONS TEACHER P; Sanders W. L., 1996, CUMULATIVE RESIDUAL; *US DEP ED, 2002, DEF NO CHILD LEFT AC	13	194	194	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1795	1796		10.1126/science.1139719	http://dx.doi.org/10.1126/science.1139719			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	151HC	17395814	Green Accepted			2022-12-28	WOS:000245280100024
J	Kurtovic, A; Widmer, A; Dickson, BJ				Kurtovic, Amina; Widmer, Alexandre; Dickson, Barry J.			A single class of olfactory neurons mediates behavioural responses to a Drosophila sex pheromone	NATURE			English	Article							MALE COURTSHIP BEHAVIOR; SILKMOTH BOMBYX-MORI; ANTENNAL LOBE; HELIOTHIS-VIRESCENS; MELANOGASTER; RECEPTOR; BRAIN; REPRESENTATION; SYSTEM; MOTH	Insects, like many other animals, use sex pheromones to coordinate their reproductive behaviours(1). Volatile pheromones are detected by odorant receptors expressed in olfactory receptor neurons ( ORNs). Whereas fruit odours typically activate multiple ORN classes(2), pheromones are thought to act through single dedicated classes of ORN3. This model predicts that activation of such an ORN class should be sufficient to trigger the appropriate behavioural response. Here we show that the Drosophila melanogaster male-specific pheromone 11-cis-vaccenyl acetate ( cVA) acts through the receptor Or67d to regulate both male and female mating behaviour. Mutant males that lack Or67d inappropriately court other males, whereas mutant females are less receptive to courting males. These data suggest that cVA has opposite effects in the two sexes: inhibiting mating behaviour in males but promoting mating behaviour in females. Replacing Or67d with moth pheromone receptors renders these ORNs sensitive to the corresponding moth pheromones. In such flies, moth pheromones elicit behavioural responses that mimic the normal response to cVA. Thus, activation of a single ORN class is both necessary and sufficient to mediate behavioural responses to the Drosophila sex pheromone cVA.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Dickson, BJ (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	dickson@imp.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Kozaric, Amina/0000-0002-6063-7260				Broome BM, 2006, NEURON, V51, P467, DOI 10.1016/j.neuron.2006.07.018; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; JEFFERIS GSX, 2007, IN PRESS CELL; Kondoh Y, 2003, P ROY SOC B-BIOL SCI, V270, P1005, DOI 10.1098/rspb.2003.2331; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger J, 2005, EUR J NEUROSCI, V21, P2167, DOI 10.1111/j.1460-9568.2005.04058.x; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MANE SD, 1983, SCIENCE, V222, P419, DOI 10.1126/science.222.4622.419; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; ROELOFS WL, 1974, LIFE SCI, V14, P1555, DOI 10.1016/0024-3205(74)90166-0; Rollmann SM, 2005, J NEUROBIOL, V63, P146, DOI 10.1002/neu.20123; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Schurmann FW, 2000, ACTA BIOL HUNG, V51, P355; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yasuyama K, 2003, J COMP NEUROL, V466, P299, DOI 10.1002/cne.10867; Zou ZH, 2006, SCIENCE, V311, P1477, DOI 10.1126/science.1124755	30	486	504	7	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2007	446	7135					542	546		10.1038/nature05672	http://dx.doi.org/10.1038/nature05672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392786				2022-12-28	WOS:000245242900050
J	Bianchi, A; Shore, D				Bianchi, Alessandro; Shore, David			Early replication of short telomeres in budding yeast	CELL			English	Article							ORIGIN ACTIVATION; LENGTH REGULATION; DNA; PROTEIN; SEQUENCES; TIME; COMPLEX; CENTROMERES; DYNAMICS; REQUIRES	The maintenance of an appropriate number of telomere repeats by telomerase is essential for proper chromosome protection. The action of telomerase at the telomere terminus is regulated by opposing activities that either recruit/activate the enzyme at shorter telomeres or inhibit it at longer ones, thus achieving a stable average telomere length. To elucidate the mechanistic details of telomerase regulation we engineered specific chromosome ends in yeast so that a single telomere could be suddenly shortened and, as a consequence of its reduced length, elongated by telomerase. We show that shortened telomeres replicate early in S phase, unlike normal-length telomeres, due to the early firing of origins of DNA replication in subtelomeric regions. Early telomere replication correlates with increased telomere length and telomerase activity. These data reveal an epigenetic effect of telomere length on the activity of nearby replication origins and an unanticipated link between telomere replication timing and telomerase action.	Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; Univ Geneva, NCCR, Frontiers Genet Program, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Bianchi, A (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	alessandro.bianchi@molbio.unige.ch	Shore, David/F-6240-2015	Shore, David/0000-0002-9859-143X; Bianchi, Alessandro/0000-0001-6583-1671				Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Bianchi A, 2004, MOL CELL, V16, P139, DOI 10.1016/j.molcel.2004.09.009; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cosgrove AJ, 2002, GENE DEV, V16, P2485, DOI 10.1101/gad.231602; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dionne I, 1998, NUCLEIC ACIDS RES, V26, P5365, DOI 10.1093/nar/26.23.5365; FERGUSON BM, 1991, CELL, V65, P507, DOI 10.1016/0092-8674(91)90468-E; FERGUSON BM, 1992, CELL, V68, P333, DOI 10.1016/0092-8674(92)90474-Q; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Grossi S, 2001, MOL CELL BIOL, V21, P8117, DOI 10.1128/MCB.21.23.8117-8128.2001; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Hultdin M, 2001, EXP CELL RES, V271, P223, DOI 10.1006/excr.2001.5391; Kim SM, 2003, GENE DEV, V17, P330, DOI 10.1101/gad.1046203; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; Louis EJ, 2005, BIOESSAYS, V27, P685, DOI 10.1002/bies.20259; Makovets S, 2004, MOL CELL BIOL, V24, P4019, DOI 10.1128/MCB.24.9.4019-4031.2004; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Marcand S, 1999, EMBO J, V18, P3509, DOI 10.1093/emboj/18.12.3509; MCCARROLL RM, 1988, CELL, V54, P505, DOI 10.1016/0092-8674(88)90072-4; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; NIMMO ER, 1994, EMBO J, V13, P3801, DOI 10.1002/j.1460-2075.1994.tb06691.x; Ofir R, 1999, P NATL ACAD SCI USA, V96, P11434, DOI 10.1073/pnas.96.20.11434; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poloumienko A, 2001, MOL BIOL CELL, V12, P3317, DOI 10.1091/mbc.12.11.3317; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Raghuraman MK, 1997, SCIENCE, V276, P806, DOI 10.1126/science.276.5313.806; Smith ZE, 1999, HUM MOL GENET, V8, P1373, DOI 10.1093/hmg/8.8.1373; Stevenson JB, 1999, GENE DEV, V13, P146, DOI 10.1101/gad.13.2.146; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Tanaka S, 1996, YEAST, V12, P101, DOI 10.1002/(SICI)1097-0061(199602)12:2<101::AID-YEA885>3.0.CO;2-2; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; TENHAGEN KG, 1990, MOL CELL BIOL, V10, P6348, DOI 10.1128/MCB.10.12.6348; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; WELLINGER RJ, 1993, MOL CELL BIOL, V13, P4057, DOI 10.1128/MCB.13.7.4057; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; Wright WE, 1999, EXP CELL RES, V251, P492, DOI 10.1006/excr.1999.4602; Zappulla DC, 2002, CURR BIOL, V12, P869, DOI 10.1016/S0960-9822(02)00871-0; Zou Y, 2004, P NATL ACAD SCI USA, V101, P12928, DOI 10.1073/pnas.0404106101	47	67	68	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1051	1062		10.1016/j.cell.2007.01.041	http://dx.doi.org/10.1016/j.cell.2007.01.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382879	Bronze			2022-12-28	WOS:000245396200013
J	Jefferis, GSXE; Potter, CJ; Chan, AI; Marin, EC; Rohlfing, T; Maurer, CR; Luo, LQ				Jefferis, Gregory S. X. E.; Potter, Christopher J.; Chan, Alexander Im.; Marin, Elizabeth C.; Rohlfing, Torsten; Maurer, Calvin R., Jr.; Luo, Liqun			Comprehensive maps of Drosophila higher offactory centers: Spatially segregated fruit and pheromone representation	CELL			English	Article							MALE COURTSHIP BEHAVIOR; ANTENNAL LOBE; MUSHROOM BODY; OLFACTORY CORTEX; MOSAIC ANALYSIS; BOMBYX-MORI; NEURONS; MELANOGASTER; BRAIN; ORGANIZATION	In Drosophila, similar to 50 classes of olfactory receptor neurons (ORNs) send axons to 50 corresponding glomeruli in the antennal lobe. Uniglomerular projection neurons (PNs) relay olfactory information to the mushroom body (MB) and lateral horn (LH). Here, we combine single-cell labeling and image registration to create high-resolution, quantitative maps of the MB and LH for 35 input PN channels and several groups of LH neurons. We find (1) PN inputs to the MB are stereotyped as previously shown for the LH; (2) PN partners of ORNs from different sensillar groups are clustered in the LH; (3) fruit odors are represented mostly in the posterior-dorsal LH, whereas candidate pheromone-responsive PNs project to the anterior-ventral LH; (4) dendrites of single LH neurons each overlap with specific subsets of PN axons. Our results suggest that the LH is organized according to biological values of olfactory input.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Univ Cambridge, Dept Zool, Cambridge CB2 2EJ, England; SRI Int, Program Neurosci, Menlo Pk, CA 94025 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; University of Cambridge; SRI International	Jefferis, GSXE (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	gsxej2@cam.ac.uk	Potter, Christopher John/H-5884-2019; Rohlfing, Torsten/A-1146-2007; Jefferis, Gregory/C-6386-2012	Potter, Christopher John/0000-0002-5223-8112; Luo, Liqun/0000-0001-5467-9264; Jefferis, Gregory/0000-0002-0587-9355	NIAAA NIH HHS [AA05965, R37 AA005965, AA13521, R01 AA005965, U01 AA013521] Funding Source: Medline; NIDCD NIH HHS [R01 DC005982, R01-DC005982] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA005965, U01AA013521, R37AA005965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Cajal S.R., 1911, HISTOLOGY NERVOUS SY; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Cowan WM, 1998, NEURON, V20, P413, DOI 10.1016/S0896-6273(00)80985-X; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; Ferveur JF, 1996, P ROY SOC B-BIOL SCI, V263, P967, DOI 10.1098/rspb.1996.0143; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Ito K, 1997, DEVELOPMENT, V124, P761; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; KURTOVIC A, 2007, IN PRESS NATURE; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Penfield W., 1950, CEREBRAL CORTEX MAN; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Rein K, 2002, CURR BIOL, V12, P227, DOI 10.1016/S0960-9822(02)00656-5; Rohlfing T, 2003, IEEE T INF TECHNOL B, V7, P16, DOI 10.1109/TITB.2003.808506; SCALIA F, 1975, J COMP NEUROL, V161, P31, DOI 10.1002/cne.901610105; Schafer WR, 2005, CURR BIOL, V15, pR723, DOI 10.1016/j.cub.2005.08.020; Seki Y, 2005, J COMP NEUROL, V481, P340, DOI 10.1002/cne.20392; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Stocker RF, 2001, MICROSC RES TECHNIQ, V55, P284, DOI 10.1002/jemt.1178; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Strausfeld NJ, 2003, MICROSC RES TECHNIQ, V62, P151, DOI 10.1002/jemt.10368; Suster ML, 2003, J NEUROBIOL, V55, P233, DOI 10.1002/neu.10202; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yasuyama K, 2003, J COMP NEUROL, V466, P299, DOI 10.1002/cne.10867; Young P, 2004, CURR OPIN NEUROBIOL, V14, P642, DOI 10.1016/j.conb.2004.08.007; Zhu SJ, 2003, DEVELOPMENT, V130, P2603, DOI 10.1242/dev.00466; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012; Zou ZH, 2006, SCIENCE, V311, P1477, DOI 10.1126/science.1124755; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	51	410	418	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1187	1203		10.1016/j.cell.2007.01.040	http://dx.doi.org/10.1016/j.cell.2007.01.040			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382886	hybrid, Green Published			2022-12-28	WOS:000245396200023
J	Lin, HH; Lai, JSY; Chin, AL; Chen, YC; Chiang, AS				Lin, Hui-Hao; Lai, Jason Sih-Yu; Chin, An-Lun; Chen, Yung-Chang; Chiang, Ann-Shyn			A map of olfactory representation in the Drosophila mushroom body	CELL			English	Article							SHORT-TERM-MEMORY; NEURONS; BODIES; ORGANIZATION; RECEPTORS; NEUROTRANSMISSION; LOCALIZATION; ABLATION; SLEEP; BRAIN	Neural coding for olfactory sensory stimuli has been mapped near completion in the Drosophila first-order center, but little is known in the higher brain centers. Here, we report that the antenna lobe (AL) spatial map is transformed further in the calyx of the mushroom body (MB), an essential olfactory associated learning center, by stereotypic connections with projection neurons (PNs). We found that Kenyon cell (KC) dendrites are segregated into 17 complementary domains according to their neuroblast clonal origins and birth orders. Aligning the PN axonal map with the KC dendritic map and ultrastructural observation suggest a positional ordering such that inputs from the different AL glomeruli have distinct representations in the MB calyx, and these representations might synapse on functionally distinct KCs. Our data suggest that olfactory coding at the AL is decoded in the MB and then transferred via distinct lobes to separate higher brain centers.	Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30013, Taiwan; Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan; Natl Tsing Hua Univ, Brain Res Ctr, Hsinchu 30013, Taiwan; Natl Tsing Hua Univ, Dept Elect Engn, Engn & Syst Sci Grp, Hsinchu 30013, Taiwan; Natl Cent Univ, Dept Life Sci, Tao Yuan 32001, Taiwan; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Central University; Cold Spring Harbor Laboratory	Chiang, AS (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 30013, Taiwan.	aschiang@life.nthu.edu.tw		Chiang, Ann-Shyn/0000-0001-9668-7115				Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Chiang AS, 2001, J COMP NEUROL, V440, P1, DOI 10.1002/cne.1365; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Ito K, 1998, LEARN MEMORY, V5, P52; Ito K, 1997, DEVELOPMENT, V124, P761; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee T, 1999, DEVELOPMENT, V126, P4065; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Manoli DS, 2004, NATURE, V430, P564, DOI 10.1038/nature02713; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Rein K, 2002, CURR BIOL, V12, P227, DOI 10.1016/S0960-9822(02)00656-5; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Stopfer M, 2005, CURR BIOL, V15, pR996, DOI 10.1016/j.cub.2005.11.052; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; TECHNAU G, 1982, NATURE, V295, P405, DOI 10.1038/295405a0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2000, CURR OPIN NEUROBIOL, V10, P498, DOI 10.1016/S0959-4388(00)00111-2; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; Wang YL, 2003, CURR BIOL, V13, P1900, DOI 10.1016/j.cub.2003.10.003; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Xia SZ, 2005, CURR BIOL, V15, P603, DOI 10.1016/j.cub.2005.02.059; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zhu SJ, 2003, DEVELOPMENT, V130, P2603, DOI 10.1242/dev.00466	50	158	164	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1205	1217		10.1016/j.cell.2007.03.006	http://dx.doi.org/10.1016/j.cell.2007.03.006			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382887	Bronze			2022-12-28	WOS:000245396200024
J	Mok, KH; Kuhn, LT; Goez, M; Day, IJ; Lin, JC; Andersen, NH; Hore, PJ				Mok, K. Hun; Kuhn, Lars T.; Goez, Martin; Day, Iain J.; Lin, Jasper C.; Andersen, Niels H.; Hore, P. J.			A pre-existing hydrophobic collapse in the unfolded state of an ultrafast folding protein	NATURE			English	Article							TRP-CAGE; PHOTO-CIDNP; RESIDUAL STRUCTURE; DENATURED STATE; NMR; INTERMEDIATE; SIMULATIONS; MINIPROTEIN; RESOLUTION; BEHAVIOR	Insights into the conformational passage of a polypeptide chain across its free energy landscape have come from the judicious combination of experimental studies and computer simulations(1,2). Even though some unfolded and partially folded proteins are now known to possess biological function(3) or to be involved in aggregation phenomena associated with disease states(1,4), experimentally derived atomic-level information on these structures remains sparse as a result of conformational heterogeneity and dynamics. Here we present a technique that can provide such information. Using a 'Trp-cage' miniprotein known as TC5b ( ref. 5), we report photochemically induced dynamic nuclear polarization NMR6 pulse-labelling experiments that involve rapid in situ protein refolding(7,8). These experiments allow dipolar cross-relaxation with hyperpolarized aromatic side chain nuclei in the unfolded state to be identified and quantified in the resulting folded-state spectrum. We find that there is residual structure due to hydrophobic collapse in the unfolded state of this small protein, with strong inter-residue contacts between side chains that are relatively distant from one another in the native state. Prior structuring, even with the formation of non-native rather than native contacts, may be a feature associated with fast folding events in proteins.	Univ Oxford, Phys & Theoret Chem Lab, Dept Chem, Oxford OX1 3QZ, England; Univ Dublin Trinity Coll, Sch Biochem & Immunol, Dublin 2, Ireland; Univ Halle Wittenberg, Fachbereich Chem, D-06120 Halle, Germany; Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Oxford; Trinity College Dublin; Martin Luther University Halle Wittenberg; University of Massachusetts System; University of Massachusetts Worcester; University of Washington; University of Washington Seattle	Mok, KH (corresponding author), Univ Oxford, Phys & Theoret Chem Lab, Dept Chem, S Parks Rd, Oxford OX1 3QZ, England.	mok1@tcd.ie; peter.hore@chem.ox.ac.uk	Kuhn, Lars Thorsten/J-5451-2015; Hore, Peter/R-1923-2017; Mok, K. Hun/C-2607-2009	Kuhn, Lars Thorsten/0000-0002-3701-580X; Hore, Peter/0000-0002-8863-570X; Mok, K Hun/0000-0003-3663-2002; Day, Iain/0000-0002-2311-6837	NIGMS NIH HHS [R01 GM059658] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059658] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmed Z, 2005, J AM CHEM SOC, V127, P10943, DOI 10.1021/ja050664e; Balbach J, 1997, P NATL ACAD SCI USA, V94, P7182, DOI 10.1073/pnas.94.14.7182; Bunagan MR, 2006, J PHYS CHEM B, V110, P3759, DOI 10.1021/jp055288z; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chowdhury S, 2003, J MOL BIOL, V327, P711, DOI 10.1016/S0022-2836(03)00177-3; Crowhurst KA, 2003, BIOCHEMISTRY-US, V42, P8687, DOI 10.1021/bi034601p; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; HORE PJ, 1982, J MAGN RESON, V49, P122, DOI 10.1016/0022-2364(82)90302-X; KAPTEIN R, 1982, BIOL MAGN RESON, V4, P145; Khan F, 2006, J AM CHEM SOC, V128, P10729, DOI 10.1021/ja060618u; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101; Lyon CE, 1999, J AM CHEM SOC, V121, P6505, DOI 10.1021/ja9907663; Mok KH, 2005, P NATL ACAD SCI USA, V102, P8899, DOI 10.1073/pnas.0500661102; Mok KH, 2004, METHODS, V34, P75, DOI 10.1016/j.ymeth.2004.03.006; Mok KH, 2003, J AM CHEM SOC, V125, P12484, DOI 10.1021/ja036357v; Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798; Neuweiler H, 2005, P NATL ACAD SCI USA, V102, P16650, DOI 10.1073/pnas.0507351102; Pitera JW, 2003, P NATL ACAD SCI USA, V100, P7587, DOI 10.1073/pnas.1330954100; Qiu LL, 2002, J AM CHEM SOC, V124, P12952, DOI 10.1021/ja0279141; Religa TL, 2005, NATURE, V437, P1053, DOI 10.1038/nature04054; Sanchez IE, 2003, J MOL BIOL, V327, P867, DOI 10.1016/S0022-2836(03)00171-2; SHORT PF, 1989, J HEALTH ECON, V8, P293, DOI 10.1016/0167-6296(89)90023-4; Simmerling C, 2002, J AM CHEM SOC, V124, P11258, DOI 10.1021/ja0273851; Snow CD, 2002, J AM CHEM SOC, V124, P14548, DOI 10.1021/ja028604l; Yi Q, 2000, J MOL BIOL, V299, P1341, DOI 10.1006/jmbi.2000.3816; Zhou RH, 2003, P NATL ACAD SCI USA, V100, P13280, DOI 10.1073/pnas.2233312100	30	136	139	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2007	447	7140					106	109		10.1038/nature05728	http://dx.doi.org/10.1038/nature05728			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163GY	17429353	Green Accepted			2022-12-28	WOS:000246149300053
J	Chan, EY; Ruest, A; Meade, MO; Cook, DJ				Chan, Ee Yuee; Ruest, Annie; Meade, Maureen O.; Cook, Deborah J.			Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RESPIRATORY-TRACT INFECTIONS; SELECTIVE DECONTAMINATION; DIGESTIVE-TRACT; NOSOCOMIAL PNEUMONIA; CHLORHEXIDINE; HETEROGENEITY; COLONIZATION; PROPHYLAXIS; MORTALITY; QUALITY	Objective To evaluate the effect of oral decontamination on the incidence of ventilator associated pneumonia and mortality in mechanically ventilated adults. Design Systematic review and meta-analysis. Data sources Medline, Embase, CINAHL, the Cochrane Library, trials registers, reference lists, conference proceedings, and investigators in the specialty. Review methods Two independent reviewers screened studies for inclusion, assessed trial quality, and extracted data. Eligible trials were randomised controlled trials enrolling mechanically ventilated adults that compared the effects of daily oral application of antibiotics or antiseptics with no prophylaxis. Results 11 trials totalling 3242 patients met the inclusion criteria. Among four trials with 1098 patients, oral application of antibiotics did not significantly reduce the incidence of ventilator associated pneumonia (relative risk 0.69, 95% confidence interval 0.41 to 1.18). In seven trials with 2144 patients, however, oral application of antiseptics significantly reduced the incidence of ventilator associated pneumonia (0.56, 0.39 to 0.81). When the results of the 11 trials were pooled, rates of ventilator associated pneumonia were lower among patients receiving either method of oral decontamination (0.61, 0.45 to 0.82). Mortality was not influenced by prophylaxis with either antibiotics (0.94, 0.73 to 1.21) or antiseptics (0.96, 0.69 to 1.33) nor was duration of mechanical ventilation or stay in the intensive care unit. Conclusions Oral decontamination of mechanically ventilated adults using antiseptics is associated with a lower risk of ventilator associated pneumonia. Neither antiseptic nor antibiotic oral decontamination reduced mortality or duration of mechanical ventilation or stay in the intensive care unit.	Tan Tock Seng Hosp, Dept Nursing Serv, Singapore, Singapore; Ctr Hosp Univ Quebec Hotel Dieu, Dept Med, Quebec City, PQ, Canada; Ctr Hosp Univ Quebec Hotel Dieu, Dept Med Biol, Quebec City, PQ, Canada; McMaster Univ, Dept Med, Hamilton, ON, Canada; McMaster Univ, Dept Clin Epidemiol, Hamilton, ON L8S 4L8, Canada; McMaster Univ, Dept Biostat, Hamilton, ON, Canada	Tan Tock Seng Hospital; Laval University; Laval University; McMaster University; McMaster University; McMaster University	Chan, EY (corresponding author), Tan Tock Seng Hosp, Dept Nursing Serv, Singapore, Singapore.	ee_yuee_chan@ttsh.com.sg		Chan, Ee-Yuee/0000-0001-8662-4487				AbeleHorn M, 1997, INTENS CARE MED, V23, P187, DOI 10.1007/s001340050314; AERDTS SJA, 1993, BRIT MED J, V307, P525; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; BRUNBUISSON C, 1989, ANN INTERN MED, V110, P873, DOI 10.7326/0003-4819-110-11-873; Camus C, 2005, CRIT CARE MED, V33, P307, DOI 10.1097/01.CCM.0000152224.01949.01; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Chlebicki MN, 2007, CRIT CARE MED, V35, P595, DOI 10.1097/01.CCM.0000253395.70708.AC; D'Amico R, 1998, BMJ-BRIT MED J, V316, P1275, DOI 10.1136/bmj.316.7140.1275; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Devereaux PJ, 2005, BMJ-BRIT MED J, V331, P313, DOI 10.1136/bmj.38503.623646.8F; Dodek P, 2004, ANN INTERN MED, V141, P305, DOI 10.7326/0003-4819-141-4-200408170-00011; ESTES RJ, 1995, INTENS CARE MED, V21, P365, DOI 10.1007/BF01705418; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; GASTINNE H, 1992, NEW ENGL J MED, V326, P594, DOI 10.1056/NEJM199202273260903; Genuit T, 2001, Surg Infect (Larchmt), V2, P5, DOI 10.1089/109629601750185316; Grap MJ, 2004, HEART LUNG, V33, P83, DOI 10.1016/j.hrtlng.2003.12.004; Hatala R, 2005, CAN MED ASSOC J, V172, P661, DOI 10.1503/cmaj.1031920; Heyland D, 2006, NEW ENGL J MED, V355, P2619, DOI 10.1056/NEJMoa052904; HEYLAND DK, 1994, CHEST, V105, P1221, DOI 10.1378/chest.105.4.1221; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Houston S, 2002, AM J CRIT CARE, V11, P567, DOI 10.4037/ajcc2002.11.6.567; HURLEY JC, 1995, ANTIMICROB AGENTS CH, V39, P941, DOI 10.1128/AAC.39.4.941; KERVER AJH, 1988, CRIT CARE MED, V16, P1087, DOI 10.1097/00003246-198811000-00001; Kollef MH, 2000, CRIT CARE, V4, P327, DOI 10.1186/cc716; KOLLEF MH, 1994, CHEST, V105, P1101, DOI 10.1378/chest.105.4.1101; LIBERATI A, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000022.PUB2; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Mori H, 2006, INTENS CARE MED, V32, P230, DOI 10.1007/s00134-005-0014-4; Nathens AB, 1999, ARCH SURG-CHICAGO, V134, P170, DOI 10.1001/archsurg.134.2.170; Ogata J, 2004, CAN J ANAESTH, V51, P932, DOI 10.1007/BF03018895; Pineda LA, 2006, CRIT CARE, V10, DOI 10.1186/cc4837; PINGLETON SK, 1992, CHEST, V102, pS553, DOI 10.1378/chest.102.5_Supplement_1.553S; PITTET D, 2003, PREVENTION CONTROL N, P532; PUGIN J, 1991, JAMA-J AM MED ASSOC, V265, P2704, DOI 10.1001/jama.265.20.2704; Rello J, 2002, CHEST, V122, P2115, DOI 10.1378/chest.122.6.2115; RELLO J, IN PRESS INTENSIVE C; RODRIGUEZROLDAN JM, 1990, CRIT CARE MED, V18, P1239, DOI 10.1097/00003246-199011000-00011; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Silvestri L, 2004, EUR RESPIR J, V23, P921, DOI 10.1183/09031936.04.00109704; STOUTENBEEK CP, 1984, INTENS CARE MED, V10, P185, DOI 10.1007/BF00259435; American Medical Association, 2004, MMWR Recomm Rep, V53, P1; VANDENBROUCKEGRAULS CMJE, 1991, LANCET, V338, P859, DOI 10.1016/0140-6736(91)91510-2	44	217	231	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2007	334	7599					889	893		10.1136/bmj.39136.528160.BE	http://dx.doi.org/10.1136/bmj.39136.528160.BE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164FB	17387118	Bronze, Green Published			2022-12-28	WOS:000246217800030
J	Toumbourou, JW; Stockwell, T; Neighbors, C; Marlatt, GA; Sturge, J; Rehm, J				Toumbourou, J. W.; Stockwell, T.; Neighbors, C.; Marlatt, G. A.; Sturge, J.; Rehm, J.			Adolescent health 4 - Interventions to reduce harm associated with adolescent substance use	LANCET			English	Review							MOTIVATIONAL ENHANCEMENT; PROTECTIVE FACTORS; FOLLOW-UP; DRUG-USE; PRIMARY PREVENTION; ALCOHOL-PROBLEMS; HOME VISITATION; UNITED-STATES; SCHOOL-HEALTH; YOUNG-PEOPLE	A major proportion of the disease burden and deaths for young people in developed nations is attributable to misuse of alcohol and illicit drugs. Patterns of substance use established in adolescence are quite stable and predict chronic patterns of use, mortality and morbidity later in life. We integrated findings of systematic reviews to summarise evidence for interventions aimed at prevention and reduction of harms related to adolescent substance use. Evidence of efficacy was available for developmental prevention interventions that aim to prevent onset of harmful patterns in settings such as vulnerable families, schools, and communities, and universal strategies to reduce attractiveness of substance use. Regulatory interventions aim to increase perceived costs and reduce availability and accessibility of substances. Increasing price, restricting settings of use, and raising legal purchase age are effective in reducing use of alcohol and tobacco and related harms. Screening and brief intervention are efficacious, but efficacy of a range of treatment approaches has not been reliably established. Harm-reduction interventions are effective in young people involved in risky and injecting substance use.	Deakin Univ, Sch Psychol, Geelong, Vic 3217, Australia; Deakin Univ, Ctr Adolescent Hlth, Murdoch Childrens Res Inst, Geelong, Vic 3217, Australia; Curtin Univ, Natl Drug Res Inst, Perth, WA, Australia; Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; Ctr Addict & Mental Hlth, Toronto, ON, Canada	Deakin University; Deakin University; Murdoch Children's Research Institute; Curtin University; University of Washington; University of Washington Seattle; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Stockwell, T (corresponding author), Univ Victoria, Ctr Addict Res British Columbia, POB 1700 STN,CSC, Victoria, BC V8W 2Y2, Canada.	timstock@uvic.ca	Toumbourou, John W/W-8632-2018; Rem, Jürgen/H-1309-2011	Toumbourou, John W/0000-0002-8431-3762; Stockwell, Tim/0000-0002-5696-6803; Sturge, Jodi L./0000-0002-7598-1558				[Anonymous], 2005, CANADIAN ADDICTION S; Aos S., 2004, BENEFITS COSTS PREVE; APA, 1994, DIAGN STAT MAN MENT; Armstrong TD, 2002, J CONSULT CLIN PSYCH, V70, P1224, DOI 10.1037/0022-006X.70.6.1224; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Arthur MW, 2002, EVALUATION REV, V26, P575, DOI 10.1177/019384102237850; *AUSTR I HLTH WELF, 2005, 2004 NAT DRUG STRAT; Australian Ministerial Council on Drug Strategy, 1998, NAT DRUG STRAT FRAM; Babor TF, 2003, ALCOHOL NO ORDINARY; BAER JS, 1995, ALCOHOL CLIN EXP RES, V19, P54, DOI 10.1111/j.1530-0277.1995.tb01472.x; Baer JS, 2001, AM J PUBLIC HEALTH, V91, P1310, DOI 10.2105/AJPH.91.8.1310; Bauman KE, 2001, AM J PUBLIC HEALTH, V91, P604, DOI 10.2105/AJPH.91.4.604; Beaglehole R, 2003, LANCET, V362, P903, DOI 10.1016/S0140-6736(03)14335-8; Beck J, 1998, EVALUATION REV, V22, P15, DOI 10.1177/0193841X9802200102; Beyers JM, 2004, J ADOLESCENT HEALTH, V35, P3, DOI 10.1016/j.jadohealth.2003.08.015; BIEN TH, 1993, ADDICTION, V88, P315, DOI 10.1111/j.1360-0443.1993.tb00820.x; Bishai DM, 2005, PREV MED, V40, P197, DOI 10.1016/j.ypmed.2004.05.021; Biven A, 2004, EVALUATION COMGAS SC; Bluthenthal RN, 2000, AIDS, V14, P605, DOI 10.1097/00002030-200003310-00015; BRY BH, 1982, J ABNORM PSYCHOL, V91, P273, DOI 10.1037/0021-843X.91.4.273; Buchanan J, 2000, DRUG-EDUC PREV POLIC, V7, P409, DOI 10.1080/713660130; Budney AJ, 2000, J CONSULT CLIN PSYCH, V68, P1051, DOI 10.1037/0022-006X.68.6.1051; Burke BL, 2003, J CONSULT CLIN PSYCH, V71, P843, DOI 10.1037/0022-006X.71.5.843; Butler CC, 1999, BRIT J GEN PRACT, V49, P611; Carey MP, 2000, HEALTH PSYCHOL, V19, P3, DOI 10.1037/0278-6133.19.1.3; Carpenter C, 2005, J HEALTH ECON, V24, P613, DOI 10.1016/j.jhealeco.2004.09.014; Carpenter C, 2004, J POLICY ANAL MANAG, V23, P831, DOI 10.1002/pam.20049; CATALANO RF, 1991, INT J ADDICT, V25, P1085, DOI 10.3109/10826089109081039; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Chikritzhs T, 2005, ADDICTION, V100, P1625, DOI 10.1111/j.1360-0443.2005.01234.x; CHIKRITZHS T, 2004, NATL ALCOHOL INDICAT, V6; CHIKRITZHS T, 2004, NATL ALCOHOL INDICAT, V7; Cicero TJ, 2005, J PAIN, V6, P662, DOI 10.1016/j.jpain.2005.05.004; Coffey C, 2000, ADDICTION, V95, P1679, DOI 10.1046/j.1360-0443.2000.951116798.x; Collins D.J., 2002, NATL DRUG STRATEGY M, V49; Deas D, 2005, J CHILD ADOL PSYCHOP, V15, P723, DOI 10.1089/cap.2005.15.723; Dent CW, 2005, PREV MED, V40, P355, DOI 10.1016/j.ypmed.2004.06.014; Dimeff L.A., 1999, BRIEF ALCOHOL SCREEN; Dishion TJ, 1999, AM PSYCHOL, V54, P755, DOI 10.1037/0003-066X.54.9.755; Drucker E, 1999, DRUG ALCOHOL REV, V18, P103, DOI 10.1080/09595239996824; Dunn C, 2001, ADDICTION, V96, P1725, DOI 10.1046/j.1360-0443.2001.961217253.x; Eddy JM, 2000, J EMOT BEHAV DISORD, V8, P165, DOI 10.1177/106342660000800304; English D.R., 1995, QUANTIFICATION DRUG; ESSAU CA, 2002, SUBSTANCE ABUSE DEPE; Ezzati M., 2004, COMP QUANTIFICATION; Faggiano F, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003020.pub2; FERGUSSON DM, 1994, J CHILD PSYCHOL PSYC, V35, P1123, DOI 10.1111/j.1469-7610.1994.tb01813.x; Ferri M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003410.pub2; Fleming MF, 2002, ALCOHOL CLIN EXP RES, V26, P36, DOI 10.1111/j.1530-0277.2002.tb02429.x; Foxcroft DR, 2003, ADDICTION, V98, P397, DOI 10.1046/j.1360-0443.2003.00355.x; Gentilello LM, 2005, ANN SURG, V241, P541, DOI 10.1097/01.sla.0000157133.80396.1c; Gibson DR, 2001, AIDS, V15, P1329, DOI 10.1097/00002030-200107270-00002; Grube JW, 2005, PREVENTING HARMFUL SUBSTANCE USE: THE EVIDENCE BASE FOR POLICY AND PRACTICE, P113, DOI 10.1002/9780470713624.ch10; HANSEN WB, 1992, HEALTH EDUC RES, V7, P403, DOI 10.1093/her/7.3.403; HAWKINS JD, 1992, PSYCHOL BULL, V112, P64, DOI 10.1037/0033-2909.112.1.64; Hibell B., 2004, 2003 ESPAD REPORT AL; Holdcraft LC, 2002, ADDICTION, V97, P1025, DOI 10.1046/j.1360-0443.2002.00142.x; HOLDER H, 2005, PREVENTING HARMFUL S, P25; JOHNSTON ID, 2005, MONITORING FUTURE NA; Johnston LD, 2005, MONITORING FUTURE NA, VII; Kaminer Y, 2005, ADDICT BEHAV, V30, P1765, DOI 10.1016/j.addbeh.2005.07.002; Kokkevi A, 2000, EUR ADDICT RES, V6, P42, DOI 10.1159/000019008; Lau JTF, 2005, SUBST USE MISUSE, V40, P187, DOI 10.1081/JA-200048454; Lenton S, 2005, PREVENTING HARMFUL SUBSTANCE USE: THE EVIDENCE BASE FOR POLICY AND PRACTICE, P267, DOI 10.1002/9780470713624.ch22; Loxley W., 2004, PREVENTION SUBSTANCE; Loxley WM, 2005, MED J AUSTRALIA, V182, P54, DOI 10.5694/j.1326-5377.2005.tb06574.x; Lynam DR, 1999, J CONSULT CLIN PSYCH, V67, P590, DOI 10.1037/0022-006X.67.4.590; Marlatt GA, 1996, ADDICT BEHAV, V21, P779, DOI 10.1016/0306-4603(96)00042-1; Marlatt GA, 1998, J CONSULT CLIN PSYCH, V66, P604, DOI 10.1037/0022-006X.66.4.604; Martin G, 2005, J SUBST ABUSE TREAT, V29, P207, DOI 10.1016/j.jsat.2005.06.005; Masterman PW, 2003, J SUBST ABUSE TREAT, V24, P347, DOI 10.1016/S0740-5472(03)00047-3; Mathers M, 2006, ADDICTION, V101, P948, DOI 10.1111/j.1360-0443.2006.01438.x; Mattick RP, 2003, COCHRANE DB SYST REV, V2; McBride N, 2004, ADDICTION, V99, P278, DOI 10.1111/j.1360-0443.2003.00620.x; Mcbride N, 2003, DRUG ALCOHOL REV, V22, P263, DOI 10.1080/0959523031000154409; McCabe SE, 2005, ADDICT BEHAV, V30, P1342, DOI 10.1016/j.addbeh.2005.01.012; McCambridge J, 2004, ADDICTION, V99, P39, DOI 10.1111/j.1360-0443.2004.00564.x; McLellan AT, 2004, BIOL PSYCHIAT, V56, P764, DOI 10.1016/j.biopsych.2004.06.018; Miller W, 2002, MOTIVATIONAL INTERVI, V2<feminine; MITCHELL P, 2001, LIT REV ROLE FAMILIE; Mohler-Kuo M, 2004, J STUD ALCOHOL, V65, P266, DOI 10.15288/jsa.2004.65.266; Monti PM, 1999, J CONSULT CLIN PSYCH, V67, P989, DOI 10.1037/0022-006X.67.6.989; MOSKOWITZ JM, 1989, J STUD ALCOHOL, V50, P54, DOI 10.15288/jsa.1989.50.54; Mrazek P., 1994, REDUCING RISKS MENTA; Neighbors C, 2006, INT J DRUG POLICY, V17, P304, DOI 10.1016/j.drugpo.2006.05.004; NEWCOMB MD, 1992, J PERS SOC PSYCHOL, V63, P280, DOI 10.1037/0022-3514.63.2.280; O'Brien CP, 2005, AM J PSYCHIAT, V162, P1423, DOI 10.1176/appi.ajp.162.8.1423; ODONNELL J, 1995, AM J ORTHOPSYCHIAT, V65, P87, DOI 10.1037/h0079598; Olds DL, 1999, FUTURE CHILD, V9, P44, DOI 10.2307/1602721; Olds DL, 1997, JAMA-J AM MED ASSOC, V278, P637, DOI 10.1001/jama.278.8.637; OXMAN AD, 1994, BMJ-BRIT MED J, V309, P648, DOI 10.1136/bmj.309.6955.648; Patton GC, 2004, PEDIATRICS, V114, pE300, DOI 10.1542/peds.2003-0626-F; Petraitis J, 1998, SUBST USE MISUSE, V33, P2561, DOI 10.3109/10826089809059341; Prochaska J. O., 1984, TRANSTHEORETICAL APP; PUMARIEGA AJ, 2004, ADDICT DISORD TREAT, V0003, P00145; Rehm J, 1999, ADDICTION, V94, P173; Rehm J, 2004, COMP QUANTIFICATION, P959; Roche AM, 2004, DRUG ALCOHOL REV, V23, P11, DOI 10.1080/09595230410001645510; ROOM R, 2003, ALCOHOL DEV SOC PUBL; Rowe CL, 2004, J SUBST ABUSE TREAT, V26, P129, DOI 10.1016/S0740-5472(03)00166-1; Sanci LA, 2000, BRIT MED J, V320, P224, DOI 10.1136/bmj.320.7229.224; SCHWEINHART LJ, 1993, YOUNG CHILDREN, V49, P54; Society for Prevention Research, STAND EV CRIT EFF EF; Stephens RS, 2000, J CONSULT CLIN PSYCH, V68, P898, DOI 10.1037/0022-006X.68.5.898; STOCKWELL T, 2005, PREVENTING HARMFUL S, P337; *SUBST AB MENT HLT, 2003, OV FIND 2002 NAT SUR; Sussman S, 1998, PREV MED, V27, P632, DOI 10.1006/pmed.1998.0338; Tait RJ, 2003, DRUG ALCOHOL REV, V22, P337, DOI 10.1080/0959523031000154481; Tauras JA, 2005, ADV HEALTH ECON HEAL, V16, P277; Tevyaw TO, 2004, ADDICTION, V99, P63, DOI 10.1111/j.1360-0443.2004.00855.x; Toumbourou JW, 2005, PREVENTING HARMFUL SUBSTANCE USE: THE EVIDENCE BASE FOR POLICY AND PRACTICE, P53, DOI 10.1002/9780470713624.ch5; TOUMBOUROU JW, 2005, BEHAV CHANGE EVIDENC, P87; *UN, 1998, POL DECL AR 20 SPEC; Upadhyaya H, 2005, J AM ACAD CHILD PSY, V44, P942, DOI 10.1097/01.chi.0000170881.94451.14; *UUN, 1988, UN CONV ILL TRAFF NA; Wagenaar AC, 2005, ALCOHOL CLIN EXP RES, V29, P255, DOI 10.1097/01.ALC.0000153540.97325.3A; Wagenaar AC, 2002, J STUD ALCOHOL, P206, DOI 10.15288/jsas.2002.s14.206; Waxmonsky JG, 2005, J CHILD ADOL PSYCHOP, V15, P810, DOI 10.1089/cap.2005.15.810; West R, 2005, ADDICTION, V100, P1036, DOI 10.1111/j.1360-0443.2005.01139.x; White AM, 2004, ANN NY ACAD SCI, V1021, P206, DOI 10.1196/annals.1308.026; WHITE HR, 1989, J STUD ALCOHOL, V50, P30, DOI 10.15288/jsa.1989.50.30; White T, 2002, SUBST USE MISUSE, V37, P973, DOI 10.1081/JA-120004161; WHO, 2008, ICD 10 INT STAT CLAS; Williams RJ, 2004, AM J ADDICTION, V13, P381, DOI 10.1080/10550490490483053; Winters KC, 2002, BEHAV RES THER, V40, P1443, DOI 10.1016/S0005-7967(02)00041-4; World Health Organization, 2004, WORLD HLTH REP 2003; Younie S, 2005, PREVENTING HARMFUL SUBSTANCE USE: THE EVIDENCE BASE FOR POLICY AND PRACTICE, P337, DOI 10.1002/9780470713624.ch28; [No title captured]	128	316	319	0	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1391	1401		10.1016/S0140-6736(07)60369-9	http://dx.doi.org/10.1016/S0140-6736(07)60369-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	159HL	17448826				2022-12-28	WOS:000245856100033
J	Parman, SW				Parman, S. W.			Helium isotopic evidence for episodic mantle melting and crustal growth	NATURE			English	Article							EARTHS MANTLE; OCEANIC ISLANDS; CONTINENTAL-GROWTH; HIGH HE-3/HE-4; NOBLE-GASES; EVOLUTION; PLUMES; MODELS; HETEROGENEITY; SYSTEMATICS	The timing of formation of the Earth's continental crust is the subject of a long-standing debate(1,2), with models ranging from early formation with little subsequent growth, to pulsed growth, to steadily increasing growth. But most models do agree that the continental crust was extracted from the mantle by partial melting(3). If so, such crustal extraction should have left a chemical fingerprint in the isotopic composition of the mantle. The subduction of oceanic crust and subsequent convective mixing, however, seems to have largely erased this record in most mantle isotopic systems ( for example, strontium, neodymium and lead). In contrast, helium is not recycled into the mantle because it is volatile and degasses from erupted oceanic basalts. Therefore helium isotopes may potentially preserve a clearer record of mantle depletion than recycled isotopes. Here I show that the spectrum of He-4/He-3 ratios in ocean island basalts appears to preserve the mantle's depletion history, correlating closely with the ages of proposed continental growth pulses(4,5). The correlation independently predicts both the dominant He-4/He-3 peak found in modern mid-ocean-ridge basalts, as well as estimates of the initial He-4/He-3 ratio of the Earth(6). The correspondence between the ages of mantle depletion events and pulses of crustal production implies that the formation of the continental crust was indeed episodic and punctuated by large, potentially global, melting events. The proposed helium isotopic evolution model does not require a primitive, undegassed mantle reservoir, and therefore is consistent with whole mantle convection.	Univ Durham, Dept Earth Sci, Durham DH1 3LE, England	Durham University	Parman, SW (corresponding author), Univ Durham, Dept Earth Sci, South Rd, Durham DH1 3LE, England.	stephen.parman@durham.ac.uk		Parman, Stephen/0000-0002-7523-8684				Abedini A. A., 2006, US GEOLOGICAL SURVEY, V202; Allegre CJ, 2004, EARTH PLANET SC LETT, V228, P85, DOI 10.1016/j.epsl.2004.07.041; Allegre CJ, 1996, GEOPHYS RES LETT, V23, P3555, DOI 10.1029/96GL03373; ALLEGRE CJ, 1986, NATURE, V323, P123, DOI 10.1038/323123a0; ARMSTRONG RL, 1981, PHILOS T R SOC A, V301, P443, DOI 10.1098/rsta.1981.0122; BOWRING SA, 1995, SCIENCE, V269, P1535, DOI 10.1126/science.7667634; Brooker RA, 2003, NATURE, V423, P738, DOI 10.1038/nature01708; Burke K, 2004, EARTH PLANET SC LETT, V227, P531, DOI 10.1016/j.epsl.2004.09.015; Butler SL, 2005, PHYS EARTH PLANET IN, V152, P22, DOI 10.1016/j.pepi.2005.05.005; Class C, 2005, NATURE, V436, P1107, DOI 10.1038/nature03930; Condie KC, 1998, EARTH PLANET SC LETT, V163, P97, DOI 10.1016/S0012-821X(98)00178-2; Courtillot V, 2003, EARTH PLANET SC LETT, V205, P295, DOI 10.1016/S0012-821X(02)01048-8; Davies GF, 1995, EARTH PLANET SC LETT, V136, P363, DOI 10.1016/0012-821X(95)00167-B; Davies GF, 2002, GEOCHIM COSMOCHIM AC, V66, P3125, DOI 10.1016/S0016-7037(02)00915-8; GRAHAM D, 1990, NATURE, V347, P545, DOI 10.1038/347545a0; Helffrich GR, 2001, NATURE, V412, P501, DOI 10.1038/35087500; HOFMANN AW, 1988, EARTH PLANET SC LETT, V90, P297, DOI 10.1016/0012-821X(88)90132-X; HOFMANN AW, 1982, EARTH PLANET SC LETT, V57, P421, DOI 10.1016/0012-821X(82)90161-3; Kemp AIS, 2006, NATURE, V439, P580, DOI 10.1038/nature04505; KURZ MD, 1982, NATURE, V297, P43, DOI 10.1038/297043a0; KURZ MD, 1993, PHILOS T ROY SOC A, V342, P91, DOI 10.1098/rsta.1993.0007; Moreira M, 2001, EARTH PLANET SC LETT, V185, P15, DOI 10.1016/S0012-821X(00)00351-4; Parman SW, 2005, NATURE, V437, P1140, DOI 10.1038/nature04215; Porcelli D, 2002, REV MINERAL GEOCHEM, V47, P411, DOI 10.2138/rmg.2002.47.11; Seta A, 2001, EARTH PLANET SC LETT, V188, P211, DOI 10.1016/S0012-821X(01)00307-7; STEIN M, 1994, NATURE, V372, P63, DOI 10.1038/372063a0; Stuart FM, 2003, NATURE, V424, P57, DOI 10.1038/nature01711; TAYLOR SR, 1995, REV GEOPHYS, V33, P241, DOI 10.1029/95RG00262; Wen LX, 2006, EARTH PLANET SC LETT, V246, P138, DOI 10.1016/j.epsl.2006.04.024; ZINDLER A, 1986, ANNU REV EARTH PL SC, V14, P493, DOI 10.1146/annurev.ea.14.050186.002425	31	80	83	3	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2007	446	7138					900	903		10.1038/nature05691	http://dx.doi.org/10.1038/nature05691			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17443184				2022-12-28	WOS:000245785700039
J	Lindsey, JB; Hillis, LD				Lindsey, Jason B.; Hillis, L. David			Clinical update: atrial septal defect in adults	LANCET			English	Article							SURGICAL-TREATMENT; FOLLOW-UP; TRANSCATHETER CLOSURE; DEVICE; EXPERIENCE; OCCLUDER; COMPLICATIONS; CHILDREN; TRIAL		Univ Texas, SW Med Ctr, Div Cardiol, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Hillis, LD (corresponding author), Univ Texas, SW Med Ctr, Div Cardiol, Dept Internal Med, Dallas, TX 75390 USA.	dhilli@parknet.pmh.org						Amin Z, 2004, CATHETER CARDIO INTE, V63, P496, DOI 10.1002/ccd.20211; Attie F, 2001, J AM COLL CARDIOL, V38, P2035, DOI 10.1016/S0735-1097(01)01635-7; Butera G, 2006, AM HEART J, V151, P228, DOI 10.1016/j.ahj.2005.02.051; Carminati M, 2000, CARDIOL YOUNG, V10, P519; Divekar A, 2005, J AM COLL CARDIOL, V45, P1213, DOI 10.1016/j.jacc.2004.12.072; Du ZD, 2002, J AM COLL CARDIOL, V39, P1836, DOI 10.1016/S0735-1097(02)01862-4; Fischer G, 2003, HEART, V89, P199, DOI 10.1136/heart.89.2.199; Giamberti A, 2006, ANN THORAC SURG, V82, P1327, DOI 10.1016/j.athoracsur.2006.05.010; Hausdorf G, 1996, HEART, V75, P83, DOI 10.1136/hrt.75.1.83; HORVATH KA, 1992, J AM COLL CARDIOL, V20, P1156, DOI 10.1016/0735-1097(92)90372-T; KONSTANTINIDES S, 1995, NEW ENGL J MED, V333, P469, DOI 10.1056/NEJM199508243330801; Masura J, 2005, J AM COLL CARDIOL, V45, P505, DOI 10.1016/j.jacc.2004.10.066; Mills NL, 2003, AM J CARDIOL, V92, P353, DOI 10.1016/S0002-9149(03)00647-7; MURPHY JG, 1990, NEW ENGL J MED, V323, P1645, DOI 10.1056/NEJM199012133232401; Podnar T, 2001, CATHETER CARDIO INTE, V53, P386, DOI 10.1002/ccd.1187; SHAH D, 1994, BRIT HEART J, V71, P224; Sharafuddin MJA, 1997, CIRCULATION, V95, P2162, DOI 10.1161/01.CIR.95.8.2162; SUTTON MGS, 1981, CIRCULATION, V64, P402, DOI 10.1161/01.CIR.64.2.402; Thanopoulos BD, 1998, J AM COLL CARDIOL, V31, P1110, DOI 10.1016/S0735-1097(98)00039-4; Theodoro DA, 1998, ANN THORAC SURG, V65, P149, DOI 10.1016/S0003-4975(97)01193-4	20	46	49	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2007	369	9569					1244	1246		10.1016/S0140-6736(07)60576-5	http://dx.doi.org/10.1016/S0140-6736(07)60576-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164YA	17434386				2022-12-28	WOS:000246269700010
J	Thoen, CO; LoBue, PA				Thoen, Charles O.; LoBue, Philip A.			Mycobacterium bovis tuberculosis: forgotten, but not gone	LANCET			English	Editorial Material									Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA; Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA	Iowa State University; Centers for Disease Control & Prevention - USA	Thoen, CO (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA.	cthoen@iastate.edu						Blazquez J, 1997, J CLIN MICROBIOL, V35, P1390; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; ENARSON DA, 2006, MYCOBACTERIUM BOVIS; Evans JT, 2007, LANCET, V369, P1270, DOI 10.1016/S0140-6736(07)60598-4; Gilsdorf M. J., 2006, MYCOBACTERIUM BOVIS; Grange JM, 2001, TUBERCULOSIS, V81, P71, DOI 10.1054/tube.2000.0263; LoBue PA, 2004, INT J TUBERC LUNG D, V8, P1142; LoBue PA, 2003, INT J TUBERC LUNG D, V7, P180; LoBue RA, 2004, INT J TUBERC LUNG D, V8, P868; Thoen C, 2006, VET MICROBIOL, V112, P339, DOI 10.1016/j.vetmic.2005.11.047; Winters A., 2005, Morbidity and Mortality Weekly Report, V54, P605	11	16	16	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2007	369	9569					1236	1238		10.1016/S0140-6736(07)60572-8	http://dx.doi.org/10.1016/S0140-6736(07)60572-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164YA	17434381				2022-12-28	WOS:000246269700005
J	Han, K; Konkel, MK; Xing, J; Wang, H; Lee, J; Meyer, TJ; Huang, CT; Sandifer, E; Hebert, K; Barnes, EW; Hubley, R; Miller, W; Smit, AFA; Ullmer, B; Batzer, MA				Han, Kyudong; Konkel, Miriam K.; Xing, Jinchuan; Wang, Hui; Lee, Jungnam; Meyer, Thomas J.; Huang, Charles T.; Sandifer, Erin; Hebert, Kristi; Barnes, Erin W.; Hubley, Robert; Miller, Webb; Smit, Arian F. A.; Ullmer, Brygg; Batzer, Mark A.			Mobile DNA in old world monkeys: A glimpse through the rhesus macaque genome	SCIENCE			English	Article							LYON REPEAT HYPOTHESIS; INTERSPERSED REPEATS; LINE-1 ELEMENTS; ALU ELEMENTS; RETROTRANSPOSITION; EVOLUTION; PRIMATES; INACTIVATION; DIVERSITY; LINEAGES	The completion of the draft sequence of the rhesus macaque genome allowed us to study the genomic composition and evolution of transposable elements in this representative of the Old World monkey lineage, a group of diverse primates closely related to humans. The L1 family of long interspersed elements appears to have evolved as a single lineage, and Alu elements have evolved into four currently active lineages. We also found evidence of elevated horizontal transmissions of retroviruses and the absence of DNA transposon activity in the Old World monkey lineage. In addition, similar to 100 precursors of composite SVA ( short interspersed element, variable number of tandem repeat, and Alu) elements were identified, with the majority being shared by the common ancestor of humans and rhesus macaques. Mobile elements compose roughly 50% of primate genomes, and our findings illustrate their diversity and strong influence on genome evolution between closely related species.	Louisiana State Univ, Dept Biol Sci, Biol Computat & Visualizat Ctr, Ctr Biomodular Multiscale Syst, Baton Rouge, LA 70803 USA; Inst Syst Biol, Seattle, WA 98103 USA; Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; Louisiana State Univ, Dept Comp Sci, Ctr Computat Technol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Institute for Systems Biology (ISB); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Louisiana State University System; Louisiana State University	Batzer, MA (corresponding author), Louisiana State Univ, Dept Biol Sci, Biol Computat & Visualizat Ctr, Ctr Biomodular Multiscale Syst, Baton Rouge, LA 70803 USA.	mbatzer@lsu.edu	Xing, Jinchuan/A-2489-2012; Han, Kyudong/AAF-1788-2019	Han, Kyudong/0000-0001-6791-2408; Barnes, Erin W./0000-0002-9930-7664	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Benit L, 2003, VIROLOGY, V312, P159, DOI 10.1016/S0042-6822(03)00163-6; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Callinan P, 2006, GENOME DYN, V1, P104, DOI 10.1159/000092503; Carlsson HE, 2004, AM J PRIMATOL, V63, P225, DOI 10.1002/ajp.20054; Chen JM, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/56182; Cordaux R, 2004, TRENDS GENET, V20, P464, DOI 10.1016/j.tig.2004.07.012; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; Furano AV, 2004, TRENDS GENET, V20, P9, DOI 10.1016/j.tig.2003.11.006; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Han KD, 2005, NUCLEIC ACIDS RES, V33, P4040, DOI 10.1093/nar/gki718; Hansen RS, 2003, HUM MOL GENET, V12, P2559, DOI 10.1093/hmg/ddg268; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lev-Maor G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r29; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Mills RE, 2006, AM J HUM GENET, V78, P671, DOI 10.1086/501028; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Ray DA, 2006, SYSTEMATIC BIOL, V55, P928, DOI 10.1080/10635150600865419; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Shedlock AM, 2004, TRENDS ECOL EVOL, V19, P545, DOI 10.1016/j.tree.2004.08.002; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Xing J, 2006, P NATL ACAD SCI USA, V103, P17608, DOI 10.1073/pnas.0603224103	27	78	81	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					238	240		10.1126/science.1139462	http://dx.doi.org/10.1126/science.1139462			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431169	Green Submitted			2022-12-28	WOS:000245654500039
J	Larsen, CM; Faulenbach, M; Vaag, A; Volund, A; Ehses, JA; Seifert, B; Mandrup-Poulsen, T; Donath, MY				Larsen, Claus M.; Faulenbach, Mirjam; Vaag, Allan; Volund, Aage; Ehses, Jan A.; Seifert, Burkhardt; Mandrup-Poulsen, Thomas; Donath, Marc Y.			Interleukin-1-receptor antagonist in type 2 diabetes mellitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BETA-CELL APOPTOSIS; RECEPTOR ANTAGONIST; GLUCOSE; EXPRESSION; INSULIN; OBESITY; ISLETS; MUSCLE	Background: The expression of interleukin-1-receptor antagonist is reduced in pancreatic islets of patients with type 2 diabetes mellitus, and high glucose concentrations induce the production of interleukin-1(beta) in human pancreatic beta cells, leading to impaired insulin secretion, decreased cell proliferation, and apoptosis. Methods: In this double-blind, parallel-group trial involving 70 patients with type 2 diabetes, we randomly assigned 34 patients to receive 100 mg of anakinra (a recombinant human interleukin-1-receptor antagonist) subcutaneously once daily for 13 weeks and 36 patients to receive placebo. At baseline and at 13 weeks, all patients underwent an oral glucose-tolerance test, followed by an intravenous bolus of 0.3 g of glucose per kilogram of body weight, 0.5 mg of glucagon, and 5 g of arginine. In addition, 35 patients underwent a hyperinsulinemic-euglycemic clamp study. The primary end point was a change in the level of glycated hemoglobin, and secondary end points were changes in beta-cell function, insulin sensitivity, and inflammatory markers. Results: At 13 weeks, in the anakinra group, the glycated hemoglobin level was 0.46 percentage point lower than in the placebo group (P=0.03); C-peptide secretion was enhanced (P=0.05), and there were reductions in the ratio of proinsulin to insulin (P=0.005) and in levels of interleukin-6 (P<0.001) and C-reactive protein (P=0.002). Insulin resistance, insulin-regulated gene expression in skeletal muscle, serum adipokine levels, and the body-mass index were similar in the two study groups. Symptomatic hypoglycemia was not observed, and there were no apparent drug-related serious adverse events. Conclusions: The blockade of interleukin-1 with anakinra improved glycemia and beta-cell secretory function and reduced markers of systemic inflammation.	Steno Diabet Ctr, DK-2820 Gentofte, Denmark; Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark; Univ Zurich Hosp, Clin Endocrinol & Diabet, CH-8091 Zurich, Switzerland; Ctr Integrat Human Physiol, Zurich, Switzerland; Univ Zurich, Dept Biostat, Zurich, Switzerland; Lund Univ, Lund, Sweden; Karolinska Inst, Stockholm, Sweden	Steno Diabetes Center; Novo Nordisk; University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; Lund University; Karolinska Institutet	Donath, MY (corresponding author), Univ Zurich Hosp, Div Endocrinol & Diabet, CH-8091 Zurich, Switzerland.	marc.donath@usz.ch	Ehses, Jan/AAK-1635-2020	Seifert, Burkhardt/0000-0002-5829-2478; Ehses, Jan/0000-0001-9066-7607; Vaag, Allan Arthur/0000-0002-3690-2191; Mandrup-Poulsen, Thomas/0000-0002-3215-9273				Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; ANDERSEN L, 1993, CLIN CHEM, V39, P578; [Anonymous], 1995, Diabetes, V44, P1249; [Anonymous], 1996, DIABETES; BENDTZEN K, 1986, SCIENCE, V232, P1545, DOI 10.1126/science.3086977; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; CERASI E, 1967, ACTA ENDOCRINOL-COP, V55, P330, DOI 10.1530/acta.0.0550330; Chida D, 2006, DIABETES, V55, P971, DOI 10.2337/diabetes.55.04.06.db05-1250; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Dinarello CA, 2000, NEW ENGL J MED, V343, P732, DOI 10.1056/NEJM200009073431011; Dinarello CA, 2005, ARTHRITIS RHEUM-US, V52, P1960, DOI 10.1002/art.21107; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; Garcia MC, 2006, DIABETES, V55, P1205, DOI 10.2337/db05-1304; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; HARTLING SG, 1986, CLIN CHIM ACTA, V156, P289, DOI 10.1016/0009-8981(86)90072-0; HEDING LG, 1975, DIABETOLOGIA, V11, P541, DOI 10.1007/BF01222104; HELLERSTROM C, 1984, DIABETOLOGIA, V26, P393; Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889; Maedler K, 2004, DIABETES, V53, P1706, DOI 10.2337/diabetes.53.7.1706; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Maedler K, 2004, P NATL ACAD SCI USA, V101, P8138, DOI 10.1073/pnas.0305683101; Maedler K, 2001, DIABETES, V50, P1683, DOI 10.2337/diabetes.50.8.1683; MandrupPoulsen T, 1996, DIABETOLOGIA, V39, P1005, DOI 10.1007/BF00400649; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; VAAG A, 1995, DIABETOLOGIA, V38, P326, DOI 10.1007/s001250050289; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Welsh N, 2005, DIABETES, V54, P3238, DOI 10.2337/diabetes.54.11.3238; ZUMSTEG U, 1993, DIABETOLOGIA, V36, P759, DOI 10.1007/BF00401148	29	1313	1401	0	75	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 12	2007	356	15					1517	1526		10.1056/NEJMoa065213	http://dx.doi.org/10.1056/NEJMoa065213			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156CA	17429083	Green Accepted, Bronze			2022-12-28	WOS:000245624400005
J	Wright, AA; Katz, IT				Wright, Alexi A.; Katz, Ingrid T.			Tobacco tightrope - Balancing disease prevention and economic development in China	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Dana Farber Canc Inst, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center	Wright, AA (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.		Wright, Alexi/T-5793-2019	Katz, Ingrid/0000-0002-3014-238X				FELL J, 2005, TOBACCO IND OVERVIEW; Hu TW, 2006, TOB CONTROL, V15, pI37, DOI 10.1136/tc.2005.014621; Mackay J, 2006, TOBACCO ATLAS; Taylor AL, 2000, TOBACCO CONTROL DEV, P343	4	34	37	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 12	2007	356	15					1493	1496		10.1056/NEJMp078018	http://dx.doi.org/10.1056/NEJMp078018			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	156CA	17429080				2022-12-28	WOS:000245624400001
J	Coombes, R				Coombes, Rebecca			Life saving treatment or giant experiment?	BRITISH MEDICAL JOURNAL			English	Article							HPV					rcoombes@bmjgroup.com						*ALL HUM RES PROT, FACTS MERCKS MAND VA; BOSELEY S, 2007, GUARDIAN        0326; CARREYROU J, 2007, WALL STREET J   0207; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; FROSCH D, 2007, NY TIMES        0314; *JOINT COMM VACC I, 2006, MIN HPV SUB GROUP M; Lowy DR, 2006, J CLIN INVEST, V116, P1167, DOI 10.1172/JCI28607; Tanne JH, 2007, BRIT MED J, V334, P332, DOI 10.1136/bmj.39122.403044.DB	8	7	7	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 7	2007	334	7596					721	723		10.1136/bmj.39164.510127.AD	http://dx.doi.org/10.1136/bmj.39164.510127.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AO	17413171	Green Published			2022-12-28	WOS:000245763300025
J	Simon, RW; Simon-Schulthess, A; Amman-Vesti, BR				Simon, Roger W.; Simon-Schulthess, Andre; Amman-Vesti, Beatrice R.			10-minute consultation - Intermittent daudication	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Zurich Hosp, Div Angiol, Dept Internal Med, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Simon, RW (corresponding author), Univ Zurich Hosp, Div Angiol, Dept Internal Med, CH-8091 Zurich, Switzerland.	roger.simon@usz.ch							0	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2007	334	7596					746	746		10.1136/bmj.39036.624306.68	http://dx.doi.org/10.1136/bmj.39036.624306.68			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AO	17413176	Green Published			2022-12-28	WOS:000245763300033
J	Stein, A				Stein, Andrew			Every hospital needs a Gerry Robinson	LANCET			English	Editorial Material									Univ Hosp Coventry & Warwickshire, Renal Unit, Coventry CV2 2DX, W Midlands, England	University of Warwick	Stein, A (corresponding author), Univ Hosp Coventry & Warwickshire, Renal Unit, Coventry CV2 2DX, W Midlands, England.	andrewstein@btinternet.com							0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2007	369	9568					1150	1151		10.1016/S0140-6736(07)60543-1	http://dx.doi.org/10.1016/S0140-6736(07)60543-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155RH	17416246				2022-12-28	WOS:000245595100009
J	Christianson, DW				Christianson, David W.			Roots of biosynthetic diversity	SCIENCE			English	Editorial Material							DIPHOSPHATE SYNTHASE; CRYSTAL-STRUCTURE; ENZYME		Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA	University of Pennsylvania	Christianson, DW (corresponding author), Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA.	chris@sas.upenn.edu			NIGMS NIH HHS [GM56838] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056838] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cane D. E., 1999, ISOPRENOIDS INCLUDIN, V2; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Greenhagen BT, 2006, P NATL ACAD SCI USA, V103, P9826, DOI 10.1073/pnas.0601605103; Hosfield DJ, 2004, J BIOL CHEM, V279, P8526, DOI 10.1074/jbc.C300511200; Pandit J, 2000, J BIOL CHEM, V275, P30610, DOI 10.1074/jbc.M004132200; Rynkiewicz MJ, 2001, P NATL ACAD SCI USA, V98, P13543, DOI 10.1073/pnas.231313098; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Steele CL, 1998, J BIOL CHEM, V273, P2078, DOI 10.1074/jbc.273.4.2078; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; Thulasiram HV, 2007, SCIENCE, V316, P73, DOI 10.1126/science.1137786; Whittington DA, 2002, P NATL ACAD SCI USA, V99, P15375, DOI 10.1073/pnas.232591099; Yoshikuni Y, 2006, NATURE, V440, P1078, DOI 10.1038/nature04607	12	60	70	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2007	316	5821					60	61		10.1126/science.1141630	http://dx.doi.org/10.1126/science.1141630			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412944				2022-12-28	WOS:000245470500027
J	Myers, RA; Baum, JK; Shepherd, TD; Powers, SP; Peterson, CH				Myers, Ransom A.; Baum, Julia K.; Shepherd, Travis D.; Powers, Sean P.; Peterson, Charles H.			Cascading effects of the loss of apex predatory sharks from a coastal ocean	SCIENCE			English	Article							LOWER CHESAPEAKE BAY; TROPHIC CASCADES; INTERACTION STRENGTH; RHINOPTERA-BONASUS; MARINE ECOSYSTEMS; COWNOSE RAY; FOOD WEBS; SCALLOPS; EXTINCTIONS; COLLAPSE	Impacts of chronic overfishing are evident in population depletions worldwide, yet indirect ecosystem effects induced by predator removal from oceanic food webs remain unpredictable. As abundances of all 11 great sharks that consume other elasmobranchs (rays, skates, and small sharks) fell over the past 35 years, 12 of 14 of these prey species increased in coastal northwest Atlantic ecosystems. Effects of this community restructuring have cascaded downward from the cownose ray, whose enhanced predation on its bay scallop prey was sufficient to terminate a century-long scallop fishery. Analogous top-down effects may be a predictable consequence of eliminating entire functional groups of predators.	Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA; Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; Univ S Alabama, Dept Marine Sci, Dauphin Isl, AL 36528 USA; Dauphin Isl Sea Lab, Dauphin Isl, AL 36528 USA	University of North Carolina; University of North Carolina Chapel Hill; Dalhousie University; University of South Alabama; Dauphin Island Sea Lab	Baum, JK (corresponding author), Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA.	baum@mscs.dal.ca; cpeters@email.unc.edu	Baum, Julia K/A-4693-2008	Powers, Sean/0000-0002-4770-9944; Baum, Julia/0000-0002-9827-1612				Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; BLAYLOCK RA, 1993, ESTUARIES, V16, P255, DOI 10.2307/1352498; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Duffy JE, 2002, OIKOS, V99, P201, DOI 10.1034/j.1600-0706.2002.990201.x; Dulvy NK, 2000, CONSERV BIOL, V14, P283, DOI 10.1046/j.1523-1739.2000.98540.x; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; FAHRENTHOLD DA, 2004, WASHINGTON POST 0824; FOWLER SL, 2005, RAYS CHIMAERAS STATU; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Grusha, 2005, THESIS COLL WILLIAM; Ha D., 2006, THESIS COLL WILLIAM; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; ORTH R J, 1975, Chesapeake Science, V16, P205, DOI 10.2307/1350896; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; PAINE RT, 1980, J ANIM ECOL, V49, P667; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Peterson CH, 1996, MAR ECOL PROG SER, V132, P93, DOI 10.3354/meps132093; PETERSON CH, 1989, J EXP MAR BIOL ECOL, V127, P121, DOI 10.1016/0022-0981(89)90179-2; Peterson CH, 2001, OECOLOGIA, V129, P349, DOI 10.1007/s004420100742; Rogers SI, 2000, ICES J MAR SCI, V57, P866, DOI 10.1006/jmsc.2000.0574; SMITH JW, 1985, ESTUARIES, V8, P305, DOI 10.2307/1351491; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; Yamaguchi A, 2005, ENVIRON BIOL FISH, V74, P229, DOI 10.1007/s10641-005-0217-0	26	881	902	20	1155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1846	1850		10.1126/science.1138657	http://dx.doi.org/10.1126/science.1138657			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395829				2022-12-28	WOS:000245280100044
J	Shine, KP; Sturges, WT				Shine, Keith P.; Sturges, William T.			Atmospheric science - CO2 is not the only gas	SCIENCE			English	Editorial Material							CLIMATE; EMISSIONS; METHANE; AIR		Univ Reading, Dept Meteorol, Reading RG6 6BB, Berks, England; Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	University of Reading; University of East Anglia	Shine, KP (corresponding author), Univ Reading, Dept Meteorol, Reading RG6 6BB, Berks, England.	k.p.shine@reading.ac.uk; w.sturges@uea.ac.uk	Shine, Keith P/D-9093-2012	Shine, Keith P/0000-0003-2672-9978	Natural Environment Research Council [NER/L/S/2001/00661] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Butler JH, 1999, NATURE, V399, P749, DOI 10.1038/21586; Dlugokencky EJ, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006035; Fiore AM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026199; Fuglestvedt JS, 2003, CLIMATIC CHANGE, V58, P267, DOI 10.1023/A:1023905326842; Hansen J, 2004, P NATL ACAD SCI USA, V101, P16109, DOI 10.1073/pnas.0406982101; Harnisch J, 1996, NATURE, V384, P32, DOI 10.1038/384032a0; Hofmann DJ, 2006, TELLUS B, V58, P614, DOI 10.1111/j.1600-0889.2006.00201.x; Keppler F, 2006, NATURE, V439, P187, DOI 10.1038/nature04420; RAMANATHAN V, 1987, REV GEOPHYS, V25, P1441, DOI 10.1029/RG025i007p01441; Shindell DT, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021900; Sturges WT, 2000, SCIENCE, V289, P611, DOI 10.1126/science.289.5479.611; Sturrock GA, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002548; van Vuuren DP, 2006, ENERG ECON, V28, P102, DOI 10.1016/j.eneco.2005.10.003; *WORLD MET ORG, 2007, 50 WORLD MET ORG; Worton DR, 2007, ENVIRON SCI TECHNOL, V41, P2184, DOI 10.1021/es061710t; 1971, INADVERTENT CLIMATE	16	70	73	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2007	315	5820					1804	1805		10.1126/science.1141677	http://dx.doi.org/10.1126/science.1141677			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	151HC	17395819				2022-12-28	WOS:000245280100030
J	Nutt, D; King, LA; Saulsbury, W; Blakemore, C				Nutt, David; King, Leslie A.; Saulsbury, William; Blakemore, Colin			Development of a rational scale to assess the harm of drugs of potential misuse	LANCET			English	Article							TOXICITY; DEPENDENCE; SUBSTANCES; POLICY	Drug misuse and abuse are major health problems. Harmful drugs are regulated according to classification systems that purport to relate to the harms and risks of each drug. However, the methodology and processes underlying classification systems are generally neither specified nor transparent, which reduces confidence in their accuracy and undermines health education messages. We developed and explored the feasibility of the use of a nine-category matrix of harm, with an expert delphic procedure, to assess the harms of a range of illicit drugs in an evidence-based fashion. We also included five legal drugs of misuse (alcohol, khat, solvents, alkyl nitrites, and tobacco) and one that has since been classified (ketamine) for reference. The process proved practicable, and yielded roughly similar scores and rankings of drug harm when used by two separate groups of experts. The ranking of drugs produced by our assessment of harm differed from those used by current regulatory systems. Our methodology offers a systematic framework and process that could be used by national and international regulatory bodies to assess the harm of current and future drugs of abuse.	Univ Bristol, Psychopharmacol Unit, Bristol BS1 3NY, Avon, England; Forens Sci Serv Inc, London, England; Police Fdn, London, England; MRC, London, England; Dept Physiol Anat & Genet, Oxford, England	University of Bristol; Forensic Science Service UK	Nutt, D (corresponding author), Univ Bristol, Psychopharmacol Unit, Bristol BS1 3NY, Avon, England.	david.j.nutt@bristol.ac.uk		Blakemore, Colin/0000-0003-2659-7899; nutt, david/0000-0002-1286-1401	Medical Research Council [G0400575] Funding Source: Medline; MRC [G0400575] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Academy of Medical Sciences (AMS), 2004, CALL TIM NAT DRINK M; Anthony JC, 1994, EXP CLIN PSYCHOPHARM, V2, P244, DOI 10.1037/1064-1297.2.3.244; CORKERY JM, 2002, DRUG SEIZURES OFFEND; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; EMCDDA, 1999, GUID RISK ASS NEW SY; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Figuera J., 2005, MULTIPLE CRITERIA DE; *FOR, 2005, BRAIN SCI ADD DRUGS; Gable RS, 2004, ADDICTION, V99, P686, DOI 10.1111/j.1360-0443.2004.00744.x; GABLE RS, 1993, AM J DRUG ALCOHOL AB, V19, P263, DOI 10.3109/00952999309001618; GOLDSTEIN A, 1990, SCIENCE, V249, P1513, DOI 10.1126/science.2218493; Gonzalez A, 2005, J PSYCHOPHARMACOL, V19, P195, DOI 10.1177/0269881105049041; GRIFFITHS C, 2002, HLTH STAT Q, V13, P76; HALL W, 1999, HLTH EFFECTS CANABIS; *HC SCI TECHN COMM, 2006, DRUG CLASS MAK HASH; KING LA, 1983, MED SCI LAW, V23, P193, DOI 10.1177/002580248302300307; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; MacCoun RJ., 2001, DRUG WAR HERESIES LE; MACDONALD Z, MEASURING HARM ILLEG; NUTT DJ, 2002, CANNABIS UPDATE; TUROFF M, 1970, TECHNOL FORECAST SOC, V2, P149, DOI 10.1016/0040-1625(70)90161-7; TYRER P, 1983, LANCET, V1, P1402; *UK HOM OFF, PROP CHANG MIS DRUGS; van Amsterdam JGC, 2004, REGUL TOXICOL PHARM, V39, P1, DOI 10.1016/j.yrtph.2003.09.001	24	702	724	5	205	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2007	369	9566					1047	1053		10.1016/S0140-6736(07)60464-4	http://dx.doi.org/10.1016/S0140-6736(07)60464-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	151JO	17382831				2022-12-28	WOS:000245286500033
J	Mozaffarian, D				Mozaffarian, Dariush			JELIS, fish oil, and cardiac events	LANCET			English	Editorial Material							CORONARY-HEART-DISEASE; POLYUNSATURATED FATTY-ACIDS; MYOCARDIAL-INFARCTION; RISK-FACTORS; HEALTH; TRIAL; DIET; CONSUMPTION; BENEFITS; DEATH		Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Mozaffarian, D (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.	dmozaffa@hsph.harvard.edu	Mozaffarian, Dariush/B-2276-2008					Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; BURR ML, 1989, LANCET, V2, P757; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; *FDA, CONS DRUG INF SHEET; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Iso H, 2006, CIRCULATION, V113, P195, DOI 10.1161/CIRCULATIONAHA.105.581355; Ministry of Health Labor and Welfare, 2003, NAT NUTR SURV JAP 20; Mozaffarian D, 2005, CIRCULATION, V111, P157, DOI 10.1161/01.CIR.0000152099.87287.83; Mozaffarian D, 2003, CIRCULATION, V107, P1372, DOI 10.1161/01.CIR.0000055315.79177.16; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	13	28	82	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2007	369	9567					1062	1063		10.1016/S0140-6736(07)60504-2	http://dx.doi.org/10.1016/S0140-6736(07)60504-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151XF	17398290				2022-12-28	WOS:000245323700007
J	Inoue, D; Ohe, M; Kanemori, Y; Nobui, T; Sagata, N				Inoue, Daigo; Ohe, Munemichi; Kanemori, Yoshinori; Nobui, Toshiya; Sagata, Noriyuki			A direct link of the Mos-MAPK pathway to Erp1/Emi2 in meiotic arrest of Xenopus laevis eggs	NATURE			English	Article							CYTOSTATIC FACTOR ARREST; ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; MEIOSIS-II; METAPHASE ARREST; VERTEBRATE EGGS; CELL-CYCLE; KINASE; OOCYTES; INHIBITOR; EMI2	In vertebrates, unfertilized eggs ( or mature oocytes) are arrested at metaphase of meiosis II by a cytoplasmic activity called cytostatic factor (CSF)(1). The classical Mos - MAPK pathway has long been implicated in CSF arrest of vertebrate eggs, but exactly how it exerts CSF activity remains unclear(2-4). Recently, Erp1 ( also called Emi2), an inhibitor of the anaphase-promoting complex/cyclosome (APC/C) required for degradation of the mitotic regulator cyclin B (ref. 5), has also been shown to be a component of CSF in both Xenopus and mice(6-8). Erp1 is destroyed on fertilization or egg activation(9,10), like Mos(11). However, despite these similarities the Mos-MAPK (mitogen-activated protein kinase) pathway and Erp1 are thought to act rather independently in CSF arrest(3,6,8). Here, we show that p90rsk, the kinase immediately downstream from Mos MAPK, directly targets Erp1 for CSF arrest in Xenopus oocytes. Erp1 is synthesized immediately after meiosis I, and the Mos MAPK pathway or p90rsk is essential for CSF arrest by Erp1. p90rsk can directly phosphorylate Erp1 on Ser 335/Thr 336 both in vivo and in vitro, and upregulates both Erp1 stability and activity. Erp1 is also present in early embryos, but has little CSF activity owing, at least in part, to the absence of p90rsk activity. These results clarify the direct link of the classical Mos - MAPK pathway to Erp1 in meiotic arrest of vertebrate oocytes.	Kyushu Univ, Grad Sch Sci, Dept Biol, Fukuoka 8128581, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Kyushu University; Japan Science & Technology Agency (JST)	Sagata, N (corresponding author), Kyushu Univ, Grad Sch Sci, Dept Biol, Hakozaki 6-10-1, Fukuoka 8128581, Japan.	nsagascb@mbox.nc.kyushu-u.ac.jp						Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; Brunet S, 2005, REPRODUCTION, V130, P801, DOI 10.1530/rep.1.00364; Dumont J, 2005, J CELL BIOL, V169, P227, DOI 10.1083/jcb.200501027; Furuno N, 1997, EMBO J, V16, P3860, DOI 10.1093/emboj/16.13.3860; FURUNO N, 1994, EMBO J, V13, P2399, DOI 10.1002/j.1460-2075.1994.tb06524.x; Gross SD, 2000, CURR BIOL, V10, P430, DOI 10.1016/S0960-9822(00)00425-5; Gross SD, 1999, SCIENCE, V286, P1365, DOI 10.1126/science.286.5443.1365; Hansen DV, 2006, P NATL ACAD SCI USA, V103, P608, DOI 10.1073/pnas.0509549102; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Inoue D, 2005, EMBO J, V24, P1057, DOI 10.1038/sj.emboj.7600567; Lefebvre C, 2002, J CELL BIOL, V157, P603, DOI 10.1083/jcb.200202052; Liu JJ, 2006, J BIOL CHEM, V281, P34736, DOI 10.1074/jbc.M606607200; Madgwick S, 2006, J CELL BIOL, V174, P791, DOI 10.1083/jcb.200604140; Masui Y, 2000, NAT REV MOL CELL BIO, V1, P228, DOI 10.1038/35043096; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; Murakami MS, 1999, GENE DEV, V13, P620, DOI 10.1101/gad.13.5.620; Ohe M, 2007, DEV BIOL, V303, P157, DOI 10.1016/j.ydbio.2006.10.044; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093; Reimann JDR, 2002, NATURE, V416, P850, DOI 10.1038/416850a; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Sagata N, 1996, TRENDS CELL BIOL, V6, P22, DOI 10.1016/0962-8924(96)81034-8; Schmidt A, 2005, GENE DEV, V19, P502, DOI 10.1101/gad.320705; Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953; Smith JA, 2005, CANCER RES, V65, P1027; Tung JJ, 2005, P NATL ACAD SCI USA, V102, P4318, DOI 10.1073/pnas.0501108102; Tunquist BJ, 2003, GENE DEV, V17, P683, DOI 10.1101/gad.1071303; WATANABE N, 1991, NATURE, V352, P247, DOI 10.1038/352247a0; Yamamoto TM, 2005, DEV BIOL, V279, P345, DOI 10.1016/j.ydbio.2004.12.025	29	98	100	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2007	446	7139					1100	1104		10.1038/nature05688	http://dx.doi.org/10.1038/nature05688			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	160NU	17410130				2022-12-28	WOS:000245950400054
J	Schaefer, CB; Ooi, SKT; Bestor, TH; Bourc'his, D				Schaefer, Christopher B.; Ooi, Steen K. T.; Bestor, Timothy H.; Bourc'his, Deborah			Epigenetic decisions in mammalian germ cells	SCIENCE			English	Review							DNA METHYLATION; RNA INTERFERENCE; DNMT3L; METHYLTRANSFERASE; MUTATION	Specific sequences are designated for de novo DNA methylation at CpG dinucleotides in mammalian germ cells. The result is the long-term transcriptional silencing of the methylated sequences, most of which are retrotransposons and CpG-rich sequences associated with imprinted genes. There is profound sexual dimorphism in both the nature of the sequences that undergo de novo methylation in germ cells and in the mechanism by which de novo methylation is regulated. The restriction of future gene expression by the imposition of heritable methylation patterns in germ cell genomes is characteristic of mammals but is rare in other taxa.	Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Univ Paris 07, INSERM, U741, F-75251 Paris 05, France	Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bourc'his, D (corresponding author), Tour 43-44,2 Etage 2 Pl Jussieu, F-75251 Paris 05, France.	bourchis@ijm.jussieu.fr		Bourc'his, Deborah/0000-0001-9499-7291; Ooi, Steen/0000-0003-4198-9014				Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Bourc'his D, 2006, CYTOGENET GENOME RES, V113, P36, DOI 10.1159/000090813; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Freitag M, 2004, SCIENCE, V304, P1939, DOI 10.1126/science.1099709; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gonzalgo ML, 1997, MUTAT RES-REV MUTAT, V386, P107, DOI 10.1016/S1383-5742(96)00047-6; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Mertineit C, 1998, DEVELOPMENT, V125, P889; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Shovlin TC, 2007, HUM REPROD, V22, P457, DOI 10.1093/humrep/del379; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stein P, 2005, DEV BIOL, V286, P464, DOI 10.1016/j.ydbio.2005.08.015; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Trasler JM, 2006, REPROD FERT DEVELOP, V18, P63, DOI 10.1071/RD05118; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	21	131	136	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					398	399		10.1126/science.1137544	http://dx.doi.org/10.1126/science.1137544			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446388				2022-12-28	WOS:000245813400039
J	Almeida, AM; Murakami, Y; Baker, A; Maeda, Y; Roberts, IAG; Kinoshita, T; Layton, DM; Karadimitris, A				Almeida, Antonio M.; Murakami, Yoshiko; Baker, Alastair; Maeda, Yusuke; Roberts, Irene A. G.; Kinoshita, Taroh; Layton, D. Mark; Karadimitris, Anastasios			Brief report: Targeted therapy for inherited GPI deficiency.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; HISTONE DEACETYLASE INHIBITORS; TRANSCRIPTION FACTORS; PROMOTER ACTIVITY; SP1; CELLS; GLYCOSYLPHOSPHATIDYLINOSITOL; PNH	Disrupted binding of the transcription factor Sp1 to the mutated promoter region of the mannosyl transferase-encoding gene PIGM causes inherited glycosylphosphatidylinositol (GPI) deficiency characterized by splanchnic vein thrombosis and epilepsy. We show that this results in histone hypoacetylation at the promoter of PIGM. The histone deacetylase inhibitor butyrate increases PIGM transcription and surface GPI expression in vitro as well as in vivo through enhanced histone acetylation in an Sp1-dependent manner. More important, the drug caused complete cessation of intractable seizures in a child with inherited GPI deficiency.	Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Haematol, London W12 0NN, England; Kings Coll Hosp London, Paediat Liver Ctr, London, England; Osaka Univ, Dept Immunoregulat, Res Inst Microbial Dis, Osaka, Japan; Core Res Evolut Sci & Technol, Saitama, Japan; Japan Sci & Technol Agcy, Saitama, Japan	Imperial College London; King's College Hospital NHS Foundation Trust; King's College Hospital; Osaka University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Karadimitris, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Haematol, Du Cane Rd, London W12 0NN, England.	a.karadimitris@imperial.ac.uk	KARADIMITRIS, ANASTASIOS/B-4353-2009; Kinoshita, Taroh/C-7353-2009	Almeida, Antonio/0000-0003-4361-0928; Karadimitris, Anastasios/0000-0002-9566-9780				Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; BESSLER M, 1994, EMBO J, V13, P110, DOI 10.1002/j.1460-2075.1994.tb06240.x; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; HILLMEN P, 1995, NEW ENGL J MED, V333, P1253, DOI 10.1056/NEJM199511093331904; Huang WQ, 2005, J BIOL CHEM, V280, P10047, DOI 10.1074/jbc.M408680200; Hugel B, 1999, BLOOD, V93, P3451, DOI 10.1182/blood.V93.10.3451.410k27_3451_3456; Jang SI, 2002, J BIOL CHEM, V277, P42268, DOI 10.1074/jbc.M205593200; Karadimitris A, 2000, BRIT J HAEMATOL, V111, P1158, DOI 10.1046/j.1365-2141.2000.02494.x; Kinoshita T, 1997, J BIOCHEM-TOKYO, V122, P251; Koutsodontis G, 2004, ONCOGENE, V23, P9190, DOI 10.1038/sj.onc.1208141; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Madore N, 1999, EMBO J, V18, P6917, DOI 10.1093/emboj/18.24.6917; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Murakami Y, 1999, BLOOD, V94, P2963, DOI 10.1182/blood.V94.9.2963.421k18_2963_2970; Parker C, 2005, BLOOD, V106, P3699, DOI 10.1182/blood-2005-04-1717; ROSSE WF, 1995, BLOOD, V86, P3277, DOI 10.1182/blood.V86.9.3277.bloodjournal8693277; Ryu H, 2003, P NATL ACAD SCI USA, V100, P6890, DOI 10.1073/pnas.1231735100; Ryu H, 2003, P NATL ACAD SCI USA, V100, P4281, DOI 10.1073/pnas.0737363100; Steiner E, 2004, BIOCHEM BIOPH RES CO, V317, P235, DOI 10.1016/j.bbrc.2004.03.029; Sun JM, 2002, J BIOL CHEM, V277, P35783, DOI 10.1074/jbc.C200378200	23	66	67	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2007	356	16					1641	1647		10.1056/NEJMoa063369	http://dx.doi.org/10.1056/NEJMoa063369			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AB	17442906	Bronze			2022-12-28	WOS:000245762000006
J	Stegmeier, F; Rape, M; Draviam, VM; Nalepa, G; Sowa, ME; Ang, XLL; McDonald, ER; Li, MZ; Hannon, GJ; Sorger, PK; Kirschner, MW; Harper, JW; Elledge, SJ				Stegmeier, Frank; Rape, Michael; Draviam, Viji M.; Nalepa, Grzegorz; Sowa, Mathew E.; Ang, Xiaolu L.; McDonald, E. Robert, III; Li, Mamie Z.; Hannon, Gregory J.; Sorger, Peter K.; Kirschner, Marc W.; Harper, J. Wade; Elledge, Stephen J.			Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities	NATURE			English	Article							SPINDLE CHECKPOINT; MITOTIC CHECKPOINT; PROMOTING COMPLEX/CYCLOSOME; CYCLIN-A; MITOSIS; BISTABILITY; ANEUPLOIDY; P31(COMET); PROTEIN; CANCER	The spindle checkpoint prevents chromosome mis-segregation by delaying sister chromatid separation until all chromosomes have achieved bipolar attachment to the mitotic spindle. Its operation is essential for accurate chromosome segregation, whereas its dysregulation can contribute to birth defects and tumorigenesis. The target of the spindle checkpoint is the anaphase-promoting complex (APC), a ubiquitin ligase that promotes sister chromatid separation and progression to anaphase. Using a short hairpin RNA screen targeting components of the ubiquitin-proteasome pathway in human cells, we identified the deubiquitinating enzyme USP44 (ubiquitin-specific protease 44) as a critical regulator of the spindle checkpoint. USP44 is not required for the initial recognition of unattached kinetochores and the subsequent recruitment of checkpoint components. Instead, it prevents the premature activation of the APC by stabilizing the APC-inhibitory Mad2 - Cdc20 complex. USP44 deubiquitinates the APC coactivator Cdc20 both in vitro and in vivo, and thereby directly counteracts the APC-driven disassembly of Mad2 - Cdc20 complexes ( discussed in an accompanying paper). Our findings suggest that a dynamic balance of ubiquitination by the APC and deubiquitination by USP44 contributes to the generation of the switch-like transition controlling anaphase entry, analogous to the way that phosphorylation and dephosphorylation of Cdk1 by Wee1 and Cdc25 controls entry into mitosis.	Harvard Univ, Harvard Partners Ctr Genet & Genom, Howard Hughes Med Inst, Dept Genet,Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Cold Spring Harbor Laboratory	Elledge, SJ (corresponding author), Harvard Univ, Harvard Partners Ctr Genet & Genom, Howard Hughes Med Inst, Dept Genet,Sch Med, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	marc@hms.harvard.edu; wade_harper@hms.harvard.edu; selledge@genetics.med.harvard.edu	Hannon, Gregory/AAB-3568-2019; Cambronne, Xiaolu Ang/GRY-7149-2022; 高, 雨莉/HGU-8187-2022	Cambronne, Xiaolu Ang/0000-0002-3547-448X; Harper, Jeffrey/0000-0002-6944-7236; Sorger, Peter/0000-0002-3364-1838; Nalepa, Grzegorz/0000-0002-5779-9103; Lab, Nalepa/0000-0002-7560-1906; Draviam, Viji/0000-0001-8295-3689; Rape, Michael/0000-0003-4849-6343	NIA NIH HHS [R01 AG011085] Funding Source: Medline; NINDS NIH HHS [F31 NS054507-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Draviam VM, 2004, CURR OPIN GENET DEV, V14, P120, DOI 10.1016/j.gde.2004.02.007; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322	25	293	303	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2007	446	7138					876	881		10.1038/nature05694	http://dx.doi.org/10.1038/nature05694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17443180				2022-12-28	WOS:000245785700034
J	Lucht, RP				Lucht, Robert P.			Femtosecond lasers for molecular measurements	SCIENCE			English	Editorial Material							STOKES-RAMAN-SCATTERING; MICROSCOPY; PULSE		Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Lucht, RP (corresponding author), Purdue Univ, Sch Mech Engn, 585 Purdue Mall, W Lafayette, IN 47907 USA.	lucht@purdue.edu						Cheng JX, 2004, J PHYS CHEM B, V108, P827, DOI 10.1021/jp035693v; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Eckbreth A.C., 1996, LASER DIAGNOSTICS CO, V2nd; Hayden CC, 1995, J CHEM PHYS, V103, P10465, DOI 10.1063/1.469896; Jain M, 1996, PHYS REV LETT, V77, P4326, DOI 10.1103/PhysRevLett.77.4326; Knopp G, 2002, J RAMAN SPECTROSC, V33, P861, DOI 10.1002/jrs.949; Knutsen KP, 2004, CHEM PHYS LETT, V387, P436, DOI 10.1016/j.cplett.2004.02.049; Lang T, 2002, J OPT SOC AM B, V19, P340, DOI 10.1364/JOSAB.19.000340; Lang T, 2001, J CHEM PHYS, V115, P5418, DOI 10.1063/1.1397325; Lucht RP, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2410237; Meshulach D, 1998, NATURE, V396, P239, DOI 10.1038/24329; Pestov D, 2007, SCIENCE, V316, P265, DOI 10.1126/science.1139055; Roy S, 2002, J CHEM PHYS, V116, P571, DOI 10.1063/1.1423949	13	17	17	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					207	208		10.1126/science.1141973	http://dx.doi.org/10.1126/science.1141973			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431158				2022-12-28	WOS:000245654500028
J	Engel, GS; Calhoun, TR; Read, EL; Ahn, TK; Mancal, T; Cheng, YC; Blankenship, RE; Fleming, GR				Engel, Gregory S.; Calhoun, Tessa R.; Read, Elizabeth L.; Ahn, Tae-Kyu; Mancal, Tomas; Cheng, Yuan-Chung; Blankenship, Robert E.; Fleming, Graham R.			Evidence for wavelike energy transfer through quantum coherence in photosynthetic systems	NATURE			English	Article							2-DIMENSIONAL FEMTOSECOND SPECTROSCOPY; BACTERIOCHLOROPHYLL PROTEIN; ELECTRONIC SPECTROSCOPY; CHLOROBIUM-TEPIDUM; ANTENNA COMPLEXES; DYNAMICS; ECHOES; MODEL	Photosynthetic complexes are exquisitely tuned to capture solar light efficiently, and then transmit the excitation energy to reaction centres, where long term energy storage is initiated. The energy transfer mechanism is often described by semiclassical models that invoke 'hopping' of excited-state populations along discrete energy levels(1,2). Two-dimensional Fourier transform electronic spectroscopy(3-5) has mapped(6) these energy levels and their coupling in the Fenna - Matthews - Olson (FMO) bacteriochlorophyll complex, which is found in green sulphur bacteria and acts as an energy 'wire' connecting a large peripheral light-harvesting antenna, the chlorosome, to the reaction centre(7-9). The spectroscopic data clearly document the dependence of the dominant energy transport pathways on the spatial properties of the excited-state wavefunctions of the whole bacteriochlorophyll complex(6,10). But the intricate dynamics of quantum coherence, which has no classical analogue, was largely neglected in the analyses - even though electronic energy transfer involving oscillatory populations of donors and acceptors was first discussed more than 70 years ago(11), and electronic quantum beats arising from quantum coherence in photosynthetic complexes have been predicted(12,13) and indirectly observed(14). Here we extend previous two-dimensional electronic spectroscopy investigations of the FMO bacteriochlorophyll complex, and obtain direct evidence for remarkably long-lived electronic quantum coherence playing an important part in energy transfer processes within this system. The quantum coherence manifests itself in characteristic, directly observable quantum beating signals among the excitons within the Chlorobium tepidum FMO complex at 77 K. This wavelike characteristic of the energy transfer within the photosynthetic complex can explain its extreme efficiency, in that it allows the complexes to sample vast areas of phase space to find the most efficient path.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Washington Univ, Dept Chem, St Louis, MO 63130 USA; Washington Univ, Dept Biol, St Louis, MO 63130 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Washington University (WUSTL); Washington University (WUSTL)	Fleming, GR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	grfleming@lbl.gov	Calhoun, Tessa/AHI-1645-2022; Ahn, Tae Kyu/A-5838-2013; Engel, Gregory/C-1108-2012; Cheng, Yuan-Chung/A-6566-2008; Mančal, Tomáš/B-9688-2014	Calhoun, Tessa/0000-0002-4952-0010; Ahn, Tae Kyu/0000-0002-7474-6513; Engel, Gregory/0000-0002-6740-5243; Cheng, Yuan-Chung/0000-0003-0125-4267; Mančal, Tomáš/0000-0003-1736-3054; Read, Elizabeth/0000-0002-9186-284X				Abramavicius D, 2004, PHYS CHEM CHEM PHYS, V6, P3097, DOI 10.1039/b315252a; [Anonymous], 2002, PHOTOSYNTHETICA; [Anonymous], 1932, ANN PHYS; Brixner T, 2005, NATURE, V434, P625, DOI 10.1038/nature03429; Brixner T, 2004, J CHEM PHYS, V121, P4221, DOI 10.1063/1.1776112; Brixner T, 2004, OPT LETT, V29, P884, DOI 10.1364/OL.29.000884; Camara-Artigas A, 2003, PHOTOSYNTH RES, V75, P49, DOI 10.1023/A:1022406703110; Cho MH, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1955444; Cho MH, 2005, J PHYS CHEM B, V109, P10542, DOI 10.1021/jp050788d; Cowan ML, 2004, CHEM PHYS LETT, V386, P184, DOI 10.1016/j.cplett.2004.01.027; DREYER J, 2003, B KOR CHEM SOC, V24, P1091; FENNA RE, 1975, NATURE, V258, P573, DOI 10.1038/258573a0; Frigo M, 2005, P IEEE, V93, P216, DOI 10.1109/JPROC.2004.840301; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; Hochstrasser RM, 2001, CHEM PHYS, V266, P273, DOI 10.1016/S0301-0104(01)00232-4; JANG SJ, 2004, PHYS REV LETT, V92, P9312; Jonas DM, 2003, ANNU REV PHYS CHEM, V54, P425, DOI 10.1146/annurev.physchem.54.011002.103907; JOO T, 1995, OPT LETT, V20, P389, DOI 10.1364/OL.20.000389; Kempe J, 2003, CONTEMP PHYS, V44, P307, DOI 10.1080/00107151031000110776; Knox RS, 1996, PHOTOSYNTH RES, V48, P35, DOI 10.1007/BF00040993; Leegwater JA, 1996, J PHYS CHEM-US, V100, P14403, DOI 10.1021/jp961448i; Lepetit L, 1995, J OPT SOC AM B, V12, P2467, DOI 10.1364/JOSAB.12.002467; Li YF, 1997, J MOL BIOL, V271, P456, DOI 10.1006/jmbi.1997.1189; Novoderezhkin V, 2003, J PHYS CHEM B, V107, P11534, DOI 10.1021/jp035432l; Pisliakov AV, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2200705; Renger T, 2001, PHYS REP, V343, P138, DOI 10.1016/S0370-1573(00)00078-8; Savikhin S, 1997, CHEM PHYS, V223, P303, DOI 10.1016/S0301-0104(97)00223-1; van Amerongen H., 2000, PHOTOSYNTHETIC EXCIT; Vulto SIE, 1999, J PHYS CHEM B, V103, P8153, DOI 10.1021/jp984702a; [No title captured]	30	2328	2354	16	747	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2007	446	7137					782	786		10.1038/nature05678	http://dx.doi.org/10.1038/nature05678			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429397	Green Submitted			2022-12-28	WOS:000245626800037
J	Thulasiram, HV; Erickson, HK; Poulter, CD				Thulasiram, Hirekodathakallu V.; Erickson, Hans K.; Poulter, C. Dale			Chimeras of two isoprenoid synthases catalyze all four coupling reactions in isoprenoid biosynthesis	SCIENCE			English	Article							FARNESYL DIPHOSPHATE SYNTHASE; ABSOLUTE-CONFIGURATION; RECOMBINANT SQUALENE; CRYSTAL-STRUCTURE; SEX-PHEROMONE; PRESQUALENE; MONOTERPENES; MECHANISM; MEALYBUG; GENE	The carbon skeletons of over 55,000 naturally occurring isoprenoid compounds are constructed from four fundamental coupling reactions: chain elongation, cyclopropanation, branching, and cyclobutanation. Enzymes that catalyze chain elongation and cyclopropanation are well studied, whereas those that catalyze branching and cyclobutanation are unknown. We have catalyzed the four reactions with chimeric proteins generated by replacing segments of a chain-elongation enzyme with corresponding sequences from a cyclopropanation enzyme. Stereochemical and mechanistic considerations suggest that the four coupling enzymes could have evolved from a common ancestor through relatively small changes in the catalytic site.	Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Thulasiram, HV (corresponding author), Univ Utah, Dept Chem, 315 S 1400 E,Room 2020, Salt Lake City, UT 84112 USA.	poulter@chemistry.utah.edu			NIGMS NIH HHS [GM 21328] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM021328, R37GM021328, R01GM021328] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEXANDER K, 1975, J ORG CHEM, V40, P2576, DOI 10.1021/jo00905a053; ALTMAN LF, 1972, J AM CHEM SOC, V94, P3257, DOI 10.1021/ja00764a073; ALTMAN LJ, 1978, J AM CHEM SOC, V100, P6174, DOI 10.1021/ja00487a037; BIERLLEONHARDT BA, 1981, TETRAHEDRON LETT, V22, P389, DOI 10.1016/0040-4039(81)80107-4; Blagg BSJ, 2002, J AM CHEM SOC, V124, P8846, DOI 10.1021/ja020411a; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; DOLENCE JM, 1999, COMPREHENSIVE NATURA, V5, P18473; Erickson HK, 2003, J AM CHEM SOC, V125, P6886, DOI 10.1021/ja034520g; Giner JL, 2000, J NAT PROD, V63, P267, DOI 10.1021/np990081g; Gunawardena K, 2002, PHYTOCHEMISTRY, V59, P197, DOI 10.1016/S0031-9422(01)00438-1; HEATHCOCK CH, 1985, SCIENCE, V229, P862, DOI 10.1126/science.3927485; Hemmerlin A, 2003, J BIOL CHEM, V278, P32132, DOI 10.1074/jbc.M213045200; Iwata-Reuyl D, 2003, BIOCHEMISTRY-US, V42, P3359, DOI 10.1021/bi0206614; Jarstfer MB, 2002, J AM CHEM SOC, V124, P8834, DOI 10.1021/ja020410i; Pandit J, 2000, J BIOL CHEM, V275, P30610, DOI 10.1074/jbc.M004132200; POPJAK G, 1973, J AM CHEM SOC, V95, P2713, DOI 10.1021/ja00789a066; Poulter C. Dale, 2006, Phytochemistry Reviews, V5, P17, DOI 10.1007/s11101-005-4887-1; RILLING HC, 1969, J AM CHEM SOC, V91, P1041, DOI 10.1021/ja01032a052; Rivera SB, 2001, P NATL ACAD SCI USA, V98, P4373, DOI 10.1073/pnas.071543598; SOUCEK M, 1959, COLLECT CZECH CHEM C, V24, P3802; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; Thulasiram HV, 2006, J AM CHEM SOC, V128, P15819, DOI 10.1021/ja065573b; Zhang AJ, 2004, P NATL ACAD SCI USA, V101, P9601, DOI 10.1073/pnas.0401298101	23	134	141	3	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2007	316	5821					73	76		10.1126/science.1137786	http://dx.doi.org/10.1126/science.1137786			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	153XD	17412950				2022-12-28	WOS:000245470500033
J	Zhou, Y; Atkins, JB; Rompani, SB; Bancescu, DL; Petersen, PH; Tang, HY; Zou, KY; Stewart, SB; Zhong, WM				Zhou, Yan; Atkins, Joshua B.; Rompani, Santiago B.; Bancescu, Daria L.; Petersen, Petur H.; Tang, Haiyan; Zou, Kaiyong; Stewart, Sinead B.; Zhong, Weimin			The mammalian golgi regulates numb signaling in asymmetric cell division by releasing ACBD3 during mitosis	CELL			English	Article							PROGENITOR CELLS; MOUSE NUMB; STEM-CELLS; PROTEIN; ORIENTATION; MEMBRANE; DOMAIN; FATES; IDENTIFICATION; FRAGMENTATION	Mammalian neural progenitor cells divide asymmetrically to self-renew and produce a neuron by segregating cytosolic Numb proteins primarily to one daughter cell. Numb signaling specifies progenitor over neuronal fates but, paradoxically, also promotes neuronal differentiation. Here we report that ACBD3 is a Numb partner in cell-fate specification. ACBD3 and Numb proteins interact through an essential Numb domain, and the respective loss- and gain-of-function mutant mice share phenotypic similarities. Interestingly, ACBD3 associates with the Golgi apparatus in neurons and interphase progenitor cells but becomes cytosolic after Golgi fragmentation during mitosis, when Numb activity is needed to distinguish the two daughter cells. Accordingly, cytosolic ACBD3 can act synergistically with Numb to specify cell fates, and its continuing presence during the progenitor cell cycle inhibits neuron production. We propose that Golgi fragmentation and reconstitution during cell cycle differentially regulate Numb signaling through changes in ACBD3 subcellular distribution and represent a mechanism for coupling cell-fate specification and cell-cycle progression.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Interdept Neurosci Program, New Haven, CT 06520 USA	Yale University; Yale University	Zhong, WM (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	weimin.zhong@yale.edu	Zhou, Yan/AAM-3591-2021; , PeturHenry/H-1506-2011	Zhou, Yan/0000-0002-2713-4442; Rompani, Santiago/0000-0002-3994-3052	NINDS NIH HHS [R01 NS042048] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altan-Bonnet N, 2004, CURR OPIN CELL BIOL, V16, P364, DOI 10.1016/j.ceb.2004.06.011; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BANG AG, 1991, DEVELOPMENT, V111, P89; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Cayouette M, 2003, DEVELOPMENT, V130, P2329, DOI 10.1242/dev.00446; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Colanzi A, 2003, CURR OPIN CELL BIOL, V15, P462, DOI 10.1016/S0955-0674(03)00067-X; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gho M, 1999, DEVELOPMENT, V126, P3573; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Huang EJ, 2005, GENE DEV, V19, P138, DOI 10.1101/gad.1246005; Knoblich JA, 1997, P NATL ACAD SCI USA, V94, P13005, DOI 10.1073/pnas.94.24.13005; Li H, 2001, MOL ENDOCRINOL, V15, P2211, DOI 10.1210/me.15.12.2211; Li SC, 1998, NAT STRUCT BIOL, V5, P1075, DOI 10.1038/4185; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Petersen PH, 2006, DEV NEUROSCI-BASEL, V28, P156, DOI 10.1159/000090761; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Prokopenko SN, 2005, SEMIN CELL DEV BIOL, V16, P423, DOI 10.1016/j.semcdb.2005.02.005; Qian XM, 1998, DEVELOPMENT, V125, P3143; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Shen Q, 2002, DEVELOPMENT, V129, P4843; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; Sohda M, 2001, J BIOL CHEM, V276, P45298, DOI 10.1074/jbc.M108961200; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Stanley H, 1997, P NATL ACAD SCI USA, V94, P14467, DOI 10.1073/pnas.94.26.14467; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Tang HY, 2005, MOL CELL BIOL, V25, P2899, DOI 10.1128/MCB.25.8.2899-2909.2005; Yaich L, 1998, J BIOL CHEM, V273, P10381, DOI 10.1074/jbc.273.17.10381; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; Zhong WM, 2000, P NATL ACAD SCI USA, V97, P6844, DOI 10.1073/pnas.97.12.6844; Zhong WM, 2003, NEURON, V37, P11, DOI 10.1016/S0896-6273(02)01178-9	39	89	97	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2007	129	1					163	178		10.1016/j.cell.2007.02.037	http://dx.doi.org/10.1016/j.cell.2007.02.037			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418793	Bronze			2022-12-28	WOS:000245661100019
J	Raghavan, R				Raghavan, Ramesh			A question of faith	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2007	297	13					1412	1412		10.1001/jama.297.13.1412	http://dx.doi.org/10.1001/jama.297.13.1412			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AM	17405957				2022-12-28	WOS:000245404100001
J	Buffett, BA				Buffett, Bruce A.			Geophysics - Taking Earth's temperature	SCIENCE			English	Editorial Material							POST-PEROVSKITE PHASE; MANTLE; INVERSION; MGSIO3; DISCONTINUITIES; TRANSITION; CONVECTION; BOUNDARY; PLATE		Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of Chicago	Buffett, BA (corresponding author), Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA.	buffett@geosci.uchicago.edu						BEYLKIN G, 1985, J MATH PHYS, V26, P99, DOI 10.1063/1.526755; Boehler R, 2000, REV GEOPHYS, V38, P221, DOI 10.1029/1998RG000053; Bostock MG, 2001, J GEOPHYS RES-SOL EA, V106, P30771, DOI 10.1029/2001JB000330; Hernlund JW, 2005, NATURE, V434, P882, DOI 10.1038/nature03472; Hirose K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024468; Lay T, 2006, SCIENCE, V314, P1272, DOI 10.1126/science.1133280; Mitrovica JX, 2004, EARTH PLANET SC LETT, V225, P177, DOI 10.1016/j.epsl.2004.06.005; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Oganov AR, 2004, NATURE, V430, P445, DOI 10.1038/nature02701; Ono S, 2005, EARTH PLANET SC LETT, V236, P914, DOI 10.1016/j.epsl.2005.06.001; SHEARER PM, 1991, J GEOPHYS RES-SOL EA, V96, P18147, DOI 10.1029/91JB01592; Tackley PJ, 2000, SCIENCE, V288, P2002, DOI 10.1126/science.288.5473.2002; Thomas C, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003013; Tsuchiya T, 2004, EARTH PLANET SC LETT, V224, P241, DOI 10.1016/j.epsl.2004.05.017; van der Hilst RD, 2007, SCIENCE, V315, P1813, DOI 10.1126/science.1137867; Wookey J, 2005, NATURE, V438, P1004, DOI 10.1038/nature04345	16	3	3	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1801	1802		10.1126/science.1140470	http://dx.doi.org/10.1126/science.1140470			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395817				2022-12-28	WOS:000245280100028
J	Rajagopalan, J; Han, JH; Saif, MTA				Rajagopalan, Jagannathan; Han, Jong H.; Saif, M. Taher A.			Plastic deformation recovery in freestanding nanocrystalline aluminum and gold thin films	SCIENCE			English	Article							TRANSMISSION ELECTRON-MICROSCOPE; MOLECULAR-DYNAMICS SIMULATION; DIFFUSION WEDGES; METAL-FILMS; COPPER; MECHANISMS; STRENGTH; BEHAVIOR; NICKEL	In nanocrystalline metals, lack of intragranular dislocation sources leads to plastic deformation mechanisms that substantially differ from those in coarse-grained metals. However, irrespective of grain size, plastic deformation is considered irrecoverable. We show experimentally that plastically deformed nanocrystalline aluminum and gold films with grain sizes of 65 nanometers and 50 nanometers, respectively, recovered a substantial fraction (50 to 100%) of plastic strain after unloading. This recovery was time dependent and was expedited at higher temperatures. Furthermore, the stress-strain characteristics during the next loading remained almost unchanged when strain recovery was complete. These observations in two dissimilar face-centered cubic metals suggest that strain recovery might be characteristic of other metals with similar grain sizes and crystalline packing.	Univ Illinois, Dept Engn Sci & Mech, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Saif, MTA (corresponding author), Univ Illinois, Dept Engn Sci & Mech, Urbana, IL 61801 USA.	saif@uiuc.edu		Rajagopalan, Jagannathan/0000-0002-0146-0805				Arzt E, 1998, ACTA MATER, V46, P5611, DOI 10.1016/S1359-6454(98)00231-6; Baker SP, 2001, MAT SCI ENG A-STRUCT, V319, P16, DOI 10.1016/S0921-5093(00)02004-9; Brandstetter S, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2138359; Brandstetter S, 2006, ADV MATER, V18, P1545, DOI 10.1002/adma.200600397; Budrovic Z, 2004, SCIENCE, V304, P273, DOI 10.1126/science.1095071; Buehler MJ, 2003, J MECH PHYS SOLIDS, V51, P2105, DOI 10.1016/j.jmps.2003.09.024; Conrad H, 2002, APPL PHYS LETT, V81, P2241, DOI 10.1063/1.1507353; Cottrell A. H., 1953, DISLOCATIONS PLASTIC; Gao H, 1999, ACTA MATER, V47, P2865, DOI 10.1016/S1359-6454(99)00178-0; Gianola DS, 2006, ACTA MATER, V54, P2253, DOI 10.1016/j.actamat.2006.01.023; Han JH, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2188368; Haque MA, 2005, J MATER RES, V20, P1769, DOI 10.1557/JMR.2005.0220; Haque MA, 2004, P NATL ACAD SCI USA, V101, P6335, DOI 10.1073/pnas.0400066101; Haque MA, 2003, ACTA MATER, V51, P3053, DOI 10.1016/S1359-6454(03)00116-2; Haque MA, 2002, SENSOR ACTUAT A-PHYS, V97-8, P239, DOI 10.1016/S0924-4247(01)00861-5; Haque MA, 2002, SCRIPTA MATER, V47, P863, DOI 10.1016/S1359-6462(02)00306-8; Hartmaier A, 2005, MAT SCI ENG A-STRUCT, V400, P260, DOI 10.1016/j.msea.2005.03.069; Kumar KS, 2003, ACTA MATER, V51, P387, DOI 10.1016/S1359-6454(02)00421-4; Legros M, 2000, PHILOS MAG A, V80, P1017, DOI 10.1080/01418610008212096; Schiotz J, 2003, SCIENCE, V301, P1357, DOI 10.1126/science.1086636; Schiotz J, 1998, NATURE, V391, P561, DOI 10.1038/35328; Van Petegem S, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2336726; Van Swygenhoven H, 2006, ACTA MATER, V54, P1975, DOI 10.1016/j.actamat.2005.12.026; Van Swygenhoven H, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.024101; Van Vliet KJ, 2003, APPL PHYS LETT, V83, P1441, DOI 10.1063/1.1597417; Wang YM, 2006, ACTA MATER, V54, P2715, DOI 10.1016/j.actamat.2006.02.013; Wang YM, 2003, SCRIPTA MATER, V48, P1581, DOI 10.1016/S1359-6462(03)00159-3; Weertman J.R., 2002, NANOSTRUCTURED MAT P; Weiss D, 2001, ACTA MATER, V49, P2395, DOI 10.1016/S1359-6454(01)00168-9; Yamakov V, 2004, NAT MATER, V3, P43, DOI 10.1038/nmat1035; Yamakov V, 2002, NAT MATER, V1, P45, DOI 10.1038/nmat700	31	136	137	2	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2007	315	5820					1831	1834		10.1126/science.1137580	http://dx.doi.org/10.1126/science.1137580			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395826				2022-12-28	WOS:000245280100039
J	Vasudevan, S; Steitz, JA				Vasudevan, Shobha; Steitz, Joan A.			AU-rich-element-mediated upregulation of translation by FXR1 and argonaute 2	CELL			English	Article							TUMOR-NECROSIS-FACTOR; MESSENGER-RNA DEGRADATION; MICRORNA-DEPENDENT LOCALIZATION; MENTAL-RETARDATION PROTEIN; X-RELATED PROTEIN; FACTOR-ALPHA; CELL-CYCLE; GW BODIES; BINDING PROTEINS; EXPRESSION	AU-rich elements (AREs), present in mRNA 3'-UTRs, are potent posttranscriptional regulatory signals that can rapidly effect changes in mRNA stability and translation, thereby dramatically altering gene expression with clinical and developmental consequences. In human cell lines, the TNF alpha ARE enhances translation relative to mRNA levels upon serum starvation, which induces cell-cycle arrest. An in vivo crosslinking-coupled affinity purification method was developed to isolate ARE-associated complexes from activated versus basal translation conditions. We surprisingly found two microRNP-related proteins, fragile-X-mental-retardation-related protein 1 (FXR1) and Argonaute 2 (AGO2), that associate with the ARE exclusively during translation activation. Through tethering and shRNA-knockdown experiments, we provide direct evidence for the translation activation function of both FXR1 and AGO2 and demonstrate their interdependence for upregulation. This novel cell-growth-dependent translation activation role for FXR1 and AGO2 allows new insights into ARE-mediated signaling and connects two important posttranscriptional regulatory systems in an unexpected way.	Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biophys & Biochem,BCMM, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University	Steitz, JA (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biophys & Biochem,BCMM, 295 Congress Ave, New Haven, CT 06536 USA.	joan.steitz@yale.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026154, R01GM026154] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM026154, GM26154] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson K, 2000, CYTOKINE, V12, P1784, DOI 10.1006/cyto.2000.0784; Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Bakheet T, 2001, NUCLEIC ACIDS RES, V29, P246, DOI 10.1093/nar/29.1.246; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Baron-Benhamou Julie, 2004, Methods Mol Biol, V257, P135, DOI 10.1385/1-59259-750-5:135; Barreau C, 2006, RNA, V12, P1790, DOI 10.1261/rna.191706; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Boonstra J, 2003, J CELL BIOCHEM, V90, P244, DOI 10.1002/jcb.10617; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brewer G, 2002, AGEING RES REV, V1, P607, DOI 10.1016/S1568-1637(02)00023-5; Brooks SA, 2004, J IMMUNOL, V172, P7263, DOI 10.4049/jimmunol.172.12.7263; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Dube M, 2000, BMC Genet, V1, P4, DOI 10.1186/1471-2156-1-4; Espel E, 2005, SEMIN CELL DEV BIOL, V16, P59, DOI 10.1016/j.semcdb.2004.11.008; Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203; Garnon J, 2005, J BIOL CHEM, V280, P5750, DOI 10.1074/jbc.M401988200; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; HASKILL S, 1988, J IMMUNOL, V140, P1690; Hofmann I, 2006, MOL BIOL CELL, V17, P1388, DOI 10.1091/mbc.e05-08-0708; Ikeda K, 2006, J IMMUNOL METHODS, V317, P38, DOI 10.1016/j.jim.2006.09.010; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; JEOUNG DI, 1995, J BIOL CHEM, V270, P18367, DOI 10.1074/jbc.270.31.18367; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kirkpatrick LL, 1999, GENOMICS, V59, P193, DOI 10.1006/geno.1999.5868; Kirkpatrick LL, 2001, GENOMICS, V78, P169, DOI 10.1006/geno.2001.6667; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Lian SL, 2006, CELL CYCLE, V5, P242, DOI 10.4161/cc.5.3.2410; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Mientjes EJ, 2004, HUM MOL GENET, V13, P1291, DOI 10.1093/hmg/ddh150; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Moneo V, 2003, J CELL BIOCHEM, V89, P484, DOI 10.1002/jcb.10529; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Osman F, 1999, GENE DEV, V13, P3280, DOI 10.1101/gad.13.24.3280; Park-Lee S, 2003, J BIOL CHEM, V278, P39801, DOI 10.1074/jbc.M307105200; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Pomorski P, 2004, CELL MOTIL CYTOSKEL, V57, P143, DOI 10.1002/cm.10159; ROY AL, 1988, BIOCHEMISTRY-US, V27, P8203, DOI 10.1021/bi00421a033; Schafer KA, 1998, VET PATHOL, V35, P461, DOI 10.1177/030098589803500601; Sirenko OI, 1997, MOL CELL BIOL, V17, P3898, DOI 10.1128/MCB.17.7.3898; Srisawat C, 2002, METHODS, V26, P156, DOI 10.1016/S1046-2023(02)00018-X; Stoecklin G, 2000, MOL CELL BIOL, V20, P3753, DOI 10.1128/MCB.20.11.3753-3763.2000; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Stoecklin G, 2003, MOL CELL BIOL, V23, P3506, DOI 10.1128/MCB.23.10.3506-3515.2003; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wilhelm JE, 2005, BIOL CELL, V97, P235, DOI 10.1042/BC20040097; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Xu KY, 2004, CURR BIOL, V14, P1025, DOI 10.1016/j.cub.2004.05.055; Yang Z, 2004, J CELL SCI, V117, P5567, DOI 10.1242/jcs.01477; Zou C, 1998, GENE, V211, P187, DOI 10.1016/S0378-1119(98)00107-3	65	463	499	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1105	1118		10.1016/j.cell.2007.01.038	http://dx.doi.org/10.1016/j.cell.2007.01.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382880	Green Accepted, Bronze			2022-12-28	WOS:000245396200017
J	Braun, J; Sieper, J				Braun, Juergen; Sieper, Joachim			Ankylosing spondylitis	LANCET			English	Review							PLACEBO-CONTROLLED TRIAL; TUMOR-NECROSIS-FACTOR; INFLAMMATORY BACK-PAIN; OPEN-LABEL TRIAL; RESONANCE-IMAGING EXAMINATIONS; HLA-B27 POSITIVE INDIVIDUALS; RANDOMIZED CONTROLLED TRIAL; ASAS CONSENSUS STATEMENT; SHORT-TERM TREATMENT; DOUBLE-BLIND	Ankylosing spondylitis is a common inflammatory rheumatic disease that affects the axial skeleton, causing characteristic inflammatory back pain, which can lead to structural and functional impairments and a decrease in quality of life. New imaging techniques and therapies have substantially changed the management of this disease in the past decade. Whether inhibition of radiographic progression and structural damage can be reached with available drugs is as yet unclear. Furthermore, treatment with non-steroidal anti-inflammatory agents and physiotherapy remains an important approach to long-term management of patients with ankylosing spondylitis. The new treatment options with tumour necrosis factor blockers seems a breakthrough for patients refractory to conventional treatment.	Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet, D-44652 Herne, Germany; Charite, Dept Med 1, Berlin, Germany	Rheumazentrum Ruhrgebiet; Ruhr University Bochum; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Braun, J (corresponding author), Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet, D-44652 Herne, Germany.	j.braun@rheumazentrum-ruhrgebiet.de	Braun, Juergen/E-8127-2013	Braun, Juergen/0000-0002-9156-5095				Akkoc N, 2005, ANKYLOSING SPONDYLIT, P117; AMOR B, 1994, J RHEUMATOL, V21, P1883; AMOR B, 1995, REV RHUM, V62, P10; Appel H, 2006, ARTHRITIS RHEUM-US, V54, P2845, DOI 10.1002/art.22060; Appel H, 2006, ARTHRITIS RHEUM-US, V54, P1805, DOI 10.1002/art.21907; Atagunduz P, 2005, ARTHRITIS RHEUM-US, V52, P892, DOI 10.1002/art.20948; AUFDERMAUR M, 1989, ANN RHEUM DIS, V48, P628, DOI 10.1136/ard.48.8.628; Bakland G, 2005, ARTHRIT RHEUM-ARTHR, V53, P850, DOI 10.1002/art.21577; Balint PV, 2002, ANN RHEUM DIS, V61, P905, DOI 10.1136/ard.61.10.905; Baraliakos X, 2007, ANN RHEUM DIS, V66, P910, DOI 10.1136/ard.2006.066415; Baraliakos X, 2005, ARTHRIT RHEUM-ARTHR, V53, P856, DOI 10.1002/art.21588; Baraliakos X, 2005, ANN RHEUM DIS, V64, P1462, DOI 10.1136/ard.2004.033472; Baraliakos X, 2005, ARTHRITIS RES THER, V7, pR439, DOI 10.1186/ar1693; Baraliakos X, 2005, ARTHRITIS RHEUM-US, V52, P1216, DOI 10.1002/art.20977; Baraliakos X, 2005, ANN RHEUM DIS, V64, P1141, DOI 10.1136/ard.2004.031609; Bardos T, 2005, ANN RHEUM DIS, V64, P981, DOI 10.1136/ard.2004.029710; Barthel T, 2002, ACTA ORTHOP SCAND, V73, P611, DOI 10.1080/000164702321039543; Bellow M, 2000, ANN RHEUM DIS, V59, P135, DOI 10.1136/ard.59.2.135; BENNETT PH, 1968, POPULATION STUDIES R, P456; Boonen A, 2006, ANN RHEUM DIS, V65, P201, DOI 10.1136/ard.2004.032565; Brandt J, 2005, RHEUMATOLOGY, V44, P342, DOI 10.1093/rheumatology/keh475; Brandt J, 1999, RHEUMATOLOGY, V38, P831, DOI 10.1093/rheumatology/38.9.831; Brandt J, 2004, J RHEUMATOL, V31, P531; Brandt J, 2002, J RHEUMATOL, V29, P118; Braun J, 2005, ARTHRITIS RHEUM, V52, P2447, DOI 10.1002/art.21197; Braun J, 2002, LANCET, V359, P1187, DOI 10.1016/S0140-6736(02)08215-6; Braun J, 2006, ARTHRITIS RHEUM, V54, P1646, DOI 10.1002/art.21790; Braun J, 2006, ANN RHEUM DIS, V65, P316, DOI 10.1136/ard.2005.040758; Braun J, 2005, ARTHRITIS RHEUM, V52, P4049, DOI 10.1002/art.21609; Braun J, 1997, J RHEUMATOL, V24, P1101; Braun J, 2004, ANN RHEUM DIS, V63, P1046, DOI 10.1136/ard.2003.019968; Braun J, 1998, RHEUM DIS CLIN N AM, V24, P697, DOI 10.1016/S0889-857X(05)70038-7; Braun J, 2005, RHEUMATOLOGY, V44, P670, DOI 10.1093/rheumatology/keh584; Braun J, 2003, ANN RHEUM DIS, V62, P817, DOI 10.1136/ard.62.9.817; Braun J, 2003, ARTHRITIS RHEUM-US, V48, P1126, DOI 10.1002/art.10883; Braun J, 1998, ARTHRITIS RHEUM-US, V41, P58, DOI 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G; BRAUN J, 1995, ARTHRITIS RHEUM, V38, P499, DOI 10.1002/art.1780380407; BRAUN J, 2006, ANN RHEUM DIS; BREWERTON DA, 1973, LANCET, V1, P904; Brown MA, 1997, ARTHRITIS RHEUM, V40, P1823, DOI 10.1002/art.1780401015; BURGOSVARGAS R, 1995, ARTHRITIS RHEUM-US, V38, P835, DOI 10.1002/art.1780380618; Calin A, 2004, ANN RHEUM DIS, V63, P1594, DOI 10.1136/ard.2004.020875; CALIN A, 1977, JAMA-J AM MED ASSOC, V237, P2613, DOI 10.1001/jama.237.24.2613; CARETTE S, 1983, ARTHRITIS RHEUM, V26, P186, DOI 10.1002/art.1780260210; Chen J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004800.pub2; CHEN J, 2004, COCHRANE DB SYST REV, V3; COLLANTESESTEVEZ E, 1995, J RHEUMATOL, V22, P246; COOPER C, 1994, J RHEUMATOL, V21, P1877; Crane AM, 2002, ARTHRITIS RHEUM, V46, P1629, DOI 10.1002/art.10329; Creemers MCW, 2005, ANN RHEUM DIS, V64, P127, DOI 10.1136/ard.2004.020503; Dagfinrud H, 2005, J RHEUMATOL, V32, P1899; Davis JC, 2003, ARTHRITIS RHEUM, V48, P3230, DOI 10.1002/art.11325; DEVOS M, 1989, GASTROENTEROLOGY, V96, P339, DOI 10.1016/0016-5085(89)91557-6; DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218, DOI 10.1002/art.1780341003; Dougados M, 2002, ANN RHEUM DIS, V61, P40; DOUGADOS M, 1995, ARTHRITIS RHEUM, V38, P618, DOI 10.1002/art.1780380507; Einhorn TA, 2003, ARTHRITIS RES THER, V5, P5, DOI 10.1186/ar607; Feldtkeller E, 2003, RHEUMATOL INT, V23, P61, DOI 10.1007/s00296-002-0237-4; Gonzalez-Lopez L, 2004, J RHEUMATOL, V31, P1568; Gran JT, 1997, BRIT J RHEUMATOL, V36, P766; GRANFORS K, 1989, NEW ENGL J MED, V320, P216, DOI 10.1056/NEJM198901263200404; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Guerassimov A, 1998, ARTHRITIS RHEUM, V41, P1019, DOI 10.1002/1529-0131(199806)41:6<1019::AID-ART8>3.0.CO;2-X; Haibel H, 2007, ANN RHEUM DIS, V66, P419, DOI 10.1136/ard.2006.054098; Haibel H, 2006, ARTHRITIS RHEUM-US, V54, P678, DOI 10.1002/art.21563; Haibel H, 2005, ANN RHEUM DIS, V64, P124, DOI 10.1136/ard.2003.019174; Haibel H, 2003, RHEUMATOLOGY, V42, DOI 10.1093/rheumatology/keg256; Haibel H, 2005, ANN RHEUM DIS, V64, P296, DOI 10.1136/ard.2004.023176; Hamersma J, 2001, ARTHRITIS RHEUM, V44, P1396, DOI 10.1002/1529-0131(200106)44:6<1396::AID-ART233>3.0.CO;2-A; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Heiberg MS, 2005, ARTHRITIS RHEUM-US, V52, P2506, DOI 10.1002/art.21209; Hermann KGA, 2005, J RHEUMATOL, V32, P2056; Heuft-Dorenbosch L, 2006, ANN RHEUM DIS, V65, P804, DOI 10.1136/ard.2005.044206; Hoyle E, 2000, ARTHRITIS RHEUM, V43, P1353, DOI 10.1002/1529-0131(200006)43:6<1353::AID-ANR19>3.0.CO;2-B; Huang F, 2002, ARTHRIT RHEUM-ARTHR, V47, P249, DOI 10.1002/art.10396; Kaltwasser JP, 2004, ARTHRITIS RHEUM-US, V50, P1939, DOI 10.1002/art.20253; Karberg K, 2005, J RHEUMATOL, V32, P1290; KEBS W, 1934, ROFO FORTSCHR RONTG, V50, P537; KELLGREN J H, 1962, Bull Rheum Dis, V13, P291; Khan MA, 1996, CLIN RHEUMATOL, V15, P10, DOI 10.1007/BF03342637; Kobelt G, 2004, RHEUMATOLOGY, V43, P1158, DOI 10.1093/rheumatology/keh271; KRAAG G, 1990, J RHEUMATOL, V17, P228; Lautermann D, 2002, CLIN EXP RHEUMATOL, V20, pS11; Laval SH, 2001, AM J HUM GENET, V68, P918, DOI 10.1086/319509; LeirisaloRepo M, 1997, ANN RHEUM DIS, V56, P516, DOI 10.1136/ard.56.9.516; Lories RJU, 2005, J CLIN INVEST, V115, P1571, DOI 10.1172/JCI23738; Maksymowych WP, 2003, ARTHRITIS RHEUM-US, V48, P2011, DOI 10.1002/art.11037; Maksymowych WP, 2002, ARTHRITIS RHEUM, V46, P766, DOI 10.1002/art.10139; Maksymowych WP, 2000, J RHEUMATOL, V27, P2295; Martin TM, 2005, ARTHRITIS RHEUM, V52, P269, DOI 10.1002/art.20777; Martin TM, 2002, CURR OPIN RHEUMATOL, V14, P337, DOI 10.1097/00002281-200207000-00001; Marzo-Ortega H, 2003, ANN RHEUM DIS, V62, P74, DOI 10.1136/ard.62.1.74; MAU W, 1988, J RHEUMATOL, V15, P1109; McGonagle D, 1998, LANCET, V352, P1137, DOI 10.1016/S0140-6736(97)12004-9; McGonagle D, 1998, ARTHRITIS RHEUM, V41, P694, DOI 10.1002/1529-0131(199804)41:4<694::AID-ART17>3.0.CO;2-#; Mease PJ, 2004, ARTHRITIS RHEUM-US, V50, P2264, DOI 10.1002/art.20335; Miceli-Richard C, 2004, HUM MOL GENET, V13, P1641, DOI 10.1093/hmg/ddh179; Onderdonk AB, 1998, INFECT IMMUN, V66, P6022, DOI 10.1128/IAI.66.12.6022-6023.1998; Oostveen J, 1999, J RHEUMATOL, V26, P1953; Poole AR, 1998, AM J MED SCI, V316, P228, DOI 10.1097/00000441-199810000-00002; Porcher R, 2005, ARTHRIT RHEUM-ARTHR, V53, P263, DOI 10.1002/art.21070; PURRMANN J, 1988, J RHEUMATOL, V15, P1658; Radi ZA, 2005, INFLAMM RES, V54, P358, DOI 10.1007/s00011-005-1367-4; Reddi AH, 2003, ANN RHEUM DIS, V62, P73; Ritchlin CT, 2003, J CLIN INVEST, V111, P821, DOI 10.1172/JCI200316069; Rudwaleit M, 2004, ANN RHEUM DIS, V63, P665, DOI 10.1136/ard.2003.016386; Rudwaleit M, 2006, ARTHRITIS RHEUM, V54, P569, DOI 10.1002/art.21619; Rudwaleit M, 2004, ANN RHEUM DIS, V63, P535, DOI 10.1136/ard.2003.011247; Rudwaleit M, 2005, ARTHRITIS RHEUM, V52, P1000, DOI 10.1002/art.20990; Rudwaleit M, 2001, CURR OPIN RHEUMATOL, V13, P250, DOI 10.1097/00002281-200107000-00002; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Said-Nahal R, 2001, ARTHRIT RHEUM-ARTHR, V45, P478, DOI 10.1002/1529-0131(200112)45:6<478::AID-ART372>3.0.CO;2-I; Sandborn WJ, 2001, GASTROENTEROLOGY, V121, P1088, DOI 10.1053/gast.2001.28674; Saraux A, 1999, J RHEUMATOL, V26, P2622; Sieper J, 2005, RHEUMATOLOGY, V44, P1525, DOI 10.1093/rheumatology/kei046; Sieper J, 2005, ANN RHEUM DIS, V64, P659, DOI 10.1136/ard.2004.028753; Sieper J, 2000, ARTHRITIS RHEUM, V43, P720, DOI 10.1002/1529-0131(200004)43:4<720::AID-ANR2>3.0.CO;2-8; Spoorenberg A, 1999, J RHEUMATOL, V26, P980; Stone M, 2005, ARTHRIT RHEUM-ARTHR, V53, P445, DOI 10.1002/art.21174; Tan AL, 2004, ANN RHEUM DIS, V63, P1041, DOI 10.1136/ard.2004.020800; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; Underwood MR, 1995, BRIT J RHEUMATOL, V34, P1074; van Denderen JC, 2005, ANN RHEUM DIS, V64, P1761, DOI 10.1136/ard.2005.036491; van der Heijde D, 2005, ARTHRITIS RHEUM-US, V52, P582, DOI 10.1002/art.20852; Van der Heijde D, 2006, ARTHRIT RHEUM-ARTHR, V55, P569, DOI 10.1002/art.22097; van der Heijde D, 2006, ARTHRITIS RHEUM-US, V54, P2136, DOI 10.1002/art.21913; Van der Heijde DMFM, 2004, ANN RHEUM DIS, V63, P98; van der Linden S, 1998, RHEUM DIS CLIN N AM, V24, P663, DOI 10.1016/S0889-857X(05)70036-3; van Tubergen A, 2003, ANN RHEUM DIS, V62, P519, DOI 10.1136/ard.62.6.519; Van Tubergen A, 2001, ARTHRIT RHEUM-ARTHR, V45, P430, DOI 10.1002/1529-0131(200110)45:5<430::AID-ART362>3.0.CO;2-F; VANDERLINDEN S, 1983, BRIT J RHEUMATOL, V22, P18; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; VANDERLINDEN SM, 1984, ARTHRITIS RHEUM, V27, P241; Vosse D, 2006, ANN RHEUM DIS, V65, P770, DOI 10.1136/ard.2005.044081; Walsh NC, 2005, IMMUNOL REV, V208, P228, DOI 10.1111/j.0105-2896.2005.00338.x; Wanders A, 2005, ARTHRITIS RHEUM-US, V52, P1756, DOI 10.1002/art.21054; Wanders A, 2005, ANN RHEUM DIS, V64, P988, DOI 10.1136/ard.2004.029728; Wanders AJB, 2004, ARTHRITIS RHEUM-US, V50, P2622, DOI 10.1002/art.20446; Ward MM, 2005, ARTHRIT RHEUM-ARTHR, V53, P710, DOI 10.1002/art.21444; Ward MM, 2002, ARTHRIT RHEUM-ARTHR, V47, P234, DOI 10.1002/art.10399; Zhang G, 2004, ARTHRITIS RHEUM-US, V50, P2246, DOI 10.1002/art.20308; Zhang YP, 2003, RHEUM DIS CLIN N AM, V29, P631, DOI 10.1016/S0889-857X(03)00049-8; Zochling J, 2006, ANN RHEUM DIS, V65, P442, DOI 10.1136/ard.2005.041137; Zou J, 2005, ANN RHEUM DIS, V64, P722, DOI 10.1136/ard.2004.024455; Zou J, 2003, RHEUMATOLOGY, V42, P846, DOI 10.1093/rheumatology/keg230	145	1261	1353	5	150	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1379	1390		10.1016/S0140-6736(07)60635-7	http://dx.doi.org/10.1016/S0140-6736(07)60635-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	159HL	17448825				2022-12-28	WOS:000245856100032
J	Cellot, S; Sauvageau, G				Cellot, Sonia; Sauvageau, Guy			Zfx: At the crossroads of survival and self-renewal	CELL			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; BMI-1	As the molecular mechanisms that govern stem cell fate are beginning to be unraveled, Galan-Caridad et al. (2007) report in this issue of Cell a common role for the transcription factor Zfx in the self-renewal/maintenance of both embryonic stem cells and hematopoietic stem cells. Their work suggests that a regulator of self-renewal can be shared between two different cell types.	IRIC, Lab Mol Genet Stem Cells, Montreal, PQ H3C 3J7, Canada; Maisonneuve Rosemont Hosp, Dept Med, Montreal, PQ H3C 3J7, Canada; Maisonneuve Rosemont Hosp, Div Hematol & Leukemia Cell Bank Quebec, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Sauvageau, G (corresponding author), IRIC, Lab Mol Genet Stem Cells, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	guy.sauvageau@umontreal.ca		Sauvageau, Guy/0000-0002-4333-7266				Carlson H, 2002, ONCOGENE, V21, P3827, DOI 10.1038/sj.onc.1205476; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; TANAKA Y, 2007, IN PRESS BLOOD; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003	8	22	25	1	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2007	129	2					239	241		10.1016/j.cell.2007.04.002	http://dx.doi.org/10.1016/j.cell.2007.04.002			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448983	Bronze			2022-12-28	WOS:000246474600009
J	Ross, DB				Ross, David B.			The FDA and the case of Ketek	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TELITHROMYCIN		George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA	George Washington University	Ross, DB (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA.							Clay KD, 2006, ANN INTERN MED, V144, P415, DOI 10.7326/0003-4819-144-6-200503210-00121; *FOOD DRUG ADM, 2004, NDA21144 FOOD DRUG A; Graham DJ, 2006, NEW ENGL J MED, V355, P2260, DOI 10.1056/NEJMc066372; GRASSLEY CE, 2006, COMMUNICATION   1213; Kaul S, 2006, ANN INTERN MED, V145, P62, DOI 10.7326/0003-4819-145-1-200607040-00011	5	91	94	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 19	2007	356	16					1601	1604		10.1056/NEJMp078032	http://dx.doi.org/10.1056/NEJMp078032			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AB	17442902				2022-12-28	WOS:000245762000001
J	Cohen, MS; Gay, C; Kashuba, ADM; Blower, S; Paxton, L				Cohen, Myron S.; Gay, Cynthia; Kashuba, Angela D. M.; Blower, Sally; Paxton, Lynn			Narrative review: Antiretroviral therapy to prevent the sexual transmission of HIV-1	ANNALS OF INTERNAL MEDICINE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; INJECTION-DRUG USE; POSTEXPOSURE PROPHYLAXIS PEP; HEALTH-CARE WORKERS; GENITAL-TRACT; SEMINAL PLASMA; HETEROSEXUAL TRANSMISSION; VIRAL LOAD; INHIBITOR CONCENTRATIONS; OCCUPATIONAL-EXPOSURE	Antiretroviral therapy (ART) has prolonged and improved the lives of persons infected with HIV. Theoretically, it can also be used to prevent the transmission of HIV. The pharmacology of ART in the male and female genital tract can be expected to affect the success of the intervention, and ART agents differ considerably in their ability to concentrate in genital tract secretions. Emergency ART is considered to be the standard of care after occupational exposures to fluids or tissues infected with HIV. More recently, ART for prophylaxis after nonoccupational HIV exposures has been widely used and most countries have developed specific guidelines for its implementation. However, developing clinical trials to prove the efficacy of ART postexposure prophylaxis has not been possible. Experiments with rhesus macaques suggest that therapy must be offered as soon as possible after exposure (within 72 hours) and must be continued for 28 days. Additional nonhuman primate experiments have demonstrated protection from HIV infection with ART preexposure prophylaxis, and several clinical trials are under way to evaluate the safety and efficacy of this approach. The degree to which ART offered to infected persons reduces infectiousness is of considerable public health importance, but the question has not been sufficiently answered. This article provides a review of the data on the use of ART to prevent the sexual transmission of HIV and identify challenges to improving and clarifying this approach.	Univ N Carolina, Chapel Hill, NC 27599 USA; Univ Calif Los Angeles, Los Angeles, CA 90024 USA; Ctr Dis Control & Prevent, Atlanta, GA USA	University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Los Angeles; Centers for Disease Control & Prevention - USA	Cohen, MS (corresponding author), Univ N Carolina, CB 7030,130 Mason Farm Rd,2115 Bioinformat Bldg, Chapel Hill, NC 27599 USA.	mscohen@med.unc.edu	Gay, Cynthia/AAG-2927-2019	Gay, Cynthia/0000-0002-3620-3059	NIAID NIH HHS [T32AI07151] Funding Source: Medline; PHS HHS [R0154980, R0141935, U01067854, R37049381] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007151] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Almeda J, 2002, ENFERM INFEC MICR CL, V20, P391, DOI 10.1016/S0213-005X(02)72826-7; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P1; [Anonymous], 16 INT AIDS C TOR ON; Auerbach JD, 2006, WHO TECH REP SER, V938, P43; Baggaley RF, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-9; Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; Bassett IV, 2004, CLIN INFECT DIS, V39, P395, DOI 10.1086/422459; Bernasconi E, 2001, SWISS MED WKLY, V131, P433; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Braitstein P, 2001, AIDS, V15, P2345, DOI 10.1097/00002030-200111230-00027; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; *CDCP, CDC TRIALS PREEXP PR; Chakraborty H, 2001, AIDS, V15, P621, DOI 10.1097/00002030-200103300-00012; Chaudry NI, 2002, CLIN INFECT DIS, V35, P760, DOI 10.1086/342389; Cohen J, 2006, SCIENCE, V313, P1030, DOI 10.1126/science.313.5790.1030; Cohen MS, 2005, J INFECT DIS, V191, P1391, DOI 10.1086/429414; Cohen MS, 2002, CURR CLIN TOPICS INF, V22, P214; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Coombs RW, 1998, J INFECT DIS, V177, P320, DOI 10.1086/514213; Coombs RW, 2003, AIDS, V17, P455, DOI 10.1097/00002030-200303070-00001; Cordes C, 2004, AIDS, V18, P582, DOI 10.1097/00002030-200402200-00036; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Cu-Uvin S, 2000, AIDS, V14, P415, DOI 10.1097/00002030-200003100-00015; Dukers NHTM, 2002, AIDS, V16, pF19, DOI 10.1097/00002030-200207050-00001; Dumond J, 2006, 13 C RETR OPP INF DE; Eron JJ, 1998, AIDS, V12, pF181, DOI 10.1097/00002030-199815000-00003; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; FOLKS T, 2006, 1 INT WORKSH HIV TRA; Garcia MT, 2005, SEX TRANSM DIS, V32, P214, DOI 10.1097/01.olq.0000149785.48574.3e; GARCIALERMA J, 2006, 13 C RETR OPP INF DE; Ghosn J, 2004, AIDS, V18, P1958, DOI 10.1097/00002030-200409240-00014; Ghys PD, 1997, AIDS, V11, pF85, DOI 10.1097/00002030-199712000-00001; Giele CM, 2002, SEX TRANSM INFECT, V78, P130, DOI 10.1136/sti.78.2.130; Grant RM, 2005, SCIENCE, V309, P2170, DOI 10.1126/science.1116204; GRULICH A, 2006, 16 INT AIDS C TOR ON; Hosseinipour M, 2002, CLIN INFECT DIS, V34, P1391, DOI 10.1086/340403; Kahn JO, 2001, J INFECT DIS, V183, P707, DOI 10.1086/318829; Katz MH, 2002, AM J PUBLIC HEALTH, V92, P388, DOI 10.2105/AJPH.92.3.388; Kim CN, 2006, J MED PRIMATOL, V35, P210, DOI 10.1111/j.1600-0684.2006.00169.x; KINDRICK A, 2006, 13 C RETR OPP INF DE; Kotler DP, 1998, AIDS, V12, P597, DOI 10.1097/00002030-199806000-00008; Kunches LM, 2001, J ACQ IMMUN DEF SYND, V26, P263, DOI 10.1097/00126334-200103010-00008; Law MG, 2001, AIDS, V15, P1287, DOI 10.1097/00002030-200107060-00011; Le Grand R, 2000, AIDS, V14, P1864; Little SJ, 1999, JAMA-J AM MED ASSOC, V282, P1142, DOI 10.1001/jama.282.12.1142; Magierowska M, 2004, J VIROL, V78, P2434, DOI 10.1128/JVI.78.5.2434-2444.2004; Martin JN, 2004, AIDS, V18, P787, DOI 10.1097/00002030-200403260-00010; MAYER K, 2006, 16 INT AIDS C TOR ON; McClelland RS, 2001, AIDS, V15, P105, DOI 10.1097/00002030-200101050-00015; Meel BL, 2005, MED SCI LAW, V45, P219, DOI 10.1258/rsmmsl.45.3.219; Min SS, 2004, JAIDS-J ACQ IMM DEF, V37, P1577, DOI 10.1097/00126334-200412150-00008; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; MUSICCO M, 1994, ARCH INTERN MED, V154, P1971, DOI 10.1001/archinte.154.17.1971; Otten RA, 2000, J VIROL, V74, P9771, DOI 10.1128/JVI.74.20.9771-9775.2000; Page-Shafer K, 2005, LANCET, V366, P1499, DOI 10.1016/S0140-6736(05)67146-2; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pereira AS, 1999, J INFECT DIS, V180, P2039, DOI 10.1086/315149; PETERSON L, 2006, 16 INT AIDS C TOR ON; Pilcher CD, 2001, JAMA-J AM MED ASSOC, V286, P1713, DOI 10.1001/jama.286.14.1713; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pinkerton SD, 2004, ARCH INTERN MED, V164, P46, DOI 10.1001/archinte.164.1.46; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Quirino T, 2000, ANTIVIR THER, V5, P195; Reddy S, 2003, 10 C RETR OPP INF BO; REY D, 2002, 14 INT AIDS C BARC S; Richens J, 2005, SEX TRANSM INFECT, V81, P190, DOI 10.1136/sti.2005.014886; ROLAND M, 2006, 13 C RETR OPP INF DE; ROLAND M, 2006, 16 INT AIDS C TOR ON; Roland ME, 2005, CLIN INFECT DIS, V41, P1507, DOI 10.1086/497268; Roland ME, 2001, J INFECT DIS, V184, P1608, DOI 10.1086/324580; Routy JP, 2004, AIDS, V18, P2305, DOI 10.1097/00002030-200411190-00011; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Sadiq ST, 2002, AIDS, V16, P219, DOI 10.1097/00002030-200201250-00011; Schechter M, 2004, JAIDS-J ACQ IMM DEF, V35, P519, DOI 10.1097/00126334-200404150-00010; Si-Mohamed A, 2000, J INFECT DIS, V182, P112, DOI 10.1086/315679; SMITH D, 2006, 16 INT AIDS C TOR ON; Smith Dawn K., 2005, Morbidity and Mortality Weekly Report, V54, P1; Solas C, 2003, ANTIMICROB AGENTS CH, V47, P238, DOI 10.1128/AAC.47.1.238-243.2003; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; Taylor S, 2000, AIDS, V14, P1979, DOI 10.1097/00002030-200009080-00014; Tovanabutra S, 2002, J ACQ IMMUN DEF SYND, V29, P275, DOI 10.1097/00126334-200203010-00008; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; Tsai CC, 1998, J VIROL, V72, P4265, DOI 10.1128/JVI.72.5.4265-4273.1998; Turner D, 2004, JAIDS-J ACQ IMM DEF, V37, P1627, DOI 10.1097/00126334-200412150-00017; van Praag RME, 2001, CLIN INFECT DIS, V33, pE91, DOI 10.1086/322682; Van Rompay KKA, 2002, J INFECT DIS, V186, P1508, DOI 10.1086/344360; Van Rompay KKA, 2001, J INFECT DIS, V184, P429, DOI 10.1086/322781; Vella S, 2005, CLIN INFECT DIS, V41, pS239, DOI 10.1086/430784; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; VITORIA M, 2006, 13 C RETR OPP INF DE; VOURVAHIS M, 2006, 13 C RETR OPP INF DE; Wade NA, 1998, NEW ENGL J MED, V339, P1409, DOI 10.1056/NEJM199811123392001; Wawer MJ, 2003, 10 C RETR OPP INF BO, P40; Wiebe ER, 2000, CAN MED ASSOC J, V162, P641; Winston A, 2005, HIV MED, V6, P191, DOI 10.1111/j.1468-1293.2005.00288.x; Yerly S, 2004, ANTIVIR THER, V9, P375	102	176	188	1	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2007	146	8					591	U63		10.7326/0003-4819-146-8-200704170-00010	http://dx.doi.org/10.7326/0003-4819-146-8-200704170-00010			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158FV	17438318				2022-12-28	WOS:000245778000005
J	Tonin, V				Tonin, Vittoria			Young people seeking mental-health care	LANCET			English	Editorial Material									ORYGEN Youth Hlth, Platform, Melbourne, Vic 3052, Australia	Orygen, The National Centre of Excellence in Youth Mental Health	Tonin, V (corresponding author), ORYGEN Youth Hlth, Platform, Melbourne, Vic 3052, Australia.								0	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 14	2007	369	9569					1239	1240		10.1016/S0140-6736(07)60375-4	http://dx.doi.org/10.1016/S0140-6736(07)60375-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	164YA	17434383				2022-12-28	WOS:000246269700007
J	Boden, WE; O'Rourke, RA; Teo, KK; Hartigan, PM; Maron, DJ; Kostuk, WJ; Knudtson, M; Dada, M; Casperson, P; Harris, CL; Chaitman, BR; Shaw, L; Gosselin, G; Nawaz, S; Title, LM; Gau, G; Blaustein, AS; Booth, DC; Bates, ER; Spertus, JA; Berman, DS; Mancini, GBJ; Weintraub, WS; Boden, W; O'Rourke, R; Teo, K; Hartigan, P; Weintraub, W; Maron, D; Mancini, J; Weintraub, W; Boden, W; O'Rourke, R; Teo, K; Hartigan, P; Knudtson, M; Maron, D; Bates, E; Blaustein, A; Booth, D; Carere, R; Ellis, S; Gosselin, G; Gau, G; Jacobs, A; King, S; Kostuk, W; Harris, C; Spertus, J; Peduzzi, P; Ryan, T; Turnbull, B; Feldman, T; Bonow, R; Haskell, W; Diehr, P; Lachenbruch, P; Waters, D; Johnstone, D; Cohen, L; Cantin, B; Hager, W; Samaha, F; Januzzi, J; Arrighi, J; Chaitman, B; Weintraub, W; Hartigan, P; O'Rourke, R; Boden, W; Barnett, P; Spertus, J; Goeree, R; Maron, D; Boden, W; O'Rourke, R; Teo, K; Weintraub, W; Peduzzi, P; Antonelli, M; Smith, J; Kilstrom, R; Hunter, B; O'Neil, S; Economou, T; Nabors, J; Kossack, A; Sather, M; Harris, C; Gagne, W; Fye, C; Marottoli, R; Allore, H; Beckwith, D; Farrell, W; Feldman, R; Mehta, R; Neiderman, J; Perry, E; Kasl, S; Zeman, M; O'Leary, T; Huang, G; Boden, W; Dada, M; Potter, K; Rivera, T; O'Rourke, R; Casperson, P; O'Shea, A; Teo, K; Woodcock, G; Weintraub, W; Barnett, P; Goeree, R; O'Brien, B; Mancini, GBJ; Yeoh, E; Ladenson, J; Thompson, V; Chaitman, B; Bertran, T; Berman, D; Gerlach, J; Littman, R; Shaw, L; Calfas, K; Sallis, J; O'Rourke, R; Baker, P; Bolton, J; Blaustein, A; Rowe, C; Morris, K; Hoffman, S; Sedlis, S; Keary, M; Duvernoy, C; Majors, C; Shockey, M; Zoble, R; Fernandez, I; Lehmann, K; Sorley, A; Abel, M; Sheldon, M; Wagoner, K; Murphy, E; Avalos, K; Rossen, J; Schneider, K; Molavi, B; Garza, L; Barton, P; Mavromatis, K; Forghani, Z; Smith, R; Mitchell, C; Ramanathan, K; Touchstone, T; Kostuk, W; Sridhar, K; Carr, S; Wiseman, D; Nawaz, S; Dion, C; Gosselin, G; Theberge, J; Cuso, M; Title, L; Simon, P; Carroll, L; Courtney-Cox, K; Cohen, E; Hsu, E; Dzavik, V; Lan, J; Knudtson, M; Lundberg, D; Natarajan, M; Cappelli, G; Kutryk, M; DiMarco, A; Strauss, B; Fung, A; Chow, J; Marr, D; Fitzgerald, F; Carere, R; Nacario, T; Tymchak, W; Harris, L; Lazzam, C; Carter, A; Palisaitis, D; Mercure, C; Bell, M; Peterson, M; Vicari, R; Carroll, M; Bates, E; Luciano, A; Mahrer, P; Reyes, S; Saucedo, J; Vanwieren, D; O'Keefe, J; Kennedy, P; Jacobs, A; Berger, C; Mayo, S; Miller, J; Arnold, T; Kiernan, F; Murphy, D; Kugelmass, A; Pangilinan, R; Schwartz, R; Caufield, L; Hansen, D; Mitchell, C; Carhart, R; Pennella, A; Ellis, S; Stevenson, C; Krone, R; Humphrey, J; Appleton, C; Wisbey, J; Stillabower, M; Davidson, M; Mathien, J				Boden, William E.; O'Rourke, Robert A.; Teo, Koon K.; Hartigan, Pamela M.; Maron, David J.; Kostuk, William J.; Knudtson, Merril; Dada, Marcin; Casperson, Paul; Harris, Crystal L.; Chaitman, Bernard R.; Shaw, Leslee; Gosselin, Gilbert; Nawaz, Shah; Title, Lawrence M.; Gau, Gerald; Blaustein, Alvin S.; Booth, David C.; Bates, Eric R.; Spertus, John A.; Berman, Daniel S.; Mancini, G. B. John; Weintraub, William S.; Boden, W.; O'Rourke, R.; Teo, K.; Hartigan, P.; Weintraub, W.; Maron, D.; Mancini, J.; Weintraub, W.; Boden, W.; O'Rourke, R.; Teo, K.; Hartigan, P.; Knudtson, M.; Maron, D.; Bates, E.; Blaustein, A.; Booth, D.; Carere, R.; Ellis, S.; Gosselin, G.; Gau, G.; Jacobs, A.; King, S., III; Kostuk, W.; Harris, C.; Spertus, J.; Peduzzi, P.; Ryan, T.; Turnbull, B.; Feldman, T.; Bonow, R.; Haskell, W.; Diehr, P.; Lachenbruch, P.; Waters, D.; Johnstone, D.; Cohen, L.; Cantin, B.; Hager, W.; Samaha, F.; Januzzi, J.; Arrighi, J.; Chaitman, B.; Weintraub, W.; Hartigan, P.; O'Rourke, R.; Boden, W.; Barnett, P.; Spertus, J.; Goeree, R.; Maron, D.; Boden, W.; O'Rourke, R.; Teo, K.; Weintraub, W.; Peduzzi, P.; Antonelli, M.; Smith, J.; Kilstrom, R.; Hunter, B.; O'Neil, S.; Economou, T.; Nabors, J.; Kossack, A.; Sather, M.; Harris, C.; Gagne, W.; Fye, C.; Marottoli, R.; Allore, H.; Beckwith, D.; Farrell, W.; Feldman, R.; Mehta, R.; Neiderman, J.; Perry, E.; Kasl, S.; Zeman, M.; O'Leary, T.; Huang, G.; Boden, W.; Dada, M.; Potter, K.; Rivera, T.; O'Rourke, R.; Casperson, P.; O'Shea, A.; Teo, K.; Woodcock, G.; Weintraub, W.; Barnett, P.; Goeree, R.; O'Brien, B.; Mancini, G. B. J.; Yeoh, E.; Ladenson, J.; Thompson, V.; Chaitman, B.; Bertran, T.; Berman, D.; Gerlach, J.; Littman, R.; Shaw, L.; Calfas, K.; Sallis, J.; O'Rourke, R.; Baker, P.; Bolton, J.; Blaustein, A.; Rowe, C.; Morris, K.; Hoffman, S.; Sedlis, S.; Keary, M.; Duvernoy, C.; Majors, C.; Shockey, M.; Zoble, R.; Fernandez, I.; Lehmann, K.; Sorley, A.; Abel, M.; Sheldon, M.; Wagoner, K.; Murphy, E.; Avalos, K.; Rossen, J.; Schneider, K.; Molavi, B.; Garza, L.; Barton, P.; Mavromatis, K.; Forghani, Z.; Smith, R.; Mitchell, C.; Ramanathan, K.; Touchstone, T.; Kostuk, W.; Sridhar, K.; Carr, S.; Wiseman, D.; Nawaz, S.; Dion, C.; Gosselin, G.; Theberge, J.; Cuso, M.; Title, L.; Simon, P.; Carroll, L.; Courtney-Cox, K.; Cohen, E.; Hsu, E.; Dzavik, V.; Lan, J.; Knudtson, M.; Lundberg, D.; Natarajan, M.; Cappelli, G.; Kutryk, M.; DiMarco, A.; Strauss, B.; Fung, A.; Chow, J.; Marr, D.; Fitzgerald, F.; Carere, R.; Nacario, T.; Tymchak, W.; Harris, L.; Lazzam, C.; Carter, A.; Palisaitis, D.; Mercure, C.; Bell, M.; Peterson, M.; Vicari, R.; Carroll, M.; Bates, E.; Luciano, A.; Mahrer, P.; Reyes, S.; Saucedo, J.; vanWieren, D.; O'Keefe, J.; Kennedy, P.; Jacobs, A.; Berger, C.; Mayo, S.; Miller, J.; Arnold, T.; Kiernan, F.; Murphy, D.; Kugelmass, A.; Pangilinan, R.; Schwartz, R.; Caufield, L.; Hansen, D.; Mitchell, C.; Carhart, R.; Pennella, A.; Ellis, S.; Stevenson, C.; Krone, R.; Humphrey, J.; Appleton, C.; Wisbey, J.; Stillabower, M.; Davidson, M.; Mathien, J.		COURAGE Trial Res Grp	Optimal medical therapy with or without PCI for stable coronary disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OUTCOMES UTILIZING REVASCULARIZATION; RANDOMIZED CLINICAL-TRIALS; SIROLIMUS-ELUTING STENTS; ARTERY-DISEASE; MYOCARDIAL-INFARCTION; ANGIOPLASTY; STRATEGIES; INTERVENTION; SURVIVAL; EFFICACY	Background: In patients with stable coronary artery disease, it remains unclear whether an initial management strategy of percutaneous coronary intervention (PCI) with intensive pharmacologic therapy and lifestyle intervention (optimal medical therapy) is superior to optimal medical therapy alone in reducing the risk of cardiovascular events. Methods: We conducted a randomized trial involving 2287 patients who had objective evidence of myocardial ischemia and significant coronary artery disease at 50 U.S. and Canadian centers. Between 1999 and 2004, we assigned 1149 patients to undergo PCI with optimal medical therapy (PCI group) and 1138 to receive optimal medical therapy alone (medical-therapy group). The primary outcome was death from any cause and nonfatal myocardial infarction during a follow-up period of 2.5 to 7.0 years (median, 4.6). Results: There were 211 primary events in the PCI group and 202 events in the medical-therapy group. The 4.6-year cumulative primary-event rates were 19.0% in the PCI group and 18.5% in the medical-therapy group (hazard ratio for the PCI group, 1.05; 95% confidence interval [CI], 0.87 to 1.27; P=0.62). There were no significant differences between the PCI group and the medical-therapy group in the composite of death, myocardial infarction, and stroke (20.0% vs. 19.5%; hazard ratio, 1.05; 95% CI, 0.87 to 1.27; P=0.62); hospitalization for acute coronary syndrome (12.4% vs. 11.8%; hazard ratio, 1.07; 95% CI, 0.84 to 1.37; P=0.56); or myocardial infarction (13.2% vs. 12.3%; hazard ratio, 1.13; 95% CI, 0.89 to 1.43; P=0.33). Conclusions: As an initial management strategy in patients with stable coronary artery disease, PCI did not reduce the risk of death, myocardial infarction, or other major cardiovascular events when added to optimal medical therapy.	SUNY Buffalo, Buffalo Gen Hosp, Div Cardiol, Buffalo, NY 14203 USA; Western New York Vet Affairs VA Healthcare Networ, Buffalo, NY USA; S Texas Vet Hlth Care Syst, San Antonio, TX USA; McMaster Univ, Med Ctr, Hamilton, ON, Canada; VA Connecticut Healthcare Syst, Cooperat Studies Program Coordinating Ctr, West Haven, CT USA; Vanderbilt Univ, Med Ctr, Nashville, TN USA; London Hlth Sci Ctr, London, ON, Canada; Foothills Prov Gen Hosp, Calgary, AB T2N 2T9, Canada; Hartford Hosp, Hartford, CT 06115 USA; VA Cooperat Studies Program Clin Res Pharm Coordi, Albuquerque, NM USA; St Louis Univ, St Louis, MO 63103 USA; Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; Sudbury Reg Hosp, Sudbury, ON, Canada; Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada; Mayo Clin, Rochester, MN USA; Houston VA Med Ctr, Houston, TX USA; Lexington VA Med Ctr, Lexington, KY USA; Univ Michigan, Med Ctr, Ann Arbor, MI USA; St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA; Vancouver Hosp & Hlth Sci Ctr, Vancouver, BC V5Z 1M9, Canada; Christiana Care Hlth Syst, Newark, DE USA	Buffalo General Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; McMaster University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Vanderbilt University; London Health Sciences Centre; University of Calgary; Hartford Hospital; Saint Louis University; Cedars Sinai Medical Center; Universite de Montreal; Health Sciences North; Queen Elizabeth II Health Sciences Centre; Mayo Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center; University of Michigan System; University of Michigan; Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of British Columbia; Christiana Care Health System	Boden, WE (corresponding author), SUNY Buffalo, Buffalo Gen Hosp, Div Cardiol, 100 High St, Buffalo, NY 14203 USA.	wboden@kaleidahealth.org	Spertus, John/ABD-3075-2021; Januzzi, James/Y-2436-2019; Sallis, James F/D-3001-2014	Sallis, James F/0000-0003-2555-9452				Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; AMBROSE JA, 1988, J AM COLL CARDIOL, V12, P56, DOI 10.1016/0735-1097(88)90356-7; Antman EM, 2005, CIRCULATION, V111, P2013; Boden WE, 2007, AM J CARDIOL, V99, P208, DOI 10.1016/j.amjcard.2006.07.082; Boden WE, 2006, AM HEART J, V151, P1173, DOI 10.1016/j.ahj.2005.08.015; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Chamberlain DA, 1997, LANCET, V350, P461; *CLOP UNST ANG PRE, 2001, NEW ENGL J MED, V345, P1716; *CLOP UNST ANG PRE, 2001, NEW ENGL J MED, V345, P1506; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; COX DR, 1972, J R STAT SOC B, V34, P187; Curfman GD, 2007, NEW ENGL J MED, V356, P1059, DOI 10.1056/NEJMe068306; De Giorgio L, 2000, NEW ENGL J MED, V342, P1376; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; de Winter RJ, 2005, NEW ENGL J MED, V353, P1095, DOI 10.1056/NEJMoa044259; Feldman DN, 2006, AM J CARDIOL, V98, P1334, DOI 10.1016/j.amjcard.2006.06.026; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Fox KM, 2003, LANCET, V362, P782; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; Henderson RA, 2003, J AM COLL CARDIOL, V42, P1161, DOI 10.1016/S0735-1097(03)00951-3; Hochman JS, 2006, NEW ENGL J MED, V355, P2395, DOI 10.1056/NEJMoa066139; Hueb W, 2004, J AM COLL CARDIOL, V43, P1743, DOI 10.1016/j.jacc.2003.08.065; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484; Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; LITTLE WC, 1988, CIRCULATION, V78, P1157, DOI 10.1161/01.CIR.78.5.1157; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; OCONNOR GT, 1989, CIRCULATION, V80, P234, DOI 10.1161/01.CIR.80.2.234; PARISI AF, 1992, NEW ENGL J MED, V326, P10, DOI 10.1056/NEJM199201023260102; PEDERSEN TR, 1994, LANCET, V344, P1383; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pitt B, 1999, NEW ENGL J MED, V341, P70, DOI 10.1056/NEJM199907083410202; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; SCHOENFELD DA, 1987, BIOMETRIKA, V74, P167, DOI 10.2307/2336031; Shih JH, 1995, CONTROL CLIN TRIALS, V16, P395, DOI 10.1016/S0197-2456(95)00132-8; Smith SC, 2006, CIRCULATION, V113, P156, DOI 10.1161/CIRCULATIONAHA.105.170815; Spaulding C, 2007, NEW ENGL J MED, V356, P989, DOI 10.1056/NEJMoa066633; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Tanguay JF, 2003, J AM COLL CARDIOL, V41, p404A; Wallentin L, 1999, LANCET, V354, P708; Weintraub WS, 2006, AM HEART J, V151, P1180, DOI 10.1016/j.ahj.2005.07.035; YUSUF S, 1988, JAMA-J AM MED ASSOC, V260, P2088, DOI 10.1001/jama.260.14.2088; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Yusuf S, 2000, NEW ENGL J MED, V342, P145	50	3162	3353	2	120	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 12	2007	356	15					1503	1516		10.1056/NEJMoa070829	http://dx.doi.org/10.1056/NEJMoa070829			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156CA	17387127				2022-12-28	WOS:000245624400004
J	Chanana, C; Malhotra, N				Chanana, Charu; Malhotra, Neena			Gravid uterus in an incisional hernia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									All India Inst Med Sci, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Chanana, C (corresponding author), All India Inst Med Sci, New Delhi 110029, India.	charuchanana@rediffmail.com							0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 12	2007	356	15					E13	E13		10.1056/NEJMicm062163	http://dx.doi.org/10.1056/NEJMicm062163			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156CA	17429079				2022-12-28	WOS:000245624400010
J	Weatherall, D				Weatherall, David			Animal research: the debate continues	LANCET			English	Editorial Material									Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England	University of Oxford	Weatherall, D (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	liz.rose@imm.ox.ac.uk						BOSELEY S, 2006, GUARDIAN        1215; CONNOR S, 2007, INDEPENDENT     0105; Krimsky S., 2004, SCI PRIVATE INTEREST; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; *UK AC MED SCI, 2006, US NONH PRIM RES; *US I MED, 2002, STEM CELLS FUT REG M	6	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2007	369	9568					1147	1148		10.1016/S0140-6736(07)60541-8	http://dx.doi.org/10.1016/S0140-6736(07)60541-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	155RH	17416244				2022-12-28	WOS:000245595100007
J	Boutin, AT; Johnson, RS				Boutin, Adam T.; Johnson, Randall S.			Waiting to inhale: HIF-1 modulates aerobic respiration	CELL			English	Editorial Material							CYTOCHROME-C-OXIDASE; ISOFORMS; ADAPTATION; HYPOXIA	The hypoxia-inducible factor HIF-1 is known to promote anaerobic respiration during low oxygen conditions (hypoxia). In this issue, Fukuda et al. (2007) expand the range of HIF-1's functions by showing that it modulates aerobic respiration as well.	Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Johnson, RS (corresponding author), Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rjohnson@biomail.ucsd.edu	Johnson, Randall/AAM-1189-2021	Johnson, Randall/0000-0002-4084-6639				ALLEN LA, 1995, J BIOL CHEM, V270, P110, DOI 10.1074/jbc.270.1.110; Burke PV, 1998, J EXP BIOL, V201, P1163; FUKUDA R, 2007, CELL; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; WATERLAND RA, 1991, J BIOL CHEM, V266, P4180	6	5	5	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					29	30		10.1016/j.cell.2007.03.031	http://dx.doi.org/10.1016/j.cell.2007.03.031			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418782	Bronze			2022-12-28	WOS:000245661100007
J	Tarduno, JA; Cottrell, RD; Watkeys, MK; Bauch, D				Tarduno, John A.; Cottrell, Rory D.; Watkeys, Michael K.; Bauch, Dorothy			Geomagnetic field strength 3.2 billion years ago recorded by single silicate crystals	NATURE			English	Article							SOUTH-AFRICA; ROCK-MAGNETISM; INTENSITY; GA; PALEOMAGNETISM; PALEOINTENSITY; BARBERTON; GEODYNAMO; MAGNETIZATION; CONSTRAINTS	The strength of the Earth's early geomagnetic field is of importance for understanding the evolution of the Earth's deep interior, surface environment and atmosphere. Palaeomagnetic and palaeointensity data from rocks formed near the boundary of the Proterozoic and Archaean eons, some 2.5 Gyr ago, show many hallmarks of the more recent geomagnetic field. Reversals are recorded(1), palaeosecular variation data(2) indicate a dipole-dominated morphology and available palaeointensity values are similar to those from younger rocks(1-3). The picture before 2.8 Gyr ago is much less clear. Rocks of the Archaean Kaapvaal craton ( South Africa) are among the best-preserved, but even they have experienced low-grade metamorphism(4). The variable acquisition of later magnetizations by these rocks is therefore expected, precluding use of conventional palaeointensity methods. Silicate crystals from igneous rocks, however, can contain minute magnetic inclusions capable of preserving Archaean-age magnetizations. Here we use a CO2 laser heating approach and direct-current SQUID magnetometer measurements to obtain palaeodirections and intensities from single silicate crystals that host magnetite inclusions. We find 3.2-Gyr-old field strengths that are within 50 per cent of the present-day value, indicating that a viable magnetosphere sheltered the early Earth's atmosphere from solar wind erosion.	Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA; Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA; Univ KwaZulu Natal, Sch Geol Sci, ZA-4041 Durban, South Africa	University of Rochester; University of Rochester; University of Kwazulu Natal	Tarduno, JA (corresponding author), Univ Rochester, Dept Earth & Environm Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	john@earth.rochester.edu		Cottrell, Rory/0000-0003-4174-6389; Tarduno, John/0000-0002-0490-0124				BROWN EM, 1984, GEOPHYS RES LETT, V11, P205, DOI 10.1029/GL011i003p00205; Cottrell RD, 1999, EARTH PLANET SC LETT, V169, P1, DOI 10.1016/S0012-821X(99)00068-0; Cottrell RD, 2000, J GEOPHYS RES-SOL EA, V105, P23579, DOI 10.1029/2000JB900219; Dunlop D. J., 1997, ROCK MAGNETISM FUNDA; Dunlop DJ, 2004, GEOPHYS MONOGR SER, V145, P85, DOI 10.1029/145GM07; GEISSMAN JW, 1988, GEOPHYS RES LETT, V15, P479, DOI 10.1029/GL015i005p00479; Gose WA, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003897; Gubbins D, 2004, GEOPHYS J INT, V157, P1407, DOI 10.1111/j.1365-246X.2004.02219.x; HALE CJ, 1987, EARTH PLANET SC LETT, V86, P354, DOI 10.1016/0012-821X(87)90232-9; HALGEDAHL SL, 1980, J GEOPHYS RES, V85, P3690, DOI 10.1029/JB085iB07p03690; Hargraves RB, 1997, S AFR J GEOL, V100, P195; Hulot G, 2002, NATURE, V416, P620, DOI 10.1038/416620a; KRONER A, 1992, SCIENCE, V256, P1405, DOI 10.1126/science.256.5062.1405; Layer PW, 1998, GEOPHYS J INT, V135, P129, DOI 10.1046/j.1365-246X.1998.00613.x; Layer PW, 1996, SCIENCE, V273, P943, DOI 10.1126/science.273.5277.943; MCELHINNY MW, 1980, J GEOPHYS RES, V85, P3523, DOI 10.1029/JB085iB07p03523; NEEL L, 1955, ADV PHYS, V4, P191, DOI 10.1080/00018735500101204; Ozima M, 2005, NATURE, V436, P655, DOI 10.1038/nature03929; Poujol M, 2003, PRECAMBRIAN RES, V127, P181, DOI 10.1016/S0301-9268(03)00187-6; PULLAIAH G, 1975, EARTH PLANET SC LETT, V28, P133, DOI 10.1016/0012-821X(75)90221-6; RENNE PR, 1988, SCIENCE, V242, P1152, DOI 10.1126/science.242.4882.1152; Sinnhuber M, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017265; Smirnov AV, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020333; Smirnov AV, 2003, GEOLOGY, V31, P415, DOI 10.1130/0091-7613(2003)031<0415:POTEGG>2.0.CO;2; Stevenson DJ, 2001, NATURE, V412, P214, DOI 10.1038/35084155; Tarduno JA, 2006, REV GEOPHYS, V44, DOI 10.1029/2005RG000189; Tice MM, 2004, GEOLOGY, V32, P37, DOI 10.1130/G19915.1; Valet JP, 2003, REV GEOPHYS, V41, DOI 10.1029/2001RG000104; Wingate MTD, 1998, S AFR J GEOL, V101, P257; Yoshihara A, 2004, PRECAMBRIAN RES, V131, P111, DOI 10.1016/j.precamres.2004.01.003	30	87	88	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2007	446	7136					657	660		10.1038/nature05667	http://dx.doi.org/10.1038/nature05667			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17410173				2022-12-28	WOS:000245438300037
J	Lehman, CD; Gatsonis, C; Kuhl, CK; Hendrick, RE; Pisano, ED; Hanna, L; Peacock, S; Smazal, SF; Maki, DD; Julian, TB; DePeri, ER; Bluemke, DA; Schnall, MD; Julian, T; Poller, W; Schilling, K; Neal, C; Wichterman, L; Seifert, P; O'Loughlin, M; Bluemke, D; Kawamoto, S; DePeri, E; Hendrick, E; Wolfman, J; Smazal, S; Thickman, D; Korn, R; Maki, D; Whitfill, C; Cook, A; Causer, P; Rao, V; Piccoli, C; Ferris, E; Harms, S; Kuhl, C; DeBruhl, N; Hylton, N; Mahoney, M; Pisano, E; Schnall, M; Weinstein, S; Keesara, S; Weatherall, P; DeAngelis, G; Lehman, C; Li, T; Soulen, R				Lehman, Constance D.; Gatsonis, Constantine; Kuhl, Christiane K.; Hendrick, R. Edward; Pisano, Etta D.; Hanna, Lucy; Peacock, Sue; Smazal, Stanley F.; Maki, Daniel D.; Julian, Thomas B.; DePeri, Elizabeth R.; Bluemke, David A.; Schnall, Mitchell D.; Julian, T.; Poller, W.; Schilling, K.; Neal, C.; Wichterman, L.; Seifert, P.; O'Loughlin, M.; Bluemke, D.; Kawamoto, S.; DePeri, E.; Hendrick, E.; Wolfman, J.; Smazal, S.; Thickman, D.; Korn, R.; Maki, D.; Whitfill, C.; Cook, A.; Causer, P.; Rao, V.; Piccoli, C.; Ferris, E.; Harms, S.; Kuhl, C.; DeBruhl, N.; Hylton, N.; Mahoney, M.; Pisano, E.; Schnall, M.; Weinstein, S.; Keesara, S.; Weatherall, P.; DeAngelis, G.; Lehman, C.; Li, T.; Soulen, R.		ACRIN Trial 6667 Investigators Grp	MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONSERVATION THERAPY; FOLLOW-UP; CARCINOMA; MASTECTOMY; MAMMOGRAPHY; EFFICACY; SURGERY	BACKGROUND Even after careful clinical and mammographic evaluation, cancer is found in the contralateral breast in up to 10% of women who have received treatment for unilateral breast cancer. We conducted a study to determine whether magnetic resonance imaging (MRI) could improve on clinical breast examination and mammography in detecting contralateral breast cancer soon after the initial diagnosis of unilateral breast cancer. METHODS A total of 969 women with a recent diagnosis of unilateral breast cancer and no abnormalities on mammographic and clinical examination of the contralateral breast underwent breast MRI. The diagnosis of MRI-detected cancer was confirmed by means of biopsy within 12 months after study entry. The absence of breast cancer was determined by means of biopsy, the absence of positive findings on repeat imaging and clinical examination, or both at 1 year of follow-up. RESULTS MRI detected clinically and mammographically occult breast cancer in the contralateral breast in 30 of 969 women who were enrolled in the study (3.1%). The sensitivity of MRI in the contralateral breast was 91%, and the specificity was 88%. The negative predictive value of MRI was 99%. A biopsy was performed on the basis of a positive MRI finding in 121 of the 969 women (12.5%), 30 of whom had specimens that were positive for cancer (24.8%); 18 of the 30 specimens were positive for invasive cancer. The mean diameter of the invasive tumors detected was 10.9 mm. The additional number of cancers detected was not influenced by breast density, menopausal status, or the histologic features of the primary tumor. CONCLUSIONS MRI can detect cancer in the contralateral breast that is missed by mammography and clinical examination at the time of the initial breast-cancer diagnosis.	Univ Washington, Med Ctr, Seattle Canc Care Alliance, Seattle, WA 98109 USA; Brown Univ, Providence, RI 02912 USA; Univ Bonn, D-5300 Bonn, Germany; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; Univ N Carolina, Chapel Hill, NC USA; Porter Adventist Hosp, Denver, CO USA; Scottsdale Med Imaging, Scottsdale, AZ USA; Allegheny Gen Hosp, Allegheny, PA USA; Mayo Clin, Jacksonville, FL 32224 USA; Johns Hopkins Univ, Sch Med, Bethesda, MD USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	Seattle Cancer Care Alliance; University of Washington; University of Washington Seattle; Brown University; University of Bonn; Northwestern University; Feinberg School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Allegheny General Hospital; Mayo Clinic; Johns Hopkins University; University of Pennsylvania	Lehman, CD (corresponding author), Univ Washington, Med Ctr, Seattle Canc Care Alliance, 825 Eastlake Ave E,Rm G3-200,POB 19023, Seattle, WA 98109 USA.	lehman@u.washington.edu	Hylton, Nola/AAF-7861-2019; Poller, Wolfgang/AAB-2185-2021; Bluemke, David/GYU-8169-2022	Kuhl, Christiane/0000-0001-8696-2363; Bluemke, David/0000-0002-8323-8086	NCI NIH HHS [CA 79778, CA 80098] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U10CA080098, U01CA080098, U10CA079778, U01CA079778] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2003, BREAST IM REP DAT SY; [Anonymous], 2004, STAT US GUID; Berg WA, 2004, RADIOLOGY, V233, P830, DOI 10.1148/radiol.2333031484; Bluemke DA, 2004, JAMA-J AM MED ASSOC, V292, P2735, DOI 10.1001/jama.292.22.2735; Collins LC, 2005, CANCER-AM CANCER SOC, V103, P1778, DOI 10.1002/cncr.20979; Fischer U, 1999, RADIOLOGY, V213, P881, DOI 10.1148/radiology.213.3.r99dc01881; FOWBLE BL, 1993, SEMIN ROENTGENOL, V28, P279, DOI 10.1016/S0037-198X(05)80086-0; Griggs JJ, 2004, J CLIN ONCOL, V22, p43S; Heron DE, 2000, CANCER, V88, P2739, DOI 10.1002/1097-0142(20000615)88:12<2739::AID-CNCR12>3.3.CO;2-A; Herrinton LJ, 2005, J CLIN ONCOL, V23, P4275, DOI 10.1200/JCO.2005.10.080; Jobsen JJ, 2003, BREAST, V12, P83, DOI 10.1016/S0960-9776(02)00278-3; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; Kuhl CK, 2000, RADIOLOGY, V217, P268; Lee SG, 2003, RADIOLOGY, V226, P773, DOI 10.1148/radiol.2263020041; Lehman CD, 2005, J SURG ONCOL, V92, P9, DOI 10.1002/jso.20350; Liberman L, 2003, AM J ROENTGENOL, V180, P333, DOI 10.2214/ajr.180.2.1800333; MORROW M, 1995, SURGERY, V118, P621, DOI 10.1016/S0039-6060(05)80027-3; Morrow M, 2002, CA-CANCER J CLIN, V52, P277, DOI 10.3322/canjclin.52.5.277; PEPE M, 2003, STAT EVALUATION MED, P39; Pisano ED, 2006, NEW ENGL J MED, V355, P1840; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Poggi MM, 2003, CANCER, V98, P697, DOI 10.1002/cncr.11580; Polednak AP, 2001, J AM COLL SURGEONS, V192, P804, DOI 10.1016/S1072-7515(01)00912-7; POMERANTZ RA, 1989, AM SURGEON, V55, P441; Rieber A, 1997, J COMPUT ASSIST TOMO, V21, P773, DOI 10.1097/00004728-199709000-00023; Samant R S, 2001, Breast J, V7, P405, DOI 10.1046/j.1524-4741.2001.07605.x; Silverstein MJ, 2005, J AM COLL SURGEONS, V201, P586, DOI 10.1016/j.jamcollsurg.2005.05.032; Slanetz Priscilla J, 2002, Breast J, V8, P145, DOI 10.1046/j.1524-4741.2002.08304.x; *STAT PRESS, 2005, STAT REF MAN REL 9; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; Viehweg Petra, 2004, Eur Radiol, V14, P402, DOI 10.1007/s00330-003-2086-2	31	633	659	0	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2007	356	13					1295	1303		10.1056/NEJMoa065447	http://dx.doi.org/10.1056/NEJMoa065447			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150MN	17392300				2022-12-28	WOS:000245221000003
J	Verma, S; Slutsky, AS				Verma, Subodh; Slutsky, Arthur S.			Idiopathic pulmonary fibrosis - New insights	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; Univ Toronto, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Verma, S (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada.		Slutsky, Arthur S/A-6013-2008; Slutsky, Arthur/M-3325-2019	Slutsky, Arthur S/0000-0002-6063-3876; 				Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Khalil N, 2004, CAN MED ASSOC J, V171, P153, DOI 10.1503/cmaj.1030055; Li H, 2006, J BIOL CHEM, V281, P25588, DOI 10.1074/jbc.M602381200; Schwencke C, 2006, CARDIOVASC RES, V70, P42, DOI 10.1016/j.cardiores.2005.11.029; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Sharma O P, 1999, Curr Opin Pulm Med, V5, P275, DOI 10.1097/00063198-199909000-00001; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536	7	46	54	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2007	356	13					1370	1372		10.1056/NEJMcibr070490	http://dx.doi.org/10.1056/NEJMcibr070490			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150MN	17392309				2022-12-28	WOS:000245221000015
J	AbouZahr, C; Adjei, S; Kanchanachitra, C				AbouZahr, Carla; Adjei, Sam; Kanchanachitra, Churnrurtai			Health Statistics 4 - From data to policy: good practices and cautionary tales	LANCET			English	Article							LESSONS	Sound statistics are a key component of evidence. However, many institutional, political, and practical barriers impede effective use of data to inform policy. In the fourth paper in this Series on health statistics, we look at the relation between health statistics and policymaking at country and global levels. We propose a fourfold framework to help the transition from data to policy. Good practices include: (1) reconciling statistics from different sources; (2) fostering communication and transparency, including reaching out to the media for dissemination; (3) promoting country ownership of data and statistical analyses; and (4) addressing conflicts of interest, including those arising when workers responsible for attainment of health goals are also charged with measurement and monitoring of progress. Further investments are needed not only in primary data collection across a full range of sources but also in building capacity in countries to analyse, interpret, and present statistics effectively in ways that are meaningful and useful for policymaking.	WHO, Hlth Metr Network, CH-1211 Geneva 27, Switzerland; Univ Aberdeen, Initiat Maternal Mortal Programme Assessment, Aberdeen, Scotland; Mahidol Univ, Inst Populat Social Res, Bangkok 10700, Thailand	World Health Organization; University of Aberdeen; Mahidol University	AbouZahr, C (corresponding author), WHO, Hlth Metr Network, 27 Ave Appia, CH-1211 Geneva 27, Switzerland.	abouzahrc@who.int						Anderson James E., 2000, PUBLIC POLICYMAKING, V4th; [Anonymous], SCI DAILY; *B M GAT FDN MCKIN, 2005, 3 HIGH LEV FOR HLTH; Boerma JT, 2007, LANCET, V369, P779, DOI 10.1016/S0140-6736(07)60364-X; Bradshaw D, 2003, INITIAL BURDEN DIS E; CABLE V, 2003, ODI 7 MAY; *CDC, DAT DEC MAK; Davies P, 2004, 4 ANN CAMPB COLL C W; *DEV ASS COMM ORG, 2005, PAR DECL AID EFF; FARAMNUAYPHOL P, 2005, THAILAND HLTH SITUAT, V1; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; *GHAN MIN HLTH, 2003, APPR INF MON EV IME; Ghys PD, 2006, SEX TRANSM INFECT, V82, pI52, DOI 10.1136/sti.2005.016428; *HARV IN GLOB HLTH, MISS; *HIGH LEV FOR HLTH, 2005, 3 HIGH LEV FOR HLTH; *HLTH SYST TRUST, HLTH MAN INF SYST; *HLTH SYST TRUST, 2003, SAPA            0227; Horton R, 2005, LANCET, V366, P179, DOI 10.1016/S0140-6736(05)66883-3; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; *IMMPACT, IMMPACT; *INF CTR, INF CTR HLTH SOC CAR; *INT DEV RES CTR, TANZ ESS HLTH INT PR; JONGUDOMSUK P, 2005, 6 GLOB C HLTH PROM 7; Kapiriri L, 2003, HEALTH POLICY PLANN, V18, P205, DOI 10.1093/heapol/czg025; Lopez A, MEASURING GLOBAL BUR; MARSTON G, DRAWING BOARD AUSTR, V3, P143; Mathers Colin D, 2003, Popul Health Metr, V1, P6, DOI 10.1186/1478-7954-1-6; *MIN HLTH KINGD CA, 2005, NAT HLTH STAT 2005; *MIN HLTH UG, 2003, STAT ABSTR WORK PAP; Murray CJL, 2007, LANCET, V369, P862, DOI 10.1016/S0140-6736(07)60415-2; Murray CJL, 2004, BMJ-BRIT MED J, V329, P1096, DOI 10.1136/bmj.329.7474.1096; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; *ORG EC COOP DEV, STAT KNOWL POL OECD; *PARIS21, 2007, COUNT DOWN POV ROL S; *ROYAL SOC, 2003, ROYAL SOC REV DEFRAS; SCOTT C, 2005, MEASURING MEASUREMEN; *SOC ISS RES CTR, GUID SCI HLTH COMM W; SRINIVASAN S, 1999, HUMANSCAPE, V6, P37; *STAT COMM EC COMM, 1999, C EUR STAT WORK SESS; Tangcharoensathien V, 2006, B WORLD HEALTH ORGAN, V84, P233, DOI 10.2471/BLT.05.026310; Theo Lippeveld RS, 2000, DESIGN INPLMENTATION; *UN EC SOC COUNC, 2006, REP FRIENDS CHAIR MI; *UN POP DIV, WORLD POP PROSP 2004; *UN STAT DIV, MILL DEV GOALS IND; Upadhyay U, 2001, POPULATION REPORTS J; Walker N, 2007, LANCET, V369, P956, DOI 10.1016/S0140-6736(07)60454-1; *WHO, 2002, REP SCI PEER REV GRO; WHO, 1997, WHORHT9728; *WHO UNICEF UNFPA, 2005, EST MAT MORT 2000; World Health Organization, 2000, WORLD HLTH REP 2000; Wright J, 2006, LANCET, V367, P1139, DOI 10.1016/S0140-6736(06)68497-3; Wyatt JC, 1998, LANCET, V352, P1375, DOI 10.1016/S0140-6736(97)08306-2	52	49	55	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2007	369	9566					1039	1046		10.1016/S0140-6736(07)60463-2	http://dx.doi.org/10.1016/S0140-6736(07)60463-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151JO	17382830				2022-12-28	WOS:000245286500032
J	Wang, RN; He, GG; Nelman-Gonzalez, M; Ashorn, CL; Gallick, GE; Stukenberg, PT; Kirschner, MW; Kuang, J				Wang, Ruoning; He, Guangan; Nelman-Gonzalez, Mayra; Ashorn, Cheryl L.; Gallick, Gary E.; Stukenberg, P. Todd; Kirschner, Marc W.; Kuang, Jian			Regulation of Cdc25C by ERK-MAP kinases during the G(2)/M transition	CELL			English	Article							ACTIVATED PROTEIN-KINASE; XENOPUS-OOCYTE MATURATION; CELL-CYCLE; M-PHASE; MEIOTIC MATURATION; MPF ACTIVATION; EGG EXTRACTS; OKADAIC ACID; POLO KINASE; PHOSPHORYLATION	Induction of G(2)/M phase transition in mitotic and meiotic cell cycles requires activation by phosphorylation of the protein phosphatase Cdc25. Although Cdc2/cyclin B and polo-like kinase (PLK) can phosphorylate and activate Cdc25 in vitro, phosphorylation by these two kinases is insufficient to account for Cdc25 activation during M phase induction. Here we demonstrate that p42 MAP kinase (MAPK), the Xenopus ortholog of ERK2, is a major Cdc25 phosphorylating kinase in extracts of M phase-arrested Xenopus eggs. In Xenopus oocytes, p42 MAPK interacts with hypophosphorylated Cdc25 before meiotic induction. During meiotic induction, p42 MAPK phosphorylates Cdc25 at T48, T138, and S205, increasing Cdc25's phosphatase activity. In a mammalian cell line, ERK1/2 interacts with Cdc25C in interphase and phosphorylates Cdc25C at T48 in mitosis. Inhibition of ERK activation partially inhibits T48 phosphorylation, Cdc25C activation, and mitotic induction. These findings demonstrate that ERK-MAP kinases; are directly involved in activating Cdc25 during the G2/M transition.	Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; Univ Texas, Grad Sch Biomed Sci, Program Genes & Dev, Houston, TX 77030 USA; Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Virginia; Harvard University; Harvard Medical School	Kuang, J (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jkuang@mdanderson.org	Wang, Ruoning/C-1683-2014	Ashorn, Cheryl/0000-0003-1207-7323; Stukenberg, Todd/0000-0002-6788-2111	NATIONAL CANCER INSTITUTE [P30CA016672, R01CA093941] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA93941, CA-16672] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Castro A, 2001, MOL BIOL CELL, V12, P2660, DOI 10.1091/mbc.12.9.2660; Che SL, 1999, J BIOL CHEM, V274, P5522, DOI 10.1074/jbc.274.9.5522; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Dupre A, 2002, EMBO J, V21, P4026, DOI 10.1093/emboj/cdf400; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Ferrell JE, 1999, BIOESSAYS, V21, P833, DOI 10.1002/(SICI)1521-1878(199910)21:10<833::AID-BIES5>3.0.CO;2-P; Fisher DL, 1999, DEVELOPMENT, V126, P4537; Foijer F, 2005, CANCER CELL, V8, P455, DOI 10.1016/j.ccr.2005.10.021; Gavin AC, 1999, MOL BIOL CELL, V10, P2971, DOI 10.1091/mbc.10.9.2971; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; GORIS J, 1989, FEBS LETT, V245, P91, DOI 10.1016/0014-5793(89)80198-X; Gotoh Y, 1995, Prog Cell Cycle Res, V1, P287; GOTOH Y, 1991, EMBO J, V10, P2661, DOI 10.1002/j.1460-2075.1991.tb07809.x; GOTOH Y, 1995, J BIOL CHEM, V270, P25898, DOI 10.1074/jbc.270.43.25898; Gottlin EB, 1996, J BIOL CHEM, V271, P27445, DOI 10.1074/jbc.271.44.27445; Gross SD, 2000, CURR BIOL, V10, P430, DOI 10.1016/S0960-9822(00)00425-5; He GG, 2005, ONCOGENE, V24, P2929, DOI 10.1038/sj.onc.1208474; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; HSIAO KM, 1994, P NATL ACAD SCI USA, V91, P5480, DOI 10.1073/pnas.91.12.5480; Huang CYF, 1996, EMBO J, V15, P2169, DOI 10.1002/j.1460-2075.1996.tb00570.x; IZUMI T, 1992, MOL BIOL CELL, V3, P927, DOI 10.1091/mbc.3.8.927; IZUMI T, 1993, MOL BIOL CELL, V4, P1337, DOI 10.1091/mbc.4.12.1337; Karaiskou A, 1999, J CELL SCI, V112, P3747; Karaiskou A, 1998, EXP CELL RES, V244, P491, DOI 10.1006/excr.1998.4220; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; KOSAKO H, 1994, EMBO J, V13, P2131, DOI 10.1002/j.1460-2075.1994.tb06489.x; KUANG J, 1993, J CELL BIOL, V123, P859, DOI 10.1083/jcb.123.4.859; KUANG J, 1991, DEV BIOL, V144, P54, DOI 10.1016/0012-1606(91)90478-L; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; LEWIS T, 1995, J CELL SCI, V108, P2885; Liu X, 2004, ONCOGENE, V23, P763, DOI 10.1038/sj.onc.1207188; Margolis SS, 2006, MOL BIOL CELL, V17, P1779, DOI 10.1091/mbc.E05-08-0751; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; NEBREDA AR, 1993, EMBO J, V12, P1979, DOI 10.1002/j.1460-2075.1993.tb05847.x; NEBREDA AR, 1995, EMBO J, V14, P5597, DOI 10.1002/j.1460-2075.1995.tb00247.x; Okano-Uchida T, 2003, EMBO J, V22, P5633, DOI 10.1093/emboj/cdg535; Palmer A, 2000, Prog Cell Cycle Res, V4, P131; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Perdiguero E, 2004, CELL CYCLE, V3, P733; RIME H, 1990, CELL DIFFER DEV, V29, P47, DOI 10.1016/0922-3371(90)90023-P; Roberts EC, 2002, MOL CELL BIOL, V22, P7226, DOI 10.1128/MCB.22.20.7226-7241.2002; SHIBUYA EK, 1992, P NATL ACAD SCI USA, V89, P9831, DOI 10.1073/pnas.89.20.9831; Sillje HHW, 2003, SCIENCE, V299, P1190; Sohaskey ML, 2002, MOL BIOL CELL, V13, P454, DOI 10.1091/mbc.01-11-0553; STRAUSFELD U, 1994, J BIOL CHEM, V269, P5989; Tanoue TJ, 2003, CELL SIGNAL, V15, P455, DOI 10.1016/S0898-6568(02)00112-2; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; Wright JH, 1999, P NATL ACAD SCI USA, V96, P11335, DOI 10.1073/pnas.96.20.11335; WU M, 1980, DEV BIOL, V79, P455; Wu Y, 2001, DIFFERENTIATION, V67, P139, DOI 10.1046/j.1432-0436.2001.670406.x; Yue JB, 2004, CURR BIOL, V14, P1581, DOI 10.1016/j.cub.2004.08.056	56	101	106	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2007	128	6					1119	1132		10.1016/j.cell.2006.11.053	http://dx.doi.org/10.1016/j.cell.2006.11.053			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382881	Green Submitted, Bronze			2022-12-28	WOS:000245396200018
J	Zheng, YC; Lay, T; Flanagan, MP; Williams, Q				Zheng, Yingcai; Lay, Thorne; Flanagan, Megan P.; Williams, Quentin			Pervasive seismic wave reflectivity and metasomatism of the Tonga mantle wedge	SCIENCE			English	Article							SUBDUCTION ZONES; SS-PRECURSORS; HIGH-PRESSURE; DISCONTINUITY; BENEATH; ARC; LITHOSPHERE; CONSTRAINTS; DENSITIES; REGION	Subduction zones play critical roles in the recycling of oceanic lithosphere and the generation of continental crust. Seismic imaging can reveal structures associated with key dynamic processes occurring in the upper-mantle wedge above the sinking oceanic slab. Three-dimensional images of reflecting interfaces throughout the upper-mantle wedge above the subducting Tonga slab were obtained by migration of teleseismic recordings of underside P- and S-wave reflections. Laterally continuous weak reflectors with tens of kilometers of topography were detected at depths near 90, 125, 200, 250, 300, 330, 390, 410, and 450 kilometers. P- and S-wave impedances decreased at the 330-kilometer and 450-kilometer reflectors, and S-wave impedance decreased near 200 kilometers in the vicinity of the slab and near 390 kilometers, just above the global 410-kilometer increase. The pervasive seismic reflectivity results from phase transitions and compositional zonation associated with extensive metasomatism involving slab-derived fluids rising through the wedge.	Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; Lawrence Livermore Natl Lab, Energy & Environm Directorate, Inst Geophys & Planetary Phys, Livermore, CA 94551 USA	University of California System; University of California Santa Cruz; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Lay, T (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA.	thorne@pmc.ucsc.edu	Lay, Thorne/ABE-6272-2021; Flanagan, Megan/AAW-1613-2020	Flanagan, Megan/0000-0002-5389-3872; Zheng, Yingcai/0000-0001-9179-8940				Anderson DL, 2006, TECTONOPHYSICS, V416, P7, DOI 10.1016/j.tecto.2005.07.011; Arai S, 2003, ISL ARC, V12, P233, DOI 10.1046/j.1440-1738.2003.00392.x; Bass JD., 1995, MINERAL PHYS CRYSTAL, V2, P45, DOI DOI 10.1029/RF002P0045; BEVIS M, 1995, NATURE, V374, P249, DOI 10.1038/374249a0; BOETTCHER AL, 1968, CONTRIB MINERAL PETR, V17, P224, DOI DOI 10.1007/BF00388945; Chen L, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003666; Chen WP, 2001, SCIENCE, V292, P2475, DOI 10.1126/science.292.5526.2475; Conder JA, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001113; Deuss A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014768; ENGDAHL ER, 1998, J GEOPHYS RES, V88, P3247; Flanagan MP, 1998, J GEOPHYS RES-SOL EA, V103, P21165, DOI 10.1029/98JB00595; GAHERTY JB, 1995, SCIENCE, V268, P1468, DOI 10.1126/science.268.5216.1468; Ganguly J, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003910; Gilbert HJ, 2001, GEOPHYS RES LETT, V28, P1855, DOI 10.1029/2000GL012192; Gurnis M, 2000, GEOPHYS RES LETT, V27, P2373, DOI 10.1029/2000GL011420; Hacker BR, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001127; IIBI R, 2005, J GEOPHYS RES, V110; Kelley KA, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003732; KENNETT BLN, 1991, GEOPHYS J INT, V105, P429, DOI 10.1111/j.1365-246X.1991.tb06724.x; Kent AJR, 2002, EARTH PLANET SC LETT, V202, P361, DOI 10.1016/S0012-821X(02)00786-0; Kung J, 2004, PHYS EARTH PLANET IN, V147, P27, DOI 10.1016/j.pepi.2004.05.008; Li X, 2000, EARTH PLANET SC LETT, V183, P527, DOI 10.1016/S0012-821X(00)00294-6; Prouteau G, 2001, NATURE, V410, P197, DOI 10.1038/35065583; REVENAUGH J, 1991, J GEOPHYS RES-SOL EA, V96, P19781, DOI 10.1029/91JB01487; REVENAUGH J, 1994, NATURE, V369, P474, DOI 10.1038/369474a0; Rost S, 2001, GEOPHYS J INT, V147, P12, DOI 10.1046/j.1365-246X.2001.00497.x; Roth EG, 1999, J GEOPHYS RES-SOL EA, V104, P4795, DOI 10.1029/1998JB900052; Schmidt MW, 1998, EARTH PLANET SC LETT, V163, P361, DOI 10.1016/S0012-821X(98)00142-3; SHEARER PM, 1993, GEOPHYS J INT, V115, P878, DOI 10.1111/j.1365-246X.1993.tb01499.x; Smith GP, 2001, SCIENCE, V292, P713, DOI 10.1126/science.1058763; Song TRA, 2004, NATURE, V427, P530, DOI 10.1038/nature02231; Suzuki A, 2003, PHYS CHEM MINER, V30, P449, DOI 10.1007/s00269-003-0322-6; Turner S, 1997, NATURE, V389, P568, DOI 10.1038/39257; VANDERHILST R, 1995, NATURE, V374, P154, DOI 10.1038/374154a0; VIDALE JE, 1992, NATURE, V356, P678, DOI 10.1038/356678a0; Williams Q, 2005, GEOLOGY, V33, P1, DOI 10.1130/G20968.1; Zanetti A, 1999, CONTRIB MINERAL PETR, V134, P107, DOI 10.1007/s004100050472; ZHANG Z, 1993, J GEOPHYS RES-SOL EA, V98, P4389, DOI 10.1029/92JB02050; Zhao DP, 1997, SCIENCE, V278, P254, DOI 10.1126/science.278.5336.254; Zheng YC, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003724	40	33	33	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2007	316	5826					855	859		10.1126/science.1138074	http://dx.doi.org/10.1126/science.1138074			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17431138				2022-12-28	WOS:000246369800029
J	Amorim, C; Douste-Blazy, P; Wirayuda, H; Store, JG; Gadio, CT; Dlamini-Zuma, N; Pibulsonggram, N				Amorim, Celso; Douste-Blazy, Philippe; Wirayuda, Hasan; Store, Jonas Gahr; Gadio, Cheikh Tidiane; Dlamini-Zuma, Nkosazana; Pibulsonggram, Nitya			Oslo Ministerial Declaration - global health: a pressing foreign policy issue of our time	LANCET			English	Article								Under their initiative on Global Health and Foreign Policy, launched in September, 2006, in New York, the Ministers of Foreign Affairs of Brazil, France, Indonesia, Norway, Senegal, South Africa, and Thailand issued the following statement in Oslo on March 20, 2007-In today's era of globalisation and interdependence there is an urgent need to broaden the scope of foreign policy. Together, we face a number of pressing challenges that require concerted responses and collaborative efforts. We must encourage new ideas, seek and develop new partnerships and mechanisms, and create new paradigms of cooperation. We believe that health is one of the most important, yet still broadly neglected, long-term foreign policy issues of our time. Life and health are our most precious assets. There is a growing awareness that investment in health is fundamental to economic growth and development. It is generally acknowledged that threats to health may compromise a country's stability and security. We believe that health as a foreign policy issue needs a stronger strategic focus on the international agenda. We have therefore agreed to make impact on health a point of departure and a defining lens that each of our countries will use to examine key elements of foreign policy and development strategies, and to engage in a dialogue on how to deal with policy options from this perspective. As Ministers of Foreign Affairs, we will work to: increase awareness of our common vulnerability in the face of health threats by bringing health issues more strongly into the arenas of foreign policy discussions and decisions, in order to strengthen our commitment to concerted action at the global level; build bilateral, regional and multilateral cooperation for global health security by strengthening the case for collaboration and brokering broad agreement, accountability, and action; reinforce health as a key element in strategies for development and for fighting poverty, in order to reach the Millennium Development Goals; ensure that a higher priority is given to health in dealing with trade issues and in conforming to the Doha principles, affirming the right of each country to make full use of TRIPS flexibilities in order to ensure universal access to medicines; strengthen the place of health measures in conflict and crisis management and in reconstruction efforts. For this purpose, we have prepared a first set of actionable steps for raising the priority of health in foreign policy in an Agenda for Action. We pledge to pursue these issues in our respective regional settings and in relevant international bodies. We invite Ministers of Foreign Affairs from all regions to join us in further exploring ways and means to achieve our objectives.			Store, JG (corresponding author), Royal Norwegian Minist Foreign Affairs, POB 8114 Dep, N-0032 Oslo, Norway.	post@mfa.no							0	121	126	0	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1373	1378		10.1016/S0140-6736(07)60498-X	http://dx.doi.org/10.1016/S0140-6736(07)60498-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	159HL	17448824				2022-12-28	WOS:000245856100031
J	Telford, MJ				Telford, Maximilian J.			A single origin of the central nervous system?	CELL			English	Editorial Material								As Denes et al. (2007) reveal in this issue, the expression profile and roles of genes that pattern the nervous system in embryos of chordates and annelids are surprisingly similar. This extraordinary conservation suggests that the patterning mechanism has been inherited largely unchanged from the bilaterian common ancestor and that the central nervous system, although dorsal in fish and ventral in worms, is an ancient characteristic of animals.	UCL, Dept Biol, London WC1E 6BT, England	University of London; University College London	Telford, MJ (corresponding author), UCL, Dept Biol, Darwin Bldg,Gower St, London WC1E 6BT, England.	m.telford@ucl.ac.uk	Telford, Maximilian J/B-7178-2008	Telford, Maximilian J/0000-0002-3749-5620				ARENDT D, 1994, NATURE, V380, P37; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; Dohrn A., 1875, URSPRUNG WIRBELTHIER; Lowe CJ, 2006, PLOS BIOL, V4, P1603, DOI 10.1371/journal.pbio.0040291; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; Matus DQ, 2006, P NATL ACAD SCI USA, V103, P11195, DOI 10.1073/pnas.0601257103	6	9	9	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2007	129	2					237	239		10.1016/j.cell.2007.03.035	http://dx.doi.org/10.1016/j.cell.2007.03.035			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448982	Bronze			2022-12-28	WOS:000246474600008
J	Ravdin, PM; Cronin, KA; Howlader, N; Berg, CD; Chlebowski, RT; Feuer, EJ; Edwards, BK; Berry, DA				Ravdin, Peter M.; Cronin, Kathleen A.; Howlader, Nadia; Berg, Christine D.; Chlebowski, Rowan T.; Feuer, Eric J.; Edwards, Brenda K.; Berry, Donald A.			The decrease in breast-cancer incidence in 2003 in the United States.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HORMONE REPLACEMENT THERAPY	An initial analysis of data from the National Cancer Institute's Surveillance, Epidemiology, and End Results ( SEER) registries shows that the age-adjusted incidence rate of breast cancer in women in the United States fell sharply ( by 6.7%) in 2003, as compared with the rate in 2002. Data from 2004 showed a leveling off relative to the 2003 rate, with little additional decrease. Regression analysis showed that the decrease began in mid-2002 and had begun to level off by mid-2003. A comparison of incidence rates in 2001 with those in 2004 ( omitting the years in which the incidence was changing) showed that the decrease in annual age-adjusted incidence was 8.6% (95% confidence interval [CI], 6.8 to 10.4). The decrease was evident only in women who were 50 years of age or older and was more evident in cancers that were estrogen-receptor - positive than in those that were estrogen-receptor - negative. The decrease in breast-cancer incidence seems to be temporally related to the first report of the Women's Health Initiative and the ensuing drop in the use of hormone-replacement therapy among postmenopausal women in the United States. The contributions of other causes to the change in incidence seem less likely to have played a major role but have not been excluded.	Univ Texas, MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; NCI, Div Canc Prevent, Bethesda, MD 20892 USA; Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA	University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Ravdin, PM (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Biostat, 1515 Holcombe Blvd, Houston, TX 77030 USA.							Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Buist DSM, 2004, OBSTET GYNECOL, V104, P1042, DOI 10.1097/01.AOG.0000143826.38439.af; Collaborative Group on Hormonal Factors in Breast Cancer, 1997, LANCET, V350, P1484; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Freedman Andrew N., 2004, EJC Supplements, V2, P17; Haller DG, 2006, J CLIN ONCOL, V24, p149S; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; Howe HL, 2006, CANCER-AM CANCER SOC, V107, P1711, DOI 10.1002/cncr.22193; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; *NAT CTR HLTH STAT, 2006, DHHS PUBL, P313; Porter PL, 1999, J NATL CANCER I, V91, P2020, DOI 10.1093/jnci/91.23.2020; POWLES TJ, 1995, LANCET, V345, P1442, DOI 10.1016/S0140-6736(95)92632-1; Prasad R, 2003, CANCER, V98, P2539, DOI 10.1002/cncr.11836; Ravdin PM, 2006, BREAST CANCER RES TR, V100, pS6; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; DRUG TOPICS DRUGS UN	18	706	722	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2007	356	16					1670	1674		10.1056/NEJMsr070105	http://dx.doi.org/10.1056/NEJMsr070105			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AB	17442911				2022-12-28	WOS:000245762000012
J	Berman, B				Berman, Brian			A 60-year-old woman considering acupuncture for knee pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INTRAARTICULAR HYALURONIC-ACID; ALTERNATIVE MEDICINE; ELECTRICAL-STIMULATION; PLACEBO CONTROLS; UNITED-STATES; OSTEOARTHRITIS; ELECTROACUPUNCTURE; COMPLEMENTARY; ARTHRITIS	Mrs A, an active 60-year-old woman, has a history of degenerative osteoarthritis of her knee with pain that has progressed over the past 8 years. She has undergone arthroscopic surgery for a meniscal tear and has taken nonsteroidal anti-inflammatory drugs ( NSAIDs), glucosamine, and chondroitin sulfate occasionally, but generally does not like taking medications. She is open to other therapeutic approaches and wants to know if acupuncture can help the pain, improve function, and stop her condition from progressing. The evidence for the effectiveness of acupuncture for knee pain and other common treatments, including exercise, NSAIDs, glucosamine and chondroitin, and intra-articular knee injections are compared, and costs and methods of acupuncture and selecting an acupuncturist are discussed.	Univ Maryland, Sch Med, Kernan Hosp Mans, Ctr Integrat Med, Baltimore, MD 21207 USA	University System of Maryland; University of Maryland Baltimore	Berman, B (corresponding author), Univ Maryland, Sch Med, Kernan Hosp Mans, Ctr Integrat Med, 2200 Kernan Dr, Baltimore, MD 21207 USA.	bberman@compmed.umm.edu			NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [U01AT000171] Funding Source: NIH RePORTER	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		Altman RD, 2004, J RHEUMATOL, V31, P5; Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; [Anonymous], COCHRANE HDB SYSTEMA; Arrich J, 2005, CAN MED ASSOC J, V172, DOI 10.1503/cmaj.1041203; Arroll B, 2004, BMJ-BRIT MED J, V328, P869, DOI 10.1136/bmj.38039.573970.7C; Barnes Patricia M, 2004, Adv Data, P1; Bellamy N, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005321.pub2; Berman BM, 2002, ARCH INTERN MED, V162, P766, DOI 10.1001/archinte.162.7.766; Berman BM, 2004, ANN INTERN MED, V141, P901, DOI 10.7326/0003-4819-141-12-200412210-00006; Berman BM, 2000, PAIN, V85, P313, DOI 10.1016/S0304-3959(00)00258-X; Birch S, 2006, J ALTERN COMPLEM MED, V12, P303, DOI 10.1089/acm.2006.12.303; Bjordal JM, 2004, BMJ-BRIT MED J, V329, P1317, DOI 10.1136/bmj.38273.626655.63; Bleumink GS, 2003, DRUGS, V63, P525, DOI 10.2165/00003495-200363060-00001; Burr DB, 2004, J RHEUMATOL, V31, P77; CHENG X, 1987, KCHINESE ACUPUNCTURE, P361; CHRISTENSEN BV, 1992, ACTA ANAESTH SCAND, V36, P519, DOI 10.1111/j.1399-6576.1992.tb03511.x; Clegg DO, 2006, NEW ENGL J MED, V354, P795, DOI 10.1056/NEJMoa052771; Cohen J., 1988, STAT POWER ANAL BEHA, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; *COMM US COMPL ALT, 2005, COMPL ALT MED US; DENNISON E, 2003, RHEUMATOLOGY, P1781; ECKMAN P, 2002, CONT CHINESE MED ACU, P12; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Ernst E, 2001, AM J MED, V110, P481, DOI 10.1016/S0002-9343(01)00651-9; Eskinazi D, 1998, J ALTERN COMPLEM MED, V4, P459, DOI 10.1089/acm.1998.4.459; Eskinazi D P, 1996, J Altern Complement Med, V2, P3, DOI 10.1089/acm.1996.2.3; FAIRCLOUGH JA, 2003, RHEUMATOLOGY, P661; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Felson DT, 2000, ANN INTERN MED, V133, P726, DOI 10.7326/0003-4819-133-9-200011070-00015; FELSON DT, 2003, OSTEOARTHRITIS, P9; FEMANDES JC, 2002, BIORHEOLOGY, V39, P237; Fransen M, 2003, COCHRANE DB SYST REV, V3; Furlan AD, 2006, CAN MED ASSOC J, V174, P1589, DOI 10.1503/cmaj.051528; Han JS, 2003, TRENDS NEUROSCI, V26, P17, DOI 10.1016/S0166-2236(02)00006-1; Herman Carla J, 2004, Prev Chronic Dis, V1, pA12; Hernandez-Diaz S, 2000, ARCH INTERN MED, V160, P2093, DOI 10.1001/archinte.160.14.2093; Hernandez-Diaz Sonia, 2001, American Journal of Medicine, V110, p20S; HOCHBERG MC, 1995, ARTHRITIS RHEUM, V38, P1541, DOI 10.1002/art.1780381104; Huang MH, 2003, SEMIN ARTHRITIS RHEU, V32, P398, DOI 10.1053/sarh.2003.50021; Hui KKS, 2005, NEUROIMAGE, V27, P479, DOI 10.1016/j.neuroimage.2005.04.037; Hui KKS, 2000, HUM BRAIN MAPP, V9, P13, DOI 10.1002/(SICI)1097-0193(2000)9:1<13::AID-HBM2>3.0.CO;2-F; HUNTER DJ, 2004, AM COLL RHEUM 68 ANN; JANSEN G, 1989, NEUROSCI LETT, V97, P305, DOI 10.1016/0304-3940(89)90615-0; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; KABATZINN J, 1985, J BEHAV MED, V8, P163, DOI 10.1007/BF00845519; *KAIS FAM FDN HLTH, 2004, EMPL HLTH BEN 2004 A; KASHIBA H, 1991, AM J CHINESE MED, V19, P189, DOI 10.1142/S0192415X91000260; Kirkley A, 1999, J BONE JOINT SURG AM, V81A, P539, DOI 10.2106/00004623-199904000-00012; Langevin HM, 2001, FASEB J, V15, P2275, DOI 10.1096/fj.01-0015hyp; Lao L, 1996, J Altern Complement Med, V2, P27, DOI 10.1089/acm.1996.2.27; Lao LX, 2004, BRAIN RES, V1020, P18, DOI 10.1016/j.brainres.2004.01.092; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Lee GS, 2003, BRAIN RES BULL, V62, P161, DOI 10.1016/j.brainresbull.2003.09.007; LEONG M L, 1987, Alternative Medicine, V2, P103; LEWITH GT, 1984, SOC SCI MED, V19, P1367, DOI 10.1016/0277-9536(84)90026-1; Lin FY, 2004, BMJ-BRIT MED J, V329, P324, DOI 10.1136/bmj.38159.639028.7C; Lo GH, 2003, JAMA-J AM MED ASSOC, V290, P3115, DOI 10.1001/jama.290.23.3115; Lorig K, 1998, ARTHRIT CARE RES, V11, P448, DOI 10.1002/art.1790110604; MacPherson H, 2001, BMJ-BRIT MED J, V323, P486, DOI 10.1136/bmj.323.7311.486; McAlindon TE, 2000, JAMA-J AM MED ASSOC, V283, P1469, DOI 10.1001/jama.283.11.1469; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Michel BA, 2005, ARTHRITIS RHEUM-US, V52, P779, DOI 10.1002/art.20867; Osiri M., 2000, COCHRANE DB SYST REV, pCD002823, DOI [10.1002/14651858.CD002823, DOI 10.1002/14651858.CD002823, 10.1002/14651858.cd002823]; Pariente J, 2005, NEUROIMAGE, V25, P1161, DOI 10.1016/j.neuroimage.2005.01.016; Paterson C, 2005, BMJ-BRIT MED J, V330, P1202, DOI 10.1136/bmj.330.7501.1202; POMERANZ B, 1988, SCI BASIS ACUPUNCTUR; PRADHAN EK, 2005, 2005 AM COLL RHEUM A; Quandt SA, 2005, ARTHRIT RHEUM-ARTHR, V53, P748, DOI 10.1002/art.21443; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; Ramsey SD, 2001, ARTHRIT RHEUM-ARTHR, V45, P222, DOI 10.1002/1529-0131(200106)45:3<222::AID-ART252>3.0.CO;2-N; Rao JK, 1999, ANN INTERN MED, V131, P409, DOI 10.7326/0003-4819-131-6-199909210-00003; Richy F, 2003, ARCH INTERN MED, V163, P1514, DOI 10.1001/archinte.163.13.1514; Rodriguez LAG, 2000, EPIDEMIOLOGY, V11, P382, DOI 10.1097/00001648-200007000-00004; Scharf HP, 2006, ANN INTERN MED, V145, P12, DOI 10.7326/0003-4819-145-1-200607040-00005; Tang NM, 1997, PAIN, V71, P71, DOI 10.1016/S0304-3959(97)03341-1; Towheed TE, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002946.pub2; TOWHEED TE, 2003, COCHRANE DB SYST REV, V2; Tramer MR, 2000, PAIN, V85, P169, DOI 10.1016/S0304-3959(99)00267-5; TURNER JA, 1994, JAMA-J AM MED ASSOC, V271, P1609, DOI 10.1001/jama.271.20.1609; Unschuld Paul O., 1985, MED CHINA HIST IDEAS; *US COMM HLTH ED L, 2004, CTR DIS CONTR ROL CO; Vas J, 2004, BMJ-BRIT MED J, V329, P1216, DOI 10.1136/bmj.38238.601447.3A; VINCENT C, 1995, J ROY SOC MED, V88, P199; Wan Y, 2001, PAIN, V91, P5, DOI 10.1016/S0304-3959(00)00416-4; Watkins PB, 2006, JAMA-J AM MED ASSOC, V296, P87, DOI 10.1001/jama.296.1.87; Whelton A., 1999, AM J MED, V106, p13S, DOI [10.1016/s0002-9343(99)00113-8, DOI 10.1016/S0002-9343(99)00113-8]; White A, 2007, RHEUMATOLOGY, V46, P384, DOI 10.1093/rheumatology/kel413; White AR, 2001, COMPLEMENT THER MED, V9, P237, DOI 10.1054/ctim.2001.0489; White P, 2004, ANN INTERN MED, V141, P911, DOI 10.7326/0003-4819-141-12-200412210-00007; Wilcox CM, 2006, CLIN GASTROENTEROL H, V4, P1082, DOI 10.1016/j.cgh.2006.04.010; Witt C, 2005, LANCET, V366, P136, DOI 10.1016/S0140-6736(05)66871-7; Wu CW, 2005, CLIN GERIATR MED, V21, P589, DOI 10.1016/j.cger.2005.02.008; Wyatt FB, 2001, J STRENGTH COND RES, V15, P337; Yelin E, 1998, OSTEOARTHRITIS, P23; Zhang LX, 1997, BRAIN RES, V745, P158, DOI 10.1016/S0006-8993(96)01095-5; Zhang RX, 2005, J ALTERN COMPLEM MED, V11, P135, DOI 10.1089/acm.2005.11.135; 2002, Z RHEUMATOL, V61, P229	97	14	17	3	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2007	297	15					1697	1707		10.1001/jama.297.15.1697	http://dx.doi.org/10.1001/jama.297.15.1697			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	157UR	17440146				2022-12-28	WOS:000245747400023
J	Grinsztejn, B; Nguyen, BY; Katlama, C; Gatell, JM; Lazzarin, A; Vittecoq, D; Gonzalez, CJ; Chen, J; Harvey, CM; Isaacs, RD				Grinsztejn, Beatriz; Nguyen, Bach-Yen; Katlama, Christine; Gatell, Jose M.; Lazzarin, Adriano; Vittecoq, Daniel; Gonzalez, Charles J.; Chen, Joshua; Harvey, Charlotte M.; Isaacs, Robin D.		Protocol 005 Team	Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial	LANCET			English	Article							DRUG-RESISTANCE; ANTIRETROVIRAL DRUGS; HIV-1-INFECTED INDIVIDUALS; THERAPY; ENFUVIRTIDE; PREVALENCE; INFECTION	Background Raltegravir (MK-0518) is an HIV-1 integrase inhibitor with potent in-vitro activity against HIV-1 strains including those resistant to currently available antiretroviral drugs. The aim of this study was to assess the safety and efficacy of raltegravir when added to optimised background regimens in HIV-infected patients. Methods HIV-infected patients with HIV-1 RNA viral load over 5000 copies per mL, CD4 cell counts over 50 cells per mu L, and documented genotypic and phenotypic resistance to at least one nucleoside reverse transcriptase inhibitor, one non-nucleoside reverse transcriptase inhibitor, and one protease inhibitor were randomly assigned to receive raltegravir (200 mg, 400 mg, or 600 mg) or placebo orally twice daily in this multicentre, triple-blind, dose-ranging, randomised study. The primary endpoints were change in viral load from baseline at week 24 and safety. Analyses were done on a modified intention-to-treat basis. This trial is registered with ClinicalTrials.gov, with the number NCT00105157. Findings 179 patients were eligible for randomisation. 44 patients were randomly assigned to receive 200 mg raltegravir, 45 to receive 400 mg raltegravir, and 45 to receive 600 mg raltegravir; 45 patients were randomly assigned to receive placebo. One patient in the 200 mg group did not receive treatment and was therefore excluded from the analyses. For all groups, the median duration of previous antiretroviral therapy was 9.9 years (range 0.4-17.3 years) and the mean baseline viral load was 4.7 (SD 0.5) log(10) copies per mL. Four patients discontinued due to adverse experiences, three (2%) of the 133 patients across all raltegravir groups and one (2%) of the 45 patients on placebo. 41 patients discontinued due to lack of efficacy: 14 (11%) of the 133 patients across all raltegravir groups and 27 (60%) of the 45 patients on placebo. At week 24, mean change in viral load from baseline was -1.80 (95% CI -2.10 to -1.50) log(10) copies per mL in the 200 mg group, -1.87 (-2.16 to -1.58) log(10) copies per mL in the 400 mg group, -1.84 (-2.10 to -1.58) log(10) copies per mL in the 600 mg group, and -0.35 (-0.61 to -0.09) log(10) copies per mL for the placebo group. Raltegravir at all doses showed a safety profile much the same as placebo; there were no dose-related toxicities. Interpretation In patients with few remaining treatment options, raltegravir at all doses studied provided better viral suppression than placebo when added to an optimised background regimen. The safety profile of raltegravir is comparable with that of placebo at all doses studied.	Fundacao Oswaldo Cruz, Evandro Chagas Clin Res Inst, Rio De Janeiro, Brazil; Merck Res Labs, West Point, PA USA; Hop La Pitie Salpetriere, Paris, France; Univ Barcelona, Barcelona, Spain; Ist Sci San Raffaele, I-20132 Milan, Italy; Hop Paul Brousse, Villejuif, France; NYU, Sch Med, New York, NY USA	Fundacao Oswaldo Cruz; Merck & Company; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Barcelona; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; New York University	Nguyen, BY (corresponding author), Merck Res Labs, POB 1000, N Wales, PA 19454 USA.	bachyen-nguyen@merck.com	Gatell, Jose M/ABC-3607-2020; LAZZARIN, Adriano/K-3607-2018	LAZZARIN, Adriano/0000-0003-2551-7754				Couto-Fernandez JC, 2005, MEM I OSWALDO CRUZ, V100, P73, DOI 10.1590/S0074-02762005000100014; de Bethune MP, 2006, CURR MED RES OPIN, V22, P2603, DOI 10.1185/030079906X154114; De Clercq Erik, 2005, Expert Opin Emerg Drugs, V10, P241, DOI 10.1517/14728214.10.2.241; *DHHS PAN OFF AIDS, 2006, GUID US ANT AG HIV 1; Gulick RM, 2003, CLIN MICROBIOL INFEC, V9, P186, DOI 10.1046/j.1469-0691.2003.00570.x; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Hicks CB, 2006, LANCET, V368, P466, DOI 10.1016/S0140-6736(06)69154-X; IWAMOTO M, 2006, 46 ANN INT C ANT AG; KASSAHUN K, 2006, 46 ANN INT C ANT AG; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; Machouf N, 2006, J MED VIROL, V78, P608, DOI 10.1002/jmv.20582; MARKOWITZ M, 2006, 16 INT AIDS C TOR CA; Markowitz M, 2006, JAIDS-J ACQ IMM DEF, V43, P509, DOI 10.1097/QAI.0b013e31802b4956; Miller M., 2006, 16 INT AIDS C TOR CA; MISTRY GC, 2006, 8 INT C DRUG THER HI; Richman DD, 2004, AIDS, V18, P1393, DOI 10.1097/01.aids.0000131310.52526.c7; Tozzi V, 2006, ANTIVIR THER, V11, P553; WENNING LA, 2006, 46 ANN INT C ANT AG; YOUNG B, 2006, JAAPA S, V1, P3	21	447	464	2	27	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 14	2007	369	9569					1261	1269		10.1016/S0140-6736(07)60597-2	http://dx.doi.org/10.1016/S0140-6736(07)60597-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164YA	17434401				2022-12-28	WOS:000246269700028
J	Tuthill, PG; Lloyd, JP				Tuthill, P. G.; Lloyd, J. P.			A symmetric bipolar nebula around MWC 922	SCIENCE			English	Article							RED-RECTANGLE		Univ Sydney, Dept Phys, Sydney, NSW 2006, Australia; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA	University of Sydney; Cornell University	Tuthill, PG (corresponding author), Univ Sydney, Dept Phys, Sydney, NSW 2006, Australia.	p.tuthill@physics.usyd.edu.au	Lloyd, James P/B-3769-2011	Tuthill, Peter/0000-0001-7026-6291				Cohen M, 2004, ASTRON J, V127, P2362, DOI 10.1086/382902; Jura M, 1997, ASTROPHYS J, V474, P741, DOI 10.1086/303476; LUBOW SH, 1993, ASTROPHYS J, V409, P360, DOI 10.1086/172669; Molster FJ, 2002, ASTRON ASTROPHYS, V382, P184, DOI 10.1051/0004-6361:20011550; RUDY RJ, 1992, ASTROPHYS J, V398, P278, DOI 10.1086/171855; SMITH N, IN PRESS ASTRON J	6	16	16	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					247	247		10.1126/science.1135950	http://dx.doi.org/10.1126/science.1135950			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431173				2022-12-28	WOS:000245654500043
J	Bruey, JM; Bruey-Sedano, N; Luciano, F; Zhai, DY; Balpai, R; Xu, CY; Kress, CL; Bailly-Maitre, B; Li, XQ; Osterman, A; Matsuzawa, SI; Terskikh, AV; Faustin, B; Reed, JC				Bruey, Jean-Marie; Bruey-Sedano, Nathalie; Luciano, Frederic; Zhai, Dayong; Balpai, Ruchi; Xu, Chunyan; Kress, Christina L.; Bailly-Maitre, Beatrice; Li, Xiaoqing; Osterman, Andrei; Matsuzawa, Shu-ichi; Terskikh, Alexey V.; Faustin, Benjamin; Reed, John C.			Bcl-2 and Bcl-X-L regulate proinf lammatory caspase-1 activation by interaction with NALP1	CELL			English	Article							BACTERIAL MURAMYL DIPEPTIDE; PROGRAMMED CELL-DEATH; INFLAMMATORY CASPASES; IMMUNE-SYSTEM; CYTOCHROME-C; APOPTOSIS; INNATE; IDENTIFICATION; IPAF; BAX	Caspases are intracellular proteases that cleave substrates involved in apoptosis or inflammation. In C. elegans, a paradigm for caspase regulation exists in which caspase CED-3 is activated by In ucleotide-binding protein CED-4, which is suppressed by Bcl-2-family protein CED-9. We have identified a mammalian analog of this caspase-regulatory system in the NLR-family protein NALP1, a nucleotide-dependent activator of cytokine-processing protease caspase-1, which responds to bacterial ligand muramyl-dipeptide (MDP). Antiapoptotic proteins Bcl-2 and Bcl-X-L bind and suppress NALP1, reducing caspase-1 activation and interleukin-1 beta (IL-1 beta) production. When exposed to MDP, Bcl-2-deficient macrophages exhibit more caspase-1 processing and IL-1 beta production, whereas Bcl-2-overexpressing macrophages demonstrate less caspase-1 processing and IL-1 beta production. The findings reveal an interaction of host defense and apoptosis machinery.	Burnham Inst Med Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), Burnham Inst Med Res, La Jolla, CA 92037 USA.	reedoffice@burnham.org	luciano, frederic/P-6264-2016; Terskikh, Alexey/U-8407-2019	luciano, frederic/0000-0001-9253-4998; Bailly-Maitre, Beatrice/0000-0002-8389-8498				Adams JM, 2002, CURR OPIN CELL BIOL, V14, P715, DOI 10.1016/S0955-0674(02)00381-2; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Chang BS, 1997, EMBO J, V16, P968, DOI 10.1093/emboj/16.5.968; Chu ZL, 2001, J BIOL CHEM, V276, P9239, DOI 10.1074/jbc.M006309200; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Kufer TA, 2005, TRENDS MICROBIOL, V13, P381, DOI 10.1016/j.tim.2005.06.004; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Navarre WW, 2000, CELL MICROBIOL, V2, P265, DOI 10.1046/j.1462-5822.2000.00056.x; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Saito H, 2003, MECH AGEING DEV, V124, P1047, DOI 10.1016/j.mad.2003.08.002; Stehlik C, 2004, J EXP MED, V200, P551, DOI 10.1084/jem.20032234; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Wang SJ, 2005, DEV BIOL, V279, P205, DOI 10.1016/j.ydbio.2004.12.017; Yan N, 2005, NATURE, V437, P831, DOI 10.1038/nature04002; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; ZHAI D, 2006, IN PRESS CELL DEATH; Zhang WH, 2003, P NATL ACAD SCI USA, V100, P16012, DOI 10.1073/pnas.2534856100; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	32	248	267	1	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					45	56		10.1016/j.cell.2007.01.045	http://dx.doi.org/10.1016/j.cell.2007.01.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418785	Bronze			2022-12-28	WOS:000245661100010
J	Lynch-Stieglitz, J; Adkins, JF; Curry, WB; Dokken, T; Hall, IR; Herguera, JC; Hirschi, JJM; Ivanova, EV; Kissel, C; Marchal, O; Marchitto, TM; McCave, IN; McManus, JF; Mulitza, S; Ninnemann, U; Peeters, F; Yu, EF; Zahn, R				Lynch-Stieglitz, Jean; Adkins, Jess F.; Curry, William B.; Dokken, Trond; Hall, Ian R.; Herguera, Juan Carlos; Hirschi, Joel J. -M.; Ivanova, Elena V.; Kissel, Catherine; Marchal, Olivier; Marchitto, Thomas M.; McCave, I. Nicholas; McManus, Jerry F.; Mulitza, Stefan; Ninnemann, Ulysses; Peeters, Frank; Yu, Ein-Fen; Zahn, Rainer			Atlantic meridional overturning circulation during the Last Glacial Maximum	SCIENCE			English	Review							OCEAN THERMOHALINE CIRCULATION; DEEP-WATER CIRCULATION; NORTH-ATLANTIC; BENTHIC FORAMINIFERA; HEAT-TRANSPORT; CLIMATE; VARIABILITY; SIMULATION; AGE; RECONSTRUCTION	The circulation of the deep Atlantic Ocean during the height of the last ice age appears to have been quite different from today. We review observations implying that Atlantic meridional overturning circulation during the Last Glacial Maximum was neither extremely sluggish nor an enhanced version of present-day circulation. The distribution of the decay products of uranium in sediments is consistent with a residence time for deep waters in the Atlantic only slightly greater than today. However, evidence from multiple water-mass tracers supports a different distribution of deep-water properties, including density, which is dynamically linked to circulation.	Georgia Inst Technol, Atlanta, GA 30332 USA; CALTECH, Pasadena, CA 91125 USA; Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; Bjerknes Ctr Climate Res, N-5007 Bergen, Norway; Cardiff Univ, Cardiff CF10 3YE, S Glam, Wales; CICESE Oceanol, Ensenada, Baja California, Mexico; Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Russian Acad Sci, PP Shirshov Oceanol Inst, Moscow 117997, Russia; UVSQ, CNRS, CEA, Lab Sci Climat & Environm, F-91198 Gif Sur Yvette, France; Univ Colorado, Boulder, CO 80309 USA; Univ Cambridge, Cambridge CB2 3EQ, England; Univ Bremen, Forschungszentrum Ozeanrander MARUM, D-28334 Bremen, Germany; Univ Bergen, Bjerknes Ctr Climate Res, N-5007 Bergen, Norway; Vrije Univ Amsterdam, NL-1081 HV Amsterdam, Netherlands; Natl Taiwan Normal Univ, Dept Chem, Taipei 116, Taiwan; Univ Autonoma Barcelona, Inst Catalana Rec & Estudis Avancats, E-08193 Barcelona, Spain	University System of Georgia; Georgia Institute of Technology; California Institute of Technology; Woods Hole Oceanographic Institution; Bjerknes Centre for Climate Research; Cardiff University; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; NERC National Oceanography Centre; University of Southampton; Russian Academy of Sciences; Shirshov Institute of Oceanology; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); University of Colorado System; University of Colorado Boulder; University of Cambridge; University of Bremen; Bjerknes Centre for Climate Research; University of Bergen; Vrije Universiteit Amsterdam; National Taiwan Normal University; Autonomous University of Barcelona; ICREA	Lynch-Stieglitz, J (corresponding author), Georgia Inst Technol, Atlanta, GA 30332 USA.	jean@eas.gatech.edu	Lynch-Stieglitz, Jean/J-2277-2018; Ivanova, Elena/AAW-2881-2020; Herguera, Juan Carlos/B-7812-2016; Ivanova, Elena/B-3775-2016; Adkins, Jess/GYI-8778-2022; Hirschi, Joel/F-5631-2013; Dokken, Trond/AAE-9168-2021; Hall, Ian R/C-2755-2009; McCave, I. Nick/O-3992-2018; McCave, Nick N/G-7323-2016; Catherine, Kissel/AAH-1647-2019; Mulitza, Stefan/G-5357-2011	Lynch-Stieglitz, Jean/0000-0002-9353-1972; Ivanova, Elena/0000-0003-3926-0590; Herguera, Juan Carlos/0000-0001-8335-2607; Ivanova, Elena/0000-0003-3926-0590; Hirschi, Joel/0000-0003-1481-3697; Hall, Ian R/0000-0001-6960-1419; McCave, I. Nick/0000-0002-4702-5489; McCave, Nick N/0000-0002-4702-5489; Catherine, Kissel/0000-0002-2572-2742; Mulitza, Stefan/0000-0002-3842-1447; Peeters, Frank J.C./0000-0002-5678-9288	Natural Environment Research Council [NE/C509531/1, NER/A/S/2001/01189, NER/T/S/2002/00436] Funding Source: researchfish; ICREA Funding Source: Custom	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ICREA(ICREA)		Adkins JF, 2003, EARTH PLANET SC LETT, V216, P109, DOI 10.1016/S0012-821X(03)00502-8; Adkins JF, 1997, NATURE, V390, P154, DOI 10.1038/36540; Adkins JF, 1999, RECONSTRUCTING OCEAN HISTORY, P103; BACON MP, 1982, J GEOPHYS RES-OCEANS, V87, P2045, DOI 10.1029/JC087iC03p02045; Bickert T, 2004, SOUTH ATLANTIC IN THE LATE QUATERNARY: RECONSTRUCTION OF MATERIAL BUDGETS AND CURRENT SYSTEMS, P671; BOYLE EA, 1982, SCIENCE, V218, P784, DOI 10.1126/science.218.4574.784; BROECKER W, 1988, RADIOCARBON, V30, P261, DOI 10.1017/S0033822200044234; Chase Z, 2002, EARTH PLANET SC LETT, V204, P215, DOI 10.1016/S0012-821X(02)00984-6; Clark PU, 2002, NATURE, V415, P863, DOI 10.1038/415863a; Conkright M., 2002, NOAA ATLAS NESDIS42; Curry WB, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001021; CURRY WB, 1982, QUATERNARY RES, V18, P218, DOI 10.1016/0033-5894(82)90071-0; DUPIESSY JC, 1980, NATURE, V286, P479; Duplessy JC, 1988, PALEOCEANOGRAPHY, V3, P343, DOI 10.1029/PA003i003p00343; DUPLESSY JC, 1989, RADIOCARBON, V31, P493; Elderfield H, 2006, EARTH PLANET SC LETT, V250, P633, DOI 10.1016/j.epsl.2006.07.041; EMILIANI C, 1955, J GEOL, V63, P538, DOI 10.1086/626295; Ganachaud A, 2000, NATURE, V408, P453, DOI 10.1038/35044048; Gebbie G, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001383; Gherardi JM, 2005, EARTH PLANET SC LETT, V240, P710, DOI 10.1016/j.epsl.2005.09.061; Hall IR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026239; HALL MM, 1982, DEEP-SEA RES, V29, P339, DOI 10.1016/0198-0149(82)90099-1; Hewitt CD, 2003, CLIM DYNAM, V20, P203, DOI 10.1007/s00382-002-0272-6; Hirschi JJM, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001301; Huybers P, 2007, J PHYS OCEANOGR, V37, P394, DOI 10.1175/JPO3018.1; Keigwin LD, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001029; Kissel C, 1999, EARTH PLANET SC LETT, V171, P489, DOI 10.1016/S0012-821X(99)00162-4; Kitoh A, 2001, GEOPHYS RES LETT, V28, P2221, DOI 10.1029/2000GL012271; Kucera M, 2005, QUATERNARY SCI REV, V24, P951, DOI 10.1016/j.quascirev.2004.07.014; KUMAR N, 1993, NATURE, V362, P45, DOI 10.1038/362045a0; LEGRAND P, 1995, PALEOCEANOGRAPHY, V10, P1011, DOI 10.1029/95PA01455; LeGrande AN, 2006, P NATL ACAD SCI USA, V103, P837, DOI 10.1073/pnas.0510095103; Lynch-Stieglitz J, 1999, PALEOCEANOGRAPHY, V14, P360, DOI 10.1029/1999PA900001; Lynch-Stieglitz J., 2003, TREATISE GEOCHEM, V6, P433, DOI DOI 10.1016/B0-08-043751-6/06117-X; Lynch-Stieglitz J, 2001, GEOCHEM GEOPHY GEOSY, V2, P1069, DOI DOI 10.1029/2001GC000208; Lynch-Stieglitz J, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001226; Manabe S, 1988, J CLIMATE, V1, P841, DOI 10.1175/1520-0442(1988)001<0841:TSEOAC>2.0.CO;2; Mangini A, 1998, NATURE, V392, P347, DOI 10.1038/32804; Marchal O, 2000, PALEOCEANOGRAPHY, V15, P625, DOI 10.1029/2000PA000496; Marchitto TM, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001323; Marchitto TM, 2000, PALEOCEANOGRAPHY, V15, P299, DOI 10.1029/1999PA000420; Marotzke J, 1999, J GEOPHYS RES-OCEANS, V104, P29529, DOI 10.1029/1999JC900236; Matsumoto K, 1999, PALEOCEANOGRAPHY, V14, P149, DOI 10.1029/1998PA900028; McCave IN, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001284; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Mix AC, 2001, QUATERNARY SCI REV, V20, P627, DOI 10.1016/S0277-3791(00)00145-1; Otto-Bliesner BL, 2006, J CLIMATE, V19, P2526, DOI 10.1175/JCLI3748.1; Paul A, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000783; Piotrowski AM, 2005, SCIENCE, V307, P1933, DOI 10.1126/science.1104883; Robinson LF, 2005, SCIENCE, V310, P1469, DOI 10.1126/science.1114832; ROEMMICH D, 1985, DEEP-SEA RES, V32, P619, DOI 10.1016/0198-0149(85)90070-6; SARNTHEIN M, 1994, PALEOCEANOGRAPHY, V9, P209, DOI 10.1029/93PA03301; Schmittner A, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002283; SHACKLETON NJ, 1988, NATURE, V335, P708, DOI 10.1038/335708a0; Shin SI, 2003, CLIM DYNAM, V20, P127, DOI 10.1007/s00382-002-0260-x; STOMMEL H, 1961, TELLUS, V13, P224, DOI 10.1111/j.2153-3490.1961.tb00079.x; STREETER SS, 1979, SCIENCE, V203, P168, DOI 10.1126/science.203.4376.168; Vellinga M, 2002, CLIMATIC CHANGE, V54, P251, DOI 10.1023/A:1016168827653; Wunsch C, 2003, QUATERNARY SCI REV, V22, P371, DOI 10.1016/S0277-3791(02)00177-4; Yu EF, 1996, NATURE, V379, P689, DOI 10.1038/379689a0; Zhang R, 2005, J CLIMATE, V18, P1853, DOI 10.1175/JCLI3460.1	61	279	282	5	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2007	316	5821					66	69		10.1126/science.1137127	http://dx.doi.org/10.1126/science.1137127			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412948				2022-12-28	WOS:000245470500031
J	Pluth, MD; Bergman, RG; Raymond, KN				Pluth, Michael D.; Bergman, Robert G.; Raymond, Kenneth N.			Acid catalysis in basic solution: A supramolecular host promotes orthoformate hydrolysis	SCIENCE			English	Article							H BOND ACTIVATION; GUEST COMPLEXATION; DIELS-ALDER; MECHANISM; EXCHANGE; SCOPE	Although many enzymes can promote chemical reactions by tuning substrate properties purely through the electrostatic environment of a docking cavity, this strategy has proven challenging to mimic in synthetic host-guest systems. Here, we report a highly charged, water-soluble, metal-ligand assembly with a hydrophobic interior cavity that thermodynamically stabilizes protonated substrates and consequently catalyzes the normally acidic hydrolysis of orthoformates in basic solution, with rate accelerations of up to 890-fold. The catalysis reaction obeys Michaelis-Menten kinetics and exhibits competitive inhibition, and the substrate scope displays size selectivity, consistent with the constrained binding environment of the molecular host.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Bergman, RG (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	rbergman@berkeley.edu; raymond@socrates.berkeley.edu	Pluth, Michael/A-7222-2012	Pluth, Michael/0000-0003-3604-653X				Bain AD, 1996, J MAGN RESON SER A, V118, P21, DOI 10.1006/jmra.1996.0004; Bakirci H, 2006, CHEM-EUR J, V12, P4799, DOI 10.1002/chem.200501479; Bronsted JN, 1929, T FARADAY SOC, V25, P0059, DOI 10.1039/tf9292500059; Brumaghim JL, 2004, EUR J ORG CHEM, V2004, P5115, DOI 10.1002/ejoc.200400533; Brumaghim JL, 2004, EUR J ORG CHEM, V2004, P4552, DOI 10.1002/ejoc.200400428; Caulder DL, 1999, ACCOUNTS CHEM RES, V32, P975, DOI 10.1021/ar970224v; Caulder DL, 1999, J CHEM SOC DALTON, P1185, DOI 10.1039/a808370c; Cleland WW, 1998, J BIOL CHEM, V273, P25529, DOI 10.1074/jbc.273.40.25529; CORDES EH, 1974, CHEM REV, V74, P581, DOI 10.1021/cr60291a004; Davis AV, 2006, J AM CHEM SOC, V128, P1324, DOI 10.1021/ja056556+; Dong VM, 2006, J AM CHEM SOC, V128, P14464, DOI 10.1021/ja0657915; Eadie GS, 1942, J BIOL CHEM, V146, P85; Fiedler D, 2004, ANGEW CHEM INT EDIT, V43, P6748, DOI 10.1002/anie.200461776; Fiedler D, 2006, J AM CHEM SOC, V128, P10240, DOI 10.1021/ja062329b; Ha NC, 2000, J BIOL CHEM, V275, P41100, DOI 10.1074/jbc.M007561200; HAAS CH, 2005, J CHEM SOC CHEM COMM, V48, P6044; HOFSTEE BHJ, 1952, SCIENCE, V116, P329, DOI 10.1126/science.116.3013.329; Kang JM, 1997, NATURE, V385, P50, DOI 10.1038/385050a0; Leung DH, 2006, J AM CHEM SOC, V128, P9781, DOI 10.1021/ja061412w; Leung DH, 2004, ANGEW CHEM INT EDIT, V43, P963, DOI 10.1002/anie.200352772; Marquez C, 2001, ANGEW CHEM INT EDIT, V40, P3155, DOI 10.1002/1521-3773(20010903)40:17<3155::AID-ANIE3155>3.0.CO;2-7; Mohanty J, 2006, J PHYS CHEM B, V110, P5132, DOI 10.1021/jp056411p; Ortega-Caballero F, 2005, J AM CHEM SOC, V127, P3238, DOI 10.1021/ja042678a; Rao K. R., 2005, ADV ORGANIC SYNTHESI, V1, P301; Sanders JKM, 1998, CHEM-EUR J, V4, P1378, DOI 10.1002/(SICI)1521-3765(19980807)4:8<1378::AID-CHEM1378>3.3.CO;2-V; SHINKAI S, 1988, J CHEM SOC CHEM COMM, P187, DOI 10.1039/c39880000187; SZARAZ S, 1994, BIOPHYS J, V67, P1706, DOI 10.1016/S0006-3495(94)80644-7; Terpin AJ, 2001, ANGEW CHEM INT EDIT, V40, P157, DOI 10.1002/1521-3773(20010105)40:1<157::AID-ANIE157>3.0.CO;2-4; WESTHEIMER FH, 1995, TETRAHEDRON, V51, P3, DOI 10.1016/0040-4020(94)00865-R; Yoshizawa M, 2006, SCIENCE, V312, P251, DOI 10.1126/science.1124985; Zepik HH, 1999, J ORG CHEM, V64, P8080, DOI 10.1021/jo982418+; Zhang XY, 2002, J AM CHEM SOC, V124, P254, DOI 10.1021/ja011866n	32	608	610	4	250	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2007	316	5821					85	88		10.1126/science.1138748	http://dx.doi.org/10.1126/science.1138748			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	153XD	17412953	Green Submitted			2022-12-28	WOS:000245470500036
J	Shim, SB; Imboden, M; Mohanty, P				Shim, Seung-Bo; Imboden, Matthias; Mohanty, Pritiraj			Synchronized oscillation in coupled nanomechanical oscillators	SCIENCE			English	Article							PARAMETRIC AMPLIFICATION; MICROMECHANICAL OSCILLATORS; PHASE-LOCKING; SPIN; RESONATORS	We report measurements of synchronization in two nanomechanical beam oscillators coupled by a mechanical element. We charted multiple regions of frequency entrainment or synchronization by their corresponding Arnold's tongue diagrams as the oscillator was driven at subharmonic and rational commensurate frequencies. Demonstration of multiple synchronized regions could be fundamentally important to neurocomputing with mechanical oscillator networks and nanomechanical signal processing for microwave communication.	Boston Univ, Dept Phys, Boston, MA 02215 USA	Boston University	Mohanty, P (corresponding author), Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA.	mohanty@physics.bu.du	Imboden, Matthias/B-5159-2008	Imboden, Matthias/0000-0003-4629-4246				Badzey RL, 2005, NATURE, V437, P995, DOI 10.1038/nature04124; BUCK J, 1968, SCIENCE, V159, P1319, DOI 10.1126/science.159.3821.1319; Carr DW, 2000, APPL PHYS LETT, V77, P1545, DOI 10.1063/1.1308270; Cleland AN, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/235; Cleland AN, 1996, APPL PHYS LETT, V69, P2653, DOI 10.1063/1.117548; Cross MC, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.224101; Dermott SF, 2004, NATURE, V429, P814, DOI 10.1038/429814a; Gaidarzhy A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.030402; Izhikevich EM, 2003, SIAM J APPL MATH, V63, P1935, DOI 10.1137/S0036139902400945; Kaka S, 2005, NATURE, V437, P389, DOI 10.1038/nature04035; Mancoff FB, 2005, NATURE, V437, P393, DOI 10.1038/nature04036; RUGAR D, 1991, PHYS REV LETT, V67, P699, DOI 10.1103/PhysRevLett.67.699; Turner KL, 1998, NATURE, V396, P149, DOI 10.1038/24122; van der Pol B, 1927, PHILOS MAG, V3, P65; Zalalutdinov M, 2001, APPL PHYS LETT, V79, P695, DOI 10.1063/1.1388869; Zalalutdinov M, 2001, APPL PHYS LETT, V78, P3142, DOI 10.1063/1.1371248; [No title captured]	17	204	211	2	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2007	316	5821					95	99		10.1126/science.1137307	http://dx.doi.org/10.1126/science.1137307			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412955				2022-12-28	WOS:000245470500039
J	Stoleru, D; Nawathean, P; Fernandez, MDLP; Menet, JS; Ceriani, MF; Rosbash, M				Stoleru, Dan; Nawathean, Pipat; Fernandez, Maria de la Paz; Menet, Jerome S.; Ceriani, M. Fernanda; Rosbash, Michael			The Drosophila circadian network is a seasonal timer	CELL			English	Article							NEGATIVE FEEDBACK LOOP; CLOCK-GENE; TRANSCRIPTIONAL REPRESSOR; FUNCTIONAL-ANALYSIS; BEHAVIORAL RHYTHMS; PACEMAKER NEURONS; LIGHT RESPONSE; PERIOD PROTEIN; CRYPTOCHROME; MELANOGASTER	Previous work in Drosophila has defined two populations of circadian brain neurons, morning cells (M-cells) and evening cells (E-cells), both of which keep circadian time and regulate morning and evening activity, respectively. It has long been speculated that a multiple oscillator circadian network in animals underlies the behavioral and physiological pattern variability caused by seasonal fluctuations of photoperiod. We have manipulated separately the circadian photoentrainment pathway within E- and M-cells and show that E-cells process light information and function as master clocks in the presence of light. M-cells in contrast need darkness to cycle autonomously and dominate the network. The results indicate that the network switches control between these two centers as a function of photoperiod. Together with the different entraining properties of the two clock centers, the results suggest that the functional organization of the network underlies the behavioral adjustment to variations in daylength and season.	Brandeis Univ, Howard Hughes Med Inst, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Natl Ctr Behav Genom, Dept Biol, Waltham, MA 02454 USA; Fdn Inst Leloir, Lab Genet Comportamiento, RA-1405 Buenos Aires, DF, Argentina	Brandeis University; Howard Hughes Medical Institute; Brandeis University; Leloir Institute	Rosbash, M (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Dept Biol, Waltham, MA 02454 USA.	rosbash@brandeis.edu	de la Paz Fernandez, Maria/ABC-5366-2020; Menet, Jerome/B-7054-2015	de la Paz Fernandez, Maria/0000-0002-9261-6114; Menet, Jerome/0000-0002-7682-0967; Ceriani, Maria/0000-0001-8945-3070	NIGMS NIH HHS [GM66778] Funding Source: Medline; NINDS NIH HHS [T32 NS007292, NS44232] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292, P01NS044232] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; ASCHOFF J, 1979, Z TIERPSYCHOL, V49, P225; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Collins B, 2006, CURR BIOL, V16, P441, DOI 10.1016/j.cub.2006.01.034; Dissel S, 2004, NAT NEUROSCI, V7, P834, DOI 10.1038/nn1285; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hall JC, 2003, ADV GENET, V48, P1, DOI 10.1016/S0065-2660(03)48000-0; HAMBLEN M, 1986, J NEUROGENET, V3, P249, DOI 10.3109/01677068609106855; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Kaneko M, 2000, J NEUROBIOL, V43, P207, DOI 10.1002/(SICI)1097-4695(20000605)43:3<207::AID-NEU1>3.0.CO;2-0; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-5; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Lin FJ, 2001, MOL CELL BIOL, V21, P7287, DOI 10.1128/MCB.21.21.7287-7294.2001; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Magnusson A, 2003, CHRONOBIOL INT, V20, P189, DOI 10.1081/CBI-120019310; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Murad A, 2007, NEURON, V53, P689, DOI 10.1016/j.neuron.2007.01.034; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Nawathean P, 2004, MOL CELL, V13, P213, DOI 10.1016/S1097-2765(03)00503-3; Nawathean P, 2005, METHOD ENZYMOL, V393, P610, DOI 10.1016/S0076-6879(05)93032-2; Papadopoulou D, 2004, MOL CELL BIOL, V24, P4909, DOI 10.1128/MCB.24.11.4909-4919.2004; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Qiu J, 1996, MOL CELL BIOL, V16, P4182; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Rosato E, 2001, CURR BIOL, V11, P909, DOI 10.1016/S0960-9822(01)00259-7; Ruel L, 1999, J BIOL CHEM, V274, P21790, DOI 10.1074/jbc.274.31.21790; Rush BL, 2006, J BIOL RHYTHM, V21, P272, DOI 10.1177/0748730406290416; Rutila JE, 1998, J BIOL RHYTHM, V13, P380, DOI 10.1177/074873098129000200; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Shafer OT, 2004, CURR BIOL, V14, P424, DOI 10.1016/j.cub.2004.02.038; Shafer OT, 2002, J NEUROSCI, V22, P5946; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Suri VP, 1998, NEURON, V21, P225, DOI 10.1016/S0896-6273(00)80529-2; Worby C A, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.95.pl1; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	55	183	188	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					207	219		10.1016/j.cell.2007.02.038	http://dx.doi.org/10.1016/j.cell.2007.02.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418796	Bronze			2022-12-28	WOS:000245661100022
J	Wortmann, UG; Chernyavsky, BM				Wortmann, Ulrich G.; Chernyavsky, Boris M.			Effect of evaporite deposition on Early Cretaceous carbon and sulphur cycling	NATURE			English	Article							ISOTOPE FRACTIONATION; SEA-LEVEL; SEAWATER; SULFATE; SEDIMENTS; RECORDS; CALCIUM; MODEL	The global carbon and sulphur cycles are central to our understanding of the Earth's history, because changes in the partitioning between the reduced and oxidized reservoirs of these elements are the primary control on atmospheric oxygen concentrations. In modern marine sediments, the burial rates of reduced carbon and sulphur are positively coupled, but high-resolution isotope records indicate that these rates were inversely related during the Early Cretaceous period(1). This inverse relationship is difficult to reconcile with our understanding of the processes that control organic matter remineralization and pyrite burial. Here we show that the inverse correlation can be explained by the deposition of evaporites during the opening of the South Atlantic Ocean basin. Evaporite deposition can alter the chemical composition of sea water(2,3), which can in turn affect the ability of sulphate-reducing bacteria to remineralize organic matter and mediate pyrite burial. We use a reaction - transport model to quantify these effects, and the resulting changes in the burial rates of carbon and sulphur, during the Early Cretaceous period. Our results indicate that deposition of the South Atlantic evaporites removed enough sulphate from the ocean temporarily to reduce biologically mediated pyrite burial and organic matter remineralization by up to fifty per cent, thus explaining the inverse relationship between the burial rates of reduced carbon and sulphur during this interval. Furthermore, our findings suggest that the effect of changing seawater sulphate concentrations on the marine subsurface biosphere may be the key to understanding other large-scale perturbations of the global carbon and sulphur cycles.	Univ Toronto, Dept Geol, Geobiol Isotope Lab, Toronto, ON M5S 3B1, Canada	University of Toronto	Wortmann, UG (corresponding author), Univ Toronto, Dept Geol, Geobiol Isotope Lab, 22 Russell St, Toronto, ON M5S 3B1, Canada.	uli.wortmann@utoronto.ca		Wortmann, Ulrich/0000-0001-7854-9173				Arthur MA, 1982, NATURE ORIGIN CRETAC, P7; BERNER RA, 1983, GEOCHIM COSMOCHIM AC, V47, P855, DOI 10.1016/0016-7037(83)90151-5; Berner RA, 2004, AM J SCI, V304, P438, DOI 10.2475/ajs.304.5.438; Bjerrum CJ, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001032; Brunner B, 2005, GEOCHIM COSMOCHIM AC, V69, P4759, DOI 10.1016/j.gca.2005.04.015; BURKE K, 1988, MAR GEOL, V83, P309, DOI 10.1016/0025-3227(88)90064-3; Chernyavsky BM, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001442; Deines P, 1980, HDB ENV GEOCHEMISTRY, V1, P239; Erba E, 1999, J FORAMIN RES, V29, P371; Herrle JO, 2004, EARTH PLANET SC LETT, V218, P149, DOI 10.1016/S0012-821X(03)00646-0; Holland HD, 2005, AM J SCI, V305, P220, DOI 10.2475/ajs.305.3.220; Holser W. T., 1988, CHEM CYCLES EVOLUTIO, P105; Leckie RM, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000623; Lowenstein TK, 2003, GEOLOGY, V31, P857, DOI 10.1130/G19728R.1; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; Paytan A, 2004, SCIENCE, V304, P1663, DOI 10.1126/science.1095258; Raiswell R, 1998, AM J SCI, V298, P219, DOI 10.2475/ajs.298.3.219; RHONOV AB, 1982, INT GEOL REV, V24, P1365; RYAN WBF, 1977, MAR GEOL, V23, P197, DOI 10.1016/0025-3227(77)90089-5; SCHLANGER S O, 1976, Geologie en Mijnbouw, V55, P179; SOUTHAM JR, 1981, SEA, V7, P1617; Weissert H, 2004, J GEOL SOC LONDON, V161, P695, DOI 10.1144/0016-764903-087; Wortmann UG, 2001, GEOLOGY, V29, P647, DOI 10.1130/0091-7613(2001)029<0647:HDBIES>2.0.CO;2; Wortmann UG, 2004, EARTH PLANET SC LETT, V220, P69, DOI 10.1016/S0012-821X(04)00031-7; Wortmann UG, 1999, PALEOCEANOGRAPHY, V14, P525, DOI 10.1029/1999PA900015; ZHARKOV MA, 1981, HIST PALEOZOIC SALT, P1; [No title captured]	28	61	61	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2007	446	7136					654	656		10.1038/nature05693	http://dx.doi.org/10.1038/nature05693			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17410172				2022-12-28	WOS:000245438300036
J	Cutler, DM				Cutler, David M.			The demise of the blockbuster?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Cambridge, MA 02138 USA	Harvard University	Cutler, DM (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.			Cutler, David/0000-0002-4949-8917				DiMasi JA, 2004, PHARMACOECONOMICS, V22, P1, DOI 10.2165/00019053-200422002-00002; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; HENSLEY S, 2006, WALL STREET J   0714; Neumann PJ, 2000, HEALTH AFFAIR, V19, P92, DOI 10.1377/hlthaff.19.2.92; TRUSHEIM MR, IN PRESS NAT R EV DR	5	36	37	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2007	356	13					1292	1293		10.1056/NEJMp078020	http://dx.doi.org/10.1056/NEJMp078020			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150MN	17392299				2022-12-28	WOS:000245221000002
J	Nissen, SE; Nicholls, SJ; Wolski, K; Howey, DC; McErlean, E; Wang, MD; Gomez, EV; Russo, JM				Nissen, Steven E.; Nicholls, Stephen J.; Wolski, Kathy; Howey, Daniel C.; McErlean, Ellen; Wang, Ming-Dauh; Gomez, Elisa V.; Russo, John M.			Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia - Two randomized controlled trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							APOLIPOPROTEIN A-II; CARDIOVASCULAR EVENTS; RISK-FACTORS; FENOFIBRATE; GEMFIBROZIL; PREVENTION; INCREASE; HDL; MEN	Context Fibrates are weak agonists of peroxisome proliferator-activated receptor alpha (PPAR-alpha). No trials have reported effects of more potent and selective agents. Objectives To examine the safety and efficacy of LY518674, a PPAR-alpha agonist. Design, Setting, and Participants Two multicenter, randomized, double-blind, placebo-controlled trials: 1 in patients with elevated triglycerides and low HDL-C (atherogenic dyslipidemia), the other in patients with elevated LDL-C (hypercholesterolemia). Between August 2005 and August 2006, the dyslipidemia study randomized 309 patients at US centers; the hypercholesterolemia study, 304 patients. Interventions Dyslipidemia study: placebo, fenofibrate (200 mg), or LY518674 (10, 25, 50, or 100 mu g) for 12 weeks. Hypercholesterolemia study: placebo or atorvastatin (10 or 40 mg) for 4 weeks, then placebo or LY518674 (10 or 50 mu g) for 12 more weeks. Main Outcome Measures Dyslipidemia study: percentage change in levels of HDL-C and triglycerides. Hypercholesterolemia study: percentage change in levels of LDL-C. Results Dyslipidemia study: LY518674 (25 mu g) and fenofibrate increased HDL-C by 5.9 and 5.5 mg/dL (15.8% and 14.4%) (both P <= .001 vs placebo, P = .79 between treatments). Higher LY518674 doses yielded smaller increases. LY518674 decreased triglycerides by 97.3 to 114.5 mg/dL (34.9% to 41.7%) but was similar to fenofibrate. LY518674 produced a dose-dependent increase in LDL-C, reaching 20.4 mg/dL (19.5%) for the 100-mu g dose vs 0.3 mg/dL (2.3%) for fenofibrate (P <= .01). Fenofibrate and LY518674 (50 mu g and 100 mu g) increased serum creatinine (P <= .001 vs placebo), with 38% and 37.3% of patients exceeding the normal range. Fenofibrate, but not LY518674, increased creatine phosphokinase (P = .004 vs placebo). Hypercholesterolemia study: LY518674 (10 mu g or 50 mu g) decreased LDL-C by 21.4 to 26.0 mg/dL (13.2%-15.8%) and triglycerides approximate to 37% for both doses, and increased HDL-C by 6.3 to 6.7 mg/dL (12.5%-15.0%). When added to atorvastatin, LY518674 changed HDL-C by -0.7 to 6.2 mg/dL (-0.6% to 11.9%) and significantly decreased triglycerides but had no additional effect on LDL-C. Conclusions In patients with dyslipidemia, LY518674 and fenofibrate decreased triglycerides and increased HDL-C but also increased serum creatinine. LY518674, but not fenofibrate, increased LDL-C. In those with hypercholesterolemia, LY518674 reduced triglycerides and increased HDL-C, but did not further reduce LDL-C in combination with atorvastatin. Fenofibrate and LY518674 both raised safety concerns. Trial Registration clinicaltrials.gov Identifiers: NCT00133380 and NCT00116519.	Cleveland Clin Fdn, Dept Cardiovasc Med, Lerner Sch Med, Cleveland, OH 44195 USA; Eli Lilly & Co, Indianapolis, IN 46285 USA; Guilford Med Assoc, Greensboro, NC USA; Moses Cone Hlth Syst, Greensboro, NC USA	Case Western Reserve University; Cleveland Clinic Foundation; Eli Lilly	Nissen, SE (corresponding author), Cleveland Clin Fdn, Dept Cardiovasc Med, Lerner Sch Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.	nissens@ccf.org		Nicholls, Stephen/0000-0002-9668-4368				Angeles C, 2004, AM J KIDNEY DIS, V44, P543, DOI 10.1053/j.ajkd.2004.05.040; Barker BJ, 2003, DIABETES CARE, V26, P2482, DOI 10.2337/diacare.26.8.2482; Broeders N, 2000, NEPHROL DIAL TRANSPL, V15, P1993, DOI 10.1093/ndt/15.12.1993; Castellani LW, 1997, J CLIN INVEST, V100, P464, DOI 10.1172/JCI119554; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dayspring Thomas, 2006, Curr Atheroscler Rep, V8, P356, DOI 10.1007/s11883-006-0032-x; Despres JP, 2004, DRUGS, V64, P2177, DOI 10.2165/00003495-200464190-00003; ELHAGE J, PEROXISOME PROLIFERA; Escola-Gil JC, 1998, J LIPID RES, V39, P457; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Gazi IF, 2007, EXPERT OPIN BIOL TH, V7, P53, DOI 10.1517/14712598.7.1.53; Grundy Scott M, 2006, Clin Cornerstone, V8 Suppl 1, pS21, DOI 10.1016/S1098-3597(06)80005-0; Hottelart C, 2002, NEPHRON, V92, P536, DOI 10.1159/000064083; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Libby P, 2005, J AM COLL CARDIOL, V46, P1225, DOI 10.1016/j.jacc.2005.07.006; Lipscombe J, 2001, CLIN NEPHROL, V55, P39; Molavi Behzad, 2002, Journal of Cardiovascular Pharmacology and Therapeutics, V7, P1, DOI 10.1177/107424840200700i101; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sambandam N, 2006, AM J PHYSIOL-HEART C, V290, pH87, DOI 10.1152/ajpheart.00285.2005; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21; SCHULTZ JR, 1993, NATURE, V365, P762, DOI 10.1038/365762a0; Seimandi M, 2005, ANAL BIOCHEM, V344, P8, DOI 10.1016/j.ab.2005.06.010; SHARVILL DE, 1964, P ROY SOC MED, V57, P44, DOI 10.1177/003591576405700109; Singh JP, 2005, MOL PHARMACOL, V68, P763, DOI 10.1124/mol.105.010991; Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460; Steiner G, 2001, LANCET, V357, P905; Tailleux A, 2002, ATHEROSCLEROSIS, V164, P1, DOI 10.1016/S0021-9150(01)00751-1; Vamecq J, 1999, LANCET, V354, P141, DOI 10.1016/S0140-6736(98)10364-1; VUDAC N, 1995, J CLIN INVEST, V96, P741, DOI 10.1172/JCI118118; Watts GF, 2003, DIABETES, V52, P803, DOI 10.2337/diabetes.52.3.803; Xu YP, 2003, J MED CHEM, V46, P5121, DOI 10.1021/jm034173l	32	106	112	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2007	297	12					1362	1373		10.1001/jama.297.12.1362	http://dx.doi.org/10.1001/jama.297.12.1362			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150JN	17384435	Bronze			2022-12-28	WOS:000245212600023
J	Wang, A; Athan, E; Pappas, PA; Fowler, VG; Olaison, L; Pare, C; Almirante, B; Munoz, P; Rizzi, M; Naber, C; Logar, M; Tattevin, P; Iarussi, DL; Selton-Suty, C; Jones, SB; Casabe, J; Morris, A; Corey, GR; Cabell, CH				Wang, Andrew; Athan, Eugene; Pappas, Paul A.; Fowler, Vance G., Jr.; Olaison, Lars; Pare, Carlos; Almirante, Benito; Munoz, Patricia; Rizzi, Marco; Naber, Christoph; Logar, Mateja; Tattevin, Pierre; Iarussi, Diana L.; Selton-Suty, Christine; Jones, Sandra Braun; Casabe, Jose; Morris, Arthur; Corey, G. Ralph; Cabell, Christopher H.		Int Collaboration Endocarditis Pro	Contemporary clinical profile and outcome of prosthetic valve endocarditis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFECTIVE ENDOCARDITIS; MEDICAL PROGRESS; ACQUIRED INFECTIONS; PROPENSITY ANALYSIS; DUKE CRITERIA; RISK-FACTORS; FOLLOW-UP; MORTALITY; DIAGNOSIS; ADULTS	Context Prosthetic valve endocarditis (PVE) is associated with significant mortality and morbidity. The contemporary clinical profile and outcome of PVE are not well defined. Objectives To describe the prevalence, clinical characteristics, and outcome of PVE, with attention to health care-associated infection, and to determine prognostic factors associated with in-hospital mortality. Design, Setting, and Participants Prospective, observational cohort study conducted at 61 medical centers in 28 countries, including 556 patients with definite PVE as defined by Duke University diagnostic criteria who were enrolled in the International Collaboration on Endocarditis-Prospective Cohort Study from June 2000 to August 2005. Main Outcome Measure In-hospital mortality. Results Definite PVE was present in 556 (20.1%) of 2670 patients with infective endocarditis. Staphylococcus aureus was the most common causative organism (128 patients [23.0%]), followed by coagulase-negative staphylococci (94 patients [16.9%]). Health care-associated PVE was present in 203 (36.5%) of the overall cohort. Seventy-one percent of health care-associated PVE occurred within the first year of valve implantation, and the majority of cases were diagnosed after the early (60-day) period. Surgery was performed in 272 (48.9%) patients during the index hospitalization. In-hospital death occurred in 127 (22.8%) patients and was predicted by older age, health care associated infection (62/203 [30.5%]; adjusted odds ratio [OR], 1.62; 95% confidence interval [CI], 1.08-2.44; P = .02), S aureus infection (44/128 [34.4%]; adjusted OR, 1.73; 95% CI, 1.01-2.95; P = .05), and complications of PVE, including heart failure (60/183 [32.8%]; adjusted OR, 2.33; 95% CI, 1.62-3.34; P < .001), stroke (34/101 [33.7%]; adjusted OR, 2.25; 95% CI, 1.25-4.03; P = .007), intracardiac abscess (47/144 [32.6%]; adjusted OR, 1.86; 95% CI, 1.10-3.15; P = .02), and persistent bacteremia (27/49 [55.1%]; adjusted OR, 4.29; 95% CI, 1.99-9.22; P < .001). Conclusions Prosthetic valve endocarditis accounts for a high percentage of all cases of infective endocarditis in many regions of the world. Staphylococcus aureus is now the leading cause of PVE. Health care - associated infection significantly influences the clinical characteristics and outcome of PVE. Complications of PVE strongly predict in-hospital mortality, which remains high despite prompt diagnosis and the frequent use of surgical intervention.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Univ Melbourne, Geelong Hosp, Dept Infect Dis, Melbourne, Vic, Australia; Duke Clin Res Inst, Outcomes Res & Assessment Grp, Durham, NC USA; Sahlgrenska Universitetssjukhuset Ostra, Dept Infect Dis, Gothenburg, Sweden; Univ Barcelona, Dept Cardiol, Barcelona, Spain; Hosp Univ Valle Hebron, Dept Infect Dis, Barcelona, Spain; Hosp Gen Univ Gregorio Maranon, Dept Infect Dis, Barcelona, Spain; Osped Riuniti Bergamo, Dept Infect Dis, I-24100 Bergamo, Italy; Univ Essen Gesamthsch, Cardiol Clin, Essen, Germany; Med Ctr Ljublijana, Dept Infect Dis, Ljubljana, Slovenia; Pontchaillou Univ, Dept Infect Dis, Rennes, France; Univ Naples 2, Dept Cardiol, Naples, Italy; CHU Nancy Brabois, Serv Cardiol, Nancy, France; Pontificia Univ Catolica Chile, Hosp Clin, Lab Tecn No Invasivas, Santiago, Chile; Fdn Favaloro, Dept Cardiol, Inst Cardiol & Cirugia Cardiovasc, Buenos Aires, DF, Argentina; Auckland City Hosp, Diag Medlab, Auckland, New Zealand	Duke University; Geelong Hospital; University of Melbourne; Duke University; Sahlgrenska University Hospital; University of Barcelona; Hospital Universitari Vall d'Hebron; General University Gregorio Maranon Hospital; Ospedali Riuniti di Bergamo; University of Duisburg Essen; CHU Rennes; Universita della Campania Vanvitelli; CHU de Nancy; Pontificia Universidad Catolica de Chile; Auckland City Hospital	Wang, A (corresponding author), Duke Univ, Med Ctr, Dept Med, DUMC 3428,Room 7624A, Durham, NC 27710 USA.	a.wang@duke.edu	Muñoz, Patricia/E-9431-2017; Fowler, Vance/AAW-2017-2021	Muñoz, Patricia/0000-0001-5706-5583; Almirante, Benito/0000-0002-1189-2361; Gordon, David/0000-0003-3276-9685; Wang, Andrew/0000-0001-8729-0933; Athan, Eugene/0000-0001-9838-6471; Selton-Suty, Christine/0000-0003-4129-5784				Akowuah EF, 2003, HEART, V89, P269, DOI 10.1136/heart.89.3.269; BLOCK PC, 1970, J THORAC CARDIOV SUR, V60, P540, DOI 10.1016/S0022-5223(19)42335-0; Cabell CH, 2002, ARCH INTERN MED, V162, P90, DOI 10.1001/archinte.162.1.90; Cabell CH, 2002, INFECT DIS CLIN N AM, V16, P255, DOI 10.1016/S0891-5520(01)00007-1; CALDERWOOD SB, 1985, CIRCULATION, V72, P31, DOI 10.1161/01.CIR.72.1.31; Castillo JC, 2004, AM J CARDIOL, V93, P1185, DOI 10.1016/j.amjcard.2004.01.056; Cheng Allen, 2002, Heart Lung Circ, V11, P26, DOI 10.1046/j.1444-2892.2002.00108.x; Chu VH, 2004, CIRCULATION, V109, P1745, DOI 10.1161/01.CIR.0000124719.61827.7F; DANIEL WG, 1991, NEW ENGL J MED, V324, P795, DOI 10.1056/NEJM199103213241203; Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415; DISMUKES WE, 1973, CIRCULATION, V48, P365, DOI 10.1161/01.CIR.48.2.365; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; Edwards MB, 1998, EUR J CARDIO-THORAC, V14, P156, DOI 10.1016/S1010-7940(98)00148-1; FANG GD, 1993, ANN INTERN MED, V119, P560, DOI 10.7326/0003-4819-119-7_Part_1-199310010-00003; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; GERACI J E, 1963, Wis Med J, V62, P302; GHOSH P, 2002, CARDIAC SURG CATHETE; GROVER FL, 1994, J THORAC CARDIOV SUR, V108, P207; Hasbun R, 2003, JAMA-J AM MED ASSOC, V289, P1933, DOI 10.1001/jama.289.15.1933; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; KUYVENHOVEN JP, 1994, EUR J CARDIO-THORAC, V8, P420, DOI 10.1016/1010-7940(94)90083-3; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159; Martin-Davila P, 2005, CHEST, V128, P772, DOI 10.1378/chest.128.2.772; MASUR H, 1980, J THORAC CARDIOV SUR, V80, P31; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; O'Grady NP, 2002, INFECT CONT HOSP EP, V23, P759, DOI 10.1086/502007; Perez-Vazquez A, 2000, ARCH INTERN MED, V160, P1185, DOI 10.1001/archinte.160.8.1185; Rivas P, 2005, CHEST, V128, P764, DOI 10.1378/chest.128.2.764; Sidhu P, 2001, ANN THORAC SURG, V71, pS257, DOI 10.1016/S0003-4975(01)02522-X; SLAUGHTER L, 1973, CIRCULATION, V47, P1319, DOI 10.1161/01.CIR.47.6.1319; TOMOS P, 1997, CLIN INFECT DIS, V24, P381; Truninger K, 1999, HEART, V82, P714, DOI 10.1136/hrt.82.6.714; Varstela E, 1998, ANN CHIR GYNAECOL FE, V87, P205; Vikram HR, 2003, JAMA-J AM MED ASSOC, V290, P3207, DOI 10.1001/jama.290.24.3207; Vlessis AA, 1997, J HEART VALVE DIS, V6, P443; Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607; Wang A, 2005, AM HEART J, V150, P1086, DOI 10.1016/j.ahj.2005.01.023; WILSON WR, 1975, ANN INTERN MED, V82, P751, DOI 10.7326/0003-4819-82-6-751	41	413	436	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2007	297	12					1354	1361		10.1001/jama.297.12.1354	http://dx.doi.org/10.1001/jama.297.12.1354			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150JN	17392239	Bronze, Green Published			2022-12-28	WOS:000245212600022
J	Brown, M; Boon, N; Brooks, N; Brown, E; Camm, J; Caulfield, M; Chilvers, E; Gibson, J; Griffin, G; Grossman, A; Hall, A; Hart, G; Heagerty, T; Home, P; Hodgson, H; Horton, R; Hughes, R; Khaw, KT; Lazarus, J; Leaper, D; McCollum, P; Monson, J; O'Rahilly, S; Rowlands, B; Scott, J; Sutton, R; Taylor, R; Watkins, H; Wright, N				Brown, Morris; Boon, Nick; Brooks, Nick; Brown, Edwina; Camm, John; Caulfield, Mark; Chilvers, Edwin; Gibson, John; Griffin, George; Grossman, Ashley; Hall, Alistair; Hart, George; Heagerty, Tony; Home, Philip; Hodgson, Humphrey; Horton, Richard; Hughes, Richard; Khaw, Kay-Tee; Lazarus, John; Leaper, David; McCollum, Peter; Monson, John; O'Rahilly, Stephen; Rowlands, Brian; Scott, Julian; Sutton, Robert; Taylor, Roy; Watkins, Hugh; Wright, Nick			Modernising Medical Careers, Medical Training Application Service, and the Postgraduate Medical Education and Training Board: time for the emperors to don their clothes	LANCET			English	Editorial Material									Univ Cambridge, Cambridge CB2 2QQ, England; British Cardiovasc Soc, London, England; Univ London Imperial Coll Sci Technol & Med, London, England; Univ London St Georges Hosp, Sch Med, London SW17 0RE, England; Univ London, Queen Mary Coll, London, England; Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Liverpool, Liverpool L69 3BX, Merseyside, England; Univ Leeds, Leeds, W Yorkshire, England; UCL Royal Free & Univ Coll Sch Med, London, England; Lancet, London, England; Univ Manchester, Manchester, Lancs, England; Kings Coll London, London WC2R 2LS, England; Univ Cardiff, Cardiff, S Glam, Wales; Univ Hull, Kingston Upon Hull HU6 7RX, N Humberside, England; Univ Nottingham, Nottingham NG7 2RD, England; Univ Oxford, Oxford, England	University of Cambridge; Imperial College London; St Georges University London; University of London; Queen Mary University London; Newcastle University - UK; University of Liverpool; University of Leeds; University of London; University College London; University of Manchester; University of London; King's College London; Cardiff University; University of Hull; University of Nottingham; University of Oxford	Brown, M (corresponding author), Univ Cambridge, Cambridge CB2 2QQ, England.	mjb14@medschl.cam.ac.uk	Khaw, Kay-Tee/AAZ-3209-2021; Hall, Alistair/K-1953-2019; Sutton, Robert/I-3587-2016; O'Rahilly, Stephen/ABF-6509-2020	Sutton, Robert/0000-0001-6600-562X; O'Rahilly, Stephen/0000-0003-2199-4449; Chilvers, Edwin/0000-0002-4230-9677; Hall, Alistair/0000-0003-0306-7887; Caulfield, Mark/0000-0001-9295-3594				BROWN MJ, 2007, BMJ RAPID RESPO 0307; QUESTIONNAIRE MMC MT; 2007, LANCET, V369, P879	3	9	9	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2007	369	9566					967	968		10.1016/S0140-6736(07)60459-0	http://dx.doi.org/10.1016/S0140-6736(07)60459-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151JO	17382804				2022-12-28	WOS:000245286500004
J	Kim, SY; Ferrell, JE				Kim, Sun Young; Ferrell, James E., Jr.			Substrate competition as a source of ultrasensitivity in the inactivation of Wee1	CELL			English	Article							ACTIVATED PROTEIN-KINASE; CELL-CYCLE REGULATION; LAEVIS EGG EXTRACTS; PHOSPHORYLATES CDC2; SWITCH-LIKE; MULTISITE PHOSPHORYLATION; DUAL PHOSPHORYLATION; BIOCHEMICAL SYSTEMS; BIOLOGICAL-SYSTEMS; INHIBITORY KINASE	The mitotic regulators Wee1 and Cdk1 can inactivate each other through inhibitory phosphorylations. This double-negative feedback loop is part of a bistable trigger that makes the transition into mitosis abrupt and decisive. To generate a bistable response, some component of a double-negative feedback loop must exhibit an ultrasensitive response to its upstream regulator. Here, we experimentally demonstrate that Wee1 exhibits a highly ultrasensitive response to Cdk1. Several mechanisms can, in principle, give rise to ultrasensitivity, including zero-order effects, multisite phosphorylation, and competition mechanisms. We found that the ultrasensitivity in the inactivation of Wee1 arises mainly through two competition mechanisms: competition between two sets of phosphorylation sites in Wee1 and between Wee1 and other high-affinity Cdk1 targets. Based on these findings, we were able to reconstitute a highly ultrasensitive Wee1 response with purified components. Competition provides a simple way of generating the equivalent of a highly cooperative allosteric response.	Stanford Univ, Sch Med, Ctr Clin Sci Res, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Ferrell, JE (corresponding author), Stanford Univ, Sch Med, Ctr Clin Sci Res, Dept Chem & Syst Biol, 269 W Campus Dr,Room 3155, Stanford, CA 94305 USA.	james.ferrell@stanford.edu	Kim, Sun/GSN-4867-2022		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046383] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM46383] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Bagowski CP, 2003, CURR BIOL, V13, P315, DOI 10.1016/S0960-9822(03)00083-6; Brown GC, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82216-5; Burack WR, 1997, BIOCHEMISTRY-US, V36, P5929, DOI 10.1021/bi970535d; Chen MZ, 1997, MOL CELL BIOL, V17, P1904, DOI 10.1128/MCB.17.4.1904; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Fattaey A, 1997, Prog Cell Cycle Res, V3, P233; Ferrell JE, 1998, TRENDS BIOCHEM SCI, V23, P461, DOI 10.1016/S0968-0004(98)01316-4; Ferrell JE, 1997, TRENDS BIOCHEM SCI, V22, P288, DOI 10.1016/S0968-0004(97)82217-7; Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Georgi AB, 2002, CURR BIOL, V12, P105, DOI 10.1016/S0960-9822(01)00662-5; GOLDBETER A, 1982, Q REV BIOPHYS, V15, P555, DOI 10.1017/S0033583500003449; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Hardie DG, 1999, BIOCHEM J, V338, P717, DOI 10.1042/0264-6021:3380717; Harvey SL, 2005, CELL, V122, P407, DOI 10.1016/j.cell.2005.05.029; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Kim SY, 2005, MOL CELL BIOL, V25, P10580, DOI 10.1128/MCB.25.23.10580-10590.2005; Klein P, 2003, CURR BIOL, V13, P1669, DOI 10.1016/j.cub.2003.09.027; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; LAPORTE DC, 1983, NATURE, V305, P286, DOI 10.1038/305286a0; Laurent M, 1999, TRENDS BIOCHEM SCI, V24, P418, DOI 10.1016/S0968-0004(99)01473-5; Liu F, 1997, MOL CELL BIOL, V17, P571, DOI 10.1128/MCB.17.2.571; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; MCGOWAN CH, 1995, EMBO J, V14, P2166, DOI 10.1002/j.1460-2075.1995.tb07210.x; MCGOWAN CH, 1993, EMBO J, V12, P75, DOI 10.1002/j.1460-2075.1993.tb05633.x; MEINKE MH, 1986, P NATL ACAD SCI USA, V83, P2865, DOI 10.1073/pnas.83.9.2865; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; NOVAK B, 1993, J CELL SCI, V106, P1153; PARKER LL, 1995, P NATL ACAD SCI USA, V92, P9638, DOI 10.1073/pnas.92.21.9638; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Patra D, 1996, GENE DEV, V10, P1503, DOI 10.1101/gad.10.12.1503; Patra D, 1999, J BIOL CHEM, V274, P36839, DOI 10.1074/jbc.274.52.36839; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Shou WY, 1996, MOL BIOL CELL, V7, P457, DOI 10.1091/mbc.7.3.457; SMYTHE C, 1991, METHOD CELL BIOL, V35, P449; SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; SU JY, 1995, P NATL ACAD SCI USA, V92, P10187, DOI 10.1073/pnas.92.22.10187; TANG ZH, 1993, EMBO J, V12, P3427, DOI 10.1002/j.1460-2075.1993.tb06017.x; Thomas R, 1981, SPRINGER SERIES SYNE, V9, P180; Thron CD, 1996, BIOPHYS CHEM, V57, P239, DOI 10.1016/0301-4622(95)00075-5; Tyson JJ, 1996, TRENDS BIOCHEM SCI, V21, P89; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; WALTER CF, 1970, J THEOR BIOL, V27, P259, DOI 10.1016/0022-5193(70)90141-4; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; Wells NJ, 1999, J CELL SCI, V112, P3361	60	182	183	0	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2007	128	6					1133	1145		10.1016/j.cell.2007.01.039	http://dx.doi.org/10.1016/j.cell.2007.01.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382882	Bronze			2022-12-28	WOS:000245396200019
J	Yokoyama, M; Origasa, H; Matsuzaki, M; Matsuzawa, Y; Saito, Y; Ishikawa, Y; Oikawa, S; Sasaki, J; Hishida, H; Itakura, H; Kita, T; Kitabatake, A; Nakaya, N; Sakata, T; Shimada, K; Shirato, K				Yokoyama, Mitsuhiro; Origasa, Hideki; Matsuzaki, Masunori; Matsuzawa, Yuji; Saito, Yasushi; Ishikawa, Yuichi; Oikawa, Shinichi; Sasaki, Jun; Hishida, Hitoshi; Itakura, Hiroshige; Kita, Toru; Kitabatake, Akira; Nakaya, Noriaki; Sakata, Toshiie; Shimada, Kazuyuki; Shirato, Kunio		JELIS Investigators	Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis	LANCET			English	Article							POLYUNSATURATED FATTY-ACIDS; HEART-DISEASE; FISH CONSUMPTION; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; LIPID INTERVENTION; JAPANESE PATIENTS; ETHYL-ESTER; RISK; EPA	Background Epidemiological and clinical evidence suggests that an increased intake of long-chain n-3 fatty acids protects against mortality from coronary artery disease. We aimed to test the hypothesis that long-term use of eicosapentaenoic acid (EPA) is effective for prevention of major coronary events in hypercholesterolaemic patients in Japan who consume a large amount of fish. Methods 18645 patients with a total cholesterol of 6.5 mmol/L or greater were recruited from local physicians throughout Japan between 1996 and 1999. Patients were randomly assigned to receive either 1800 mg of EPA daily with statin (EPA group; n=9326) or statin only (controls; n=9319) with a 5-year follow-up. The primary endpoint was any major coronary event, including sudden cardiac death, fatal and non-fatal myocardial infarction, and other non-fatal events including unstable angina pectoris, angioplasty, stenting, or coronary artery bypass grafting. Analysis was by intention-to-treat. The study was registered at clinicaltrials.gov, number NCT00231738. Findings At mean follow-up of 4.6 years, we detected the primary endpoint in 262 (2.8%) patients in the EPA group and 324 (3.5%) in controls-a 19% relative reduction in major coronary events (p=0.011). Post-treatment LDL cholesterol concentrations decreased 25%, from 4.7 mmol/L in both groups. Serum LDL cholesterol was not a significant factor in a reduction of risk for major coronary events. Unstable angina and non-fatal coronary events were also significantly reduced in the EPA group. Sudden cardiac death and coronary death did not differ between groups. In patients with a history of coronary artery disease who were given EPA treatment, major coronary events were reduced by 19% (secondary prevention subgroup: 158 [8.7%] in the EPA group vs 197 [10.7%] in the control group; p=0.048). In patients with no history of coronary artery disease, EPA treatment reduced major coronary events by 18%, but this finding was not significant (104 [1.4%] in the EPA group vs 127 [1.7%] in the control group; p=0.132). Interpretation EPA is a promising treatment for prevention of major coronary events, and especially non-fatal coronary events, in Japanese hypercholesterolaemic patients.	Kobe Univ, Grad Sch Med, Div Cardiovasc Med, Dept Internal Med,Chuo Ku, Kobe, Hyogo 6500017, Japan; Toyama Univ, Div Clin Epidemiol & Biostat, Toyama 930, Japan; Yamaguchi Univ, Yamaguchi, Japan; Sumitomo Hosp, Osaka, Japan; Chiba Univ, Chiba, Japan; Kobe Univ, Kobe, Hyogo 657, Japan; Nippon Med Sch, Tokyo 113, Japan; Int Univ Hlth & Welf, Grad Sch Publ Hlth Med, Fukuoka, Japan; Fujita Hlth Univ, Sch Med, Aichi, Japan; Ibaraki Christian Univ, Ibaraki, Japan; Kyoto Univ, Kyoto, Japan; Nakamura Gakuen Univ, Fukuoka, Japan; Jichi Med Sch, Minami Kawachi, Tochigi 32904, Japan	Kobe University; University of Toyama; Yamaguchi University; Sumitomo Hospital; Chiba University; Kobe University; Nippon Medical School; International University of Health & Welfare; Fujita Health University; Kyoto University; Jichi Medical University	Yokoyama, M (corresponding author), Kobe Univ, Grad Sch Med, Div Cardiovasc Med, Dept Internal Med,Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	yokoyama@med.kobe-u.ac.jp						Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; Ando M, 1999, J AM SOC NEPHROL, V10, P2177; Baumann KH, 1999, ARTERIOSCL THROM VAS, V19, P59, DOI 10.1161/01.ATV.19.1.59; BURR ML, 1989, LANCET, V2, P757; Chen HJ, 2003, J MOL CELL CARDIOL, V35, P769, DOI 10.1016/S0022-2828(03)00120-2; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Daviglus ML, 1997, NEW ENGL J MED, V336, P1046, DOI 10.1056/NEJM199704103361502; Din JN, 2004, BMJ-BRIT MED J, V328, P30, DOI 10.1136/bmj.328.7430.30; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Durrington PN, 2001, HEART, V85, P544, DOI 10.1136/heart.85.5.544; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; HAMAZAKI T, 1982, PROSTAG OTH LIPID M, V23, P557, DOI 10.1016/0090-6980(82)90116-2; Hansson L, 1992, Blood Press, V1, P113, DOI 10.3109/08037059209077502; Harris WS, 2003, CURR OPIN LIPIDOL, V14, P9, DOI 10.1097/00041433-200302000-00003; He K, 2004, CIRCULATION, V109, P2705, DOI 10.1161/01.CIR.0000132503.19410.6B; HIRAI A, 1982, THROMB RES, V28, P285, DOI 10.1016/0049-3848(82)90112-8; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Iso H, 2006, CIRCULATION, V113, P195, DOI 10.1161/CIRCULATIONAHA.105.581355; ISO H, 1989, INT J EPIDEMIOL, V18, P374, DOI 10.1093/ije/18.2.374; Kang JX, 2000, AM J CLIN NUTR, V71, p202S, DOI 10.1093/ajcn/71.1.202S; Kawano Hiroyuki, 2002, J Atheroscler Thromb, V9, P170; KROMHOUT D, 1985, NEW ENGL J MED, V312, P1205, DOI 10.1056/NEJM198505093121901; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lemaitre RN, 2003, AM J CLIN NUTR, V77, P319, DOI 10.1093/ajcn/77.2.319; MATAKI H, 1998, J INTERN MED, V5, P35; Matsuzaki M, 2002, CIRC J, V66, P1087, DOI 10.1253/circj.66.1087; Miles EA, 2000, ATHEROSCLEROSIS, V152, P43, DOI 10.1016/S0021-9150(99)00446-3; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; Nakamura N, 1999, INT J CLIN LAB RES, V29, P22, DOI 10.1007/s005990050057; Nakamura T, 2003, BRIT J NUTR, V89, P267, DOI 10.1079/BJN2002747; NOZAKI S, 1992, INT J VITAM NUTR RES, V62, P256; Okuda Y, 1997, BIOCHEM BIOPH RES CO, V232, P487, DOI 10.1006/bbrc.1997.6328; PEDERSEN TR, 1994, LANCET, V344, P1383; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; TAMURA Y, 1986, PROG LIPID RES, V25, P461, DOI 10.1016/0163-7827(86)90092-5; Terano T, 1996, LIPIDS, V31, pS301, DOI 10.1007/BF02637096; TERANO T, 1984, BIOCHEM PHARMACOL, V33, P3071, DOI 10.1016/0006-2952(84)90611-7; Thies F, 2003, LANCET, V361, P477, DOI 10.1016/S0140-6736(03)12468-3; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; WALLACE JMW, 1995, ARTERIOSCL THROM VAS, V15, P185, DOI 10.1161/01.ATV.15.2.185; Yokoyama M, 2003, AM HEART J, V146, P613, DOI 10.1016/S0002-8703(03)00367-3	43	1725	1851	5	104	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2007	369	9567					1090	1098		10.1016/S0140-6736(07)60527-3	http://dx.doi.org/10.1016/S0140-6736(07)60527-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151XF	17398308				2022-12-28	WOS:000245323700029
J	Bagenal, F				Bagenal, Fran			A new spin on Saturn's rotation	SCIENCE			English	Editorial Material							ENCELADUS		Univ Colorado, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Bagenal, F (corresponding author), Univ Colorado, Boulder, CO 80309 USA.	bagenal@colorado.edu						Cowling TG, 1933, MON NOT R ASTRON SOC, V94, P0039, DOI 10.1093/mnras/94.1.39; DELAMERE P, 2007, J GEOPHYS RES, P64902, DOI DOI 10.1029/2007GL029437; DESSLER AJ, 1981, PLANET SPACE SCI, V29, P215, DOI 10.1016/0032-0633(81)90035-0; Dougherty MK, 2006, SCIENCE, V311, P1406, DOI 10.1126/science.1120985; Gurnett DA, 2007, SCIENCE, V316, P442, DOI 10.1126/science.1138562; Kurth WS, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028336; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Sanchez-Lavega A, 2005, SCIENCE, V307, P1223, DOI 10.1126/science.1104956; SOUTHWOOD DJ, 2006, AM GEOPH UN M 11 15, P64902; Steffl AJ, 2006, ICARUS, V180, P124, DOI 10.1016/j.icarus.2005.07.013; STEVENSON DJ, 1980, SCIENCE, V208, P746, DOI 10.1126/science.208.4445.746; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290	12	3	3	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					380	381		10.1126/science.1142329	http://dx.doi.org/10.1126/science.1142329			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446379				2022-12-28	WOS:000245813400030
J	Tardif, JC; Gregoire, J; L'Allier, PL; Ibrahim, R; Lesperance, J; Heinonen, TM; Kouz, S; Berry, C; Basser, R; Lavoie, MA; Guertin, MC; Rodes-Cabau, J				Tardif, Jean-Claude; Gregoire, Jean; L'Allier, Philippe L.; Ibrahim, Reda; Lesperance, Jacques; Heinonen, Therese M.; Kouz, Simon; Berry, Colin; Basser, Russell; Lavoie, Marc-Andre; Guertin, Marie-Claude; Rodes-Cabau, Josep		ERASE Investigators	Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REVERSE CHOLESTEROL TRANSPORT; INTRAVASCULAR ULTRASOUND; HEART-DISEASE; ENDOTHELIAL FUNCTION; INTERVENTION TRIAL; ARTERY-DISEASE; PROGRESSION; PROBUCOL; ANGIOPLASTY; LESIONS	Context High-density lipoprotein (HDL) cholesterol is an inverse predictor of coronary atherosclerotic disease. Preliminary data have suggested that HDL infusions can induce atherosclerosis regression. Objective To investigate the effects of reconstituted HDL on plaque burden as assessed by intravascular ultrasound (IVUS). Design and Setting A randomized placebo-controlled trial was conducted at 17 centers in Canada. Intravascular ultrasound was performed to assess coronary atheroma at baseline and 2 to 3 weeks after the last study infusion. Patients Between July 2005 and October 2006, 183 patients had a baseline IVUS examination and of those, 145 had evaluable serial IVUS examinations after 6 weeks. Intervention Sixty patients were randomly assigned to receive 4 weekly infusions of placebo ( saline), 111 to receive 40 mg/kg of reconstituted HDL (CSL-111); and 12 to receive 80 mg/kg of CSL-111. Main Outcome Measures The primary efficacy parameter was the percentage change in atheroma volume. Nominal changes in plaque volume and plaque characterization index on IVUS and coronary score on quantitative coronary angiography were also prespecified end points. Results The higher-dosage CSL-111 treatment group was discontinued early because of liver function test abnormalities. The percentage change in atheroma volume was- 3.4% with CSL-111 and - 1.6% for placebo (P=. 48 between groups, P <. 001 vs baseline for CSL-111). The nominal change in plaque volume was - 5.3 mm(3) with CSL-111 and - 2.3 mm(3) with placebo ( P=. 39 between groups, P <. 001 vs baseline for CSL-111). The mean changes in plaque characterization index on IVUS (- 0.0097 for CSL-111 and 0.0128 with placebo) and mean changes in coronary score (- 0.039 mm for CSL-111 and - 0.071 mm with placebo) on quantitative coronary angiography were significantly different between groups ( P=. 01 and P=. 03, respectively). Administration of CSL-111 40 mg/kg was associated with mild, self-limiting transaminase elevation but was clinically well tolerated. Conclusions Short-term infusions of reconstituted HDL resulted in no significant reductions in percentage change in atheroma volume or nominal change in plaque volume compared with placebo but did result in statistically significant improvement in the plaque characterization index and coronary score on quantitative coronary angiography. Elevation of HDL remains a valid target in vascular disease and further studies of HDL infusions, including trials with clinical end points, appear warranted.	Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; Univ Montreal, MHICC, Montreal, PQ, Canada; Ctr Hosp Reg Lanaudiere, Quebec City, PQ, Canada; CSL Ltd, Parkville, Vic, Australia; Laval Hosp, Quebec Heart Inst, Quebec City, PQ, Canada	Universite de Montreal; Universite de Montreal; CSL; Laval University	Tardif, JC (corresponding author), Montreal Heart Inst, 500 Belanger St, Montreal, PQ H1T 1C8, Canada.	jean-claude.tardif@icm-mhi.org	Ibrahim, Reda/AAX-7882-2021; Berry, Colin/AAF-5268-2020					Bisoendial RJ, 2003, CIRCULATION, V107, P2944, DOI 10.1161/01.CIR.0000070934.69310.1A; Boden WE, 2000, AM J CARDIOL, V86, p19L; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cote G, 1999, CIRCULATION, V99, P30, DOI 10.1161/01.CIR.99.1.30; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; JUKEMA JW, 1995, CIRCULATION, V91, P2528, DOI 10.1161/01.CIR.91.10.2528; Krause B R, 2001, Curr Opin Investig Drugs, V2, P375; Lee HS, 2002, CAN J CARDIOL, V18, P271; Lerch PG, 1996, VOX SANG, V71, P155, DOI 10.1046/j.1423-0410.1996.7130155.x; Libby P, 2001, AM J CARDIOL, V88, p3N; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Nanjee MN, 2001, J LIPID RES, V42, P1586; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Packard C, 2002, INT J CLIN PRACT, V56, P761; Palmer ND, 1999, EUR HEART J, V20, P1701, DOI 10.1053/euhj.1999.1627; PEDERSEN TR, 1994, LANCET, V344, P1383; Rader DJ, 2003, AM J CARDIOL, V92, p42J, DOI 10.1016/S0002-9149(03)00615-5; Schartl M, 2001, CIRCULATION, V104, P387, DOI 10.1161/hc2901.093188; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Spieker LE, 2002, CIRCULATION, V105, P1399, DOI 10.1161/01.CIR.0000013424.28206.8F; Sviridov D, 2002, ATHEROSCLEROSIS, V161, P245, DOI 10.1016/S0021-9150(01)00677-3; Tall AR, 2007, ARTERIOSCL THROM VAS, V27, P257, DOI 10.1161/01.ATV.0000256728.60226.77; Tardif JC, 2004, CIRCULATION, V110, P3372, DOI 10.1161/01.CIR.0000147777.12010.EF; Tardif JC, 2003, CIRCULATION, V107, P552, DOI 10.1161/01.CIR.0000047525.58618.3C; Tardif JC, 1997, NEW ENGL J MED, V337, P365, DOI 10.1056/NEJM199708073370601; Tardif JC, 2002, AM HEART J, V144, P589, DOI 10.1067/mhj.2002.125329; von Eckardstein A, 2001, ARTERIOSCL THROM VAS, V21, P13, DOI 10.1161/01.ATV.21.1.13; WATERS D, 1994, CIRCULATION, V89, P959, DOI 10.1161/01.CIR.89.3.959; WATERS D, 1993, CIRCULATION, V87, P1067, DOI 10.1161/01.CIR.87.4.1067; Wierzbicki AS, 2002, CURR MED RES OPIN, V18, P36, DOI 10.1185/030079902125000165	32	580	613	3	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2007	297	15					1675	1682		10.1001/jama.297.15.jpc70004	http://dx.doi.org/10.1001/jama.297.15.jpc70004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	157UR	17387133				2022-12-28	WOS:000245747400021
J	Anand, S; Barnighausen, T				Anand, Sudhir; Baernighausen, Till			Health workers and vaccination coverage in developing countries: an econometric analysis	LANCET			English	Article							IMMUNIZATION COVERAGE; HUMAN-RESOURCES; MEASLES; DETERMINANTS; ERADICATION; CHILDREN; BANGLADESH; EDUCATION; POLIO; AREA	Background Vaccine-preventable diseases cause more than 1 million deaths among children in developing countries every year. Although health workers are needed to do vaccinations, the role of human resources for health as a determinant of vaccination coverage at the population level has not been investigated. our aim was to test whether health worker density was positively associated with childhood vaccination coverage in developing countries. Methods We did cross-country multiple regression analyses with coverage of three vaccinations-measles-containing vaccine (MCV); diphtheria, tetanus, and pertussis (DTP3); and poliomyelitis (polio3)-as dependent variables. Aggregate health worker density was an independent variable in one set of regressions; doctor and nurse densities were used separately in another set. We controlled for national income per person, female adult literacy, and land area. Findings Health worker density was significantly associated with coverage of all three vaccinations (MCV p=0.0024; DTP3 p=0.0004; polio3 p=0.0008). However, when the effects of doctors and nurses were assessed separately, we found that nurse density was significantly associated with coverage of all three vaccinations (MCV p=0.0097; DTP3 p=0.0083; polio3 p=0.0089), but doctor density was not (MCV p=0.7953; DTP3 p=0.7971; polio3 p=0.7885). Female adult literacy was positively associated, and land area negatively associated, with vaccination coverage. National income per person had no effect on coverage. Interpretation A higher density of health workers (nurses) increases the availability of vaccination services over time and space, making it more likely that children will be vaccinated. After controlling for other determinants, the level of income does not contribute to improved immunisation coverage. Health workers can be a major constraining factor on vaccination coverage in developing countries.	Univ Oxford St Catherines Coll, Dept Econ, Oxford OX1 3UJ, England; Harvard Univ, Cambridge, MA 02138 USA; Univ KwaZulu Natal, Africa Ctr hlth & Populat Studies, Mtubatuba, South Africa; Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA	University of Oxford; Harvard University; University of Kwazulu Natal; Harvard University; Harvard T.H. Chan School of Public Health	Anand, S (corresponding author), Univ Oxford St Catherines Coll, Dept Econ, Oxford OX1 3UJ, England.	sudhir.anand@economics.ox.ac.uk	Bärnighausen, Till/Y-2388-2019					Abuwa P N, 1997, West Afr J Med, V16, P174; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Aylward RB, 2005, B WORLD HEALTH ORGAN, V83, P268; BERRY DJ, 1991, S AFR MED J, V79, P433; BOERMA JT, 1994, QUALITY DATA CHILD I; Brown J., 2002, WP0253 MEASURE U N C; BRUGHA R, 1995, HEALTH POLICY PLANN, V10, P312, DOI 10.1093/heapol/10.3.312; Chowdhury AMR, 2003, J HEALTH POPUL NUTR, V21, P193; COETZEE N, 1990, S AFR MED J, V78, P733; CUTTS FT, 1991, INT J EPIDEMIOL, V20, P1099, DOI 10.1093/ije/20.4.1099; CUTTS FT, 1989, INT J EPIDEMIOL, V18, P427, DOI 10.1093/ije/18.2.427; Dayan GH, 2004, VACCINE, V22, P475, DOI 10.1016/j.vaccine.2003.07.007; de Quadros CA, 2002, MED MICROBIOL IMMUN, V191, P75, DOI 10.1007/s00430-002-0120-7; DEFO BK, 1994, SOC BIOL, V41, P181; DIALLO K, 2004, METHODOLOGICAL NOTE; Dubois CA, 2006, HEALTH ECON POLICY L, V1, P59, DOI 10.1017/S1744133105001027; Ekwueme DU, 2000, ARCH PEDIAT ADOL MED, V154, P797, DOI 10.1001/archpedi.154.8.797; ENGLAND S, 2001, CHM WORKING PAPER SE; Gauri V, 2002, WORLD DEV, V30, P2109, DOI 10.1016/S0305-750X(02)00151-1; *GAVI, 2003, 11 GAVI BOARD M HUM; *GAVI, 2005, ANN DEATHS 2002 VACC; *GAVI, 2005, GAVI OBJ; *GAVI, 2005, KEY EUR NAT JOIN UK; Gilling C M, 1989, Nurse Educ Today, V9, P82, DOI 10.1016/0260-6917(89)90058-0; HADI AS, 1994, J ROY STAT SOC B MET, V56, P393; JLI (Joint Learning Initiative), 2004, HUM RES HLTH OV CRIS; Kamau N, 2001, East Afr Med J, V78, P590; Khaleghian P, 2004, SOC SCI MED, V59, P163, DOI 10.1016/j.socscimed.2003.10.013; Langsten R, 1998, SOC SCI MED, V46, P1205, DOI 10.1016/S0277-9536(97)10049-1; Luman ET, 2003, PEDIATRICS, V111, P1215; *MACR INT, 2007, DEM HLTH SURV STATC; Murray CJL, 2003, LANCET, V362, P1022, DOI 10.1016/S0140-6736(03)14411-X; Nokes DJ, 1997, TRENDS MICROBIOL, V5, P14, DOI 10.1016/S0966-842X(97)81769-6; Nolte A, 1995, Curationis, V18, P49; NUTTER DO, 1983, J MED EDUC, V58, P555; OBERMEYER CM, 1993, J BIOSOC SCI, V25, P371, DOI 10.1017/S0021932000020708; PILLAI VK, 1992, J BIOSOC SCI, V24, P201, DOI 10.1017/S0021932000019738; REES H, 1991, S AFR MED J, V80, P378; Rolls C, 1996, Aust Coll Midwives Inc J, V9, P18, DOI 10.1016/S1031-170X(96)80007-9; Steele F, 1996, J ROY STAT SOC A STA, V159, P289, DOI 10.2307/2983175; STREATFIELD K, 1990, DEMOGRAPHY, V27, P447, DOI 10.2307/2061378; Stronegger WJ, 1998, ZBL HYG UMWELTMED, V201, P437; Ughade S N, 2000, J Indian Med Assoc, V98, P4; *UNDP, 1993, HUM DEV REP 1993 200; United Nations Development Programme (UNDP), 2007, MILL DEV GOALS TRACK; Uzicanin A, 2004, VACCINE, V22, P3419, DOI 10.1016/j.vaccine.2004.02.042; *WHO, 2002, COR INF DEV IMM POL; *WHO, 2005, GLOB POL IN 2004 ANN; *WHO, IMM PRACT PRACT RES; *WHO, 2004, WHO EST HLTH PERS PH; *WHO, 2005, EC IMM GUI LIT OTH R; *WHO, 2005, IMM COV; *WHO, 2004, EST ANN DEATHS DIS A; *WORLD BANK, 2006, WORLD DEV IND; World Health Organization, 2006, WORK HLTH WORLD HLTH; World Health Organization, 2005, GLOB ATL HLTH WORKF GLOB ATL HLTH WORKF; Zeleke SA, 2000, LANCET, V356, pS21, DOI 10.1016/S0140-6736(00)92007-5	57	163	165	2	20	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 14	2007	369	9569					1277	1285		10.1016/S0140-6736(07)60599-6	http://dx.doi.org/10.1016/S0140-6736(07)60599-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	164YA	17434403				2022-12-28	WOS:000246269700030
J	Trauger, JT; Traub, WA				Trauger, John T.; Traub, Wesley A.			A laboratory demonstration of the capability to image an Earth-like extrasolar planet	NATURE			English	Article							TERRESTRIAL PLANETS; CORONAGRAPHS; MASK; MISSION; PUPILS; SPACE	The detection and characterization of an Earth-like planet orbiting a nearby star requires a telescope with an extraordinarily large contrast at small angular separations. At visible wavelengths, an Earth-like planet would be 1 x 10(-10) times fainter than the star at angular separations of typically 0.1 arcsecond or less(1,2). There are several proposed space telescope systems that could, in principle, achieve this(3-6). Here we report a laboratory experiment that reaches these limits. We have suppressed the diffracted and scattered light near a star- like source to a level of 6 x 10(-10) times the peak intensity in individual coronagraph images. In a series of such images, together with simple image processing, we have effectively reduced this to a residual noise level of about 0.1 x 10(-10). This demonstrates that a coronagraphic telescope in space could detect and spectroscopically characterize nearby exoplanetary systems, with the sensitivity to image an ` Earth- twin' orbiting a nearby star.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Trauger, JT (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	john.trauger@jpl.nasa.gov						Borde PJ, 2006, ASTROPHYS J, V638, P488, DOI 10.1086/498669; Born M., 2002, PRINCIPLES OPTICS; Brown RA, 2005, ASTROPHYS J, V624, P1010, DOI 10.1086/429124; Cash W, 2006, NATURE, V442, P51, DOI 10.1038/nature04930; Des Marais DJ, 2002, ASTROBIOLOGY, V2, P153, DOI 10.1089/15311070260192246; Guyon O, 2006, ASTROPHYS J SUPPL S, V167, P81, DOI 10.1086/507630; Guyon O, 2003, ASTRON ASTROPHYS, V404, P379, DOI 10.1051/0004-6361:20030457; Heap SR, 2000, ASTROPHYS J, V539, P435, DOI 10.1086/309188; Henry C, 2004, P SOC PHOTO-OPT INS, V5491, P265, DOI 10.1117/12.552345; Kaltenegger L, 2005, ADV SPACE RES-SERIES, V36, P1114, DOI 10.1016/j.asr.2005.05.061; Kasdin NJ, 2005, APPL OPTICS, V44, P1117, DOI 10.1364/AO.44.001117; KRIST J, 2006, P SOC PHOTO-OPT INS, V6265, P301; Kuchner MJ, 2002, ASTROPHYS J, V570, P900, DOI 10.1086/339625; Kuchner MJ, 2005, ASTROPHYS J, V628, P466, DOI 10.1086/430200; Lowrance PJ, 2005, ASTRON J, V130, P1845, DOI 10.1086/432839; Lyot B., 1939, MNRAS, V99, P580, DOI DOI 10.1093/MNRAS/99.8.580; Riaud P, 2003, PUBL ASTRON SOC PAC, V115, P712, DOI 10.1086/375385; Soummer R, 2005, ASTROPHYS J, V618, pL161, DOI 10.1086/427923; TRAUB WA, 2006, P SOC PHOTO-OPT INS, V6268, pOT1; Trauger J, 2004, P SOC PHOTO-OPT INS, V5487, P1330, DOI 10.1117/12.552520; Trauger J., 2006, D35484 JPL; TRAUGER J, 2002, P SOC PHOTO-OPT INS, V4854, P116; Vanderbei RJ, 2004, ASTROPHYS J, V615, P555, DOI 10.1086/423947	23	222	224	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2007	446	7137					771	773		10.1038/nature05729	http://dx.doi.org/10.1038/nature05729			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429394				2022-12-28	WOS:000245626800034
J	Fawzi, WW; Msamanga, GI; Urassa, W; Hertzmark, E; Petraro, P; Willett, WC; Spiegelman, D				Fawzi, Wafaie W.; Msamanga, Gernard I.; Urassa, Willy; Hertzmark, Ellen; Petraro, Paul; Willett, Walter C.; Spiegelman, Donna			Vitamins and perinatal outcomes among HIV-negative women in Tanzania	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTIPLE MICRONUTRIENT SUPPLEMENTATION; LOW-BIRTH-WEIGHT; DOUBLE-BLIND; RANDOMIZED-TRIAL; PREGNANCY; SIZE; NUTRITION; MORTALITY; COMMUNITY; GROWTH	BACKGROUND Prematurity and low birth weight are associated with high perinatal and infant mortality, especially in developing countries. Maternal micronutrient deficiencies may contribute to these adverse outcomes. METHODS In a double-blind trial in Dar es Salaam, Tanzania, we randomly assigned 8468 pregnant women (gestational age of fetus, 12 to 27 weeks) who were negative for human immunodeficiency virus infection to receive daily multivitamins (including multiples of the recommended dietary allowance) or placebo. All the women received prenatal supplemental iron and folic acid. The primary outcomes were low birth weight (<2500 g), prematurity, and fetal death. RESULTS The incidence of low birth weight was 7.8% among the infants in the multivitamin group and 9.4% among those in the placebo group (relative risk, 0.82; 95% confidence interval [CI], 0.70 to 0.95; P=0.01). The mean difference in birth weight between the groups was modest (67 g, P<0.001). The rates of prematurity were 16.9% in the multivitamin group and 16.7% in the placebo group (relative risk, 1.01; 95% CI, 0.91 to 1.11; P=0.87), and the rates of fetal death were 4.3% and 5.0%, respectively (relative risk, 0.87; 95% CI, 0.72 to 1.05; P=0.15). Supplementation reduced both the risk of a birth size that was small for gestational age (<10th percentile; 10.7% in the multivitamin group vs. 13.6% in the placebo group; relative risk, 0.77; 95% CI, 0.68 to 0.87; P<0.001) and the risk of maternal anemia (hemoglobin level, <11 g per deciliter; relative risk, 0.88; 95% CI, 0.80 to 0.97; P=0.01), although the difference in the mean hemoglobin levels between the groups was small (0.2 g per deciliter, P<0.001). CONCLUSIONS Multivitamin supplementation reduced the incidence of low birth weight and small-for-gestational-age births but had no significant effects on prematurity or fetal death. Multivitamins should be considered for all pregnant women in developing countries. (ClinicalTrials.gov number, NCT00197548.).	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Muhimbili Univ, Coll Hlth Sci, Dept Community Hlth, Dar Es Salaam, Tanzania; Muhimbili Univ, Coll Hlth Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Fawzi, WW (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	mina@hsph.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK040561, P30 DK040561-12] Funding Source: Medline; PHS HHS [R01 37701] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Allen LH, 2005, AM J CLIN NUTR, V81, p1206S; BAUM M, 1994, NUTRITION, V10, P16; BRENNER WE, 1976, AM J OBSTET GYNECOL, V126, P555, DOI 10.1016/0002-9378(76)90748-1; Christian P, 2005, LANCET, V366, P711, DOI 10.1016/S0140-6736(05)67166-8; Christian P, 2003, BMJ-BRIT MED J, V326, P571, DOI 10.1136/bmj.326.7389.571; Fawzi WW, 1998, LANCET, V351, P1477, DOI 10.1016/S0140-6736(98)04197-X; Fawzi WW, 2002, AIDS, V16, P1935, DOI 10.1097/00002030-200209270-00011; Fishman SM, 2000, PUBLIC HEALTH NUTR, V3, P125, DOI 10.1017/S1368980000000173; Friis H, 2004, AM J CLIN NUTR, V80, P178; Gillman MW, 2005, NEW ENGL J MED, V353, P1848, DOI 10.1056/NEJMe058187; Hughes MD, 1995, AIDS CLIN TRIALS, P177; Humphrey JH, 2006, J INFECT DIS, V193, P960; Kaestel P, 2005, EUR J CLIN NUTR, V59, P1081, DOI 10.1038/sj.ejcn.1602215; LUMLEY J, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001056.pub2, 10.1002/14651858.CD001056, DOI 10.1002/14651858.CD001056]; Mathews F, 1999, BRIT MED J, V319, P339, DOI 10.1136/bmj.319.7206.339; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; Mungen E, 2003, J PERINAT MED, V31, P420, DOI 10.1515/JPM.2003.065; Muthayya S, 2006, EUR J CLIN NUTR, V60, P791, DOI 10.1038/sj.ejcn.1602383; Osendarp SJM, 2003, J NUTR, V133, p817S; Osrin D, 2005, LANCET, V365, P955, DOI 10.1016/S0140-6736(05)71084-9; Ramakrishnan U, 1999, J NUTR, V129, p544S, DOI 10.1093/jn/129.2.544S; Ramakrishnan U, 2003, AM J CLIN NUTR, V77, P720, DOI 10.1093/ajcn/77.3.720; RAMSAY VP, 1983, AM J CLIN NUTR, V37, P969, DOI 10.1093/ajcn/37.6.969; Rao S, 2001, J NUTR, V131, P1217, DOI 10.1093/jn/131.4.1217; Rosner B., 2006, FUNDAMENTALS BIOSTAT; Shrimpton R, 2002, P NUTR SOC, V61, P223, DOI 10.1079/PNS2002163; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; United Nations Children's Fund and World Health Organization, 2004, LOW BIRTHW COUNTR RE; Urassa W, 1999, J CLIN VIROL, V14, P25, DOI 10.1016/S1386-6532(99)00043-8; Villar J, 1997, ACTA OBSTET GYN SCAN, V76, P1, DOI 10.3109/00016349709047778; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	31	134	138	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 5	2007	356	14					1423	1431		10.1056/NEJMoa064868	http://dx.doi.org/10.1056/NEJMoa064868			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153GG	17409323				2022-12-28	WOS:000245419600005
J	Brown, H				Brown, Hannah			Sweetening the pil	BRITISH MEDICAL JOURNAL			English	Editorial Material												Hannah@two-cultures.com							0	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 31	2007	334	7595					664	666		10.1136/bmj.39153.511701.BE	http://dx.doi.org/10.1136/bmj.39153.511701.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154ON	17395944	Green Published			2022-12-28	WOS:000245517100028
J	van der Hilst, RD; de Hoop, MV; Wang, P; Shim, SH; Ma, P; Tenorio, L				van der Hilst, R. D.; de Hoop, M. V.; Wang, P.; Shim, S -H; Ma, P.; Tenorio, L.			Seismostratigraphy and thermal structure of Earth's core-mantle boundary region	SCIENCE			English	Article							POST-PEROVSKITE PHASE; SUBDUCTED LITHOSPHERE; MGSIO3 PEROVSKITE; LOWERMOST-MANTLE; TEMPERATURE; HETEROGENEITY; TRANSITION; DISCONTINUITY; CONDUCTIVITY; BENEATH	We used three-dimensional inverse scattering of core-reflected shear waves for large-scale, high-resolution exploration of Earth's deep interior (D '') and detected multiple, piecewise continuous interfaces in the lowermost layer (D '') beneath Central and North America. With thermodynamic properties of phase transitions in mantle silicates, we interpret the images and estimate in situ temperatures. A widespread wave-speed increase at 150 to 300 kilometers above the core-mantle boundary is consistent with a transition from perovskite to postperovskite. Internal D '' stratification may be due to multiple phase-boundary crossings, and a deep wave-speed reduction may mark the base of a postperovskite lens about 2300 kilometers wide and 250 kilometers thick. The core-mantle boundary temperature is estimated at 3950 +/- 200 kelvin. Beneath Central America, a site of deep subduction, the D '' is relatively cold (Delta T = 700 +/- 100 kelvin). Accounting for a factor-of-two uncertainty in thermal conductivity, core heat flux is 80 to 160 milliwatts per square meter (mW m(-2)) into the coldest D '' region and 35 to 70 mW m(-2) away from it. Combined with estimates from the central Pacific, this suggests a global average of 50 to 100 mW m(-2) and a total heat loss of 7.5 to 15 terawatts.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Purdue Univ, Ctr Computat & Appl Math, W Lafayette, IN 47907 USA; Univ Illinois, Dept Stat, Urbana, IL 61801 USA; Colorado Sch Mines, Golden, CO 80401 USA	Massachusetts Institute of Technology (MIT); Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Illinois System; University of Illinois Urbana-Champaign; Colorado School of Mines	van der Hilst, RD (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.		Ma, Ping/M-7746-2015	Ma, Ping/0000-0002-5728-3596; Shim, Sang-Heon/0000-0001-5203-6038				Alfe D, 2002, EARTH PLANET SC LETT, V195, P91, DOI 10.1016/S0012-821X(01)00568-4; Bloxham J, 2000, PHILOS T R SOC A, V358, P1171, DOI 10.1098/rsta.2000.0579; BOEHLER R, 1993, NATURE, V363, P534, DOI 10.1038/363534a0; BOEHLER R, 1995, CHEM GEOL, V120, P199, DOI 10.1016/0009-2541(94)00138-X; Buffett BA, 2000, SCIENCE, V288, P2007, DOI 10.1126/science.288.5473.2007; CLEARY JR, 1972, NATURE, V240, P549, DOI 10.1038/240549a0; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; FIORES C, 2005, GEOPHYS RES LETT, V32, DOI DOI 10.1029/2005GL024366; Garnero EJ, 2000, ANNU REV EARTH PL SC, V28, P509, DOI 10.1146/annurev.earth.28.1.509; Grand SP, 2002, PHILOS T R SOC A, V360, P2475, DOI 10.1098/rsta.2002.1077; Hedlin MAH, 1997, NATURE, V387, P145, DOI 10.1038/387145a0; Helmberger D, 2005, P NATL ACAD SCI USA, V102, P17257, DOI 10.1073/pnas.0502504102; Hernlund JW, 2005, NATURE, V434, P882, DOI 10.1038/nature03472; HIROSE K, 2006, GEOPHYS RES LETT, V333, P1310; Hofmeister AM, 1999, SCIENCE, V283, P1699, DOI 10.1126/science.283.5408.1699; Hutko AR, 2006, NATURE, V441, P333, DOI 10.1038/nature04757; Iitaka T, 2004, NATURE, V430, P442, DOI 10.1038/nature02702; Karason H, 2001, J GEOPHYS RES-SOL EA, V106, P6569, DOI 10.1029/2000JB900380; KNITTLE E, 1991, J GEOPHYS RES-SOL EA, V96, P16169, DOI 10.1029/90JB00653; Kobayashi Y, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023257; Lay T, 2004, GEOPHYS MONOGR SER, V150, P25, DOI 10.1029/150GM04; Lay T, 2006, SCIENCE, V314, P1272, DOI 10.1126/science.1133280; MA P, UNPUB J GEOPHYS RES; Mao WL, 2004, P NATL ACAD SCI USA, V101, P15867, DOI 10.1073/pnas.0407135101; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Oganov AR, 2004, NATURE, V430, P445, DOI 10.1038/nature02701; Ribe NM, 2007, EARTH PLANET SC LETT, V254, P173, DOI 10.1016/j.epsl.2006.11.028; Shim SH, 2005, GEOPHYS MONOGR SER, V160, P261, DOI 10.1029/160GM16; Shim SH, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019639; Sidorin I, 1999, SCIENCE, V286, P1326, DOI 10.1126/science.286.5443.1326; Stacey F. D., 1992, PHYS EARTH; Sun DL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024780; Thomas C, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003013; Tsuchiya T, 2004, EARTH PLANET SC LETT, V224, P241, DOI 10.1016/j.epsl.2004.05.017; van den Berg AP, 2005, PHYS EARTH PLANET IN, V149, P259, DOI 10.1016/j.pepi.2004.10.008; van der Hilst RD, 1999, SCIENCE, V283, P1885, DOI 10.1126/science.283.5409.1885; Wang P, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004241; WILLIAMS Q, 1987, SCIENCE, V236, P181, DOI 10.1126/science.236.4798.181; Wookey J, 2005, NATURE, V438, P1004, DOI 10.1038/nature04345; Wysession ME, 1998, GEODYNAMICS, V28, P273	40	203	204	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1813	1817		10.1126/science.1137867	http://dx.doi.org/10.1126/science.1137867			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395822	Green Submitted			2022-12-28	WOS:000245280100034
J	Bininda-Emonds, ORP; Cardillo, M; Jones, KE; MacPhee, RDE; Beck, RMD; Grenyer, R; Price, SA; Vos, RA; Gittleman, JL; Purvis, A				Bininda-Emonds, Olaf R. P.; Cardillo, Marcel; Jones, Kate E.; MacPhee, Ross D. E.; Beck, Robin M. D.; Grenyer, Richard; Price, Samantha A.; Vos, Rutger A.; Gittleman, John L.; Purvis, Andy			The delayed rise of present-day mammals	NATURE			English	Article							PHYLOGENETIC INFERENCE; FOSSIL RECORD; EVOLUTION; DIVERSIFICATION; EXTINCTION; PATTERNS; TREES; AGE	Did the end-Cretaceous mass extinction event, by eliminating non-avian dinosaurs and most of the existing fauna, trigger the evolutionary radiation of present-day mammals? Here we construct, date and analyse a species-level phylogeny of nearly all extant Mammalia to bring a new perspective to this question. Our analyses of how extant lineages accumulated through time show that net per-lineage diversification rates barely changed across the Cretaceous/Tertiary boundary. Instead, these rates spiked significantly with the origins of the currently recognized placental superorders and orders approximately 93 million years ago, before falling and remaining low until accelerating again throughout the Eocene and Oligocene epochs. Our results show that the phylogenetic 'fuses' leading to the explosion of extant placental orders are not only very much longer than suspected previously, but also challenge the hypothesis that the end-Cretaceous mass extinction event had a major, direct influence on the diversification of today's mammals.	Tech Univ Munich, Lehrstuhl Tierzucht, D-85354 Freising Weihenstephan, Germany; Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; Zool Soc London, Inst Zool, London NW1 4RY, England; Amer Museum Nat Hist, Div Vertebrate Zool, New York, NY 10024 USA; Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; Royal Bot Gardens, Jodrell Lab, Surrey TW9 3AB, England; Natl Evolutionary Synth Ctr, Durham, NC 27705 USA; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Univ Georgia, Inst Ecol, Athens, GA 30602 USA	Technical University of Munich; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Zoological Society of London; American Museum of Natural History (AMNH); University of New South Wales Sydney; Royal Botanic Gardens, Kew; The National Evolutionary Synthesis Center; University of British Columbia; University System of Georgia; University of Georgia	Bininda-Emonds, ORP (corresponding author), Univ Jena, Inst Spezielle Zool & Evolut Biol Phyletischem Mu, D-07743 Jena, Germany.	olaf.bininda@uni-jena.de	Price, Samantha A/A-3162-2011; Jones, Kate E/G-4768-2010; Jones, Kate/Y-3317-2019; Cardillo, Marcel/C-9396-2009; Bininda-Emonds, Olaf/P-6718-2019; Vos, Rutger A/H-9032-2012; Self, Casey J/B-6871-2011; Purvis, Andy/A-7529-2008; Bininda-Emonds, Olaf R.P:/C-5405-2008	Jones, Kate E/0000-0001-5231-3293; Jones, Kate/0000-0001-5231-3293; Cardillo, Marcel/0000-0001-9855-0817; Vos, Rutger A/0000-0001-9254-7318; Purvis, Andy/0000-0002-8609-6204; Bininda-Emonds, Olaf R.P:/0000-0003-4432-224X; Price, Samantha/0000-0002-1389-8521; Beck, Robin/0000-0002-7050-7072	NERC [cpb010001] Funding Source: UKRI; Natural Environment Research Council [cpb010001, NE/C517992/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Alroy J, 1999, SYST BIOL, V48, P107, DOI 10.1080/106351599260472; Alroy J, 2000, PALEOBIOLOGY, V26, P707, DOI 10.1666/0094-8373(2000)026<0707:NMFQMP>2.0.CO;2; Archibald J. David, 2001, Journal of Mammalian Evolution, V8, P107, DOI 10.1023/A:1011317930838; Asher RJ, 2005, SCIENCE, V307, P1091, DOI 10.1126/science.1107808; BAUM BR, 1992, TAXON, V41, P3, DOI 10.2307/1222480; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; Bininda-Emonds O.R., 2004, COMPU BIOL, P267; Bininda-Emonds ORP, 2002, ANNU REV ECOL SYST, V33, P265, DOI 10.1146/annurev.ecolsys.33.010802.150511; Bowen GJ, 2002, SCIENCE, V295, P2062, DOI 10.1126/science.1068700; Bromham L, 1999, TRENDS ECOL EVOL, V14, P113, DOI 10.1016/S0169-5347(98)01507-9; Cooper A, 1998, TRENDS ECOL EVOL, V13, P151, DOI 10.1016/S0169-5347(97)01277-9; Crawley MJ., 2002, STAT COMPUTING INTRO; Falkowski PG, 2005, SCIENCE, V309, P2202, DOI 10.1126/science.1116047; Flynn JJ, 1999, NATURE, V401, P57, DOI 10.1038/43420; Foote M, 1999, SCIENCE, V283, P1310, DOI 10.1126/science.283.5406.1310; Gingerich PD, 2006, TRENDS ECOL EVOL, V21, P246, DOI 10.1016/j.tree.2006.03.006; HARVEY PH, 1994, EVOLUTION, V48, P523, DOI 10.1111/j.1558-5646.1994.tb01341.x; Jones KE, 2005, EVOLUTION, V59, P2243, DOI 10.1111/j.0014-3820.2005.tb00932.x; Krause D. W., 1986, VERTEBRATES PHYLOGEN, P95; KUBO T, 1995, EVOLUTION, V49, P694, DOI 10.1111/j.1558-5646.1995.tb02306.x; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; MAAS MC, 1988, PALEOBIOLOGY, V14, P410, DOI 10.1017/S0094837300012148; McKenna MC, 1997, CLASSIFICATION MAMMA; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Musser G G, 1993, MAMMAL SPECIES WORLD; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Penny D, 2004, TRENDS ECOL EVOL, V19, P516, DOI 10.1016/j.tree.2004.07.015; Penny D, 1999, SYST BIOL, V48, P76, DOI 10.1080/106351599260454; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; *R DEV COR TEAM, 2005, R LANG ENV STAT COMP; Ragan MA, 1992, MOL PHYLOGENET EVOL, V1, P53, DOI 10.1016/1055-7903(92)90035-F; ROSE KD, 2006, BEGINNING AGE MAMMAL; Sanderson MJ, 1998, TRENDS ECOL EVOL, V13, P105, DOI 10.1016/S0169-5347(97)01242-1; Springer Mark S., 1997, Journal of Mammalian Evolution, V4, P285, DOI 10.1023/A:1027378615412; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Tavare S, 2002, NATURE, V416, P726, DOI 10.1038/416726a; Wood S.N., 2001, R NEWS, V1, P20; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd, DOI 10.1201/9781315370279	42	1527	1563	4	509	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2007	446	7135					507	512		10.1038/nature05634	http://dx.doi.org/10.1038/nature05634			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392779				2022-12-28	WOS:000245242900042
J	Hendeles, L; Colice, GL; Meyer, RJ				Hendeles, Leslie; Colice, Gene L.; Meyer, Robert J.			Current concepts - Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							METERED-DOSE INHALER; EXERCISE-INDUCED BRONCHOCONSTRICTION; HYDROFLUOROALKANE-134A HFA ALBUTEROL; TO-MODERATE ASTHMATICS; CFC ALBUTEROL; PROVENTIL HFA; SALBUTAMOL SULFATE; ELECTROSTATIC CHARGE; PLASTIC SPACERS; REGULAR USE		Univ Florida, Coll Pharm, Gainesville, FL 32610 USA; Univ Florida, Pediat Pulm Div, Gainesville, FL 32610 USA; George Washington Univ, Sch Med, Washington, DC USA; Washington Hosp Ctr, Washington, DC 20010 USA; US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; George Washington University; MedStar Washington Hospital Center; US Food & Drug Administration (FDA)	Hendeles, L (corresponding author), Univ Florida, Coll Pharm, Box 100486, Gainesville, FL 32610 USA.	hendeles@cop.ufl.edu						Ahrens RC, 1999, AM J RESP CRIT CARE, V160, P1238, DOI 10.1164/ajrccm.160.4.9806101; Anhoj J, 1999, BRIT J CLIN PHARMACO, V47, P333, DOI 10.1046/j.1365-2125.1999.00893.x; Ayres JG, 1998, BRIT MED J, V317, P926; Bamber MG, 1996, LANCET, V348, P1737, DOI 10.1016/S0140-6736(05)65865-5; Barry PW, 1999, RESP MED, V93, P167, DOI 10.1016/S0954-6111(99)90002-1; Barry PW, 1997, EUR RESPIR J, V10, P1345, DOI 10.1183/09031936.97.10061345; Baumgarten CR, 2000, RESP MED, V94, pS17; Bleecker ER, 1998, CHEST, V113, P283, DOI 10.1378/chest.113.2.283; Bronsky E, 1999, J ASTHMA, V36, P107, DOI 10.3109/02770909909065154; Cain WT, 2001, ANN ALLERG ASTHMA IM, V87, P417, DOI 10.1016/S1081-1206(10)62924-9; Cheng YS, 2001, J AEROSOL MED, V14, P255, DOI 10.1089/08942680152484180; Clark DJ, 1996, BRIT J CLIN PHARMACO, V41, P247, DOI 10.1111/j.1365-2125.1996.tb00191.x; Colice GL, 1999, J ASTHMA, V36, P671, DOI 10.3109/02770909909055419; Craig-McFeely PM, 2003, INT J CLIN PHARM TH, V41, P67; *CTR DRUG EV RES, 2006, EL OR BOOK APPR DRUG; DOCKHORN R, 1995, J ALLERGY CLIN IMMUN, V96, P50, DOI 10.1016/S0091-6749(95)70032-3; Dockhorn RJ, 1997, ANN ALLERG ASTHMA IM, V79, P85, DOI 10.1016/S1081-1206(10)63091-8; *FOOD DRUG ADM, 2004, FED REGISTER, V69, P33602; Harrison LI, 1996, J PHARM PHARMACOL, V48, P596, DOI 10.1111/j.2042-7158.1996.tb05980.x; Harrison LI, 1996, THER DRUG MONIT, V18, P240, DOI 10.1097/00007691-199606000-00004; Hawksworth RJ, 2002, ANN ALLERG ASTHMA IM, V88, P473, DOI 10.1016/S1081-1206(10)62385-X; Joguparthi V, 2003, J AEROSOL MED, V16, P47, DOI 10.1089/089426803764928356; June D, 1997, EUR RESPIR REV, V7, P32; Kleerup EC, 1996, CHEST, V109, P702, DOI 10.1378/chest.109.3.702; Langley SJ, 2002, ANN ALLERG ASTHMA IM, V88, P488, DOI 10.1016/S1081-1206(10)62387-3; LEACH C, 1997, EUR RESPIR REV, V7, P35; Levin PD, 2004, BRIT J ANAESTH, V92, P865, DOI 10.1093/bja/aeh154; Lipworth BJ, 1998, BRIT J CLIN PHARMACO, V46, P45, DOI 10.1046/j.1365-2125.1998.00041.x; LLOYD SA, 1993, LANCET, V342, P1156, DOI 10.1016/0140-6736(93)92130-L; LOVELOCK JE, 1971, NATURE, V230, P379, DOI 10.1038/230379a0; Lugo RA, 2001, PEDIATR PULM, V31, P247, DOI 10.1002/ppul.1035; Lumry W, 2001, ANN ALLERG ASTHMA IM, V86, P297, DOI 10.1016/S1081-1206(10)63302-9; MOLINA MJ, 1974, NATURE, V249, P810, DOI 10.1038/249810a0; Parameswaran KN, 1999, AM J RESP CRIT CARE, V160, P354, DOI 10.1164/ajrccm.160.1.9812035; Pierart F, 1999, EUR RESPIR J, V13, P673, DOI 10.1183/09031936.99.13367399; Ramsdell JW, 1998, ANN ALLERG ASTHMA IM, V81, P593, DOI 10.1016/S1081-1206(10)62711-1; Ross DL, 1999, J AEROSOL MED, V12, P151, DOI 10.1089/jam.1999.12.151; Salat D, 2000, RESP MED, V94, pS22; SCHULTZ RK, 1995, J ALLERGY CLIN IMMUN, V96, P284, DOI 10.1016/S0091-6749(95)70207-5; Shapiro G, 2000, ARCH PEDIAT ADOL MED, V154, P1219, DOI 10.1001/archpedi.154.12.1219; Shapiro GS, 2000, J ASTHMA, V37, P667, DOI 10.3109/02770900009087305; Stewart BA, 2000, CHEST, V117, P714, DOI 10.1378/chest.117.3.714; Tinkelman DC, 1998, CHEST, V113, P290, DOI 10.1378/chest.113.2.290; *UN ENV PROGR, 2005, FED REGISTER, V70, P17167; *UN ENV PROGR, 2006, PROGR REP TECHN EC A; United Nations Environment Programme, 2000, MONTR PROT SUBST DEP; West SK, 1998, JAMA-J AM MED ASSOC, V280, P714, DOI 10.1001/jama.280.8.714; *WHO, 1996, 133 WHO; Williams G, 1999, J ALLERGY CLIN IMMUN, V104, pS227, DOI 10.1016/S0091-6749(99)70035-7	49	50	51	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2007	356	13					1344	1351		10.1056/NEJMra050380	http://dx.doi.org/10.1056/NEJMra050380			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150MN	17392304				2022-12-28	WOS:000245221000008
J	Kimberlin, DW; Whitley, RJ				Kimberlin, David W.; Whitley, Richard J.			Varicella-zoster vaccine for the prevention of herpes zoster	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSTHERPETIC NEURALGIA; IMMUNE-RESPONSES; VIRUS; OLDER; EPIDEMIOLOGY; INFECTIONS; PAIN; AGE		Univ Alabama Birmingham, Div Pediat Infect Dis, Dept Pediat, Birmingham, AL 35233 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35233 USA; Univ Alabama Birmingham, Dept Med, Birmingham, AL 35233 USA; Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kimberlin, DW (corresponding author), Univ Alabama Birmingham, Div Pediat Infect Dis, Dept Pediat, 1600 7th Ave S,CHB 303, Birmingham, AL 35233 USA.	dkimberlin@peds.uab.edu						*ADV COMM IMM PRAC, 2006, CONS SHINGL VACC REC; *AM AC PED COMM IN, IN PRESS PEDIATRICS; Arvin A, 2005, NEW ENGL J MED, V352, P2266, DOI 10.1056/NEJMp058091; BERGER R, 1981, INFECT IMMUN, V32, P24, DOI 10.1128/IAI.32.1.24-27.1981; Brisson M, 2001, EPIDEMIOL INFECT, V127, P305, DOI 10.1017/S0950268801005921; BROWN GR, 1976, SOUTHERN MED J, V69, P576, DOI 10.1097/00007611-197605000-00028; BUCHBINDER SP, 1992, J INFECT DIS, V166, P1153, DOI 10.1093/infdis/166.5.1153; BURKE BL, 1982, ARCH INTERN MED, V142, P291, DOI 10.1001/archinte.142.2.291; *CDCP, 2006, ACIP PROV REC US ZOS; *CDCP, 2006, ACIP PROV REC PREV V; DOLIN R, 1978, ANN INTERN MED, V89, P375, DOI 10.7326/0003-4819-89-3-375; DONAHUE JG, 1995, ARCH INTERN MED, V155, P1605, DOI 10.1001/archinte.155.15.1605; Edmunds WJ, 2001, VACCINE, V19, P3076, DOI 10.1016/S0264-410X(01)00044-5; ESIRI MM, 1972, J NEUROL SCI, V15, P35, DOI 10.1016/0022-510X(72)90120-7; Galil K, 1997, ARCH INTERN MED, V157, P1209, DOI 10.1001/archinte.157.11.1209; Gershon AA, 2000, NEW ENGL J MED, V343, P222; Gilden DH, 2000, NEW ENGL J MED, V342, P635, DOI 10.1056/NEJM200003023420906; Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674; Haanpaa M, 2000, J PAIN SYMPTOM MANAG, V20, P50, DOI 10.1016/S0885-3924(00)00149-4; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; Kanazi GE, 2000, DRUGS, V59, P1113, DOI 10.2165/00003495-200059050-00007; Kilgore Paul E., 2003, Journal of Medical Virology, V70, pS111, DOI 10.1002/jmv.10364; KISHOREKUMAR R, 1990, CLIN PHARMACOL THER, V47, P305, DOI 10.1038/clpt.1990.33; Kost RG, 1996, NEW ENGL J MED, V335, P32, DOI 10.1056/NEJM199607043350107; LEVIN MJ, 1992, J INFECT DIS, V166, P253, DOI 10.1093/infdis/166.2.253; Levin MJ, 1998, J INFECT DIS, V178, pS109, DOI 10.1086/514264; Levin MJ, 2001, ARCH VIR S, V17, P151; LOCKSLEY RM, 1985, J INFECT DIS, V152, P1172, DOI 10.1093/infdis/152.6.1172; LUNGU O, 1995, P NATL ACAD SCI USA, V92, P10980, DOI 10.1073/pnas.92.24.10980; MAX MB, 1988, NEUROLOGY, V38, P1427, DOI 10.1212/WNL.38.9.1427; *MERCK CO, 2005, VAR; *MERCK CO, 2005, PROQUAD; *MERCK CO, 2006, ZOST; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Oxman MN, 1995, NEUROLOGY, V45, pS41, DOI 10.1212/WNL.45.12_Suppl_8.S41; RAGOZZINO MW, 1982, MEDICINE, V61, P310, DOI 10.1097/00005792-198209000-00003; ROGERS RS, 1971, J AM GERIATR SOC, V19, P495, DOI 10.1111/j.1532-5415.1971.tb01208.x; Rowbotham M, 1998, JAMA-J AM MED ASSOC, V280, P1837, DOI 10.1001/jama.280.21.1837; Scott Fiona T., 2003, Journal of Medical Virology, V70, pS24, DOI 10.1002/jmv.10316; Scott FT, 2006, VACCINE, V24, P1308, DOI 10.1016/j.vaccine.2005.09.026; STRAUS SE, 1984, NEW ENGL J MED, V311, P1362, DOI 10.1056/NEJM198411223112107; Trannoy E, 2000, VACCINE, V18, P1700, DOI 10.1016/S0264-410X(99)00510-1; Watson CPN, 1998, NEUROLOGY, V50, P1837; WELLER TH, 1983, NEW ENGL J MED, V309, P1362, DOI 10.1056/NEJM198312013092205; WILSON A, 1992, J INFECT DIS, V165, P119, DOI 10.1093/infdis/165.1.119; Wood MJ, 1996, CLIN INFECT DIS, V22, P341, DOI 10.1093/clinids/22.2.341	46	100	102	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2007	356	13					1338	1343		10.1056/NEJMct066061	http://dx.doi.org/10.1056/NEJMct066061			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150MN	17392303				2022-12-28	WOS:000245221000007
J	Bolshakov, VY				Bolshakov, Vadim Y.			SCOPing out proteases in long-term memory	CELL			English	Editorial Material							SYNAPTIC PLASTICITY; MAPK PATHWAY; CONSOLIDATION; ACTIVATION; CASCADE; RAS	The ERK1/2 MAP kinase (MAPK) signaling pathway is important for the formation of long-term memories. In this issue, Shimizu et al. (2007) provide new insight into the regulation of this pathway by demonstrating that activation of MAP kinase occurs through the calcium-dependent degradation of SCOP (suprachiasmatic nucleus circadian oscillatory protein) by the protease calpain.	Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA 02478 USA	Harvard University; McLean Hospital	Bolshakov, VY (corresponding author), Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, 115 Mill St, Belmont, MA 02478 USA.	vadimb@mclean.harvard.edu						Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Schafe GE, 2000, J NEUROSCI, V20, P8177; Shimizu K, 2003, J BIOL CHEM, V278, P14920, DOI 10.1074/jbc.M213214200; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Winters BD, 2005, J NEUROSCI, V25, P52, DOI 10.1523/JNEUROSCI.3827-04.2005; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	9	0	0	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1029	1030		10.1016/j.cell.2007.02.034	http://dx.doi.org/10.1016/j.cell.2007.02.034			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17382874	Bronze			2022-12-28	WOS:000245396200008
J	Adhikari, NKJ; Burns, KEA; Friedrich, JO; Granton, JT; Cook, DJ; Meade, MO				Adhikari, Neill K. J.; Burns, Karen E. A.; Friedrich, Jan O.; Granton, John T.; Cook, Deborah J.; Meade, Maureen O.			Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RESPIRATORY-DISTRESS-SYNDROME; FAILURE; CARE	Objective To review the literature on the use of inhaled nitric oxide to treat acute lung injury/acute respiratory distress syndrome (ALI/ARDS) and to summarise the effects of nitric oxide, compared with placebo or usual care without nitric oxide, in adults and children with ALI or ARDS. Design Systematic review and meta-analysis. Data sources Medline, CINAHL, Embase, and CENTRAL (to October 2006), proceedings from four conferences, and additional information from authors of 10 trials. Review methods Two reviewers independently selected parallel group randomised controlled trials comparing nitric oxide with control and extracted data related to study methods, clinical and physiological outcomes, and adverse events. Main outcome measures Mortality, duration of ventilation, oxygenation, pulmonary arterial pressure, adverse events. Results 12 trials randomly assigning 1237 patients met inclusion criteria. Overall methodological quality was good. Using random effects models, we found no significant effect of nitric oxide on hospital mortality (risk ratio 1.10, 95% confidence interval 0.94 to 1.30), duration of ventilation, or ventilator-free days. On day one of treatment, nitric oxide increased the ratio of partial pressure of oxygen to fraction of inspired oxygen (PaO2/FiO(2) ratio) (13%, 4% to 23%) and decreased the oxygenation index (14%, 2% to 25%). Some evidence suggested that improvements in oxygenation persisted until day four. There was no effect on mean pulmonary arterial pressure. Patients receiving nitric oxide had an increased risk of developing renal dysfunction (1.50, 1.11 to 2.02). Conclusions Nitric oxide is associated with limited improvement in oxygenation in patients with ALI or ARDS but confers no mortality benefit and may cause harm. We do not recommend its routine use in these severely ill patients.	Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; McMaster Univ, Dept Med, Hamilton, ON, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	University of Toronto; McMaster University; McMaster University	Adhikari, NKJ (corresponding author), Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada.	neill.adhikari@sunnybrook.ca		Friedrich, Jan/0000-0001-7248-2350				Beloucif S, 1998, INTENS CARE MED, V24, P864, DOI 10.1007/s001340050679; BERLIN JA, 1989, STAT MED, V8, P141, DOI 10.1002/sim.4780080202; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Brower RG, 2001, CHEST, V120, P1347, DOI 10.1378/chest.120.4.1347; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Conner BD, 2000, CLIN CHEST MED, V21, P563, DOI 10.1016/S0272-5231(05)70167-2; Cranshaw J, 2002, THORAX, V57, P823, DOI 10.1136/thorax.57.9.823; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; dos Santos C C, 2002, Expert Opin Pharmacother, V3, P875; Fan Eddy, 2005, Crit Care Med, V33, pS182, DOI 10.1097/01.CCM.0000155927.54034.34; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Friedrich JO, 2005, ANN INTERN MED, V142, P510, DOI 10.7326/0003-4819-142-7-200504050-00010; Furchgott RF, 1996, JAMA-J AM MED ASSOC, V276, P1186, DOI 10.1001/jama.276.14.1186; GORIS RJA, 1985, ARCH SURG-CHICAGO, V120, P1109; Gries A, 1998, CIRCULATION, V97, P1481; Griffiths MJD, 2005, NEW ENGL J MED, V353, P2683, DOI 10.1056/NEJMra051884; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; McIntyre RC, 2000, CRIT CARE MED, V28, P3314, DOI 10.1097/00003246-200009000-00034; Meade MO, 2004, CRIT CARE MED, V32, P946, DOI 10.1097/01.CCM.0000120056.76356.AD; MONTGOMERY AB, 1985, AM REV RESPIR DIS, V132, P485; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; POLLACK MM, 1987, JAMA-J AM MED ASSOC, V258, P1481, DOI 10.1001/jama.258.11.1481; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; RANLERI VM, 1999, JAMA-J AM MED ASSOC, V282, P54; Sokol J, 2003, ANESTH ANALG, V97, P989, DOI [10.1213/01.ANE.0000078819.48523.26, 10.1213/01.ANE.0000078819.45523.26]; Sokol J, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002787; Tasaka S, 2002, PULM PHARMACOL THER, V15, P83, DOI 10.1006/pupt.2001.0325; Valdivielso JM, 2002, ANTIOXID REDOX SIGN, V4, P925, DOI 10.1089/152308602762197461; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wiedemann Herbert P, 2003, Respir Care Clin N Am, V9, P419, DOI 10.1016/S1078-5337(03)00033-9	33	278	295	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2007	334	7597					779	782		10.1136/bmj.39139.716794.55	http://dx.doi.org/10.1136/bmj.39139.716794.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161SX	17383982	Green Published, Bronze			2022-12-28	WOS:000246037300027
J	Mulugu, S; Bai, WL; Fridy, PC; Bastidas, RJ; Otto, JC; Dollins, DE; Haystead, TA; Ribeiro, AA; York, JD				Mulugu, Sashidhar; Bai, Wenli; Fridy, Peter C.; Bastidas, Robert J.; Otto, James C.; Dollins, D. Eric; Haystead, Timothy A.; Ribeiro, Anthony A.; York, John D.			A conserved family of enzymes that phosphorylate inositol hexakisphosphate	SCIENCE			English	Article							MESSENGER-RNA EXPORT; ARP2/3 COMPLEX; SACCHAROMYCES-CEREVISIAE; ACTIN; PYROPHOSPHATES; PHOSPHATES; TETRAKISPHOSPHATE; POLYPHOSPHATES; DICTYOSTELIUM; METABOLISM	Inositol pyrophosphates are a diverse group of high-energy signaling molecules whose cellular roles remain an active area of study. We report a previously uncharacterized class of inositol pyrophosphate synthase and find it is identical to yeast Vip1 and Asp1 proteins, regulators of actin-related protein-2/3 (ARP 2/3) complexes. Vip1 and Asp1 acted as enzymes that encode inositol hexakisphosphate (IP6) and inositol heptakisphosphate (IP7) kinase activities. Alterations in kinase activity led to defects in cell growth, morphology, and interactions with ARP complex members. The functionality of Asp1 and Vip1 may provide cells with increased signaling capacity through metabolism of IP6.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, NMR Ctr, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University	York, JD (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Pharmacol & Canc Biol, DUMC 3813, Durham, NC 27710 USA.	yorkj@duke.edu		Fridy, Peter/0000-0002-8208-9154	NCI NIH HHS [2-P30-CA14236-3, P30-CA-14236] Funding Source: Medline; NHLBI NIH HHS [R01-HL-55672] Funding Source: Medline; NIDDK NIH HHS [R33-DK-070272] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK070272] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; EUROPEFINNER GN, 1991, BIOCHEM BIOPH RES CO, V181, P191, DOI 10.1016/S0006-291X(05)81400-7; Feoktistova A, 1999, GENETICS, V152, P895; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GLENNON MC, 1993, BIOCHEM J, V293, P583, DOI 10.1042/bj2930583; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Grishin NV, 1999, J MOL BIOL, V291, P239, DOI 10.1006/jmbi.1999.2973; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Laussmann T, 1996, BIOCHEM J, V315, P715, DOI 10.1042/bj3150715; Laussmann T, 1998, FEBS LETT, V426, P145, DOI 10.1016/S0014-5793(98)00329-9; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; Mullaney EJ, 2003, BIOCHEM BIOPH RES CO, V312, P179, DOI 10.1016/j.bbrc.2003.09.176; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Saiardi A, 2000, FEBS LETT, V468, P28, DOI 10.1016/S0014-5793(00)01194-7; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Seeds AM, 2005, J BIOL CHEM, V280, P27654, DOI 10.1074/jbc.M505089200; SHEARS SB, 1995, J BIOL CHEM, V270, P10489, DOI 10.1074/jbc.270.18.10489; Shears SB, 1998, BBA-MOL CELL BIOL L, V1436, P49, DOI 10.1016/S0005-2760(98)00131-3; STEPHENS L, 1993, J BIOL CHEM, V268, P4009; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; York JD, 2006, BBA-MOL CELL BIOL L, V1761, P552, DOI 10.1016/j.bbalip.2006.04.014; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200	30	181	190	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2007	316	5821					106	109		10.1126/science.1139099	http://dx.doi.org/10.1126/science.1139099			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412958				2022-12-28	WOS:000245470500042
J	Patel, SS; Belmont, BJ; Sante, JM; Rexach, MF				Patel, Samir S.; Belmont, Brian J.; Sante, Joshua M.; Rexach, Michael F.			Natively unfolded nucleoporins gate protein diffusion across the nuclear pore complex	CELL			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; SACCHAROMYCES-CEREVISIAE; PROTEOMIC ANALYSIS; FG NUCLEOPORINS; PERMEABILITY; ARCHITECTURE; DETERMINANT; SYSTEM; DOMAIN	Nuclear pore complexes (NPCs) form aqueous conduits in the nuclear envelope and gate the diffusion of large proteins between the cytoplasm and nucleoplasm. NPC proteins (nucleoporins) that contain phenylalanine-glycine motifs in filamentous, natively unfolded domains (FG domains) line the diffusion conduit of the NPC, but their role in the size-selective barrier is unclear. We show that deletion of individual FG domains in yeast relaxes the NPC permeability barrier. At the molecular level, the FG domains of five nucleoporins anchored at the NPC center form a cohesive meshwork of filaments through hydrophobic interactions, which involve phenylalanines in FG motifs and are dispersed by aliphatic alcohols. In contrast, the FG domains of four peripherally anchored nucleoporins are generally noncohesive. The results support a two-gate model of NPC architecture featuring a central diffusion gate formed by a meshwork of cohesive FG nucleoporin filaments and a peripheral gate formed by repulsive FG nucleoporin filaments.	Univ Calif Santa Cruz, MCD Biol, Santa Cruz, CA 95064 USA; Stanford Univ, Stanford, CA 94305 USA	University of California System; University of California Santa Cruz; Stanford University	Rexach, MF (corresponding author), Univ Calif Santa Cruz, MCD Biol, Santa Cruz, CA 95064 USA.	rexach@biology.ucsc.edu		Patel, Samir/0000-0002-9489-5516; Belmont, Brian/0000-0002-8314-4565				Allen NPC, 2002, MOL CELL PROTEOMICS, V1, P930, DOI 10.1074/mcp.T200012-MCP200; Allen NPC, 2001, J BIOL CHEM, V276, P29268, DOI 10.1074/jbc.M102629200; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; De Souza CPC, 2004, CURR BIOL, V14, P1973, DOI 10.1016/j.cub.2004.10.050; Denning D, 2001, J CELL BIOL, V154, P937, DOI 10.1083/jcb.200101007; Denning DP, 2007, MOL CELL PROTEOMICS, V6, P272, DOI 10.1074/mcp.M600309-MCP200; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Eaglestone SS, 2000, P NATL ACAD SCI USA, V97, P240, DOI 10.1073/pnas.97.1.240; Feldherr CM, 1997, J CELL SCI, V110, P3065; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gillen KM, 1998, J CELL SCI, V111, P3235; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kenna MA, 1996, MOL CELL BIOL, V16, P2025; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Mohana-Borges R, 2000, J BIOL CHEM, V275, P4708, DOI 10.1074/jbc.275.7.4708; Rhee Y, 2000, NAT BIOTECHNOL, V18, P433, DOI 10.1038/74500; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shulga N, 2000, J CELL BIOL, V149, P1027, DOI 10.1083/jcb.149.5.1027; Shulga N, 2003, MOL CELL BIOL, V23, P534, DOI 10.1128/MCB.23.2.534-542.2003; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; YANG MJ, 1995, NUCLEIC ACIDS RES, V23, P1152, DOI 10.1093/nar/23.7.1152; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4	28	370	373	3	38	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					83	96		10.1016/j.cell.2007.01.044	http://dx.doi.org/10.1016/j.cell.2007.01.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418788	Bronze			2022-12-28	WOS:000245661100013
J	Price, AS; Savchenko, AK; Narozhny, BN; Allison, G; Ritchie, DA				Price, A. S.; Savchenko, A. K.; Narozhny, B. N.; Allison, G.; Ritchie, D. A.			Giant fluctuations of Coulomb drag in a bilayer system	SCIENCE			English	Article							2-DIMENSIONAL ELECTRON-SYSTEMS; GAS LAYERS; TRANSPORT	The Coulomb drag in a system of two parallel layers is the result of electron-electron interaction between the layers. We have observed reproducible fluctuations of the drag, both as a function of magnetic field and electron concentration, which are a manifestation of quantum interference of electrons in the layers. At low temperatures the fluctuations exceed the average drag, giving rise to random changes of the sign of the drag. The fluctuations are found to be much larger than previously expected, and we propose a model that explains their enhancement by considering fluctuations of local electron properties.	Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England; Abdus Salam Int Ctr Theoret Phys, I-34100 Trieste, Italy; Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England	University of Exeter; Abdus Salam International Centre for Theoretical Physics (ICTP); University of Cambridge	Savchenko, AK (corresponding author), Univ Exeter, Sch Phys, Stocker Rd, Exeter EX4 4QL, Devon, England.	a.k.savchenko@ex.ac.uk	Price, Adam/C-3360-2009; Narozhny, Boris N/B-7712-2018; Ritchie, David/K-2206-2014	Narozhny, Boris N/0000-0001-7933-2945; Ritchie, David/0000-0002-9844-8350; Allison, Giles/0000-0002-4810-092X				Altshuler B. L., 1991, MESOSCOPIC PHENOMENA; BEENAKKER CWJ, 1991, SOLID STATE PHYS; FLENSBERG K, 1995, PHYS REV B, V52, P14761, DOI 10.1103/PhysRevB.52.14761; GRAMILA TJ, 1991, PHYS REV LETT, V66, P1216, DOI 10.1103/PhysRevLett.66.1216; JAUHO AP, 1993, PHYS REV B, V47, P4420, DOI 10.1103/PhysRevB.47.4420; KAMENEV A, 1995, PHYS REV B, V52, P7516, DOI 10.1103/PhysRevB.52.7516; Kellogg M, 2002, SOLID STATE COMMUN, V123, P515, DOI 10.1016/S0038-1098(02)00426-X; LERNER IV, 1988, PHYS LETT A, V133, P253, DOI 10.1016/0375-9601(88)91027-4; Lilly MP, 1998, PHYS REV LETT, V80, P1714, DOI 10.1103/PhysRevLett.80.1714; Lok JGS, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.041305; Mortensen NA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.085317; Narozhny BN, 2000, PHYS REV LETT, V84, P5383, DOI 10.1103/PhysRevLett.84.5383; Narozhny BN, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.180202; Pillarisetty R, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.115307; POGREBINSKII MB, 1977, SOV PHYS SEMICOND+, V11, P372; PRICE PJ, 1983, PHYSICA B & C, V117, P750, DOI 10.1016/0378-4363(83)90642-3; Rojo AG, 1999, J PHYS-CONDENS MAT, V11, pR31, DOI 10.1088/0953-8984/11/5/004; SIVAN U, 1992, PHYS REV LETT, V68, P1196, DOI 10.1103/PhysRevLett.68.1196; Snoke D, 2002, SCIENCE, V298, P1368, DOI 10.1126/science.1078082; SOLOMON PM, 1989, PHYS REV LETT, V63, P2508, DOI 10.1103/PhysRevLett.63.2508; Yamamoto M, 2006, SCIENCE, V313, P204, DOI 10.1126/science.1126601; ZHENG L, 1993, PHYS REV B, V48, P8203, DOI 10.1103/PhysRevB.48.8203	23	37	37	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2007	316	5821					99	102		10.1126/science.1139227	http://dx.doi.org/10.1126/science.1139227			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412956	Green Submitted			2022-12-28	WOS:000245470500040
J	Chait, R; Craney, A; Kishony, R				Chait, Remy; Craney, Allison; Kishony, Roy			Antibiotic interactions that select against resistance	NATURE			English	Article							TETRACYCLINE-RESISTANCE; ESCHERICHIA-COLI; EXPRESSION; ELEMENTS; PROMOTER; FITNESS; GENE	Multidrug combinations are increasingly important in combating the spread of antibiotic-resistance in bacterial pathogens(1-3). On a broader scale, such combinations are also important in understanding microbial ecology and evolution(4,5). Although the effects of multidrug combinations on bacterial growth have been studied extensively, relatively little is known about their impact on the differential selection between sensitive and resistant bacterial populations(1,6,7). Normally, the presence of a drug confers an advantage on its resistant mutants incompetition with the sensitive wild-type population(1). Here we show, by using a direct competition assay between doxycycline-resistant and doxycycline-sensitive Escherichia coli, that this differential selection can be inverted in a hyper-antagonistic class of drug combinations. Used in such a combination, a drug can render the combined treatment selective against the drug's own resistance allele. Further, this inversion of selection seems largely insensitive to the underlying resistance mechanism and occurs, at sublethal concentrations, while maintaining inhibition of the wild type. These seemingly paradoxical results can be rationalized in terms of a simple geometric argument. Our findings demonstrate a previously unappreciated feature of the fitness landscape for the evolution of resistance and point to a trade-off between the effect of drug interactions on absolute potency and the relative competitive selection that they impose on emerging resistant populations.	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Kishony, R (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA.	roy_kishony@hms.harvard.edu		Chait, Remy/0000-0003-0876-3187				Bjarnason J, 2003, J BACTERIOL, V185, P4973, DOI 10.1128/JB.185.16.4973-4982.2003; CHAO L, 1978, NATURE, V271, P385, DOI 10.1038/271385a0; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Czaran TL, 2002, P NATL ACAD SCI USA, V99, P786, DOI 10.1073/pnas.012399899; Deeks SG, 2003, LANCET, V362, P2002, DOI 10.1016/S0140-6736(03)15022-2; Drlica K., 2003, QUINOLONE ANTIMICROB, P19; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fraser T R, 1872, Br Med J, V2, P457; Golan DE, 2005, PRINCIPLES PHARM PAT; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; KISHONY R, 2003, J BIOL, V2, DOI UNSP 14.1-14.10; KLEIN M, 1953, J BACTERIOL, V65, P454, DOI 10.1128/JB.65.4.454-465.1953; LENSKI RE, 1994, J BACTERIOL, V176, P3140, DOI 10.1128/jb.176.11.3140-3147.1994; LENSKI RE, 1994, MOL ECOL, V3, P127, DOI 10.1111/j.1365-294X.1994.tb00113.x; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lipsitch M, 1997, ANTIMICROB AGENTS CH, V41, P363, DOI 10.1128/AAC.41.2.363; LOEWE S, 1953, ARZNEIMITTEL-FORSCH, V3, P285; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Pillai SK, 2005, ANTIBIOTICS LAB MED, P365; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; SINGER M, 1989, MICROBIOL REV, V53, P1; Tsui WHW, 2004, CHEM BIOL, V11, P1307, DOI 10.1016/j.chembiol.2004.07.010; Walsh C., 2003, ANTIBIOTICS ACTIONS, P335; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Whittle G, 2003, APPL ENVIRON MICROB, V69, P4151, DOI 10.1128/AEM.69.7.4151-4158.2003; Yang WR, 2004, J BIOL CHEM, V279, P52346, DOI 10.1074/jbc.M409573200; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; Yim G, 2006, INT J MED MICROBIOL, V296, P163, DOI 10.1016/j.ijmm.2006.01.039	30	314	325	4	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2007	446	7136					668	671		10.1038/nature05685	http://dx.doi.org/10.1038/nature05685			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17410176				2022-12-28	WOS:000245438300040
J	Cohen, SB; Graham, ME; Lovrecz, GO; Bache, N; Robinson, PJ; Reddel, RR				Cohen, Scott B.; Graham, Mark E.; Lovrecz, George O.; Bache, Nicolai; Robinson, Phillip J.; Reddel, Roger R.			Protein composition of catalytically active human telomerase from immortal cells	SCIENCE			English	Article							DOMINANT DYSKERATOSIS-CONGENITA; REVERSE-TRANSCRIPTASE; RNA COMPONENT; PURIFICATION; SUBUNIT	Telomerase is a ribonucleoprotein enzyme complex that adds 5'-TTAGGG-3' repeats onto the ends of human chromosomes, providing a telomere maintenance mechanism for similar to 90% of human cancers. We have purified human telomerase similar to 10(8)-fold, with the final elution dependent on the enzyme's ability to catalyze nucleotide addition onto a DNA oligonucleotide of telomeric sequence, thereby providing specificity for catalytically active telomerase. Mass spectrometric sequencing of the protein components and molecular size determination indicated an enzyme composition of two molecules each of telomerase reverse transcriptase, telomerase RNA, and dyskerin.	Childrens Med Res Inst, Canc Res Unit, Westmead, NSW 2145, Australia; Childrens Med Res Inst, Cell Signalling Unit, Westmead, NSW 2145, Australia; CSIRO, Mol & Hlth Technol, Fermentat Lab, Parkville, Vic 3052, Australia; Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	Children's Medical Research Institute - Australia; Children's Medical Research Institute - Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Southern Denmark	Reddel, RR (corresponding author), Childrens Med Res Inst, Canc Res Unit, 214 Hawkesbury Rd, Westmead, NSW 2145, Australia.	rreddel@cmri.usyd.edu.au	Lovrecz, George/H-8602-2013; Reddel, Roger R/A-6635-2014; Graham, Mark E/A-6480-2014; Robinson, Phillip J/G-4008-2011	Reddel, Roger R/0000-0002-6302-6107; Graham, Mark E/0000-0002-7290-1217; Robinson, Phillip J/0000-0002-7878-0313				Arai K, 2002, J BIOL CHEM, V277, P8538, DOI 10.1074/jbc.M111068200; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Beattie TL, 2001, MOL CELL BIOL, V21, P6151, DOI 10.1128/MCB.21.18.6151-6160.2001; Bryan TM, 1998, EXP CELL RES, V239, P370, DOI 10.1006/excr.1997.3907; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Lingner J, 1996, P NATL ACAD SCI USA, V93, P10712, DOI 10.1073/pnas.93.20.10712; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Schnapp G, 1998, NUCLEIC ACIDS RES, V26, P3311, DOI 10.1093/nar/26.13.3311; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Wallweber G, 2003, BIOCHEMISTRY-US, V42, P589, DOI 10.1021/bi026914a; Wenz C, 2001, EMBO J, V20, P3526, DOI 10.1093/emboj/20.13.3526	19	495	521	3	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2007	315	5820					1850	1853		10.1126/science.1138596	http://dx.doi.org/10.1126/science.1138596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395830				2022-12-28	WOS:000245280100045
J	Fortini, ME				Fortini, Mark E.			Medicine - Anticipating trouble from gene transcription	SCIENCE			English	Editorial Material							REPEAT INSTABILITY; CAG REPEATS; DISEASE; DROSOPHILA; SPERM; MECHANISMS; EXPANSION		NCI, Canc & Dev Biol Lab, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Fortini, ME (corresponding author), NCI, Canc & Dev Biol Lab, Frederick, MD 21702 USA.	fortini@ncifcrf.gov			NATIONAL CANCER INSTITUTE [Z01BC010529, Z01BC010913] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bowater RP, 1997, NUCLEIC ACIDS RES, V25, P2861, DOI 10.1093/nar/25.14.2861; Chan HM, 2001, J CELL SCI, V114, P2363; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Grewal RP, 1999, HUM MOL GENET, V8, P1779, DOI 10.1093/hmg/8.9.1779; Jackson SM, 2005, GENE, V347, P35, DOI 10.1016/j.gene.2004.12.008; Jung J, 2007, SCIENCE, V315, P1857, DOI 10.1126/science.1139517; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Muqit MMK, 2002, NAT REV NEUROSCI, V3, P237, DOI 10.1038/nrn751; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Takiyama Y, 1997, HUM MOL GENET, V6, P1063, DOI 10.1093/hmg/6.7.1063; Zhang Y, 2002, HUM MOL GENET, V11, P791, DOI 10.1093/hmg/11.7.791	12	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2007	315	5820					1800	1801		10.1126/science.1141279	http://dx.doi.org/10.1126/science.1141279			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395816				2022-12-28	WOS:000245280100027
J	Smith, BD				Smith, Bruce D.			The ultimate ecosystem engineers	SCIENCE			English	Editorial Material									Smithsonian Inst, Natl Museum Nat Hist, Archaeobiol Program, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Smith, BD (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Archaeobiol Program, Washington, DC 20560 USA.	smithb@si.edu						Anderson M., 2005, TENDING WILD; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Odling-Smee F., 2003, NICHE CONSTRUCTION; Weiss E, 2006, SCIENCE, V312, P1608, DOI 10.1126/science.1127235; Zeder MA, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P1; Zeder MA, 2006, EVOL ANTHROPOL, V15, P105, DOI 10.1002/evan.20101	6	86	92	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1797	1798		10.1126/science.1137740	http://dx.doi.org/10.1126/science.1137740			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395815				2022-12-28	WOS:000245280100025
J	Uzoigwe, CE; Dewsbery, S; Bitra, K; Iqbal, R; Ali, F; May, JC; Gokhale, JA				Uzoigwe, Chika Edward; Dewsbery, Simon; Bitra, Krishna; Iqbal, Rizwan; Ali, Faisal; May, John C.; Gokhale, Jay A.			A surgical solution for vasculitis?	LANCET			English	Editorial Material							HENOCH-SCHONLEIN PURPURA; CLASSIFICATION		Bradford Teaching Hosp, Bradford Royal Infirm, Dept Gen Surg, Bradford BD9 6RJ, W Yorkshire, England; Bradford Teaching Hosp, Bradford Royal Infirm, Dept Histopathol, Bradford BD9 6RJ, W Yorkshire, England	Bradford Royal Infirmary; Bradford Royal Infirmary	Uzoigwe, CE (corresponding author), Bradford Teaching Hosp, Bradford Royal Infirm, Dept Gen Surg, Duckworth Lane, Bradford BD9 6RJ, W Yorkshire, England.	chika@doctors.org.uk						Blanco R, 1997, ARTHRITIS RHEUM, V40, P859, DOI 10.1002/art.1780400513; Garcia-Porrua C, 2006, SEMIN ARTHRITIS RHEU, V35, P403, DOI 10.1016/j.semarthrit.2006.03.001; GUNASEKARAN T, 2000, J PEDIAT GASTROENTER, V30, P5; MILLS JA, 1990, ARTHRITIS RHEUM, V33, P1114; Watts RA, 1997, BAILLIERE CLIN RHEUM, V11, P191, DOI 10.1016/S0950-3579(97)80043-X	5	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2007	369	9566					1054	1054		10.1016/S0140-6736(07)60465-6	http://dx.doi.org/10.1016/S0140-6736(07)60465-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151JO	17382832				2022-12-28	WOS:000245286500034
J	Holmes, WR; Savage, F				Holmes, Wendy R.; Savage, Felicity			Exclusive breastfeeding and HIV	LANCET			English	Editorial Material							TO-CHILD TRANSMISSION; RISK		Macfarlane Burnet Inst Med Res & Publ Hlth, Ctr Int Hlth, Melbourne, Vic 3001, Australia; Ctr Int Hlth & Dev, London, England	Burnet Institute; University of London; University College London	Holmes, WR (corresponding author), Macfarlane Burnet Inst Med Res & Publ Hlth, Ctr Int Hlth, Melbourne, Vic 3001, Australia.	holmes@burnet.edu.au						Arifeen S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e67; Bhandari N, 2003, LANCET, V361, P1418, DOI 10.1016/S0140-6736(03)13134-0; Coovadia HM, 2007, LANCET, V369, P1107, DOI 10.1016/S0140-6736(07)60283-9; Coutsoudis A, 1999, LANCET, V354, P471, DOI 10.1016/S0140-6736(99)01101-0; CREEK T, 2006, PEPFAR IMPL M DURB S; DUNN DT, 1992, LANCET, V340, P585, DOI 10.1016/0140-6736(92)92115-V; HUMPHREY J, 2006, 16 INT AIDS C TOR AU; Humphrey JH, 2006, AIDS, V20, P1437, DOI 10.1097/01.aids.0000233578.72091.09; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Nankunda J, 2006, INT BREASTFEED J, V1, DOI 10.1186/1746-4358-1-19; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; ROLLINS N, 2006, 16 INT AIDS C TOR AU; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; *WHO DEP CHILD AD, 2006, HIV INF FEED NEW EV	15	7	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2007	369	9567					1065	1066		10.1016/S0140-6736(07)60505-4	http://dx.doi.org/10.1016/S0140-6736(07)60505-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	151XF	17398292				2022-12-28	WOS:000245323700009
J	Pearse, RM; Young, JD				Pearse, Rupert M.; Young, J. Duncan			Steroids to prevent postextubation laryngeal oedema	LANCET			English	Editorial Material							MECHANICAL VENTILATION; DOUBLE-BLIND; DEXAMETHASONE; EXTUBATION; STRIDOR; ADULTS		Royal London Hosp, Barts & London Sch Med & Dent, London E1 1BB, England; John Radcliffe Hosp, Adult Intens Care Unit, Oxford OX3 9DU, England	Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London; University of Oxford	Pearse, RM (corresponding author), Royal London Hosp, Barts & London Sch Med & Dent, London E1 1BB, England.	rupert.pearse@bartsandthelondon.nhs.uk	Pearse, Rupert/H-5426-2011; Young, John D/M-9756-2016	Pearse, Rupert/0000-0002-4373-5934; Young, John Duncan/0000-0002-6838-4835				Anene O, 1996, CRIT CARE MED, V24, P1666, DOI 10.1097/00003246-199610000-00011; Cheng KC, 2006, CRIT CARE MED, V34, P1345, DOI 10.1097/01.CCM.0000214678.92134.BD; DARMON JY, 1992, ANESTHESIOLOGY, V77, P245, DOI 10.1097/00000542-199208000-00004; Epstein SK, 1997, CHEST, V112, P186, DOI 10.1378/chest.112.1.186; Esteban A, 1998, INTENS CARE MED, V24, P999, DOI 10.1007/s001340050708; Ferrara T B, 1989, J Perinatol, V9, P287; Francois B, 2007, LANCET, V369, P1083, DOI 10.1016/S0140-6736(07)60526-1; Ho LI, 1996, INTENS CARE MED, V22, P933; TELLEZ DW, 1991, J PEDIATR-US, V118, P289, DOI 10.1016/S0022-3476(05)80505-0	9	2	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR-APR	2007	369	9567					1060	1061		10.1016/S0140-6736(07)60503-0	http://dx.doi.org/10.1016/S0140-6736(07)60503-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151XF	17398289				2022-12-28	WOS:000245323700006
J	Quinn, AE; Georges, A; Sarre, SD; Guarino, F; Ezaz, T; Graves, JAM				Quinn, Alexander E.; Georges, Arthur; Sarre, Stephen D.; Guarino, Fiorenzo; Ezaz, Tariq; Graves, Jennifer A. Marshall			Temperature sex reversal implies sex gene dosage in a reptile	SCIENCE			English	Article									Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia; Australian Natl Univ, Res Sch Biol Sci, Comparat Genom Grp, Canberra, ACT 2601, Australia	University of Canberra; Australian National University	Quinn, AE (corresponding author), Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia.	quinn@aerg.canberra.edu.au	Graves, Jennifer A.M./A-1387-2008; Sarre, Stephen D/C-6795-2011; Georges, Arthur/D-2153-2009; Ezaz, Tariq/D-9875-2011; Quinn, Alexander/C-2778-2013	Georges, Arthur/0000-0003-2428-0361; Ezaz, Tariq/0000-0003-4763-1347; Guarino, Fiorenzo/0000-0002-1458-7389; Graves, Jennifer/0000-0001-6480-7856; Sarre, Stephen D./0000-0002-7158-2517				Bull J.J., 1983, EVOLUTION SEX DETERM; Ezaz T, 2005, CHROMOSOME RES, V13, P763, DOI 10.1007/s10577-005-1010-9; Sarre SD, 2004, BIOESSAYS, V26, P639, DOI 10.1002/bies.20050; Shine R, 2002, ECOL LETT, V5, P486, DOI 10.1046/j.1461-0248.2002.00351.x; Valenzuela N., 2004, TEMPERATURE DEPENDEN; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407	6	204	211	2	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					411	411		10.1126/science.1135925	http://dx.doi.org/10.1126/science.1135925			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446395	Green Submitted			2022-12-28	WOS:000245813400046
J	Groblacher, S; Paterek, T; Kaltenbaek, R; Brukner, C; Zukowski, M; Aspelmeyer, M; Zeilinger, A				Groeblacher, Simon; Paterek, Tomasz; Kaltenbaek, Rainer; Brukner, Caslav; Zukowski, Marek; Aspelmeyer, Markus; Zeilinger, Anton			An experimental test of non-local realism	NATURE			English	Article							HIDDEN-VARIABLE THEORIES; QUANTUM-MECHANICS; BELL INEQUALITIES; CURRENT SITUATION; LOCAL THEORIES; THEOREM; VIOLATION	Most working scientists hold fast to the concept of 'realism' - a viewpoint according to which an external reality exists independent of observation. But quantum physics has shattered some of our cornerstone beliefs. According to Bell's theorem, any theory that is based on the joint assumption of realism and locality ( meaning that local events cannot be affected by actions in space-like separated regions) is at variance with certain quantum predictions. Experiments with entangled pairs of particles have amply confirmed these quantum predictions, thus rendering local realistic theories untenable. Maintaining realism as a fundamental concept would therefore necessitate the introduction of 'spooky' actions that defy locality. Here we show by both theory and experiment that a broad and rather reasonable class of such non-local realistic theories is incompatible with experimentally observable quantum correlations. In the experiment, we measure previously untested correlations between two entangled photons, and show that these correlations violate an inequality proposed by Leggett for non-local realistic theories. Our result suggests that giving up the concept of locality is not sufficient to be consistent with quantum experiments, unless certain intuitive features of realism are abandoned.	Univ Vienna, Fac Phys, A-1090 Vienna, Austria; Austrian Acad Sci, IQOQI, A-1090 Vienna, Austria; Univ Gdansk, Inst Theoret Phys & Astrophys, PL-08952 Gdansk, Poland; Erwin Schrodinger Int Inst Math Phys, A-1090 Vienna, Austria	University of Vienna; Austrian Academy of Sciences; Fahrenheit Universities; University of Gdansk	Aspelmeyer, M (corresponding author), Univ Vienna, Fac Phys, Boltzmanngasse 5, A-1090 Vienna, Austria.	markus.aspelmeyer@quantum.at; zeilinger-office@quantum.at	Groeblacher, Simon/O-2455-2014; Kaltenbaek, Rainer/C-8141-2015; Brukner, Caslav/C-1405-2011; Aspelmeyer, Markus/C-4098-2017; Zeilinger, Anton/A-1170-2011	Groeblacher, Simon/0000-0003-3932-7820; Kaltenbaek, Rainer/0000-0002-9991-9919; Aspelmeyer, Markus/0000-0003-4499-7335; Zukowski, Marek/0000-0001-7882-7962				ASPECT A, 1981, PHYS REV LETT, V47, P460, DOI 10.1103/PhysRevLett.47.460; Aspect A, 1999, NATURE, V398, P189, DOI 10.1038/18296; ASPECT A, 1982, PHYS REV LETT, V49, P1804, DOI 10.1103/PhysRevLett.49.1804; Bacon D, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.157904; BELL JS, 1985, DIALECTICA, V39, P103; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; BOHM D, 1952, PHYS REV, V85, P166, DOI 10.1103/PhysRev.85.166; Born M., 1964, PRINCIPLES OPTICS EL; Clauser JF, 2002, QUANTUM (UN)SPEAKABLES FROM BELL TO QUANTUM INFORMATION, P61; CLAUSER JF, 1978, REP PROG PHYS, V41, P1881, DOI 10.1088/0034-4885/41/12/002; CLAUSER JF, 1974, PHYS REV D, V10, P526, DOI 10.1103/PhysRevD.10.526; DEWDNEY C, 1987, J PHYS A-MATH GEN, V20, P4717, DOI 10.1088/0305-4470/20/14/016; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Einstein A., 1935, COMMUNICATION   0619, p[234, 75]; FREEDMAN SJ, 1972, PHYS REV LETT, V28, P938, DOI 10.1103/PhysRevLett.28.938; Grangier P, 2001, NATURE, V409, P774, DOI 10.1038/35057415; KOCHER CA, 1967, PHYS REV LETT, V18, P575, DOI 10.1103/PhysRevLett.18.575; Leggett AJ, 2003, FOUND PHYS, V33, P1469, DOI 10.1023/A:1026096313729; NEEMAN Y, 1986, FOUND PHYS, V16, P361, DOI 10.1007/BF01882693; Rowe MA, 2001, NATURE, V409, P791, DOI 10.1038/35057215; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P844, DOI 10.1007/BF01491987; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P807, DOI 10.1007/BF01491891; Schroedinger E., 1935, NATURWISSENSCHAFTEN, V23, P823, DOI [DOI 10.1007/BF01491914, 10.1007/BF01491914]; Weihs G, 1998, PHYS REV LETT, V81, P5039, DOI 10.1103/PhysRevLett.81.5039; ZEILINGER A, 1986, PHYS LETT A, V118, P1, DOI 10.1016/0375-9601(86)90520-7; [No title captured]	31	245	251	4	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2007	446	7138					871	875		10.1038/nature05677	http://dx.doi.org/10.1038/nature05677			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17443179	Green Submitted			2022-12-28	WOS:000245785700033
J	Bankovich, AJ; Raunser, S; Juo, ZS; Walz, T; Davis, MM; Garcia, KC				Bankovich, Alexander J.; Raunser, Stefan; Juo, Z. Sean; Walz, Thomas; Davis, Mark M.; Garcia, K. Christopher			Structural insight into pre-B cell receptor function	SCIENCE			English	Article							SURROGATE LIGHT-CHAIN; HEAVY-CHAIN; V-H; LAMBDA-5; LYMPHOCYTES; REPERTOIRE; DIVERSITY; VPREB; GENE; MECHANISMS	The pre-B cell receptor (pre-BCR) serves as a checkpoint in B cell development. In the 2.7 angstrom structure of a human pre-BCR Fab-like fragment, consisting of an antibody heavy chain (HC) paired with the surrogate light chain, the "unique regions" of VpreB and lambda 5 replace the complementarity-determining region 3 (CDR3) loop of an antibody light chain and appear to "probe" the HC CDR3, potentially influencing the selection of the antibody repertoire. Biochemical analysis indicates that the pre-BCR is impaired in its ability to recognize antigen, which, together with electron microscopic visualization of a pre-BCR dimer, suggests ligand-independent oligomerization as the likely signaling mechanism.	Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Harvard University; Harvard Medical School	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Raunser, Stefan/AHE-1573-2022	Davis, Mark/0000-0001-6868-657X; Raunser, Stefan/0000-0001-9373-3016; Walz, Thomas/0000-0003-2606-2835; Bankovich, Alexander/0000-0003-2368-4479	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Bradl H, 2003, J IMMUNOL, V171, P2338, DOI 10.4049/jimmunol.171.5.2338; Davis MM, 2004, SEMIN IMMUNOL, V16, P239, DOI 10.1016/j.smim.2004.08.003; DECKER DJ, 1991, J IMMUNOL, V146, P350; Gauthier L, 2002, P NATL ACAD SCI USA, V99, P13014, DOI 10.1073/pnas.202323999; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; HENDERSHOT LM, 1990, J CELL BIOL, V111, P829, DOI 10.1083/jcb.111.3.829; Hess J, 2001, P NATL ACAD SCI USA, V98, P1745, DOI 10.1073/pnas.041492098; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KEYNA U, 1995, J IMMUNOL, V155, P5536; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KUDO A, 1987, EMBO J, V6, P2267, DOI 10.1002/j.1460-2075.1987.tb02500.x; KUDO A, 1989, PROGR IMMUNOLOGY, V7, P339; Lanig H, 2004, MOL IMMUNOL, V40, P1263, DOI 10.1016/j.molimm.2003.11.030; MELCHERS F, 1993, IMMUNOL TODAY, V14, P60, DOI 10.1016/0167-5699(93)90060-X; Milili M, 1996, EUR J IMMUNOL, V26, P63, DOI 10.1002/eji.1830260110; Minegishi Y, 1999, P NATL ACAD SCI USA, V96, P3041, DOI 10.1073/pnas.96.6.3041; Minegishi Y, 1998, J EXP MED, V187, P71, DOI 10.1084/jem.187.1.71; Ohnishi K, 2003, NAT IMMUNOL, V4, P849, DOI 10.1038/ni959; PILLAI S, 1987, NATURE, V329, P172, DOI 10.1038/329172a0; SAKAGUCHI N, 1986, NATURE, V324, P579, DOI 10.1038/324579a0; tenBoekel E, 1997, IMMUNITY, V7, P357; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973; Wang LD, 2003, IMMUNOLOGY, V110, P411, DOI 10.1111/j.1365-2567.2003.01756.x; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007	28	74	90	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					291	294		10.1126/science.1139412	http://dx.doi.org/10.1126/science.1139412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431183				2022-12-28	WOS:000245654500055
J	Chun, J				Chun, Jerold			The sources of a lipid conundrum	SCIENCE			English	Editorial Material							ENDOTHELIAL BARRIER FUNCTION; LYMPHOCYTE EGRESS; MULTIPLE-SCLEROSIS; FTY720; SPHINGOSINE-1-PHOSPHATE; RECEPTOR-1		Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Chun, J (corresponding author), Scripps Res Inst, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jchun@scripps.edu	Chun, Jerold/Y-4670-2019					Bartfai T., 2006, DRUG DISCOVERY BEDSI; Baumruker T, 2007, EXPERT OPIN INV DRUG, V16, P283, DOI 10.1517/13543784.16.3.283; Brinkmann V, 2004, AM J TRANSPLANT, V4, P1019, DOI 10.1111/j.1600-6143.2004.00476.x; Gardell SE, 2006, TRENDS MOL MED, V12, P65, DOI 10.1016/j.molmed.2005.12.001; HANEL P, 2007, FASEB J; Hla T, 2005, PROSTAG OTH LIPID M, V77, P197, DOI 10.1016/j.prostaglandins.2005.06.008; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Rosen H, 2007, TRENDS IMMUNOL, V28, P102, DOI 10.1016/j.it.2007.01.007; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505	15	10	12	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					208	210		10.1126/science.1142239	http://dx.doi.org/10.1126/science.1142239			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431159				2022-12-28	WOS:000245654500029
J	Sundareshwar, PV; Murtugudde, R; Srinivasan, G; Singh, S; Ramesh, KJ; Ramesh, R; Verma, SB; Agarwal, D; Baldocchi, D; Baru, CK; Baruah, KK; Chowdhury, GR; Dadhwal, VK; Dutt, CBS; Fuentes, J; Gupta, PK; Hargrove, WW; Howard, M; Jha, CS; Lal, S; Michener, WK; Mitra, AP; Morris, JT; Myneni, RR; Naja, M; Nemani, R; Purvaja, R; Raha, S; Vanan, SKS; Sharma, M; Subramaniam, A; Sukumar, R; Twilley, RR; Zimmerman, PR				Sundareshwar, P. V.; Murtugudde, R.; Srinivasan, G.; Singh, S.; Ramesh, K. J.; Ramesh, R.; Verma, S. B.; Agarwal, D.; Baldocchi, D.; Baru, C. K.; Baruah, K. K.; Chowdhury, G. R.; Dadhwal, V. K.; Dutt, C. B. S.; Fuentes, J.; Gupta, Prabhat K.; Hargrove, W. W.; Howard, M.; Jha, C. S.; Lal, S.; Michener, W. K.; Mitra, A. P.; Morris, J. T.; Myneni, R. R.; Naja, M.; Nemani, R.; Purvaja, R.; Raha, S.; Vanan, S. K. Santhana; Sharma, M.; Subramaniam, A.; Sukumar, R.; Twilley, R. R.; Zimmerman, P. R.			Environmental monitoring network for India	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; VARIABILITY; MONSOON					pvs@sdsmt.edu	Myneni, Ranga B/F-5129-2012; morris, james/ABC-8111-2020; Ramachandran, Ramesh/B-4814-2018; , Nobody/M-9571-2019; Dadhwal, Vinay K/F-9825-2010; Raman, Sukumar/C-9809-2013; subramaniam, ajit/AAA-6116-2022; Ramachandran, Ramesh/AAI-1583-2020; Ramachandran, Purvaja/K-5522-2018; Manchun, Kang/D-3194-2011; Baldocchi, Dennis/A-1625-2009; Myneni, Ranga B./AAU-6088-2021	Myneni, Ranga B/0000-0002-0234-6393; Ramachandran, Ramesh/0000-0003-2471-7746; subramaniam, ajit/0000-0003-1316-5827; Ramachandran, Ramesh/0000-0003-2471-7746; Ramachandran, Purvaja/0000-0001-7937-3763; Baldocchi, Dennis/0000-0003-3496-4919; Agarwal, Deborah/0000-0001-5045-2396; Naja, Manish/0000-0002-4597-1690; Hargrove, William/0000-0002-9830-0022; Dadhwal, Vinay/0000-0001-5084-1367				Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Charles CD, 1997, SCIENCE, V277, P925, DOI 10.1126/science.277.5328.925; Christian RR, 2006, ESTUAR COAST, V29, P871, DOI 10.1007/BF02786538; Giannini A, 2003, SCIENCE, V302, P1027, DOI 10.1126/science.1089357; Hargrove W.W., 2003, EOS T AGU, V84, P529, DOI [10.1029/2003EO480001, DOI 10.1029/2003EO480001]; Hargrove WW, 2004, ENVIRON MANAGE, V34, pS39, DOI 10.1007/s00267-003-1084-0; Hoerling M, 2003, SCIENCE, V299, P691, DOI 10.1126/science.1079053; Huntingford C, 2005, SCIENCE, V309, P1789, DOI 10.1126/science.1115898; *IA STAT U DEP AN, 1999, R134 IOW STAT U DEP; Knutson TR, 2006, J CLIMATE, V19, P1624, DOI 10.1175/JCLI3709.1; Kripalani RH, 2007, THEOR APPL CLIMATOL, V87, P1, DOI 10.1007/s00704-006-0238-4; Kripalani RH, 2003, NAT HAZARDS, V29, P189, DOI 10.1023/A:1023695326825; Kumar SP, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016013; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; *MIN ENV FOR, 2004, IND NAT COMM UN FRAM; Ravindranath NH, 2006, CURR SCI INDIA, V90, P354; Sathaye J, 2006, CURR SCI INDIA, V90, P314; Saxon E, 2005, ECOL LETT, V8, P53, DOI 10.1111/j.1461-0248.2004.00694.x; Stern N., STERN REV EC CLIMATE; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084	20	26	28	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					204	205		10.1126/science.1137417	http://dx.doi.org/10.1126/science.1137417			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	156MV	17431156				2022-12-28	WOS:000245654500026
J	Keime-Guibert, F; Chinot, O; Taillandier, L; Cartalat-Carel, S; Frenay, M; Kantor, G; Guillamo, J; Jadaud, E; Colin, P; Bondiau, P; Menei, P; Loiseau, H; Bernier, V; Honnorat, J; Barrie, M; Mokhtari, K; Mazeron, J; Bissery, A; Delattre, JY; Lacomblez, L; Levy-Soussan, M; Mallet, A; Houssard, C; Delgadillo, D; Poitou, M; Hoang-Xuan, K; Sanson, M; Carpentier, AF; Laigle-Donadey, F; Taillibert, S; Cornu, P; Omuro, A; Capelle, L; Boch, AL; Duffau, H; Simon, JM; Medioni, J; Broet, P; Schmitt, A; Garat, E; Mathieu, P; Camille, N; Collin, JP; Bailet, B; Ciais, C; Fauchon, F; Lebrun, C; Guesdan, G; Stadelmaier, N; Lombard, I; Delassus, P; Lalevec, C; Aubin, G; Fournier, D; Hayek, G				Keime-Guibert, Florence; Chinot, Olivier; Taillandier, Luc; Cartalat-Carel, Stephanie; Frenay, Marc; Kantor, Guy; Guillamo, Jean-Sebastien; Jadaud, Eric; Colin, Philippe; Bondiau, Pierre-Yves; Menei, Philippe; Loiseau, Hugues; Bernier, Valerie; Honnorat, Jerome; Barrie, Maryline; Mokhtari, Karima; Mazeron, Jean-Jacques; Bissery, Anne; Delattre, Jean-Yves; Lacomblez, L.; Levy-Soussan, M.; Mallet, A.; Houssard, C.; Delgadillo, D.; Poitou, M.; Hoang-Xuan, K.; Sanson, M.; Carpentier, A. F.; Laigle-Donadey, F.; Taillibert, S.; Cornu, P.; Omuro, A.; Capelle, L.; Boch, A. -L.; Duffau, H.; Simon, J. -M.; Medioni, J.; Broet, P.; Schmitt, A.; Garat, E.; Mathieu, P.; Camille, N.; Collin, J. -P.; Bailet, B.; Ciais, C.; Fauchon, F.; Lebrun, C.; Guesdan, G.; Stadelmaier, N.; Lombard, I.; Delassus, P.; Lalevec, C.; Aubin, G.; Fournier, D.; Hayek, G.		Assoc French Speaking Neuro Oncolo	Radiotherapy for glioblastoma in the elderly	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; CANCER-TREATMENT TRIALS; RADIATION-THERAPY; MALIGNANT GLIOMA; CLINICAL-TRIALS; OLDER PATIENTS; MULTIFORME; AGE; ASTROCYTOMAS; IRRADIATION	Background: There is no community standard for the treatment of glioblastoma in patients 70 years of age or older. We conducted a randomized trial that compared radiotherapy and supportive care with supportive care alone in such patients. Methods: Patients 70 years of age or older with a newly diagnosed anaplastic astrocytoma or glioblastoma and a Karnofsky performance score of 70 or higher were randomly assigned to receive supportive care only or supportive care plus radiotherapy (focal radiation in daily fractions of 1.8 Gy given 5 days per week, for a total dose of 50 Gy). The primary end point was overall survival; secondary end points were progression-free survival, tolerance of radiotherapy, health-related quality of life, and cognition. Results: We randomly assigned 85 patients from 10 centers to receive either radiotherapy and supportive care or supportive care alone. The trial was discontinued at the first interim analysis, which showed that with a preset boundary of efficacy, radiotherapy and supportive care were superior to supportive care alone. A final analysis was carried out for the 81 patients with glioblastoma (median age, 73 years; range, 70 to 85). At a median follow-up of 21 weeks, the median survival for the 39 patients who received radiotherapy plus supportive care was 29.1 weeks, as compared with 16.9 weeks for the 42 patients who received supportive care alone. The hazard ratio for death in the radiotherapy group was 0.47 (95% confidence interval, 0.29 to 0.76; P=0.002). There were no severe adverse events related to radiotherapy. The results of quality-of-life and cognitive evaluations over time did not differ significantly between the treatment groups. Conclusions: Radiotherapy results in a modest improvement in survival, without reducing the quality of life or cognition, in elderly patients with glioblastoma.	Grp Hosp Pitie Salpetriere, Assistance Publ Hop Paris, INSERM, Unite 711, F-75634 Paris, France; Univ Paris 06, Paris, France; Hop Enfants La Timone, Marseille, France; Hop St Julien, Nancy, France; Univ Lyon 1, INSERM, Unite 842, F-69365 Lyon, France; Hosp Civils Lyon, Lyon, France; Ctr Antoine Lacassagne, F-06054 Nice, France; Inst Bergonie, Bordeaux, France; Univ Cote Nacre, Ctr Hosp, Caen, France; Ctr Paul Papin, Angers, France; Polyclin Courlancy, Reims, France; CHU Angers, Angers, France; Ctr Hosp Univ Bordeaux, Bordeaux, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; UNICANCER; Centre Antoine Lacassagne; UNICANCER; Institut Bergonie; CHU de Caen NORMANDIE; Universite de Caen Normandie; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Bordeaux	Delattre, JY (corresponding author), Hop La Pitie Salpetriere, Serv Neurol Mazarin, 47 Blvd Hop, F-75013 Paris, France.	jean-yves.delattre@psl.aphp.fr	MENEI, Philippe/L-6860-2015; Hoang-Xuan, Khe/O-7527-2017; Guillamo, Jean-Sebastien/AAC-9525-2021; CHINOT, Olivier/M-9196-2018; Honnorat, jerome/G-6394-2017	Guillamo, Jean-Sebastien/0000-0003-0165-8333; CHINOT, Olivier/0000-0001-6317-9691; Honnorat, jerome/0000-0002-4721-5952; menei, philippe/0000-0002-2794-1316				AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; ASAI A, 1989, CANCER-AM CANCER SOC, V63, P1962, DOI 10.1002/1097-0142(19890515)63:10<1962::AID-CNCR2820631016>3.0.CO;2-V; BLEEHEN NM, 1991, BRIT J CANCER, V64, P769, DOI 10.1038/bjc.1991.396; Chakrabarti I, 2005, CANCER-AM CANCER SOC, V104, P2798, DOI 10.1002/cncr.21539; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; CURRAN WJ, 1993, J NATL CANCER I, V85, P704, DOI 10.1093/jnci/85.9.704; Efficace F, 2002, EUR J CANCER, V38, P1824, DOI 10.1016/S0959-8049(02)00173-9; Elia-Pasquet S, 2004, NEUROEPIDEMIOLOGY, V23, P110, DOI 10.1159/000075953; FAYERS PM, 2001, BORTC QLQ C30 SCORIN; Fleury A, 1997, CANCER, V79, P1195, DOI 10.1002/(SICI)1097-0142(19970315)79:6<1195::AID-CNCR19>3.0.CO;2-V; GRANT R, 1995, NEUROLOGY, V45, P929, DOI 10.1212/WNL.45.5.929; Gross CP, 2005, J CLIN ONCOL, V23, P4755, DOI 10.1200/JCO.2005.14.365; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; KRISTIANSEN K, 1981, CANCER, V47, P649, DOI 10.1002/1097-0142(19810215)47:4<649::AID-CNCR2820470405>3.0.CO;2-W; Osoba D, 1996, QUAL LIFE RES, V5, P139, DOI 10.1007/BF00435979; Osoba D, 2000, J CLIN ONCOL, V18, P1481, DOI 10.1200/JCO.2000.18.7.1481; Roa W, 2004, J CLIN ONCOL, V22, P1583, DOI 10.1200/JCO.2004.06.082; SHELINE GE, 1980, INT J RADIAT ONCOL, V6, P1215, DOI 10.1016/0360-3016(80)90175-3; Taphoorn MJB, 2005, LANCET ONCOL, V6, P937, DOI 10.1016/S1470-2045(05)70432-0; Unger JM, 2006, J CLIN ONCOL, V24, P141, DOI 10.1200/JCO.2005.02.8928; Walker M, 2003, J NEURO-ONCOL, V63, P179, DOI 10.1023/A:1023900802254; WALKER MD, 1979, INT J RADIAT ONCOL, V5, P1725, DOI 10.1016/0360-3016(79)90553-4; WALKER MD, 1980, NEW ENGL J MED, V303, P1323, DOI 10.1056/NEJM198012043032303; Yee KWL, 2003, J CLIN ONCOL, V21, P1618, DOI 10.1200/JCO.2003.12.044; [No title captured]	25	570	578	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 12	2007	356	15					1527	1535		10.1056/NEJMoa065901	http://dx.doi.org/10.1056/NEJMoa065901			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	156CA	17429084				2022-12-28	WOS:000245624400006
J	Sarkar, AK; Luijten, M; Miyashima, S; Lenhard, M; Hashimoto, T; Nakajima, K; Scheres, B; Heidstra, R; Laux, T				Sarkar, Ananda K.; Luijten, Marijn; Miyashima, Shunsuke; Lenhard, Michael; Hashimoto, Takashi; Nakajima, Keiji; Scheres, Ben; Heidstra, Renze; Laux, Thomas			Conserved factors regulate signalling in Arabidopsis thaliana shoot and root stem cell organizers	NATURE			English	Article							TRANSCRIPTION FACTOR; MERISTEM; WUSCHEL; GENE; FATE; MAINTENANCE; EMBRYO; PLANTS; NICHE; CLV3	Throughout the lifespan of a plant, which in some cases can last more than one thousand years, the stem cell niches in the root and shoot apical meristems provide cells for the formation of complete root and shoot systems, respectively. Both niches are superficially different and it has remained unclear whether common regulatory mechanisms exist. Here we address whether root and shoot meristems use related factors for stem cell maintenance. In the root niche the quiescent centre cells, surrounded by the stem cells, express the homeobox gene WOX5 (WUSCHEL-RELATED HOMEOBOX 5)(1), a homologue of the WUSCHEL (WUS) gene that non-cell-autonomously maintains stem cells in the shoot meristem(2). Loss of WOX5 function in the root meristem stem cell niche causes terminal differentiation in distal stem cells and, redundantly with other regulators, also provokes differentiation of the proximal meristem. Conversely, gain of WOX5 function blocks differentiation of distal stem cell descendents that normally differentiate. Importantly, both WOX5 and WUS maintain stem cells in either a root or shoot context. Together, our data indicate that stem cell maintenance signalling in both meristems employs related regulators.	Univ Freiburg, Inst Biol 3, D-79104 Freiburg, Germany; Univ Utrecht, Dept Mol Cell Biol, NL-3584 CH Utrecht, Netherlands; Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan	University of Freiburg; Utrecht University; Nara Institute of Science & Technology	Laux, T (corresponding author), Univ Freiburg, Inst Biol 3, Schanzlestr 1, D-79104 Freiburg, Germany.	laux@biologie.uni-freiburg.de	Miyashima, Shunsuke/AAV-1196-2021; Lenhard, Michael/J-1554-2015	Miyashima, Shunsuke/0000-0001-8267-3978; Nakajima, Keiji/0000-0002-1580-3354; Scheres, Ben/0000-0001-5400-9578				Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; BERLETH T, 1993, DEVELOPMENT, V118, P575; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Casamitjana-Martinez E, 2003, CURR BIOL, V13, P1435, DOI 10.1016/S0960-9822(03)00533-5; Gallois JL, 2004, GENE DEV, V18, P375, DOI 10.1101/gad.291204; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; Hamada S, 2000, PLANT J, V24, P91, DOI 10.1046/j.1365-313x.2000.00858.x; Hobe M, 2003, DEV GENES EVOL, V213, P371, DOI 10.1007/s00427-003-0329-5; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kenrick P., 1997, ORIGIN EARLY DIVERSI; Laux T, 2003, CELL, V113, P281, DOI 10.1016/S0092-8674(03)00312-X; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Vernoux T, 2005, CURR OPIN GENET DEV, V15, P388, DOI 10.1016/j.gde.2005.06.008; Weijers D, 2006, DEV CELL, V10, P265, DOI 10.1016/j.devcel.2005.12.001; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Willemsen V, 1998, DEVELOPMENT, V125, P521	24	701	758	11	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2007	446	7137					811	814		10.1038/nature05703	http://dx.doi.org/10.1038/nature05703			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429400				2022-12-28	WOS:000245626800044
J	Fenton, JJ; Taplin, SH; Carney, PA; Abraham, L; Sickles, EA; D'Orsi, C; Berns, EA; Cutter, G; Hendrick, RE; Barlow, WE; Elmore, JG				Fenton, Joshua J.; Taplin, Stephen H.; Carney, Patricia A.; Abraham, Linn; Sickles, Edward A.; D'Orsi, Carl; Berns, Eric A.; Cutter, Gary; Hendrick, R. Edward; Barlow, William E.; Elmore, Joann G.			Influence of computer-aided detection on performance of screening mammography	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the Breast Cancer Surveillance Consortium	APR 24, 2006	Chapel Hill, NC				CARCINOMA IN-SITU; DETECTION SYSTEM; ROC CURVE; BREAST; COMMUNITY; WOMEN; ACCURACY; MICROCALCIFICATIONS; RADIOLOGISTS; SENSITIVITY	BACKGROUND Computer-aided detection identifies suspicious findings on mammograms to assist radiologists. Since the Food and Drug Administration approved the technology in 1998, it has been disseminated into practice, but its effect on the accuracy of interpretation is unclear. METHODS We determined the association between the use of computer-aided detection at mammography facilities and the performance of screening mammography from 1998 through 2002 at 43 facilities in three states. We had complete data for 222,135 women (a total of 429,345 mammograms), including 2351 women who received a diagnosis of breast cancer within 1 year after screening. We calculated the specificity, sensitivity, and positive predictive value of screening mammography with and without computer-aided detection, as well as the rates of biopsy and breast-cancer detection and the overall accuracy, measured as the area under the receiver-operating-characteristic (ROC) curve. RESULTS Seven facilities (16%) implemented computer-aided detection during the study period. Diagnostic specificity decreased from 90.2% before implementation to 87.2% after implementation (P<0.001), the positive predictive value decreased from 4.1% to 3.2% (P=0.01), and the rate of biopsy increased by 19.7% (P<0.001). The increase in sensitivity from 80.4% before implementation of computer-aided detection to 84.0% after implementation was not significant (P=0.32). The change in the cancer-detection rate (including invasive breast cancers and ductal carcinomas in situ) was not significant (4.15 cases per 1000 screening mammograms before implementation and 4.20 cases after implementation, P=0.90). Analyses of data from all 43 facilities showed that the use of computer-aided detection was associated with significantly lower overall accuracy than was nonuse (area under the ROC curve, 0.871 vs. 0.919; P=0.005). CONCLUSIONS The use of computer-aided detection is associated with reduced accuracy of interpretation of screening mammograms. The increased rate of biopsy with the use of computer-aided detection is not clearly associated with improved detection of invasive breast cancer.	Univ Calif Davis, Sacramento, CA 95817 USA; NCI, Bethesda, MD 20892 USA; Oregon Hlth & Sci Univ, Portland, OR USA; Grp Hlth Cooperat Puget Sound, Seattle, WA 98121 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Emory Clin, Atlanta, GA 30322 USA; Northwestern Univ, Chicago, IL 60611 USA; Univ Alabama Birmingham, Birmingham, AL USA; Canc Res & Biostat, Seattle, WA USA; Univ Washington, Seattle, WA 98195 USA	University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Oregon Health & Science University; Group Health Cooperative; University of California System; University of California San Francisco; Emory University; Northwestern University; University of Alabama System; University of Alabama Birmingham; Cancer Research & Biostatistics; University of Washington; University of Washington Seattle	Fenton, JJ (corresponding author), UC Davis Hlth Syst, Dept Family & Community Med, 4860 Y St,Ste 2300, Sacramento, CA 95817 USA.	joshua.fenton@ucdmc.ucdavis.edu	Cutter, Gary/AAY-5392-2021; Fenton, Joshua/AAD-4114-2021	Cutter, Gary/0000-0002-8455-980X; Fenton, Joshua/0000-0002-0581-835X	NATIONAL CANCER INSTITUTE [U01CA069976, R01CA107623, U01CA086082, U01CA063736, K05CA104699] Funding Source: NIH RePORTER; NCI NIH HHS [U01CA63736, U01 CA086082, U01 CA69976, R01 CA 107623, U01 CA069976, K05 CA104699, U01CA86082, U01 CA063736, R01 CA107623] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BallardBarbash R, 1997, AM J ROENTGENOL, V169, P1001, DOI 10.2214/ajr.169.4.9308451; Barlow WE, 2004, JNCI-J NATL CANCER I, V96, P1840, DOI 10.1093/jnci/djh333; Barlow WE, 2006, JNCI-J NATL CANCER I, V98, P1204, DOI 10.1093/jnci/djj331; Birdwell RL, 2005, RADIOLOGY, V236, P451, DOI 10.1148/radiol.2362040864; Birdwell RL, 2001, RADIOLOGY, V219, P192, DOI 10.1148/radiology.219.1.r01ap16192; Brem RF, 2003, AM J ROENTGENOL, V181, P687, DOI 10.2214/ajr.181.3.1810687; Brem RF, 2001, CLIN RADIOL, V56, P150, DOI 10.1053/crad.2000.0592; Brenner RJ, 2006, AM J ROENTGENOL, V186, P48, DOI 10.2214/AJR.05.0215; Burhenne LJW, 2000, RADIOLOGY, V215, P554; Burhenne LJW, 2000, RADIOLOGY, V217, P353; CASTELLINO RA, 2001, APPL RADIOL S11, V30, P5; CHAN HP, 1987, MED PHYS, V14, P538, DOI 10.1118/1.596065; *CTR MED MED SERV, 2004, CMS INCR REIMB COMP; Cupples TE, 2005, AM J ROENTGENOL, V185, P944, DOI 10.2214/AJR.04.1300; D'Orsi C, 2005, RADIOLOGY, V235, P391, DOI 10.1148/radiol.2352040132; D'Orsi CJ, 2001, RADIOLOGY, V221, P585, DOI 10.1148/radiol.2213011476; Das M, 2006, RADIOLOGY, V241, P564, DOI 10.1148/radiol.2412051139; Doi, 1997, Breast Cancer, V4, P228, DOI 10.1007/BF02966511; DOrsi C.J, 1998, BREAST IMAGING REPOR; Elmore JG, 2005, RADIOLOGY, V236, P37, DOI 10.1148/radiol.2361040512; Ernster VL, 2002, J NATL CANCER I, V94, P1546; Evans AJ, 2001, J MED SCREEN, V8, P149, DOI 10.1136/jms.8.3.149; *FDA, SUMM SAF EFF DAT MAM; Freer TW, 2001, RADIOLOGY, V220, P781, DOI 10.1148/radiol.2203001282; Gur D, 2004, J NATL CANCER I, V96, P185, DOI 10.1093/jnci/djh067; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hendrick RE, 2005, AM J ROENTGENOL, V184, P433, DOI 10.2214/ajr.184.2.01840433; Kerlikowske K, 1999, JAMA-J AM MED ASSOC, V282, P2156, DOI 10.1001/jama.282.22.2156; Khoo LAL, 2005, RADIOLOGY, V237, P444, DOI 10.1148/radiol.2372041362; Malich A, 2003, RADIOLOGY, V228, P851, DOI 10.1148/radiol.2283011906; Miglioretti DL, 2004, JAMA-J AM MED ASSOC, V291, P442, DOI 10.1001/jama.291.4.442; Morton MJ, 2006, RADIOLOGY, V239, P375, DOI 10.1148/radiol.2392042121; Sanders ME, 2005, CANCER, V103, P2481, DOI 10.1002/cncr.21069; Smith-Bindman R, 2005, JNCI-J NATL CANCER I, V97, P358, DOI 10.1093/jnci/dji060; Summers RM, 2002, RADIOLOGY, V225, P391, DOI 10.1148/radiol.2252011619; Taplin SH, 2002, RADIOLOGY, V222, P529, DOI 10.1148/radiol.2222010647; Taplin SH, 2006, AM J ROENTGENOL, V187, P1475, DOI 10.2214/AJR.05.0940; TOSTESON ANA, 1988, MED DECIS MAKING, V8, P204, DOI 10.1177/0272989X8800800309; Yankaskas BC, 2005, RADIOLOGY, V234, P363, DOI 10.1148/radiol.2342040048	39	374	382	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 5	2007	356	14					1399	1409		10.1056/NEJMoa066099	http://dx.doi.org/10.1056/NEJMoa066099			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	153GG	17409321	Green Accepted			2022-12-28	WOS:000245419600003
J	Burnett, J; Clarke, M; Darbyshire, J; Haines, A; Roberts, I; Shakur, H; Siegfried, N; Wilkinson, P				Burnett, Jill; Clarke, Mike; Darbyshire, Janet; Haines, Andy; Roberts, Ian; Shakur, Haleema; Siegfried, Nandi; Wilkinson, Paul		Susteinable Trials Study Grp	Towards sustainable clinical trials	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLIMATE-CHANGE; HUMAN HEALTH; FRAUD		Univ London London Sch Hyg & Trop Med, Sustainabil Grp, London WC1E 7HT, England; UK Cochrane Ctr, Oxford, England; UK Clin Res Network, Moscow, Russia	University of London; London School of Hygiene & Tropical Medicine; Cochrane Centre	Roberts, I (corresponding author), Univ London London Sch Hyg & Trop Med, Sustainabil Grp, Keppel St, London WC1E 7HT, England.	crash@Lshtm.ac.uk		Shakur-Still, Haleema/0000-0002-6511-109X; Haines, Andy/0000-0002-8053-4605				Buyse M, 1999, STAT MED, V18, P3435, DOI 10.1002/(SICI)1097-0258(19991230)18:24<3435::AID-SIM365>3.3.CO;2-F; Clarke M, 2004, PLOS MED, V1, P100, DOI 10.1371/journal.pmed.0010035; *DEP ENV, 2003, EN CONS GUID, V19; *DEP ENV FOOD RUR, GUID CO REP GREENH G; Evans S, 2001, FRAUD MISCONDUCT MED, P186; Grimes DA, 2005, LANCET, V366, P172, DOI 10.1016/S0140-6736(05)66875-4; Haines A, 2006, LANCET, V367, P2101, DOI 10.1016/S0140-6736(06)68933-2; HM Treasury, 2006, STERN REV FIN REP; Houghton J., 2004, GLOBAL WARMING COMPL; *INT PAN CLIM CHAN, CLIM CHANG SYNTH REP; Jamtvedt G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub2; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Monbiot George, 2006, HEAT; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Stott R, 2006, BRIT MED J, V333, P983, DOI 10.1136/bmj.39028.427164.BE; Taylor RN, 2002, DRUG INF J, V36, P115, DOI 10.1177/009286150203600115; Wald DS, 2004, BRIT MED J, V329, P282, DOI 10.1136/bmj.329.7460.282; *WORLD RES I WORLD, 2006, GREENH GAS PROT CORP	18	22	22	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2007	334	7595					671	673						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	154ON	17395948				2022-12-28	WOS:000245517100032
J	Watts, G				Watts, Geoff			Genes on ice	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 31	2007	334	7595					662	663		10.1136/bmj.39162.630914.94	http://dx.doi.org/10.1136/bmj.39162.630914.94			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154ON	17395943	Green Published			2022-12-28	WOS:000245517100027
J	Haesler, J; Schindelholz, I; Riguet, E; Bochet, CG; Hug, W				Haesler, J.; Schindelholz, I.; Riguet, E.; Bochet, C. G.; Hug, W.			Absolute configuration of chirally deuterated neopentane	NATURE			English	Article							RAMAN OPTICAL-ACTIVITY; CIRCULAR-DICHROISM; ISOTOPIC-SUBSTITUTION; INTERNAL ROTATION; BROMOCHLOROFLUOROMETHANE; SCATTERING; MOLECULES; HYDROGEN; MODES	The relationship between macroscopic chirality and chirality on the molecular level was unequivocally established in 1951 through anomalous X-ray scattering(1). Although this technique became the definitive method for determining the absolute configuration of a molecule, one important limitation of the approach is that the molecule must contain 'heavy' atoms ( for example, bromine). The direct determination of absolute configurations for a wider range of molecules has recently become possible by measuring a molecule's vibrational optical activity(2,3). Here we show that instrumental advances in Raman optical activity(4,5), combined with quantum chemical computations(6-8), make it possible to determine the absolute configuration of ( R)-[H-2(1), H-2(2), H-2(3)]-neopentane(9). This saturated hydrocarbon represents the archetype of all molecules that are chiral as a result of a dissymmetric mass distribution. It is chemically inert and cannot be derivatized to yield molecules that would reveal the absolute configuration of the parent compound. Diastereomeric interactions with other molecules, optical rotation, and electronic circular dichroism are, in contrast to the well-known case of bromochlorofluoromethane(10-12), not expected to be measurable. Vibronic effects in the vacuum ultraviolet circular dichroism might reveal that the molecule is chiral, but the presence of nine rotamers would make it extremely difficult to interpret the spectra, because the spatial arrangement of the rotamers' nuclei resembles that of enantiomers. The unequivocal spectroscopic determination of the absolute configuration of ( R)-[H-2(1), H-2(2), H-2(3)]-neopentane therefore presented a major challenge, one that was at the very limit of what is possible.	Univ Fribourg, Dept Chem, CH-1700 Fribourg, Switzerland	University of Fribourg	Hug, W (corresponding author), Univ Fribourg, Dept Chem, Ch Musee 9, CH-1700 Fribourg, Switzerland.	jacques.haesler@unifr.ch; w.hug@gmx.net		Bochet, Christian/0000-0003-4267-0523				Abe T, 2003, TETRAHEDRON LETT, V44, P9303, DOI 10.1016/j.tetlet.2003.10.081; BARRON LD, 1977, J CHEM SOC CHEM COMM, P305, DOI 10.1039/c39770000305; BARRON LD, 1973, J AM CHEM SOC, V95, P603, DOI 10.1021/ja00783a058; BARRON LD, 2004, MOL LIGHT SCATTERING, V162, pCH3; BARTH G, 1981, TETRAHEDRON, V37, P4123, DOI 10.1016/0040-4020(81)85003-X; BIJVOET JM, 1951, NATURE, V168, P271, DOI 10.1038/168271a0; Costante J, 1997, ANGEW CHEM INT EDIT, V36, P885, DOI 10.1002/anie.199708851; Crassous J, 2000, ENANTIOMER, V5, P429; DURIG JR, 1970, J CHEM PHYS, V52, P2046, DOI 10.1063/1.1673258; Frisch M.J., 2016, GAUSSIAN16 REV B01; GRANT DM, 1968, PHYS REV LETT, V20, P983, DOI 10.1103/PhysRevLett.20.983; HAESLER J, 2006, THESIS U FRIBOURG; HELGAKER T, 1994, FARADAY DISCUSS, V99, P165, DOI 10.1039/fd9949900165; HOLZWART.G, 1974, J AM CHEM SOC, V96, P251, DOI 10.1021/ja00808a042; Hug W, 2005, INT J QUANTUM CHEM, V104, P695, DOI 10.1002/qua.20600; Hug W, 1999, J RAMAN SPECTROSC, V30, P841, DOI 10.1002/(SICI)1097-4555(199909)30:9<841::AID-JRS456>3.0.CO;2-1; Hug W, 2003, APPL SPECTROSC, V57, P1, DOI 10.1366/000370203321165142; Hug W., 1982, RAMAN SPECTROSCOPY, P3; Jiang ZJ, 2005, CHIRALITY, V17, P488, DOI 10.1002/chir.20191; LONG DA, 1977, RAMAN SPECTROSCOPY, V130; Palmo K, 1998, J PHYS CHEM A, V102, P6448, DOI 10.1021/jp981105f; Petryk MWP, 2002, J PHYS CHEM A, V106, P8599, DOI 10.1021/jp0209493; PITZER KS, 1946, CHEM REV, V39, P435, DOI 10.1021/cr60124a005; POLAVARAPU PL, 1981, J AM CHEM SOC, V103, P5349, DOI 10.1021/ja00408a012; RUSH JJ, 1967, J CHEM PHYS, V46, P2285, DOI 10.1063/1.1841033; Ruud K, 2002, J PHYS CHEM A, V106, P7448, DOI 10.1021/jp026037i; WEISS S, 1969, SPECTROCHIM ACTA A-M, VA 25, P1759, DOI 10.1016/0584-8539(69)80204-7; Zuber G, 2004, J PHYS CHEM A, V108, P2108, DOI 10.1021/jp031284n	28	177	177	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2007	446	7135					526	529		10.1038/nature05653	http://dx.doi.org/10.1038/nature05653			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	150TQ	17392783	Green Submitted			2022-12-28	WOS:000245242900046
J	Tulvatana, W; Kulvichit, K				Tulvatana, Wasee; Kulvichit, Kittisak			Conjunctival viral papilloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Chulalongkorn Univ, Bangkok 10330, Thailand	Chulalongkorn University	Tulvatana, W (corresponding author), Chulalongkorn Univ, Bangkok 10330, Thailand.	wasee.t@chula.ac.th		Tulvatana, Wasee/0000-0002-5421-5619					0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2007	356	13					1352	1352		10.1056/NEJMicm031159	http://dx.doi.org/10.1056/NEJMicm031159			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150MN	17392305				2022-12-28	WOS:000245221000009
J	Francois, B; Bellissant, E; Gissot, V; Desachy, A; Normand, S; Boulain, T; Brenet, O; Preux, PM; Vignon, P				Francois, Bruno; Bellissant, Eric; Gissot, Valerie; Desachy, Arnaud; Normand, Sandrine; Boulain, Thierry; Brenet, Olivier; Preux, Pierre-Marie; Vignon, Philippe		ARCO	12-h pretreatment with methylprednisolone versus placebo for prevention of postextubation laryngeal oedema: a randomised double-blind trial	LANCET			English	Article							ENDOTRACHEAL INTUBATION; TRACHEAL EXTUBATION; LONG-TERM; STRIDOR; DEXAMETHASONE; COMPLICATIONS; FAILURE; CORTICOSTEROIDS; REINTUBATION; CHILDREN	Background The efficacy of corticosteroids in reducing the incidence of postextubation laryngeal oedema is controversial. We aimed to test our hypothesis that methylprednisolone started 12 h before a planned extubation could prevent postextubation laryngeal oedema. Methods We did a placebo-controlled, double-blind multicentre trial in 761 adults in intensive-care units. Patients who were ventilated for more than 36 h and underwent a planned extubation received intravenous 20 mg methylprednisolone (n=380) or placebo (381) 12 h before extubation and every 4 h until tube removal. The primary endpoint was occurrence of laryngeal oedema within 24 h of extubation. Laryngeal oedema was clinically diagnosed and deemed serious if tracheal reintubation was needed. Analyses were done on a per protocol and intention-to-treat basis. This trial is registered at ClinicalTrials.gov, number NCT00199576. Findings 63 patients could not be assessed, mainly because of self-extubation (n=16) or cancelled extubation (44) between randomisation and planned extubation. 698 patients were analysed (343 in placebo group, 355 in methylprednisolone group). Methylprednisolone significantly reduced the incidence of postextubation. laryngeal oedema (11 of 355,3% vs 76 of 343,22%, p<0.0001), the global incidence of reintubations (13 of 355,4% vs 26 of 343, 8%, p=0.02), and the proportion of reintubations secondary to laryngeal oedema (one of 13, 8% vs 14 of 26, 54%, p=0.005). One patient in each group died after extubation, and atelectasia occurred in one patient given methylprednisolone. Interpretation Methylprednisolone started 12 h before a planned extubation substantially reduced the incidence of postextubation laryngeal oedema and reintubation. Such pretreatment should be considered in adult patients before a planned extubation that follows a tracheal intubation of more than 36 h.	Dupuytren Teaching Hosp, Med Surg Intens Care Unit, Limoges, France; Ctr Hosp Univ Limoges, Ctr Rech Clin, Limoges, France; Univ Limoges, Limoges, France; CHU Rennes, Ctr Invest Clin Inserm 0203, Unite Pharmacol Clin, Hop Pontchaillou, Rennes, France; Univ Rennes 1, Rennes, France; Bretonneau Teaching Hosp, Intens Care Unit, Tours, France; Med Surg Intens Care Unit, Angouleme, France; Med Surg Intens Care Unit, Orleans, France; Med Surg Intens Care Unit, Cholet, France; Dupuytren Teaching Hosp, Dept Biostat, Limoges, France	CHU Limoges; CHU Limoges; Universite de Limoges; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Tours; CHU Limoges	Vignon, P (corresponding author), CHU Dupuytren, Serv Reanimat Polyvalente, F-87042 Limoges, France.	philippe.vignon@unilim.fr	Preux, Pierre-Marie/N-3538-2019; François, Bruno/O-8404-2016; PREUX, Pierre-Marie/B-8393-2014; Boulain, Thierry/M-3309-2019; Vignon, Philippe/O-8886-2016	Preux, Pierre-Marie/0000-0002-2171-2977; François, Bruno/0000-0002-2531-1652; PREUX, Pierre-Marie/0000-0002-2171-2977; Boulain, Thierry/0000-0003-4664-3661; Vignon, Philippe/0000-0003-4551-5772				Anene O, 1996, CRIT CARE MED, V24, P1666, DOI 10.1097/00003246-199610000-00011; BRYANT LR, 1971, J AMER MED ASSOC, V215, P625, DOI 10.1001/jama.215.4.625; Cheng KC, 2006, CRIT CARE MED, V34, P1345, DOI 10.1097/01.CCM.0000214678.92134.BD; COLICE GL, 1989, CHEST, V96, P877, DOI 10.1378/chest.96.4.877; DARMON JY, 1992, ANESTHESIOLOGY, V77, P245, DOI 10.1097/00000542-199208000-00004; De Bast Y, 2002, INTENS CARE MED, V28, P1267, DOI 10.1007/s00134-002-1422-3; DEMING MV, 1961, ANESTHESIOLOGY, V22, P933, DOI 10.1097/00000542-196111000-00011; Dixon T C, 1968, Med J Aust, V2, P529; DONNELLY WH, 1969, ARCH PATHOL, V88, P511; DUBICK MN, 1978, ANESTH ANALG, V57, P663; Epstein SK, 1998, AM J RESP CRIT CARE, V158, P489, DOI 10.1164/ajrccm.158.2.9711045; Ferrara T B, 1989, J Perinatol, V9, P287; GAUSSORGUES P, 1987, PRESSE MED, V16, P1531; Harel Y, 1997, INT J PEDIATR OTORHI, V39, P147, DOI 10.1016/S0165-5876(97)01488-2; HAWKINS DB, 1983, OTOLARYNG HEAD NECK, V91, P593, DOI 10.1177/019459988309100601; Ho LI, 1996, INTENS CARE MED, V22, P933; JABER S, 2003, INTENS CARE MED, V29, P1563; KASTANOS N, 1983, CRIT CARE MED, V11, P362, DOI 10.1097/00003246-198305000-00009; Kriner Eric J, 2005, Respir Care, V50, P1632; MACKENZIE CF, 1979, ANESTHESIOLOGY, V50, P235, DOI 10.1097/00000542-197903000-00015; Miller RL, 1996, CHEST, V110, P1035, DOI 10.1378/chest.110.4.1035; PARFITT K, 1999, MARTINDALE COMPLETE, P1046; RASHKIN MC, 1986, CHEST, V89, P165, DOI 10.1378/chest.89.2.165; STAUFFER JL, 1981, AM J MED, V70, P65, DOI 10.1016/0002-9343(81)90413-7; TELLEZ DW, 1991, J PEDIATR-US, V118, P289, DOI 10.1016/S0022-3476(05)80505-0; WAY WL, 1965, ANN OTO RHINOL LARYN, V74, P799, DOI 10.1177/000348946507400318	26	131	142	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR-APR	2007	369	9567					1083	1089		10.1016/S0140-6736(07)60526-1	http://dx.doi.org/10.1016/S0140-6736(07)60526-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151XF	17398307				2022-12-28	WOS:000245323700028
J	Resnick, MD; Bowes, G				Resnick, Michael D.; Bowes, Glenn			Us and them: worldwide health issues for adolescents	LANCET			English	Editorial Material									Univ Minnesota, Healthy Youth Dev Prevent Res Ctr, Minneapolis, MN 55455 USA; Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia	University of Minnesota System; University of Minnesota Twin Cities; University of Melbourne	Resnick, MD (corresponding author), Univ Minnesota, Healthy Youth Dev Prevent Res Ctr, Minneapolis, MN 55455 USA.	resni001@umn.edu						BEARINGER SH, 2007, LANCET          0327; Burdekin B., 1989, OUR HOMELESS CHILDRE; Edelman MW, 1987, FAMILIES PERIL AGEND; Harrington Michael, 1962, OTHER AM POVERTY US; LLOYD CB, 2005, I MED GROWING GLOBAL; Resnick MD, 2005, MED J AUSTRALIA, V183, P398, DOI 10.5694/j.1326-5377.2005.tb07101.x; Riffs J. A, 1890, OTHER HALF LIVES STU; World Bank, 2005, EC GROWTH 1990S LEAR; World Bank, 2006, WORLD DEV REP 2007 D; World Health Organization, 2002, WORLD REPORT VIOLENC	10	9	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2007	369	9567					1058	1060		10.1016/S0140-6736(07)60372-9	http://dx.doi.org/10.1016/S0140-6736(07)60372-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	151XF	17398288				2022-12-28	WOS:000245323700005
J	Motoyoshi, I; Nishida, S; Sharan, L; Adelson, EH				Motoyoshi, Isamu; Nishida, Shin'ya; Sharan, Lavanya; Adelson, Edward H.			Image statistics and the perception of surface qualities	NATURE			English	Article							NATURAL IMAGE; REFLECTANCE; LIGHTNESS; ORGANIZATION; CONSTANCY; TEXTURE	The world is full of surfaces, and by looking at them we can judge their material qualities. Properties such as colour or glossiness can help us decide whether a pancake is cooked, or a patch of pavement is icy. Most studies of surface appearance have emphasized textureless matte surfaces(1-3), but real-world surfaces, which may have gloss and complex mesostructure, are now receiving increased attention(4-7). Their appearance results from a complex interplay of illumination, reflectance and surface geometry, which are difficult to tease apart given an image. If there were simple image statistics that were diagnostic of surface properties it would be sensible to use them(8-11). Here we show that the skewness of the luminance histogram and the skewness of sub-band filter outputs are correlated with surface gloss and inversely correlated with surface albedo ( diffuse reflectance). We find evidence that human observers use skewness, or a similar measure of histogram asymmetry, in making judgements about surfaces. When the image of a surface has positively skewed statistics, it tends to appear darker and glossier than a similar surface with lower skewness, and this is true whether the skewness is inherent to the original image or is introduced by digital manipulation. We also find a visual aftereffect based on skewness: adaptation to patterns with skewed statistics can alter the apparent lightness and glossiness of surfaces that are subsequently viewed. We suggest that there are neural mechanisms sensitive to skewed statistics, and that their outputs can be used in estimating surface properties.	NTT Corp, Human & Informat Sci Lab, NTT Commun Sci Labs, Atsugi, Kanagawa 2430198, Japan; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA	Nippon Telegraph & Telephone Corporation; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Motoyoshi, I (corresponding author), NTT Corp, Human & Informat Sci Lab, NTT Commun Sci Labs, 3-1 Morinosato, Atsugi, Kanagawa 2430198, Japan.	motoyosi@apollo3.brl.ntt.co.jp						BAIZER JS, 1977, J NEUROPHYSIOL, V40, P1024, DOI 10.1152/jn.1977.40.5.1024; Brainard DH, 1998, J OPT SOC AM A, V15, P307, DOI 10.1364/JOSAA.15.000307; Chubb C, 2004, VISION RES, V44, P3223, DOI 10.1016/j.visres.2004.07.019; Dana KJ, 1999, ACM T GRAPHIC, V18, P1, DOI 10.1145/300776.300778; Dror R, 2004, J VISION, V4, P821, DOI 10.1167/4.9.11; Fleming RW, 2003, J VISION, V3, P347, DOI 10.1167/3.5.3; Fleming RW., 2005, ACM T APPL PERCEPT, V2, P346, DOI [10.1145/1077399.1077409, DOI 10.1145/1077399.1077409]; Gilchrist A, 1999, PSYCHOL REV, V106, P795, DOI 10.1037/0033-295X.106.4.795; HEEGER DJ, 1993, J NEUROPHYSIOL, V70, P1885, DOI 10.1152/jn.1993.70.5.1885; Kagan I, 2002, J NEUROPHYSIOL, V88, P2557, DOI 10.1152/jn.00858.2001; Kingdom FAA, 2001, VISION RES, V41, P585, DOI 10.1016/S0042-6989(00)00284-4; LAND EH, 1971, J OPT SOC AM, V61, P1, DOI 10.1364/JOSA.61.000001; Levoy M., 2000, DIGITAL MICHELANGELO; MACGILLIVRAY HL, 1986, ANN STAT, V14, P994, DOI 10.1214/aos/1176350046; MALIK J, 1990, J OPT SOC AM A, V7, P923, DOI 10.1364/JOSAA.7.000923; Mata ML, 2005, J NEUROPHYSIOL, V93, P919, DOI 10.1152/jn.00668.2004; NICODEMU.FE, 1965, APPL OPTICS, V4, P767, DOI 10.1364/AO.4.000767; Nishida S, 1998, J OPT SOC AM A, V15, P2951, DOI 10.1364/JOSAA.15.002951; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Pont SC, 2005, INT J COMPUT VISION, V62, P17, DOI 10.1007/s11263-005-4633-6; Robilotto R, 2006, J VISION, V6, P18, DOI 10.1167/6.1.3; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; Shipp S, 2002, VISUAL NEUROSCI, V19, P187, DOI 10.1017/S0952523802191164; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Todd JT, 2004, PSYCHOL SCI, V15, P33, DOI 10.1111/j.0963-7214.2004.01501006.x	25	406	410	7	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2007	447	7141					206	209		10.1038/nature05724	http://dx.doi.org/10.1038/nature05724			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	165WT	17443193				2022-12-28	WOS:000246338700043
J	Gedik, N; Yang, DS; Logvenov, G; Bozovic, I; Zewail, AH				Gedik, Nuh; Yang, Ding-Shyue; Logvenov, Gennady; Bozovic, Ivan; Zewail, Ahmed H.			Nonequilibrium phase transitions in cuprates observed by ultrafast electron crystallography	SCIENCE			English	Article							SINGLE-CRYSTAL; DIFFRACTION; MICROSCOPY; CHEMISTRY; ENERGY; OXIDES; STATE	Nonequilibrium phase transitions, which are defined by the formation of macroscopic transient domains, are optically dark and cannot be observed through conventional temperature- or pressure-change studies. We have directly determined the structural dynamics of such a nonequilibrium phase transition in a cuprate superconductor. Ultrafast electron crystallography with the use of a tilted optical geometry technique afforded the necessary atomic-scale spatial and temporal resolutions. The observed transient behavior displays a notable "structural isosbestic" point and a threshold effect for the dependence of c-axis expansion (Delta c) on fluence ( F), with Delta c/F = 0.02 angstrom/(millijoule per square centimeter). This threshold for photon doping occurs at similar to 0.12 photons per copper site, which is unexpectedly close to the density ( per site) of chemically doped carriers needed to induce superconductivity.	CALTECH, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA; Brookhaven Natl Lab, Upton, NY 11973 USA	California Institute of Technology; United States Department of Energy (DOE); Brookhaven National Laboratory	Zewail, AH (corresponding author), CALTECH, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.	zewail@caltech.edu	Yang, Ding-Shyue/A-8648-2010	Yang, Ding-Shyue/0000-0003-2713-9128; gaber, sarah/0000-0002-5995-7291				Bargheer M, 2006, CHEMPHYSCHEM, V7, P783, DOI 10.1002/cphc.200500591; Basov DN, 2005, REV MOD PHYS, V77, P721, DOI 10.1103/RevModPhys.77.721; Baum P, 2006, P NATL ACAD SCI USA, V103, P16105, DOI 10.1073/pnas.0607451103; BLOEMBERGEN N, 1994, AIP CONF P, V288, P3; Bozovic I, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.132503; Bozovic I, 2001, IEEE T APPL SUPERCON, V11, P2686, DOI 10.1109/77.919617; Bressler C, 2004, CHEM REV, V104, P1781, DOI 10.1021/cr0206667; Cavalleri A, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.011004; Collet E, 2003, SCIENCE, V300, P612, DOI 10.1126/science.1082001; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Grinolds MS, 2006, P NATL ACAD SCI USA, V103, P18427, DOI 10.1073/pnas.0609233103; KUMAGAI K, 1988, PHYS REV LETT, V60, P724, DOI 10.1103/PhysRevLett.60.724; MARCUS RA, 1993, ANGEW CHEM INT EDIT, V32, P1111, DOI 10.1002/anie.199311113; McMillan PF, 2005, PHILOS T R SOC A, V363, P311, DOI 10.1098/rsta.2004.1512; MOKHTARI A, 1990, NATURE, V348, P225, DOI 10.1038/348225a0; Moller KB, 1998, CHEM PHYS LETT, V295, P1, DOI 10.1016/S0009-2614(98)00927-0; Pergament A, 2006, J PHYS A-MATH GEN, V39, P4619, DOI 10.1088/0305-4470/39/17/S48; Perkins JD, 1998, PHYS REV B, V58, P9390, DOI 10.1103/PhysRevB.58.9390; PIVETEAU B, 1991, PHYS REV B, V43, P493, DOI 10.1103/PhysRevB.43.493; RAMDAS S, 1980, NATURE, V284, P153, DOI 10.1038/284153a0; Rousse A, 2001, REV MOD PHYS, V73, P17, DOI 10.1103/RevModPhys.73.17; Ruan CY, 2004, SCIENCE, V304, P80, DOI 10.1126/science.1094818; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; SUZUKI M, 1989, PHYS REV B, V39, P2312, DOI 10.1103/PhysRevB.39.2312; Thomas JM, 2005, ANGEW CHEM INT EDIT, V44, P5563, DOI 10.1002/anie.200501466; THOMAS JM, 1974, PHILOS T R SOC A, V277, P251, DOI 10.1098/rsta.1974.0051; vonderLinde D, 1997, APPL SURF SCI, V109, P1, DOI 10.1016/S0169-4332(96)00611-3; WANG ZL, 1996, REFLECTION ELECT MIC; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Yang DS, 2007, J PHYS CHEM C, V111, P4889, DOI 10.1021/jp067466+; Yonemitsu K, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.011008; Yu JD, 1996, PHYS REV B, V54, P7455, DOI 10.1103/PhysRevB.54.7455; Zewail AH, 2006, ANNU REV PHYS CHEM, V57, P65, DOI 10.1146/annurev.physchem.57.032905.104748; ZOU X, 2006, ELECT CRYSTALLOGRAPH; [No title captured]	35	188	189	0	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					425	429		10.1126/science.1138834	http://dx.doi.org/10.1126/science.1138834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446397				2022-12-28	WOS:000245813400050
J	Ahmed-Little, Y				Ahmed-Little, Yasmin			Implications of shift work for junior doctors	BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH; RISK; SYSTEMS; DISEASE; IMPACT; NIGHT; SLEEP; WOMEN		N Western Deanery NHS NW, Manchester M1 3DZ, Lancs, England		Ahmed-Little, Y (corresponding author), N Western Deanery NHS NW, Manchester M1 3DZ, Lancs, England.	y.ahmed-little@nwpgmd.nhs.uk						AHMEDLITTLE Y, 2006, BR J HLTH CARE MANAG, V12, P373; Boggild H, 1999, SCAND J WORK ENV HEA, V25, P85, DOI 10.5271/sjweh.410; British Medical Association, 1999, HLTH SAF PROBL ASS D; BUELL P, 1960, J Chronic Dis, V11, P615, DOI 10.1016/0021-9681(60)90060-6; Costa G, 1996, APPL ERGON, V27, P9, DOI 10.1016/0003-6870(95)00047-X; Costa G, 2003, THEOR ISS ERGON SCI, V4, P263, DOI DOI 10.1080/14639220210158880; *DEP HLTH, 1991, JUN DOCT HOURS NEW D; *DEP HLTH, 2000, NHS PLAN; Douglas NJ, 2005, CLIN MED, V5, P95, DOI 10.7861/clinmedicine.5-2-95; Hansen J, 2001, EPIDEMIOLOGY, V12, P74, DOI 10.1097/00001648-200101000-00013; Harma M, 1996, APPL ERGON, V27, P25, DOI 10.1016/0003-6870(95)00046-1; Harrington JM, 2001, OCCUP ENVIRON MED, V58, P68, DOI 10.1136/oem.58.1.68; HARRINGTON JM, 1994, BRIT MED J, V308, P1581, DOI 10.1136/bmj.308.6944.1581; HORROCKS N, WORKING NIGHT SHIFT; Horrocks N, 2006, WORKING NIGHT SHIFT; KAWACHI I, 1995, CIRCULATION, V92, P3178, DOI 10.1161/01.CIR.92.11.3178; Kawakami N, 1999, J EPIDEMIOL COMMUN H, V53, P359, DOI 10.1136/jech.53.6.359; Knauth P, 2003, OCCUP MED-OXFORD, V53, P109, DOI 10.1093/occmed/kqg049; Knauth P, 1982, J Hum Ergol (Tokyo), V11 Suppl, P337; KNAUTH P, 1993, ERGONOMICS, V36, P15, DOI 10.1080/00140139308967850; Knauth P, 1996, APPL ERGON, V27, P39, DOI 10.1016/0003-6870(95)00044-5; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; KURAMATANI N, 1994, ERGONOMICS, V37, P995; MACDONALD R, 2004, BMJ CANC FOCUS, V328, P19; MATHER H, 2004, COPING PROBLEMS ACUT; OLSEN O, 1991, J EPIDEMIOL COMMUN H, V45, P4, DOI 10.1136/jech.45.1.4; ROBERTS IH, 2005, BMJ S, V330, P13; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; [No title captured]	29	14	14	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 14	2007	334	7597					777	778A		10.1136/bmj.39154.516667.BE	http://dx.doi.org/10.1136/bmj.39154.516667.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161SX	17431264	Green Published			2022-12-28	WOS:000246037300026
J	Olusanya, BO; Newton, VE				Olusanya, Bolajoko O.; Newton, Valerie E.			Global burden of childhood hearing impairment and disease control priorities for developing countries	LANCET			English	Article							LANGUAGE; CHILDREN		UCL, Inst Child Hlth, Unit Audiol Med, London WC1N 1EH, England; Univ Lagos, Coll Med, Inst Child Hlth & Primary Care, Lagos, Nigeria; Univ Manchester, Manchester M13 9PL, Lancs, England	University of London; University College London; University of Lagos; University of Manchester	Olusanya, BO (corresponding author), UCL, Inst Child Hlth, Unit Audiol Med, London WC1N 1EH, England.	b.olusanya@ich.ucl.ac.uk	Olusanya, Bolajoko O./F-4504-2012	Olusanya, Bolajoko O./0000-0002-3826-0583				AABY P, 1993, BRIT MED J, V307, P1308, DOI 10.1136/bmj.307.6915.1308; [Anonymous], 2005, STAT WORLDS CHILDR 2; Bess FH, 1998, EAR HEARING, V19, P339, DOI 10.1097/00003446-199810000-00001; Clark J G, 1981, ASHA, V23, P493; DAVIS A, 1997, HEALTH TECHNOL ASSES, V1, P1, DOI DOI 10.3310/HTA1100; Finitzo T, 2000, PEDIATRICS, V106, P798, DOI 10.1044/1059-0889(2000/005); Fortnum H.M., 2001, BRIT MED J, V323, P1, DOI DOI 10.1136/bmj.323.7312.536; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P3, DOI 10.1596/978-0-8213-6179-5/Chpt-1; Kennedy CR, 2006, NEW ENGL J MED, V354, P2131, DOI 10.1056/NEJMoa054915; Lagunju I A, 2005, Afr J Med Med Sci, V34, P383; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; Lieu JEC, 2004, ARCH OTOLARYNGOL, V130, P524, DOI 10.1001/archotol.130.5.524; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1; Moeller MP, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.3.e43; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Morzaria S, 2004, INT J PEDIATR OTORHI, V68, P1193, DOI 10.1016/j.ijporl.2004.04.013; NEWTON VE, 2006, INFECT HEARING IMPAI; Olusanya BO, 2006, TROP MED INT HEALTH, V11, P381, DOI 10.1111/j.1365-3156.2006.01573.x; Olusanya BO, 2004, DISABIL REHABIL, V26, P1221, DOI 10.1080/09638280410001724852; Ozcelik T., 1997, Acta Oto-Rhino-Laryngologica Belgica, V51, P31; Ruben RJ, 2000, LARYNGOSCOPE, V110, P241, DOI 10.1097/00005537-200002010-00010; Schroeder L, 2006, PEDIATRICS, V117, P1101, DOI 10.1542/peds.2005-1335; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; *UN DEP PUBL INF, 2005, MILL DEV GOALS REP 2; *UNESCO, 2006, STRONG FDN EARLY CHI; *WHO, 1995, PREV HEAR IMP RES 48; *WHO, 2006, PRIM CAR TRAIN RES A; World Health Organization, 2001, INT CLASS FUNCT DIS; Young ME, 2007, EARLY CHILD DEVELOPMENT FROM MEASUREMENT TO ACTION: A PRIORITY FOR GROWTH AND EQUITY, P1, DOI 10.1596/978-0-8213-7086-5	30	124	133	2	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2007	369	9569					1314	1317		10.1016/S0140-6736(07)60602-3	http://dx.doi.org/10.1016/S0140-6736(07)60602-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	164YA	17434407				2022-12-28	WOS:000246269700034
J	El-Kaderi, HM; Hunt, JR; Mendoza-Cortes, JL; Cote, AP; Taylor, RE; O'Keeffe, M; Yaghi, OM				El-Kaderi, Hani M.; Hunt, Joseph R.; Mendoza-Cortes, Jose L.; Cote, Adrien P.; Taylor, Robert E.; O'Keeffe, Michael; Yaghi, Omar M.			Designed synthesis of 3D covalent organic frameworks	SCIENCE			English	Article							SURFACE-AREA	Three-dimensional covalent organic frameworks (3D COFs) were synthesized by targeting two nets based on triangular and tetrahedral nodes: ctn and bor. The respective 3D COFs were synthesized as crystalline solids by condensation reactions of tetrahedral tetra(4-dihydroxyborylphenyl) methane or tetra(4-dihydroxyborylphenyl) silane and by co-condensation of triangular 2,3,6,7,10,11-hexahydroxytriphenylene. Because these materials are entirely constructed from strong covalent bonds (C-C, C-O, C-B, and B-O), they have high thermal stabilities (400 degrees to 500 degrees C), and they also have high surface areas (3472 and 4210 square meters per gram for COF-102 and COF-103, respectively) and extremely low densities (0.17 grams per cubic centimeter).	Univ Calif Los Angeles, Dept Chem & Biochem, Calif Nanosyst Inst, Ctr Reticular Chem, Los Angeles, CA 90095 USA; Arizona State Univ, Dept Chem, Tempe, AZ 85287 USA	University of California System; University of California Los Angeles; Arizona State University; Arizona State University-Tempe	Yaghi, OM (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Calif Nanosyst Inst, Ctr Reticular Chem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	yaghi@chem.ucla.edu	Mendoza-Cortes, Jose L/A-4175-2013; Yaghi, Omar M/C-6749-2013	Mendoza-Cortes, Jose L/0000-0001-5184-1406; Yaghi, Omar/0000-0002-5611-3325				Ahn JH, 2006, MACROMOLECULES, V39, P627, DOI 10.1021/ma051152n; Chae HK, 2004, NATURE, V427, P523, DOI 10.1038/nature02311; Cote AP, 2005, SCIENCE, V310, P1166, DOI 10.1126/science.1120411; Cullity B.D., 1978, ANSWERS PROBLEMS ELE; Delgado-Friedrichs O, 2006, ACTA CRYSTALLOGR A, V62, P350, DOI 10.1107/S0108767306022707; Ferey G, 2005, SCIENCE, V309, P2040, DOI 10.1126/science.1116275; Ghanem BS, 2007, CHEM COMMUN, P67, DOI 10.1039/b614214a; Li H, 1999, NATURE, V402, P276, DOI 10.1038/46248; *MOL SIM INC, 1999, CER 2 MOD ENV VERS 4; Schumacher K, 2000, LANGMUIR, V16, P4648, DOI 10.1021/la991595i; Texier-Mandoki N, 2004, CARBON, V42, P2744, DOI 10.1016/j.carbon.2004.05.018; Thommes M., 2004, NANOPOR MAT SCI ENG, P317, DOI [10.1142/9781860946561_0011, DOI 10.1142/9781860946561_0011]; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650	13	1651	1726	130	2453	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					268	272		10.1126/science.1139915	http://dx.doi.org/10.1126/science.1139915			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431178				2022-12-28	WOS:000245654500048
J	Klajn, R; Bishop, KJM; Fialkowski, M; Paszewski, M; Campbell, CJ; Gray, TP; Grzybowski, BA				Klajn, Rafal; Bishop, Kyle J. M.; Fialkowski, Marcin; Paszewski, Maciej; Campbell, Christopher J.; Gray, Timothy P.; Grzybowski, Bartosz A.			Plastic and moldable metals by self-assembly of sticky nanoparticle aggregates	SCIENCE			English	Article							SUPERLATTICES	Deformable, spherical aggregates of metal nanoparticles connected by long-chain dithiol ligands self-assemble into nanostructured materials of macroscopic dimensions. These materials are plastic and moldable against arbitrarily shaped masters and can be thermally hardened into polycrystalline metal structures of controllable porosity. In addition, in both plastic and hardened states, the assemblies are electrically conductive and exhibit Ohmic characteristics down to similar to 20 volts per meter. The self-assembly method leading to such materials is applicable both to pure metals and to bimetallic structures of various elemental compositions.	Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA; Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Grzybowski, BA (corresponding author), Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA.	grzybor@northwestern.edu	Grzybowski, Bartosz A/H-5741-2017; Campbell, Christopher James/AHC-0077-2022; Bishop, Kyle J M/F-1742-2010	Grzybowski, Bartosz/0000-0001-6613-4261; Fialkowski, Marcin/0000-0003-1529-2539				Beck A, 2000, APPL PHYS LETT, V77, P139, DOI 10.1063/1.126902; Boal AK, 2000, NATURE, V404, P746, DOI 10.1038/35008037; Deegan RD, 2000, PHYS REV E, V62, P756, DOI 10.1103/PhysRevE.62.756; HASLACH HW, 2004, DEFORMABLE BODIES TH; Hussain I, 2006, LANGMUIR, V22, P2938, DOI 10.1021/la053126o; Kalsin AM, 2006, SCIENCE, V312, P420, DOI 10.1126/science.1125124; Kashchiev D., 2000, NUCL BASIC THEORY AP; Kiely CJ, 1998, NATURE, V396, P444, DOI 10.1038/24808; KINGERY WD, 1996, INTRO CERAMICS; LEFF DV, 1995, J PHYS CHEM-US, V99, P7036, DOI 10.1021/j100018a041; Maye MM, 2005, J AM CHEM SOC, V127, P1519, DOI 10.1021/ja044408y; MURRAY CB, 1995, SCIENCE, V270, P1335, DOI 10.1126/science.270.5240.1335; Schessler HM, 1996, J AM CHEM SOC, V118, P9645, DOI 10.1021/ja961565r; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Stellacci F, 2005, NAT MATER, V4, P113, DOI 10.1038/nmat1316; Tong X, 2005, J PHYS CHEM B, V109, P20281, DOI 10.1021/jp0524274	16	227	231	3	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					261	264		10.1126/science.1139131	http://dx.doi.org/10.1126/science.1139131			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431176				2022-12-28	WOS:000245654500046
J	Fuyuno, I				Fuyuno, Ichiko			Plastic promises	NATURE			English	News Item																			0	3	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2007	446	7137					715	715		10.1038/446715a	http://dx.doi.org/10.1038/446715a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429369	Bronze			2022-12-28	WOS:000245626800010
J	Morgan, TM; Krumholz, HM; Lifton, RP; Spertus, JA				Morgan, Thomas M.; Krumholz, Harlan M.; Lifton, Richard P.; Spertus, John A.			Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							NONFATAL MYOCARDIAL-INFARCTION; ISCHEMIC-HEART-DISEASE; TRANSFER PROTEIN GENE; ARTERY-DISEASE; RECEPTOR GENE; HAPLOTYPE ANALYSIS; PLASMA-LEVELS; ALPHA GENE; PROMOTER POLYMORPHISM; COMMON POLYMORPHISM	Context Given the numerous, yet inconsistent, reports of genetic variants being associated with acute coronary syndromes (ACS), there is a need for comprehensive validation of ACS susceptibility genotypes. Objective To perform an extensive validation of putative genetic risk factors for ACS. Design, Setting, and Participants Through a systematic literature search of articles published before March 10, 2005, we identified genetic variants previously reported as significant susceptibility factors for atherosclerosis or ACS. Restricting our analysis to white patients to reduce confounding from racial admixture, we identifed 811 patients who presented from March 2001 through June 2003 with ACS at 2 Kansas City, Mo, university-affiliated hospitals. During 2005-2006, we genotyped the 811 patients along with 650 age- and sex- matched controls for 85 variants in 70 genes and attempted to replicate previously reported associations. We further explored possible associations without prior assumption of specific risk models and used the Sign test to search for weak associations. Main Outcome Measures Compare each prespecified gene variant associated with ACS risk among cases and controls. A surplus of associations would imply that some are associated with ACS. Results Of 85 variants tested, only 1 putative risk genotype (- 455 promoter variant in beta-fibrinogen) was nominally statistically significant (P=. 03). Only 4 additional genes were positive in model-free analysis. Neither number of associations was more frequent than expected by chance, given the number of comparisons. Finally, only 41 of 84 predefined risk variants were even marginally more frequent in cases than in controls ( with 1 tie), representing a 48.8% "win rate" (95% confidence interval, 38.1%-59.5%) for the collective risk genotypes ( P=. 91, Sign test). Conclusions Our null results provide no support for the hypothesis that any of the 85 genetic variants tested is a susceptibility factor for ACS. These results emphasize the need for robust replication of putative genetic risk factors before their introduction into clinical care.	Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA; Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA; Univ Missouri, Kansas City, MO 64110 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City	Morgan, TM (corresponding author), Washington Univ, Sch Med, Dept Pediat, Div Genet & Genom Med, Mcdonnell Pediat Res Bldg 3103,660 Euclid Ave, St Louis, MO 63110 USA.	morgan_t@kids.wustl.edu; richard.lifton@yale.edu	, Harlan/AAI-2875-2020; Morgan, Tom/C-3478-2012; Spertus, John/ABD-3075-2021		AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS011282] Funding Source: NIH RePORTER; AHRQ HHS [R-01 HS11282-01] Funding Source: Medline; NHLBI NIH HHS [K23 HI77272] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Andreotti F, 2002, HEART, V87, P107, DOI 10.1136/heart.87.2.107; Aoki S, 2001, JPN CIRC J, V65, P621, DOI 10.1253/jcj.65.621; Baroni MG, 1999, ARTERIOSCL THROM VAS, V19, P2975, DOI 10.1161/01.ATV.19.12.2975; Boekholdt SM, 2001, CIRCULATION, V104, P3063, DOI 10.1161/hc5001.100793; Boekholdt SM, 2002, ARTERIOSCL THROM VAS, V22, pE24, DOI 10.1161/01.ATV.0000046235.22451.66; BRAUNWALD E, 1989, CIRCULATION, V80, P410, DOI 10.1161/01.CIR.80.2.410; Casas JP, 2006, ANN HUM GENET, V70, P145, DOI 10.1111/j.1469-1809.2005.00241.x; Chao TH, 2004, AM J CARDIOL, V93, P204, DOI 10.1016/j.amjcard.2003.09.039; Chiodini BD, 2003, ATHEROSCLEROSIS, V167, P355, DOI 10.1016/S0021-9150(02)00425-2; Cipollone F, 2004, JAMA-J AM MED ASSOC, V291, P2221, DOI 10.1001/jama.291.18.2221; Clee SM, 2001, CIRCULATION, V103, P1198; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Doggen CJM, 1998, THROMB HAEMOSTASIS, V80, P743; Douglas H, 2002, HEART, V87, P70, DOI 10.1136/heart.87.1.70; Durrington PN, 2001, ARTERIOSCL THROM VAS, V21, P473, DOI 10.1161/01.ATV.21.4.473; Endler G, 2003, CLIN CHIM ACTA, V330, P31, DOI 10.1016/S0009-8981(03)00022-6; Endler G, 2002, J MOL MED, V80, P791, DOI 10.1007/s00109-002-0385-8; Endler G, 2001, BRIT J HAEMATOL, V115, P1007, DOI 10.1046/j.1365-2141.2001.03201.x; Eriksson AL, 2004, EUR HEART J, V25, P386, DOI 10.1016/j.ehj.2003.12.026; Fatini C, 2000, EUR HEART J, V21, P633, DOI 10.1053/euhj.1999.1738; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Funk M, 2004, CLIN CHEM, V50, P2395, DOI 10.1373/clinchem.2004.038034; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gardemann A, 1999, ATHEROSCLEROSIS, V145, P315, DOI 10.1016/S0021-9150(99)00083-0; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Gauderman WJ, 2003, GENET EPIDEMIOL, V25, P327, DOI 10.1002/gepi.10262; Georges JL, 2001, J MOL MED, V79, P300, DOI 10.1007/s001090100209; Girelli D, 2000, NEW ENGL J MED, V343, P774, DOI 10.1056/NEJM200009143431104; Gonzalez P, 2001, GENES IMMUN, V2, P191, DOI 10.1038/sj.gene.6363760; Gonzalez-Conejero R, 2002, BLOOD, V100, P2081, DOI 10.1182/blood.V100.6.2081.h81802002081_2081_2086; Gruchala M, 2003, AM HEART J, V145, P125, DOI 10.1067/mhj.2003.52; Hautanen A, 1999, CIRCULATION, V100, P2213, DOI 10.1161/01.CIR.100.22.2213; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Herrmann SM, 2000, ARTERIOSCL THROM VAS, V20, P2386, DOI 10.1161/01.ATV.20.11.2386; Herrmann SM, 1998, HUM MOL GENET, V7, P1277, DOI 10.1093/hmg/7.8.1277; Hetet G, 2001, EUR J CLIN INVEST, V31, P382, DOI 10.1046/j.1365-2362.2001.00829.x; Higashi K, 1997, BIOCHEM BIOPH RES CO, V232, P728, DOI 10.1006/bbrc.1997.6339; Hines LM, 2001, NEW ENGL J MED, V344, P549, DOI 10.1056/NEJM200102223440802; Hokanson JE, 1999, CURR OPIN LIPIDOL, V10, P393, DOI 10.1097/00041433-199910000-00003; Hubacek JA, 1999, CIRCULATION, V99, P3218, DOI 10.1161/01.CIR.99.25.3218; Humphries SE, 2002, ANN HUM GENET, V66, P343, DOI 10.1017/S0003480002001264; Hyndman ME, 2000, AM J CARDIOL, V86, P1144, DOI 10.1016/S0002-9149(00)01177-2; Inoue N, 1998, CIRCULATION, V97, P135, DOI 10.1161/01.CIR.97.2.135; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jenny NS, 2002, ARTERIOSCL THROM VAS, V22, P2066, DOI 10.1161/01.ATV.0000040224.49362.60; Ji JY, 2002, J CARDIOVASC RISK, V9, P105, DOI 10.1097/00043798-200204000-00006; Jiang H, 2002, INT J CARDIOL, V84, P171, DOI 10.1016/S0167-5273(02)00138-9; Juo SHH, 2000, ARTERIOSCL THROM VAS, V20, P1316, DOI 10.1161/01.ATV.20.5.1316; Jurinke C, 2004, MOL BIOTECHNOL, V26, P147, DOI 10.1385/MB:26:2:147; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; Kenny D, 2002, J THROMB THROMBOLYS, V13, P13, DOI 10.1023/A:1015307823578; Klerk M, 2002, JAMA-J AM MED ASSOC, V288, P2023, DOI 10.1001/jama.288.16.2023; Klerkx AHEM, 2003, HUM MOL GENET, V12, P111, DOI 10.1093/hmg/ddg013; Kolek MJ, 2004, AM HEART J, V148, P1034, DOI 10.1016/j.ahj.2004.05.049; Kuivenhoven JA, 1998, NEW ENGL J MED, V338, P86, DOI 10.1056/NEJM199801083380203; Lambert JC, 2000, HUM MOL GENET, V9, P57, DOI 10.1093/hmg/9.1.57; Lamblin N, 2002, J AM COLL CARDIOL, V40, P43, DOI 10.1016/S0735-1097(02)01909-5; Ledmyr H, 2004, CIRCULATION, V109, P2279, DOI 10.1161/01.CIR.0000130070.96758.7b; Lin RCY, 2003, HYPERTENSION, V41, P404, DOI 10.1161/01.HYP.0000055342.40301.DC; Liu SM, 2003, ATHEROSCLEROSIS, V166, P323, DOI 10.1016/S0021-9150(02)00335-0; Lutucuta S, 2001, CIRC RES, V88, P969, DOI 10.1161/hh0901.090301; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; McDermott DH, 2001, CIRC RES, V89, P401, DOI 10.1161/hh1701.095642; Moatti D, 1999, ARTERIOSCL THROM VAS, V19, P862, DOI 10.1161/01.ATV.19.4.862; Momiyama Y, 2001, J AM COLL CARDIOL, V38, P712, DOI 10.1016/S0735-1097(01)01438-3; Morgan TM, 2003, CLIN GENET, V64, P7, DOI 10.1034/j.1399-0004.2003.00088.x; Niessner A, 2005, THROMB HAEMOSTASIS, V93, P949, DOI 10.1160/TH04-11-0735; Ortlepp JR, 2003, J MOL MED-JMM, V81, P363, DOI 10.1007/s00109-003-0435-x; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Padovani JC, 2000, THROMB RES, V100, P263, DOI 10.1016/S0049-3848(00)00315-7; Patel S, 2000, AM J HYPERTENS, V13, P134, DOI 10.1016/S0895-7061(99)00176-4; Poirier O, 2004, EUR J HUM GENET, V12, P213, DOI 10.1038/sj.ejhg.5201143; Reguero JR, 1998, CARDIOLOGY, V90, P231, DOI 10.1159/000006849; Ridker PM, 2003, ARTERIOSCL THROM VAS, V23, P859, DOI 10.1161/01.ATV.0000068680.19521.34; Rosendaal FR, 1997, BLOOD, V90, P1747, DOI 10.1182/blood.V90.5.1747; Salanti G, 2005, GENET MED, V7, P13, DOI 10.1097/01.GIM.0000151839.12032.1A; Samara WM, 2003, CORONARY ARTERY DIS, V14, P65, DOI 10.1097/00019501-200302000-00008; Sanghera DK, 1998, AM J HUM GENET, V62, P36, DOI 10.1086/301669; Santoso S, 1999, BLOOD, V93, P2449, DOI 10.1182/blood.V93.8.2449.408k34_2449_2453; Scheuner MT, 2004, PRIMARY CARE, V31, P711, DOI 10.1016/j.pop.2004.04.001; Schuit SCE, 2004, JAMA-J AM MED ASSOC, V291, P2969, DOI 10.1001/jama.291.24.2969; Schulz Susanne, 2002, Hum Mutat, V20, P404, DOI 10.1002/humu.9070; Sethi AA, 2003, ARTERIOSCL THROM VAS, V23, P1269, DOI 10.1161/01.ATV.0000079007.40884.5C; Shearman AM, 2003, JAMA-J AM MED ASSOC, V290, P2263, DOI 10.1001/jama.290.17.2263; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tatsuguchi M, 2003, BIOCHEM BIOPH RES CO, V303, P247, DOI 10.1016/S0006-291X(03)00326-7; Tobin MD, 2004, EUR HEART J, V25, P459, DOI 10.1016/j.ehj.2003.11.014; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910; Tregouet DA, 2004, ARTERIOSCL THROM VAS, V24, P775, DOI 10.1161/01.ATV.0000121573.29550.1a; Wang XL, 1996, J CLIN INVEST, V98, P372, DOI 10.1172/JCI118802; Watkins H, 2004, EUR J HUM GENET, V12, P770, DOI 10.1038/sj.ejhg.5201244; Webb KE, 2001, ATHEROSCLEROSIS, V154, P703, DOI 10.1016/S0021-9150(00)00633-X; Weng L, 2005, J CLIN INVEST, V115, P1016, DOI 10.1172/JCI24186; Wenzel K, 1999, Hum Mutat, V14, P545, DOI 10.1002/(SICI)1098-1004(199912)14:6<545::AID-HUMU20>3.0.CO;2-5; Wilson PWF, 1996, ARTERIOSCL THROM VAS, V16, P1250, DOI 10.1161/01.ATV.16.10.1250; Wu KK, 2001, CIRCULATION, V103, P1386, DOI 10.1161/01.CIR.103.10.1386; Yamada S, 2000, ATHEROSCLEROSIS, V150, P143, DOI 10.1016/S0021-9150(99)00356-1; Yamada Y, 2002, NEW ENGL J MED, V347, P1916, DOI 10.1056/NEJMoa021445; Yamada Y, 2006, CIRC J, V70, P1240, DOI 10.1253/circj.70.1240; Yan J, 2004, BIOTECHNIQUES, V37, P136, DOI 10.2144/04371DD04; Yasar U, 2003, PHARMACOGENETICS, V13, P715, DOI [10.1097/00008571-200312000-00002, 10.1097/01.fpc.0000054141.14659.28]; Ye L, 1997, AM J MED GENET, V68, P494, DOI 10.1002/(SICI)1096-8628(19970211)68:4<494::AID-AJMG30>3.0.CO;2-L; Zambon A, 2003, CURR OPIN LIPIDOL, V14, P179, DOI 10.1097/00041433-200304000-00010; Zee RYL, 2005, GENETICS, V169, P1583, DOI 10.1534/genetics.104.037812; Zee RYL, 2004, ATHEROSCLEROSIS, V175, P91, DOI 10.1016/j.atherosclerosis.2004.01.042; Zwarts KY, 2002, CLIN GENET, V61, P115, DOI 10.1034/j.1399-0004.2002.610206.x	109	223	234	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2007	297	14					1551	1561		10.1001/jama.297.14.1551	http://dx.doi.org/10.1001/jama.297.14.1551			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155PG	17426274	Bronze			2022-12-28	WOS:000245589800023
J	Voltarelli, JC; Couri, CEB; Stracieri, ABPL; Oliveira, MC; Moraes, DA; Pieroni, F; Coutinho, M; Malmegrim, KCR; Foss-Freitas, MC; Simoes, BP; Foss, MC; Squiers, E; Burt, RK				Voltarelli, Julio C.; Couri, Carlos E. B.; Stracieri, Ana B. P. L.; Oliveira, Maria C.; Moraes, Daniela A.; Pieroni, Fabiano; Coutinho, Marina; Malmegrim, Kelen C. R.; Foss-Freitas, Maria C.; Simoes, Belinda P.; Foss, Milton C.; Squiers, Elizabeth; Burt, Richard K.			Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOUBLE-BLIND; COMPLICATIONS; AZATHIOPRINE; THERAPY	Context Type 1 diabetes mellitus (DM) results from a cell-mediated autoimmune attack against pancreatic beta cells. Previous animal and clinical studies suggest that moderate immunosuppression in newly diagnosed type 1 DM can prevent further loss of insulin production and can reduce insulin needs. Objective To determine the safety and metabolic effects of high-dose immunosuppression followed by autologous nonmyeloablative hematopoietic stem cell transplantation (AHST) in newly diagnosed type 1 DM. Design, Setting, and Participants A prospective phase 1/2 study of 15 patients with type 1 DM ( aged 14-31 years) diagnosed within the previous 6 weeks by clinical findings and hyperglycemia and confirmed with positive antibodies against glutamic acid decarboxylase. Enrollment was November 2003-July 2006 with observation until February 2007 at the Bone Marrow Transplantation Unit of the School of Medicine of Ribeirao Preto, Ribeirao Preto, Brazil. Patients with previous diabetic ketoacidosis were excluded after the first patient with diabetic ketoacidosis failed to benefit from AHST. Hematopoietic stem cells were mobilized with cyclophosphamide ( 2.0 g/m(2)) and granulocyte colony-stimulating factor ( 10 mu g/kg per day) and then collected from peripheral blood by leukapheresis and cryopreserved. The cells were injected intravenously after conditioning with cyclophosphamide ( 200 mg/kg) and rabbit antithymocyte globulin (4.5 mg/kg). Main Outcome Measures Morbidity and mortality from transplantation and temporal changes in exogenous insulin requirements ( daily dose and duration of usage). Secondary end points: serum levels of hemoglobin A(1c), C-peptide levels during the mixed-meal tolerance test, and anti - glutamic acid decarboxylase antibody titers measured before and at different times following AHST. Results During a 7- to 36-month follow-up ( mean 18.8), 14 patients became insulin-free ( 1 for 35 months, 4 for at least 21 months, 7 for at least 6 months; and 2 with late response were insulin-free for 1 and 5 months, respectively). Among those, 1 patient resumed insulin use 1 year after AHST. At 6 months after AHST, mean total area under the C-peptide response curve was significantly greater than the pretreatment values, and at 12 and 24 months it did not change. Anti - glutamic acid decarboxylase antibody levels decreased after 6 months and stabilized at 12 and 24 months. Serum levels of hemoglobin A1c were maintained at less than 7% in 13 of 14 patients. The only acute severe adverse effect was culture-negative bilateral pneumonia in 1 patient and late endocrine dysfunction ( hypothyroidism or hypogonadism) in 2 others. There was no mortality. Conclusions High-dose immunosuppression and AHST were performed with acceptable toxicity in a small number of patients with newly diagnosed type 1 DM. With AHST, beta cell function was increased in all but 1 patient and induced prolonged insulin independence in the majority of the patients.	Univ Sao Paulo, Dept Clin Med, Sch Med, BR-14049 Ribeirao Preto, Brazil; Ys Therapeut Inc, Burlingame, CA USA; Northwestern Univ, Div Immunotherapy, Chicago, IL 60611 USA	Universidade de Sao Paulo; Northwestern University	Voltarelli, JC (corresponding author), Reg Blood Ctr Hemoctr, Campus USP, BR-14051140 Ribeirao Preto, Brazil.	jcvoltar@fmrp.usp.br	Malmegrim, Kelen/H-1016-2015; Rodrigues, Maria Carolina Oliveira/A-2302-2012; Foss-Freitas, Maria/AAV-5971-2021; Malmegrim, Kelen/B-8514-2012; SIMOES, BELINDA/A-1896-2014; Simoes, Belinda P/M-7469-2016; Foss-Freitas, Maria C/F-1197-2013	Malmegrim, Kelen/0000-0002-9303-0086; Rodrigues, Maria Carolina Oliveira/0000-0003-0691-2222; Foss-Freitas, Maria/0000-0002-1350-1125; SIMOES, BELINDA/0000-0003-4508-8934; Foss-Freitas, Maria C/0000-0002-1350-1125; Burt, Richard K/0000-0002-0922-4145				American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; Au WY, 2005, BONE MARROW TRANSPL, V35, P383, DOI 10.1038/sj.bmt.1704766; Burt RK, 2006, JAMA-J AM MED ASSOC, V295, P527, DOI 10.1001/jama.295.5.527; Burt RK, 2002, BLOOD, V99, P768, DOI 10.1182/blood.V99.3.768; *CAN EUR RAND CONT, 1988, DIABETES, V37, P1574; COOK JJ, 1989, DIABETES, V38, P779, DOI 10.2337/diabetes.38.6.779; Couri CEB, 2006, BRAZ J MED BIOL RES, V39, P1271, DOI 10.1590/S0100-879X2006005000010; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Eisenbarth GS, 2004, NEW ENGL J MED, V350, P2068, DOI 10.1056/NEJMra030158; ELLIOTT RB, 1981, LANCET, V2, P631; HARRISON LC, 1985, DIABETES, V34, P1306, DOI 10.2337/diabetes.34.12.1306; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Hussain MA, 2004, LANCET, V364, P203, DOI 10.1016/S0140-6736(04)16635-X; Kang EM, 2005, EXP HEMATOL, V33, P699, DOI 10.1016/j.exphem.2005.03.008; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Muraro PA, 2005, J EXP MED, V201, P805, DOI 10.1084/jem.20041679; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; Nelson JL, 1997, J RHEUMATOL, V24, P23; Notkins AL, 2001, J CLIN INVEST, V108, P1247, DOI 10.1172/JCI200114257; Raz I, 2001, LANCET, V358, P1749, DOI 10.1016/S0140-6736(01)06801-5; Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O; Saudek Frantisek, 2004, Rev Diabet Stud, V1, P80, DOI 10.1900/RDS.2004.1.80; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SILVERSTEIN J, 1988, NEW ENGL J MED, V319, P599, DOI 10.1056/NEJM198809083191002; Sosenko JM, 2004, DIABETES, V53, pA425; Steffes MW, 2003, DIABETES CARE, V26, P832, DOI 10.2337/diacare.26.3.832; Weinhaus AJ, 2000, ENDOCRINOLOGY, V141, P1384, DOI 10.1210/en.141.4.1384	27	397	454	0	50	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2007	297	14					1568	1576		10.1001/jama.297.14.1568	http://dx.doi.org/10.1001/jama.297.14.1568			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155PG	17426276				2022-12-28	WOS:000245589800025
J	Roberts, H				Roberts, Helen			Managing the menopause	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ESTROGEN PLUS PROGESTIN; CONJUGATED EQUINE ESTROGENS; MILD COGNITIVE IMPAIRMENT; POSTMENOPAUSAL WOMEN; BREAST-CANCER; HORMONE-THERAPY; MAMMOGRAPHY; DEMENTIA; RISK		Univ Auckland, Dept Obstet & Gynaecol, Auckland 1, New Zealand	University of Auckland	Roberts, H (corresponding author), Univ Auckland, Dept Obstet & Gynaecol, Private Bag 92019, Auckland 1, New Zealand.	h.roberts@auckland.ac.nz		Roberts, Helen/0000-0002-8107-5746				Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Boothby LA, 2004, MENOPAUSE, V11, P356, DOI 10.1097/01.GME.0000094356.92081.EF; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Cirillo DJ, 2005, JAMA-J AM MED ASSOC, V293, P330, DOI 10.1001/jama.293.3.330; Col NF, 2005, AM J MED, V118, P1411, DOI 10.1016/j.amjmed.2005.10.027; Curb JD, 2006, ARCH INTERN MED, V166, P772, DOI 10.1001/archinte.166.7.772; Cushman M, 2004, JAMA-J AM MED ASSOC, V292, P1573, DOI 10.1001/jama.292.13.1573; Farquhar CM, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004143.pub2, 10.1002/14651858.CD003139.pub2, 10.1002/14651858.CD001122.pub2, 10.1002/14651858.CD003142.pub2]; Grady D, 2005, AM J MED, V118, P1411, DOI 10.1016/j.amjmed.2005.10.028; Hickey M, 2005, LANCET, V366, P409, DOI 10.1016/S0140-6736(05)66519-1; Holmberg L, 2004, LANCET, V363, P453, DOI 10.1016/S0140-6736(04)15493-7; Hsia J, 2006, ARCH INTERN MED, V166, P357, DOI 10.1001/archinte.166.3.357; Kenemans P, 2005, MATURITAS, V51, P21, DOI 10.1016/j.maturitas.2005.02.011; LaCroix Andrea Z, 2005, Am J Med, V118 Suppl 12B, P79, DOI 10.1016/j.amjmed.2005.09.039; MACLENNAN AH, 2002, COCHRANE DB SYST REV, V1; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Mom CH, 2006, CRIT REV ONCOL HEMAT, V57, P63, DOI 10.1016/j.critrevonc.2005.04.009; *N AM MEN SOC, 2006, MENOPAUSE, V13, P348; Naftolin F, 2005, MATURITAS, V51, P15, DOI 10.1016/j.maturitas.2005.02.007; Nelson HD, 2006, JAMA-J AM MED ASSOC, V295, P2057, DOI 10.1001/jama.295.17.2057; NIH, 2005, NIH STAT SCI C STAT; *NZ GUID GROUP, 2004, HORM REPL THER SUMM; Roberts HE, 2006, AUST NZ J OBSTET GYN, V46, P74, DOI 10.1111/j.1479-828X.2006.00563.x; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; *ROYAL COLL OBST G, 2006, ALT HRT MAN SYMPT ME; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Skouby SO, 2005, MATURITAS, V51, P8, DOI 10.1016/j.maturitas.2005.02.019; Stefanick ML, 2006, JAMA-J AM MED ASSOC, V295, P1647, DOI 10.1001/jama.295.14.1647; Wierman ME, 2006, J CLIN ENDOCR METAB, V91, P3697, DOI 10.1210/jc.2006-1121; Woods NF, 2005, AM J MED, V118, P1405, DOI 10.1016/j.amjmed.2005.10.008; 2006, J OBSTET GYNAECOL CA, V172, pS95	32	25	27	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2007	334	7596					736	741		10.1136/bmj.39153.522535.BE	http://dx.doi.org/10.1136/bmj.39153.522535.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AO	17413174	Green Published			2022-12-28	WOS:000245763300031
J	Wilcken, B; Gaskin, K				Wilcken, Bridget; Gaskin, Kevin			More evidence to favour newborn screening for cystic fibrosis	LANCET			English	Editorial Material							EARLY-DIAGNOSIS; OUTCOMES		Childrens Hosp, Westmead, NSW 2145, Australia; Univ Sydney, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Wilcken, B (corresponding author), Childrens Hosp, Westmead, NSW 2145, Australia.	bridgetw@chw.edu.au						ABMAN SH, 1985, J PEDIATR-US, V107, P933, DOI 10.1016/S0022-3476(85)80194-3; CHATFIELD S, 1991, ARCH DIS CHILD-FETAL, V66, P29, DOI 10.1136/adc.66.1_Spec_No.29; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; Farrell PM, 2001, PEDIATRICS, V107, P1, DOI 10.1542/peds.107.1.1; Grosse SD, 2001, PEDIATRICS, V107, P1492, DOI 10.1542/peds.107.6.1492; Koscik RL, 2005, J PEDIATR-US, V147, pS51, DOI 10.1016/j.jpeds.2005.08.003; McKay KO, 2005, J PEDIATR-US, V147, pS47, DOI 10.1016/j.jpeds.2005.08.013; NAZER HM, 1992, J TROP PEDIATRICS, V38, P113, DOI 10.1093/tropej/38.3.113; ROCK MJ, 1990, PEDIATRICS, V85, P1001; ROSENBERG MA, J PEDIAT S3, V147, pS101; Schmidt DR, 2006, ARCH DIS CHILD, V91, P661, DOI 10.1136/adc.2004.066514; Sims EJ, 2007, LANCET, V369, P1187, DOI 10.1016/S0140-6736(07)60565-0; Southern KW, 2007, J CYST FIBROS, V6, P57, DOI 10.1016/j.jcf.2006.05.008; *US NAT NEWB SCREE, NAT NEWB SCREEN STAT; WILCKEN B, 1985, LANCET, V2, P1319	15	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2007	369	9568					1146	1147		10.1016/S0140-6736(07)60540-6	http://dx.doi.org/10.1016/S0140-6736(07)60540-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155RH	17416243				2022-12-28	WOS:000245595100006
J	Brandes, JL; Kudrow, D; Stark, SR; O'Carroll, CP; Adelman, JU; O'Donnell, FJ; Alexander, WJ; Spruill, SE; Barrett, PS; Lener, SE				Brandes, Jan Lewis; Kudrow, David; Stark, Stuart R.; O'Carroll, C. Phillip; Adelman, James U.; O'Donnell, Francis J.; Alexander, W. James; Spruill, Susan E.; Barrett, Pamela S.; Lener, Shelly E.			Sumatriptan-naproxen for acute treatment of migraine - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CENTRAL SENSITIZATION; RELEASE FORMULATION; ERGOTAMINE TARTRATE; SODIUM; PAIN; TRIPTANS; THERAPY; PATHOPHYSIOLOGY; TOLERABILITY; RIZATRIPTAN	Context Multiple pathogenic mechanisms may be involved in generating the migraine symptom complex, and multimechanism-targeted therapy may confer advantages over monotherapy. Objective To evaluate the efficacy and safety of a fixed-dose tablet containing sumatriptan succinate and naproxen sodium relative to efficacy and safety of each monotherapy and placebo for the acute treatment of migraine. Design, Setting, and Participants Two replicate, randomized, double-blind, single-attack, parallel-group studies conducted among 1461 ( study 1) and 1495 ( study 2) patients at 118 US clinical centers who were diagnosed as having migraine and received study treatment for a moderate or severe migraine attack. Interventions Patients were randomized in a 1: 1: 1: 1 ratio to receive a single tablet containing sumatriptan, 85 mg, and naproxen sodium, 500 mg; sumatriptan, 85 mg ( monotherapy); naproxen sodium, 500 mg ( monotherapy); or placebo, to be used after onset of a migraine with moderate to severe pain. Main Outcome Measures Primary outcome measures included the percentages of patients with headache relief 2 hours after dosing, absence of photophobia, absence of phonophobia, and absence of nausea for the comparison between sumatriptan - naproxen sodium and placebo, and the percentages of patients with sustained pain-free response for the comparison between sumatriptan - naproxen sodium and each monotherapy. Results Sumatriptan - naproxen sodium was more effective than placebo for headache relief at 2 hours after dosing ( study 1, 65% vs 28%; P <. 001 and study 2, 57% vs 29%; P <. 001), absence of photophobia at 2 hours (58% vs 26%; P <. 001 and 50% vs 32%; P <. 001), and absence of phonophobia at 2 hours(61% vs 38%; P <. 001 and 56% vs 34%; P <. 001). The absence of nausea 2 hours after dosing was higher with sumatriptan - naproxen sodium than placebo in study 1 (71% vs 65%; P=. 007), but in study 2 rates of absence of nausea did not differ between sumatriptan - naproxen sodium and placebo ( 65% vs 64%; P=. 71). For 2- to 24-hour sustained pain-free response, sumatriptan - naproxen sodium was superior at P <. 01(25% and 23% in studies 1 and 2, respectively) to sumatriptan monotherapy( 16% and 14% in studies 1 and 2), naproxen sodium monotherapy(10% and 10% in studies 1 and 2), and placebo (8% and 7% in studies 1 and 2). The incidence of adverse events was similar between sumatriptan - naproxen sodium and sumatriptan monotherapy. Conclusion Sumatriptan, 85 mg, plus naproxen sodium, 500 mg, as a single tablet for acute treatment of migraine resulted in more favorable clinical benefits compared with either monotherapy, with an acceptable and well-tolerated adverse effect profile.	Nashville Neurosci Grp, Nashville, TN 37203 USA; Calif Med Clin Headache, Santa Monica, CA USA; Innovat Clin Res Ctr, Alexandria, VA USA; Headache Inst, Newport Beach, CA USA; Headache Wellness Ctr, Greensboro, NC USA; OrthoNeuro, Columbus, OH USA; Pozen Inc, Chapel Hill, NC USA; GlaxoSmithKline, Res Triangle Pk, NC USA	POZEN Inc.; GlaxoSmithKline	Brandes, JL (corresponding author), Nashville Neurosci Grp, 300 20th Ave N,603, Nashville, TN 37203 USA.	jbrandes@nashvilleneuroscience.com						Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N; Burstein R, 2004, ANN NEUROL, V55, P19, DOI 10.1002/ana.10786; Burstein R, 2000, BRAIN, V123, P1703, DOI 10.1093/brain/123.8.1703; Burstein R, 2006, NEUROLOGY, V66, pA69; Burstein R, 2005, NEUROLOGY, V64, pS16, DOI 10.1212/WNL.64.10_suppl_2.S16; Burstein R, 2004, ANN NEUROL, V55, P27, DOI 10.1002/ana.10785; Burstein R, 2001, PAIN, V89, P107, DOI 10.1016/S0304-3959(00)00478-4; Carpay J, 2004, CLIN THER, V26, P214, DOI 10.1016/S0149-2918(04)90020-3; Cipolla G, 2001, PHARMACOL RES, V43, P205, DOI 10.1006/phrs.2000.0766; Ferrari MD, 2001, LANCET, V358, P1668, DOI 10.1016/S0140-6736(01)06711-3; Gendolla A, 2005, CURR MED RES OPIN, V21, pS3, DOI 10.1185/030079905X46269; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; Goadsby PJ, 1997, NEUROL CLIN, V15, P27, DOI 10.1016/S0733-8619(05)70293-0; Hargreaves RJ, 1999, CAN J NEUROL SCI, V26, pS12, DOI 10.1017/S0317167100000147; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hochberg Y., 1987, MULTIPLE COMP PROCED; HOLLAND BS, 1987, BIOMETRICS, V43, P417, DOI 10.2307/2531823; HOLM S, 1979, SCAND J STAT, V6, P65; HOUGHTON LA, 1992, ALIMENT PHARM THERAP, V6, P685; Jakubowski M, 2005, HEADACHE, V45, P850, DOI 10.1111/j.1526-4610.2005.05153.x; Kori S, 2005, CEPHALALGIA, V25, P933; Krymchantowski AV, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-10; Krymchantowski AV, 2000, ARQ NEURO-PSIQUIAT, V58, P428, DOI 10.1590/S0004-282X2000000300006; Krymchantowski AV, 2002, CEPHALALGIA, V22, P309, DOI 10.1046/j.1468-2982.2002.00369.x; Lipton RB, 2005, AM J MED, V118, p3S, DOI 10.1016/j.amjmed.2005.01.014; Lipton RB, 2002, HEADACHE, V42, pS3, DOI 10.1046/j.1526-4610.2002.0420s1003.x; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; MOSKOWITZ MA, 1993, ANNU REV MED, V44, P145, DOI 10.1146/annurev.med.44.1.145; PRADALIER A, 1985, CEPHALALGIA, V5, P107, DOI 10.1046/j.1468-2982.1985.0502107.x; *ROCH LAB INC, 2006, NAPR COMPL PRESCR IN; SHAFFER JP, 1986, J AM STAT ASSOC, V81, P826, DOI 10.2307/2289016; Sheftell FD, 2005, CLIN THER, V27, P407, DOI 10.1016/j.clinthera.2005.04.003; Smith TR, 2005, HEADACHE, V45, P983, DOI 10.1111/j.1526-4610.2005.05178.x; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; TREVES TA, 1992, HEADACHE, V32, P280, DOI 10.1111/j.1526-4610.1992.hed3206280.x; Watkins LR, 2003, ADV EXP MED BIOL, V521, P1; Winner P, 2007, MAYO CLIN PROC, V82, P61; Yarnitsky D, 2003, HEADACHE, V43, P704, DOI 10.1046/j.1526-4610.2003.03127.x	38	182	186	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2007	297	13					1443	1454		10.1001/jama.297.13.1443	http://dx.doi.org/10.1001/jama.297.13.1443			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AM	17405970	Bronze			2022-12-28	WOS:000245404100021
J	Deer, B				Deer, Brian			What makes an expert?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												bd@briandeer.com						Geier DA, 2005, MED SCI MONITOR, V11, pCR160; GEIER DA, 2006, AUTOIMMUN REV, DOI DOI 10.1016/J.AUTREV.2006.09.014; Geier M.R., 2007, LANCET NEUROL, V6, P212; SIEDEL K, 2006, SIGNIFICANT MISREP 1; SIEDEL K, 2007, SIGNIFICANT MISRE 13; SIEDEL K, 2006, SIGNIFICANT MISREP 8	6	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2007	334	7595					666	667		10.1136/bmj.39146.498785.BE	http://dx.doi.org/10.1136/bmj.39146.498785.BE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154ON	17395945	Green Published			2022-12-28	WOS:000245517100029
J	Heath, I				Heath, Iona			The growing gap	BRITISH MEDICAL JOURNAL			English	Editorial Material												iona.heath@dst.pipex.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 31	2007	334	7595					670	670		10.1136/bmj.39164.469815.47	http://dx.doi.org/10.1136/bmj.39164.469815.47			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154ON	17395947	Green Published			2022-12-28	WOS:000245517100031
J	Yin, H; Slusky, JS; Berger, BW; Walters, RS; Vilaire, G; Litvinov, RI; Lear, JD; Caputo, GA; Bennett, JS; DeGrado, WF				Yin, Hang; Slusky, Joanna S.; Berger, Bryan W.; Walters, Robin S.; Vilaire, Gaston; Litvinov, Rustem I.; Lear, James D.; Caputo, Gregory A.; Bennett, Joel S.; DeGrado, William F.			Computational design of peptides that target transmembrane helices	SCIENCE			English	Article							MEMBRANE-PROTEINS; INTEGRIN ACTIVATION; ESCHERICHIA-COLI; DOMAIN; BINDING; RECEPTOR; MOTIFS; AFFINITY; STATE; HETERODIMERIZATION	A variety of methods exist for the design or selection of antibodies and other proteins that recognize the water-soluble regions of proteins; however, companion methods for targeting transmembrane (TM) regions are not available. Here, we describe a method for the computational design of peptides that target TM helices in a sequence-specific manner. To illustrate the method, peptides were designed that specifically recognize the TM helices of two closely related integrins (alpha(IIb)beta(3) and alpha(v)beta(3)) in micelles, bacterial membranes, and mammalian cells. These data show that sequence-specific recognition of helices in TM proteins can be achieved through optimization of the geometric complementarity of the target-host complex.	Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	DeGrado, WF (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	wdegrado@mail.med.upenn.edu	Berger, Bryan/D-7985-2014; YIN, HANG/O-2097-2014; Litvinov, Rustem/E-5291-2011	Berger, Bryan/0000-0002-6135-8677; YIN, HANG/0000-0002-9762-4818; Litvinov, Rustem/0000-0003-0643-1496; Caputo, Gregory/0000-0002-4510-2815; Slusky, Joanna/0000-0003-0842-6340	NATIONAL CANCER INSTITUTE [T32CA101968] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL040387, P50HL054500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054616, T32GM008275, R01GM054616, R01GM060610] Funding Source: NIH RePORTER; NCI NIH HHS [5T32 CA101968] Funding Source: Medline; NHLBI NIH HHS [HL54500, HL40387, P01 HL040387] Funding Source: Medline; NIGMS NIH HHS [GM54616, 5T32 GM08275, GM60610, T32 GM008275] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamian L, 2002, PROTEINS, V47, P209, DOI 10.1002/prot.10071; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; Binz HK, 2005, CURR OPIN BIOTECH, V16, P459, DOI 10.1016/j.copbio.2005.06.005; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; DESJARLAIS JR, 1995, PROTEIN SCI, V4, P2006, DOI 10.1002/pro.5560041006; Doura AK, 2004, J MOL BIOL, V343, P1487, DOI 10.1016/j.jmb.2004.09.011; Ebie AZ, 2007, J MOL BIOL, V366, P517, DOI 10.1016/j.jmb.2006.11.035; Engelman DM, 2003, FEBS LETT, V555, P122, DOI 10.1016/S0014-5793(03)01106-2; FAIRMAN R, 1993, P NATL ACAD SCI USA, V90, P10429, DOI 10.1073/pnas.90.22.10429; Freeman-Cook LL, 2004, J MOL BIOL, V338, P907, DOI 10.1016/j.jmb.2004.03.044; Gerber D, 2005, FASEB J, V19, P1190, DOI 10.1096/fj.04-3498fje; Gerber D, 2004, J BIOL CHEM, V279, P21177, DOI 10.1074/jbc.M400847200; Gerber D, 2004, J MOL BIOL, V339, P243, DOI 10.1016/j.jmb.2004.03.004; Ghirlanda G, 1998, J MOL BIOL, V281, P379, DOI 10.1006/jmbi.1998.1912; Gottschalk KE, 2005, STRUCTURE, V13, P703, DOI 10.1016/j.str.2005.02.014; Harris JM, 2001, CLIN PHARMACOKINET, V40, P539, DOI 10.2165/00003088-200140070-00005; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kim S, 2005, P NATL ACAD SCI USA, V102, P14278, DOI 10.1073/pnas.0501234102; Kortemme T, 2004, CURR OPIN CHEM BIOL, V8, P91, DOI 10.1016/j.cbpa.2003.12.008; Langosch D, 1996, J MOL BIOL, V263, P525, DOI 10.1006/jmbi.1996.0595; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; Litvinov RI, 2003, J BIOL CHEM, V278, P51285, DOI 10.1074/jbc.M304581200; Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Manolios N, 1997, NAT MED, V3, P84, DOI 10.1038/nm0197-84; Partridge AW, 2005, J BIOL CHEM, V280, P7294, DOI 10.1074/jbc.M412701200; Partridge AW, 2003, J BIOL CHEM, V278, P22056, DOI 10.1074/jbc.M210685200; Reina J, 2002, NAT STRUCT BIOL, V9, P621, DOI 10.1038/nsb815; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; Senes A, 2007, J MOL BIOL, V366, P436, DOI 10.1016/j.jmb.2006.09.020; Shifman JM, 2003, P NATL ACAD SCI USA, V100, P13274, DOI 10.1073/pnas.2234277100; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Winter G, 1998, FEBS LETT, V430, P92, DOI 10.1016/S0014-5793(98)00628-0; Yin H, 2006, J BIOL CHEM, V281, P36732, DOI 10.1074/jbc.M605877200	43	232	238	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2007	315	5820					1817	1822		10.1126/science.1136782	http://dx.doi.org/10.1126/science.1136782			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395823				2022-12-28	WOS:000245280100035
J	Gheorghiade, M; Konstam, MA; Burnett, JC; Grinfeld, L; Maggioni, AP; Swedberg, K; Udelson, JE; Zannad, F; Cook, T; Ouyang, J; Zimmer, C; Orlandi, C				Gheorghiade, Mihai; Konstam, Marvin A.; Burnett, John C., Jr.; Grinfeld, Liliana; Maggioni, Aldo P.; Swedberg, Karl; Udelson, James E.; Zannad, Faiez; Cook, Thomas; Ouyang, John; Zimmer, Christopher; Orlandi, Cesare		EVEREST Investigators	Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure - The EVEREST clinical status trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOUBLE-BLIND; RATIONALE; NESIRITIDE; MILRINONE; OUTCOMES; PROGRAM; DESIGN; RISK	Context Heart failure causes more than 1 million US hospitalizations yearly, mostly related to congestion. Tolvaptan, an oral, nonpeptide, selective vasopressin V-2-receptor antagonist, shows promise in this condition. Objective To evaluate short-term effects of tolvaptan when added to standard therapy in patients hospitalized with heart failure. Design, Setting, and Patients Two identical prospective, randomized, double-blind, placebo-controlled trials at 359 sites in North America, South America, and Europe were conducted during the inpatient period of the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) between October 7, 2003, and February 3, 2006. A total of 2048 (trial A) and 2085 (trial B) patients hospitalized with heart failure and congestion were studied. Intervention Patients were randomized to receive either tolvaptan (30 mg/d) or matching placebo, within 48 hours of admission. Main Outcome Measures Primary end point was a composite of changes in global clinical status based on a visual analog scale and body weight at day 7 or discharge if earlier. Secondary end points included dyspnea (day 1), global clinical status (day 7 or discharge), body weight (days 1 and 7 or discharge), and peripheral edema (day 7 or discharge). Results Rank sum analysis of the composite primary end point showed greater improvement with tolvaptan vs placebo (trial A, mean [SD], 1.06 [0.43] vs 0.99 [0.44]; and trial B, 1.07 [0.42] vs 0.97 [0.43]; both trials P < .001). Mean (SD) body weight reduction was greater with tolvaptan on day 1 (trial A, 1.71 [1.80] vs 0.99 [ 1.83] kg; P < .001; and trial B, 1.82 [2.01] vs 0.95 [1.85] kg; P < .001) and day 7 or discharge (trial A, 3.35 [3.27] vs 2.73 [3.34] kg; P < .001; and trial B, 3.77 [3.59] vs 2.79 [3.46] kg; P < .001), whereas improvements in global clinical status were not different between groups. More patients receiving tolvaptan (684 [76.7%] and 678 [72.1%] for trial A and trial B, respectively) vs patients receiving placebo (646 [70.6%] and 597 [65.3%], respectively) reported improvement in dyspnea at day 1 (both trials P < .001). Edema at day 7 or discharge improved significantly with tolvaptan in trial B (P = .02) but did not reach significance in trial A (P = .07). Serious adverse event frequencies were similar between groups, without excess renal failure or hypotension. Conclusion In patients hospitalized with heart failure, oral tolvaptan in addition to standard therapy including diuretics improved many, though not all, heart failure signs and symptoms, without serious adverse events. Trial Registration clinicaltrials.gov Identifier: NCT00071331.	Northwestern Univ, Div Cardiol, Feinberg Sch Med, Chicago, IL 60611 USA; Tufts Univ, New England Med Ctr, Div Cardiol, Boston, MA 02111 USA; Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; Otsuka Maryland Res Inst, Dept Biometr, Rockville, MD USA; Otsuka Maryland Res Inst, Dept Clin Dev, Rockville, MD USA; Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA; Hosp Italiano Buenos Aires, Dept Diag & Tratamiento, Serv Hemodinamia, Buenos Aires, DF, Argentina; Assoc Nazl Med Cardiol Osped Res Ctr, Florence, Italy; Sahlgrens Univ Hosp, S-41345 Gothenburg, Sweden; Ctr Invest Clin, INSERM, Nancy, France	Northwestern University; Feinberg School of Medicine; Tufts Medical Center; Tufts University; Mayo Clinic; University of Wisconsin System; University of Wisconsin Madison; Hospital Italiano de Buenos Aires; University of Buenos Aires; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); Sahlgrenska University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm)	Gheorghiade, M (corresponding author), Northwestern Univ, Div Cardiol, Feinberg Sch Med, Galter 10-240,201 E Huron St, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu	Perna, Eduardo Roque/AAT-6497-2021; Zannad, Faiez/K-4649-2019; Maggioni, Aldo Pietro/AAL-5334-2020; Swedberg, Karl/B-2475-2008; Lowes, Brian/M-9020-2017; Reis, Gilmar/I-4500-2013	Perna, Eduardo Roque/0000-0002-9977-7623; Maggioni, Aldo Pietro/0000-0003-2764-6779; Gabriel, Laurence/0000-0002-0816-2317; Frantz, Robert/0000-0003-4128-3978; Lowes, Brian/0000-0002-5919-2540; Nikita, Perepech/0000-0003-4057-5813; Miyamoto, Michael/0000-0002-8204-2815; Albuquerque, Denilson/0000-0003-1883-6546; Reis, Gilmar/0000-0002-4847-1034				Aaronson KD, 2006, JAMA-J AM MED ASSOC, V296, P1465, DOI 10.1001/jama.296.12.1465; Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Bayram M, 2005, AM J CARDIOL, V96, p47G, DOI 10.1016/j.amjcard.2005.07.021; Cleland JGF, 2006, EUR J HEART FAIL, V8, P105, DOI 10.1016/j.ejheart.2005.12.003; Cleland JGF, 2003, EUR HEART J, V24, P442, DOI 10.1016/S0195-668X(02)00823-0; Cleland JGF, 2006, AM J MED, V119, P26, DOI 10.1016/j.amjmed.2006.09.014; COHN JN, 1982, NEW ENGL J MED, V306, P1129, DOI 10.1056/NEJM198205133061902; Costanzo MR, 2007, J AM COLL CARDIOL, V49, P675, DOI 10.1016/j.jacc.2006.07.073; Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541; De Luca L, 2006, EUR HEART J, V27, P1908, DOI 10.1093/eurheartj/ehi875; Elkayam U, 2004, J CARDIOVASC PHARM T, V9, P227, DOI 10.1177/107424840400900403; Elkayam U, 2007, AM HEART J, V153, P98, DOI 10.1016/j.ahj.2006.09.005; Fonarow GC, 2004, AM HEART J, V148, P43, DOI 10.1016/j.ahj.2004.03.004; Fonarow Gregg C, 2003, Rev Cardiovasc Med, V4 Suppl 7, pS21; Gheorghiade M, 2005, J CARD FAIL, V11, P260, DOI 10.1016/j.cardfail.2005.03.009; Gheorghiade M, 2004, JAMA-J AM MED ASSOC, V291, P1963, DOI 10.1001/jama.291.16.1963; Gheorghiade M, 2005, CIRCULATION, V112, P3958, DOI 10.1161/CIRCULATIONAHA.105.590091; Gheorghiade M, 2003, CIRCULATION, V107, P2690, DOI 10.1161/01.CIR.0000070422.41439.04; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Gheorghiade M, 2006, AM J MED, V119, P3, DOI 10.1016/j.amjmed.2006.09.011; Goldsmith SR, 2005, J AM COLL CARDIOL, V46, P1785, DOI 10.1016/j.jacc.2005.02.095; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Nieminen MS, 2006, EUR HEART J, V27, P2725, DOI 10.1093/eurheartj/ehl193; Nieminen MS, 2005, EUR HEART J, V26, P384; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Sackner-Bernstein JD, 2005, CIRCULATION, V111, P1487, DOI 10.1161/01.CIR.0000159340.93220.E4; SACKNERBERNSTEI.JD, 2005, JAMA-J AM MED ASSOC, V293, P190; Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181; Shin DD, 2007, AM J CARDIOL, V99, p4A, DOI 10.1016/j.amjcard.2006.11.025; Tavazzi L, 2006, EUR HEART J, V27, P1207, DOI 10.1093/eurheartj/ehi845; VANELTEREN P, 1960, B INT STATIST INST, V37, P351; World Medical Association, 2002, J Postgrad Med, V48, P206; Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531, DOI 10.1001/jama.287.12.1531	34	598	635	1	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2007	297	12					1332	1343		10.1001/jama.297.12.1332	http://dx.doi.org/10.1001/jama.297.12.1332			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150JN	17384438	Bronze			2022-12-28	WOS:000245212600020
J	Obot, IS				Obot, Isidore S.			Limits of substance-use interventions in developing countries	LANCET			English	Editorial Material									Morgan State Univ, Sch Publ Hlth & Policy, Dept Behav Hlth Sci, Baltimore, MD 21251 USA	Morgan State University	Obot, IS (corresponding author), Morgan State Univ, Sch Publ Hlth & Policy, Dept Behav Hlth Sci, Baltimore, MD 21251 USA.	isobot@moac.morgan.edu	Obot, Isidore/AAZ-8477-2020	Obot, Isidore/0000-0002-7207-0652				Babor TF, 2003, ALCOHOL NO ORDINARY; Obot I. S., 2005, Substance use among young people in urban environments, P203; Obot IS, 2005, ADDICTION, V100, P1210, DOI 10.1111/j.1360-0443.2005.01156.x; Obot IS, 2004, SUBST USE MISUSE, V39, P1287, DOI 10.1081/JA-120038687; PARRY C.D.H., 2006, AFR J DRUG ALCOHOL S, V5, P41; TOURNBOUROU JW, 2007, LANCET; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	7	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1323	1325		10.1016/S0140-6736(07)60373-0	http://dx.doi.org/10.1016/S0140-6736(07)60373-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	159HL	17448801				2022-12-28	WOS:000245856100006
J	Sykes, NP				Sykes, Nigel P.			Morphine kills the pain, not the patient	LANCET			English	Editorial Material							OPIOID USE; LIFE; END; CANCER		St Christophers Hospice, London SE26 6DZ, England		Sykes, NP (corresponding author), St Christophers Hospice, London SE26 6DZ, England.	n.sykes@stchristophers.org.uk						BILLINGS A, 2007, BBC THOUGHT DAY; *INT NARC CONTR BO, 2006, NARC DRUGS EST WORLD, P109; MORGAN J P, 1985, Advances in Alcohol and Substance Abuse, V5, P163; Morita Tatsuya, 2003, J Palliat Med, V6, P557, DOI 10.1089/109662103768253669; Pargeon KL, 1999, J PAIN SYMPTOM MANAG, V18, P358, DOI 10.1016/S0885-3924(99)00097-4; Portenoy RK, 2006, J PAIN SYMPTOM MANAG, V32, P532, DOI 10.1016/j.jpainsymman.2006.08.003; PORTER J, 1980, NEW ENGL J MED, V302, P123; Regnard C, 2003, PALLIATIVE MED, V17, P714, DOI 10.1191/0269216303pm838cr; Seale C, 2006, PALLIATIVE MED, V20, P3, DOI 10.1191/0269216306pm1094oa; Stjernsward J, 2004, OXFORD TXB PALLIATIV, P1199; Sykes N, 2003, LANCET ONCOL, V4, P312, DOI 10.1016/S1470-2045(03)01079-9; Thorns A, 2000, LANCET, V356, P398, DOI 10.1016/S0140-6736(00)02534-4; WALSH TD, 1984, RECENT RESULTS CANC, V89, P115; *WHO, 1987, CANC PAIN REL	14	15	15	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 21	2007	369	9570					1325	1326		10.1016/S0140-6736(07)60611-4	http://dx.doi.org/10.1016/S0140-6736(07)60611-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	159HL	17448802				2022-12-28	WOS:000245856100007
J	Miller, JS				Miller, Joseph S.			Donald E. Osterbrock (1924-2007) - Astrophysicist and historian of astronomy - Obituary	NATURE			English	Biographical-Item									Univ Calif Santa Cruz, Univ Calif Observ, Lick Observ, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Miller, JS (corresponding author), Univ Calif Santa Cruz, Lick Observ, Santa Cruz, CA 95064 USA.	miller@ucolick.org							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2007	446	7138					870	870		10.1038/446870a	http://dx.doi.org/10.1038/446870a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17443178	Bronze			2022-12-28	WOS:000245785700032
J	Reddy, SK; Rape, M; Margansky, WA; Kirschner, MW				Reddy, S. K.; Rape, M.; Margansky, W. A.; Kirschner, M. W.			Ubiquitination by the anaphase-promoting complex drives spindle checkpoint inactivation	NATURE			English	Article							ASSEMBLY CHECKPOINT; MITOTIC CHECKPOINT; PROTEIN BUBR1; MAD2; ACTIVATION; BINDING; UBCH10; OVEREXPRESSION; INHIBITION; CARCINOMAS	Eukaryotic cells rely on a surveillance mechanism known as the spindle checkpoint to ensure accurate chromosome segregation. The spindle checkpoint prevents sister chromatids from separating until all kinetochores achieve bipolar attachments to the mitotic spindle(1-3). Checkpoint proteins tightly inhibit the anaphase-promoting complex (APC), a ubiquitin ligase required for chromosome segregation and progression to anaphase. Unattached kinetochores promote the binding of checkpoint proteins Mad2 and BubR1 to the APC-activator Cdc20, rendering it unable to activate APC. Once all kinetochores are properly attached, however, cells inactivate the checkpoint within minutes, allowing for the rapid and synchronous segregation of chromosomes(4). How cells switch from strong APC inhibition before kinetochore attachment to rapid APC activation once attachment is complete remains a mystery. Here we show that checkpoint inactivation is an energy-consuming process involving APC-dependent multi-ubiquitination. Multi-ubiquitination by APC leads to the dissociation of Mad2 and BubR1 from Cdc20, a process that is reversed by a Cdc20-directed de-ubiquitinating enzyme(5). The mutual regulation between checkpoint proteins and APC leaves the cell poised for rapid checkpoint inactivation and ensures that chromosome segregation promptly follows the completion of kinetochore attachment. In addition, our results suggest a mechanistic basis for how cancer cells can have a compromised spindle checkpoint without corresponding mutations in checkpoint genes(6).	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Harvard Mit Div Hlth Sci & Technol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	marc@hms.harvard.edu	高, 雨莉/HGU-8187-2022	Rape, Michael/0000-0003-4849-6343				Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Mapelli M, 2006, EMBO J, V25, P1273, DOI 10.1038/sj.emboj.7601033; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Okamoto Y, 2003, CANCER RES, V63, P4167; Pallante P, 2005, BRIT J CANCER, V93, P464, DOI 10.1038/sj.bjc.6602721; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; STEGMEIER F, IN PRESS NATURE; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Tao WK, 2005, CANCER CELL, V8, P49, DOI 10.1016/j.ccr.2005.06.003; Wagner KW, 2004, ONCOGENE, V23, P6621, DOI 10.1038/sj.onc.1207861; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yu HT, 2006, J CELL BIOL, V173, P153, DOI 10.1083/jcb.200601172; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4	22	274	284	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2007	446	7138					921	925		10.1038/nature05734	http://dx.doi.org/10.1038/nature05734			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158IR	17443186				2022-12-28	WOS:000245785700044
J	Hochman, JS; Alexander, JH; Reynolds, HR; Stebbins, AL; Dzavik, V; Harrington, RA; de Werf, FV				Hochman, Judith S.; Alexander, John H.; Reynolds, Harmony R.; Stebbins, Amanda L.; Dzavik, Vladimir; Harrington, Robert A.; de Werf, Frans Van		TRIUMPH Investigators	Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock - The TRIUMPH randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS CORONARY INTERVENTION; CARDIOVASCULAR CLINICAL-TRIALS; OXIDE SYNTHASE INHIBITOR; ST-SEGMENT ELEVATION; NITRIC-OXIDE; HEART-FAILURE; COMMA TRIAL; MORTALITY; REVASCULARIZATION; PEXELIZUMAB	Context Cardiogenic shock complicating acute myocardial infarction (MI) remains a common and lethal disorder despite aggressive use of early revascularization. Systemic inflammation, including expression of inducible nitric oxide synthase ( NOS) and generation of excess nitric oxide, is believed to contribute to the pathogenesis and inappropriate vasodilatation of persistent cardiogenic shock. Preliminary, single-center studies suggested a beneficial effect of NOS inhibition on hemodynamics, renal function, and survival in patients with cardiogenic shock. Objective To examine the effects of an isoform-nonselective NOS inhibitor in patients with MI and refractory cardiogenic shock despite establishment of an open infarct artery. Design, Setting, and Patients International, multicenter, randomized, doubleblind, placebo-controlled trial (Tilarginine Acetate Injection in a Randomized International Study in Unstable MI Patients With Cardiogenic Shock [ TRIUMPH]) with planned enrollment of 658 patients at 130 centers. Participants were enrolled between January 2005 and August 2006 when the study was terminated early. Intervention Tilarginine (L-N-G-monomethylarginine [L-NMMA]), 1-mg/kg bolus and 1-mg/kg per hour 5-hour infusion, vs matching placebo. Main Outcome Measures The primary outcome was 30-day all-cause mortality among patients who received study medication. Secondary outcomes included shock resolution and duration, New York Heart Association (NYHA) functional class at 30 days, and 6-month mortality. Results Enrollment was terminated at 398 patients based on a prespecified futility analysis. Six-month follow-up was completed in February 2007. There was no difference in 30-day all-cause mortality between patients who received tilarginine (97/201 [ 48%]) vs placebo (76/180 [42%]) ( risk ratio, 1.14; 95% confidence interval, 0.92-1.41; P=.24). Resolution of shock (133/201 [66%] tilarginine vs 110/180 [61%] placebo; P =. 31) and duration of shock ( median, 156 [interquartile range, 78-759] hours tilarginine vs 190 [100-759] placebo; P =. 16) were similar. At 30 days a similar percentage of patients had heart failure ( 48% tilarginine vs 51% placebo; P =. 51) with a similar percentage of those patients in NYHA class I/II (73% tilarginine vs 75% placebo; P =. 27). After 6 months mortality rates were similar in the 2 groups (58% tilarginine vs 59% placebo; hazard ratio, 1.04; 95% confidence interval, 0.79-1.36; P=. 80). Conclusions Tilarginine, 1-mg/kg bolus and 5-hour infusion, did not reduce mortality rates in patients with refractory cardiogenic shock complicating MI despite an open infarct artery. Early mortality rates in this patient group are high. Further research is needed to develop effective therapies for patients with cardiogenic shock following acute MI.	NYU, Sch Med, Cardiovasc Clin Res Ctr, New York, NY 10016 USA; Duke Univ, Durham, NC USA; Duke Clin Res Inst, Durham, NC USA; Univ Toronto, Toronto, ON, Canada; Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium	New York University; Duke University; Duke University; University of Toronto; KU Leuven; University Hospital Leuven	Hochman, JS (corresponding author), NYU, Sch Med, Cardiovasc Clin Res Ctr, 530 1st Ave HCC-1170, New York, NY 10016 USA.	judith.hochman@med.nyu.edu	Alexander, John/GVS-7271-2022; Reynolds, Harmony/AAU-3154-2021; Reynolds, Harmony/M-4818-2013	Reynolds, Harmony/0000-0003-0284-0655; Hochman, Judith/0000-0002-5889-5981; Van de Werf, Frans/0000-0001-9479-7767; Chizynski, Krzysztof/0000-0001-8723-7403; Alexander, John/0000-0002-1444-2462				Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; AGRESS CM, 1957, AM HEART J, V54, P458, DOI 10.1016/0002-8703(57)90136-9; Akiyama K, 1997, J MOL CELL CARDIOL, V29, P1, DOI 10.1006/jmcc.1996.9998; Akiyama K, 1998, J AM COLL CARDIOL, V32, P373, DOI 10.1016/S0735-1097(98)00270-8; Armstrong PW, 2007, JAMA-J AM MED ASSOC, V297, P43; Arnold JMO, 2006, CAN J CARDIOL, V22, P23, DOI 10.1016/S0828-282X(06)70237-9; Babaev A, 2005, JAMA-J AM MED ASSOC, V294, P448, DOI 10.1001/jama.294.4.448; Berger PB, 1997, CIRCULATION, V96, P122; Cotter G, 2003, EUR HEART J, V24, P1287, DOI 10.1016/S0195-668X(03)00193-3; Cotter G, 2000, CIRCULATION, V101, P1358, DOI 10.1161/01.CIR.101.12.1358; Dauerman HL, 2002, AM J CARDIOL, V90, P838, DOI 10.1016/S0002-9149(02)02704-2; DeMets DL, 2002, CIRCULATION, V106, P880, DOI 10.1161/01.CIR.0000023220.26465.89; DeMets DL, 2002, CIRCULATION, V106, P746, DOI 10.1161/01.CIR.0000023219.51483.66; DZAVIK V, IN PRESS EUR HEART J; Fincke R, 2004, J AM COLL CARDIOL, V44, P340, DOI 10.1016/j.jacc.2004.03.060; Goldberg RJ, 1999, NEW ENGL J MED, V340, P1162, DOI 10.1056/NEJM199904153401504; Granger CB, 2003, CIRCULATION, V108, P1184, DOI 10.1161/01.CIR.0000087447.12918.85; Hasdai D, 1999, AM HEART J, V138, P21, DOI 10.1016/S0002-8703(99)70241-3; Himbert D, 2002, AM J CARDIOL, V89, P73, DOI 10.1016/S0002-9149(01)02169-5; Hochman JS, 2003, CIRCULATION, V107, P2998, DOI 10.1161/01.CIR.0000075927.67673.F2; Hochman JS, 2006, JAMA-J AM MED ASSOC, V295, P2511, DOI 10.1001/jama.295.21.2511; Hunt Sharon Ann, 2005, J Am Coll Cardiol, V46, pe1, DOI 10.1016/j.jacc.2005.08.022; Klein LW, 2005, AM J CARDIOL, V96, P35, DOI 10.1016/j.amjcard.2005.02.040; Kuehn BM, 2006, JAMA-J AM MED ASSOC, V296, P1955, DOI 10.1001/jama.296.16.1955; KUHN LA, 1967, AM HEART J, V74, P578, DOI 10.1016/0002-8703(67)90019-1; Lindholm MG, 2003, EUR HEART J, V24, P258, DOI 10.1016/S0195-668X(02)00429-3; Lopez A, 2004, CRIT CARE MED, V32, P21, DOI 10.1097/01.CCM.0000105581.01815.C6; Mehta RH, 2004, AM HEART J, V147, P253, DOI 10.1016/j.ahj.2003.08.007; Nordhaug D, 2004, EUR J HEART FAIL, V6, P705, DOI 10.1016/j.ejheart.2003.11.010; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Theroux P, 2005, EUR HEART J, V26, P1964, DOI 10.1093/eurheartj/ehi292; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8; Zeymer U, 2004, EUR HEART J, V25, P322, DOI 10.1016/j.ehj.2003.12.008	33	224	240	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2007	297	15					1657	1666						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	157UR	17387132				2022-12-28	WOS:000245747400019
J	Ventura, M; Antonacci, F; Cardone, MF; Stanyon, R; D'Addabbo, P; Cellamare, A; Sprague, LJ; Eichler, EE; Archidiacono, N; Rocchi, M				Ventura, Mario; Antonacci, Francesca; Cardone, Maria Francesca; Stanyon, Roscoe; D'Addabbo, Pietro; Cellamare, Angelo; Sprague, L. James; Eichler, Evan E.; Archidiacono, Nicoletta; Rocchi, Mariano			Evolutionary formation of new centromeres in macaque	SCIENCE			English	Article							PRIMATE SEGMENTAL DUPLICATIONS; LATENT CENTROMERES; NEOCENTROMERES; HYBRIDIZATION; TRANSCRIPTION; CHROMOSOMES; HOMOLOGIES; DOMAINS	A systematic fluorescence in situ hybridization comparison of macaque and human synteny organization disclosed five additional macaque evolutionary new centromeres ( ENCs) for a total of nine ENCs. To understand the dynamics of ENC formation and progression, we compared the ENC of macaque chromosome 4 with the human orthologous region, at 6q24.3, that conserves the ancestral genomic organization. A 250-kilobase segment was extensively duplicated around the macaque centromere. These duplications were strictly intrachromosomal. Our results suggest that novel centromeres may trigger only local duplication activity and that the absence of genes in the seeding region may have been important in ENC maintenance and progression.	Univ Bari, Dept Genet & Microbiol, I-70126 Bari, Italy; Univ Florence, Dept Anim Biol & Genet, I-50125 Florence, Italy; Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Genome Sci, Seattle, WA 98195 USA	Universita degli Studi di Bari Aldo Moro; University of Florence; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Rocchi, M (corresponding author), Univ Bari, Dept Genet & Microbiol, I-70126 Bari, Italy.	rocchi@biologia.uniba.it	D'Addabbo, Pietro/D-8551-2016; Antonacci, Francesca/F-5457-2013; Cardone, Maria Francesca/G-8818-2012; Rocchi, Mariano/B-8451-2011; D'Addabbo, Pietro/AAC-7731-2020; Ventura, Mario/E-6420-2011; archidiacono, nicoletta/B-8471-2011	D'Addabbo, Pietro/0000-0003-3325-4931; Antonacci, Francesca/0000-0002-5833-6186; Cardone, Maria Francesca/0000-0002-7597-7313; Ventura, Mario/0000-0001-7762-8777; Rocchi, Mariano/0000-0002-9451-5616; archidiacono, nicoletta/0000-0002-1439-9521; Stanyon, Roscoe/0000-0002-7229-1092	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058815] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alonso A, 2003, HUM MOL GENET, V12, P2711, DOI 10.1093/hmg/ddg282; Amor DJ, 2004, P NATL ACAD SCI USA, V101, P6542, DOI 10.1073/pnas.0308637101; Amor DJ, 2002, AM J HUM GENET, V71, P695, DOI 10.1086/342730; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Cardone MF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r91; CARDONE MF, IN PRESS GENOMICS; Choo KHA, 1997, AM J HUM GENET, V61, P1225, DOI 10.1086/301657; Eder V, 2003, MOL BIOL EVOL, V20, P1506, DOI 10.1093/molbev/msg165; Ferreri GC, 2005, J HERED, V96, P217, DOI 10.1093/jhered/esi029; Horvath JE, 2005, GENOME RES, V15, P914, DOI 10.1101/gr.3916405; Lam AL, 2006, P NATL ACAD SCI USA, V103, P4186, DOI 10.1073/pnas.0507947103; Marzella R, 2000, GENOMICS, V63, P307, DOI 10.1006/geno.1999.6092; Montefalcone G, 1999, GENOME RES, V9, P1184, DOI 10.1101/gr.9.12.1184; Muller S, 2001, HUM GENET, V109, P85; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; Murphy WJ, 2003, GENOME RES, V13, P1880, DOI 10.1101/gr.1022303; MURPHY WJ, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-6-REVIEWS0005; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; Rocchi M, 2006, GENOME RES, V16, P1441, DOI 10.1101/gr.5687906; Roizes G, 2006, NUCLEIC ACIDS RES, V34, P1912, DOI 10.1093/nar/gkl137; Saffery R, 2003, MOL CELL, V12, P509, DOI 10.1016/S1097-2765(03)00279-X; She XW, 2006, GENOME RES, V16, P576, DOI 10.1101/gr.4949406; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Stanyon R, 2000, AM J PRIMATOL, V50, P95, DOI 10.1002/(SICI)1098-2345(200002)50:2<95::AID-AJP1>3.0.CO;2-8; Ventura M, 2004, GENOME RES, V14, P1696, DOI 10.1101/gr.2608804; Ventura M, 2003, GENOME RES, V13, P2059, DOI 10.1101/gr.1155103; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045; WIENBERG J, 1992, CHROMOSOMA, V101, P265, DOI 10.1007/BF00346004; Wong NC, 2006, PLOS GENET, V2, P172, DOI 10.1371/journal.pgen.0020017; Yan HH, 2006, PLANT CELL, V18, P2123, DOI 10.1105/tpc.106.043794	30	107	112	2	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					243	246		10.1126/science.1140615	http://dx.doi.org/10.1126/science.1140615			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431171	Green Published			2022-12-28	WOS:000245654500041
J	Gupta, GP; Nguyen, DX; Chiang, AC; Bos, PD; Kim, JY; Nadal, C; Gomis, RR; Manova-Todorova, K; Massague, J				Gupta, Gaorav P.; Nguyen, Don X.; Chiang, Anne C.; Bos, Paula D.; Kim, Juliet Y.; Nadal, Cristina; Gomis, Roger R.; Manova-Todorova, Katia; Massague, Joan			Mediators of vascular remodelling co-opted for sequential steps in lung metastasis	NATURE			English	Article							GROWTH-FACTOR RECEPTOR; BREAST-CANCER METASTASIS; TUMOR; ANGIOGENESIS; CYCLOOXYGENASE-2; GENES; INHIBITOR; CELECOXIB; SURVIVAL; EFFICACY	Metastasis entails numerous biological functions that collectively enable cancerous cells from a primary site to disseminate and overtake distant organs. Using genetic and pharmacological approaches, we show that the epidermal growth factor receptor ligand epiregulin, the cyclooxygenase COX2, and the matrix metalloproteinases 1 and 2, when expressed in human breast cancer cells, collectively facilitate the assembly of new tumour blood vessels, the release of tumour cells into the circulation, and the breaching of lung capillaries by circulating tumour cells to seed pulmonary metastasis. These findings reveal how aggressive primary tumorigenic functions can be mechanistically coupled to greater lung metastatic potential, and how such biological activities may be therapeutically targeted with specific drug combinations.	Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Mol Cytol Core Facil, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	j-massague@ski.mskcc.org	Gomis, Roger R/E-9788-2016; Gupta, Gaorav/AAL-4472-2021	Gomis, Roger R/0000-0001-6473-2858; Massague, Joan/0000-0001-9324-8408				Baselga J, 2002, CANCER CELL, V1, P319, DOI 10.1016/S1535-6108(02)00066-1; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Dannenberg AJ, 2005, J CLIN ONCOL, V23, P254, DOI 10.1200/JCO.2005.09.112; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gately S, 2004, SEMIN ONCOL, V31, P2, DOI 10.1053/j.seminoncol.2004.03.040; GIJBELS K, 1994, J CLIN INVEST, V94, P2177, DOI 10.1172/JCI117578; Giordano SH, 2004, CANCER, V100, P44, DOI 10.1002/cncr.11859; Goldstein NI, 1995, CLIN CANCER RES, V1, P1311; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Gupta GP, 2005, COLD SH Q B, V70, P149, DOI 10.1101/sqb.2005.70.018; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Howe LR, 2005, CANCER RES, V65, P10113, DOI 10.1158/0008-5472.CAN-05-1524; Hynes RO, 2003, CELL, V113, P821, DOI 10.1016/S0092-8674(03)00468-9; Jacoby RF, 2000, CANCER RES, V60, P5040; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Karashima T, 2002, CLIN CANCER RES, V8, P1253; Krysan K, 2005, CANCER RES, V65, P6275, DOI 10.1158/0008-5472.CAN-05-0216; Luo FR, 2005, CANCER CHEMOTH PHARM, V56, P455, DOI 10.1007/s00280-005-1022-3; Massague J, 2007, NEW ENGL J MED, V356, P294, DOI 10.1056/NEJMe068292; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Niederberger E, 2001, FASEB J, V15, P1622, DOI 10.1096/fj.00-0716fje; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Solomayer EF, 2000, BREAST CANCER RES TR, V59, P271, DOI 10.1023/A:1006308619659; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wary Kishore K, 2003, Mol Cancer, V2, P25, DOI 10.1186/1476-4598-2-25; Wild R, 2000, MICROVASC RES, V59, P368, DOI 10.1006/mvre.1999.2233	37	541	565	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					765	U2		10.1038/nature05760	http://dx.doi.org/10.1038/nature05760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17429393				2022-12-28	WOS:000245626800033
J	Koh, HK; Joossens, LX; Connolly, GN				Koh, Howard K.; Joossens, Luk X.; Connolly, Gregory N.			Making smoking history worldwide	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Assoc European Canc Leagues, Brussels, Belgium	Harvard University; Harvard T.H. Chan School of Public Health	Koh, HK (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; Fong GT, 2006, TOB CONTROL, V15, P51, DOI 10.1136/tc.2005.013649; HHS (Department of Health and Human Services), 2006, HLTH CONS INV EXP TO; Mackay J, 2006, TOBACCO ATLAS; Scollo M, 2003, TOB CONTROL, V12, P13, DOI 10.1136/tc.12.1.13	5	68	72	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 12	2007	356	15					1496	1498		10.1056/NEJMp068279	http://dx.doi.org/10.1056/NEJMp068279			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	156CA	17429081	Bronze			2022-12-28	WOS:000245624400002
J	Lau, KS; Partridge, EA; Grigorian, A; Silvescu, CI; Reinhold, VN; Demetriou, M; Dennis, JW				Lau, Ken S.; Partridge, Emily A.; Grigorian, Ani; Silvescu, Cristina I.; Reinhold, Vernon N.; Demetriou, Michael; Dennis, James W.			Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation	CELL			English	Article							ACETYLGLUCOSAMINYLTRANSFERASE-V; CAENORHABDITIS-ELEGANS; LINKED GLYCOSYLATION; MATHEMATICAL-MODEL; TGF-BETA; RECEPTOR; GROWTH; MICE; BIOSYNTHESIS; ENDOCYTOSIS	The number of N-glycans (n) is a distinct feature of each glycoprotein sequence and cooperates with the physical properties of the Golgi N-glycan-branching pathway to regulate surface glycoprotein levels. The Golgi pathway is ultrasensitive to hexosamine flux for the production of tri- and tetra-antennary N-glycans, which bind to galectins and form a molecular lattice that opposes glycoprotein endocytosis. Glycoproteins with few N-glycans (e.g., T beta R, CTLA-4, and GLUT4) exhibit enhanced cell-surface expression with switch-like responses to increasing hexosamine concentration, whereas glycoproteins with high numbers of N-glycans (e.g., EGFR, IGFR, FGFR, and PDGFR) exhibit hyperbolic responses. Computational and experimental data reveal that these features allow nutrient flux stimulated by growth-promoting high-n receptors to drive arrest/differentiation programs by increasing surface levels of low-n glycoproteins. We have identified a mechanism for metabolic regulation of cellular transition between growth and arrest in mammals arising from apparent coevolution of N-glycan number and branching.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1L5, Canada; Univ Toronto, Dept Lab Med & Pathol, Toronto, ON M5G 1L5, Canada; Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Neurol, Irvine, CA 92862 USA; Univ New Hampshire, Durham, NH 03824 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of California System; University of California Irvine; University of California System; University of California Irvine; University System Of New Hampshire; University of New Hampshire	Dennis, JW (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave R988, Toronto, ON M5G 1X5, Canada.	dennis@mshri.on.ca	Dennis, James/E-7268-2013; Lau, Ken/I-7958-2019	Lau, Ken/0000-0001-8438-0319; Demetriou, Michael/0000-0002-2224-7798				Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Al-Hasani H, 2002, J CELL SCI, V115, P131; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; Bradshaw JD, 1997, BIOCHEMISTRY-US, V36, P15975, DOI 10.1021/bi971762i; Broschat KO, 2002, J BIOL CHEM, V277, P14764, DOI 10.1074/jbc.M201056200; Buckhaults P, 1997, J BIOL CHEM, V272, P19575, DOI 10.1074/jbc.272.31.19575; Chikuma Shunsuke, 2002, Mol Interv, V2, P205, DOI 10.1124/mi.2.4.205; Cipollo JF, 2005, J BIOL CHEM, V280, P26063, DOI 10.1074/jbc.M503828200; Collins BE, 2006, NAT IMMUNOL, V7, P199, DOI 10.1038/ni1283; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; DO KY, 1994, J BIOL CHEM, V269, P23456; Ehrlich M, 2001, J CELL SCI, V114, P1777; Elleman TC, 2000, BIOCHEM J, V347, P771, DOI 10.1042/0264-6021:3470771; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Granovsky M, 2000, NAT MED, V6, P306; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Ishida H, 2005, FEBS LETT, V579, P71, DOI 10.1016/j.febslet.2004.11.037; KATZ EB, 1995, NATURE, V377, P151, DOI 10.1038/377151a0; Klein P, 2003, CURR BIOL, V13, P1669, DOI 10.1016/j.cub.2003.09.027; Koli KM, 1997, J BIOL CHEM, V272, P6423, DOI 10.1074/jbc.272.10.6423; Kolm-Litty V, 1998, J CLIN INVEST, V101, P160, DOI 10.1172/JCI119875; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Krambeck FJ, 2005, BIOTECHNOL BIOENG, V92, P711, DOI 10.1002/bit.20645; KUMAR R, 1989, MOL CELL BIOL, V9, P5713, DOI 10.1128/MCB.9.12.5713; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Oft M, 2002, NAT CELL BIOL, V4, P487, DOI 10.1038/ncb807; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Sasai K, 2002, GLYCOBIOLOGY, V12, P119, DOI 10.1093/glycob/12.2.119; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Slawson C, 2006, J CELL BIOCHEM, V97, P71, DOI 10.1002/jcb.20676; SOBKO A, 2006, SCI STKE, pRE9; Takamatsu S, 1999, CANCER RES, V59, P3949; Tsao TS, 1996, DIABETES, V45, P28, DOI 10.2337/diabetes.45.1.28; Umana P, 1997, BIOTECHNOL BIOENG, V55, P890, DOI 10.1002/(SICI)1097-0290(19970920)55:6<890::AID-BIT7>3.0.CO;2-B; vanDelft S, 1997, J CELL BIOL, V136, P811, DOI 10.1083/jcb.136.4.811; VILAR J, 2006, PLOS COMPUT BIOL, V2; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Wang Y, 2001, GLYCOBIOLOGY, V11, P1051, DOI 10.1093/glycob/11.12.1051; Warren CE, 2002, J BIOL CHEM, V277, P22829, DOI 10.1074/jbc.M201390200; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Zhen YJ, 2003, BIOCHEMISTRY-US, V42, P5478, DOI 10.1021/bi027101p; Zhu SX, 2004, BIOCHEM J, V382, P995, DOI 10.1042/BJ20040793	51	630	660	3	97	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					123	134		10.1016/j.cell.2007.01.049	http://dx.doi.org/10.1016/j.cell.2007.01.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418791	Bronze			2022-12-28	WOS:000245661100016
J	Byrne, P				Byrne, Peter			Managing the acute psychotic episode	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ATYPICAL ANTIPSYCHOTIC-DRUGS; 1ST-EPISODE PSYCHOSIS; CARDIOVASCULAR RISK; FOLLOW-UP; SCHIZOPHRENIA; SYMPTOMS; 2ND-GENERATION; INTERVENTION; METAANALYSIS; ASSOCIATION		Early Intervent Team Ealing, Southall UB2 4EU, Middx, England		Byrne, P (corresponding author), Early Intervent Team Ealing, Southall UB2 4EU, Middx, England.	p.byrne@ucl.ac.uk						Bertolote J, 2005, BRIT J PSYCHIAT, V187, pS116, DOI 10.1192/bjp.187.48.s116; Boydell J, 2004, SOC PSYCH PSYCH EPID, V39, P597, DOI 10.1007/s00127-004-0789-6; Brugha T, 2005, AM J PSYCHIAT, V162, P774, DOI 10.1176/appi.ajp.162.4.774; Crowther R, 2001, COCHRANE DATABASE SY; Davis JM, 2003, ARCH GEN PSYCHIAT, V60, P553, DOI 10.1001/archpsyc.60.6.553; DeSilva P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001948.pub2; Duggan L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001359.pub2; Edwards J, 2005, BRIT J PSYCHIAT, V187, pS91, DOI 10.1192/bjp.187.48.s91; ELSAYEH HG, 2006, COCHRANE DATABASE SY; Garety PA, 2006, BRIT J PSYCHIAT, V188, P37, DOI 10.1192/bjp.bp.104.007286; GIBSON RC, 2004, COCHRANE DATABASE SY; GILBODY SM, 2000, COCHRANE DATABASE SY; Gill SS, 2005, BMJ-BRIT MED J, V330, P445, DOI 10.1136/bmj.38330.470486.8F; Hale AS, 1997, BRIT MED J, V315, P43, DOI 10.1136/bmj.315.7099.43; Harrison G, 2001, BRIT J PSYCHIAT, V178, P506, DOI 10.1192/bjp.178.6.506; HARTUNG B, 2005, COCHRANE DATABASE SY; Henquet C, 2005, BMJ-BRIT MED J, V330, P11, DOI 10.1136/bmj.38267.664086.63; HOGARTY GE, 1988, J PSYCHIATR RES, V32, P243; HOSALLI P, 2003, COCHRANE DATABASE SY; JEFFERY DP, 2000, COCHRANE DATABASE SY; Jones C., 2004, COCHRANE DB SYST REV, V4, pCD000524; Jones PB, 2006, ARCH GEN PSYCHIAT, V63, P1079, DOI 10.1001/archpsyc.63.10.1079; JOY CB, 2006, COCHRANE DATABASE SY; Kerwin R., 2005, ADV PSYCHIAT TREATME, V11, P101, DOI DOI 10.1192/APT.11.2.101]; Khunti K, 2005, BMJ-BRIT MED J, V331, P1153, DOI 10.1136/bmj.331.7526.1153; Kingdon D. G., 2005, COGNITIVE THERAPY SC; Lambert M, 2005, ACTA PSYCHIAT SCAND, V112, P141, DOI 10.1111/j.1600-0447.2005.00554.x; Larsen TK, 2006, SCHIZOPHRENIA BULL, V32, P758, DOI 10.1093/schbul/sbl005; Lieberman JA, 2005, ARCH GEN PSYCHIAT, V62, P361, DOI 10.1001/archpsyc.62.4.361; MARQUES LO, 2004, COCHRANE DATABASE SY; Marshall M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004718.pub2; Marshall M, 2005, ARCH GEN PSYCHIAT, V62, P975, DOI 10.1001/archpsyc.62.9.975; McCreadie RG, 2003, BRIT J PSYCHIAT, V183, P534, DOI 10.1192/bjp.183.6.534; McIntosh AM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003442.pub2; MOTANETO JIS, 2002, COCHRANE DATABASE SY; Muller-Oerlinghausen B, 2002, LANCET, V359, P241, DOI 10.1016/S0140-6736(02)07450-0; Nordentoft M, 2004, BRIT MED J, V329, P261, DOI 10.1136/bmj.38133.622488.63; Ostling S, 2002, ARCH GEN PSYCHIAT, V59, P53, DOI 10.1001/archpsyc.59.1.53; PEKKALA E, 2002, COCHRANE DATABASE SY; Penn DL, 2005, AM J PSYCHIAT, V162, P2220, DOI 10.1176/appi.ajp.162.12.2220; Petersen L, 2005, BMJ-BRIT MED J, V331, P602, DOI 10.1136/bmj.38565.415000.E01; Pilling S, 2002, PSYCHOL MED, V32, P763, DOI 10.1017/S0033291702005895; RATHBONE J, 2005, COCHRANE DATABASE SY; Read J, 2006, ACTA PSYCHIAT SCAND, V114, P303, DOI 10.1111/j.1600-0447.2006.00824.x; ROBERTSON L, 1998, COCHRANE DATABASE SY; Rummel C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005581.pub2; Sachdev P, 1998, AM J PSYCHIAT, V155, P325, DOI 10.1176/ajp.155.3.325; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Schneider LS, 2006, NEW ENGL J MED, V355, P1525, DOI 10.1056/NEJMoa061240; Singh SP, 2000, BRIT J PSYCHIAT, V176, P210, DOI 10.1192/bjp.176.3.210; SOARES BGO, 1999, COCHRANE DATABASE SY; SRISURAPANONT M, 2004, COCHRANE DATABASE SY; SULTANA A, 2000, COCHRANE DATABASE SY; Talwar N, 2006, BRIT J PSYCHIAT, V189, P405, DOI 10.1192/bjp.bp.105.015073; Tarrier N, 2004, BRIT J PSYCHIAT, V184, P231, DOI 10.1192/bjp.184.3.231; Taylor D, 2005, MAUDSLEY 2005 2006 P; THORNLEY B, 2003, COCHRANE DATABASE SY; TURNER MS, J PSYCHOPHARMACOLOGY, V20, P20; Tyrer P., 2005, ADV PSYCHIAT TREATME, V11, P232, DOI DOI 10.1192/apt.11.3.232; WAHLBECK K, 1999, COCHRANE DATABASE SY; WHITEHEAD C, 2002, COCHRANE DATABASE SY; Wolff G, 1996, BRIT J PSYCHIAT, V168, P183, DOI [10.1192/bjp.168.2.183, DOI 10.1192/BJP.168.2.183]	62	20	22	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2007	334	7595					686	692C		10.1136/bmj.39148.668160.80	http://dx.doi.org/10.1136/bmj.39148.668160.80			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154ON	17395949	Green Published			2022-12-28	WOS:000245517100040
J	Seewaldt, VL; Scott, V				Seewaidt, Victoria L.; Scott, Victoria			Rapid progression of basal-type breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Duke Univ, Durham, NC 27710 USA	Duke University	Seewaldt, VL (corresponding author), Duke Univ, Durham, NC 27710 USA.	seewa001@mc.duke.edu							0	17	19	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2007	356	13					E12	E12		10.1056/NEJMicm063760	http://dx.doi.org/10.1056/NEJMicm063760			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150MN	17392297				2022-12-28	WOS:000245221000010
J	Spar, D				Spar, Debora			The egg trade - Making sense of the market for human oocytes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Business, Boston, MA 02163 USA	Harvard University	Spar, D (corresponding author), Harvard Univ, Sch Business, Boston, MA 02163 USA.							*BBC, 2005, BBC NEWS ONL; GALPERN E, 2006, WOMENS HLTH ACTI MAY; Guidice L., 2007, ASSESSING MED RISKS; ORTIZ, 2006, 1260 SB; Practice Committe of the American Society for Reproductive Medicine, 2003, Fertil Steril, V80, P1309	5	30	30	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 29	2007	356	13					1289	1291		10.1056/NEJMp078012	http://dx.doi.org/10.1056/NEJMp078012			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150MN	17392298				2022-12-28	WOS:000245221000001
J	Beeson, TD; Mastracchio, A; Hong, JB; Ashton, K; MacMillan, DWC				Beeson, Teresa D.; Mastracchio, Anthony; Hong, Jun-Bae; Ashton, Kate; MacMillan, David W. C.			Enantioselective organocatalysis using SOMO activation	SCIENCE			English	Article							ORGANIC CATALYSIS; TRANSITION-METAL; RADICAL-CATION; STRATEGIES; ENAMINES	The asymmetric alpha-addition of relatively nonpolar hydrocarbon substrates, such as allyl and aryl groups, to aldehydes and ketones remains a largely unsolved problem in organic synthesis, despite the wide potential utility of direct routes to such products. We reasoned that well-established chiral amine catalysis, which activates aldehydes toward electrophile addition by enamine formation, could be expanded to this important reaction class by applying a single-electron oxidant to create a transient radical species from the enamine. We demonstrated the concept of singly occupied molecular orbital (SOMO) activation with a highly selective alpha-allylation of aldehydes, and we here present preliminary results for enantioselective heteroarylations and cyclization/halogenation cascades.	Princeton Univ, Dept Chem, Merck Ctr Catalysis, Princeton, NJ 08544 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Princeton University; California Institute of Technology	MacMillan, DWC (corresponding author), Princeton Univ, Dept Chem, Merck Ctr Catalysis, Princeton, NJ 08544 USA.	dmacmill@princeton.edu			NIGMS NIH HHS [R01 GM078201, R01 GM078201-01-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078201] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahrendt KA, 2000, J AM CHEM SOC, V122, P4243, DOI 10.1021/ja000092s; [Anonymous], [No title captured]; CRABTREE RH, 2000, ORGANOMETALLIC CHEM; Ibrahem I, 2006, ANGEW CHEM INT EDIT, V45, P1952, DOI 10.1002/anie.200504021; Jacobsen E. N., 1999, COMPREHENSIVE ASYMME, V1-3; Kirchgessner M, 2006, J ORG CHEM, V71, P9849, DOI 10.1021/jo061809i; Lee HB, 2001, J AM CHEM SOC, V123, P11322, DOI 10.1021/ja017043f; Lelais G, 2006, ALDRICHIM ACTA, V39, P79; LeTadicBiadatti MH, 1996, J CHEM SOC PERK T 2, P1467, DOI 10.1039/p29960001467; Lide D.R., 1995, HDB CHEM PHYS, P220; List B, 2000, J AM CHEM SOC, V122, P2395, DOI 10.1021/ja994280y; List B, 2006, CHEM COMMUN, P819, DOI 10.1039/b514296m; MULLER K, 1981, HELV CHIM ACTA, V64, P2497, DOI 10.1002/hlca.19810640802; NARASAKA K, 1992, CHEM LETT, P2099, DOI 10.1246/cl.1992.2099; NOYORI R, 1994, ASYMMETRIC CATALYSIS, P123; Ojima I., 2000, CATALYTIC ASYMMETRIC; Renaud P., 2001, RADICALS ORGANIC SYN, V2, P144; SEYDENPENNE J, 1995, CHIRAL AUXILIARIES L, P166; Sibi MP, 2007, J AM CHEM SOC, V129, P395, DOI 10.1021/ja066425o; Sutterer A, 2000, J AM CHEM SOC, V122, P5636, DOI 10.1021/ja001063k; Taylor MS, 2006, ANGEW CHEM INT EDIT, V45, P1520, DOI 10.1002/anie.200503132; Trost BM, 2003, CHEM REV, V103, P2921, DOI 10.1021/cr020027w; VIEHE HG, 1988, PURE APPL CHEM, V60, P1635, DOI 10.1351/pac198860111635; Yamamoto H., 2000, LEWIS ACIDS ORGANIC, V1	24	531	534	10	391	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2007	316	5824					582	585		10.1126/science. 1142696	http://dx.doi.org/10.1126/science. 1142696			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	160ZC	17395791				2022-12-28	WOS:000245983100040
J	Sachs, GS; Nierenberg, AA; Calabrese, JR; Marangell, LB; Wisniewski, SR; Gyulai, L; Friedman, ES; Bowden, CL; Fossey, MD; Ostacher, MJ; Ketter, TA; Patel, J; Hauser, P; Rapport, D; Martinez, JM; Allen, MH; Miklowitz, DJ; Otto, MW; Dennehy, EB; Thase, ME				Sachs, Gary S.; Nierenberg, Andrew A.; Calabrese, Joseph R.; Marangell, Lauren B.; Wisniewski, Stephen R.; Gyulai, Laszlo; Friedman, Edward S.; Bowden, Charles L.; Fossey, Mark D.; Ostacher, Michael J.; Ketter, Terence A.; Patel, Jayendra; Hauser, Peter; Rapport, Daniel; Martinez, James M.; Allen, Michael H.; Miklowitz, David J.; Otto, Michael W.; Dennehy, Ellen B.; Thase, Michael E.			Effectiveness of adjunctive antidepressant treatment for bipolar depression	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TREATMENT ENHANCEMENT PROGRAM; DOUBLE-BLIND; DSM-IV; DISORDER; VENLAFAXINE; BUPROPION; PREVALENCE; PAROXETINE; RATIONALE; INTERVIEW	BACKGROUND: Episodes of depression are the most frequent cause of disability among patients with bipolar disorder. The effectiveness and safety of standard antidepressant agents for depressive episodes associated with bipolar disorder (bipolar depression) have not been well studied. Our study was designed to determine whether adjunctive antidepressant therapy reduces symptoms of bipolar depression without increasing the risk of mania. METHODS: In this double-blind, placebo-controlled study, we randomly assigned subjects with bipolar depression to receive up to 26 weeks of treatment with a mood stabilizer plus adjunctive antidepressant therapy or a mood stabilizer plus a matching placebo, under conditions generalizable to routine clinical care. A standardized clinical monitoring form adapted from the mood-disorder modules of the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, was used at all follow-up visits. The primary outcome was the percentage of subjects in each treatment group meeting the criterion for a durable recovery (8 consecutive weeks of euthymia). Secondary effectiveness outcomes and rates of treatment-emergent affective switch (a switch to mania or hypomania early in the course of treatment) were also examined. RESULTS: Forty-two of the 179 subjects (23.5%) receiving a mood stabilizer plus adjunctive antidepressant therapy had a durable recovery, as did 51 of the 187 subjects (27.3%) receiving a mood stabilizer plus a matching placebo (P=0.40). Modest nonsignificant trends favoring the group receiving a mood stabilizer plus placebo were observed across the secondary outcomes. Rates of treatment-emergent affective switch were similar in the two groups. CONCLUSIONS: The use of adjunctive, standard antidepressant medication, as compared with the use of mood stabilizers, was not associated with increased efficacy or with increased risk of treatment-emergent affective switch. Longer-term outcome studies are needed to fully assess the benefits and risks of antidepressant therapy for bipolar disorder.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Biopolar Clin & Res Program, Boston, MA 02114 USA; Boston Univ, Boston, MA 02215 USA; Case Western Reserve Univ, Univ Hosp, Case Med Ctr, Cleveland, OH 44106 USA; Baylor Coll Med, Houston, TX 77030 USA; S Cent Mental Illness Res Educ & Clin Core, Houston, TX USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; Univ Penn, Philadelphia, PA 19104 USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; Univ Oklahoma, Coll Med, Tulsa, OK USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA; Univ Massachusetts, Sch Med, Worcester, MA USA; Portland VA Med Ctr, Portland, OR USA; Oregon Hlth & Sci Univ, Portland, OR USA; Univ Toledo, Coll Med, Toledo, OH 43606 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Boulder, CO 80309 USA; Purdue Univ, W Lafayette, IN 47907 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; Case Western Reserve University; University Hospitals of Cleveland; Baylor College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; University of Texas System; University of Texas Health San Antonio; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma - Tulsa; Stanford University; University of Massachusetts System; University of Massachusetts Worcester; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; University System of Ohio; University of Toledo; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Sachs, GS (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Biopolar Clin & Res Program, 50 Staniford St,Suite 580, Boston, MA 02114 USA.	gsachs@partners.org	Hauser, Peter Viktor/D-4255-2009; Allen, Michael H/A-8776-2011; Miklowitz, David/AAE-3065-2022	Hauser, Peter Viktor/0000-0003-1168-034X; Allen, Michael H/0000-0002-6479-9793; Ostacher, Michael/0000-0003-0353-7535; Wisniewski, Stephen/0000-0002-3877-9860; Otto, Michael/0000-0002-8915-7578	NIMH NIH HHS [N01MH80001] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [N01MH080001] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Frank E, 1999, J ABNORM PSYCHOL, V108, P579, DOI 10.1037/0021-843X.108.4.579; Ghaemi SN, 2006, PSYCHIAT SERV, V57, P660, DOI 10.1176/appi.ps.57.5.660; Gijsman HJ, 2004, AM J PSYCHIAT, V161, P1537, DOI 10.1176/appi.ajp.161.9.1537; Goldberg JF, 2005, PSYCHIAT SERV, V56, P1534, DOI 10.1176/appi.ps.56.12.1534; Goodwin GM, 2003, J PSYCHOPHARMACOL, V17, P149, DOI 10.1177/0269881103017002003; Judd LL, 2002, ARCH GEN PSYCHIAT, V59, P530, DOI 10.1001/archpsyc.59.6.530; Kane JM, 2002, AM J PSYCHIAT, V159, P1, DOI 10.1176/appi.ajp.159.1.1; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P709; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266; Leverich GS, 2006, AM J PSYCHIAT, V163, P232, DOI 10.1176/appi.ajp.163.2.232; MIKLOWITZ DJ, IN PRESS ARCH GEN PS; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P495; Nemeroff CB, 2001, AM J PSYCHIAT, V158, P906, DOI 10.1176/appi.ajp.158.6.906; Perlis RH, 2006, AM J PSYCHIAT, V163, P217, DOI 10.1176/appi.ajp.163.2.217; Post RM, 2006, BRIT J PSYCHIAT, V189, P124, DOI 10.1192/bjp.bp.105.013045; Post RM, 2006, BRIT J PSYCHIAT, V189, P569; Post RIVI, 2003, J CLIN PSYCHIAT, P738; Post RM, 2003, J CLIN PSYCHIAT, V64, P680, DOI 10.4088/JCP.v64n0610; SACHS GS, 1994, J CLIN PSYCHIAT, V55, P391; Sachs GS, 2002, BIPOLAR DISORD, V4, P323, DOI 10.1034/j.1399-5618.2002.01195.x; Sachs GS, 2003, BIOL PSYCHIAT, V53, P1028, DOI 10.1016/S0006-3223(03)00165-3; Scott J, 2006, BRIT J PSYCHIAT, V188, P313, DOI 10.1192/bjp.188.4.313; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Simon GE, 1999, PSYCHIATR SERV, V50, P1303, DOI 10.1176/ps.50.10.1303; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Suppes T, 2005, J CLIN PSYCHIAT, V66, P870, DOI 10.4088/JCP.v66n0710; Tohen M, 2004, ARCH GEN PSYCHIAT, V61, P176; Tohen M, 2003, ARCH GEN PSYCHIAT, V60, P1079, DOI 10.1001/archpsyc.60.11.1079; Vieta E, 2002, J CLIN PSYCHIAT, V63, P508, DOI 10.4088/JCP.v63n0607	30	636	654	0	59	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2007	356	17					1711	1722		10.1056/NEJMoa064135	http://dx.doi.org/10.1056/NEJMoa064135			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	160LQ	17392295				2022-12-28	WOS:000245942600006
J	Goshima, G; Wollman, R; Goodwin, SS; Zhang, N; Scholey, JM; Vale, RD; Stuurman, N				Goshima, Gohta; Wollman, Roy; Goodwin, Sarah S.; Zhang, Nan; Scholey, Jonathan M.; Vale, Ronald D.; Stuurman, Nico			Genes required for mitotic spindle assembly in Drosophila S2 cells	SCIENCE			English	Article							ABNORMAL-SPINDLE; KINETOCHORE; MITOSIS; PROTEIN; CANCER; IDENTIFICATION; MELANOGASTER; INSTABILITY; PROGRESSION; COMPONENTS	The formation of a metaphase spindle, a bipolar microtubule array with centrally aligned chromosomes, is a prerequisite for the faithful segregation of a cell's genetic material. Using a full-genome RNA interference screen of Drosophila S2 cells, we identified about 200 genes that contribute to spindle assembly, more than half of which were unexpected. The screen, in combination with a variety of secondary assays, led to new insights into how spindle microtubules are generated; how centrosomes are positioned; and how centrioles, centrosomes, and kinetochores are assembled.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; Marine Biol Lab, Physiol Course, Woods Hole, MA 02543 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis; Marine Biological Laboratory - Woods Hole	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 600 16th St, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu	Stuurman, Nico/AAV-4894-2021	Goodwin, Sarah/0000-0003-4686-0914; Stuurman, Nico/0000-0002-6179-8613	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038499] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R37 GM038499-21, R37 GM038499] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Bharadwaj R, 2004, J BIOL CHEM, V279, P13076, DOI 10.1074/jbc.M310224200; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303; DOHENY KF, 1993, CELL, V73, P761, DOI 10.1016/0092-8674(93)90255-O; Fung SM, 2002, DEVELOPMENT, V129, P347; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Mahoney NM, 2006, CURR BIOL, V16, P564, DOI 10.1016/j.cub.2006.01.053; Maiato H, 2004, J CELL BIOL, V167, P831, DOI 10.1083/jcb.200407090; McIntosh JR, 2002, ANNU REV CELL DEV BI, V18, P193, DOI 10.1146/annurev.cellbio.18.032002.132412; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Mitchison TJ, 2001, NAT CELL BIOL, V3, pE17, DOI 10.1038/35050656; Morales-Mulia S, 2005, MOL BIOL CELL, V16, P3176, DOI 10.1091/mbc.E04-12-1110; Muller H, 2006, SCIENCE, V314, P654, DOI 10.1126/science.1132834; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Rieder CL, 2003, SCIENCE, V300, P91, DOI 10.1126/science.1082177; Rodionov VI, 1997, SCIENCE, V275, P215, DOI 10.1126/science.275.5297.215; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Saunders RDC, 1997, J CELL BIOL, V137, P881, DOI 10.1083/jcb.137.4.881; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; TAKAHASHI K, 1994, MOL BIOL CELL, V5, P1145, DOI 10.1091/mbc.5.10.1145; Yanagida M, 1998, TRENDS CELL BIOL, V8, P144, DOI 10.1016/S0962-8924(98)01236-7; Yuen KWY, 2005, CURR OPIN CELL BIOL, V17, P576, DOI 10.1016/j.ceb.2005.09.012	35	418	433	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					417	421		10.1126/science.1141314	http://dx.doi.org/10.1126/science.1141314			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17412918	Green Accepted			2022-12-28	WOS:000245813400048
J	Hayashi, K; Lopes, SMCD; Surani, MA				Hayashi, Katsuhiko; de Sousa Lopes, Susana M. Chuva; Surani, M. Azim			Germ cell specification in mice	SCIENCE			English	Review							EARLY MOUSE EMBRYO; EXTRAEMBRYONIC TISSUES; SM PROTEINS; STEM-CELLS; GENERATION; LINEAGE; SMAD1; METHYLTRANSFERASE; METHYLATION; EXPRESSION	Specification of germ cells in mice occurs relatively late in embryonic development. It is initiated by signals that induce expression of Blimp1, a key regulator of the germ cell, in a few epiblast cells of early postimplantation embryos. Blimp1 represses the incipient somatic program in these cells and promotes progression toward the germ cell fate. Blimp1 may also have a role in the maintenance of early germ cell characteristics by ensuring their escape from the somatic fate as well as possible reversion to pluripotent stem cells.	Univ Cambridge, Wellcome Trust Canc Res UK, Gurdon Inst, Cambridge CB2 1QN, England	Cancer Research UK; University of Cambridge	Surani, MA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	as10021@mole.bio.cam.ac.uk		Surani, Azim/0000-0002-8640-4318	Medical Research Council [G0300723B] Funding Source: researchfish; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)		Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Anne J, 2007, DEVELOPMENT, V134, P137, DOI 10.1242/dev.02687; Arnold SJ, 2006, DEV BIOL, V296, P104, DOI 10.1016/j.ydbio.2006.04.442; Barbee SA, 2006, DEV BIOL, V291, P132, DOI 10.1016/j.ydbio.2005.12.011; Chang H, 2001, MECH DEVELOP, V104, P61, DOI 10.1016/S0925-4773(01)00367-7; Chu GC, 2004, DEVELOPMENT, V131, P3501, DOI 10.1242/dev.01248; Durcova-Hills G, 2006, STEM CELLS, V24, P1441, DOI 10.1634/stemcells.2005-0424; Gonsalvez GB, 2006, CURR BIOL, V16, P1077, DOI 10.1016/j.cub.2006.04.037; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hayashi K, 2002, MECH DEVELOP, V118, P99, DOI 10.1016/S0925-4773(02)00237-X; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Lopes SMCD, 2004, GENE DEV, V18, P1838, DOI 10.1101/gad.294004; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; McLaren A, 2005, DIFFERENTIATION, V73, P435, DOI 10.1111/j.1432-0436.2005.00049.x; O'Farrell PH, 2004, CURR BIOL, V14, pR35, DOI 10.1016/j.cub.2003.12.022; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tam PPL, 1996, DEV BIOL, V178, P124, DOI 10.1006/dbio.1996.0203; Tanaka SS, 2002, MECH DEVELOP, V119, pS261, DOI 10.1016/S0925-4773(03)00126-6; Thomas PQ, 1998, DEVELOPMENT, V125, P85; Tremblay KD, 2001, DEVELOPMENT, V128, P3609; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Ying Y, 2001, DEV BIOL, V232, P484, DOI 10.1006/dbio.2001.0173; Yoshimizu T, 2001, DEVELOPMENT, V128, P481	33	225	242	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					394	396		10.1126/science.1137545	http://dx.doi.org/10.1126/science.1137545			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446386				2022-12-28	WOS:000245813400037
J	Salinas, E; Romo, R				Salinas, Emilio; Romo, Ranulfo			Molecules to remember	CELL			English	Editorial Material							PREFRONTAL CORTEX; GUANFACINE; MONKEYS; MEMORY	'' Working memory '' is used for the transient storage of information in the brain. In this issue of Cell, Wang et al. (2007) now reveal how a series of molecular events involving alpha 2A-adrenoceptors and a class of ion channels gated by cAMP tune the responses of neural circuits that function in working memory in mammals.	Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; Wake Forest Univ, Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27157 USA	Universidad Nacional Autonoma de Mexico; Wake Forest University	Romo, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.	rromo@ifc.unam.mx		romo, ranulfo/0000-0003-3529-3635; Salinas, Emilio/0000-0001-7411-5693				ARNSTEN AFT, 1988, J NEUROSCI, V8, P4287; Baddeley A.D., 1986, WORKING MEMORY THOUG; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Ramos BP, 2003, NEURON, V40, P835, DOI 10.1016/S0896-6273(03)00694-9; Ramos BP, 2006, LEARN MEMORY, V13, P770, DOI 10.1101/lm.298006; Scahill L, 2001, AM J PSYCHIAT, V158, P1067, DOI 10.1176/appi.ajp.158.7.1067; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616	9	0	0	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2007	129	2					245	247		10.1016/j.cell.2007.04.003	http://dx.doi.org/10.1016/j.cell.2007.04.003			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17448986	Bronze			2022-12-28	WOS:000246474600012
J	Strome, S; Lehmann, R				Strome, Susan; Lehmann, Ruth			Germ versus soma decisions: Lessons from flies and worms	SCIENCE			English	Review							CAENORHABDITIS-ELEGANS; P GRANULES; RNA; COMPLEX; NANOS; TRANSCRIPTION; TOTIPOTENCY; TRANSLATION; REPRESSION; PROTEIN		Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; NYU, Sch Med, Dept Cell Biol, Skirball Inst,Howard Hughes Med Inst, New York, NY 10016 USA	Indiana University System; Indiana University Bloomington; Howard Hughes Medical Institute; New York University	Strome, S (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	sstrome@indiana.edu; lehmann@saturn.med.nyu.edu		Lehmann, Ruth/0000-0002-8454-5651	NIGMS NIH HHS [R01 GM034059] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034059] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; Boag PR, 2005, DEVELOPMENT, V132, P4975, DOI 10.1242/dev.02060; Ciosk R, 2006, SCIENCE, V311, P851, DOI 10.1126/science.1122491; Deshpande G, 2005, MECH DEVELOP, V122, P645, DOI 10.1016/j.mod.2004.12.009; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; Hayashi Y, 2004, P NATL ACAD SCI USA, V101, P10338, DOI 10.1073/pnas.0401647101; Lin MD, 2006, DEV CELL, V10, P601, DOI 10.1016/j.devcel.2006.02.021; Martinho RG, 2004, CURR BIOL, V14, P159, DOI 10.1016/j.cub.2003.12.036; Megosh HB, 2006, CURR BIOL, V16, P1884, DOI 10.1016/j.cub.2006.08.051; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Pitt JN, 2000, DEV BIOL, V219, P315, DOI 10.1006/dbio.2000.9607; Santos AC, 2004, CURR BIOL, V14, pR578, DOI 10.1016/j.cub.2004.07.018; Schaner CE, 2003, DEV CELL, V5, P747, DOI 10.1016/S1534-5807(03)00327-7; Seydoux G, 1997, DEVELOPMENT, V124, P2191; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; STORNE S, 2005, WORMBOOK C ELEGANS R, DOI DOI 10.1895/WORMBOOK.1.9.1; Tadros W, 2005, DEV DYNAM, V232, P593, DOI 10.1002/dvdy.20297; Takasaki T, 2007, DEVELOPMENT, V134, P757, DOI 10.1242/dev.02771; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Zhang F, 2003, GENE DEV, V17, P748, DOI 10.1101/gad.1068203	22	139	142	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2007	316	5823					392	393		10.1126/science.1140846	http://dx.doi.org/10.1126/science.1140846			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446385				2022-12-28	WOS:000245813400036
J	Kurer, MA; Chintapatla, S				Kurer, Mohamed A.; Chintapatla, Srinivas			Intestinal obstruction due to inspissated barium	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									York Hosp, York YO30 4YJ, N Yorkshire, England		Kurer, MA (corresponding author), York Hosp, York YO30 4YJ, N Yorkshire, England.	mohamed.kurer@york.nhs.uk	Chintapatla, Srinivas/ABG-6444-2021	Chintapatla, Srinivas/0000-0001-8326-2847					0	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 19	2007	356	16					1656	1656		10.1056/NEJMicm054136	http://dx.doi.org/10.1056/NEJMicm054136			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AB	17442908				2022-12-28	WOS:000245762000008
J	DasGupta, S				DasGupta, Sayantani			Holding	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												sd2030@columbia.edu						WILLIAMS WC, 1984, DOCTOR STORIES, P56	1	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2007	297	15					1631	1632		10.1001/jama.297.15.1631	http://dx.doi.org/10.1001/jama.297.15.1631			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	157UR	17440134				2022-12-28	WOS:000245747400001
J	Reichenbach, S; Sterchi, R; Scherer, M; Trelle, S; Burgi, E; Burgi, U; Dieppe, PA; Juni, P				Reichenbach, Stephan; Sterchi, Rebekka; Scherer, Martin; Trelle, Sven; Buergi, Elizabeth; Buergi, Ulrich; Dieppe, Paul A.; Jueni, Peter			Meta-analysis: Chondroitin for osteoarthritis of the knee or hip	ANNALS OF INTERNAL MEDICINE			English	Review							CLINICAL-TRIALS; DOUBLE-BLIND; SYSTEMATIC REVIEWS; SULFATE; EFFICACY; QUALITY; MULTICENTER; GLUCOSAMINE; BIAS; HETEROGENEITY	Background: Previous meta-analyses described moderate to large benefits of chondroitin in patients with osteoarthritis. However, recent large-scale trials did not find evidence of an effect. Purpose: To determine the effects of chondroitin on pain in patients with osteoarthritis. Data Sources: The authors searched the Cochrane Central Register of Controlled Trials (1970 to 2006), MEDLINE (1966 to 2006), EMBASE (1980 to 2006), CINAHL (1970 to 2006), and conference proceedings; checked reference lists; and contacted authors. The last update of searches was performed on 30 November 2006. Study Selection: Studies were included if they were randomized or quasi-randomized, controlled trials that compared chondroitin with placebo or with no treatment in patients with osteoarthritis of the knee or hip. There were no language restrictions. Data Extraction: The authors extracted data in duplicate. Effect sizes were calculated from the differences in means of pain-related outcomes between treatment and control groups at the end of the trial, divided by the pooled SD. Trials were combined by using random-effects meta-analysis. Data Synthesis: 20 trials (3846 patients) contributed to the meta-analysis, which revealed a high degree of heterogeneity among the trials (12 = 92%). Small trials, trials with unclear concealment of allocation, and trials that were not analyzed according to the intention-to-treat principle showed larger effects in favor of chondroitin than did the remaining trials. When the authors restricted the analysis to the 3 trials with large sample sizes and an intention-to-treat analysis, 40% of patients were included. This resulted in an effect size of = 0.03 (95% CI, - 0.13 to 0.07; 12 = 0%) and corresponded to a difference of 0.6 mm on a 10-cm visual analogue scale. A meta-analysis of 12 trials showed a pooled relative risk of 0.99 (CI, 0.76 to 1.31) for any adverse event. Limitations: For 9 trials, the authors had to use approximations to calculate effect sizes. Trial quality was generally low, heterogeneity among the trials made initial interpretation of results difficult, and exploring sources of heterogeneity in meta-regression and stratified analyses may be unreliable. Conclusions: scale, methodologically sound trials indicate that the symptomatic benefit of chondroitin is minimal or nonexistent. Use of chondroitin in routine clinical practice should therefore be discouraged.	Univ Bern, Dept Social & Prevent Med, CH-3012 Bern, Switzerland; Univ Bristol, Bristol BS8 1TH, Avon, England; Univ Gottingen, D-3400 Gottingen, Germany	University of Bern; University of Bristol; University of Gottingen	Juni, P (corresponding author), Univ Bern, Dept Social & Prevent Med, Finkenhubleweg 11, CH-3012 Bern, Switzerland.	juni@ispm.unibe.ch	Juni, Peter/Q-8700-2016; Trelle, Sven/D-3760-2009	Juni, Peter/0000-0002-5985-0670; Trelle, Sven/0000-0002-8162-8910; Reichenbach, Stephan/0000-0001-8098-6567				Alekseeva LI, 1999, TERAPEVT ARKH, V71, P51; Bjordal JM, 2007, EUR J PAIN, V11, P125, DOI 10.1016/j.ejpain.2006.02.013; Bourgeois P, 1998, OSTEOARTHR CARTILAGE, V6, P25, DOI 10.1016/S1063-4584(98)80008-3; Bucsi L, 1998, OSTEOARTHR CARTILAGE, V6, P31, DOI 10.1016/S1063-4584(98)80009-5; Clegg DO, 2006, NEW ENGL J MED, V354, P795, DOI 10.1056/NEJMoa052771; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Conrozier T, 1998, PRESSE MED, V27, P1862; CONROZIER T, 1992, LITERA RHEUMATOIOGIC, V14, P69; CONTE A, 1995, ARZNEIMITTEL-FORSCH, V45-2, P918; CONTE A, 1999, ARZNEIMITTELFORSCH, V41, P768; DEEKS J, 1997, COCHRANE NEWS, V10, P11; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DICKERSIN K, 1994, BMJ-BRIT MED J, V309, P1286, DOI 10.1136/bmj.309.6964.1286; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M, 2003, Health Technol Assess, V7, P1; Egger M., 2001, SYSTEMATIC REV HLTH, V2nd ed., P23, DOI DOI 10.1002/9780470693926.CH2; Felson DT, 2000, ANN INTERN MED, V133, P726, DOI 10.7326/0003-4819-133-9-200011070-00015; FLEISH AM, 1997, OSTEOARTHR CARTILAGE, V5, P70; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hochberg MC, 2006, NEW ENGL J MED, V354, P858, DOI 10.1056/NEJMe058324; International Conference on Harmonization, 1996, INT C HARM TECHN REQ; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Juni P, 2006, BEST PRACT RES CL RH, V20, P721, DOI 10.1016/j.berh.2006.05.002; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; KAHAN A, STOPP NEW 2 YEAR TRI; KERZBERG EM, 1987, SCAND J RHEUMATOL, V16, P377, DOI 10.3109/03009748709102512; LABBE KA, 1987, ANN INTERN MED, V107, P224, DOI 10.7326/0003-4819-107-2-224; Leeb BF, 2000, J RHEUMATOL, V27, P205; LHIRONDEL JL, 1992, LITERA RHEUMATOLOGIC, V14, P77; Light RJ, 1984, SCI REV RES; MALAISE M, 1999, LITERA RHEUMATOLOGIC, V24, P31; Mazieres B, 2006, ANN RHEUM DIS, V65, P398; MAZIERES B, 1992, REV RHUM, V59, P466; Mazieres B, 2001, J RHEUMATOL, V28, P173; McAlindon TE, 2000, JAMA-J AM MED ASSOC, V283, P1469, DOI 10.1001/jama.283.11.1469; Michel BA, 2005, ARTHRITIS RHEUM-US, V52, P779, DOI 10.1002/art.20867; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Morreale P, 1996, J RHEUMATOL, V23, P1385; Nasonova V A, 2001, Ter Arkh, V73, P84; Owens Stephen, 2004, J Knee Surg, V17, P185; PAVELKA K, 1999, LITERA RHUMATOLOGICA, V24, P21; Richy F, 2003, ARCH INTERN MED, V163, P1514, DOI 10.1001/archinte.163.13.1514; Ronca F, 1998, OSTEOARTHR CARTILAGE, V6, P14, DOI 10.1016/S1063-4584(98)80006-X; ROVETTA G, 1991, DRUG EXP CLIN RES, V17, P53; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SMALLEY WE, 1995, AM J EPIDEMIOL, V141, P539, DOI 10.1093/oxfordjournals.aje.a117469; SOROKA NF, 2002, ANN RHEUM DIS S1, V61; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; THOMPSON SG, 1994, BMJ-BRIT MED J, V309, P1351, DOI 10.1136/bmj.309.6965.1351; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Uebelhart D, 1998, OSTEOARTHR CARTILAGE, V6, P39, DOI 10.1016/S1063-4584(98)80011-3; UEBELHART D, 1999, SCHWEIZ MED WOCHENSC, V129, P1174; Volpi N, 2002, OSTEOARTHR CARTILAGE, V10, P768, DOI 10.1053/joca.2002.0824; Wood Angela M, 2004, Clin Trials, V1, P368; 2005, NUTR BUSINESS J, V10, P6	58	220	229	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2007	146	8					580	U51		10.7326/0003-4819-146-8-200704170-00009	http://dx.doi.org/10.7326/0003-4819-146-8-200704170-00009			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158FV	17438317				2022-12-28	WOS:000245778000004
J	Asara, JM; Schweitzer, MH; Freimark, LM; Phillips, M; Cantley, LC				Asara, John M.; Schweitzer, Mary H.; Freimark, Lisa M.; Phillips, Matthew; Cantley, Lewis C.			Protein sequences from mastodon and Tyrannosaurus rex revealed by mass spectrometry	SCIENCE			English	Article							OSTEOCALCIN PROTEIN; SOFT-TISSUE; PRESERVATION; COLLAGEN; BONES; DNA	Fossilized bones from extinct taxa harbor the potential for obtaining protein or DNA sequences that could reveal evolutionary links to extant species. We used mass spectrometry to obtain protein sequences from bones of a 160,000- to 600,000-year-old extinct mastodon (Mammut americanum) and a 68-million-year-old dinosaur (Tyrannosaurus rex). The presence of T. rex sequences indicates that their peptide bonds were remarkably stable. Mass spectrometry can thus be used to determine unique sequences from ancient organisms from peptide fragmentation patterns, a valuable tool to study the evolution and adaptation of ancient taxa from which genomic sequences are unlikely to be obtained.	Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; N Carolina Museum Nat Sci, Raleigh, NC 27601 USA; Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Montana State University System; Montana State University Bozeman; University of North Carolina; North Carolina State University; Harvard University; Harvard Medical School	Asara, JM (corresponding author), Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA.	jasara@bidmc.harvard.edu	Schweitzer, Mary/V-8143-2019; Smejda, Ladislav/B-8474-2008; Cantley, Lewis C/D-1800-2014; schweitzer, mary h/A-6756-2010	Cantley, Lewis C/0000-0002-1298-7653; schweitzer, mary h/0000-0002-0427-3829				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bhattacharjee A, 2005, IUBMB LIFE, V57, P161, DOI 10.1080/15216540500090710; Collins MJ, 2000, GEOLOGY, V28, P1139, DOI 10.1130/0091-7613(2000)28<1139:SRODOO>2.0.CO;2; Dayhoff M.O., 1978, ATLAS PROTEIN SEQ ST; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Hill CL, 2006, QUATERN INT, V142, P87, DOI 10.1016/j.quaint.2005.03.007; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; MARIN M, 2003, NAT BIOTECHNOL, V21, P255; Nielsen-Marsh CM, 2005, P NATL ACAD SCI USA, V102, P4409, DOI 10.1073/pnas.0500450102; Nielsen-Marsh CM, 2002, GEOLOGY, V30, P1099, DOI 10.1130/0091-7613(2002)030<1099:SPOOPA>2.0.CO;2; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; Ostrom PH, 2006, GEOCHIM COSMOCHIM AC, V70, P2034, DOI 10.1016/j.gca.2006.01.004; Pruvost M, 2007, P NATL ACAD SCI USA, V104, P739, DOI 10.1073/pnas.0610257104; Schweitzer MH, 2007, SCIENCE, V316, P277, DOI 10.1126/science.1138709; Schweitzer MH, 2007, P ROY SOC B-BIOL SCI, V274, P183, DOI 10.1098/rspb.2006.3705; Schweitzer MH, 2005, SCIENCE, V307, P1952, DOI 10.1126/science.1108397; Schweitzer MH, 2002, J MOL EVOL, V55, P696, DOI 10.1007/s00239-002-2365-6; Schweitzer MH, 2005, SCIENCE, V308, P1456, DOI 10.1126/science.1112158; Tauber MM, 2000, APPL ENVIRON MICROB, V66, P1634, DOI 10.1128/AEM.66.4.1634-1638.2000; TUROSS N, 1988, GEOCHIM COSMOCHIM AC, V52, P929, DOI 10.1016/0016-7037(88)90364-X; Yang H, 1996, P NATL ACAD SCI USA, V93, P1190, DOI 10.1073/pnas.93.3.1190	25	201	211	2	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					280	285		10.1126/science.1137614	http://dx.doi.org/10.1126/science.1137614			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431180				2022-12-28	WOS:000245654500052
J	Sweatt, JD				Sweatt, J. David			An atomic switch for memory	CELL			English	Editorial Material							PHOSPHORYLATION; CAMKII; LTP	Molecular genetic techniques are beginning to bring about a detailed understanding of the biochemical processes underlying complex cognitive phenomena such as memory, with investigations approaching atomic-level resolution. An excellent example of this is provided in this issue of Cell by Costa-Mattioli et al. (2007), whose results implicate a single protein dephosphorylation event in the control of long-term memory formation in mice.	Univ Alabama, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Alabama, McKnight Brain Inst, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sweatt, JD (corresponding author), Univ Alabama, Dept Neurobiol, SHEL 1010,1825 Univ Blvd, Birmingham, AL 35294 USA.	dsweatt@nrc.uab.edu		Sweatt, J. David/0000-0003-3567-485X				COSTAMATTIOLI M, 2007, CELL; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; van Woerden GM, 2007, NAT NEUROSCI, V10, P280, DOI 10.1038/nn1845; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134	7	2	3	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					23	24		10.1016/j.cell.2007.03.021	http://dx.doi.org/10.1016/j.cell.2007.03.021			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418779	Bronze			2022-12-28	WOS:000245661100004
J	Tse, D; Langston, RF; Kakeyama, M; Bethus, I; Spooner, PA; Wood, ER; Witter, MP; Morris, RGM				Tse, Dorothy; Langston, Rosamund F.; Kakeyama, Masaki; Bethus, Ingrid; Spooner, Patrick A.; Wood, Emma R.; Witter, Menno P.; Morris, Richard G. M.			Schemas and memory consolidation	SCIENCE			English	Article							REMOTE SPATIAL MEMORY; LONG-TERM-MEMORY; COMPLEMENTARY-LEARNING-SYSTEMS; RETROGRADE-AMNESIA; HIPPOCAMPAL-LESIONS; IBOTENATE LESIONS; COGNITIVE MEMORY; RATS; ORGANIZATION; DAMAGE	Memory encoding occurs rapidly, but the consolidation of memory in the neocortex has long been held to be a more gradual process. We now report, however, that systems consolidation can occur extremely quickly if an associative "schema" into which new information is incorporated has previously been created. In experiments using a hippocampal-dependent paired-associate task for rats, the memory of flavor-place associations became persistent over time as a putative neocortical schema gradually developed. New traces, trained for only one trial, then became assimilated and rapidly hippocampal-independent. Schemas also played a causal role in the creation of lasting associative memory representations during one-trial learning. The concept of neocortical schemas may unite psychological accounts of knowledge structures with neurobiological theories of systems memory consolidation.	Univ Edinburgh, Ctr Cognit & Neural Syst, Lab Cognit Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland; Univ Edinburgh, Neurosci Res Ctr, Edinburgh EH8 9JZ, Midlothian, Scotland; Univ Tokyo, Grad Sch, Div Environm Hlth SCi, Ctr Dis Biol & Integrat Med,Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; Med Tech Res Ctr, Ctr Biol Memory, NO-7489 Trondheim, Norway	University of Edinburgh; University of Edinburgh; University of Tokyo; University of Tokyo	Morris, RGM (corresponding author), Univ Edinburgh, Ctr Cognit & Neural Syst, Lab Cognit Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland.	r.g.m.morris@ed.ac.uk	Morris, Richard G M/C-9982-2013	MORRIS, Richard G M/0000-0001-8661-1520; Kakeyama, Masaki/0000-0001-9063-9673; Tse, Dorothy/0000-0003-2263-8139; Langston, Rosamund/0000-0002-4668-3105; Bethus, Ingrid/0000-0001-8356-6963	MRC [G9200370] Funding Source: UKRI; Medical Research Council [G9200370] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Bartlett F. C., 1932, REMEMBERING; Bayley PJ, 2005, NEURON, V46, P799, DOI 10.1016/j.neuron.2005.04.034; Bayley PJ, 2002, J NEUROSCI, V22, P5741; BOLHUIS JJ, 1994, Q J EXP PSYCHOL-B, V47, P129; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Bransford J., 1979, HUMAN COGNITION LEAR; BRANSFORD JD, 1972, J VERB LEARN VERB BE, V11, P717, DOI 10.1016/S0022-5371(72)80006-9; Bunsey M, 1996, NATURE, V379, P255, DOI 10.1038/379255a0; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Clark RE, 2005, HIPPOCAMPUS, V15, P260, DOI 10.1002/hipo.20056; Craik K. J. W., 1943, NATURE EXPLANATION; Day M, 2003, NATURE, V424, P205, DOI 10.1038/nature01769; DUDAI Y, 2001, ADV COGNITIVE SCI, P147; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; EICHENBAUM H, 1990, J NEUROSCI, V10, P3531; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; GREENOUGH WT, 1992, MINN SYM CHILD PSYCH, V24, P155; HARLOW HF, 1949, PSYCHOL REV, V56, P51, DOI 10.1037/h0062474; Hebb Donald O., 1949, ORG BEHAV; Johnson-Laird P. N., 1983, MENTAL MODELS; Kesner RP, 2005, BEHAV NEUROSCI, V119, P781, DOI 10.1037/0735-7044.119.3.781; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Maguire EA, 1999, BRAIN, V122, P1839, DOI 10.1093/brain/122.10.1839; Martin SJ, 2005, NEUROPSYCHOLOGIA, V43, P609, DOI 10.1016/j.neuropsychologia.2004.07.007; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCGONIGLE BO, 1977, NATURE, V267, P694, DOI 10.1038/267694a0; McNaughton, 2003, SLEEP BRAIN PLASTICI, P225, DOI DOI 10.1093/ACPROF:OSO/9780198574002.003.0013; Mishkin M, 1997, PHILOS T R SOC B, V352, P1461, DOI 10.1098/rstb.1997.0132; Miyashita Y, 2004, SCIENCE, V306, P435, DOI 10.1126/science.1101864; Morris RGM, 2006, EUR J NEUROSCI, V23, P2829, DOI 10.1111/j.1460-9568.2006.04888.x; MORRIS RGM, 1990, EUR J NEUROSCI, V2, P1016, DOI 10.1111/j.1460-9568.1990.tb00014.x; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Rosenbaum RS, 2001, BEHAV BRAIN RES, V127, P183, DOI 10.1016/S0166-4328(01)00363-1; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Sutherland RJ, 2001, HIPPOCAMPUS, V11, P27, DOI 10.1002/1098-1063(2001)11:1<27::AID-HIPO1017>3.0.CO;2-4; Teng E, 1999, NATURE, V400, P675, DOI 10.1038/23276; TEYLER TJ, 1986, BEHAV NEUROSCI, V100, P147, DOI 10.1037/0735-7044.100.2.147; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Winocur G, 2005, NAT NEUROSCI, V8, P273, DOI 10.1038/nn1401; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	53	736	742	2	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2007	316	5821					76	82		10.1126/science.1135935	http://dx.doi.org/10.1126/science.1135935			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412951	Green Published			2022-12-28	WOS:000245470500034
J	Rainey, PB				Rainey, Paul B.			Unity from conflict	NATURE			English	Editorial Material									Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Auckland	Rainey, PB (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1, New Zealand.		Rainey, Paul/A-3207-2008	Rainey, Paul/0000-0003-0879-5795				Michod Richard E., 1999, DARWINIAN DYNAMICS E; Okasha S., 2006, EVOLUTION LEVELS SEL, DOI [10.1093/acprof:oso/9780199267972.001.0001, DOI 10.1093/ACPROF:OSO/9780199267972.001.0001]; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Szathmary E, 1995, MAJOR TRANSITIONS EV	4	29	31	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2007	446	7136					616	616		10.1038/446616a	http://dx.doi.org/10.1038/446616a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153LZ	17410161	Bronze			2022-12-28	WOS:000245438300022
J	Berghous, TM; Haeckel, T; Wagner, T; von Scheidt, W; Schwaiblmair, MG				Berghous, Thomas M.; Haeckel, Thomas; Wagner, Theodor; von Scheidt, Wolfgang; Schwaiblmair, Martin G.			Endogenous lipoid pneumonia associated with primary sclerosing cholangitis	LANCET			English	Editorial Material									Univ Munich, Klinikum Augsburg, Dept Med 1, Munich, Germany; Univ Munich, Klinikum Augsburg, Dept Radiol, Munich, Germany; Univ Munich, Klinikum Augsburg, Dept Pathol, Munich, Germany	University of Munich; University of Munich; University of Munich	Schwaiblmair, MG (corresponding author), Univ Munich, Klinikum Augsburg, Dept Med 1, Munich, Germany.	Martin.Schwaiblmair@klinikum-ausberg.de						CHIN NK, 1994, CHEST, V105, P956, DOI 10.1378/chest.105.3.956; Ikehara K, 2002, LANCET, V359, P1300, DOI 10.1016/S0140-6736(02)08269-7; Nicholson AG, 2002, AM J RESP CRIT CARE, V165, P128, DOI 10.1164/ajrccm.165.1.2103113; Sulkowska M, 1997, NEOPLASMA, V44, P167; VIANA MB, 1990, J MED GENET, V27, P132	5	14	14	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR-APR	2007	369	9567					1140	1140		10.1016/S0140-6736(07)60530-3	http://dx.doi.org/10.1016/S0140-6736(07)60530-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151XF	17398313				2022-12-28	WOS:000245323700034
J	Miyamoto, H; Yano, H; Scheeres, DJ; Abe, S; Barnouin-Jha, O; Cheng, AF; Demura, H; Gaskell, RW; Hirata, N; Ishiguro, M; Michikami, T; Nakamura, AM; Nakamura, R; Saito, J; Sasaki, S				Miyamoto, Hideaki; Yano, Hajime; Scheeres, Daniel J.; Abe, Shinsuke; Barnouin-Jha, Olivier; Cheng, Andrew F.; Demura, Hirohide; Gaskell, Robert W.; Hirata, Naru; Ishiguro, Masateru; Michikami, Tatsuhiro; Nakamura, Akiko M.; Nakamura, Ryosuke; Saito, Jun; Sasaki, Sho			Regolith migration and sorting on asteroid Itokawa	SCIENCE			English	Article							INDUCED SEISMIC ACTIVITY; SIZE SEGREGATION; IMPACT; HAYABUSA; FRAGMENTS; VELOCITY; 433-EROS	High-resolution images of the surface of asteroid Itokawa from the Hayabusa mission reveal it to be covered with unconsolidated millimeter-sized and larger gravels. Locations and morphologic characteristics of this gravel indicate that Itokawa has experienced considerable vibrations, which have triggered global-scale granular processes in its dry, vacuum, microgravity environment. These processes likely include granular convection, landslide-like granular migrations, and particle sorting, resulting in the segregation of the fine gravels into areas of potential lows. Granular processes become major resurfacing processes because of Itokawa's small size, implying that they can occur on other small asteroids should those have regolith.	Univ Tokyo, Univ Museum, Dept Museum Collect Utilizat Studies, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Dept Geosyst Engn, Bunkyo Ku, Tokyo 1138656, Japan; Planetary Sci Inst, Tucson, AZ 85719 USA; Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Kanagawa 2298510, Japan; Univ Michigan, Dept Aerosp Engn, Ann Arbor, MI 48109 USA; Kobe Univ, Grad Sch Sci & Technol, Nada Ku, Kobe, Hyogo 6578501, Japan; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Univ Aizu, Dept Comp Software, Aizu Wakamatsu, Fukushima 9658580, Japan; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Seoul Natl Univ, Dept Astron, Seoul 151747, South Korea; Fukushima Natl Coll Technol, Iwaki, Fukushima 9708034, Japan; Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3068568, Japan; Tokai Univ, Sch Engn, Kanagawa 2591292, Japan; Natl Astron Observ Japan, Res Selenodesy Project Off, Mizusawa, Oshu 0230861, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of Michigan System; University of Michigan; Kobe University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Aizu; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Seoul National University (SNU); National Institute of Advanced Industrial Science & Technology (AIST); Tokai University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ)	Miyamoto, H (corresponding author), Univ Tokyo, Univ Museum, Dept Museum Collect Utilizat Studies, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	hm@um.u-tokyo.ac.jp	Nakamura, Akiko/AAC-4191-2020; Abe, Shinsuke/AFU-9903-2022; Miyamoto, Hideaki/E-3381-2012; Barnouin, Olivier S/I-7475-2015; Nakamura, Akiko M/I-1993-2012; Sasaki, Sho/S-3845-2019; Miyamoto, Hideaki/B-9666-2008	Nakamura, Akiko/0000-0001-6990-8496; Abe, Shinsuke/0000-0002-6247-4979; Barnouin, Olivier S/0000-0002-3578-7750; Nakamura, Akiko M/0000-0001-6990-8496; Sasaki, Sho/0000-0002-7646-5248; Miyamoto, Hideaki/0000-0001-8013-6124; Hirata, Naru/0000-0002-2435-604X; Michikami, Tatsuhiro/0000-0003-3096-5789; SCHEERES, DANIEL/0000-0003-0558-3842				Abe S, 2006, SCIENCE, V312, P1344, DOI 10.1126/science.1126272; ASADA N, 1985, J GEOPHYS RES-SOLID, V90, P2445, DOI 10.1029/JB090iB14p12445; ASPHAUG E, 2001, 32 LUN PLAN SCI C AB, P1708; Blair TC, 1999, J SEDIMENT RES, V69, P6, DOI 10.2110/jsr.69.6; Chapman C.R, 2002, ASTEROIDS, VIII, P315; Cheng AF, 2002, METEORIT PLANET SCI, V37, P1095, DOI 10.1111/j.1945-5100.2002.tb00880.x; CLEMENT E, 1992, PHYS REV LETT, V69, P1189, DOI 10.1103/PhysRevLett.69.1189; EVESQUE P, 1989, PHYS REV LETT, V62, P44, DOI 10.1103/PhysRevLett.62.44; Flynn GJ, 2004, PLANET SPACE SCI, V52, P1129, DOI 10.1016/j.pss.2004.07.010; Fujiwara A, 2006, SCIENCE, V312, P1330, DOI 10.1126/science.1125841; Guibout V, 2003, CELEST MECH DYN ASTR, V87, P263, DOI 10.1023/B:CELE.0000005720.09027.ee; Jaeger HM, 1996, REV MOD PHYS, V68, P1259, DOI 10.1103/RevModPhys.68.1259; JIONGMING Z, 1998, IL NUOVO CIMENTO, V20, P1443; KNIGHT JB, 1993, PHYS REV LETT, V70, P3728, DOI 10.1103/PhysRevLett.70.3728; Lambe T.W., 1979, SOIL MECH; Lee P, 1996, ICARUS, V124, P181, DOI 10.1006/icar.1996.0197; NAKAMURA AM, 1994, PLANET SPACE SCI, V42, P1043, DOI 10.1016/0032-0633(94)90005-1; Richardson JE, 2005, ICARUS, V179, P325, DOI 10.1016/j.icarus.2005.07.005; Richardson JE, 2004, SCIENCE, V306, P1526, DOI 10.1126/science.1104731; ROSATO A, 1987, PHYS REV LETT, V58, P1038, DOI 10.1103/PhysRevLett.58.1038; Saito J, 2006, SCIENCE, V312, P1341, DOI 10.1126/science.1125722; Scheeres D.J., 2005, LUN PLAN SCI C ABSTR, V36, P1919; SCHEERES DJ, 2007, ICARUS B; Thomas PC, 2005, NATURE, V436, P366, DOI 10.1038/nature03855; Yano H, 2006, SCIENCE, V312, P1350, DOI 10.1126/science.1126164	25	224	225	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2007	316	5827					1011	1014		10.1126/science.1134390	http://dx.doi.org/10.1126/science.1134390			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	168WF	17446355				2022-12-28	WOS:000246554000042
J	Kostelansky, MS; Schluter, C; Tam, YYC; Lee, S; Ghirlando, R; Beach, B; Conibear, E; Hurley, JH				Kostelansky, Michael S.; Schluter, Cayetana; Tam, Yuen Yi C.; Lee, Sangho; Ghirlando, Rodolfo; Beach, Bridgette; Conibear, Elizabeth; Hurley, James H.			Molecular architecture and functional model of the complete yeast ESCRT-I heterotetramer	CELL			English	Article							SORTING COMPLEX; UBIQUITIN RECOGNITION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; TRANSPORT; PROTEINS; TSG101; DOMAIN; COMPONENT; PATHWAY	The endosomal sorting complex required for transport-1 (ESCRT-1) complex, which is conserved from yeast to humans, directs the lysosomal degradation of ubiquitinated transmembrane proteins and the budding of the HIV virus. Yeast ESCRT-1 contains four subunits, Vps23, Vps28, Vps37, and Mvb12. The crystal structure of the heterotetrameric ESCRT-1 complex reveals a highly asymmetric complex of 1:1:1:1 subunit stoichiometry. The core complex is nearly 18 nm long and consists of a headpiece attached to a 13 nm stalk. The stalk is important for cargo sorting by ESCRT-1 and is proposed to serve as a spacer regulating the correct disposition of cargo and other ESCRT components. Hydrodynamic constraints and crystallographic structures were used to generate a model of intact ESCRT-1 in solution. The results show how ESCRT-1 uses a combination of a rigid stalk and flexible tethers to interact with lipids, cargo, and other ESCRT complexes over a span of similar to 25 nm.	NIDDKD, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Univ British Columbia, Ctr Mol Med & Therapeut, Child & Family Res Inst, Dept Med Genet, Vancouver, BC V5Z 4H4, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Child & Family Research Institute; University of British Columbia	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	hurley@helix.nih.gov	Ghirlando, Rodolfo/A-8880-2009; Lee, Sangho/P-4204-2018; Conibear, Elizabeth/G-5297-2010	Lee, Sangho/0000-0003-3886-4579; Conibear, Elizabeth/0000-0001-5129-0499	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK033007, Z01DK036118, Z01DK036123] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DK036118-14] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Bilodeau PS, 2003, J CELL BIOL, V163, P237, DOI 10.1083/jcb.200305007; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Chu T, 2006, J CELL BIOL, V175, P815, DOI 10.1083/jcb.200608053; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Conibear E, 2002, METHOD ENZYMOL, V351, P408; Conibear E, 2002, MOL CELL, V10, P215, DOI 10.1016/S1097-2765(02)00601-9; Curtiss M, 2007, MOL BIOL CELL, V18, P636, DOI 10.1091/mbc.E06-07-0588; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Eastman SW, 2005, J BIOL CHEM, V280, P628, DOI 10.1074/jbc.M410384200; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gill DJ, 2007, EMBO J, V26, P600, DOI 10.1038/sj.emboj.7601501; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kostelansky MS, 2006, CELL, V125, P113, DOI 10.1016/j.cell.2006.01.049; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Oestreich AJ, 2007, MOL BIOL CELL, V18, P646, DOI 10.1091/mbc.E06-07-0601; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pineda-Molina E, 2006, TRAFFIC, V7, P1007, DOI 10.1111/j.1600-0854.2006.00440.x; Pornillos O, 2002, NAT STRUCT BIOL, V9, P812, DOI 10.1038/nsb856; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Slagsvold T, 2005, J BIOL CHEM, V280, P19600, DOI 10.1074/jbc.M501510200; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; Sundquist WI, 2004, MOL CELL, V13, P783, DOI 10.1016/S1097-2765(04)00129-7; Teo H, 2004, J BIOL CHEM, V279, P28689, DOI 10.1074/jbc.M400023200; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047	43	118	127	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2007	129	3					485	498		10.1016/j.cell.2007.03.016	http://dx.doi.org/10.1016/j.cell.2007.03.016			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	166IY	17442384	Green Accepted, Bronze			2022-12-28	WOS:000246373600016
J	Thompson, KM; Tebbens, RJD				Thompson, Kimberly M.; Tebbens, Radboud J. Duintjer			Eradication versus control for poliomyelitis: an economic analysis	LANCET			English	Article							VACCINE-DERIVED POLIOVIRUSES; POLIO ERADICATION; RISK-MANAGEMENT; OPV CESSATION; DISEASE; WILD; CONTAINMENT; OUTBREAKS	Background Worldwide eradication of wild polioviruses is likely to yield substantial health and financial benefits, provided we finish the job. Challenges in the four endemic areas combined with continuing demands for financial resources for eradication have led some to question the goal of eradication and to suggest switching to a policy of control. Methods We developed a dynamic model, based on modelling of the currently endemic areas in India, to show the importance of maintaining and increasing the immunisation intensity to complete eradication and to illustrate how policies based on perception about high short-term costs or cost-effectiveness ratios without consideration of long-term benefits could undermine any eradication effort. An extended model assesses the economic implications and disease burden of a change in policy from eradication to control. Findings Our results suggest that the intensity of immunisation must be increased to achieve eradication, and that even small decreases in intensity could lead to large outbreaks. This finding implies the need to pay even higher short-run costs than are currently being spent, which will further exacerbate concerns about continued investment in interventions with high perceived cost-effectiveness ratios. We show that a wavering commitment leads to a failure to eradicate, greater cumulative costs, and a much larger number of cases. We further show that as long as it is technically achievable, eradication offers both lower cumulative costs and cases than control, even with the costs of achieving eradication exceeding several billion dollars more. A low-cost control policy that relies only on routine immunisation for 20 years with discounted costs of more than $3500 million could lead to roughly 200000 expected paralytic poliomyelitis cases every year in low-income countries, whereas a low-case control policy that keeps the number of cases at about 1500 per year could cost around $10000 million discounted over the 20 years. Interpretation Focusing on the large costs for poliomyelitis eradication, without assessing the even larger potential benefits of eradication and the enormous long-term costs of effective control, might inappropriately affect commitments to the goal of eradication, and thus debate should include careful consideration of the options.	Harvard Univ, Sch Publ Hlth, Kids Risk Project, Boston, MA 02115 USA; MIT, Alfred P Sloan Sch Management, Cambridge, MA 02139 USA	Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT)	Thompson, KM (corresponding author), Harvard Univ, Sch Publ Hlth, Kids Risk Project, 665 Huntington Ave, Boston, MA 02115 USA.	kimt@hsph.harvard.edu		Thompson, Kimberly/0000-0002-0849-9147				ANDERSON R M, 1991; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P286; Arita I, 2006, SCIENCE, V312, P852, DOI 10.1126/science.1124959; Auld MC, 2003, J HEALTH ECON, V22, P361, DOI 10.1016/S0167-6296(02)00103-0; Aylward RB, 2006, RISK ANAL, V26, P1441, DOI 10.1111/j.1539-6924.2006.00840.x; Aylward RB, 2005, SCIENCE, V310, P625, DOI 10.1126/science.1115547; Aylward RB, 2004, B WORLD HEALTH ORGAN, V82, P40; Barrett S, 2004, B WORLD HEALTH ORGAN, V82, P683; Barrett S., 2003, OPTIMAL DIS ERADICAT; Barrett S, 2003, J EUR ECON ASSOC, V1, P591, DOI 10.1162/154247603322391224; Bart KJ, 1996, B WORLD HEALTH ORGAN, V74, P35; BRITO DL, 1991, J PUBLIC ECON, V45, P69, DOI 10.1016/0047-2727(91)90048-7; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P145; Dowdle W, 2006, RISK ANAL, V26, P1449, DOI 10.1111/j.1539-6924.2006.00844.x; Dowdle WR, 2003, REV MED VIROL, V13, P277, DOI 10.1002/rmv.401; Dowdle WR, 2002, B WORLD HEALTH ORGAN, V80, P311; Dowdle WR, 1997, J INFECT DIS, V175, pS286, DOI 10.1093/infdis/175.Supplement_1.S286; *E MED REG WHO OFF, POL FAX; Eichner E, 1996, AM J EPIDEMIOL, V143, P816, DOI 10.1093/oxfordjournals.aje.a008820; Fine P E, 2001, Dev Biol (Basel), V105, P129; Fine PEM, 2004, B WORLD HEALTH ORGAN, V82, P47; Francis PJ, 1997, J PUBLIC ECON, V63, P383, DOI 10.1016/S0047-2727(96)01586-1; Geoffard PY, 1997, AM ECON REV, V87, P222; Gersovitz M, 2003, WORLD BANK RES OBSER, V18, P129, DOI 10.1093/wbro/lkg011; Gold MR, 1996, COST EFFECTIVENESS H; Government of India, 2006, POPULATION PROJECTIO; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Henderson DA, 2002, CLIN INFECT DIS, V34, P79, DOI 10.1086/323897; Henderson DA, 1999, MMWR-MORBID MORTAL W, V48, P16; Jezek Z, 1988, HUMAN MONKEYPOX; Kew OM, 2004, B WORLD HEALTH ORGAN, V82, P16; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Khan MM, 2003, VACCINE, V21, P702, DOI 10.1016/S0264-410X(02)00584-4; Kimman TG, 2006, LANCET INFECT DIS, V6, P675, DOI 10.1016/S1473-3099(06)70603-X; Musgrove P, 1988, Bull Pan Am Health Organ, V22, P1; *OFF ARW, WILD POL INF 2005; *S E AS REG WHO OF, VPD SURV B; Sangrujee Nalinee, 2003, MedGenMed, V5, P35; Sterman J., 2010, BUSINESS DYNAMICS, DOI DOI 10.4324/9781351152723-7; STERMAN JD, 1989, ORGAN BEHAV HUM DEC, V43, P301, DOI 10.1016/0749-5978(89)90041-1; Tebbens RJD, 2006, RISK ANAL, V26, P1471, DOI 10.1111/j.1539-6924.2006.00827.x; Tebbens RJD, 2006, RISK ANAL, V26, P1507, DOI 10.1111/j.1539-6924.2006.00842.x; Tebbens RJD, 2005, AM J EPIDEMIOL, V162, P358, DOI 10.1093/aje/kwi206; Thompson KM, 2006, RISK ANAL, V26, P1423, DOI 10.1111/j.1539-6924.2006.00831.x; Thompson KM, 2006, RISK ANAL, V26, P1541, DOI 10.1111/j.1539-6924.2006.00843.x; *UN POP DIV, WORLD POP PROSP POP; *WHO, POL CAS COUNC; WHO, 2006, WKLY EPIDEMIOL REC, V81, P453; *WHO, 2004, UNPUB PROJ; *WHO, 2006, WHOPOLIO060120062008; *WORLD BANK, 2002, WORLD BANK LIST EC	51	121	125	1	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1363	1371		10.1016/S0140-6736(07)60532-7	http://dx.doi.org/10.1016/S0140-6736(07)60532-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	159HL	17448822				2022-12-28	WOS:000245856100029
J	Han, JH; Kushner, SA; Yiu, AP; Cole, CJ; Matynia, A; Brown, RA; Neve, RL; Guzowski, JF; Silva, AJ; Josselyn, SA				Han, Jin-Hee; Kushner, Steven A.; Yiu, Adelaide P.; Cole, Christy J.; Matynia, Anna; Brown, Robert A.; Neve, Rachael L.; Guzowski, John F.; Silva, Alcino J.; Josselyn, Sheena A.			Neuronal competition and selection during memory formation	SCIENCE			English	Article							ELEMENT-BINDING PROTEIN; LONG-TERM-MEMORY; FEAR MEMORIES; IN-VIVO; AMYGDALA; CREB; EXPRESSION; OVEREXPRESSION; PLASTICITY; ACTIVATOR	Competition between neurons is necessary for refining neural circuits during development and may be important for selecting the neurons that participate in encoding memories in the adult brain. To examine neuronal competition during memory formation, we conducted experiments with mice in which we manipulated the function of CREB ( adenosine 3',5'-monophosphate response element-binding protein) in subsets of neurons. Changes in CREB function influenced the probability that individual lateral amygdala neurons were recruited into a fear memory trace. Our results suggest a competitive model underlying memory formation, in which eligible neurons are selected to participate in a memory trace as a function of their relative CREB activity at the time of learning.	Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Harvard Univ, Sch Med, Dept Psychiat, Mol Neurogenet Lab, Belmont, MA 02478 USA; Univ Calif Irvine, Sch Biol Sci, Irvine, CA 92697 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Columbia University; New York State Psychiatry Institute; Harvard University; University of California System; University of California Irvine	Josselyn, SA (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sheena.josselyn@sickkids.ca	Silva, Alcino/ABD-7684-2021; Han, Jin-Hee/C-2069-2011	Silva, Alcino/0000-0002-1587-4558; Kushner, Steven/0000-0002-9777-3338; Han, Jin-Hee/0000-0002-2139-5596; Silva, Alcino/0000-0001-5525-0494	NIA NIH HHS [AG13622] Funding Source: Medline; NICHD NIH HHS [P01HD33098] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD033098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013622, U01AG013622, R01AG013622] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barco A, 2005, NEURON, V48, P123, DOI 10.1016/j.neuron.2005.09.005; Barrientos RM, 2002, BEHAV BRAIN RES, V134, P299, DOI 10.1016/S0166-4328(02)00045-1; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Dong Y, 2006, NAT NEUROSCI, V9, P475, DOI 10.1038/nn1661; Du KY, 2000, MOL CELL BIOL, V20, P4320, DOI 10.1128/MCB.20.12.4320-4327.2000; Fanselow MS, 2003, ANN NY ACAD SCI, V985, P125; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Jasnow AM, 2005, BEHAV NEUROSCI, V119, P1125, DOI 10.1037/0735-7044.119.4.1125; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; Mower AF, 2002, J NEUROSCI, V22, P2237, DOI 10.1523/JNEUROSCI.22-06-02237.2002; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Pham TA, 2001, NEURON, V31, P409, DOI 10.1016/S0896-6273(01)00381-6; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; WAITEREIT R, 2001, J NEUROSCI, V21, P5484; Wallace TL, 2004, BIOL PSYCHIAT, V56, P151, DOI 10.1016/j.biopsych.2004.04.010; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5	27	422	444	4	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					457	460		10.1126/science.1139438	http://dx.doi.org/10.1126/science.1139438			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446403				2022-12-28	WOS:000245813400059
J	Smogorzewska, A; Matsuoka, S; Vinciguerra, P; McDonald, ER; Hurov, KE; Luo, J; Ballif, BA; Gygi, SP; Hofmann, K; D'Andrea, AD; Elledge, SJ				Smogorzewska, Agata; Matsuoka, Shuhei; Vinciguerra, Patrizia; McDonald, E. Robert, III; Hurov, Kristen E.; Luo, Ji; Ballif, Bryan A.; Gygi, Steven P.; Hofmann, Kay; D'Andrea, Alan D.; Elledge, Stephen J.			Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair	CELL			English	Article							HOMOLOGOUS RECOMBINATION; DAMAGE RESPONSE; ANEMIA PATHWAY; COMPLEX; CHROMATIN; CANCER; BRCA2; PALB2; PHOSPHORYLATION; EXPRESSION	Fanconi anemia (FA) is a developmental and cancer-predisposition syndrome caused by mutations in genes controlling DNA interstrand crosslink repair. Several FA proteins form a ubiquitin ligase that controls monoubiquitination of the FANCD2 protein in an ATR-dependent manner. Here we describe the FA protein FANCI, identified as an ATM/ATR kinase substrate required for resistance to mitomycin C. FANCI shares sequence similarity with FANCD2, likely evolving from a common ancestral gene. The FANCI protein associates with FANCD2 and, together, as the FANCI-FANCD2 (ID) complex, localize to chromatin in response to DNA damage. Like FANCD2, FANCI is monoubiquitinated and unexpectedly, ubiquitination of each protein is important for the maintenance of ubiquitin on the other, indicating the existence of a dual ubiquitin-locking mechanism required for ID complex function. Mutation in FANCI is responsible for loss of a functional FA pathway in a patient with Fanconi anemia complementation group I.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Howard Hughes Med Inst,Ctr Genet & Genom,Dept Gen, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02214 USA; Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02215 USA; Miltenyi Biotec GmbH, D-50829 Cologne, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Miltenyi Biotec	Elledge, SJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Howard Hughes Med Inst,Ctr Genet & Genom,Dept Gen, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	高, 雨莉/HGU-8187-2022; Hofmann, Kay/D-6714-2011; Smogorzewska, Agata/B-8891-2011	Hofmann, Kay/0000-0002-2289-9083; Smogorzewska, Agata/0000-0001-6285-1562	NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL052725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM044664] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [T32CA09216, T32 CA009216] Funding Source: Medline; NHLBI NIH HHS [R37 HL052725] Funding Source: Medline; NIAID NIH HHS [U19 AI067751-01, U19 AI067751-020002, U19 AI067751] Funding Source: Medline; NIGMS NIH HHS [R37 GM044664-18, R37 GM044664, R37 GM044664-19] Funding Source: Medline; PHS HHS [1U19A1067751] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Addison CL, 1997, J GEN VIROL, V78, P1653, DOI 10.1099/0022-1317-78-7-1653; Alter BP, 2003, BLOOD, V101, P2072, DOI 10.1182/blood-2002-11-3597; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; BUTTURINI A, 1994, BLOOD, V84, P1650, DOI 10.1182/blood.V84.5.1650.bloodjournal8451650; de Oca RM, 2005, BLOOD, V105, P1003, DOI 10.1182/blood-2003-11-3997; ELLEDGE SJ, 1991, P NATL ACAD SCI USA, V88, P1731, DOI 10.1073/pnas.88.5.1731; FANCONI G., 1967, SEMINARS HAMATOL, V4, P233; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gurtan AM, 2006, DNA REPAIR, V5, P1119, DOI 10.1016/j.dnarep.2006.05.009; Ho GPH, 2006, MOL CELL BIOL, V26, P7005, DOI 10.1128/MCB.02018-05; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; JAKOBS PM, 1996, CELL MOL GENET, V22, P151; Levitus M, 2004, BLOOD, V103, P2498, DOI 10.1182/blood-2003-08-2915; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Meetei AR, 2004, CELL CYCLE, V3, P179; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; SCHMID W, 1978, CYTOGENET CELL GENET, V20, P141, DOI 10.1159/000130845; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yamamoto K, 2005, MOL CELL BIOL, V25, P34, DOI 10.1128/MCB.25.1.34-43.2005; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	38	528	543	1	39	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2007	129	2					289	301		10.1016/j.cell.2007.03.009	http://dx.doi.org/10.1016/j.cell.2007.03.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17412408	Bronze, Green Accepted			2022-12-28	WOS:000246474600017
J	Zhao, Y; Ransom, JF; Li, A; Vedantham, V; von Drehle, M; Muth, AN; Tsuchihashi, T; McManus, MT; Schwartz, RJ; Srivastava, D				Zhao, Yong; Ransom, Joshua F.; Li, Ankang; Vedantham, Vasanth; von Drehle, Morgan; Muth, Alecia N.; Tsuchihashi, Takatoshi; McManus, Michael T.; Schwartz, Robert J.; Srivastava, Deepak			Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2	CELL			English	Article							BHLH TRANSCRIPTION FACTOR; MUSCLE-SPECIFIC MICRORNA; C-ELEGANS; CARDIOVASCULAR DEVELOPMENT; CAENORHABDITIS-ELEGANS; HEART-DISEASE; DIFFERENTIATION; MORPHOGENESIS; RNA; HYPERTROPHY	MicroRNAs (miRNAs) are genomically encoded small RNAs used by organisms to regulate the expression of proteins generated from messenger RNA transcripts. The in vivo requirement of specific miRNAs in mammals through targeted deletion remains unknown, and reliable prediction of mRNA targets is still problematic. Here, we show that miRNA biogenesis in the mouse heart is essential for cardiogenesis. Furthermore, targeted deletion of the muscle-specific miRNA, miR-1-2, revealed numerous functions in the heart, including regulation of cardiac morphogenesis, electrical conduction, and cellcycle control. Analyses of miR-1 complementary sequences in mRNAs upregulated upon miR-1-2 deletion revealed an enrichment of miR-1 '' seed matches '' and a strong tendency for potential miR-1 binding sites to be located in physically accessible regions. These findings indicate that subtle alteration of miRNA dosage can have profound consequences in mammals and demonstrate the utility of mammalian lossof-function models in revealing physiologic miRNA targets.	Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Pediat Cardiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Internal Med Cardiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; Baylor Coll Med, Grad Program Cardiovasc Sci, Houston, TX 77030 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Srivastava, D (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, 1650 Owens St, San Francisco, CA 94158 USA.	dsrivastava@gladstone.ucsf.edu	mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569; Vedantham, Vasanth/0000-0003-1032-700X; Ransom, Joshua/0000-0002-3591-0288	NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007731] Funding Source: NIH RePORTER; NCRR NIH HHS [C06 RR018928] Funding Source: Medline; NHLBI NIH HHS [T32HL007731] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheng CF, 2003, TRENDS MOL MED, V9, P59, DOI 10.1016/S1471-4914(03)00004-2; Cohen SM, 2006, GENE DEV, V20, P2769, DOI 10.1101/gad.1484606; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Desai AD, 2006, AM J MED, V119, P600, DOI 10.1016/j.amjmed.2005.08.028; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Fischer A, 2003, TRENDS CARDIOVAS MED, V13, P221, DOI 10.1016/S1050-1738(03)00082-3; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Gourdie RG, 1999, TRENDS CARDIOVAS MED, V9, P18, DOI 10.1016/S1050-1738(98)00035-8; HAFE BD, 2005, P NATL ACAD SCI USA, V102, P10898; Hoffman JIE, 2004, AM HEART J, V147, P425, DOI 10.1016/j.ahj.2003.05.003; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Liao J, 2004, HUM MOL GENET, V13, P1577, DOI 10.1093/hmg/ddh176; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; MacLellan WR, 2000, ANNU REV PHYSIOL, V62, P289, DOI 10.1146/annurev.physiol.62.1.289; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Mendez-Ferrer S, 2006, NAT CLIN PRACT CARD, V3, pS8; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; RAO PK, 2006, IN PRESS P NATL ACAD; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Wei Y, 1998, P NATL ACAD SCI USA, V95, P7480, DOI 10.1073/pnas.95.13.7480; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xin M, 2006, P NATL ACAD SCI USA, V103, P11189, DOI 10.1073/pnas.0604604103; Yamagishi H, 2003, GENE DEV, V17, P269, DOI 10.1101/gad.1048903; Yamagishi H, 2001, DEV BIOL, V239, P190, DOI 10.1006/dbio.2001.0417; Yelon D, 2000, DEVELOPMENT, V127, P2573; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; ZHAO Y, 2007, IN PRESS TRENDS BIOC; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	69	1069	1182	1	82	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2007	129	2					303	317		10.1016/j.cell.2007.03.030	http://dx.doi.org/10.1016/j.cell.2007.03.030			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	167TI	17397913	Bronze			2022-12-28	WOS:000246474600018
J	Wilson, JF				Wilson, Jennifer Fisher			Posttraumatic stress disorder needs to be recognized in primary care	ANNALS OF INTERNAL MEDICINE			English	News Item							INTERNATIONAL CONSENSUS GROUP; ANXIETY; DEPRESSION; STATEMENT					jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Ballenger JC, 2000, J CLIN PSYCHIAT, V61, P60; Ballenger JC, 2004, J CLIN PSYCHIAT, V65, P55; BLAKE DD, 1990, CLIN ADM PTSD SCALE; Culpepper L, 2006, J CLIN PSYCHIAT, V67, P31; Frueh BC, 1997, J PERS ASSESS, V68, P369, DOI 10.1207/s15327752jpa6802_8; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Okie S, 2006, NEW ENGL J MED, V355, P2609, DOI 10.1056/NEJMp068235; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; Schelling G, 2001, BIOL PSYCHIAT, V50, P978, DOI 10.1016/S0006-3223(01)01270-7; *US DEP VET AFF OF, 2005, REV STAT VAR VA DIS; Weathers FW, 1991, PTSD CHECKLIST CIVIL	12	5	6	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2007	146	8					617	620		10.7326/0003-4819-146-8-200704170-00025	http://dx.doi.org/10.7326/0003-4819-146-8-200704170-00025			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158FV	17438329				2022-12-28	WOS:000245778000019
J	Harris, RA; Rogers, J; Milosavljevic, A				Harris, R. A.; Rogers, J.; Milosavljevic, A.			Human-specific changes of genome structure detected by genomic triangulation	SCIENCE			English	Article							RHESUS MACAQUE; SEGMENTAL DUPLICATIONS; ANCESTRAL GENOME; CHIMPANZEE; SEQUENCE; RECONSTRUCTION; REARRANGEMENT; EVOLUTIONARY; CYTOGENETICS; MODELS	Knowledge of the rhesus macaque genome sequence enables reconstruction of the ancestral state of the human genome before the divergence of chimpanzees. However, the draft quality of nonhuman primate genome assemblies challenges the ability of current methods to detect insertions, deletions, and copy-number variations between humans, chimpanzees, and rhesus macaques and hinders the identification of evolutionary changes between these species. Because of the abundance of segmental duplications, genome comparisons require the integration of genomic assemblies and data from large-insert clones, linkage maps, and radiation hybrid maps. With genomic triangulation, an integrative method that reconstructs ancestral states and the structural evolution of genomes, we identified 130 human-specific breakpoints in genome structure due to rearrangements at an intermediate scale ( 10 kilobases to 4 megabases), including 64 insertions affecting 58 genes. Comparison with a human structural polymorphism database indicates that many of the rearrangements are polymorphic.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA	Baylor College of Medicine; Baylor College of Medicine; Texas Biomedical Research Institute	Milosavljevic, A (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.		Harris, R. Alan/AAI-2784-2020	Harris, R. Alan/0000-0002-7333-4752	NATIONAL CENTER FOR RESEARCH RESOURCES [U01RR018464, R24RR015383] Funding Source: NIH RePORTER	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Barton NH, 2006, CURR BIOL, V16, pR647, DOI 10.1016/j.cub.2006.07.032; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bourque G, 2006, GENOME RES, V16, P311, DOI 10.1101/gr.4631806; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Froenicke L, 2006, GENOME RES, V16, P306, DOI 10.1101/gr.3955206; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Goidts V, 2006, HUM GENET, V120, P270, DOI 10.1007/s00439-006-0217-y; Kalafus KJ, 2004, GENOME RES, V14, P672, DOI 10.1101/gr.1963804; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Ma J, 2006, GENOME RES, V16, P1557, DOI 10.1101/gr.5383506; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Milosavljevic A, 2005, GENOME RES, V15, P292, DOI 10.1101/gr.3162505; Murphy WJ, 2005, GENOMICS, V86, P383, DOI 10.1016/j.ygeno.2005.05.013; Myers G, 1999, COMPUT SCI ENG, V1, P33, DOI 10.1109/5992.764214; Newman TL, 2005, GENOME RES, V15, P1344, DOI 10.1101/gr.4338005; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Popesco MC, 2006, SCIENCE, V313, P1304, DOI 10.1126/science.1127980; Rocchi M, 2006, GENOME RES, V16, P1441, DOI 10.1101/gr.5687906; Rogers J, 2006, GENOMICS, V87, P30, DOI 10.1016/j.ygeno.2005.10.004; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Wienberg J, 2005, CYTOGENET GENOME RES, V108, P139, DOI 10.1159/000080811; Wilson GM, 2006, GENOME RES, V16, P173, DOI 10.1101/gr.4456006; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861	25	21	23	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					235	237		10.1126/science.1139477	http://dx.doi.org/10.1126/science.1139477			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431168				2022-12-28	WOS:000245654500038
J	Fox, MA; Sanes, JR; Borza, DB; Eswarakumar, VP; Fassler, R; Hudson, BG; John, SWM; Ninomiya, Y; Pedchenko, V; Pfaff, SL; Rheault, MN; Sado, Y; Segal, Y; Werle, MJ; Umemori, H				Fox, Michael A.; Sanes, Joshua R.; Borza, Dorin-Bogdan; Eswarakumar, Veraragavan P.; Faessler, Reinhard; Hudson, Billy G.; John, Simon W. M.; Ninomiya, Yoshifumi; Pedchenko, Vadim; Pfaff, Samuel L.; Rheault, Michelle N.; Sado, Yoshikazu; Segal, Yoav; Werle, Michael J.; Umemori, Hisashi			Distinct target-derived signals organize formation, maturation, and maintenance of motor nerve terminals	CELL			English	Article							FIBROBLAST-GROWTH-FACTOR; NEUROMUSCULAR-JUNCTION; BASEMENT-MEMBRANE; IV COLLAGEN; ALPORT-SYNDROME; NEUROTRANSMITTER RELEASE; NONCOLLAGENOUS DOMAINS; CALCIUM-CHANNEL; XVIII COLLAGEN; MUTANT MICE	Target-derived factors organize synaptogenesis by promoting differentiation of nerve terminals at synaptic sites. Several candidate organizing molecules have been identified based on their bioactivities in vitro, but little is known about their roles in vivo. Here, we show that three sets of organizers act sequentially to pattern motor nerve terminals: FGFs, beta 2 laminins, and collagen alpha(IV) chains. FGFs of the 7/10/22 subfamily and broadly distributed collagen IV chains (alpha 1/2) promote clustering of synaptic vesicles as nerve terminals form. beta 2 laminins concentrated at synaptic sites are dispensable for embryonic development of nerve terminals but are required for their postnatal maturation. Synapse-specific collagen IV chains (alpha 3-6) accumulate only after synapses are mature and are required for synaptic maintenance. Thus, multiple target-derived signals permit discrete control of the formation, maturation, and maintenance of presynaptic specializations.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37232 USA; Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; Howard Hughes Med Inst, Bar Harbor, ME 04609 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Okayama Univ, Dept Mol Biol & Biochem, Okayama 700, Japan; Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Univ Minnesota, Dept Med, Div Renal, Minneapolis, MN 55455 USA; Shigei Med Res Inst, Div Immunol, Okayama 7010202, Japan; Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA; Univ Michigan, Sch Med, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	Harvard University; Yale University; Vanderbilt University; Max Planck Society; Howard Hughes Medical Institute; Jackson Laboratory; Okayama University; Salk Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Kansas; University of Kansas Medical Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sanes, JR (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	sanesj@mcb.harvard.edu	Borza, Dorin-Bogdan/AAF-2156-2020; Pedchenko, Vadim/A-6873-2009	Borza, Dorin-Bogdan/0000-0003-4568-279X; Eswarakumar, V.P./0000-0001-7941-8714; Hudson, Billy/0000-0002-5420-4100; Eswarakumar, Jacob/0000-0003-0784-0507; Umemori, Hisashi/0000-0001-7198-2062; Rheault, Michelle N./0000-0003-2494-3970; Fox, Michael/0000-0002-1649-7782				Ackley BD, 2001, J CELL BIOL, V152, P1219, DOI 10.1083/jcb.152.6.1219; Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Borza DB, 2001, J BIOL CHEM, V276, P28532, DOI 10.1074/jbc.M103690200; Boutaud A, 2000, J BIOL CHEM, V275, P30716, DOI 10.1074/jbc.M004569200; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cosgrove D, 1996, GENE DEV, V10, P2981, DOI 10.1101/gad.10.23.2981; Craig AM, 2006, TRENDS NEUROSCI, V29, P8, DOI 10.1016/j.tins.2005.11.002; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Eswarakumar VP, 2002, DEVELOPMENT, V129, P3783; Feng GP, 2000, NEURON, V25, P295, DOI 10.1016/S0896-6273(00)80895-8; Fox MA, 2006, J NEUROCHEM, V97, P1215, DOI 10.1111/j.1471-4159.2006.03834.x; Goritz C, 2005, MOL CELL NEUROSCI, V29, P190, DOI 10.1016/j.mcn.2005.02.006; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; HENDERSON CE, 1996, NERVE CELL CULTURE P, P69; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; Knight D, 2003, J PHYSIOL-LONDON, V546, P789, DOI 10.1113/jphysiol.2002.030924; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Kummer TT, 2004, J CELL BIOL, V164, P1077, DOI 10.1083/jcb.200401115; Lee SK, 2004, DEVELOPMENT, V131, P3295, DOI 10.1242/dev.01179; LEIN PJ, 1991, J CELL BIOL, V113, P417, DOI 10.1083/jcb.113.2.417; LUPA MT, 1990, DEV BIOL, V142, P31, DOI 10.1016/0012-1606(90)90148-C; Miner JH, 2006, DEVELOPMENT, V133, P967, DOI 10.1242/dev.02270; MINER JH, 1994, J CELL BIOL, V127, P879, DOI 10.1083/jcb.127.3.879; Miner JH, 1996, J CELL BIOL, V135, P1403, DOI 10.1083/jcb.135.5.1403; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; NINOMIYA Y, 1995, J CELL BIOL, V130, P1219, DOI 10.1083/jcb.130.5.1219; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; OOHASHI T, 1995, J BIOL CHEM, V270, P26863, DOI 10.1074/jbc.270.45.26863; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Ortega N, 2002, J CELL SCI, V115, P4201, DOI 10.1242/jcs.00106; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Petitclerc E, 2000, J BIOL CHEM, V275, P8051, DOI 10.1074/jbc.275.11.8051; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Pun S, 2002, NEURON, V34, P357, DOI 10.1016/S0896-6273(02)00670-0; Rheault MN, 2004, J AM SOC NEPHROL, V15, P1466, DOI 10.1097/01.ASN.0000130562.90255.8F; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schneider VA, 2006, NEURON, V50, P683, DOI 10.1016/j.neuron.2006.04.024; Smirnov SP, 2005, J BIOL CHEM, V280, P41449, DOI 10.1074/jbc.M508939200; Son YJ, 1999, EUR J NEUROSCI, V11, P3457, DOI 10.1046/j.1460-9568.1999.00766.x; Sons MS, 2006, NEUROSCIENCE, V138, P433, DOI 10.1016/j.neuroscience.2005.11.040; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sunderland WJ, 2000, J NEUROSCI, V20, P1009, DOI 10.1523/JNEUROSCI.20-03-01009.2000; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Urbano FJ, 2002, MOL MEMBR BIOL, V19, P293, DOI 10.1080/0968768021000035087; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	56	187	198	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2007	129	1					179	193		10.1016/j.cell.2007.02.035	http://dx.doi.org/10.1016/j.cell.2007.02.035			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	156PJ	17418794	Bronze			2022-12-28	WOS:000245661100020
J	Lee, M; Wanke, MC				Lee, Mark; Wanke, Michael C.			Searching for a solid-state terahertz technology	SCIENCE			English	Editorial Material									Sandia Natl Labs, Albuquerque, NM 87185 USA	United States Department of Energy (DOE); Sandia National Laboratories	Lee, M (corresponding author), Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA.	mcwanke@sandia.gov						Bjarnason JE, 2004, APPL PHYS LETT, V85, P3983, DOI 10.1063/1.1813635; Borak A, 2005, SCIENCE, V308, P638, DOI 10.1126/science.1109831; Kohler R, 2002, NATURE, V417, P156, DOI 10.1038/417156a; Peale RE, 2007, J NANOELECTRON OPTOE, V2, P51, DOI 10.1166/jno.2007.004; Shaner EA, 2006, IEEE PHOTONIC TECH L, V18, P1925, DOI 10.1109/LPT.2006.881670; Siegel PH, 1999, IEEE T MICROW THEORY, V47, P596, DOI 10.1109/22.763161; Tauk R, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2410215; Williams BS, 2006, ELECTRON LETT, V42, P89, DOI 10.1049/el:20063921; WILLIAMS BS, 2005, OPT EXPRESS, V13, P3111	9	118	125	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2007	316	5821					64	65		10.1126/science.1141012	http://dx.doi.org/10.1126/science.1141012			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	153XD	17412947				2022-12-28	WOS:000245470500030
J	Rodriguez, RA; Sen, S; Mehta, K; Moody-Ayers, S; Bacchetti, P; O'Hare, AM				Rodriguez, Rudolph A.; Sen, Saunak; Mehta, Kala; Moody-Ayers, Sandra; Bacchetti, Peter; O'Hare, Ann M.			Geography matters: Relationships among urban residential segregation, dialysis facilities, and patient outcomes	ANNALS OF INTERNAL MEDICINE			English	Article							STAGE RENAL-DISEASE; PAY-FOR-PERFORMANCE; HEMODIALYSIS-PATIENTS; REPLACEMENT THERAPY; RACIAL DISPARITIES; SURVIVAL ANALYSIS; HEALTH-CARE; TRANSPLANTATION; MORTALITY; QUALITY	Background: End-stage renal disease disproportionately affects black Americans. However, the impact of residential segregation by race-a prominent feature of many U.S. cities-on outcomes of patients receiving dialysis and on facility performance has not been evaluated. Objective: To examine the relationship among racial composition of ZIP codes in metropolitan areas, outcomes of patients receiving dialysis, and characteristics of dialysis facilities. Design: Retrospective cohort study of patients receiving dialysis and cross-sectional study of dialysis facilities. Setting: U.S. metropolitan ZIP codes with differing percentages of black residents. Patients: Black and non-Hispanic white patients who initiated long-term dialysis between 1 January 1995 and 31 December 2002 (n = 399 424) and dialysis facilities in operation in December 2004 (n = 3244). Measurements: Mortality and time to transplantation among patients receiving dialysis, and performance of dialysis facilities on the basis of quality indicators (anemia management, dialysis adequacy, and facility-level mortality rates). Results: Most black patients (50.3%) but few white patients (5%) lived in the 3% (n = 769) of ZIP codes in which most residents were black. in analyses adjusted for patient and ZIP code characteristics, mortality rates were higher among white patients but not among black patients living in areas with a higher percentage of black residents (adjusted hazard ratio for ZIP codes with 75% black residents vs. < 10% black residents, 1.14 [95% Cl, 1.07 to 1.21] for white patients and 1.02 [Cl, 0.99 to 1.06] for black patients). Time to transplantation was longer among both black and white patients (adjusted hazard ratio for ZIP codes with >= 75% black residents vs. < 10% black residents, 0.84 [Cl, 0.78 to 0.92] and 0.63 [Cl, 0.57 to 0.71] for black patients and white patients, respectively). Dialysis facilities located in areas with a higher percentage of black residents were more likely to have higher-than-expected mortality rates and were less likely to meet performance targets. Limitations: Patient-level analyses were restricted to black and non-Hispanic white patients. Patient-level and facility-level analyses focused only on the percentage of black residents in each ZIP code. Conclusions: The racial composition of urban residential areas is associated with time to transplantation and dialysis facility performance on standard quality measures. Closer scrutiny of care provided to patients receiving dialysis who live in predominantly black residential areas and to dialysis facilities operating in these areas may be warranted.	Univ Calif San Francisco, San Francisco Gen Hosp, Vet Affairs Med Ctr, San Francisco, CA 94110 USA; Vet Affairs San Francisco Res Enhancement Award P, San Francisco, CA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Rodriguez, RA (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Vet Affairs Med Ctr, Renal Ctr Bldg 100,Room 350,Box 1341, San Francisco, CA 94110 USA.	rrodriguez@medsfgh.ucsf.edu			NIA NIH HHS [K23 AG 028980-01] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K23AG028980] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; Alexander GC, 1998, JAMA-J AM MED ASSOC, V280, P1148, DOI 10.1001/jama.280.13.1148; Alexander GC, 2002, AM J KIDNEY DIS, V40, P824, DOI 10.1053/ajkd.2002.35695; [Anonymous], 2004, DIABETES EDUCATOR, V30, P196, DOI 10.1177/014572170403000209; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Bleyer AJ, 1996, AM J KIDNEY DIS, V28, P72, DOI 10.1016/S0272-6386(96)90133-X; BLOEMBERGEN WE, 1994, J AM SOC NEPHROL, V5, P1231; Brown WW, 2003, KIDNEY INT S, V83, pS50; COWIE CC, 1994, DIABETES CARE, V17, P681, DOI 10.2337/diacare.17.7.681; *CTR MED MED SERV, 2003, NEPHROL DIAL TRANSPL, V18, P147; EGGERS PW, 1990, AM J KIDNEY DIS, V15, P414, DOI 10.1016/S0272-6386(12)70359-1; Epstein AM, 2004, NEW ENGL J MED, V350, P406, DOI 10.1056/NEJMsb035374; Epstein AM, 2000, NEW ENGL J MED, V343, P1537, DOI 10.1056/NEJM200011233432106; Epstein AM, 2004, NEW ENGL J MED, V351, P603, DOI 10.1056/NEJMe048181; Fang L, 2003, AM J MED, V115, P448, DOI 10.1016/S0002-9343(03)00446-7; Ford B.L., 1983, INCOMPLETE DATA SAMP, P185; Frankenfield DL, 1999, AM J KIDNEY DIS, V34, P721, DOI 10.1016/S0272-6386(99)70399-9; Frederick PR, 2002, HEALTH CARE FINANC R, V23, P37; Garg PP, 1999, NEW ENGL J MED, V341, P1653, DOI 10.1056/NEJM199911253412205; HELD PJ, 1987, JAMA-J AM MED ASSOC, V257, P645, DOI 10.1001/jama.257.5.645; Himmelfarb J, 2004, J AM SOC NEPHROL, V15, P3263, DOI 10.1097/01.ASN.0000145893.61791.7B; Hirth RA, 1996, JAMA-J AM MED ASSOC, V276, P1303; Isaacs SL, 2004, NEW ENGL J MED, V351, P1137, DOI 10.1056/NEJMsb040329; Leggat JE, 1998, AM J KIDNEY DIS, V32, P139, DOI 10.1053/ajkd.1998.v32.pm9669435; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Longenecker JC, 2000, J AM SOC NEPHROL, V11, P520, DOI 10.1681/ASN.V113520; McGill JB, 2004, DIABETES ED, V30, P200; McGill JB, 2004, DIABETES ED, V30, P206; *MED PAYM ADV COMM, 2006, REP C MED PAYM POL; Milgate K, 2006, HEALTH AFFAIR, V25, P413, DOI 10.1377/hlthaff.25.2.413; *NAT ESRD CPM WORK, 2002, J AM SOC NEPHROL, V13, P2117; O'Riordan E, 2003, QJM-INT J MED, V96, P739, DOI 10.1093/qjmed/hcg127; Owen WF, 1998, JAMA-J AM MED ASSOC, V280, P1764, DOI 10.1001/jama.280.20.1764; Pei YPC, 2000, KIDNEY INT, V58, P1293, DOI 10.1046/j.1523-1755.2000.00285.x; Powe NR, 2003, KIDNEY INT, V64, P763, DOI 10.1046/j.1523-1755.2003.00138.x; PUGH JA, 1994, AM J KIDNEY DIS, V23, P803; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Saran R, 2003, KIDNEY INT, V64, P254, DOI 10.1046/j.1523-1755.2003.00064.x; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Sehgal AR, 2000, AM J KIDNEY DIS, V35, pS148, DOI 10.1016/S0272-6386(00)70242-3; Sehgal AR, 2003, JAMA-J AM MED ASSOC, V289, P996, DOI 10.1001/jama.289.8.996; Stack AG, 2002, J AM SOC NEPHROL, V13, P1279, DOI 10.1681/ASN.V1351279; Tanna MM, 2000, AM J KIDNEY DIS, V36, P1175, DOI 10.1053/ajkd.2000.19832; Werner RM, 2005, CIRCULATION, V111, P1257, DOI 10.1161/01.CIR.0000157729.59754.09; WHITEIS DG, 1992, PUBLIC HEALTH REP, V107, P409; Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1016/S0033-3549(04)50068-7	47	146	151	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2007	146	7					493	501		10.7326/0003-4819-146-7-200704030-00005	http://dx.doi.org/10.7326/0003-4819-146-7-200704030-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153VB	17404351				2022-12-28	WOS:000245463200003
J	Bezemer, TM; van der Putten, WH				Bezemer, T. Martijn; van der Putten, Wim H.			Ecology - Diversity and stability in plant communities	NATURE			English	Letter							BIODIVERSITY; PRODUCTIVITY		Netherlands Inst Ecol Res, Dept Multitroph Interact, NL-6666 ZG Heteren, Netherlands; Univ Wageningen & Res Ctr, Nematol Lab, NL-6700 ES Wageningen, Netherlands; Univ Wageningen & Res Ctr, Entomol Lab, NL-6700 EH Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research; Wageningen University & Research	Bezemer, TM (corresponding author), Netherlands Inst Ecol Res, Dept Multitroph Interact, POB 40, NL-6666 ZG Heteren, Netherlands.	martijn.bezemer@wur.nl	van der Putten, Wim H/C-3707-2011; Bezemer, Martijn/A-4068-2009	van der Putten, Wim H/0000-0002-9341-4442; Bezemer, Martijn/0000-0002-2878-3479				Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Pfisterer AB, 2002, NATURE, V416, P84, DOI 10.1038/416084a; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742	6	71	77	7	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2007	446	7135					E6	E7		10.1038/nature05749	http://dx.doi.org/10.1038/nature05749			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392741				2022-12-28	WOS:000245242900040
J	Konstam, MA; Gheorghiade, M; Burnett, JC; Grinfeld, L; Maggioni, AP; Swedberg, K; Udelson, JE; Zannad, F; Cook, T; Ouyang, J; Zimmer, C; Orlandi, C				Konstam, Marvin A.; Gheorghiade, Mihai; Burnett, John C., Jr.; Grinfeld, Liliana; Maggioni, Aldo P.; Swedberg, Karl; Udelson, James E.; Zannad, Faiez; Cook, Thomas; Ouyang, John; Zimmer, Christopher; Orlandi, Cesare		EVEREST Investigators	Effects of oral tolvaptan in patients hospitalized for worsening heart failure - The EVEREST outcome trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEFT-VENTRICULAR DYSFUNCTION; PLASMA ARGININE VASOPRESSIN; RENAL-FUNCTION; DOUBLE-BLIND; ANTAGONIST; RATIONALE; DEATH; RISK; NESIRITIDE; MORTALITY	Context Vasopressin mediates fluid retention in heart failure. Tolvaptan, a vasopressin V-2 receptor blocker, shows promise for management of heart failure. Objective To investigate the effects of tolvaptan initiated in patients hospitalized with heart failure. Design, Setting, and Participants The Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST), an event-driven, randomized, double-blind, placebo-controlled study. The outcome trial comprised 4133 patients within 2 short-term clinical status studies, who were hospitalized with heart failure, randomized at 359 North American, South American, and European sites between October 7, 2003, and February 3, 2006, and followed up during long-term treatment. Intervention Within 48 hours of admission, patients were randomly assigned to receive oral tolvaptan, 30 mg once per day (n = 2072), or placebo (n = 2061) for a minimum of 60 days, in addition to standard therapy. Main Outcome Measures Dual primary end points were all-cause mortality (superiority and noninferiority) and cardiovascular death or hospitalization for heart failure (superiority only). Secondary end points included changes in dyspnea, body weight, and edema. Results During amedian follow-up of 9.9 months, 537 patients (25.9%) in the tolvaptan group and 543 (26.3%) in the placebo group died (hazard ratio, 0.98; 95% confidence interval [CI], 0.87- 1.11; P = .68). The upper confidence limit for the mortality difference was within the prespecified noninferiority margin of 1.25 (P < .001). The composite of cardiovascular death or hospitalization for heart failure occurred in 871 tolvaptan group patients (42.0%) and 829 placebo group patients (40.2%; hazard ratio, 1.04; 95% CI, 0.95-1.14; P =. 55). Secondary end points of cardiovascular mortality, cardiovascular death or hospitalization, and worsening heart failure were also not different. Tolvaptan significantly improved secondary end points of day 1 patient-assessed dyspnea, day 1 body weight, and day 7 edema. In patients with hyponatremia, serum sodium levels significantly increased. The Kansas City Cardiomyopathy Questionnaire overall summary score was not improved at outpatient week 1, but body weight and serum sodium effects persisted long after discharge. Tolvaptan caused increased thirst and dry mouth, but frequencies of major adverse events were similar in the 2 groups. Conclusion Tolvaptan initiated for acute treatment of patients hospitalized with heart failure had no effect on long-term mortality or heart failure-related morbidity.	Tufts Univ, New England Med Ctr, Div Cardiol, Boston, MA 02111 USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; Mayo Clin, Rochester, MN USA; Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina; Assoc Nazl Med Cardiol Osped Res Ctr, Florence, Italy; Sahlgrens Univ Hosp, S-41345 Gothenburg, Sweden; Ctr Invest Clin, INSERM, Nancy, France; Univ Wisconsin, Madison, WI USA; Otsuka Maryland Res Inst, Rockville, MD USA	Tufts Medical Center; Tufts University; Northwestern University; Feinberg School of Medicine; Mayo Clinic; Hospital Italiano de Buenos Aires; University of Buenos Aires; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); Sahlgrenska University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Wisconsin System; University of Wisconsin Madison	Konstam, MA (corresponding author), Tufts Univ, New England Med Ctr, Div Cardiol, Box 108,750 Washington St, Boston, MA 02111 USA.	mkonstam@tufts-nemc.org	Zannad, Faiez/K-4649-2019; Maggioni, Aldo Pietro/AAL-5334-2020; Swedberg, Karl/B-2475-2008	Maggioni, Aldo Pietro/0000-0003-2764-6779; 				Abraham WT, 2005, J AM COLL CARDIOL, V46, P57, DOI 10.1016/j.jacc.2005.03.051; Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; AYRAM M, 2005, AM J CARDIOL, V96, pG47; Benza RL, 2004, J CARD FAIL, V10, P279, DOI 10.1016/j.cardfail.2003.12.007; Butler J, 2004, AM HEART J, V147, P331, DOI 10.1016/j.ahj.2003.08.012; Cleland JGF, 2003, EUR HEART J, V24, P442, DOI 10.1016/S0195-668X(02)00823-0; Cohn JN, 1997, CARDIOLOGY, V88, P2, DOI 10.1159/000177477; COHN JN, 1981, AM HEART J, V102, P509, DOI 10.1016/0002-8703(81)90739-0; Costello-Boerrigter LC, 2006, AM J PHYSIOL-RENAL, V290, pF273, DOI 10.1152/ajprenal.00195.2005; CREAGER MA, 1986, J AM COLL CARDIOL, V7, P758, DOI 10.1016/S0735-1097(86)80333-3; Cuffe MS, 2002, JAMA-J AM MED ASSOC, V287, P1541, DOI 10.1001/jama.287.12.1541; Domanski M, 2003, J AM COLL CARDIOL, V42, P705, DOI 10.1016/S0735-1097(03)00765-4; Drazner MH, 2001, NEW ENGL J MED, V345, P574, DOI 10.1056/NEJMoa010641; Emerman CL, 2004, J CARD FAIL, V10, pS116, DOI 10.1016/j.cardfail.2004.06.367; Eshaghian S, 2006, AM J CARDIOL, V97, P1759, DOI 10.1016/j.amjcard.2005.12.072; Fonarow GC, 2004, AM HEART J, V148, P43, DOI 10.1016/j.ahj.2004.03.004; FRANCIS GS, 1990, CIRCULATION, V82, P1724, DOI 10.1161/01.CIR.82.5.1724; Gheorghiade M, 2005, J CARD FAIL, V11, P260, DOI 10.1016/j.cardfail.2005.03.009; Gheorghiade M, 2004, JAMA-J AM MED ASSOC, V291, P1963, DOI 10.1001/jama.291.16.1963; Gheorghiade M, 2005, CIRCULATION, V112, P3958, DOI 10.1161/CIRCULATIONAHA.105.590091; Gheorghiade M, 2003, CIRCULATION, V107, P2690, DOI 10.1161/01.CIR.0000070422.41439.04; Gheorghiade M, 2007, JAMA-J AM MED ASSOC, V297, P1332, DOI 10.1001/jama.297.12.1332; Gheorghiade M, 2006, AM J MED, V119, P3, DOI 10.1016/j.amjmed.2006.09.011; GOLDSMITH SR, 1983, J AM COLL CARDIOL, V1, P1385, DOI 10.1016/S0735-1097(83)80040-0; Lucas C, 2000, AM HEART J, V140, P840, DOI 10.1067/mhj.2000.110933; MARCUS R, 1976, BIOMETRIKA, V63, P655, DOI 10.1093/biomet/63.3.655; Mebazaa A, 2005, CIRCULATION, V112, P3364; Nieminen MS, 2006, EUR HEART J, V27, P2725, DOI 10.1093/eurheartj/ehl193; O'Connor CM, 1999, AM HEART J, V138, P78, DOI 10.1016/S0002-8703(99)70250-4; Packer M, 2005, CIRCULATION, V112, P3363; Publication Committee for the VMAC Investigators, 2002, JAMA-J AM MED ASSOC, V287, P1531; Sackner-Bernstein JD, 2005, JAMA-J AM MED ASSOC, V293, P1900, DOI 10.1001/jama.293.15.1900; Sackner-Bernstein JD, 2005, CIRCULATION, V111, P1487, DOI 10.1161/01.CIR.0000159340.93220.E4; Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181; SZATALOWICZ VL, 1981, NEW ENGL J MED, V305, P263, DOI 10.1056/NEJM198107303050506; Tavazzi L, 2006, EUR HEART J, V27, P1207, DOI 10.1093/eurheartj/ehi845; Udelson JE, 2001, CIRCULATION, V104, P2417, DOI 10.1161/hc4501.099313; UDELSON JE, IN PRESS J AM COLL C; VANELTEREN P, 1960, B INT STATIST INST, V37, P351; Young JB, 2002, JAMA-J AM MED ASSOC, V287, P1531, DOI 10.1001/jama.287.12.1531	40	1077	1125	3	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2007	297	12					1319	1331		10.1001/jama.297.12.1319	http://dx.doi.org/10.1001/jama.297.12.1319			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	150JN	17384437	Bronze			2022-12-28	WOS:000245212600019
J	Wagner, GR				Wagner, Gregory R.			The fallout from asbestos	LANCET			English	Editorial Material									NIOSH, Washington, DC 20201 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Wagner, GR (corresponding author), NIOSH, Washington, DC 20201 USA.	gwagner@cdc.gov						BENNHOLD K, 2006, INT HERALD TRIB 0215; *CHRYS I, SAF US CHRYS; *COMM ASB, 2006, SEL HLTH EFF ASB SEL; *FINN I OCC HLTH, 2006, ASB DEADL SER PREV E; *INT LAB ORG, 2006, INT LAB C PROV REC 9; LaDou L, 2001, CAN MED ASSOC J, V164, P489; Lin RT, 2007, LANCET, V369, P844, DOI 10.1016/S0140-6736(07)60412-7; World Health Organization, 2005, WHO WORKSH MECH FIBR	8	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2007	369	9566					973	974		10.1016/S0140-6736(07)60472-3	http://dx.doi.org/10.1016/S0140-6736(07)60472-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	151JO	17382808				2022-12-28	WOS:000245286500008
J	Burns, B; Watkins, L; Goadsby, PJ				Burns, Brian; Watkins, Laurence; Goadsby, Peter J.			Treatment of medically intractable cluster headache by occipital nerve stimulation: long-term follow-up of eight patients	LANCET			English	Article							PERIPHERAL NEUROSTIMULATION; HYPOTHALAMIC-STIMULATION; SURGICAL-TREATMENT; INJECTION; EFFICACY; ACTIVATION; MANAGEMENT; NEURALGIA; BLOCKADE; SECTION	Background Cluster headache is a form of primary headache that features repeated attacks of excruciatingly severe headache usually occurring several times a day. Patients with chronic cluster headache have unremitting illness that necessitates daily preventive medical treatment for years. When medically intractable, the condition has previously been treatable only with cranially invasive or neurally destructive methods. Methods Eight patients with medically intractable chronic cluster headache were implanted in the suboccipital region with electrodes for occipital nerve stimulation. Other than the first patient, who was initially stimulated unilaterally before being stimulated bilaterally, all patients were stimulated bilaterally during treatment. Findings At a median follow-up of 20 months (range 6-27 months for bilateral stimulation), six of eight patients reported responses that were sufficiently meaningful for them to recommend the treatment to similarly affected patients with chronic cluster headache. Two patients noticed a substantial improvement (90% and 95%) in their attacks; three patients noticed a moderate improvement (40%, 60%, and 20-80%) and one reported mild improvement (25%). Improvements occurred in both frequency and severity of attacks. These changes took place over weeks or months, although attacks returned in days when the device malfunctioned (eg, with battery depletion). Adverse events of concern were lead migrations in one patient and battery depletion requiring replacement in four. Interpretation Occipital nerve stimulation in cluster headache seems to offer a safe, effective treatment option that could begin a new era of neurostimulation therapy for primary headache syndromes.	UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, Headache Grp, London WC1N 3BG, England; UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, Div Neurosurg, London WC1N 3BG, England; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of California System; University of California San Francisco	Goadsby, PJ (corresponding author), UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, Headache Grp, London WC1N 3BG, England.	peterg@ion.ucl.ac.uk	Goadsby, Peter J/B-2267-2009; Goadsby, Peter J/Z-1970-2019; Watkins, Laurence/AAH-6973-2021	Goadsby, Peter J/0000-0003-3260-5904; Watkins, Laurence/0000-0003-0678-3774				Afridi SK, 2006, PAIN, V122, P126, DOI 10.1016/j.pain.2006.01.016; Ambrosini A, 2005, PAIN, V118, P92, DOI 10.1016/j.pain.2005.07.015; Anthony m, 1985, MIGRAINE CLIN RES AD, P169; Bahra A, 2002, NEUROLOGY, V58, P354, DOI 10.1212/WNL.58.3.354; Bartsch T, 2002, BRAIN, V125, P1496, DOI 10.1093/brain/awf166; Bartsch T, 2003, BRAIN, V126, P1801, DOI 10.1093/brain/awg190; Bartsch T, 2005, HEADACHE CURRENTS, V2, P42, DOI DOI 10.1111/J.1743-5013.2005.20201.X; Dodick D, 2003, CEPHALALGIA, V23, P701; Donnet A, 2005, J NEUROL NEUROSUR PS, V76, P218, DOI 10.1136/jnnp.2004.041202; EKBOM K, 1987, CEPHALALGIA, V7, P21, DOI 10.1046/j.1468-2982.1987.0701021.x; Felisati G, 2006, LARYNGOSCOPE, V116, P1447, DOI 10.1097/01.mlg.0000227997.48020.44; Franzini A, 2003, NEUROSURGERY, V52, P1095, DOI 10.1227/01.NEU.0000057698.29634.D6; Goadsby PJ, 2006, CEPHALALGIA, V26, P1168, DOI 10.1111/j.1468-2982.2006.01173.x; Goadsby PJ, 2002, LANCET NEUROL, V1, P251, DOI 10.1016/S1474-4422(02)00104-7; Green MW, 2003, HEADACHE, V43, P479, DOI 10.1046/j.1526-4610.2003.03093.x; Jarrar RG, 2003, NEUROLOGY, V60, P1360, DOI 10.1212/01.WNL.0000055902.23139.16; Johnstone CSH, 2006, NEUROMODULATION, V9, P41, DOI 10.1111/j.1525-1403.2006.00041.x; Kapural L, 2005, ANESTH ANALG, V101, P171, DOI 10.1213/01.ANE.0000156207.73396.8E; KIRKPATRICK PJ, 1993, BRIT J NEUROSURG, V7, P483, DOI 10.3109/02688699308995070; Lance JW, 2005, MECH MANAGEMENT HEAD; Leone M, 2004, CEPHALALGIA, V24, P934, DOI 10.1111/j.1468-2982.2004.00742.x; Leone M, 2006, NEUROLOGY, V67, P150, DOI 10.1212/01.wnl.0000223319.56699.8a; Lovely TJ, 1998, HEADACHE, V38, P590, DOI 10.1046/j.1526-4610.1998.3808590.x; Magis D, 2006, CEPHALALGIA, V26, P1398; Magis D, 2005, CEPHALALGIA, V25, P1197; Matharu Manjit S, 2004, Expert Rev Neurother, V4, P895, DOI 10.1586/14737175.4.5.895; Matharu MS, 2006, ANN NEUROL, V59, P535, DOI 10.1002/ana.20763; Matharu MS, 2004, BRAIN, V127, P220, DOI 10.1093/brain/awh022; Matharu MS, 2003, DRUGS, V63, P1637, DOI 10.2165/00003495-200363160-00002; Matharu MS, 2002, BRAIN, V125, P976, DOI 10.1093/brain/awf118; MATHEW NT, 1988, HEADACHE, V28, P328, DOI 10.1111/j.1526-4610.1988.hed2805328.x; May A, 2005, LANCET, V366, P843, DOI 10.1016/S0140-6736(05)67217-0; May A, 1999, NAT MED, V5, P836, DOI 10.1038/10561; May A, 1998, LANCET, V352, P275, DOI 10.1016/S0140-6736(98)02470-2; MORGENLANDER JC, 1990, J NEUROSURG, V72, P866, DOI 10.3171/jns.1990.72.6.0866; Peres MFP, 2002, CEPHALALGIA, V22, P520, DOI 10.1046/j.1468-2982.2002.00410.x; Piovesan EJ, 2001, CEPHALALGIA, V21, P107, DOI 10.1046/j.1468-2982.2001.00166.x; Popeney CA, 2003, HEADACHE, V43, P369, DOI 10.1046/j.1526-4610.2003.03072.x; Remahl AIMN, 2003, CEPHALALGIA, V23, P504, DOI 10.1046/j.1468-2982.2003.00531.x; ROWED DW, 1990, HEADACHE, V30, P401, DOI 10.1111/j.1526-4610.1990.hed3007401.x; Sanders M, 1997, J NEUROSURG, V87, P876, DOI 10.3171/jns.1997.87.6.0876; Schoenen J, 2005, BRAIN, V128, P940, DOI 10.1093/brain/awh411; Schwedt TJ, 2006, CEPHALALGIA, V26, P1025, DOI 10.1111/j.1468-2982.2006.01142.x; Shields KG, 2004, NEUROLOGY, V63, P2193, DOI 10.1212/01.WNL.0000145832.26051.3C; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Sjaastad O, 2003, CEPHALALGIA, V23, P528, DOI 10.1046/j.1468-2982.2003.00585.x; Slavin KV, 2006, NEUROSURGERY, V58, P112, DOI 10.1227/01.NEU.0000192163.55428.62; SOLOMON S, 1986, ARCH NEUROL-CHICAGO, V43, P479, DOI 10.1001/archneur.1986.00520050055022; Stojanovic M P, 2001, Curr Pain Headache Rep, V5, P130, DOI 10.1007/s11916-001-0081-3; SWEET WH, 1988, HEADACHE, V28, P669, DOI 10.1111/j.1526-4610.1988.hed2810669.x; Weiner RL, 2006, PAIN MED, V7, pS137, DOI 10.1111/j.1526-4637.2006.00129.x; Weiner RL, 1999, NEUROMODULATION, V2, P217, DOI 10.1046/j.1525-1403.1999.00217.x	52	222	231	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2007	369	9567					1099	1106		10.1016/S0140-6736(07)60328-6	http://dx.doi.org/10.1016/S0140-6736(07)60328-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151XF	17398309				2022-12-28	WOS:000245323700030
J	Gulani, A; Nagpal, J; Osmond, C; Sachdev, HPS				Gulani, Anjana; Nagpal, Jitender; Osmond, Clive; Sachdev, H. P. S.			Effect of administration of intestinal anthelmintic drugs on haemoglobin: systematic review of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHILDREN	Objective To evaluate the effect of routine administration of intestinal anthelmintic drugs on haemoglobin. Design Systematic review of randomised controlled trials. Data sources Electronic databases and hand search of reviews, bibliographies of books, and abstracts and proceedings of international conferences. Study selection Included studies were randomised or quasi-randomised controlled trials using an intestinal anthelmintic agent in the intervention group, in which haemoglobin was evaluated as an outcome measure. Trials in which treatment for schistosoma (praziquantel) was given exclusively to the intervention group were excluded. Results The search identified 14 eligible randomised controlled trials. Data were available for 7829 subjects, of whom 4107 received an anthelmintic drug and 3722 received placebo. The pooled weighted mean difference (random effect model) of the change in haemoglobin was 1.71 (95% confidence interval 0.70 to 2.73) g/1 (P < 0.001; test for heterogeneity: Cochran Q=51.17, P < 0.001; 12 =61% (37% to 76%). With the World Health Organization's recommended haemoglobin cut-offs of 120 g/1 in adults and 110 g/l in children, the average estimated reduction in prevalence of anaemia ranged from 1.1% to 12.4% in adults and from 4.4% to 21.0% in children. The estimated reductions in the prevalence of anaemia increased with lower haemoglobin cut-offs used to define anaemia. Conclusions Routine administration of intestinal anthelmintic agents results in a marginal increase in haemoglobin (1.71 g/1), which could translate on a public health scale into a small (5% to 10%) reduction in the prevalence of anaemia in populations with a relatively high prevalence of intestinal helminthiasis.	Sitaram Bhartia Inst Sci & Res, Dept Pediat & Clin Epidemiol, Qutab Inst Area, New Delhi 110016, India; Univ Southampton, Southampton Gen Hosp, MRC, Epidemiol Resource Ctr, Southampton SO16 6YD, Hants, England	Sitaram Bhartia Institute of Science & Research; University of Southampton	Sachdev, HPS (corresponding author), Sitaram Bhartia Inst Sci & Res, Dept Pediat & Clin Epidemiol, Qutab Inst Area, B-16, New Delhi 110016, India.	hpssachdev@gmail.com	Nagpal, Jitender/HIR-8178-2022	Nagpal, Jitender/0000-0003-4752-5843; Sachdev, Harshpal Singh/0000-0002-4956-9391; Osmond, Clive/0000-0002-9054-4655				Dickson R, 2000, BMJ-BRIT MED J, V320, P1697, DOI 10.1136/bmj.320.7251.1697; Ezeamama AE, 2005, J INFECT DIS, V192, P2160, DOI 10.1086/498219; Gera T, 2007, J PEDIATR GASTR NUTR, V44, P468, DOI 10.1097/01.mpg.0000243440.85452.38; Juni P, 2001, SYSTEMATIC REV HLTH, P87; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Mason J., 2001, MICRONUTRIENT REPORT; *ROYAL COLL PAED C, 2004, MED CHILDR, P379; *ROYAL COLL PAED C, 2004, MED CHILDR, P14; STEME JAC, 2001, SYSTEMATIC REV HLTH, P189; STEPHENSON LS, 1993, IMPACT HELMINTH INFE, P131; *UN CC SCN, 2000, 4 ACCSCN INT FOOD PO; *WHO, 2002, WHOCDCCPEPVC20024; *WHO, 2005, WHOCDSCPEPVC20051; *WHO UN CHILDR FUN, 2004, FOC AN INT APPR EFF	14	68	70	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 26	2007	334	7603					1095	1097		10.1136/bmj.39150.510475.AE	http://dx.doi.org/10.1136/bmj.39150.510475.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	174XB	17434954	Green Published, Bronze			2022-12-28	WOS:000246975000032
J	Wuchty, S; Jones, BF; Uzzi, B				Wuchty, Stefan; Jones, Benjamin F.; Uzzi, Brian			The increasing dominance of teams in production of knowledge	SCIENCE			English	Article							PATENT CITATIONS; COLLABORATION	We have used 19.9 million papers over 5 decades and 2.1 million patents to demonstrate that teams increasingly dominate solo authors in the production of knowledge. Research is increasingly done in teams across nearly all fields. Teams typically produce more frequently cited research than individuals do, and this advantage has been increasing over time. Teams now also produce the exceptionally high-impact research, even where that distinction was once the domain of solo authors. These results are detailed for sciences and engineering, social sciences, arts and humanities, and patents, suggesting that the process of knowledge creation has fundamentally changed.	Northwestern Univ, NICO, Evanston, IL 60208 USA; Northwestern Univ, Kellogg Sch Management, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Uzzi, B (corresponding author), Northwestern Univ, NICO, Evanston, IL 60208 USA.	uzzi@northwestern.edu						Adams JD, 2005, RES POLICY, V34, P259, DOI 10.1016/j.respol.2005.01.014; Aksnes DW, 2006, J AM SOC INF SCI TEC, V57, P169, DOI 10.1002/asi.20262; Alcacer J, 2006, REV ECON STAT, V88, P774, DOI 10.1162/rest.88.4.774; Ali S. N., 1996, LIB REV, V45, P39, DOI DOI 10.1108/00242539610107749; [Anonymous], 1999, AM SOCIOL, DOI DOI 10.1007/S12108-999-1007-5; BECKER GS, 1992, Q J ECON, V107, P1137, DOI 10.2307/2118383; Bowler P.J., 2005, MAKING MODERN SCI HI; Collins Randall, 1998, SOCIOLOGY PHILOS GLO; Cronin B, 2003, J AM SOC INF SCI TEC, V54, P855, DOI 10.1002/asi.10278; Cronin B, 2001, J AM SOC INF SCI TEC, V52, P558, DOI 10.1002/asi.1097; De Solla Price D. J., 1963, LITTLE SCI BIG SCI, DOI 10.7312/pric91844; Drenth JPH, 1998, JAMA-J AM MED ASSOC, V280, P219, DOI 10.1001/jama.280.3.219; English James F., 2005, EC PRESTIGE PRIZES; FITZGERALD FS, 1993, CRACK UP, P122; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Hall BH, 2005, RAND J ECON, V36, P16; HALL BH, 2001, NATL BUR EC RES WORK, V8498; JONES BF, 2005, NAT BUR EC RES WORK; Kuhn T.S., 1970, STRUCTURE SCI REVOLU, P174; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Sampat B., 2005, DETERMINANTS PATENT; TRAJTENBERG M, 1990, RAND J ECON, V21, P172, DOI 10.2307/2555502; Williams KY, 1998, RES ORGAN BEHAV, V20, P77; ZUCKERMAN H, 1973, SOCIOL SCI, P545	24	1685	1714	24	447	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2007	316	5827					1036	1039		10.1126/science.1136099	http://dx.doi.org/10.1126/science.1136099			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	168WF	17431139	Green Submitted			2022-12-28	WOS:000246554000049
J	Kurotaki, Y; Hatta, K; Nakao, K; Nabeshima, Y; Fujimori, T				Kurotaki, Yoko; Hatta, Kohei; Nakao, Kazuki; Nabeshima, Yo-ichi; Fujimori, Toshihiko			Blastocyst axis is specified independently of early cell lineage but aligns with the ZP shape	SCIENCE			English	Article							1ST 2 BLASTOMERES; MOUSE BLASTOCYST; BILATERAL SYMMETRY; CLEAVAGE; TROPHECTODERM; EMBRYO; PROTEIN; ZYGOTE; STAGE; DIFFERENTIATION	The mechanisms controlling the establishment of the embryonic-abembryonic (E-Ab) axis of the mammalian blastocyst are controversial. We used in vitro time-lapse imaging and in vivo lineage labeling to provide evidence that the E-Ab axis of the mouse blastocyst is generated independently of early cell lineage. Rather, both the boundary between two-cell blastomeres and the E-Ab axis of the blastocyst align relative to the ellipsoidal shape of the zona pellucida (ZP), an extraembryonic structure. Lack of correlation between cell lineage and the E-Ab axis can be explained by the rotation of the embryo within the ZP.	Kyoto Univ, Grad Sch Sci, Dept Pathol & Tumor Biol, Sakyo Ku, Kyoto 6068501, Japan; JST, CREST, Kawaguchi, Saitama 3320012, Japan; RIKEN, Ctr Dev Biol, Vertebrate Body Plan Grp, Chuo Ku, Kobe, Hyogo 6500047, Japan; Riken Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan	Kyoto University; Japan Science & Technology Agency (JST); RIKEN; RIKEN	Fujimori, T (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Pathol & Tumor Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	fujimori@lmls.med.kyoto-u.ac.jp	Fujimori, Toshihiko/L-7711-2016	Fujimori, Toshihiko/0000-0001-5200-4634; zhong wei, he gui/0000-0002-3066-3564				Alarcon VB, 2005, MOL REPROD DEV, V72, P354, DOI 10.1002/mrd.20353; Alarcon VB, 2003, BIOL REPROD, V69, P1208, DOI 10.1095/biolreprod.103.018283; Chroscicka A, 2004, MOL REPROD DEV, V68, P308, DOI 10.1002/mrd.20081; FLEMING TP, 1987, DEV BIOL, V119, P520, DOI 10.1016/0012-1606(87)90055-8; Fujimori T, 2003, DEVELOPMENT, V130, P5113, DOI 10.1242/dev.00725; Gardner RL, 2007, HUM REPROD, V22, P798, DOI 10.1093/humrep/del424; Gardner RL, 1997, DEVELOPMENT, V124, P289; Gardner RL, 2006, HUM REPROD, V21, P492, DOI 10.1093/humrep/dei318; Gardner RL, 2001, DEVELOPMENT, V128, P839; Gardner RL, 2002, HUM REPROD, V17, P1839, DOI 10.1093/humrep/17.7.1839; Gray D, 2004, CURR BIOL, V14, P397, DOI 10.1016/j.cub.2004.02.031; HANDYSIDE AH, 1978, J EMBRYOL EXP MORPH, V45, P37; Hatta K, 2006, NAT PROTOC, V1, P960, DOI 10.1038/nprot.2006.96; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; KESSLER DS, 1995, DEVELOPMENT, V121, P2155; Motosugi N, 2005, GENE DEV, V19, P1081, DOI 10.1101/gad.1304805; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Piotrowska K, 2001, DEVELOPMENT, V128, P3739; Piotrowska-Nitsche K, 2005, DEVELOPMENT, V132, P479, DOI 10.1242/dev.01602; Piotrowska-Nitsche K, 2005, MECH DEVELOP, V122, P487, DOI 10.1016/j.mod.2004.11.014; Plusa B, 2005, NATURE, V434, P391, DOI 10.1038/nature03388; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; TARKOWSKI AK, 1967, J EMBRYOL EXP MORPH, V18, P155; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Waksmundzka M, 2006, BIOL REPROD, V75, P582, DOI 10.1095/biolreprod.106.053165	27	149	155	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2007	316	5825					719	723		10.1126/science.1138591	http://dx.doi.org/10.1126/science.1138591			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17446354				2022-12-28	WOS:000246181400038
J	Jenni, S; Leibundgut, M; Boehringer, D; Frick, C; Mikolasek, B; Ban, N				Jenni, Simon; Leibundgut, Marc; Boehringer, Daniel; Frick, Christian; Mikolasek, Bohdan; Ban, Nenad			Structure of fungal fatty acid synthase and implications for iterative substrate shuttling	SCIENCE			English	Article							MULTIFUNCTIONAL ENZYME TYPE-2; CARRIER PROTEIN TRANSACYLASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ACTIVE-SITE; PALMITOYL TRANSFERASE; MULTIENZYME COMPLEX; YEAST; SYNTHETASE; MALONYL	We report crystal structures of the 2.6-megadalton alpha(6)beta(6) heterododecameric fatty acid synthase from Thermomyces lanuginosus at 3.1 angstrom resolution. The alpha and beta polypeptide chains form the six catalytic domains required for fatty acid synthesis and numerous expansion segments responsible for extensive intersubunit connections. Detailed views of all active sites provide insights into substrate specificities and catalytic mechanisms and reveal their unique characteristics, which are due to the integration into the multienzyme. The mode of acyl carrier protein attachment in the reaction chamber, together with the spatial distribution of active sites, suggests that iterative substrate shuttling is achieved by a relatively restricted circular motion of the carrier domain in the multifunctional enzyme.	ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Ban, N (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland.	ban@mol.biol.ethz.ch						Asturias FJ, 2005, NAT STRUCT MOL BIOL, V12, P225, DOI 10.1038/nsmb899; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; ENGESER H, 1979, EUR J BIOCHEM, V101, P407, DOI 10.1111/j.1432-1033.1979.tb19733.x; ENGESER H, 1979, EUR J BIOCHEM, V101, P413, DOI 10.1111/j.1432-1033.1979.tb19734.x; FOX JL, 1980, EUR J BIOCHEM, V109, P417, DOI 10.1111/j.1432-1033.1980.tb04810.x; Ha JY, 2006, J BIOL CHEM, V281, P18660, DOI 10.1074/jbc.M601658200; Haapalainen AM, 2006, TRENDS BIOCHEM SCI, V31, P64, DOI 10.1016/j.tibs.2005.11.011; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; Hubbard PA, 2003, J BIOL CHEM, V278, P37553, DOI 10.1074/jbc.M304642200; Ishikawa M, 2004, EMBO J, V23, P2745, DOI 10.1038/sj.emboj.7600298; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; Keatinge-Clay AT, 2003, STRUCTURE, V11, P147, DOI 10.1016/S0969-2126(03)00004-2; Kolodziej SJ, 1997, J STRUCT BIOL, V120, P158, DOI 10.1006/jsbi.1997.3911; Koski MK, 2005, J MOL BIOL, V345, P1157, DOI 10.1016/j.jmb.2004.11.009; Koski MK, 2004, J BIOL CHEM, V279, P24666, DOI 10.1074/jbc.M400293200; LEIBUNDGUT M, 2006, SCIENCE, V316, pR30; LYNEN F, 1980, EUR J BIOCHEM, V112, P431; LYNEN F, 1967, BIOCHEM J, V102, P381, DOI 10.1042/bj1020381; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Marrakchi H, 2003, BIOCHEM J, V370, P1055, DOI 10.1042/BJ20021699; Oefner C, 2006, ACTA CRYSTALLOGR D, V62, P613, DOI 10.1107/S0907444906009474; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; Price AC, 2001, BIOCHEMISTRY-US, V40, P12772, DOI 10.1021/bi010737g; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; Qin YM, 2000, J BIOL CHEM, V275, P4965, DOI 10.1074/jbc.275.7.4965; RADFORD SE, 1989, J BIOL CHEM, V264, P767; Rangan VS, 1997, J BIOL CHEM, V272, P11975, DOI 10.1074/jbc.272.18.11975; SCHUSTER H, 1995, EUR J BIOCHEM, V228, P417; Schweizer E, 2004, MICROBIOL MOL BIOL R, V68, P501, DOI 10.1128/MMBR.68.3.501-517.2004; SERRE L, 1995, J BIOL CHEM, V270, P12961, DOI 10.1074/jbc.270.22.12961; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; STOOPS JK, 1980, P NATL ACAD SCI-BIOL, V77, P4544, DOI 10.1073/pnas.77.8.4544; STOOPS JK, 1992, P NATL ACAD SCI USA, V89, P6585, DOI 10.1073/pnas.89.14.6585; STOOPS JK, 1978, J BIOL CHEM, V253, P4464; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WERKMEISTER K, 1981, EUR J BIOCHEM, V116, P303, DOI 10.1111/j.1432-1033.1981.tb05334.x; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; WIELAND F, 1978, P NATL ACAD SCI USA, V75, P5792, DOI 10.1073/pnas.75.12.5792	40	170	181	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2007	316	5822					254	261		10.1126/science.1138248	http://dx.doi.org/10.1126/science.1138248			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156MV	17431175				2022-12-28	WOS:000245654500045
J	Harpole, WS; Tilman, D				Harpole, W. Stanley; Tilman, David			Grassland species loss resulting from reduced niche dimension	NATURE			English	Article							RESOURCE COMPETITION; LIMITING RESOURCES; DIVERSITY; BIODIVERSITY; ECOSYSTEM; RICHNESS; PRODUCTIVITY; ENRICHMENT; ECOLOGY	Intact ecosystems contain large numbers of competing but coexisting species. Although numerous alternative theories have provided potential explanations for this high biodiversity, there have been few field experiments testing between these theories. In particular, theory predicts that higher diversity of coexisting competitors could result from greater niche dimensionality(1), for example larger numbers of limiting resources or factors. Alternatively, diversity could be independent of niche dimensionality because large numbers of species can coexist when limited by just one or two factors if species have appropriate trade-offs(2). Here we show that plant coexistence and diversity result from the 'niche dimensionality' of a habitat. Plant species numbers decreased with increasing numbers of added limiting soil resources ( soil moisture, nitrogen, phosphorus and base cations), which is consistent with theoretical predictions that an increased supply of multiple limiting resources can reduce niche dimension. An observational field study gave similar results. The niche dimension hypothesis also explained diversity changes in the classic Park Grass Experiment at Rothamsted. Our results provide an alternative mechanistic explanation for the effects of nutrient eutrophication on the diversity of terrestrial, freshwater and marine ecosystems.	Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of California System; University of California Irvine; University of Minnesota System; University of Minnesota Twin Cities	Harpole, WS (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, 321 Steinhaus Hall, Irvine, CA 92697 USA.	wharpole@uci.edu	Harpole, William S/C-2814-2013; Tilman, David/ABD-5309-2021	Harpole, William S/0000-0002-3404-9174; 				Baer SG, 2003, ECOLOGY, V84, P724, DOI 10.1890/0012-9658(2003)084[0724:SRRPAD]2.0.CO;2; Braakhekke WG, 1999, J VEG SCI, V10, P187, DOI 10.2307/3237140; Brenchley W.E., 1958, PARK GRASS PLOTS ROT; Chase J.M., 2009, ECOLOGICAL NICHES LI; Crawley MJ, 2005, AM NAT, V165, P179, DOI 10.1086/427270; DITOMMASO A, 1989, VEGETATIO, V84, P9, DOI 10.1007/BF00054662; Foster BL, 1998, ECOLOGY, V79, P2593, DOI 10.1890/0012-9658(1998)079[2593:SRIASG]2.0.CO;2; GOLDBERG DE, 1990, ECOLOGY, V71, P213, DOI 10.2307/1940261; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; Grover JP, 2004, ECOL MONOGR, V74, P533, DOI 10.1890/03-4073; Herbert DA, 2004, ECOSYSTEMS, V7, P296, DOI 10.1007/s10021-003-0233-x; HUSTON MA, 1994, AM NAT, V144, P954, DOI 10.1086/285720; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Interlandi SJ, 2001, ECOLOGY, V82, P1270, DOI 10.2307/2679988; Lawes JB, 1882, PHILOS T R SOC LONDO, V173, P1181, DOI DOI 10.1098/RSTL.1882.0029; Leibold MA, 1999, EVOL ECOL RES, V1, P73; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; SILVERTOWN J, 1980, J APPL ECOL, V17, P491, DOI 10.2307/2402344; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tilman D., 1982, Monographs in Population Biology, pi; Tilman D, 2001, P NATL ACAD SCI USA, V98, P5433, DOI 10.1073/pnas.091093198; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830	24	382	419	19	443	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					791	793		10.1038/nature05684	http://dx.doi.org/10.1038/nature05684			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17384633				2022-12-28	WOS:000245626800039
J	Nisbet, MC; Mooney, C				Nisbet, Matthew C.; Mooney, Chris			Science and society - Framing science	SCIENCE			English	Editorial Material									American Univ, Sch Commun, Washington, DC 20016 USA	American University	Nisbet, MC (corresponding author), American Univ, Sch Commun, Washington, DC 20016 USA.	nisbet@american.edu	Nisbet, Matthew C./E-4245-2010; Nisbet, Matthew C./AAG-7562-2019	Nisbet, Matthew C./0000-0002-6765-1364; 				BEARDSLEY TM, 2006, BIOSCIENCE, V56, P7; GAMSON WA, 1989, AM J SOCIOL, V95, P1, DOI 10.1086/229213; McCright AM, 2003, SOC PROBL, V50, P348, DOI 10.1525/sp.2003.50.3.348; Nisbet MC, 2005, INT J PUBLIC OPIN R, V17, P90, DOI 10.1093/ijpor/edh058; Popkin S., 1991, REASONING VOTER; Price V, 2005, PUBLIC OPIN QUART, V69, P179, DOI 10.1093/poq/nfi014; Zaller JohnR., 1992, NATURE ORIGINS MASS	7	243	245	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2007	316	5821					56	56		10.1126/science.1142030	http://dx.doi.org/10.1126/science.1142030			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	153XD	17412941				2022-12-28	WOS:000245470500024
J	Koziel, MJ; Peters, MG				Koziel, Margaret James; Peters, Marion G.			Viral hepatitis in HIV infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; INTERFERON-ALPHA-2B PLUS RIBAVIRIN; ACTIVE ANTIRETROVIRAL THERAPY; LIVER-RELATED MORTALITY; B CORE ANTIGEN; C VIRUS; PEGINTERFERON ALPHA-2A; COINFECTED PATIENTS; PEGYLATED INTERFERON-ALPHA-2B; TREATMENT ALGORITHM		Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Calif San Francisco, Div Gastroenterol, San Francisco, CA 94143 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of California System; University of California San Francisco	Koziel, MJ (corresponding author), Harvard Inst Med, Rm 223A,330 Brookline Ave, Boston, MA 02215 USA.	mkoziel@bidnic.harvard.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI027663, U01AI027659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NIAID NIH HHS [U01 AI027663, U01 AI027659, UO1 AI27663, AI27659] Funding Source: Medline; NIDDK NIH HHS [P30 DK026743] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Alvarez D, 2006, J VIRAL HEPATITIS, V13, P683, DOI 10.1111/j.1365-2893.2006.00749.x; Angus P, 2003, GASTROENTEROLOGY, V125, P292, DOI 10.1016/S0016-5085(03)00939-9; Aranzabal L, 2005, CLIN INFECT DIS, V40, P588, DOI 10.1086/427216; Bani-Sadr F, 2005, JAIDS-J ACQ IMM DEF, V40, P47, DOI 10.1097/01.qai.0000174649.51084.46; Benhamou Y, 2006, J HEPATOL, V44, pS90, DOI 10.1016/j.jhep.2005.11.019; Benhamou Y, 2006, J HEPATOL, V44, P62, DOI 10.1016/j.jhep.2005.08.020; Benhamou Y, 1999, HEPATOLOGY, V30, P1302, DOI 10.1002/hep.510300525; Benhamou Y, 2004, CLIN INFECT DIS, V38, pS98, DOI 10.1086/381451; Braitstein P, 2006, AIDS, V20, P323, DOI 10.1097/01.aids.0000198091.70325.f4; Butt AA, 2004, HEPATOLOGY, V40, P115, DOI 10.1002/hep.20289; Carrat F, 2004, JAMA-J AM MED ASSOC, V292, P2839, DOI 10.1001/jama.292.23.2839; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Cherner M, 2005, NEUROLOGY, V64, P1343, DOI 10.1212/01.WNL.0000158328.26897.0D; Chung RT, 2004, NEW ENGL J MED, V351, P451, DOI 10.1056/NEJMoa032653; Coelmont L, 2006, ANTIMICROB AGENTS CH, V50, P3444, DOI 10.1128/AAC.00372-06; Cornejo-Juarez Patricia, 2006, AIDS Res Ther, V3, P9, DOI 10.1186/1742-6405-3-9; de Ledinghen V, 2006, JAIDS-J ACQ IMM DEF, V41, P175; *DEP HHS, 2006, DHHS GUID US ANT AG; Fleming CA, 2004, CLIN INFECT DIS, V38, P572, DOI 10.1086/381263; Fung SK, 2004, HEPATOLOGY, V40, P790, DOI 10.1002/hep.20455; Fuster D, 2006, ANTIVIR THER, V11, P473; Fuster D, 2006, ANTIVIR THER, V11, P667; Gandhi RT, 2005, J INFECT DIS, V191, P1435, DOI 10.1086/429302; Ghany MG, 2003, GASTROENTEROLOGY, V124, P97, DOI 10.1053/gast.2003.50018; Goedert JJ, 2004, HAEMOPHILIA, V10, P205, DOI 10.1111/j.1365-2516.2004.00997.x; Goedert JJ, 2001, J INFECT DIS, V184, P1202, DOI 10.1086/323665; Gotz HM, 2005, AIDS, V19, P969, DOI 10.1097/01.aids.0000171412.61360.f8; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Greub G, 2001, LANCET, V357, P1536; HADLER SC, 1991, J INFECT DIS, V163, P454, DOI 10.1093/infdis/163.3.454; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hofer M, 1998, EUR J CLIN MICROBIOL, V17, P6, DOI 10.1007/BF01584356; Hooshyar D, 2006, AIDS, V20, P575, DOI 10.1097/01.aids.0000210612.37589.12; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Keeffe EB, 2006, CLIN GASTROENTEROL H, V4, P936, DOI 10.1016/j.cgh.2006.05.016; Kelleher TB, 2006, J HEPATOL, V44, pS126, DOI 10.1016/j.jhep.2005.11.026; Kellerman SE, 2003, J INFECT DIS, V188, P571, DOI 10.1086/377135; Koev G, 2007, ANTIVIR RES, V73, P78, DOI 10.1016/j.antiviral.2006.07.009; Lada O, 2004, ANTIVIR THER, V9, P353; Laguno M, 2004, AIDS, V18, pF27, DOI 10.1097/00002030-200409030-00003; Lai CL, 2005, GASTROENTEROLOGY, V129, P528, DOI 10.1053/j.gastro.2005.05.053; Lau DTY, 1998, HEPATOLOGY, V28, P1121, DOI 10.1002/hep.510280430; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Laurence JC, 2005, AM J MED, V118, P75, DOI 10.1016/j.amjmed.2005.07.024; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Libman H, 2006, AM J GASTROENTEROL, V101, P1804, DOI 10.1111/j.1572-0241.2006.00616.x; Locarnini S, 2004, SEMIN LIVER DIS, V24, P3, DOI 10.1055/s-2004-828672; Lok ASF, 2004, HEPATOLOGY, V39, P857, DOI 10.1002/hep.20110; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marcellin P, 2004, NEW ENGL J MED, V351, P1206, DOI 10.1056/NEJMoa040431; Marks KM, 2005, J INFECT DIS, V192, P1943, DOI 10.1086/497608; Mast EE, 2005, J INFECT DIS, V192, P1880, DOI 10.1086/497701; MCMAHON BJ, 1992, GASTROENTEROLOGY, V103, P590, DOI 10.1016/0016-5085(92)90851-O; Merchante N, 2006, AIDS, V20, P49, DOI 10.1097/01.aids.0000198087.47454.e1; Miller MF, 2005, CLIN INFECT DIS, V41, P713, DOI 10.1086/432618; Miro JM, 2006, J HEPATOL, V44, pS140, DOI 10.1016/j.jhep.2005.11.028; Moreno A, 2005, J HEPATOL, V43, P783, DOI 10.1016/j.jhep.2005.05.019; Nunes D, 2006, ALCOHOL CLIN EXP RES, V30, P1520, DOI 10.1111/j.1530-0277.2006.00183.x; Nunez M, 2006, J HEPATOL, V44, pS132, DOI 10.1016/j.jhep.2005.11.027; Overton ET, 2005, CLIN INFECT DIS, V41, P1045, DOI 10.1086/433180; Pasricha N, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-65; Pawlotsky Jean-Michel, 2003, Clin Liver Dis, V7, P45, DOI 10.1016/S1089-3261(02)00065-X; Pawlotsky JM, 2006, J HEPATOL, V44, pS10, DOI 10.1016/j.jhep.2005.11.005; Peters MG, 2006, HEPATOLOGY, V44, P1110, DOI 10.1002/hep.21388; Pineda JA, 2005, J ANTIMICROB CHEMOTH, V55, P417, DOI 10.1093/jac/dkh555; Piroth L, 2002, J HEPATOL, V36, P681, DOI 10.1016/S0168-8278(02)00019-3; Pogany K, 2005, AIDS RES HUM RETROV, V21, P922, DOI 10.1089/aid.2005.21.922; Pol S, 2004, CLIN INFECT DIS, V38, pS65, DOI 10.1086/381499; Powderly WG, 2004, CLIN INFECT DIS, V38, pS109, DOI 10.1086/381443; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Qurishi N, 2003, LANCET, V362, P1708, DOI 10.1016/S0140-6736(03)14844-1; Reesink HW, 2006, GASTROENTEROLOGY, V131, P997, DOI 10.1053/j.gastro.2006.07.013; Rimland D, 2005, AIDS, V19, P1702, DOI 10.1097/01.aids.0000186815.99993.55; Roland ME, 2006, SEMIN LIVER DIS, V26, P273, DOI 10.1055/s-2006-947297; Runyon BA, 2004, HEPATOLOGY, V39, P841, DOI 10.1002/hep.20066; Salmon-Ceron D, 2005, J HEPATOL, V42, P799, DOI 10.1016/j.jhep.2005.01.022; Sanchez-Conde M, 2006, CLIN INFECT DIS, V43, P640, DOI 10.1086/506440; Santos EA, 2003, EUR J CLIN MICROBIOL, V22, P92, DOI 10.1007/s10096-002-0868-0; Schmutz G, 2006, AIDS, V20, P1951, DOI 10.1097/01.aids.0000247116.89455.5d; Sheldon J, 2005, ANTIVIR THER, V10, P727; Shire NJ, 2006, VACCINE, V24, P272, DOI 10.1016/j.vaccine.2005.07.102; Shire NJ, 2004, JAIDS-J ACQ IMM DEF, V36, P869, DOI 10.1097/00126334-200407010-00015; Solomon L, 2004, J URBAN HEALTH, V81, P25, DOI 10.1093/jurban/jth085; Sulkowski MS, 2004, CLIN INFECT DIS, V38, pS90, DOI 10.1086/381444; Sulkowski MS, 2005, AIDS, V19, P585, DOI 10.1097/01.aids.0000163935.99401.25; Sullivan PS, 2006, AIDS, V20, P1171, DOI 10.1097/01.aids.0000226958.87471.48; Thio CL, 2003, SEMIN LIVER DIS, V23, P125; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Thompson VV, 2005, AIDS, V19, pS208, DOI 10.1097/01.aids.0000192091.38883.f9; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Uneke CJ, 2005, MEM I OSWALDO CRUZ, V100, P13, DOI 10.1590/S0074-02762005000100002; van Bommel F, 2004, HEPATOLOGY, V40, P1421, DOI 10.1002/hep.20464; Vento S, 1998, NEW ENGL J MED, V338, P286, DOI 10.1056/NEJM199801293380503; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Yuen MF, 2001, HEPATOLOGY, V34, P785, DOI 10.1053/jhep.2001.27563; 2007, IMPORTANT INFORMATIO	99	222	236	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 5	2007	356	14					1445	1454		10.1056/NEJMra065142	http://dx.doi.org/10.1056/NEJMra065142			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153GG	17409326	Green Accepted			2022-12-28	WOS:000245419600008
J	Gupta, R; Plantinga, LC; Fink, NE; Melamed, ML; Coresh, J; Fox, CS; Levin, NW; Powe, NR				Gupta, Rajesh; Plantinga, Laura C.; Fink, Nancy E.; Melamed, Michal L.; Coresh, Josef; Fox, Caroline S.; Levin, Nathan W.; Powe, Neil R.			Statin use and hospitalization for sepsis in patients with chronic kidney disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC-HEMODIALYSIS PATIENTS; PLACEBO-CONTROLLED TRIAL; COA REDUCTASE INHIBITOR; REACTIVE PROTEIN-LEVELS; DIALYSIS PATIENTS; RISK-FACTORS; IMPROVES SURVIVAL; UNITED-STATES; IN-VIVO; MORTALITY	Context Patients with chronic kidney disease are at high risk for sepsis and sepsis-related mortality. Objective To assess whether statin use is associated with a reduction in hospitalizations for sepsis in dialysis patients. Design, Setting, and Patients National prospective cohort study that enrolled 1041 incident dialysis patients at 81 US not-for-profit outpatient dialysis clinics from October 1995 to June 1998, with follow-up to January 2005. Statin use was determined by medical record review. Rates of hospitalization for sepsis between statin users and control patients were compared using multivariate regression models, with adjustment for potential confounders in the overall cohort and in a subcohort in which control patients were matched to statin users according to their likelihood ( propensity) to have been prescribed a statin. Main Outcome Measure Hospitalizations for sepsis were determined through hospital records from the United States Renal Data System ( mean follow-up, 3.4 years). Results There were 303 hospitalizations for sepsis. Rates of sepsis-related hospitalizations were significantly lower in patients receiving statins ( crude incidence rate, 41/ 1000 patient-years) than in those not receiving statins ( crude incidence rate, 110/ 1000 patient-years) ( P <. 001). With adjustment for demographics and dialysis modality, statin users were substantially less likely to be subsequently hospitalized for sepsis ( incidence rate ratio, 0.41; 95% confidence interval [CI], 0.25-0.68). Further adjustment for comorbidities and laboratory values continued to show this protective association ( incidence rate ratio, 0.38; 95% CI, 0.21-0.67). In the propensity-matched subcohort, statin use was even more protective ( incidence rate ratio, 0.24; 95% CI, 0.11-0.49). Conclusions Use of statins was strongly and independently associated with a reduction in the risk of hospitalization for sepsis in patients who had chronic kidney disease and were receiving dialysis. Randomized trials of statins in patients with chronic kidney disease should examine the prevention of sepsis as a potentially important benefit.	Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Epidemiol, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Populat Hlth, Bronx, NY 10467 USA; Blood Inst Framingham Heart Study, Framingham, MA USA; Renal Res Inst, New York, NY USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Framingham Heart Study; Renal Research Institute	Powe, NR (corresponding author), Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, 2024 E Monument St,Suite 2-600, Baltimore, MD 21205 USA.	npowe@jhmi.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS008365] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059616, F32DK069017, K24DK002643] Funding Source: NIH RePORTER; AHRQ HHS [R01-HS-08365] Funding Source: Medline; NHLBI NIH HHS [R01-HL 62985] Funding Source: Medline; NIDDK NIH HHS [R01-DK 59616, F32DK069017, K24DK02643] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aikawa M, 2001, CIRCULATION, V103, P276; Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; Ando H, 2000, J PHARMACOL EXP THER, V294, P1043; Astor BC, 2005, J AM SOC NEPHROL, V16, P1449, DOI 10.1681/ASN.2004090748; Athienites NV, 2000, SEMIN DIALYSIS, V13, P320, DOI 10.1046/j.1525-139x.2000.00095.x; Baigent C, 2003, KIDNEY INT, V63, pS207, DOI 10.1046/j.1523-1755.63.s84.4.x; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; Catron DM, 2004, INFECT IMMUN, V72, P1036, DOI 10.1128/IAI.72.2.1036-1042.2004; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Coresh J, 1998, J Am Soc Nephrol, V9, pS24; del Real G, 2004, J EXP MED, V200, P541, DOI 10.1084/jem.20040061; Endo A, 2004, ATHEROSCLEROSIS SUPP, V5, P125, DOI 10.1016/j.atherosclerosissup.2004.08.033; Endo A, 2004, ATHEROSCLEROSIS SUPP, V5, P67, DOI 10.1016/j.atherosclerosissup.2004.08.026; Equils O, 2006, CLIN EXP IMMUNOL, V143, P58, DOI 10.1111/j.1365-2249.2005.02961.x; Fox CS, 2004, CLIN NEPHROL, V61, P299; Giguere JF, 2004, J VIROL, V78, P12062, DOI 10.1128/JVI.78.21.12062-12065.2004; Giusti-Paiva A, 2004, SHOCK, V21, P271, DOI 10.1097/10.shk.0000115756.74059.ce; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; Hoen B, 1998, J AM SOC NEPHROL, V9, P869; IKEURA R, 1988, J ANTIBIOT, V41, P1148, DOI 10.7164/antibiotics.41.1148; Iseki K, 2002, KIDNEY INT, V61, P1887, DOI 10.1046/j.1523-1755.2002.00324.x; Kinchen KS, 2002, ANN INTERN MED, V137, P479, DOI 10.7326/0003-4819-137-6-200209170-00007; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Liappis AP, 2001, CLIN INFECT DIS, V33, P1352, DOI 10.1086/323334; Liu YM, 2004, JAMA-J AM MED ASSOC, V291, P451, DOI 10.1001/jama.291.4.451; LOWRIE EG, 1990, AM J KIDNEY DIS, V15, P458, DOI 10.1016/S0272-6386(12)70364-5; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McCarey DW, 2004, LANCET, V363, P2015, DOI 10.1016/S0140-6736(04)16449-0; Merx MW, 2004, CIRCULATION, V109, P2560, DOI 10.1161/01.CIR.0000129774.09737.5B; Miskulin DC, 2002, AM J KIDNEY DIS, V39, P324, DOI 10.1053/ajkd.2002.30552; Niessner A, 2006, ATHEROSCLEROSIS, V189, P408, DOI 10.1016/j.atherosclerosis.2005.12.022; Ollendorf DA, 2002, VALUE HEALTH, V5, P79, DOI 10.1046/j.1524-4733.2002.52013.x; Parsons L, REDUCING BIAS PROPEN; Plantinga LC, 2004, J AM SOC NEPHROL, V15, P3144, DOI 10.1097/01.ASN.0000146424.91128.2A; Powe NR, 1999, KIDNEY INT, V55, P1081, DOI 10.1046/j.1523-1755.1999.0550031081.x; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Sarnak MJ, 2000, KIDNEY INT, V58, P1758, DOI 10.1111/j.1523-1755.2000.00337.x; Sola S, 2006, J AM COLL CARDIOL, V47, P332, DOI 10.1016/j.jacc.2005.06.088; Vollmer T, 2004, LANCET, V363, P1607, DOI 10.1016/S0140-6736(04)16205-3; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058	45	92	99	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2007	297	13					1455	1464		10.1001/jama.297.13.1455	http://dx.doi.org/10.1001/jama.297.13.1455			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AM	17405971				2022-12-28	WOS:000245404100022
J	Hatakeyama, S; Sugaya, N; Ito, M; Yamazaki, M; Ichikawa, M; Kimura, K; Kiso, M; Shimizu, H; Kawakami, C; Koike, K; Mitamura, K; Kawaoka, Y				Hatakeyama, Shuji; Sugaya, Norio; Ito, Mutsumi; Yamazaki, Masahiko; Ichikawa, Masataka; Kimura, Kazuhiro; Kiso, Maki; Shimizu, Hideaki; Kawakami, Chiharu; Koike, Kazuhiko; Mitamura, Keiko; Kawaoka, Yoshihiro			Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IN-VITRO; OSELTAMIVIR; RESISTANT; ZANAMIVIR; SUSCEPTIBILITIES; SEQUENCE; MUTATION	Context Very little is known about the frequency of generation and transmissibility of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. Furthermore, transmission of resistant virus, whether influenza A or B, has not been recognized to date. Objective To assess the prevalence and transmissibility of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. Design, Setting, and Patients Investigation of the neuraminidase inhibitor sensitivity of influenza B isolates from 74 children before and after oseltamivir therapy and from 348 untreated patients with influenza ( including 66 adults) seen at 4 community hospitals in Japan during the 2004-2005 influenza season. Four hundred twenty-two viruses from untreated patients and 74 samples from patients after oseltamivir therapy were analyzed. Main Outcome Measure Sialidase inhibition assay was used to test the drug sensitivities of influenza B viruses. The neuraminidase and hemagglutinin genes of viruses showing reduced sensitivity to neuraminidase inhibitors were sequenced to identify mutations that have the potential to confer reduced sensitivity to these drugs. Results In 1 (1.4%) of the 74 children who had received oseltamivir, we identified a variant with reduced drug sensitivity possessing a Gly402Ser neuraminidase substitution. We also identified variants with reduced sensitivity carrying an Asp198Asn, Ile222Thr, or Ser250Gly mutation in 7 (1.7%) of the 422 viruses from untreated patients. Review of the clinical and viral genetic information available on these 7 patients indicated that 4 were likely infected in a community setting, while the remaining 3 were probably infected through contact with siblings shedding the mutant viruses. Conclusions In this population, influenza B viruses with reduced sensitivity to neuraminidase inhibitors do not arise as frequently as resistant influenza A viruses. However, they appear to be transmitted within communities and families, requiring continued close monitoring.	Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol,Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Grad Sch Med, Dept Infect Dis, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo, Japan; Keiyu Hosp, Dept Pediat, Kanagawa, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; Zama Childrens Clin, Kanagawa, Japan; Isehara Kyodo Hosp, Dept Pediat, Isehara, Kanagawa, Japan; Kawasaki City Inst Publ Hlth, Kanagawa, Japan; Yokohama City Inst Hlth, Kanagawa, Japan; Eiju Gen Hosp, Dept Pediat, Tokyo, Japan; Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); University of Wisconsin System; University of Wisconsin Madison	Kawaoka, Y (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kawaoka@ims.u-tokyo.ac.jp						[Anonymous], 2005, PRINCIPLES PRACTICE; BURMEISTER WP, 1992, EMBO J, V11, P49, DOI 10.1002/j.1460-2075.1992.tb05026.x; Carr J, 2002, ANTIVIR RES, V54, P79, DOI 10.1016/S0166-3542(01)00215-7; Cass LMR, 1999, CLIN PHARMACOKINET, V36, P21, DOI 10.2165/00003088-199936001-00003; COLMAN PM, 1993, J VIROL, V67, P2972, DOI 10.1128/JVI.67.6.2972-2980.1993; De Clercq E, 2004, J CLIN VIROL, V30, P115, DOI 10.1016/j.jcv.2004.02.009; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Gubareva LV, 2004, VIRUS RES, V103, P199, DOI 10.1016/j.virusres.2004.02.034; Gubareva LV, 1998, J INFECT DIS, V178, P1257, DOI 10.1086/314440; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; HARPER SA, 2005, MMWR-MORBID MORTAL W, V54, P750; Harper Scott A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Herlocher ML, 2002, ANTIVIR RES, V54, P99, DOI 10.1016/S0166-3542(01)00214-5; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Le QM, 2005, NATURE, V438, P754, DOI 10.1038/438754b; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; McKimm-Breschkin J, 2003, ANTIMICROB AGENTS CH, V47, P2264, DOI 10.1128/AAC.47.7.2264-2272.2003; McKimm-Breschkin JL, 2000, ANTIVIR RES, V47, P1, DOI 10.1016/S0166-3542(00)00103-0; Mishin VP, 2005, ANTIMICROB AGENTS CH, V49, P4515, DOI 10.1128/AAC.49.11.4515-4520.2005; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Oo C, 2003, EUR J CLIN PHARMACOL, V59, P411, DOI 10.1007/s00228-003-0639-6; Pillay D, 1998, BMJ-BRIT MED J, V317, P660, DOI 10.1136/bmj.317.7159.660; *ROCH, 2005, FACTSH TAM; Ward P, 2005, J ANTIMICROB CHEMOTH, V55, P5, DOI 10.1093/jac/dki018; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002; *WHO, 2005, WKLY EPIDEMIOL REC, V80, P156	30	170	189	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2007	297	13					1435	1442		10.1001/jama.297.13.1435	http://dx.doi.org/10.1001/jama.297.13.1435			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AM	17405969				2022-12-28	WOS:000245404100020
J	Follows, MJ; Dutkiewicz, S; Grant, S; Chisholm, SW				Follows, Michael J.; Dutkiewicz, Stephanie; Grant, Scott; Chisholm, Sallie W.			Emergent biogeography of microbial communities in a model ocean	SCIENCE			English	Article							PROCHLOROCOCCUS ECOTYPES; MARINE; PHYTOPLANKTON	A marine ecosystem model seeded with many phytoplankton types, whose physiological traits were randomly assigned from ranges defined by field and laboratory data, generated an emergent community structure and biogeography consistent with observed global phytoplankton distributions. The modeled organisms included types analogous to the marine cyanobacterium Prochlorococcus. Their emergent global distributions and physiological properties simultaneously correspond to observations. This flexible representation of community structure can be used to explore relations between ecosystems, biogeochemical cycles, and climate change.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); University of Hawaii System; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Follows, MJ (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 54-1514 MIT, Cambridge, MA 02139 USA.	mick@mit.edu	chen, qi/C-8585-2011; Follows, Michael/G-9824-2011	Chisholm, Sallie/0000-0003-1480-2445				Anderson TR, 2005, J PLANKTON RES, V27, P1073, DOI 10.1093/plankt/fbi076; ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Bouman HA, 2006, SCIENCE, V312, P918, DOI 10.1126/science.1122692; Dandonneau Y, 2006, DEEP-SEA RES PT I, V53, P689, DOI 10.1016/j.dsr.2006.01.002; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Gregg WW, 2003, DEEP-SEA RES PT II, V50, P3143, DOI 10.1016/j.dsr2.2003.07.013; Hood RR, 2006, DEEP-SEA RES PT II, V53, P459, DOI 10.1016/j.dsr2.2006.01.025; HUTCHINSON G, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kleidon A, 2000, GLOB CHANGE BIOL, V6, P507, DOI 10.1046/j.1365-2486.2000.00332.x; Le Quere C, 2005, GLOBAL CHANGE BIOL, V11, P2016, DOI 10.1111/j.1365-2468.2005.01004.x; Litchman E, 2006, BIOGEOSCIENCES, V3, P585, DOI 10.5194/bg-3-585-2006; Lomas MW, 2006, LIMNOL OCEANOGR, V51, P2453, DOI 10.4319/lo.2006.51.5.2453; Margalef R., 1968, PERSPECTIVES ECOLOGI; Moore JK, 2001, DEEP-SEA RES PT II, V49, P403, DOI 10.1016/S0967-0645(01)00108-4; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Moore LR, 1999, LIMNOL OCEANOGR, V44, P628, DOI 10.4319/lo.1999.44.3.0628; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; PIMM SL, 1977, NATURE, V268, P329, DOI 10.1038/268329a0; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; THOMPSON PA, 1989, LIMNOL OCEANOGR, V34, P1014, DOI 10.4319/lo.1989.34.6.1014; TILMAN D, 1977, ECOLOGY, V58, P338, DOI 10.2307/1935608; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wunsch C, 2007, PHYSICA D, V230, P197, DOI 10.1016/j.physd.2006.09.040; Zubkov MV, 2000, PROG OCEANOGR, V45, P369, DOI 10.1016/S0079-6611(00)00008-2	27	566	571	7	211	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1843	1846		10.1126/science.1138544	http://dx.doi.org/10.1126/science.1138544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395828				2022-12-28	WOS:000245280100043
J	Stone, L; Olinky, R; Huppert, A				Stone, Lewi; Olinky, Ronen; Huppert, Amit			Seasonal dynamics of recurrent epidemics	NATURE			English	Article							CHAOS; MEASLES; MODEL; ENGLAND	Seasonality is a driving force that has a major effect on the spatiotemporal dynamics of natural systems and their populations(1-5). This is especially true for the transmission of common infectious diseases ( such as influenza, measles, chickenpox and pertussis), and is of great relevance for host-parasite relationships in general(1-23). Here we gain further insights into the nonlinear dynamics of recurrent diseases through the analysis of the classical seasonally forced SIR ( susceptible, infectious or recovered) epidemic model(6,7). Ouranalysis differs from other modelling studies in that the focus is more on post-epidemic dynamics than the outbreak itself. Despite the mathematical intractability of the forced SIR model, we identify a new threshold effect and give clear analytical conditions for predicting the occurrence of either a future epidemic outbreak, or a 'skip'-a year in which an epidemic fails to initiate. The threshold is determined by the population's susceptibility measured after the last outbreak and the rate at which new susceptible individuals are recruited into the population. Moreover, the time of occurrence ( that is, the phase) of an outbreak proves to be a useful parameter that carries important epidemiological information. In forced systems, seasonal changes can prevent late-peaking diseases ( that is, those having high phase) from spreading widely, thereby increasing population susceptibility, and controlling the triggering and intensity of future epidemics. These principles yield forecasting tools that should have relevance for the study of newly emerging and re-emerging diseases controlled by seasonal vectors.	Tel Aviv Univ, Fac Life Sci, Dept Zool, Biomath Unit, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Porter Sch Environm Studies, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Stone, L (corresponding author), Tel Aviv Univ, Fac Life Sci, Dept Zool, Biomath Unit, IL-69978 Tel Aviv, Israel.	lewi@post.tau.ac.il		Stone, Lewi/0000-0002-6465-579X				Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ANDERSON R M, 1991; Andreasen V, 2003, J MATH BIOL, V46, P504, DOI 10.1007/s00285-002-0186-2; ARON JL, 1984, J THEOR BIOL, V110, P665, DOI 10.1016/S0022-5193(84)80150-2; Billings L, 2002, J MATH BIOL, V44, P31, DOI 10.1007/s002850100110; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; BOLKER BM, 1993, P ROY SOC B-BIOL SCI, V251, P75, DOI 10.1098/rspb.1993.0011; Casagrandi R, 2006, MATH BIOSCI, V200, P152, DOI 10.1016/j.mbs.2005.12.029; Dietz K, 1976, MATH MODELS MED, P1; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; ENGBERT R, 1994, CHAOS SOLITON FRACT, V4, P1147, DOI 10.1016/0960-0779(94)90028-0; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; Finkenstadt B, 1998, P ROY SOC B-BIOL SCI, V265, P211, DOI 10.1098/rspb.1998.0284; Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187; Huppert A, 2005, J THEOR BIOL, V236, P276, DOI 10.1016/j.jtbi.2005.03.012; Keeling MJ, 2001, PHYSICA D, V148, P317, DOI 10.1016/S0167-2789(00)00187-1; LONDON WP, 1973, AM J EPIDEMIOL, V98, P453, DOI 10.1093/oxfordjournals.aje.a121575; Madden LV, 2002, BIOSCIENCE, V52, P65, DOI 10.1641/0006-3568(2002)052[0065:APDATA]2.0.CO;2; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Murray J. D., 1989, MATH BIOL, DOI DOI 10.1007/978-3-662-08539-4; OLINKY R, UNPUB P NATL ACAD SC; OLSEN LF, 1988, THEOR POPUL BIOL, V33, P344, DOI 10.1016/0040-5809(88)90019-6; OLSEN LF, 1990, SCIENCE, V249, P499, DOI 10.1126/science.2382131; Pascual M, 2005, PLOS MED, V2, P18, DOI 10.1371/journal.pmed.0020005; RAND DA, 1991, P ROY SOC B-BIOL SCI, V246, P179, DOI 10.1098/rspb.1991.0142; SCHAFFER WM, 1985, J THEOR BIOL, V112, P403, DOI 10.1016/S0022-5193(85)80294-0; SCHWARTZ IB, 1983, J MATH BIOL, V18, P233, DOI 10.1007/BF00276090; Shulgin B, 1998, B MATH BIOL, V60, P1123, DOI 10.1016/S0092-8240(98)90005-2; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0	30	202	210	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2007	446	7135					533	536		10.1038/nature05638	http://dx.doi.org/10.1038/nature05638			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392785				2022-12-28	WOS:000245242900048
J	French, JA				French, Jacqueline A.			First-choice drug for newly diagnosed epilepsy	LANCET			English	Editorial Material							LAMOTRIGINE; CARBAMAZEPINE; VALPROATE		Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania	French, JA (corresponding author), Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA.	frenchj@mail.med.upenn.edu	French, Jacqueline A/G-6795-2013	French, Jacqueline A/0000-0003-2242-8027				Arroyo S, 1999, NEUROLOGY, V53, P1170, DOI 10.1212/WNL.53.6.1170; BENMENACHEM E, 2006, EFFICACY LEVETIRACET; Chapman SA, 2001, PHARMACOTHERAPY, V21, P1549, DOI 10.1592/phco.21.20.1549.34480; French JA, 2005, NEUROLOGY, V64, P1834, DOI 10.1212/WNL.64.11.1834; Glauser T, 2006, EPILEPSIA, V47, P1094, DOI 10.1111/j.1528-1167.2006.00585.x; KONIG SA, 1994, EPILEPSIA, V35, P1005; Marson AG, 2007, LANCET, V369, P1016, DOI 10.1016/S0140-6736(07)60461-9; Marson AG, 2007, LANCET, V369, P1000, DOI 10.1016/S0140-6736(07)60460-7; Meador KJ, 2006, NEUROLOGY, V67, P407, DOI 10.1212/01.wnl.0000227919.81208.b2; *NAT I CLIN EXC, 2004, NEW DRUGS EP AD; Pennell PB, 2004, NEUROLOGY, V62, P292, DOI 10.1212/01.WNL.0000103286.47129.F8; Sadler M, 1999, EPILEPSIA, V40, P322, DOI 10.1111/j.1528-1157.1999.tb00712.x; Tennis P, 1997, NEUROLOGY, V49, P542, DOI 10.1212/WNL.49.2.542; Wong ICK, 1999, ANN PHARMACOTHER, V33, P1037, DOI 10.1345/aph.18422	14	19	19	1	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 24	2007	369	9566					970	971		10.1016/S0140-6736(07)60470-X	http://dx.doi.org/10.1016/S0140-6736(07)60470-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151JO	17382806				2022-12-28	WOS:000245286500006
J	Huang, YH; Grasis, JA; Miller, AT; Xu, R; Soonthornvacharin, S; Andreotti, AH; Tsoukas, CD; Cooke, MP; Sauer, K				Huang, Yina H.; Grasis, Juris A.; Miller, Andrew T.; Xu, Ruo; Soonthornvacharin, Stephen; Andreotti, Amy H.; Tsoukas, Constantine D.; Cooke, Michael P.; Sauer, Karsten			Positive regulation of ltk PH domain function by soluble IP4	SCIENCE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; T-LYMPHOCYTE DEVELOPMENT; INOSITOL 1,3,4,5-TETRAKISPHOSPHATE; GAP1 FAMILY; PROTEIN; KINASE; CELLS; ACTIVATION; SELECTION	Pleckstrin homology (PH) domain-mediated protein recruitment to cellular membranes is of paramount importance for signal transduction. The recruitment of many PH domains is controlled through production and turnover of their membrane ligand, phosphatidylinositol 3,4,5-trisphosphate (PIP3). We show that phosphorylation of the second messenger inositol 1,4,5-trisphosphate (IP3) into inositol 1,3,4,5-tetrakisphosphate (IP4) establishes another mode of PH domain regulation through a soluble ligand. At physiological concentrations, IP4 promoted PH domain binding to PIP3. In primary mouse CD4(+)CD8(+) thymocytes, this was required for full activation of the protein tyrosine kinase Itk after T cell receptor engagement. Our data suggest that IP4 establishes a feedback loop of phospholipase C-gamma 1 activation through Itk that is essential for T cell development.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; San Diego State Univ, Ctr Microbial Studies, San Diego, CA 92182 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Iowa State Univ Sci & Technol, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Scripps Research Institute; California State University System; San Diego State University; California State University System; San Diego State University; Novartis; Iowa State University	Sauer, K (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ksauer@scripps.edu	Grasis, Juris A./K-2568-2012	Grasis, Juris A./0000-0002-3945-0135; Huang, Yina/0000-0002-0125-9351	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048848] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR048848] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		August A, 1997, P NATL ACAD SCI USA, V94, P11227, DOI 10.1073/pnas.94.21.11227; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Ching KA, 1999, J IMMUNOL, V163, P6006; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; CULLEN PJ, 1995, NATURE, V376, P527, DOI 10.1038/376527a0; Fukuda M, 1996, J BIOL CHEM, V271, P18838, DOI 10.1074/jbc.271.31.18838; Fukuda M, 1996, J BIOL CHEM, V271, P30303, DOI 10.1074/jbc.271.48.30303; GUSE AH, 1993, J BIOL CHEM, V268, P7129; Kojima T, 1997, BIOCHEM BIOPH RES CO, V236, P333, DOI 10.1006/bbrc.1997.6947; Miller AT, 2007, NAT IMMUNOL, V8, P514, DOI 10.1038/ni1458; Pouillon V, 2003, NAT IMMUNOL, V4, P1136, DOI 10.1038/ni980; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Serrano CJ, 2005, J IMMUNOL, V174, P6233, DOI 10.4049/jimmunol.174.10.6233; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stricker R, 1999, EUR J BIOCHEM, V265, P815, DOI 10.1046/j.1432-1327.1999.00795.x; Wen BG, 2004, P NATL ACAD SCI USA, V101, P5604, DOI 10.1073/pnas.0306907101; Yarwood S, 2006, BIOCHEM SOC T, V34, P846, DOI 10.1042/BST0340846	17	68	68	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2007	316	5826					886	889		10.1126/science.1138684	http://dx.doi.org/10.1126/science.1138684			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166HM	17412921				2022-12-28	WOS:000246369800037
J	Aravin, AA; Sachidanandam, R; Girard, A; Fejes-Toth, K; Hannon, GJ				Aravin, Alexei A.; Sachidanandam, Ravi; Girard, Angelique; Fejes-Toth, Katalin; Hannon, Gregory J.			Developmentally regulated piRNA clusters implicate MILI in transposon control	SCIENCE			English	Article							SMALL RNAS; METHYLATION; MAINTENANCE; EXPRESSION; GENE	Nearly half of the mammalian genome is composed of repeated sequences. In Drosophila, Piwi proteins exert control over transposons. However, mammalian Piwi proteins, MIWI and MILI, partner with Piwi-interacting RNAs (piRNAs) that are depleted of repeat sequences, which raises questions about a role for mammalian Piwi's in transposon control. A search for murine small RNAs that might program Piwi proteins for transposon suppression revealed developmentally regulated piRNA loci, some of which resemble transposon master control loci of Drosophila. We also find evidence of an adaptive amplification loop in which MILI catalyzes the formation of piRNA 5' ends. Mili mutants derepress LINE-1 (L1) and intracisternal A particle and lose DNA methylation of L1 elements, demonstrating an evolutionarily conserved role for PIWI proteins in transposon suppression.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	sachidanandam, ravi/Q-6916-2019; Hannon, Gregory/AAB-3568-2019	sachidanandam, ravi/0000-0001-9844-4459; 				Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aufsatz W, 2002, P NATL ACAD SCI USA, V99, P16499, DOI 10.1073/pnas.162371499; Bestor TH, 2004, COLD SPRING HARB SYM, V69, P381, DOI 10.1101/sqb.2004.69.381; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; BRANCIFORTE D, 1994, MOL CELL BIOL, V14, P2584, DOI 10.1128/MCB.14.4.2584; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BUCHETON A, 1995, TRENDS GENET, V11, P349, DOI 10.1016/S0168-9525(00)89105-2; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Gaudet F, 2004, MOL CELL BIOL, V24, P1640, DOI 10.1128/MCB.24.4.1640-1648.2004; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kuramochi-Miyagawa S, 2001, MECH DEVELOP, V108, P121, DOI 10.1016/S0925-4773(01)00499-3; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Mathieu O, 2004, J CELL SCI, V117, P4881, DOI 10.1242/jcs.01479; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	20	716	759	6	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2007	316	5825					744	747		10.1126/science.1142612	http://dx.doi.org/10.1126/science.1142612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17446352				2022-12-28	WOS:000246181400046
J	Koussevitzky, S; Nott, A; Mockler, TC; Hong, F; Sachetto-Martins, G; Surpin, M; Lim, IJ; Mittler, R; Chory, J				Koussevitzky, Shai; Nott, Ajit; Mockler, Todd C.; Hong, Fangxin; Sachetto-Martins, Gilberto; Surpin, Marci; Lim, Il Jason; Mittler, Ron; Chory, Joanne			Signals from chloroplasts converge to regulate nuclear gene expression	SCIENCE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; CHELATASE H-SUBUNIT; ABSCISIC-ACID; BINDING PROTEIN; ARABIDOPSIS; STRESS; MITOCHONDRIAL; PATHWAYS; REVEALS; GLUCOSE	Plastid-to-nucleus retrograde signaling coordinates nuclear gene expression with chloroplast function and is essential for the photoautotrophic life-style of plants. Three retrograde signals have been described, but little is known of their signaling pathways. We show here that GUN1, a chloroplast-localized pentatricopeptide-repeat protein, and ABI4, an Apetala 2 (AP2)-type transcription factor, are common to all three pathways. ABI4 binds the promoter of a retrograde-regulated gene through a conserved motif found in close proximity to a light-regulatory element. We propose a model in which multiple indicators of aberrant plastid function in Arabidopsis are integrated upstream of GUN1 within plastids, which leads to ABI4-mediated repression of nuclear-encoded genes.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; Hebrew Univ Jerusalem, Dept Plant Sci, IL-91904 Jerusalem, Israel	Howard Hughes Medical Institute; Salk Institute; Salk Institute; Nevada System of Higher Education (NSHE); University of Nevada Reno; Hebrew University of Jerusalem	Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chory@salk.edu	Sachetto-Martins, Gilberto/AAT-4095-2021; Mittler, Ron/ABE-6496-2020; Sachetto-Martins, Gilberto/AAN-6328-2020		NIGMS NIH HHS [F32 GM 69090, F32 GM 18172] Funding Source: Medline; PHS HHS [DRG-1865-05] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM018172, F32GM069090] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arroyo A, 2003, PLANT PHYSIOL, V133, P231, DOI 10.1104/pp.103.021089; Aubourg S, 2000, PLANT MOL BIOL, V42, P603, DOI 10.1023/A:1006352315928; Avonce N, 2004, PLANT PHYSIOL, V136, P3649, DOI 10.1104/pp.104.052084; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; Dijkwel PP, 1997, PLANT CELL, V9, P583, DOI 10.1105/tpc.9.4.583; Dojcinovic D, 2005, PLANT MOL BIOL, V58, P159, DOI 10.1007/s11103-005-5390-1; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Gray JC, 2003, PHILOS T R SOC B, V358, P135, DOI 10.1098/rstb.2002.1180; Gray JC, 2003, TRENDS GENET, V19, P526, DOI 10.1016/j.tig.2003.08.001; Hattori T, 2002, PLANT CELL PHYSIOL, V43, P136, DOI 10.1093/pcp/pcf014; Himmelbach A, 2003, CURR OPIN PLANT BIOL, V6, P470, DOI 10.1016/S1369-5266(03)00090-6; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Ikeda TM, 1999, MOL CELL BIOL, V19, P8113; Kazan K, 2006, TRENDS PLANT SCI, V11, P109, DOI 10.1016/j.tplants.2006.01.004; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Leister D, 2005, GENE, V354, P110, DOI 10.1016/j.gene.2005.03.039; Leister D, 2003, TRENDS GENET, V19, P47, DOI 10.1016/S0168-9525(02)00003-3; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; McCormac AC, 2004, PLANT J, V40, P672, DOI 10.1111/j.1365-313X.2004.02243.x; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Moreira D, 1999, TRENDS BIOCHEM SCI, V24, P298, DOI 10.1016/S0968-0004(99)01419-X; Niu XP, 2002, PLANT CELL, V14, P2565, DOI 10.1105/tpc.003400; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; OELMULLER R, 1986, PLANTA, V168, P482, DOI 10.1007/BF00392267; Oswald O, 2001, P NATL ACAD SCI USA, V98, P2047, DOI 10.1073/pnas.021449998; Pfalz J, 2006, PLANT CELL, V18, P176, DOI 10.1105/tpc.105.036392; Richly E, 2003, EMBO REP, V4, P491, DOI 10.1038/sj.embor.embor828; Rizhsky L, 2004, J BIOL CHEM, V279, P11736, DOI 10.1074/jbc.M313350200; Rock CD, 2000, NEW PHYTOL, V148, P357, DOI 10.1046/j.1469-8137.2000.00769.x; Schmitz-Linneweber C, 2006, PLANT CELL, V18, P2650, DOI 10.1105/tpc.106.046110; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Soderman EM, 2000, PLANT PHYSIOL, V124, P1752, DOI 10.1104/pp.124.4.1752; Strand A, 2003, NATURE, V421, P79, DOI 10.1038/nature01204; TERZAGHI WB, 1995, ANNU REV PLANT PHYS, V46, P445, DOI 10.1146/annurev.pp.46.060195.002305; Tsuchiya N, 2004, BIOCHEM BIOPH RES CO, V317, P736, DOI 10.1016/j.bbrc.2004.03.103; Vinti G, 2000, PLANT J, V24, P883, DOI 10.1046/j.1365-313x.2000.00936.x; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x	40	651	698	7	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2007	316	5825					715	719		10.1126/science. 1140516	http://dx.doi.org/10.1126/science. 1140516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17395793				2022-12-28	WOS:000246181400037
J	Schier, AF				Schier, Alexander F.			The maternal-zygotic transition: Death and birth of RNAs	SCIENCE			English	Review							MAJOR DEVELOPMENTAL TRANSITION; EARLY XENOPUS-EMBRYOS; TRANSCRIPTION; ACTIVATION; DROSOPHILA; STAGE	Maternal gene products drive early development when the newly formed embryo is transcriptionally inactive. During the maternal-zygotic transition, embryonic transcription is initiated and many maternal RNAs are degraded. Multiple mechanisms regulate the birth of zygotic RNAs and the death of maternal RNAs. Genome activation appears to rely in part on the sequestration of transcriptional repressors by the exponentially increasing amount of DNA during cleavage divisions. Maternal RNA degradation is induced by the binding of proteins and microRNAs to the 3' untranslated region of target RNAs.	Harvard Univ, Ctr Brain Sci, Harvard Stem Cell Inst, Dept Mol & Cellular Biol,Broad Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Schier, AF (corresponding author), Harvard Univ, Ctr Brain Sci, Harvard Stem Cell Inst, Dept Mol & Cellular Biol,Broad Inst, 16 Divin Ave,Room 1027, Cambridge, MA 02138 USA.	schier@fas.harvard.edu		Schier, Alexander Franz/0000-0001-7645-5325				EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Kikyo N, 2000, J CELL SCI, V113, P11; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; O'Farrell PH, 2004, CURR BIOL, V14, pR35, DOI 10.1016/j.cub.2003.12.022; PRIOLEAU MN, 1994, CELL, V77, P439, DOI 10.1016/0092-8674(94)90158-9; Pritchard DK, 1996, GENE DEV, V10, P1131, DOI 10.1101/gad.10.9.1131; Ruzov A, 2004, DEVELOPMENT, V131, P6185, DOI 10.1242/dev.01549; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; Tadros W, 2005, DEV DYNAM, V232, P593, DOI 10.1002/dvdy.20297; Yang J, 2002, DEVELOPMENT, V129, P5743, DOI 10.1242/dev.00150	13	280	294	6	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2007	316	5823					406	407		10.1126/science.1140693	http://dx.doi.org/10.1126/science.1140693			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158RY	17446392				2022-12-28	WOS:000245813400043
J	Lau, JY; Leung, WK; Wu, JCY; Chan, FKL; Wong, VWS; Chiu, PWY; Lee, VWY; Lee, KKC; Cheung, FKY; Siu, P; Ng, EKW; Sung, JJY				Lau, James Y.; Leung, Wai K.; Wu, Justin C. Y.; Chan, Francis K. L.; Wong, Vincent W. S.; Chiu, Philip W. Y.; Lee, Vivian W. Y.; Lee, Kenneth K. C.; Cheung, Frances K. Y.; Siu, Priscilla; Ng, Enders K. W.; Sung, Joseph J. Y.			Omeprazole before endoscopy in patients with gastrointestinal bleeding	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PEPTIC-ULCER; INTRAVENOUS OMEPRAZOLE; CONTROLLED-TRIAL; HEMORRHAGE; PLACEBO	BACKGROUND: A neutral gastric pH is critical for the stability of clots over bleeding arteries. We investigated the effect of preemptive infusion of omeprazole before endoscopy on the need for endoscopic therapy. METHODS: Consecutive patients admitted with upper gastrointestinal bleeding underwent stabilization and were then randomly assigned to receive either omeprazole or placebo (each as an 80-mg intravenous bolus followed by an 8-mg infusion per hour) before endoscopy the next morning. RESULTS: Over a 17-month period, 638 patients were enrolled and randomly assigned to omeprazole or placebo (319 in each group). The need for endoscopic treatment was lower in the omeprazole group than in the placebo group (60 of the 314 patients included in the analysis [19.1%] vs. 90 of 317 patients [28.4%], P=0.007). There were no significant differences between the omeprazole group and the placebo group in the mean amount of blood transfused (1.54 and 1.88 units, respectively; P=0.12) or the number of patients who had recurrent bleeding (11 and 8, P=0.49), who underwent emergency surgery (3 and 4, P=1.00), or who died within 30 days (8 and 7, P=0.78). The hospital stay was less than 3 days in 60.5% of patients in the omeprazole group, as compared with 49.2% in the placebo group (P=0.005). On endoscopy, fewer patients in the omeprazole group had actively bleeding ulcers (12 of 187, vs. 28 of 190 in the placebo group; P=0.01) and more omeprazole-treated patients had ulcers with clean bases (120 vs. 90, P=0.001). CONCLUSIONS: Infusion of high-dose omeprazole before endoscopy accelerated the resolution of signs of bleeding in ulcers and reduced the need for endoscopic therapy.	Chinese Univ Hong Kong, Inst Digest Dis, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Sch Pharm, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Lau, JY (corresponding author), Prince Wales Hosp, Dept Surg, 4th Fl,Clin Sci Bldg,32 Ngan Shing St, Shatin, Hong Kong, Peoples R China.	laujyw@surgery.cuhk.edu.hk	Wong, Vincent WS/K-3864-2014; Ng, Enders Kwok Wai/E-8276-2016; Chiu, Philip/A-4019-2009; Lee, Yeong Yeh/G-2470-2010; Lee, Vivian WY/B-9389-2008; Lee, Vivian WY/ABE-2416-2021; Sung, Joseph J. Y./R-3203-2018; Chiu, Philip/ABB-1454-2020; Wu, Justin/N-6916-2015; Lau, James Y. W./O-2612-2016; Leung, Wai Keung/B-8140-2011; Chan, Francis K. L./F-4851-2010	Wong, Vincent WS/0000-0003-2215-9410; Chiu, Philip/0000-0001-9292-112X; Lee, Yeong Yeh/0000-0002-6486-7717; Lee, Vivian WY/0000-0001-5802-8899; Lee, Vivian WY/0000-0001-5802-8899; Sung, Joseph J. Y./0000-0003-3125-5199; Chiu, Philip/0000-0001-9292-112X; Lau, James Y. W./0000-0003-0122-4068; Leung, Wai Keung/0000-0002-5993-1059; Chan, Francis K. L./0000-0001-7388-2436				Bardou M, 2005, ALIMENT PHARM THER, V21, P677, DOI 10.1111/j.1365-2036.2005.02391.x; Barkun A, 2003, ANN INTERN MED, V139, P843, DOI 10.7326/0003-4819-139-10-200311180-00012; DANESHMEND TK, 1992, BRIT MED J, V304, P143, DOI 10.1136/bmj.304.6820.143; Enns R, 2004, CAN J GASTROENTEROL, V18, P567, DOI 10.1155/2004/204968; GREEN FW, 1978, GASTROENTEROLOGY, V74, P38; Khuroo MS, 1997, NEW ENGL J MED, V336, P1054, DOI 10.1056/NEJM199704103361503; Labenz J, 1997, GUT, V40, P36, DOI 10.1136/gut.40.1.36; Lau JY, 2005, GASTROENTEROLOGY, V128, pA50; Lau JYW, 2000, NEW ENGL J MED, V343, P310, DOI 10.1056/NEJM200008033430501; Leontiadis GI, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002094.pub3; MORRIS JA, 1988, BRIT MED J, V296, P1313, DOI 10.1136/bmj.296.6632.1313; Palmer KR, 2002, GUT, V51, P1; ROCKALL TA, 1995, BRIT MED J, V311, P222, DOI 10.1136/bmj.311.6999.222; Sung J, 2006, GASTROENTEROLOGY, V130, pA44	14	196	221	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2007	356	16					1631	1640		10.1056/NEJMoa065703	http://dx.doi.org/10.1056/NEJMoa065703			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158AB	17442905				2022-12-28	WOS:000245762000005
J	Hodge, JG; Gostin, LO; Vernick, JS				Hodge, James G., Jr.; Gostin, Lawrence O.; Vernick, Jon S.			The pandemic and all-hazards preparedness act - Improving public health emergency response	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROFESSIONALS		Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Law & Publ Hlth, Baltimore, MD 21205 USA; Johns Hopkins Univ, Washington, DC USA; Johns Hopkins Univ, Baltimore, MD USA; Oneill Inst Natl & Global Hlth Law, Washington, DC USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Hodge, JG (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Law & Publ Hlth, 624 N Broadway,Hampton House Room 588, Baltimore, MD 21205 USA.	jhodge@jhsph.edu						Gostin LO, 2006, JAMA-J AM MED ASSOC, V295, P554, DOI 10.1001/jama.295.5.554; GOSTIN LO, IN PRESS PUBLIC HLTH; *HLTH RES SERV AG, 2006, EM SYST ADV REG VOL; Hodge JG, 2006, PUBLIC HEALTH REP, V121, P205, DOI 10.1177/003335490612100217; Hodge JG, 2005, BIOSECUR BIOTERROR, V3, P216, DOI 10.1089/bsp.2005.3.216; Hodge JG, 2004, J LAW MED ETHICS, V32, P670, DOI 10.1111/j.1748-720X.2004.tb01972.x; Institute of Medicine, 2002, FUT PUBL HLTH 21 CEN; THOMPSON AK, 2006, BMC MED ETHICS, V7, P1; *U NC SCH PUBL HLT, PUBL PRIV LEG PREP I; *US CDCP, BIOSENSE; US Department of Health and Human Services, HHS PAND INFL PLAN; *WHIT HOUS, 2006, FED RESP HURR KATR L, V58; *WHO DEP COMM DIS, 2005, WHO GLOB INFL PREP P; NATL RESPONSE PLAN	14	33	33	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2007	297	15					1708	1711		10.1001/jama.297.15.1708	http://dx.doi.org/10.1001/jama.297.15.1708			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	157UR	17440147				2022-12-28	WOS:000245747400024
J	Ferreira-Gonzalez, I; Busse, JW; Heels-Ansdell, D; Montori, VM; Akl, EA; Bryant, DM; Alonso, J; Jaeschke, R; Schunemann, HJ; Permanyer-Miralda, G; Domingo-Salvany, A; Guyatt, GH				Ferreira-Gonzalez, I.; Busse, J. W.; Heels-Ansdell, D.; Montori, V. M.; Akl, E. A.; Bryant, D. M.; Alonso, J.; Jaeschke, R.; Schuenemann, H. J.; Permanyer-Miralda, G.; Domingo-Salvany, A.; Guyatt, G. H.			Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials	BRITISH MEDICAL JOURNAL			English	Review							CLINICAL-TRIALS	Objective To explore the extent to which components of: composite end points in randomised controlled trials vary in importance to patients, the frequency of events in the more and less important components, and the extent of variability in the relative risk reductions across components. Design Systematic review of randomised controlled trials. Data sources Cardiovascular randomised controlled trials published in the Lancet, Annals of Internal Medicine, Circulation, European Heart Journal, JAMA, and New England Journal of Medicine, from 1 January 2002 to 30 June 2003. Component end points of composite end points were categorised according to importance to patients as fatal, critical, major, moderate, or minor. Results Of 114 identified randomised controlled trials that included a composite end point of importance to patients, 68% (n=77) reported complete component data for the primary composite end point; almost all (98%; n=112) primary composite end points included a fatal end point. Of 84 composite end points for which component data were available, 54% (n=45) showed large or moderate gradients in both importance to patients and magnitude of effect across components. When analysed by categories of importance to patients, the most important components were associated with lower event rates in the control group (medians of 3.3-3.7% for fatal, critical, and major outcomes; 12.3% for moderate outcomes; and 8.0% for minor outcomes). Components of greater importance to patients were associated with smaller treatment effects than less important ones (relative risk. reduction of 8% for death and 33% for components. of minor importance to patients). Conclusion The use of composite end points in cardiovascular trials is frequently complicated by large gradients in importance to patients and in magnitude of the effect of treatment across component end points. Higher event rates and larger treatment effects associated with less important components may result in misleading impressions of the impact of treatment.	McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; Univ Autonoma Barcelona, Dept Med, Barcelona 08035, Spain; Hosp Valle De Hebron, Barcelona 08035, Spain	McMaster University; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Busse, JW (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada.	j.busse@utoronto.ca	Akl, Elie/K-5269-2019; Akl, Elie A/R-2079-2016; Busse, Jason/CAH-3696-2022; Alonso, Jordi/A-5514-2010; Bryant, Dianne M/K-6766-2013	Akl, Elie A/0000-0002-3444-8618; Busse, Jason/0000-0002-0178-8712; Alonso, Jordi/0000-0001-8627-9636; Bryant, Dianne M/0000-0002-7535-8707; Domingo-Salvany, Antonia/0000-0003-3302-4538; Schunemann, Holger/0000-0003-3211-8479; Montori, Victor/0000-0003-0595-2898				BRAUNWALD E, 1992, CIRCULATION, V86, P683, DOI 10.1161/01.CIR.86.2.683; Cochrane Collaboration, 2006, COCHR HDB SYST REV I; DeMets DL, 2002, CIRCULATION, V106, P746, DOI 10.1161/01.CIR.0000023219.51483.66; FERREIRAGONZALE.I, IN PRESS J CLIN EPID; Freemantle N, 2003, JAMA-J AM MED ASSOC, V289, P2554, DOI 10.1001/jama.289.19.2554; Guyatt Gordon, 2004, ACP J Club, V140, pA11; HALLSTROM AP, 1992, CONTROL CLIN TRIALS, V13, P148, DOI 10.1016/0197-2456(92)90020-Z; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Lubsen J, 2002, STAT MED, V21, P2959, DOI 10.1002/sim.1300; Montori VM, 2005, BMJ-BRIT MED J, V330, P594, DOI 10.1136/bmj.330.7491.594; Moye L. A., 2003, MULTIPLE ANAL CLIN T; Neaton JD, 2005, J CARD FAIL, V11, P567, DOI 10.1016/j.cardfail.2005.08.350; Tengs TO, 2000, MED CARE, V38, P583, DOI 10.1097/00005650-200006000-00004; Waksman R, 2002, NEW ENGL J MED, V346, P1194, DOI 10.1056/NEJMoa012579	15	268	271	1	17	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 14	2007	334	7597					786	788A		10.1136/bmj.39136.682083.AE	http://dx.doi.org/10.1136/bmj.39136.682083.AE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	161SX	17403713	Green Published, Bronze			2022-12-28	WOS:000246037300029
J	Mukherjee, R; Eastman, N; Turk, J; Hollins, S				Mukherjee, Raja; Eastman, Nigel; Turk, Jeremy; Hollins, Sheila			Fetal alcohol syndrome: law and ethics	LANCET			English	Editorial Material									Bracketts Resource Ctr, Surrey Border Partnership Trust, Surrey RH8 0QA, England; Univ London, St Georges, Div Mental Hlth, London SW17 0RE, England; Univ London, St Georges, Div Clin Dev Sci, London SW17 0RE, England	St Georges University London; University of London; St Georges University London; University of London	Mukherjee, R (corresponding author), Bracketts Resource Ctr, Surrey Border Partnership Trust, Surrey RH8 0QA, England.	rmukherj@sgul.ac.uk		Mukherjee, Raja/0000-0002-2171-928X				ABEL EL, 1988, NEUROTOXICOL TERATOL, V10, P1, DOI 10.1016/0892-0362(88)90060-8; Armstrong EM, 1998, SOC SCI MED, V47, P2025, DOI 10.1016/S0277-9536(98)00308-6; GOVARGUE S, 1998, MED LAW REV, V6, P265; Kesmodel U, 2002, ALCOHOL CLIN EXP RES, V26, P1553, DOI 10.1097/01.ALC.0000034702.14322.25; May PA, 2007, DRUG ALCOHOL DEPEN, V88, P259, DOI 10.1016/j.drugalcdep.2006.11.007; NANSON JL, 1995, CAN MED ASSOC J, V152, P1071; *PRIM MIN STRAT GR, 2004, ALC HARM RED STRAT E; Sayal K, 2007, PEDIATRICS, V119, pE426, DOI 10.1542/peds.2006-1840; SMITH JC, 2002, HOGAN CRIMINAL LAW	9	9	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2007	369	9568					1149	1150		10.1016/S0140-6736(07)60542-X	http://dx.doi.org/10.1016/S0140-6736(07)60542-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	155RH	17416245				2022-12-28	WOS:000245595100008
J	Sims, EJ; Mugford, M; Clark, A; Aitken, D; McCormick, J; Mehta, G; Mehta, A				Sims, Erika J.; Mugford, Miranda; Clark, Allan; Aitken, David; McCormick, Jonathan; Mehta, Gita; Mehta, Anil		UK Cystic Fibrosis Database	Economic implications of newborn screening for cystic fibrosis: a cost of illness retrospective cohort study	LANCET			English	Article							CONTROLLED-TRIAL; DORNASE-ALPHA; LUNG-FUNCTION; DIAGNOSIS; BENEFITS; OUTCOMES	Background Newborn screening for cystic fibrosis might not be introduced if implementation and running costs are perceived as prohibitive. Compared with clinical diagnosis, newborn screening is associated with clinical benefit and reduced treatment needs. We estimate the potential savings in treatment costs attributable to newborn screening. Methods Using the UK Cystic Fibrosis Database, we used a prevalence strategy to undertake a cost of illness retrospective snapshot cohort study. We estimated yearly costs of long-term therapies and intravenous antibiotics for 184 patients who were diagnosed as a result of screening as newborn babies, and 950 patients who were clinically diagnosed aged 1-9 years in 2002. Costs of adding cystic fibrosis screening to an established newborn screening service in Scotland were adjusted to 2002 prices and applied to the UK as a whole. Costs were recalculated in US$. Findings Cost of therapy for patients diagnosed by newborn screening was significantly lower than equivalent therapies for clinically diagnosed patients: mean ($7228 vs $12008, 95% CI of difference -6736 to -2028, p < 0.0001) and median ($352 vs $2442, -1916 to -180, p < 0.0001). When we limited the clinically diagnosed group to only those diagnosable with a 31 cystic fibrosis transmembrane regulator mutation assay and assumed similar disease progression in the clinically diagnosed group as in the newborn screening group, we showed that mean ($3397 344) or median ($947 032) drug cost savings could have offset the estimated cost of adding cystic fibrosis to a UK national newborn screening service ($2 971551). Interpretation Including indirect costs savings, newborn screening for cystic fibrosis might have even greater financial benefits to society than our estimate shows. Clinical, social, and now economic evidence suggests that universal newborn screening programmes for cystic fibrosis should be adopted internationally.	Univ E Anglia, Hlth Econ Grp, Sch Med Hlth Policy & Practice, Sch Med, Norwich NR4 7TJ, Norfolk, England; Univ Dundee, UK Cyst Fibrosis Database, Div Maternal Child Hlth Sci, Ninewells Hosp, Dundee, Scotland; Univ Dundee, Sch Med, Dundee, Scotland; Univ E Anglia, Populat Hlth Grp, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Hlth Econ Grp, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; Inst Med Genet, Scottish Newborn Screening Lab, Glasgow, Lanark, Scotland; Royal Hosp Sick Children, Resp Unit, Yorkhill NHS Trust, Glasgow G3 8SJ, Lanark, Scotland	University of East Anglia; University of Dundee; University of Dundee; University of East Anglia; University of East Anglia; University of Glasgow; University of Glasgow	Sims, EJ (corresponding author), Univ E Anglia, Hlth Econ Grp, Sch Med Hlth Policy & Practice, Sch Med, Norwich NR4 7TJ, Norfolk, England.	e.sims@uea.ac.uk		Clark, Allan/0000-0003-2965-8941				[Anonymous], 1997, MMWR Recomm Rep, V46, P1; *BRIT MED ASS, 2002, BRIT NAT FORM; Farrell PM, 2003, AM J RESP CRIT CARE, V168, P1100, DOI 10.1164/rccm.200303-434OC; Farrell PM, 1997, NEW ENGL J MED, V337, P963, DOI 10.1056/NEJM199710023371403; Farrell PM, 2001, PEDIATRICS, V107, P1, DOI 10.1542/peds.107.1.1; FARRELL PM, 1997, PEDIATRICS, V100, P2; HALL P, 1991, BIOMETRICS, V47, P757, DOI 10.2307/2532163; Hamosh A, 1998, J PEDIATR-US, V132, P255, DOI 10.1016/S0022-3476(98)70441-X; Lee DS, 2003, J PEDIATR-US, V142, P617, DOI 10.1067/mpd.2003.209; LITTLEWOOD J, 2002, ANTIBIOTIC TREATMENT; Mastella G, 2001, PANCREATOLOGY, V1, P531, DOI 10.1159/000055856; McCabe ERB, 1999, ACTA PAEDIATR, V88, P58, DOI 10.1080/080352599750029402; McCormick J, 2002, EUR J HUM GENET, V10, P583, DOI 10.1038/sj.ejhg.5200850; McCormick Jonathan, 2005, J Cyst Fibros, V4, P53, DOI 10.1016/j.jcf.2004.11.003; Mehta A, 2001, LANCET, V358, P1546, DOI 10.1016/S0140-6736(01)06593-X; Mehta G, 2004, J ROY SOC MED, V97, P60; *NO IR STAT RES AG, 2002, 81 ANN NO IR STAT RE; *OFF NAT STAT, BIRTH STAT 2002; *ORG EC COOP DEV, PURCH POW PAR OECD C; *ORG EC COOP DEV, CONS PRIC IND IND HL; Paul K, 2004, AM J RESP CRIT CARE, V169, P719, DOI 10.1164/rccm.200307-959OC; POLLITT RJ, 1997, HEALTH TECHNOL ASSES, V1, pI202; Quan JM, 2001, J PEDIATR-US, V139, P813, DOI 10.1067/mpd.2001.118570; RANDALL J, SCOTLANDS POPULATION; Rosenberg MA, 2005, J PEDIATR-US, V147, pS101, DOI 10.1016/j.jpeds.2005.08.018; Simpson Neil, 2005, Cost Eff Resour Alloc, V3, P8, DOI 10.1186/1478-7547-3-8; Sims EJ, 2005, J PEDIATR-US, V147, pS42, DOI 10.1016/j.jpeds.2005.08.002; Sims EJ, 2005, J PEDIATR-US, V147, P306, DOI 10.1016/j.jpeds.2005.05.034; Sims EJ, 2005, DIABETES CARE, V28, P1581, DOI 10.2337/diacare.28.7.1581; Sims EJ, 2007, PEDIATRICS, V119, P19, DOI 10.1542/peds.2006-1498; Siret D, 2003, PEDIATR PULM, V35, P342, DOI 10.1002/ppul.10259; Smyth A, 2005, LANCET, V365, P573, DOI 10.1016/S0140-6736(05)17906-9; *UK NAT STAT, 2005, CONS PRIC IND IND 06; *US C OFF TECHN AS, 1992, CYST FIBR DNA TESTS; Waters DL, 1999, ARCH DIS CHILD-FETAL, V80, pF1, DOI 10.1136/fn.80.1.F1; Zielenski J, 2000, RESPIRATION, V67, P117, DOI 10.1159/000029497	36	70	71	1	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2007	369	9568					1187	1195		10.1016/S0140-6736(07)60565-0	http://dx.doi.org/10.1016/S0140-6736(07)60565-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	155RH	17416263				2022-12-28	WOS:000245595100030
J	Serre, C; Mellot-Draznieks, C; Surble, S; Audebrand, N; Filinchuk, Y; Ferey, G				Serre, C.; Mellot-Draznieks, C.; Surble, S.; Audebrand, N.; Filinchuk, Y.; Ferey, G.			Role of solvent-host interactions that lead to very large swelling of hybrid frameworks	SCIENCE			English	Article							COORDINATION POLYMERS; PORES	An unusually large expansion upon solvent adsorption occurs without apparent bond breaking in the network of a series of isoreticular chromium(III) or iron(III) diarboxylates labeled MIL-88A to D [dicarbox = fumarate (88A); terephthalate (1,4-BDC) (88B); 2,6-naphthalenedicarboxylate (2,6-NDC) (88C); and 4-4'-biphenyldicarboxylate (4-4'-BPDC) (88D)]. This reversible "breathing" motion was analyzed in terms of cell dimensions (extent of breathing), movements within the framework (mechanism of transformation), and the interactions between the guests and the skeleton. In situ techniques show that these flexible solids are highly selective absorbents and that this selectivity is strongly dependent on the nature of the organic linker.	Univ Versailles, CNRS, UMR 8180, Inst Lavoiser, F-78035 Versailles, France; UCL Royal Inst Great Britain, London W1S 4BS, England; Univ Rennes 1, CNRS, UMR 6226, F-35042 Rennes, France; European Synchrotron Radiat Facil, Swiss Norwegian Beamlines, F-38043 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Rennes; European Synchrotron Radiation Facility (ESRF)	Serre, C (corresponding author), Univ Versailles, CNRS, UMR 8180, Inst Lavoiser, 45 Ave Etats Unis, F-78035 Versailles, France.	serre@chimie.uvsq.fr	Surblé, Suzy/B-5652-2014; Serre, Christian/AAJ-3990-2020	Surblé, Suzy/0000-0001-6228-5919; Serre, Christian/0000-0003-3040-2564				Barthelet K, 2002, ANGEW CHEM INT EDIT, V41, P281, DOI 10.1002/1521-3773(20020118)41:2<281::AID-ANIE281>3.0.CO;2-Y; Ferey G, 2004, ANGEW CHEM INT EDIT, V43, P6296, DOI 10.1002/anie.200460592; Ferey G, 2005, SCIENCE, V309, P2040, DOI 10.1126/science.1116275; Fletcher AJ, 2005, J SOLID STATE CHEM, V178, P2491, DOI 10.1016/j.jssc.2005.05.019; Kitagawa S, 2005, CHEM SOC REV, V34, P109, DOI 10.1039/b313997m; Mellot-Draznieks C, 2004, ANGEW CHEM INT EDIT, V43, P6290, DOI 10.1002/anie.200454251; Mellot-Draznieks C, 2005, J AM CHEM SOC, V127, P16273, DOI 10.1021/ja054900x; Serre C, 2004, ANGEW CHEM INT EDIT, V43, P6286, DOI 10.1002/anie.200454250; Serre C, 2002, J AM CHEM SOC, V124, P13519, DOI 10.1021/ja0276974; Surble S, 2006, CHEM COMMUN, P284, DOI 10.1039/b512169h; Uemura K, 2005, J SOLID STATE CHEM, V178, P2420, DOI 10.1016/j.jssc.2005.05.036	11	788	803	31	580	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2007	315	5820					1828	1831		10.1126/science.1137975	http://dx.doi.org/10.1126/science.1137975			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151HC	17395825				2022-12-28	WOS:000245280100038
J	Shim, JH; Haule, K; Kotliar, G				Shim, J. H.; Haule, K.; Kotliar, G.			Fluctuating valence in a correlated solid and the anomalous properties of delta-plutonium	NATURE			English	Article							MEAN-FIELD THEORY; ELECTRONIC-STRUCTURE; MAGNETIC-SUSCEPTIBILITY; MOMENT; METAL; PU	Although the nuclear properties of the late actinides ( plutonium, americium and curium) are fully understood and widely applied to energy generation, their solid-state properties do not fit within standard models and are the subject of active research 1. Plutonium displays phases with enormous volume differences, and both its Pauli-like magnetic susceptibility and resistivity are an order of magnitude larger than those of simple metals 2. Curium is also highly resistive, but its susceptibility is Curie-like at high temperatures and orders antiferromagnetically 3 at low temperatures. The anomalous properties of the late actinides stem from the competition between itinerancy and localization of their f-shell electrons, which makes these elements strongly correlated materials. A central problem in this field is to understand the mechanism by which these conflicting tendencies are resolved in such materials. Here we identify the electronic mechanisms responsible for the anomalous behaviour of late actinides, revisiting the concept of valence using a theoretical approach that treats magnetism, Kondo screening, atomic multiplet effects and crystal field splitting on the same footing. We find that the ground state in plutonium is a quantum superposition of two distinct atomic valences, whereas curium settles into a magnetically ordered single valence state at low temperatures. The f(7) configuration of curium is contrasted with the multiple valences of the plutonium ground state, which we characterize by a valence histogram. The balance between the Kondo screening and magnetism is controlled by the competition between spin-orbit coupling, the strength of atomic multiplets and the degree of itinerancy. Our approach highlights the electronic origin of the bonding anomalies in plutonium, and can be applied to predict generalized valences and the presence or absence of magnetism in other compounds starting from first principles.	Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; Rutgers State Univ, Ctr Condensed Matter, Piscataway, NJ 08854 USA; Rutgers State Univ, Ctr Condensed Matter Theory, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Haule, K (corresponding author), Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA.	haule@physics.rutgers.edu	Shim, Ji Hoon/F-5375-2013	Haule, Kristjan/0000-0002-2284-1551				Arko AJ, 2000, PHYS REV B, V62, P1773, DOI 10.1103/PhysRevB.62.1773; BRODSKY MB, 1978, REP PROG PHYS, V41, P1547, DOI 10.1088/0034-4885/41/10/001; COWAN RD, 1981, THEORY ATOMIC SPECTR; Georges A, 1996, REV MOD PHYS, V68, P13, DOI 10.1103/RevModPhys.68.13; Gouder T, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.165101; GOUNDER T, 2001, EUROPHYS LETT, V55, P705; HAULE K, 2006, HTTPARXIVORGCONDMAT0; HURAY PG, 1980, PHYSICA B & C, V102, P217, DOI 10.1016/0378-4363(80)90160-6; KANELLAKOPULOS B, 1975, SOLID STATE COMMUN, V17, P713, DOI 10.1016/0038-1098(75)90392-0; Kotliar G, 2006, REV MOD PHYS, V78, P865, DOI 10.1103/RevModPhys.78.865; Lander GH, 2003, SCIENCE, V301, P1057, DOI 10.1126/science.1088510; Lashley JC, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.054416; Lashley JC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.205901; Moore KT, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.033109; Moore KT, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.196404; Pourovskii LV, 2006, EUROPHYS LETT, V74, P479, DOI 10.1209/epl/i2005-10548-5; Savrasov SY, 2001, NATURE, V410, P793, DOI 10.1038/35071035; Savrasov SY, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.036404; Shick AB, 2005, EUROPHYS LETT, V69, P588, DOI 10.1209/epl/i2004-10380-5; Shorikov AO, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.024458; SOLOVYEV IV, 1991, PHYS REV B, V43, P14414, DOI 10.1103/PhysRevB.43.14414; SVANE A, 2006, HTTPARXIVORGCONDMAT0; THOLE BT, 1988, PHYS REV A, V38, P1943, DOI 10.1103/PhysRevA.38.1943; Tobin JG, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.085109; Tobin JG, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.155109; van der Laan G, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.097401; VARMA CM, 1976, REV MOD PHYS, V48, P219, DOI 10.1103/RevModPhys.48.219; Werner P, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.076405; Wills JM, 2004, J ELECTRON SPECTROSC, V135, P163, DOI 10.1016/j.elspec.2004.02.169	30	221	223	3	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2007	446	7135					513	516		10.1038/nature05647	http://dx.doi.org/10.1038/nature05647			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	150TQ	17392780	Green Submitted			2022-12-28	WOS:000245242900043
J	Skalli, W; Dubousset, J				Skalli, Wafa; Dubousset, Jean			Intervertebral disc transplantation	LANCET			English	Editorial Material							ARTIFICIAL DISC; FOLLOW-UP		CNRS, ENSAM, Biomech Lab, F-75013 Paris, France	Arts et Metiers Institute of Technology; Centre National de la Recherche Scientifique (CNRS); heSam Universite; Conservatoire National Arts & Metiers (CNAM)	Skalli, W (corresponding author), CNRS, ENSAM, Biomech Lab, F-75013 Paris, France.	wafa.skalli@paris.ensam.fr						ALI ES, 2006, EUR SPINE J, V21, P1; Champain S, 2006, EUR SPINE J, V15, P982, DOI 10.1007/s00586-005-0927-1; Lemaire JP, 2005, J SPINAL DISORD TECH, V18, P353, DOI 10.1097/01.bsd.0000172361.07479.6b; Lin EL, 2006, J AM ACAD ORTHOP SUR, V14, P705, DOI 10.5435/00124635-200612000-00002; Mehren C, 2006, SPINE, V31, P2802, DOI 10.1097/01.brs.0000245852.70594.d5; O'Halloran DM, 2007, TISSUE ENG, V13, P1927, DOI 10.1089/ten.2005.0608; Rajasekaran S, 2007, J MAGN RESON IMAGING, V25, P410, DOI 10.1002/jmri.20853; Ruan DK, 2007, LANCET, V369, P993, DOI 10.1016/S0140-6736(07)60496-6; Schwab F, 2006, SPINE, V31, pE959, DOI 10.1097/01.brs.0000248126.96737.0f; Shasha N, 2003, J BONE JOINT SURG AM, V85A, P33, DOI 10.2106/00004623-200300002-00005; Yue WM, 2005, SPINE, V30, P2138, DOI 10.1097/01.brs.0000180479.63092.17	11	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2007	369	9566					968	969		10.1016/S0140-6736(07)60469-3	http://dx.doi.org/10.1016/S0140-6736(07)60469-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151JO	17382805				2022-12-28	WOS:000245286500005
J	Pang, CL				Pang, Ching Ling			A code of ethics for scientists	LANCET			English	Editorial Material									Univ Oxford St Hildas Coll, Oxford OX4 1DY, England	University of Oxford	Pang, CL (corresponding author), Univ Oxford St Hildas Coll, Oxford OX4 1DY, England.	ching.pang@st-hildas.ox.ac.uk						*AAAS, 2007, PROF ETH REP; *DEP TRAD IND, 2007, RIG RESP RESP UN ETH; Lombardo PA, 2006, B HIST MED, V80, P291, DOI 10.1353/bhm.2006.0066	3	1	1	2	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR-APR	2007	369	9567					1068	1068		10.1016/S0140-6736(07)60507-8	http://dx.doi.org/10.1016/S0140-6736(07)60507-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	151XF	17398294				2022-12-28	WOS:000245323700011
J	Braithwaite, RS; Roberts, MS; Justice, AC				Braithwaite, R. Scott; Roberts, Mark S.; Justice, Amy C.			Incorporating quality of evidence into decision analytic modeling	ANNALS OF INTERNAL MEDICINE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; COST-EFFECTIVENESS ANALYSIS; SELF-ADMINISTERED THERAPY; INFECTED DRUG-USERS; HIV-INFECTION; ADHERENCE; WOMEN; TUBERCULOSIS; METAANALYSIS; UNCERTAINTY	Our objective was to illustrate the effects of using stricter standards for the quality of evidence used in decision analytic modeling. We created a simple 10-parameter probabilistic Markov model to estimate the cost-effectiveness of directly observed therapy (DOT) for individuals with newly diagnosed HIV infection. We evaluated quality of evidence on the basis of U.S. Preventive Services Task Force methods, which specified 3 separate domains: study design, internal validity, and external validity. We varied the evidence criteria for each of these domains individually and collectively. We used published research as a source of data only if the quality of the research met specified criteria; otherwise, we specified the parameter by randomly choosing a number from a range within which every number has the same probability of being selected (a uniform distribution). When we did not eliminate poor-quality evidence, DOT improved health 99% of the time and cost less than $100 000 per additional quality-adjusted life-year (QALY) 85% of the time. The confidence ellipse was extremely narrow, suggesting high precision. When we used the most rigorous standards of evidence, we could use fewer than one fifth of the data sources, and DOT improved health only 49% of the time and cost less than $100 000 per additional QALY only 4% of the time. The confidence ellipse became much larger, showing that the results were less precise. We conclude that the results of decision modeling may vary dramatically depending on the stringency of the criteria for selecting evidence to use in the model.	Yale Univ, Sch Med, Vet Affairs Connecticut Healthcare Syst, West Haven, CT 06516 USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Braithwaite, RS (corresponding author), Yale Univ, Sch Med, Vet Affairs Connecticut Healthcare Syst, Mailstop 11 ACSLG,950 Campbell Ave, West Haven, CT 06516 USA.	ronald.braithwaite@va.gov		Braithwaite, Ronald Scott/0000-0001-7067-3655	NIAAA NIH HHS [K23 AA14483-01] Funding Source: Medline; NIAAA NIH HHS [U24 AA020794, K23 AA14483-01, K23 AA014483] Funding Source: Medline	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Altice FL, 2004, CLIN INFECT DIS, V38, pS376, DOI 10.1086/421400; Anderson K, 2006, ANN INTERN MED, V144, P397, DOI 10.7326/0003-4819-144-6-200603210-00006; Arias Elizabeth, 2004, Natl Vital Stat Rep, V53, P1; Arnsten JH, 2002, J GEN INTERN MED, V17, P377, DOI 10.1007/s11606-002-0044-3; Bozzette SA, 2001, NEW ENGL J MED, V344, P817, DOI 10.1056/NEJM200103153441107; Braithwaite RS, 2006, J ANTIMICROB CHEMOTH, V58, P1036, DOI 10.1093/jac/dkl386; Braithwaite RS, 2005, AM J MED, V118, P890, DOI 10.1016/j.amjmed.2004.12.034; BRAITHWAITE RS, IN PRESS VALUE HLTH; Burman WJ, 1997, CHEST, V112, P63, DOI 10.1378/chest.112.1.63; Burstrom K, 2001, QUAL LIFE RES, V10, P621, DOI 10.1023/A:1013171831202; Claxton K, 2005, HEALTH ECON, V14, P339, DOI 10.1002/hec.985; *COCHR COLL, 2002, REV MAN 4 2 WIND; Cooper NJ, 2002, STAT METHODS MED RES, V11, P491, DOI 10.1191/0962280202sm306ra; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; EDDY DM, 1990, MED DECIS MAKING, V10, P15, DOI 10.1177/0272989X9001000104; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Enger C, 1996, JAMA-J AM MED ASSOC, V275, P1329, DOI 10.1001/jama.275.17.1329; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Freedberg KA, 1998, JAMA-J AM MED ASSOC, V279, P130, DOI 10.1001/jama.279.2.130; Gold MR, 1996, COST EFFECTIVENESS H; Goldie SJ, 2003, AM J MED, V115, P632, DOI 10.1016/j.amjmed.2003.07.007; Greenland S, 2005, J R STAT SOC A STAT, V168, P267, DOI 10.1111/j.1467-985X.2004.00349.x; Guyatt GH, 2000, JAMA-J AM MED ASSOC, V284, P1290, DOI 10.1001/jama.284.10.1290; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Haubrich RH, 1999, AIDS, V13, P1099, DOI 10.1097/00002030-199906180-00014; Howard AA, 2002, AIDS, V16, P2175, DOI 10.1097/00002030-200211080-00010; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kanis JA, 2004, OSTEOPOROSIS INT, V15, P20, DOI 10.1007/s00198-003-1463-7; Leibson CL, 2002, J AM GERIATR SOC, V50, P1644, DOI 10.1046/j.1532-5415.2002.50455.x; Lohr KN, 2004, INT J QUAL HEALTH C, V16, P9, DOI 10.1093/intqhc/mzh005; Moore RD, 1996, AM J RESP CRIT CARE, V154, P1013, DOI 10.1164/ajrccm.154.4.8887600; Neumann PJ, 2004, AM J MANAG CARE, V10, P308; Palmer C S, 1998, J Public Health Manag Pract, V4, P1; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Schousboe JT, 2005, ANN INTERN MED, V142, P734, DOI 10.7326/0003-4819-142-9-200505030-00008; Spiegelhalter DJ, 2003, STAT MED, V22, P3687, DOI 10.1002/sim.1586	38	54	54	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2007	146	2					133	141		10.7326/0003-4819-146-2-200701160-00008	http://dx.doi.org/10.7326/0003-4819-146-2-200701160-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131WF	17227937	Green Accepted			2022-12-28	WOS:000243901000007
J	Strandberg, TE; Pitkala, KH				Strandberg, Timo E.; Pitkala, Kaisu H.			Frailty in elderly people	LANCET			English	Editorial Material							OLDER-ADULTS; CATABOLISM; HEALTH		Univ Oulu, FIN-90014 Oulu, Finland; Univ Helsinki, Helsinki, Finland	University of Oulu; University of Helsinki	Strandberg, TE (corresponding author), Univ Oulu, FIN-90014 Oulu, Finland.	timo.strandberg@oulu.fi		young, john/0000-0003-4085-9306; Pitkala, Kaisu/0000-0001-9659-6985; Iliffe, Stephen/0000-0003-2806-3997; Clegg, Andrew/0000-0001-5972-1097	The Dunhill Medical Trust [RCP/DMT 2ND ROUND (2)] Funding Source: Medline	The Dunhill Medical Trust(Dunhill Medical Trust)		Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Boockvar KS, 2006, JAMA-J AM MED ASSOC, V296, P2245, DOI 10.1001/jama.296.18.2245; Drachman DA, 2006, NEUROLOGY, V67, P1340, DOI 10.1212/01.wnl.0000240127.89601.83; Ferrucci L, 2002, J Endocrinol Invest, V25, P10; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Morley JE, 2006, MED CLIN N AM, V90, P837, DOI 10.1016/j.mcna.2006.05.019; Newman AB, 2001, J GERONTOL A-BIOL, V56, pM158, DOI 10.1093/gerona/56.3.M158; Omwancha J, 2006, CURR OPIN INVEST DR, V7, P873; Ozaki A, 2007, J AM GERIATR SOC, V55, P95, DOI 10.1111/j.1532-5415.2006.01019.x; Purser JL, 2006, J AM GERIATR SOC, V54, P1674, DOI 10.1111/j.1532-5415.2006.00914.x; Roubenoff R, 2003, CURR OPIN CLIN NUTR, V6, P295, DOI 10.1097/01.mco.0000068965.34812.62; Sanders PM, 2005, BRIT J CANCER, V93, P425, DOI 10.1038/sj.bjc.6602725; Sullivan DH, 2007, J AM GERIATR SOC, V55, P20, DOI 10.1111/j.1532-5415.2006.01010.x	14	1175	1254	5	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2007	369	9570					1328	1329		10.1016/S0140-6736(07)60613-8	http://dx.doi.org/10.1016/S0140-6736(07)60613-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	159HL	23395245				2022-12-28	WOS:000245856100009
